PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Fujiwara, T; Ikeda, T; Nagasaka, Y; Okitsu, Y; Katsuoka, Y; Fukuhara, N; Onishi, Y; Ishizawa, K; Ichinohasama, R; Tomosugi, N; Harigae, H				Fujiwara, Tohru; Ikeda, Takashi; Nagasaka, Yuki; Okitsu, Yoko; Katsuoka, Yuna; Fukuhara, Noriko; Onishi, Yasushi; Ishizawa, Kenichi; Ichinohasama, Ryo; Tomosugi, Naohisa; Harigae, Hideo			A Low-Molecular-Weight Compound K7174 Represses Hepcidin: Possible Therapeutic Strategy against Anemia of Chronic Disease	PLOS ONE			English	Article							INHIBITOR K-7174; IRON; INFLAMMATION; EXPRESSION; FERROPORTIN; INDUCTION; BINDING; GENE	Hepcidin is the principal iron regulatory hormone, controlling the systemic absorption and remobilization of iron from intracellular stores. The expression of the hepcidin gene, HAMP, is increased in patients with anemia of chronic disease. Previously, the synthetic compound K7174 was identified through chemical screening as a novel inhibitor of the adhesion of monocytes to cytokine-stimulated endothelial cells. K7174 also ameliorated anemia induced by inflammatory cytokines in mice, which suggests a possible involvement of hepcidin regulation. The present study was performed to assess the impact of K7174 on hepcidin expression in a human hematoma cell line and in mice in vivo. We first demonstrated that K7174 treatment in HepG2 cells significantly decreased HAMP expression. Then, we conducted microarray analysis to determine the molecular mechanism by which K7174 inhibits HAMP expression. Transcriptional profiling confirmed the downregulation of HAMP. Surprisingly, we found that K7174 strongly induced GDF15, known as a negative regulator of HAMP expression. Western blotting analysis as well as ELISA confirmed the induction of GDF15 by K7174 treatment. Furthermore, K7174-mediated HAMP suppression was rescued by the silencing of GDF15 expression. Interestingly, we found that K7174 also upregulates CEBPB. Promoter analysis and chromatin immunoprecipitation analysis revealed that CEBPB could contribute to K7174-mediated transcriptional activation of GDF15. Subsequently, we also examined whether K7174 inhibits hepcidin expression in mice. Quantitative RT-PCR analysis with liver samples from K7174-treated mice demonstrated significant upregulation of Gdf15 and downregulation of Hamp expression, as compared to control mice. Furthermore, serum hepcidin concentration was also significantly decreased in K7174-treated mice. In conclusion, K7174 inhibits hepcidin expression partly by inducing GDF15. K-7174 may be a potential therapeutic option to treat anemia of chronic disease.	[Fujiwara, Tohru; Ikeda, Takashi; Nagasaka, Yuki; Okitsu, Yoko; Katsuoka, Yuna; Fukuhara, Noriko; Onishi, Yasushi; Ishizawa, Kenichi; Harigae, Hideo] Tohoku Univ, Grad Sch, Dept Hematol & Rheumatol, Sendai, Miyagi 980, Japan; [Fujiwara, Tohru; Ichinohasama, Ryo; Harigae, Hideo] Tohoku Univ, Grad Sch, Sendai, Miyagi 980, Japan; [Ishizawa, Kenichi] Tohoku Univ Hosp, Clin Res Innovat & Educ Ctr, Sendai, Miyagi, Japan; [Tomosugi, Naohisa] Kanazawa Med Coll, Med Res Inst, Div Adv Med, Aging Res Unit, Kanazawa, Ishikawa, Japan	Tohoku University; Tohoku University; Tohoku University; Kanazawa Medical University	Fujiwara, T (corresponding author), Tohoku Univ, Grad Sch, Dept Hematol & Rheumatol, Sendai, Miyagi 980, Japan.	fujiwara-to@apple.email.ne.jp	Fujiwara, Tohru/GOG-9775-2022		Japan Society of the Promotion Science	Japan Society of the Promotion Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The research was supported by Japan Society of the Promotion Science (http://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NC, 2004, J CLIN INVEST, V113, P1251, DOI 10.1172/JCI200421441; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Finberg KE, 2013, CURR OPIN HEMATOL, V20, P208, DOI 10.1097/MOH.0b013e32835f5a47; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Fujiwara T, 2013, EXP HEMATOL, V41, P303, DOI 10.1016/j.exphem.2012.10.015; Fujiwara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040959; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Hattori A, 2012, BLOOD CELL MOL DIS, V48, P179, DOI 10.1016/j.bcmd.2012.01.002; Hayakawa K, 2010, J AM SOC NEPHROL, V21, P73, DOI 10.1681/ASN.2009040432; Imagawa S, 2003, FASEB J, V17, P1742, DOI 10.1096/fj.02-1134fje; Island ML, 2011, BIOCHEM J, V437, P477, DOI 10.1042/BJ20110225; Lee SH, 2010, CARCINOGENESIS, V31, P719, DOI 10.1093/carcin/bgq016; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Nakano Y, 2004, BLOOD, V104, P4300, DOI 10.1182/blood-2004-04-1631; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Rizzo JD, 2010, BLOOD, V116, P4045, DOI 10.1182/blood-2010-08-300541; Shimada T, 2007, BIOCHEM BIOPH RES CO, V363, P355, DOI 10.1016/j.bbrc.2007.08.167; Shimizu S, 2013, BIOCHEM BIOPH RES CO, V430, P1277, DOI 10.1016/j.bbrc.2012.11.137; Solomon SD, 2010, NEW ENGL J MED, V363, P1146, DOI 10.1056/NEJMoa1005109; Steinbicker AU, 2011, BLOOD, V117, P4915, DOI 10.1182/blood-2010-10-313064; Sun CC, 2012, AM J HEMATOL, V87, P392, DOI 10.1002/ajh.23110; Takano Y, 2007, BIOCHEM BIOPH RES CO, V360, P470, DOI 10.1016/j.bbrc.2007.06.082; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Theurl I, 2011, BLOOD, V118, P4977, DOI 10.1182/blood-2011-03-345066; Umetani M, 2000, BIOCHEM BIOPH RES CO, V272, P370, DOI 10.1006/bbrc.2000.2784; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Zhang AS, 2009, J BIOL CHEM, V284, P22580, DOI 10.1074/jbc.M109.027318	30	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75568	10.1371/journal.pone.0075568	http://dx.doi.org/10.1371/journal.pone.0075568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086573	Green Published, Green Submitted, gold			2022-12-27	WOS:000325223900047
J	Ishiga, Y; Ishiga, T; Uppalapati, SR; Mysore, KS				Ishiga, Yasuhiro; Ishiga, Takako; Uppalapati, Srinivasa Rao; Mysore, Kirankumar S.			Jasmonate ZIM-Domain (JAZ) Protein Regulates Host and Nonhost Pathogen-Induced Cell Death in Tomato and Nicotiana benthamiana	PLOS ONE			English	Article							SYRINGAE PV. TOMATO; PSEUDOMONAS-SYRINGAE; PHYTOTOXIN CORONATINE; SYMPTOM DEVELOPMENT; DEFENSE RESPONSES; METHYL JASMONATE; GENE-EXPRESSION; ARABIDOPSIS; RESISTANCE; DISEASE	The nonhost-specific phytotoxin coronatine (COR) produced by several pathovars of Pseudomonas syringae functions as a jasmonic acid-isoleucine (JA-Ile) mimic and contributes to disease development by suppressing plant defense responses and inducing reactive oxygen species in chloroplast. It has been shown that the F-box protein CORONATINE INSENSITIVE 1 (COI1) is the receptor for COR and JA-Ile. JASMONATE ZIM DOMAIN (JAZ) proteins act as negative regulators for JA signaling in Arabidopsis. However, the physiological significance of JAZ proteins in P. syringae disease development and nonhost pathogen-induced hypersensitive response (HR) cell death is not completely understood. In this study, we identified JAZ genes from tomato, a host plant for P. syringae pv. tomato DC3000 (Pst DC3000), and examined their expression profiles in response to COR and pathogens. Most JAZ genes were induced by COR treatment or inoculation with COR-producing Pst DC3000, but not by the COR-defective mutant DB29. Tomato SlJAZ2, SlJAZ6 and SlJAZ7 interacted with SlCOI1 in a COR-dependent manner. Using virus-induced gene silencing (VIGS), we demonstrated that SlJAZ2, SlJAZ6 and SlJAZ7 have no effect on COR-induced chlorosis in tomato and Nicotiana benthamiana. However, SlJAZ2-, SlJAZ6- and SlJAZ7-silenced tomato plants showed enhanced disease-associated cell death to Pst DC3000. Furthermore, we found delayed HR cell death in response to the nonhost pathogen Pst T1 or a pathogen-associated molecular pattern (PAMP), INF1, in SlJAZ2- and SlJAZ6-silenced N. benthamiana. These results suggest that tomato JAZ proteins regulate the progression of cell death during host and nonhost interactions.	[Ishiga, Yasuhiro; Ishiga, Takako; Uppalapati, Srinivasa Rao; Mysore, Kirankumar S.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA	Noble Research Institute	Ishiga, Y (corresponding author), Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA.	yishiga@noble.org; ksmysore@noble.org	Ishiga, Yasuhiro/H-3814-2011; Mysore, Kirankumar/AAG-7112-2020; Ishiga, Yasuhiro/L-2987-2017	Ishiga, Yasuhiro/0000-0001-8871-8882; Mysore, Kirankumar/0000-0002-9805-5741; Ishiga, Yasuhiro/0000-0002-4449-3498	Samuel Roberts Noble Foundation	Samuel Roberts Noble Foundation	This work was funded by the Samuel Roberts Noble Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Brooks DM, 2004, MOL PLANT MICROBE IN, V17, P162, DOI 10.1094/MPMI.2004.17.2.162; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Chung HS, 2009, PHYTOCHEMISTRY, V70, P1547, DOI 10.1016/j.phytochem.2009.08.022; Demianski AJ, 2012, MOL PLANT PATHOL, V13, P46, DOI 10.1111/j.1364-3703.2011.00727.x; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Ishiga Y, 2009, NEW PHYTOL, V181, P147, DOI 10.1111/j.1469-8137.2008.02639.x; Ishiga Y, 2012, MOL PLANT MICROBE IN, V25, P294, DOI 10.1094/MPMI-05-11-0130; Ishiga Y, 2010, J GEN PLANT PATHOL, V76, P188, DOI 10.1007/s10327-010-0228-3; Ishiga Y, 2009, PLANT SIGNAL BEHAV, V4, P237, DOI 10.4161/psb.4.3.7915; Katou S, 2005, PLANT PHYSIOL, V139, P1914, DOI 10.1104/pp.105.066795; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; KEANE PJ, 1970, AUST J BIOL SCI, V23, P585, DOI 10.1071/BI9700585; Kloek AP, 2001, PLANT J, V26, P509, DOI 10.1046/j.1365-313x.2001.01050.x; Laurie-Berry N, 2006, MOL PLANT MICROBE IN, V19, P789, DOI 10.1094/MPMI-19-0789; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Moreno JE, 2013, PLANT PHYSIOL, V162, P1006, DOI 10.1104/pp.113.218164; Oh Y, 2012, PLANT PHYSIOL, V159, P769, DOI 10.1104/pp.112.193771; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Ryu CM, 2004, PLANT J, V40, P322, DOI 10.1111/j.1365-313X.2004.02211.x; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Sun JQ, 2011, MOL PLANT, V4, P607, DOI 10.1093/mp/ssr008; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Uppalapati SR, 2005, PLANT J, V42, P201, DOI 10.1111/j.1365-313X.2005.02366.x; Uppalapati SR, 2008, MOL PLANT MICROBE IN, V21, P383, DOI 10.1094/MPMI-21-4-0383; Uppalapati SR, 2007, MOL PLANT MICROBE IN, V20, P955, DOI 10.1094/MPMI-20-8-0955; Uppalapati SR, 2011, NEW PHYTOL, V189, P83, DOI 10.1111/j.1469-8137.2010.03470.x; Wangdi T, 2010, PLANT PHYSIOL, V152, P281, DOI 10.1104/pp.109.148106; WEILER EW, 1994, FEBS LETT, V345, P9, DOI 10.1016/0014-5793(94)00411-0; Yamada S, 2012, PLANT CELL PHYSIOL, V53, P2060, DOI 10.1093/pcp/pcs145; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Zhao YF, 2003, PLANT J, V36, P485, DOI 10.1046/j.1365-313X.2003.01895.x	35	38	42	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75728	10.1371/journal.pone.0075728	http://dx.doi.org/10.1371/journal.pone.0075728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086622	Green Submitted, Green Published, gold			2022-12-27	WOS:000325223900061
J	Bunda, S; Kommaraju, K; Heir, P; Ohh, M				Bunda, Severa; Kommaraju, Kamya; Heir, Pardeep; Ohh, Michael			SOCS-1 Mediates Ubiquitylation and Degradation of GM-CSF Receptor	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; COMMON BETA-SUBUNIT; ERYTHROPOIETIN RECEPTOR; TUMOR-SUPPRESSOR; ACTIVATION; BOX; PHOSPHORYLATION; UBIQUITINATION; INTERLEUKIN-3; PROTEIN	Granulocyte-macrophage colony-stimulating factor (GM-CSF) and the related cytokines interleukin (IL)-3 and IL-5 regulate the production and functional activation of hematopoietic cells. GM-CSF acts on monocytes/macrophages and granulocytes, and several chronic inflammatory diseases and a number of haematological malignancies such as Juvenile myelomonocytic leukaemia (JMML) are associated with deregulated GM-CSF receptor (GMR) signaling. The downregulation of GMR downstream signaling is mediated in part by the clearance of activated GMR via the proteasome, which is dependent on the ubiquitylation of beta c signaling subunit of GMR via an unknown E3 ubiquitin ligase. Here, we show that suppressor of cytokine signaling 1 (SOCS-1), best known for its ability to promote ubiquitin-mediated degradation of the non-receptor tyrosine kinase Janus kinase 2 (JAK2), also targets GMR beta c for ubiquitin-mediated degradation and attenuates GM-CSF-induced downstream signaling.	[Bunda, Severa; Kommaraju, Kamya; Heir, Pardeep; Ohh, Michael] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Ohh, Michael] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto; University of Toronto	Ohh, M (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	michael.ohh@utoronto.ca			Canadian Institutes of Health Research (CIHR) [MOP119356]; Cancer Research Society; Canadian Cancer Society [20110]; CIHR/Kidney Cancer Canada fellowship award	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cancer Research Society; Canadian Cancer Society(Canadian Cancer Society (CCS)); CIHR/Kidney Cancer Canada fellowship award	This work was supported by funds from the Canadian Institutes of Health Research (CIHR, MOP119356), Cancer Research Society, and the Canadian Cancer Society (20110). S. B. is a recipient of the CIHR/Kidney Cancer Canada fellowship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley CJ, 1997, BLOOD, V89, P1471, DOI 10.1182/blood.V89.5.1471.1471_1471_1482; Boyle K, 2009, CELL SIGNAL, V21, P394, DOI 10.1016/j.cellsig.2008.11.002; Bunda S, 2013, CANC RES; Emanuel PD, 2008, LEUKEMIA, V22, P1335, DOI 10.1038/leu.2008.162; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Lei JT, 2011, J BIOL CHEM, V286, P40091, DOI 10.1074/jbc.M111.273482; Loh ML, 2010, HEMATOL-AM SOC HEMAT, P357, DOI 10.1182/asheducation-2010.1.357; Loh ML, 2009, BLOOD, V114, P1859, DOI 10.1182/blood-2009-01-198416; Lopez AF, 2010, IUBMB LIFE, V62, P509, DOI 10.1002/iub.350; Martinez-Moczygemba M, 2001, J CLIN INVEST, V108, P1797, DOI 10.1172/JCI200113877; Martinez-Moczygemba M, 2007, J LEUKOCYTE BIOL, V81, P1137, DOI 10.1189/jlb.0706465; Metcalf D, 1999, LEUKEMIA, V13, P926, DOI 10.1038/sj.leu.2401440; Metcalf D, 2003, P NATL ACAD SCI USA, V100, P8436, DOI 10.1073/pnas.1032925100; Meyer L, 2007, BLOOD, V109, P5215, DOI 10.1182/blood-2006-10-055350; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Perugini M, 2010, BLOOD, V115, P3346, DOI 10.1182/blood-2009-08-235846; Piessevaux J, 2008, CYTOKINE GROWTH F R, V19, P371, DOI 10.1016/j.cytogfr.2008.08.006; Russell RC, 2011, NAT MED, V17, P845, DOI 10.1038/nm.2370; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; Walrafen P, 2005, BLOOD, V105, P600, DOI 10.1182/blood-2004-03-1216; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Zahn S, 2000, CYTOKINE, V12, P1299, DOI 10.1006/cyto.2000.0718; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071	24	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76370	10.1371/journal.pone.0076370	http://dx.doi.org/10.1371/journal.pone.0076370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086733	Green Published, Green Submitted, gold			2022-12-27	WOS:000325220000065
J	Kogure, T; Kinghorn, AD; Yan, I; Bolon, B; Lucas, DM; Grever, MR; Patel, T				Kogure, Takayuki; Kinghorn, A. Douglas; Yan, Irene; Bolon, Brad; Lucas, David M.; Grever, Michael R.; Patel, Tushar			Therapeutic Potential of the Translation Inhibitor Silvestrol in Hepatocellular Cancer	PLOS ONE			English	Article							MESSENGER-RNAS; CARCINOMA; INITIATION; PATHWAYS; LYMPHOMA; DRUGS; HCC	Background & Aims: Although hepatocellular cancers (HCC) frequently arise in the setting of fibrosis and a hepatic regenerative response requiring new cell growth, therapeutic strategies for these cancers have not targeted protein synthesis. Silvestrol, a rocaglate isolated from Aglaia foveolata, can inhibit protein synthesis by modulating the initiation of translation through the eukaryotic initiation factor 4A. In this study, we evaluated the therapeutic efficacy of silvestrol for HCC. Methods: The efficacy of silvestrol was examined using human HCC cells in vitro using an orthotopic tumor cell xenograft model in a fibrotic liver. The impact of silvestrol on the liver was assessed in vivo in wild-type mice. Results: Silvestrol inhibited cell growth with an IC50 of 12.5-86 nM in four different HCC cell lines. In vitro, silvestrol increased apoptosis and caspase 3/7 activity accompanied by loss of mitochondrial membrane potential and decreased expression of Mcl-1 and Bcl-xL. A synergistic effect was observed when silvestrol was combined with other therapeutic agents, with a dose-reduction index of 3.42-fold with sorafenib and 1.75-fold with rapamycin at a fractional effect of 0.5. In vivo, an antitumor effect was observed with 0.4 mg/kg silvestrol compared to controls after one week, and survival of tumor-bearing mice was improved with a median survival time of 42 and 28 days in the silvestrol and control groups, respectively. The effect on survival was not observed in orthotopic xenografts in non-fibrotic livers. Silvestrol treatment in vivo did not alter liver structure. Conclusions: These data identify silvestrol as a novel, structurally unique drug with potent anticancer activity for HCC and support the potential value of targeting initiation of translation in the treatment of HCC.	[Kogure, Takayuki; Lucas, David M.; Grever, Michael R.; Patel, Tushar] Ohio State Univ, Coll Med, Dept Internal Med, Columbus, OH 43210 USA; [Kinghorn, A. Douglas; Lucas, David M.] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; [Bolon, Brad] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Kogure, Takayuki; Yan, Irene; Patel, Tushar] Mayo Clin, Dept Transplantat, Jacksonville, FL 32224 USA; [Kogure, Takayuki; Yan, Irene; Patel, Tushar] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Mayo Clinic; Mayo Clinic	Patel, T (corresponding author), Ohio State Univ, Coll Med, Dept Internal Med, Columbus, OH 43210 USA.	patel.tushar@mayo.edu	patel, tushar/J-3976-2013; Lucas, David M/E-3555-2011; Kogure, Takayuki/AAI-3946-2021	patel, tushar/0000-0001-7021-9532; Kinghorn, A. Douglas/0000-0002-6647-8707	National Institutes of Health [DK069370]; National Cancer Institute [P01 CA125066]; NATIONAL CANCER INSTITUTE [P01CA125066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grant funding from the National Institutes of Health, DK069370 (TP) and National Cancer Institute, P01 CA125066 (ADK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinari L, 2012, CLIN CANCER RES, V18, P4600, DOI 10.1158/1078-0432.CCR-12-0839; Antonaci S, 2007, CURR PHARM DESIGN, V13, P3288, DOI 10.2174/138161207782360645; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Cencic R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005223; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; El Sous M, 2007, ANGEW CHEM INT EDIT, V46, P7835, DOI 10.1002/anie.200702700; Han ZG, 2012, ANNU REV GENOM HUM G, V13, P171, DOI 10.1146/annurev-genom-090711-163752; Hwang BY, 2004, J ORG CHEM, V69, P3350, DOI 10.1021/jo040120f; Kinghorn AD, 2011, J NAT PROD, V74, P1539, DOI 10.1021/np200391c; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Lindqvist L, 2009, FUTURE MED CHEM, V1, P1709, DOI 10.4155/FMC.09.122; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lucas DM, 2009, BLOOD, V113, P4656, DOI 10.1182/blood-2008-09-175430; Marquardt JU, 2012, J HEPATOL, V56, P267, DOI 10.1016/j.jhep.2011.07.007; Nordenstedt H, 2010, DIGEST LIVER DIS, V42, pS206, DOI 10.1016/S1590-8658(10)60507-5; Rizell M, 2008, INT J CLIN ONCOL, V13, P66, DOI 10.1007/s10147-007-0733-3; Shuda M, 2000, ANTICANCER RES, V20, P2489; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Treiber G, 2009, EXPERT REV ANTICANC, V9, P247, DOI 10.1586/14737140.9.2.247; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Wang XL, 2012, WORLD J GASTROENTERO, V18, P2540, DOI 10.3748/wjg.v18.i20.2540; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Zhang DY, 2012, HEPATOLOGY, V56, P769, DOI 10.1002/hep.25670; Zhu AX, 2011, CANCER-AM CANCER SOC, V117, P5094, DOI 10.1002/cncr.26165	25	45	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76136	10.1371/journal.pone.0076136	http://dx.doi.org/10.1371/journal.pone.0076136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086701	gold, Green Submitted, Green Published			2022-12-27	WOS:000325220000060
J	Lambertucci, SA; Carrete, M; Speziale, KL; Hiraldo, F; Donazar, JA				Lambertucci, Sergio A.; Carrete, Martina; Speziale, Karina L.; Hiraldo, Fernando; Antonio Donazar, Jose			Population Sex Ratios: Another Consideration in the Reintroduction - Reinforcement Debate?	PLOS ONE			English	Article							ANDEAN CONDORS; CONSERVATION; VULTURES; WILD	Reintroduction or reinforcement (RorR) of wild populations is a common conservation strategy. Many conservation projects involve the release of individuals of poorly studied species. This may lead to inefficient results or negative impacts on the conservation efforts. Here, we provide new insights into the conservation implications and potential consequences of a skew in the sex ratio of released birds and of the number of birds supplemented for the demography of a long-lived dimorphic bird species, the Andean condor (Vultur gryphus). We demonstrate that a RorR conservation program may be less effective in conserving a species if the sex ratios of the releases and the recipient populations are not considered. We also show that releases can reduce population declines but only if carried out over long periods (i.e., several decades). This can mean high costs for release programs and the added challenge of maintaining programs over time. If RorR programs are to be implemented, bearing in mind the importance of properly assessing their effectiveness, we urge conservation researchers and managers to consider the implications of sex ratio biases for wild populations, and particularly for dimorphic species with sexually despotic behaviour.	[Lambertucci, Sergio A.; Speziale, Karina L.] Univ Nacl Comahue, CONICET, INIBIOMA, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina; [Carrete, Martina] Univ Pablo Olavide, Dept Phys Chem & Nat Syst, Seville, Spain; [Hiraldo, Fernando; Antonio Donazar, Jose] CSIC, Estac Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Universidad Pablo de Olavide; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Lambertucci, SA (corresponding author), Univ Nacl Comahue, CONICET, INIBIOMA, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina.	slambertucci@comahue-conicet.gob.ar	Carrete, Martina/D-2618-2017; Carrete, Martina/A-6376-2009; Hiraldo, Fernando/AAA-8314-2019; Speziale, Karina/O-9415-2014	Carrete, Martina/0000-0002-0491-2950; Donazar, Jose Antonio/0000-0002-9433-9755; Speziale, Karina/0000-0003-2224-2097; LAMBERTUCCI, SERGIO/0000-0002-2624-2185	Fundacion BBVA (Fundacion Banco Bilbao Vizcaya Argentaria) [BIOCON 08 126]	Fundacion BBVA (Fundacion Banco Bilbao Vizcaya Argentaria)	Funding was provided through the Project BIOCON 08 126, from Fundacion BBVA (Fundacion Banco Bilbao Vizcaya Argentaria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bose M, 2007, ORYX, V41, P503, DOI 10.1017/S0030605307000312; Bruning D.F., 1984, International Zoo Yearbook, V23, P11; Carrete M, 2010, ANIM CONSERV, V13, P390, DOI 10.1111/j.1469-1795.2010.00352.x; Carrete M, 2006, ECOL APPL, V16, P1674, DOI 10.1890/1051-0761(2006)016[1674:DPDIPB]2.0.CO;2; Clout MN, 2002, BIOL CONSERV, V107, P13, DOI 10.1016/S0006-3207(01)00267-1; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; Donazar JA, 1999, BEHAV ECOL SOCIOBIOL, V45, P55, DOI 10.1007/s002650050539; Ewen JG, 2012, REINTRODUCTION BIOL; Ferguson-Lees J, 2001, RAPTORS WORLD; IUCN, 1998, IUCN GUID REINTR; Lacy RC, 2003, VORTEX STOCH SIM EXT; Lambertucci S, 2007, HORNERO, V22, P149; Lambertucci SA, 2008, J FIELD ORNITHOL, V79, P147, DOI 10.1111/j.1557-9263.2008.00156.x; Lambertucci SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046347; Lambertucci SA, 2011, BIOL CONSERV, V144, P1464, DOI 10.1016/j.biocon.2011.01.015; Lambertucci SA, 2010, ORYX, V44, P441, DOI 10.1017/S0030605310000451; Meretsky VJ, 2000, CONSERV BIOL, V14, P957, DOI 10.1046/j.1523-1739.2000.99113.x; Ministerio de Ambiente Vivienda y Desarrollo Territorial, 2006, PROGR NAC CONS COND, p[2006, 32]; Onichimowska Anna., 2012, KONIEC GRY; Oro D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004084; Perez I, 2012, FRONT ECOL ENVIRON, V10, P494, DOI 10.1890/110175; Raptor AZA. TAG, 2010, AND COND VULTURGRYPH; Robertson BC, 2006, BIOL LETTERS, V2, P229, DOI 10.1098/rsbl.2005.0430; Sarrazin F, 2000, CONSERV BIOL, V14, P488, DOI 10.1046/j.1523-1739.2000.97305.x; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Temple S.A., 1989, P247; WALLACE MP, 1987, J WILDLIFE MANAGE, V51, P541, DOI 10.2307/3801266; White C.M., 1994, NEW WORLD VULTURES G	29	20	21	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75821	10.1371/journal.pone.0075821	http://dx.doi.org/10.1371/journal.pone.0075821			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086641	Green Published, gold			2022-12-27	WOS:000325220000046
J	Parra-Bonilla, G; Alvarez, DF; Alexeyev, M; Vasauskas, A; Stevens, T				Parra-Bonilla, Glenda; Alvarez, Diego F.; Alexeyev, Mikhail; Vasauskas, Audrey; Stevens, Troy			Lactate Dehydrogenase A Expression Is Necessary to Sustain Rapid Angiogenesis of Pulmonary Microvascular Endothelium	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; VIVO GENE TRANSFECTION; CHRONIC LUNG-DISEASE; PROGENITOR CELLS; ARTERIAL-HYPERTENSION; CHRONIC INFLAMMATION; AIRWAY VASCULATURE; PLEXIFORM LESIONS; PROLIFERATION; CIRCULATION	Angiogenesis is a fundamental property of endothelium, yet not all endothelial cells display equivalent angiogenic responses; pulmonary microvascular endothelial cells undergo rapid angiogenesis when compared to endothelial cells isolated from conduit vessels. At present it is not clear how pulmonary microvascular endothelial cells fulfill the bioenergetic demands that are necessary to sustain such rapid blood vessel formation. We have previously established that pulmonary microvascular endothelial cells utilize aerobic glycolysis to generate ATP during growth, a process that requires the expression of lactate dehydrogenase A to convert pyruvate to lactate. Here, we test the hypothesis that lactate dehydrogenase A is required for pulmonary microvascular endothelial cells to sustain rapid angiogenesis. To test this hypothesis, Tet-On and Tet-Off conditional expression systems were developed in pulmonary microvascular endothelial cells, where doxycycline is utilized to induce lactate dehydrogenase A shRNA expression. Expression of LDH-A shRNA induced a time-dependent decrease in LDH-A protein, which corresponded with a decrease in glucose consumption from the media, lactate production and cell growth; re-expression of LDH-A rescued each of these parameters. LDH-A silencing greatly reduced network formation on Matrigel in vitro, and decreased blood vessel formation in Matrigel in vivo. These findings demonstrate that LDH-A is critically important for sustaining the rapid angiogenesis of pulmonary microvascular endothelial cells.	[Parra-Bonilla, Glenda; Alvarez, Diego F.; Stevens, Troy] Univ S Alabama, Dept Pharmacol, Mobile, AL 36688 USA; [Alvarez, Diego F.; Stevens, Troy] Univ S Alabama, Dept Med, Mobile, AL 36688 USA; [Alexeyev, Mikhail] Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA; [Vasauskas, Audrey] Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL 36688 USA; [Parra-Bonilla, Glenda; Alvarez, Diego F.; Alexeyev, Mikhail; Vasauskas, Audrey; Stevens, Troy] Univ S Alabama, Ctr Lung Biol, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama; University of South Alabama; University of South Alabama; University of South Alabama	Stevens, T (corresponding author), Univ S Alabama, Dept Pharmacol, Mobile, AL 36688 USA.	tstevens@jaguar1.usouthal.edu	Alvarez, Diego/AAT-3897-2020	Alvarez, Diego/0000-0001-8244-629X; Vasauskas, Audrey/0000-0002-1724-5923	American Heart Association;  [HL60024];  [HL66299]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR031286] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060024, P01HL066299, R37HL060024] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD010944] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by HL60024 and HL66299 (to TS) and an American Heart Association Predoctoral Fellowship (to GPB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Alexeyev MF, 2010, MOL BIOL REP, V37, P1987, DOI 10.1007/s11033-009-9647-7; Alvarez DF, 2008, AM J PHYSIOL-LUNG C, V294, pL419, DOI 10.1152/ajplung.00314.2007; BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; Clark J, 2008, AM J PHYSIOL-LUNG C, V294, pL431, DOI 10.1152/ajplung.00316.2007; Dai RP, 2008, J BIOL CHEM, V283, P26894, DOI 10.1074/jbc.M804307200; Davie NJ, 2006, AM J PATHOL, V168, P1793, DOI 10.2353/ajpath.2006.050754; Davie NJ, 2004, AM J PHYSIOL-LUNG C, V286, pL668, DOI 10.1152/ajplung.00108.2003; Dutly AE, 2005, AM J TRANSPLANT, V5, P248, DOI 10.1111/j.1600-6143.2004.00680.x; Ezaki T, 2001, AM J PATHOL, V158, P2043, DOI 10.1016/S0002-9440(10)64676-7; Farha S, 2007, J APPL PHYSIOL, V103, P1789, DOI 10.1152/japplphysiol.00614.2007; Favre CJ, 2003, AM J PHYSIOL-HEART C, V285, pH1917, DOI 10.1152/ajpheart.00983.2002; Foster DJ, 2004, AM J PHYSIOL-LUNG C, V287, pL1107, DOI 10.1152/ajplung.00119.2004; Gargett CE, 2001, REPRODUCTION, V121, P181, DOI 10.1530/rep.0.1210181; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HOBSON B, 1984, BRIT J CANCER, V49, P405, DOI 10.1038/bjc.1984.66; Hopkins N, 2002, J ANAT, V201, P335, DOI 10.1046/j.1469-7580.2002.00096.x; Hopkins N, 2001, J APPL PHYSIOL, V91, P919, DOI 10.1152/jappl.2001.91.2.919; Howell K, 2003, J PHYSIOL-LONDON, V547, P133, DOI 10.1113/jphysiol.2002.030676; Howell K, 2009, AM J PHYSIOL-LUNG C, V296, pL1042, DOI 10.1152/ajplung.90327.2008; HUDLICKA O, 1992, PHYSIOL REV, V72, P369, DOI 10.1152/physrev.1992.72.2.369; Ingram DA, 2005, BLOOD, V105, P2783, DOI 10.1182/blood-2004-08-3057; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; King J, 2004, MICROVASC RES, V67, P139, DOI 10.1016/j.mvr.2003.11.006; Kwan ML, 2001, AM J PHYSIOL-LUNG C, V280, pL286, DOI 10.1152/ajplung.2001.280.2.L286; McDonald DM, 2001, AM J RESP CRIT CARE, V164, pS39, DOI 10.1164/ajrccm.164.supplement_2.2106065; Mitzner W, 2000, AM J PATHOL, V157, P93, DOI 10.1016/S0002-9440(10)64521-X; Montani D, 2011, AM J RESP CRIT CARE, V184, P116, DOI 10.1164/rccm.201006-0905OC; Morino S, 2007, EXP LUNG RES, V33, P15, DOI 10.1080/01902140601113070; Ono M, 2002, CIRCULATION, V106, pI264, DOI 10.1161/cir.0000032879.55215.f4; Parra-Bonilla G, 2010, AM J PHYSIOL-LUNG C, V299, pL513, DOI 10.1152/ajplung.00274.2009; Pietra GG, 2004, J AM COLL CARDIOL, V43, p25S, DOI 10.1016/j.jacc.2004.02.033; Rai PR, 2008, AM J RESP CRIT CARE, V178, P558, DOI 10.1164/rccm.200709-1369PP; Reynolds LP, 1998, J ANIM SCI, V76, P1671; Schraufnagel DE, 1997, AM J PHYSIOL-LUNG C, V272, pL139, DOI 10.1152/ajplung.1997.272.1.L139; Shigemura N, 2005, CIRCULATION, V111, P1407, DOI 10.1161/01.CIR.0000158433.89103.85; Solodushko V, 2007, AM J PHYSIOL-LUNG C, V292, pL671, DOI 10.1152/ajplung.00304.2006; Starnes SL, 2000, J THORAC CARDIOV SUR, V120, P902, DOI 10.1067/mtc.2000.110248; Stevens T, 2005, CHEST, V128, p558S, DOI 10.1378/chest.128.6_suppl.558S; SYPNIEWSKA G, 1987, EUR J CLIN INVEST, V17, P202, DOI 10.1111/j.1365-2362.1987.tb01236.x; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; TUDER RM, 1994, AM J PATHOL, V144, P275; Voelkel NF, 2007, CHEST, V131, P874, DOI 10.1378/chest.06-2453; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Zhang JL, 2009, GASTROENTEROLOGY, V136, P1070, DOI 10.1053/j.gastro.2008.12.001	45	27	27	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75984	10.1371/journal.pone.0075984	http://dx.doi.org/10.1371/journal.pone.0075984			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086675	Green Published, gold, Green Submitted			2022-12-27	WOS:000325220000055
J	Blom, V; Bodin, L; Bergstrom, G; Hallsten, L; Svedberg, P				Blom, Victoria; Bodin, Lennart; Bergstrom, Gunnar; Hallsten, Lennart; Svedberg, Pia			The Importance of Genetic and Shared Environmental Factors for the Associations between Job Demands, Control, Support and Burnout	PLOS ONE			English	Article							SWEDISH TWIN REGISTRY; VALIDITY; MODEL; DEPRESSION; STRAIN; ANXIETY; CLUSTER	Within occupational health research, one of the most influential models is the Job Demands-Control-Support model. Numerous studies have applied the model to different domains, with both physical and psychological health outcomes, such as burnout. The twin design provides a unique and powerful research methodology for examining the effects of environmental risk factors on burnout while taking familial factors (genetic and shared environment) into account. The aim of the present study was to investigate the impact of familial factors on the associations of burnout with job demands, control and support. A total of 14 516 individuals from the Swedish Twin Registry, who were born between 1959 and 1986, and who participated in the Study of Twin Adults: Genes and Environment (STAGE) by responding to a web-based questionnaire in 2005, were included in the analyses. Of these, there were 5108 individuals in complete same-sex twin pairs. Co-twin control analyses were performed using linear mixed modeling, comparing between-pairs effects and within-pair effects, stratified also by zygosity and sex. The results indicate that familial factors are of importance in the association between support and burnout in both women and men, but not between job demands and burnout. There are also tendencies towards familial factors being involved in the association between control and burnout in men. These results offer increased understanding of the mechanisms involved in the associations between work stress and burnout.	[Blom, Victoria; Hallsten, Lennart; Svedberg, Pia] Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden; [Blom, Victoria] Swedish Sch Sport & Hlth Sci, Stockholm, Sweden; [Bodin, Lennart; Bergstrom, Gunnar] Karolinska Inst, Inst Environm Med, Div Intervent & Implementat Res, S-10401 Stockholm, Sweden	Karolinska Institutet; Swedish School of Sport & Health Sciences; Karolinska Institutet	Blom, V (corresponding author), Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden.	victoria.blom@ki.se			FAS [2009-0548]	FAS	This work was supported by FAS dnr 2009-0548 http://www.fas.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begg MD, 2003, STAT MED, V22, P2591, DOI 10.1002/sim.1524; Belkic KL, 2004, SCAND J WORK ENV HEA, V30, P85, DOI 10.5271/sjweh.769; Bergeman CS, 2001, INT J AGING HUM DEV, V53, P107, DOI 10.2190/CTKR-F6FF-Q8AW-E68V; Blom V, 2012, EUR J EPIDEMIOL, V27, P225, DOI 10.1007/s10654-012-9661-2; Borritz M, 2010, J OCCUP ENVIRON MED, V52, P964, DOI 10.1097/JOM.0b013e3181f12f95; Carlin JB, 2005, INT J EPIDEMIOL, V34, P1089, DOI 10.1093/ije/dyi153; Castanheira F, 2011, HUMAN FACTORS ERGONO; de Lange Annet H, 2003, J Occup Health Psychol, V8, P282, DOI 10.1037/1076-8998.8.4.282; Dwyer T, 2002, LANCET, V359, P2205, DOI 10.1016/S0140-6736(02)09083-9; Enzmann D, 1998, J OCCUP ORGAN PSYCH, V71, P331, DOI 10.1111/j.2044-8325.1998.tb00680.x; Gurrin LC, 2006, BIOMETRICS, V62, P745, DOI 10.1111/j.1541-0420.2006.00561.x; Gustavsson JP, 2010, INT J NURS STUD, V47, P864, DOI 10.1016/j.ijnurstu.2009.12.007; Hausser JA, 2010, WORK STRESS, V24, P1, DOI 10.1080/02678371003683747; Hallsten L, 2005, NEW HORIZ MANAG, P516; Hu FB, 1998, STAT MED, V17, P957, DOI 10.1002/(SICI)1097-0258(19980515)17:9<957::AID-SIM791>3.3.CO;2-F; Karasek R, 1990, HLTH WORK STRESS PRO; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; KENDLER KS, 1995, AM J PSYCHIAT, V152, P833; Lichtenstein P, 2002, J INTERN MED, V252, P184, DOI 10.1046/j.1365-2796.2002.01032.x; Lichtenstein P, 2006, TWIN RES HUM GENET, V9, P875, DOI 10.1375/twin.9.6.875; Maas H, 2012, J OCCUP HEALTH PSYCH, V17, P376, DOI 10.1037/a0027641; Marchand A, 2011, WORK, V40, P425, DOI 10.3233/WOR-2011-1254; Marchand A, 2011, J OCCUP ENVIRON MED, V53, P185, DOI 10.1097/JOM.0b013e318206f0e9; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Middeldorp CM, 2006, J AFFECT DISORDERS, V90, P163, DOI 10.1016/j.jad.2005.11.004; Middeldorp CM, 2005, PSYCHOL MED, V35, P113, DOI 10.1017/S0033291704002983; Pelfrene E, 2001, WORK STRESS, V15, P297, DOI 10.1080/02678370110086399; Pines A., 1981, BURNOUT TEDIUM PERSO; Sanne B, 2005, SCAND J PUBLIC HEALT, V33, P166, DOI 10.1080/14034940410019217; Schaufeli W., 1998, BURNOUT COMPANION ST; Schaufeli WB, 2001, PSYCHOL HEALTH, V16, P565, DOI 10.1080/08870440108405527; Shirom A, 2003, ANXIETY STRESS COPIN, V16, P83, DOI 10.1080/1061580021000057059; Toker S, 2005, J OCCUP HEALTH PSYCH, V10, P344, DOI 10.1037/1076-8998.10.4.344; van der Doef M, 1998, PSYCHOL HEALTH, V13, P909, DOI 10.1080/08870449808407440; Van der Doef M, 1999, WORK STRESS, V13, P87, DOI 10.1080/026783799296084; VIKEN RJ, 1994, J PERS SOC PSYCHOL, V66, P722, DOI 10.1037/0022-3514.66.4.722; Wennerstad KM, 2010, SOC SCI MED, V70, P575, DOI 10.1016/j.socscimed.2009.10.050; Westerlund H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035967	38	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75387	10.1371/journal.pone.0075387	http://dx.doi.org/10.1371/journal.pone.0075387			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VC	24086520	gold, Green Published, Green Submitted			2022-12-27	WOS:000325218700083
J	Raychaudhuri, N; Fernando, R; Smith, TJ				Raychaudhuri, Nupur; Fernando, Roshini; Smith, Terry J.			Thyrotropin Regulates IL-6 Expression in CD34(+) Fibrocytes: Clear Delineation of Its cAMP-Independent Actions	PLOS ONE			English	Article							THYROID-STIMULATING HORMONE; KINASE-C-BETA; PROTEIN-KINASE; TSH RECEPTOR; CIRCULATING FIBROCYTES; GENE-EXPRESSION; T-CELLS; INTERLEUKIN-6 PRODUCTION; GRAVES OPHTHALMOPATHY; SERUM CONCENTRATIONS	IL-6 plays diverse roles in normal and disease-associated immunity such as that associated with Graves' disease (GD). In that syndrome, the orbit undergoes remodeling during a process known as thyroid-associated ophthalmopathy (TAO). Recently, CD34(+) fibrocytes were found to infiltrate the orbit in TAO where they transition into CD34(+) orbital fibroblasts. Surprisingly, fibrocytes display high levels of functional thyrotropin receptor (TSHR), the central antigen in GD. We report here that TSH and the pathogenic anti-TSHR antibodies that drive hyperthyroidism in GD induce IL-6 expression in fibrocytes and orbital fibroblasts. Unlike TSHR signaling in thyroid epithelium, that occurring in fibrocytes is completely independent of adenylate cyclase activation and cAMP generation. Instead TSH activates PDK1 and both AKT/PKB and PKC pathways. Expression and use of PKCbII switches to that of PKCm as fibrocytes transition to TAO orbital fibroblasts. This shift is imposed by CD34(-) orbital fibroblasts but reverts when CD34(+) fibroblasts are isolated. The up-regulation of IL-6 by TSH results from coordinately enhanced IL-6 gene promoter activity and increased IL-6 mRNA stability. TSH-dependent IL-6 expression requires activity at both CREB (-213 to -208 nt) and NF-kappa B (-78 to -62 nt) binding sites. These results provide novel insights into the molecular action of TSH and signaling downstream for TSHR in non-thyroid cells. Fibrocytes neither express adenylate cyclase nor generate cAMP and thus these findings are free from any influence of cAMP-related signaling. They identify potential therapeutic targets for TAO.	[Raychaudhuri, Nupur; Fernando, Roshini; Smith, Terry J.] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Smith, Terry J.] Univ Michigan, Sch Med, Dept Internal Med, Div Metab Endocrine & Diabet, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Smith, TJ (corresponding author), Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.	terrysmi@med.umich.edu	Smith, Terry/ABG-1360-2020	Smith, Terry/0000-0002-6279-9685	National Institutes of Health; Nuclear Energy Institute [EY008976, EY011708, DK063121, EY007003]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011708, R01EY008976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nuclear Energy Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported in part by grants from the National Institutes of Health (nih.gov); EY008976, EY011708, DK063121, and core Center for Vision Research grant EY007003 from the Nuclear Energy Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Antunes TT, 2005, OBES RES, V13, P2066, DOI 10.1038/oby.2005.256; Bell A, 2003, ARTERIOSCL THROM VAS, V23, pE65, DOI 10.1161/01.ATV.0000102520.84030.A1; Bell A, 2000, AM J PHYSIOL-CELL PH, V279, pC335, DOI 10.1152/ajpcell.2000.279.2.C335; BOTELHO LHP, 1988, METHOD ENZYMOL, V159, P159; Bowman JC, 1997, J CLIN INVEST, V100, P2189, DOI 10.1172/JCI119755; Brent GA, 2008, NEW ENGL J MED, V358, P2594, DOI 10.1056/NEJMcp0801880; Brown CY, 1996, P NATL ACAD SCI USA, V93, P13721, DOI 10.1073/pnas.93.24.13721; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Chen BL, 2005, J IMMUNOL, V175, P1310, DOI 10.4049/jimmunol.175.2.1310; Cheng L, 2008, AM J PHYSIOL-GASTR L, V295, pG493, DOI 10.1152/ajpgi.90214.2008; Chesney J, 1997, P NATL ACAD SCI USA, V94, P6307, DOI 10.1073/pnas.94.12.6307; Davidson LA, 1998, CARCINOGENESIS, V19, P253, DOI 10.1093/carcin/19.2.253; DAVIES TF, 1978, MOL CELL ENDOCRINOL, V9, P303, DOI 10.1016/0303-7207(78)90072-2; Davies TF, 2005, J CLIN INVEST, V115, P1972, DOI 10.1172/JCI26031; DECARLI M, 1993, J CLIN ENDOCR METAB, V77, P1120, DOI 10.1210/jc.77.5.1120; Douglas RS, 2010, J CLIN ENDOCR METAB, V95, P430, DOI 10.1210/jc.2009-1614; DREYER C, 1978, NUCLEIC ACIDS RES, V5, P3325, DOI 10.1093/nar/5.9.3325; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; ENDO T, 1995, J BIOL CHEM, V270, P10833, DOI 10.1074/jbc.270.18.10833; Fernando R, 2012, P NATL ACAD SCI USA, V109, P7427, DOI 10.1073/pnas.1202064109; Freson K, 2002, HUM MOL GENET, V11, P2741, DOI 10.1093/hmg/11.22.2741; Gillespie EF, 2012, J CLIN ENDOCR METAB, V97, pE740, DOI 10.1210/jc.2011-2514; Grassl C, 1999, J AM SOC NEPHROL, V10, P1466; GRUBECKLOEBENSTEIN B, 1994, J CLIN INVEST, V93, P2738, DOI 10.1172/JCI117289; GRUBECKLOEBENSTEIN B, 1989, CLIN EXP IMMUNOL, V77, P324; Hara T, 1999, ENDOCRINOLOGY, V140, P1724, DOI 10.1210/en.140.4.1724; HEUFELDER AE, 1993, THYROID, V3, P297, DOI 10.1089/thy.1993.3.297; Hirano T, 1998, Int Rev Immunol, V16, P249; Hiromatsu Y, 2000, J CLIN ENDOCR METAB, V85, P1194, DOI 10.1210/jc.85.3.1194; Iankov I, 2002, LEUKEMIA RES, V26, P363, DOI 10.1016/S0145-2126(01)00132-1; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; JAUME JC, 1994, J CLIN ENDOCR METAB, V78, P348, DOI 10.1210/jc.78.2.348; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Kazim M, 2002, ARCH OPHTHALMOL-CHIC, V120, P380; Kero J, 2007, J CLIN INVEST, V117, P2399, DOI 10.1172/JCI30380; Klein JR, 2003, AUTOIMMUNITY, V36, P417, DOI 10.1080/08916930310001603019; Konopatskaya O, 2011, BLOOD, V118, P416, DOI 10.1182/blood-2010-10-312199; Legrand-Poels S, 2000, BIOCHEM J, V349, P765, DOI 10.1042/bj3490765; LICHTENSTEIN A, 1995, CELL IMMUNOL, V162, P248, DOI 10.1006/cimm.1995.1076; MARCUS C, 1988, J CLIN INVEST, V82, P1793, DOI 10.1172/JCI113793; MARTIN CA, 1991, CELL IMMUNOL, V135, P245, DOI 10.1016/0008-8749(91)90269-H; Martiny-Baron G, 2007, PHARMACOL RES, V55, P477, DOI 10.1016/j.phrs.2007.04.001; Miyazawa K, 1998, J BIOL CHEM, V273, P24832, DOI 10.1074/jbc.273.38.24832; Molnar I, 1997, AUTOIMMUNITY, V25, P91, DOI 10.3109/08916939708996275; Morshed SA, 2009, ENDOCRINOLOGY, V150, P519, DOI 10.1210/en.2008-0878; Motomura T, 1998, J BONE MINER RES, V13, P1084, DOI 10.1359/jbmr.1998.13.7.1084; MURAGUCHI A, 1981, J IMMUNOL, V127, P412; Naka T, 2002, ARTHRITIS RES THER, V4, pS233, DOI 10.1186/ar565; Nguyen LQ, 2000, MOL ENDOCRINOL, V14, P1448, DOI 10.1210/me.14.9.1448; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; PARMENTIER M, 1989, SCIENCE, V246, P1620, DOI 10.1126/science.2556796; PASCHKE R, 1994, J CLIN ENDOCR METAB, V79, P1234, DOI 10.1210/jc.79.5.1234; Pham N, 2000, CURR BIOL, V10, pR577, DOI 10.1016/S0960-9822(00)00627-8; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Porcellini A, 2003, J BIOL CHEM, V278, P40621, DOI 10.1074/jbc.M307501200; Raychaudhuri S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011930; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Salvi M, 1996, J CLIN ENDOCR METAB, V81, P2976, DOI 10.1210/jc.81.8.2976; Salvi M, 2000, EUR J ENDOCRINOL, V143, P197, DOI 10.1530/eje.0.1430197; Sanders JL, 2000, J BONE MINER RES, V15, P885, DOI 10.1359/jbmr.2000.15.5.885; SAUNIER B, 1995, J BIOL CHEM, V270, P3693, DOI 10.1074/jbc.270.8.3693; SAUNIER B, 1993, EUR J BIOCHEM, V218, P1091, DOI 10.1111/j.1432-1033.1993.tb18469.x; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380; SEHGAL PB, 1992, RES IMMUNOL, V143, P724, DOI 10.1016/0923-2494(92)80011-9; Sledge GW, 2006, SEMIN ONCOL, V33, pS15, DOI 10.1016/j.seminoncol.2006.03.019; Smith TJ, 2011, J CLIN ENDOCR METAB, V96, P3827, DOI 10.1210/jc.2011-1249; SMITH TJ, 1995, J CLIN ENDOCR METAB, V80, P2620, DOI 10.1210/jc.80.9.2620; Sunthornthepvarakul T, 2004, NEW ENGL J MED, V332, P155; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Tayze T, 2008, ENDOCRINOLOGY, V149, P3062; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Tsui S, 2008, J IMMUNOL, V181, P4397, DOI 10.4049/jimmunol.181.6.4397; Tsygankova OM, 2001, MOL CELL BIOL, V21, P1921, DOI 10.1128/MCB.21.6.1921-1929.2001; Vassart G, 1992, ENDOCR REV, V13, P96; WOLOSHIN PI, 1992, MOL ENDOCRINOL, V6, P1725, DOI 10.1210/me.6.10.1725; Zaballos MA, 2008, MOL ENDOCRINOL, V22, P1183, DOI 10.1210/me.2007-0093; ZAKARIJA M, 1987, ENDOCRIN METAB CLIN, V16, P343, DOI 10.1016/S0889-8529(18)30483-3; ZAKARIJA M, 1988, J CLIN INVEST, V81, P879, DOI 10.1172/JCI113398; Zhu JX, 2004, CANCER RES, V64, P4309, DOI 10.1158/0008-5472.CAN-03-4063	83	42	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75100	10.1371/journal.pone.0075100	http://dx.doi.org/10.1371/journal.pone.0075100			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086448	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700053
J	Steffan, SA; Chikaraishi, Y; Horton, DR; Ohkouchi, N; Singleton, ME; Miliczky, E; Hogg, DB; Jones, VP				Steffan, Shawn A.; Chikaraishi, Yoshito; Horton, David R.; Ohkouchi, Naohiko; Singleton, Merritt E.; Miliczky, Eugene; Hogg, David B.; Jones, Vincent P.			Trophic Hierarchies Illuminated via Amino Acid Isotopic Analysis	PLOS ONE			English	Article							AQUATIC FOOD-WEB; STABLE-ISOTOPES; DISCRIMINATION FACTORS; LABORATORY EXPERIMENTS; NITROGEN ISOTOPES; DELTA-N-15 VALUES; CONSUMER-DIET; FRACTIONATION; ECOLOGY; POSITION	Food web ecologists have long sought to characterize the trophic niches of animals using stable isotopic analysis. However, distilling trophic position from isotopic composition has been difficult, largely because of the variability associated with trophic discrimination factors (inter-trophic isotopic fractionation and routing). We circumvented much of this variability using compound-specific isotopic analysis (CSIA). We examined the N-15 signatures of amino acids extracted from organisms reared in pure culture at four discrete trophic levels, across two model communities. We calculated the degree of enrichment at each trophic level and found there was a consistent trophic discrimination factor (similar to 7.6 parts per thousand). The constancy of the CSIA-derived discrimination factor permitted unprecedented accuracy in the measurement of animal trophic position. Conversely, trophic position estimates generated via bulk-N-15 analysis significantly underestimated trophic position, particularly among higher-order consumers. We then examined the trophic hierarchy of a free-roaming arthropod community, revealing the highest trophic position (5.07) and longest food chain ever reported using CSIA. High accuracy in trophic position estimation brings trophic function into sharper focus, providing greater resolution to the analysis of food webs.	[Steffan, Shawn A.] ARS, USDA, Madison, WI 53706 USA; [Steffan, Shawn A.; Singleton, Merritt E.; Hogg, David B.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Chikaraishi, Yoshito; Ohkouchi, Naohiko] Japan Agcy Marine Earth Sci & Technol, Inst Biogeosci, Yokosuka, Kanagawa 2370061, Japan; [Horton, David R.; Miliczky, Eugene] ARS, USDA, Yakima Area Res Lab, Wapato, WA USA; [Jones, Vincent P.] Washington State Univ, Ctr Tree Fruit Res & Extens, Dept Entomol, Wenatchee, WA 98801 USA	United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); United States Department of Agriculture (USDA); Washington State University	Steffan, SA (corresponding author), ARS, USDA, Madison, WI 53706 USA.	steffan2@wisc.edu	Steffan, Shawn/AFU-4054-2022; Chikaraishi, Yoshito/O-5250-2019; Ohkouchi, Naohiko/B-2071-2008	Chikaraishi, Yoshito/0000-0002-7506-1524; Steffan, Shawn/0000-0002-2219-6409; Ohkouchi, Naohiko/0000-0002-6355-7469	USDA-ARS [3655-21220-001-00D, 5352-22430-001-13]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding was provided by USDA-ARS appropriated funds (3655-21220-001-00D), as well as grant funds (5352-22430-001-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARROLL DP, 1984, ENVIRON ENTOMOL, V13, P469, DOI 10.1093/ee/13.2.469; Caut S, 2008, CAN J ZOOL, V86, P438, DOI 10.1139/Z08-012; Caut S, 2008, FUNCT ECOL, V22, P255, DOI 10.1111/j.1365-2435.2007.01360.x; Caut S, 2010, J APPL ECOL, V47, P948, DOI 10.1111/j.1365-2664.2010.01832.x; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; Chikaraishi Y., 2010, EARTH LIFE ISOTOPES, P37; Chikaraishi Y, 2007, MAR ECOL PROG SER, V342, P85, DOI 10.3354/meps342085; Chikaraishi Y, 2011, ECOL RES, V26, P835, DOI 10.1007/s11284-011-0844-1; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; Cottingham KL, 2005, FRONT ECOL ENVIRON, V3, P145, DOI 10.1890/1540-9295(2005)003[0145:KWTDTL]2.0.CO;2; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DELRIO CM, 2005, PHYSL ECOLOGICAL ADA, P141; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Eggers T, 2000, TRENDS ECOL EVOL, V15, P265, DOI 10.1016/S0169-5347(00)01877-2; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; Gibson G, 1997, 40392 NAT RES COUNC; Hannides CCS, 2009, LIMNOL OCEANOGR, V54, P50, DOI 10.4319/lo.2009.54.1.0050; HAYES JM, 1990, ORG GEOCHEM, V16, P1115, DOI 10.1016/0146-6380(90)90147-R; Lorrain A, 2009, MAR ECOL PROG SER, V391, P293, DOI 10.3354/meps08215; MACKO SA, 1987, CHEM GEOL, V65, P79, DOI 10.1016/0168-9622(87)90064-9; McCarthy MD, 2007, GEOCHIM COSMOCHIM AC, V71, P4727, DOI 10.1016/j.gca.2007.06.061; McClelland JW, 2003, DEEP-SEA RES PT I, V50, P849, DOI 10.1016/S0967-0637(03)00073-6; McClelland JW, 2002, ECOLOGY, V83, P2173, DOI 10.1890/0012-9658(2002)083[2173:TRATNI]2.0.CO;2; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; McMahon KW, 2010, J ANIM ECOL, V79, P1132, DOI 10.1111/j.1365-2656.2010.01722.x; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; O'Brien DM, 2002, P NATL ACAD SCI USA, V99, P4413, DOI 10.1073/pnas.072346699; Ogawa NO, 2009, ECOL RES, P1; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Popp BN, 2007, TERR ECOL SER, V1, P173; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Schmidt K, 2004, MAR ECOL PROG SER, V266, P43, DOI 10.3354/meps266043; Schmidt SN, 2007, ECOLOGY, V88, P2793, DOI 10.1890/07-0121.1; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Spence KO, 2005, OECOLOGIA, V146, P89, DOI 10.1007/s00442-005-0170-9; Vander Zanden MJ, 1999, ECOLOGY, V80, P1395; Vander Zanden MJ, 1997, CAN J FISH AQUAT SCI, V54, P1142, DOI 10.1139/cjfas-54-5-1142; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; WAINRIGHT SC, 1993, MAR BIOL, V115, P481, DOI 10.1007/BF00349847; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x	45	93	93	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76152	10.1371/journal.pone.0076152	http://dx.doi.org/10.1371/journal.pone.0076152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086703	gold, Green Published			2022-12-27	WOS:000325218700122
J	Yao, B; Vasiljevic, M; Weick, M; Sereno, ME; O'Donnell, PJ; Sereno, SC				Yao, Bo; Vasiljevic, Milica; Weick, Mario; Sereno, Margaret E.; O'Donnell, Patrick J.; Sereno, Sara C.			Semantic Size of Abstract Concepts: It Gets Emotional When You Can't See It	PLOS ONE			English	Article							VOICE-SELECTIVE AREAS; LEXICAL DECISIONS; WORDS; SPEECH; CORTEX; CONCRETENESS; INFORMATION; MEDIATION; LANGUAGE; VALENCE	Size is an important visuo-spatial characteristic of the physical world. In language processing, previous research has demonstrated a processing advantage for words denoting semantically "big" (e. g., jungle) versus "small" (e. g., needle) concrete objects. We investigated whether semantic size plays a role in the recognition of words expressing abstract concepts (e. g., truth). Semantically "big" and "small" concrete and abstract words were presented in a lexical decision task. Responses to "big" words, regardless of their concreteness, were faster than those to "small" words. Critically, we explored the relationship between semantic size and affective characteristics of words as well as their influence on lexical access. Although a word's semantic size was correlated with its emotional arousal, the temporal locus of arousal effects may depend on the level of concreteness. That is, arousal seemed to have an earlier (lexical) effect on abstract words, but a later (post-lexical) effect on concrete words. Our findings provide novel insights into the semantic representations of size in abstract concepts and highlight that affective attributes of words may not always index lexical access.	[Yao, Bo; Weick, Mario] Univ Kent, Sch Psychol, Canterbury, Kent, England; [Yao, Bo] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Vasiljevic, Milica] Univ Cambridge, Inst Publ Hlth, Behav & Hlth Res Unit, Cambridge, England; [Sereno, Margaret E.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [O'Donnell, Patrick J.; Sereno, Sara C.] Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland; [Sereno, Sara C.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	University of Kent; University of Manchester; University of Cambridge; University of Oregon; University of Glasgow; University of Glasgow	Yao, B (corresponding author), Univ Kent, Sch Psychol, Canterbury, Kent, England.	b.yao@kent.ac.uk	Yao, Bo/F-9846-2010	Yao, Bo/0000-0003-1852-2774; Sereno, Sara/0000-0001-7957-9542; Vasiljevic, Milica/0000-0001-7454-7744	Economic and Social Research Council (ESRC) [RES-062-23-1900]; Institute of Neuroscience and Psychology, University of Glasgow; ESRC [ES/G035571/1] Funding Source: UKRI; Economic and Social Research Council [ES/G035571/1] Funding Source: researchfish	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Institute of Neuroscience and Psychology, University of Glasgow; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The study was supported by an Economic and Social Research Council (ESRC) grant RES-062-23-1900 to S.C. Sereno and by the Institute of Neuroscience and Psychology, University of Glasgow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchley RA, 2003, BRAIN LANG, V84, P105, DOI 10.1016/S0093-934X(02)00523-0; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Beattie G, 1999, J LANG SOC PSYCHOL, V18, P438, DOI 10.1177/0261927X99018004005; Bonner J.T., 2006, WHY SIZE MATTERS; Bradley M. M., 1999, C1 U FLOR CTR RES PS, V30, P25; BRUNER JS, 1947, J ABNORM SOC PSYCH, V42, P33, DOI 10.1037/h0058484; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Dahl M, 2001, SCAND J PSYCHOL, V42, P97, DOI 10.1111/1467-9450.00218; Estes Z, 2008, COGNITION, V108, P557, DOI 10.1016/j.cognition.2008.03.003; Fischer MH, 2001, NEUROLOGY, V57, P822, DOI 10.1212/WNL.57.5.822; Greenberg Joseph H., 1966, UNIVERSALS LANGUAGE; Hayes A. F., 2012, PROCESS VERSATILE CO; JAMES CT, 1975, J EXP PSYCHOL HUMAN, V104, P130, DOI 10.1037/0096-1523.1.2.130; Kakolewski KE, 1999, INT J PSYCHOPHYSIOL, V34, P283, DOI 10.1016/S0167-8760(99)00085-9; Kanske P, 2007, BRAIN RES, V1148, P138, DOI 10.1016/j.brainres.2007.02.044; Kiefer M, 2008, J NEUROSCI, V28, P12224, DOI 10.1523/JNEUROSCI.3579-08.2008; Konkle T, 2012, NEURON, V74, P1114, DOI 10.1016/j.neuron.2012.04.036; Kousta ST, 2011, J EXP PSYCHOL GEN, V140, P14, DOI 10.1037/a0021446; Kousta ST, 2009, COGNITION, V112, P473, DOI 10.1016/j.cognition.2009.06.007; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Muller D, 2005, J PERS SOC PSYCHOL, V89, P852, DOI 10.1037/0022-3514.89.6.852; Murray SO, 2006, NAT NEUROSCI, V9, P429, DOI 10.1038/nn1641; Osgood C.E., 1957, MEASUREMENT MEANING; Palazova M, 2013, BRAIN LANG, V125, P264, DOI 10.1016/j.bandl.2013.02.008; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316; Pulvermuller F, 1999, BEHAV BRAIN SCI, V22, P253, DOI 10.1017/S0140525X9900182X; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Roduner E, 2006, CHEM SOC REV, V35, P583, DOI 10.1039/b502142c; RUBIN DC, 1980, J VERB LEARN VERB BE, V19, P736, DOI 10.1016/S0022-5371(80)90415-6; Rubinsten O, 2002, ACTA PSYCHOL, V111, P141, DOI 10.1016/S0001-6918(02)00047-1; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Schacht A, 2009, COGN AFFECT BEHAV NE, V9, P28, DOI 10.3758/CABN.9.1.28; SCHWANENFLUGEL PJ, 1988, J MEM LANG, V27, P499, DOI 10.1016/0749-596X(88)90022-8; Scott GG, 2012, J EXP PSYCHOL LEARN, V38, P783, DOI 10.1037/a0027209; Scott GG, 2009, BIOL PSYCHOL, V80, P95, DOI 10.1016/j.biopsycho.2008.03.010; Sereno M. E., 1993, NEURAL COMPUTATION P; Sereno SC, 2011, Q J EXP PSYCHOL, V64, P1872, DOI 10.1080/17470218.2011.611004; Sereno SC, 2009, Q J EXP PSYCHOL, V62, P1115, DOI 10.1080/17470210802618900; Speer NK, 2009, PSYCHOL SCI, V20, P989, DOI 10.1111/j.1467-9280.2009.02397.x; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; TINBERGEN N, 1950, BEHAVIOUR, V3, P1, DOI 10.1163/156853951X00197; WHALEY CP, 1978, J VERB LEARN VERB BE, V17, P143, DOI 10.1016/S0022-5371(78)90110-X; Wilcox R. R., 2011, INTRO ROBUST ESTIMAT; Yao B, 2012, NEUROIMAGE, V60, P1832, DOI 10.1016/j.neuroimage.2012.01.111; Yao B, 2011, J COGNITIVE NEUROSCI, V23, P3146, DOI 10.1162/jocn_a_00022	46	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75000	10.1371/journal.pone.0075000	http://dx.doi.org/10.1371/journal.pone.0075000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VC	24086421	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000325218700048
J	Chen, YF; Tsai, HY; Wu, KJ; Siao, LR; Wood, WG				Chen, Yuh-Fung; Tsai, Huei-Yann; Wu, Kuo-Jen; Siao, Lian-Ru; Wood, W. Gibson			Pipoxolan Ameliorates Cerebral Ischemia via Inhibition of Neuronal Apoptosis and Intimal Hyperplasia through Attenuation of VSMC Migration and Modulation of Matrix Metalloproteinase-2/9 and Ras/MEK/ERK Signaling Pathways	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; CAROTID-ARTERY LIGATION; IN-VITRO; NEOINTIMAL FORMATION; BALLOON ANGIOPLASTY; PROLIFERATION; EXPRESSION; REPLICATION; MECHANISMS; INVASION	Pipoxolan (PIPO) has anti-spasmodic effects, and it is used clinically to relieve smooth muscle spasms. Cerebrovascular disease is one of the leading causes of disability and death worldwide. The main aim of this study was to investigate the effects of PIPO on cerebral ischemia and vascular smooth muscle cell (VSMC) migration in vivo and in vitro. Cerebral infarction area, ratio of intima to media area (I/M ratio) and PCNA antibody staining of the carotid artery in vivo were measured. Cell viability of A7r5 cells, PDGF-BB-stimulated cell migration, and potential mechanisms of PIPO were evaluated by wound healing, transwell and Western blotting. PIPO (10 and 30 mg/kg p.o.) reduced: the cerebral infarction area; neurological deficit; TUNEL-positive cells; cleaved caspase 3-positive cells; intimal hyperplasia; and inhibited proliferating cell nuclear antigen (PCNA)-positive cells in rodents. PIPO (5, 10 and 15 mu M) significantly inhibited PDGF-BB-stimulated VSMC migration and reduced Ras, MEK, and p-ERK levels. Moreover, PIPO decreased levels of matrix metalloproteinases -2 and -9 in PDGF-BB-stimulated A7r5 cells. In summary, PIPO is protective in models of ischemia/reperfusion-induced cerebral infarction, carotid artery ligation-induced intimal hyperplasia and VSMC migration both in vivo and in vitro. PIPO could be potentially efficacious in preventing cerebrovascular and vascular diseases.	[Chen, Yuh-Fung; Wu, Kuo-Jen; Siao, Lian-Ru] China Med Univ, Coll Med, Dept Pharmacol, Taichung, Taiwan; [Chen, Yuh-Fung; Tsai, Huei-Yann] China Med Univ Hosp, Dept Pharm, Taichung, Taiwan; [Wood, W. Gibson] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Wood, W. Gibson] VA Med Ctr, Geriatr Res Educ & Clin Ctr, Minneapolis, MN USA	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Minnesota System; University of Minnesota Twin Cities; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Chen, YF (corresponding author), China Med Univ, Coll Med, Dept Pharmacol, Taichung, Taiwan.	yfchen@mail.cmu.edu.tw			China Medical University [CMU99-COL-42-1, CMU99-COL-42-2]; National Science Council, Taiwan, ROC [NSC101-2320-B-039-026]	China Medical University(China Medical University); National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This study was partially supported by grants from China Medical University (CMU99-COL-42-1, CMU99-COL-42-2) and National Science Council (NSC101-2320-B-039-026), Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AH, 1998, J CLIN INVEST, V101, P1478, DOI 10.1172/JCI1584; BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539; Berk BC, 2001, PHYSIOL REV, V81, P999, DOI 10.1152/physrev.2001.81.3.999; BORNFELDT KE, 1994, J CLIN INVEST, V93, P1266, DOI 10.1172/JCI117081; Chandrasekar B, 2000, J AM COLL CARDIOL, V35, P555, DOI 10.1016/S0735-1097(99)00596-3; Chen YF, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/482428; Chlud K, 1969, Med Welt, V33, P1801; Cho A, 2002, CIRC RES, V91, P845, DOI 10.1161/01.RES.0000040420.17366.2E; DOLLERY CM, 1995, CIRC RES, V77, P863, DOI 10.1161/01.RES.77.5.863; Fateev IV, 2012, B EXP BIOL MED+, V152, P378, DOI 10.1007/s10517-012-1533-y; Felix W, 1969, DRUG RES, V19, P1860; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Gennaro G, 2004, CIRCULATION, V110, P3367, DOI 10.1161/01.CIR.0000147773.86866.CD; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; GORELICK PB, 1986, NURS CLIN N AM, V21, P275; HALL PA, 1990, J PATHOL, V162, P285, DOI 10.1002/path.1711620403; Hasso A N, 1994, Neuroimaging Clin N Am, V4, P733; Indolfi C, 1999, Cardiol Rev, V7, P324, DOI 10.1097/00045415-199911000-00010; Johnson C, 2004, ARTERIOSCL THROM VAS, V24, P54, DOI 10.1161/01.ATV.0000100402.69997.C3; Kumar A, 1997, CIRCULATION, V96, P4333; Kuzuya M, 2003, CIRCULATION, V108, P1375, DOI 10.1161/01.CIR.0000086463.15540.3C; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Marti-Vilalta JL, 1999, REV NEUROLOGIA, V28, P1016, DOI 10.33588/rn.2810.99061; MINEMATSU K, 1992, STROKE, V23, P1304, DOI 10.1161/01.STR.23.9.1304; MORSDORF K, 1970, PHARMACOLOGY, V3, P193, DOI 10.1159/000136072; Muslin AJ, 2008, CLIN SCI, V115, P203, DOI 10.1042/CS20070430; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; PAILER M, 1968, MONATSH CHEM, V99, P891, DOI 10.1007/BF00913736; PAULY RR, 1994, CIRC RES, V75, P41, DOI 10.1161/01.RES.75.1.41; Peng CC, 2007, J ETHNOPHARMACOL, V109, P93, DOI 10.1016/j.jep.2006.07.009; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SCHWARTZ SM, 1986, CIRC RES, V58, P427, DOI 10.1161/01.RES.58.4.427; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; Shafi N, 2011, NEUROTHERAPEUTICS, V8, P425, DOI 10.1007/s13311-011-0041-5; Sorriento D, 2012, HYPERTENSION, V60, P129, DOI 10.1161/HYPERTENSIONAHA.111.189605; Terasoma K, 1971, Hinyokika Kiyo, V17, P592; Vali A F, 1972, Schweiz Rundsch Med Prax, V61, P893; WEXLER BC, 1979, AGE, V2, P39, DOI 10.1007/BF02432254; WEXLER BC, 1975, STROKE, V6, P432, DOI 10.1161/01.STR.6.4.432; Wu KJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/656150; Wu KJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/163106; Zempo N, 1996, ARTERIOSCL THROM VAS, V16, P28, DOI 10.1161/01.ATV.16.1.28	44	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75654	10.1371/journal.pone.0075654	http://dx.doi.org/10.1371/journal.pone.0075654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086601	gold, Green Submitted, Green Published			2022-12-27	WOS:000325025200058
J	Etang, J; Nwane, P; Piameu, M; Manga, B; Souop, D; Awono-Ambene, P				Etang, Josiane; Nwane, Philippe; Piameu, Michael; Manga, Blaise; Souop, Daniel; Awono-Ambene, Parfait			Evaluation of New Tools for Malaria Vector Control in Cameroon: Focus on Long Lasting Insecticidal Nets	PLOS ONE			English	Article							TREATED NETS; WASH-RESISTANCE; ANOPHELES-ARABIENSIS; TANZANIA; EFFICACY; INDIA; INTERCEPTOR(R); AREA	Background: From 2006 to 2011, biological activity of insecticides for Indoor Residual Spraying (IRS), conventional treatment of nets (CTNs) or long lasting insecticidal nets (LLINs) was evaluated before their approval in Cameroon. The objective of the study was to select the best tools for universal malaria vector control coverage. Methodology: Bioassays were performed using WHO cones and the Kisumu susceptible strain of Anopheles gambiae s.s.. Among tested products, residual activity and wash resistance of Alpha-cypermethrin LLINs (Interceptor) and CTNs (Fendona) were assessed during 5 months in the Ntougou neighborhood. Principal Findings: All the 14 tested products were found effective (95-100% knockdown and mortality rates), although a significant decrease of efficacy was seen with lambda-cyhalothrinWP IRS, alpha-cypermethrin CTNs and LLINs (p< 0.05). However, the efficacy of Interceptor nets did not decrease during the 5 months evaluation, even after 25 washes (0.07<p<0.9). Meanwhile Fendona SC nets displayed a drastic decrease of activity after 5 washes, odds ratio was 3.07 (1.0-8.59). Conclusion: This study provided useful data for decision making and community education toward universal coverage of malaria vector control in Cameroon.	[Etang, Josiane; Piameu, Michael; Awono-Ambene, Parfait] Org Coordinat Lutte Endemies Afrique Cent OCEAC, Lab Med Entomol, Yaounde, Cameroon; [Etang, Josiane] Univ Douala, Fac Med & Pharmaceut Sci, Douala, Cameroon; [Nwane, Philippe] Univ Yaounde I, Fac Sci, Yaounde, Cameroon; [Piameu, Michael] Univ Catholique Afrique Cent, Ctr Super Sci Sante, Yaounde, Cameroon; [Manga, Blaise] Minist Publ Hlth, Div Hlth Promot, Yaounde, Cameroon; [Souop, Daniel] Minist Agr & Rural Dev, Serv Pesticide Regulat, Yaounde, Cameroon	University of Yaounde I	Etang, J (corresponding author), Org Coordinat Lutte Endemies Afrique Cent OCEAC, Lab Med Entomol, Yaounde, Cameroon.	josyet2@gmail.com		PIAMEU, Michael/0000-0001-7409-3359	Ministry of Public Health; Ministry of Agriculture and Rural development in Cameroon	Ministry of Public Health; Ministry of Agriculture and Rural development in Cameroon	The study was funded by partners of the Ministry of Public Health and the Ministry of Agriculture and Rural development in Cameroon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, COCHRANE DB SYST REV; Banek K, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-84; Beier JC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S4; Bhatt RM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-189; Clarke SE, 2001, T ROY SOC TROP MED H, V95, P457, DOI 10.1016/S0035-9203(01)90001-X; Darriet F, 1998, Med Trop (Mars), V58, P349; Dev V, 2010, T ROY SOC TROP MED H, V104, P273, DOI 10.1016/j.trstmh.2009.08.010; Erlanger TE, 2004, MED VET ENTOMOL, V18, P153, DOI 10.1111/j.0269-283X.2004.00491.x; Etang J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-333; Gimnig JE, 2005, TROP MED INT HEALTH, V10, P1022, DOI 10.1111/j.1365-3156.2005.01481.x; Hougard JM, 2003, B WORLD HEALTH ORGAN, V81, P324; Lindblade KA, 2005, TROP MED INT HEALTH, V10, P1141, DOI 10.1111/j.1365-3156.2005.01501.x; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; Maxwell CA, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-28; Miller JE, 1999, TROP MED INT HEALTH, V4, P167, DOI 10.1046/j.1365-3156.1999.43378.x; Mosha FW, 2008, ANN TROP MED PARASIT, V102, P367, DOI 10.1179/136485908X278829; Norris LC, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-254; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Sharma SK, 2010, ACTA TROP, V116, P24, DOI 10.1016/j.actatropica.2010.05.002; Tami A, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-19; Tanner M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-24; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2005, WHOCDSWHOPESGCDPP200; WHO, 2011, GUID MON DUR LONG LA; WHO, 2004, WHOCDSCPEPCV200410; WHO, 2006, WHO GUID TEST MOSQ A; WHO, GLOB PLAN INS RES MA; WHO, 2007, WHO REC INS PROD TRE; [WHO] World Health Organization, 2009, WHO REC INS IND RES; World Health Organisation WHO, 2012, WHO REC LONG LAST IN; World Health Organization, 2012, 15 WHOPES WORK GROUP	31	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74929	10.1371/journal.pone.0074929	http://dx.doi.org/10.1371/journal.pone.0074929			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086399	gold, Green Submitted, Green Published			2022-12-27	WOS:000326520200055
J	Lou, Y; Peng, WJ; Cao, DS; Xie, J; Li, HH; Jiang, ZX				Lou, Yin; Peng, Wen-jia; Cao, Dong-sheng; Xie, Juan; Li, Hong-hong; Jiang, Zheng-xuan			DNA Repair Gene XRCC1 Polymorphisms and Head and Neck Cancer Risk: An Updated Meta-Analysis Including 16344 Subjects	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; SINGLE-NUCLEOTIDE POLYMORPHISMS; ORAL-CANCER; NASOPHARYNGEAL CARCINOMA; LARYNGEAL-CANCER; ASSOCIATION; SMOKING; DAMAGE; XPD; LEUKOPLAKIA	Background: DNA repair gene X-ray repair cross complementing group 1 (XRCC1) plays an important role in the maintenance of the genomic integrity and protection of cells from DNA damage. Sequence variation in XRCC1 gene may alter head and neck cancer (HNC) susceptibility. However, these results are inconclusive. To derive a more precise estimation of the relationship between XRCC1 polymorphism and HNC risk, we undertook a meta-analysis involving 16,344 subjects. Methods: A search of the literature by PubMed, Embase, Web of Science and China National Knowledge Infrastructure was performed to identify studies based on the predetermined inclusion criteria. The odds ratio (OR) with 95% confidence interval (CI) was combined using a random-effects model or a fixed-effects model. Results: Twenty-nine studies consisting of 6,719 cases and 9,627 controls were identified and analyzed. Overall, no evidence of significant association was observed between XRCC1 Arg194Trp, XRCC1 Arg280His, XRCC1 Arg399Gln genotypes and the risk of HNC in any genetic models. Subgroup analyses according to ethnicity, tumor site, publication year, genotyping method also detected no significant association in any subgroup, except that oral cancer was associated with Arg194Trp variant in recessive model. Furthermore, no significant effect of these polymorphisms interacted with smoking on HNC risk was detected but Arg194Trp homozygous variant. Conclusion: In conclusion, this meta-analysis suggests that the XRCC1 Arg194Trp, Arg280His and Arg399Gln polymorphism may not involve in HNC susceptibility. Further studies about gene-gene and gene-environment interactions in different populations are required.	[Lou, Yin; Cao, Dong-sheng; Xie, Juan; Li, Hong-hong] Anhui Med Univ, Hosp 2, Dept Plast Surg, Hefei, Peoples R China; [Peng, Wen-jia] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Peoples R China; [Jiang, Zheng-xuan] Anhui Med Univ, Hosp 2, Dept Ophthalmol, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Cao, DS (corresponding author), Anhui Med Univ, Hosp 2, Dept Plast Surg, Hefei, Peoples R China.	dscao1966@126.com						Al-Hadyan KS, 2012, GENET TEST MOL BIOMA, V16, P95, DOI 10.1089/gtmb.2011.0126; Applebaum KM, 2009, INT J CANCER, V124, P2690, DOI 10.1002/ijc.24256; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Cao Y, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-167; Cho EY, 2003, CANCER EPIDEM BIOMAR, V12, P1100; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Csejtei A, 2009, ANTICANCER RES, V29, P4169; Demokan S, 2005, PATHOL ONCOL RES, V11, P22, DOI 10.1007/BF03032401; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; dos Reis MB, 2013, J ORAL PATHOL MED, V42, P180, DOI 10.1111/j.1600-0714.2012.01192.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Flores-Obando RE, 2010, BIOMARKERS, V15, P379, DOI 10.3109/13547501003797664; Gajecka M, 2005, ADV OTO-RHINO-LARYNG, V62, P25; Gal TJ, 2005, LARYNGOSCOPE, V115, P2221, DOI 10.1097/01.mlg.0000183736.96004.f7; Geisler SA, 2001, AM J EPIDEMIOL, V154, P95, DOI 10.1093/aje/154.2.95; Gugatschka M, 2011, EXP MOL PATHOL, V91, P331, DOI 10.1016/j.yexmp.2011.03.004; Harth V, 2008, J TOXICOL ENV HEAL A, V71, P887, DOI 10.1080/15287390801988160; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HIYAMA T, 1992, JPN J CANCER RES, V83, P334, DOI 10.1111/j.1349-7006.1992.tb00111.x; Ho T, 2007, CANCER, V110, P318, DOI 10.1002/cncr.22794; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Jelonek K, 2010, J APPL GENET, V51, P343, DOI 10.1007/BF03208865; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Khlifi R, 2012, J GENET, V91, P375, DOI 10.1007/s12041-012-0193-z; Kietthubthew S, 2006, INT J HYG ENVIR HEAL, V209, P21, DOI 10.1016/j.ijheh.2005.06.002; Kostrzewska-Poczekaj M, 2013, EUR ARCH OTO-RHINO-L, V270, P271, DOI 10.1007/s00405-012-1993-8; Kowalski M, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-37; Kumar A, 2012, TUMOR BIOL, V33, P111, DOI 10.1007/s13277-011-0253-7; Kumar A, 2012, MUTAT RES-FUND MOL M, V729, P24, DOI 10.1016/j.mrfmmm.2011.09.001; Laantri N, 2011, MOL CARCINOGEN, V50, P732, DOI 10.1002/mc.20754; Li CY, 2007, CANCER-AM CANCER SOC, V110, P867, DOI 10.1002/cncr.22861; Mahjabeen I, 2013, PATHOL ONCOL RES, V19, P183, DOI 10.1007/s12253-012-9567-z; Majumder M, 2005, CANCER EPIDEM BIOMAR, V14, P2106, DOI 10.1158/1055-9965.EPI-05-0108; Majumder M, 2007, INT J CANCER, V120, P2148, DOI 10.1002/ijc.22547; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marcu LG, 2009, J CANCER RES CLIN, V135, P1303, DOI 10.1007/s00432-009-0648-7; Matullo G, 2006, CARCINOGENESIS, V27, P997, DOI 10.1093/carcin/bgi280; Olshan AF, 2002, CANCER LETT, V178, P181, DOI 10.1016/S0304-3835(01)00822-9; Parkin DM, 1999, CA-CANCER J CLIN, V49, P33, DOI 10.3322/canjclin.49.1.33; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Pratesi N, 2011, RADIOTHER ONCOL, V99, P356, DOI 10.1016/j.radonc.2011.05.062; Ramachandran S, 2006, ORAL ONCOL, V42, P350, DOI 10.1016/j.oraloncology.2005.08.010; Ruwali M, 2009, ENVIRON MOL MUTAGEN, V50, P473, DOI 10.1002/em.20488; Rydzanicz M, 2005, CANCER LETT, V224, P263, DOI 10.1016/j.canlet.2005.01.015; SILVERMAN S, 1990, J AM DENT ASSOC, V120, P495, DOI 10.14219/jada.archive.1990.0082; Sturgis EM, 1999, CARCINOGENESIS, V20, P2125, DOI 10.1093/carcin/20.11.2125; Tae K, 2004, INT J CANCER, V111, P805, DOI 10.1002/ijc.20338; Vaezi A, 2011, PHARMACOGEN PERS MED, V4, P47, DOI 10.2147/PGPM.S20317; Varzim G, 2003, EUR J CANCER PREV, V12, P495, DOI 10.1097/00008469-200312000-00008; Yang CH, 2012, KAOHSIUNG J MED SCI, V28, P362, DOI 10.1016/j.kjms.2012.02.002; Yang ZH, 2007, DNA CELL BIOL, V26, P491, DOI 10.1089/dna.2006.0537; Yen CY, 2008, J ORAL PATHOL MED, V37, P271, DOI 10.1111/j.1600-0714.2007.00608.x; Yu HP, 2004, CANCER DETECT PREV, V28, P194, DOI 10.1016/j.cdp.2004.01.004; Yuan H, 2012, EXP THER MED, V3, P719, DOI 10.3892/etm.2012.476; Zhong Y, 2011, CHEM RES TOXICOL, V24, P246, DOI 10.1021/tx100345x; Zhou CC, 2009, TOHOKU J EXP MED, V219, P43, DOI 10.1620/tjem.219.43	57	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74059	10.1371/journal.pone.0074059	http://dx.doi.org/10.1371/journal.pone.0074059			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086310	gold, Green Submitted, Green Published			2022-12-27	WOS:000326520200019
J	Xu, L; Zhou, X; Jiang, F; Qiu, MT; Zhang, Z; Yin, R; Xu, L				Xu, Lei; Zhou, Xin; Jiang, Feng; Qiu, Man-Tang; Zhang, Zhi; Yin, Rong; Xu, Lin			FASL rs763110 Polymorphism Contributes to Cancer Risk: An Updated Meta-Analysis Involving 43,295 Subjects	PLOS ONE			English	Article							DEATH PATHWAY GENES; SQUAMOUS-CELL CARCINOMA; FUNCTIONAL POLYMORPHISMS; LIGAND GENES; BREAST-CANCER; LUNG-CANCER; APOPTOSIS; PROGRESSION; SUSCEPTIBILITY; ASSOCIATION	Background: Published studies investigating the association between genetic polymorphism -884C/T (rs763110) of the FAS ligand (FASL) promoter and cancer risk reported inconclusive results. To derive a more precise estimation of the relationship, we performed an updated meta-analysis of all eligible studies. Methodology/Principal Findings: We carried out a meta-analysis, including 47 studies with 19,810 cases and 23,485 controls, to confirm a more conclusive association between the FASL rs763110 polymorphism and cancer susceptibility. Overall, significantly reduced cancer risk was associated with the variant -884T when all studies were pooled (TC vs. CC: OR = 0.83, 95% CI = 0.75-0.92; P-heterogeneity < 0.001; TT+TC vs. CC: OR = 0.85, 95% CI = 0.77-0.94; P-heterogeneity < 0.001). Stratified analysis revealed that there was a statistically reduced cancer risk in Asians (TC vs. CC: OR = 0.76, 95% CI = 0.67-0.87; P-heterogeneity < 0.001; TT+TC vs. CC: OR = 0.79, 95% CI = 0.70-0.90; P-heterogeneity < 0.001) and in patients with cancers of head and neck (TC vs. CC: OR = 0.87, 95% CI = 0.77-0.99; P-heterogeneity = 0.118; TT+TC vs. CC: OR = 0.88, 95% CI = 0.78-0.99; P-heterogeneity = 0.168) and ovarian cancer (TC vs. CC: OR = 0.67, 95% CI = 0.49-0.90; P-heterogeneity = 0.187; TT+TC vs. CC: OR = 0.64, 95% CI = 0.48-0.86; P-heterogeneity = 0.199). Meta-regression showed that ethnicity (p = 0.029) and genotyping method (p = 0.043) but not cancer types (p = 0.772), sample size (p = 0.518), or source of controls (p = 0.826) were the source of heterogeneity in heterozygote comparison. Conclusion: Our results suggest that the FASL polymorphism rs763110 is associated with a significantly reduced risk of cancer, especially in Asian populations.	[Xu, Lei; Qiu, Man-Tang] Nanjing Med Univ, Clin Coll 4, Nanjing, Jiangsu, Peoples R China; [Xu, Lei; Jiang, Feng; Qiu, Man-Tang; Zhang, Zhi; Yin, Rong; Xu, Lin] Nanjing Med Univ, Affiliated Canc Hosp, Canc Inst Jiangsu Prov, Dept Thorac Surg, Nanjing, Jiangsu, Peoples R China; [Zhou, Xin] Nanjing Med Univ, Clin Coll 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Xu, L (corresponding author), Nanjing Med Univ, Affiliated Canc Hosp, Canc Inst Jiangsu Prov, Dept Thorac Surg, Nanjing, Jiangsu, Peoples R China.	yinhero001@126.com	Qiu, Mantang/L-8937-2019		National Natural Science Foundation of China [81201830]; Natural Science Key Research Fundation of Jiangsu Province [BK2011036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Key Research Fundation of Jiangsu Province	This work was supported by the National Natural Science Foundation of China (81201830) and Natural Science Key Research Fundation of Jiangsu Province (BK2011036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao Y, 2010, MOL CARCINOGEN, V49, P944, DOI 10.1002/mc.20676; Chatterjee Koushik, 2009, BMC Res Notes, V2, P238, DOI 10.1186/1756-0500-2-238; Chen Xia-bin, 2009, Zhonghua Yufang Yixue Zazhi, V43, P559, DOI 10.3760/cma.j.issn.0253-9624.2009.07.006; Crew KD, 2007, CARCINOGENESIS, V28, P2548, DOI 10.1093/carcin/bgm211; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Erdogan M, 2007, J ENDOCRINOL INVEST, V30, P411, DOI 10.1007/BF03346319; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gastman BR, 1999, CANCER RES, V59, P5356; Gormus U, 2007, ANTICANCER RES, V27, P991; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hashemi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053075; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hsu PI, 2008, ANTICANCER RES, V28, P97; Ivansson EL, 2007, INT J CANCER, V121, P2451, DOI 10.1002/ijc.22989; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang S, 2008, CANCER GENET CYTOGEN, V180, P1, DOI 10.1016/j.cancergencyto.2007.09.002; Karimi MY, 2013, CANCER INVEST, V31, P1, DOI 10.3109/07357907.2012.743555; Kim HJ, 2010, DNA CELL BIOL, V29, P619, DOI 10.1089/dna.2010.1032; Krippl P, 2004, J NATL CANCER I, V96, P1478, DOI 10.1093/jnci/djh289; Kupcinskas J, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-112; Lai HC, 2005, GYNECOL ONCOL, V99, P113, DOI 10.1016/j.ygyno.2005.05.010; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Li CP, 2006, PHARMACOGENET GENOM, V16, P245, DOI 10.1097/01.fpc.0000194425.58511.a7; Li CY, 2006, PHARMACOGENET GENOM, V16, P253, DOI 10.1097/01.fpc.0000199501.54466.de; Li Y, 2013, GYNECOL ONCOL, V128, P584, DOI 10.1016/j.ygyno.2012.12.002; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lin YD, 2013, ANN THORAC SURG, V95, P412, DOI 10.1016/j.athoracsur.2012.08.012; Liu J, 2012, CHINESE J HLTH HERED, V20, P28; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Liu Y, 2009, EUR J CANCER, V45, P2574, DOI 10.1016/j.ejca.2009.04.001; Los M, 1999, IMMUNITY, V10, P629, DOI 10.1016/S1074-7613(00)80062-X; LOS M, 1995, NATURE, V375, P81, DOI 10.1038/375081a0; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Mahfoudh W, 2012, HUM IMMUNOL, V73, P932, DOI 10.1016/j.humimm.2012.06.001; Park SH, 2006, LUNG CANCER, V54, P303, DOI 10.1016/j.lungcan.2006.09.002; Qureshi A, 2010, J DERMATOL SCI, V58, P78, DOI 10.1016/j.jdermsci.2010.01.003; Randhawa SR, 2010, ANN ALLERG ASTHMA IM, V104, P286, DOI 10.1016/j.anai.2010.01.021; Rashedi I, 2007, CURR MED CHEM, V14, P3139, DOI 10.2174/092986707782793952; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Shao PF, 2011, PROSTATE, V71, P1122, DOI 10.1002/pros.21328; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sun T, 2004, JNCI-J NATL CANCER I, V96, P1030, DOI 10.1093/jnci/djh187; Sun T, 2005, J EXP MED, V202, P967, DOI 10.1084/jem.20050707; TAKAHASHI T, 1994, INT IMMUNOL, V6, P1567, DOI 10.1093/intimm/6.10.1567; Ter-Minassian M, 2008, CARCINOGENESIS, V29, P2147, DOI 10.1093/carcin/bgn205; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tong N, 2012, LEUKEMIA LYMPHOMA, V53, P1360, DOI 10.3109/10428194.2011.654117; Villa-Morales M, 2012, EXPERT OPIN THER TAR, V16, P85, DOI 10.1517/14728222.2011.628937; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang JW, 2013, GENE, V524, P193, DOI 10.1016/j.gene.2013.04.034; Wang LH, 2010, J ORAL PATHOL MED, V39, P155, DOI 10.1111/j.1600-0714.2009.00873.x; Wang ML, 2009, BIOCHEM GENET, V47, P559, DOI 10.1007/s10528-009-9264-0; Wang WM, 2012, ONCOL LETT, V3, P625, DOI 10.3892/ol.2011.541; Wu JM, 2003, J IMMUNOL, V170, P132, DOI 10.4049/jimmunol.170.1.132; Wu SF, 2012, EUR REV MED PHARMACO, V16, P2044; Yang M, 2008, CLIN CANCER RES, V14, P3230, DOI 10.1158/1078-0432.CCR-08-0177; Yang Shen, 2005, Zhonghua Yi Xue Za Zhi, V85, P2132; Zhai RH, 2010, J CLIN ONCOL, V28, P2445, DOI 10.1200/JCO.2009.26.2790; Zhang BL, 2007, CARCINOGENESIS, V28, P1067, DOI 10.1093/carcin/bgl250; Zhang H, 2007, CANCER J, V13, P233, DOI 10.1097/PPO.0b013e318046f214; Zhang M, 2010, MED LAB CLIN, V21, P1; Zhang M, 2010, MED LAB CLIN, V21, P6; Zhang M, 2011, J SHANGDONG U HLTH S, V49, P107; Zhang WM, 2012, HEPATO-GASTROENTEROL, V59, P141, DOI 10.5754/hge11300; Zhang X, 2005, J MED GENET, V42, P479, DOI 10.1136/jmg.2004.030106; Zhang Z, 2006, CLIN CANCER RES, V12, P5596, DOI 10.1158/1078-0432.CCR-05-1739; Zhang ZZ, 2009, EUR J HUM GENET, V17, P1294, DOI 10.1038/ejhg.2009.45; Zhou RM, 2010, J GASTROEN HEPATOL, V25, P555, DOI 10.1111/j.1440-1746.2009.06116.x; Zhu JA, 2010, MOL CARCINOGEN, V49, P810, DOI 10.1002/mc.20656	71	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74543	10.1371/journal.pone.0074543	http://dx.doi.org/10.1371/journal.pone.0074543			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086353	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200035
J	Esteves, CL; Verma, M; Rog-Zielinska, E; Kelly, V; Sai, S; Breton, A; Donadeu, FX; Seckl, JR; Chapman, KE				Esteves, Cristina L.; Verma, Manu; Rog-Zielinska, Ewa; Kelly, Val; Sai, Shuji; Breton, Amandine; Donadeu, Francesc X.; Seckl, Jonathan R.; Chapman, Karen E.			Pro-Inflammatory Cytokine Induction of 11 beta-hydroxysteroid Dehydrogenase Type 1 in A549 Cells Requires Phosphorylation of C/EBP beta at Thr235	PLOS ONE			English	Article							BINDING-PROTEIN-BETA; MAP KINASE PATHWAY; GLUCOCORTICOID METABOLISM; GENE-EXPRESSION; HUMAN OBESITY; TRANSCRIPTION; ACTIVATION; MECHANISM; TISSUE; PROMOTER	11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) converts inert glucocorticoids into active forms, thereby increasing intracellular glucocorticoid levels, important to restrain acute inflammation. 11 beta-HSD1 is induced by pro-inflammatory cytokines in a variety of cells. Here, we show 11 beta-HSD1 expression in human A549 epithelial cells is increased by pro-inflammatory cytokines (IL-1 alpha/TNF alpha) via the P2 promoter of the HSD11B1 gene. Inhibition of p38 MAPK attenuated the pro-inflammatory cytokine induction of mRNA encoding 11 beta-HSD1 as well as that encoding C/EBP beta. IL-1 alpha/TNF alpha-induced phosphorylation of C/EBP beta at Thr235 was also attenuated by p38 MAPK inhibition suggesting involvement of a p38 MAPK-C/EBP beta pathway. siRNA-mediated knock-down of C/EBP beta and NF-kappa B/RelA implicated both transcription factors in the IL-1 alpha/TNF alpha induction of HSD11B1 mRNA. Transient transfections of HSD11B1 promoter-reporter constructs identified the proximal region of the P2 promoter of HSD11B1 as essential for this induction. IL-1 alpha increased binding of C/EBP beta to the HSD11B1 P2 promoter, but this was not observed for NF-kappa B/RelA, suggesting indirect regulation by NF-kappa B/RelA. Ectopic expression of mutant chicken C/EBP beta constructs unable to undergo phosphorylation at the threonine equivalent to Thr235 attenuated the IL-1 alpha-induction of HSD11B1, whereas mimicking constitutive phosphorylation of Thr235 (by mutation to aspartate) increased basal expression of HSD11B1 mRNA without affecting IL-1 alpha-induced levels. These data clearly demonstrate a role for both C/EBP beta and NF-kappa B/RelA in the pro-inflammatory cytokine induction of HSD11B1 in human epithelial cells and show that p38 MAPK-induced phosphorylation of C/EBP beta at Thr235 is critical in this.	[Esteves, Cristina L.; Verma, Manu; Rog-Zielinska, Ewa; Kelly, Val; Sai, Shuji; Seckl, Jonathan R.; Chapman, Karen E.] Univ Edinburgh, Queens Med Res Inst, Univ BHF Ctr Cardiovasc Sci, Endocrinol Unit, Edinburgh, Midlothian, Scotland; [Breton, Amandine; Donadeu, Francesc X.] Univ Edinburgh, Roslin Inst, Div Dev Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Chapman, KE (corresponding author), Univ Edinburgh, Queens Med Res Inst, Univ BHF Ctr Cardiovasc Sci, Endocrinol Unit, Edinburgh, Midlothian, Scotland.	Karen.Chapman@ed.ac.uk	Sai, Shuji/W-1456-2019; Esteves, Cristina/Y-5577-2019	Verma, Manu/0000-0002-5689-2808; Chapman, Karen/0000-0001-7777-6817	Wellcome Trust [WT083184]; Medical Research Council [MR/K026992/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Wellcome Trust Programme Grant (grant number WT083184 to JRS and KEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahasan MM, 2012, ARTHRITIS RHEUM-US, V64, P2404, DOI 10.1002/art.34414; Arai N, 2007, ENDOCRINOLOGY, V148, P5268, DOI 10.1210/en.2007-0349; Atalar F, 2012, GENET MOL RES, V11, P3122, DOI 10.4238/2012.August.31.10; Balachandran A, 2008, ENDOCRINOLOGY, V149, P4069, DOI 10.1210/en.2008-0088; Bruley C, 2006, ENDOCRINOLOGY, V147, P2879, DOI 10.1210/en.2005-1621; Chapman KE, 2013, J STEROID BIOCHEM, V137, P82, DOI 10.1016/j.jsbmb.2013.02.002; Chapman KE, 2009, MOL CELL ENDOCRINOL, V301, P123, DOI 10.1016/j.mce.2008.09.031; Dahl JA, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1158; Esteves CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037953; Gout J, 2006, BIOCHIMIE, V88, P1115, DOI 10.1016/j.biochi.2006.05.020; Hadoke PWF, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0320-1; Hardy R, 2008, ANN RHEUM DIS, V67, P1204, DOI 10.1136/ard.2008.090662; Hardy RS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1993; Hata K, 2005, MOL CELL BIOL, V25, P1971, DOI 10.1128/MCB.25.5.1971-1979.2005; Horie R, 2007, MICROBES INFECT, V9, P721, DOI 10.1016/j.micinf.2007.02.017; Ignatova ID, 2009, AM J PHYSIOL-ENDOC M, V296, pE367, DOI 10.1152/ajpendo.90531.2008; Kowenz-Leutz E, 2010, EMBO J, V29, P1105, DOI 10.1038/emboj.2010.3; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Li HX, 2008, CYTOKINE, V41, P1, DOI 10.1016/j.cyto.2007.09.016; Malavasi ELV, 2010, ENDOCRINOLOGY, V151, P195, DOI 10.1210/en.2009-0663; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Sai S, 2008, MOL ENDOCRINOL, V22, P2049, DOI 10.1210/me.2007-0489; Sai S, 2011, LEUKEMIA RES, V35, P1644, DOI 10.1016/j.leukres.2011.07.002; Staab CA, 2011, CHEM-BIOL INTERACT, V191, P104, DOI 10.1016/j.cbi.2010.12.027; Svotelis A, 2005, BIOCHEM BIOPH RES CO, V328, P461, DOI 10.1016/j.bbrc.2005.01.002; Tanoue TJ, 2003, CELL SIGNAL, V15, P455, DOI 10.1016/S0898-6568(02)00112-2; Wake DJ, 2003, J CLIN ENDOCR METAB, V88, P3983, DOI 10.1210/jc.2003-030286; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; Williams LJS, 2000, J BIOL CHEM, V275, P30232, DOI 10.1074/jbc.M001286200; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Yang Z, 2009, ENDOCRINE, V36, P404, DOI 10.1007/s12020-009-9245-4; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	35	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75874	10.1371/journal.pone.0075874	http://dx.doi.org/10.1371/journal.pone.0075874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086653	Green Published, Green Submitted, gold			2022-12-27	WOS:000325220000050
J	Fowler, AM; Booth, DJ				Fowler, Ashley M.; Booth, David J.			Seasonal Dynamics of Fish Assemblages on Breakwaters and Natural Rocky Reefs in a Temperate Estuary: Consistent Assemblage Differences Driven by Sub-Adults	PLOS ONE			English	Article							CORAL-REEF; ARTIFICIAL REEF; INTERTIDAL ASSEMBLAGES; HABITAT COMPLEXITY; BOTANY BAY; RED-SEA; RECRUITMENT; AUSTRALIA; USA; COMMUNITIES	Development of infrastructure around cities is rapidly increasing the amount of artificial substrate (termed artificial reef, 'AR') in coastal marine habitats. However, effects of ARs on marine communities remain unknown, because it is unclear whether ARs can maintain similar communities to natural reefs. We investigated whether well-established (>30 years old) breakwaters could consistently approximate fish assemblages on interspersed rocky reefs in a temperate estuary over 6 consecutive seasons using regular visual surveys between June 2009 (winter) and November 2010 (spring). We examined whether assemblage differences between reef types were driven by differences in juvenile recruitment, or were related to differences in older life-stages. Assemblages on both reef types were dominated by juveniles (61% of individuals) and sub-adults (34% of individuals). Seasonal fluctuations in assemblage parameters (species richness, diversity, sub-adult abundance) were similar between reef types, and levels of species diversity and assemblage composition were generally comparable. However, abundance and species richness were consistently higher (1.9-7.6 and 1.3-2.6 times, respectively) on breakwaters. These assemblage differences could not be explained by differences in juvenile recruitment, with seasonal patterns of recruitment and juvenile species found to be similar between reef types. In contrast, abundances of sub-adults were consistently higher (1.1-12 times) at breakwaters, and assemblage differences appeared to be driven by this life-stage. Our results indicate that breakwaters in temperate estuaries are capable of supporting abundant and diverse fish assemblages with similar recruitment process to natural reefs. However, breakwaters may not approximate all aspects of natural assemblage structure, with differences maintained by a single-life stage in some cases.	[Fowler, Ashley M.; Booth, David J.] Univ Technol Sydney, Sch Environm, Fish Ecol Lab, Sydney, NSW 2007, Australia	University of Technology Sydney	Fowler, AM (corresponding author), Univ Technol Sydney, Sch Environm, Fish Ecol Lab, Sydney, NSW 2007, Australia.	ashley.fowler@uts.edu.au	Fowler, Ashley M/N-8623-2016	Fowler, Ashley M/0000-0003-3075-7066; Booth, David/0000-0002-8256-1412	Australian Research Council	Australian Research Council(Australian Research Council)	This research was funded by an Australian Research Council Linkage Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE RF, 1994, B MAR SCI, V55, P694; AMBROSE RF, 1989, B MAR SCI, V44, P718; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Arena PT, 2007, HYDROBIOLOGIA, V580, P157, DOI 10.1007/s10750-006-0456-x; Attrill MJ, 2002, NATURE, V417, P275, DOI 10.1038/417275a; Bell J. D., 1994, B MAR SCI, V55, P1344; BLABER SJM, 1980, J FISH BIOL, V17, P143, DOI 10.1111/j.1095-8649.1980.tb02749.x; BOHNSACK JA, 1989, B MAR SCI, V44, P631; BOHNSACK JA, 1994, B MAR SCI, V55, P796; Booth DJ, 2007, ESTUAR COAST SHELF S, V72, P102, DOI 10.1016/j.ecss.2006.10.003; Bulleri F, 2005, AUSTRAL ECOL, V30, P655, DOI 10.1111/j.1442-9993.2005.01507.x; Bulleri F, 2004, MAR BIOL, V145, P381, DOI 10.1007/s00227-004-1316-8; BURCHMORE JJ, 1985, B MAR SCI, V37, P70; Burt J, 2009, CORAL REEFS, V28, P663, DOI 10.1007/s00338-009-0500-1; Burt JA, 2013, MAR POLLUT BULL, V72, P342, DOI 10.1016/j.marpolbul.2012.10.019; Chapman MG, 2003, MAR ECOL PROG SER, V264, P21, DOI 10.3354/meps264021; Clark S, 1999, AQUAT CONSERV, V9, P5, DOI 10.1002/(SICI)1099-0755(199901/02)9:1<5::AID-AQC330>3.3.CO;2-L; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Clynick BG, 2008, AUSTRAL ECOL, V33, P140, DOI 10.1111/j.1442-9993.2007.01802.x; Davenport J, 2006, ESTUAR COAST SHELF S, V67, P280, DOI 10.1016/j.ecss.2005.11.026; DOHERTY P, 1994, SCIENCE, V263, P935, DOI 10.1126/science.263.5149.935; Fujita T, 1996, ENVIRON BIOL FISH, V46, P351, DOI 10.1007/BF00005013; Glasby TM, 2007, MAR BIOL, V151, P887, DOI 10.1007/s00227-006-0552-5; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Grossman GD, 1997, FISHERIES, V22, P17, DOI 10.1577/1548-8446(1997)022<0017:DARIRF>2.0.CO;2; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; Honorio PPF, 2010, J FISH BIOL, V77, P907, DOI 10.1111/j.1095-8649.2010.02728.x; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jenkins GP, 1998, J EXP MAR BIOL ECOL, V221, P147, DOI 10.1016/S0022-0981(97)00121-4; Kellison GT, 1998, B MAR SCI, V62, P763; Kingsford MJ, 1996, ESTUAR COAST SHELF S, V43, P33, DOI 10.1006/ecss.1996.0056; Kuiter RH, 2000, OASTAL FISHES S E; Lewis AR, 1997, CORAL REEFS, V16, P139, DOI 10.1007/s003380050068; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; Nagelkerken I, 2000, ESTUAR COAST SHELF S, V51, P31, DOI 10.1006/ecss.2000.0617; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Perez-Ruzafa A, 2006, MAR POLLUT BULL, V53, P107, DOI 10.1016/j.marpolbul.2005.09.014; Perkol-Finkel S, 2004, CORAL REEFS, V23, P195, DOI 10.1007/s00338-004-0384-z; Relini G, 2002, ICES J MAR SCI, V59, pS132, DOI 10.1006/jmsc.2002.1272; Rilov G, 2000, MAR BIOL, V136, P931, DOI 10.1007/s002279900250; ROBERTS CM, 1987, MAR ECOL PROG SER, V41, P1, DOI 10.3354/meps041001; Rooker JR, 1997, CORAL REEFS, V16, P83, DOI 10.1007/s003380050062; SHULMAN MJ, 1987, MAR ECOL PROG SER, V39, P233, DOI 10.3354/meps039233; SHULMAN MJ, 1984, J EXP MAR BIOL ECOL, V74, P85, DOI 10.1016/0022-0981(84)90039-X; STEPHENS JS, 1994, B MAR SCI, V55, P1224; STEPHENS JS, 1984, ENVIRON BIOL FISH, V11, P259, DOI 10.1007/BF00001373; Syms C, 2000, ECOLOGY, V81, P2714, DOI 10.1890/0012-9658(2000)081[2714:DHSATD]2.0.CO;2; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Thanner Sara E., 2006, Bulletin of Marine Science, V78, P57; Tupper M, 1998, B MAR SCI, V62, P919; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Wen CKC, 2010, J FISH BIOL, V77, P1674, DOI 10.1111/j.1095-8649.2010.02809.x; Whitfield AK, 1999, REV FISH BIOL FISHER, V9, P151, DOI 10.1023/A:1008994405375	54	18	18	2	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75790	10.1371/journal.pone.0075790	http://dx.doi.org/10.1371/journal.pone.0075790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086634	Green Published, Green Submitted, gold			2022-12-27	WOS:000325220000044
J	Akhtar, Y; Isman, MB				Akhtar, Yasmin; Isman, Murray B.			Horizontal Transfer of Diatomaceous Earth and Botanical Insecticides in the Common Bed Bug, Cimex lectularius L.; Hemiptera: Cimicidae	PLOS ONE			English	Article							GERMAN-COCKROACH; ENTOMOPATHOGENIC FUNGI; ANT HYMENOPTERA; TRANSMISSION; AGGREGATION; COLEOPTERA; EFFICACY; TEMPERATURE; ARRESTMENT; INDOXACARB	Background: Horizontal transfer of insecticide occurs when insects contact or ingest an insecticide, return to an aggregation or a nest, and transfer the insecticide to other conspecific insects through contact. This phenomenon has been reported in a number of insects including social insects, however it has not been reported in bed bugs. Since horizontal transfer can facilitate the spread of insecticide into hard to reach spaces, it could contribute greatly to the management of these public health pests. Methodology/Results: To demonstrate horizontal transfer of diatomaceous earth and botanical insecticides in C. lectularius, an exposed (donor) bed bug, following a 10-minute acquisition period, was placed with unexposed (recipient) bed bugs. Mortality data clearly demonstrates that diatomaceous earth (DE 51) was actively transferred from a single exposed bug to unexposed bugs in a concentration dependent manner. LC50 values varied from 24.4 mg at 48 h to 5.1 mg at 216 h when a single exposed bed bug was placed with 5 unexposed bed bugs. LT50 values also exhibited a concentration response. LT50 values varied from 1.8 days to 8.4 days when a 'donor' bug exposed to 20 and 5 mg of dust respectively was placed with 5 'recipient' bugs. Dust was also actively transferred from adult bed bugs to the nymphs. In addition we observed horizontal transfer of botanical insecticides including neem, ryania, and rotenone to varying degrees. Conclusion/Significance: Our data clearly demonstrate horizontal transfer of diatomaceous earth and botanical insecticides in the common bed bug, C. lectularius. Use of a fluorescent dust provided visual confirmation that contaminated bed bugs transfer dust to untreated bed bugs in harborage. This result is important because bedbugs live in hard-to-reach places and interaction between conspecifics can be exploited for delivery and dissemination of management products directed at this public health pest.	[Akhtar, Yasmin; Isman, Murray B.] Univ British Columbia, Fac Land & Food Syst, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Isman, MB (corresponding author), Univ British Columbia, Fac Land & Food Syst, Vancouver, BC V5Z 1M9, Canada.	murray.isman@ubc.ca	Akhtar, Yasmin/AAH-1096-2020	Isman, Murray/0000-0002-3285-1315	RJP Textile Ltd.; SemiosBIO Technologies Inc.	RJP Textile Ltd.; SemiosBIO Technologies Inc.	RJP Textile Ltd. and SemiosBIO Technologies Inc. have provided funding for bed bug research in the laboratory, but the research described in the manuscript is completely outside of the scope of the research funded by those companies. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	ALLAN SA, 1994, EXP APPL ACAROL, V18, P691; Appel AG, 1999, ENVIRON ENTOMOL, V28, P979; Athanassiou CG, 2007, J STORED PROD RES, V43, P330, DOI 10.1016/j.jspr.2006.08.004; Athanassiou CG, 2005, J STORED PROD RES, V41, P47, DOI 10.1016/j.jspr.2003.12.001; Barbarin AM, 2012, J INVERTEBR PATHOL, V111, P82, DOI 10.1016/j.jip.2012.04.009; Benoit JB, 2007, AM J TROP MED HYG, V76, P987, DOI 10.4269/ajtmh.2007.76.987; Benoit JB, 2009, J MED ENTOMOL, V46, P572, DOI 10.1603/033.046.0323; Brinkman MA, 2001, FLA ENTOMOL, V84, P740, DOI 10.2307/3496418; Buczkowski G, 2001, PESTIC BIOCHEM PHYS, V71, P147, DOI 10.1006/pest.2001.2572; Buczkowski G, 2001, J ECON ENTOMOL, V94, P1229, DOI 10.1603/0022-0493-94.5.1229; Buczkowski G, 2008, J ECON ENTOMOL, V101, P894, DOI 10.1603/0022-0493(2008)101[894:HTOBIT]2.0.CO;2; Choe DH, 2008, J ECON ENTOMOL, V101, P1397, DOI 10.1603/0022-0493(2008)101[1397:HTOIIL]2.0.CO;2; Doggett S, 2004, ENVIRON HEALTH-GLOB, V4, P30; Domingue MJ, 2010, PHYSIOL ENTOMOL, V35, P203, DOI 10.1111/j.1365-3032.2010.00738.x; Ekesi S., 2007, Use of entomopathogenic fungi in biological pest management, P239; Faulde MK, 2006, J PEST SCI, V79, P155, DOI 10.1007/s10340-006-0127-8; Fields P, 2000, J STORED PROD RES, V36, P1, DOI 10.1016/S0022-474X(99)00021-1; Furlong MJ, 2001, BIOL CONTROL, V22, P288, DOI 10.1006/bcon.2001.0981; Haynes KF, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-117; Hu XP, 2005, PEST MANAG SCI, V61, P1209, DOI 10.1002/ps.1124; Hwang SW, 2005, EMERG INFECT DIS, V11, P533, DOI 10.3201/eid1104.041126; Klein MG, 1999, BIOCONTROL SCI TECHN, V9, P151, DOI 10.1080/09583159929730; le Patourel G, 2000, PEST MANAG SCI, V56, P732, DOI 10.1002/1526-4998(200009)56:9<732::AID-PS206>3.0.CO;2-F; Olson JF, 2009, J INSECT PHYSIOL, V55, P580, DOI 10.1016/j.jinsphys.2009.03.001; PINTO LJ, 2007, BED BUGS HDB COMPLET; Potter M.F., 2010, PEST WORLD       SEP, V18, P8; Quesada-Moraga E, 2004, J INVERTEBR PATHOL, V87, P51, DOI 10.1016/j.jip.2004.07.002; Romero A., 2007, Pest Control Technology, V35, P42; Romero A, 2007, J MED ENTOMOL, V44, P175, DOI 10.1603/0022-2585(2007)44[175:IRITBB]2.0.CO;2; Romero A, 2010, J INSECT PHYSIOL, V56, P1516, DOI 10.1016/j.jinsphys.2010.04.025; Scholte EJ, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.19; Siljander E, 2008, J CHEM ECOL, V34, P708, DOI 10.1007/s10886-008-9446-y; Siljander E, 2007, ENTOMOL EXP APPL, V125, P215, DOI 10.1111/j.1570-7458.2007.00617.x; Soeprono AM, 2004, J ECON ENTOMOL, V97, P1675, DOI 10.1603/0022-0493-97.5.1675; Statistix, 2000, AN SOFTW STAT 7 WIND; Usinger R, 1966, MON CIM; Zhu F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01456	37	22	24	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75626	10.1371/journal.pone.0075626	http://dx.doi.org/10.1371/journal.pone.0075626			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086593	gold, Green Published, Green Submitted			2022-12-27	WOS:000325218700104
J	Ding, J; Tasker, C; Valere, K; Sihvonen, T; Descalzi-Montoya, DB; Lu, WY; Chang, TL				Ding, Jian; Tasker, Carley; Valere, Kimyata; Sihvonen, Tiina; Descalzi-Montoya, Dante B.; Lu, Wuyuan; Chang, Theresa L.			Anti-HIV Activity of Human Defensin 5 in Primary CD4+T Cells under Serum-Deprived Conditions Is a Consequence of Defensin-Mediated Cytotoxicity	PLOS ONE			English	Article							HUMAN ALPHA-DEFENSINS; VIRUS TYPE-1 INFECTION; HERPES-SIMPLEX-VIRUS; INNATE IMMUNITY; T-CELLS; ANTIMICROBIAL PEPTIDES; NEISSERIA-GONORRHOEAE; CERVICOVAGINAL FLUID; PROTEOMIC ANALYSIS; VAGINAL FLUID	Background: We have previously shown that human defensin 5 (HD5) promotes HIV infectivity in both primary CD4+ T cells and HeLa cells expressing CD4 and CCR5. HD5 is induced in response to sexually transmitted infections (STIs) such as Chlamydia trachomatis and Neisseria gonorrhoeae, suggesting it plays a role in STI-mediated enhancement of HIV transmission. In contrast to our findings, a recent study reports that HD5 has an anti-HIV effect in primary CD4+ T cells under serum-deprived conditions. To resolve these apparently contradictory observations, we investigated experimental parameters that might contribute to contrasting effects of HD5. Results: Serum-deprived culture conditions were associated with anti-HIV activity. In contrast to the dependence of the HIV enhancing effect on HD5 structure, the anti-HIV activity in serum-deprived primary CD4+ T cells was independent of HD5 structure as the linear peptide [Abu] HD5 exhibited similar anti-HIV activity. Under serum deprived conditions, HD5 blocked CD4-receptor-independent HIV-1(vsv) infection before or after viral entry. We found that HD5 and its linear form induced significant cell death in primary CD4+ T cells under serum-deprived culture conditions. HD5-mediated apoptosis was observed as early as 2 h after addition of defensins to serum-deprived primary CD4+ T cells. In contrast to primary CD4+ T cells, HD5 did not induce cytotoxicity and promote HIV infectivity of HeLa-CD4-CCR5 cells under serum-deprived conditions. Conclusions: These results indicate that under serum-deprived culture conditions HD5 is toxic for primary CD4+ T cells, warranting caution in data interpretation.	[Ding, Jian; Sihvonen, Tiina; Chang, Theresa L.] Rutgers Biomed & Hlth Sci New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07103 USA; [Tasker, Carley; Valere, Kimyata; Chang, Theresa L.] Rutgers Biomed & Hlth Sci New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ USA; [Descalzi-Montoya, Dante B.] Rutgers Biomed & Hlth Sci New Jersey Med Sch, Dept Pathol & Lab Med, Newark, NJ USA; [Tasker, Carley; Valere, Kimyata; Descalzi-Montoya, Dante B.] Rutgers Biomed & Hlth Sci New Jersey Med Sch, Grad Sch Biomed Sci, Newark, NJ USA; [Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Lu, Wuyuan] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Chang, TL (corresponding author), Rutgers Biomed & Hlth Sci New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07103 USA.	changth@umdnj.edu	Lu, Wuyuan/J-8452-2017; Lu, Wuyuan/B-2268-2010	Lu, Wuyuan/0000-0003-1318-9968; 	National Institutes of Health [AI081559]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by National Institutes of Health grant AI081559. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarbiou J, 2006, INFLAMM RES, V55, P119, DOI 10.1007/s00011-005-0062-9; Brown BK, 2005, J VIROL, V79, P6089, DOI 10.1128/JVI.79.10.6089-6101.2005; Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; CHEN BK, 1994, J VIROL, V68, P654, DOI 10.1128/JVI.68.2.654-660.1994; Classen S, 2007, J IMMUNOL, V178, P6931, DOI 10.4049/jimmunol.178.11.6931; DAHER KA, 1986, J VIROL, V60, P1068, DOI 10.1128/JVI.60.3.1068-1074.1986; Ding J, 2012, J IMMUNOL, V188, P992, DOI 10.4049/jimmunol.1102098; Ding JA, 2011, J INNATE IMMUN, V3, P208, DOI 10.1159/000322355; Ding J, 2009, J INNATE IMMUN, V1, P413, DOI 10.1159/000226256; Dugan AS, 2008, J BIOL CHEM, V283, P31125, DOI 10.1074/jbc.M805902200; Fan SR, 2008, INT J GYNECOL OBSTET, V103, P50, DOI 10.1016/j.ijgo.2008.05.020; Furci L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045208; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gounder AP, 2012, J BIOL CHEM, V287, P24554, DOI 10.1074/jbc.M112.354068; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Guo J, 2011, J VIROL, V85, P9824, DOI 10.1128/JVI.05170-11; Hazrati E, 2006, J IMMUNOL, V177, P8658, DOI 10.4049/jimmunol.177.12.8658; JONES DE, 1992, J BIOL CHEM, V267, P23216; Klotman ME, 2008, J IMMUNOL, V180, P6176, DOI 10.4049/jimmunol.180.9.6176; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Lehrer RI, 2009, J IMMUNOL, V183, P480, DOI 10.4049/jimmunol.0900244; Li CY, 2006, J IMMUNOL, V177, P5163, DOI 10.4049/jimmunol.177.8.5163; Meyerholz DK, 2004, J CLIN MICROBIOL, V42, P4780, DOI 10.1128/JCM.42.10.4780-4787.2004; NOVELLI F, 1994, J IMMUNOL, V152, P496; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Porter E, 2005, INFECT IMMUN, V73, P4823, DOI 10.1128/IAI.73.8.4823-4833.2005; Porter EM, 1997, INFECT IMMUN, V65, P2389, DOI 10.1128/IAI.65.6.2389-2395.1997; Quayle AJ, 1998, AM J PATHOL, V152, P1247; Rapista A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-45; Rehaume LM, 2008, CRIT REV IMMUNOL, V28, P185, DOI 10.1615/CritRevImmunol.v28.i3.10; Ryan LK, 2011, J LEUKOCYTE BIOL, V90, P343, DOI 10.1189/jlb.0209079; Salzman NH, 2010, GUT MICROBES, V1, P401, DOI 10.4161/gmic.1.6.14076; Seidel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009737; Shaw JLV, 2007, J PROTEOME RES, V6, P2859, DOI 10.1021/pr0701658; Smith JG, 2008, CELL HOST MICROBE, V3, P11, DOI 10.1016/j.chom.2007.12.001; VANTWOUT AB, 1994, J CLIN INVEST, V94, P2060, DOI 10.1172/JCI117560; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; Wehkamp J, 2006, FEBS LETT, V580, P5344, DOI 10.1016/j.febslet.2006.08.083; Wu Z, 2004, J PEPT RES, V64, P118, DOI 10.1111/j.1399-3011.2004.00179.x; Yang D, 2004, ARTHRITIS RHEUM, V50, P3401, DOI 10.1002/art.20604; Zegels G, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-63; Zegels G, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-17; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	45	7	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76038	10.1371/journal.pone.0076038	http://dx.doi.org/10.1371/journal.pone.0076038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086683	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700119
J	Dong, M; Yang, DF; Lang, QL; Zhou, W; Xu, SW; Xu, T				Dong, Miao; Yang, Dongfeng; Lang, Qiulei; Zhou, Wei; Xu, Shaowei; Xu, Tao			Microarray and Degradome Sequencing Reveal MicroRNA Differential Expression Profiles and Their Targets in Pinellia pedatisecta	PLOS ONE			English	Article							STRESS-REGULATED MICRORNAS; MANNOSE-BINDING LECTIN; PLANT MICRORNA; SMALL RNAS; CONSERVED MICRORNAS; WIDE IDENTIFICATION; PARALLEL ANALYSIS; GENE-EXPRESSION; ARABIDOPSIS; ARGONAUTE1	MicroRNAs (miRNAs) are endogenous small non-coding RNAs which play a critical role in gene regulation in plants. Pinellia pedatisecta is one of the most important herbs in traditional Chinese medicine, but there are no microRNAs of Pinellia pedatisecta were deposited in miRBase and the research of the related miRNA biological functions is still insufficient. To detect Pinellia pedatisecta miRNAs and discover their expression difference with Pinellia ternata, we carried out a microarray profiling. A total of 101 miRNAs belonging to 22 miRNA families were detected both in Pinellia pedatisecta and Pinellia ternata respectively, among them 21 miRNAs showed their differentially expression. GO (gene ontology) term enrichment analysis of the target genes of differential expression miRNAs reveal that these miRNAs mainly affect the reproduction, transcription factor activity and plant developmental process. To elucidate the target function of miRNAs, we constructed a degradome library from Pinellia pedatisecta leaf. The result showed that a total of 18 transcript were identified as targets of miRNAs and further analysis indicated that miR156 and miR529 may function together to repress SPL14.	[Dong, Miao; Yang, Dongfeng; Zhou, Wei; Xu, Shaowei; Xu, Tao] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Lang, Qiulei] LC Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang Sci-Tech University	Xu, T (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	xutao1998cn@163.com			National Natural Science Fund of China [30772712]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Fund of China (No. 30772712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2009, RNA, V15, P2112, DOI 10.1261/rna.1774909; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Allen RS, 2007, P NATL ACAD SCI USA, V104, P16371, DOI 10.1073/pnas.0707653104; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Buhtz A, 2008, PLANT J, V53, P739, DOI 10.1111/j.1365-313X.2007.03368.x; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chuck G, 2010, DEVELOPMENT, V137, P1243, DOI 10.1242/dev.048348; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Frazier TP, 2011, MOL BIOTECHNOL, V49, P159, DOI 10.1007/s12033-011-9387-5; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; German MA, 2009, NAT PROTOC, V4, P356, DOI 10.1038/nprot.2009.8; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kanaan Z, 2013, INNATE IMMUN-LONDON, V19, P203, DOI 10.1177/1753425912460557; Kim J, 2005, PLANT J, V42, P84, DOI 10.1111/j.1365-313X.2005.02354.x; Kim SK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-411; Ko JH, 2006, NEW PHYTOL, V169, P469, DOI 10.1111/j.1469-8137.2005.01623.x; Lang QL, 2011, J ZHEJIANG UNIV-SC B, V12, P116, DOI 10.1631/jzus.B1000278; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Lin JA, 2007, J BIOSCIENCES, V32, P241, DOI 10.1007/s12038-007-0024-1; Lin J, 2006, BIOCELL, V30, P15; Liu DM, 2009, PHYSIOL PLANTARUM, V136, P223, DOI 10.1111/j.1399-3054.2009.01229.x; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Lynn K, 1999, DEVELOPMENT, V126, P469; Mao WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033040; Meng YJ, 2009, PLANTA, V230, P883, DOI 10.1007/s00425-009-0994-3; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Pradervand S, 2010, BIOTECHNIQUES, V48, P219, DOI 10.2144/000113367; Pulido A, 2010, J EXP BOT, V61, P1277, DOI 10.1093/jxb/erp397; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwarz S, 2008, PLANT MOL BIOL, V67, P183, DOI 10.1007/s11103-008-9310-z; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shomron N, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/594678; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Varkonyi-Gasic E, 2011, METHODS MOL BIOL, V744, P145, DOI 10.1007/978-1-61779-123-9_10; Vaucheret H, 2006, MOL CELL, V22, P129, DOI 10.1016/j.molcel.2006.03.011; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Wang B, 2012, GENE, V498, P36, DOI 10.1016/j.gene.2012.01.075; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Xing SP, 2010, PLANT CELL, V22, P3935, DOI 10.1105/tpc.110.079343; Xu T, 2012, GENE, V493, P267, DOI 10.1016/j.gene.2011.08.009; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhao M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029669; Zhou ZS, 2012, PLANT CELL ENVIRON, V35, P86, DOI 10.1111/j.1365-3040.2011.02418.x	60	6	10	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75978	10.1371/journal.pone.0075978	http://dx.doi.org/10.1371/journal.pone.0075978			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086673	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700117
J	Matsudaira, K; Shimazu, A; Fujii, T; Kubota, K; Sawada, T; Kikuchi, N; Takahashi, M				Matsudaira, Ko; Shimazu, Akihito; Fujii, Tomoko; Kubota, Kazumi; Sawada, Takayuki; Kikuchi, Norimasa; Takahashi, Masaya			Workaholism as a Risk Factor for Depressive Mood, Disabling Back Pain, and Sickness Absence	PLOS ONE			English	Article							WORK ENGAGEMENT; JOB DEMANDS; STRAIN; MODEL; COST; NETHERLANDS; ILLNESS; SF-36	Objectives: Although it is understood that work-related factors, including job demands, job control, and workplace support, are associated with workers' health and well-being, the role played by personal characteristics, especially workaholism, has not been fully investigated. This study examined workaholism's associations with psychological ill health, low back pain with disability, and sickness absence among Japanese workers. Methods: A cross-sectional Internet survey was conducted using self-administered questionnaires. Data from 3,899 Japanese workers were analyzed. Workaholism was measured using the Dutch Workaholism Scale (DUWAS). Scores were divided into tertiles, where respondents were classified into three groups (high, middle, and low). Depressive mood as a measure of psychological ill health was assessed using the SF-36 mental health subscale, and low back pain using a standardized question. Sickness absence, except that due to physical injuries, was categorized either as absence due to mental health problems or to physical/somatic problems including the common cold. Multiple logistic regression analyses were conducted to examine the association between workaholism and depressive mood, low back pain with disability, and sickness absence, adjusting for demographic characteristics, job demand, job control, and workplace support. Results: Compared to the low workaholism group, the middle and high workaholism groups had significantly higher odds for depressive mood (Odds ratio (OR) = 1.93 and 3.62 for the middle and high groups, respectively), disabling back pain (ORs = 1.36 and 1.77 for the middle and high groups, respectively). Workaholism was more strongly associated with sickness absence due to mental health problems than that for other reasons (ORs = 1.76 vs. 1.21 for the middle group and 3.52 vs. 1.37 for the high groups). Conclusions: Workaholism is significantly associated with poor psychological health, disabling back pain, and sickness absence, particularly from mental health problems. Therefore, workaholism must be considered when addressing well-being of workers.	[Matsudaira, Ko; Fujii, Tomoko] Kanto Rosai Hosp, Clin Res Ctr Occupat Musculoskeletal Disorders, Kawasaki, Kanagawa, Japan; [Shimazu, Akihito; Kubota, Kazumi] Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Bunkyo Ku, Tokyo, Japan; [Sawada, Takayuki; Kikuchi, Norimasa] CLIN STUDY SUPPORT Inc, Nagoya, Aichi, Japan; [Takahashi, Masaya] Natl Inst Occupat Safety & Hlth, Kawasaki, Kanagawa, Japan	University of Tokyo	Matsudaira, K (corresponding author), Kanto Rosai Hosp, Clin Res Ctr Occupat Musculoskeletal Disorders, Kawasaki, Kanagawa, Japan.	kohart801@gmail.com	kubota, kazumi/AAI-3036-2021; kubota, kazumi/AFS-2460-2022	Shimazu, Akihito/0000-0002-7172-0043	Japan Labor Health and Welfare Organization	Japan Labor Health and Welfare Organization(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a dissemination project on the 13 fields of occupational injuries and illness of the Japan Labor Health and Welfare Organization. No funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker A, 2010, SPINE, V35, P1714, DOI 10.1097/BRS.0b013e3181cd656f; Burke RJ, 2004, STRESS HEALTH, V20, P301, DOI 10.1002/smi.1025; Burke RJ, 2000, STRESS MEDICINE, V16, P11, DOI 10.1002/(SICI)1099-1700(200001)16:1<11::AID-SMI825>3.0.CO;2-U; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Hayden JA, 2009, J CLIN EPIDEMIOL, V62, P781, DOI 10.1016/j.jclinepi.2008.09.004; Johnson JV, 1994, PSYCHOSOCIAL PROCESS, P25; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kato M., 2000, MINISTRY LABOUR SPON, pp. 126; Kubota K, 2012, INT J BEHAV MED; Kubota K, 2010, IND HEALTH, V48, P864, DOI 10.2486/indhealth.MS1139; Manchikanti L, 2009, PAIN PHYSICIAN, V12, P35; Melloh M, 2009, INT ORTHOP, V33, P301, DOI 10.1007/s00264-008-0707-8; Ministry of Health Labour and Welfare, 2009, NAT HLTH NUTR SURV 2; Ministry of Health Labour and Welfare, 2010, COMPR SURV LIV COND; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Schaufeli WB, 2008, APPL PSYCHOL-INT REV, V57, P173, DOI 10.1111/j.1464-0597.2007.00285.x; Schaufeli WB, 2009, CROSS-CULT RES, V43, P320, DOI 10.1177/1069397109337239; Scott KS, 1997, HUM RELAT, V50, P287, DOI 10.1177/001872679705000304; Shimazu A, 2011, SOC SCI MED, V73, P399, DOI 10.1016/j.socscimed.2011.05.049; Shimazu A, 2010, INT J BEHAV MED, V17, P154, DOI 10.1007/s12529-010-9077-x; Shimazu A, 2009, IND HEALTH, V47, P495, DOI 10.2486/indhealth.47.495; SPENCE JT, 1992, J PERS ASSESS, V58, P160, DOI 10.1207/s15327752jpa5801_15; Statistics Bureau Ministry of Internal Affairs and Communication, 2010, POP CENS; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Taris TW, 2008, WORK STRESS, V22, P153, DOI 10.1080/02678370701758074; Taris TW, 2005, APPL PSYCHOL-INT REV, V54, P37, DOI 10.1111/j.1464-0597.2005.00195.x; van der Doef M, 1998, PSYCHOL HEALTH, V13, P909, DOI 10.1080/08870449808407440; Van der Doef M, 1999, WORK STRESS, V13, P87, DOI 10.1080/026783799296084; VANTULDER MW, 1995, PAIN, V62, P233, DOI 10.1016/0304-3959(94)00272-G; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Waddell G, 2001, OCCUP MED-OXFORD, V51, P124, DOI 10.1093/occmed/51.2.124; Walker BF, 2004, J MANIP PHYSIOL THER, V27, P238, DOI 10.1016/j.jmpt.2004.02.002; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Yamazaki Shin, 2005, Health Qual Life Outcomes, V3, P48	38	33	35	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75140	10.1371/journal.pone.0075140	http://dx.doi.org/10.1371/journal.pone.0075140			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VC	24086457	Green Submitted, Green Published, gold			2022-12-27	WOS:000325218700054
J	Sun, Y; Guo, R; Yin, WJ; Tang, LL; Yu, XL; Chen, M; Qi, ZY; Liu, MZ; Ma, J				Sun, Ying; Guo, Rui; Yin, Wen-Jing; Tang, Ling-Long; Yu, Xiao-Li; Chen, Mo; Qi, Zhen-Yu; Liu, Meng-Zhong; Ma, Jun			Which T Category of Nasopharyngeal Carcinoma May Benefit Most from Volumetric Modulated Arc Therapy Compared with Step and Shoot Intensity Modulated Radiation Therapy	PLOS ONE			English	Article							NECK CANCER; HEAD; RADIOTHERAPY; IMRT; RISK	Background: To compare volumetric modulated arc therapy (VMAT) with conventional step and shoot intensity modulated radiation therapy (s-IMRT) in nasopharyngeal carcinoma (NPC) patients, and identify which T category patient gains the maximum benefit from VMAT. Methods: Fifty-two patients that randomly selected from 205 patients received VMAT at a single center were retrospectively replanned with s-IMRT. For a fair comparison, the planning target volume (PTV) coverage of the 2 plans was normalized to the same level. A standard planning constraint set was used; the constraints for the organs at risk (OARs) were individually adapted. The calculated doses to the PTV and OARs were compared for s-IMRT and VMAT plans generated using the Monaco treatment planning system. Results: VMAT and s-IMRT plans had similar PTV coverage and OAR sparing within all T categories. However, in stratified analysis, VMAT plans lead to better or similar sparing of the OARs in early T category patients; and lead to poorer sparing of the OARs in advanced T category patients (P<0.05). VMAT shows significant advantages for low dose burden (P<0.05) compared with s-IMRT. The delivery time per fraction for VMAT (424 +/- 64 s) was shorter than s-IMRT (778 +/- 126 s, p<0.01). Conclusions: VMAT provides similar dose coverage of the PTVs and similar/better normal tissue sparing in early T category NPC, and poorer OARs sparing in advanced T category NPC. And VMAT shows significant advantages for low dose burden and delivery time.	[Sun, Ying; Guo, Rui; Yin, Wen-Jing; Tang, Ling-Long; Yu, Xiao-Li; Chen, Mo; Qi, Zhen-Yu; Liu, Meng-Zhong; Ma, Jun] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University	Ma, J (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China.	drjunma@hotmail.com			National Natural Science Foundation of China [81071836]; Guangdong Provincial Science and Technology Department [2009B03080101]; Science Foundation of Key Hospital Clinical Program of Ministry of Health, P. R. China [2010-178]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Science and Technology Department; Science Foundation of Key Hospital Clinical Program of Ministry of Health, P. R. China; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme	This work was supported by grants from the National Natural Science Foundation of China (81071836), Guangdong Provincial Science and Technology Department (2009B03080101), the Science Foundation of Key Hospital Clinical Program of Ministry of Health, P. R. China (2010-178), and the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, IARC SCI PUBL, VVIII; Bertelsen A, 2010, RADIOTHER ONCOL, V95, P142, DOI 10.1016/j.radonc.2010.01.011; Bortfeld T, 2009, PHYS MED BIOL, V54, pN9, DOI 10.1088/0031-9155/54/1/N02; Clemente S, 2011, INT J RADIAT ONCOL, V80, P1248, DOI 10.1016/j.ijrobp.2010.08.007; Doornaert P, 2011, INT J RADIAT ONCOL, V79, P429, DOI 10.1016/j.ijrobp.2009.11.014; Guckenberger M, 2009, RADIOTHER ONCOL, V93, P259, DOI 10.1016/j.radonc.2009.08.015; Hall EJ, 2006, INT J RADIAT ONCOL, V65, P1, DOI 10.1016/j.ijrobp.2006.01.027; Hartford AC, 2009, INT J RADIAT ONCOL, V73, P9, DOI 10.1016/j.ijrobp.2008.04.049; Hoogeman MS, 2008, INT J RADIAT ONCOL, V70, P609, DOI 10.1016/j.ijrobp.2007.08.066; Johnston M, 2011, CLIN ONCOL-UK, V23, P503, DOI 10.1016/j.clon.2011.02.002; Kam MKM, 2003, INT J RADIAT ONCOL, V56, P145, DOI 10.1016/S0360-3016(03)00075-0; Kam MKM, 2004, INT J RADIAT ONCOL, V60, P1440, DOI 10.1016/j.ijrobp.2004.05.022; Liang SB, 2009, INT J RADIAT ONCOL, V75, P742, DOI 10.1016/j.ijrobp.2008.11.053; Patil VM, 2010, J CANCER RES THER, V6, P442, DOI 10.4103/0973-1482.77082; Vanetti E, 2009, RADIOTHER ONCOL, V92, P111, DOI 10.1016/j.radonc.2008.12.008; Verbakel WFAR, 2009, INT J RADIAT ONCOL, V74, P252, DOI 10.1016/j.ijrobp.2008.12.033; Wiezorek T, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-20; Wolden SL, 2006, INT J RADIAT ONCOL, V64, P57, DOI 10.1016/j.ijrobp.2005.03.057; YU CX, 1995, PHYS MED BIOL, V40, P1435, DOI 10.1088/0031-9155/40/9/004	19	9	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75304	10.1371/journal.pone.0075304	http://dx.doi.org/10.1371/journal.pone.0075304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086503	gold, Green Published, Green Submitted			2022-12-27	WOS:000325218700072
J	Moreno, D; Balasiddaiah, A; Lamas, O; Duret, C; Neri, L; Guembe, L; Galarraga, M; Larrea, E; Daujat-Chavanieu, M; Muntane, J; Maurel, P; Riezu, JI; Prieto, J; Aldabe, R				Moreno, Daniel; Balasiddaiah, Anangi; Lamas, Oscar; Duret, Cedric; Neri, Leire; Guembe, Laura; Galarraga, Miguel; Larrea, Esther; Daujat-Chavanieu, Martine; Muntane, Jordi; Maurel, Patrick; Ignacio Riezu, Jose; Prieto, Jesus; Aldabe, Rafael			Usage of Adenovirus Expressing Thymidine Kinase Mediated Hepatocellular Damage for Enabling Mouse Liver Repopulation with Allogenic or Xenogenic Hepatocytes	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CHIMERIC MICE; HUMANIZED LIVER; C VIRUS; IN-VIVO; INFECTION; MODEL; TRANSPLANTATION; METABOLISM; RESPONSES	It has been shown that the liver of immunodeficient mice can be efficiently repopulated with human hepatocytes when subjected to chronic hepatocellular damage. Mice with such chimeric livers represent useful reagents for medical and clinical studies. However all previously reported models of humanized livers are difficult to implement as they involve cross-breeding of immunodeficient mice with mice exhibiting genetic alterations causing sustained hepatic injury. In this paper we attempted to create chimeric livers by inducing persistent hepatocellular damage in immunodeficient Rag2(-/-) gamma c(-/-) mice using an adenovirus encoding herpes virus thymidine kinase (AdTk) and two consecutive doses of ganciclovir (GCV). We found that this treatment resulted in hepatocellular damage persisting for at least 10 weeks and enabled efficient engraftment and proliferation within the liver of either human or allogenic hepatocytes. Interestingly, while the nodules generated from the transplanted mouse hepatocytes were well vascularized, the human hepatocytes experienced progressive depolarization and exhibited reduced numbers of murine endothelial cells inside the nodules. In conclusion, AdTk/GCV-induced liver damage licenses the liver of immunodeficient mice for allogenic and xenogenic hepatocyte repopulation. This approach represents a simple alternative strategy for chimeric liver generation using immunodeficient mice without additional genetic manipulation of the germ line.	[Moreno, Daniel; Balasiddaiah, Anangi; Lamas, Oscar; Neri, Leire; Larrea, Esther; Ignacio Riezu, Jose; Prieto, Jesus; Aldabe, Rafael] Univ Navarra, Ctr Appl Med Res CIMA, Gene Therapy & Hepatol Area, E-31080 Pamplona, Spain; [Duret, Cedric; Daujat-Chavanieu, Martine; Maurel, Patrick] INSERM, U1040, Montpellier, France; [Duret, Cedric; Daujat-Chavanieu, Martine; Maurel, Patrick] Univ Montpellier I, UMR S1040, F-34006 Montpellier, France; [Duret, Cedric; Daujat-Chavanieu, Martine; Maurel, Patrick] Hop St Eloi, CHU Montpellier, Inst Rech Biotherapie, Montpellier, France; [Guembe, Laura] Univ Navarra, Dept Morphol, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain; [Galarraga, Miguel] Univ Navarra, Dept Imaging, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain; [Muntane, Jordi] Reina Sofia Univ Hosp, Liver Res Unit, Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain; [Muntane, Jordi; Prieto, Jesus] Univ Navarra, Univ Clin, CIBER EHD, E-31080 Pamplona, Spain; [Prieto, Jesus] Univ Navarra, Liver Unit, Univ Clin, E-31080 Pamplona, Spain	University of Navarra; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; University of Navarra; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Navarra; University of Navarra	Aldabe, R (corresponding author), Univ Navarra, Ctr Appl Med Res CIMA, Gene Therapy & Hepatol Area, E-31080 Pamplona, Spain.	raldabe@unav.es	Larrea, Esther/L-7586-2014; Aldabe, Rafael/F-3112-2015; Daujat-Chavanieu, Martine/T-5155-2018; Riezu-Boj, Jose Ignacio/M-3748-2014; Daujat-Chavanieu, Martine/AAU-2908-2020; Moreno-Luqui, Daniel/AAE-4121-2021	Larrea, Esther/0000-0002-1443-6513; Aldabe, Rafael/0000-0002-9461-020X; Daujat-Chavanieu, Martine/0000-0001-5560-1610; Riezu-Boj, Jose Ignacio/0000-0002-1885-8457; Daujat-Chavanieu, Martine/0000-0001-5560-1610; Guembe, Laura/0000-0002-5157-8588; Moreno-Luqui, Daniel/0000-0003-0802-9695; Duret, Cedric/0000-0003-1769-8081; Prieto, Jesus/0000-0002-1091-9593	UTE project CIMA	UTE project CIMA	This work has been funded by UTE project CIMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Bissig KD, 2010, J CLIN INVEST, V120, P924, DOI 10.1172/JCI40094; Braun KM, 2000, NAT MED, V6, P320; Bustos M, 2000, AM J PATHOL, V157, P549, DOI 10.1016/S0002-9440(10)64565-8; Dandri M, 2001, HEPATOLOGY, V33, P981, DOI 10.1053/jhep.2001.23314; Douglas DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009209; Elaut G, 2006, CURR DRUG METAB, V7, P629, DOI 10.2174/138920006778017759; Gilgenkrantz H, 2010, METHODS MOL BIOL, V640, P475, DOI 10.1007/978-1-60761-688-7_26; Guguen-Guillouzo C, 2010, METHODS MOL BIOL, V640, P1, DOI 10.1007/978-1-60761-688-7_1; Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042; He ZY, 2010, AM J PATHOL, V177, P1311, DOI 10.2353/ajpath.2010.091154; Kamimura H, 2010, DRUG METAB PHARMACOK, V25, P223, DOI 10.2133/dmpk.25.223; LOKE SL, 1990, J CLIN PATHOL, V43, P654, DOI 10.1136/jcp.43.8.654; Lootens L, 2009, DRUG TEST ANAL, V1, P531, DOI 10.1002/dta.67; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Meuleman P, 2005, HEPATOLOGY, V41, P847, DOI 10.1002/hep.20657; Meuleman P, 2012, HEPATOLOGY, V55, P364, DOI 10.1002/hep.24692; Molina-Jimenez F, 2012, VIROLOGY, V425, P31, DOI 10.1016/j.virol.2011.12.021; Okumura H, 2007, TOXICOL SCI, V97, P533, DOI 10.1093/toxsci/kfm041; Petersen J, 2008, NAT BIOTECHNOL, V26, P335, DOI 10.1038/nbt1389; Peterson Richard A, 2010, Drug Metab Lett, V4, P180; Pichard Lydiane, 2006, Methods Mol Biol, V320, P283; RHIM JA, 1995, P NATL ACAD SCI USA, V92, P4942, DOI 10.1073/pnas.92.11.4942; Sato Y, 2008, TOXICOL PATHOL, V36, P581, DOI 10.1177/0192623308318212; Schulze A, 2012, HEPATOLOGY, V55, P373, DOI 10.1002/hep.24707; Sheahan T, 2010, EXPERT REV GASTROENT, V4, P541, DOI [10.1586/egh.10.53, 10.1586/EGH.10.53]; Steenbergen RHG, 2010, AM J PHYSIOL-GASTR L, V299, pG844, DOI 10.1152/ajpgi.00200.2010; Strom SC, 2010, METHODS MOL BIOL, V640, P491, DOI 10.1007/978-1-60761-688-7_27; Sugiyama M, 2009, GASTROENTEROLOGY, V136, P652, DOI 10.1053/j.gastro.2008.10.048; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Tateno C, 2011, ENDOCRINOLOGY, V152, P1479, DOI 10.1210/en.2010-0953; Utoh R, 2010, AM J PATHOL, V177, P654, DOI 10.2353/ajpath.2010.090430; Vanwolleghem T, 2010, J HEPATOL, V53, P468, DOI 10.1016/j.jhep.2010.03.024; Walters KA, 2006, PLOS PATHOG, V2, P591, DOI 10.1371/journal.ppat.0020059; Washburn ML, 2011, GASTROENTEROLOGY, V140, P1334, DOI 10.1053/j.gastro.2011.01.001; Yoshizato K, 2009, EXPERT OPIN DRUG MET, V5, P1435, DOI 10.1517/17425250903216664	36	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e74948	10.1371/journal.pone.0074948	http://dx.doi.org/10.1371/journal.pone.0074948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086405	Green Submitted, Green Published, gold			2022-12-27	WOS:000325025200018
J	Seminati, E; Nardello, F; Zamparo, P; Ardigo, LP; Faccioli, N; Minetti, AE				Seminati, Elena; Nardello, Francesca; Zamparo, Paola; Ardigo, Luca P.; Faccioli, Niccolo; Minetti, Alberto E.			Anatomically Asymmetrical Runners Move More Asymmetrically at the Same Metabolic Cost	PLOS ONE			English	Article							ABLE-BODIED GAIT; ENERGY-COST; LENGTH DISCREPANCY; DISTANCE RUNNERS; RUNNING ECONOMY; SYMMETRY; LOCOMOTION; PERFORMANCE; WALKING; HUMANS	We hypothesized that, as occurring in cars, body structural asymmetries could generate asymmetry in the kinematics/dynamics of locomotion, ending up in a higher metabolic cost of transport, i.e. more 'fuel' needed to travel a given distance. Previous studies found the asymmetries in horses' body negatively correlated with galloping performance. In this investigation, we analyzed anatomical differences between the left and right lower limbs as a whole by performing 3D cross-correlation of Magnetic Resonance Images of 19 male runners, clustered as Untrained Runners, Occasional Runners and Skilled Runners. Running kinematics of their body centre of mass were obtained from the body segments coordinates measured by a 3D motion capture system at incremental running velocities on a treadmill. A recent mathematical procedure quantified the asymmetry of the body centre of mass trajectory between the left and right steps. During the same sessions, runners' metabolic consumption was measured and the cost of transport was calculated. No correlations were found between anatomical/kinematic variables and the metabolic cost of transport, regardless of the training experience. However, anatomical symmetry significant correlated to the kinematic symmetry, and the most trained subjects showed the highest level of kinematic symmetry during running. Results suggest that despite the significant effects of anatomical asymmetry on kinematics, either those changes are too small to affect economy or some plastic compensation in the locomotor system mitigates the hypothesized change in energy expenditure of running.	[Seminati, Elena; Minetti, Alberto E.] Univ Milan, Fac Med, Dept Pathophysiol & Transplantat, Milan, Italy; [Nardello, Francesca; Zamparo, Paola; Ardigo, Luca P.] Univ Verona, Sch Exercise & Sport Sci, Dept Neurol & Movement Sci, I-37100 Verona, Italy; [Faccioli, Niccolo] Univ Verona, Dept Pathol & Diagnost, Sect Radiol, I-37100 Verona, Italy	University of Milan; University of Verona; University of Verona	Seminati, E (corresponding author), Univ Milan, Fac Med, Dept Pathophysiol & Transplantat, Milan, Italy.	elena.seminati@unimi.it	Minetti, Alberto Enrico/P-2320-2017; Ardigò, Luca Paolo/H-8955-2019; Zamparo, Paola/AAF-7700-2020	Minetti, Alberto Enrico/0000-0002-0120-4406; Ardigò, Luca Paolo/0000-0001-7677-5070; Zamparo, Paola/0000-0002-6919-6721; Seminati, Elena/0000-0002-6736-893X; Faccioli, Niccolo'/0000-0001-6655-9825; NARDELLO, FRANCESCA/0000-0001-8942-3920	Department of Pathophysiology and Transplantation -Human Physiology section- University of Milan	Department of Pathophysiology and Transplantation -Human Physiology section- University of Milan	The project was supported by the Department of Pathophysiology and Transplantation -Human Physiology section- University of Milan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1989, PHYSIOL REV, V69, P1199, DOI 10.1152/physrev.1989.69.4.1199; Ambrosini RD, 2010, J MAGN RESON IMAGING, V31, P85, DOI 10.1002/jmri.22009; Beneke R, 2005, MED SCI SPORT EXER, V37, P1794, DOI 10.1249/01.mss.0000176399.67121.02; Cavanagh P R, 1977, Ann N Y Acad Sci, V301, P328, DOI 10.1111/j.1749-6632.1977.tb38211.x; CUK T, 2001, VAR EVOL, V9, P19; DANIELS JT, 1985, MED SCI SPORT EXER, V17, P332; DEMPSTER WT, 1959, AM J PHYS ANTHROPOL, V17, P289, DOI 10.1002/ajpa.1330170405; DIPRAMPERO PE, 1986, INT J SPORTS MED, V7, P55, DOI 10.1055/s-2008-1025736; Forczek W, 2012, J HUM KINET, V35, P47, DOI 10.2478/v10078-012-0078-5; Gurney B, 2002, GAIT POSTURE, V15, P195, DOI 10.1016/S0966-6362(01)00148-5; Gurney B, 2001, J BONE JOINT SURG AM, V83A, P907, DOI 10.2106/00004623-200106000-00013; Hardin EC, 2004, MED SCI SPORT EXER, V36, P838, DOI 10.1249/01.MSS.0000126605.65966.40; HERZOG W, 1989, MED SCI SPORT EXER, V21, P110, DOI 10.1249/00005768-198902000-00020; Kong PW, 2009, BRIT J SPORT MED, V43, P745, DOI 10.1136/bjsm.2008.047761; Lee Y, 2001, IEEE T MED IMAGING, V20, P595, DOI 10.1109/42.932744; Lewis J, 1996, FAST NORMALIZED CROS; Lund FH, 1930, AM J PSYCHOL, V42, P51, DOI 10.2307/1414419; MANNING JT, 1994, NATURE, V370, P185, DOI 10.1038/370185a0; Manning JT, 1998, INT J SPORTS MED, V19, P205, DOI 10.1055/s-2007-971905; MARGARIA R, 1963, J APPL PHYSIOL, V18, P367, DOI 10.1152/jappl.1963.18.2.367; Mattes SJ, 2000, ARCH PHYS MED REHAB, V81, P561, DOI 10.1016/S0003-9993(00)90035-2; Maupas E, 1999, CLIN BIOMECH, V14, P403, DOI 10.1016/S0268-0033(99)00005-4; McGregor SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007355; MINETTI AE, 1994, J EXP BIOL, V195, P211; Minetti AE, 2009, GAIT POSTURE, V30, pS153, DOI [10.1016/j.gaitpost.2009.08.230, DOI 10.1016/J.GAITPOST.2009.08.230]; Minetti AE, 2011, J BIOMECH, V44, P1471, DOI 10.1016/j.jbiomech.2011.03.014; Nakayama Y, 2010, GAIT POSTURE, V31, P331, DOI 10.1016/j.gaitpost.2009.12.003; Nardello F, 2009, GAIT POSTURE, V30, pS80; Sadeghi H, 2000, GAIT POSTURE, V12, P34, DOI 10.1016/S0966-6362(00)00070-9; Saibene F, 2003, EUR J APPL PHYSIOL, V88, P297, DOI 10.1007/s00421-002-0654-9; Seeley MK, 2010, J SPORT SCI MED, V9, P572; Slawinski JS, 2004, MED SCI SPORT EXER, V36, P1440, DOI 10.1249/01.MSS.0000135785.68760.96; Souman JL, 2009, CURR BIOL, V19, P1538, DOI 10.1016/j.cub.2009.07.053; Srinivasan M, 2011, J R SOC INTERFACE, V8, P74, DOI 10.1098/rsif.2009.0544; Thomsen MH, 2010, J BIOMECH, V43, P2608, DOI 10.1016/j.jbiomech.2010.05.004; Wang P, 2007, MED PHYS, V34, P915, DOI 10.1118/1.2436970; Winter D, 2005, BIOMECHANICS MOTOR C	37	29	29	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e74134	10.1371/journal.pone.0074134	http://dx.doi.org/10.1371/journal.pone.0074134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086316	Green Published, gold, Green Submitted			2022-12-27	WOS:000325025200010
J	Friedrich, EVC; Neuper, C; Scherer, R				Friedrich, Elisabeth V. C.; Neuper, Christa; Scherer, Reinhold			Whatever Works: A Systematic User-Centered Training Protocol to Optimize Brain-Computer Interfacing Individually	PLOS ONE			English	Article							SINGLE-TRIAL EEG; IMAGERY; CLASSIFICATION; PERFORMANCE; COMMUNICATION; RHYTHMS	This study implemented a systematic user-centered training protocol for a 4-class brain-computer interface (BCI). The goal was to optimize the BCI individually in order to achieve high performance within few sessions for all users. Eight able-bodied volunteers, who were initially naive to the use of a BCI, participated in 10 sessions over a period of about 5 weeks. In an initial screening session, users were asked to perform the following seven mental tasks while multi-channel EEG was recorded: mental rotation, word association, auditory imagery, mental subtraction, spatial navigation, motor imagery of the left hand and motor imagery of both feet. Out of these seven mental tasks, the best 4-class combination as well as most reactive frequency band (between 8-30 Hz) was selected individually for online control. Classification was based on common spatial patterns and Fisher's linear discriminant analysis. The number and time of classifier updates varied individually. Selection speed was increased by reducing trial length. To minimize differences in brain activity between sessions with and without feedback, sham feedback was provided in the screening and calibration runs in which usually no real-time feedback is shown. Selected task combinations and frequency ranges differed between users. The tasks that were included in the 4-class combination most often were (1) motor imagery of the left hand (2), one brain-teaser task (word association or mental subtraction) (3), mental rotation task and (4) one more dynamic imagery task (auditory imagery, spatial navigation, imagery of the feet). Participants achieved mean performances over sessions of 44-84% and peak performances in single-sessions of 58-93% in this user-centered 4-class BCI protocol. This protocol is highly adjustable to individual users and thus could increase the percentage of users who can gain and maintain BCI control. A high priority for future work is to examine this protocol with severely disabled users.	[Friedrich, Elisabeth V. C.; Neuper, Christa] Graz Univ, Dept Psychol, Graz, Austria; [Neuper, Christa; Scherer, Reinhold] Graz Univ Technol, Inst Knowledge Discovery, A-8010 Graz, Austria	University of Graz; Graz University of Technology	Scherer, R (corresponding author), Graz Univ Technol, Inst Knowledge Discovery, A-8010 Graz, Austria.	reinhold.scherer@tugraz.at	Friedrich, Elisabeth V. C./AAV-3839-2021	Scherer, Reinhold/0000-0003-3407-9709	EU; Games and Learning Alliance (GALA) Network of Excellence [258169]; ABC [287774]	EU(European Commission); Games and Learning Alliance (GALA) Network of Excellence; ABC	This work was supported by the EU under the FP7, in the Games and Learning Alliance (GALA) Network of Excellence, Grant Agreement No. 258169 and the research project ABC, Grant Agreement No. 287774. This paper only reflects the authors' views and funding agencies are not liable for any use that may be made of the information contained herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison BZ, 2010, HUM-COMPUT INT-SPRIN, P35, DOI 10.1007/978-1-84996-272-8_3; Billinger M., 2012, PRACTICAL BRAIN COMP, P333, DOI [10.1007/978-3-642-29746-5_17, DOI 10.1007/978-3-642-29746-5_17]; Blankertz B, 2007, NEUROIMAGE, V37, P539, DOI 10.1016/j.neuroimage.2007.01.051; Blankertz B, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00198; Blankertz B, 2010, NEUROIMAGE, V51, P1303, DOI 10.1016/j.neuroimage.2010.03.022; Cabrera AF, 2008, J NEUROSCI METH, V174, P135, DOI 10.1016/j.jneumeth.2008.06.026; Conson M, 2008, NEUROPSYCHOLOGIA, V46, P2622, DOI 10.1016/j.neuropsychologia.2008.04.015; Curran E, 2004, IEEE T NEUR SYS REH, V12, P48, DOI 10.1109/TNSRE.2003.821372; Curran EA, 2003, BRAIN COGNITION, V51, P326, DOI 10.1016/S0278-2626(03)00036-8; Daly I., 2012, P TOBI WORKSH 2012 W, P57; Duda R.O., 2006, PATTERN CLASSIFICATI; Friedrich EVC, 2013, CLIN NEUROPHYSIOL, V124, P916, DOI 10.1016/j.clinph.2012.11.010; Friedrich EVC, 2013, CLIN NEUROPHYSIOL, V124, P61, DOI 10.1016/j.clinph.2012.05.020; Friedrich EVC, 2012, INT J PSYCHOPHYSIOL, V84, P86, DOI 10.1016/j.ijpsycho.2012.01.014; Friedrich EVC, 2011, CLIN NEUROPHYSIOL, V122, P2003, DOI 10.1016/j.clinph.2011.03.019; FRIEDRICH EVC, 2011, P 5 INT BRAIN COMP I, P153; FRIEDRICH EVC, 2012, LONG TIME STABILITY; Graimann B, 2002, CLIN NEUROPHYSIOL, V113, P43, DOI 10.1016/S1388-2457(01)00697-6; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Kleih SC, 2011, PROG BRAIN RES, V194, P27, DOI 10.1016/B978-0-444-53815-4.00019-4; Krauledat M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002967; Krausz G, 2003, APPL PSYCHOPHYS BIOF, V28, P233, DOI 10.1023/A:1024637331493; Kubler A, 2005, NEUROLOGY, V64, P1775, DOI 10.1212/01.WNL.0000158616.43002.6D; Kubler A, 2001, PSYCHOL BULL, V127, P358, DOI 10.1037//0033-2909.127.3.358; KUBLER A, 2008, P 4 INT BRAIN COMP I; Maguire M, 2001, INT J HUM-COMPUT ST, V55, P587, DOI 10.1006/ijhc.2001.0503; McFarland D. J., 2010, J NEURAL ENG, V7, P1; McFarland DJ, 1997, ELECTROEN CLIN NEURO, V103, P386, DOI 10.1016/S0013-4694(97)00022-2; Millan JD, 2004, ARTIF INTELL, V159, P241, DOI 10.1016/j.artint.2004.05.008; Millan JD, 2002, IEEE T NEURAL NETWOR, V13, P678, DOI 10.1109/TNN.2002.1000132; Muller KR, 2008, J NEUROSCI METH, V167, P82, DOI 10.1016/j.jneumeth.2007.09.022; Muller-Gerking J, 1999, CLIN NEUROPHYSIOL, V110, P787, DOI 10.1016/S1388-2457(98)00038-8; Neuper C, 1999, J CLIN NEUROPHYSIOL, V16, P373, DOI 10.1097/00004691-199907000-00010; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Neuper C, 2001, INT J PSYCHOPHYSIOL, V43, P41, DOI 10.1016/S0167-8760(01)00178-7; Neuper C, 2009, CLIN NEUROPHYSIOL, V120, P239, DOI 10.1016/j.clinph.2008.11.015; Nijholt A, 2009, ENTERTAIN COMPUT, V1, P85, DOI 10.1016/j.entcom.2009.09.007; Obermaier B, 2001, IEEE T NEUR SYS REH, V9, P283, DOI 10.1109/7333.948456; Pfurtscheller G, 2000, NEUROSCI LETT, V292, P211, DOI 10.1016/S0304-3940(00)01471-3; Piccione F, 2006, CLIN NEUROPHYSIOL, V117, P531, DOI 10.1016/j.clinph.2005.07.024; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Royer AS, 2010, IEEE T NEUR SYS REH, V18, P581, DOI 10.1109/TNSRE.2010.2077654; SCHERER R, 2012, SOFT COMPUTING; Scherer R, 2008, P 4 INT BRAIN COMP I, P186; Sellers EW., 2012, BRAIN COMPUTER INTER, pp 215; Shenoy P, 2006, J NEURAL ENG, V3, pR13, DOI 10.1088/1741-2560/3/1/R02; Vidaurre C, 2006, IEEE T BIO-MED ENG, V53, P1214, DOI 10.1109/TBME.2006.873542; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Zander TO, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025005; Zhang L, 2010, J MED SYST, V34, P51, DOI 10.1007/s10916-008-9215-z; Zickler C, 2011, CLIN EEG NEUROSCI, V42, P236, DOI 10.1177/155005941104200409	52	57	57	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e76214	10.1371/journal.pone.0076214	http://dx.doi.org/10.1371/journal.pone.0076214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	246EK	24086710	Green Submitted, Green Published, gold			2022-12-27	WOS:000326520200132
J	Koochekpour, S; Marlowe, T; Singh, KK; Attwood, K; Chandra, D				Koochekpour, Shahriar; Marlowe, Timothy; Singh, Keshav K.; Attwood, Kristopher; Chandra, Dhyan			Reduced Mitochondrial DNA Content Associates with Poor Prognosis of Prostate Cancer in African American Men	PLOS ONE			English	Article							INDUCED CELL-DEATH; COMPLEX-I; MUTATIONS; P53; CARCINOMA; ACTIVATION; NUCLEAR; PROGRESSION; TUMORS; RESPIRATION	Reduction or depletion of mitochondrial DNA (mtDNA) has been associated with cancer progression. Although imbalanced mtDNA content is known to occur in prostate cancer, differences in mtDNA content between African American (AA) and Caucasian American (CA) men are not defined. We provide the first evidence that tumors in AA men possess reduced level of mtDNA compared to CA men. The median tumor mtDNA content was reduced in AA men. mtDNA content was also reduced in normal prostate tissues of AA men compared to CA men, suggesting a possible predisposition to cancer in AA men. mtDNA content was also reduced in benign prostatic hyperplasia (BPH) tissue from AA men. Tumor and BPH tissues from patients >= 60 years of age possess reduced mtDNA content compared to patients,60 years of age. In addition, mtDNA content was higher in normal tissues from patients with malignant T3 stage disease compared to patients with T2 stage disease. mtDNA levels in matched normal prostate tissues were nearly doubled in Gleason grade of >7 compared to <= 7, whereas reduced mtDNA content was observed in tumors of Gleason grade >7 compared to <= 7. Together, our data suggest that AA men possess lower mtDNA levels in normal and tumor tissues compared to CA men, which could contribute to higher risk and more aggressive prostate cancer in AA men.	[Koochekpour, Shahriar] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Koochekpour, Shahriar] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA; [Marlowe, Timothy; Chandra, Dhyan] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Singh, Keshav K.] Univ Alabama Birmingham, UAB Comprehens Canc Ctr, Dept Genet Pathol & Environm Hlth, Birmingham, AL USA; [Singh, Keshav K.] Univ Alabama Birmingham, Sch Med, Ctr Free Rad Biol, Birmingham, AL USA; [Attwood, Kristopher] Roswell Pk Canc Inst, Dept Biostat & Bioinformat, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Roswell Park Cancer Institute	Chandra, D (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA.	dhyan.chandra@roswellpark.org		Chandra, Dhyan/0000-0001-7272-9384	National Cancer Institute of National Institutes of Health [R01CA160685, K01CA123142]; American Cancer Society [RSG-12-214-01 - CCG]; National Cancer Institute Center Support Grant [P30 CA016056];  [R01MD005824];  [R21CA149137];  [R21CA143589];  [R01 CA121904];  [R21 CA153097]; NATIONAL CANCER INSTITUTE [R21CA149137, R21CA153097, R21CA143589, P30CA016056, K01CA123142, R01CA160685, R01CA121904, T32CA009072] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD005824] Funding Source: NIH RePORTER	National Cancer Institute of National Institutes of Health; American Cancer Society(American Cancer Society); National Cancer Institute Center Support Grant; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study received financial support from the National Cancer Institute of the National Institutes of Health under Award Number R01CA160685 and K01CA123142, and the American Cancer Society Research Scholar Grant RSG-12-214-01 - CCG to DC and the National Cancer Institute Center Support Grant P30 CA016056 to the Roswell Park Cancer Institute. Additional support was provided by R01MD005824, R21CA149137, and R21CA143589 to SK and R01 CA121904 and R21 CA153097 to KKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Arnold RS, 2009, PROSTATE, V69, P1, DOI 10.1002/pros.20854; Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Bonora E, 2006, CANCER RES, V66, P6087, DOI 10.1158/0008-5472.CAN-06-0171; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chandra D, 2011, BBA-BIOENERGETICS, V1807, P620, DOI 10.1016/j.bbabio.2010.10.023; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chauvin C, 2001, J BIOL CHEM, V276, P41394, DOI 10.1074/jbc.M106417200; Chen J, 2007, NUCLEIC ACIDS RES, V35, P1377, DOI 10.1093/nar/gkm010; Chen JJZ, 2002, CANCER RES, V62, P6470; Chen PL, 2013, ONCOGENE, V32, P1193, DOI 10.1038/onc.2012.120; Chornokur G, 2011, PROSTATE, V71, P985, DOI 10.1002/pros.21314; Compton S, 2011, J BIOL CHEM, V286, P20297, DOI 10.1074/jbc.M110.163063; Cook CC, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.141; Dong JT, 2006, J CELL BIOCHEM, V97, P433, DOI 10.1002/jcb.20696; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Gasparre G, 2007, P NATL ACAD SCI USA, V104, P9001, DOI 10.1073/pnas.0703056104; Godley PA, 2003, JNCI-J NATL CANCER I, V95, P1702, DOI 10.1093/jnci/djg094; Grignon DJ, 1997, JNCI-J NATL CANCER I, V89, P158, DOI 10.1093/jnci/89.2.158; Heddi A, 1996, BBA-MOL BASIS DIS, V1316, P203, DOI 10.1016/0925-4439(96)00026-9; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Higuchi M, 2006, ONCOGENE, V25, P1437, DOI 10.1038/sj.onc.1209190; Higuchi M, 1997, J CLIN INVEST, V99, P1751, DOI 10.1172/JCI119339; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jeronimo C, 2001, ONCOGENE, V20, P5195, DOI 10.1038/sj.onc.1204646; Jessie BC, 2001, EXP GERONTOL, V37, P169, DOI 10.1016/S0531-5565(01)00153-X; Johnson RF, 2012, TRENDS BIOCHEM SCI, V37, P317, DOI 10.1016/j.tibs.2012.04.002; Jones JB, 2001, CANCER RES, V61, P1299; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Kulawiec Mariola, 2009, J Carcinog, V8, P8, DOI 10.4103/1477-3163.50893; LUCIAKOVA K, 1992, EUR J BIOCHEM, V205, P1187, DOI 10.1111/j.1432-1033.1992.tb16889.x; Mambo E, 2005, INT J CANCER, V116, P920, DOI 10.1002/ijc.21110; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; McClintock DS, 2002, MOL CELL BIOL, V22, P94, DOI 10.1128/MCB.22.1.94-104.2002; Meyers FJ, 1998, CANCER, V83, P2534, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2534::AID-CNCR19>3.3.CO;2-M; Mizumachi T, 2008, ONCOGENE, V27, P831, DOI 10.1038/sj.onc.1210681; Mizumachi T, 2008, PROSTATE, V68, P408, DOI 10.1002/pros.20697; Moro L, 2009, CELL DEATH DIFFER, V16, P571, DOI 10.1038/cdd.2008.178; Moro L, 2008, CELL ONCOL, V30, P307, DOI 10.3233/CLO-2008-0427; Naito A, 2008, CANCER SCI, V99, P1584, DOI 10.1111/j.1349-7006.2008.00879.x; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Prabhu V, 2012, MITOCHONDRION; Qian W, 2005, AM J PHYSIOL-CELL PH, V289, pC1466, DOI 10.1152/ajpcell.00265.2005; Simonnet H, 2002, CARCINOGENESIS, V23, P759, DOI 10.1093/carcin/23.5.759; Xia P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-454	50	39	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74688	10.1371/journal.pone.0074688	http://dx.doi.org/10.1371/journal.pone.0074688			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086362	gold, Green Submitted, Green Published			2022-12-27	WOS:000326520200038
J	Lu, RQ; Jiang, ML; Chen, ZJ; Xu, XF; Hu, HF; Zhao, XM; Gao, X; Guo, L				Lu, Renquan; Jiang, Minglei; Chen, Zhujun; Xu, Xiaofeng; Hu, Hongfeng; Zhao, Xinmin; Gao, Xiang; Guo, Lin			Lactate Dehydrogenase 5 Expression in Non-Hodgkin Lymphoma Is Associated with the Induced Hypoxia Regulated Protein and Poor Prognosis	PLOS ONE			English	Article							CELL LUNG-CANCER; LDH-5 EXPRESSION; FACTOR PATHWAY; TUMOR-CELLS; HIF-1-ALPHA; GLYCOLYSIS; METABOLISM; SURVIVAL; TARGET; LINK	Lactate dehydrogenase 5 (LDH-5) is one of the major isoenzymes catalyzing the biochemical process of pyruvate to lactate. The purpose of this study was to investigate the expression of serum LDH-5 and test whether this enzyme is regulated by tumor hypoxia and represents a prognostic marker in patients with Non-Hodgkin's lymphoma (NHL). In this study, LDH-5 levels were detected using agarose gel electrophoresis in NHL patients (n = 266) and non-NHL controls including benign lymphadenectasis (n = 30) and healthy cohorts (n = 233). We also explored the expression of LDH-5 and hypoxia-inducible factor (HIF) 1 alpha in NHL and benign controls by immunohistochemistry and immunofluorescence staining, respectively. Moreover, the role of LDH-5 in the progression of NHL was assessed by multivariate Cox analyses and Kaplan-Meier survival estimates. Serum concentrations of LDH-5 were significantly higher in NHL patients (9.3%) than in benign patients and healthy controls (7.5% and 7.2%, respectively, P < 0.01). Application of LDH-5 detection increased the sensitivity of NHL detection, identifying 53.4% of NHL patients as positive, compared with the measurement of total LDH levels (36.5% sensitivity). LDH-5 concentrations increased with clinical stage, extra-nodal site involvement, and WHO performance status of patients with NHL. Exposure to a hypoxic environment induced the expression of LDH-5 and its overexpression correlated with HIF1 alpha cytoplasmic accumulation in NHL cells. In multivariate analyses, LDH-5 was an independent marker for progression-free survival in patients with NHL (P < 0.001). Overall, the expression of LDH-5 was elevated in NHL, showing an association with tumor hypoxia and unfavorable prognosis. Thus, LDH-5 emerges as a promising prognostic predictor for NHL patients.	[Lu, Renquan; Jiang, Minglei; Chen, Zhujun; Xu, Xiaofeng; Hu, Hongfeng; Gao, Xiang; Guo, Lin] Fudan Univ, Shanghai Canc Ctr, Dept Clin Lab, Shanghai 200433, Peoples R China; [Lu, Renquan; Zhao, Xinmin; Gao, Xiang; Guo, Lin] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Zhao, Xinmin] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Guo, L (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Clin Lab, Shanghai 200433, Peoples R China.	guolin500@hotmail.com			Science and Technology Commission of Shanghai Municipality [124119a0202, 114119a0400]; National Basic Research Program of China [2010CB933902]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by Science and Technology Commission of Shanghai Municipality (124119a0202; 114119a0400), and National Basic Research Program of China (2010CB933902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adida C, 2000, BLOOD, V96, P1921; Armstrong AJ, 2012, J CLIN ONCOL, V30, P3402, DOI 10.1200/JCO.2011.40.9631; Baker LCJ, 2012, BRIT J CANCER, V106, P1638, DOI 10.1038/bjc.2012.131; Boehme V, 2007, ANN ONCOL, V18, P149, DOI 10.1093/annonc/mdl327; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Feron O, 2009, RADIOTHER ONCOL, V92, P329, DOI 10.1016/j.radonc.2009.06.025; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Giatromanolaki A, 2001, BRIT J CANCER, V85, P881, DOI 10.1054/bjoc.2001.2018; Giatromanolaki A, 2008, LEUKEMIA LYMPHOMA, V49, P2181, DOI 10.1080/10428190802450629; Giatromanolaki A, 2006, GYNECOL ONCOL, V103, P912, DOI 10.1016/j.ygyno.2006.05.043; Giatromanolaki A, 2012, CANCER BIOL THER, V13, P1284, DOI 10.4161/cbt.21785; Granchi C, 2011, BIOORG MED CHEM LETT, V21, P7331, DOI 10.1016/j.bmcl.2011.10.031; Grimm M, 2013, CLIN EXP METASTAS, V30, P529, DOI 10.1007/s10585-012-9557-2; Guo L, 2003, J DIAGN CONCEPTS PRA, V2, P300; Hecht JR, 2005, J CLIN ONCOL, V23, p2S; Kayser G, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-22; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kolev Y, 2008, ANN SURG ONCOL, V15, P2336, DOI 10.1245/s10434-008-9955-5; Koukourakis MI, 2003, BRIT J CANCER, V89, P877, DOI 10.1038/sj.bjc.6601205; Koukourakis MI, 2005, CLIN EXP METASTAS, V22, P25, DOI 10.1007/s10585-005-2343-7; Koukourakis MI, 2006, J CLIN ONCOL, V24, P4301, DOI 10.1200/JCO.2006.05.9501; Langhammer S, 2011, TARGET ONCOL, V6, P155, DOI 10.1007/s11523-011-0184-7; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Lu R, 2013, ONCOGENE, DOI DOI 10.1038/0NC.2013.103; Lu RQ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-607; Lu RQ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-270; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Prensner JR, 2012, CLIN EXP METASTAS, V29, P645, DOI 10.1007/s10585-012-9507-z; Rattigan YL, 2012, EXP CELL RES, V318, P326, DOI 10.1016/j.yexcr.2011.11.014; Serganova I, 2011, CLIN CANCER RES, V17, P6250, DOI 10.1158/1078-0432.CCR-11-0397; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Swerdlow SH, 2008, WHO CLASSIFICATION T; Xue QF, 1996, J CHROMATOGR B, V677, P233, DOI 10.1016/0378-4347(95)00467-X; Zhuang LQ, 2010, MODERN PATHOL, V23, P45, DOI 10.1038/modpathol.2009.129	36	28	33	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74853	10.1371/journal.pone.0074853	http://dx.doi.org/10.1371/journal.pone.0074853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086384	Green Submitted, gold, Green Published			2022-12-27	WOS:000326520200043
J	Qiao, N; Huang, Y; Naveed, H; Green, CD; Han, JDJ				Qiao, Nan; Huang, Yi; Naveed, Hammad; Green, Christopher D.; Han, Jing-Dong J.			CoCiter: An Efficient Tool to Infer Gene Function by Assessing the Significance of Literature Co-Citation	PLOS ONE			English	Article							INTEGRATIVE ANALYSIS; EXPRESSION DATA; NETWORK; ONTOLOGY	A routine approach to inferring functions for a gene set is by using function enrichment analysis based on GO, KEGG or other curated terms and pathways. However, such analysis requires the existence of overlapping genes between the query gene set and those annotated by GO/KEGG. Furthermore, GO/KEGG databases only maintain a very restricted vocabulary. Here, we have developed a tool called "CoCiter" based on literature co-citations to address the limitations in conventional function enrichment analysis. Co-citation analysis is widely used in ranking articles and predicting protein-protein interactions (PPIs). Our algorithm can further assess the co-citation significance of a gene set with any other user-defined gene sets, or with free terms. We show that compared with the traditional approaches, CoCiter is a more accurate and flexible function enrichment analysis method. CoCiter is freely available at www.picb.ac.cn/hanlab/cociter/.	[Qiao, Nan; Huang, Yi; Naveed, Hammad; Green, Christopher D.; Han, Jing-Dong J.] Chinese Acad Sci, Shanghai Inst Biol Sci, Chinese Acad Sci Max Planck Partner Inst Computat, Chinese Acad Sci Key Lab Computat Biol, Shanghai, Peoples R China; [Qiao, Nan] Chinese Acad Sci, Ctr Mol Syst Biol, Inst Genet & Dev Biol, Beijing, Peoples R China; [Qiao, Nan; Huang, Yi] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Han, JDJ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Chinese Acad Sci Max Planck Partner Inst Computat, Chinese Acad Sci Key Lab Computat Biol, Shanghai, Peoples R China.	jdhan@picb.ac.cn	Naveed, Hammad/N-8851-2013	Naveed, Hammad/0000-0002-1867-974X	National Natural Science Foundation of China (NSFC) [31210103916, 91019019]; Chinese Ministry of Science and Technology [2011CB504206]; Chinese Academy of Sciences (CAS) [KSCX2-EW-R-02, KSCX2-EW-J-15, YZ201243]; Stem Cell Leading Project [XDA01010303]; Shanghai Academic Leader Project [11XD1405700]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Stem Cell Leading Project; Shanghai Academic Leader Project	This project was funded by grants from the National Natural Science Foundation of China (NSFC; grants 31210103916 and 91019019), Chinese Ministry of Science and Technology (grant 2011CB504206), Chinese Academy of Sciences (CAS; grants KSCX2-EW-R-02 and KSCX2-EW-J-15 and YZ201243), Stem Cell Leading Project (XDA01010303) and Shanghai Academic Leader Project (11XD1405700) to JDJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chowdhary R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034480; Doms A, 2005, NUCLEIC ACIDS RES, V33, pW783, DOI 10.1093/nar/gki470; Fleuren WWM, 2011, NUCLEIC ACIDS RES, V39, pW450, DOI 10.1093/nar/gkr310; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Han YX, 2012, AGING CELL, V11, P1055, DOI 10.1111/acel.12007; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Hou L, 2012, CURR GENOMICS, V13, P558, DOI 10.2174/138920212803251418; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang Q, 2012, CHIN J CANC; Jelier R, 2011, BRIEF BIOINFORM, V12, P518, DOI 10.1093/bib/bbq082; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/88213; Kaimal V, 2010, NUCLEIC ACIDS RES, V38, pW96, DOI 10.1093/nar/gkq418; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Liu Y, 2013, CELL RES, V23, P440, DOI 10.1038/cr.2013.8; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Minguez P, 2007, BIOINFORMATICS, V23, P3098, DOI 10.1093/bioinformatics/btm445; Plake C, 2009, NUCLEIC ACIDS RES, V37, pW300, DOI 10.1093/nar/gkp429; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Sayers E., 2009, E UTILITIES IN DEPTH; Soldatos TG, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-1; Soldatos TG, 2010, NUCLEIC ACIDS RES, V38, P26, DOI 10.1093/nar/gkp876; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang QH, 2011, BIOINFORMATICS, V27, P1521, DOI 10.1093/bioinformatics/btr154; Yu HY, 2007, BIOINFORMATICS, V23, P2163, DOI 10.1093/bioinformatics/btm291	30	29	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74074	10.1371/journal.pone.0074074	http://dx.doi.org/10.1371/journal.pone.0074074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086311	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200020
J	Smith, ME; Bozinovski, S; Malmhall, C; Sjostrand, M; Glader, P; Venge, P; Hiemstra, PS; Anderson, GP; Linden, A; Qvarfordt, I				Smith, Margaretha E.; Bozinovski, Steven; Malmhall, Carina; Sjostrand, Margareta; Glader, Pernilla; Venge, Per; Hiemstra, Pieter S.; Anderson, Gary P.; Linden, Anders; Qvarfordt, Ingemar			Increase in Net Activity of Serine Proteinases but Not Gelatinases after Local Endotoxin Exposure in the Peripheral Airways of Healthy Subjects	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NF-KAPPA-B; NEUTROPHIL LIPOCALIN HNL; MATRIX-METALLOPROTEINASE; LUNG INFLAMMATION; ALLERGEN CHALLENGE; CIGARETTE-SMOKE; INNATE IMMUNITY; LAVAGE FLUID; IN-VIVO	We tested the hypothesis that activation of the innate immune response induces an imbalance in the proteolytic homeostasis in the peripheral airways of healthy subjects, towards excess serine or gelatinase proteinase activity. During bronchoscopy, 18 healthy human subjects underwent intra-bronchial exposure to endotoxin and contra-lateral exposure to vehicle. Bronchoalveolar lavage (BAL) samples were harvested 24 or 48 hours (h) later. We quantified archetype proteinases, anti-proteinases, inflammatory BAL cells, and, importantly, total plus net proteinase activities using functional substrate assays. As expected, endotoxin exposure increased the concentrations of polymorphonuclear leukocytes (PMN's) and macrophages, of proteinases and the anti-proteinases tissue inhibitor of metalloproteinase-1, alpha-1-antitrypsin and, to a lesser extent, secretory leukoproteinase inhibitor, at both time points. Notably, at these time points, endotoxin exposure substantially increased the quantitative NE/SLPI ratio and the net serine proteinase activity corresponding to neutrophil elastase (NE). Endotoxin exposure also increased the total gelatinase activity corresponding to matrix metalloproteinase (MMP)-9; an activity dominating over that of MMP-2. However, endotoxin exposure had no impact on net gelatinolytic activity at 24 or 48 h after exposure. Thus, local activation of the innate immune response induces an imbalance towards increased net serine proteinase activity in the proteolytic homeostasis of the peripheral airways in healthy subjects. Hypothetically, this serine proteinase activity can contribute to tissue remodelling and hypersecretion via NE from PMN's, if it is triggered repeatedly, as might be the case in chronic inflammatory airway disorders.	[Smith, Margaretha E.; Malmhall, Carina; Sjostrand, Margareta; Glader, Pernilla; Linden, Anders; Qvarfordt, Ingemar] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Lung Immunol Grp, Gothenburg, Sweden; [Bozinovski, Steven; Anderson, Gary P.] Univ Melbourne, Dept Med & Pharmacol, Lung Dis Res Grp, Parkville, Vic 3052, Australia; [Venge, Per] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Hiemstra, Pieter S.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands; [Linden, Anders] Karolinska Univ Hosp, Karolinska Inst, Inst Environm Med, Unit Lung & Airway Res, Stockholm, Sweden; [Linden, Anders] Karolinska Univ Hosp, Lung Allergy Clin, Stockholm, Sweden	University of Gothenburg; University of Melbourne; Uppsala University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Linden, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Lung Immunol Grp, Gothenburg, Sweden.	anders.linden@ki.se	Hiemstra, Pieter S/K-8587-2018; /V-8478-2019	Hiemstra, Pieter S/0000-0002-0238-5982; Linden, Anders/0000-0003-1258-2928; Anderson, Gary/0000-0001-6580-3398; Bozinovski, Steven/0000-0001-6533-8641	Swedish Heart-Lung Fund [20100290]; Federal Project Funding; King Gustav V's and Queen Victoria's Freemason Foundation; Gothenburg Medical Society	Swedish Heart-Lung Fund(Swedish Heart-Lung Foundation); Federal Project Funding; King Gustav V's and Queen Victoria's Freemason Foundation; Gothenburg Medical Society	Funding from the Swedish Heart-Lung Fund (Project No. 20100290), Federal Project Funding according to the ALF/LUA agreement, King Gustav V's and Queen Victoria's Freemason Foundation and from Gothenburg Medical Society. No funding was obtained from the tobacco industry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert J, 2003, ACTA ANAESTH SCAND, V47, P407, DOI 10.1034/j.1399-6576.2003.00059.x; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Baines KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018426; Betsuyaku T, 1999, AM J RESP CRIT CARE, V159, P1985, DOI 10.1164/ajrccm.159.6.9809043; BIRRER P, 1992, J APPL PHYSIOL, V73, P317, DOI 10.1152/jappl.1992.73.1.317; Bozinovski S, 2002, J BIOL CHEM, V277, P42808, DOI 10.1074/jbc.M207840200; CASTILLO MJ, 1979, ANAL BIOCHEM, V99, P53, DOI 10.1016/0003-2697(79)90043-5; Churg A, 2012, EUR RESPIR J, V39, P197, DOI 10.1183/09031936.00121611; Clemmensen SN, 2011, EUR J HAEMATOL, V86, P517, DOI 10.1111/j.1600-0609.2011.01601.x; Cosgrove S, 2011, J BIOL CHEM, V286, P7692, DOI 10.1074/jbc.M110.183863; Dabbagh K, 2001, J CELL PHYSIOL, V186, P73, DOI 10.1002/1097-4652(200101)186:1<73::AID-JCP1002>3.0.CO;2-Q; Doyen V, 2012, INFLAMMATION, V35, P33, DOI 10.1007/s10753-010-9286-0; DUBOIS RM, 1991, BLOOD, V77, P2724; Geraghty P, 2007, J IMMUNOL, V178, P5871, DOI 10.4049/jimmunol.178.9.5871; Glader P, 2010, EUR RESPIR J, V36, P1155, DOI 10.1183/09031936.00170609; Greene C, 2003, J INFECT DIS, V188, P769, DOI 10.1086/377238; Hiemstra PS, 1998, EUR RESPIR J, V12, P1200, DOI 10.1183/09031936.98.12051200; Hiltermann JTN, 1999, FREE RADICAL BIO MED, V27, P1448, DOI 10.1016/S0891-5849(99)00191-4; Ho SC, 2009, J IMMUNOL, V183, P411, DOI 10.4049/jimmunol.0803729; Hoogerwerf JJ, 2008, AM J RESP CRIT CARE, V178, P34, DOI 10.1164/rccm.200708-1261OC; Kelly EAB, 2000, AM J RESP CRIT CARE, V162, P1157; KJELDSEN L, 1993, BLOOD, V82, P3183; Korsgren M, 2012, CLIN PHYSIOL FUNCT I, V32, P71, DOI 10.1111/j.1475-097X.2011.01058.x; Kuwahara I, 2006, AM J PHYSIOL-LUNG C, V291, pL407, DOI 10.1152/ajplung.00471.2005; Mackarel AJ, 1999, AM J RESP CELL MOL, V20, P1209; Mattos W, 2002, CHEST, V122, P1543, DOI 10.1378/chest.122.5.1543; O'Grady NP, 2001, AM J RESP CRIT CARE, V163, P1591, DOI 10.1164/ajrccm.163.7.2009111; Ohnishi K, 1998, LAB INVEST, V78, P1077; Paone G, 2011, DIS MARKERS, V31, P91, DOI [10.1155/2011/139493, 10.3233/DMA-2011-0807]; Ratjen F, 2002, THORAX, V57, P930, DOI 10.1136/thorax.57.11.930; Sallenave JM, 1997, J LEUKOCYTE BIOL, V61, P695, DOI 10.1002/jlb.61.6.695; Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684; Sethi S, 2006, AM J RESP CRIT CARE, V173, P991, DOI 10.1164/rccm.200509-1525OC; Seveus L, 1997, HISTOCHEM CELL BIOL, V107, P423, DOI 10.1007/s004180050129; TETLEY TD, 1993, THORAX, V48, P560, DOI 10.1136/thx.48.5.560; Turino GM, 2011, AM J RESP CRIT CARE, V184, P637, DOI 10.1164/rccm.201103-0450PP; Vandenbroucke RE, 2011, EUR RESPIR J, V38, P1200, DOI 10.1183/09031936.00027411; Vernooy JHJ, 2004, CHEST, V126, P1802, DOI 10.1378/chest.126.6.1802; Vlahos R, 2006, AM J PHYSIOL-LUNG C, V290, pL931, DOI 10.1152/ajplung.00201.2005; Vlahos R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033277; Witherden IR, 2004, AM J RESP CELL MOL, V30, P500, DOI 10.1165/rcmb.4890; Xu SY, 2000, BBA-PROTEIN STRUCT M, V1482, P298, DOI 10.1016/S0167-4838(00)00163-1; XU SY, 1994, J IMMUNOL METHODS, V171, P245, DOI 10.1016/0022-1759(94)90044-2	43	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75032	10.1371/journal.pone.0075032	http://dx.doi.org/10.1371/journal.pone.0075032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086430	Green Published, gold			2022-12-27	WOS:000326520200073
J	Cejudo-Roman, A; Pinto, FM; Subiran, N; Ravina, CG; Fernandez-Sanchez, M; Perez-Hernandez, N; Perez, R; Pacheco, A; Irazusta, J; Candenas, L				Cejudo-Roman, Antonio; Pinto, Francisco M.; Subiran, Nerea; Ravina, Cristina G.; Fernandez-Sanchez, Manuel; Perez-Hernandez, Natalia; Perez, Ricardo; Pacheco, Alberto; Irazusta, Jon; Candenas, Luz			The Voltage-Gated Sodium Channel Na(v)1.8 Is Expressed in Human Sperm	PLOS ONE			English	Article							HUMAN SPERMATOZOA; CATSPER CHANNEL; MALE-FERTILITY; CA2+ CHANNEL; CAPACITATION; DIVERSITY; CALCIUM; TACHYKININS; ACTIVATION; PRINCIPAL	The role of Na+ fluxes through voltage-gated sodium channels in the regulation of sperm cell function remains poorly understood. Previously, we reported that several genes encoding voltage-gated Na+ channels were expressed in human testis and mature spermatozoa. In this study, we analyzed the presence and function of the TTX-resistant VGSC a subunit Na(v)1.8 in human capacitated sperm cells. Using an RT-PCR assay, we found that the mRNA of the gene SCN10A, that encode Na-v1.8, was abundantly and specifically expressed in human testis and ejaculated spermatozoa. The Na-v1.8 protein was detected in capacitated sperm cells using three different specific antibodies against this channel. Positive immunoreactivity was mainly located in the neck and the principal piece of the flagellum. The presence of Na-v1.8 in sperm cells was confirmed by Western blot. Functional studies demonstrated that the increases in progressive motility produced by veratridine, a voltage-gated sodium channel activator, were reduced in sperm cells preincubated with TTX (10 mu M), the Na-v1.8 antagonist A-803467, or a specific Na-v1.8 antibody. Veratridine elicited similar percentage increases in progressive motility in sperm cells maintained in Ca2+-containing or Ca2+-free solution and did not induce hyperactivation or the acrosome reaction. Veratridine caused a rise in sperm intracellular Na+, [Na+](i), and the sustained phase of the response was inhibited in the presence of A-803467. These results verify that the Na+ channel Na-v1.8 is present in human sperm cells and demonstrate that this channel participates in the regulation of sperm function.	[Cejudo-Roman, Antonio; Pinto, Francisco M.; Perez-Hernandez, Natalia; Perez, Ricardo; Candenas, Luz] Univ Seville, CSIC, IIQ, Seville, Spain; [Subiran, Nerea; Irazusta, Jon] Univ Basque Country, Fac Med & Odontol, Dept Fisiol, Leioa, Bizkaia, Spain; [Ravina, Cristina G.; Fernandez-Sanchez, Manuel] Inst Valenciano Infertilidad, Seville, Spain; [Pacheco, Alberto] Inst Madrileno Infertilidad, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-USE - Instituto de Investigaciones Quimicas (IIQ); University of Basque Country; University of Valencia	Candenas, L (corresponding author), Univ Seville, CSIC, IIQ, Seville, Spain.	luzcandenas@iiq.csic.es	Irazusta, Jon/ABB-1237-2020; Pinto, Francisco M./P-4995-2014; Subirán, Nerea/AAA-4395-2019; Perez-Afonso, Ricardo/L-5566-2015; Fernández-Sánchez, Manuel/O-6336-2018; Candenas, L./P-3247-2014; irazusta, Jon/H-8568-2015	Pinto, Francisco M./0000-0001-9694-9816; Subirán, Nerea/0000-0001-9202-1287; Fernández-Sánchez, Manuel/0000-0002-1214-2984; Candenas, L./0000-0001-7886-1095; Irazusta, Jon/0000-0002-6763-8602	Junta de Andalucia [P08-CVI-04185]; Ministerio de Economia y Competitividad, Spain [CTQ2011-25564]; European Union	Junta de Andalucia(Junta de Andalucia); Ministerio de Economia y Competitividad, Spain; European Union(European Commission)	This work was financially supported by grants from Junta de Andalucia (P08-CVI-04185) and Ministerio de Economia y Competitividad (CTQ2011-25564), Spain, with joint financing by FEDER and FSE funds from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Baldi E, 2009, MOL CELL ENDOCRINOL, V308, P39, DOI 10.1016/j.mce.2009.02.006; Battistone MA, 2013, MOL HUM REPROD, V19, P570, DOI 10.1093/molehr/gat033; Brenker C, 2012, EMBO J, V31, P1654, DOI 10.1038/emboj.2012.30; Candenas L, 2006, EUR J PHARMACOL, V541, P9, DOI 10.1016/j.ejphar.2006.04.025; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chang HX, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096578; Chang HX, 2011, BIOL REPROD, V85, P296, DOI 10.1095/biolreprod.110.089789; Chavez JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060578; Chen WY, 2009, BIOL REPROD, V80, P115, DOI 10.1095/biolreprod.108.068528; Darszon A, 2006, REPRODUCTION, V131, P977, DOI 10.1530/rep.1.00612; Darszon A, 2011, PHYSIOL REV, V91, P1305, DOI 10.1152/physrev.00028.2010; Escoffier J, 2012, J CELL SCI, V125, P473, DOI 10.1242/jcs.093344; Garcia MA, 1999, MOL REPROD DEV, V52, P189, DOI 10.1002/(SICI)1098-2795(199902)52:2<189::AID-MRD10>3.0.CO;2-D; Garolla A, 2013, FERTIL STERIL, V99, P125, DOI 10.1016/j.fertnstert.2012.09.006; Garrido N, 2008, REPROD BIOMED ONLINE, V17, P855, DOI 10.1016/S1472-6483(10)60415-4; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hernandez-Gonzalez EO, 2006, J BIOL CHEM, V281, P5623, DOI 10.1074/jbc.M508172200; Jimenez-Gonzalez MC, 2007, J CELL PHYSIOL, V213, P801, DOI 10.1002/jcp.21153; Kwon WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054192; Kwon WS, 2013, FERTIL STERIL, V99, P354, DOI 10.1016/j.fertnstert.2012.09.021; Lishko PV, 2012, ANNU REV PHYSIOL, V74, P453, DOI 10.1146/annurev-physiol-020911-153258; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Mahfouz R, 2010, FERTIL STERIL, V94, P2141, DOI 10.1016/j.fertnstert.2009.12.030; McGaraughty S, 2008, J PHARMACOL EXP THER, V324, P1204, DOI 10.1124/jpet.107.134148; O'Brien BJ, 2008, J COMP NEUROL, V508, P940, DOI 10.1002/cne.21701; Page NM, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-4; Patak E, 2003, BRIT J PHARMACOL, V139, P523, DOI 10.1038/sj.bjp.0705279; Pinto FM, 2012, INT J ANDROL, V35, P63, DOI 10.1111/j.1365-2605.2011.01177.x; Pinto FM, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-71; Plummer NW, 1999, GENOMICS, V57, P323, DOI 10.1006/geno.1998.5735; Publicover SJ, 2008, FRONT BIOSCI, V13, P5623; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Ravina CG, 2007, HUM REPROD, V22, P1617, DOI 10.1093/humrep/dem069; Rossato M, 2001, MOL HUM REPROD, V7, P119, DOI 10.1093/molehr/7.2.119; Smith JF, 2013, P NATL ACAD SCI USA, V110, P6823, DOI 10.1073/pnas.1216588110; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; Torres-Flores V, 2011, HUM REPROD, V26, P2626, DOI 10.1093/humrep/der237; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verkerk AO, 2012, CIRC RES, V111, P333, DOI 10.1161/CIRCRESAHA.112.274035; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Xu WM, 2007, P NATL ACAD SCI USA, V104, P9816, DOI 10.1073/pnas.0609253104; Zeng XH, 2011, P NATL ACAD SCI USA, V108, P5879, DOI 10.1073/pnas.1100240108	43	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76084	10.1371/journal.pone.0076084	http://dx.doi.org/10.1371/journal.pone.0076084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086692	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900079
J	Predescu, S; Knezevic, I; Bardita, C; Neamu, RF; Brovcovych, V; Predescu, D				Predescu, Sanda; Knezevic, Ivana; Bardita, Cristina; Neamu, Radu Florin; Brovcovych, Viktor; Predescu, Dan			Platelet Activating Factor-Induced Ceramide Micro-Domains Drive Endothelial NOS Activation and Contribute to Barrier Dysfunction	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; VASCULAR-PERMEABILITY; ENOS PHOSPHORYLATION; FACTOR PAF; CELLS; MEMBRANE; CAVEOLAE; RELEASE; PROTEIN; PULMONARY	The spatial and functional relationship between platelet activating factor-receptor (PAF-R) and nitric oxide synthase (eNOS) in the lateral plane of the endothelial plasma membrane is poorly characterized. In this study, we used intact mouse pulmonary endothelial cells (ECs) as well as endothelial plasma membrane patches and subcellular fractions to define a new microdomain of plasmalemma proper where the two proteins colocalize and to demonstrate how PAF-mediated nitric oxide (NO) production fine-tunes ECs function as gatekeepers of vascular permeability. Using fluorescence microscopy and immunogold labeling electron microscopy (EM) on membrane patches we demonstrate that PAF-R is organized as clusters and colocalizes with a subcellular pool of eNOS, outside recognizable vesicular profiles. Moreover, PAF-induced acid sphingomyelinase activation generates a ceramide-based microdomain on the external leaflet of plasma membrane, inside of which a signalosome containing eNOS shapes PAF-stimulated NO production. Real-time measurements of NO after PAF-R ligation indicated a rapid (5 to 15 min) increase in NO production followed by a > 45 min period of reduction to basal levels. Moreover, at the level of this new microdomain, PAF induces a dynamic phosphorylation/dephosphorylation of Ser, Thr and Tyr residues of eNOS that correlates with NO production. Altogether, our findings establish the existence of a functional partnership PAF-R/eNOS on EC plasma membrane, at the level of PAF-induced ceramide plasma membrane microdomains, outside recognized vesicular profiles.	[Predescu, Sanda; Knezevic, Ivana; Bardita, Cristina; Predescu, Dan] Rush Univ, Div Pulm & Crit Care, Dept Med & Pharmacol, Chicago, IL 60612 USA; [Neamu, Radu Florin] Emory Univ, Sch Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA USA; [Brovcovych, Viktor] Univ Illinois, Dept Pharmacol, Chicago, IL USA	Rush University; Emory University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Predescu, D (corresponding author), Rush Univ, Div Pulm & Crit Care, Dept Med & Pharmacol, Chicago, IL 60612 USA.	Dan_Predescu@rush.edu		Predescu, Sanda/0000-0002-9386-6756	National Institute of Health [HLO95430]; Rush University; American Heart Association [SDG0635175N]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rush University; American Heart Association(American Heart Association)	This work was supported by National Institute of Health grant HLO95430 to D. Predescu, start-up funds from Rush University and American Heart Association grant SDG0635175N to Sanda Predescu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andries LJ, 1998, CIRC RES, V82, P195; Axelrad TW, 2004, FASEB J, V18, P568, DOI 10.1096/fj.03-0479fje; BENVENISTE J, 1989, ADV PROSTAG THROMB L, V19, P355; BJORK J, 1983, EUR J PHARMACOL, V96, P87, DOI 10.1016/0014-2999(83)90532-0; Boo YC, 2006, FREE RADICAL BIO MED, V41, P144, DOI 10.1016/j.freeradbiomed.2006.03.024; BROCK TA, 1986, AM J PHYSIOL, V250, P1086, DOI 10.1152/ajpheart.1986.250.6.H1086; Brovkovych V, 1999, J PHARMACEUT BIOMED, V19, P135, DOI 10.1016/S0731-7085(98)00090-9; Bulotta S, 2006, EXP CELL RES, V312, P877, DOI 10.1016/j.yexcr.2005.12.014; BUSSOLINO F, 1994, J BIOL CHEM, V269, P2877; BUSSOLINO F, 1987, J IMMUNOL, V139, P2439; CAMUSSI G, 1983, INT ARCH ALLER A IMM, V70, P245, DOI 10.1159/000233331; CAMUSSI G, 1983, J IMMUNOL, V131, P2397; CHIGNARD M, 1979, NATURE, V279, P799, DOI 10.1038/279799a0; COOPER JA, 1987, J APPL PHYSIOL, V62, P1076, DOI 10.1152/jappl.1987.62.3.1076; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Duran WN, 2010, CARDIOVASC RES, V87, P254, DOI 10.1093/cvr/cvq139; Duran WN, 2000, MICROVASC RES, V60, P104, DOI 10.1006/mvre.2000.2250; Feron O, 1998, BIOCHEMISTRY-US, V37, P193, DOI 10.1021/bi972307p; Fleming I, 2010, PFLUG ARCH EUR J PHY, V459, P793, DOI 10.1007/s00424-009-0767-7; FOLDESFILEP E, 1987, BIOCHEM BIOPH RES CO, V148, P1412; Fulton D, 2008, CIRC RES, V102, P497, DOI 10.1161/CIRCRESAHA.107.162933; Goggel R, 2004, NAT MED, V10, P155, DOI 10.1038/nm977; Gorodeski GI, 2000, AM J PHYSIOL-CELL PH, V278, pC942, DOI 10.1152/ajpcell.2000.278.5.C942; Govers R, 2002, BIOCHEM J, V361, P193, DOI 10.1042/0264-6021:3610193; GRIGORIAN GY, 1987, CIRC RES, V61, P389, DOI 10.1161/01.RES.61.3.389; Haberkant P, 2008, J LIPID RES, V49, P251, DOI 10.1194/jlr.D700023-JLR200; Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002; Harris MB, 2001, J BIOL CHEM, V276, P16587, DOI 10.1074/jbc.M100229200; Heijnen HFG, 2004, J HISTOCHEM CYTOCHEM, V52, P1277, DOI 10.1369/jhc.4A6307.2004; Hickey MJ, 1997, EXP PHYSIOL, V82, P339, DOI 10.1113/expphysiol.1997.sp004029; HUMPHREY DM, 1984, LAB INVEST, V50, P16; Ihida K, 1999, J CELL SCI, V112, P285; Jacobson Julie, 2002, J Extra Corpor Technol, V34, P144; Jagnandan D, 2005, AM J PHYSIOL-CELL PH, V289, pC1024, DOI 10.1152/ajpcell.00162.2005; Knezevic II, 2009, J BIOL CHEM, V284, P5381, DOI 10.1074/jbc.M808958200; Kojima H, 1998, CHEM PHARM BULL, V46, P373; Korzeniowski M, 2007, CELL PHYSIOL BIOCHEM, V20, P347, DOI 10.1159/000107520; Kuebler WM, 2010, CELL PHYSIOL BIOCHEM, V26, P29, DOI 10.1159/000315103; Kuhr F, 2010, NEUROPEPTIDES, V44, P145, DOI 10.1016/j.npep.2009.12.004; KURZCHALIA T, 1995, TRENDS CELL BIOL, V5, P187, DOI 10.1016/S0962-8924(00)88990-4; Lachmanovich E, 2003, J MICROSC-OXFORD, V212, P122, DOI 10.1046/j.1365-2818.2003.01239.x; Liu JW, 1996, BIOCHEMISTRY-US, V35, P13277, DOI 10.1021/bi961720e; MACIAG T, 1979, P NATL ACAD SCI USA, V76, P5674, DOI 10.1073/pnas.76.11.5674; Marrache AM, 2002, J IMMUNOL, V169, P6474, DOI 10.4049/jimmunol.169.11.6474; Michel T, 1999, BRAZ J MED BIOL RES, V32, P1361, DOI 10.1590/S0100-879X1999001100006; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Poisson C, 2009, J IMMUNOL, V183, P2747, DOI 10.4049/jimmunol.0802651; Predescu D, 1996, EUR J CELL BIOL, V69, P86; Predescu D, 2005, AM J PHYSIOL-LUNG C, V289, pL371, DOI 10.1152/ajplung.00175.2004; Predescu D, 1998, P NATL ACAD SCI USA, V95, P6175, DOI 10.1073/pnas.95.11.6175; PREDESCU D, 1994, P NATL ACAD SCI USA, V91, P3014, DOI 10.1073/pnas.91.8.3014; Predescu SA, 1997, AM J PHYSIOL-HEART C, V272, pH937, DOI 10.1152/ajpheart.1997.272.2.H937; Predescu SA, 2005, J BIOL CHEM, V280, P37130, DOI 10.1074/jbc.M505659200; Predescu SA, 2001, MOL BIOL CELL, V12, P1019, DOI 10.1091/mbc.12.4.1019; PRESCOTT SM, 1984, P NATL ACAD SCI-BIOL, V81, P3534, DOI 10.1073/pnas.81.11.3534; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; Quest AFG, 2004, BIOCHEM CELL BIOL, V82, P129, DOI 10.1139/o03-071; Reiner M, 2001, J HISTOCHEM CYTOCHEM, V49, P1605, DOI 10.1177/002215540104901214; Sakoda T, 1995, MOL CELL BIOCHEM, V152, P143, DOI 10.1007/BF01076076; Sanchez FA, 2011, J BIOL CHEM, V286, P30409, DOI 10.1074/jbc.M111.234294; SESSA WC, 1993, CIRC RES, V72, P921, DOI 10.1161/01.RES.72.4.921; Singla S, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-46; Sirois MG, 1997, AM J PHYSIOL-HEART C, V272, pH2746, DOI 10.1152/ajpheart.1997.272.6.H2746; Sot J, 2006, BIOPHYS J, V90, P903, DOI 10.1529/biophysj.105.067710; STOLZ DB, 1992, J CELL SCI, V103, P39; Walford G, 2003, J THROMB HAEMOST, V1, P2112, DOI 10.1046/j.1538-7836.2003.00345.x; Yang Y, 2010, EUR RESPIR J, V36, P417, DOI 10.1183/09031936.00095609; Zhang J, 2006, MICRON, V37, P14, DOI 10.1016/j.micron.2005.03.014	69	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75846	10.1371/journal.pone.0075846	http://dx.doi.org/10.1371/journal.pone.0075846			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086643	Green Published, Green Submitted, gold			2022-12-27	WOS:000325223900063
J	Rognoni, P; Lavatelli, F; Casarini, S; Palladini, G; Verga, L; Pedrazzoli, P; Valentini, G; Merlini, G; Perfetti, V				Rognoni, Paola; Lavatelli, Francesca; Casarini, Simona; Palladini, Giovanni; Verga, Laura; Pedrazzoli, Paolo; Valentini, Giovanna; Merlini, Giampaolo; Perfetti, Vittorio			A Strategy for Synthesis of Pathogenic Human Immunoglobulin Free Light Chains in E-coli	PLOS ONE			English	Article							GERMLINE GENE; PROTEINS; AMYLOIDOSIS; INVOLVEMENT; DYSFUNCTION; EXPRESSION; REGION; SERUM	Monoclonal immunoglobulin light chains are normally synthesized in excess compared to the heavy chain partners and can be detected in serum and urine ("free" LC). Occasionally free LC are per se cause of organ toxicity, as in free LC-related disorders. In AL amyloidosis, the most common of these conditions, free LC with peculiar biophysical properties related to their primary structure damage target organs and organize in amyloid fibrils. Unlimited availability of well-characterized free LC is instrumental to investigate the toxic effect of these proteins and to study their interactions with targets. We present a straightforward strategy to obtain recombinant monoclonal free LC by using a bacterial system. These proteins, expressed as inclusion bodies, were subjected to solubilization and refolding procedures to recover them in native form. To minimize differences from the circulating natural LC, full-length recombinant LC were expressed, i.e. complete of variable and constant regions, with the original amino acid sequence along the entire protein, and with no purification tags. The strategy was exploited to generate free LC from three AL amyloidosis patients. After purification, recombinant proteins were biochemically characterized and compared to the natural Bence Jones protein isolated from one of the patients. Results showed that the recombinant free LC were properly folded and formed homodimers in solution, similar to the natural Bence Jones protein used for comparison. Furthermore, as proof of pathogenicity, recombinant proteins formed amyloid fibrils in vitro. We believe that the present strategy represents a valuable tool to speed research in free LC-related disorders.	[Rognoni, Paola; Lavatelli, Francesca; Casarini, Simona; Palladini, Giovanni; Merlini, Giampaolo; Perfetti, Vittorio] Fdn IRCCS Policlin S Matteo, Amyloidosis Res & Treatment Ctr, Pavia, Italy; [Rognoni, Paola; Lavatelli, Francesca; Casarini, Simona; Palladini, Giovanni; Merlini, Giampaolo; Perfetti, Vittorio] Fdn IRCCS Policlin S Matteo, Biotechnol Res Labs, Pavia, Italy; [Rognoni, Paola; Lavatelli, Francesca; Casarini, Simona; Palladini, Giovanni; Merlini, Giampaolo; Perfetti, Vittorio] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Verga, Laura] Fdn IRCCS Policlin S Matteo, Pathol Unit, Pavia, Italy; [Pedrazzoli, Paolo] Fdn IRCCS Policlin S Matteo, Sect Oncol, Dept Hematol & Oncol, Pavia, Italy; [Valentini, Giovanna] Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, I-27100 Pavia, Italy	IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; University of Pavia; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; University of Pavia	Perfetti, V (corresponding author), Fdn IRCCS Policlin S Matteo, Sect Oncol, Dept Hematol & Oncol, Pavia, Italy.	v.perfetti@smatteo.pv.it	Palladini, Giovanni/G-1763-2010; Verga, Laura/AAG-5105-2020; Rognoni, Paola/P-9092-2019; Perfetti, Vittorio/B-6795-2014; Lavatelli, Francesca/K-5741-2016; Pedrazzoli, Paolo/AAB-8690-2019; Merlini, Giampaolo/A-3817-2008	Palladini, Giovanni/0000-0001-5994-5138; Rognoni, Paola/0000-0001-6350-1919; Perfetti, Vittorio/0000-0003-4690-4892; Lavatelli, Francesca/0000-0002-7693-4825; Pedrazzoli, Paolo/0000-0002-9419-7160; Merlini, Giampaolo/0000-0001-7680-3254	Fondazione IRCCS Policlinico San Matteo by AIRC (Associazione Italiana per la Ricerca sul Cancro) [9965]; Italian Ministry of Health [GR-2010-2317596]; Amyloid Foundation; Fondazione Mintas, Ghislieri College, Pavia	Fondazione IRCCS Policlinico San Matteo by AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); Amyloid Foundation; Fondazione Mintas, Ghislieri College, Pavia	This work was supported by Fondazione IRCCS Policlinico San Matteo, Grant 2009-2012 by AIRC (Associazione Italiana per la Ricerca sul Cancro) Special Program Molecular Clinical Oncology 5 per mille n. 9965, Italian Ministry of Health (GR-2010-2317596), Amyloid Foundation and Fondazione Mintas, Ghislieri College, Pavia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RS, 2003, BLOOD, V101, P3801, DOI 10.1182/blood-2002-09-2707; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Bradwell AR, 2001, CLIN CHEM, V47, P673; Brenner DA, 2004, CIRC RES, V94, P1008, DOI 10.1161/01.RES.0000126569.75419.74; BUCHNER J, 1991, BIO-TECHNOL, V9, P157, DOI 10.1038/nbt0291-157; Clark ED, 1999, METHOD ENZYMOL, V309, P217; Colombo R, 2009, ELECTROPHORESIS, V30, P1418, DOI 10.1002/elps.200800377; Comenzo RL, 2001, BLOOD, V98, P714, DOI 10.1182/blood.V98.3.714; Connors LH, 2007, BIOCHEMISTRY-US, V46, P14259, DOI 10.1021/bi7013773; Honegger A, 2001, J MOL BIOL, V309, P687, DOI 10.1006/jmbi.2001.4664; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; Klimtchuk ES, 2010, BIOCHEMISTRY-US, V49, P9848, DOI 10.1021/bi101351c; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Lavatelli F, 2011, BBA-PROTEINS PROTEOM, V1814, P409, DOI 10.1016/j.bbapap.2010.12.012; Levinson RT, 2013, SCI REP-UK, V3, DOI 10.1038/srep01278; Liao RL, 2001, CIRCULATION, V104, P1594, DOI 10.1161/circ.104.14.1594; Lilie H, 1998, CURR OPIN BIOTECH, V9, P497, DOI 10.1016/S0958-1669(98)80035-9; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Merlini G, 2006, BLOOD, V108, P2520, DOI 10.1182/blood-2006-03-001164; Mo HP, 2001, P NATL ACAD SCI USA, V98, P2352, DOI 10.1073/pnas.051627998; Omtvedt LA, 2000, AMYLOID, V7, P227, DOI 10.3109/13506120009146437; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Palladini G, 2006, BLOOD, V107, P3854, DOI 10.1182/blood-2005-11-4385; Perfetti V, 2002, BLOOD, V100, P948, DOI 10.1182/blood-2002-01-0114; Perfetti V, 1996, ANAL BIOCHEM, V239, P107, DOI 10.1006/abio.1996.0297; Perfetti V, 2012, BLOOD, V119, P144, DOI 10.1182/blood-2011-05-355784; Raffen R, 1999, PROTEIN SCI, V8, P509; Ren RY, 2010, J BIOL CHEM, V285, P37672, DOI 10.1074/jbc.M110.149575; SAXENA VP, 1970, BIOCHEMISTRY-US, V9, P5015; Shi JR, 2010, P NATL ACAD SCI USA, V107, P4188, DOI 10.1073/pnas.0912263107; SKERRA A, 1993, CURR OPIN IMMUNOL, V5, P256, DOI 10.1016/0952-7915(93)90014-J; SOLOMON A, 1985, METHOD ENZYMOL, V116, P101; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; Uversky VN, 2010, FEBS J, V277, P2940, DOI 10.1111/j.1742-4658.2010.07721.x; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j	36	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76022	10.1371/journal.pone.0076022	http://dx.doi.org/10.1371/journal.pone.0076022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086679	gold, Green Submitted, Green Published			2022-12-27	WOS:000325223900071
J	Kamsu, JM; Constans, JM; Lamberton, F; Courtheoux, P; Denise, P; Philoxene, B; Coquemont, M; Besnard, S				Kamsu, Jeanine Manuella; Constans, Jean-Marc; Lamberton, Franck; Courtheoux, Patrick; Denise, Pierre; Philoxene, Bruno; Coquemont, Maelle; Besnard, Stephane			Structural Layers of Ex Vivo Rat Hippocampus at 7T MRI	PLOS ONE			English	Article							MAGNETIC-RESONANCE MICROSCOPY; MOUSE-BRAIN; ALZHEIMERS-DISEASE; ANIMAL MRI; IN-VIVO; MEMORY; VOLUME; SEGMENTATION; MANGANESE; HISTOLOGY	Magnetic resonance imaging (MRI) applied to the hippocampus is challenging in studies of the neurophysiology of memory and the physiopathology of numerous diseases such as epilepsy, Alzheimer's disease, ischemia, and depression. The hippocampus is a well-delineated cerebral structure with a multi-layered organization. Imaging of hippocampus layers is limited to a few studies and requires high magnetic field and gradient strength. We performed one conventional MRI sequence on a 7T MRI in order to visualize and to delineate the multi-layered hippocampal structure ex vivo in rat brains. We optimized a volumic three-dimensional T2 Rapid Acquisition Relaxation Enhancement (RARE) sequence and quantified the volume of the hippocampus and one of its thinnest layers, the stratum granulare of the dentate gyrus. Additionally, we tested passive staining by gadolinium with the aim of decreasing the acquisition time and increasing image contrast. Using appropriated settings, six discrete layers were differentiated within the hippocampus in rats. In the hippocampus proper or Ammon's Horn (AH): the stratum oriens, the stratum pyramidale of, the stratum radiatum, and the stratum lacunosum moleculare of the CA1 were differentiated. In the dentate gyrus: the stratum moleculare and the stratum granulare layer were seen distinctly. Passive staining of one brain with gadolinium decreased the acquisition time by four and improved the differentiation between the layers. A conventional sequence optimized on a 7T MRI with a standard receiver surface coil will allow us to study structural layers (signal and volume) of hippocampus in various rat models of neuropathology (anxiety, epilepsia, neurodegeneration).	[Kamsu, Jeanine Manuella; Denise, Pierre; Philoxene, Bruno; Besnard, Stephane] Univ Caen, Unite Mixte Rech, UMR 1075, F-14032 Caen, France; [Constans, Jean-Marc] Ctr Hosp Univ Amiens, Serv Radiol, Amiens, France; [Lamberton, Franck] Univ Caen, CEA, CNRS, Unite Mixte Rech,UMR 6194, F-14032 Caen, France; [Lamberton, Franck] Univ Paris, F-75252 Paris, France; [Courtheoux, Patrick; Coquemont, Maelle] Ctr Hosp Univ Cote Nacre, Unite Imagerie Resonance Magnet Pole Imagerie, Caen, France; [Courtheoux, Patrick; Coquemont, Maelle] Univ Caen, Ctr Hosp Univ Cote Nacre, Hop Cote Nacre, Serv Histol, F-14032 Caen, France	Universite de Caen Normandie; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie; UDICE-French Research Universities; Universite Paris Cite; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie	Besnard, S (corresponding author), Univ Caen, Unite Mixte Rech, UMR 1075, F-14032 Caen, France.	besnard-s@phycog.org	Besnard, stephane SB/O-7453-2015; Lamberton, Franck/GRO-7517-2022; Denise, Pierre/E-2174-2011	Denise, Pierre/0000-0002-9049-7692; Lamberton, Franck/0000-0002-4655-4397; Constans, Jean-Marc/0000-0002-6751-4378	Centre National d'Etude Spatiale	Centre National d'Etude Spatiale	This study was supported by a grant from the Centre National d'Etude Spatiale. Special thanks to Solene Collet (PhD student) and Valerie Fong-Constans (English revision). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badea A, 2007, NEUROIMAGE, V37, P683, DOI 10.1016/j.neuroimage.2007.05.046; Benveniste H, 2002, PROG NEUROBIOL, V67, P393, DOI 10.1016/S0301-0082(02)00020-5; Benveniste H, 2000, NEUROIMAGE, V11, P601, DOI 10.1006/nimg.2000.0567; Besnard S, 2012, HIPPOCAMPUS, V22, P814, DOI 10.1002/hipo.20942; Beuf O, 2006, MAGN RESON MATER PHY, V19, P202, DOI 10.1007/s10334-006-0048-9; Boretius S, 2009, NEUROIMAGE, V47, P1252, DOI 10.1016/j.neuroimage.2009.05.095; Bouilleret V, 2011, J MAGN RESON IMAGING, V34, P774, DOI 10.1002/jmri.22669; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cahill LS, 2012, NEUROIMAGE, V60, P933, DOI 10.1016/j.neuroimage.2012.01.100; Dedeurwaerdere S, 2013, NEUROIMAGE, V68, P30, DOI 10.1016/j.neuroimage.2012.11.054; Dhenain M, 2006, MAGN RESON MED, V55, P687, DOI 10.1002/mrm.20810; Fujioka M, 2000, CEREBROVASC DIS, V10, P2, DOI 10.1159/000016018; Hosseini-Sharifabad M, 2007, J NEUROSCI METH, V162, P206, DOI 10.1016/j.jneumeth.2007.01.009; Johnson GA, 2007, NEUROIMAGE, V37, P82, DOI 10.1016/j.neuroimage.2007.05.013; Johnson GA, 2012, NEUROIMAGE, V62, P1848, DOI 10.1016/j.neuroimage.2012.05.041; Kalisch R, 2006, NEUROPSYCHOPHARMACOL, V31, P925, DOI 10.1038/sj.npp.1300910; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Redwine JM, 2003, P NATL ACAD SCI USA, V100, P1381, DOI 10.1073/pnas.242746599; Schmitz C, 2002, MOL PSYCHIATR, V7, P810, DOI 10.1038/sj.mp.4001118; Sharief AA, 2008, NEUROIMAGE, V39, P136, DOI 10.1016/j.neuroimage.2007.08.028; Shepherd TM., 2005, P INT SOC MAGN RESON, V13, P619; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; VANHOESEN GW, 1990, PROG BRAIN RES, V83, P445; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Wieshmann UC, 1999, J ANAT, V195, P131, DOI 10.1046/j.1469-7580.1999.19510131.x; Woermann FG, 1998, J NEUROL NEUROSUR PS, V65, P656, DOI 10.1136/jnnp.65.5.656; Wolf OT, 2002, BRAIN RES, V934, P87, DOI 10.1016/S0006-8993(02)02363-6; Wolf OT, 2002, BRAIN RES PROTOC, V10, P41; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Yushkevich PA, 2009, NEUROIMAGE, V44, P385, DOI 10.1016/j.neuroimage.2008.08.042	30	4	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76135	10.1371/journal.pone.0076135	http://dx.doi.org/10.1371/journal.pone.0076135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086700	gold, Green Published, Green Submitted			2022-12-27	WOS:000325220000059
J	Verissimo, CS; Elands, R; Cheng, S; Saaltink, DJ; ter Horst, JP; Alme, MN; Pont, C; van de Water, B; Havik, B; Fitzsimons, CP; Vreugdenhil, E				Verissimo, Carla S.; Elands, Rachel; Cheng, Sou; Saaltink, Dirk-Jan; ter Horst, Judith P.; Alme, Maria N.; Pont, Chantal; van de Water, Bob; Havik, Bjarte; Fitzsimons, Carlos P.; Vreugdenhil, Erno			Silencing of Doublecortin-Like (DCL) Results in Decreased Mitochondrial Activity and Delayed Neuroblastoma Tumor Growth	PLOS ONE			English	Article							CELL-PROLIFERATION; MICROTUBULE; BIOGENESIS; CYTOSKELETON; TRANSPORT; DIFFERENTIATION; TRANSCRIPTION; METABOLISM; MORPHOLOGY; EXPRESSION	Doublecortin-like (DCL) is a microtubule-binding protein crucial for neuroblastoma (NB) cell proliferation. We have investigated whether the anti-proliferative effect of DCL knockdown is linked to reduced mitochondrial activity. We found a delay in tumor development after DCL knockdown in vivo in doxycycline-inducible NB tumor xenografts. To understand the mechanisms underlying this tumor growth retardation we performed a series of in vitro experiments in NB cell lines. DCL colocalizes with mitochondria, interacts with the mitochondrial outer membrane protein OMP25/SYNJ2BP and DCL knockdown results in decreased expression of genes involved in oxidative phosphorylation. Moreover, DCL knockdown decreases cytochrome c oxidase activity and ATP synthesis. We identified the C-terminal Serine/Proline-rich domain and the second microtubule-binding area as crucial DCL domains for the regulation of cytochrome c oxidase activity and ATP synthesis. Furthermore, DCL knockdown causes a significant reduction in the proliferation rate of NB cells under an energetic challenge induced by low glucose availability. Together with our previous studies, our results corroborate DCL as a key player in NB tumor growth in which DCL controls not only mitotic spindle formation and the stabilization of the microtubule cytoskeleton, but also regulates mitochondrial activity and energy availability, which makes DCL a promising molecular target for NB therapy.	[Verissimo, Carla S.; Elands, Rachel; Saaltink, Dirk-Jan; ter Horst, Judith P.; Vreugdenhil, Erno] Leiden Univ, Med Ctr, Leiden Amsterdam Ctr Drug Res, Div Med Pharmacol, Leiden, Netherlands; [Cheng, Sou] Prosensa Therapeut BV, Leiden, Netherlands; [Alme, Maria N.] Univ Bergen, KG Jebsen Ctr Res Neuropsychiat Disorders, Dept Biomed, Bergen, Norway; [Pont, Chantal; van de Water, Bob] Leiden Univ, Med Ctr, Leiden Amsterdam Ctr Drug Res, Div Toxicol, Leiden, Netherlands; [Havik, Bjarte] Univ Bergen, Dept Clin Med, Dr E Martens Res Grp Biol Psychiat, Bergen, Norway; [Havik, Bjarte] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Fitzsimons, Carlos P.] Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Amsterdam, Netherlands; [Vreugdenhil, Erno] Leiden Univ, Med Ctr, Migraine Res Grp, Dept Human Genet, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; BioMarin Pharmaceutical Inc.; Prosensa; University of Bergen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Bergen; University of Bergen; Haukeland University Hospital; University of Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Verissimo, CS (corresponding author), Univ Med Ctr Utrecht, Dept Mol Canc Res, Ctr Biomed Genet, Utrecht, Netherlands.	c.s.leiriaverissimo@umcutrecht.nl; e.vreugdenhil.HG@lumc.nl		Fitzsimons, Carlos P./0000-0002-1556-2650	Foundation Villa Joep; Top Institute Pharma (TI Pharma); Netherlands Organization for Scientific Research (NWO) [H64.09.016]	Foundation Villa Joep; Top Institute Pharma (TI Pharma); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Foundation Villa Joep and Top Institute Pharma (TI Pharma). CPF was supported by the Netherlands Organization for Scientific Research (NWO), grant H64.09.016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Anesti V, 2006, BBA-BIOENERGETICS, V1757, P692, DOI 10.1016/j.bbabio.2006.04.013; Appaix F, 2003, EXP PHYSIOL, V88, P175, DOI 10.1113/eph8802511; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; Biasutto L, 2010, MITOCHONDRION, V10, P670, DOI 10.1016/j.mito.2010.06.004; Bielas SL, 2007, CELL, V129, P579, DOI 10.1016/j.cell.2007.03.023; Breen EC, 2003, J CELL BIOCHEM, V88, P848, DOI 10.1002/jcb.10398; Coppi E, 2007, STEM CELLS, V25, P1840, DOI 10.1634/stemcells.2006-0669; D'Souza AD, 2007, MITOCHONDRION, V7, P374, DOI 10.1016/j.mito.2007.08.001; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; Dijkmans Thomas Frederik, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P32; Dinkelmann MV, 2007, GENETICS, V177, P1609, DOI 10.1534/genetics.107.078386; Fitzsimons CP, 2008, MOL ENDOCRINOL, V22, P248, DOI 10.1210/me.2007-0233; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Fritz V, 2010, ONCOGENE, V29, P4369, DOI 10.1038/onc.2010.182; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Garedew A, 2012, CELL METAB, V15, P466, DOI 10.1016/j.cmet.2012.03.003; Genkai N, 2006, ONCOL REP, V15, P1569; George RE, 2010, EXPERT OPIN PHARMACO, V11, P1467, DOI 10.1517/14656566.2010.482100; Gershon TR, 2005, NEOPLASIA, V7, P575, DOI 10.1593/neo.04637; Herzig RP, 2000, J BIOL CHEM, V275, P13134, DOI 10.1074/jbc.275.17.13134; Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; Kimura I, 2006, J NEUROSCI RES, V83, P1415, DOI 10.1002/jnr.20849; Kushner BH, 2001, J CLIN ONCOL, V19, P3397, DOI 10.1200/JCO.2001.19.14.3397; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Lee CH, 2011, AM J PATHOL, V178, P2066, DOI 10.1016/j.ajpath.2011.01.056; Lee S, 2007, BIOCHEM BIOPH RES CO, V357, P111, DOI 10.1016/j.bbrc.2007.03.091; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Li LN, 2013, CHINESE J CANCER RES, V25, P134, DOI 10.3978/j.issn.1000-9604.2013.03.02; Ligon LA, 2000, J COMP NEUROL, V427, P351, DOI 10.1002/1096-9861(20001120)427:3<351::AID-CNE3>3.0.CO;2-R; LINDEN M, 1989, J BIOENERG BIOMEMBR, V21, P507, DOI 10.1007/BF00762522; Liu LY, 2009, CELL ONCOL, V31, P393, DOI 10.3233/CLO-2009-0484; Liu LY, 2002, IN VITRO CELL DEV-AN, V38, P582; Losfeld ME, 2009, EXP CELL RES, V315, P357, DOI 10.1016/j.yexcr.2008.10.039; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakanishi Y, 2013, NAT GENET, V45, P98, DOI 10.1038/ng.2481; Nelson NJ, 2011, J NATL CANCER I, V103, P1218, DOI 10.1093/jnci/djr323; Nemoto Y, 1999, EMBO J, V18, P2991, DOI 10.1093/emboj/18.11.2991; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Petrelli A, 2008, CURR MED CHEM, V15, P422; RACKER E, 1981, SCIENCE, V213, P303, DOI 10.1126/science.6264596; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Ralph SJ, 2009, MOL NUTR FOOD RES, V53, P9, DOI 10.1002/mnfr.200800044; Rappaport L, 1998, MOL CELL BIOCHEM, V184, P101, DOI 10.1023/A:1006843113166; Rohlena J, 2011, ANTIOXID REDOX SIGN, V15, P2951, DOI 10.1089/ars.2011.3990; Saaltink DJ, 2012, J COMP NEUROL, V520, P2805, DOI 10.1002/cne.23144; Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850; Scheller K, 2003, EXP PHYSIOL, V88, P129, DOI 10.1113/eph8802507; Seibler J, 2010, METHOD ENZYMOL, V477, P367, DOI 10.1016/S0076-6879(10)77019-1; Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039; Smith DJ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-259; Sureban SM, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-40; Tantin D, 2012, CELL METAB, V15, P413, DOI 10.1016/j.cmet.2012.03.012; van Noesel MM, 2004, GENE, V325, P1, DOI 10.1016/j.gene.2003.09.042; Verissimo CS, 2012, J PHARMACOL EXP THER, V342, P119, DOI 10.1124/jpet.111.188813; Verissimo CS, 2011, ENDOCR-RELAT CANCER, V18, pR213, DOI 10.1530/ERC-11-0251; Verissimo CS, 2010, ENDOCR-RELAT CANCER, V17, P399, DOI 10.1677/ERC-09-0301; Vreugdenhil E, 1999, J NEUROBIOL, V39, P41, DOI 10.1002/(SICI)1097-4695(199904)39:1<41::AID-NEU4>3.0.CO;2-X; Vreugdenhil E, 2007, EUR J NEUROSCI, V25, P635, DOI 10.1111/j.1460-9568.2007.05318.x; Wagner LM, 2009, J CELL BIOCHEM, V107, P46, DOI 10.1002/jcb.22094; WARBURG O, 1956, SCIENCE, V124, P269; Xie R, 2011, J BIOL CHEM, V286, P10367, DOI 10.1074/jbc.M110.206532; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	66	10	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75752	10.1371/journal.pone.0075752	http://dx.doi.org/10.1371/journal.pone.0075752			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086625	Green Published, gold			2022-12-27	WOS:000325220000039
J	Xiao, MJ; Wang, YM; Gao, Y				Xiao, Mingjia; Wang, Yiming; Gao, Yi			Association between Helicobacter pylori Infection and Pancreatic Cancer Development: A Meta-Analysis	PLOS ONE			English	Article							VIRULENCE FACTORS; RISK; EPIDEMIOLOGY; SEROPOSITIVITY; PATHOGENESIS; ERADICATION; IMMUNOBLOT; ACTIVATION; STOMACH; STRAINS	Background: Pancreatic cancer is one of the most troublesome malignancies with dismal prognosis. H. pylori has been recognized as a type I carcinogen. Several studies have evaluated the association between H. pylori infection and pancreatic cancer development, however, the conclusions are inconsistent. Methods: Literature search was carried out in PubMed, EMBASE, Cochrane Library and CNKI databases to identify eligible researches. We performed overall meta-analysis of all studies included and subgroup analysis based on regional distribution. Quality of the studies (assessed by Newcastle-Ottawa quality assessment scale for case-control studies) and CagA+ strains of H. pylori were taken into consideration, and we conducted additional analyses including high-quality researches and those concerning CagA+ H. pylori respectively. Results: 9 studies involving 3033 subjects (1083 pancreatic cancer cases, 1950 controls) were included. Summary OR and 95% CI of the overall meta-analysis of all included studies were 1.47 and 1.22-1.77, pooled data of the 4 high-quality studies were OR 1.28, 95% CI 1.01-1.63. OR of the 5 studies examined CagA+ strains was 1.42, corresponding 95% CI was 0.79 to 2.57. Summary estimates of subgroup analysis based on regional distribution are as follows, Europe group: OR 1.56, 95% CI 1.15-2.10; East Asia group: OR 2.01, 95% CI 1.33-3.02; North America group: OR 1.17, 95% CI 0.87-1.58. There was not obvious heterogeneity across the 9 studies. No publication bias was detected. Conclusion: H. pylori infection is significantly, albeit weakly, associated with pancreatic cancer development. The association is prominent in Europe and East Asia, but not in North America. CagA+ H. pylori strains appear not to be associated with pancreatic cancer. However, more studies, especially prospective studies, are needed to validate our results.	[Xiao, Mingjia] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Hepatobiliary Surg, Wuxi, Jiangsu, Peoples R China; [Xiao, Mingjia; Gao, Yi] Southern Med Univ, Zhujiang Hosp, Dept Hepatobiliary Surg 2, Guangzhou, Guangdong, Peoples R China; [Wang, Yiming] Southern Med Univ, Zhujiang Hosp, Dept Urol Surg, Guangzhou, Guangdong, Peoples R China	Jiangnan University; Nanjing Medical University; Southern Medical University - China; Southern Medical University - China	Gao, Y (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Hepatobiliary Surg 2, Guangzhou, Guangdong, Peoples R China.	gaoyi6146@163.com						[Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P1; Aschebrook-Kilfoy B, 2011, AM J EPIDEMIOL, V174, P305, DOI 10.1093/aje/kwr092; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Blaser MJ, 2008, GUT, V57, P561, DOI 10.1136/gut.2007.133462; BLASER MJ, 1992, GASTROENTEROLOGY, V102, P720, DOI 10.1016/0016-5085(92)90126-J; Boncristiano M, 2003, J EXP MED, V198, P1887, DOI 10.1084/jem.20030621; Brenner H, 2004, AM J EPIDEMIOL, V159, P252, DOI 10.1093/aje/kwh039; Brown LM, 2000, EPIDEMIOL REV, V22, P283, DOI 10.1093/oxfordjournals.epirev.a018040; Chey WD, 2001, ARCH INTERN MED, V161, P2129, DOI 10.1001/archinte.161.17.2129; Chow WH, 1998, CANCER RES, V58, P588; de Martel C, 2008, CANCER EPIDEM BIOMAR, V17, P1188, DOI 10.1158/1055-9965.EPI-08-0185; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; [窦逾常 DOU Yuchang], 2008, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V34, P317; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fox JG, 1998, GASTROENTEROLOGY, V114, P755, DOI 10.1016/S0016-5085(98)70589-X; Gawin Alicja, 2012, Pol Merkur Lekarski, V32, P103; Goh KL, 2011, HELICOBACTER, V16, P1, DOI 10.1111/j.1523-5378.2011.00874.x; HANSSON LE, 1993, GASTROENTEROLOGY, V105, P1098, DOI 10.1016/0016-5085(93)90954-B; Hassan MM, 2007, AM J GASTROENTEROL, V102, P2696, DOI 10.1111/j.1572-0241.2007.01510.x; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; HOUBEN GMP, 1995, SCAND J GASTROENTERO, V30, P13, DOI 10.3109/00365529509090296; Huang JQ, 2003, GASTROENTEROLOGY, V125, P1636, DOI 10.1053/j.gastro.2003.08.033; Hunt RH, 2011, J GASTROINTEST LIVER, V20, P299, DOI 10.1097/MCG.0b013e31820fb8f6; Kang R, 2012, AM J CANCER RES, V2, P383; Kim JM, 2007, INFECT IMMUN, V75, P3373, DOI 10.1128/IAI.01940-06; Kist M, 1999, FEMS IMMUNOL MED MIC, V24, P239, DOI 10.1111/j.1574-695X.1999.tb01289.x; KOKKINAKIS DM, 1993, CARCINOGENESIS, V14, P1705, DOI 10.1093/carcin/14.8.1705; Kosunen TU, 2011, INT J CANCER, V128, P433, DOI 10.1002/ijc.25337; Kowalski M, 2001, J Physiol Pharmacol, V52, P3; Ladabaum U, 2002, ALIMENT PHARM THERAP, V16, P1491, DOI 10.1046/j.1365-2036.2002.01306.x; Larsson SC, 2012, BRIT J CANCER, V106, P603, DOI 10.1038/bjc.2011.585; Lindkvist B, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-321; Lowenfels AB, 2002, HEMATOL ONCOL CLIN N, V16, P1, DOI 10.1016/S0889-8588(01)00003-X; Lu CY, 2005, WORLD J GASTROENTERO, V11, P5672, DOI 10.3748/wjg.v11.i36.5672; Lu H, 2005, CURR OPIN GASTROEN, V21, P653, DOI 10.1097/01.mog.0000181711.04529.d5; MANTEL N, 1959, J NATL CANCER I, V22, P719; MARSHALL BJ, 1984, LANCET, V1, P1311; Moher D, 2000, ONKOLOGIE, V23, P597, DOI 10.1159/000055014; Nilsson HO, 2006, WORLD J GASTROENTERO, V12, P3038, DOI 10.3748/wjg.v12.i19.3038; Noto Jennifer M, 2012, Methods Mol Biol, V921, P7; Popovic N, 2010, HEPATO-GASTROENTEROL, V57, P167; Raderer M, 1998, ONCOLOGY-BASEL, V55, P16, DOI 10.1159/000011830; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; Risch HA, 2003, JNCI-J NATL CANCER I, V95, P948, DOI 10.1093/jnci/95.13.948; Risch HA, 2012, MOL CARCINOGEN, V51, P109, DOI 10.1002/mc.20826; Risch HA, 2010, JNCI-J NATL CANCER I, V102, P502, DOI 10.1093/jnci/djq007; Rundle A, 2012, EUR J CLIN INVEST, V42, P1350, DOI 10.1111/j.1365-2362.2012.02727.x; Shimoyama T, 2010, J GASTROEN HEPATOL, V25, pS86, DOI 10.1111/j.1440-1746.2010.06224.x; Shiota S, 2013, J DIGEST DIS, V14, P341, DOI 10.1111/1751-2980.12054; Sorberg M, 1997, SCAND J INFECT DIS, V29, P147, DOI 10.3109/00365549709035875; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stolzenberg-Solomon RZ, 2001, J NATL CANCER I, V93, P937, DOI 10.1093/jnci/93.12.937; Tonkic A, 2012, HELICOBACTER, V17, P1, DOI 10.1111/j.1523-5378.2012.00975.x; Trikudanathan G, 2011, J PANCREAS, V12, P26; Vicari JJ, 1998, GASTROENTEROLOGY, V115, P50, DOI 10.1016/S0016-5085(98)70364-6; Wu C, 2012, NAT GENET, V44, P62, DOI 10.1038/ng.1020; Zhang XM, 2011, MOL CARCINOGEN, V50, P876, DOI 10.1002/mc.20784; Zhou D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027390; Zhufeng Q, 2012, J GUIYANG MED COLL, V37, P411	59	59	61	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75559	10.1371/journal.pone.0075559	http://dx.doi.org/10.1371/journal.pone.0075559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086571	Green Published, gold, Green Submitted			2022-12-27	WOS:000325220000028
J	Glukhov, SI; Rubtsov, MA; Alexeyevsky, DA; Alexeevski, AV; Razin, SV; Iarovaia, OV				Glukhov, Sergey I.; Rubtsov, Mikhail A.; Alexeyevsky, Daniil A.; Alexeevski, Andrei V.; Razin, Sergey V.; Iarovaia, Olga V.			The Broken MLL Gene Is Frequently Located Outside the Inherent Chromosome Territory in Human Lymphoid Cells Treated with DNA Topoisomerase II Poison Etoposide	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; ACUTE MYELOID-LEUKEMIA; TRANSLOCATIONS; REARRANGEMENTS; SECONDARY; CANCER; REPAIR; SITES; ARCHITECTURE; INHIBITORS	The mixed lineage leukaemia (MLL) gene is frequently rearranged in secondary leukaemias, in which it could fuse to a variety of different partners. Breakage in the MLL gene preferentially occurs within a similar to 8 kb region that possesses a strong DNA topoisomerase II cleavage site. It has been proposed that DNA topoisomerase II-mediated DNA cleavage within this and other regions triggers translocations that occur due to incorrect joining of broken DNA ends. To further clarify a possible mechanism for MLL rearrangements, we analysed the frequency of MLL cleavage in cells exposed to etoposide, a DNA topoisomerase II poison commonly used as an anticancer drug, and positioning of the broken 3'-end of the MLL gene in respect to inherent chromosomal territories. It was demonstrated that exposure of human Jurkat cells to etoposide resulted in frequent cleavage of MLL genes. Using MLL-specific break-apart probes we visualised cleaved MLL genes in similar to 17% of nuclei. Using confocal microscopy and 3D modelling, we demonstrated that in cells treated with etoposide and cultivated for 1 h under normal conditions, similar to 9% of the broken MLL alleles were present outside the chromosome 11 territory, whereas in both control cells and cells inspected immediately after etoposide treatment, virtually all MLL alleles were present within the chromosomal territory. The data are discussed in the framework of the "breakage first" model of juxtaposing translocation partners. We propose that in the course of repairing DNA topoisomerase II-mediated DNA lesions (removal of stalled DNA topoisomerase II complexes and non-homologous end joining), DNA ends acquire additional mobility, which allows the meeting and incorrect joining of translocation partners.	[Glukhov, Sergey I.; Rubtsov, Mikhail A.; Razin, Sergey V.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Mol Biol, Moscow, Russia; [Razin, Sergey V.; Iarovaia, Olga V.] Inst Gene Biol RAS, Moscow, Russia; [Razin, Sergey V.] LIA 1066 French Russian Joint Canc Res Lab, Villejuif, France; [Razin, Sergey V.] LIA 1066 French Russian Joint Canc Res Lab, Moscow, Russia; [Alexeevski, Andrei V.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Phys & Chem Biol, Moscow, Russia; [Alexeyevsky, Daniil A.; Alexeevski, Andrei V.] Moscow MV Lomonosov State Univ, Dept Bioengn & Bioinformat, Moscow, Russia; [Alexeevski, Andrei V.] Sci Res Inst Syst Studies NIISI RAN, Moscow, Russia	Lomonosov Moscow State University; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Lomonosov Moscow State University; Lomonosov Moscow State University; Russian Academy of Sciences; Scientific Research Institute for System Analysis of the Russian Academy of Sciences (SRISA)	Razin, SV (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Dept Mol Biol, Moscow, Russia.	sergey.v.razin@usa.net	Rubtsov, Mikhail A/A-8435-2014; Razin, Sergey V/M-6701-2015; Glukhov, Sergey I/I-9526-2016; Iarovaia, Olga/AAV-2321-2021; Alexeevski, Andrei V/A-7935-2012; Alexeyevsky, Daniil/C-7762-2016	Razin, Sergey V/0000-0003-1976-8661; Glukhov, Sergey I/0000-0002-4913-0557; Alexeevski, Andrei V/0000-0001-7939-9939; Rubtsov, Mikhail/0000-0003-4947-1009; Alexeyevsky, Daniil/0000-0003-1459-1297	Ministry of Science and Education of the Russian Federation [14.740.12.1344, 16.740.11.0483, 16.740.11.0629, 8052, 8800]; Russian Foundation of Basic Research [11-04-00361, 12-04-93109_CNRS, 12-04-33031, 12-04-31338, 13-07-00969, 11-04-91340]; Presidium of the Russian Academy of Sciences; M.V.Lomonosov Moscow State University Program of Development; Ministry of Education and Science of Russian Federation	Ministry of Science and Education of the Russian Federation(Ministry of Education and Science, Russian Federation); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); M.V.Lomonosov Moscow State University Program of Development; Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation)	This work was supported by the Ministry of Science and Education of the Russian Federation (contracts 14.740.12.1344, 16.740.11.0483, 16.740.11.0629 and grants 8052, 8800), by the Russian Foundation of Basic Research (grants 11-04-00361, 12-04-93109_CNRS, 12-04-33031, 12-04-31338, 13-07-00969, 11-04-91340) and by the Presidium of the Russian Academy of Sciences (grant from the Program on Molecular and Cellular Biology to SVR). This work was supported in part by M.V.Lomonosov Moscow State University Program of Development. Some experiments were performed at User Facilities Center of M.V.Lomonosov Moscow State University under financial support of Ministry of Education and Science of Russian Federation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2006, DNA REPAIR, V5, P1075, DOI 10.1016/j.dnarep.2006.05.029; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364; Bystritskiy AA, 2004, CRIT REV EUKAR GENE, V14, P65, DOI 10.1615/CritRevEukaryotGeneExpr.v14.40; Chikamori K, 2010, CURR CANCER DRUG TAR, V10, P758, DOI 10.2174/156800910793605785; Cowell IG, 2012, P NATL ACAD SCI USA, V109, P8989, DOI 10.1073/pnas.1204406109; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; CREMER T, 1993, COLD SPRING HARB SYM, V58, P777, DOI 10.1101/SQB.1993.058.01.085; de Campos-Nebel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012541; Elliott B, 2002, CELL MOL LIFE SCI, V59, P373, DOI 10.1007/s00018-002-8429-3; Felix CA, 1998, BBA-GENE STRUCT EXPR, V1400, P233, DOI 10.1016/S0167-4781(98)00139-0; Felix CA, 2006, DNA REPAIR, V5, P1093, DOI 10.1016/j.dnarep.2006.05.031; Fortune JM, 2000, PROG NUCLEIC ACID RE, V64, P221, DOI 10.1016/S0079-6603(00)64006-0; Harper DP, 2008, CANCER RES, V68, P10024, DOI 10.1158/0008-5472.CAN-08-2208; Heisig P, 2009, MUTAGENESIS, V24, P465, DOI 10.1093/mutage/gep035; Iannuccelli E, 2010, BIOINFORMATICS, V26, P696, DOI 10.1093/bioinformatics/btq013; Jakob B, 2009, P NATL ACAD SCI USA, V106, P3172, DOI 10.1073/pnas.0810987106; Joannides M, 2010, CLIN TRANSL ONCOL, V12, P8, DOI 10.1007/s12094-010-0460-5; Krawczyk PM, 2012, J CELL SCI, V125, P2127, DOI 10.1242/jcs.089847; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lieber MR, 2010, SUBCELL BIOCHEM, V50, P279, DOI 10.1007/978-90-481-3471-7_14; Lin CR, 2012, ADV CANCER RES, V113, P241, DOI 10.1016/B978-0-12-394280-7.00015-4; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; Mahy NL, 2002, J CELL BIOL, V157, P579, DOI 10.1083/jcb.200111071; McClendon AK, 2007, MUTAT RES-FUND MOL M, V623, P83, DOI 10.1016/j.mrfmmm.2007.06.009; Nambiar M, 2008, BBA-REV CANCER, V1786, P139, DOI 10.1016/j.bbcan.2008.07.005; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; RATAIN MJ, 1992, ANN ONCOL, V3, P107, DOI 10.1093/oxfordjournals.annonc.a058121; Rowley JD, 1997, BLOOD, V90, P535; Rubtsov M. A., 2011, Biopolymers and Cell, V27, P398; Rubtsov MA, 2008, J CELL BIOCHEM, V104, P692, DOI 10.1002/jcb.21656; Savage JRK, 2000, SCIENCE, V290, P62, DOI 10.1126/science.290.5489.62; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Super HG, 1997, GENE CHROMOSOME CANC, V20, P185, DOI 10.1002/(SICI)1098-2264(199710)20:2<185::AID-GCC9>3.0.CO;2-#; SUPER HJG, 1993, BLOOD, V82, P3705; Wang Jing H, 2012, Front Med, V6, P263, DOI 10.1007/s11684-012-0215-5; Wilstermann AM, 2003, CURR TOP MED CHEM, V3, P321, DOI 10.2174/1568026033452519; Zhang YM, 2002, P NATL ACAD SCI USA, V99, P3070, DOI 10.1073/pnas.042702899; TITLE ERROR, DOI DOI 10.2174/092986710793361252.PUBMED:20939813	44	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75871	10.1371/journal.pone.0075871	http://dx.doi.org/10.1371/journal.pone.0075871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086652	Green Submitted, gold, Green Published			2022-12-27	WOS:000325218700115
J	McCallum, GB; Morris, PS; Chatfield, MD; Maclennan, C; White, AV; Sloots, TP; Mackay, IM; Chang, AB				McCallum, Gabrielle B.; Morris, Peter S.; Chatfield, Mark D.; Maclennan, Carolyn; White, Andrew V.; Sloots, Theo P.; Mackay, Ian M.; Chang, Anne B.			A Single Dose of Azithromycin Does Not Improve Clinical Outcomes of Children Hospitalised with Bronchiolitis: A Randomised, Placebo-Controlled Trial	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTION; INDIGENOUS CHILDREN; RSV BRONCHIOLITIS; YOUNG-CHILDREN; VIRUSES; ASSOCIATION; INFANTS; DISEASE; BRONCHIECTASIS; CLARITHROMYCIN	Objective: Bronchiolitis, one of the most common reasons for hospitalisation in young children, is particularly problematic in Indigenous children. Macrolides may be beneficial in settings where children have high rates of nasopharyngeal bacterial carriage and frequent prolonged illness. The aim of our double-blind placebo-controlled randomised trial was to determine if a large single dose of azithromycin (compared to placebo) reduced length of stay (LOS), duration of oxygen (O-2) and respiratory readmissions within 6 months of children hospitalised with bronchiolitis. We also determined the effect of azithromycin on nasopharyngeal microbiology. Methods: Children aged <= 18 months were randomised to receive a single large dose (30 mg/kg) of either azithromycin or placebo within 24 hrs of hospitalisation. Nasopharyngeal swabs were collected at baseline and 48hrs later. Primary endpoints (LOS, O-2) were monitored every 12 hrs. Hospitalised respiratory readmissions 6-months post discharge was collected. Results: 97 children were randomised (n = 50 azithromycin, n = 47 placebo). Median LOS was similar in both groups; azithromycin = 54 hours, placebo = 58 hours (difference between groups of 4 hours 95% CI -8, 13, p = 0.6). O-2 requirement was not significantly different between groups; Azithromycin = 35 hrs; placebo = 42 hrs (difference 7 hours, 95% CI -9, 13, p = 0.7). Number of children re-hospitalised was similar 10 per group (OR = 0.9, 95% CI 0.3, 2, p = 0.8). At least one virus was detected in 74% of children. The azithromycin group had reduced nasopharyngeal bacterial carriage (p = 0.01) but no difference in viral detection at 48 hours. Conclusion: Although a single dose of azithromycin reduces carriage of bacteria, it is unlikely to be beneficial in reducing LOS, duration of O2 requirement or readmissions in children hospitalised with bronchiolitis. It remains uncertain if an earlier and/or longer duration of azithromycin improves clinical and microbiological outcomes for children. The trial was registered with the Australian and New Zealand Clinical Trials Register. Clinical trials number: ACTRN12608000150347. http://www.anzctr.org.au/TrialSearch.aspx.	[McCallum, Gabrielle B.; Morris, Peter S.; Chatfield, Mark D.; Chang, Anne B.] Charles Darwin Univ, Child Hlth Div, Menzies Sch Hlth Res, Darwin, NT 0909, Australia; [Morris, Peter S.; Maclennan, Carolyn] Royal Darwin Hosp, Dept Paediat, Darwin, NT, Australia; [White, Andrew V.] Townsville Hosp, Dept Paediat, Townsville, Qld, Australia; [Sloots, Theo P.; Mackay, Ian M.] Univ Queensland, Childrens Hlth Queensland Hosp & Hlth Serv, Sir Albert Sakzewski Virus Res Ctr, Queensland Childrens Med Res Inst,Queensland Paed, Brisbane, Qld, Australia; [Chang, Anne B.] Royal Childrens Hosp, Queensland Childrens Resp Ctr, Brisbane, Qld, Australia; [Chang, Anne B.] Queensland Univ Technol, Kelvin Grove, Australia	Charles Darwin University; Menzies School of Health Research; University of Queensland; Royal Children's Hospital Brisbane; Queensland University of Technology (QUT)	McCallum, GB (corresponding author), Charles Darwin Univ, Child Hlth Div, Menzies Sch Hlth Res, Darwin, NT 0909, Australia.	Gabrielle.McCallum@menzies.edu.au	McCallum, Gabrielle/AAO-8158-2020; Mackay, Ian M/B-2537-2010; Chang, Anne/F-2066-2013; Chatfield, Mark D/N-2278-2013	McCallum, Gabrielle/0000-0002-0210-1468; Mackay, Ian M/0000-0003-3598-2350; Chang, Anne/0000-0002-1331-3706; Chatfield, Mark D/0000-0002-0004-6274	Channel 7 Foundation; Financial Markets Foundation for Children; National Health and Medical Research Council (NHMRC) Centre for Research Excellence in Lung Health of Aboriginal and Torres Strait Islander Children [1040830]; NHMRC scholarship [1055262]; NHMRC practitioner fellowship [545216]	Channel 7 Foundation; Financial Markets Foundation for Children; National Health and Medical Research Council (NHMRC) Centre for Research Excellence in Lung Health of Aboriginal and Torres Strait Islander Children(National Health and Medical Research Council (NHMRC) of Australia); NHMRC scholarship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC practitioner fellowship(National Health and Medical Research Council (NHMRC) of Australia)	Study was funded by grants from the Channel 7 Foundation (seed funding 2007), the Financial Markets Foundation for Children (for 2 years), and supported by a National Health and Medical Research Council (NHMRC) Centre for Research Excellence in Lung Health of Aboriginal and Torres Strait Islander Children (grant number 1040830). GBM is supported by a NHMRC scholarship (grant 1055262), AC is funded by a NHMRC practitioner fellowship (grant 545216). The views expressed in this publication are those of the authors and do not reflect the views of any of the granting bodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman Douglas, 1989, DESIGNING RES PRACTI, P74; Arden KE, 2006, J MED VIROL, V78, P1232, DOI 10.1002/jmv.20689; Arden KE, 2010, J MED VIROL, V82, P1458, DOI 10.1002/jmv.21819; Baccala GP, 2008, J CLIN VIROL, V43, P407, DOI 10.1016/j.jcv.2008.08.010; Bailey EJ, 2009, J PAEDIATR CHILD H, V45, P593, DOI 10.1111/j.1440-1754.2009.01571.x; Baumer JH, 2007, ARCH DIS CHILDHOOD-E, V92, pEP149, DOI 10.1136/adc.2007.126524; Bezerra PGM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018928; Bisgaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4978; Blasi F, 2005, EXPERT OPIN PHARMACO, V6, P2335, DOI 10.1517/14656566.6.13.2335; Bosis S, 2008, CLIN MICROBIOL INFEC, V14, P677, DOI 10.1111/j.1469-0691.2008.02016.x; Brodzinski H, 2009, PEDIATR EMERG CARE, V25, P352, DOI 10.1097/PEC.0b013e3181a3497e; Chang AB, 2006, MED J AUSTRALIA, V184, P107, DOI 10.5694/j.1326-5377.2006.tb00147.x; Chang AB, 2002, MED J AUSTRALIA, V177, P200, DOI 10.5694/j.1326-5377.2002.tb04733.x; Chang Anne B, 2009, Pediatr Clin North Am, V56, P1303, DOI 10.1016/j.pcl.2009.09.003; Chang AB, 2009, PEDIATR INFECT DIS J, V28, P290, DOI 10.1097/INF.0b013e31819067b1; DAWSON K, 1993, J PAEDIATR CHILD H, V29, P335, DOI 10.1111/j.1440-1754.1993.tb00529.x; Didierlaurent A, 2008, J EXP MED, V205, P323, DOI 10.1084/jem.20070891; Ducharme FM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1658; Galobardes B, 2008, THORAX, V63, P423, DOI 10.1136/thx.2007.086744; GHAFOOR A, 1990, REV INFECT DIS, V12, pS907; Giamarellos-Bourboulis EJ, 2008, INT J ANTIMICROB AG, V31, P12, DOI 10.1016/j.ijantimicag.2007.08.001; Grimwood K, 2008, EPIDEMIOLINFECT, P1; Hare KM, 2008, PEDIATR INFECT DIS J, V27, P178, DOI 10.1097/INF.0b013e31815bb6c5; Hare KM, 2010, J PEDIAT; Jartti T, 2012, CURROPINPULMMED; Klein JO, 1997, PEDIATR INFECT DIS J, V16, P427, DOI 10.1097/00006454-199704000-00025; Kneyber M, 2000, ACTA PAEDIATR, V89, P654, DOI 10.1080/080352500750043945; Kneyber MCJ, 2008, PEDIATR PULM, V43, P142, DOI 10.1002/ppul.20748; LEACH AJ, 1994, PEDIATR INFECT DIS J, V13, P983, DOI 10.1097/00006454-199411000-00009; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Mansbach JM, 2009, CLIN LAB MED, V29, P741, DOI 10.1016/j.cll.2009.07.011; McCallum GB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009834.pub2; Midulla F, 2012, EUR RESPIR J, V39, P396, DOI 10.1183/09031936.00188210; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; O'Grady KAF, 2010, J PAEDIATR CHILD H, V46, P461, DOI 10.1111/j.1440-1754.2010.01845.x; O'Grady KAF, 2010, MED J AUSTRALIA, V192, P586, DOI 10.5694/j.1326-5377.2010.tb03643.x; O'Grady KAF, 2010, CLIN INFECT DIS, V50, P970, DOI 10.1086/651079; Pinto LA, 2012, JPEDIATR; Singleton RJ, 2013, PEDIAT PULM IN PRESS; Singleton RJ, 2006, PEDIATR INFECT DIS J, V25, P1116, DOI 10.1097/01.inf.0000245104.26996.57; Smith-Vaughan H, 2006, BMC EAR NOSE THROAT, V6, DOI 10.1186/1472-6815-6-10; Spurling GK, 2011, COCHRANE DB SYST REV, V6; Stubbs E, 2005, PEDIATR INFECT DIS J, V24, P423, DOI 10.1097/01.inf.0000160945.87356.ca; Sugiyama K, 2007, CLIN EXP IMMUNOL, V147, P540, DOI 10.1111/j.1365-2249.2007.03299.x; Tahan F, 2007, EUR RESPIR J, V29, P91, DOI 10.1183/09031936.00029206; Tennant PWG, 2008, THORAX, V63, P823, DOI 10.1136/thx.2008.096388; Torzillo P, 1999, PEDIATR INFECT DIS J, V18, P714, DOI 10.1097/00006454-199908000-00012; Trenholme AA, 2012, PEDIAT PULMONOL; Valery PC, 2004, PEDIATR INFECT DIS J, V23, P902, DOI 10.1097/01.inf.0000142508.33623.2f; Weber MW, 1999, J PEDIATR-US, V135, P683, DOI 10.1016/S0022-3476(99)70085-5; Zorc JJ, 2010, PEDIATRICS, V125, P342, DOI 10.1542/peds.2009-2092	51	31	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74316	10.1371/journal.pone.0074316	http://dx.doi.org/10.1371/journal.pone.0074316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086334	Green Submitted, gold, Green Published			2022-12-27	WOS:000325218700022
J	Olivier, J; Walter, SR				Olivier, Jake; Walter, Scott R.			Bicycle Helmet Wearing Is Not Associated with Close Motor Vehicle Passing: A Re-Analysis of Walker, 2007	PLOS ONE			English	Article							NEW-SOUTH-WALES; RISK COMPENSATION; HEAD; AUSTRALIA; SELECTION; TRIALS; INJURY; IMPACT; POWER	Objectives: To re-analyse bicycle overtaking data collected by Walker (2007) with a view to assess factors associated with close passing (<1 m), to adjust for other observed factors in a multivariable analysis, and to assess the extent to which the sample size in the original analysis may have contributed to spurious results. Method: A re-analysis of 2,355 motor vehicle passing events recorded by Walker that includes information on cyclist's distance to the kerb, vehicle size and colour, city of observation, time of day, whether the event occurred while in a bikelane and helmet wearing. Each variable was considered for a final, multivariable model using purposeful selection of variables. The analysis was repeated using multiple logistic regression with passing distance dichotomised by the one metre rule. Bootstrap p-values were computed using sample sizes computed from conventional values of power and effect size. Results: The previously observed significant association between passing distance and helmet wearing was not found when dichotomised by the one metre rule. Other factors were found to be significantly associated with close passing including cyclists' distance to the kerb, vehicle size and city of observation (Salisbury or Bristol, UK). P-values from bootstrap samples indicate the significance of helmet wearing resulted from an overly large sample size. Conclusions: After re-analysis of Walker's data, helmet wearing is not associated with close motor vehicle passing. The results, however, highlight other more important factors that may inform effective bicycle safety strategies.	[Olivier, Jake] Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia; [Walter, Scott R.] Univ New S Wales, Ctr Hlth Syst & Safety Res, Australian Inst Hlth Innovat, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Olivier, J (corresponding author), Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia.	j.olivier@unsw.edu.au	Olivier, Jake/D-2034-2012	Olivier, Jake/0000-0002-3144-4507				Amoros E, 2012, INJURY PREV, V18, P27, DOI 10.1136/ip.2011.031815; Amy Gillett Foundation, MET MATT; [Anonymous], 2011, ALBERTAS HELMET LAW; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Bambach MR, 2013, ACCIDENT ANAL PREV, V53, P78, DOI 10.1016/j.aap.2013.01.005; Basford L, 2002, TRL549; Bell ML, 2013, PSYCHO-ONCOLOGY, V22, P499, DOI 10.1002/pon.3046; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; CAMERON MH, 1994, ACCIDENT ANAL PREV, V26, P325, DOI 10.1016/0001-4575(94)90006-X; Case L. Douglas, 2007, V404, P377, DOI 10.1007/978-1-59745-530-5_19; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Efron B, 1993, INTRO BOOTSTRAP, DOI [DOI 10.1007/978-1-4899-4541-9, 10.1007/978-1-4899-4541-9]; Ewald B, 2006, J CLIN EPIDEMIOL, V59, P798, DOI 10.1016/j.jclinepi.2005.11.025; Foot Rule, LIST US STAT HAV 3 F; Fox T, 2010, J AUSTRALAS COLL ROA, V21, P22; GREENLAND S, 1989, AM J EPIDEMIOL, V130, P1066, DOI 10.1093/oxfordjournals.aje.a115409; HOSMER DW, 1989, APPL LOGISTIC REGRES; Johnson M, 2011, ACCIDENT ANAL PREV, V43, P323, DOI 10.1016/j.aap.2010.08.030; Johnston MF, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-1; Julious SA, 2004, STAT MED, V23, P1921, DOI 10.1002/sim.1783; Khan A., 1995, TRANSPORT RES REC, P8; Lardelli-Claret P, 2003, INJURY PREV, V9, P128, DOI 10.1136/ip.9.2.128; Love DC, 2012, ACCIDENT ANAL PREV, V48, P451, DOI 10.1016/j.aap.2012.03.002; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Macpherson A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005401.pub2; Messiah A, 2012, AM J PUBLIC HEALTH, V102, pS204, DOI 10.2105/AJPH.2012.300711; Nolan R, 2010, COMMUNICATION; Nova Scotia Government, FREQ ASK QUEST ON ME; O'Reilly M, 2012, SYDNEY MORNING HERAL; Olivier J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058777; Olivier J, 2013, ACCIDENT ANAL PREV, V50, P1128, DOI 10.1016/j.aap.2012.09.003; Phillips RO, 2011, RISK ANAL, V31, P1187, DOI 10.1111/j.1539-6924.2011.01589.x; Safe Cycling Australia, CAMP; Stone M, 2003, ACCIDENT ANAL PREV, V35, P549, DOI 10.1016/S0001-4575(02)00032-5; Thompson DC, 1999, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001855, DOI 10.1002/14651858.CD001855]; Walker I, BICYCLE OVERTAKING S; Walker I, 2007, ACCIDENT ANAL PREV, V39, P417, DOI 10.1016/j.aap.2006.08.010; Walter SR, 2011, ACCIDENT ANAL PREV, V43, P2064, DOI 10.1016/j.aap.2011.05.029; Wiltshire Council, CHILDC SUFF 2011 201	40	19	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75424	10.1371/journal.pone.0075424	http://dx.doi.org/10.1371/journal.pone.0075424			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VC	24086528	gold, Green Submitted, Green Published			2022-12-27	WOS:000325218700085
J	Strauss, A; Smith, KG				Strauss, Alex; Smith, Kevin G.			Why Does Amphibian Chytrid (Batrachochytrium dendrobatidis) Not Occur Everywhere? An Exploratory Study in Missouri Ponds	PLOS ONE			English	Article							EMERGING DISEASE; PATHOGEN; FUNGUS; CHYTRIDIOMYCOSIS; SUSCEPTIBILITY; DISINFECTANTS; TRANSMISSION; BIODIVERSITY; PREVALENCE; PREDATION	The amphibian chytrid fungus, Batrachochytrium dendrobatidis (Bd), is a globally emerging pathogen that has caused widespread amphibian population declines, extirpations, and extinctions. However, Bd does not occur in all apparently suitable amphibian populations, even within regions where it is widespread, and it is often unclear why Bd occurs in some habitats but not others. In this study, we rigorously surveyed the amphibian and invertebrate biodiversity of 29 ponds in Missouri, screened resident amphibian larvae (Rana (Lithobates) sp.) for Bd infection, and characterized the aquatic physiochemical environment of each pond (temperature pH, conductivity, nitrogen, phosphorus, and chlorophyll-a). Our goal was to generate hypotheses toward answering the question, "Why does Bd not occur in all apparently suitable habitats?" Bd occurred in assayed amphibians in 11 of the 29 ponds in our study area (38% of ponds). We found no significant relationship between any single biotic or abiotic variable and presence of Bd. However, multivariate analyses (nonmetric multidimensional scaling and permutational tests of dispersion) revealed that ponds in which Bd occurred were a restricted subset of all ponds in terms of amphibian community structure, macroinvertebrate community structure, and pond physiochemistry. In other words, Bd ponds from 6 different conservation areas were more similar to each other than would be expected based on chance. The results of a structural equation model suggest that patterns in the occurrence of Bd among ponds are primarily attributable to variation in macroinvertebrate community structure. When combined with recent results showing that Bd can infect invertebrates as well as amphibians, we suggest that additional research should focus on the role played by non-amphibian biota in determining the presence, prevalence, and pathogenicity of Bd in amphibian populations.	[Smith, Kevin G.] Washington Univ, Tyson Res Ctr, St Louis, MO 63130 USA; Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Smith, KG (corresponding author), Washington Univ, Tyson Res Ctr, St Louis, MO 63130 USA.	kgs@wustl.edu	Smith, Kevin/A-5044-2010	Strauss, Alexander/0000-0003-0633-8443	Washington University's International Center for Advanced Renewable Energy and Sustainability; NSF [DEB-0816113]; Tyson Research Center; Direct For Biological Sciences [0816113] Funding Source: National Science Foundation	Washington University's International Center for Advanced Renewable Energy and Sustainability; NSF(National Science Foundation (NSF)); Tyson Research Center; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this study was provided by 1) Washington University's International Center for Advanced Renewable Energy and Sustainability (http://icares.wustl.edu/), NSF grant DEB-0816113 to KGS (http://www.nsf.gov/), and Tyson Research Center (http://tyson.wustl.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Berger L., 1999, DECLINES DISAPPEARAN, V1999, P23; Bielby J, 2008, CONSERV LETT, V1, P82, DOI 10.1111/j.1755-263X.2008.00015.x; Bodinof CM, 2011, DIS AQUAT ORGAN, V96, P1, DOI 10.3354/dao02380; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Buck JC, 2011, BIODIVERS CONSERV, V20, P3549, DOI 10.1007/s10531-011-0147-4; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Conradie W, 2011, AFR ZOOL, V46, P95, DOI 10.3377/004.046.0122; Daszak P, 1999, TRENDS ECOL EVOL, V14, P279, DOI 10.1016/S0169-5347(99)01665-1; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Frias-Alvarez P, 2008, ECOHEALTH, V5, P18, DOI 10.1007/s10393-008-0155-3; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Greer AL, 2008, OIKOS, V117, P1667, DOI 10.1111/j.1600-0706.2008.16783.x; Hamilton PT, 2012, FRESHWATER BIOL, V57, P676, DOI 10.1111/j.1365-2427.2011.02731.x; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Kriger KM, 2007, DIVERS DISTRIB, V13, P781, DOI 10.1111/j.1472-4642.2007.00394.x; LaDeau SL, 2008, BIOSCIENCE, V58, P937, DOI 10.1641/B581007; Laurance WF, 1996, CONSERV BIOL, V10, P406, DOI 10.1046/j.1523-1739.1996.10020406.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; McMahon TA, 2013, P NATL ACAD SCI USA, V110, P210, DOI 10.1073/pnas.1200592110; MORIN PJ, 1983, ECOL MONOGR, V53, P119, DOI 10.2307/1942491; Murray KA, 2012, HUM ECOL RISK ASSESS, V18, P200, DOI 10.1080/10807039.2012.632310; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; Ortiz-Santaliestra ME, 2011, CONSERV BIOL, V25, P975, DOI 10.1111/j.1523-1739.2011.01700.x; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Rachowicz LJ, 2007, J ANIM ECOL, V76, P711, DOI 10.1111/j.1365-2656.2007.01256.x; Rachowicz LJ, 2004, DIS AQUAT ORGAN, V61, P75, DOI 10.3354/dao061075; Raffel TR, 2010, ECOHEALTH, V7, P526, DOI 10.1007/s10393-010-0358-2; Richards-Hrdlicka KL, 2013, DIS AQUAT ORGAN, V102, P169, DOI 10.3354/dao02552; Rohr JR, 2011, J APPL ECOL, V48, P174, DOI 10.1111/j.1365-2664.2010.01891.x; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Rothermel BB, 2008, DIS AQUAT ORGAN, V82, P3, DOI 10.3354/dao01974; Schmidt BR, 2009, AMPHIBIA-REPTILIA, V30, P313, DOI 10.1163/156853809788795245; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Searle CL, 2011, P NATL ACAD SCI USA, V108, P16322, DOI 10.1073/pnas.1108490108; Shapard EJ, 2012, MYCOPATHOLOGIA, V173, P121, DOI 10.1007/s11046-011-9470-2; Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x; Smith KG, 2009, ECOL LETT, V12, P1069, DOI 10.1111/j.1461-0248.2009.01363.x; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Turner AM, 1997, J N AM BENTHOL SOC, V16, P694, DOI 10.2307/1468154; Van Sluys M, 2009, ECOHEALTH, V6, P576, DOI 10.1007/s10393-010-0278-1; Venesky MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024991; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190	49	14	14	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76035	10.1371/journal.pone.0076035	http://dx.doi.org/10.1371/journal.pone.0076035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086681	Green Published, gold			2022-12-27	WOS:000325218700118
J	Campos, AH; Vassallo, J; Soares, FA				Campos, Antonio Hugo; Vassallo, Jose; Soares, Fernando Augusto			Matrix Metalloproteinase-9 Expression by Hodgkin-Reed-Sternberg Cells Is Associated with Reduced Overall Survival in Young Adult Patients with Classical Hodgkin Lymphoma	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; NITRIC-OXIDE SYNTHASES; MEMBRANE-PROTEIN 1; MATRIX METALLOPROTEINASES; DISEASE; CANCER; ICAM-1; ACTIVATION; INFECTION; PREDICTS	Previous studies have investigated the prognostic relevance of MMP9 in classical Hodgkin lymphoma (cHL), with negative results. However, we have found that MMP9 immunoistochemical expression by Hodgkin-Reed-Sternberg cells is associated with reduced overall survival in a subset of young adult Brazilian patients diagnosed with cHL. Additionally, we have observed that MMP9 expression by neoplastic cells in cHL is associated with EBV positivity. These results may support a rational basis for additional studies on the role of this metalloproteinase as a target for therapy in classical Hodgkin lymphoma.	[Campos, Antonio Hugo; Vassallo, Jose; Soares, Fernando Augusto] AC Camargo Canc Care Ctr, Dept Anat Pathol, Sao Paulo, Brazil; [Vassallo, Jose] Univ Estadual Campinas, Fac Med Sci, Lab Invest & Mol Pathol CIPED, Campinas, SP, Brazil	A.C.Camargo Cancer Center; Universidade Estadual de Campinas	Campos, AH (corresponding author), AC Camargo Canc Care Ctr, Dept Anat Pathol, Sao Paulo, Brazil.	ahcampos@hcancer.org.br	VASSALLO, JOSE/AAP-4600-2021; Campos, Antonio Hugo/AAB-9287-2019	VASSALLO, JOSE/0000-0002-2192-4865; Campos, Antonio Hugo/0000-0001-5322-7549; Soares, Fernando Augusto/0000-0003-1647-7842; Soares, Fernando/0000-0002-1212-9093	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [06/02183-1]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The present study was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Grant #06/02183-1, www.fapesp.br). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred V, 2008, LEUKEMIA LYMPHOMA, V49, P2198, DOI 10.1080/10428190802239170; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Benson HL, 2011, AM J RESP CELL MOL, V44, P700, DOI 10.1165/rcmb.2010-0125OC; Campos AHJFM, 2009, MOL CELL BIOCHEM, V321, P95, DOI 10.1007/s11010-008-9923-1; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Chetaille B, 2009, BLOOD, V113, P2765, DOI 10.1182/blood-2008-07-168096; CHRISTIANSEN I, 1995, LEUKEMIA LYMPHOMA, V19, P243, DOI 10.3109/10428199509107894; Creighton Chad, 2003, In Silico Biology, V3, P301; Cunha IW, 2006, APPL IMMUNOHISTO M M, V14, P404, DOI 10.1097/01.pai.0000190175.98576.a3; Diehl Volker, 2003, Hematology Am Soc Hematol Educ Program, P225, DOI 10.1182/asheducation-2003.1.225; Diepstra A, 2009, J CLIN ONCOL, V27, P3815, DOI 10.1200/JCO.2008.20.5138; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fiore E, 2002, ONCOGENE, V21, P5213, DOI 10.1038/sj.onc.1205684; Flavell JR, 2000, J CLIN PATHOL-MOL PA, V53, P145, DOI 10.1136/mp.53.3.145; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Gulley ML, 2002, AM J CLIN PATHOL, V117, P259; Hasenclever D, 1998, NEW ENGL J MED, V339, P1506, DOI 10.1056/NEJM199811193392104; Keegan THM, 2005, J CLIN ONCOL, V23, P7604, DOI 10.1200/JCO.2005.02.6310; Kuittinen O, 2002, EUR J HAEMATOL, V69, P205, DOI 10.1034/j.1600-0609.2002.02751.x; Raffo D, 2011, CURR PHARM BIOTECHNO, V12, P1937, DOI 10.2174/138920111798377085; Rassidakis GZ, 2002, BLOOD, V100, P3935, DOI 10.1182/blood.V100.12.3935; Re D, 2005, BLOOD, V105, P4553, DOI 10.1182/blood-2004-12-4750; Sakata K, 2004, CANCER, V100, P356, DOI 10.1002/cncr.11905; Schmitz R, 2009, ANNU REV PATHOL-MECH, V4, P151, DOI 10.1146/annurev.pathol.4.110807.092209; Soares A, 2007, INT J CANCER, V120, P875, DOI 10.1002/ijc.22417; Souza EM, 2012, MED ONCOL, V29, P2148, DOI 10.1007/s12032-011-0063-1; Syrigos KN, 2004, ANTICANCER RES, V24, P1243; Takeshita H, 1999, J VIROL, V73, P5548, DOI 10.1128/JVI.73.7.5548-5555.1999; Uchihara JN, 2006, INT J CANCER, V118, P1098, DOI 10.1002/ijc.21427; Vassallo J, 2001, HAEMATOLOGICA, V86, P1227; Vihinen P, 2002, INT J CANCER, V99, P157, DOI 10.1002/ijc.10329; Wang BQ, 2011, J CANCER RES CLIN, V137, P1525, DOI 10.1007/s00432-011-1010-4; Yoshizaki T, 1998, P NATL ACAD SCI USA, V95, P3621, DOI 10.1073/pnas.95.7.3621	33	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e74793	10.1371/journal.pone.0074793	http://dx.doi.org/10.1371/journal.pone.0074793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086377	Green Published, gold, Green Submitted			2022-12-27	WOS:000325025200017
J	Papasergi, S; Cariccio, VL; Pietrocola, G; Domina, M; D'Aliberti, D; Trunfio, MG; Signorino, G; Peppoloni, S; Biondo, C; Mancuso, G; Midiri, A; Rindi, S; Teti, G; Speziale, P; Felici, F; Beninati, C				Papasergi, Salvatore; Cariccio, Veronica Lanza; Pietrocola, Giampiero; Domina, Maria; D'Aliberti, Deborah; Trunfio, Maria Grazia; Signorino, Giacomo; Peppoloni, Samuele; Biondo, Carmelo; Mancuso, Giuseppe; Midiri, Angelina; Rindi, Simonetta; Teti, Giuseppe; Speziale, Pietro; Felici, Franco; Beninati, Concetta			Immunogenic Properties of Streptococcus agalactiae FbsA Fragments	PLOS ONE			English	Article							FIBRINOGEN-BINDING PROTEIN; HUMAN EPITHELIAL-CELLS; STAPHYLOCOCCUS-AUREUS; HYPERVARIABLE REGION; TOXOPLASMA-GONDII; NEONATAL SEPSIS; CDNA LIBRARIES; LAMBDA-DISPLAY; INFECTIONS; ADHERENCE	Several species of Gram-positive bacteria can avidly bind soluble and surface-associated fibrinogen (Fng), a property that is considered important in the pathogenesis of human infections. To gain insights into the mechanism by which group B Streptococcus (GBS), a frequent neonatal pathogen, interacts with Fng, we have screened two phage displayed genomic GBS libraries. All of the Fng-binding phage clones contained inserts encoding fragments of FbsA, a protein displaying multiple repeats. Since the functional role of this protein is only partially understood, representative fragments were recombinantly expressed and analyzed for Fng binding affinity and ability to induce immune protection against GBS infection. Maternal immunization with 6pGST, a fragment containing five repeats, significantly protected mouse pups against lethal GBS challenge and these protective effects could be recapitulated by administration of anti-6pGST serum from adult animals. Notably, a monoclonal antibody that was capable of neutralizing Fng binding by 6pGST, but not a non-neutralizing antibody, could significantly protect pups against lethal GBS challenge. These data suggest that FbsA-Fng interaction promotes GBS pathogenesis and that blocking such interaction is a viable strategy to prevent or treat GBS infections.	[Papasergi, Salvatore; Cariccio, Veronica Lanza; Domina, Maria; D'Aliberti, Deborah; Trunfio, Maria Grazia; Signorino, Giacomo; Biondo, Carmelo; Mancuso, Giuseppe; Midiri, Angelina; Teti, Giuseppe; Beninati, Concetta] Univ Messina, Metchnikoff Lab, Messina, Italy; [Pietrocola, Giampiero; Rindi, Simonetta; Speziale, Pietro] Univ Pavia, Biochem Unit, Dept Mol Med, I-27100 Pavia, Italy; [Peppoloni, Samuele] Univ Modena & Reggio Emilia, Dept Diagnost Clin & Publ Hlth Med, Modena, Italy; [Felici, Franco] Univ Molise, DiBT, Dept Biosci & Terr, Pesche, Isernia, Italy	University of Messina; University of Pavia; Universita di Modena e Reggio Emilia; University of Molise	Teti, G (corresponding author), Univ Messina, Metchnikoff Lab, Messina, Italy.	gteti@unime.it	Felici, Franco/H-5693-2012; Peppoloni, Samuele/L-2177-2016; papasergi, salvatore/AAE-8818-2021; Biondo, Carmelo/AAA-3391-2019; Domina, Maria/K-7883-2016	Felici, Franco/0000-0003-2205-5195; Peppoloni, Samuele/0000-0003-4191-6974; Midiri, Angelina/0000-0002-4128-9678; Domina, Maria/0000-0002-0445-8356; Mancuso, Giuseppe/0000-0001-5454-3228; PIETROCOLA, GIAMPIERO/0000-0002-7069-8155; BENINATI, Concetta/0000-0001-8305-1337; Signorino, Giacomo/0000-0002-5366-6020	Progetti di Ricerca di Rilevante Interesse Nazionale (PRIN) from the Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) of Italy	Progetti di Ricerca di Rilevante Interesse Nazionale (PRIN) from the Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) of Italy(Ministry of Education, Universities and Research (MIUR))	The work was supported by grants Progetti di Ricerca di Rilevante Interesse Nazionale (PRIN) 2003, 2005 and 2008 from the Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) of Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RA, 2007, CURR MED CHEM, V14, P2925, DOI 10.2174/092986707782360015; Al Safadi R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014658; Beghetto E, 2003, INT J PARASITOL, V33, P163, DOI 10.1016/S0020-7519(02)00256-4; Beghetto E, 2001, INT J PARASITOL, V31, P1659, DOI 10.1016/S0020-7519(01)00288-0; Beghetto E, 2006, FEMS MICROBIOL LETT, V262, P14, DOI 10.1111/j.1574-6968.2006.00360.x; Camacho-Gonzalez A, 2013, PEDIATR CLIN N AM, V60, P367, DOI 10.1016/j.pcl.2012.12.003; Cardaci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036588; Carlsson F, 2005, MOL MICROBIOL, V56, P28, DOI 10.1111/j.1365-2958.2005.04527.x; Dramsi S, 2012, MICROBES INFECT, V14, P1044, DOI 10.1016/j.micinf.2012.07.004; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; EDWARDS MS, 1983, PEDIATR RES, V17, P685, DOI 10.1203/00006450-198308000-00017; Flick MJ, 2013, BLOOD, V121, P1783, DOI 10.1182/blood-2012-09-453894; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; Gutekunst H, 2004, INFECT IMMUN, V72, P3495, DOI 10.1128/IAI.72.6.3495-3504.2004; Jonsson IM, 2005, J INFECT DIS, V192, P1456, DOI 10.1086/491478; Lannergard J, 2011, CELL HOST MICROBE, V10, P147, DOI 10.1016/j.chom.2011.06.011; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Magliani W, 1998, NAT MED, V4, P705, DOI 10.1038/nm0698-705; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; McAdow M, 2012, J INNATE IMMUN, V4, P141, DOI 10.1159/000333447; Ohlsson A, 2013, COCHRANE DB SYST REV, V1; Papasergi S, 2010, J BIOL CHEM, V285, P7517, DOI 10.1074/jbc.M109.062075; Pietrocola G, 2005, BLOOD, V105, P1052, DOI 10.1182/blood-2004-06-2149; Poyart C, 2008, EMERG INFECT DIS, V14, P1647, DOI 10.3201/eid1410.080185; Rajagopal L, 2009, FUTURE MICROBIOL, V4, P201, DOI 10.2217/17460913.4.2.201; Rivera J, 2007, THROMB HAEMOSTASIS, V98, P503, DOI 10.1160/TH07-03-0233; Rosenau A, 2007, INFECT IMMUN, V75, P1310, DOI 10.1128/IAI.00996-06; Schrag SJ, 2006, PEDIATR INFECT DIS J, V25, P939, DOI 10.1097/01.inf.0000239267.42561.06; Schubert A, 2004, INFECT IMMUN, V72, P6197, DOI 10.1128/IAI.72.11.6197-6205.2004; Schubert A, 2002, MOL MICROBIOL, V46, P557, DOI 10.1046/j.1365-2958.2002.03177.x; Senn BM, 2011, VACCINE, V29, P4116, DOI 10.1016/j.vaccine.2011.03.100; Seo HW, 2012, BMC VET RES, V8, P1, DOI 10.1186/1746-6148-8-194; Tenenbaum T, 2005, INFECT IMMUN, V73, P4404, DOI 10.1128/IAI.73.7.4404-4409.2005; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Waldemarsson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007279; WIBAWAN WT, 1992, J VET MED B, V39, P376, DOI 10.1111/j.1439-0450.1992.tb01183.x; WILSON CB, 1985, J INFECT DIS, V152, P323, DOI 10.1093/infdis/152.2.323	37	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75266	10.1371/journal.pone.0075266	http://dx.doi.org/10.1371/journal.pone.0075266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086487	Green Published, gold, Green Submitted			2022-12-27	WOS:000325025200034
J	Sanchez-Jimenez, C; Izquierdo, JM				Sanchez-Jimenez, Carmen; Izquierdo, Jose M.			T-cell Intracellular Antigen (TIA)-Proteins Deficiency in Murine Embryonic Fibroblasts Alters Cell Cycle Progression and Induces Autophagy	PLOS ONE			English	Article							BINDING PROTEIN TIAR; MESSENGER-RNA; MICROARRAY DATA; DNA; GENE; IDENTIFICATION; NORMALIZATION; TRANSCRIPTION; LYMPHOCYTES; MICROSCOPY	Mice lacking either T-cell intracellular antigen 1 (TIA1) or TIA1 related/like protein (TIAR/TIAL1) show high rates of embryonic lethality, suggesting a relevant role for these proteins during embryonic development. However, intrinsic molecular and cellular consequences of either TIA1 or TIAR deficiency remain poorly defined. By using genome-wide expression profiling approach, we demonstrate that either TIA1 or TIAR inactivation broadly alter normal development-associated signalling pathways in murine embryonic fibroblasts (MEF). Indeed, these analyses highlighted alterations of cytokine-cytokine and ECM-receptor interactions and Wnt, MAPK, TGF-beta dependent signalling pathways. Consistent with these results, TIA1 and TIAR knockout (KO) MEF show reduced rates of cell proliferation, cell cycle progression delay and increased cell size. Furthermore, TIA-proteins deficiency also caused metabolic deficiencies, increased ROS levels and DNA damage, promoting a gentle rise of cell death. Concomitantly, high rates of autophagy were detected in both TIA1 and TIAR KO MEF with induction of the formation of autophagosomes, as evidenced by the up-regulation of the LC3B protein, and autolysosomes, measured by colocalization of LC3B and LAMP1, as a survival mechanism attempt. Taken together, these observations support that TIA proteins orchestrate a transcriptome programme to activate specific developmental decisions. This program is likely to contribute to mouse physiology starting at early stages of the embryonic development. TIA1/TIAR might function as cell sensors to maintain homeostasis and promote adaptation/survival responses to developmental stress.	[Sanchez-Jimenez, Carmen; Izquierdo, Jose M.] Univ Autonoma Madrid CSIC UAM, Consejo Super Invest Cient, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Izquierdo, JM (corresponding author), Univ Autonoma Madrid CSIC UAM, Consejo Super Invest Cient, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	jmizquierdo@cbm.uam.es		Izquierdo, Jose M/0000-0002-7942-4046	Ministerio de Ciencia e Innovacion-FEDER [BFU2008-00354, BFU2011-29653]; Fundacion Ramon Areces, Spain	Ministerio de Ciencia e Innovacion-FEDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces, Spain	This work was supported by grants from Ministerio de Ciencia e Innovacion-FEDER (BFU2008-00354 and BFU2011-29653). The CBMSO receives an institutional grant from Fundacion Ramon Areces, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Beck ARP, 1998, P NATL ACAD SCI USA, V95, P2331, DOI 10.1073/pnas.95.5.2331; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Damgaard CK, 2011, GENE DEV, V25, P2057, DOI 10.1101/gad.17355911; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; Forch P, 2000, MOL CELL, V6, P1089, DOI 10.1016/S1097-2765(00)00107-6; Gal-Mark N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000717; Gottschald OR, 2010, J MOL CELL BIOL, V2, P345, DOI 10.1093/jmcb/mjq032; Hayashi M, 2006, NAT MED, V12, P128, DOI 10.1038/nm1327; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Izquierdo JM, 2007, J BIOL CHEM, V282, P19410, DOI 10.1074/jbc.M700688200; Izquierdo JM, 2011, BIOCHEM J, V435, P337, DOI 10.1042/BJ20101030; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; KAWAKAMI A, 1992, P NATL ACAD SCI USA, V89, P8681, DOI 10.1073/pnas.89.18.8681; Kharraz Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011352; Kim HS, 2007, MOL CELL BIOL, V27, P6806, DOI 10.1128/MCB.01036-07; Kim HS, 2011, NUCLEIC ACIDS RES, V39, P1117, DOI 10.1093/nar/gkq837; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Liao BS, 2007, NAT STRUCT MOL BIOL, V14, P511, DOI 10.1038/nsmb1249; Mazan-Mamczarz K, 2006, MOL CELL BIOL, V26, P2716, DOI 10.1128/MCB.26.7.2716-2727.2006; McAlinden A, 2007, J BIOL CHEM, V282, P24444, DOI 10.1074/jbc.M702717200; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Miller BC, 2008, AUTOPHAGY, V4, P309, DOI 10.4161/auto.5474; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Oliveros JC., 2007, FIESTA BIOINFOGP INT; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Pua HH, 2009, AUTOPHAGY, V5, P745, DOI 10.4161/auto.5.5.8702; Reyes R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r87; Sanchez-Jimenez C, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-4; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Soultanakis RP, 2000, FREE RADICAL BIO MED, V28, P987, DOI 10.1016/S0891-5849(00)00185-4; Suswam EA, 2005, NUCLEIC ACIDS RES, V33, P4507, DOI 10.1093/nar/gki763; TIAN QS, 1991, CELL, V67, P629, DOI 10.1016/0092-8674(91)90536-8; Wang Z, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000530; Yamasaki S, 2007, J BIOL CHEM, V282, P30070, DOI 10.1074/jbc.M706273200	45	26	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75127	10.1371/journal.pone.0075127	http://dx.doi.org/10.1371/journal.pone.0075127			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086455	Green Published, Green Submitted, gold			2022-12-27	WOS:000325025200027
J	Canivell, S; Ruano, EG; Siso-Almirall, A; Kostov, B; Gonzalez-de Paz, L; Fernandez-Rebollo, E; Hanzu, F; Parrizas, M; Novials, A; Gomis, R				Canivell, Silvia; Ruano, Elena G.; Siso-Almirall, Antoni; Kostov, Belchin; Gonzalez-de Paz, Luis; Fernandez-Rebollo, Eduardo; Hanzu, Felicia; Parrizas, Marcelina; Novials, Anna; Gomis, Ramon			Gastric Inhibitory Polypeptide Receptor Methylation in Newly Diagnosed, Drug-Naive Patients with Type 2 Diabetes: A Case-Control Study	PLOS ONE			English	Article							BETA-CELL FUNCTION; DNA METHYLATION; INSULIN-RESISTANCE; HOMEOSTASIS MODEL; GENE-EXPRESSION; GENOME; ASSOCIATION; GLUCOSE; OBESITY; MELLITUS	GIP action in type 2 diabetic (T2D) patients is altered. We hypothesized that methylation changes could be present in GIP receptor of T2D patients. This study aimed to assess the differences in DNA methylation profile of GIPR promoter between T2D patients and age-and Body Mass Index (BMI)-matched controls. We included 93 T2D patients (cases) that were uniquely on diet (without any anti-diabetic pharmacological treatment). We matched one control (with oral glucose tolerance test negative, non diabetic), by age and BMI, for every case. Cytokines and hormones were determined by ELISA. DNA was extracted from whole blood and DNA methylation was assessed using the Sequenom EpiTYPER system. Our results showed that T2D patients were more insulin resistant and had a poorer beta cell function than their controls. Fasting adiponectin was lower in T2D patients as compared to controls (7.0 +/- 3.8 mu gr/mL vs. 10.0 +/- 4.2 mu gr/mL). Levels of IL 12 in serum were almost double in T2D patients (52.8 +/- 58.3 pg/mL vs. 29.7 +/- 37.4 pg/mL). We found that GIPR promoter was hypomethylated in T2D patients as compared to controls. In addition, HOMA-IR and fasting glucose correlated negatively with mean methylation of GIPR promoter, especially in T2D patients. This case-control study confirms that newly diagnosed, drug-naive T2D patients are more insulin resistant and have worse beta cell function than age- and BMI-matched controls, which is partly related to changes in the insulin-sensitizing metabolites (adiponectin), in the proinflammatory profile (IL12) and we suggest in the methylation pattern of GIPR. Our study provides novel findings on GIPR promoter methylation profile which may improve our ability to understand type 2 diabetes pathogenesis.	[Canivell, Silvia; Hanzu, Felicia; Novials, Anna; Gomis, Ramon] Hosp Clin Barcelona, Inst Invest Biomed August Pi I Sunyer, Dept Endocrinol & Nutr, Barcelona, Spain; [Canivell, Silvia; Siso-Almirall, Antoni; Kostov, Belchin; Gonzalez-de Paz, Luis] Inst Invest Biomed August Pi I Sunyer, Transverse Grp Res Primary Care, Les Corts Primary Hlth Care Ctr, Barcelona, Spain; [Canivell, Silvia; Ruano, Elena G.; Fernandez-Rebollo, Eduardo; Hanzu, Felicia; Parrizas, Marcelina; Novials, Anna; Gomis, Ramon] Inst Invest Biomed August Pi I Sunyer, Diabet & Obes Lab, Barcelona, Spain; [Ruano, Elena G.; Fernandez-Rebollo, Eduardo; Novials, Anna; Gomis, Ramon] Spanish Biomed Res Ctr Diabet & Associated Metab, Barcelona, Spain; [Siso-Almirall, Antoni; Gomis, Ramon] Univ Barcelona, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona	Gomis, R (corresponding author), Hosp Clin Barcelona, Inst Invest Biomed August Pi I Sunyer, Dept Endocrinol & Nutr, Barcelona, Spain.	RGOMIS@clinic.ub.es	, EFR1981/AAV-6334-2020; Parrizas, Marcelina/AAS-3629-2021	, EFR1981/0000-0002-4378-7590; Parrizas, Marcelina/0000-0003-1296-8302; Kostov, Belchin/0000-0002-2126-3892; Gonzalez de Paz, Luis/0000-0002-4767-8121; Hanzu, Felicia Alexandra/0000-0002-2399-4023; Novials, Anna/0000-0003-0465-2949; Siso Almirall, Antoni/0000-0001-9832-2689; Canivell, Silvia/0000-0002-0280-5035	FIS [PI 1000219]; MEDIGENE [279171]; EC; Spanish Ministry of Science and Innovation [SAF 2010-19527]; Spanish Ministry of Science and Innovation; BIOTRACK Postdoctoral Fellowship in Institut d'Investigacions Biomediques August Pi i Sunyer; European Community [229673]	FIS(Instituto de Salud Carlos III); MEDIGENE; EC(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); BIOTRACK Postdoctoral Fellowship in Institut d'Investigacions Biomediques August Pi i Sunyer; European Community(European Commission)	This work was supported by the FIS Grant PI 1000219, the MEDIGENE project, grant agreement number 279171, funded by the EC Seventh Framework Programme theme FP7-HEALTH-2011 and by the Spanish Ministry of Science and Innovation (under de the grant agreement number SAF 2010-19527). CIBER de Diabetes y Enfermedades Metabolicas is an initiative of the Spanish Ministry of Science and Innovation. The Rio Hortega Grant from the Spanish Ministry of Science and Innovation was awarded to Silvia Canivell. Eduardo Fernandez-Rebollo (EF-R) has been the recipient of a BIOTRACK Postdoctoral Fellowship in Institut d'Investigacions Biomediques August Pi i Sunyer, supported by the European Community's Seventh Framework Programme (EC FP7/2009-2013) under the agreement no. 229673. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlqvist E, 2013, DIABETES; American Diabetes Association, 2011, DIABETES CARE S1, V35, pS11; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Bluher M, 2005, EXP CLIN ENDOCR DIAB, V113, P534, DOI 10.1055/s-2005-872851; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Haffner SM, 1997, DIABETES CARE, V20, P1087, DOI 10.2337/diacare.20.7.1087; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Holst JJ, 1997, DIABETOLOGIA, V40, P984, DOI 10.1007/s001250050779; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Lehtovirta M, 2010, DIABETOLOGIA, V53, P1314, DOI 10.1007/s00125-010-1746-4; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Mari A, 2010, DIABETOLOGIA, V53, P749, DOI 10.1007/s00125-009-1647-6; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942; Mishra M, 2011, DIABETES RES CLIN PR, V94, P255, DOI 10.1016/j.diabres.2011.07.037; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Murea Mariana, 2012, Rev Diabet Stud, V9, P6, DOI 10.1900/RDS.2012.9.6; Relton CL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000356; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Shu LA, 2009, HUM MOL GENET, V18, P2388, DOI 10.1093/hmg/ddp178; Slomko H, 2012, ENDOCRINOLOGY, V153, P1025, DOI 10.1210/en.2011-1759; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Taylor-Fishwick DA, 2013, DIABETOLOGIA, V56, P126, DOI 10.1007/s00125-012-2732-9; Toperoff G, 2012, HUM MOL GENET, V21, P371, DOI 10.1093/hmg/ddr472; USDIN TB, 1993, ENDOCRINOLOGY, V133, P2861, DOI 10.1210/en.133.6.2861; Volkmar M, 2012, EMBO J; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wheeler E, 2011, BRIEF FUNCT GENOMICS, V10, P52, DOI 10.1093/bfgp/elr008	30	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75474	10.1371/journal.pone.0075474	http://dx.doi.org/10.1371/journal.pone.0075474			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086540	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200104
J	Dammermann, W; Schipper, P; Ullrich, S; Fraedrich, K; zur Wiesch, JS; Frundt, T; Tiegs, G; Lohse, A; Luth, S				Dammermann, Werner; Schipper, Pim; Ullrich, Sebastian; Fraedrich, Katharina; zur Wiesch, Julian Schulze; Fruendt, Thorben; Tiegs, Gisa; Lohse, Ansgar; Lueth, Stefan			Increased Expression of Complement Regulators CD55 and CD59 on Peripheral Blood Cells in Patients with EAHEC O104:H4 Infection	PLOS ONE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; HEMOLYTIC-UREMIC SYNDROME; INHIBITOR ECULIZUMAB; GENE-EXPRESSION; T-CELLS; ANEMIA; ERYTHROCYTES; IMMUNITY; DEFICIENCY; ACTIVATION	Background: An outbreak of Shiga Toxin 2 (Stx-2) producing enterohemorrhagic and enteroaggregative E. coli (EAHEC) O104H4 infection in May 2011 caused enterocolitis and an unprecedented high 22% rate of hemolytic uremic syndrome (HUS). The monoclonal anti-C5 antibody Eculizumab (ECU) has been used experimentally in EAHEC patients with HUS but treatment efficacy is uncertain. ECU can effectively prevent hemolysis in paroxysmal nocturnal hemoglobinuria (PNH) caused by a lack of complement-regulating CD55 and CD59 on blood cells. We hypothesized a low expression of CD55 and CD59, as seen in PNH, might correlate with HUS development in EAHEC patients. Methods: 76 EAHEC patients (34 only gastrointestinal symptoms [GI], 23: HUS, 19: HUS and neurological symptoms [HUS/N]) and 12 healthy controls (HC) were tested for the expression of CD55 and CD59 on erythrocytes and leukocytes retrospectively. Additionally, the effect of Stx-2 on CD55 and CD59 expression on erythrocytes and leukocytes was studied ex vivo. Results: CD55 expression on erythrocytes was similar in all patient groups and HC while CD59 showed a significantly higher expression in HUS and HUS/N patients compared to HC and the GI group. CD55 and CD59 expression on leukocytes and their subsets was significantly higher in all patient groups compared to HC regardless of treatment type. However, CD59 expression on erythrocytes was significantly higher in HUS and HUS/N patients treated combined with plasma separation (PS) and ECU compared to HC. Adding Stx-2 ex vivo had no effect on CD55 and CD59 expression on leukocytes from HC or patients. Conclusion: HUS evolved independently from CD55 and CD59 expression on peripheral blood cells in EAHEC O104:H4 infected patients. Our data do not support a role for CD55 and CD59 in HUS development during EAHEC O104:H4 infection and point to a different mechanism within the complement system for HUS development in EAHEC patients.	[Dammermann, Werner; Schipper, Pim; Fraedrich, Katharina; zur Wiesch, Julian Schulze; Fruendt, Thorben; Lohse, Ansgar; Lueth, Stefan] Univ Med Ctr Eppendorf, Dept Med, Hamburg, Germany; [Ullrich, Sebastian] Univ Med Ctr Eppendorf, Dept Anat & Expt Morphol, Hamburg, Germany; [Tiegs, Gisa] Univ Med Ctr Eppendorf, Inst Expt Immunol & Hepatol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Luth, S (corresponding author), Univ Med Ctr Eppendorf, Dept Med, Hamburg, Germany.	s.lueth@uke.de	Wiesch, Julian Schulze zur/AAT-8452-2021; Dammermann, Werner/G-5811-2016; Dammermann, Werner/GZN-1268-2022	Dammermann, Werner/0000-0001-6847-3769; Luth, Stefan/0000-0001-9946-0960	German Federal Ministry of Health; Deutsche Forschungsgemeinschaft (DFG) [LU 1362/2-1 581069]	German Federal Ministry of Health; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study is funded by the German Federal Ministry of Health and the Deutsche Forschungsgemeinschaft (DFG), grant # LU 1362/2-1 581069. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros MMO, 2009, TRANSFUSION, V49, P154, DOI 10.1111/j.1537-2995.2008.01936.x; Brodsky RA, 2008, BLOOD, V111, P1840, DOI 10.1182/blood-2007-06-094136; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; Fendel R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010038; Geelen J, 2008, NEPHROL DIAL TRANSPL, V23, P3091, DOI 10.1093/ndt/gfn244; German EHEC-HUS registry, 2011, NEPHROL DIAL TRANSPL, V26, P2723, DOI [10.1093/ndt/gfr462, DOI 10.1093/NDT/GFR462]; Greinacher A, 2011, LANCET, V378, P1166, DOI 10.1016/S0140-6736(11)61253-1; Gwamaka M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-386; Heeger PS, 2005, J EXP MED, V201, P1523, DOI 10.1084/jem.20041967; Hillmen P, 2004, NEW ENGL J MED, V350, P552, DOI 10.1056/NEJMoa031688; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Kavanagh D, 2007, MOL IMMUNOL, V44, P3162, DOI 10.1016/j.molimm.2007.01.036; Kawamoto Y, 1997, IMMUNOLOGY, V91, P7, DOI 10.1046/j.1365-2567.1997.00188.x; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Kimberley FC, 2007, MOL IMMUNOL, V44, P73, DOI 10.1016/j.molimm.2006.06.019; Lapeyraque AL, 2011, NEW ENGL J MED, V364, P2561, DOI 10.1056/NEJMc1100859; Liu JN, 2005, J EXP MED, V201, P567, DOI 10.1084/jem.20040863; Longhi MP, 2006, TRENDS IMMUNOL, V27, P102, DOI 10.1016/j.it.2005.12.008; Mahajan RC, 2011, INDIAN J MED RES, V133, P662; Mahtout H, 2011, FEMS IMMUNOL MED MIC, V62, P295, DOI 10.1111/j.1574-695X.2011.00813.x; Martin BK, 2007, IMMUNOL RES, V39, P146, DOI 10.1007/s12026-007-0078-z; Matthes T, 2002, TRANSFUSION, V42, P1448, DOI 10.1046/j.1537-2995.2002.00214.x; Menne J, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4565; Morigi M, 2011, J IMMUNOL, V187, P172, DOI 10.4049/jimmunol.1100491; Orth D, 2009, J IMMUNOL, V182, P6394, DOI 10.4049/jimmunol.0900151; Pettigrew HD, 2009, ANN NY ACAD SCI, V1173, P108, DOI 10.1111/j.1749-6632.2009.04633.x; Qin JJ, 2011, J CLIN MICROBIOL, V49, P3439, DOI 10.1128/JCM.01312-11; Robert Koch Institute, 2012, FIN PRES EV EP FIND; Ruiz-Arguelles A, 2007, AUTOIMMUN REV, V6, P155, DOI 10.1016/j.autrev.2006.09.008; Stahl AL, 2011, BLOOD, V117, P5503, DOI 10.1182/blood-2010-09-309161; Stoute JA, 2003, J INFECT DIS, V187, P522, DOI 10.1086/367712; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; TAGUCHI R, 1990, FEBS LETT, V261, P142, DOI 10.1016/0014-5793(90)80656-4; Terpos E, 2008, MED SCI MONITOR, V14, pCR276; Ubol S, 2008, J INFECT DIS, V197, P1459, DOI 10.1086/587699; Waitumbi JN, 2000, BLOOD, V95, P1481, DOI 10.1182/blood.V95.4.1481.004k15_1481_1486; Wiesner J, 1997, EUR J IMMUNOL, V27, P2708, DOI 10.1002/eji.1830271034; WILCOX LA, 1991, BLOOD, V78, P820, DOI 10.1182/blood.V78.3.820.bloodjournal783820	38	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74880	10.1371/journal.pone.0074880	http://dx.doi.org/10.1371/journal.pone.0074880			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086391	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200049
J	Strafella, E; Bracci, M; Staffolani, S; Manzella, N; Giantomasi, D; Valentino, M; Amati, M; Tomasetti, M; Santarelli, L				Strafella, Elisabetta; Bracci, Massimo; Staffolani, Sara; Manzella, Nicola; Giantomasi, Daniele; Valentino, Matteo; Amati, Monica; Tomasetti, Marco; Santarelli, Lory			Occupational Styrene Exposure Induces Stress-Responsive Genes Involved in Cytoprotective and Cytotoxic Activities	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; LIVER-REGENERATION; OXIDATIVE STRESS; DNA-DAMAGE; WORKERS; CANCER; EXPRESSION; INJURY; MICE; HEAT-SHOCK-PROTEIN-70	Objective: The aim of this study was to evaluate the expression of a panel of genes involved in toxicology in response to styrene exposure at levels below the occupational standard setting. Methods: Workers in a fiber glass boat industry were evaluated for a panel of stress- and toxicity-related genes and associated with biochemical parameters related to hepatic injury. Urinary styrene metabolites (MA+PGA) of subjects and environmental sampling data collected for air at workplace were used to estimate styrene exposure. Results: Expression array analysis revealed massive upregulation of genes encoding stress-responsive proteins (HSPA1L, EGR1, IL-6, IL-1 beta, TNSF10 and TNF alpha) in the styrene-exposed group; the levels of cytokines released were further confirmed in serum. The exposed workers were then stratified by styrene exposure levels. EGR1 gene upregulation paralleled the expression and transcriptional protein levels of IL-6, TNSF10 and TNF alpha in styrene exposed workers, even at low level. The activation of the EGR1 pathway observed at low-styrene exposure was associated with a slight increase of hepatic markers found in highly exposed subjects, even though they were within normal range. The ALT and AST levels were not affected by alcohol consumption, and positively correlated with urinary styrene metabolites as evaluated by multiple regression analysis. Conclusion: The pro-inflammatory cytokines IL-6 and TNF alpha are the primary mediators of processes involved in the hepatic injury response and regeneration. Here, we show that styrene induced stress responsive genes involved in cytoprotection and cytotoxicity at low-exposure, that proceed to a mild subclinical hepatic toxicity at high-styrene exposure.	[Strafella, Elisabetta; Bracci, Massimo; Staffolani, Sara; Manzella, Nicola; Giantomasi, Daniele; Valentino, Matteo; Amati, Monica; Tomasetti, Marco; Santarelli, Lory] Polytech Univ Marche, Dept Clin & Mol Sci, Ancona, Italy	Marche Polytechnic University	Bracci, M (corresponding author), Polytech Univ Marche, Dept Clin & Mol Sci, Ancona, Italy.	m.bracci@univpm.it	Santarelli, Lory/AAU-4494-2020; Bracci, Massimo/K-1192-2018	Bracci, Massimo/0000-0003-3901-5376; santarelli, lory/0000-0003-1015-7098	National Institute of Occupational Injury Insurance (INAIL)	National Institute of Occupational Injury Insurance (INAIL)	This study was supported by National Institute of Occupational Injury Insurance (INAIL). The institute had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Conference of the Governmental Industrial Hygienist (ACGIH), 2003, STYR MON ACGIH DOC T; AXELSON O, 1978, SCAND J WORK ENV HEA, V4, P215, DOI 10.5271/sjweh.2745; Boffetta P, 2009, J OCCUP ENVIRON MED, V51, P1275, DOI 10.1097/JOM.0b013e3181ad49b2; Brodkin CA, 2001, OCCUP ENVIRON MED, V58, P95, DOI 10.1136/oem.58.2.95; Calderwood SK, 2008, INT J HYPERTHER, V24, P31, DOI 10.1080/02656730701858305; Carlson GP, 2011, DRUG CHEM TOXICOL, V34, P440, DOI 10.3109/01480545.2011.562899; Cocco P, 2010, OCCUP ENVIRON MED, V67, P341, DOI 10.1136/oem.2009.046839; Collins JJ, 2013, EPIDEMIOLOGY, V24, P195, DOI 10.1097/EDE.0b013e318281a30f; Costa C, 2012, J TOXICOL ENV HEAL A, V75, P735, DOI 10.1080/15287394.2012.688488; Czaja MJ, 2002, ANTIOXID REDOX SIGN, V4, P759, DOI 10.1089/152308602760598909; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Garg AK, 2002, MOL IMMUNOL, V39, P509, DOI 10.1016/S0161-5890(02)00207-9; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Godderis L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039205; HARKONEN H, 1984, SCAND J WORK ENV HEA, V10, P59, DOI 10.5271/sjweh.2369; HATAYAMA T, 1993, J BIOCHEM-TOKYO, V114, P592, DOI 10.1093/oxfordjournals.jbchem.a124222; Hirasawa F, 2007, BIOMED RES-TOKYO, V28, P323, DOI 10.2220/biomedres.28.323; Kaplowitz N, 1996, Prog Liver Dis, V14, P131; Lacour Sandrine, 2005, Cancer Biomarkers, V1, P29; Laffon B, 2001, J CHROMATOGR B, V753, P385, DOI 10.1016/S0378-4347(00)00583-1; LAVNIKOVA N, 1993, J LEUKOCYTE BIOL, V54, P322, DOI 10.1002/jlb.54.4.322; Liao YJ, 2004, J BIOL CHEM, V279, P43107, DOI 10.1074/jbc.M407969200; Liu SF, 1999, CIRCULATION, V100, P1330, DOI 10.1161/01.CIR.100.12.1330; LORIMER WV, 1978, SCAND J WORK ENV HEA, V4, P220, DOI 10.5271/sjweh.2743; MILLER RR, 1994, CRIT REV TOXICOL, V24, pS1, DOI 10.3109/10408449409020137; Mogel I, 2011, TOXICOLOGY, V289, P28, DOI 10.1016/j.tox.2011.07.006; Pritchard MT, 2010, J HEPATOL, V53, P655, DOI 10.1016/j.jhep.2010.04.017; Pritchard MT, 2005, ALCOHOL CLIN EXP RES, V29, p146S, DOI 10.1097/01.alc.0000189286.81943.51; Sati PC, 2011, HUM EXP TOXICOL, V30, P1743, DOI 10.1177/0960327111401436; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Singh R, 2010, CURR PHARM DESIGN, V16, P796, DOI 10.2174/138161210790883499; Srivastava SP, 1982, J APPL TOXICOL, V2, P219, DOI 10.1002/jat.2550020411; Streetz KL, 2003, HEPATOLOGY, V38, P218, DOI 10.1053/jhep.2003.50268; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Teoh NC, 2011, J GASTROEN HEPATOL, V26, P180, DOI 10.1111/j.1440-1746.2010.06584.x; THIESS AM, 1978, SCAND J WORK ENV HEA, V4, P203, DOI 10.5271/sjweh.2746; Unoshima M, 2001, J LAB CLIN MED, V137, P28, DOI 10.1067/mlc.2001.111514; Vodicka P, 2006, DRUG METAB REV, V38, P805, DOI 10.1080/03602530600952222; Won YL, 2011, SAF HEALTH WORK-KR, V2, P365, DOI 10.5491/SHAW.2011.2.4.365; Wongvijitsuk S, 2011, INT J HYG ENVIR HEAL, V214, P127, DOI 10.1016/j.ijheh.2010.09.007	40	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75401	10.1371/journal.pone.0075401	http://dx.doi.org/10.1371/journal.pone.0075401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086524	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200100
J	Surbanovski, N; Sargent, DJ; Else, MA; Simpson, DW; Zhang, HM; Grant, OM				Surbanovski, Nada; Sargent, Daniel J.; Else, Mark A.; Simpson, David W.; Zhang, Hanma; Grant, Olga M.			Expression of Fragaria vesca PIP Aquaporins in Response to Drought Stress: PIP Down-Regulation Correlates with the Decline in Substrate Moisture Content	PLOS ONE			English	Article							PLASMA-MEMBRANE AQUAPORINS; MAJOR INTRINSIC PROTEINS; WATER TRANSPORT; GENE FAMILY; HYDRAULIC CONDUCTIVITY; PLANT AQUAPORINS; ROOT PRESSURE; LEAF GROWTH; ARABIDOPSIS; CONDUCTANCE	PIP aquaporin responses to drought stress can vary considerably depending on the isoform, tissue, species or level of stress; however, a general down-regulation of these genes is thought to help reduce water loss and prevent backflow of water to the drying soil. It has been suggested therefore, that it may be necessary for the plant to limit aquaporin production during drought stress, but it is unknown whether aquaporin down-regulation is gradual or triggered by a particular intensity of the stress. In this study, ten Fragaria PIP genes were identified from the woodland strawberry (Fragaria vesca L.) genome sequence and characterised at the sequence level. The water relations of F. vesca were investigated and the effect of different intensities of drought stress on the expression of four PIP genes, as well as how drought stress influences their diurnal transcription was determined. PIP down-regulation in the root corresponded to the level of drought stress. Moreover, transcript abundance of two genes highly expressed in the root (FvPIP1;1 and FvPIP2;1) was strongly correlated to the decline in substrate moisture content. The amplitude of diurnal aquaporin expression in the leaves was down-regulated by drought without altering the pattern, but showing an intensity-dependent effect. The results show that transcription of PIP aquaporins can be fine-tuned with the environment in response to declining water availability.	[Surbanovski, Nada; Sargent, Daniel J.] Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, Trentino, Italy; [Surbanovski, Nada; Else, Mark A.; Simpson, David W.] East Malling Res, East Malling, Kent, England; [Zhang, Hanma] Univ Leeds, Fac Biol Sci, Leeds, W Yorkshire, England; [Grant, Olga M.] Univ Coll Dublin, Univ Coll Dublin Forestry, Dublin 2, Ireland	Fondazione Edmund Mach; University of Leeds; University College Dublin	Surbanovski, N (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, Trentino, Italy.	nada.surbanovski@fmach.it	Sargent, Daniel James/A-2933-2014	Sargent, Daniel James/0000-0002-6686-7147	East Malling Trust for Horticultural Research; Autonomous Province of Trento, Italy	East Malling Trust for Horticultural Research; Autonomous Province of Trento, Italy(Autonomous Province of Trento)	This work was funded by the East Malling Trust for Horticultural Research. DJS acknowledges funding for Applied Rosaceous Genomics from the Autonomous Province of Trento, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo J, 2007, HYDROLOG SCI J, V52, P247, DOI 10.1623/hysj.52.2.247; Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Alexandersson E, 2010, PLANT J, V61, P650, DOI 10.1111/j.1365-313X.2009.04087.x; Alleva K, 2010, J EXP BOT, V61, P3935, DOI 10.1093/jxb/erq210; Aroca R, 2007, NEW PHYTOL, V173, P808, DOI 10.1111/j.1469-8137.2006.01961.x; Aroca R, 2012, J EXP BOT, V63, P43, DOI 10.1093/jxb/err266; Beaudette PC, 2007, J EXP BOT, V58, P1291, DOI 10.1093/jxb/erl289; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Chaumont F, 2005, BIOL CELL, V97, P749, DOI 10.1042/BC20040133; Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025; Cochard H, 2007, PLANT PHYSIOL, V143, P122, DOI 10.1104/pp.106.090092; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; FOWLER J, 1992, PRACTICAL STAT FIELD; Galmes J, 2007, PLANTA, V226, P671, DOI 10.1007/s00425-007-0515-1; Guo L, 2006, CELL RES, V16, P277, DOI 10.1038/sj.cr.7310035; Hachez C, 2008, PLANT MOL BIOL, V68, P337, DOI 10.1007/s11103-008-9373-x; Hachez C, 2006, BBA-BIOMEMBRANES, V1758, P1142, DOI 10.1016/j.bbamem.2006.02.017; Heinen RB, 2009, J EXP BOT, V60, P2971, DOI 10.1093/jxb/erp171; Henzler T, 1999, PLANTA, V210, P50, DOI 10.1007/s004250050653; Hill AE, 2004, J MEMBRANE BIOL, V197, P1, DOI 10.1007/s00232-003-0639-6; Jang JY, 2004, PLANT MOL BIOL, V54, P713, DOI 10.1023/B:PLAN.0000040900.61345.a6; Javot H, 2002, ANN BOT-LONDON, V90, P301, DOI 10.1093/aob/mcf199; Javot H, 2003, PLANT CELL, V15, P509, DOI 10.1105/tpc.008888; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; Kaldenhoff R, 2008, PLANT CELL ENVIRON, V31, P658, DOI 10.1111/j.1365-3040.2008.01792.x; Kaldenhoff R, 2006, BBA-BIOMEMBRANES, V1758, P1134, DOI 10.1016/j.bbamem.2006.03.012; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Knight CD, 2002, PRACT APPROACH SER, V259, P285; Knipfer T, 2010, NEW PHYTOL, V187, P159, DOI 10.1111/j.1469-8137.2010.03240.x; Kramer P.J., 1983, WATER RELATIONS PLAN; Kramer P.J., 1995, WATER RELATIONS PLAN; Lopez M, 2003, PLANT CELL PHYSIOL, V44, P1384, DOI 10.1093/pcp/pcg168; Luu DT, 2005, PLANT CELL ENVIRON, V28, P85, DOI 10.1111/j.1365-3040.2004.01295.x; Ma N, 2008, PLANT PHYSIOL, V148, P894, DOI 10.1104/pp.108.120154; MacRobbie EAC, 2006, P NATL ACAD SCI USA, V103, P1135, DOI 10.1073/pnas.0510023103; Mahdieh M, 2008, PLANT CELL PHYSIOL, V49, P801, DOI 10.1093/pcp/pcn054; Mariaux JB, 1998, PLANT MOL BIOL, V38, P1089, DOI 10.1023/A:1006013130681; Martre P, 2002, PLANT PHYSIOL, V130, P2101, DOI 10.1104/pp.009019; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Maurel C, 2007, FEBS LETT, V581, P2227, DOI 10.1016/j.febslet.2007.03.021; Maurel C, 2010, J EXP BOT, V61, P3191, DOI 10.1093/jxb/erq150; Moshelion M, 2002, PLANT CELL, V14, P727, DOI 10.1105/tpc.010351; Mut P, 2008, PHYSIOL PLANTARUM, V132, P538, DOI 10.1111/j.1399-3054.2007.01046.x; Nardini A, 2005, PLANT CELL ENVIRON, V28, P750, DOI 10.1111/j.1365-3040.2005.01320.x; Oosumi T, 2006, PLANTA, V223, P1219, DOI 10.1007/s00425-005-0170-3; Parent B, 2009, PLANT PHYSIOL, V149, P2000, DOI 10.1104/pp.108.130682; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakurai-Ishikawa J, 2011, PLANT CELL ENVIRON, V34, P1150, DOI 10.1111/j.1365-3040.2011.02313.x; Sargent DJ, 2007, THEOR APPL GENET, V114, P373, DOI 10.1007/s00122-006-0441-9; Secchi F, 2007, ANN APPL BIOL, V150, P163, DOI 10.1111/j.1744-7348.2007.00118.x; Shulaev V, 2008, PLANT PHYSIOL, V147, P985, DOI 10.1104/pp.107.115618; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Steudle E, 1998, J EXP BOT, V49, P775, DOI 10.1093/jexbot/49.322.775; Sugaya S, 2003, ACTA HORTIC, P363, DOI 10.17660/ActaHortic.2003.618.42; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tardieu F, 2010, PLANT CELL ENVIRON, V33, P636, DOI 10.1111/j.1365-3040.2009.02091.x; Vandeleur RK, 2009, PLANT PHYSIOL, V149, P445, DOI 10.1104/pp.108.128645; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wallace IS, 2004, PLANT PHYSIOL, V135, P1059, DOI 10.1104/pp.103.033415	60	34	37	7	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74945	10.1371/journal.pone.0074945	http://dx.doi.org/10.1371/journal.pone.0074945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086403	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200058
J	Vite, A; Gandjbakhch, E; Prost, C; Fressart, V; Fouret, P; Neyroud, N; Gary, F; Donal, E; Varnous, S; Fontaine, G; Fornes, P; Hidden-Lucet, F; Komajda, M; Charron, P; Villard, E				Vite, Alexia; Gandjbakhch, Estelle; Prost, Catherine; Fressart, Veronique; Fouret, Pierre; Neyroud, Nathalie; Gary, Francoise; Donal, Erwan; Varnous, Shaida; Fontaine, Guy; Fornes, Paul; Hidden-Lucet, Francoise; Komajda, Michel; Charron, Philippe; Villard, Eric			Desmosomal Cadherins Are Decreased in Explanted Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patient Hearts	PLOS ONE			English	Article							DILATED CARDIOMYOPATHY; NUCLEAR PLAKOGLOBIN; MOLECULAR-GENETICS; CLINICAL IMPACT; NAXOS-DISEASE; WOOLLY HAIR; MUTATIONS; KERATODERMA; DYSPLASIA; DIAGNOSIS	Aims: Arrhythmogenic right ventricular Dysplasia/cardiomyopathy (ARVD/C) is an autosomal dominant inherited cardiomyopathy associated with ventricular arrhythmia, heart failure and sudden death. Genetic studies have demonstrated the central role of desmosomal proteins in this disease, where 50% of patients harbor a mutation in a desmosmal gene. However, clinical diagnosis of the disease remains difficult and molecular mechanisms appears heterogeneous and poorly understood. The aim of this study was to characterize the expression profile of desmosomal proteins in explanted ARVD/C heart samples, in order to identify common features of the disease. Methods and Results: We examined plakophilin-2, desmoglein-2, desmocollin-2, plakoglobin and beta-catenin protein expression levels from seven independent ARVD/C heart samples compared to two ischemic, five dilated cardiomyopathy and one healthy heart sample as controls. Ventricular and septum sections were examined by immunoblot analysis of total heart protein extracts and by immunostaining. Immunoblots indicated significant decreases in desmoglein-2 and desmocollin-2, independent of any known underlying mutations, whereas immune-histochemical analysis showed normal localization of all desmosomal proteins. Quantitative RT-PCR revealed normal DSG2 and DSC2 mRNA transcript levels, suggesting increased protein turn-over rather than transcriptional down regulation. Conclusion: Reduced cardiac desmoglein-2 and desmocollin-2 levels appear to be specifically associated with ARVD/C, independent of underlying mutations. These findings highlight a key role of desmosomal cadherins in the pathophysiology of ARVD/C. Whether these reductions could be considered as specific markers for ARVD/C requires replication analysis.	[Vite, Alexia; Gandjbakhch, Estelle; Fouret, Pierre; Neyroud, Nathalie; Gary, Francoise; Komajda, Michel; Charron, Philippe; Villard, Eric] Univ Paris, Hop Pitie Salpetriere, UPMC, F-75252 Paris, France; [Vite, Alexia; Gandjbakhch, Estelle; Neyroud, Nathalie; Gary, Francoise; Komajda, Michel; Charron, Philippe; Villard, Eric] Hop La Pitie Salpetriere, Inst Natl Sante & Rech Med UMR S956, ICAN, Paris, France; [Gandjbakhch, Estelle; Varnous, Shaida; Fontaine, Guy; Hidden-Lucet, Francoise; Komajda, Michel; Charron, Philippe] Hop La Pitie Salpetriere, Inst Cardiol AP HP, Paris, France; [Prost, Catherine] Univ Paris 08, Lab Histol & Therapie Gen, Bobigny, France; [Prost, Catherine] Univ Paris 05, Dept Pathol, Hop Necker Enfants Malad, Paris, France; [Fressart, Veronique] Hop La Pitie Salpetriere, Unite Cardiogenet, Serv Biochim Metabol, Paris, France; [Fouret, Pierre] Hop La Pitie Salpetriere, Serv Anat Pathol, Paris, France; [Donal, Erwan] Hop Pontchaillou, Dept Cardiol, Rennes, France; [Fornes, Paul] Hop Univ, Dept Pathol, F-51092 Reims, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris-VIII; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Rennes; CHU de Reims	Villard, E (corresponding author), Univ Paris, Hop Pitie Salpetriere, UPMC, F-75252 Paris, France.	eric.villard@upmc.fr	donal, erwan/ABC-9736-2020; Villard, Eric/AAI-2464-2021; Neyroud, Nathalie/D-1013-2017; villard, eric/AAH-2868-2021	Villard, Eric/0000-0001-9801-7297; Neyroud, Nathalie/0000-0003-3382-7680; Vite, Alexia/0000-0002-6589-8996; Charron, Philippe/0000-0002-1782-1118; gandjbakhch, estelle/0000-0002-4846-5021; hidden-lucet, francoise/0000-0003-1257-5357	Assistance Publique - Hopitaux de Paris (PHRC programme hospitalier de recherche clinique) [AOM05073]; Federation Francaise de Cardiologie; Societe francaise de cardiologie; Ligue contre la Cardiomyopathie	Assistance Publique - Hopitaux de Paris (PHRC programme hospitalier de recherche clinique); Federation Francaise de Cardiologie; Societe francaise de cardiologie; Ligue contre la Cardiomyopathie	This work was supported by grants from Assistance Publique - Hopitaux de Paris (PHRC programme hospitalier de recherche clinique AOM05073), "Federation Francaise de Cardiologie," "Societe francaise de cardiologie," and "Ligue contre la Cardiomyopathie". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asimaki A, 2007, AM J HUM GENET, V81, P964, DOI 10.1086/521633; Asimaki A, 2009, NEW ENGL J MED, V360, P1075, DOI 10.1056/NEJMoa0808138; Awad MM, 2008, NAT CLIN PRACT CARD, V5, P258, DOI 10.1038/ncpcardio1182; Basso C, 2006, EUR HEART J, V27, P1847, DOI 10.1093/eurheartj/ehl095; Basso C, 2009, LANCET, V373, P1289, DOI 10.1016/S0140-6736(09)60256-7; Calkins CC, 2006, J BIOL CHEM, V281, P7623, DOI 10.1074/jbc.M512447200; Christensen AH, 2010, J MED GENET, V47, P736, DOI 10.1136/jmg.2010.077891; Corrado D, 2006, CIRCULATION, V113, P1634, DOI 10.1161/CIRCULATIONAHA.105.616490; Delmar M, 2010, CIRC RES, V107, P700, DOI 10.1161/CIRCRESAHA.110.223412; Elliott P, 2010, CIRC-CARDIOVASC GENE, V3, P314, DOI 10.1161/CIRCGENETICS.110.937805; Fontaine G, 1999, ANNU REV MED, V50, P17, DOI 10.1146/annurev.med.50.1.17; Fontaine GH, 2011, EUR HEART J, V32, P1049, DOI 10.1093/eurheartj/ehr088; Fressart V, 2010, EUROPACE, V12, P861, DOI 10.1093/europace/euq104; Gaertner A, 2012, PHYSIOL GENOMICS, V44, P99, DOI 10.1152/physiolgenomics.00094.2011; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Gehmlich K, 2012, CARDIOVASC PATHOL, V21, P275, DOI 10.1016/j.carpath.2011.09.005; Gehmlich K, 2011, HEART RHYTHM, V8, P711, DOI 10.1016/j.hrthm.2011.01.010; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; Hulot JS, 2004, CIRCULATION, V110, P1879, DOI 10.1161/01.CIR.0000143375.93288.82; Jolly PS, 2010, J BIOL CHEM, V285, P8936, DOI 10.1074/jbc.M109.087999; Kaplan SR, 2004, HEART RHYTHM, V1, P3, DOI 10.1016/j.hrthm.2004.01.001; Kaplan SR, 2004, CARDIOVASC PATHOL, V13, P26, DOI 10.1016/S1054-8807(03)00107-8; Kim C, 2013, NATURE, V494, P105, DOI 10.1038/nature11799; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombardi R, 2011, CIRC RES, V109, P1342, DOI 10.1161/CIRCRESAHA.111.255075; Marcus FI, 2010, EUR HEART J, V31, P806, DOI [10.1093/eurheartj/ehq025, 10.1161/CIRCULATIONAHA.108.840827]; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Munkholm J, 2012, AM J CARDIOL, V109, P272, DOI 10.1016/j.amjcard.2011.08.044; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; Pilichou K, 2006, CIRCULATION, V113, P1171, DOI 10.1161/CIRCULATIONAHA.105.583674; Pilichou K, 2011, CIRC-CARDIOVASC GENE, V4, P318, DOI 10.1161/CIRCGENETICS.110.959031; Quarta G, 2011, CIRCULATION, V123, P2701, DOI 10.1161/CIRCULATIONAHA.110.976936; Thomason HA, 2010, BIOCHEM J, V429, P419, DOI 10.1042/BJ20100567; van Tintelen JP, 2007, CURR OPIN CARDIOL, V22, P185, DOI 10.1097/HCO.0b013e3280d942c4	36	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75082	10.1371/journal.pone.0075082	http://dx.doi.org/10.1371/journal.pone.0075082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086444	Green Submitted, Green Published, gold			2022-12-27	WOS:000326520200081
J	Andersen, JP; Silver, RC; Stewart, B; Koperwas, B; Kirschbaum, C				Andersen, Judith Pizarro; Silver, Roxane Cohen; Stewart, Brandon; Koperwas, Billie; Kirschbaum, Clemens			Psychological and Physiological Responses following Repeated Peer Death	PLOS ONE			English	Article							SUICIDAL BEHAVIORS; CORTISOL; HAIR; STRESS; TRAUMA; EXPERIENCES; CHILDHOOD; EXPOSURE; VICTIMS	Objective: Undergraduates at a university in the United States were exposed - directly and indirectly - to 14 peer deaths during one academic year. We examined how individual and social factors were associated with psychological (e.g., anxiety, depression, somatization) and physiological (i.e., cortisol) distress responses following this unexpected and repeated experience with loss. Method: Two to three months after the final peer death, respondents (N = 122, 61% female, 18-23 years, M = 20.13, SD = 1.14) reported prior adverse experiences, degree of closeness with the deceased, acute responses to the peer deaths, ongoing distress responses, social support, support seeking, and media viewing. A subset (n = 24) returned hair samples for evaluation of cortisol responses during the previous 3 months. Results: Ongoing psychological distress was associated with a) prior interpersonal trauma, b) fewer social supports, and c) media exposure to news of the deaths (p's<.05). Participants who had no prior bereavements showed, on average, high cortisol (>25 p/mg) compared to individuals with one or two prior bereavement experiences (who were, on average, within the normal range, 10 to 25 p/mg) (p<.05). Only 8% of the sample utilized available university psychological or physical health resources and support groups. Conclusions: Limited research has examined the psychological and physiological impact of exposure to chronic, repeated peer loss, despite the fact that there are groups of individuals (e.g., police, military soldiers) that routinely face such exposures. Prior adversity appears to play a role in shaping psychological and physiological responses to repeated loss. This topic warrants further research given the health implications of repeated loss for individuals in high-risk occupations and university settings.	[Andersen, Judith Pizarro] Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada; [Silver, Roxane Cohen] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA; [Stewart, Brandon] Harvard Univ, Dept Govt, Cambridge, MA 02138 USA; [Koperwas, Billie] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA; [Kirschbaum, Clemens] Tech Univ Dresden, Dept Psychol, D-01062 Dresden, Germany	University of Toronto; University Toronto Mississauga; University of California System; University of California Irvine; Harvard University; Cornell University; Technische Universitat Dresden	Andersen, JP (corresponding author), Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada.	judith.andersen@utoronto.ca	Kirschbaum, Clemens/AAB-1752-2020; Stewart, Brandon Michael/ADW-8389-2022					Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Beautrais AL, 1997, J AM ACAD CHILD PSY, V36, P1543, DOI 10.1016/S0890-8567(09)66563-1; Boden JM, 2007, PSYCHOL MED, V37, P431, DOI 10.1017/S0033291706009147; BORNSTEIN PE, 1973, BRIT J PSYCHIAT, V122, P561, DOI 10.1192/bjp.122.5.561; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Calcagno V, 2010, J STAT SOFTW, V34, P1; D'Andrea Wendy, 2011, J Am Psychiatr Nurses Assoc, V17, P378, DOI 10.1177/1078390311425187; Davenport MD, 2006, GEN COMP ENDOCR, V147, P255, DOI 10.1016/j.ygcen.2006.01.005; Derogatis LR, 2001, BSI 18 ADM SCORING P; Dougall AL, 2000, J CONSULT CLIN PSYCH, V68, P290, DOI 10.1037/0022-006X.68.2.290; Gow R, 2010, FORENSIC SCI INT, V196, P32, DOI 10.1016/j.forsciint.2009.12.040; Grills-Taquechel AE, 2011, J ANXIETY DISORD, V25, P498, DOI 10.1016/j.janxdis.2010.12.003; Heim C, 2001, AM J PSYCHIAT, V158, P575, DOI 10.1176/appi.ajp.158.4.575; Holman EA, 2008, ARCH GEN PSYCHIAT, V65, P73, DOI 10.1001/archgenpsychiatry.2007.6; Honaker J, 2011, J STAT SOFTW, V45, P1; Hughes M, 2011, PSYCHOL TRAUMA-US, V3, P403, DOI 10.1037/a0024565; Karlen J, 2011, BMC CLIN PATHOL, V11, DOI 10.1186/1472-6890-11-12; McKeown RE, 1998, J AM ACAD CHILD PSY, V37, P612, DOI 10.1097/00004583-199806000-00011; NORRIS FH, 1988, AM J COMMUN PSYCHOL, V16, P665, DOI 10.1007/BF00930020; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Pereg D, 2011, STRESS, V14, P73, DOI 10.3109/10253890.2010.511352; Pfefferbaum B, 2001, PSYCHIATRY, V64, P202, DOI 10.1521/psyc.64.3.202.18462; Pizarro J, 2006, ARCH GEN PSYCHIAT, V63, P193, DOI 10.1001/archpsyc.63.2.193; R Core Team, 2021, R LANGUAGE ENV STAT; RESNICK HS, 1995, AM J PSYCHIAT, V152, P1675; Seery MD, 2010, J PERS SOC PSYCHOL, V99, P1025, DOI 10.1037/a0021344; Silver RC, 2013, PSYCHOL SCI, V24, P1623, DOI 10.1177/0956797612460406; Stalder T, 2012, BRAIN BEHAV IMMUN, V26, P1019, DOI 10.1016/j.bbi.2012.02.002; Stalder T, 2012, BIOL PSYCHOL, V90, P218, DOI 10.1016/j.biopsycho.2012.03.010; Stalder T, 2012, PSYCHONEUROENDOCRINO, V37, P602, DOI 10.1016/j.psyneuen.2011.08.007; Wayment HA, 2004, PERS SOC PSYCHOL B, V30, P515, DOI 10.1177/0146167203261892	31	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75881	10.1371/journal.pone.0075881	http://dx.doi.org/10.1371/journal.pone.0075881			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228WY	24086655	Green Published, gold			2022-12-27	WOS:000325223900066
J	Krezymon, A; Richetin, K; Halley, H; Roybon, L; Lassalle, JM; Frances, B; Verret, L; Rampon, C				Krezymon, Alice; Richetin, Kevin; Halley, Helene; Roybon, Laurent; Lassalle, Jean-Michel; Frances, Bernard; Verret, Laure; Rampon, Claire			Modifications of Hippocampal Circuits and Early Disruption of Adult Neurogenesis in the Tg2576 Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							INDUCED NEURONAL DYSFUNCTION; DENTATE GRANULE CELLS; AMYLOID-BETA PROTEIN; NEUROPEPTIDE-Y; COGNITIVE IMPAIRMENTS; TRANSGENIC MICE; A-BETA; MEMORY; BRAIN; GYRUS	At advanced stages of Alzheimer's disease, cognitive dysfunction is accompanied by severe alterations of hippocampal circuits that may largely underlie memory impairments. However, it is likely that anatomical remodeling in the hippocampus may start long before any cognitive alteration is detected. Using the well-described Tg2576 mouse model of Alzheimer's disease that develops progressive age-dependent amyloidosis and cognitive deficits, we examined whether specific stages of the disease were associated with the expression of anatomical markers of hippocampal dysfunction. We found that these mice develop a complex pattern of changes in their dentate gyrus with aging. Those include aberrant expression of neuropeptide Y and reduced levels of calbindin, reflecting a profound remodeling of inhibitory and excitatory circuits in the dentate gyrus. Preceding these changes, we identified severe alterations of adult hippocampal neurogenesis in Tg2576 mice. We gathered converging data in Tg2576 mice at young age, indicating impaired maturation of new neurons that may compromise their functional integration into hippocampal circuits. Thus, disruption of adult hippocampal neurogenesis occurred before network remodeling in this mouse model and therefore may account as an early event in the etiology of Alzheimer's pathology. Ultimately, both events may constitute key components of hippocampal dysfunction and associated cognitive deficits occurring in Alzheimer's disease.	[Krezymon, Alice; Richetin, Kevin; Halley, Helene; Lassalle, Jean-Michel; Frances, Bernard; Verret, Laure; Rampon, Claire] Univ Toulouse UPS, Ctr Rech Cognit Anim, Toulouse, France; [Krezymon, Alice; Richetin, Kevin; Halley, Helene; Lassalle, Jean-Michel; Frances, Bernard; Verret, Laure; Rampon, Claire] Ctr Rech Cognit Anim, CNRS, Toulouse, France; [Roybon, Laurent] Lund Univ, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Lund, Sweden	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Lund University	Rampon, C (corresponding author), Univ Toulouse UPS, Ctr Rech Cognit Anim, Toulouse, France.	claire.rampon@univ-tlse3.fr	Verret, Laure/D-2219-2011; Verret, Laure/D-9224-2017; Richetin, kevin/R-2040-2016	Verret, Laure/0000-0001-5272-6063; Verret, Laure/0000-0001-5272-6063; Richetin, kevin/0000-0001-7859-9517; rampon, claire/0000-0001-8551-8682	Agence Nationale pour la Recherche [ANR-06-JCJC, ANR-10-05-MALZ]; Centre National de la Recherche Scientifique (CNRS); University of Toulouse; Region Midi-Pyrenees; France Alzheimer Association; Singer-Polignac Foundation; Philippe Foundation Awards; French Ministry of Research	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University of Toulouse; Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); France Alzheimer Association; Singer-Polignac Foundation; Philippe Foundation Awards; French Ministry of Research(Ministry of Research, FranceEuropean Commission)	C. Rampon acknowledges the support of the Agence Nationale pour la Recherche (ANR-06-JCJC and ANR-10-05-MALZ); the Centre National de la Recherche Scientifique (CNRS), the University of Toulouse, and the Region Midi-Pyrenees; L. Verret was supported by ANR-06-JCJC, the France Alzheimer Association, the Singer-Polignac Foundation, and the Philippe Foundation Awards. A. Krezymon and K. Richetin were supported by the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017669; Alpar A, 2006, BRAIN RES, V1099, P189, DOI 10.1016/j.brainres.2006.04.109; Arendash GW, 2002, PHYSIOL BEHAV, V75, P643, DOI 10.1016/S0031-9384(02)00640-6; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Busche MA, 2012, P NATL ACAD SCI USA, V109, P8740, DOI 10.1073/pnas.1206171109; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Cotel MC, 2008, BRAIN RES, V1222, P207, DOI 10.1016/j.brainres.2008.05.052; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Couillard-Despres S, 2011, GERONTOLOGY, V57, P559, DOI 10.1159/000323481; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dickey CA, 2003, J NEUROSCI, V23, P5219; Dong H, 2004, NEUROSCIENCE, V127, P601, DOI 10.1016/j.neuroscience.2004.05.040; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Faure A, 2011, NEUROBIOL AGING, V32, P407, DOI 10.1016/j.neurobiolaging.2009.03.009; Freir DB, 2011, NEUROBIOL AGING, V32, P2211, DOI 10.1016/j.neurobiolaging.2010.01.001; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; He P, 2009, J NEUROSCI, V29, P6545, DOI 10.1523/JNEUROSCI.0421-09.2009; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Ihunwo AO, 2010, ACTA NEUROBIOL EXP, V70, P362; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Klinger M, 2003, INT J DEV NEUROSCI, V21, P357, DOI 10.1016/j.ijdevneu.2003.08.001; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lanz TA, 2003, NEUROBIOL DIS, V13, P246, DOI 10.1016/S0969-9961(03)00079-2; Lassalle JM, 2008, BEHAV BRAIN RES, V191, P104, DOI 10.1016/j.bbr.2008.03.017; Lazarov O, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00081; Lazarov O, 2010, EXP NEUROL, V223, P267, DOI 10.1016/j.expneurol.2009.08.009; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lopez-Toledano MA, 2004, J NEUROSCI, V24, P5439, DOI 10.1523/JNEUROSCI.0974-04.2004; Marin-Burgin A, 2012, BEHAV BRAIN RES, V227, P391, DOI 10.1016/j.bbr.2011.07.001; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Mitchell JC, 2009, HUM MOL GENET, V18, P4492, DOI 10.1093/hmg/ddp408; Morgenstern NA, 2013, MOL CELL NEUROSCI, V56, P298, DOI 10.1016/j.mcn.2013.07.003; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Palop JJ, 2005, J NEUROSCI, V25, P9686, DOI 10.1523/JNEUROSCI.2829-05.2005; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Palop JJ, 2010, NEUROMOL MED, V12, P48, DOI 10.1007/s12017-009-8097-7; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Pathania M, 2010, NEUROPHARMACOLOGY, V58, P865, DOI 10.1016/j.neuropharm.2010.01.010; Perez-Cruz C, 2011, J NEUROSCI, V31, P3926, DOI 10.1523/JNEUROSCI.6142-10.2011; Popovic M, 2008, NEUROSCIENCE, V155, P182, DOI 10.1016/j.neuroscience.2008.05.023; Rabinovici GD, 2009, BEHAV NEUROL, V21, P117, DOI [10.3233/BEN-2009-0232, 10.1155/2009/609839]; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Roybon L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004779; Sala C, 2002, NEUROSIGNALS, V11, P213, DOI 10.1159/000065433; Scharfman HE, 2006, EXP SUPPL, V95, P193; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; Song J, 2012, DEV NEUROBIOL, V72, P1032, DOI 10.1002/dneu.22014; SPERK G, 1992, NEUROSCIENCE, V50, P831, DOI 10.1016/0306-4522(92)90207-I; Sperk G, 2007, PROG BRAIN RES, V163, P285, DOI 10.1016/S0079-6123(07)63017-9; Stewart S, 2011, J ALZHEIMERS DIS, V26, P105, DOI 10.3233/JAD-2011-101827; SUN B, 2009, CELL STEM CELL, V6, P10; Sun BG, 2009, CELL STEM CELL, V5, P624, DOI 10.1016/j.stem.2009.10.003; Takahashi H, 2010, BRAIN STRUCT FUNCT, V214, P145, DOI 10.1007/s00429-010-0242-4; Trouche S, 2009, P NATL ACAD SCI USA, V106, P5919, DOI 10.1073/pnas.0811054106; Unger C, 2005, MOL CELL NEUROSCI, V30, P218, DOI 10.1016/j.mcn.2005.07.012; Verret L, 2007, PSYCHONEUROENDOCRINO, V32, pS26, DOI 10.1016/j.psyneuen.2007.04.014; Verret L, 2007, J NEUROSCI, V27, P6771, DOI 10.1523/JNEUROSCI.5564-06.2007; Verret L, 2013, NEUROBIOL AGING, V34, P211, DOI 10.1016/j.neurobiolaging.2012.05.013; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Vezzani A, 1999, TRENDS NEUROSCI, V22, P25, DOI 10.1016/S0166-2236(98)01284-3; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	74	58	61	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76497	10.1371/journal.pone.0076497	http://dx.doi.org/10.1371/journal.pone.0076497			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086745	Green Published, Green Submitted, gold			2022-12-27	WOS:000325223900103
J	Ko, BS; Lu, YJ; Yao, WL; Liu, TA; Tzean, SS; Shen, TL; Liou, JY				Ko, Bor-Sheng; Lu, Yi-Jhu; Yao, Wen-Ling; Liu, Tzu-An; Tzean, Shean-Shong; Shen, Tang-Long; Liou, Jun-Yang			Cordycepin Regulates GSK-3 beta/beta-Catenin Signaling in Human Leukemia Cells	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; ACUTE MYELOID-LEUKEMIA; MOUSE MELANOMA-CELLS; BETA-CATENIN; STEM-CELLS; CARCINOMA CELLS; WNT; EXPRESSION; 3'-DEOXYADENOSINE; METASTASIS	Background: Leukemia stem cells (LSCs) are a limitless cell source for the initiation and maintenance of leukemia. Activation of the Wnt/beta-catenin pathway is required for the survival and development of LSCs. Therefore, targeting beta-catenin is considered a therapeutic strategy for the treatment of leukemia. The goal of this study was to explore whether cordycepin, an active component of the traditional medicine Cordyceps sinensis, regulates beta-catenin expression in leukemia cells. Methodology and Principal Findings: In this study, we found that cordycepin significantly suppressed cell proliferation in all malignant cancer cells, including U937, K562, A549, HepG2, SK-Hep1 and MCF7 in a dose-dependent manner. However, cordycepin reduced beta-catenin levels in U937, K562 and THP1 leukemia cells and had no effect on other solid cancer cells. In addition, treatment with cordycepin significantly suppressed leukemia colony formation in soft agar assay. Cordycepin enhanced proteasome-dependent degradation and inhibited nuclear translocation of beta-catenin in leukemia cells. Cordycepin-reduced beta-catenin stability was restored by the addition of a pharmacological inhibitor of GSK-3 beta, indicating that cordycepin-suppressed beta-catenin stability is mediated by the activation of GSK-3 beta. Furthermore, cordycepin abolished the effect of Wnt3a-induced beta-catenin in leukemia cells. In addition, cordycepin-impaired beta-catenin is regulated by Akt activation but is not significantly influenced by AMPK or mTOR signal pathways. Significance: Our findings show for the first time that codycepin selectively reduces beta-catenin stability in leukemia but not in other solid tumor cells. This suppressive effect is mediated by regulating GSK-3 beta. A synergistic combination of cordycepin with other treatments should be used as a novel strategy to eradicate leukemia via elimination of LSCs.	[Ko, Bor-Sheng; Lu, Yi-Jhu; Yao, Wen-Ling; Liu, Tzu-An; Liou, Jun-Yang] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Ko, Bor-Sheng] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Yao, Wen-Ling; Tzean, Shean-Shong; Shen, Tang-Long] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan; [Liou, Jun-Yang] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; China Medical University Taiwan	Liou, JY (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan.	jliou@nhri.org.tw	Liou, Jun-Yang/B-1065-2010	KO, BOR-SHENG/0000-0002-7965-7579; Shen, Tang-Long/0000-0001-6264-3608	National Health Research Institutes [01A1-CSPP07-014, 01A1-CSPP16-014]; National Science Council of Taiwan [101-2321-B-400-011, 100-2314-B-002-062]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by The National Health Research Institutes (01A1-CSPP07-014, 01A1-CSPP16-014) and The National Science Council (101-2321-B-400-011, 100-2314-B-002-062) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buenz EJ, 2005, J ETHNOPHARMACOL, V96, P19, DOI 10.1016/j.jep.2004.09.029; Chang TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040193; Chen LS, 2008, BRIT J HAEMATOL, V140, P682, DOI 10.1111/j.1365-2141.2007.06955.x; Chen Y, 2010, J AGR FOOD CHEM, V58, P11645, DOI 10.1021/jf1028976; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eaves CJ, 2010, NEW ENGL J MED, V362, P2326, DOI 10.1056/NEJMcibr1003522; Heidel FH, 2012, CELL STEM CELL, V10, P412, DOI 10.1016/j.stem.2012.02.017; Hu Y, 2009, LEUKEMIA, V23, P109, DOI 10.1038/leu.2008.262; Jen CY, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nen084; Jeong JW, 2011, TOXICOL IN VITRO, V25, P817, DOI 10.1016/j.tiv.2011.02.001; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kleber M, 2004, CURR OPIN CELL BIOL, V16, P681, DOI 10.1016/j.ceb.2004.08.006; Kleppe M, 2012, CELL STEM CELL, V10, P351, DOI 10.1016/j.stem.2012.03.006; Ko BS, 2010, LIFE SCI, V86, P199, DOI 10.1016/j.lfs.2009.12.003; Kodama EN, 2000, BIOCHEM PHARMACOL, V59, P273, DOI 10.1016/S0006-2952(99)00325-1; Kunnev D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-318; Lee EJ, 2010, PHYTOTHER RES, V24, P1755, DOI 10.1002/ptr.3132; Lee HJ, 2012, INVEST NEW DRUG, V30, P1917, DOI 10.1007/s10637-012-9859-x; Lee SJ, 2010, FOOD CHEM TOXICOL, V48, P277, DOI 10.1016/j.fct.2009.09.042; Lee SJ, 2009, ARCH BIOCHEM BIOPHYS, V490, P103, DOI 10.1016/j.abb.2009.09.001; Liu TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057968; Liu TA, 2011, AM J PATHOL, V179, P2698, DOI 10.1016/j.ajpath.2011.08.010; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Matsuda H, 2009, CHEM PHARM BULL, V57, P411, DOI 10.1248/cpb.57.411; Nakamura K, 2006, ANTICANCER RES, V26, P43; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; OLSSON I, 1983, CANCER RES, V43, P5862; Paterson RRM, 2008, PHYTOCHEMISTRY, V69, P1469, DOI 10.1016/j.phytochem.2008.01.027; Rodman LE, 1997, TOXICOL APPL PHARM, V147, P39, DOI 10.1006/taap.1997.8264; Soman G, 2009, J IMMUNOL METHODS, V348, P83, DOI 10.1016/j.jim.2009.07.010; Thomadaki H, 2008, CANCER CHEMOTH PHARM, V61, P703, DOI 10.1007/s00280-007-0533-5; Wang PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010202; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Wehbe-Janek H, 2007, ANTICANCER RES, V27, P3143; Wong YY, 2010, J BIOL CHEM, V285, P2610, DOI 10.1074/jbc.M109.071159; Wu WC, 2007, CANCER CHEMOTH PHARM, V60, P103, DOI 10.1007/s00280-006-0354-y; Yoshikawa N, 2008, N-S ARCH PHARMACOL, V377, P591, DOI 10.1007/s00210-007-0218-y; Yoshikawa N, 2009, ANTICANCER RES, V29, P3857; Ysebaert L, 2006, LEUKEMIA, V20, P1211, DOI 10.1038/sj.leu.2404239; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	41	31	32	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76320	10.1371/journal.pone.0076320	http://dx.doi.org/10.1371/journal.pone.0076320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086728	Green Submitted, gold, Green Published			2022-12-27	WOS:000325220000063
J	Carbonnelle, D; Vignard, V; Sehedic, D; Moreau-Aubry, A; Florenceau, L; Charpentier, M; Mikulits, W; Labarriere, N; Lang, F				Carbonnelle, Delphine; Vignard, Virginie; Sehedic, Delphine; Moreau-Aubry, Agnes; Florenceau, Laetitia; Charpentier, Maud; Mikulits, Wolfgang; Labarriere, Nathalie; Lang, Francois			The Melanoma Antigens MELOE-1 and MELOE-2 Are Translated from a Bona Fide Polycistronic mRNA Containing Functional IRES Sequences	PLOS ONE			English	Article							OPEN READING FRAME; DROSOPHILA-MELANOGASTER; MEDIATED TRANSLATION; CANCER ANTIGEN; LAMININ B1; T-CELLS; REGION; GENE; IMMUNOTHERAPY; ENTRY	Our previous studies on melanoma antigens identified two new polypeptides, named MELOE-1 and MELOE-2, that are involved in immunosurveillance. Intriguingly, these antigens are coded by distinct open reading frames (ORF) of the meloe mRNA which is significantly expressed only in the melanocytic lineage. In addition, MELOE-1 and -2 specific T cell clones recognized melanoma cells but very poorly normal melanocytes suggesting differential translation of meloe in normal vs tumor cells. This prompted us to elucidate the mechanisms of translation of these antigens in melanoma cells. We first demonstrated that no splicing event or cryptic promoter could generate shorter meloe transcripts containing only one of the two ORFs. Triggering meloe RNA degradation with a siRNA close to the ORF coding for MELOE-2 abrogated expression of both MELOE-1 and MELOE-2, thus confirming that the two ORFs are always associated. Next we showed, in a bicistronic reporter system, that IRES activities could be detected upstream of MELOE-1 and MELOE-2 and finally confirmed their translation from full length meloe cDNA in melanoma cells with eGFP constructs. In conclusion, meloe is a polycistronic mRNA that generates both MELOE-1 and MELOE-2 antigens through IRES-dependent translation in melanoma cells and that may explain their tumor specificity.	[Carbonnelle, Delphine; Vignard, Virginie; Sehedic, Delphine; Moreau-Aubry, Agnes; Florenceau, Laetitia; Charpentier, Maud; Labarriere, Nathalie; Lang, Francois] INSERM, U892, Nantes, France; [Carbonnelle, Delphine; Vignard, Virginie; Sehedic, Delphine; Moreau-Aubry, Agnes; Florenceau, Laetitia; Charpentier, Maud; Labarriere, Nathalie; Lang, Francois] Univ Nantes, Nantes, France; [Carbonnelle, Delphine; Vignard, Virginie; Sehedic, Delphine; Moreau-Aubry, Agnes; Florenceau, Laetitia; Charpentier, Maud; Labarriere, Nathalie; Lang, Francois] CNRS, UMR 6299, Nantes, France; [Vignard, Virginie] CHU Nantes, F-44035 Nantes 01, France; [Mikulits, Wolfgang] Ctr Comprehens Canc, Inst Canc Res, Vienna, Austria	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; CHU de Nantes	Lang, F (corresponding author), INSERM, U892, Nantes, France.	francois.lang@univ-nantes.fr	Vignard, Virginie/K-7540-2015; Charpentier, Maud/K-6843-2015; Mikulits, Wolfgang/AAH-4043-2021; Florenceau, Laetitia/K-7428-2015; Aubry, Agnes/K-8771-2015; LANG, François/K-7403-2015; Labarriere, Nathalie/H-8876-2015	Vignard, Virginie/0000-0002-6702-2824; Florenceau, Laetitia/0000-0003-1284-414X; LANG, François/0000-0002-0762-4647; Labarriere, Nathalie/0000-0002-1407-6546; Mikulits, Wolfgang/0000-0003-4612-7106; MOREAU-AUBRY, Agnes/0000-0001-5540-3374	Association pour la Recherche sur le Cancer [SFI20111203534]	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by grant #SFI20111203534 from the Association pour la Recherche sur le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse CA, 1999, INT J CANCER, V82, P442, DOI 10.1002/(SICI)1097-0215(19990730)82:3<442::AID-IJC19>3.3.CO;2-Q; Andrews J, 1996, GENETICS, V143, P1699; Brogna S, 1997, EMBO J, V16, P2023, DOI 10.1093/emboj/16.8.2023; Butterfield LH, 1997, GENE, V191, P129, DOI 10.1016/S0378-1119(96)00789-5; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; Godet Y, 2008, J EXP MED, V205, P2673, DOI 10.1084/jem.20081356; Godet Y, 2010, EUR J IMMUNOL, V40, P1786, DOI 10.1002/eji.200940132; Godet Y, 2010, CANCER IMMUNOL IMMUN, V59, P431, DOI 10.1007/s00262-009-0762-z; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; Holcik M, 2005, RNA, V11, P1605, DOI 10.1261/rna.2158605; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Jean D, 2008, BIOCHEM J, V413, P125, DOI 10.1042/BJ20071255; Kanamori Y, 2010, J BIOL CHEM, V285, P36933, DOI 10.1074/jbc.M110.180398; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Kozak M, 2007, GENE, V403, P194, DOI 10.1016/j.gene.2007.08.017; LEE SJ, 1991, P NATL ACAD SCI USA, V88, P4250, DOI 10.1073/pnas.88.10.4250; Liu H, 2000, GENETICS, V154, P1735; Moreau-Aubry A, 2000, J EXP MED, V191, P1617, DOI 10.1084/jem.191.9.1617; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Petz M, 2007, NUCLEIC ACIDS RES, V35, P2473, DOI 10.1093/nar/gkm096; Petz M, 2012, NUCLEIC ACIDS RES, V40, P290, DOI 10.1093/nar/gkr717; Ramanathan P, 2008, RNA BIOL, V5, P149, DOI 10.4161/rna.5.3.6676; Reiss J, 1999, AM J HUM GENET, V64, P706, DOI 10.1086/302296; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Rosenberg SA, 2002, J IMMUNOL, V168, P2402, DOI 10.4049/jimmunol.168.5.2402; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Starck SR, 2011, CELL MOL LIFE SCI, V68, P1471, DOI 10.1007/s00018-011-0655-0; Tautz Diethard, 2009, Briefings in Functional Genomics & Proteomics, V8, P68, DOI 10.1093/bfgp/eln054; van der Bruggen P, 2013, CANC IMMUN; Wall AA, 2005, J BIOL CHEM, V280, P27670, DOI 10.1074/jbc.M500255200; Wang RF, 1996, J EXP MED, V183, P1131, DOI 10.1084/jem.183.3.1131; Wang RF, 1998, J IMMUNOL, V161, P3596; Xiong Z, 2006, J IMMUNOL, V177, P4907, DOI 10.4049/jimmunol.177.7.4907	35	21	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75233	10.1371/journal.pone.0075233	http://dx.doi.org/10.1371/journal.pone.0075233			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086473	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700058
J	Cong, ZJ; Hu, LH; Bian, ZQ; Ye, GY; Yu, MH; Gao, YH; Li, ZS; Yu, ED; Zhong, M				Cong, Zhi-Jie; Hu, Liang-Hao; Bian, Zheng-Qian; Ye, Guang-Yao; Yu, Min-Hao; Gao, Yun-He; Li, Zhao-Shen; Yu, En-Da; Zhong, Ming			Systematic Review of Anastomotic Leakage Rate According to an International Grading System Following Anterior Resection for Rectal Cancer	PLOS ONE			English	Review							TOTAL MESORECTAL EXCISION; RISK-FACTORS; DEFUNCTIONING STOMA; COLORECTAL ANASTOMOSIS; J-POUCH; LAPAROSCOPIC RESECTION; COLOANAL ANASTOMOSIS; LOOP ILEOSTOMY; COLONIC POUCH; SURGERY	Background: A generally acceptable definition and a severity grading system for anastomotic leakages (ALs) following rectal resection were not available until 2010, when the International Study Group of Rectal Cancer (ISGRC) proposed a definition and a grading system for AL. Methods: A search for published data was performed using the MEDLINE database (2000 to December 5, 2012) to perform a systematic review of the studies that described AL, grade AL according to the grading system, pool data, and determine the average rate of AL for each grade after anterior resection (AR) for rectal cancer. Results: A total of 930 abstracts were retrieved; 40 articles on AR, 25 articles on low AR (LAR), and 5 articles on ultralow AR (ULAR) were included in the review and analysis. The pooled overall AL rate of AR was 8.58% (2,085/24,288); the rate of the asymptomatic leakage (Grade A) was 2.57%, that of AL that required active intervention without relaparotomy (Grade B) was 2.37%, and that of AL that required relaparotomy (Grade C) was 5.40%. The pooled rate of AL that required relaparotomy was higher in AR (5.40%) than in LAR (4.70%) and in ULAR (1.81%), which could be attributed to the higher rate of protective defunctioning stoma in LAR (40.72%) and ULAR (63.44%) compared with that in AR (30.11%). Conclusions: The new grading system is simple that the ALs of each grade can be easily extracted from past publications, therefore likely to be accepted and applied in future studies.	[Cong, Zhi-Jie; Bian, Zheng-Qian; Ye, Guang-Yao; Yu, Min-Hao; Gao, Yun-He; Zhong, Ming] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Colorectal Surg, Shanghai 200030, Peoples R China; [Cong, Zhi-Jie; Hu, Liang-Hao; Li, Zhao-Shen; Yu, En-Da] Second Mil Med Univ, Changhai Hosp, Digest Endoscopy Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University; Naval Medical University	Yu, ED (corresponding author), Second Mil Med Univ, Changhai Hosp, Digest Endoscopy Ctr, Shanghai, Peoples R China.	dryuenda@gmail.com; drzhongm@126.com	ye, guangyao/AAV-9151-2021					Akagi T, 2012, SURG LAPARO ENDO PER, V22, P52, DOI 10.1097/SLE.0b013e31824019fc; Akasu T, 2010, J GASTROINTEST SURG, V14, P104, DOI 10.1007/s11605-009-1067-4; Akiyoshi T, 2011, AM J SURG, V202, P259, DOI 10.1016/j.amjsurg.2010.11.014; Beirens K, 2012, ACTA CHIR BELG, V112, P10, DOI 10.1080/00015458.2012.11680789; Bell SW, 2003, BRIT J SURG, V90, P1261, DOI 10.1002/bjs.4219; Bennis M, 2012, ANN SURG, V255, P504, DOI 10.1097/SLA.0b013e31824485c4; Bianchi PP, 2007, DIS COLON RECTUM, V50, P2047, DOI 10.1007/s10350-007-9055-9; Biondo S, 2013, SURGERY, V153, P383, DOI 10.1016/j.surg.2012.08.012; Bittorf B, 2003, LANGENBECK ARCH SURG, V387, P406, DOI 10.1007/s00423-003-0349-7; Brennan DJ, 2007, DIS COLON RECTUM, V50, P302, DOI 10.1007/10350-006-0811-z; Bretagnol F, 2007, BRIT J SURG, V94, P1266, DOI 10.1002/bjs.5524; Chamlou R, 2007, ANN SURG, V246, P916, DOI 10.1097/SLA.0b013e31815c29ff; Chen WR, 2011, J SURG ONCOL, V104, P493, DOI 10.1002/jso.21965; Choi Dong Hyun, 2010, J Korean Soc Coloproctol, V26, P265, DOI 10.3393/jksc.2010.26.4.265; Chude GG, 2008, HEPATO-GASTROENTEROL, V55, P1562; Cong ZJ, 2009, WORLD J SURG, V33, P1292, DOI 10.1007/s00268-009-0008-4; Dehni N, 1998, BRIT J SURG, V85, P1114; den Dulk M, 2009, BRIT J SURG, V96, P1066, DOI 10.1002/bjs.6694; Eberl T, 2008, AM J SURG, V196, P592, DOI 10.1016/j.amjsurg.2007.10.023; Eckmann C, 2004, INT J COLORECTAL DIS, V19, P128, DOI 10.1007/s00384-003-0498-8; Eriksen MT, 2005, COLORECTAL DIS, V7, P51, DOI 10.1111/j.1463-1318.2004.00700.x; Ferenschild FTJ, 2009, INT J COLORECTAL DIS, V24, P923, DOI 10.1007/s00384-009-0732-0; Fouda E, 2011, J GASTROINTEST SURG, V15, P137, DOI 10.1007/s11605-010-1364-y; Fujita S, 2012, LANCET ONCOL, V13, P616, DOI 10.1016/S1470-2045(12)70158-4; Fukunaga Y, 2010, SURG ENDOSC, V24, P145, DOI 10.1007/s00464-009-0551-y; Gastinger I, 2005, BRIT J SURG, V92, P1137, DOI 10.1002/bjs.5045; Glancy DG, 2012, COLORECTAL DIS, V14, P453, DOI 10.1111/j.1463-1318.2011.02682.x; GOLIGHER JC, 1977, BRIT J SURG, V64, P609, DOI 10.1002/bjs.1800640902; Gong H, 2013, CELL BIOCHEM BIOPHYS, V65, P491, DOI 10.1007/s12013-012-9445-z; Hallbook O, 1996, BRIT J SURG, V83, P60, DOI 10.1002/bjs.1800830119; Ho YH, 2002, ANN SURG, V236, P49, DOI 10.1097/00000658-200207000-00009; Ito M, 2008, INT J COLORECTAL DIS, V23, P703, DOI 10.1007/s00384-008-0470-8; Joh YG, 2009, DIS COLON RECTUM, V52, P91, DOI 10.1007/DCR.0b013e3181973d7f; Jung SH, 2008, DIS COLON RECTUM, V51, P902, DOI 10.1007/s10350-008-9272-x; Kanellos D, 2010, TECH COLOPROCTOL, V14, pS35, DOI 10.1007/s10151-010-0620-1; Kanellos I, 2004, Tech Coloproctol, V8 Suppl 1, ps79, DOI 10.1007/s10151-004-0119-8; Kanellos I, 2002, Tech Coloproctol, V6, P153, DOI 10.1007/s101510200035; Khalil El-Sayed Ashraf, 2004, J Egypt Natl Canc Inst, V16, P210; Kim JS, 2009, J AM COLL SURGEONS, V209, P694, DOI 10.1016/j.jamcollsurg.2009.09.021; Kim SH, 2008, DIS COLON RECTUM, V51, P844, DOI 10.1007/s10350-008-9256-x; Kruschewski M, 2011, COLORECTAL DIS, V13, P284, DOI 10.1111/j.1463-1318.2009.02140.x; Kruschewski M, 2007, INT J COLORECTAL DIS, V22, P919, DOI 10.1007/s00384-006-0260-0; Law WL, 2004, SURG ENDOSC, V18, P1592, DOI 10.1007/s00464-003-9249-8; Law WL, 2000, AM J SURG, V179, P92, DOI 10.1016/S0002-9610(00)00252-X; Lee MR, 2006, HEPATO-GASTROENTEROL, V53, P682; Leester B, 2002, Acta Chir Iugosl, V49, P67; Lefebure B, 2008, INT J COLORECTAL DIS, V23, P283, DOI 10.1007/s00384-007-0380-1; Lin JK, 2011, J GASTROINTEST SURG, V15, P2251, DOI 10.1007/s11605-011-1721-5; Liu HB, 2011, INT SURG, V96, P13; Maggiori L, 2011, COLORECTAL DIS, V13, P632, DOI 10.1111/j.1463-1318.2010.02252.x; Marusch F, 2002, DIS COLON RECTUM, V45, P1164, DOI 10.1007/s10350-004-6384-9; Matthiessen P, 2004, Colorectal Dis, V6, P462, DOI 10.1111/j.1463-1318.2004.00657.x; Matthiessen P, 2007, ANN SURG, V246, P207, DOI 10.1097/SLA.0b013e3180603024; Merkel S, 2001, Colorectal Dis, V3, P154, DOI 10.1046/j.1463-1318.2001.00232.x; Miyajima N, 2009, SURG ENDOSC, V23, P113, DOI 10.1007/s00464-008-0078-7; Mroczkowski Pawel, 2011, Pol Przegl Chir, V83, P144, DOI 10.2478/v10035-011-0022-8; Nesbakken A, 2005, COLORECTAL DIS, V7, P576, DOI 10.1111/j.1463-1318.2005.00870.x; Nesbakken A, 2001, BRIT J SURG, V88, P400, DOI 10.1046/j.1365-2168.2001.01719.x; Ogiso S, 2010, SURG ENDOSC, V24, P2822, DOI 10.1007/s00464-010-1057-3; Peeters KCMJ, 2005, BRIT J SURG, V92, P211, DOI 10.1002/bjs.4806; Peng JJ, 2010, AM J SURG, V199, P753, DOI 10.1016/j.amjsurg.2009.03.026; Penninckx F, 2012, COLORECTAL DIS, V14, pE413, DOI 10.1111/j.1463-1318.2012.02977.x; Ptok H, 2007, BRIT J SURG, V94, P1548, DOI 10.1002/bjs.5707; Rahbari NN, 2010, SURGERY, V147, P339, DOI 10.1016/j.surg.2009.10.012; Rondelli F, 2012, EJSO-EUR J SURG ONC, V38, P1065, DOI 10.1016/j.ejso.2012.07.110; Rutegard M, 2012, BRIT J SURG, V99, P127, DOI 10.1002/bjs.7712; Scheidbach H, 2002, SURG ENDOSC, V16, P7, DOI 10.1007/s00464-001-8314-4; Schmidt O, 2003, EUR J SURG ONCOL, V29, P239, DOI 10.1053/ejso.2002.1416; Shin US, 2010, INT J COLORECTAL DIS, V25, P843, DOI 10.1007/s00384-010-0938-1; Shiomi A, 2011, INT J COLORECTAL DIS, V26, P79, DOI 10.1007/s00384-010-1036-0; Smith JD, 2012, ANN SURG, V256, P1034, DOI 10.1097/SLA.0b013e318257d2c1; Tocchi A, 2000, DIS COLON RECTUM, V43, P951, DOI 10.1007/BF02237357; Tsujinaka S, 2008, INT J COLORECTAL DIS, V23, P67, DOI 10.1007/s00384-007-0369-9; Ulrich AB, 2009, DIS COLON RECTUM, V52, P412, DOI 10.1007/DCR.0b013e318197e1b1; Vlot EA, 2005, SURG TODAY, V35, P629, DOI 10.1007/s00595-005-2999-2; Vorobiev GI, 2004, BRIT J SURG, V91, P1506, DOI 10.1002/bjs.4330; Warschkow R, 2011, ANN SURG ONCOL, V18, P2772, DOI 10.1245/s10434-011-1696-1; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Wong NY, 2005, DIS COLON RECTUM, V48, P2076, DOI 10.1007/s10350-005-0146-1; Xiao L, 2011, WORLD J SURG, V35, P1367, DOI 10.1007/s00268-011-1053-3; Yamamoto S, 2012, SURG LAPARO ENDO PER, V22, P239, DOI 10.1097/SLE.0b013e31824fbb56; Z'graggen K, 2001, ANN SURG, V234, P780, DOI 10.1097/00000658-200112000-00009; Zhao WT, 2013, WORLD J SURG, V37, P227, DOI 10.1007/s00268-012-1812-9; Zhu QL, 2010, WORLD J GASTROENTERO, V16, P4605, DOI 10.3748/wjg.v16.i36.4605	84	61	68	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75519	10.1371/journal.pone.0075519	http://dx.doi.org/10.1371/journal.pone.0075519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086552	Green Submitted, gold, Green Published			2022-12-27	WOS:000325218700095
J	Kyostila, K; Lappalainen, AK; Lohi, H				Kyostila, Kaisa; Lappalainen, Anu K.; Lohi, Hannes			Canine Chondrodysplasia Caused by a Truncating Mutation in Collagen-Binding Integrin Alpha Subunit 10	PLOS ONE			English	Article							MESSENGER-RNA DECAY; SKELETAL DYSPLASIAS; SULFATE TRANSPORTER; GROWTH; GENE; DWARFISM; RECEPTOR; BONE; CHONDROCYTE; CARTILAGE	The skeletal dysplasias are disorders of the bone and cartilage tissues. Similarly to humans, several dog breeds have been reported to suffer from different types of genetic skeletal disorders. We have studied the molecular genetic background of an autosomal recessive chondrodysplasia that affects the Norwegian Elkhound and Karelian Bear Dog breeds. The affected dogs suffer from disproportionate short stature dwarfism of varying severity. Through a genome-wide approach, we mapped the chondrodysplasia locus to a 2-Mb region on canine chromosome 17 in nine affected and nine healthy Elkhounds (p(raw) = 7.42x10(-6), p(genome-wide) = 0.013). The associated locus contained a promising candidate gene, cartilage specific integrin alpha 10 (ITGA10), and mutation screening of its 30 exons revealed a nonsense mutation in exon 16 (c.2083C>T; p.Arg695*) that segregated fully with the disease in both breeds (p = 2.5x10(-23)). A 24% mutation carrier frequency was indicated in NEs and an 8% frequency in KBDs. The ITGA10 gene product, integrin receptor alpha 10-subunit combines into a collagen-binding alpha 10 beta 1 integrin receptor, which is expressed in cartilage chondrocytes and mediates chondrocyte-matrix interactions during endochondral ossification. As a consequence of the nonsense mutation, the alpha 10-protein was not detected in the affected cartilage tissue. The canine phenotype highlights the importance of the alpha 10 beta 1 integrin in bone growth, and the large animal model could be utilized to further delineate its specific functions. Finally, this study revealed a candidate gene for human chondrodysplasias and enabled the development of a genetic test for breeding purposes to eradicate the disease from the two dog breeds.	[Kyostila, Kaisa; Lohi, Hannes] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Kyostila, Kaisa; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Kyostila, Kaisa; Lohi, Hannes] Folkhalsan Inst Genet, Dept Mol Genet, Helsinki, Finland; [Lappalainen, Anu K.] Univ Helsinki, Fac Vet Med, Dept Equine & Small Anim Med, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Lohi, H (corresponding author), Univ Helsinki, Res Programs Unit, Helsinki, Finland.	hannes.lohi@helsinki.fi	Lohi, Hannes/F-4596-2011	Lohi, Hannes/0000-0003-1087-5532	Academy of Finland; Sigrid Juselius Foundation; Biocentrum Helsinki; Jane and Aatos Erkko Foundation; University of Helsinki	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocentrum Helsinki; Jane and Aatos Erkko Foundation; University of Helsinki	This study was supported partly by the Academy of Finland, the Sigrid Juselius Foundation, Biocentrum Helsinki, the Jane and Aatos Erkko Foundation and the University of Helsinki Research Funds. HL is a member of Biocentrum Helsinki and KK is a student in the Helsinki Graduate Program in Biotechnology and Molecular Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed JN, 2013, DIS MODEL MECH, V6, P755, DOI 10.1242/dmm.011668; Ali BR, 2010, HUM MOL GENET, V19, P2239, DOI 10.1093/hmg/ddq103; Alman BA, 2008, CLIN GENET, V73, P24, DOI 10.1111/j.1399-0004.2007.00933.x; Arnaout MA, 2002, IMMUNOL REV, V186, P125, DOI 10.1034/j.1600-065X.2002.18612.x; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; Baldridge D, 2010, ANNU REV GENOM HUM G, V11, P189, DOI 10.1146/annurev-genom-082908-150158; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bargal R, 2009, AM J HUM GENET, V84, P80, DOI 10.1016/j.ajhg.2008.12.004; Bengtsson T, 2005, J CELL SCI, V118, P929, DOI 10.1242/jcs.01678; Bengtsson T, 2001, MATRIX BIOL, V20, P565, DOI 10.1016/S0945-053X(01)00164-0; BINGEL SA, 1982, AM J PATHOL, V107, P219; BINGEL SA, 1994, J AM VET MED ASSOC, V205, P845; Boyko AR, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-216; BREUR GJ, 1989, J AM VET MED ASSOC, V195, P606; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Camper L, 1998, J BIOL CHEM, V273, P20383, DOI 10.1074/jbc.273.32.20383; Camper L, 2001, CELL TISSUE RES, V306, P107, DOI 10.1007/s004410100385; CARRIG CB, 1977, J AM VET MED ASSOC, V170, P49; Everts RE, 2000, VET QUART, V22, P63, DOI 10.1080/01652176.2000.9695027; FLETCH SM, 1973, J AM VET MED ASSOC, V162, P357; Foldynova-Trantirkova S, 2012, HUM MUTAT, V33, P29, DOI 10.1002/humu.21636; Frischknecht M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060149; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Goldstein O, 2010, MAMM GENOME, V21, P398, DOI 10.1007/s00335-010-9276-4; Gullberg DE, 2002, PROG HISTOCHEM CYTO, V37, P9; Hanssen I, 1998, J SMALL ANIM PRACT, V39, P10, DOI 10.1111/j.1748-5827.1998.tb03662.x; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Hecht JT, 2005, MATRIX BIOL, V23, P525, DOI 10.1016/j.matbio.2004.09.006; Huang LL, 2012, WIRES RNA, V3, P807, DOI 10.1002/wrna.1137; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kano K, 2008, MOL ENDOCRINOL, V22, P1866, DOI 10.1210/me.2007-0310; Karam R, 2013, BBA-GENE REGUL MECH, V1829, P624, DOI 10.1016/j.bbagrm.2013.03.002; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Karniski LP, 2001, HUM MOL GENET, V10, P1485, DOI 10.1093/hmg/10.14.1485; Krakow D, 2010, GENET MED, V12, P327, DOI 10.1097/GIM.0b013e3181daae9b; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; Labrador JP, 2001, EMBO REP, V2, P446, DOI 10.1093/embo-reports/kve094; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LAVELLE RB, 1984, AUST VET J, V61, P268, DOI 10.1111/j.1751-0813.1984.tb15544.x; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Mackie EJ, 2011, J ENDOCRINOL, V211, P109, DOI 10.1530/JOE-11-0048; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Martinez S, 2000, CAN J VET RES, V64, P243; Martinez S, 2007, CAN J VET RES, V71, P66; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; Mertz EL, 2012, J BIOL CHEM, V287, P22030, DOI 10.1074/jbc.M110.116467; MEYERS VN, 1983, J AM VET MED ASSOC, V183, P975; Mortier GR, 2001, EUR J RADIOL, V40, P161, DOI 10.1016/S0720-048X(01)00397-7; Mundlos S, 1997, FASEB J, V11, P227, DOI 10.1096/fasebj.11.4.9068611; Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Neff MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051917; Neu-Yilik G, 2011, RNA, V17, P843, DOI 10.1261/rna.2401811; Newman B, 2003, CLIN GENET, V63, P241, DOI 10.1034/j.1399-0004.2003.00046.x; Nishimura G, 2005, HUM MUTAT, V26, P36, DOI 10.1002/humu.20179; Nissenson RA, 1998, ENDOCRINOLOGY, V139, P4753, DOI 10.1210/en.139.12.4753; Parker HG, 2009, SCIENCE, V325, P995, DOI 10.1126/science.1173275; Patterson DF, 2000, J VET INTERN MED, V14, P1, DOI 10.1892/0891-6640(2000)14[1:CAMITA]2.0.CO;2; Perrin-Vidoz L, 2002, HUM MOL GENET, V11, P2805, DOI 10.1093/hmg/11.23.2805; Popova SN, 2007, ACTA PHYSIOL, V190, P179, DOI 10.1111/j.1748-1716.2007.01718.x; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RISER WH, 1980, J AM VET MED ASSOC, V176, P335; SANDE RD, 1982, AM J PATHOL, V106, P224; SANDE RD, 1983, VET CLIN N AM-SMALL, V13, P71, DOI 10.1016/S0195-5616(83)50005-3; Schibler L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007633; SCHMID TM, 1985, DEV BIOL, V107, P373, DOI 10.1016/0012-1606(85)90319-7; Schwartz NB, 2002, GLYCOBIOLOGY, V12, p57R, DOI 10.1093/glycob/12.4.57R; SMART ME, 1971, CANADIAN VET J, V12, P31; Smit JJ, 2011, VET J, V187, P269, DOI 10.1016/j.tvjl.2009.11.009; Superti-Furga A, 2001, AM J MED GENET, V106, P282, DOI 10.1002/ajmg.10233; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Wang J, 2002, EMBO REP, V3, P274, DOI 10.1093/embo-reports/kvf036; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; White DJ, 2004, INT J BIOCHEM CELL B, V36, P1405, DOI 10.1016/j.biocel.2003.08.016; Young AE, 2008, ANIM BIOTECHNOL, V19, P1, DOI 10.1080/10495390701638328; Young AE, 2006, MAMM GENOME, V17, P761, DOI 10.1007/s00335-005-0163-3; Zhang Y, 2011, J BONE MINER RES, V26, P604, DOI 10.1002/jbmr.225	83	24	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75621	10.1371/journal.pone.0075621	http://dx.doi.org/10.1371/journal.pone.0075621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086591	gold, Green Published, Green Submitted			2022-12-27	WOS:000325218700103
J	Morozov, A; Petrovskii, S				Morozov, Andrew; Petrovskii, Sergei			Feeding on Multiple Sources: Towards a Universal Parameterization of the Functional Response of a Generalist Predator Allowing for Switching	PLOS ONE			English	Article							ECOSYSTEM MODELS; PLANKTON DYNAMICS; PREY; PHYTOPLANKTON; COMMUNITY; BIODIVERSITY; GROWTH; RATES; PRODUCTIVITY; PHAEOCYSTIS	Understanding of complex trophic interactions in ecosystems requires correct descriptions of the rate at which predators consume a variety of different prey species. Field and laboratory data on multispecies communities are rarely sufficient and usually cannot provide an unambiguous test for the theory. As a result, the conventional way of constructing a multi-prey functional response is speculative, and often based on assumptions that are difficult to verify. Predator responses allowing for prey selectivity and active switching are thought to be more biologically relevant compared to the standard proportion-based consumption. However, here we argue that the functional responses with switching may not be applicable to communities with a broad spectrum of resource types. We formulate a set of general rules that a biologically sound parameterization of a predator functional response should satisfy, and show that all existing formulations for the multispecies response with prey selectivity and switching fail to do so. Finally, we propose a universal framework for parameterization of a multi-prey functional response by combining patterns of food selectivity and proportion-based feeding.	[Morozov, Andrew; Petrovskii, Sergei] Univ Leicester, Dept Math, Leicester, Leics, England	University of Leicester	Morozov, A (corresponding author), Univ Leicester, Dept Math, Leicester, Leics, England.	am379@leicester.ac.uk	Morozov, Andrew/AAI-6528-2020	Petrovskii, Sergei/0000-0001-6259-2695				Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; Adamson MW, 2013, P ROY SOC A-MATH PHY, V469, DOI 10.1098/rspa.2012.0500; Adjou M, 2012, ECOL MODEL, V225, P19, DOI 10.1016/j.ecolmodel.2011.11.005; AKRE BG, 1979, J ANIM ECOL, V48, P703, DOI 10.2307/4191; Anderson TR, 2010, PROG OCEANOGR, V87, P201, DOI 10.1016/j.pocean.2010.06.003; [Anonymous], 2005, FUNDAMENTALS ECOLOGY; ARDITI R, 1989, J THEOR BIOL, V139, P311, DOI 10.1016/S0022-5193(89)80211-5; Arditi R., 1995, FOOD WEBS INTEGRATIO, P122; Armstrong RA, 1999, J PLANKTON RES, V21, P445, DOI 10.1093/plankt/21.3.445; Begon M., 2005, ECOLOGY INDIVIDUALS, V4th ed.; Calbet A, 2004, LIMNOL OCEANOGR, V49, P51, DOI 10.4319/lo.2004.49.1.0051; Cohen JE, 2003, P NATL ACAD SCI USA, V100, P1781, DOI 10.1073/pnas.232715699; COLTON TF, 1987, ECOLOGY, V68, P900, DOI 10.2307/1938361; COMINS HN, 1976, J THEOR BIOL, V62, P93, DOI 10.1016/0022-5193(76)90053-9; DALE BW, 1994, J ANIM ECOL, V63, P644, DOI 10.2307/5230; DEMOTT WR, 1982, LIMNOL OCEANOGR, V27, P518, DOI 10.4319/lo.1982.27.3.0518; Diekmann O, 2010, J MATH BIOL, V61, P277, DOI 10.1007/s00285-009-0299-y; Edwards AM, 1999, B MATH BIOL, V61, P303, DOI 10.1006/bulm.1998.0082; Elliott JM, 2006, FRESHWATER BIOL, V51, P913, DOI 10.1111/j.1365-2427.2006.01549.x; Elliott JM, 2004, FRESHWATER BIOL, V49, P709, DOI 10.1111/j.1365-2427.2004.01222.x; Erbach A, 2013, ECOL COMPLEX, V14, P48, DOI 10.1016/j.ecocom.2013.02.005; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; FASHAM MJR, 1990, J MAR RES, V48, P591, DOI 10.1357/002224090784984678; Flora C, 2011, J THEOR BIOL, V283, P82, DOI 10.1016/j.jtbi.2011.05.021; Franks PJS, 2009, J PLANKTON RES, V31, P1299, DOI 10.1093/plankt/fbp069; Fussmann GF, 2005, BIOL LETTERS, V1, P9, DOI 10.1098/rsbl.2004.0246; Gentleman W, 2003, DEEP-SEA RES PT II, V50, P2847, DOI 10.1016/J.DSR2.2003.07.001; Gross K, 2007, AM NAT, V170, P207, DOI 10.1086/518950; HANSEN B, 1990, J PLANKTON RES, V12, P1173, DOI 10.1093/plankt/12.6.1173; HAYDON D, 1994, AM NAT, V144, P14, DOI 10.1086/285658; Hirst AG, 2003, LIMNOL OCEANOGR, V48, P1988, DOI 10.4319/lo.2003.48.5.1988; HOLT RD, 1983, AM NAT, V122, P521, DOI 10.1086/284153; HUSTON M, 1985, CORAL REEFS, V4, P19, DOI 10.1007/BF00302200; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; HUTSON V, 1984, MATH BIOSCI, V68, P233, DOI 10.1016/0025-5564(84)90033-6; Irigoien X, 2005, J PLANKTON RES, V27, P313, DOI 10.1093/plankt/fbi011; Irigoien X, 2004, NATURE, V429, P863, DOI 10.1038/nature02593; Jeschke JM, 2004, BIOL REV, V79, P337, DOI 10.1017/S1464793103006286; Johnson PTJ, 2006, ECOLOGY, V87, P1973, DOI 10.1890/0012-9658(2006)87[1973:DODHIB]2.0.CO;2; Kiorboe T, 1996, MAR ECOL PROG SER, V143, P65, DOI 10.3354/meps143065; Koen-Alonso M, 2005, CAN J FISH AQUAT SCI, V62, P1490, DOI 10.1139/F05-087; KOENALONSO M, 2007, ENERGETICS ECOSYSTEM; Krivan V, 1996, THEOR POPUL BIOL, V49, P265, DOI 10.1006/tpbi.1996.0014; Leising AW, 2005, PROG OCEANOGR, V67, P384, DOI 10.1016/j.pocean.2005.09.008; Massol F, 2011, ECOL LETT, V14, P313, DOI 10.1111/j.1461-0248.2011.01588.x; MCNAIR JN, 1981, THEOR POPUL BIOL, V19, P147, DOI 10.1016/0040-5809(81)90014-9; Morozov AY, 2010, J THEOR BIOL, V262, P346, DOI 10.1016/j.jtbi.2009.09.023; Morozov AY, 2010, J THEOR BIOL, V265, P45, DOI 10.1016/j.jtbi.2010.04.016; MURDOCH W W, 1975, P1; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Nejstgaard JC, 2007, BIOGEOCHEMISTRY, V83, P147, DOI 10.1007/s10533-007-9098-y; PACE ML, 1984, MAR BIOL, V82, P47, DOI 10.1007/BF00392763; Petrovskii S, 2009, AM NAT, V173, P278, DOI 10.1086/595755; Prowe AEF, 2012, ECOL MODEL, V225, P167, DOI 10.1016/j.ecolmodel.2011.11.018; Raymont J.E.G., 1980, PLANKTON PRODUCTIVIT, V1, DOI 10.1016/c2009-0-10951-0; REAL LA, 1977, AM NAT, V111, P289, DOI 10.1086/283161; Ryabchenko VA, 1997, J MARINE SYST, V13, P33, DOI 10.1016/S0924-7963(96)00110-8; Smout S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010761; Steinke M, 2002, J PHYCOL, V38, P630, DOI 10.1046/j.1529-8817.2002.02057.x; Stephens D.W., 1986, pi; Stock CA, 2008, J MARINE SYST, V74, P134, DOI 10.1016/j.jmarsys.2007.12.004; STOECKER DK, 1986, J EXP MAR BIOL ECOL, V95, P113, DOI 10.1016/0022-0981(86)90196-6; Strom SL, 1998, J PLANKTON RES, V20, P831, DOI 10.1093/plankt/20.5.831; TANSKY M, 1978, J THEOR BIOL, V70, P263, DOI 10.1016/0022-5193(78)90376-4; Vallina SM, 2012, COMM ASLO M 2012; van Baalen M, 2001, AM NAT, V157, P512, DOI 10.1086/319933; van Leeuwen E, 2013, J THEOR BIOL, V328, P89, DOI 10.1016/j.jtbi.2013.02.003; VANCE RR, 1978, AM NAT, V112, P797, DOI 10.1086/283324; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Visser AW, 2013, MAR ECOL PROG SER, V473, P91, DOI 10.3354/meps10079; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	72	34	34	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74586	10.1371/journal.pone.0074586	http://dx.doi.org/10.1371/journal.pone.0074586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086356	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700027
J	Nomura, J; Busso, N; Ives, A; Tsujimoto, S; Tamura, M; So, A; Yamanaka, Y				Nomura, Johji; Busso, Nathalie; Ives, Annette; Tsujimoto, Syunsuke; Tamura, Mizuho; So, Alexander; Yamanaka, Yoshihiro			Febuxostat, an Inhibitor of Xanthine Oxidase, Suppresses Lipopolysaccharide-Induced MCP-1 Production via MAPK Phosphatase-1-Mediated Inactivation of JNK	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PROINFLAMMATORY CYTOKINE BIOSYNTHESIS; SELECTIVE INHIBITOR; ATHEROSCLEROSIS; OXIDOREDUCTASE	Excess reactive oxygen species (ROS) formation can trigger various pathological conditions such as inflammation, in which xanthine oxidase (XO) is one major enzymatic source of ROS. Although XO has been reported to play essential roles in inflammatory conditions, the molecular mechanisms underlying the involvement of XO in inflammatory pathways remain unclear. Febuxostat, a selective and potent inhibitor of XO, effectively inhibits not only the generation of uric acid but also the formation of ROS. In this study, therefore, we examined the effects of febuxostat on lipopolysaccharide (LPS)-mediated inflammatory responses. Here we show that febuxostat suppresses LPS-induced MCP-1 production and mRNA expression via activating MAPK phosphatase-1 (MKP-1) which, in turn, leads to dephosphorylation and inactivation of JNK in macrophages. Moreover, these effects of febuxostat are mediated by inhibiting XO-mediated intracellular ROS production. Taken together, our data suggest that XO mediates LPS-induced phosphorylation of JNK through ROS production and MKP-1 inactivation, leading to MCP-1 production in macrophages. These studies may bring new insights into the novel role of XO in regulating inflammatory process through MAPK phosphatase, and demonstrate the potential use of XO inhibitor in modulating the inflammatory processes.	[Nomura, Johji; Tsujimoto, Syunsuke; Tamura, Mizuho; Yamanaka, Yoshihiro] Teijin Pharma Ltd, Pharmaceut Dept Res Labs, Teijin Inst Biomed Res, Tokyo, Japan; [Busso, Nathalie; Ives, Annette; So, Alexander] Univ Lausanne, Serv Rheumatol, Ctr Hosp Univ Vaudois, Dept Appareil Locomoteur, Lausanne, Switzerland	Teijin Pharma Limited; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Nomura, J (corresponding author), Teijin Pharma Ltd, Pharmaceut Dept Res Labs, Teijin Inst Biomed Res, Tokyo, Japan.	j.nomura@teijin.co.jp		Ives, Annette/0000-0002-7407-960X	Teijin Pharma Limited	Teijin Pharma Limited(Teijin Pharma Limited)	This study was supported by Teijin Pharma Limited. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin W, 2011, DIABETES, V60, P1258, DOI 10.2337/db10-0916; Becker MA, 2004, NUCLEOS NUCLEOT NUCL, V23, P1111, DOI 10.1081/NCN-200027372; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Brandes RP, 1999, HYPERTENSION, V33, P1243, DOI 10.1161/01.HYP.33.5.1243; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Cape JL, 2009, ARCH BIOCHEM BIOPHYS, V484, P190, DOI 10.1016/j.abb.2009.01.010; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Cirillo P, 2009, J AM SOC NEPHROL, V20, P545, DOI 10.1681/ASN.2008060576; Comhair SAA, 2002, AM J PHYSIOL-LUNG C, V283, pL246, DOI 10.1152/ajplung.00491.2001; Engberding N, 2004, CIRCULATION, V110, P2175, DOI 10.1161/01.CIR.0000144303.24894.1C; Filippin LI, 2008, CLIN EXP IMMUNOL, V152, P415, DOI 10.1111/j.1365-2249.2008.03634.x; Hassoun PM, 1998, AM J RESP CRIT CARE, V158, P299, DOI 10.1164/ajrccm.158.1.9709116; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kayyali US, 2001, J BIOL CHEM, V276, P14359, DOI 10.1074/jbc.M010100200; Khosravan R, 2008, J CLIN PHARMACOL, V48, P1014, DOI 10.1177/0091270008322035; Kushiyama A, 2012, ARTERIOSCL THROM VAS, V32, P291, DOI 10.1161/ATVBAHA.111.234559; Li LW, 2009, INT J CLIN EXP MED, V2, P48; Malik UZ, 2011, FREE RADICAL BIO MED, V51, P179, DOI 10.1016/j.freeradbiomed.2011.04.004; Nakai K, 2006, P NATL ACAD SCI USA, V103, P4616, DOI 10.1073/pnas.0510352103; Omori H, 2012, CLIN EXP NEPHROL, V16, P549, DOI 10.1007/s10157-012-0609-3; OSADA Y, 1993, EUR J PHARMACOL, V241, P183, DOI 10.1016/0014-2999(93)90201-R; Park JG, 2011, BMB REP, V44, P497, DOI 10.5483/BMBRep.2011.44.8.497; Schroder K, 2006, FREE RADICAL BIO MED, V41, P1353, DOI 10.1016/j.freeradbiomed.2006.03.026; Teng CH, 2007, J BIOL CHEM, V282, P28395, DOI 10.1074/jbc.M705142200; Tsuda H, 2012, BIOCHEM BIOPH RES CO, V427, P266, DOI 10.1016/j.bbrc.2012.09.032; Wright RM, 2004, AM J RESP CELL MOL, V30, P479, DOI 10.1165/rcmb.2003-0309OC; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200	27	55	57	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75527	10.1371/journal.pone.0075527	http://dx.doi.org/10.1371/journal.pone.0075527			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086554	gold, Green Published, Green Submitted			2022-12-27	WOS:000325218700096
J	Schultz, BG; Stevens, CJ; Keller, PE; Tillmann, B				Schultz, Benjamin G.; Stevens, Catherine J.; Keller, Peter E.; Tillmann, Barbara			A Sequence Identification Measurement Model to Investigate the Implicit Learning of Metrical Temporal Patterns	PLOS ONE			English	Article							DISCREPANCY-ATTRIBUTION HYPOTHESIS; PROCESSING TREE MODELS; UNCONSCIOUS KNOWLEDGE; MEMORY; EXPLICIT; REPRESENTATIONS; PERFORMANCE; FAMILIARITY; FEELINGS; FLUENCY	Implicit learning (IL) occurs unconsciously and without intention. Perceptual fluency is the ease of processing elicited by previous exposure to a stimulus. It has been assumed that perceptual fluency is associated with IL. However, the role of perceptual fluency following IL has not been investigated in temporal pattern learning. Two experiments by Schultz, Stevens, Keller, and Tillmann demonstrated the IL of auditory temporal patterns using a serial reaction-time task and a generation task based on the process dissociation procedure. The generation task demonstrated that learning was implicit in both experiments via motor fluency, that is, the inability to suppress learned information. With the aim to disentangle conscious and unconscious processes, we analyze unreported recognition data associated with the Schultz et al. experiments using the sequence identification measurement model. The model assumes that perceptual fluency reflects unconscious processes and IL. For Experiment 1, the model indicated that conscious and unconscious processes contributed to recognition of temporal patterns, but that unconscious processes had a greater influence on recognition than conscious processes. In the model implementation of Experiment 2, there was equal contribution of conscious and unconscious processes in the recognition of temporal patterns. As Schultz et al. demonstrated IL in both experiments using a generation task, and the conditions reported here in Experiments 1 and 2 were identical, two explanations are offered for the discrepancy in model and behavioral results based on the two tasks: 1) perceptual fluency may not be necessary to infer IL, or 2) conscious control over implicitly learned information may vary as a function of perceptual fluency and motor fluency.	[Schultz, Benjamin G.; Stevens, Catherine J.; Keller, Peter E.; Tillmann, Barbara] Univ Western Sydney, MARCS Inst, Sydney, NSW, Australia; [Schultz, Benjamin G.; Tillmann, Barbara] Univ Lyon, INSERM, U1028,CNRS,Unite Mixtes Rech 5292, Lyon Neurosci Res Ctr,Team Auditory Cognit & Psyc, Lyon, Rhone Alpes, France; [Keller, Peter E.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Saxony, Germany	Western Sydney University; Centre National de la Recherche Scientifique (CNRS); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Max Planck Society	Schultz, BG (corresponding author), Univ Western Sydney, MARCS Inst, Sydney, NSW, Australia.	b.schultz@uws.edu.au	Stevens, Catherine J/D-9948-2012; Schultz, Ben/AAD-9976-2019	Stevens, Catherine J/0000-0002-7558-2717; Schultz, Ben/0000-0002-8306-0206; Keller, Peter/0000-0001-7579-6515	Australian Research Council [DP0986394]; Australian Postgraduate Award; University of Western Sydney	Australian Research Council(Australian Research Council); Australian Postgraduate Award(Australian Government); University of Western Sydney	The research was supported by an Australian Research Council Discovery Grant (DP0986394) held by Catherine Stevens, Barbara Tillmann, and Peter Keller. The primary research was supported by an Australian Postgraduate Award and University of Western Sydney top up grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Batchelder WH, 1999, PSYCHON B REV, V6, P57, DOI 10.3758/BF03210812; BOWERS JS, 1990, J EXPT PSYCHOL LEARN, V15, P763, DOI DOI 10.1037/0278-7393.16.3.404.PUBMED:2140400; Buchner A, 2001, PSYCHOL RES-PSYCH FO, V65, P71, DOI 10.1007/s004260000052; Buchner A, 1997, Q J EXP PSYCHOL-A, V50, P631, DOI 10.1080/027249897392053; Buchner A, 1998, Q J EXP PSYCHOL-A, V51, P251, DOI 10.1080/713755757; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Curran T, 2001, TRENDS COGN SCI, V5, P503, DOI 10.1016/S1364-6613(00)01791-5; Destrebecqz A, 2001, PSYCHON B REV, V8, P343, DOI 10.3758/BF03196171; Destrebecqz A., 2003, ADV CONSCIOUSNESS RE, V48, P181, DOI [10.1075/aicr.48.11des, DOI 10.1075/AICR.48.11DES]; Dienes Z, 2005, PSYCHOL RES-PSYCH FO, V69, P338, DOI 10.1007/s00426-004-0208-3; DIENES Z, 1995, J EXP PSYCHOL LEARN, V21, P1322, DOI 10.1037/0278-7393.21.5.1322; DUNN JC, 1988, PSYCHOL REV, V95, P91, DOI 10.1037/0033-295X.95.1.91; Erdfelder E, 2009, Z PSYCHOL, V217, P108, DOI 10.1027/0044-3409.217.3.108; ESSENS PJ, 1985, PERCEPT PSYCHOPHYS, V37, P1, DOI 10.3758/BF03207132; Franco A, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00229; Fu QF, 2010, CONSCIOUS COGN, V19, P478, DOI 10.1016/j.concog.2009.12.006; Gaillard V, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00208; Gardiner JM, 2006, MEM COGNITION, V34, P227, DOI 10.3758/BF03193401; GRAF P, 1994, EUR J COGN PSYCHOL, V6, P113, DOI 10.1080/09541449408520139; Hu XG, 1999, BEHAV RES METH INS C, V31, P689, DOI 10.3758/BF03200747; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; JACOBY LL, 1981, J EXP PSYCHOL GEN, V110, P306, DOI 10.1037/0096-3445.110.3.306; Karabanov A, 2008, J NEUROPHYSIOL, V100, P733, DOI 10.1152/jn.01303.2007; London J., 2004, HEARING TIME; Moshagen M, 2010, BEHAV RES METHODS, V42, P42, DOI 10.3758/BRM.42.1.42; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Norman E, 2006, CONSCIOUS COGN, V15, P723, DOI 10.1016/j.concog.2005.06.003; Norman E, 2011, CONSCIOUS COGN, V20, P1920, DOI 10.1016/j.concog.2011.07.008; PALMER C, 1990, J EXP PSYCHOL HUMAN, V16, P728, DOI 10.1037/0096-1523.16.4.728; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; PERRUCHET P, 1992, J EXP PSYCHOL LEARN, V18, P785, DOI 10.1037/0278-7393.18.4.785; Perruchet P., 2008, LEARNING MEMORY COMP, V2, P597, DOI DOI 10.1016/B978-012370509-9.00149-2; POVEL DJ, 1985, MUSIC PERCEPT, V2, P411; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; REBER AS, 1989, J EXP PSYCHOL GEN, V118, P219, DOI 10.1037/0096-3445.118.3.219; REED J, 1994, J EXP PSYCHOL LEARN, V20, P585, DOI 10.1037/0278-7393.20.3.585; RIEFER DM, 1988, PSYCHOL REV, V95, P318, DOI 10.1037/0033-295X.95.3.318; SCHACTER DL, 1986, J EXP PSYCHOL LEARN, V12, P432, DOI 10.1037/0278-7393.12.3.432; Schultz BG, 2013, Q J EXP PSYCHOL, V66, P360, DOI 10.1080/17470218.2012.712146; Scott RB, 2008, J EXP PSYCHOL LEARN, V34, P1264, DOI 10.1037/a0012943; Shanks D. R., 2005, HDB COGNITION, P203, DOI [10.4135/9781848608177.n8, DOI 10.4135/9781848608177.N8]; Shanks DR, 2012, Q J EXP PSYCHOL, V65, P1449, DOI 10.1080/17470218.2012.691887; Shanks DR, 1999, J EXP PSYCHOL LEARN, V25, P1435, DOI 10.1037/0278-7393.25.6.1435; SHANKS DR, 1994, BEHAV BRAIN SCI, V17, P367, DOI 10.1017/S0140525X00035032; Wagner AD, 1998, ACTA PSYCHOL, V98, P211, DOI 10.1016/S0001-6918(97)00043-7; Wan LL, 2008, CONSCIOUS COGN, V17, P1209, DOI 10.1016/j.concog.2008.06.007; Whittlesea BWA, 2001, J EXP PSYCHOL LEARN, V27, P14, DOI 10.1037/0278-7393.27.1.14; Whittlesea BWA, 2001, J EXP PSYCHOL LEARN, V27, P3, DOI 10.1037/0278-7393.27.1.3; Yang SJ, 2009, J EXP PSYCHOL LEARN, V35, P1359, DOI 10.1037/a0016547; Yonelinas AP, 2012, MEM COGNITION, V40, P663, DOI 10.3758/s13421-012-0205-5	53	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75163	10.1371/journal.pone.0075163	http://dx.doi.org/10.1371/journal.pone.0075163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VC	24086461	Green Published, gold			2022-12-27	WOS:000325218700055
J	Singleton, CK; Xiong, YH				Singleton, Charles K.; Xiong, Yanhua			Loss of the Histidine Kinase DhkD Results in Mobile Mounds during Development of Dictyostelium discoideum	PLOS ONE			English	Article							CELL-CELL ADHESION; 3-DIMENSIONAL SCROLL WAVES; PATTERN-FORMATION; GENE-EXPRESSION; TERMINAL DIFFERENTIATION; PRESTALK; PROTEIN; RESISTANCE; EVOLUTION; MOVEMENT	Background: Histidine kinases are receptors for sensing cellular and environmental signals, and in response to the appropriate cue they initiate phosphorelays that regulate the activity of response regulators. The Dictyostelium discoideum genome encodes 15 histidine kinases that function to regulate several processes during the multicellular developmental program, including the slug to culmination transition, osmoregulation, and spore differentiation. While there are many histidine kinases, there is only a single response regulator, RegA. Not surprisingly given the ubiquitous involvement of cAMP in numerous processes of development in Dictyostelium, RegA is a cAMP phosphodiesterase that is activated upon receiving phosphates through a phosphorelay. Hence, all of the histidine kinases characterized to date regulate developmental processes through modulating cAMP production. Here we investigate the function of the histidine kinase DhkD. Principal Findings: The dhkD gene was disrupted, and the resulting cells when developed gave a novel phenotype. Upon aggregation, which occurred without streaming, the mounds were motile, a phenotype termed the pollywog stage. The pollywog phenotype was dependent on a functional RegA. After a period of random migration, the pollywogs attempted to form fingers but mostly generated aberrant structures with no tips. While prestalk and prespore cell differentiation occurred with normal timing, proper patterning did not occur. In contrast, wild type mounds are not motile, and the cAMP chemotactic movement of cells within the mound facilitates proper prestalk and prespore patterning, tip formation, and the vertical elongation of the mound into a finger. Conclusions: We postulate that DhkD functions to ensure the proper cAMP distribution within mounds that in turn results in patterning, tip formation and the transition of mounds to fingers. In the absence of DhkD, aberrant cell movements in response to an altered cAMP distribution result in mound migration, a lack of proper patterning, and an inability to generate normal finger morphology.	[Singleton, Charles K.; Xiong, Yanhua] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Singleton, CK (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	charles.k.singleton@vanderbilt.edu			Vanderbilt College of Arts and Sciences	Vanderbilt College of Arts and Sciences	The work was supported by the Vanderbilt College of Arts and Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjard C, 2005, P NATL ACAD SCI USA, V102, P7607, DOI 10.1073/pnas.0501820102; ANJARD C, 2006, ICTYOSTELIUM HISTIDI, P1; Anjard C, 2008, DEVELOPMENT, V135, P819, DOI 10.1242/dev.018051; BRETSCHNEIDER T, 1995, P NATL ACAD SCI USA, V92, P4387, DOI 10.1073/pnas.92.10.4387; Capra EJ, 2012, ANNU REV MICROBIOL, V66, P325, DOI 10.1146/annurev-micro-092611-150039; Clow PA, 2000, DEVELOPMENT, V127, P2715; COCUCCI SM, 1970, J CELL BIOL, V45, P399, DOI 10.1083/jcb.45.2.399; Das S, 2011, J BIOL CHEM, V286, P38649, DOI 10.1074/jbc.M111.284182; DINGERMANN T, 1989, GENE, V85, P353, DOI 10.1016/0378-1119(89)90428-9; Dormann D, 1997, J CELL SCI, V110, P1831; Dormann D, 2001, DEVELOPMENT, V128, P4535; EGELHOFF TT, 1989, MOL CELL BIOL, V9, P1965, DOI 10.1128/MCB.9.5.1965; Giusti C, 2010, MOL BIOL CELL, V21, P1825, DOI 10.1091/mbc.E09-11-0976; JERMYN KA, 1989, NATURE, V340, P144, DOI 10.1038/340144a0; Kirsten JH, 2005, DEV BIOL, V287, P146, DOI 10.1016/j.ydbio.2005.08.043; Kriebel PW, 2003, CELL, V112, P549, DOI 10.1016/S0092-8674(03)00081-3; Levi S, 2000, PLASMID, V44, P231, DOI 10.1006/plas.2000.1487; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; MATSUKUMA S, 1979, J EMBRYOL EXP MORPH, V50, P243; MEE JD, 1986, BIOCHEM CELL BIOL, V64, P722, DOI 10.1139/o86-099; NEWELL PC, 1982, J GEN MICROBIOL, V128, P1639; Pekovich SR, 1998, J NUTR, V128, P683, DOI 10.1093/jn/128.4.683; Puta F, 1998, FOLIA BIOL-PRAGUE, V44, P185; Roisin-Bouffay C, 2000, MOL CELL, V6, P953, DOI 10.1016/S1097-2765(05)00082-1; Schaap P, 2011, DEV GROWTH DIFFER, V53, P452, DOI 10.1111/j.1440-169X.2011.01263.x; Schuster SC, 1996, EMBO J, V15, P3880, DOI 10.1002/j.1460-2075.1996.tb00762.x; Shaulsky G, 1998, DEVELOPMENT, V125, P691; SIEGERT F, 1992, P NATL ACAD SCI USA, V89, P6433, DOI 10.1073/pnas.89.14.6433; SIEGERT F, 1995, CURR BIOL, V5, P937, DOI 10.1016/S0960-9822(95)00184-9; Singleton CK, 2006, EUKARYOT CELL, V5, P991, DOI 10.1128/EC.00058-06; Singleton CK, 1998, DEV BIOL, V203, P345, DOI 10.1006/dbio.1998.9049; SINGLETON CK, 1987, DEV BIOL, V119, P433, DOI 10.1016/0012-1606(87)90047-9; Siu CH, 2004, SEMIN CELL DEV BIOL, V15, P633, DOI 10.1016/j.semcdb.2004.09.004; Siu CH, 2011, DEV GROWTH DIFFER, V53, P518, DOI 10.1111/j.1440-169X.2011.01267.x; STERNFELD J, 1981, DIFFERENTIATION, V20, P10, DOI 10.1111/j.1432-0436.1981.tb01150.x; Tekinay T, 2003, EUKARYOT CELL, V2, P618, DOI 10.1128/EC.2.3.618-626.2003; Thomason PA, 1999, J BIOL CHEM, V274, P27379, DOI 10.1074/jbc.274.39.27379; Thomason PA, 2006, DEV BIOL, V292, P358, DOI 10.1016/j.ydbio.2006.01.010; Thomason PA, 1998, EMBO J, V17, P2838, DOI 10.1093/emboj/17.10.2838; Thompson CRL, 2004, DEV GROWTH DIFFER, V46, P363; Umeda T, 2004, J THEOR BIOL, V226, P215, DOI 10.1016/j.jtbi.2003.08.016; Varney TR, 2002, DEVELOPMENT, V129, P2381; Vasiev B, 2003, J THEOR BIOL, V223, P347, DOI 10.1016/S0022-5193(03)00103-6; Vasiev B, 1999, BIOPHYS J, V76, P595, DOI 10.1016/S0006-3495(99)77228-0; Wang J, 2000, DEV BIOL, V227, P734, DOI 10.1006/dbio.2000.9881; Wang N, 1996, EMBO J, V15, P3890, DOI 10.1002/j.1460-2075.1996.tb00763.x; Weijer CJ, 2004, CURR OPIN GENET DEV, V14, P392, DOI 10.1016/j.gde.2004.06.006; ZHANG Q, 1995, THESIS VANDERBILT U; Zinda MJ, 1998, DEV BIOL, V196, P171, DOI 10.1006/dbio.1998.8854	49	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75618	10.1371/journal.pone.0075618	http://dx.doi.org/10.1371/journal.pone.0075618			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086589	Green Submitted, Green Published, gold			2022-12-27	WOS:000325218700102
J	Zhao, GJ; Tang, SL; Lv, YC; Ouyang, XP; He, PP; Yao, F; Chen, WJ; Lu, Q; Tang, YY; Zhang, M; Fu, YC; Zhang, DW; Yin, K; Tang, CK				Zhao, Guo-Jun; Tang, Shi-Lin; Lv, Yun-Cheng; Ouyang, Xin-Ping; He, Ping-Ping; Yao, Feng; Chen, Wu-Jun; Lu, Qian; Tang, Yan-Yan; Zhang, Min; Fu, Yuchang; Zhang, Da-Wei; Yin, Kai; Tang, Chao-Ke			Antagonism of Betulinic Acid on LPS-Mediated Inhibition of ABCA1 and Cholesterol Efflux through Inhibiting Nuclear Factor-kappaB Signaling Pathway and miR-33 Expression	PLOS ONE			English	Article							CASSETTE TRANSPORTER A1; REGULATES ABCA1; B ACTIVATION; LXR-ALPHA; INFLAMMATION; ATHEROSCLEROSIS; CONTRIBUTES; MACROPHAGES; METABOLISM; MODULATION	ATP-binding cassette transporter A1 (ABCA1) is critical in exporting cholesterol from macrophages and plays a protective role in the development of atherosclerosis. The purpose of this study was to investigate the effects of betulinic acid (BA), a pentacyclic triterpenoid, on ABCA1 expression and cholesterol efflux, and to further determine the underlying mechanism. BA promoted ABCA1 expression and cholesterol efflux, decreased cellular cholesterol and cholesterol ester content in LPS-treated macrophages. Furthermore, we found that BA promoted ABCA1 expression via down-regulation of miR-33s. The inhibition of LPS-induced NF-kappa B activation further decreased miR-33s expression and enhanced ABCA1 expression and cholesterol efflux when compared with BA only treatment. In addition, BA suppressed I kappa B phosphorylation, p65 phosphorylation and nuclear translocation, and the transcription of NF-kappa B-dependent related gene. Moreover, BA reduced atherosclerotic lesion size, miR-33s levels and NF-kappa B activation, and promoted ABCA1 expression in apoE(-/-) mice. Taken together, these results reveal a novel mechanism for the BA-mediated ABCA1 expression, which may provide new insights for developing strategies for modulating vascular inflammation and atherosclerosis.	[Zhao, Guo-Jun; Tang, Shi-Lin; Lv, Yun-Cheng; Ouyang, Xin-Ping; He, Ping-Ping; Yao, Feng; Chen, Wu-Jun; Lu, Qian; Tang, Yan-Yan; Zhang, Min; Yin, Kai; Tang, Chao-Ke] Univ South China, Inst Cardiovasc Res, Key Lab Atherosclerol Hunan Prov, Hengyang, Hunan, Peoples R China; [Zhao, Guo-Jun] Univ South China, Dept Histol & Embryol, Hengyang, Hunan, Peoples R China; [He, Ping-Ping] Univ South China, Sch Nursing, Hengyang, Hunan, Peoples R China; [Fu, Yuchang] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Zhang, Da-Wei] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Zhang, Da-Wei] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB, Canada	University of South China; University of South China; University of South China; University of Alabama System; University of Alabama Birmingham; University of Alberta; University of Alberta	Yin, K (corresponding author), Univ South China, Inst Cardiovasc Res, Key Lab Atherosclerol Hunan Prov, Hengyang, Hunan, Peoples R China.	kaiyinby@yahoo.com.cn; tangchaoke@qq.com	; Zhang, Dawei/ABD-8990-2022	, Wujun/0000-0002-1256-3201; Zhang, Dawei/0000-0001-8279-8041	National Natural Sciences Foundation of China [81200218, 81070220, 81170278]; Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Human Province, China [2008-244]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Human Province, China	The authors gratefully acknowledge the financial support from the National Natural Sciences Foundation of China (81200218, 81070220 and 81170278), and Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions (2008-244) of Human Province, China. http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen H, 2012, CIRC J, V76, P995, DOI 10.1253/circj.CJ-11-0344; de Melo CL, 2009, J AGR FOOD CHEM, V57, P8776, DOI 10.1021/jf900768w; Fitzgerald ML, 2010, ATHEROSCLEROSIS, V211, P361, DOI 10.1016/j.atherosclerosis.2010.01.011; Gonzalez-Ramos R, 2012, FERTIL STERIL, V98, P520, DOI 10.1016/j.fertnstert.2012.06.021; Hao XR, 2009, ATHEROSCLEROSIS, V203, P417, DOI 10.1016/j.atherosclerosis.2008.07.029; Jennewein C, 2010, J BIOL CHEM, V285, P11846, DOI 10.1074/jbc.M109.066399; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Lee D, 2012, ANN NY ACAD SCI, V1271, P118, DOI 10.1111/j.1749-6632.2012.06745.x; Lee J, 2012, J NUTR BIOCHEM, V23, P1, DOI [10.1016/j.jnutbio.2011.03.001, 10.6107/JKHA.2012.23.5.001]; Maitra U, 2013, ARTERIOSCL THROM VAS, V33, P24, DOI 10.1161/ATVBAHA.112.300049; McGillicuddy FC, 2009, CIRCULATION, V119, P1135, DOI 10.1161/CIRCULATIONAHA.108.810721; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Rabi T, 2008, MOL CARCINOGEN, V47, P964, DOI 10.1002/mc.20447; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Stoll G, 2006, STROKE, V37, P1923, DOI 10.1161/01.STR.0000226901.34927.10; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takada Y, 2003, J IMMUNOL, V171, P3278, DOI 10.4049/jimmunol.171.6.3278; Tang SL, 2012, ATHEROSCLEROSIS, V222, P344, DOI 10.1016/j.atherosclerosis.2012.03.005; Tian GP, 2012, BIOCHIMIE, V94, P2749, DOI 10.1016/j.biochi.2012.08.018; Viji V, 2010, INT IMMUNOPHARMACOL, V10, P843, DOI 10.1016/j.intimp.2010.04.013; Wang ZX, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/535918; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Yin K, 2012, J ATHEROSCLER THROMB, V19, P823, DOI 10.5551/jat.12823; Yin K, 2011, J BIOL CHEM, V286, P13834, DOI 10.1074/jbc.M110.202275; Yin K, 2010, MOL MED, V16, P438, DOI 10.2119/molmed.2010.00004; Yogeeswari P, 2005, CURR MED CHEM, V12, P657, DOI 10.2174/0929867053202214; Yu XH, 2012, CIRC J, V76, P1780, DOI 10.1253/circj.CJ-11-1338; Yuan Y, 2012, PROTEIN CELL, V3, P173, DOI 10.1007/s13238-012-2025-6; Zhao GJ, 2012, MOL MED, V18, P149, DOI 10.2119/molmed.2011.00183	32	35	38	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74782	10.1371/journal.pone.0074782	http://dx.doi.org/10.1371/journal.pone.0074782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086374	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700036
J	Benevides, L; Cardoso, CR; Milanezi, CM; Castro-Filice, LS; Barenco, PVC; Sousa, RO; Rodrigues, RM; Mineo, JR; Silva, JS; Silva, NM				Benevides, Luciana; Cardoso, Cristina R.; Milanezi, Cristiane M.; Castro-Filice, Leticia S.; Barenco, Paulo V. C.; Sousa, Romulo O.; Rodrigues, Rosangela M.; Mineo, Jose R.; Silva, Joao S.; Silva, Neide M.			Toxoplasma gondii Soluble Tachyzoite Antigen Triggers Protective Mechanisms against Fatal Intestinal Pathology in Oral Infection of C57BL/6 Mice	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LAMINA PROPRIA; IFN-GAMMA; INTRAEPITHELIAL LYMPHOCYTES; IL-12 PRODUCTION; T-CELLS; PERORAL INFECTION; INTERFERON-GAMMA; RESISTANCE; RECEPTOR	Toxoplasma gondii induces a potent IL-12 response early in infection that results in IFN-gamma-dependent control of parasite growth. It was previously shown that T. gondii soluble tachyzoite antigen (STAg) injected 48 hr before intraperitoneal infection reduces lipoxin A(4) and 5-lipoxygenase (5-LO)-dependent systemic IL-12 and IFN-gamma production as well as hepatic immunopathology. This study investigated the ability of STAg-pretreatment to control the fatal intestinal pathology that develops in C57BL/6 mice orally infected with 100 T. gondii cysts. STAg-pretreatment prolonged the animals' survival by decreasing tissue parasitism and pathology, mainly in the ilea. Protection was associated with decreases in the systemic IFN-gamma levels and IFN-gamma and TNF message levels in the ilea and with increased TGF-beta production in this tissue, but protection was independent of 5-LO and IL-4. STAg-pretreatment decreased CD4(+) T cell, NK cell, CD11b(+) monocyte and CD11b(+)CD11c(+) dendritic cell numbers in the lamina propria and increased CD8(+) T cells in the intestinal epithelial compartment. In parallel, decreases were observed in iNOS and IL-17 expression in this organ. These results demonstrate that pretreatment with STAg can induce the recruitment of protective CD8(+) T cells to the intraepithelial compartment and decrease proinflammatory immune mechanisms that promote intestinal pathology in T. gondii infection.	[Benevides, Luciana; Milanezi, Cristiane M.; Silva, Joao S.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Biochem & Immunol, BR-14049 Ribeirao Preto, SP, Brazil; [Cardoso, Cristina R.] Univ Sao Paulo, Dept Clin Anal Toxicol Bromatol, Ribeirao Preto Coll Pharmaceut Sci, BR-14049 Ribeirao Preto, SP, Brazil; [Castro-Filice, Leticia S.; Barenco, Paulo V. C.; Sousa, Romulo O.; Mineo, Jose R.; Silva, Neide M.] Univ Fed Uberlandia, Inst Biomed Sci, BR-38400 Uberlandia, MG, Brazil; [Rodrigues, Rosangela M.] Univ Fed Goias, Goiania, Go, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Uberlandia; Universidade Federal de Goias	Silva, NM (corresponding author), Univ Fed Uberlandia, Inst Biomed Sci, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil.	nmsilva@icbim.ufu.br	Barenco, Paulo Victor/A-2221-2015; Benevides, Luciana/D-2715-2012; Ribeiro de Barros Cardoso, Cristina/AGO-5764-2022; de Barros Cardoso, Cristina Ribeiro/L-8396-2017; Silva, Neide/C-7813-2013; SILVA, NEIDE MARIA/AAQ-7995-2020; Mineo, Jose R/B-4151-2009; Silva, Joao/A-4484-2008	Ribeiro de Barros Cardoso, Cristina/0000-0002-6156-3144; de Barros Cardoso, Cristina Ribeiro/0000-0002-6156-3144; Silva, Neide/0000-0002-3615-1340; Mineo, Jose R/0000-0002-9010-7228; Silva, Joao/0000-0002-3410-3927; Czarnewski, Paulo/0000-0001-8150-4021	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [00355-11, 20/12, APQ-04312-10]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [481482/2010-5]; Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV); FAPEMIG [20/12]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [grants 00355-11, 20/12; APQ-04312-10]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [grant 481482/2010-5]; Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV); and Rede Mineira which received funding from FAPEMIG [grant 20/12]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; Alexander J, 1998, INT J PARASITOL, V28, P113, DOI 10.1016/S0020-7519(97)00168-9; Aliberti J, 2002, NAT IMMUNOL, V3, P76, DOI 10.1038/ni745; Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Aliberti J, 2002, J EXP MED, V196, P1253, DOI 10.1084/jem.20021183; Arstila T, 2000, J EXP MED, V191, P823, DOI 10.1084/jem.191.5.823; Buzoni-Gatel D, 2006, CELL MICROBIOL, V8, P535, DOI 10.1111/j.1462-5822.2006.00692.x; Buzoni-Gatel D, 2001, GASTROENTEROLOGY, V120, P914, DOI 10.1053/gast.2001.22432a; Cerwenka A, 1999, MICROBES INFECT, V1, P1291, DOI 10.1016/S1286-4579(99)00255-5; CHARDES T, 1994, J IMMUNOL, V153, P4596; Courret N, 2006, BLOOD, V107, P309, DOI 10.1182/blood-2005-02-0666; De Trez C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000494; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Egan CE, 2011, MUCOSAL IMMUNOL, V4, P658, DOI 10.1038/mi.2011.31; Egan CE, 2009, MUCOSAL IMMUNOL, V2, P527, DOI 10.1038/mi.2009.105; Fux B, 2003, INFECT IMMUN, V71, P6392, DOI 10.1128/IAI.71.11.6392-6401.2003; GAZZINELLI RT, 1991, J IMMUNOL, V146, P286; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Guiton R, 2010, J INFECT DIS, V202, P427, DOI 10.1086/653738; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jensen KDC, 2011, CELL HOST MICROBE, V9, P472, DOI 10.1016/j.chom.2011.04.015; Kelly MN, 2005, INFECT IMMUN, V73, P617, DOI 10.1128/IAI.73.1.617-621.2005; KHAN IA, 1995, PARASITE IMMUNOL, V17, P185, DOI 10.1111/j.1365-3024.1995.tb00888.x; Khan IA, 2006, PLOS PATHOG, V2, P484, DOI 10.1371/journal.ppat.0020049; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liesenfeld O, 1999, PARASITE IMMUNOL, V21, P365, DOI 10.1046/j.1365-3024.1999.00237.x; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; Ma GY, 2009, EXP PARASITOL, V122, P41, DOI 10.1016/j.exppara.2009.01.011; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; Mennechet FJD, 2002, J IMMUNOL, V168, P2988, DOI 10.4049/jimmunol.168.6.2988; Mennechet FJD, 2004, EUR J IMMUNOL, V34, P1059, DOI 10.1002/eji.200324416; Moustakas A, 2001, J CELL SCI, V114, P4359; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Passos ST, 2010, J IMMUNOL, V184, P1776, DOI 10.4049/jimmunol.0901843; REIS, 1999, IMMUNITY, V11, P637, DOI DOI 10.1016/S1074-7613(00)80138-7.PUBMED:10591188; REIS, 1997, J EXP MED, V186, P1819, DOI DOI 10.1084/JEM.186.11.1819.PUBMED:9382881; Resende MG, 2008, AN ACAD BRAS CIENC, V80, P85, DOI 10.1590/S0001-37652008000100005; Saleh M, 2011, IMMUNITY, V34, P293, DOI 10.1016/j.immuni.2011.03.008; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; Schulthess J, 2012, IMMUNITY, V37, P108, DOI 10.1016/j.immuni.2012.05.013; Silva NM, 2009, EXP PARASITOL, V123, P65, DOI 10.1016/j.exppara.2009.05.011; Suzuki Y, 1996, J IMMUNOL, V157, P2564; Suzuki Y, 2000, J IMMUNOL, V164, P5375, DOI 10.4049/jimmunol.164.10.5375; Vossenkamper A, 2004, EUR J IMMUNOL, V34, P3197, DOI 10.1002/eji.200424993; Wang S, 2013, TRANSPL P, V45, P677, DOI 10.1016/j.transproceed.2012.02.036; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	52	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75138	10.1371/journal.pone.0075138	http://dx.doi.org/10.1371/journal.pone.0075138			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086456	Green Published, gold, Green Submitted			2022-12-27	WOS:000325025200028
J	Adler, UC; Kruger, S; Teut, M; Ludtke, R; Schutzler, L; Martins, F; Willich, SN; Linde, K; Witt, CM				Adler, Ubiratan C.; Krueger, Stephanie; Teut, Michael; Luedtke, Rainer; Schuetzler, Lena; Martins, Friederike; Willich, Stefan N.; Linde, Klaus; Witt, Claudia M.			Homeopathy for Depression: A Randomized, Partially Double-Blind, Placebo-Controlled, Four-Armed Study (DEP-HOM)	PLOS ONE			English	Article							COMMUNICATION; OUTCOMES	Background: The specific clinical benefit of the homeopathic consultation and of homeopathic remedies in patients with depression has not yet been investigated. Aims: To investigate the 1) specific effect of individualized homeopathic Q-potencies compared to placebo and 2) the effect of an extensive homeopathic case taking (case history I) compared to a shorter, rather conventional one (case history II) in the treatment of acute major depression (moderate episode) after six weeks. Methods: A randomized, partially double-blind, placebo-controlled, four-armed trial using a 262 factorial design with a six-week study duration per patient was performed. Results: A total of 44 from 228 planned patients were randomized (2:1:2:1 randomization: 16 homeopathic Q-potencies/case history I, 7 placebo/case history I, 14 homeopathic Q-potencies/case history II, 7 placebo/case history II). Because of recruitment problems, the study was terminated prior to full recruitment, and was underpowered for the preplanned confirmatory hypothesis testing. Exploratory data analyses showed heterogeneous and inconclusive results with large variance in the sample. The mean difference for the Hamilton-D after 6 weeks was 2.0 (95% CI -1.2; 5.2) for Q-potencies vs. placebo and -3.1 (-5.9; 20.2) for case history I vs. case history II. Overall, no consistent or clinically relevant results across all outcomes between homeopathic Q-potencies versus placebo and homeopathic versus conventional case taking were observed. The frequency of adverse events was comparable for all groups. Conclusions: Although our results are inconclusive, given that recruitment into this trial was very difficult and we had to terminate early, we cannot recommend undertaking a further trial addressing this question in a similar setting. Prof. Dr. Claudia Witt had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. registration:	[Adler, Ubiratan C.; Teut, Michael; Schuetzler, Lena; Martins, Friederike; Willich, Stefan N.; Witt, Claudia M.] Charite, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany; [Krueger, Stephanie] Charite, Teaching Hosp, Head Ctr Womens Mental Hlth, Vivantes Humboldt Klin, D-13353 Berlin, Germany; [Luedtke, Rainer] Karl & Veron Carstens Fdn, Essen, Germany; [Linde, Klaus] Tech Univ Munich, Inst Gen Practice, D-80290 Munich, Germany; [Witt, Claudia M.] Univ Maryland, Sch Med, Ctr Integrat Med, Baltimore, MD 21201 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Munich; University System of Maryland; University of Maryland Baltimore	Witt, CM (corresponding author), Charite, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany.	claudia.witt@charite.de	Witt, Claudia M./AAX-2370-2021	Witt, Claudia M./0000-0002-5440-7805; Linde, Klaus/0000-0002-2902-970X; Teut, Michael/0000-0001-7150-7165	chair for complementary medicine research, Carstens Foundation	chair for complementary medicine research, Carstens Foundation	This project was funded within the grant of the chair for complementary medicine research by the Carstens Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler UC, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep114; Adler UC, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-43; Adler UC, 2009, INT J HIGH DILUTION, V8, P173; Bawden S, 2012, HOMEOPATHY, V101, P51, DOI 10.1016/j.homp.2011.10.003; Becker-Witt C, 2004, FORSCH KOMP KLAS NAT, V11, P98, DOI 10.1159/000078231; Bullinger M, 1998, SF 36 FRAGEBOGEN ZUM; Finset A, 2006, PATIENT EDUC COUNS, V60, P115, DOI 10.1016/j.pec.2005.03.005; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Frei H, 2009, HOMEOPATHY, V98, P49, DOI 10.1016/j.homp.2008.10.002; Grolleau A, 2011, EUR PSYCHIAT; Hahnemann S, 1992, ORGANON HEILKUNST; Hautzinger M, 1995, BECK DEPRESSIONS INV, P5; Jacobs J, 1998, ARCH FAM MED, V7, P537, DOI 10.1001/archfami.7.6.537; Katz T, 2005, Homeopathy, V94, P145, DOI 10.1016/j.homp.2005.04.002; National Institute for Clinical Excellence, 2004, DEPR MAN DEPR PRIM S; National Institute for Clinical Excellence, DEPR TREATM MAN DEPR; Posner K, COLUMBIA BEURTEILUNK; Sevar R, 2000, Br Homeopath J, V89, P178, DOI 10.1054/homp.1999.0438; Siebenwirth J, 2009, FORSCH KOMPLEMENTMED, V16, P315, DOI 10.1159/000242434; Spence DS, 2005, J ALTERN COMPLEM MED, V11, P793, DOI 10.1089/acm.2005.11.793; Steinsbekk A, 2008, HOMEOPATHY, V97, P178, DOI 10.1016/j.homp.2008.08.005; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Thompson EA, 2008, HOMEOPATHY, V97, P114, DOI 10.1016/j.homp.2008.06.005; Walsh BT, 2002, JAMA-J AM MED ASSOC, V287, P1840, DOI 10.1001/jama.287.14.1840; Weyer G, 2004, INT SKALEN PSYCHIAT; Witt CM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-413; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Zajecka J, 2010, J CLIN PSYCHOPHARM, V30, P135, DOI 10.1097/JCP.0b013e3181d420a7	28	7	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74537	10.1371/journal.pone.0074537	http://dx.doi.org/10.1371/journal.pone.0074537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086352	gold, Green Published, Green Submitted			2022-12-27	WOS:000326520200034
J	Aller, E; Sanchez-Sanchez, AV; Chicote, JU; Garcia-Garcia, G; Udaondo, P; Cavalle, L; Piquer-Gil, M; Garcia-Espana, A; Diaz-Llopis, M; Millan, JM; Mullor, JL				Aller, Elena; Sanchez-Sanchez, Ana V.; Chicote, Javier U.; Garcia-Garcia, Gema; Udaondo, Patricia; Cavalle, Laura; Piquer-Gil, Marina; Garcia-Espana, Antonio; Diaz-Llopis, Manuel; Millan, Jose M.; Mullor, Jose L.			Analysis of the Ush2a Gene in Medaka Fish (Oryzias latipes)	PLOS ONE			English	Article							USHER-SYNDROME; RETINITIS-PIGMENTOSA; PROTEIN; ZEBRAFISH; MUTATIONS; EXPRESSION; HEARING; MODEL; CILIOPATHIES; DEAFNESS	Patients suffering from Usher syndrome (USH) exhibit sensorineural hearing loss, retinitis pigmentosa (RP) and, in some cases, vestibular dysfunction. USH is the most common genetic disorder affecting hearing and vision and is included in a group of hereditary pathologies associated with defects in ciliary function known as ciliopathies. This syndrome is clinically classified into three types: USH1, USH2 and USH3. USH2 accounts for well over one-half of all Usher cases and mutations in the USH2A gene are responsible for the majority of USH2 cases, but also for atypical Usher syndrome and recessive nonsyndromic RP. Because medaka fish (Oryzias latypes) is an attractive model organism for genetic-based studies in biomedical research, we investigated the expression and function of the USH2A ortholog in this teleost species. Ol-Ush2a encodes a protein of 5.445 aa codons, containing the same motif arrangement as the human USH2A. Ol-Ush2a is expressed during early stages of medaka fish development and persists into adulthood. Temporal Ol-Ush2a expression analysis using whole mount in situ hybridization (WMISH) on embryos at different embryonic stages showed restricted expression to otoliths and retina, suggesting that Ol-Ush2a might play a conserved role in the development and/or maintenance of retinal photoreceptors and cochlear hair cells. Knockdown of Ol-Ush2a in medaka fish caused embryonic developmental defects (small eyes and heads, otolith malformations and shortened bodies with curved tails) resulting in late embryo lethality. These embryonic defects, observed in our study and in other ciliary disorders, are associated with defective cell movement specifically implicated in left-right (LR) axis determination and planar cell polarity (PCP).	[Aller, Elena; Millan, Jose M.] CIBER Enfermedades Raras CIBERER, Valencia, Spain; [Aller, Elena; Sanchez-Sanchez, Ana V.; Garcia-Garcia, Gema; Udaondo, Patricia; Cavalle, Laura; Piquer-Gil, Marina; Diaz-Llopis, Manuel; Millan, Jose M.; Mullor, Jose L.] IIS La Fe, Grp Invest Enfermedades Neurosensoriales, Valencia, Spain; [Chicote, Javier U.; Garcia-Espana, Antonio] Univ Rovira & Virgili, Inst Invest Sanitaria Rovira & Virgili IISPV, Hosp Joan XXIII, Unitat Recerca, E-43007 Tarragona, Spain; [Udaondo, Patricia; Diaz-Llopis, Manuel] Hosp Univ La Fe, Serv Oftalmol, Valencia, Spain; [Cavalle, Laura] Hosp Univ La Fe, Serv Otorrinolaringol, Valencia, Spain; [Millan, Jose M.] Hosp Univ La Fe, Unidad Genet & Diagnost Prenatal, Valencia, Spain; [Mullor, Jose L.] Biopolo La Fe Hosp La Fe, Bionos SL, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe	Aller, E (corresponding author), CIBER Enfermedades Raras CIBERER, Valencia, Spain.	elenaller@yahoo.es; jlmullor@iislafe.es	garcia-españa, antonio/I-4756-2015; García-García, Gema/J-9387-2015; Garcia, Gema/AEN-8767-2022; Aller, Elena/A-4803-2010	garcia-españa, antonio/0000-0002-9957-3161; García-García, Gema/0000-0002-2113-0600; Aller, Elena/0000-0001-7973-5250; UGARTE CHICOTE, JAVIER/0000-0001-6771-8584; Piquer Gil, Marina/0000-0003-1941-7175; Udaondo, Patricia/0000-0002-5241-0066	Conselleria de Sanitat de la Comunitat Valenciana [GE-011/10]; Fondo de Investigaciones Sanitarias, FIS [PI10/01825]; Ministerio de Economia y Competitividad [BFU2009-10808]; MICINN (Spain) [CSD-2010-00065]; Research Stabilization Program of the Instituto de Salud Carlos III-Institut Catala de la Salut in Catalonia	Conselleria de Sanitat de la Comunitat Valenciana; Fondo de Investigaciones Sanitarias, FIS(Instituto de Salud Carlos III); Ministerio de Economia y Competitividad(Spanish Government); MICINN (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Research Stabilization Program of the Instituto de Salud Carlos III-Institut Catala de la Salut in Catalonia	This work was supported by grants from the "Conselleria de Sanitat de la Comunitat Valenciana" (GE-011/10) and from the "Fondo de Investigaciones Sanitarias, FIS" (PI10/01825) and Ministerio de Economia y Competitividad BFU2009-10808. The authors would like to thank MICINN (Spain) for financial support (Projects CONSOLIDER INGENIO CSD-2010-00065). AGE is supported by the Research Stabilization Program of the Instituto de Salud Carlos III-Institut Catala de la Salut in Catalonia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adato A, 2005, HUM MOL GENET, V14, P3921, DOI 10.1093/hmg/ddi416; Aller E, 2004, EUR J HUM GENET, V12, P407, DOI 10.1038/sj.ejhg.5201138; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Baux D, 2007, HUM MUTAT, V28, P781, DOI 10.1002/humu.20513; Camp E, 2009, STEM CELLS, V27, P2081, DOI 10.1002/stem.133; Caron A, 2012, DEVELOPMENT, V139, P514, DOI 10.1242/dev.071746; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Dreyer B, 2008, HUM MUTAT, V29, P451, DOI 10.1002/humu.9524; Ebermann I, 2007, HUM GENET, V121, P203, DOI 10.1007/s00439-006-0304-0; Ebermann I, 2010, J CLIN INVEST, V120, P1812, DOI 10.1172/JCI39715; Ernest S, 2000, HUM MOL GENET, V9, P2189, DOI 10.1093/hmg/9.14.2189; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P629, DOI 10.1016/j.mod.2004.05.010; Garcia-Espana A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004680; Garcia-Garcia G, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-65; Gibert Y, 2005, GENE, V353, P200, DOI 10.1016/j.gene.2005.05.015; Glover G, 2012, MOL VIS, V18, P2309; Hyodo-Taguchi Y, 1996, FISH BIOL J MEDAKA, V8, p[29, 30]; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Khanna H, 2005, J BIOL CHEM, V280, P33580, DOI 10.1074/jbc.M505827200; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Liu XQ, 2007, P NATL ACAD SCI USA, V104, P4413, DOI 10.1073/pnas.0610950104; Lu B, 2010, INVEST OPHTH VIS SCI, V51, P2269, DOI 10.1167/iovs.09-4526; Maerker T, 2008, HUM MOL GENET, V17, P71, DOI 10.1093/hmg/ddm285; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Millan JM, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/417217; Pearsall N, 2002, HEARING RES, V174, P55, DOI 10.1016/S0378-5955(02)00635-4; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petit C, 2009, NAT NEUROSCI, V12, P703, DOI 10.1038/nn.2330; Phillips JB, 2011, DIS MODEL MECH, V4, P786, DOI 10.1242/dmm.006429; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Riazuddin S, 2012, NAT GENET, V44, P1265, DOI 10.1038/ng.2426; Rivolta C, 2000, AM J HUM GENET, V66, P1975, DOI 10.1086/302926; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Seiler C, 2005, DEVELOPMENT, V132, P615, DOI 10.1242/dev.01591; Shu XH, 2011, INVEST OPHTH VIS SCI, V52, P2960, DOI 10.1167/iovs.10-6800; Shu XH, 2010, HUM MOL GENET, V19, P657, DOI 10.1093/hmg/ddp533; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Tucker RP, 2010, BIOL BULL-US, V218, P105, DOI 10.1086/BBLv218n2p105; van Reeuwijk J, 2011, HUM MOL GENET, V20, pR149, DOI 10.1093/hmg/ddr354; van Wijk E, 2004, AM J HUM GENET, V74, P738, DOI 10.1086/383096; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Williams DS, 2008, VISION RES, V48, P433, DOI 10.1016/j.visres.2007.08.015; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; YAMAMOTO T, 1975, MEDAKA KILLIFISH BIO; Yokoi H, 2007, DEV BIOL, V304, P326, DOI 10.1016/j.ydbio.2006.12.043	47	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74995	10.1371/journal.pone.0074995	http://dx.doi.org/10.1371/journal.pone.0074995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086419	Green Submitted, Green Published, gold			2022-12-27	WOS:000326520200069
J	Chen, PF; Zhang, J; Zhan, Y; Su, JJ; Du, YR; Xu, GL; Shi, YF; Siebenlist, U; Zhang, XR				Chen, Pengfei; Zhang, Jun; Zhan, Yu; Su, Juanjuan; Du, Yarui; Xu, Guoliang; Shi, Yufang; Siebenlist, Ulrich; Zhang, Xiaoren			Established Thymic Epithelial Progenitor/Stem Cell-Like Cell Lines Differentiate into Mature Thymic Epithelial Cells and Support T Cell Development	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; NEGATIVE SELECTION; MICROENVIRONMENT; IDENTIFICATION; PROLIFERATION; MAINTENANCE; GENERATION; ANTIGENS; DNMT3A; GROWTH	Common thymic epithelial progenitor/stem cells (TEPCs) differentiate into cortical and medullary thymic epithelial cells (TECs), which are required for the development and selection of thymocytes. Mature TEC lines have been widely established. However, the establishment of TEPC lines is rarely reported. Here we describe the establishment of thymic epithelial stomal cell lines, named TSCs, from fetal thymus. TSCs express some of the markers present on tissue progenitor/stem cells such as Sca-1. Gene expression profiling verifies the thymic identity of TSCs. RANK stimulation of these cells induces expression of autoimmune regulator (Aire) and Aire-dependent tissue-restricted antigens (TRAs) in TSCs in vitro. TSCs could be differentiated into medullary thymic epithelial cell-like cells with exogenously expressed NF-kappa B subunits ReIB and p52. Importantly, upon transplantation under the kidney capsules of nude mice, TSCs are able to differentiate into mature TEC-like cells that can support some limited development of T cells in vivo. These findings suggest that the TSC lines we established bear some characteristics of TEPC cells and are able to differentiate into functional TEC-like cells in vitro and in vivo. The cloned TEPC-like cell lines may provide useful tools to study the differentiation of mature TEC cells from precursors.	[Chen, Pengfei; Zhan, Yu; Su, Juanjuan; Shi, Yufang; Zhang, Xiaoren] Chinese Acad Sci, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai, Peoples R China; [Chen, Pengfei; Zhan, Yu; Su, Juanjuan; Shi, Yufang; Zhang, Xiaoren] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Zhang, Jun] Bengbu Med Coll, Affiliated Hosp 1, Dept Transfus, Bengbu, Anhui, Peoples R China; [Du, Yarui; Xu, Guoliang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China; [Siebenlist, Ulrich] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	Chinese Academy of Sciences; Shanghai Jiao Tong University; Bengbu Medical College; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Zhang, XR (corresponding author), Chinese Acad Sci, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai, Peoples R China.	xrzhang@sibs.ac.cn	Shi, Yufang/AAE-4431-2020; Su, Juanjuan/C-4040-2018	Shi, Yufang/0000-0001-8964-319X; Su, Juanjuan/0000-0002-6159-1954	National Basic Research program [2011CB946102]; National Natural Science Foundation of China [90919017, 30972695, 31270937]; Chinese Academy of Sciences [KSCX1-YW-22]; National Key Programs on Infectious Disease [2008ZX10002-014]; National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000722] Funding Source: NIH RePORTER	National Basic Research program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Programs on Infectious Disease; National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Basic Research program (2011CB946102), the National Natural Science Foundation of China (90919017, 30972695 and 31270937), Knowledge Innovation Project of Chinese Academy of Sciences (KSCX1-YW-22), National Key Programs on Infectious Disease (2008ZX10002-014) and with support from the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Anderson G, 1996, ANNU REV IMMUNOL, V14, P73, DOI 10.1146/annurev.immunol.14.1.73; Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; Baik S, 2013, EUR J IMMUNOL, V43, P589, DOI 10.1002/eji.201243209; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; Blanpain C, 2007, NAT CELL BIOL, V9, P731, DOI 10.1038/ncb0707-731; Boehm T, 2008, CURR OPIN IMMUNOL, V20, P178, DOI 10.1016/j.coi.2008.03.001; Bonfanti P, 2010, NATURE, V466, P978, DOI 10.1038/nature09269; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen W F, 1992, Eur Cytokine Netw, V3, P43; Chin RK, 2003, NAT IMMUNOL, V4, P1121, DOI 10.1038/ni982; Depreter MGL, 2008, P NATL ACAD SCI USA, V105, P961, DOI 10.1073/pnas.0711170105; FAAS SJ, 1993, EUR J IMMUNOL, V23, P1201, DOI 10.1002/eji.1830230602; FARR AG, 1989, CELL IMMUNOL, V119, P427, DOI 10.1016/0008-8749(89)90256-6; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Guerder S, 2012, CURR OPIN IMMUNOL, V24, P99, DOI 10.1016/j.coi.2012.01.008; Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Liu B, 2013, DEVELOPMENT, V140, P780, DOI 10.1242/dev.085035; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Medawar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003441; Murumagi A, 2003, J BIOL CHEM, V278, P19784, DOI 10.1074/jbc.M210437200; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Papadopoulou AS, 2012, NAT IMMUNOL, V13, P181, DOI 10.1038/ni.2193; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Rossi SW, 2007, EUR J IMMUNOL, V37, P2411, DOI 10.1002/eji.200737275; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; SHORES EW, 1991, EUR J IMMUNOL, V21, P1657, DOI 10.1002/eji.1830210711; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; SURH CD, 1992, J EXP MED, V176, P611, DOI 10.1084/jem.176.2.611; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Zhang XR, 2007, IMMUNITY, V27, P438, DOI 10.1016/j.immuni.2007.07.017; Zhu MZ, 2008, IMMUNITY, V29, P386, DOI 10.1016/j.immuni.2008.09.001	39	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75222	10.1371/journal.pone.0075222	http://dx.doi.org/10.1371/journal.pone.0075222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086471	Green Submitted, Green Published, gold			2022-12-27	WOS:000326520200090
J	Gaschler, R; Vaterrodt, B; Frensch, PA; Eichler, A; Haider, H				Gaschler, Robert; Vaterrodt, Bianca; Frensch, Peter A.; Eichler, Alexandra; Haider, Hilde			Spontaneous Usage of Different Shortcuts Based on the Commutativity Principle	PLOS ONE			English	Article							ADDITIVE COMMUTATIVITY; CHILDRENS ADDITION; KNOWLEDGE; INVERSION; YOUNG; PRESCHOOLERS; FLEXIBILITY; MATHEMATICS; EXPERTISE; SKILL	Based on research on expertise a person can be said to possess integrated conceptual knowledge when she/he is able to spontaneously identify task relevant information in order to solve a problem efficiently. Despite the lack of instruction or explicit cueing, the person should be able to recognize which shortcut strategy can be applied - even when the task context differs from the one in which procedural knowledge about the shortcut was originally acquired. For mental arithmetic, first signs of such adaptive flexibility should develop already in primary school. The current study introduces a paper-and-pencil-based as well as an eyetracking-based approach to unobtrusively measure how students spot and apply (known) shortcut options in mental arithmetic. We investigated the development and the relation of the spontaneous use of two strategies derived from the mathematical concept of commutativity. Children from grade 2 to grade 7 and university students solved three-addends addition problems, which are rarely used in class. Some problems allowed the use of either of two commutativity-based shortcut strategies. Results suggest that from grade three onwards both of the shortcuts were used spontaneously and application of one shortcut correlated positively with application of the other. Rate of spontaneous usage was substantial but smaller than in an instructed variant. Eyetracking data suggested similar fixation patterns for spontaneous an instructed shortcut application. The data are consistent with the development of an integrated concept of the mathematical principle so that it can be spontaneously applied in different contexts and strategies.	[Gaschler, Robert] Univ Koblenz Landau, Koblenz, Germany; [Gaschler, Robert; Vaterrodt, Bianca; Frensch, Peter A.] Humboldt Univ, D-10099 Berlin, Germany; [Eichler, Alexandra; Haider, Hilde] Univ Cologne, D-50931 Cologne, Germany	University of Koblenz & Landau; Humboldt University of Berlin; University of Cologne	Gaschler, R (corresponding author), Univ Koblenz Landau, Koblenz, Germany.	gaschler@uni-landau.de			Deutsche Forschungsgemeinschaft (DFG) [FR 1471/12-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Grant FR 1471/12-1 from the Deutsche Forschungsgemeinschaft (DFG, www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Jr, 2000, ADV INSTR P, V5, P1; Baroody AJ, 2006, COGNITION INSTRUCT, V24, P123, DOI 10.1207/s1532690xci2401_3; Baroody AJ, 2003, STUD MATH TH LEARN, P127; Baroody AJ, 1999, COGNITION INSTRUCT, V17, P137, DOI 10.1207/S1532690XCI170201; Baroody AJ., 1983, J RES MATH EDUC, V14, P156, DOI [10.2307/748379, DOI 10.2307/748379]; BAROODY AJ, 1984, COGNITION INSTRUCT, V1, P321, DOI [DOI 10.1207/S1532690XCI0103_3, DOI 10.1207/S1532690XCI0103_]; Bilalic M, 2008, COGNITIVE PSYCHOL, V56, P73, DOI 10.1016/j.cogpsych.2007.02.001; Bilalic M, 2007, INTELLIGENCE, V35, P457, DOI 10.1016/j.intell.2006.09.005; Bisanz J., 1990, CHILDRENS STRATEGIES, P213; Bisanz J, 2009, MATH THINK LEARN, V11, P10, DOI 10.1080/10986060802583907; Bryant P, 1999, J EXP CHILD PSYCHOL, V74, P194, DOI 10.1006/jecp.1999.2517; Canobi K., 2002, ED PSYCHOL, V22, P513, DOI DOI 10.1080/0144341022000023608; Canobi KH, 2009, J EXP CHILD PSYCHOL, V102, P131, DOI 10.1016/j.jecp.2008.07.008; Canobi KH, 2003, DEV PSYCHOL, V39, P521, DOI 10.1037/0012-1649.39.3.521; Canobi KH, 1998, DEV PSYCHOL, V34, P882, DOI 10.1037/0012-1649.34.5.882; Chevalier N, 2008, DEVELOPMENTAL SCI, V11, P339, DOI 10.1111/j.1467-7687.2008.00679.x; Dube AK, 2010, CAN J EXP PSYCHOL, V64, P60, DOI 10.1037/a0017756; Frensch PA, 2008, LEARNING MEMORY COMP, P579; Geary D. C., 2006, COGNITION PERCEPTION, V2, P777, DOI [10.1002/9780470147658.CHPSY0218, DOI 10.1002/9780470147658.CHPSY0218]; Geary DC, 2008, EPORT TASK GROUP LEA; GENTNER D, 1986, COGNITIVE SCI, V10, P277, DOI 10.1207/s15516709cog1003_2; Gilmore CK, 2006, BRIT J EDUC PSYCHOL, V76, P309, DOI 10.1348/000709905X39125; Gray WD, 2006, PSYCHOL REV, V113, P461, DOI 10.1037/0033-295X.113.3.461; Haider H, 2005, CONSCIOUS COGN, V14, P495, DOI 10.1016/j.concog.2004.12.002; Haider H, 1996, COGNITIVE PSYCHOL, V30, P304, DOI 10.1006/cogp.1996.0009; Hannula MM, 2010, J EXP CHILD PSYCHOL, V107, P394, DOI 10.1016/j.jecp.2010.06.004; Hannula MM, 2005, LEARN INSTR, V15, P237, DOI 10.1016/j.learninstruc.2005.04.005; Heinze A, 2009, ZDM-MATH EDUC, V41, P591, DOI 10.1007/s11858-009-0205-5; Klein JS, 2000, CAN J EXP PSYCHOL, V54, P105, DOI 10.1037/h0087333; KOEDINGER KR, 1990, COGNITIVE SCI, V14, P511, DOI 10.1207/s15516709cog1404_2; Masson MEJ, 2003, CAN J EXP PSYCHOL, V57, P203, DOI 10.1037/h0087426; McMullen JA, 2011, PME CONFERENCE PROCE, P217; Prather RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048868; Prather RW, 2009, DEV REV, V29, P221, DOI 10.1016/j.dr.2009.09.001; Renton M., 1996, EDUC PSYCHOL, V16, P407, DOI [DOI 10.1080/0144341960160405, 10.1080/0144341960160405]; Resnick L. B., 1992, ANAL ARITHMETIC MATH, P373; Rittle-Johnson B, 2001, J EDUC PSYCHOL, V93, P346, DOI 10.1037/0022-0663.93.2.346; Rittle-Johnson B., 1998, DEV MATH SKILL, P75, DOI DOI 10.1016/JJECP.2009.02.007; Robinson KM, 2009, J EXP CHILD PSYCHOL, V103, P532, DOI 10.1016/j.jecp.2008.12.002; Schneider M, 2010, DEV PSYCHOL, V46, P178, DOI 10.1037/a0016701; Selter C, 2009, ZDM-MATH EDUC, V41, P619, DOI 10.1007/s11858-009-0203-7; SIEGLER RS, 1989, J EDUC PSYCHOL, V81, P497; Siegler RS, ORIGINS COGNITIVE SK, P229; Sloutsky VM, 2008, CHILD DEV, V79, P639, DOI 10.1111/j.1467-8624.2008.01148.x; Star JR, 2006, CONTEMP EDUC PSYCHOL, V31, P280, DOI 10.1016/j.cedpsych.2005.08.001; STERN E, 1992, CONTEMP EDUC PSYCHOL, V17, P266, DOI 10.1016/0361-476X(92)90065-7; Torbeyns J, 2009, EDUC STUD MATH, V71, P1, DOI 10.1007/s10649-008-9155-z; Touron DR, 2004, MEM COGNITION, V32, P298, DOI 10.3758/BF03196860; Verschaffel L, RES MATH LEARNING IN, P153; Verschaffel L, 2009, EUR J PSYCHOL EDUC, V24, P335, DOI 10.1007/BF03174765; Weaver JF, 1982, ADDITION SUBTRACTION; Wilkins JLM, 2001, J EXP CHILD PSYCHOL, V79, P23, DOI 10.1006/jecp.2000.2580; Yehene E, 2007, ACTA PSYCHOL, V126, P169, DOI 10.1016/j.actpsy.2006.11.007	53	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74972	10.1371/journal.pone.0074972	http://dx.doi.org/10.1371/journal.pone.0074972			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	246EK	24086413	gold, Green Submitted, Green Published			2022-12-27	WOS:000326520200064
J	Gilbert, MK; Bland, JM; Shockey, JM; Cao, H; Hinchliffe, DJ; Fang, DD; Naoumkina, M				Gilbert, Matthew K.; Bland, John M.; Shockey, Jay M.; Cao, Heping; Hinchliffe, Doug J.; Fang, David D.; Naoumkina, Marina			A Transcript Profiling Approach Reveals an Abscisic Acid-Specific Glycosyltransferase (UGT73C14) Induced in Developing Fiber of Ligon lintless-2 Mutant of Cotton (Gossypium hirsutum L.)	PLOS ONE			English	Article							PLANT-GROWTH SUBSTANCES; UDP-GLYCOSYLTRANSFERASE; GENOMICS APPROACH; EXPRESSION; METABOLISM; GENE; TRISTETRAPROLIN; GLYCOSYLATION; BIOSYNTHESIS; HYDROLYSIS	Ligon lintless-2, a monogenic dominant cotton (Gossypium hirsutum L.) fiber mutation, causing extreme reduction in lint fiber length with no pleiotropic effects on vegetative growth, represents an excellent model system to study fiber elongation. A UDP-glycosyltransferase that was highly expressed in developing fibers of the mutant Ligon lintless-2 was isolated. The predicted amino acid sequence showed similar to 53% similarity with Arabidopsis UGT73C sub-family members and the UDP-glycosyltransferase was designated as UGT73C14. When expressed in Escherichia coli as a recombinant protein with a maltose binding protein tag, UGT73C14 displayed enzymatic activity toward ABA and utilized UDP-glucose and UDP-galactose as the sugar donors. The recombinant UGT73C14 converted natural occurring isoform (+)-cis, trans-ABA better than (+)-trans, trans-ABA and (-)-cis, trans-ABA. Transgenic Arabidopsis plants constitutively overexpressing UGT73C14 did not show phenotypic changes under standard growth conditions. However, the increased glycosylation of ABA resulted in phenotypic changes in post-germinative growth and seedling establishment, confirming in vivo activity of UGT73C14 for ABA. This suggests that the expression level of UGT73C14 is regulated by the observed elevated levels of ABA in developing fibers of the Li-2 mutant line and may be involved in the regulation of ABA homeostasis.	[Gilbert, Matthew K.; Fang, David D.; Naoumkina, Marina] USDA ARS, So Reg Res Ctr, Cotton Fiber Biosci Res Unit, New Orleans, LA USA; [Bland, John M.] USDA ARS, So Reg Res Ctr, Food Proc & Sensory Qual Res Unit, New Orleans, LA USA; [Shockey, Jay M.; Cao, Heping] USDA ARS, So Reg Res Ctr, Commod Utilizat Res Unit, New Orleans, LA USA; [Hinchliffe, Doug J.] USDA ARS, So Reg Res Ctr, Cotton Chem & Utilizat Res Unit, New Orleans, LA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Naoumkina, M (corresponding author), USDA ARS, So Reg Res Ctr, Cotton Fiber Biosci Res Unit, POB 19687, New Orleans, LA USA.	marina.naoumkina@ars.usda.gov	Cao, Heping/AAC-1666-2021; FANG, DAVID/AAV-5774-2020	FANG, DAVID/0000-0003-0036-5459; Cao, Heping/0000-0002-0958-1468; Bland, John/0000-0003-1167-7415; Shockey, Jay/0000-0002-5057-5457	United States Department of Agriculture-Agricultural Research Service [6435-21000-017-00D]; Cotton Incorporated project [12-210]	United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Cotton Incorporated project	This research was funded by United States Department of Agriculture-Agricultural Research Service project number 6435-21000-017-00D and Cotton Incorporated project number 12-210. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achnine L, 2005, PLANT J, V41, P875, DOI 10.1111/j.1365-313X.2005.02344.x; BEASLEY CA, 1974, AM J BOT, V61, P188, DOI 10.2307/2441189; BEASLEY CA, 1973, AM J BOT, V60, P130, DOI 10.2307/2441099; Bowles D, 2006, ANNU REV PLANT BIOL, V57, P567, DOI 10.1146/annurev.arplant.57.032905.105429; BOYER GL, 1982, PLANT PHYSIOL, V70, P227, DOI 10.1104/pp.70.1.227; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao HP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-73; Cao HP, 2004, BIOCHEMISTRY-US, V43, P13724, DOI 10.1021/bi049014y; Cao HP, 2004, J BIOL CHEM, V279, P21489, DOI 10.1074/jbc.M400900200; CARPITA NC, 1981, J BIOL CHEM, V256, P308; Chen JG, 1997, J PLANT GROWTH REGUL, V16, P181, DOI 10.1007/PL00006994; Chen XD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030056; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dietz KJ, 2000, J EXP BOT, V51, P937, DOI 10.1093/jexbot/51.346.937; Dowd MK, 2001, IND CROP PROD, V14, P113, DOI 10.1016/S0926-6690(00)00094-7; DRUMMOND AJ, 2011, ENEIOUS V6 1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FRANZ G, 1969, PHYTOCHEMISTRY, V8, P737, DOI 10.1016/S0031-9422(00)85845-8; Hendrix B, 2005, ANN BOT-LONDON, V95, P789, DOI 10.1093/aob/mci078; Hinchliffe DJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-445; Hou BK, 2004, J BIOL CHEM, V279, P47822, DOI 10.1074/jbc.M409569200; Jones P, 2001, PLANTA, V213, P164, DOI 10.1007/s004250000492; Karaca M, 2002, J HERED, V93, P221, DOI 10.1093/jhered/93.3.221; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kim JH, 2006, BIOSCI BIOTECH BIOCH, V70, P1471, DOI 10.1271/bbb.60006; Kubo A, 2004, ARCH BIOCHEM BIOPHYS, V429, P198, DOI 10.1016/j.abb.2004.06.021; LEHMANN H, 1988, J PLANT PHYSIOL, V132, P98, DOI 10.1016/S0176-1617(88)80191-3; LESHEM Y, 1974, BIOCHEM BIOPH RES CO, V57, P526, DOI 10.1016/0006-291X(74)90964-4; Lim EK, 2005, TETRAHEDRON-ASYMMETR, V16, P143, DOI 10.1016/j.tetasy.2004.11.062; Lim EK, 2004, EMBO J, V23, P2915, DOI 10.1038/sj.emboj.7600295; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; Machado A, 2009, PLANT J, V59, P52, DOI 10.1111/j.1365-313X.2009.03847.x; Mackenzie PI, 1997, PHARMACOGENETICS, V7, P255, DOI 10.1097/00008571-199708000-00001; Mansoor S, 2012, TRENDS BIOTECHNOL, V30, P521, DOI 10.1016/j.tibtech.2012.06.003; Modolo LV, 2007, PLANT MOL BIOL, V64, P499, DOI 10.1007/s11103-007-9167-6; Naoumkina MA, 2010, PLANT CELL, V22, P850, DOI 10.1105/tpc.109.073270; NARBUTH EV, 1990, J HERED, V81, P131; Paquette S, 2003, PHYTOCHEMISTRY, V62, P399, DOI 10.1016/S0031-9422(02)00558-7; Paquette SM, 2009, PHYTOCHEMISTRY, V70, P1940, DOI 10.1016/j.phytochem.2009.08.024; Piotrowska A, 2011, PHYTOCHEMISTRY, V72, P2097, DOI 10.1016/j.phytochem.2011.08.012; Poppenberger B, 2005, P NATL ACAD SCI USA, V102, P15253, DOI 10.1073/pnas.0504279102; Priest DM, 2006, PLANT J, V46, P492, DOI 10.1111/j.1365-313X.2006.02701.x; Priest DM, 2005, FEBS LETT, V579, P4454, DOI 10.1016/j.febslet.2005.06.084; Qin J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn518; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANDERMANN H, 1992, TRENDS BIOCHEM SCI, V17, P82, DOI 10.1016/0968-0004(92)90507-6; Shibuya M, 2010, FEBS LETT, V584, P2258, DOI 10.1016/j.febslet.2010.03.037; Taliercio EW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-22; Tamura K, 2011, MOL BIOL EVOL; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vilaro F, 2006, ANAL BIOANAL CHEM, V386, P306, DOI 10.1007/s00216-006-0664-2; Vogt T, 1999, PLANT J, V19, P509, DOI 10.1046/j.1365-313X.1999.00540.x; Vogt T, 2000, TRENDS PLANT SCI, V5, P380, DOI 10.1016/S1360-1385(00)01720-9; Weaver S, 2010, METHODS, V50, P271, DOI 10.1016/j.ymeth.2010.01.003; Xu ZJ, 2002, PLANT PHYSIOL, V129, P1285, DOI 10.1104/pp.001784; Zeevaart JAD, 1999, N COMP BIOC, V33, P189; Zhang HP, 2009, ACTA PHYSIOL PLANT, V31, P979, DOI 10.1007/s11738-009-0313-4; Zhang M, 2011, NAT BIOTECHNOL, V29, P453, DOI 10.1038/nbt.1843; ZUCKERKANDL EMILE, 1965, P97	60	19	23	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75268	10.1371/journal.pone.0075268	http://dx.doi.org/10.1371/journal.pone.0075268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086489	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200094
J	Mirzoyan, Z; Pandur, P				Mirzoyan, Zhasmine; Pandur, Petra			The Iroquois Complex Is Required in the Dorsal Mesoderm to Ensure Normal Heart Development in Drosophila	PLOS ONE			English	Article							HOMEOBOX GENES; CELL FATES; TRANSCRIPTION-FACTORS; SIGNALING PATHWAYS; BOX GENES; TINMAN; PANNIER; SPECIFICATION; POLARITY; PROTEIN	Drosophila heart development is an invaluable system to study the orchestrated action of numerous factors that govern cardiogenesis. Cardiac progenitors arise within specific dorsal mesodermal regions that are under the influence of temporally coordinated actions of multiple signaling pathways. The Drosophila Iroquois complex (Iro-C) consists of the three homeobox transcription factors araucan (ara), caupolican (caup) and mirror (mirr). The Iro-C has been shown to be involved in tissue patterning leading to the differentiation of specific structures, such as the lateral notum and dorsal head structures and in establishing the dorsal-ventral border of the eye. A function for Iro-C in cardiogenesis has not been investigated yet. Our data demonstrate that loss of the whole Iro complex, as well as loss of either ara/caup or mirr only, affect heart development in Drosophila. Furthermore, the data indicate that the GATA factor Pannier requires the presence of Iro-C to function in cardiogenesis. Furthermore, a detailed expression pattern analysis of the members of the Iro-C revealed the presence of a possibly novel subpopulation of Even-skipped expressing pericardial cells and seven pairs of heart-associated cells that have not been described before. Taken together, this work introduces Iro-C as a new set of transcription factors that are required for normal development of the heart. As the members of the Iro-C may function, at least partly, as competence factors in the dorsal mesoderm, our results are fundamental for future studies aiming to decipher the regulatory interactions between factors that determine different cell fates in the dorsal mesoderm.	[Mirzoyan, Zhasmine; Pandur, Petra] Univ Ulm, Inst Biochem & Mol Biol, D-89069 Ulm, Germany	Ulm University	Pandur, P (corresponding author), Univ Ulm, Inst Biochem & Mol Biol, D-89069 Ulm, Germany.	petra.pandur@uni-ulm.de			Deutsche Forschungsgemeinschaft [SFB497, TP8]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant to P.P. from the Deutsche Forschungsgemeinschaft (SFB497, TP8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AD, 2003, DEVELOPMENT, V130, P3015, DOI 10.1242/dev.00488; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Azpiazu N, 1996, GENE DEV, V10, P3183, DOI 10.1101/gad.10.24.3183; Bate Michael, 1993, P1013; Bilioni A, 2005, P NATL ACAD SCI USA, V102, P14671, DOI 10.1073/pnas.0502480102; BODMER R, 1993, DEVELOPMENT, V118, P719; Broihier HT, 1998, DEVELOPMENT, V125, P655; Bruneau BG, 2001, MOL CELL BIOL, V21, P1730, DOI 10.1128/MCB.21.5.1730-1736.2001; Calleja M, 2000, DEVELOPMENT, V127, P3971; Calleja M, 2002, GENE, V292, P1, DOI 10.1016/S0378-1119(02)00628-5; Carmena A, 1998, GENE DEV, V12, P3910, DOI 10.1101/gad.12.24.3910; Carmena A, 2002, DEV BIOL, V244, P226, DOI 10.1006/dbio.2002.0606; Carrasco-Rando M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002186; Cavodeassi F, 2000, DEVELOPMENT, V127, P1921; Cavodeassi F, 1999, DEVELOPMENT, V126, P4933; Cavodeassi F, 2001, DEVELOPMENT, V128, P2847; Chartier A, 2002, DEVELOPMENT, V129, P3241; Christoffels VM, 2000, DEV BIOL, V224, P263, DOI 10.1006/dbio.2000.9801; de Navascues J, 2007, DEVELOPMENT, V134, P1779, DOI 10.1242/dev.02844; Diez del Corral R, 1999, GENE DEV, V13, P1754, DOI 10.1101/gad.13.13.1754; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; Frasch M, 1999, ADV D BIOCH, V5, P1, DOI 10.1016/S1064-2722(08)60015-8; FRASCH M, 1987, EMBO J, V6, P749, DOI 10.1002/j.1460-2075.1987.tb04817.x; FRASCH M, 1995, NATURE, V374, P464, DOI 10.1038/374464a0; Fuchs A, 2012, P NATL ACAD SCI USA, V109, P1572, DOI 10.1073/pnas.1115190109; Gajewski K, 1999, DEVELOPMENT, V126, P5679; GomezSkarmeta JL, 1996, CELL, V85, P95, DOI 10.1016/S0092-8674(00)81085-5; Grigorian M, 2011, DEV BIOL, V353, P105, DOI 10.1016/j.ydbio.2011.02.024; Haenlin M, 1997, GENE DEV, V11, P3096, DOI 10.1101/gad.11.22.3096; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; Haltiwanger RS, 2002, BBA-GEN SUBJECTS, V1573, P328, DOI 10.1016/S0304-4165(02)00400-2; Herranz H, 2001, DEVELOPMENT, V128, P4837; Ikmi A, 2008, DEV BIOL, V317, P634, DOI 10.1016/j.ydbio.2007.12.034; Jagla T, 2002, DEVELOPMENT, V129, P1037; Johnson AN, 2011, DEVELOPMENT, V138, P4627, DOI 10.1242/dev.071464; Kehl BT, 1998, DEVELOPMENT, V125, P1217; Kim KH, 2012, CIRC RES, V110, P1513, DOI 10.1161/CIRCRESAHA.112.265041; Klinedinst SL, 2003, DEVELOPMENT, V130, P3027, DOI 10.1242/dev.00517; Knirr S, 1999, DEVELOPMENT, V126, P4525; Kremser T, 1999, DEV BIOL, V216, P327, DOI 10.1006/dbio.1999.9425; LaBeau EM, 2009, MECH DEVELOP, V126, P478, DOI 10.1016/j.mod.2009.01.001; Lee HH, 2005, DEVELOPMENT, V132, P1429, DOI 10.1242/dev.01687; LEISS D, 1988, DEVELOPMENT, V104, P525; Letizia A, 2007, DEVELOPMENT, V134, P1337, DOI 10.1242/dev.02823; Leyns L, 1996, MECH DEVELOP, V59, P63, DOI 10.1016/0925-4773(96)00577-1; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; Liu JD, 2006, DEV BIOL, V290, P373, DOI 10.1016/j.ydbio.2005.11.033; Lockwood WK, 2002, MECH DEVELOP, V114, P13, DOI 10.1016/S0925-4773(02)00044-8; Mann T, 2009, DEVELOPMENT, V136, P317, DOI 10.1242/dev.022533; Matsumoto K, 2004, NAT NEUROSCI, V7, P605, DOI 10.1038/nn1249; McNeill H, 1997, GENE DEV, V11, P1073, DOI 10.1101/gad.11.8.1073; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; Park M, 1998, MECH DEVELOP, V75, P117, DOI 10.1016/S0925-4773(98)00098-7; Park MY, 1996, DEV BIOL, V177, P104, DOI 10.1006/dbio.1996.0149; Pichaud F, 2000, MECH DEVELOP, V96, P15, DOI 10.1016/S0925-4773(00)00372-5; RAMAIN P, 1993, DEVELOPMENT, V119, P1277; Reim I, 2005, DEVELOPMENT, V132, P4911, DOI 10.1242/dev.02077; Reim I, 2003, DEVELOPMENT, V130, P3187, DOI 10.1242/dev.00548; Riechmann V, 1997, DEVELOPMENT, V124, P2915; Sotillos S, 2010, DEV BIOL, V340, P571, DOI 10.1016/j.ydbio.2010.02.015; Su MT, 1999, DEVELOPMENT, V126, P3241; Togel M, 2008, DEV BIOL, V318, P29, DOI 10.1016/j.ydbio.2008.02.043; Venkatesh TV, 2000, GENESIS, V26, P55, DOI 10.1002/(SICI)1526-968X(200001)26:1<55::AID-GENE8>3.0.CO;2-A; Ward EJ, 2000, DEVELOPMENT, V127, P4959; WU XS, 1995, DEV BIOL, V169, P619, DOI 10.1006/dbio.1995.1174; Yang CH, 1999, DEVELOPMENT, V126, P5857; Yin ZZ, 1997, DEVELOPMENT, V124, P4971; Yin ZZ, 1998, DEV GENET, V22, P187; Zaffran S, 2006, DEVELOPMENT, V133, P4073, DOI 10.1242/dev.02586; Zecca M, 2002, DEVELOPMENT, V129, P1369; Zeidler MP, 1999, GENE DEV, V13, P1342, DOI 10.1101/gad.13.10.1342; Zhang SS, 2011, P NATL ACAD SCI USA, V108, P13576, DOI 10.1073/pnas.1106911108; Zhao DB, 2000, DEV GENES EVOL, V210, P449, DOI 10.1007/s004270000081; Zmojdzian M, 2013, CELL TISSUE RES, V354, P639, DOI 10.1007/s00441-013-1644-4	74	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e76498	10.1371/journal.pone.0076498	http://dx.doi.org/10.1371/journal.pone.0076498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086746	Green Published, gold			2022-12-27	WOS:000326520200138
J	Mu, DW; Gao, Z; Guo, HQ; Zhou, GB; Sun, B				Mu, Dawei; Gao, Zhuo; Guo, Heqing; Zhou, Gaobiao; Sun, Bin			Sodium Butyrate Induces Growth Inhibition and Apoptosis in Human Prostate Cancer DU145 Cells by Up-Regulation of the Expression of Annexin A1	PLOS ONE			English	Article							DECREASED EXPRESSION; PANCREATIC-CANCER; TUMOR-SUPPRESSOR; DOWN-REGULATION; BLADDER-CANCER; GASTRIC-CANCER; DIFFERENTIATION; GENE; OVEREXPRESSION; ADENOCARCINOMA	Background: Sodium butyrate, a histone deacetylase inhibitor, has emerged as a promising anticancer drug for multiple cancers. Recent studies have indicated that sodium butyrate could inhibit the progression of prostate cancer; however, the exact mechanism is still unclear. The aim of this study was to investigate the mechanism of sodium butyrate action in prostate cancer DU145 cells. Methods: The inhibitory effects of NaB on cell growth were detected by the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrrazolium bromide assay. Cell apoptosis was determined by flow cytometric analysis of DU145 cells stained with annexin V and PI. Hoechst 33258 and fluorescence microscopes were used to observe the nuclear morphology of DU145 cells after treatment with NaB. ANXA1 knockdown cells were established through transfection with ANXA1 siRNA. ANXA1 mRNA levels were measured by qRT-PCR. Bcl-2, Bax, ANXA1, ERK1/2 and pERK1/2 were detected by western blot. Results: NaB significantly inhibited the growth and induction apoptosis of DU145 and PC3 cells in a dose-dependent manner. Expression of the anti-apoptosis gene Bcl-xl and Bcl-2 in DU145 cells are decreased and expression of the pro-apoptosis gene Bax and Bak increased after NaB treatment. Further studies have demonstrated that NaB up-regulated the expression of ANXA1 and that the tumor inhibition action of NaB was reduced markedly through knockdown of the ANXA1 gene in DU145 cells. Moreover, the siANXA1 cells showed that cell proliferation increased and cell apoptosis was induced by the inactivation of extracellular regulated kinase (ERK). Conclusion: Our results support a significant correlation between NaB functions and ANXA1 expression in prostate cancer, and pave the way for further studying the molecular mechanism of NaB actions in cancers.	[Mu, Dawei; Guo, Heqing; Zhou, Gaobiao; Sun, Bin] AF Gen Hosp, Dept Urol, Beijing, Peoples R China; [Gao, Zhuo] AF Gen Hosp, Dept Nephrol, Beijing, Peoples R China		Guo, HQ (corresponding author), AF Gen Hosp, Dept Urol, Beijing, Peoples R China.	heqingguo010@163.com						Alldridge LC, 1999, J BIOL CHEM, V274, P37620, DOI 10.1074/jbc.274.53.37620; Bai XF, 2004, WORLD J GASTROENTERO, V10, P1466; Bai ZG, 2010, CELL BIOL INT, V34, P1141, DOI 10.1042/CBI20090481; BARNARD JA, 1993, CELL GROWTH DIFFER, V4, P495; Chopin V, 2009, BRIT J PHARMACOL, V135, P79; Cote MC, 2010, J BIOL CHEM, V285, P8013, DOI 10.1074/jbc.M109.098665; Giuliano M, 1999, CANCER RES, V59, P5586; Jani AB, 2003, LANCET, V361, P1045, DOI 10.1016/S0140-6736(03)12833-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaiser M, 2006, HAEMATOL-HEMATOL J, V91, P248; KRUH J, 1982, MOL CELL BIOCHEM, V42, P65; Kuefer R, 2004, BRIT J CANCER, V90, P535, DOI 10.1038/sj.bjc.6601510; Lecona E, 2008, MOL CELL BIOL, V28, P4665, DOI 10.1128/MCB.00650-07; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Lin JG, 2006, J UROLOGY, V175, P343, DOI 10.1016/S0022-5347(05)00005-4; Liu JW, 2003, ONCOGENE, V22, P1475, DOI 10.1038/sj.onc.1206196; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medina V, 1998, JPEN-PARENTER ENTER, V22, P14, DOI 10.1177/014860719802200114; Mollenhauer J, 1997, CELL MOL LIFE SCI, V53, P506, DOI 10.1007/s000180050063; Parente L, 2004, INFLAMM RES, V53, P125, DOI 10.1007/s00011-003-1235-z; Patton KT, 2005, HISTOPATHOLOGY, V47, P597, DOI 10.1111/j.1365-2559.2005.02300.x; Pedrero JMG, 2004, AM J PATHOL, V164, P73, DOI 10.1016/S0002-9440(10)63098-2; Petrella A, 2006, CANCER BIOL THER, V5, P643, DOI 10.4161/cbt.5.6.2700; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sgambato A, 2010, J CELL PHYSIOL, V224, P234, DOI 10.1002/jcp.22124; Shen DJ, 2006, HUM PATHOL, V37, P1583, DOI 10.1016/j.humpath.2006.06.001; Shimizu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045510; Shrestha Y, 2012, ONCOGENE, V31, P3397, DOI 10.1038/onc.2011.515; Song YX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-1; Srivastava M, 2001, P NATL ACAD SCI USA, V98, P4575, DOI 10.1073/pnas.071055798; Wang DG, 2008, INT J UROL, V15, P435, DOI 10.1111/j.1442-2042.2008.02025.x; Wang KL, 2006, CLIN CANCER RES, V12, P4598, DOI 10.1158/1078-0432.CCR-06-0483; Wang LD, 2008, J INT MED RES, V36, P665, DOI 10.1177/147323000803600407; Wey JS, 2005, BRIT J CANCER, V93, P233, DOI 10.1038/sj.bjc.6602663; Yu GZ, 2008, CLIN EXP METASTAS, V25, P695, DOI 10.1007/s10585-008-9178-y	35	36	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74922	10.1371/journal.pone.0074922	http://dx.doi.org/10.1371/journal.pone.0074922			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086397	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200054
J	Zuniga, J; Yu, N; Barquera, R; Alosco, S; Ohashi, M; Lebedeva, T; Acuna-Alonzo, V; Yunis, M; Granados-Montiel, J; Cruz-Lagunas, A; Vargas-Alarcon, G; Rodriguez-Reyna, TS; Fernandez-Vina, M; Granados, J; Yunis, EJ				Zuniga, Joaquin; Yu, Neng; Barquera, Rodrigo; Alosco, Sharon; Ohashi, Marina; Lebedeva, Tatiana; Acuna-Alonzo, Victor; Yunis, Maria; Granados-Montiel, Julio; Cruz-Lagunas, Alfredo; Vargas-Alarcon, Gilberto; Rodriguez-Reyna, Tatiana S.; Fernandez-Vina, Marcelo; Granados, Julio; Yunis, Edmond J.			HLA Class I and Class II Conserved Extended Haplotypes and Their Fragments or Blocks in Mexicans: Implications for the Study of Genetic Diversity in Admixed Populations	PLOS ONE			English	Article							AMERINDIAN POPULATIONS; ALLELE FREQUENCIES; MESTIZO POPULATION; CABO-VERDE; B-ALLELES; C ALLELES; LOCI; RESOLUTION; ADMIXTURE; EVOLUTION	Major histocompatibility complex (MHC) genes are highly polymorphic and informative in disease association, transplantation, and population genetics studies with particular importance in the understanding of human population diversity and evolution. The aim of this study was to describe the HLA diversity in Mexican admixed individuals. We studied the polymorphism of MHC class I (HLA-A, -B, -C), and class II (HLA-DRB1, -DQB1) genes using high-resolution sequence based typing (SBT) method and we structured the blocks and conserved extended haplotypes (CEHs) in 234 non-related admixed Mexican individuals (468 haplotypes) by a maximum likelihood method. We found that HLA blocks and CEHs are primarily from Amerindian and Caucasian origin, with smaller participation of African and recent Asian ancestry, demonstrating a great diversity of HLA blocks and CEHs in Mexicans from the central area of Mexico. We also analyzed the degree of admixture in this group using short tandem repeats (STRs) and HLA-B that correlated with the frequency of most probable ancestral HLA-C/-B and -DRB1/-DQB1 blocks and CEHs. Our results contribute to the analysis of the diversity and ancestral contribution of HLA class I and HLA class II alleles and haplotypes of Mexican admixed individuals from Mexico City. This work will help as a reference to improve future studies in Mexicans regarding allotransplantation, immune responses and disease associations.	[Zuniga, Joaquin; Cruz-Lagunas, Alfredo] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Dept Immunol, Mexico City, DF, Mexico; [Yu, Neng; Alosco, Sharon; Ohashi, Marina; Lebedeva, Tatiana] Amer Red Cross, HLA Lab, Northeast Div, Dedham, MA USA; [Barquera, Rodrigo; Acuna-Alonzo, Victor] Natl Sch Anthropol & Hist, Mol Genet Lab, Mexico City, DF, Mexico; [Yunis, Maria; Yunis, Edmond J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Granados-Montiel, Julio] Inst Nacl Rehabil, Tissue Engn Cell Therapy & Regenerat Med Res Unit, Mexico City, DF, Mexico; [Vargas-Alarcon, Gilberto] Inst Nacl Cardiol Ignacio Chavez, Lab Genom, Mexico City, DF, Mexico; [Rodriguez-Reyna, Tatiana S.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico; [Fernandez-Vina, Marcelo] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Granados, Julio] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Transplantat, Mexico City, DF, Mexico	American Red Cross; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; National Institute of Cardiology - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Stanford University; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Granados, J (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Transplantat, Mexico City, DF, Mexico.	julgrate@yahoo.com; Edmond_yunis@dfci.harvard.edu	Reyna, Tatiana Sofía Rodríguez/ABB-7864-2020	Reyna, Tatiana Sofía Rodríguez/0000-0002-5799-5016; Vargas-Alarcon, Gilberto/0000-0001-7916-5163; Zuniga, Joaquin/0000-0002-7143-0281; CRUZ-LAGUNAS, ALFREDO/0000-0001-5487-5919; Fernandez-Vina, Marcelo A./0000-0002-5707-2588; Barquera, Rodrigo/0000-0003-0518-4518				Alfirevic A, 2012, GENOME MED, V4, DOI 10.1186/gm350; Arnaiz-Villena A, 2009, INT J IMMUNOGENET, V36, P159, DOI 10.1111/j.1744-313X.2009.00841.x; Arrieta-Bolanos E, 2012, BONE MARROW RES, DOI 10.1155/2012/136087; Barquera R., 2012, CAUSES CONSEQUENCES, P201; Barquera R, 2008, MOL IMMUNOL, V45, P1171, DOI 10.1016/j.molimm.2007.07.042; Barrot C, 2005, INT J LEGAL MED, V119, P111, DOI 10.1007/s00414-004-0488-6; Calzada P, 2005, INT J LEGAL MED, V119, P107, DOI 10.1007/s00414-004-0505-9; Cao K, 2004, TISSUE ANTIGENS, V63, P293, DOI 10.1111/j.0001-2815.2004.00192.x; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Ceppellini R, 1967, HISTOCOMPATIBILITY T, P189; CERNA M, 1993, HUM IMMUNOL, V37, P213, DOI 10.1016/0198-8859(93)90504-T; Chu C, 2007, IMMUNOBIOLOGY HUMAN, P611; de Pablo R, 1997, TISSUE ANTIGENS, V50, P593; DOHERTY PC, 1975, LANCET, V1, P1406, DOI 10.1016/S0140-6736(75)92610-0; Dunne C, 2008, INT J IMMUNOGENET, V35, P295, DOI 10.1111/j.1744-313X.2008.00779.x; Ellis JM, 2000, TISSUE ANTIGENS, V56, P291, DOI 10.1034/j.1399-0039.2000.560401.x; Erlich HA, 1997, HEREDITAS, V127, P19, DOI 10.1111/j.1601-5223.1997.00019.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; FernandezVina MA, 1997, TISSUE ANTIGENS, V50, P233, DOI 10.1111/j.1399-0039.1997.tb02867.x; Finch CE, 2004, SCIENCE, V305, P1736, DOI 10.1126/science.1092556; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Garcia-Ortiz JE, 2006, TISSUE ANTIGENS, V68, P135, DOI 10.1111/j.1399-0039.2006.00636.x; Gilbert SC, 1998, SCIENCE, V279, P1173, DOI 10.1126/science.279.5354.1173; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gomez-Casado E, 2003, TISSUE ANTIGENS, V61, P425, DOI 10.1034/j.1399-0039.2003.00040.x; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Gonzalez-Martin A, 2008, AM J HUM BIOL, V20, P605, DOI 10.1002/ajhb.20787; Granados J, 1996, LUPUS, V5, P184, DOI 10.1177/096120339600500304; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hoa BK, 2008, TISSUE ANTIGENS, V71, P127, DOI 10.1111/j.1399-0039.2007.00982.x; Hollenbach JA, 2001, HUM IMMUNOL, V62, P378, DOI 10.1016/S0198-8859(01)00212-9; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hu-Dehart E., 1995, CAMBRIDGE SURVEY WOR, P220; Infante E, 2007, IMMUNOBIOLOGY HUMAN, P633; Jeffery KJM, 2000, MICROBES INFECT, V2, P1335, DOI 10.1016/S1286-4579(00)01287-9; Jinam TA, 2010, TISSUE ANTIGENS, V75, P151, DOI 10.1111/j.1399-0039.2009.01417.x; Juarez-Cedillo T, 2008, FORENSIC SCI INT-GEN, V2, pE37, DOI 10.1016/j.fsigen.2007.08.017; Kijak GH, 2009, TISSUE ANTIGENS, V73, P262, DOI 10.1111/j.1399-0039.2008.01192.x; Layrisse Z, 2001, HUM IMMUNOL, V62, P992, DOI 10.1016/S0198-8859(01)00297-X; Leal CA, 2005, TISSUE ANTIGENS, V66, P666, DOI 10.1111/j.1399-0039.2005.00495.x; Lebedeva TV, 2011, TISSUE ANTIGENS, V77, P247, DOI 10.1111/j.1399-0039.2010.01616.x; Leffell MS, 2002, HUM IMMUNOL, V63, P614, DOI 10.1016/S0198-8859(02)00415-9; LISKER R, 1990, HUM BIOL, V62, P791; Loiseau P, 2007, BIOL BLOOD MARROW TR, V13, P965, DOI 10.1016/j.bbmt.2007.04.010; Mack SJ, 2007, IMMUNOBIOLOGY HUMAN, VI, P605; Maiers M, 2007, HUM IMMUNOL, V68, P779, DOI 10.1016/j.humimm.2007.04.005; Marr JS, 2000, MED HIST, V44, P341; Martinez-Cortes G, 2013, AM J PHYS ANTHROPOL, V151, P526, DOI 10.1002/ajpa.22293; Middleton D, 2000, HUM IMMUNOL, V61, P1048, DOI 10.1016/S0198-8859(00)00178-6; Middleton D, 2000, HUM IMMUNOL, V61, P1285, DOI 10.1016/S0198-8859(00)00186-5; Monsalve MV, 1998, HUM IMMUNOL, V59, P48, DOI 10.1016/S0198-8859(97)00251-6; Moscoso J, 2008, MOL IMMUNOL, V45, P1018, DOI 10.1016/j.molimm.2007.07.024; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Pingel J, 2013, HUM IMMUNOL, V74, P330, DOI 10.1016/j.humimm.2012.10.029; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; Rani R, 2007, INT J IMMUNOGENET, V34, P201, DOI 10.1111/j.1744-313X.2007.00677.x; Renquin J, 2001, TISSUE ANTIGENS, V58, P211, DOI 10.1034/j.1399-0039.2001.580401.x; Robinson J, 2001, NUCLEIC ACIDS RES, V29, P210, DOI 10.1093/nar/29.1.210; Rosenmayr A, 2011, TRANSFUS MED HEMOTH, V38, P292, DOI 10.1159/000332579; Saito S, 2000, TISSUE ANTIGENS, V56, P522, DOI 10.1034/j.1399-0039.2000.560606.x; Saldanha N, 2009, J GENETIC GENEALOGY, V5, P76; Sanchez-Mazas A, 2000, TISSUE ANTIGENS, V56, P303, DOI 10.1034/j.1399-0039.2000.560402.x; Sanchez-Mazas A, 2012, PHILOS T R SOC B, V367, P830, DOI 10.1098/rstb.2011.0312; Sanchez-Mazas A, 2011, IMMUNOLOGY, V133, P143, DOI 10.1111/j.1365-2567.2011.03438.x; Sanz P, 2001, FORENSIC SCI INT, V119, P113, DOI 10.1016/S0379-0738(00)00422-9; Schmidt AH, 2009, HUM IMMUNOL, V70, P895, DOI 10.1016/j.humimm.2009.08.006; Shankarkumar U, 2004, HUM IMMUNOL, V65, P992, DOI 10.1016/j.humimm.2004.08.069; Shen CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013458; Shi L, 2010, INT J IMMUNOGENET, V37, P467, DOI 10.1111/j.1744-313X.2010.00949.x; Spinola H, 2005, HUM IMMUNOL, V66, P1082, DOI 10.1016/j.humimm.2005.09.001; Spinola H, 2005, TISSUE ANTIGENS, V66, P217, DOI 10.1111/j.1399-0039.2005.00471.x; Spinola H, 2002, ANN HUM GENET, V66, P285, DOI [10.1046/j.1469-1809.2002.00118.x, 10.1017/S0003480002001185]; Tereba A, 1999, PROFILES DNA, P14; Torimiro JN, 2006, TISSUE ANTIGENS, V67, P30, DOI 10.1111/j.1399-0039.2005.00527.x; Tratchenberg E, 2007, IMMUNOBIOLOGY HUMAN, P616; Tsuneto LT, 2003, TISSUE ANTIGENS, V62, P512, DOI 10.1046/j.1399-0039.2003.00139.x; VRIES RRPD, 1979, J IMMUNOGENET, V6, P271; Wang JL, 2003, GENETICS, V164, P747; Wen SH, 2008, HUM IMMUNOL, V69, P430, DOI 10.1016/j.humimm.2008.05.012; Williams R, 2009, TISSUE ANTIGENS, V74, P520, DOI 10.1111/j.1399-0039.2009.01381.x; Yan Chunxia, 2003, Genomics Proteomics & Bioinformatics, V1, P304; YASUDA N, 1988, JPN J HUM GENET, V33, P385, DOI 10.1007/BF02032870; Yunis EJ, 2003, TISSUE ANTIGENS, V62, P1, DOI 10.1034/j.1399-0039.2003.00098.x; Yunis EJ, 2005, ENCY MOL CELL BIOL M, V13, P191; Zhu BF, 2010, J ZHEJIANG UNIV-SC B, V11, P127, DOI 10.1631/jzus.B0900232	86	57	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74442	10.1371/journal.pone.0074442	http://dx.doi.org/10.1371/journal.pone.0074442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086347	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200031
J	Asaminew, T; Gelaw, Y; Bekele, S; Solomon, B				Asaminew, Tsedeke; Gelaw, Yeshigeta; Bekele, Sisay; Solomon, Berhan			Retinal Detachment in Southwest Ethiopia: A Hospital Based Prospective Study	PLOS ONE			English	Article							DISEASES	Purpose: The incidence of retinal detachment in Blacks is generally considered to be low though there are few supporting studies in Africa. This study, thus, aimed at describing the clinical profile of patients with retinal detachment in Southwest Ethiopia. Methods: A hospital-based study was done on all consecutive retinal detachment patients who presented to Jimma University Hospital over six months period. A semi-structured questionnaire was used to collect patients' sociodemographic characteristics and clinical history. Comprehensive anterior and posterior segment eye examinations were done and risk factors were sought for. Statistical tests were considered significant if P < 0.05. Results: A total of 94 eyes of 80 patients (1.5%) had retinal detachment (RD) and about 69% of patients were symptomatic for over a month before presentation. The mean age was 41.4 years (SD +/- 16.5). Fourteen patients (17.5%) had bilateral RD. At presentation, 61 eyes (64.9%) were blind from RD and 11 (13.8%) patients were bilaterally blind from RD. Rhegmatogenous RD was seen in 55 eyes (58.5%) and tractional RD in 22 eyes (23.4%). The most common risk factors were ocular trauma (32 eyes, 34.0%), myopia (23 eyes, 24.5%), posterior uveitis (13 eyes, 13.8%) and diabetic retinopathy (9 eyes, 9.6%). Most retinal breaks (25 eyes, 43.1%) were superotemporal and horse-shoe tear was the most common (19 eyes, 20.2%). Macula was off in 77 eyes (81.9%) and 38 eyes (69.1% of RRD eyes) had grade C proliferative vitreoretinopathy (PVR). Macular status was significantly associated with PVR (P=0.011), and duration of symptoms (RR=1.25, 95% CI: 1.059-1.475, P=0.040). Conclusions: A significant numbers of patients with ocular problem had retinal detachment, and nearly two third of the patients presented late. Trauma and myopia were the most important risk factors. People should be educated to improve their health seeking behavior and use eye safety precautions to prevent ocular trauma.	[Asaminew, Tsedeke; Gelaw, Yeshigeta; Bekele, Sisay; Solomon, Berhan] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Ophthalmol, Jimma, Ethiopia	Jimma University	Gelaw, Y (corresponding author), Jimma Univ, Coll Publ Hlth & Med Sci, Dept Ophthalmol, Jimma, Ethiopia.	dryeshi@yahoo.com		Alemu, Tsedeke Asaminew/0000-0002-7083-5957	Jimma University; Light-for the World	Jimma University; Light-for the World	This study was financially supported by Jimma University and Light-for the World. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIOSE A, 1979, ANN OPHTHALMOL, V11, P1067; Ahmadieh H, 2000, EUR J OPHTHALMOL, V10, P153, DOI 10.1177/112067210001000211; AVSHALOM A, 1967, AM J OPHTHALMOL, V64, P384, DOI 10.1016/0002-9394(67)92000-4; BERHANE Y, 2007, HLTH DEVICES, V21, P185; CARRERAS FJ, 1995, BRIT J OPHTHALMOL, V79, P926, DOI 10.1136/bjo.79.10.926; CHUMBLEY LC, 1977, S AFR MED J, V52, P316; Comer MB, 2000, EYE, V14, P572, DOI 10.1038/eye.2000.145; Dandona L, 2001, INVEST OPHTH VIS SCI, V42, P908; FOOS RY, 1983, AM J OPHTHALMOL, V96, P644, DOI 10.1016/S0002-9394(14)73423-3; GORDON YJ, 1980, DOC OPHTHALMOL, V49, P285, DOI 10.1007/BF01886621; Haile M, 1996, E AFR MED J, V73, P703; Kaimbo K, 1986, Bull Soc Belge Ophtalmol, V218, P83; Krohn J, 2000, ACTA OPHTHALMOL SCAN, V78, P354, DOI 10.1034/j.1600-0420.2000.078003354.x; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; PETERS AL, 1995, S AFR MED J, V85, P158; Rowe JA, 1999, OPHTHALMOLOGY, V106, P154, DOI 10.1016/S0161-6420(99)90018-0; Solomon B, 2011, ETHIOP J HEALTH DEV, V25, P31; Sullivan PM, 1997, EYE, V11, P869, DOI 10.1038/eye.1997.223; WEISS H, 1978, ANN OPHTHALMOL, V10, P799; Yorston D, 2002, EYE, V16, P353, DOI 10.1038/sj.eye.6700188; Yorston DB, 2002, OPHTHALMOLOGY, V109, P2279, DOI 10.1016/S0161-6420(02)01284-8	21	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75693	10.1371/journal.pone.0075693	http://dx.doi.org/10.1371/journal.pone.0075693			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086614	Green Submitted, gold, Green Published			2022-12-27	WOS:000325223900058
J	Kleftogiannis, D; Kalnis, P; Bajic, VB				Kleftogiannis, Dimitrios; Kalnis, Panos; Bajic, Vladimir B.			Comparing Memory-Efficient Genome Assemblers on Stand-Alone and Cloud Infrastructures	PLOS ONE			English	Article							SEQUENCE; MILLIONS; VELVET; READS	A fundamental problem in bioinformatics is genome assembly. Next-generation sequencing (NGS) technologies produce large volumes of fragmented genome reads, which require large amounts of memory to assemble the complete genome efficiently. With recent improvements in DNA sequencing technologies, it is expected that the memory footprint required for the assembly process will increase dramatically and will emerge as a limiting factor in processing widely available NGS-generated reads. In this report, we compare current memory-efficient techniques for genome assembly with respect to quality, memory consumption and execution time. Our experiments prove that it is possible to generate draft assemblies of reasonable quality on conventional multi-purpose computers with very limited available memory by choosing suitable assembly methods. Our study reveals the minimum memory requirements for different assembly programs even when data volume exceeds memory capacity by orders of magnitude. By combining existing methodologies, we propose two general assembly strategies that can improve short-read assembly approaches and result in reduction of the memory footprint. Finally, we discuss the possibility of utilizing cloud infrastructures for genome assembly and we comment on some findings regarding suitable computational resources for assembly.	[Kleftogiannis, Dimitrios; Kalnis, Panos] KAUST, Comp Elect & Math Sci & Engn Div CEMSE, Thuwal, Saudi Arabia; [Bajic, Vladimir B.] KAUST, Comp Elect & Math Sci & Engn Div CEMSE, CBRC, Thuwal, Saudi Arabia	King Abdullah University of Science & Technology; King Abdullah University of Science & Technology	Bajic, VB (corresponding author), KAUST, Comp Elect & Math Sci & Engn Div CEMSE, CBRC, Thuwal, Saudi Arabia.	vladimir.bajic@kaust.edu.sa	Kalnis, Panos/H-2826-2014; Bajic, Vladimir/D-2810-2009	Kalnis, Panos/0000-0002-5060-1360; Bajic, Vladimir/0000-0001-5435-4750; Kleftogiannis, Dimitrios/0000-0003-1086-821X	KAUST	KAUST(King Abdullah University of Science & Technology)	DK and PK are supported by the KAUST Base Research Fund of PK. VBB is supported by the KAUST Base Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Burrows M, 1994, BLOCK SORTING LOSSLE; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; CHIKHI R, 2012, LECT NOTES COMPUTER; Compeau PEC, 2011, NAT BIOTECHNOL, V29, P987, DOI 10.1038/nbt.2023; Conway TC, 2011, BIOINFORMATICS, V27, P479, DOI 10.1093/bioinformatics/btq697; DeFrancesco L, 2012, NAT BIOTECHNOL, V30, P126, DOI 10.1038/nbt0212-126a; DELABASTIDE M, 2007, CURR PROTOC BIOINFOR, pCH11, DOI DOI 10.1002/0471250953.BI1104S17; DiGuistini S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r94; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Howe A, 2012, ILLUMINA SEQUENCING; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huang XQ, 2003, GENOME RES, V13, P2164, DOI 10.1101/gr.1390403; Jackman SD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-202; KHAYYAT Z, 2013, P EUROSYS 2013 C PRA; Knuth D, 1997, SEMINUMERICAL ALGORI, V3; Kultima JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047656; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; LI Y, 2013, VLDB C TREN IN PRESS; Liu YC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-354; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; Paszkiewicz K, 2010, BRIEF BIOINFORM, V11, P457, DOI 10.1093/bib/bbq020; Pell J, 2012, P NATL ACAD SCI USA, V109, P13272, DOI 10.1073/pnas.1121464109; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; SANGER F, 1977, J MOL BIOL, V25, P441; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Schmidt B, 2009, BIOINFORMATICS, V25, P2279, DOI 10.1093/bioinformatics/btp374; Schwarz E. M., 2013, REFERENCE FREE ALGOR; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Simpson JT, 2010, BIOINFORMATICS, V26, pi367, DOI 10.1093/bioinformatics/btq217; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Stein LD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-207; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Ye CX, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S6-S1; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915	44	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75505	10.1371/journal.pone.0075505	http://dx.doi.org/10.1371/journal.pone.0075505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086547	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900044
J	Murakami, Y; Takada, S				Murakami, Yohei; Takada, Shoji			Bayesian Parameter Inference by Markov Chain Monte Carlo with Hybrid Fitness Measures: Theory and Test in Apoptosis Signal Transduction Network	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; CELL FATE DECISION; MODEL SELECTION; BIOCHEMICAL PATHWAYS; P53 PULSES; OPTIMIZATION; CASPASE-3; DYNAMICS; FRAGMENTATION; COORDINATION	When model parameters in systems biology are not available from experiments, they need to be inferred so that the resulting simulation reproduces the experimentally known phenomena. For the purpose, Bayesian statistics with Markov chain Monte Carlo (MCMC) is a useful method. Conventional MCMC needs likelihood to evaluate a posterior distribution of acceptable parameters, while the approximate Bayesian computation (ABC) MCMC evaluates posterior distribution with use of qualitative fitness measure. However, none of these algorithms can deal with mixture of quantitative, i.e., likelihood, and qualitative fitness measures simultaneously. Here, to deal with this mixture, we formulated Bayesian formula for hybrid fitness measures (HFM). Then we implemented it to MCMC (MCMC-HFM). We tested MCMC-HFM first for a kinetic toy model with a positive feedback. Inferring kinetic parameters mainly related to the positive feedback, we found that MCMC-HFM reliably infer them using both qualitative and quantitative fitness measures. Then, we applied the MCMC-HFM to an apoptosis signal transduction network previously proposed. For kinetic parameters related to implicit positive feedbacks, which are important for bistability and irreversibility of the output, the MCMC-HFM reliably inferred these kinetic parameters. In particular, some kinetic parameters that have experimental estimates were inferred without using these data and the results were consistent with experiments. Moreover, for some parameters, the mixed use of quantitative and qualitative fitness measures narrowed down the acceptable range of parameters.	[Murakami, Yohei; Takada, Shoji] Kyoto Univ, Dept Biophys, Div Biol, Grad Sch Sci, Kyoto, Japan	Kyoto University	Murakami, Y (corresponding author), Kyoto Univ, Dept Biophys, Div Biol, Grad Sch Sci, Kyoto, Japan.	murakami@theory.biophys.kyoto-u.ac.jp	Takada, Shoji/A-1163-2009		MEXT; MEXT, Japan	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by Grant-in-Aid for Scientific Research on Innovative Areas "Molecular Science of Fluctuations toward Biological Functions" of the MEXT, and by Grants for Excellent Graduate Schools, MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Ashyraliyev M, 2009, FEBS J, V276, P886, DOI 10.1111/j.1742-4658.2008.06844.x; Barnes CP, 2011, P NATL ACAD SCI USA, V108, P15190, DOI 10.1073/pnas.1017972108; Beaumont MA, 2002, GENETICS, V162, P2025; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Chen C, 2007, BIOPHYS J, V92, P4304, DOI 10.1529/biophysj.106.099606; Cui J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001469; EIBING T, 2005, IEE P SYST BIOL, V152, P221; Eydgahi H, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.69; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Iba Yukito, 2001, T JPN SOC ARTIF INTE, V16, P279, DOI DOI 10.1527/TJSAI.16.279; Ingram PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-108; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Marjoram P, 2003, P NATL ACAD SCI USA, V100, P15324, DOI 10.1073/pnas.0306899100; Mendes P, 1998, BIOINFORMATICS, V14, P869, DOI 10.1093/bioinformatics/14.10.869; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mirsky HP, 2009, P NATL ACAD SCI USA, V106, P11107, DOI 10.1073/pnas.0904837106; Moles CG, 2003, GENOME RES, V13, P2467, DOI 10.1101/gr.1262503; Murakami Yohei, 2012, Biophysics (Nagoya-shi), V8, P41, DOI 10.2142/biophysics.8.41; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Pu T, 2010, BIOPHYS J, V99, P1696, DOI 10.1016/j.bpj.2010.07.042; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sisson SA, 2007, P NATL ACAD SCI USA, V104, P1760, DOI 10.1073/pnas.0607208104; Sisson SA, 2011, CH CRC HANDB MOD STA, P313; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Spencer SL, 2011, CELL, V144, P926, DOI 10.1016/j.cell.2011.03.002; Sun TZ, 2010, FEBS LETT, V584, P954, DOI 10.1016/j.febslet.2010.01.034; Sun TZ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-190; Tian XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038164; Toni T, 2012, MOL BIOSYST, V8, P1921, DOI 10.1039/c2mb05493k; Toni T, 2010, METHODS MOL BIOL, V673, P283, DOI 10.1007/978-1-60761-842-3_18; Toni T, 2010, BIOINFORMATICS, V26, P104, DOI 10.1093/bioinformatics/btp619; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Tyson JJ, 2008, J R SOC INTERFACE, V5, pS1, DOI 10.1098/rsif.2008.0179.focus; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457; Whitley D, 2001, INFORM SOFTWARE TECH, V43, P817, DOI 10.1016/S0950-5849(01)00188-4; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Zeilinger MN, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100101; Zhang TL, 2007, CELL CYCLE, V6, P85, DOI 10.4161/cc.6.1.3705; Zhang TL, 2009, BIOPHYS J, V97, P415, DOI 10.1016/j.bpj.2009.04.053; Zhang XP, 2012, BIOPHYS J, V102, P2251, DOI 10.1016/j.bpj.2012.04.002; Zhang XP, 2011, P NATL ACAD SCI USA, V108, P8990, DOI 10.1073/pnas.1100600108; Zhang XP, 2010, J BIOL CHEM, V285, P31571, DOI 10.1074/jbc.M110.134650; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106; Zi ZK, 2005, J COMPUT SCI TECH-CH, V20, P491, DOI 10.1007/s11390-005-0491-5	52	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74178	10.1371/journal.pone.0074178	http://dx.doi.org/10.1371/journal.pone.0074178			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086320	gold, Green Submitted, Green Published			2022-12-27	WOS:000325223900022
J	Ying, SB; Dunnebier, T; Si, J; Hamann, U				Ying, Shibo; Duennebier, Thomas; Si, Jing; Hamann, Ute			Estrogen Receptor Alpha and Nuclear Factor Y Coordinately Regulate the Transcription of the SUMO-Conjugating UBC9 Gene in MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							NF-Y; PROGESTERONE-RECEPTOR; COVALENT MODIFICATION; INDUCTION PROPERTIES; ANDROGEN RECEPTOR; SUMOYLATION; EXPRESSION; PROTEIN; ACTIVATION; MECHANISMS	UBC9 encodes a protein that conjugates small ubiquitin-related modifier (SUMO) to target proteins thereby changing their functions. Recently, it was noted that UBC9 expression and activity play a role in breast tumorigenesis and response to anticancer drugs. However, the underlying mechanism is poorly understood. To investigate the transcriptional regulation of the UBC9 gene, we identified and characterized its promoter and cis-elements. Promoter activity was tested using luciferase reporter assays. The binding of transcription factors to the promoter was detected by chromatin immunoprecipitation (ChIP), and their functional role was confirmed by siRNA knockdown. UBC9 mRNA and protein levels were measured by quantitative reverse transcription PCR and Western blot analysis, respectively. An increased expression of UBC9 mRNA and protein was found in MCF-7 breast cancer cells treated with 17 beta-estradiol (E-2). Analysis of various deletion mutants revealed a 137 bp fragment upstream of the transcription initiation site to be sufficient for reporter gene transcription. Mutations of putative estrogen receptor alpha (ER-alpha) (one imperfect estrogen response element, ERE) and/or nuclear factor Y (NF-Y) binding sites (two CCAAT boxes) markedly reduced promoter activity. Similar results were obtained in ER-negative MDA-MB-231 cells except that the ERE mutation did not affect promoter activity. Additionally, promoter activity was stimulated upon E-2 treatment and overexpression of ER-alpha or NF-YA in MCF-7 cells. ChIP confirmed direct binding of both transcription factors to the UBC9 promoter in vivo. Furthermore, UBC9 expression was diminished by ER-alpha and NF-Y siRNAs on the mRNA and protein levels. In conclusion, we identified the proximal UBC9 promoter and provided evidence that ER-alpha and NF-Y regulate UBC9 expression on the transcriptional level in response to E-2 in MCF-7 cells. These findings may contribute to a better understanding of the regulation of UBC9 in ER-positive breast cancer and be useful for the development of cancer therapies targeting UBC9.	[Ying, Shibo; Duennebier, Thomas; Si, Jing; Hamann, Ute] Deutsch Krebsforschungszentrum DKFZ, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Hamann, U (corresponding author), Deutsch Krebsforschungszentrum DKFZ, Heidelberg, Germany.	u.hamann@dkfz-heidelberg.de	Ying, Shibo/K-2514-2016	Ying, Shibo/0000-0001-5275-9383	Deutsche Krebshilfe [109335]; Deutsches Krebsforschungszentrum, Heidelberg, Germany	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsches Krebsforschungszentrum, Heidelberg, Germany	The work was supported by the Deutsche Krebshilfe grant 109335 and the Deutsches Krebsforschungszentrum, Heidelberg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hafiz H, 2002, J BIOL CHEM, V277, P33950, DOI 10.1074/jbc.M204573200; Acconcia F, 2006, CANCER LETT, V238, P1, DOI 10.1016/j.canlet.2005.06.018; Bawa-Khalfe Tasneem, 2010, Genes Cancer, V1, P748; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Caretti A, 2012, INT J BIOCHEM CELL B, V44, P84, DOI 10.1016/j.biocel.2011.09.010; Chang YL, 2007, INT J BIOCHEM CELL B, V39, P1035, DOI 10.1016/j.biocel.2007.02.002; Chauchereau A, 2003, J BIOL CHEM, V278, P12335, DOI 10.1074/jbc.M207148200; Cheskis BJ, 2007, J CELL PHYSIOL, V213, P610, DOI 10.1002/jcp.21253; Cho SY, 2005, MOL ENDOCRINOL, V19, P290, DOI 10.1210/me.2004-0134; Cicatiello L, 2000, MOL CELL ENDOCRINOL, V165, P199, DOI 10.1016/S0303-7207(00)00243-4; del Val C, 2010, THEOR CHEM ACC, V125, P583, DOI 10.1007/s00214-009-0643-8; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; Dunnebier T, 2010, BREAST CANCER RES TR, V121, P185, DOI 10.1007/s10549-009-0530-y; Dunnebier T, 2009, INT J CANCER, V125, P596, DOI 10.1002/ijc.24286; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; Fang S, 2003, SEMIN CANCER BIOL, V13, P5, DOI 10.1016/S1044-579X(02)00095-0; Faus H, 2006, BIOMED PHARMACOTHER, V60, P520, DOI 10.1016/j.biopha.2006.07.082; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Ge YB, 2002, BBA-GENE STRUCT EXPR, V1579, P73, DOI 10.1016/S0167-4781(02)00509-2; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hsieh YL, 2013, EMBO J, V32, P791, DOI 10.1038/emboj.2013.5; Ishimaru F, 1997, BLOOD, V89, P4136, DOI 10.1182/blood.V89.11.4136; Jordan VC, 2009, CANCER RES, V69, P1243, DOI 10.1158/0008-5472.CAN-09-0029; Karamouzis MV, 2008, BREAST CANCER RES TR, V107, P195, DOI 10.1007/s10549-007-9552-5; Kaul S, 2002, J BIOL CHEM, V277, P12541, DOI 10.1074/jbc.M112330200; Kawabe Y, 2000, J BIOL CHEM, V275, P20963, DOI 10.1074/jbc.C000273200; Kobayashi S, 2004, ENDOCR RES, V30, P617, DOI 10.1081/ERC-200043789; Kotaja N, 2002, J BIOL CHEM, V277, P30283, DOI 10.1074/jbc.M204768200; Lee WR, 2006, J CELL BIOCHEM, V99, P209, DOI 10.1002/jcb.20902; LI XY, 1992, J BIOL CHEM, V267, P8984; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; McDoniels-Silvers AL, 2002, CLIN CANCER RES, V8, P1127; Mo YY, 2005, ONCOGENE, V24, P2677, DOI 10.1038/sj.onc.1208210; Mo YY, 2004, CANCER RES, V64, P2793, DOI 10.1158/0008-5472.CAN-03-2410; Moschos SJ, 2007, ONCOGENE, V26, P4216, DOI 10.1038/sj.onc.1210216; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Nakshatri H, 1996, J BIOL CHEM, V271, P28784, DOI 10.1074/jbc.271.46.28784; Ngwenya S, 2003, ENDOCRINOLOGY, V144, P1675, DOI 10.1210/en.2002-0009; Poukka H, 1999, J BIOL CHEM, V274, P19441, DOI 10.1074/jbc.274.27.19441; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Riising EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002704; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; Synowiec E, 2010, MUTAT RES-FUND MOL M, V694, P31, DOI 10.1016/j.mrfmmm.2010.09.002; Tomasi ML, 2012, HEPATOLOGY, V56, P982, DOI 10.1002/hep.25701; WAKELING AE, 1992, J STEROID BIOCHEM, V43, P173, DOI 10.1016/0960-0760(92)90204-V; Wang WL, 1999, MOL ENDOCRINOL, V13, P1373, DOI 10.1210/me.13.8.1373; Wu FT, 2009, CLIN CANCER RES, V15, P1550, DOI 10.1158/1078-0432.CCR-08-0820; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Xirodimas DP, 2002, FEBS LETT, V528, P207, DOI 10.1016/S0014-5793(02)03310-0; Xu J, 2009, INT J ONCOL, V34, P939, DOI 10.3892/ijo_00000220; Yang SH, 2013, EMBO J, V32, P773, DOI 10.1038/emboj.2013.21; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4; Zhao ZQ, 2012, BMB REP, V45, P641, DOI 10.5483/BMBRep.2012.45.11.097; Zhu S, 2010, ONCOGENE, V29, P1763, DOI 10.1038/onc.2009.459	61	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75695	10.1371/journal.pone.0075695	http://dx.doi.org/10.1371/journal.pone.0075695			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086615	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900059
J	Stanzani, M; Lewis, RE; Fiacchini, M; Ricci, P; Tumietto, F; Viale, P; Ambretti, S; Baccarani, M; Cavo, M; Vianelli, N				Stanzani, Marta; Lewis, Russell E.; Fiacchini, Mauro; Ricci, Paolo; Tumietto, Fabio; Viale, Pierluigi; Ambretti, Simone; Baccarani, Michele; Cavo, Michele; Vianelli, Nicola			A Risk Prediction Score for Invasive Mold Disease in Patients with Hematological Malignancies	PLOS ONE			English	Article							CELL TRANSPLANT RECIPIENTS; VERSUS-HOST-DISEASE; FUNGAL-INFECTIONS; PULMONARY ASPERGILLOSIS; NEUTROPENIC PATIENTS; MARROW; GRAFT; PROPHYLAXIS; PROGNOSIS; CONTAMINATION	Background: A risk score for invasive mold disease (IMD) in patients with hematological malignancies could facilitate patient screening and improve the targeted use of antifungal prophylaxis. Methods: We retrospectively analyzed 1,709 hospital admissions of 840 patients with hematological malignancies (2005-2008) to collect data on 17 epidemiological and treatment-related risk factors for IMD. Multivariate regression was used to develop a weighted risk score based on independent risk factors associated with proven or probable IMD, which was prospectively validated during 1,746 hospital admissions of 855 patients from 2009-2012. Results: Of the 17 candidate variables analyzed, 11 correlated with IMD by univariate analysis, but only 4 risk factors (neutropenia, lymphocytopenia or lymphocyte dysfunction in allogeneic hematopoietic stem cell transplant recipients, malignancy status, and prior IMD) were retained in the final multivariate model, resulting in a weighted risk score 0-13. A risk score of < 6 discriminated patients with low (< 1%) versus higher incidence rates (> 5%) of IMD, with a negative predictive value (NPV) of 0.99, (95% CI 0.98-0.99). During 2009-2012, patients with a calculated risk score at admission of < 6 had significantly lower 90-day incidence rates of IMD compared to patients with scores > 6 (0.9% vs. 10.6%, P < 0.001). Conclusion: An objective, weighted risk score for IMD can accurately discriminate patients with hematological malignancies at low risk for developing mold disease, and could possibly facilitate "screening-out" of low risk patients less likely to benefit from intensive diagnostic monitoring or mold-directed antifungal prophylaxis.	[Stanzani, Marta; Fiacchini, Mauro; Ricci, Paolo; Baccarani, Michele; Cavo, Michele; Vianelli, Nicola] Univ Bologna, Lorenzo & Ariosto Seragnoli SOrsola Malpighi Hosp, Dept Hematol & Clin Oncol, Inst Hematol, Bologna, Italy; [Lewis, Russell E.; Tumietto, Fabio; Viale, Pierluigi] Univ Bologna, SOrsola Malpighi Hosp, Clin Infect Dis, Dept Internal Med Geriatr & Nephrol Dis, Bologna, Italy; [Ambretti, Simone] Univ Bologna, SOrsola Malpighi Hosp, Operat Unit Microbiol, Dept Hematol Oncol & Lab Med, Bologna, Italy	University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Stanzani, M (corresponding author), Univ Bologna, Lorenzo & Ariosto Seragnoli SOrsola Malpighi Hosp, Dept Hematol & Clin Oncol, Inst Hematol, Bologna, Italy.	marta.stanzani2@unibo.it	CAVO, MICHELE/AAK-8274-2020; Lewis, Russell E/A-4616-2015; Vianelli, Nicola/AAD-1676-2021	CAVO, MICHELE/0000-0003-4514-3227; Lewis, Russell E/0000-0002-2002-4339; Stanzani, Marta/0000-0003-1569-3447; Vianelli, Nicola/0000-0001-5886-036X	Gilead Inc.; AIL foundation	Gilead Inc.(Gilead Sciences); AIL foundation	Database development was supported by an unrestricted grant from Gilead Inc. and the AIL foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam MF, 2002, SCAND J INFECT DIS, V34, P819, DOI 10.1080/0036554021000026954; Berthelot P, 2006, CLIN MICROBIOL INFEC, V12, P738, DOI 10.1111/j.1469-0691.2006.01499.x; Cornely OA, 2007, CLIN INFECT DIS, V44, P1289, DOI 10.1086/514341; Cornely OA, 2007, NEW ENGL J MED, V356, P348, DOI 10.1056/NEJMoa061094; Cornet M, 1999, INFECT CONT HOSP EP, V20, P508, DOI 10.1086/501661; de Pauw BE, 2005, CLIN INFECT DIS, V41, P1251, DOI 10.1086/496933; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; de Pauw BE, 2011, J ANTIMICROB CHEMOTH, V66, pi55, DOI 10.1093/jac/dkq442; El-Cheikh J, 2010, LEUKEMIA LYMPHOMA, V51, P1705, DOI 10.3109/10428194.2010.500433; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Fukuda T, 2003, BLOOD, V102, P827, DOI 10.1182/blood-2003-02-0456; Garcia-Vidal C, 2008, CLIN INFECT DIS, V47, P1041, DOI 10.1086/591969; Garnacho-Montero J, 2005, CRIT CARE, V9, pR191, DOI 10.1186/cc3488; Gavalda J, 2005, CLIN INFECT DIS, V41, P52, DOI 10.1086/430602; GERSON SL, 1984, ANN INTERN MED, V100, P345, DOI 10.7326/0003-4819-100-3-345; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Grigg A, 2008, TRANSPL INFECT DIS, V10, P3, DOI 10.1111/j.1399-3062.2007.00259.x; Grow WB, 2002, BONE MARROW TRANSPL, V29, P15, DOI 10.1038/sj.bmt.1703332; Herbrecht R, 2012, ANN NY ACAD SCI, V1272, P23, DOI 10.1111/j.1749-6632.2012.06829.x; Labbe AC, 2007, BIOL BLOOD MARROW TR, V13, P1192, DOI 10.1016/j.bbmt.2007.06.013; Lionakis MS, 2003, LANCET, V362, P1828, DOI 10.1016/S0140-6736(03)14904-5; Mahieu LM, 2000, J HOSP INFECT, V45, P191, DOI 10.1053/jhin.2000.0773; Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496; Martino R, 2006, BLOOD, V108, P2928, DOI 10.1182/blood-2006-03-008706; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Muhlemann K, 2005, LEUKEMIA, V19, P545, DOI 10.1038/sj.leu.2403674; O'Brien Susan N, 2003, Hematology Am Soc Hematol Educ Program, P438; Ostrosky-Zeichner L, 2011, MYCOSES, V54, P46, DOI 10.1111/j.1439-0507.2009.01756.x; Pagano L, 2006, HAEMATOLOGICA, V91, P1068; Pagano L, 2010, HAEMATOL-HEMATOL J, V95, P644, DOI 10.3324/haematol.2009.012054; Park BJ, 2011, EMERG INFECT DIS, V17, P1855, DOI 10.3201/eid1710.110087; Parulekar W, 1998, ORAL ONCOL, V34, P63, DOI 10.1016/S1368-8375(97)00065-1; Rondinelli PIP, 2006, J PEDIAT HEMATOL ONC, V28, P665, DOI 10.1097/01.mph.0000212996.94929.0b; Post MJ, 2007, TRANSPL INFECT DIS, V9, P189, DOI 10.1111/j.1399-3062.2007.00219.x; Robin M, 2007, BIOL BLOOD MARROW TR, V13, P1304, DOI 10.1016/j.bbmt.2007.07.007; Rogers TR, 2011, BRIT J HAEMATOL, V153, P681, DOI 10.1111/j.1365-2141.2011.08650.x; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Soubani AO, 2002, HAEMATOLOGIA, V32, P427; Thio CL, 2000, INFECT CONT HOSP EP, V21, P18, DOI 10.1086/501691; Thursky K, 2004, BONE MARROW TRANSPL, V34, P115, DOI 10.1038/sj.bmt.1704543; Ullmann AJ, 2007, NEW ENGL J MED, V356, P335, DOI 10.1056/NEJMoa061098; Upton A, 2007, CLIN INFECT DIS, V44, P531, DOI 10.1086/510592; Uys A, 2004, SUPPORT CARE CANCER, V12, P555, DOI 10.1007/s00520-004-0614-5; van der Velden WJFM, 2011, CURR OPIN INFECT DIS, V24, P554, DOI 10.1097/QCO.0b013e32834ab1f4; VAZQUEZ JA, 1995, INFECT DIS CLIN N AM, V9, P97; Verweij PE, 2000, JAMA-J AM MED ASSOC, V284, P2875, DOI 10.1001/jama.284.22.2875; Wingard JR, 2008, CANCER, V112, P2309, DOI 10.1002/cncr.23441	49	51	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75531	10.1371/journal.pone.0075531	http://dx.doi.org/10.1371/journal.pone.0075531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086555	Green Published, gold			2022-12-27	WOS:000325220000024
J	Harf, A; Skandrani, S; Radjack, R; Sibeoni, J; Moro, MR; Revah-Levy, A				Harf, Aurelie; Skandrani, Sara; Radjack, Rahmeth; Sibeoni, Jordan; Moro, Marie Rose; Revah-Levy, Anne			First Parent-Child Meetings in International Adoptions: A Qualitative Study	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; EXPOSURE THERAPY; ADOPTED-CHILDREN; NARRATIVES; HEALTH; EXPERIENCES; ATTACHMENT; CARE	International adoptions involve approximately 30000 children worldwide each year. Nearly all of the adoptive parents travel to the child's country of birth to meet them and bring them home. The objective of this study is to analyze the adoptive parents' account of their first meetings with their child. The study includes 46 parents who adopted one or more children internationally. Each parent participated in a semi-structured interview, focused on these first parent-child meetings. The interviews were analyzed according to a qualitative phenomenological method, Interpretative Phenomenological Analysis. The principal themes that emerged from the analysis of the interviews were: the scene when the child is entrusted to the parents, the discovery of the child's body, and the first parent-child interaction. Within these three principal themes, several subthemes dealt with difficult experiences: moments of solitude and anxiety, shocking images of the children's living conditions, lack of preparation and of information about the child, poor health, parental reactions of rejection, worry about the child's body, aggressive reactions by the child, worry about the child's reactions, and contrast with the expected interaction. Thirty-two interviews included at least one of these subthemes. At the structural level of the discourse; the characteristics of 33 interviews are those described in the literature as significantly more frequent in traumatized than in non-traumatized subjects. These results raise questions about the consequences of difficult, possibly traumatic experiences, at the moment of meeting the child, and they underline the need for work on preparation and prevention before the parents leave on their journey.	[Harf, Aurelie; Radjack, Rahmeth; Sibeoni, Jordan; Moro, Marie Rose] Univ Paris 05, Hop Cochin, AP HP, Sorbonne Paris Cite,Unite INSERM 669, Paris, France; [Skandrani, Sara] Univ Paris Ouest, Hop Cochin, AP HP, Ctr Rech Didier Anzieu, Paris, France; [Revah-Levy, Anne] Univ Paris 05, Hop Argenteuil, Ctr Soins Psychotherapeut Transit Adolescents, Sorbonne Paris Cite,Unite INSERM 669, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Harf, A (corresponding author), Univ Paris 05, Hop Cochin, AP HP, Sorbonne Paris Cite,Unite INSERM 669, Paris, France.	aurelie.harf@cch.aphp.fr		revah-levy, anne/0000-0003-1805-6275; Sibeoni, Jordan/0000-0001-9613-5513				Andersen LB, 2012, ACTA OBSTET GYN SCAN, V91, P1261, DOI 10.1111/j.1600-0412.2012.01476.x; Ashworth P., 2008, QUALITATIVE PSYCHOL; Baxter L. A., 2004, BASICS COMMUNICATION; Beck CT, 2011, BIRTH-ISS PERINAT C, V38, P216, DOI 10.1111/j.1523-536X.2011.00475.x; Bieman HJMV, 1995, J CHILD PSYCHOL PSYC, V36, P1411, DOI 10.1111/j.1469-7610.1995.tb01672.x; Bimmel N, 2003, HARVARD REV PSYCHIAT, V11, P64, DOI 10.1080/10673220303955; Cassidy P. R, 2008, HDB ATTACHMENT; Cederblad M, 1999, J CHILD PSYCHOL PSYC, V40, P1239, DOI 10.1111/1469-7610.00540; Cooklin AR, 2013, J FAM PSYCH IN PRESS; Creswell J.W., 2018, QUAL INQ, V4; Eatough V, 2008, QUALITATIVE RES PSYC; FOA EB, 1995, J TRAUMA STRESS, V8, P675, DOI 10.1007/BF02102894; Friedlander ML, 2000, J COUNS PSYCHOL, V47, P187; Furuta M, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-125; Garthus-Niegel S, 2013, ARCH WOMEN MENT HLTH, V16, P1, DOI 10.1007/s00737-012-0301-3; Gunnar MR, 2000, DEV PSYCHOPATHOL, V12, P677, DOI 10.1017/S0954579400004077; Harf Aurelie, 2011, Soins Pediatr Pueric, P24; Hesse E, 2003, HEALING TRAUMA; Hesse E., 2008, HDB ATTACHMENT THEOR, P552; Jeffer F, 2005, JAMA-J AM MED ASSOC, V293, P2501; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; O'Kearney R, 2006, J TRAUMA STRESS, V19, P81, DOI 10.1002/jts.20099; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Pierrehumbert B, 2005, ATTACHMENT PSYCHANAL; Pillemer DB, 1998, AUTOBIOGRAPHICAL MEMORY, P145; Plummer Ken, 2001, DOCUMENTS LIFE; Reynolds JL, 1997, CAN MED ASSOC J, V156, P831; Selman P, 2009, INT SOC WORK, V52, P575, DOI 10.1177/0020872809337681; Simon RJ, 1991, INTERCOUNTRY ADOPTIO, P23; Smith JA, 1996, PSYCHOL HEALTH, V11, P261, DOI 10.1080/08870449608400256; Stern D.N., 2002, 1 RELATIONSHIP INFAN; STILES WB, 1993, CLIN PSYCHOL REV, V13, P593, DOI 10.1016/0272-7358(93)90048-Q; Van den Dries L, 2012, DEV PSYCHOPATHOL, V24, P49, DOI 10.1017/S0954579411000654; van IJzendoorn MH, 2006, J CHILD PSYCHOL PSYC, V47, P1228, DOI 10.1111/j.1469-7610.2006.01675.x; Van Londen WM, 2007, J PEDIATR PSYCHOL, V32, P1249, DOI 10.1093/jpepsy/jsm062; van Minnen A, 2002, J TRAUMA STRESS, V15, P255, DOI 10.1023/A:1015263513654; Vonk ME, 2001, SOC WORK, V46, P246, DOI 10.1093/sw/46.3.246; Whitley R, 2005, CAN J PSYCHIAT, V50, P108, DOI 10.1177/070674370505000206; Yoon KE, 2000, THESIS STANFORD U	40	7	7	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75300	10.1371/journal.pone.0075300	http://dx.doi.org/10.1371/journal.pone.0075300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VC	24086500	gold, Green Submitted, Green Published			2022-12-27	WOS:000325218700071
J	Lombard, F; Guidi, L; Kiorboe, T				Lombard, Fabien; Guidi, Lionel; Kiorboe, Thomas			Effect of Type and Concentration of Ballasting Particles on Sinking Rate of Marine Snow Produced by the Appendicularian Oikopleura dioica	PLOS ONE			English	Article							ZOOPLANKTON FECAL PELLETS; LARVACEAN HOUSES; CARBON FLUX; VELOCITY; EXPORT; SEDIMENTATION; AGGREGATION; DEPOSITION; TRANSPORT; HUXLEYI	Ballast material (organic, opal, calcite, lithogenic) is suggested to affect sinking speed of aggregates in the ocean. Here, we tested this hypothesis by incubating appendicularians in suspensions of different algae or Saharan dust, and observing the sinking speed of the marine snow formed by their discarded houses. We show that calcite increases the sinking speeds of aggregates by similar to 100% and lithogenic material by similar to 150% while opal only has a minor effect. Furthermore the effect of ballast particle concentration was causing a 33 m d(-1) increase in sinking speed for a 5x10(5) mu m(3) ml(-1) increase in particle concentration, near independent on ballast type. We finally compare our observations to the literature and stress the need to generate aggregates similar to those in nature in order to get realistic estimates of the impact of ballast particles on sinking speeds.	[Lombard, Fabien; Kiorboe, Thomas] Tech Univ Denmark, Sect Oceanog & Climate, Natl Inst Aquat Resources, Ctr Ocean Life, Charlottenlund, Denmark; [Lombard, Fabien; Guidi, Lionel] Univ Paris 06, UMR 7093, Lab Oceanog Villefranche Sur Mer, Observ Oceanol Villefranche Sur Mer, F-75252 Paris 05, France	Technical University of Denmark; UDICE-French Research Universities; Sorbonne Universite	Lombard, F (corresponding author), Tech Univ Denmark, Sect Oceanog & Climate, Natl Inst Aquat Resources, Ctr Ocean Life, Charlottenlund, Denmark.	lombard@obs-vlfr.fr	Lombard, Fabien/H-6702-2012; Kiørboe, Thomas/ABI-4733-2020; Guidi, Lionel/B-3977-2012	Lombard, Fabien/0000-0002-8626-8782; Kiørboe, Thomas/0000-0002-3265-336X; Guidi, Lionel/0000-0002-6669-5744	Marie Curie Intra-European Fellowship [221696]; French program Agence Nationale de la Recherche [ANR-10-PDOC-005-01]; Danish Council for Independent Research; Villum Fonden [00007178] Funding Source: researchfish	Marie Curie Intra-European Fellowship(European Commission); French program Agence Nationale de la Recherche(French National Research Agency (ANR)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Villum Fonden(Villum Fonden)	Funding was provided by a Marie Curie Intra-European Fellowship 221696 award to F. L. and the French program Agence Nationale de la Recherche ANR-10-PDOC-005-01 "Ecogely" to F. L. The Danish Council for Independent Research provided further support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna JL, 2000, LIMNOL OCEANOGR, V45, P608, DOI 10.4319/lo.2000.45.3.0608; ALLDREDGE AL, 1988, LIMNOL OCEANOGR, V33, P339, DOI 10.4319/lo.1988.33.3.0339; ALLDREDGE AL, 1988, PROG OCEANOGR, V20, P41, DOI 10.1016/0079-6611(88)90053-5; Alldredge AL., 2005, RESPONSE MARINE ECOS, P309, DOI DOI 10.1093/PLANKT/FBI133; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Biermann A, 2010, BIOGEOSCIENCES, V7, P1017, DOI 10.5194/bg-7-1017-2010; Bouquet JM, 2009, J PLANKTON RES, V31, P359, DOI 10.1093/plankt/fbn132; Boyd PW, 2007, PROG OCEANOGR, V72, P276, DOI 10.1016/j.pocean.2006.10.007; Buesseler KO, 2007, SCIENCE, V316, P567, DOI 10.1126/science.1137959; Burd AB, 2010, DEEP-SEA RES PT II, V57, P1557, DOI 10.1016/j.dsr2.2010.02.022; De La Rocha CL, 2007, DEEP-SEA RES PT II, V54, P639, DOI 10.1016/j.dsr2.2007.01.004; De La Rocha CL, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003156; Engel A, 2009, DEEP-SEA RES PT II, V56, P1396, DOI 10.1016/j.dsr2.2008.11.027; FENAUX R, 1985, B MAR SCI, V37, P498; Flood Per R., 1998, P105; FOWLER SW, 1986, PROG OCEANOGR, V16, P147, DOI 10.1016/0079-6611(86)90032-7; Francois R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001722; Gorsky G, 1999, J GEOPHYS RES-OCEANS, V104, P3381, DOI 10.1029/98JC01850; Guerzoni S, 1999, PROG OCEANOGR, V44, P147, DOI 10.1016/S0079-6611(99)00024-5; Guidi L, 2008, DEEP-SEA RES PT I, V55, P1364, DOI 10.1016/j.dsr.2008.05.014; Guidi L, 2009, LIMNOL OCEANOGR, V54, P1951, DOI 10.4319/lo.2009.54.6.1951; Guieu C, 2010, BIOGEOSCIENCES, V7, P2765, DOI 10.5194/bg-7-2765-2010; Hamm CE, 2002, LIMNOL OCEANOGR, V47, P1790, DOI 10.4319/lo.2002.47.6.1790; Hansen JLS, 1996, MAR ECOL PROG SER, V141, P205, DOI 10.3354/meps141205; Henson SA, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004099; Iversen MH, 2010, DEEP-SEA RES PT I, V57, P771, DOI 10.1016/j.dsr.2010.03.007; Jouandet MP, 2011, LIMNOL OCEANOGR, V56, P1130, DOI 10.4319/lo.2011.56.3.1130; Kiorboe T, 2000, LIMNOL OCEANOGR, V45, P479, DOI 10.4319/lo.2000.45.2.0479; Klaas C, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001765; Lam PJ, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003868; Le Moigne FAC, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052980; LOGAN BE, 1995, WATER RES, V29, P443, DOI 10.1016/0043-1354(94)00186-B; Lombard F, 2005, MAR ECOL PROG SER, V301, P149, DOI 10.3354/meps301149; Lombard F, 2011, LIMNOL OCEANOGR, V56, P1504, DOI 10.4319/lo.2011.56.4.1504; Lombard F, 2010, MAR ECOL PROG SER, V398, P109, DOI 10.3354/meps08273; Lombard F, 2009, J MARINE SYST, V76, P151, DOI [10.1016/j.jmarsys.2009.1001.1004., DOI 10.1016/J.JMARSYS.2009.1001.1004.PUBMED:20628532]; Lombard F, 2010, DEEP-SEA RES PT I, V57, P1304, DOI 10.1016/j.dsr.2010.06.008; McDonnell AMP, 2010, LIMNOL OCEANOGR, V55, P2085, DOI 10.4319/lo.2010.55.5.2085; Passow U, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002579; Passow U, 2001, CONT SHELF RES, V21, P327, DOI 10.1016/S0278-4343(00)00101-1; Ploug H, 2008, LIMNOL OCEANOGR, V53, P1878, DOI 10.4319/lo.2008.53.5.1878; Poulton AJ, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002712; Riley JS, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004085; Robison BH, 2005, SCIENCE, V308, P1609, DOI 10.1126/science.1109104; Sanders R, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042574; Sato R, 2003, MAR ECOL PROG SER, V259, P163, DOI 10.3354/meps259163; Tiselius P, 1996, J PLANKTON RES, V18, P133, DOI 10.1093/plankt/18.2.133; Turner JT, 2002, AQUAT MICROB ECOL, V27, P57, DOI 10.3354/ame027057; Volk T., 1985, GEOPHYS MONOGR SER, V32, P99, DOI DOI 10.1029/GM032P0099; Wilson JD, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2012GB004398	50	23	23	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75676	10.1371/journal.pone.0075676	http://dx.doi.org/10.1371/journal.pone.0075676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086610	Green Submitted, Green Published, gold			2022-12-27	WOS:000325218700108
J	Babaoglan, AB; Housden, BE; Furriols, M; Bray, SJ				Babaoglan, A. Burcu; Housden, Ben E.; Furriols, Marc; Bray, Sarah J.			Deadpan Contributes to the Robustness of the Notch Response	PLOS ONE			English	Article							PAN-NEURAL GENE; CELL FATE; E(SPL) COMPLEX; DROSOPHILA; SEGMENTATION; EXPRESSION; ENHANCER; MEDIATE; SPLIT; ACTIVATION	Notch signaling regulates many fundamental events including lateral inhibition and boundary formation to generate very reproducible patterns in developing tissues. Its targets include genes of the bHLH hairy and Enhancer of split [E(spl)] family, which contribute to many of these developmental decisions. One member of this family in Drosophila, deadpan (dpn), was originally found to have functions independent of Notch in promoting neural development. Employing genome-wide chromatin-immunoprecipitation we have identified several Notch responsive enhancers in dpn, demonstrating its direct regulation by Notch in a range of contexts including the Drosophila wing and eye. dpn expression largely overlaps that of several E(spl) genes and the combined knock-down leads to more severe phenotypes than either alone. In addition, Dpn contributes to the establishment of Cut expression at the wing dorsal-ventral (D/V) boundary; in its absence Cut expression is delayed. Furthermore, over-expression of Dpn inhibits expression from E(spl) gene enhancers, but not vice versa, suggesting that dpn contributes to a feed-back mechanism that limits E(spl) gene expression following Notch activation. Thus the combined actions of dpn and E(spl) appear to provide a mechanism that confers an initial rapid output from Notch activity which becomes self-limited via feedback between the targets.	[Babaoglan, A. Burcu; Housden, Ben E.; Furriols, Marc; Bray, Sarah J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of Cambridge	Bray, SJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	sjb32@cam.ac.uk		Furriols, Marc/0000-0002-0656-1912; Housden, Benjamin/0000-0001-9134-4279; Bray, Sarah/0000-0002-1642-599X	MRC programme [G0800034]; BBSRC [BB/J008842/1] Funding Source: UKRI; MRC [G0800034, G0500926] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J008842/1] Funding Source: researchfish; Medical Research Council [G0800034, G0500926] Funding Source: researchfish	MRC programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Research supported by an MRC programme grant G0800034 to SJB (http://www.mrc.ac.uk/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIER E, 1992, GENE DEV, V6, P2137, DOI 10.1101/gad.6.11.2137; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Canon J, 2003, GENE DEV, V17, P838, DOI 10.1101/gad.1064803; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; de Celis JF, 1998, DEVELOPMENT, V125, P4617; deCelis JF, 1996, DEVELOPMENT, V122, P2719; Djiane A, 2013, EMBO J, V32, P60, DOI 10.1038/emboj.2012.326; Heitzler P, 1996, DEVELOPMENT, V122, P161; Housden BE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003162; Housden B, 2012, G3-GENES GENOM GENET, V2, P79, DOI 10.1534/g3.111.001321; JENNINGS B, 1995, DEVELOPMENT, V121, P3745; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; KRAMATSCHEK B, 1994, DEVELOPMENT, V120, P815; Krejci A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000140; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Ligoxygakis P, 1999, DEVELOPMENT, V126, P2205; McDonald JA, 1998, GENE DEV, V12, P3603, DOI 10.1101/gad.12.22.3603; Nakagoshi H, 1998, GENE DEV, V12, P2724, DOI 10.1101/gad.12.17.2724; Preston CR, 1996, GENETICS, V144, P1623; ROARK M, 1995, GENE DEV, V9, P2384, DOI 10.1101/gad.9.19.2384; RUSHLOW CA, 1989, EMBO J, V8, P3095, DOI 10.1002/j.1460-2075.1989.tb08461.x; San Juan BP, 2012, BIOL OPEN, V1, P667, DOI 10.1242/bio.20121172; San-Juan BP, 2011, DEV BIOL, V352, P70, DOI 10.1016/j.ydbio.2011.01.019; Schroter C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001364; Shankaran SS, 2007, DEV BIOL, V304, P615, DOI 10.1016/j.ydbio.2007.01.004; TATA F, 1995, MECH DEVELOP, V51, P305, DOI 10.1016/0925-4773(95)00377-0; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; XU T, 1993, DEVELOPMENT, V117, P1223; Zacharioudaki E, 2012, DEVELOPMENT, V139, P1258, DOI 10.1242/dev.071779; Zhu SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046724	30	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75632	10.1371/journal.pone.0075632	http://dx.doi.org/10.1371/journal.pone.0075632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086596	Green Published, Green Submitted, gold			2022-12-27	WOS:000325025200057
J	Kim, GJ; Kim, H; Park, YN				Kim, Gi Jeong; Kim, Hyunki; Park, Young Nyun			Increased Expression of Yes-Associated Protein 1 in Hepatocellular Carcinoma with Stemness and Combined Hepatocellular-Cholangiocarcinoma	PLOS ONE			English	Article							HIPPO SIGNALING PATHWAY; LIVER-CANCER; CLINICOPATHOLOGICAL FEATURES; CELL-PROLIFERATION; POOR-PROGNOSIS; SELF-RENEWAL; YAP; RESECTION; MARKER; SIZE	Combined hepatocellular-cholangiocarcinoma (cHC-CC) and some hepatocellular carcinomas (HCCs) express stemness-related markers, such as epithelial adhesion molecule (EpCAM) and keratin 19 (K19), the expression of which has been reported to be associated with more aggressive behavior therein than in HCCs without. Yes-associated protein 1 (YAP1), a potential oncogene, is known to promote stem cell proliferation. In the present study, YAP1 expression and clinicopathological features were evaluated and compared among three groups comprising 36 HCCs that expressed both EpCAM and K19, 64 HCCs that did not express EpCAM and K19, and 58 cHC-CCs, which consisted of 38 cases of the classical type and 20 cases of the intermediate-cell subtype. YAP1 expression was more frequently noted in EpCAM(+)/K19(+) HCCs (55.6%) and in cHC-CCs (67.2%) than in EpCAM(2)/K19(2) HCCs (17.2%) (P < 0.001 for both). In cHC-CCs, YAP1 expression was observed in 63% of classical type cHC-CCs and in 75% of the intermediate subtype; moreover, such expression was correlated with poorer histological differentiation ( P = 0.017) and was more frequently noted in transition zones than in HCC areas ( P = 0.060). Disease-free and overall survival showed a statistically significant difference among the three groups: disease-free survival was highest for EpCAM(2)/K19(2) HCCs and lowest for cHC-CCs, with EpCAM(+)/K19(+) HCCs falling in between (P < 0.05). Overall survival rate was lower in HCCs and cHC-CCs with YAP1 expression compared to those without ( P = 0.05), whereas disease-free survival showed no significant difference according to YAP1 expression. Increased YAP1 expression was more frequently found in cHC-CCs and HCCs with stemness than in HCCs without, and a YAP1 pathway is suggested to be involved in the obtainment stemness characteristics in HCCs and cHC-CCs.	[Kim, Gi Jeong; Kim, Hyunki; Park, Young Nyun] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Park, Young Nyun] Yonsei Univ, Coll Med, Integrated Genom Res Ctr Metab Regulat, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, H (corresponding author), Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea.	kimhyunki@yuhs.ac; young0608@yuhs.ac		Park, Young Nyun/0000-0003-0357-7967; Kim, Hyunki/0000-0003-2292-5584	Korea Health care technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A120631]	Korea Health care technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korea Health care technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120631). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coulouarn C, 2012, CARCINOGENESIS, V33, P1791, DOI 10.1093/carcin/bgs208; Durnez A, 2006, HISTOPATHOLOGY, V49, P138, DOI 10.1111/j.1365-2559.2006.02468.x; GOODMAN ZD, 1985, CANCER-AM CANCER SOC, V55, P124, DOI 10.1002/1097-0142(19850101)55:1<124::AID-CNCR2820550120>3.0.CO;2-Z; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kang W, 2011, CLIN CANCER RES, V17, P2130, DOI 10.1158/1078-0432.CCR-10-2467; Kango-Singh M, 2009, DEV DYNAM, V238, P1627, DOI 10.1002/dvdy.21996; Kim H, 2011, HEPATOLOGY, V54, P1707, DOI 10.1002/hep.24559; Koh KC, 2005, AM J SURG, V189, P120, DOI 10.1016/j.amjsurg.2004.03.018; Lam-Himlin DM, 2006, J GASTROINTEST CANC, V37, P103, DOI 10.1007/s12029-007-0010-8; Lee JH, 2011, J CLIN GASTROENTEROL, V45, P69, DOI 10.1097/MCG.0b013e3181ce5dfa; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liu AM, 2012, EXPERT OPIN THER TAR, V16, P243, DOI 10.1517/14728222.2012.662958; Liu AM, 2010, EXPERT OPIN THER TAR, V14, P855, DOI 10.1517/14728222.2010.499361; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Ma YC, 2013, EUR J GASTROENTEROL; MAEDA T, 1995, HUM PATHOL, V26, P956, DOI 10.1016/0046-8177(95)90084-5; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Okamura D, 2008, MODERN PATHOL, V21, P847, DOI 10.1038/modpathol.2008.59; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Shan YF, 2011, MED ONCOL, V28, P1012, DOI 10.1007/s12032-010-9600-6; Theise ND, 2010, WHO CLASSIFICATION T, P225; Wang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065539; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yamashita T, 2013, HEPATOLOGY, V57, P1484, DOI 10.1002/hep.26168; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yin X, 2012, ANN SURG ONCOL, V19, P2869, DOI 10.1245/s10434-012-2328-0; Yu XH, 2011, HEPATOB PANCREAT DIS, V10, P620, DOI 10.1016/S1499-3872(11)60105-7; Yuan RH, 2011, J GASTROINTEST SURG, V15, P321, DOI 10.1007/s11605-010-1373-x; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868	33	29	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75449	10.1371/journal.pone.0075449	http://dx.doi.org/10.1371/journal.pone.0075449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086533	Green Submitted, Green Published, gold			2022-12-27	WOS:000325025200043
J	Schokoroy, S; Juster, D; Kloog, Y; Pinkas-Kramarski, R				Schokoroy, Sari; Juster, Dolly; Kloog, Yoel; Pinkas-Kramarski, Ronit			Disrupting the Oncogenic Synergism between Nucleolin and Ras Results in Cell Growth Inhibition and Cell Death	PLOS ONE			English	Article							G-RICH OLIGONUCLEOTIDES; COLON-CANCER CELLS; TUMOR-GROWTH; FARNESYLTHIOSALICYLIC ACID; IN-VITRO; CYCLE ARREST; ANTAGONIST; SUPPRESSION; MIGRATION; PROTEIN	Background: The ErbB receptors, Ras proteins and nucleolin are major contributors to malignant transformation. The pleiotropic protein nucleolin can bind to both Ras protein and ErbB receptors. Previously, we have demonstrated a crosstalk between Ras, nucleolin and the ErbB1 receptor. Activated Ras facilitates nucleolin interaction with ErbB1 and stabilizes ErbB1 levels. The three oncogenes synergistically facilitate anchorage independent growth and tumor growth in nude mice. Methodology/Principal Findings: In the present study we used several cancer cell lines. The effect of Ras and nucleolin inhibition was determined using cell growth, cell death and cell motility assays. Protein expression was determined by immunohistochemistry. We found that inhibition of Ras and nucleolin reduces tumor cell growth, enhances cell death and inhibits anchorage independent growth. Our results reveal that the combined treatment affects Ras and nucleolin levels and localization. Our study also indicates that Salirasib (FTS, Ras inhibitor) reduces cell motility, which is not affected by the nucleolin inhibitor. Conclusions/Significance: These results suggest that targeting both nucleolin and Ras may represent an additional avenue for inhibiting cancers driven by these oncogenes.	[Schokoroy, Sari; Juster, Dolly; Kloog, Yoel; Pinkas-Kramarski, Ronit] Tel Aviv Univ, Dept Neurobiol, Ramat Aviv, Israel	Tel Aviv University	Pinkas-Kramarski, R (corresponding author), Tel Aviv Univ, Dept Neurobiol, Ramat Aviv, Israel.	lironit@post.tau.ac.il		Pinkas-Kramarski, Ronit/0000-0002-1000-369X	Israel Science Foundation [848/ 12]; Kauffman Prostate Cancer Research Fund	Israel Science Foundation(Israel Science Foundation); Kauffman Prostate Cancer Research Fund	This work was supported by the Israel Science Foundation (Grant no. 848/ 12)and by the Kauffman Prostate Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonson Z, 1998, BBA-MOL BASIS DIS, V1406, P40, DOI 10.1016/S0925-4439(97)00077-X; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; Charette N, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-256; Cox AD, 2002, CANCER BIOL THER, V1, P599, DOI 10.4161/cbt.306; Dapic V, 2002, BIOCHEMISTRY-US, V41, P367, DOI [10.1021/bi011335b, DOI 10.1021/BI011335B.PUBMED:11772036]; Destouches D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002518; Di Segni A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002310; Di-Segni A., 2009, BREAST CANC PATHOGEN, P77; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; Elad G, 1999, BBA-MOL CELL RES, V1452, P228, DOI 10.1016/S0167-4889(99)00144-5; Erlich S, 2006, BIOCHEM PHARMACOL, V72, P427, DOI 10.1016/j.bcp.2006.05.007; Etienne-Manneville S, 2006, METHOD ENZYMOL, V406, P565, DOI 10.1016/S0076-6879(06)06044-7; Farin K, 2011, CANCER RES, V71, P2140, DOI 10.1158/0008-5472.CAN-10-2887; Farin K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006128; Goldberg L, 2006, CANCER RES, V66, P11709, DOI 10.1158/0008-5472.CAN-06-1878; Haklai R, 1998, BIOCHEMISTRY-US, V37, P1306, DOI 10.1021/bi972032d; Halaschek-Wiener J, 2000, MOL MED, V6, P693, DOI 10.1007/BF03402049; Harris AL, 1992, MONOG NATL CANC I, P181; Ireson CR, 2006, MOL CANCER THER, V5, P2957, DOI 10.1158/1535-7163.MCT-06-0172; Kloog Y, 2000, MOL MED TODAY, V6, P398, DOI 10.1016/S1357-4310(00)01789-5; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; MAROM M, 1995, J BIOL CHEM, V270, P22263, DOI 10.1074/jbc.270.38.22263; McPherson RA, 2004, PROSTATE, V58, P325, DOI 10.1002/pros.10336; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; Reyes-Reyes EM, 2010, CANCER RES, V70, P8617, DOI 10.1158/0008-5472.CAN-10-0920; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rotblat B, 2008, METHOD ENZYMOL, V439, P467, DOI 10.1016/S0076-6879(07)00432-6; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Stepanova V, 2008, BLOOD, V112, P100, DOI 10.1182/blood-2007-07-104455; Storck S, 2008, BIOL CELL; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; Takaoka A, 1998, ONCOGENE, V16, P1443, DOI 10.1038/sj.onc.1201648; Teng Y, 2007, CANCER RES, V67, P10491, DOI 10.1158/0008-5472.CAN-06-4206; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Weis B, 1999, ONCOGENE, V18, P2579, DOI 10.1038/sj.onc.1202602; Xu XH, 2001, J BIOL CHEM, V276, P43221, DOI 10.1074/jbc.M104446200; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Zundelevich A, 2007, MOL CANCER THER, V6, P1765, DOI 10.1158/1535-7163.MCT-06-0706	42	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75269	10.1371/journal.pone.0075269	http://dx.doi.org/10.1371/journal.pone.0075269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086490	gold, Green Published, Green Submitted			2022-12-27	WOS:000325025200035
J	Slocum, MG; Orzell, SL				Slocum, Matthew G.; Orzell, Steve L.			A Structural Equation Model Analysis of Relationships among ENSO, Seasonal Descriptors and Wildfires	PLOS ONE			English	Article							EVERGLADES-NATIONAL-PARK; FIRE REGIMES; EL-NINO; WINTER PRECIPITATION; SOUTHERN-OSCILLATION; FLORIDA; RAINFALL; CLIMATE; TEMPERATURE; HURRICANES	Seasonality drives ecological processes through networks of forcings, and the resultant complexity requires creative approaches for modeling to be successful. Recently ecologists and climatologists have developed sophisticated methods for fully describing seasons. However, to date the relationships among the variables produced by these methods have not been analyzed as networks, but rather with simple univariate statistics. In this manuscript we used structural equation modeling (SEM) to analyze a proposed causal network describing seasonality of rainfall for a site in south-central Florida. We also described how this network was influenced by the El Nino-Southern Oscillation (ENSO), and how the network in turn affected the site's wildfire regime. Our models indicated that wet and dry seasons starting later in the year (or ending earlier) were shorter and had less rainfall. El Nino conditions increased dry season rainfall, and via this effect decreased the consistency of that season's drying trend. El Nino conditions also negatively influenced how consistent the moistening trend was during the wet season, but in this case the effect was direct and did not route through rainfall. In modeling wildfires, our models showed that area burned was indirectly influenced by ENSO via its effect on dry season rainfall. Area burned was also indirectly reduced when the wet season had consistent rainfall, as such wet seasons allowed fewer wildfires in subsequent fire seasons. Overall area burned at the study site was estimated with high accuracy (R-2 score = 0.63). In summary, we found that by using SEMs, we were able to clearly describe causal patterns involving seasonal climate, ENSO and wildfire. We propose that similar approaches could be effectively applied to other sites where seasonality exerts strong and complex forcings on ecological processes.	[Slocum, Matthew G.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Orzell, Steve L.] Avon Pk Air Force Range, Avon Pk, FL USA	Louisiana State University System; Louisiana State University	Slocum, MG (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	mateo457@yahoo.com			Avon Park Air Force Range, Department of Defense, USA	Avon Park Air Force Range, Department of Defense, USA(United States Department of Defense)	Funding was obtained from the Avon Park Air Force Range, Department of Defense, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaraz P, 2004, ECOL LETT, V7, P547, DOI 10.1111/j.1461-0248.2004.00612.x; Anderson TM, 2011, J ECOL, V99, P797, DOI 10.1111/j.1365-2745.2011.01795.x; Arbuckle JL, 2011, IBM SPSS AMOS 20 USE, P653; Baiser B, 2008, ANIM CONSERV, V11, P190, DOI 10.1111/j.1469-1795.2008.00167.x; Basille M, 2013, ECOGRAPHY, V36, P220, DOI 10.1111/j.1600-0587.2011.07367.x; Beckage B, 2003, FRONT ECOL ENVIRON, V1, P235, DOI 10.2307/3868010; Beckage B, 2003, ECOLOGY, V84, P3124, DOI 10.1890/02-0183; Bove MC, 1998, B AM METEOROL SOC, V79, P2477, DOI 10.1175/1520-0477(1998)079<2477:EOENOO>2.0.CO;2; Brenner J., 1991, Fire Management Notes, V52, P28; Brolley JM, 2007, AGR FOREST METEOROL, V145, P84, DOI 10.1016/j.agrformet.2007.04.003; BROWNE MW, 1989, MULTIVAR BEHAV RES, V24, P445, DOI 10.1207/s15327906mbr2404_4; Camberlin P, 2003, CLIMATE RES, V23, P159, DOI 10.3354/cr023159; Chen E., 1990, ECOSYSTEMS FLORIDA, P11; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; DOUGLAS AV, 1981, MON WEATHER REV, V109, P2377, DOI 10.1175/1520-0493(1981)109<2377:OASRBA>2.0.CO;2; Duncan BW, 2010, CAN J FOREST RES, V40, P286, DOI 10.1139/X09-193; Forister ML, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.13001; Gill AM, 2008, INT J WILDLAND FIRE, V17, P688, DOI 10.1071/WF07145; Gimenez O, 2012, METHODS ECOL EVOL, V3, P427, DOI 10.1111/j.2041-210X.2011.00150.x; Goodrick SL, 2009, INT J WILDLAND FIRE, V18, P476, DOI 10.1071/WF07034; Goswami BN, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023216; Grace J.B., 2006, STRUCT EQ MOD NAT; GRAY WM, 1984, MON WEATHER REV, V112, P1649, DOI 10.1175/1520-0493(1984)112<1649:ASHFPI>2.0.CO;2; Hagemeyer B, 1999, 20 C SEVERE LOCAL ST; Hanley DE, 2003, J CLIMATE, V16, P1249, DOI 10.1175/1520-0442(2003)16<1249:AQEOEI>2.0.CO;2; Hardy JW, 2003, PHYS GEOGR, V24, P120, DOI 10.2747/0272-3646.24.2.120; Howell DC, 1987, STAT METHODS PSYCHOL; Jones C. S., 1999, FLORIDA GEOGRAPHER, V30, P55; Landsea CW, 1999, CLIMATIC CHANGE, V42, P89, DOI 10.1023/A:1005416332322; Le Page Y, 2008, ATMOS CHEM PHYS, V8, P1911, DOI 10.5194/acp-8-1911-2008; Lee SY, 2004, MULTIVAR BEHAV RES, V39, P653, DOI 10.1207/s15327906mbr3904_4; Lima CHR, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007485; Meyn A, 2007, PROG PHYS GEOG, V31, P287, DOI 10.1177/0309133307079365; Moritz MA, 2005, P NATL ACAD SCI USA, V102, P17912, DOI 10.1073/pnas.0508985102; Moses CS, 2013, J PALEOLIMNOL, V49, P5, DOI 10.1007/s10933-012-9635-0; Orzell S. L., 2006, LAND FIRE WATER FLOR, P136; Philander S.G.H., 2004, OUR AFFAIR EL NINO W; Platt W.J., 2006, LAND FIRE WATER, P3; Roman-Cuesta RM, 2003, ECOL APPL, V13, P1177, DOI 10.1890/1051-0761(2003)13[1177:EAHFIF]2.0.CO;2; Ropelewski CF, 1989, J CLIMATE, V2, P268, DOI 10.1175/1520-0442(1989)002<0268:PPAWTH>2.0.CO;2; ROPELEWSKI CF, 1986, MON WEATHER REV, V114, P2352, DOI 10.1175/1520-0493(1986)114<2352:NAPATP>2.0.CO;2; Rueda M, 2008, J ARID ENVIRON, V72, P1698, DOI 10.1016/j.jaridenv.2008.03.006; Shipley B., 2000, CAUSE CORRELATIONS B; Slocum MG, 2007, NAT AREA J, V27, P41, DOI 10.3375/0885-8608(2007)27[41:DNAAFR]2.0.CO;2; Slocum MG, 2010, J APPL METEOROL CLIM, V49, P2559, DOI 10.1175/2010JAMC2532.1; Slocum MG, 2010, ECOSYSTEMS, V13, P828, DOI 10.1007/s10021-010-9357-y; Slocum MG, 2003, RESTOR ECOL, V11, P91, DOI 10.1046/j.1526-100X.2003.00115.x; Smith SR, 1998, MON WEATHER REV, V126, P3102, DOI 10.1175/1520-0493(1998)126<3102:ROMLTC>2.0.CO;2; Snyder JR, 1991, P TALL TIMBERS FIRE, V17, P303; Stein BA, 2008, BIOSCIENCE, V58, P339, DOI 10.1641/B580409; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; Trenberth KE, 1997, B AM METEOROL SOC, V78, P2771, DOI 10.1175/1520-0477(1997)078<2771:TDOENO>2.0.CO;2; van der Heijden GMF, 2009, J BIOGEOGR, V36, P1561, DOI 10.1111/j.1365-2699.2009.02099.x; Vieyra L, 2009, ECOLOGY, V90, P1084, DOI 10.1890/07-2009.1; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834	55	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75946	10.1371/journal.pone.0075946	http://dx.doi.org/10.1371/journal.pone.0075946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086670	Green Published, Green Submitted, gold			2022-12-27	WOS:000325025200072
J	Wintermann, GB; Donix, M; Joraschky, P; Gerber, J; Petrowski, K				Wintermann, Gloria-Beatrice; Donix, Markus; Joraschky, Peter; Gerber, Johannes; Petrowski, Katja			Altered Olfactory Processing of Stress-Related Body Odors and Artificial Odors in Patients with Panic Disorder	PLOS ONE			English	Article							FACIAL AFFECT; CHEMOSENSORY CUES; ACTIVATION; ANXIETY; FMRI; FEAR; AMYGDALA; NETWORK; EMOTION; DISCRIMINATION	Background: Patients with Panic Disorder (PD) direct their attention towards potential threat, followed by panic attacks, and increased sweat production. Ones own anxiety sweat odor influences the attentional focus, and discrimination of threat or non-threat. Since olfactory projection areas overlap with neuronal areas of a panic-specific fear network, the present study investigated the neuronal processing of odors in general and of stress-related sweat odors in particular in patients with PD. Methods: A sample of 13 patients with PD with/without agoraphobia and 13 age-and gender-matched healthy controls underwent an fMRI investigation during olfactory stimulation with their stress-related sweat odors (TSST, ergometry) as well as artificial odors (peach, artificial sweat) as non-fearful non-body odors. Principal Findings: The two groups did not differ with respect to their olfactory identification ability. Independent of the kind of odor, the patients with PD showed activations in fronto-cortical areas in contrast to the healthy controls who showed activations in olfaction-related areas such as the amygdalae and the hippocampus. For artificial odors, the patients with PD showed a decreased neuronal activation of the thalamus, the posterior cingulate cortex and the anterior cingulate cortex. Under the presentation of sweat odor caused by ergometric exercise, the patients with PD showed an increased activation in the superior temporal gyrus, the supramarginal gyrus, and the cingulate cortex which was positively correlated with the severity of the psychopathology. For the sweat odor from the anxiety condition, the patients with PD showed an increased activation in the gyrus frontalis inferior, which was positively correlated with the severity of the psychopathology. Conclusions: The results suggest altered neuronal processing of olfactory stimuli in PD. Both artificial odors and stress-related body odors activate specific parts of a fear-network which is associated with an increased severity of the psychopathology.	[Wintermann, Gloria-Beatrice; Joraschky, Peter; Petrowski, Katja] Tech Univ Dresden, Sch Med, Dept Psychotherapy & Psychosomat Med, Dresden, Germany; [Donix, Markus] Univ Klinikum Carl Gustav Carus, Dept Psychiat & Psychotherapy, Dresden, Germany; [Gerber, Johannes] Tech Univ Dresden, Sch Med, Dept Neuroradiol, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden	Wintermann, GB (corresponding author), Tech Univ Dresden, Sch Med, Dept Psychotherapy & Psychosomat Med, Dresden, Germany.	gloria.wintermann@uniklinikum-dresden.de	Wintermann, Gloria-Beatrice/AAN-3318-2021; Gerber, Johannes/U-4918-2019	Gerber, Johannes/0000-0001-7465-8700	Medical Faculty of Dresden University of Technology	Medical Faculty of Dresden University of Technology	Funding for the present study was provided by the Medical Faculty of Dresden University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerl K, 2002, NEUROENDOCRINOL LETT, V23, P79; Amaro E, 2006, BRAIN COGNITION, V60, P220, DOI 10.1016/j.bandc.2005.11.009; APA, 2000, DIAGN STAT MAN MENT; Bandelow B, 1997, PANIC AGORAPHOBIA SC; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Bremner JD, 2000, BIOL PSYCHIAT, V47, P96, DOI 10.1016/S0006-3223(99)00188-2; Bystritsky A, 2001, NEUROREPORT, V12, P3953, DOI 10.1097/00001756-200112210-00020; CHAMBLESS DL, 1985, BEHAV RES THER, V23, P35, DOI 10.1016/0005-7967(85)90140-8; CHAMBLESS DL, 1984, J CONSULT CLIN PSYCH, V52, P1090, DOI 10.1037/0022-006X.52.6.1090; Chechko N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005537; Chen D, 2000, PERCEPT MOTOR SKILL, V91, P771, DOI 10.2466/pms.2000.91.3.771; Crespo-Facorro B, 2001, JAMA-J AM MED ASSOC, V286, P427, DOI 10.1001/jama.286.4.427; Croy I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009362; de Carvalho MR, 2010, WORLD J BIOL PSYCHIA, V11, P188, DOI [10.3109/15622970903178176, 10.1080/15622970903178176]; de Carvalho MR, 2010, EXPERT REV NEUROTHER, V10, P291, DOI [10.1586/ern.09.161, 10.1586/ERN.09.161]; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Fichtenholtz HM, 2004, COGNITIVE BRAIN RES, V20, P67, DOI 10.1016/j.cogbrainres.2004.01.006; Franke GH, 2002, SCL90R BELTZ TEST; Friedman BH, 1998, BIOL PSYCHOL, V47, P243, DOI 10.1016/S0301-0511(97)00027-6; Gorman JM, 2000, AM J PSYCHIAT, V157, P493, DOI 10.1176/appi.ajp.157.4.493; Haegler K, 2010, NEUROPSYCHOLOGIA, V48, P3901, DOI 10.1016/j.neuropsychologia.2010.09.019; Hautzinger M, 1994, BECK DEPRESSIONS INV; Hinton DE, 2004, GEN HOSP PSYCHIAT, V26, P390, DOI 10.1016/j.genhosppsych.2004.04.007; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Jacob S, 2001, NEUROREPORT, V12, P2391, DOI 10.1097/00001756-200108080-00021; Javanmard M, 1999, BIOL PSYCHIAT, V45, P872, DOI 10.1016/S0006-3223(98)00348-5; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lautenbacher S, 2002, EUR ARCH PSY CLIN N, V252, P210, DOI 10.1007/s00406-002-0382-5; Laux L., 1981, STATE TRAIT ANGSTINV; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lueken U, 2011, NEUROIMAGE, V56, P363, DOI 10.1016/j.neuroimage.2011.02.015; Lundstrom JN, 2008, CEREB CORTEX, V18, P1466, DOI 10.1093/cercor/bhm178; Lundstrom JN, 2009, HUM BRAIN MAPP, V30, P2571, DOI 10.1002/hbm.20686; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Maddock RJ, 2003, NEUROREPORT, V14, P325, DOI 10.1097/01.wnr.0000059776.23521.25; Maddock RJ, 2003, HUM BRAIN MAPP, V18, P30, DOI 10.1002/hbm.10075; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; Miller LA, 2005, J NEUROPSYCH CLIN N, V17, P1, DOI 10.1176/appi.neuropsych.17.1.1; Mujica-Parodi LR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006415; Nishimura Y, 2009, PSYCHIAT RES-NEUROIM, V172, P168, DOI 10.1016/j.pscychresns.2009.01.001; Ottaviani C, 2012, PSYCHIAT RES-NEUROIM, V203, P159, DOI 10.1016/j.pscychresns.2011.12.010; Pannekoek JN, 2013, J AFFECT DISORDERS, V145, P29, DOI 10.1016/j.jad.2012.07.006; Pause BM, 2009, INT J PSYCHOPHYSIOL, V74, P88, DOI 10.1016/j.ijpsycho.2009.07.008; Pause BM, 2004, CHEM SENSES, V29, P797, DOI 10.1093/chemse/bjh245; Pause BM, 1998, GENETICA, V104, P285, DOI 10.1023/A:1026462701154; Pfleiderer B, 2007, WORLD J BIOL PSYCHIA, V8, P269, DOI 10.1080/15622970701216673; Pillay SS, 2007, J ANXIETY DISORD, V21, P381, DOI 10.1016/j.janxdis.2006.04.001; Pillay SS, 2006, J AFFECT DISORDERS, V94, P173, DOI 10.1016/j.jad.2006.04.007; Prehn A, 2006, NEUROSCI LETT, V394, P127, DOI 10.1016/j.neulet.2005.10.012; Prehn-Kristensen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005987; REIMAN EM, 1984, NATURE, V310, P683, DOI 10.1038/310683a0; Rosen J, 2004, BEHAV COGN NEUROSCI, V73, P49; Roy-Byrne PP, 2006, LANCET, V368, P1023, DOI 10.1016/S0140-6736(06)69418-X; Rubin D, 2012, SOC COGN AFFECT NEUR, V7, P208, DOI 10.1093/scan/nsq097; Sakai Y, 2005, NEUROREPORT, V16, P927, DOI 10.1097/00001756-200506210-00010; Sass H., 2003, DIAGNOSTISCHES STAT; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; Snow JC, 2009, P NATL ACAD SCI USA, V106, P4054, DOI 10.1073/pnas.0810086106; Sobel N, 1999, BRAIN, V122, P209, DOI 10.1093/brain/122.2.209; Sobel N., 2003, HDB OLFACTION GUSTAT; SPITZER RL, 1990, SCID USERS GUIDE STR; Uhlmann C., 2013, PSYCHOL MED, P1; van den Heuvel OA, 2005, ARCH GEN PSYCHIAT, V62, P922, DOI 10.1001/archpsyc.62.8.922; van Duinen MA, 2007, INT J NEUROPSYCHOPH, V10, P797; Wittchen H.-U., 1997, SKID STRUKTURIERTES; Wittmann A, 2011, EUR ARCH PSY CLIN N, V261, P185, DOI 10.1007/s00406-010-0167-1; Zatorre RJ, 2000, BRAIN MAPPING SYSTEM; Zhao XH, 2007, EUR J RADIOL, V63, P373, DOI 10.1016/j.ejrad.2007.02.006; Zhou W, 2008, J NEUROSCI, V28, P14416, DOI 10.1523/JNEUROSCI.3148-08.2008	72	23	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e74655	10.1371/journal.pone.0074655	http://dx.doi.org/10.1371/journal.pone.0074655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086358	Green Submitted, gold, Green Published			2022-12-27	WOS:000325025200015
J	Hu, Y; Wang, JL; Tao, HT; Wu, BS; Sun, J; Cheng, Y; Dong, WW; Li, RX				Hu, Yi; Wang, Jingliang; Tao, Haitao; Wu, Baishou; Sun, Jin; Cheng, Yao; Dong, Weiwei; Li, Ruixin			Increased Risk of High-Grade Hemorrhage in Cancer Patients Treated with Gemcitabine: A Meta-Analysis of 20 Randomized Controlled Trials	PLOS ONE			English	Article							CELL LUNG-CANCER; CISPLATIN PLUS GEMCITABINE; PHASE-III TRIAL; METASTATIC BREAST-CANCER; UNKNOWN PRIMARY SITE; 1ST-LINE TREATMENT; ELDERLY-PATIENTS; PANCREATIC-CANCER; BLADDER-CANCER; VINORELBINE	Purpose: Gemcitabine, a third-generation anticancer agent, has been shown to be active in several solid tumors. High-grade hemorrhage (grade >= 3) has been reported with this drug, although the overall risk remains unclear. We conducted a meta-analysis of randomized controlled trials evaluating the incidence and risk of high-grade hemorrhage associated with gemcitabine. Methods: Pubmed was searched for articles published from January 1, 1990 to December 31, 2012. Eligible studies included prospective randomized controlled phase II and III trials evaluating gemcitabine-based vs non-gemcitabine-based therapy in patients with solid tumors. Data on high-grade hemorrhage were extracted. Overall incidence rates, relative risk (RR), and 95% confidence intervals (CI) were calculated employing fixed-or random-effects models depending on the heterogeneity of included trials. Results: A total of 6433 patients from 20 trials were included. Among patients treated with gemcitabine-based chemotherapy, the overall incidence of high-grade hemorrhage was 1.7% (95% CI: 0.9-3.1%), and the RR of high-grade hemorrhage was 2.727 (95% CI: 1.581-4.702, p<0.001). Exploratory subgroup analysis revealed the highest RR of hemorrhage in non-small-cell lung cancer (NSCLC) patients (RR: 3.234; 95% CI, 1.678-6.233; p<0.001), phase II trials (RR 7.053, 95% CI: 1.591-31.27; p = 0.01), trials reported during 2006-2012 (RR: 3.750; 95% CI: 1.735-8.108, p<0.001) and gemcitabine used as single agent (RR 7.48; 95% CI: 0.78-71.92, p = 0.081). Conclusion: Gemcitabine is associated with a significant increase risk of high-grade hemorrhage in patients with solid tumors when compared with non-gemcitabine-based therapy.	[Hu, Yi; Wang, Jingliang; Tao, Haitao; Wu, Baishou; Sun, Jin; Cheng, Yao; Dong, Weiwei; Li, Ruixin] Chinese Peoples Liberat Army Gen Hosp, Dept Oncol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Hu, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Oncol, Beijing, Peoples R China.	huyi20130502@163.com						Addeo R, 2010, J CLIN ONCOL, V28, P543, DOI 10.1200/JCO.2008.20.8199; Avvisati G, 2003, CRIT REV ONCOL HEMAT, V48, pS13, DOI 10.1016/j.critrevonc.2003.04.001; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Brufsky A, 2011, CLIN BREAST CANCER, V11, P211, DOI 10.1016/j.clbc.2011.03.019; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cardenal F, 1999, J CLIN ONCOL, V17, P12, DOI 10.1200/JCO.1999.17.1.12; Carron PL, 2001, INTENS CARE MED, V27, P1554, DOI 10.1007/s001340101037; CHAIT MM, 1979, AM J GASTROENTEROL, V72, P227; Comella P, 2004, BRIT J CANCER, V91, P489, DOI 10.1038/sj.bjc.6602011; Crino L, 1999, J CLIN ONCOL, V17, P3522, DOI 10.1200/JCO.1999.17.11.3522; Culine S, 2003, J CLIN ONCOL, V21, P3479, DOI 10.1200/JCO.2003.12.104; De Santis M, 2009, J CLIN ONCOL, V27, P5634, DOI 10.1200/JCO.2008.21.4924; El-Khoueiry AB, 2012, INVEST NEW DRUG, V30, P1175, DOI 10.1007/s10637-011-9658-9; Elting LS, 2001, J CLIN ONCOL, V19, P1137, DOI 10.1200/JCO.2001.19.4.1137; Feher O, 2005, ANN ONCOL, V16, P899, DOI 10.1093/annonc/mdi181; Frasci G, 2000, ANN ONCOL, V11, P367, DOI 10.1023/A:1008346708604; Georgoulias V, 2005, J CLIN ONCOL, V23, P2937, DOI 10.1200/JCO.2005.04.016; Gorter JW, 1999, NEUROLOGY, V53, P1319, DOI 10.1212/WNL.53.6.1319; Gridelli C, 2011, ANN ONCOL, V22, P1528, DOI 10.1093/annonc/mdq630; Gridelli C, 2003, J CLIN ONCOL, V21, P3025, DOI 10.1200/JCO.2003.06.099; Gridelli C, 2007, J CLIN ONCOL, V25, P4663, DOI 10.1200/JCO.2007.12.5708; Gronberg BH, 2009, J CLIN ONCOL, V27, P3217, DOI 10.1200/JCO.2008.20.9114; Hainsworth JD, 2010, CANCER J, V16, P70, DOI 10.1097/PPO.0b013e3181c6aa89; Hang XF, 2011, EUR J CLIN PHARMACOL, V67, P613, DOI 10.1007/s00228-010-0988-x; Hapani S, 2010, ONCOLOGY-BASEL, V79, P27, DOI 10.1159/000314980; Je YJ, 2009, LANCET ONCOL, V10, P967, DOI 10.1016/S1470-2045(09)70222-0; Levine MN, 2001, CHEST, V119, p108S, DOI 10.1378/chest.119.1_suppl.108S; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; NCI Cancer Therapy Evaluation Program, 2006, CTC V 2 0 COMM TERM; Nichols L, 2012, ARCH PATHOL LAB MED, V136, P1552, DOI 10.5858/arpa.2011-0521-OA; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Ohe Y, 2007, ANN ONCOL, V18, P317, DOI 10.1093/annonc/mdl377; Pawarode A, 1998, AM J CLIN ONCOL-CANC, V21, P386, DOI 10.1097/00000421-199808000-00014; Paz-Ares LG, 2012, J CLIN ONCOL, V30, P3084, DOI 10.1200/JCO.2011.39.7646; Sandler AB, 2000, J CLIN ONCOL, V18, P122, DOI 10.1200/JCO.2000.18.1.122; Sculier JP, 2002, ANN ONCOL, V13, P874, DOI 10.1093/annonc/mdf154; Spigel DR, 2012, J THORAC ONCOL, V7, P196, DOI 10.1097/JTO.0b013e3182307efe; Thomas P, 2006, LUNG CANCER, V51, P105, DOI 10.1016/j.lungcan.2005.10.004; Treat JA, 2010, ANN ONCOL, V21, P540, DOI 10.1093/annonc/mdp352; Ueno H, 2009, BRIT J CANCER, V101, P908, DOI 10.1038/sj.bjc.6605256; Valle Juan, 2010, N Engl J Med, V362, P1273, DOI 10.1056/NEJMoa0908721; von der Maase H, 2000, J CLIN ONCOL, V18, P3068, DOI 10.1200/JCO.2000.18.17.3068; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Zielinski C, 2005, J CLIN ONCOL, V23, P1401, DOI 10.1200/JCO.2005.12.106; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048	46	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74872	10.1371/journal.pone.0074872	http://dx.doi.org/10.1371/journal.pone.0074872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086388	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200047
J	Sanders, JL; Watral, V; Clarkson, K; Kent, ML				Sanders, Justin L.; Watral, Virginia; Clarkson, Keri; Kent, Michael L.			Verification of Intraovum Transmission of a Microsporidium of Vertebrates: Pseudoloma neurophilia Infecting the Zebrafish, Danio rerio	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RENIBACTERIUM-SALMONINARUM; VERTICAL TRANSMISSION; TRANSOVARIAL TRANSMISSION; OVIPLEISTOPHORA-OVARIAE; CYPRINID FISH; N. SP.; EVOLUTION; DISEASE; MODEL	Direct transmission from parents to offspring, referred to as vertical transmission, occurs within essentially all major groups of pathogens. Several microsporidia (Phylum Microsporidia) that infect arthropods employ this mode of transmission, and various lines of evidence have suggested this might occur with certain fish microsporidia. The microsporidium, Pseudoloma neurophilia, is a common pathogen of the laboratory zebrafish, Danio rerio. We previously verified that this parasite is easily transmitted horizontally, but previous studies also indicated that maternal transmission occurs. We report here direct observation of Pseudoloma neurophilia in the progeny of infected zebrafish that were reared in isolation, including microscopic visualization of the parasite in all major stages of development. Histological examination of larval fish reared in isolation from a group spawn showed microsporidian spores in the resorbing yolk sac of a fish. Infections were also observed in three of 36 juvenile fish. Eggs from a second group spawn of 30 infected fish were examined using a stereomicroscope and the infection was observed from 4 to 48 hours post-fertilization in two embryos. Intraovum infections were detected in embryos from 4 of 27 pairs of infected fish that were spawned based on qPCR detection of P. neurophilia DNA. The prevalence of intraovum infections from the four spawns containing infected embryos was low (similar to 1%) based on calculation of prevalence using a maximum likelihood analysis for pooled samples. Parasite DNA was detected in the water following spawning of 11 of the infected pairs, suggesting there was also potential for extraovum transmission in these spawning events. Our study represents the first direct observation of vertical transmission within a developing embryo of a microsporidian parasite in a vertebrate. The low prevalence of vertical transmission in embryos is consistent with observations of some other fish pathogens that are also readily transmitted by both vertical and horizontal routes.	[Sanders, Justin L.; Watral, Virginia; Kent, Michael L.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Clarkson, Keri; Kent, Michael L.] Oregon State Univ, Dept Biomed Sci, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Sanders, JL (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.	Justin.Sanders@oregonstate.edu	Sanders, Justin L./AAC-6406-2020; Sanders, Justin/F-5977-2011	Sanders, Justin L./0000-0001-9970-7628; 	National Institutes of Health [NIH NCRR 5R24RR017386-02, NIH NCRR P40 RR12546-03S1]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR017386, P40RR012546] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from the National Institutes of Health (NIH NCRR 5R24RR017386-02 and NIH NCRR P40 RR12546-03S1). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Balbiani G, 1882, CR HEBD ACAD SCI, V95, P1168; Becnel James J., 1999, P447; Brown AMV, 2010, DIS AQUAT ORGAN, V91, P35, DOI 10.3354/dao02246; Brown LL, 1997, DIS AQUAT ORGAN, V29, P213, DOI 10.3354/dao029213; BRUNO DW, 1986, DIS AQUAT ORGAN, V1, P83; Cali A, 2012, J EUKARYOT MICROBIOL, V59, P40, DOI 10.1111/j.1550-7408.2011.00591.x; CANNING EU, 1986, MICROSPORIDIA VERTEB; Corradi Nicolas, 2009, Fungal Biology Reviews, V23, P1, DOI 10.1016/j.fbr.2009.05.001; Docker MF, 1997, DIS AQUAT ORGAN, V29, P41, DOI 10.3354/dao029041; Dunn AM, 2001, ADV PARASIT, V48, P57, DOI 10.1016/S0065-308X(01)48005-5; Ebert D, 1996, PARASITOL TODAY, V12, P96, DOI 10.1016/0169-4758(96)80668-5; Evelyn T, 1984, ACUIGRUP FISH DIS 4, P111; EVELYN TPT, 1984, J FISH DIS, V7, P173, DOI 10.1111/j.1365-2761.1984.tb00921.x; EWALD PW, 1987, ANN NY ACAD SCI, V503, P295, DOI 10.1111/j.1749-6632.1987.tb40616.x; Ferguson JA, 2007, DIS AQUAT ORGAN, V76, P205, DOI 10.3354/dao076205; FRYER JL, 1981, ANNU REV MICROBIOL, V35, P273, DOI 10.1146/annurev.mi.35.100181.001421; HART NH, 1983, J EXP ZOOL, V227, P277, DOI 10.1002/jez.1402270212; HERRE EA, 1993, SCIENCE, V259, P1442, DOI 10.1126/science.259.5100.1442; Holt R. A., 1993, P3; HUNT RD, 1972, J INFECT DIS, V126, P212, DOI 10.1093/infdis/126.2.212; Kent ML, 2011, DIS AQUAT ORGAN, V95, P73, DOI 10.3354/dao02333; Kent ML, 2003, BIOSECURITY IN AQUACULTURE PRODUCTION SYSTEMS: EXCLUSION OF PATHOGENS AND OTHER UNDESIRABLES, P43; Kent ML, 2003, J FISH DIS, V26, P423, DOI 10.1046/j.1365-2761.2003.00467.x; LaPatra S, 1991, P 2 INT S VIR LOW VE, P261; Matthews JL, 2001, J EUKARYOT MICROBIOL, V48, P227, DOI 10.1111/j.1550-7408.2001.tb00307.x; MAURAND J, 1988, J FISH DIS, V11, P251, DOI 10.1111/j.1365-2761.1988.tb00546.x; Meyers T, 1998, J AQUAT ANIM HEALTH, DOI [10.1577/1548-8667(1998) 0102.0.CO, DOI 10.1577/1548-8667(1998)0102.0.CO]; Meyers T, 1990, J AQUAT ANIM LDOTS, P37; Mulcahy D, 1985, J FISH DIS; Murray KN, 2011, COMPARATIVE MED, V61, P322; NAGELI KW, 1857, BOT Z, V15, P760; Pascho RJ, 1998, J VET DIAGN INVEST, V10, P60, DOI 10.1177/104063879801000111; Pekkarinen M, 2002, DIS AQUAT ORGAN, V48, P133, DOI 10.3354/dao048133; Peterson TS, 2011, DIS AQUAT ORGAN, V95, P175, DOI 10.3354/dao02346; Phelps HA, 2005, ZEBRAFISH, V2, P87, DOI 10.1089/zeb.2005.2.87; Phelps NBD, 2008, J AQUAT ANIM HEALTH, V20, P45, DOI 10.1577/H07-029.1; Phelps NBD, 2007, DIS AQUAT ORGAN, V76, P215, DOI 10.3354/dao076215; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Sabaliauskas NA, 2006, METHODS, V39, P246, DOI 10.1016/j.ymeth.2006.03.001; Sanders JL, 2012, ILAR J, V53, P106, DOI 10.1093/ilar.53.2.106; Sanders JL, 2011, DIS AQUAT ORGAN, V96, P145, DOI 10.3354/dao02375; SMITH JE, 1991, PARASITOL TODAY, V7, P146, DOI 10.1016/0169-4758(91)90283-T; Stead S. M., 2002, HDB SALMON FARMING; Sullivan C, 2008, FISH SHELLFISH IMMUN, V25, P341, DOI 10.1016/j.fsi.2008.05.005; SUMMERFELT R C, 1970, Journal of Wildlife Diseases, V6, P457; Summerfelt RC, 1972, STUDIES TRANSMISSION, P1; SUMMERFELT ROBERT C., 1964, TRANS AMER FISH SOC, V93, P6, DOI 10.1577/1548-8659(1964)93[6:ANMPFT]2.0.CO;2; Terry RS, 2004, P ROY SOC B-BIOL SCI, V271, P1783, DOI 10.1098/rspb.2004.2793; Terry RS, 1999, J EUKARYOT MICROBIOL, V46, P492, DOI 10.1111/j.1550-7408.1999.tb06066.x; Traver D, 2003, ADV IMMUNOL, V81, P253; Traxler GS, 1997, DIS AQUAT ORGAN, V28, P31, DOI 10.3354/dao028031; van der Sar AM, 2004, TRENDS MICROBIOL, V12, P451, DOI 10.1016/j.tim.2004.08.001; Vaney C, 1901, CR HEBD ACAD SCI, V133, P644; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Whipps CM, 2006, J AM ASSOC LAB ANIM, V45, P36; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949; Williams BAP, 2011, MYCOTA, V14, P25; Williams CJ, 2005, J AQUAT ANIM HEALTH, V17, P386, DOI 10.1577/H04-066.1; [No title captured]	59	35	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e76064	10.1371/journal.pone.0076064	http://dx.doi.org/10.1371/journal.pone.0076064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086686	Green Submitted, gold, Green Published			2022-12-27	WOS:000326520200129
J	Szekely, A; Thege, BK; Mergl, R; Birkas, E; Rozsa, S; Purebl, G; Hegerl, U				Szekely, Andras; Thege, Barna Konkoly; Mergl, Roland; Birkas, Emma; Rozsa, Sandor; Purebl, Gyoergy; Hegerl, Ulrich			How to Decrease Suicide Rates in Both Genders? An Effectiveness Study of a Community-Based Intervention (EAAD)	PLOS ONE			English	Article							GENERAL-PRACTITIONERS; EDUCATIONAL-PROGRAM; HELP-SEEKING; DEPRESSION; GOTLAND; ALLIANCE	Background: The suicide rate in Hungary is high in international comparison. The two-year community-based four-level intervention programme of the European Alliance Against Depression (EAAD) is designed to improve the care of depression and to prevent suicidal behaviour. Our aim was to evaluate the effectiveness of a regional community-based four-level suicide prevention programme on suicide rates. Method: The EAAD programme was implemented in Szolnok (population 76,311), a town in a region of Hungary with an exceptionally high suicide rate. Effectiveness was assessed by comparing changes in suicide rates in the intervention region after the intervention started with changes in national suicide rates and those in a control region (Szeged) in the corresponding period. Results: For the duration of the programme and the follow-up year, suicide rates in Szolnok were significantly lower than the average of the previous three years (p=.0076). The suicide rate thus went down from 30.1 per 100,000 in 2004 to 13.2 in 2005 (-56.1%), 14.6 in 2006 (-51.4 %) and 12.0 in 2007 (-60.1 %). This decrease of annual suicide rates in Szolnok after the onset of the intervention was significantly stronger than that observed in the whole country (p=.017) and in the control region (p=.0015). Men had the same decrease in suicide rates as women. As secondary outcome, an increase of emergency calls to the hotline service (200%) and outpatient visits at the local psychiatry clinic (76%) was found. Conclusions: These results seem to provide further support for the effectiveness of the EAAD concept. Whilst the majority of suicide prevention programs mainly affect female suicidal behaviour, this programme seems to be beneficial for both sexes. The sustainability and the role of the mediating factors (social service and health care utilization, community attitudes about suicide) should be key points in future research.	[Szekely, Andras; Thege, Barna Konkoly; Birkas, Emma; Purebl, Gyoergy] Semmelweis Univ, Inst Behav Sci, H-1085 Budapest, Hungary; [Thege, Barna Konkoly] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada; [Mergl, Roland; Hegerl, Ulrich] Univ Klinikum Leipzig AoR, Klin & Poliklin Psychiat & Psychotherapie, Leipzig, Germany; [Rozsa, Sandor] Eotvos Lorand Univ, Dept Personal & Hlth Psychol, Budapest, Hungary	Semmelweis University; University of Calgary; Leipzig University; Eotvos Lorand University	Szekely, A (corresponding author), Semmelweis Univ, Inst Behav Sci, H-1085 Budapest, Hungary.	szekely7@gmail.com	Konkolÿ Thege, Barna/U-2253-2019; Purebl, György/J-8518-2017	Konkolÿ Thege, Barna/0000-0002-0861-8978; Hegerl, Ulrich/0000-0002-3039-7470	European Commission [2003317]; OSPI-Europe as part of the European Community's Seventh Framework Program [223138]	European Commission(European CommissionEuropean Commission Joint Research Centre); OSPI-Europe as part of the European Community's Seventh Framework Program	The European Alliance Against Depression programme was funded within the Public Health Programme of the European Commission, under grant number 2003317. This study received funding from OSPI-Europe as part of the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement 223138. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus D, 2003, WORLD J BIOL PSYCHIA, V4, P156, DOI 10.1080/15622970310029913; Bennewith O, 2002, BRIT MED J, V324, P1254, DOI 10.1136/bmj.324.7348.1254; Csepe A, 2007, OSSZEFOGAS DEPRESSZI; European Commission, 2005, GREEN PAP IMPR MENT, P10; Gilbody S, 2003, JAMA-J AM MED ASSOC, V289, P3145, DOI 10.1001/jama.289.23.3145; Hegerl U, 2003, PHARMACOPSYCHIATRY, V36, P288; Hegerl U, 2011, GERMAN MEDO J, V11, P74; Hegerl U, 2008, WORLD J BIOL PSYCHIA, V9, P51, DOI 10.1080/15622970701216681; Hegerl U, 2006, PSYCHOL MED, V36, P1225, DOI 10.1017/S003329170600780X; Hegerl U, 2010, EUR ARCH PSY CLIN N, V260, P401, DOI 10.1007/s00406-009-0088-z; Hegerl U, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-428; Hungarian Central Statistical Office, 2010, HUNG CENTR STAT OFF, P61; KESSLER RC, 1981, J HEALTH SOC BEHAV, V22, P49, DOI 10.2307/2136367; Kopp M., 2007, SLAVERY CITIZENSHIP, P242; Kopp M, 2008, MAGYAR EPIDEMIOLOGIA, V5, P109; Kopp MS, 2011, INT J BEHAV MED, V18, P22, DOI 10.1007/s12529-010-9126-5; Kopp MS, 2010, J PSYCHOSOM RES, V69, P211, DOI 10.1016/j.jpsychores.2009.09.006; Kopp MS, 2004, BRAIN RES BULL, V62, P351, DOI 10.1016/j.brainresbull.2003.12.001; KOPP MS, 1987, ACTA PSYCHIAT SCAND, V76, P406, DOI 10.1111/j.1600-0447.1987.tb05625.x; Kopp MS, 2001, PRACTICE SOCIAL INFL, P207; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Moller-Leimkuhler AM, 2002, J AFFECT DISORDERS, V71, P1, DOI 10.1016/S0165-0327(01)00379-2; Paszthy B, 2005, FEJLESZTO PEDAGOGIA, V5-6, P12; Rethelyi JM, 2002, NATO SCI SER I LIFE, V327, P114; Rihmer Z, 1995, J AFFECT DISORDERS, V35, P147, DOI 10.1016/0165-0327(95)00055-0; Rihmer Z, 2011, SUICIDE WORDS SUICID, P179; RUTZ W, 1992, ACTA PSYCHIAT SCAND, V85, P83, DOI 10.1111/j.1600-0447.1992.tb01448.x; RUTZ W, 1990, ACTA PSYCHIAT SCAND, V82, P399, DOI 10.1111/j.1600-0447.1990.tb03068.x; RUTZ W, 1989, ACTA PSYCHIAT SCAND, V79, P19, DOI 10.1111/j.1600-0447.1989.tb09229.x; Rutz W, 1997, Int J Psychiatry Clin Pract, V1, P39, DOI 10.3109/13651509709069204; Rutz W, 1996, INT J METHOD PSYCH, V6, pS9; Szanto K, 2007, ARCH GEN PSYCHIAT, V64, P914, DOI 10.1001/archpsyc.64.8.914; Zonda Tamas, 2005, Arch Suicide Res, V9, P77, DOI 10.1080/13811110590512967	33	42	42	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75081	10.1371/journal.pone.0075081	http://dx.doi.org/10.1371/journal.pone.0075081			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	246EK	24086443	gold, Green Published, Green Submitted			2022-12-27	WOS:000326520200080
J	Rahman, KS; Cui, GY; Harvey, SC; McCarty, NA				Rahman, Kazi S.; Cui, Guiying; Harvey, Stephen C.; McCarty, Nael A.			Modeling the Conformational Changes Underlying Channel Opening in CFTR	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-BINDING DOMAIN; CYSTIC-FIBROSIS; CHLORIDE CHANNEL; ABC TRANSPORTER; MOLECULAR-DYNAMICS; ATP-BINDING; DELTA-F508 MUTATION; PORE ARCHITECTURE; POSITIVE CHARGES	Mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator protein (CFTR) cause cystic fibrosis (CF), the most common life-shortening genetic disease among Caucasians. Although general features of the structure of CFTR have been predicted from homology models, the conformational changes that result in channel opening and closing have yet to be resolved. We created new closed-and open-state homology models of CFTR, and performed targeted molecular dynamics simulations of the conformational transitions in a channel opening event. The simulations predict a conformational wave that starts at the nucleotide binding domains and ends with the formation of an open conduction pathway. Changes in side-chain interactions are observed in all major domains of the protein, and experimental confirmation was obtained for a novel intra-protein salt bridge that breaks near the end of the transition. The models and simulation add to our understanding of the mechanism of ATP-dependent gating in this disease-relevant ion channel.	[Rahman, Kazi S.; Harvey, Stephen C.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Rahman, Kazi S.; Harvey, Stephen C.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Cui, Guiying; McCarty, Nael A.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Cui, Guiying; McCarty, Nael A.] Emory Univ, Cyst Fibrosis Res Ctr, Atlanta, GA 30322 USA; [Cui, Guiying; McCarty, Nael A.] Childrens Healthcare Atlanta Inc, Atlanta, GA USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Emory University; Emory University; Children's Healthcare of Atlanta (CHOA)	McCarty, NA (corresponding author), Emory Univ, Dept Pediat, Atlanta, GA 30322 USA.	namccar@emory.edu			NIH [5R01-DK-056481]; Emory University Center for Respiratory Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056481] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University Center for Respiratory Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grant 5R01-DK-056481 to N.A.M. and by the Emory University Center for Respiratory Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2009, BIOCHEMISTRY-US, V48, P10078, DOI 10.1021/bi901314c; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; Aubin CNS, 2006, J GEN PHYSIOL, V128, P535, DOI 10.1085/jgp.200609516; Bai YH, 2011, J GEN PHYSIOL, V138, P495, DOI 10.1085/jgp.201110705; Bai YH, 2010, J GEN PHYSIOL, V136, P293, DOI 10.1085/jgp.201010480; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Beck EJ, 2008, J BIOL CHEM, V283, P4957, DOI 10.1074/jbc.M702235200; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chen EY, 2004, J BIOL CHEM, V279, P39620, DOI 10.1074/jbc.M407887200; Cotten JF, 1999, J BIOL CHEM, V274, P5429, DOI 10.1074/jbc.274.9.5429; Csanady L, 2006, J GEN PHYSIOL, V128, P523, DOI 10.1085/jgp.200609558; Cui G, 2008, J MEMBRANE BIOL, V222, P91, DOI 10.1007/s00232-008-9105-9; Cui GY, 2013, J BIOL CHEM, V288, P20758, DOI 10.1074/jbc.M113.476226; Cui GY, 2012, PFLUG ARCH EUR J PHY, V463, P405, DOI 10.1007/s00424-011-1035-1; Dalton J, 2012, J CHEM INF MODEL, V52, P1842, DOI 10.1021/ci2005884; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, J LIPID RES, V42, P1007; Fatehi M, 2008, J BIOL CHEM, V283, P6102, DOI 10.1074/jbc.M707736200; FIELD M, 1993, ANNU REV PHYSIOL, V55, P631, DOI 10.1146/annurev.ph.55.030193.003215; Fuller MD, 2005, BIOPHYS J, V89, P3960, DOI 10.1529/biophysj.105.060731; Furukawa-Hagiya T, 2013, J PHYS CHEM B, V117, P83, DOI 10.1021/jp308315w; Gong XD, 2003, J PHYSIOL-LONDON, V549, P387, DOI 10.1113/jphysiol.2002.038232; Gong XD, 2002, J PHYSIOL-LONDON, V540, P39, DOI 10.1113/jphysiol.2001.013235; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Gupta J, 2001, BIOCHEMISTRY-US, V40, P6620, DOI 10.1021/bi002819v; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; HIGGINS CF, 1995, CELL, V82, P693, DOI 10.1016/0092-8674(95)90465-4; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jordan IK, 2008, P NATL ACAD SCI USA, V105, P18865, DOI 10.1073/pnas.0806306105; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khafizov K, 2010, BIOCHEMISTRY-US, V49, P10702, DOI 10.1021/bi101256x; Kogan I, 2003, EMBO J, V22, P1981, DOI 10.1093/emboj/cdg194; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Linsdell P, 2006, EXP PHYSIOL, V91, P123, DOI 10.1113/expphysiol.2005.031757; Liu XH, 2004, BIOPHYS J, V87, P3826, DOI 10.1529/biophysj.104.050534; Liu XH, 2011, BIOCHEMISTRY-US, V50, P10311, DOI 10.1021/bi201176q; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Marcus Y., 1997, ION PROPERTIES; McCarty NA, 2001, AM J PHYSIOL-LUNG C, V281, pL852, DOI 10.1152/ajplung.2001.281.4.L852; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Norimatsu Y, 2012, MOL PHARMACOL, V82, P1042, DOI 10.1124/mol.112.080267; Norimatsu Y, 2012, BIOCHEMISTRY-US, V51, P2199, DOI 10.1021/bi201888a; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; Qian F, 2011, PFLUG ARCH EUR J PHY, V462, P559, DOI 10.1007/s00424-011-0998-2; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosenberg MF, 2011, J BIOL CHEM, V286, P42647, DOI 10.1074/jbc.M111.292268; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schriml LM, 2000, GENOMICS, V64, P24, DOI 10.1006/geno.1999.6102; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Serrano JR, 2006, BIOPHYS J, V91, P1737, DOI 10.1529/biophysj.105.078899; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Smith SS, 2001, J GEN PHYSIOL, V118, P407, DOI 10.1085/jgp.118.4.407; St-Pierre JF, 2012, J PHYS CHEM B, V116, P2934, DOI 10.1021/jp209126c; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; Wallin E, 1997, PROTEIN SCI, V6, P808; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Weng JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030465; Zhang ZR, 2005, J BIOL CHEM, V280, P41997, DOI 10.1074/jbc.M510242200; Zhang ZR, 2005, J BIOL CHEM, V280, P458, DOI 10.1074/jbc.M409626200; Zhang ZR, 2000, J MEMBRANE BIOL, V175, P35, DOI 10.1007/s002320001053; Zhou JJ, 2010, J GEN PHYSIOL, V135, P229, DOI 10.1085/jgp.200910327	73	35	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74574	10.1371/journal.pone.0074574	http://dx.doi.org/10.1371/journal.pone.0074574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086355	Green Published, Green Submitted, gold			2022-12-27	WOS:000325223900028
J	Shen, HW; Shi, WX; Wang, J; Wang, M; Li, J; Zhang, C; Nie, K; Yang, MJ; Zhang, Y; Li, AH; Tan, WJ; Ma, XJ				Shen, Hongwei; Shi, Weixian; Wang, Ji; Wang, Miao; Li, Jin; Zhang, Chen; Nie, Kai; Yang, Mengjie; Zhang, Yi; Li, Aihua; Tan, Wenjie; Ma, Xuejun			Development of a New Resequencing Pathogen Microarray Based Assay for Detection of Broad-Spectrum Respiratory Tract Viruses in Patients with Community-Acquired Pneumonia	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUS; IDENTIFICATION; ETIOLOGY; AGE	A Resequencing Pathogen Microarray (RPM) is a single, highly multiplexed assay for detecting and differentiating similarly related pathogens by using closely overlapping probe sets to determine a target organism's nucleotide sequence. In this study, a new RPM (RPM-IVDC1) that consisted of 224-bp detector tiles corresponding to 9 influenza A subtypes, 11 rhinoviruses, 28 enteroviruses and 38 other respiratory viruses was developed and optimized to provide individual and simultaneous detection sensitivities ranging from 15 to 750 genomic copies for 16 common respiratory pathogens. A total of 110 consecutive patients with community-acquired pneumonia (CAP) admitted to 5 district general hospitals in Beijing during a 1-year period were assessed using the new assay. Among the children (under age 5) and adult patients (above age 18), respiratory syncytial virus (RSV) and rhinovirus (RV) were the most common etiological agents, respectively, which is consistent with reference assays. Atypical pathogens that may cause CAP-like illness, including rubella virus, measles virus, influenza type C virus, human herpesvirus (HHV) were also detected. The results show the capability of RPM-IVDC1 for the accurate detection and identification of multiple virus types, which may be of significant use in epidemic surveillance and outbreak investigations of atypical pathogens.	[Shen, Hongwei; Wang, Ji; Wang, Miao; Li, Jin; Zhang, Chen; Nie, Kai; Yang, Mengjie; Zhang, Yi; Tan, Wenjie; Ma, Xuejun] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Minist Hlth, Key Lab Med Virol, Beijing, Peoples R China; [Shen, Hongwei] Futian Dist Ctr Dis Control & Prevent, Shenzhen, Guangdong, Peoples R China; [Shi, Weixian] Beijing Ctr Dis Control & Prevent, Inst Infect Dis & Endem Dis Control, Beijing, Peoples R China; [Li, Aihua] Beijing Ctr Dis Control & Prevent, Inst Immunizat & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Tan, WJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Minist Hlth, Key Lab Med Virol, Beijing, Peoples R China.	tanwj28@yahoo.cn; maxj@ivdc.chinacdc.cn	Nie, Kai/L-5389-2019		China Mega-Project for Infectious Disease [2011ZX10004-001, 2012ZX10004-215, 2013ZX10004-202, 2014ZX10004003-003, 2014ZX10004002-004]	China Mega-Project for Infectious Disease	This work was supported by the China Mega-Project for Infectious Disease (2011ZX10004-001, 2012ZX10004-215, 2013ZX10004-202, 2014ZX10004003-003, 2014ZX10004002-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden KE, 2006, J MED VIROL, V78, P1232, DOI 10.1002/jmv.20689; Brown PD, 1998, LANCET, V352, P1295, DOI 10.1016/S0140-6736(98)02239-9; Bruynseels P, 2003, LANCET, V362, P1536, DOI 10.1016/S0140-6736(03)14740-X; Burd EM, 2010, CLIN MICROBIOL REV, V23, P550, DOI 10.1128/CMR.00074-09; Claytor D, 1995, Crit Care Nurse, V15, P43; Cone R W, 1995, Semin Respir Infect, V10, P254; Endimiani A, 2011, CLIN INFECT DIS, V52, pS373, DOI 10.1093/cid/cir054; Ginocchio CC, 2007, J CLIN VIROL, V40, pS11, DOI 10.1016/S1386-6532(07)70004-5; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; Lauderdale TL, 2005, RESP MED, V99, P1079, DOI 10.1016/j.rmed.2005.02.026; LESKI T, 2011, MASSIVELY MULTIPLEXE; Leski TA, 2012, FUTURE MICROBIOL, V7, P625, DOI [10.2217/FMB.12.30, 10.2217/fmb.12.30]; Li J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-189; Lieberman D, 1996, EUR RESPIR J, V9, P2630, DOI 10.1183/09031936.96.09122630; Lin B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000419; Lin BC, 2007, J CLIN MICROBIOL, V45, P443, DOI 10.1128/JCM.01870-06; Lin BC, 2009, J CLIN MICROBIOL, V47, P988, DOI 10.1128/JCM.01346-08; Lin BC, 2006, GENOME RES, V16, P527, DOI 10.1101/gr.4337206; Malanoski AP, 2006, NUCLEIC ACIDS RES, V34, P5300, DOI 10.1093/nar/gkl565; McManus Terence E, 2009, Ulster Med J, V78, P137; Metzgar D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008995; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; MORIUCHI H, 1991, J PEDIATR-US, V118, P235, DOI 10.1016/S0022-3476(05)80489-5; Murdoch DR, 2009, J CLIN MICROBIOL, V47, P3405, DOI 10.1128/JCM.01685-09; Nolte FS, 2008, CLIN INFECT DIS, V47, pS123, DOI 10.1086/591392; PETHER JVS, 1989, LANCET, V1, P1210; Ruiz M, 1999, AM J RESP CRIT CARE, V160, P397, DOI 10.1164/ajrccm.160.2.9808045; Stein RT, 2007, PEDIATR PULM, V42, P1095, DOI 10.1002/ppul.20652; Tabone T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-580; Templeton KE, 2005, CLIN INFECT DIS, V41, P345, DOI 10.1086/431588; Tsolia MN, 2004, CLIN INFECT DIS, V39, P681, DOI 10.1086/422996; UNICEF, 2007, PROTECTING THE WORLD'S CHILDREN: IMPACT OF THE CONVENTION ON THE RIGHTS OF THE CHILD IN DIVERSE LEGAL SYSTEMS, P1; *UNICEF O, 2006, PNEUM FORG KILL CHIL; Wong S, 2009, J CLIN MICROBIOL, V47, P3839, DOI 10.1128/JCM.01469-09	34	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75704	10.1371/journal.pone.0075704	http://dx.doi.org/10.1371/journal.pone.0075704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086618	gold, Green Submitted, Green Published			2022-12-27	WOS:000325223900060
J	Staedler, YM; Masson, D; Schonenberger, J				Staedler, Yannick M.; Masson, David; Schoenenberger, Juerg			Plant Tissues in 3D via X-Ray Tomography: Simple Contrasting Methods Allow High Resolution Imaging	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; ARABIDOPSIS; ROOTS; VISUALIZATION; SEEDS; MICROTOMOGRAPHY; ARCHITECTURE; MICROCT; CT	Computed tomography remains strongly underused in plant sciences despite its high potential in delivering detailed 3D phenotypical information because of the low X-ray absorption of most plant tissues. Existing protocols to study soft tissues display poor performance, especially when compared to those used on animals. More efficient protocols to study plant material are therefore needed. Flowers of Arabidopsis thaliana and Marcgravia caudata were immersed in a selection of contrasting agents used to treat samples for transmission electron microscopy. Grayscale values for floral tissues and background were measured as a function of time. Contrast was quantified via a contrast index. The thick buds of Marcgravia were scanned to determine which contrasting agents best penetrate thick tissues. The highest contrast increase with cytoplasm-rich tissues was obtained with phosphotungstate, whereas osmium tetroxide and bismuth tatrate displayed the highest contrast increase with vacuolated tissues. Phosphotungstate also displayed the best sample penetration. Furthermore, infiltration with phosphotungstate allowed imaging of all plants parts at a high resolution of 3 mm, which approaches the maximum resolution of our equipment: 1.5 mm. The high affinity of phosphotungstate for vasculature, cytoplasm-rich tissue, and pollen causes these tissues to absorb more X-rays than the surrounding tissues, which, in turn, makes these tissues appear brighter on the scan data. Tissues with different brightness can then be virtually dissected from each other by selecting the bracket of grayscale to be visualized. Promising directions for the future include in silico phenotyping and developmental studies of plant inner parts (e. g., ovules, vasculature, pollen, and cell nuclei) via virtual dissection as well as correlations of quantitative phenotypes with omics datasets. Therefore, this work represents a crucial improvement of previous methods, allowing new directions of research to be undertaken in areas ranging from morphology to systems biology.	[Staedler, Yannick M.; Schoenenberger, Juerg] Univ Vienna, Dept Struct & Funct Bot, Vienna, Austria; [Masson, David] MeteoSwiss, Fed Off Meteorol & Climatol, Zurich, Switzerland	University of Vienna; Federal Office of Meteorology & Climatology (MeteoSwiss)	Staedler, YM (corresponding author), Univ Vienna, Dept Struct & Funct Bot, Vienna, Austria.	yannick.staedler@univie.ac.at	Schönenberger, Jürg/D-3413-2014; Schönenberger, Jürg/AAE-6479-2020	Schönenberger, Jürg/0000-0001-6791-2731; Schönenberger, Jürg/0000-0001-6791-2731; Stadler, Yannick/0000-0002-6328-1503; Staedler, Yannick Marc/0000-0002-0688-6995; Staedler, Yannick/0000-0002-5962-7313	University of Vienna	University of Vienna	Source of funding: University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellaire A, 2012, 23 INT C AR RES VIEN, P178; Brodersen CR, 2011, NEW PHYTOL, V191, P1168, DOI 10.1111/j.1469-8137.2011.03754.x; BROOKS RA, 1977, J COMPUT ASSIST TOMO, V1, P487, DOI 10.1097/00004728-197710000-00016; Cloetens P, 2006, P NATL ACAD SCI USA, V103, P14626, DOI 10.1073/pnas.0603490103; DeVore ML, 2006, AM J BOT, V93, P1848, DOI 10.3732/ajb.93.12.1848; Dhondt S, 2010, TRENDS PLANT SCI, V15, P419, DOI 10.1016/j.tplants.2010.05.002; Friis EM, 2007, NATURE, V450, P549, DOI 10.1038/nature06278; Gamisch A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072688; Goebel JC, 2008, BIO-MED MATER ENG, V18, P247, DOI 10.3233/BME-2008-0533; Gregory PJ, 2003, PLANT SOIL, V255, P351, DOI 10.1023/A:1026179919689; Hamza MA, 2001, AUST J SOIL RES, V39, P1387, DOI 10.1071/SR98057; Hayat MA, 2000, PRINCIPLES AND TECHNIQUES OF ELECTRON MICROSCOPY: BIOLOGICAL APPLICATIONS, FOURTH EDITION, P1; Heeraman DA, 1997, PLANT SOIL, V189, P167, DOI 10.1023/A:1004258818538; Herman GT, 2009, ADV PATTERN RECOGNIT, P1, DOI 10.1007/978-1-84628-723-7; HOUNDFIELD GN, 1973, BRIT J RADIOL, V46, P1016, DOI 10.1259/0007-1285-46-552-1016; Hounsfield G N, 1976, J Can Assoc Radiol, V27, P135; HOUNSFIELD GN, 1980, SCIENCE, V210, P22, DOI 10.1126/science.6997993; Jain A. K., 1989, FUNDAMENTALS DIGITAL; Jiang N, 2012, COMPUT ELECTRON AGR, V85, P123, DOI 10.1016/j.compag.2012.04.004; Kaestner A, 2006, GEODERMA, V136, P459, DOI 10.1016/j.geoderma.2006.04.009; Kaminuma E, 2005, PLANT CELL PHYSIOL, V46, pS62; Kaminuma E, 2008, PLANT J, V56, P470, DOI 10.1111/j.1365-313X.2008.03609.x; Korte N, 2012, PLANT BIOLOGY, V14, P537, DOI 10.1111/j.1438-8677.2011.00546.x; Korte N, 2011, MICROSC RES TECHNIQ, V74, P364, DOI 10.1002/jemt.20917; Leroux O, 2011, ANN BOT-LONDON, V108, P307, DOI 10.1093/aob/mcr161; Leroux O, 2009, J MICROSC-OXFORD, V233, P1, DOI 10.1111/j.1365-2818.2008.03088.x; Matsushima U, 2012, POSTHARVEST BIOL TEC, V72, P27, DOI 10.1016/j.postharvbio.2012.04.013; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Milien M, 2012, SCI HORTIC-AMSTERDAM, V144, P130, DOI 10.1016/j.scienta.2012.06.045; Perret JS, 2007, SOIL BIOL BIOCHEM, V39, P391, DOI 10.1016/j.soilbio.2006.07.018; Pierret A, 1999, GEODERMA, V90, P307, DOI 10.1016/S0016-7061(98)00136-0; Pika-Biolzi M, 2000, RIV ITAL PALEONTOL S, V106, P369, DOI 10.13130/2039-4942/6151; Quintana Laura, 2011, Cold Spring Harb Protoc, V2011, P586, DOI 10.1101/pdb.top116; Rengle A, 2009, IEEE T BIO-MED ENG, V56, P2891, DOI 10.1109/TBME.2008.2006015; Schneider JE, 2003, MAGN RESON MATER PHY, V16, P43, DOI 10.1007/s10334-003-0002-z; Sharpe J., 2009, ADV IMAGING BIOL MED, P199; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Tracy SR, 2010, J EXP BOT, V61, P311, DOI 10.1093/jxb/erp386; van der Niet T, 2010, TRENDS PLANT SCI, V15, P423, DOI 10.1016/j.tplants.2010.05.005; von Balthazar M, 2007, AM J BOT, V94, P2041, DOI 10.3732/ajb.94.12.2041; Weninger WJ, 2006, ANAT EMBRYOL, V211, P213, DOI 10.1007/s00429-005-0073-x; Yamauchi D, 2012, AIP CONF PROC, V1466, P237, DOI 10.1063/1.4742298	43	98	102	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75295	10.1371/journal.pone.0075295	http://dx.doi.org/10.1371/journal.pone.0075295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086499	gold, Green Published, Green Submitted			2022-12-27	WOS:000325223900043
J	Theilhaber, J; Rakhade, SN; Sudhalter, J; Kothari, N; Klein, P; Pollard, J; Jensen, FE				Theilhaber, Joachim; Rakhade, Sanjay N.; Sudhalter, Judy; Kothari, Nayantara; Klein, Peter; Pollard, Jack; Jensen, Frances E.			Gene Expression Profiling of a Hypoxic Seizure Model of Epilepsy Suggests a Role for mTOR and Wnt Signaling in Epileptogenesis	PLOS ONE			English	Article							LONG-TERM POTENTIATION; TEMPORAL-LOBE EPILEPSY; MAMMALIAN TARGET; BETA-CATENIN; SYNAPTIC PLASTICITY; PERINATAL HYPOXIA; HIPPOCAMPAL-NEURONS; TUBEROUS SCLEROSIS; RAPAMYCIN PATHWAY; NEONATAL SEIZURES	Microarray profiling was used to investigate gene expression in the hypoxic seizure model of acquired epilepsy in the rat, with the aim of characterizing functional pathways which are persistently activated or repressed during epileptogenesis. Hippocampal and cortical tissues were transcriptionally profiled over a one week period following an initial series of seizures induced by mild hypoxia at post-natal day 10 (P10), and the gene expression data was then analyzed with a focus on gene set enrichment analysis, an approach which emphasizes regulation of entire pathways rather than of individual genes. Animals were subjected to one of three conditions: a control with no hypoxia, hypoxic seizures, and hypoxic seizures followed by treatment with the AMPAR antagonist NBQX, a compound currently proposed to be a modulator of epileptogenesis. While temporal gene expression in the control samples was found to be consistent with known processes of neuronal maturation in the rat for the given time window, the hypoxic seizure response was found to be enriched for components of the PI3K/mTOR and Wnt signaling pathways, alongside gene sets representative of glutamatergic, synaptic and axonal processes, perhaps regulated as a downstream consequence of activation of these pathways. Wnt signaling components were also found enriched in the more specifically epileptogenic NBQX-responsive gene set. While activation of the mTOR pathway is consistent with its known role in epileptogenesis and strengthens the case for mTOR or PI3K pathway inhibitors as potential anti-epileptogenic drugs, investigation of the role of Wnt signaling and the effect of appropriate inhibitors might offer a parallel avenue of research toward anti-epileptogenic treatment of epilepsy.	[Theilhaber, Joachim; Sudhalter, Judy; Kothari, Nayantara; Pollard, Jack] Sanofi Cambridge Res Ctr, Cambridge, MA 08807 USA; [Rakhade, Sanjay N.] Genzyme, Dept Clin Studies, Cambridge, MA USA; [Klein, Peter] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Jensen, Frances E.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA	Sanofi-Aventis; Sanofi-Aventis; Genzyme Corporation; University of Virginia; University of Pennsylvania; Pennsylvania Medicine	Theilhaber, J (corresponding author), Sanofi Cambridge Res Ctr, Cambridge, MA 08807 USA.	joachim.theilhaber@sanofi.com		Klein, Peter/0000-0002-3232-3387	National Institutes of Health (from the Office of the Director) [NS 031718, DP1 OD003347]; Intellectual Developmental Disabilities Research Center (National Institute of Child Health and Human Development) [P30 HD18655]; Sanofi Research and Development, Biological Sciences Department; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031718, R29NS031718, R56NS031718] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003347] Funding Source: NIH RePORTER	National Institutes of Health (from the Office of the Director); Intellectual Developmental Disabilities Research Center (National Institute of Child Health and Human Development); Sanofi Research and Development, Biological Sciences Department; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants NS 031718 and DP1 OD003347 (FEJ) (from the Office of the Director), Intellectual Developmental Disabilities Research Center Grant P30 HD18655 (National Institute of Child Health and Human Development) (FEJ), and Sanofi Research and Development, Biological Sciences Department (JT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, PLACEBOCONTROLLED ST; [Anonymous], 2012, CONN MAP 02; [Anonymous], 2010, EVEROLIMUS RAD001 TH; Baljinnyam B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029455; Bateup HS, 2011, J NEUROSCI, V31, P8862, DOI 10.1523/JNEUROSCI.1617-11.2011; Bayer S.A., 1991, NEOCORTICAL DEV; Borges K, 2007, NEUROBIOL DIS, V26, P66, DOI 10.1016/j.nbd.2006.12.001; Buckmaster PS, 2009, J NEUROSCI, V29, P8259, DOI 10.1523/JNEUROSCI.4179-08.2009; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Cuesto G, 2011, J NEUROSCI, V31, P2721, DOI 10.1523/JNEUROSCI.4477-10.2011; Das N, 2012, DRUG DISCOV THER, V6, P178, DOI 10.5582/ddt.2012.v6.4.178; Elliott RC, 2003, J NEUROSCI, V23, P2218; Gould TD, 2002, NEUROSCIENTIST, V8, P497, DOI 10.1177/107385802237176; Haberman RP, 2008, P NATL ACAD SCI USA, V105, P10601, DOI 10.1073/pnas.0804292105; Hendriksen H, 2001, EUR J NEUROSCI, V14, P1475, DOI 10.1046/j.0953-816x.2001.01778.x; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huang XX, 2010, NEUROBIOL DIS, V40, P193, DOI 10.1016/j.nbd.2010.05.024; Hunsberger JG, 2005, MOL BRAIN RES, V141, P95, DOI 10.1016/j.molbrainres.2005.08.005; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jaworski J, 2006, MOL NEUROBIOL, V34, P205, DOI 10.1385/MN:34:3:205; JENSEN FE, 1991, ANN NEUROL, V29, P629, DOI 10.1002/ana.410290610; Jensen FE, 1998, J NEUROPHYSIOL, V79, P73, DOI 10.1152/jn.1998.79.1.73; JENSEN FE, 1995, EPILEPSIA, V36, P966, DOI 10.1111/j.1528-1157.1995.tb00954.x; Keeping ES, 1995, INTRO STAT INFERENCE, P256; Kelly A, 2000, NEUROPHARMACOLOGY, V39, P643, DOI 10.1016/S0028-3908(99)00169-0; Knoepfler PS, 2006, CELL CYCLE, V5, P47, DOI 10.4161/cc.5.1.2292; Koh S, 2004, EPILEPSIA, V45, P569, DOI 10.1111/j.0013-9580.2004.69103.x; Lauren HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010733; Lee CC, 2011, NEUROPHARMACOLOGY, V61, P867, DOI 10.1016/j.neuropharm.2011.06.003; Loscher W, 2004, EPILEPSY RES, V60, P77, DOI 10.1016/j.eplepsyres.2004.06.004; Lukasiuk K, 2006, PROG BRAIN RES, V158, P223, DOI 10.1016/S0079-6123(06)58011-2; Madsen TM, 2003, BIOL PSYCHIAT, V54, P1006, DOI 10.1016/S0006-3223(03)00700-5; Maguschak KA, 2012, NEUROPHARMACOLOGY, V62, P78, DOI 10.1016/j.neuropharm.2011.08.032; Maguschak KA, 2011, J NEUROSCI, V31, P13057, DOI 10.1523/JNEUROSCI.3248-11.2011; McDaniel SS, 2011, NEUROSCI LETT, V497, P231, DOI 10.1016/j.neulet.2011.02.037; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Newton SS, 2003, J NEUROSCI, V23, P10841; Nuriya M, 2006, J NEUROCHEM, V97, P652, DOI 10.1111/j.1471-4159.2006.03740.x; Okamoto OK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-230; Opazo P, 2003, J NEUROSCI, V23, P3679; R Development Core Team, 2008, R LANG ENV STAT COMP; Rakhade SN, 2008, J NEUROSCI, V28, P7979, DOI 10.1523/JNEUROSCI.1734-08.2008; Rakhade SN, 2011, EPILEPSIA, V52, P753, DOI 10.1111/j.1528-1167.2011.02992.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sui L, 2008, LEARN MEMORY, V15, P762, DOI 10.1101/lm.1067808; Talos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035885; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Theilhaber J, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-195; Theilhaber J, 2001, J COMPUT BIOL, V8, P585, DOI 10.1089/106652701753307502; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Winden KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020763; Wong M, 2010, EPILEPSIA, V51, P27, DOI 10.1111/j.1528-1167.2009.02341.x; Yang PC, 2008, J BIOL CHEM, V283, P2631, DOI 10.1074/jbc.M706954200; Yoshii A, 2007, NAT NEUROSCI, V10, P702, DOI 10.1038/nn1903; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zeng Ling-Hui, 2009, Mol Cell Pharmacol, V1, P124; Zeng LH, 2010, CELL CYCLE, V9, P2281, DOI 10.4161/cc.9.12.11866; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhang B, 2012, EPILEPSIA, V53, P506, DOI 10.1111/j.1528-1167.2011.03384.x; Zheng WH, 2004, J NEUROCHEM, V89, P844, DOI 10.1111/j.1471-4159.2004.02350.x	64	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74428	10.1371/journal.pone.0074428	http://dx.doi.org/10.1371/journal.pone.0074428			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086344	gold, Green Submitted, Green Published			2022-12-27	WOS:000325223900026
J	Wongkulab, P; Wipasa, J; Chaiwarith, R; Supparatpinyo, K				Wongkulab, Panuwat; Wipasa, Jiraprapa; Chaiwarith, Romanee; Supparatpinyo, Khuanchai			Autoantibody to Interferon-gamma Associated with Adult-Onset Immunodeficiency in Non-HIV Individuals in Northern Thailand	PLOS ONE			English	Article							MYCOBACTERIAL INFECTION; PATIENT; RECURRENT	Background: Autoantibody to interferon-gamma (IFN-gamma) has been reported to be associated with adult-onset immunodeficiency in patients from Asian countries. This study aimed to determine the prevalence of autoantibody to IFN-gamma among non-HIV patients in northern Thailand who were repeatedly infected with unusual intracellular pathogens. Methods: A cross-sectional, case-control study was conducted between March 2011 and March 2012 at Chiang Mai University Hospital. 20 cases, non-HIV, aged 18-60 years, presented with at least 2 episodes of culture or histopathology proven opportunistic infections were enrolled. Controls comprised 20 HIV-infected patients and 20 healthy adults who were age-and sex-matched with cases. Enzyme-linked immunosorbent assay (ELISA) was used to detect the presence of antibody to IFN-gamma. Results: 11 participants in each group were female. The mean ages were 48.1 +/- 6.4, 48.3 +/- 6.3, and 47.1 +/- 6.5 years among cases, HIV-infected, and healthy controls, respectively. The opportunistic infections among 20 cases included disseminated non-tuberculous mycobacterial (NTM) infection (19 patients/24 episodes), disseminated penicilliosis marneffei (12 patients/12 episodes), and non-typhoidal Salmonella bacteremia (7 patients/8 episodes). At the cutoff level of 99 percentile of controls, the prevalence of autoantibody to IFN-gamma were 100%, 0%, and 0%, among cases, HIV-infected, and healthy controls, respectively(p-value <0.001). The mean concentrations of antibody to IFN-gamma were 3.279 +/- 0.662 and 0.939 +/- 0.630 O.D. among cases with and without active opportunistic infection, respectively (p-value <0.001). Conclusions: In northern Thailand, autoantibody to IFN-gamma was strongly associated with adult-onset immunodeficiency. The level of antibody to IFN-gamma in patients who had active opportunistic infection was relatively higher than those without active infection.	[Wongkulab, Panuwat; Chaiwarith, Romanee; Supparatpinyo, Khuanchai] Chiang Mai Univ, Fac Med, Dept Med, Chiang Mai 50000, Thailand; [Wipasa, Jiraprapa; Supparatpinyo, Khuanchai] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand	Chiang Mai University; Chiang Mai University	Supparatpinyo, K (corresponding author), Chiang Mai Univ, Fac Med, Dept Med, Chiang Mai 50000, Thailand.	khuanchai.s@gmail.com		Chaiwarith, Romanee/0000-0002-1241-5954	National Research University Project under Thailand's Office of the Higher Education Commission	National Research University Project under Thailand's Office of the Higher Education Commission	This work was supported by the National Research University Project under Thailand's Office of the Higher Education Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2010, CELLULAR MOL IMMUNOL, P3; Baerlecken N, 2009, CLIN INFECT DIS, V49, pE76, DOI 10.1086/605581; Billiau A, 2009, CYTOKINE GROWTH F R, V20, P97, DOI 10.1016/j.cytogfr.2009.02.004; Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; CARUSO A, 1989, J BIOL REG HOMEOS AG, V3, P8; Chen YP, 2008, APMIS, V116, P850, DOI 10.1111/j.1600-0463.2008.00935.x; Chetchotisakd P, 2007, CLIN INFECT DIS, V45, P421, DOI 10.1086/520030; Doffinger R, 2005, CURR OPIN RHEUMATOL, V17, P440, DOI 10.1097/01.bor.0000166387.70475.dd; Doffinger R, 2004, CLIN INFECT DIS, V38, pE10, DOI 10.1086/380453; Hoflich C, 2004, BLOOD, V103, P673, DOI 10.1182/blood-2003-04-1065; Kampitak T, 2011, INFECTION, V39, P65, DOI 10.1007/s15010-010-0067-3; Kampmann B, 2005, J CLIN INVEST, V115, P2480, DOI 10.1172/JCI19316; Koya T, 2009, J INFECT CHEMOTHER, V15, P118, DOI 10.1007/s10156-008-0662-8; Patel SY, 2005, J IMMUNOL, V175, P4769, DOI 10.4049/jimmunol.175.7.4769; SUPPARATPINYO K, 1994, LANCET, V344, P110, DOI 10.1016/S0140-6736(94)91287-4; Tanaka Y, 2007, INTERNAL MED, V46, P1005, DOI 10.2169/internalmedicine.46.6452; Tang BSF, 2010, CLIN VACCINE IMMUNOL, V17, P1132, DOI 10.1128/CVI.00053-10; Vergis EN, 2000, INFECT DIS CLIN N AM, V14, P809, DOI 10.1016/S0891-5520(05)70135-5	18	59	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76371	10.1371/journal.pone.0076371	http://dx.doi.org/10.1371/journal.pone.0076371			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086734	gold, Green Submitted, Green Published			2022-12-27	WOS:000325223900098
J	Tepper, N; Noor, E; Amador-Noguez, D; Haraldsdottir, HS; Milo, R; Rabinowitz, J; Liebermeister, W; Shlomi, T				Tepper, Naama; Noor, Elad; Amador-Noguez, Daniel; Haraldsdottir, Hulda S.; Milo, Ron; Rabinowitz, Josh; Liebermeister, Wolfram; Shlomi, Tomer			Steady-State Metabolite Concentrations Reflect a Balance between Maximizing Enzyme Efficiency and Minimizing Total Metabolite Load	PLOS ONE			English	Article							GENOME-SCALE RECONSTRUCTION; ESCHERICHIA-COLI; FLUX ANALYSIS; CLOSTRIDIUM-ACETOBUTYLICUM; KNOCKOUT STRATEGIES; NETWORKS; MODELS; THERMODYNAMICS; CONSTRAINTS; PERTURBATIONS	Steady-state metabolite concentrations in a microorganism typically span several orders of magnitude. The underlying principles governing these concentrations remain poorly understood. Here, we hypothesize that observed variation can be explained in terms of a compromise between factors that favor minimizing metabolite pool sizes (e. g. limited solvent capacity) and the need to effectively utilize existing enzymes. The latter requires adequate thermodynamic driving force in metabolic reactions so that forward flux substantially exceeds reverse flux. To test this hypothesis, we developed a method, metabolic tug-of-war (mTOW), which computes steady-state metabolite concentrations in microorganisms on a genome-scale. mTOW is shown to explain up to 55% of the observed variation in measured metabolite concentrations in E. coli and C. acetobutylicum across various growth media. Our approach, based strictly on first thermodynamic principles, is the first method that successfully predicts high-throughput metabolite concentration data in bacteria across conditions.	[Tepper, Naama; Shlomi, Tomer] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel; [Noor, Elad; Milo, Ron] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Amador-Noguez, Daniel; Rabinowitz, Josh] Princeton Univ, Princeton, NJ 08544 USA; [Haraldsdottir, Hulda S.] Univ Iceland, Ctr Syst Biol, Reykjavik, Iceland; [Liebermeister, Wolfram] Charite, Inst Biochem, D-13353 Berlin, Germany	Technion Israel Institute of Technology; Weizmann Institute of Science; Princeton University; University of Iceland; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Shlomi, T (corresponding author), Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel.	tomersh@cs.technion.ac.il	Milo, Hilla/C-8767-2016; Rabinowitz, Joshua/GPP-4019-2022; Noor, Elad/AAN-9042-2020; Liebermeister, Wolfram/AAC-7326-2020	Rabinowitz, Joshua/0000-0002-1247-4727; Noor, Elad/0000-0001-8776-4799; Liebermeister, Wolfram/0000-0002-2568-2381; Milo, Ron/0000-0003-1641-2299	Israel Ministry of Science; NATIONAL CANCER INSTITUTE [R01CA163591] Funding Source: NIH RePORTER	Israel Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	TS was supported by a grant from the Israel Ministry of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiamah DA, 2010, BIOINFORMATICS, V26, P1324, DOI 10.1093/bioinformatics/btq136; Alberty R. A., 2003, THERMODYNAMICS BIOCH; Alberty RA, 2011, BIOPHYS CHEM, V155, P89, DOI 10.1016/j.bpc.2011.03.007; Amador-Noguez D, 2011, APPL ENVIRON MICROB, V77, P7984, DOI 10.1128/AEM.05374-11; Atkinson DE., 1969, CURR TOP CELL REGUL, V1, P29, DOI [10.1016/B978-0-12-152801-0.50007-9, DOI 10.1016/B978-0-12-152801-0.50007, DOI 10.1016/B978-0-12-152801-0]; Bar-Even A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002166; Beard DA, 2002, BIOPHYS J, V83, P79, DOI 10.1016/S0006-3495(02)75150-3; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bonarius HPJ, 1997, TRENDS BIOTECHNOL, V15, P308, DOI 10.1016/S0167-7799(97)01067-6; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Bulik S, 2009, FEBS J, V276, P410, DOI 10.1111/j.1742-4658.2008.06784.x; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Cakir T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100085; Canelas AB, 2011, METAB ENG; Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; Christopher S, 2007, BIOPHYS J, V92, P1792, DOI [10.1529/biophysj.106.093138, DOI 10.1529/BI0PHYSJ.106.093138.PUBMED:17172310]; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fendt SM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.11; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Goldberg RN, 2004, BIOINFORMATICS, V20, P2874, DOI 10.1093/bioinformatics/bth314; Gross C, 1996, CELL MOL BIOL; Haraldsdottir H, 2012, QUANTITATIVE ASSIGNM; Henry CS, 2007, BIOPHYS J, V92, P1792, DOI 10.1529/biophysj.106.093138; Hjersted JL, 2007, BIOTECHNOL BIOENG, V97, P1190, DOI 10.1002/bit.21332; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jankowski MD, 2008, BIOPHYS J, V95, P1487, DOI 10.1529/biophysj.107.124784; Jol SJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002415; Klitgord N, 2010, INFORM, V22, P41; KOCH AL, 1967, J THEOR BIOL, V15, P75, DOI 10.1016/0022-5193(67)90045-8; Kummel A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100074; Kurland CG, 1996, MOL MICROBIOL, V21, P1, DOI 10.1046/j.1365-2958.1996.5901313.x; Lee J, 2008, APPL MICROBIOL BIOT, V80, P849, DOI 10.1007/s00253-008-1654-4; Mavrovouniotis ML, 1990, BIOTECHNOL BIOENG, V38, P803, DOI [10.1002/bit.260380716, DOI 10.1002/BIT.260380716.PUBMED:18595046]; Mavrovouniotis ML, 1993, IDENTIFICATION LOCAL, V1, P275; Moriya H, 2006, PLOS GENET, V2, P1034, DOI 10.1371/journal.pgen.0020111; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Nathan D, 2004, NATURE REV MICROBIOL, V2; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Noor E, 2012, BIOINFORMATICS; Noor EH, 2013, PLOS COMPUT BI UNPUB; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Rummel R. J., 1976, UNDERSTANDING CORREL; Schilling CH, 2002, J BACTERIOL, V184, P4582, DOI 10.1128/JB.184.16.4582-4593.2002; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Schuetz R, 2012, SCIENCE, V336, P601, DOI 10.1126/science.1216882; SCHUSTER R, 1993, COMPUT APPL BIOSCI, V9, P79; SCHUSTER S, 1991, J MATH BIOL, V29, P425, DOI 10.1007/BF00160470; Steuer R, 2006, P NATL ACAD SCI USA, V103, P11868, DOI 10.1073/pnas.0600013103; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tepper N, 2010, METABOLIC NETW UNPUB; Tepper N, 2010, BIOINFORMATICS, V26, P536, DOI 10.1093/bioinformatics/btp704; Van Dien SJ, 2002, BIOTECHNOL BIOENG, V78, P296, DOI 10.1002/bit.10200; Vojinovic V, 2009, BIOTECHNOL BIOENG, V103, P780, DOI 10.1002/bit.22309; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178; Zhao J, 2003, J BIOTECHNOL, V101, P101, DOI 10.1016/S0168-1656(02)00316-4	59	41	43	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75370	10.1371/journal.pone.0075370	http://dx.doi.org/10.1371/journal.pone.0075370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086517	Green Published, Green Submitted, gold			2022-12-27	WOS:000325220000018
J	Abraham, R; Mudaliar, P; Padmanabhan, A; Sreekumar, E				Abraham, Rachy; Mudaliar, Prashant; Padmanabhan, Aiswaria; Sreekumar, Easwaran			Induction of Cytopathogenicity in Human Glioblastoma Cells by Chikungunya Virus	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; TUMOR-NECROSIS-FACTOR; RIG-I; VIRAL-INFECTIONS; INNATE IMMUNITY; GLIAL-CELLS; ER STRESS; DEATH	Chikungunya virus (CHIKV), an arthritogenic old-world alphavirus, has been implicated in the central nervous system (CNS) infection in infants and elderly patients. Astrocytes are the major immune cells of the brain parenchyma that mediate inflammation. In the present study we found that a local isolate of CHIKV infect and activate U-87 MG cells, a glioblastoma cell line of human astrocyte origin. The infection kinetics were similar in infected U-87 MG cells and the human embryo kidney (HEK293) cells as indicated by immunofluorescence and plaque assays, 24h post-infection (p.i.). In infected U-87 MG cells, apoptosis was detectable from 48h p.i. evidenced by DNA fragmentation, PARP cleavage, loss of mitochondrial membrane potential, nuclear condensation and visible cytopathic effects in a dose and time-dependent manner. XBP1 mRNA splicing and eIF2 alpha phosphorylation studies indicated the occurrence of endoplasmic reticulum stress in infected cells. In U-87 MG cells stably expressing a green fluorescent protein-tagged light chain-3 (GFP-LC3) protein, CHIKV infection showed increased autophagy response. The infection led to an enhanced expression of the mRNA transcripts of the pro-inflammatory cytokines IL-1 beta, TNF-alpha, IL-6 and CXCL9 within 24h p.i. Significant up-regulation of the proteins of RIG-I like receptor (RLR) pathway, such as RIG-I and TRAF-6, was observed indicating the activation of the cytoplasmic-cellular innate immune response. The overall results show that the U-87 MG cell line is a potential in vitro model for in depth study of these molecular pathways in response to CHIKV infection. The responses in these cells of CNS origin, which are inherently defective in Type I interferon response, could be analogous to that occurring in infants and very old patients who also have a compromised interferon-response. The results also point to the intriguing possibility of using this virus for studies to develop oncolytic virus therapy approaches against glioblastoma, a highly aggressive malignancy.	[Abraham, Rachy; Mudaliar, Prashant; Padmanabhan, Aiswaria; Sreekumar, Easwaran] Rajiv Gandhi Ctr Biotechnol, Viral Dis Biol Program, Thiruvananthapuram, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Sreekumar, E (corresponding author), Rajiv Gandhi Ctr Biotechnol, Viral Dis Biol Program, Thiruvananthapuram, Kerala, India.	esreekumar@rgcb.res.in	Abraham, Rachy/AAO-2298-2021	Abraham, Rachy/0000-0003-3180-2447	Department of Science and Technology, and University Grants Commission (UGC); Rajiv Gandhi Centre for Biotechnology and Department of Biotechnology, Govt. of India [BT/PR5315/MED/29/476/2012]	Department of Science and Technology, and University Grants Commission (UGC); Rajiv Gandhi Centre for Biotechnology and Department of Biotechnology, Govt. of India	The study was supported by research fellowships to RA and PM from Department of Science and Technology, and University Grants Commission (UGC); and grants from Rajiv Gandhi Centre for Biotechnology and Department of Biotechnology (Grant No. BT/PR5315/MED/29/476/2012), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abere B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034800; Arpino C, 2009, REV MED VIROL, V19, P121, DOI 10.1002/rmv.606; Barry G, 2010, J VIROL, V84, P7369, DOI 10.1128/JVI.02310-09; Brodie C, 1997, GLIA, V19, P275; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; da Conceicao TM, 2013, VIROLOGY, V435, P281, DOI 10.1016/j.virol.2012.09.038; Das T, 2010, PROG NEUROBIOL, V91, P121, DOI 10.1016/j.pneurobio.2009.12.006; Dhanwani R, 2012, VIRUS RES, V163, P563, DOI 10.1016/j.virusres.2011.12.009; Diniz JAP, 2006, AM J TROP MED HYG, V75, P691, DOI 10.4269/ajtmh.2006.75.691; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; Fouillet A, 2012, AUTOPHAGY, V8, P915, DOI 10.4161/auto.19716; Furr SR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00201; Furr SR, 2010, GLIA, V58, P1620, DOI 10.1002/glia.21034; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Griffin DE, 2010, PROG NEUROBIOL, V91, P95, DOI 10.1016/j.pneurobio.2009.12.003; Her ZS, 2010, J IMMUNOL, V184, P5903, DOI 10.4049/jimmunol.0904181; Joubert PE, 2012, AUTOPHAGY, V8, P1261, DOI 10.4161/auto.20751; Joubert PE, 2012, J EXP MED, V209, P1029, DOI 10.1084/jem.20110996; Kaur P, 2013, ANTIMICROB AGENTS CH, V57, P155, DOI 10.1128/AAC.01467-12; Kelvin AA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001279; Konno H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005674; KRAUS E, 1992, EUR J IMMUNOL, V22, P175, DOI 10.1002/eji.1830220126; Krejbich-Trotot P, 2011, FASEB J, V25, P314, DOI 10.1096/fj.10-164178; Lam S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046396; Lewthwaite P, 2009, EMERG INFECT DIS, V15, P329, DOI 10.3201/eid1502.080902; Li YG, 2013, INTERVIROLOGY, V56, P6, DOI 10.1159/000339985; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; McGavern DB, 2011, NAT REV IMMUNOL, V11, P318, DOI 10.1038/nri2971; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; MONATH TP, 1983, LAB INVEST, V48, P399; Munoz-Fernandez MA, 1998, PROG NEUROBIOL, V56, P307; Nazmi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021761; Noret M, 2012, J INFECT DIS, V206, P455, DOI 10.1093/infdis/jis368; OLOPADE OI, 1992, CANCER RES, V52, P2523; Ozden S, 2008, J BIOL CHEM, V283, P21899, DOI 10.1074/jbc.M802444200; Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527; Pyndiah M N, 2012, Med Trop (Mars), V72 Spec No, P63; Rathore APS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-36; Rosello A, 2012, CLIN EXP IMMUNOL, V168, P52, DOI 10.1111/j.1365-2249.2011.04544.x; RUBIO N, 1990, J GEN VIROL, V71, P2867, DOI 10.1099/0022-1317-71-12-2867; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Sam IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050476; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Savarin C, 2008, CURR OPIN PHARMACOL, V8, P472, DOI 10.1016/j.coph.2008.05.002; Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Sgorbissa A, 2011, APOPTOSIS, V16, P1229, DOI 10.1007/s10495-011-0639-4; Shi JY, 2012, ACTA BIOCH BIOPH SIN, V44, P375, DOI 10.1093/abbs/gms010; SINDERMANN J, 1993, MECH AGEING DEV, V70, P149, DOI 10.1016/0047-6374(93)90066-Z; Skaper SD, 2007, ANN NY ACAD SCI, V1122, P23, DOI 10.1196/annals.1403.002; Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024; Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089; Sreekumar E, 2010, VIRUS GENES, V40, P14, DOI 10.1007/s11262-009-0411-9; Sriram S, 2011, J NEUROIMMUNOL, V239, P13, DOI 10.1016/j.jneuroim.2011.08.012; Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002; Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120; Thiboutot MM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000623; Thon-Hon VG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-213; Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91; Vosters O, 2010, CLIN EXP IMMUNOL, V162, P494, DOI 10.1111/j.1365-2249.2010.04267.x; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; White LK, 2011, J VIROL, V85, P606, DOI 10.1128/JVI.00767-10; Wikan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031102; Wintachai P, 2012, J MED VIROL, V84, P1757, DOI 10.1002/jmv.23403; Wollmann G, 2005, J VIROL, V79, P6005, DOI 10.1128/JVI.79.10.6005-6022.2005; Yoboua F, 2010, J VIROL, V84, P7267, DOI 10.1128/JVI.00142-10; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	69	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75854	10.1371/journal.pone.0075854	http://dx.doi.org/10.1371/journal.pone.0075854			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086645	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700114
J	Knapp, M; Nedved, O				Knapp, Michal; Nedved, Oldrich			Gender and Timing during Ontogeny Matter: Effects of a Temporary High Temperature on Survival, Body Size and Colouration in Harmonia axyridis	PLOS ONE			English	Article							SEASONAL PHENOTYPIC PLASTICITY; LIFE-HISTORY TRAITS; COLEOPTERA-COCCINELLIDAE; DEPENDENT DEVELOPMENT; THERMAL REQUIREMENTS; SEXUAL-DIMORPHISM; LADYBIRD BEETLE; IMMUNE FUNCTION; MANDUCA-SEXTA; FRUIT-FLY	The ambient temperature experienced during development is a crucial factor affecting survival and adult phenotype in ectotherms. Moreover, the exact response of individuals to different temperature regimes is frequently sex-specific. This sex-specific response can result in varying levels of sexual dimorphism according to the experienced conditions. The majority of studies have investigated the effects of temperature on individuals reared under a constant temperature regime throughout their whole preimaginal development, whereas information on stage-dependent variation in temperature effects is scarce. Here we investigate how the stage at which elevated temperature is experienced influences survival, adult body size and colouration in the harlequin ladybird Harmonia axyridis form succinea. The effects of timing of exposure to elevated temperature on the adult phenotype are assessed separately for males and females. Control individuals were reared at a constant temperature of 20 degrees C. Beetles in other treatments were additionally exposed to 33 degrees C for 48 hours during the following developmental stages: egg, 1st to 2nd larval instar, 3rd larval instar, 4th larval instar and pupa. Exposure to an elevated temperature during the early developmental stages resulted in lower survival, but the adult phenotype of survivors was almost unaffected. Exposure to an elevated temperature during the later developmental stages (4th larval instar or pupa) resulted in the decreased melanisation of elytra, decreased structural body size and increased dry mass. Furthermore, the timing of high temperature exposure affected the degree of sexual dimorphism in elytral melanisation and dry mass. We demonstrate that the effects of elevated temperature can vary according to the developmental stage at exposure. Detailed information on how ambient temperature affects the developmental biology of ectotherms is crucial for modeling population growth and predicting the spread of invasive species such as Harmonia axyridis.	[Knapp, Michal] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic; [Nedved, Oldrich] Univ South Bohemia, Dept Zool, Fac Sci, Ceske Budejovice, Czech Republic; [Nedved, Oldrich] Biol Ctr AS CR, Inst Entomol, Dept Biochem & Physiol, Ceske Budejovice, Czech Republic	Czech University of Life Sciences Prague; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Knapp, M (corresponding author), Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic.	knapp@fzp.czu.cz	Nedvěd, Oldřich/H-7816-2014; Knapp, Michal/AAF-4864-2020	Nedvěd, Oldřich/0000-0001-9932-3456; Knapp, Michal/0000-0003-4487-7317	Ministry of Agriculture of the Czech Republic [QH82047]; Czech University of Life Sciences Prague [42900/1312/3166]	Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic); Czech University of Life Sciences Prague	The study was supported by Grant no. QH82047 awarded by the Ministry of Agriculture of the Czech Republic and partially by Grant no. 42900/1312/3166 awarded by the Czech University of Life Sciences Prague. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelghany AY, 2010, J ECON ENTOMOL, V103, P1909, DOI 10.1603/EC10054; Acar EB, 2005, ENVIRON ENTOMOL, V34, P241, DOI 10.1603/0046-225X-34.2.241; Acar EB, 2004, ENVIRON ENTOMOL, V33, P832, DOI 10.1603/0046-225X-33.4.832; Amarasekare P, 2012, FUNCT ECOL, V26, P959, DOI 10.1111/j.1365-2435.2012.02000.x; Angilletta MJ, 2003, AM NAT, V162, P332; Angilletta MJ, 2004, INTEGR COMP BIOL, V44, P498, DOI 10.1093/icb/44.6.498; Armitage SAO, 2005, HEREDITY, V94, P650, DOI 10.1038/sj.hdy.6800675; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Awad M, 2013, BIOCONTROL IN PRESS; Belyakova NA, 2011, J EVOL BIOCHEM PHYS+, V47, P552, DOI 10.1134/S0022093011060068; Berkvens N, 2008, BIOCONTROL, V53, P201, DOI 10.1007/s10526-007-9128-7; Bezzerides AL, 2007, BEHAV ECOL SOCIOBIOL, V61, P1401, DOI 10.1007/s00265-007-0371-9; Boina D, 2004, J ECON ENTOMOL, V97, P2168, DOI 10.1603/0022-0493-97.6.2168; Briscoe NJ, 2012, OIKOS, V121, P1464, DOI 10.1111/j.1600-0706.2011.20049.x; Brown PMJ, 2011, BIOCONTROL, V56, P623, DOI 10.1007/s10526-011-9379-1; Budriene A, 2013, CR BIOL, V336, P57, DOI 10.1016/j.crvi.2013.03.001; CARREL JE, 1993, EXPERIENTIA, V49, P171, DOI 10.1007/BF01989424; Castro CF, 2011, FLA ENTOMOL, V94, P923, DOI 10.1653/024.094.0429; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; Clusella Trullas S, 2007, J THERM BIOL, V32, P235, DOI 10.1016/j.jtherbio.2007.01.013; Cotter SC, 2008, J EVOLUTION BIOL, V21, P1744, DOI 10.1111/j.1420-9101.2008.01587.x; David JR, 2011, J GENET, V90, P295, DOI 10.1007/s12041-011-0076-8; Dmitriew C, 2010, AM NAT, V175, P640, DOI 10.1086/652470; Dolenska M, 2009, BIOL J LINN SOC, V98, P234, DOI 10.1111/j.1095-8312.2009.01277.x; Duyck PF, 2002, B ENTOMOL RES, V92, P461, DOI 10.1079/BER2002188; Easterling DR, 2000, B AM METEOROL SOC, V81, P417, DOI 10.1175/1520-0477(2000)081<0417:OVATIE>2.3.CO;2; Ellers J, 2003, EVOLUTION, V57, P1100, DOI 10.1111/j.0014-3820.2003.tb00319.x; Fairbairn DJ, 2005, AM NAT, V166, pS69, DOI 10.1086/444600; Fairbairn DJ, 2007, SEX SIZE GENDER ROLE; Folguera G, 2010, J INSECT PHYSIOL, V56, P1679, DOI 10.1016/j.jinsphys.2010.06.015; Forsman A, 1999, J EVOLUTION BIOL, V12, P391; Forster J, 2012, FUNCT ECOL, V26, P483, DOI 10.1111/j.1365-2435.2011.01958.x; Freitak D, 2012, BIOL LETTERS, V8, P860, DOI 10.1098/rsbl.2012.0273; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hu YW, 2011, ECOL ENTOMOL, V36, P111, DOI 10.1111/j.1365-2311.2010.01251.x; HUEY RB, 1989, TRENDS ECOL EVOL, V4, P131, DOI 10.1016/0169-5347(89)90211-5; Hukusima S., 1970, RES B FAC AGR GIFU U, V29, P53; Karl I, 2008, OECOLOGIA, V155, P215, DOI 10.1007/s00442-007-0902-0; KATZ RW, 1992, CLIMATIC CHANGE, V21, P289, DOI 10.1007/BF00139728; Ketola T, 2012, J EVOLUTION BIOL, V25, P847, DOI 10.1111/j.1420-9101.2012.02475.x; Kingsolver JG, 2008, EVOL ECOL RES, V10, P251; Knapp M, 2012, ENTOMOL EXP APPL, V143, P185, DOI 10.1111/j.1570-7458.2012.01247.x; Kooi RE, 1999, J INSECT PHYSIOL, V45, P201, DOI 10.1016/S0022-1910(98)00093-6; Lamana ML, 1998, ENVIRON ENTOMOL, V27, P1001, DOI 10.1093/ee/27.4.1001; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; Michie LJ, 2010, J EVOLUTION BIOL, V23, P1699, DOI 10.1111/j.1420-9101.2010.02043.x; Michie LJ, 2011, EVOL ECOL, V25, P1259, DOI 10.1007/s10682-011-9476-8; Moya-Larano J, 2008, J ANIM ECOL, V77, P1099, DOI 10.1111/j.1365-2656.2008.01433.x; Nedved O, IOBC B IN PRESS; Nedved O, 2011, ZOOKEYS, P77, DOI 10.3897/zookeys.106.1242; Nedvedova T, 2013, IOBC B IN PRESS; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Ohashi K, 2005, ENVIRON ENTOMOL, V34, P432, DOI 10.1603/0046-225X-34.2.432; Pappas ML, 2011, J APPL ENTOMOL, V135, P359, DOI 10.1111/j.1439-0418.2010.01579.x; Petersen C, 2000, PHYSIOL ENTOMOL, V25, P35, DOI 10.1046/j.1365-3032.2000.00163.x; Pinheiro J., 2019, NLME LINEAR NONLINEA; Potter KA, 2011, FUNCT ECOL, V25, P548, DOI 10.1111/j.1365-2435.2010.01807.x; Punzalan D, 2008, P ROY SOC B-BIOL SCI, V275, P483, DOI 10.1098/rspb.2007.1585; R Development Core Team, 2012, R LANG ENV STAT COMP; Reed TE, 2010, P ROY SOC B-BIOL SCI, V277, P3391, DOI 10.1098/rspb.2010.0771; Ricalde MP, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.3301; SCHANDERL H, 1985, AGRONOMIE, V5, P417, DOI 10.1051/agro:19850505; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shi ZH, 2010, J INSECT PHYSIOL, V56, P1696, DOI 10.1016/j.jinsphys.2010.06.013; Stathas GJ, 2011, ENVIRON ENTOMOL, V40, P1541, DOI 10.1603/EN10240; STEARNS SC, 1977, ANNU REV ECOL SYST, V8, P145, DOI 10.1146/annurev.es.08.110177.001045; Steigenga MJ, 2009, J THERM BIOL, V34, P244, DOI 10.1016/j.jtherbio.2009.03.001; Stillwell RC, 2010, P ROY SOC B-BIOL SCI, V277, P3819, DOI 10.1098/rspb.2010.0895; Stillwell RC, 2010, ANNU REV ENTOMOL, V55, P227, DOI 10.1146/annurev-ento-112408-085500; Stoehr AM, 2008, ECOL ENTOMOL, V33, P137, DOI 10.1111/j.1365-2311.2007.00931.x; Strobbe F, 2004, BIOL J LINN SOC, V83, P187, DOI 10.1111/j.1095-8312.2004.00379.x; Tammaru T, 2010, EVOL ECOL, V24, P161, DOI 10.1007/s10682-009-9297-1; Teder T, 2005, ECOL ENTOMOL, V30, P342, DOI 10.1111/j.0307-6946.2005.00693.x; Trenberth KE, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018020; vanderHave TM, 1996, J THEOR BIOL, V183, P329, DOI 10.1006/jtbi.1996.0224; Vigneron JP, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031907; Woods HA, 2004, J EXP BIOL, V207, P2267, DOI 10.1242/jeb.00991	78	47	51	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74984	10.1371/journal.pone.0074984	http://dx.doi.org/10.1371/journal.pone.0074984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086415	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700046
J	Sharon, H; Pasternak, Y; Ben Simon, E; Gruberger, M; Giladi, N; Krimchanski, B; Hassin, D; Hendler, T				Sharon, Haggai; Pasternak, Yotam; Ben Simon, Eti; Gruberger, Michal; Giladi, Nir; Krimchanski, Ben Zion; Hassin, David; Hendler, Talma			Emotional Processing of Personally Familiar Faces in the Vegetative State	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; ANTERIOR CINGULATE; BRAIN ACTIVITY; CONSCIOUSNESS; PERCEPTION; DISORDERS; AWARENESS; STIMULATION; ACTIVATION; MECHANISMS	Background: The Vegetative State (VS) is a severe disorder of consciousness in which patients are awake but display no signs of awareness. Yet, recent functional magnetic resonance imaging (fMRI) studies have demonstrated evidence for covert awareness in VS patients by recording specific brain activations during a cognitive task. However, the possible existence of incommunicable subjective emotional experiences in VS patients remains largely unexplored. This study aimed to probe the question of whether VS patients retain a brain ability to selectively process external stimuli according to their emotional value and look for evidence of covert emotional awareness in patients. Methods and Findings: In order to explore these questions we employed the emotive impact of observing personally familiar faces, known to provoke specific perceptual as well as emotional brain activations. Four VS patients and thirteen healthy controls first underwent an fMRI scan while viewing pictures of non-familiar faces, personally familiar faces and pictures of themselves. In a subsequent imagery task participants were asked to actively imagine one of their parent's faces. Analyses focused on face and familiarity selective regional brain activations and inter-regional functional connectivity. Similar to controls, all patients displayed face selective brain responses with further limbic and cortical activations elicited by familiar faces. In patients as well as controls, Connectivity was observed between emotional, visual and face specific areas, suggesting aware emotional perception. This connectivity was strongest in the two patients who later recovered. Notably, these two patients also displayed selective amygdala activation during familiar face imagery, with one further exhibiting face selective activations, indistinguishable from healthy controls. Conclusions: Taken together, these results show that selective emotional processing can be elicited in VS patients both by external emotionally salient stimuli and by internal cognitive processes, suggesting the ability for covert emotional awareness of self and the environment in VS patients.	[Sharon, Haggai; Pasternak, Yotam; Ben Simon, Eti; Gruberger, Michal; Hendler, Talma] Sourasky Med Ctr, Funct Brain Ctr, Wohl Inst Adv Imaging, Tel Aviv, Israel; [Sharon, Haggai; Hassin, David] Sourasky Med Ctr, Dept Internal Med, Tel Aviv, Israel; [Sharon, Haggai; Pasternak, Yotam; Ben Simon, Eti; Giladi, Nir; Hassin, David; Hendler, Talma] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Gruberger, Michal; Hendler, Talma] Tel Aviv Univ, Sch Psychol Sci, IL-69978 Tel Aviv, Israel; [Giladi, Nir] Sourasky Med Ctr, Dept Neurol, Tel Aviv, Israel; [Giladi, Nir; Hendler, Talma] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Krimchanski, Ben Zion] Loewenstein Hosp & Rehabil Ctr, Rehabil Intens Care Unit, Raanana, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University	Sharon, H (corresponding author), Sourasky Med Ctr, Funct Brain Ctr, Wohl Inst Adv Imaging, Tel Aviv, Israel.	haggais@tlvmc.gov.il	Giladi, Nir/AAU-8660-2020	Giladi, Nir/0000-0003-1482-8522; Ben Simon, Eti/0000-0002-3862-8288; Sharon, Haggai/0000-0003-1981-658X				[Anonymous], 1993, ANN NEUROL, V33, P386; Bernat JL, 2009, ANNU REV MED, V60, P381, DOI 10.1146/annurev.med.60.060107.091250; Boly M, 2011, CURR OPIN NEUROL, V24, P394, DOI 10.1097/WCO.0b013e328347da94; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Brooks SJ, 2012, NEUROIMAGE, V59, P2962, DOI 10.1016/j.neuroimage.2011.09.077; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P13722, DOI 10.1073/pnas.2235214100; Ffytche DH, 2011, BRAIN, V134, P247, DOI 10.1093/brain/awq305; Flavell JH, 2001, PSYCHOL SCI, V12, P430, DOI 10.1111/1467-9280.00379; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Goldfine AM, 2011, NEUROL CLIN, V29, P723, DOI 10.1016/j.ncl.2011.08.001; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Koenigs M., 2009, COGNITIVE NEUROSCIEN, P1181; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Moutoussis K, 2002, P NATL ACAD SCI USA, V99, P9527, DOI 10.1073/pnas.142305699; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Qin PM, 2010, HUM BRAIN MAPP, V31, P1993, DOI 10.1002/hbm.20989; Rees G, 2007, PHILOS T R SOC B, V362, P877, DOI 10.1098/rstb.2007.2094; Rodriguez V, 2012, J COGNITIVE NEUROSCI, V24, P396, DOI 10.1162/jocn_a_00137; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Shah SA, 2010, EUR J NEUROSCI, V32, P1135, DOI 10.1111/j.1460-9568.2010.07420.x; Talairarch J, 1998, COPLANAR STEREOTAXIC; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Taylor MJ, 2009, HUM BRAIN MAPP, V30, P2008, DOI 10.1002/hbm.20646; Terasawa Y, 2011, HUMAN BRAIN MAPPING; Yu T, 2013, NEUROLOGY, V80, P345, DOI 10.1212/WNL.0b013e31827f0846	32	27	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74711	10.1371/journal.pone.0074711	http://dx.doi.org/10.1371/journal.pone.0074711			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086365	Green Submitted, Green Published, gold			2022-12-27	WOS:000325218700032
J	Ma, M; Baumgartner, M				Ma, Min; Baumgartner, Martin			Filopodia and Membrane Blebs Drive Efficient Matrix Invasion of Macrophages Transformed by the Intracellular Parasite Theileria annulata	PLOS ONE			English	Article							ERM PROTEINS; CELL MOTILITY; SUSCEPTIBLE CATTLE; ACTIN DYNAMICS; B-LYMPHOCYTES; IN-VIVO; MIGRATION; KINASE; LAMELLIPODIA; METASTASIS	Recent technical advances have broadened our understanding of processes that govern mammalian cell migration in health and disease but many of the molecular and morphological alterations that precede and accompany movement of cells - in particular in three-dimensional (3D) environments - are still incompletely understood. In this manuscript, using high-resolution and time-lapse microscopy imaging approaches, we describe morphodynamic processes during rounded/amoeboid cell invasion and molecules associated with the cellular invasion structures. We used macrophages infected with the intracellular protozoan parasite Theileria annulata, which causes Tropical Theileriosis in susceptible ruminants such as domestic cattle. T. annulata transforms its host cell that, as a result, acquires many characteristics of human cancer cells including a markedly increased potential to migrate, disseminate and expand in the body of the host animal. Hence, virulence of the disease is associated with the capability of infected cells to disseminate inside the host. Using T. annulata-transformed macrophages as a model system, we described a novel mode of rounded/amoeboid macrophage migration. We show that filopodia-like membrane extensions at the leading edge lead the way and further evolve in blebbing membrane protrusions to promote progressive expansion of the matrix. Associated with focal invasion structures we detected ezrin, radixin, moesin-family proteins and their regulatory kinase MAP4K4. Furthermore, we linked Rho-kinase activity to contractile force generation, which is essential for infected cell motility. Thus, the motility mode of these parasite-transformed macrophages contrasts with those described so far in human macrophages such as the tunneling or mesenchymal modes, which require engulfment, compaction and ingestion of matrix or proteolytic matrix degradation, respectively. Together, our data reveal protrusion dynamics at the leading edge of invading cells in 3D at unprecedented temporal and spatial resolution and suggest a novel mode of rounded/amoeboid invasive cell motility that exploits actin-driven filopodia formation in combination with pressure-driven membrane blebs.	[Ma, Min; Baumgartner, Martin] Univ Childrens Hosp Zurich, Div Neurooncol Expt Infect Dis & Canc Res, Dept Oncol, Zurich, Switzerland	University Children's Hospital Zurich	Baumgartner, M (corresponding author), Univ Childrens Hosp Zurich, Div Neurooncol Expt Infect Dis & Canc Res, Dept Oncol, Zurich, Switzerland.	Martin.Baumgartner@kispi.uzh.ch	Baumgartner, Martin/D-2749-2017	Baumgartner, Martin/0000-0001-9539-7204	Swiss National Science Foundation [SNF_31003A_127025/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Swiss National Science Foundation (grant SNF_31003A_127025/1); http://www.snf.ch/E/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson RE, 1996, PARASITOLOGY, V113, P449, DOI 10.1017/S0031182000081518; Amieva MR, 1999, J CELL SCI, V112, P111; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Baumgartner M, 2000, CELL MICROBIOL, V2, P329, DOI 10.1046/j.1462-5822.2000.00062.x; Baumgartner M, 2003, BLOOD, V101, P1874, DOI 10.1182/blood-2002-02-0456; Baumgartner M, 2006, P NATL ACAD SCI USA, V103, P13391, DOI 10.1073/pnas.0605950103; Baumgartner M, 2011, CURR OPIN MICROBIOL, V14, P436, DOI 10.1016/j.mib.2011.07.003; Baumgartner M, 2011, CELL MICROBIOL, V13, P538, DOI 10.1111/j.1462-5822.2010.01553.x; Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Chaussepied M, 1998, MOL BIOCHEM PARASIT, V94, P215, DOI 10.1016/S0166-6851(98)00070-X; Chaussepied M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001197; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Dessauge G, 2005, ONCOGENE, V24, P1075, DOI 10.1038/sj.onc.1208314; Dobbelaere D., 2009, INTRACELLULAR NICHES, P613, DOI [10.1002/9783527629176., DOI 10.1002/9783527629176]; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Forsyth LMG, 1999, J COMP PATHOL, V120, P39, DOI 10.1053/jcpa.1998.0256; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Haubert D, 2007, EMBO J, V26, P3308, DOI 10.1038/sj.emboj.7601778; Jensen K, 2008, INT J PARASITOL, V38, P313, DOI 10.1016/j.ijpara.2007.08.007; Kramer N, 2013, MUTAT RES-REV MUTAT, V752, P10, DOI 10.1016/j.mrrev.2012.08.001; Lizundia R, 2006, CANCER RES, V66, P6105, DOI 10.1158/0008-5472.CAN-05-3861; Madsen CD, 2010, DEV CELL, V19, P13, DOI 10.1016/j.devcel.2010.06.013; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; McGuire K, 2004, VET IMMUNOL IMMUNOP, V99, P87, DOI 10.1016/j.vetimm.2004.01.003; Moreau MF, 1999, INFECT IMMUN, V67, P6678; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Reichardt Peter, 2007, Methods Mol Biol, V380, P253; Rottner K, 2011, CURR OPIN CELL BIOL, V23, P569, DOI 10.1016/j.ceb.2011.07.003; Schnittger L, 2002, MOL BIOCHEM PARASIT, V120, P247, DOI 10.1016/S0166-6851(02)00013-0; Somerville RPT, 1998, PARASITOLOGY, V116, P223, DOI 10.1017/S0031182097002151; Torka R, 2006, EXP CELL RES, V312, P3857, DOI 10.1016/j.yexcr.2006.08.025; Van Goethem E, 2011, EUR J CELL BIOL, V90, P224, DOI 10.1016/j.ejcb.2010.07.011; Van Goethem E, 2010, J IMMUNOL, V184, P1049, DOI 10.4049/jimmunol.0902223; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yu XZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030605	43	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75577	10.1371/journal.pone.0075577	http://dx.doi.org/10.1371/journal.pone.0075577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086576	Green Submitted, Green Published, gold			2022-12-27	WOS:000325025200050
J	Yan, BB; Singla, RD; Abdelli, LS; Singal, PK; Singla, DK				Yan, Binbin; Singla, Reetu D.; Abdelli, Latifa S.; Singal, Pawan K.; Singla, Dinender K.			Regulation of PTEN/Akt Pathway Enhances Cardiomyogenesis and Attenuates Adverse Left Ventricular Remodeling following Thymosin beta 4 Overexpressing Embryonic Stem Cell Transplantation in the Infarcted Heart	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; CARDIOMYOCYTE DIFFERENTIATION; CARDIAC DIFFERENTIATION; INHIBIT APOPTOSIS; THERAPY; REPAIR; NEOVASCULARIZATION; PEPTIDE; DISEASE; NOTCH	Thymosin beta 4 (T beta 4), a small G-actin sequestering peptide, mediates cell proliferation, migration, and angiogenesis. Whether embryonic stem (ES) cells, overexpressing T beta 4, readily differentiate into cardiac myocytes in vitro and in vivo and enhance cardioprotection following transplantation post myocardial infarction (MI) remains unknown. Accordingly, we established stable mouse ES cell lines, RFP-ESCs and T beta 4-ESCs, expressing RFP and an RFP-T beta 4 fusion protein, respectively. In vitro, the number of spontaneously beating embryoid bodies (EBs) was significantly increased in T beta 4-ESCs at day 9, 12 and 15, compared with RFP-ESCs. Enhanced expression of cardiac transcriptional factors GATA-4, Mef2c and Txb6 in T beta 4-EBs, as confirmed with real time-PCR analysis, was accompanied by the increased number of EB areas stained positive for sarcomeric alpha-actin in T beta 4-EBs, compared with the RFP control, suggesting a significant increase in functional cardiac myocytes. Furthermore, we transplanted T beta 4-ESCs into the infarcted mouse heart and performed morphological and functional analysis 2 weeks after MI. There was a significant increase in newly formed cardiac myocytes associated with the Notch pathway, a decrease in apoptotic nuclei mediated by an increase in Akt and a decrease in levels of PTEN. Cardiac fibrosis was significantly reduced, and left ventricular function was significantly augmented in the T beta 4-ESC transplanted group, compared with controls. It is concluded that genetically modified T beta 4-ESCs, potentiates their ability to turn into cardiac myocytes in vitro as well as in vivo. Moreover, we also demonstrate that there was a significant decrease in both cardiac apoptosis and fibrosis, thus improving cardiac function in the infarcted heart.	[Yan, Binbin; Singla, Reetu D.; Abdelli, Latifa S.; Singla, Dinender K.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Singal, Pawan K.] Univ Manitoba, St Boniface Gen Hosp, Res Ctr, Inst Cardiovasc Sci, Winnipeg, MB, Canada	State University System of Florida; University of Central Florida; University of Manitoba; Children's Hospital Research Institute of Manitoba	Singla, DK (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	dsingla@mail.ucf.edu			National Heart, Lung, and Blood Institute [1R01-HL-090646-01, 1R01HL094467-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090646, R01HL094467] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by in part grants from the National Heart, Lung, and Blood Institute (1R01-HL-090646-01 and 1R01HL094467-01 to DKS). Dr. PKS is the holder of the Naranjan Dhalla Chair from the St. Boniface Hospital & Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelli LS, 2012, CAN J PHYSIOL PHARM, V90, P307, DOI [10.1139/Y11-130, 10.1139/y11-130]; Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Boyle AJ, 2006, CIRCULATION, V114, P339, DOI 10.1161/CIRCULATIONAHA.105.590653; Choi SC, 2004, EXP MOL MED, V36, P515, DOI 10.1038/emm.2004.66; Crockford D, 2007, ANN NY ACAD SCI, V1112, P385, DOI 10.1196/annals.1415.051; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Glass C, 2011, AM J PHYSIOL-HEART C, V301, pH2038, DOI 10.1152/ajpheart.00271.2011; Grant D S, 1999, Angiogenesis, V3, P125, DOI 10.1023/A:1009041911493; Grepin C, 1997, DEVELOPMENT, V124, P2387; Gude NA, 2008, CIRC RES, V102, P1025, DOI 10.1161/CIRCRESAHA.107.164749; HANNAPPEL E, 1985, ARCH BIOCHEM BIOPHYS, V240, P236, DOI 10.1016/0003-9861(85)90028-1; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Hinkel R, 2008, CIRCULATION, V117, P2232, DOI 10.1161/CIRCULATIONAHA.107.758904; Ho JH, 2010, J ORTHOP RES, V28, P131, DOI 10.1002/jor.20956; Hodgson DM, 2004, AM J PHYSIOL-HEART C, V287, pH471, DOI 10.1152/ajpheart.01247.2003; Keyes KT, 2010, AM J PHYSIOL-HEART C, V298, pH1198, DOI 10.1152/ajpheart.00915.2009; Kumar D, 2005, BIOCHEM BIOPH RES CO, V332, P135, DOI 10.1016/j.bbrc.2005.04.098; Leor J, 2007, HEART, V93, P1278, DOI 10.1136/hrt.2006.093161; Li YX, 2011, CIRCULATION, V123, P866, DOI 10.1161/CIRCULATIONAHA.110.947531; Menard C, 2005, LANCET, V366, P1005, DOI 10.1016/S0140-6736(05)67380-1; Narita N, 1997, DEVELOPMENT, V124, P3755; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Philp D, 2003, FASEB J, V17, P385, DOI 10.1096/fj.03-0244fje; Philp D, 2003, FASEB J, V17, P2103, DOI 10.1096/fj.03-0121fje; Puceat M, 2008, METHODS, V45, P168, DOI 10.1016/j.ymeth.2008.03.003; Reinecke H, 2008, CIRC RES, V103, P1058, DOI 10.1161/CIRCRESAHA.108.180588; SAFER D, 1990, P NATL ACAD SCI USA, V87, P2536, DOI 10.1073/pnas.87.7.2536; Singla DK, 2007, AM J PHYSIOL-HEART C, V293, pH1308, DOI 10.1152/ajpheart.01277.2006; Smart N, 2007, ANN NY ACAD SCI, V1112, P171, DOI 10.1196/annals.1415.000; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Srivastava D, 2007, ANN NY ACAD SCI, V1112, P161, DOI 10.1196/annals.1415.048; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Taha MF, 2007, INT J CARDIOL, V120, P92, DOI 10.1016/j.ijcard.2006.08.118; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Tomfscot A, 2007, STEM CELLS, V25, P2200, DOI 10.1634/stemcells.2007-0133; Wen JY, 2007, J CELL BIOCHEM, V102, P149, DOI 10.1002/jcb.21285; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91	40	22	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75580	10.1371/journal.pone.0075580	http://dx.doi.org/10.1371/journal.pone.0075580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086577	Green Published, gold			2022-12-27	WOS:000325025200051
J	Kuriki, S; Yokosawa, K; Takahashi, M				Kuriki, Shinya; Yokosawa, Koichi; Takahashi, Makoto			Neural Representation of Scale Illusion: Magnetoencephalographic Study on the Auditory Illusion Induced by Distinctive Tone Sequences in the Two Ears	PLOS ONE			English	Article							STEADY-STATE RESPONSES; AMPLITUDE-MODULATION; BINAURAL INTERACTION; EVOKED-POTENTIALS; OCTAVE ILLUSION; BRAIN-STEM; CORTEX; CAT; MECHANISMS; ORGANIZATION	The auditory illusory perception "scale illusion" occurs when a tone of ascending scale is presented in one ear, a tone of descending scale is presented simultaneously in the other ear, and vice versa. Most listeners hear illusory percepts of smooth pitch contours of the higher half of the scale in the right ear and the lower half in the left ear. Little is known about neural processes underlying the scale illusion. In this magnetoencephalographic study, we recorded steady-state responses to amplitude-modulated short tones having illusion-inducing pitch sequences, where the sound level of the modulated tones was manipulated to decrease monotonically with increase in pitch. The steady-state responses were decomposed into right- and left-sound components by means of separate modulation frequencies. It was found that the time course of the magnitude of response components of illusion-perceiving listeners was significantly correlated with smooth pitch contour of illusory percepts and that the time course of response components of stimulus-perceiving listeners was significantly correlated with discontinuous pitch contour of stimulus percepts in addition to the contour of illusory percepts. The results suggest that the percept of illusory pitch sequence was represented in the neural activity in or near the primary auditory cortex, i.e., the site of generation of auditory steady-state response, and that perception of scale illusion is maintained by automatic low-level processing.	[Kuriki, Shinya] Tokyo Denki Univ, Res Ctr Sci & Technol, Inzai, Japan; [Yokosawa, Koichi] Hokkaido Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Takahashi, Makoto] Grad Sch Informat Sci & Technol, Sapporo, Hokkaido, Japan	Tokyo Denki University; Hokkaido University; Hokkaido University	Kuriki, S (corresponding author), Tokyo Denki Univ, Res Ctr Sci & Technol, Inzai, Japan.	skuriki@mail.dendai.ac.jp			Ministry of Education, Science and Culture of Japan [19300152]	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding provided by Grant-in-Aids for Scientific Research (19300152) from the Ministry of Education, Science and Culture of Japan (URL:http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brancucci A, 2009, PSYCHOL RES-PSYCH FO, V73, P303, DOI 10.1007/s00426-008-0153-7; Bregman A.S., 1990, AUDITORY SCENE ANAL; CREUTZFELDT O, 1980, EXP BRAIN RES, V39, P87; DAVIDSON B, 1987, PERCEPT PSYCHOPHYS, V41, P601, DOI 10.3758/BF03210492; Deouell LY, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.015.2007; DEUTSCH D, 1975, J ACOUST SOC AM, V57, P1156, DOI 10.1121/1.380573; DEUTSCH D, 1974, NATURE, V251, P307, DOI 10.1038/251307a0; Draganova R, 2008, CEREB CORTEX, V18, P1193, DOI 10.1093/cercor/bhm153; Engelien A, 2000, HEARING RES, V148, P153, DOI 10.1016/S0378-5955(00)00148-9; Fishman YI, 2001, HEARING RES, V151, P167, DOI 10.1016/S0378-5955(00)00224-0; FRISINA RD, 1990, HEARING RES, V44, P99, DOI 10.1016/0378-5955(90)90074-Y; Fujiki N, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0003.2002; GAESE BH, 1995, EUR J NEUROSCI, V7, P438, DOI 10.1111/j.1460-9568.1995.tb00340.x; GALAMBOS R, 1982, ANN NY ACAD SCI, V388, P722, DOI 10.1111/j.1749-6632.1982.tb50841.x; Herdman AT, 2002, BRAIN TOPOGR, V15, P69, DOI 10.1023/A:1021470822922; IMIG TJ, 1977, BRAIN RES, V138, P241, DOI 10.1016/0006-8993(77)90743-0; Jamison HL, 2006, CEREB CORTEX, V16, P1266, DOI 10.1093/cercor/bhj068; JOHNSON B W, 1988, Brain Topography, V1, P117, DOI 10.1007/BF01129176; Kaneko K, 2003, HEARING RES, V183, P1, DOI 10.1016/S0378-5955(03)00186-2; Karino S, 2006, J NEUROPHYSIOL, V96, P1927, DOI 10.1152/jn.00859.2005; KELLY JB, 1994, J NEUROPHYSIOL, V71, P904, DOI 10.1152/jn.1994.71.3.904; Krishna BS, 2000, J NEUROPHYSIOL, V84, P255, DOI 10.1152/jn.2000.84.1.255; Kuriki S, 2013, HEARING RES, V296, P25, DOI 10.1016/j.heares.2012.11.002; KUWADA S, 1979, SCIENCE, V206, P586, DOI 10.1126/science.493964; Lamminmaki S, 2000, NEUROREPORT, V11, P1469, DOI 10.1097/00001756-200005150-00021; Lamminmaki S, 2012, J ACOUST SOC AM, V132, P1747, DOI 10.1121/1.4740474; LEE YS, 1984, BRAIN, V107, P115, DOI 10.1093/brain/107.1.115; LITTMAN T, 1994, BRAIN RES, V640, P286, DOI 10.1016/0006-8993(94)91884-8; MAKELA JP, 1990, HEARING RES, V45, P41, DOI 10.1016/0378-5955(90)90181-N; Maki A, 2009, EAR HEARING, V30, P584, DOI 10.1097/AUD.0b013e3181acfb57; MCPHERSON DL, 1993, HEARING RES, V66, P91, DOI 10.1016/0378-5955(93)90263-Z; MULLERPREUSS P, 1994, HEARING RES, V80, P197, DOI 10.1016/0378-5955(94)90111-2; Okamoto H, 2009, CEREB CORTEX, V19, P2290, DOI 10.1093/cercor/bhn245; PANDYA DN, 1995, REV NEUROL, V151, P486; Pantev C, 1996, HEARING RES, V101, P62, DOI 10.1016/S0378-5955(96)00133-5; Pratt H, 2009, CLIN NEUROPHYSIOL, V120, P1514, DOI 10.1016/j.clinph.2009.06.014; PREUSS A, 1990, EXP BRAIN RES, V79, P207; RHODE WS, 1994, J NEUROPHYSIOL, V71, P1797, DOI 10.1152/jn.1994.71.5.1797; Ross J, 1996, NEUROREPORT, V8, P303, DOI 10.1097/00001756-199612200-00060; SCHREINER CE, 1988, HEARING RES, V32, P49, DOI 10.1016/0378-5955(88)90146-3; Schwarz DWF, 2005, CLIN NEUROPHYSIOL, V116, P658, DOI 10.1016/j.clinph.2004.09.014; Snyder JS, 2006, J COGNITIVE NEUROSCI, V18, P1, DOI 10.1162/089892906775250021; SPYDELL JD, 1985, ELECTROEN CLIN NEURO, V62, P193, DOI 10.1016/0168-5597(85)90014-0; Steinmann I, 2011, NEUROIMAGE, V54, P495, DOI 10.1016/j.neuroimage.2010.07.064; Tononi G, 1998, P NATL ACAD SCI USA, V95, P3198, DOI 10.1073/pnas.95.6.3198; WERNICK JS, 1968, J NEUROPHYSIOL, V31, P428, DOI 10.1152/jn.1968.31.3.428; Wong WYS, 2004, EAR HEARING, V25, P57, DOI 10.1097/01.AUD.0000111257.11898.64; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	48	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75990	10.1371/journal.pone.0075990	http://dx.doi.org/10.1371/journal.pone.0075990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086676	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200128
J	Mackie, A; Keseler, IM; Nolan, L; Karp, PD; Paulsen, IT				Mackie, Amanda; Keseler, Ingrid M.; Nolan, Laura; Karp, Peter D.; Paulsen, Ian T.			Dead End Metabolites - Defining the Known Unknowns of the E. coli Metabolic Network	PLOS ONE			English	Article							ESCHERICHIA-COLI; IN-VIVO; ACTIVE-TRANSPORT; INDUCIBLE SYSTEM; GENETIC-ANALYSIS; LIPOIC ACID; PATHWAY; BIOTIN; IDENTIFICATION; CATABOLISM	The EcoCyc database is an online scientific database which provides an integrated view of the metabolic and regulatory network of the bacterium Escherichia coli K-12 and facilitates computational exploration of this important model organism. We have analysed the occurrence of dead end metabolites within the database-these are metabolites which lack the requisite reactions (either metabolic or transport) that would account for their production or consumption within the metabolic network. 127 dead end metabolites were identified from the 995 compounds that are contained within the EcoCyc metabolic network. Their presence reflects either a deficit in our representation of the network or in our knowledge of E. coli metabolism. Extensive literature searches resulted in the addition of 38 transport reactions and 3 metabolic reactions to the database and led to an improved representation of the pathway for Vitamin B12 salvage. 39 dead end metabolites were identified as components of reactions that are not physiologically relevant to E. coli K-12-these reactions are properties of purified enzymes in vitro that would not be expected to occur in vivo. Our analysis led to improvements in the software that underpins the database and to the program that finds dead end metabolites within EcoCyc. The remaining dead end metabolites in the EcoCyc database likely represent deficiencies in our knowledge of E. coli metabolism.	[Mackie, Amanda; Nolan, Laura; Paulsen, Ian T.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Keseler, Ingrid M.; Karp, Peter D.] SRI Int, Menlo Pk, CA 94025 USA	Macquarie University; SRI International	Paulsen, IT (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia.	ian.paulsen@mq.edu.au	Nolan, Laura/AEZ-3347-2022; Karp, Peter/C-3514-2012; Paulsen, Ian/K-3832-2012	Karp, Peter/0000-0002-5876-6418; Paulsen, Ian/0000-0001-9015-9418	National Institute of General Medical Sciences of the National Institutes of Health [U24GM077678]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U24GM077678] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work on this project was supported by National Institute of General Medical Sciences of the National Institutes of Health [U24GM077678]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas M, 2010, EUR J CELL BIOL, V89, P888, DOI 10.1016/j.ejcb.2010.06.013; BELLION E, 1983, BIOCHIM BIOPHYS ACTA, V735, P337, DOI 10.1016/0005-2736(83)90147-5; BLACKWELL CM, 1976, BIOCHEM SOC T, V4, P495, DOI 10.1042/bst0040495; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; BOOS W, 1981, J BACTERIOL, V146, P725, DOI 10.1128/JB.146.2.725-732.1981; BRADBEER C, 1978, J BIOL CHEM, V253, P1347; BURLINGAME R, 1983, J BACTERIOL, V155, P113, DOI 10.1128/JB.155.1.113-121.1983; Cai H, 1999, J BIOL CHEM, V274, P13470, DOI 10.1074/jbc.274.19.13470; Cusa E, 1999, J BACTERIOL, V181, P7479, DOI 10.1128/JB.181.24.7479-7484.1999; Diaz E, 2001, MICROBIOL MOL BIOL R, V65, P523, DOI 10.1128/MMBR.65.4.523-569.2001; DYKHUIZEN D, 1973, J BACTERIOL, V115, P662, DOI 10.1128/JB.115.2.662-667.1973; Fujisawa H, 2003, BBA-PROTEINS PROTEOM, V1645, P89, DOI 10.1016/S1570-9639(02)00533-2; Green ML, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-76; GUTH A, 1980, J BACTERIOL, V143, P538, DOI 10.1128/JB.143.1.538-539.1980; Hebbeln P, 2007, P NATL ACAD SCI USA, V104, P2909, DOI 10.1073/pnas.0609905104; Herzberg M, 2006, J BACTERIOL, V188, P587, DOI 10.1128/JB.188.2.587-598.2006; Hughes JA, 2006, CAN J MICROBIOL, V52, P599, DOI 10.1139/W06-008; IIZUKA M, 1989, J BACTERIOL, V171, P6039, DOI 10.1128/jb.171.11.6039-6042.1989; Iqbal S, 2004, J BACTERIOL, V186, P6118, DOI 10.1128/jb.186.18.6118-6123.2004; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; JONES PW, 1984, J GEN MICROBIOL, V130, P299; Karp PD, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-401; Karp PD, 2007, NUCLEIC ACIDS RES, V35, P7577, DOI 10.1093/nar/gkm740; KENLEY JS, 1978, J BIOL CHEM, V253, P1341; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Lacourciere GM, 2002, J BACTERIOL, V184, P1940, DOI 10.1128/JB.184.7.1940-1946.2002; LAWRENCE JG, 1995, J BACTERIOL, V177, P6371, DOI 10.1128/jb.177.22.6371-6380.1995; LINDBLOWKULL C, 1985, J BACTERIOL, V163, P1267, DOI 10.1128/JB.163.3.1267-1269.1985; Liu GF, 2009, J BACTERIOL, V191, P6394, DOI 10.1128/JB.00552-09; Loh KD, 2006, P NATL ACAD SCI USA, V103, P5114, DOI 10.1073/pnas.0600521103; MORRIS DR, 1967, J BACTERIOL, V94, P1516, DOI 10.1128/JB.94.5.1516-1519.1967; MORRIS TW, 1995, J BACTERIOL, V177, P1; Muller HM, 2004, PLOS BIOL, V2, P1984, DOI 10.1371/journal.pbio.0020309; NAGASAWA T, 1988, ARCH MICROBIOL, V149, P413, DOI 10.1007/BF00425580; Nie L, 2008, BIOCHEMISTRY-US, V47, P7744, DOI 10.1021/bi800595f; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; PARROTT S, 1987, J GEN MICROBIOL, V133, P347; PAULI G, 1972, EUR J BIOCHEM, V29, P553, DOI 10.1111/j.1432-1033.1972.tb02021.x; PIERSON DE, 1990, J BACTERIOL, V172, P2194, DOI 10.1128/jb.172.4.2194-2198.1990; PRAKASH O, 1974, J BACTERIOL, V120, P785, DOI 10.1128/JB.120.2.785-791.1974; Putra SR, 1998, TETRAHEDRON LETT, V39, P23, DOI 10.1016/S0040-4039(97)10458-0; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Ren Y, 2004, J BIOL CHEM, V279, P11042, DOI 10.1074/jbc.M310032200; Rippa V, 2011, DNA REPAIR, V10, P934, DOI 10.1016/j.dnarep.2011.06.001; Rizk SS, 2006, PROTEIN SCI, V15, P1745, DOI 10.1110/ps.062135206; Sauer E, 2004, ANTIMICROB AGENTS CH, V48, P4532, DOI 10.1128/AAC.48.12.4532-4541.2004; SCHAEFLER S, 1967, J BACTERIOL, V93, P254, DOI 10.1128/JB.93.1.254-263.1967; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Smith AAT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002540; SOLOMON LR, 1971, BIOCHEM BIOPH RES CO, V44, P299, DOI 10.1016/0006-291X(71)90599-7; STONER GL, 1975, J BIOL CHEM, V250, P4029; TANG CT, 1977, ANTIMICROB AGENTS CH, V11, P147, DOI 10.1128/AAC.11.1.147; Thanassi DG, 1997, J BACTERIOL, V179, P2512, DOI 10.1128/jb.179.8.2512-2518.1997; Thanbichler M, 1999, J BACTERIOL, V181, P662, DOI 10.1128/JB.181.2.662-665.1999; TOEWS ML, 1979, J BIOL CHEM, V254, P1761; Wiame E, 2004, BIOCHEM J, V378, P1047, DOI 10.1042/BJ20031527; Wiame E, 2002, J BIOL CHEM, V277, P42523, DOI 10.1074/jbc.M200863200; Xavier KB, 2005, J BACTERIOL, V187, P238, DOI 10.1128/JB.187.1.238-248.2005; YAMASAKI H, 1973, J BACTERIOL, V116, P1280, DOI 10.1128/JB.116.3.1280-1286.1973; Yang KC, 2009, J BACTERIOL, V191, P4667, DOI 10.1128/JB.00235-09; Zayas CL, 2007, J BACTERIOL, V189, P2210, DOI 10.1128/JB.01665-06; Zhai YF, 2002, PROTEIN SCI, V11, P2196, DOI 10.1110/ps.0209002; Zhao X, 2003, CHEM BIOL, V10, P1293, DOI 10.1016/j.chembiol.2003.11.016	65	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75210	10.1371/journal.pone.0075210	http://dx.doi.org/10.1371/journal.pone.0075210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086468	Green Submitted, Green Published, gold			2022-12-27	WOS:000326520200089
J	Dornbusch, J; Zacharis, A; Meinhardt, M; Erdmann, K; Wolff, I; Froehner, M; Wirth, MP; Zastrow, S; Fuessel, S				Dornbusch, Juana; Zacharis, Aristeidis; Meinhardt, Matthias; Erdmann, Kati; Wolff, Ingmar; Froehner, Michael; Wirth, Manfred P.; Zastrow, Stefan; Fuessel, Susanne			Analyses of Potential Predictive Markers and Survival Data for a Response to Sunitinib in Patients with Metastatic Renal Cell Carcinoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTORS; CARBONIC-ANHYDRASE-IX; VHL GENE MUTATION; CLEAR-CELL; PATHOLOGICAL FEATURES; TUMOR AGGRESSIVENESS; ANTITUMOR-ACTIVITY; PROGNOSTIC-FACTORS; VEGF EXPRESSION	Background: Patients with metastatic clear cell renal cell carcinoma (ccRCC) are frequently treated with tyrosine kinase inhibitors (TKI) such as sunitinib. It inhibits angiogenic pathways by mainly targeting the receptors of VEGF and PDGF. In ccRCC, angiogenesis is characterized by the inactivation of the von Hippel-Lindau gene (VHL) which in turn leads to the induction of HIF1 alpha target genes such as CA9 and VEGF. Furthermore, the angiogenic phenotype of ccRCC is also reflected by endothelial markers (CD31, CD34) or other tumor-promoting factors like Ki67 or survivin. Methods: Tissue microarrays from primary tumor specimens of 42 patients with metastatic ccRCC under sunitinib therapy were immunohistochemically stained for selected markers related to angiogenesis. The prognostic and predictive potential of theses markers was assessed on the basis of the objective response rate which was evaluated according to the RECIST criteria after 3, 6, 9 months and after last report (12-54 months) of sunitinib treatment. Additionally, VHL copy number and mutation analyses were performed on DNA from cryo-preserved tumor tissues of 20 ccRCC patients. Results: Immunostaining of HIF-1 alpha, CA9, Ki67, CD31, pVEGFR1, VEGFR1 and -2, pPDGFR alpha and -beta was significantly associated with the sunitinib response after 6 and 9 months as well as last report under therapy. Furthermore, HIF-1 alpha, CA9, CD34, VEGFR1 and -3 and PDGRF alpha showed significant associations with progression-free survival (PFS) and overall survival (OS). In multivariate Cox proportional hazards regression analyses high CA9 membrane staining and a response after 9 months were independent prognostic factors for longer OS. Frequently observed copy number loss and mutation of VHL gene lead to altered expression of VHL, HIF-1 alpha, CA9, and VEGF. Conclusions: Immunoexpression of HIF-1 alpha, CA9, Ki67, CD31, pVEGFR1, VEGFR1 and -2, pPDGFR alpha and -beta in the primary tumors of metastatic ccRCC patients might support the prediction of a good response to sunitinib treatment.	[Dornbusch, Juana; Zacharis, Aristeidis; Erdmann, Kati; Wolff, Ingmar; Froehner, Michael; Wirth, Manfred P.; Zastrow, Stefan; Fuessel, Susanne] Tech Univ Dresden, Dept Urol, Dresden, Germany; [Meinhardt, Matthias] Tech Univ Dresden, Inst Pathol, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Dornbusch, J (corresponding author), Tech Univ Dresden, Dept Urol, Dresden, Germany.	juana.dornbusch@uniklinikum-dresden.de	Zastrow, Stefan/ABF-3692-2021; Wolff, Ingmar/C-6059-2014; Wolff, Ingmar/ABG-7840-2021; Wolff, Ingmar/Y-4974-2019	Wolff, Ingmar/0000-0003-4197-6643	Juergen Manchot Foundation	Juergen Manchot Foundation	This work was supported by the Juergen Manchot Foundation. http://www.manchot.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz SA, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-15; Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Biswas S, 2012, CARCINOGENESIS, V33, P1717, DOI 10.1093/carcin/bgs222; Bleumer I, 2003, EUR UROL, V44, P65, DOI 10.1016/S0302-2838(03)00191-X; Bono P, 2011, ACTA ONCOL, V50, P569, DOI 10.3109/0284186X.2010.543696; Buchner A, 2006, CANCER, V106, P1514, DOI 10.1002/cncr.21775; Bui MHT, 2004, J UROLOGY, V171, P2461, DOI 10.1097/01.ju.0000116444.08690.e2; Bui MHT, 2003, CLIN CANCER RES, V9, P802; Byun SS, 2007, UROLOGY, V69, P34, DOI 10.1016/j.urology.2006.09.024; CHOUEIRI TK, 2008, J CLIN ONCOL, V26; Choueiri TK, 2008, J UROLOGY, V180, P860, DOI 10.1016/j.juro.2008.05.015; Choueiri TK, 2010, BJU INT, V105, P1247, DOI 10.1111/j.1464-410X.2009.08972.x; Escudier B, 2012, ANN ONCOL, V23, P309, DOI 10.1093/annonc/mds352; Escudier BJ, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.e15118; Ferrara N, 1999, KIDNEY INT, V56, P794, DOI 10.1046/j.1523-1755.1999.00610.x; Fujita T, 2012, INT J UROL, V19, P908, DOI 10.1111/j.1442-2042.2012.03071.x; Garcia-Donas J, 2011, LANCET ONCOL, V12, P1143, DOI 10.1016/S1470-2045(11)70266-2; Geretti E, 2007, CELL ADHES MIGR, V1, DOI 10.4161/cam.1.2.4490; Grunwald V, 2012, ONCOTARGETS THER, V5, P111, DOI 10.2147/OTT.S23273; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Kim JJ, 2012, CANCER-AM CANCER SOC, V118, P1946, DOI 10.1002/cncr.26491; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Laird A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060483; Lei Y, 2010, MOL CELL BIOCHEM, V344, P23, DOI 10.1007/s11010-010-0525-3; Li XS, 2011, CHINESE MED J-PEKING, V124, P2920, DOI 10.3760/cma.j.issn.0366-6999.2011.18.023; Liang YX, 2009, CANCER INVEST, V27, P788, DOI 10.1080/07357900802709167; Malaguarnera M, 2001, EUR J CLIN PHARMACOL, V57, P267, DOI 10.1007/s002280100321; Matsuda D, 2008, CANCER LETT, V272, P260, DOI 10.1016/j.canlet.2008.06.015; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mendel DB, 2003, CLIN CANCER RES, V9, P327; MICHAELSON MD, 2011, J CLIN ONCOL, V29; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Motzer RJ, 2006, JAMA-J AM MED ASSOC, V295, P2516, DOI 10.1001/jama.295.21.2516; Lopez CM, 2012, INVEST NEW DRUG, V30, P2443, DOI 10.1007/s10637-012-9836-4; Nyhan MJ, 2011, CELL ONCOL, V34, P225, DOI 10.1007/s13402-011-0029-5; Patard JJ, 2009, BRIT J CANCER, V101, P1417, DOI 10.1038/sj.bjc.6605298; Patard JJ, 2008, INT J CANCER, V123, P395, DOI 10.1002/ijc.23496; Patel PH, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.5008; Paule B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010715; Penzvalto Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059503; Rini BI, 2008, J CLIN ONCOL, V26, P3743, DOI 10.1200/JCO.2007.15.5416; Rini BI, 2006, BJU INT, V98, P756, DOI 10.1111/j.1464-410X.2006.06376.x; Rini BI, 2011, JNCI-J NATL CANCER I, V103, P763, DOI 10.1093/jnci/djr128; Rini BI, 2010, CLIN CANCER RES, V16, P1348, DOI 10.1158/1078-0432.CCR-09-2273; Sakai I, 2013, BJU INT, V112, pE211, DOI 10.1111/j.1464-410X.2012.11655.x; Sandlund J, 2007, TUMOR BIOL, V28, P158, DOI 10.1159/000102980; Sauter G, 2003, NAT REV DRUG DISCOV, V2, P962, DOI 10.1038/nrd1254; Schraml P, 2003, AM J PATHOL, V163, P1013, DOI 10.1016/S0002-9440(10)63461-X; Schultz L, 2011, AM J SURG PATHOL, V35, P1549, DOI 10.1097/PAS.0b013e31822895e5; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; Sun M, 2011, EUR UROL, V60, P644, DOI 10.1016/j.eururo.2011.06.041; Tawfik OW, 2007, ARCH PATHOL LAB MED, V131, P261; Terakawa T, 2013, UROL ONCOL-SEMIN ORI, V31, P493, DOI 10.1016/j.urolonc.2011.02.012; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Turner KJ, 2002, CANCER RES, V62, P2957; van der Veldt AAM, 2011, CLIN CANCER RES, V17, P620, DOI 10.1158/1078-0432.CCR-10-1828; Wang P, 2012, MOL CARCINOGEN, V51, P586, DOI 10.1002/mc.20829; Yao M, 2002, JNCI-J NATL CANCER I, V94, P1569; Yilmazer D, 2007, INT UROL NEPHROL, V39, P691, DOI 10.1007/s11255-006-9123-4; Young AC, 2009, CLIN CANCER RES, V15, P7582, DOI 10.1158/1078-0432.CCR-09-2131; Yuasa T, 2012, BJU INT, V109, P1349, DOI 10.1111/j.1464-410X.2011.10534.x; Zurita AJ, 2012, ANN ONCOL, V23, P46, DOI 10.1093/annonc/mdr047	64	44	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76386	10.1371/journal.pone.0076386	http://dx.doi.org/10.1371/journal.pone.0076386			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086736	Green Published, Green Submitted, gold			2022-12-27	WOS:000325223900100
J	Kessler, SK; Minhas, P; Woods, AJ; Rosen, A; Gorman, C; Bikson, M				Kessler, Sudha Kilaru; Minhas, Preet; Woods, Adam J.; Rosen, Alyssa; Gorman, Casey; Bikson, Marom			Dosage Considerations for Transcranial Direct Current Stimulation in Children: A Computational Modeling Study	PLOS ONE			English	Article							MOTOR CORTEX; EXCITABILITY; THICKNESS; SKULL; FEM	Transcranial direct current stimulation (tDCS) is being widely investigated in adults as a therapeutic modality for brain disorders involving abnormal cortical excitability or disordered network activity. Interest is also growing in studying tDCS in children. Limited empirical studies in children suggest that tDCS is well tolerated and may have a similar safety profile as in adults. However, in electrotherapy as in pharmacotherapy, dose selection in children requires special attention, and simple extrapolation from adult studies may be inadequate. Critical aspects of dose adjustment include 1) differences in neurophysiology and disease, and 2) variation in brain electric fields for a specified dose due to gross anatomical differences between children and adults. In this study, we used high-resolution MRI derived finite element modeling simulations of two healthy children, ages 8 years and 12 years, and three healthy adults with varying head size to compare differences in electric field intensity and distribution. Multiple conventional and high-definition tDCS montages were tested. Our results suggest that on average, children will be exposed to higher peak electrical fields for a given applied current intensity than adults, but there is likely to be overlap between adults with smaller head size and children. In addition, exposure is montage specific. Variations in peak electrical fields were seen between the two pediatric models, despite comparable head size, suggesting that the relationship between neuroanatomic factors and bioavailable current dose is not trivial. In conclusion, caution is advised in using higher tDCS doses in children until 1) further modeling studies in a larger group shed light on the range of exposure possible by applied dose and age and 2) further studies correlate bioavailable dose estimates from modeling studies with empirically tested physiologic effects, such as modulation of motor evoked potentials after stimulation.	[Kessler, Sudha Kilaru; Woods, Adam J.; Rosen, Alyssa; Gorman, Casey] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Kessler, Sudha Kilaru; Woods, Adam J.; Rosen, Alyssa; Gorman, Casey] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Minhas, Preet] CUNY City Coll, New York, NY 10031 USA; [Woods, Adam J.; Bikson, Marom] Univ Penn, Ctr Cognit Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; City University of New York (CUNY) System; City College of New York (CUNY); University of Pennsylvania; Pennsylvania Medicine	Kessler, SK (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.	kesslers@email.chop.edu	Kessler, Sudha Kilaru/AAG-1637-2020	Woods, Adam/0000-0002-0786-0236; Kessler, Sudha/0000-0002-9325-9972	Clayton's Hope Foundation; National Institutes of Health, National Institute of Neurological Disorders and Stroke [K12NS049453]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K12NS049453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	Clayton's Hope Foundation; National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Clayton's Hope Foundation and National Institutes of Health, National Institute of Neurological Disorders and Stroke K12NS049453 (SK Kessler). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELOYE A, 1975, AM J PHYS ANTHROPOL, V43, P23, DOI 10.1002/ajpa.1330430105; Antal A, 2011, CEPHALALGIA, V31, P820, DOI 10.1177/0333102411399349; Auvichayapat N, 2013, BRAIN STIMUL, V6, P696, DOI 10.1016/j.brs.2013.01.009; Ball WS, 2012, CEREB CORTEX, V22, P1, DOI 10.1093/cercor/bhr018; Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Beauchamp MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024981; Bikson M, 2012, CLIN EEG NEUROSCI, V43, P176, DOI 10.1177/1550059412445138; Bikson M, 2012, BRAIN STIMUL, V5, P430, DOI 10.1016/j.brs.2011.06.001; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Cella M, 2010, BRIT J CLIN PHARMACO, V70, P597, DOI 10.1111/j.1365-2125.2009.03591.x; Datta A, 2008, J NEURAL ENG, V5, P163, DOI 10.1088/1741-2560/5/2/007; Datta Abhishek, 2012, Front Psychiatry, V3, P91, DOI 10.3389/fpsyt.2012.00091; Datta A, 2010, NEUROIMAGE, V52, P1268, DOI 10.1016/j.neuroimage.2010.04.252; Datta A, 2009, BRAIN STIMUL, V2, P201, DOI 10.1016/j.brs.2009.03.005; Dell'Osso B, 2012, EUR PSYCHIAT, V27, P513, DOI 10.1016/j.eurpsy.2011.02.008; Dmochowski JP, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046011; Faria P, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066017; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Kabakov AY, 2012, J NEUROPHYSIOL, V107, P1881, DOI 10.1152/jn.00715.2011; Kamida T, 2011, BEHAV BRAIN RES, V217, P99, DOI 10.1016/j.bbr.2010.08.050; Kessler SK, 2012, BRAIN STIMUL, V5, P155, DOI 10.1016/j.brs.2011.02.007; Lynnerup N, 2001, FORENSIC SCI INT, V117, P45, DOI 10.1016/S0379-0738(00)00447-3; Mattai A, 2011, BRAIN STIMUL, V4, P275, DOI 10.1016/j.brs.2011.01.001; NELLHAUS G, 1968, PEDIATRICS, V41, P106; Neuling Toralf, 2012, Front Psychiatry, V3, P83; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2011, RESTOR NEUROL NEUROS, V29, P463, DOI 10.3233/RNN-2011-0618; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Peterchev AV, 2012, BRAIN STIMUL, V5, P435, DOI 10.1016/j.brs.2011.10.001; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Poreisz C, 2007, BRAIN RES BULL, V72, P208, DOI 10.1016/j.brainresbull.2007.01.004; Sadleir RJ, 2010, NEUROIMAGE, V51, P1310, DOI 10.1016/j.neuroimage.2010.03.052; Tadini L, 2011, J ECT, V27, P134, DOI 10.1097/YCT.0b013e3181e631a8; Truong DQ, 2012, IEEE ENG MED BIO, P6587, DOI 10.1109/EMBC.2012.6347504; Varga ET, 2011, EPILEPSY RES, V97, P142, DOI 10.1016/j.eplepsyres.2011.07.016; Yook SW, 2011, ANN REHABIL MED-ARM, V35, P579, DOI 10.5535/arm.2011.35.4.579; YOUNG SJ, 2012, J CHILD NEUROL; Zaghi Soroush, 2009, J Pain Manag, V2, P339	39	124	126	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76112	10.1371/journal.pone.0076112	http://dx.doi.org/10.1371/journal.pone.0076112			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086698	Green Published, gold			2022-12-27	WOS:000325223900082
J	Ferreyra, C; Vargas, F; Rodriguez-Gomez, I; Perez-Abud, R; O'Valle, F; Osuna, A				Ferreyra, Carla; Vargas, Felix; Rodriguez-Gomez, Isabel; Perez-Abud, Rocio; O'Valle, Francisco; Osuna, Antonio			Preconditioning with Triiodothyronine Improves the Clinical Signs and Acute Tubular Necrosis Induced by Ischemia/Reperfusion in Rats	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; ISCHEMIA-REPERFUSION INJURY; B-ALPHA PHOSPHORYLATION; THYROID-HORMONE; POLY(ADP-RIBOSE) POLYMERASE; THYROXINE TREATMENT; OXIDATIVE STRESS; GENE-EXPRESSION; KIDNEY; LIVER	Background: Renal ischemia/reperfusion (I/R) injury is manifested by acute renal failure (ARF) and acute tubular necrosis (ATN). The aim of this study was to evaluate the effectiveness of preconditioning with 3, 3, 5 triiodothyronine (T-3) to prevent I/R renal injury. Methodology/Principal Findings: The rats were divided into four groups: sham-operated, placebo-treated (SO-P), sham-operated T-3-treated (SO-T-3), I/R-injured placebo-treated (IR-P), and I/R-injured T-3-treated (IR-T-3) groups. At 24 h before ischemia, the animals received a single dose of T-3 (100 mu g/kg). Renal function and plasma, urinary, and tissue variables were studied at 4, 24, and 48 h of reperfusion, including biochemical, oxidative stress, and inflammation variables, PARP-1 immunohistochemical expression, and ATN morphology. In comparison to the SO groups, the IR-P groups had higher plasma urea and creatinine levels and greater proteinuria (at all reperfusion times) and also showed: increased oxidative stress-related plasma, urinary, and tissue variables; higher plasma levels of IL6 (proinflammatory cytokine); increased glomerular and tubular nuclear PARP-1 expression; and a greater degree of ATN. The IR-T-3 group showed a marked reduction in all of these variables, especially at 48 h of reperfusion. No significant differences were observed between SO-P and SO-T-3 groups. Conclusions: This study demonstrates that preconditioning rats with a single dose of T-3 improves the clinical signs and ATN of renal I/R injury. These beneficial effects are accompanied by reductions in oxidative stress, inflammation, and renal PARP-1 expression, indicating that this sequence of factors plays an important role in the ATN induced by I/R injury.	[Ferreyra, Carla; Perez-Abud, Rocio; Osuna, Antonio] Hosp Virgen de las Nieves, Serv Nefrol, Unidad Expt, Granada, Spain; [Vargas, Felix; Rodriguez-Gomez, Isabel] Fac Med, Dept Fisiol, Granada, Spain; [O'Valle, Francisco] Fac Med, Dept Anat Patol, Granada, Spain; [O'Valle, Francisco] Fac Med, Inst Biomed Regenerat, Granada, Spain	Hospital Universitario Virgen de las Nieves	Vargas, F (corresponding author), Fac Med, Dept Fisiol, Granada, Spain.	fvargas@ugr.es	Osuna, Antonio/H-1896-2015; Rodriguez-Gomez, Isabel/K-8829-2014; OValle, Francisco/AAA-9151-2019	Rodriguez-Gomez, Isabel/0000-0001-6490-6643; 	Ministry of Education and Science [SAF2009-12294]; Carlos III Health Institute of the Spanish Ministry of Health and Consumer Affairs (Red de Investigacion Renal) [REDinREN 012/0021/0025]	Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Carlos III Health Institute of the Spanish Ministry of Health and Consumer Affairs (Red de Investigacion Renal)	This research was supported by a grant (SAF2009-12294) from the Ministry of Education and Science and from the Carlos III Health Institute of the Spanish Ministry of Health and Consumer Affairs (Red de Investigacion Renal, REDinREN 012/0021/0025). "FEDER una manera de hacer Europa." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayrak O, 2008, WORLD J UROL, V26, P285, DOI 10.1007/s00345-008-0253-4; CRONIN RE, 1985, AM J PHYSIOL, V248, pF332, DOI 10.1152/ajprenal.1985.248.3.F332; CRONIN RE, 1986, AM J PHYSIOL, V251, pF408, DOI 10.1152/ajprenal.1986.251.3.F408; Delbridge MS, 2007, TRANSPL P, V39, P2983, DOI 10.1016/j.transproceed.2007.04.028; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Fernandez V, 2005, J ENDOCRINOL, V186, P539, DOI 10.1677/joe.1.06261; Fernandez V, 2005, FREE RADICAL RES, V39, P411, DOI 10.1080/10715760400029637; Fernandez V, 2007, HEPATOLOGY, V45, P170, DOI 10.1002/hep.21476; HUMES HD, 1992, AM J PHYSIOL, V262, pF540, DOI 10.1152/ajprenal.1992.262.4.F540; Jang HR, 2009, J MOL MED, V87, P859, DOI 10.1007/s00109-009-0491-y; Legrand M, 2008, MOL MED, V14, P502, DOI 10.2119/2008-00006.Legrand; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; LO CS, 1976, J BIOL CHEM, V251, P7834; Martin DR, 2000, AM J PHYSIOL-REG I, V279, pR1834, DOI 10.1152/ajpregu.2000.279.5.R1834; Maxwell SRJ, 1997, INT J CARDIOL, V58, P95, DOI 10.1016/S0167-5273(96)02854-9; MICHAEL UF, 1991, J AM SOC NEPHROL, V1, P1236; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nath KA, 2000, AM J MED, V109, P665, DOI 10.1016/S0002-9343(00)00612-4; Noiri E, 2001, AM J PHYSIOL-RENAL, V281, pF948, DOI 10.1152/ajprenal.0071.2001; O'Valle F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007138; Parra C, 2010, TRANSPL P, V42, P245, DOI 10.1016/j.transproceed.2009.11.018; Poli G, 2004, CURR MED CHEM, V11, P1163, DOI 10.2174/0929867043365323; Radhakrishnan J, 2006, KIDNEY INT, V69, P17, DOI 10.1038/sj.ki.5000094; SCHRAUFSTATTER IU, 1986, P NATL ACAD SCI USA, V83, P4908, DOI 10.1073/pnas.83.13.4908; Schulte-Wissermann H, 1977, VIRCHOWS ARCH B, V23, P163; Senturk H, 2008, WORLD J UROL, V26, P401, DOI 10.1007/s00345-008-0256-1; STRAUB E, 1971, Z GES EXP MED, V155, P32, DOI 10.1007/BF02045981; STRAUB E, 1971, Z GES EXP MED, V154, P177, DOI 10.1007/BF02048389; SUTTER PM, 1988, PEDIATR NEPHROL, V2, P1, DOI 10.1007/BF00870370; Tapia G, 2003, FREE RADICAL BIO MED, V35, P257, DOI 10.1016/S0891-5849(03)00209-0; Thiemermann C, 1997, P NATL ACAD SCI USA, V94, P679, DOI 10.1073/pnas.94.2.679; Thurman JM, 2007, CLIN IMMUNOL, V123, P7, DOI 10.1016/j.clim.2006.09.008; Yang B, 2010, J SURG RES, V164, pE315, DOI 10.1016/j.jss.2010.07.044; Yelamos J, 2002, INMUNOLOGIA, V21, P219; Yu SY, 2005, J SURG RES, V128, P28, DOI 10.1016/j.jss.2005.04.025; ZAGER RA, 1984, KIDNEY INT, V26, P689, DOI 10.1038/ki.1984.204; Zheng JF, 2005, AM J PHYSIOL-RENAL, V288, pF387, DOI 10.1152/ajprenal.00436.2003	39	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e74960	10.1371/journal.pone.0074960	http://dx.doi.org/10.1371/journal.pone.0074960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086411	gold, Green Published, Green Submitted			2022-12-27	WOS:000325220000012
J	Hanson, E; Nilsson, S; Jood, K; Norrving, B; Engstrom, G; Blomstrand, C; Lindgren, A; Melander, O; Jern, C				Hanson, Ellen; Nilsson, Staffan; Jood, Katarina; Norrving, Bo; Engstrom, Gunnar; Blomstrand, Christian; Lindgren, Arne; Melander, Olle; Jern, Christina			Genetic Variants of Coagulation Factor XI Show Association with Ischemic Stroke Up to 70 Years of Age	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; MYOCARDIAL-INFARCTION; VENOUS THROMBOSIS; CEREBROVASCULAR EVENTS; REDUCED INCIDENCE; RISK-FACTORS; YOUNG-WOMEN; DEFICIENCY; CONTRIBUTES; PROTECTION	Background and Purpose: Coagulation factor XI (FXI) has an important role in the propagation and stabilization of a thrombus upon vessel injury. High FXI levels have been implicated in thrombotic diseases including ischemic stroke. The aim of our study was to investigate whether FXI gene (F11) variants are associated with ischemic stroke. Methods: The discovery sample, the Sahlgrenska Academy Study on Ischemic Stroke (SAHLSIS), included 844 patients with ischemic stroke and 668 controls, all aged 18-70 years. Replication was performed in the Lund Stroke Register (LSR) and Malmo Diet and Cancer study (MDC), together including 1213 patients and 788 controls up to 70 years of age, and in total 3145 patients and 1793 controls (18-102 years). Seven F11 single-nucleotide polymorphisms (SNPs) were selected using a tagging approach. Results: The SNPs rs3733403, rs925451, and rs1593 showed independent associations with overall ischemic stroke in SAHLSIS, ORs of 0.74 (95% CI 0.59-0.94), 1.24 (95% CI 1.06-1.46), and 0.70 (95% CI 0.55-0.90), respectively. The association for rs925451 was replicated in the LSR and MDC sample in a pre-specified analysis of subjects aged 70 years or younger, OR of 1.16 (95% CI 1.00-1.34), whereas no SNP was replicated when all ages were included. In line with this, one F11 haplotype was associated with overall ischemic stroke in the discovery sample and in the replication sample <= 70 years. Conclusions: We found significant associations between F11 variation and overall ischemic stroke up to 70 years of age. These findings motivate further studies on the role of F11 in ischemic stroke, especially in younger individuals.	[Hanson, Ellen; Jood, Katarina; Blomstrand, Christian; Jern, Christina] Univ Gothenburg, Sahlgrenska Acad, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol, Gothenburg, Sweden; [Nilsson, Staffan] Chalmers, Dept Math Stat, S-41296 Gothenburg, Sweden; [Norrving, Bo; Lindgren, Arne] Lund Univ, Dept Clin Sci Lund, Lund, Sweden; [Norrving, Bo; Lindgren, Arne] Skane Univ Hosp, Dept Neurol, Lund, Sweden; [Engstrom, Gunnar; Melander, Olle] Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden	University of Gothenburg; Chalmers University of Technology; Lund University; Lund University; Skane University Hospital; Lund University	Hanson, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol, Gothenburg, Sweden.	ellen.hanson@neuro.gu.se		Melander, Olle/0000-0002-2581-484X; Engstrom, Gunnar/0000-0002-8618-9152; Nilsson, Staffan/0000-0003-4748-0446; Norrving, Bo/0000-0002-8024-5096	Swedish Research Council [K2011-65X-14605-09-6, K2010-61X-20378-04-3, 2011-3891]; Swedish state [ALFGBG-148861]; Swedish Heart and Lung Foundation [20100256, 20100244, 20100228]; Lund University; Region Skane; Freemasons Lodge of Instruction EOS in Lund; King Gustav V and Queen Victoria's Foundation; Promobilia; Swedish Stroke Association; Goteborg Foundation for Neurological Research; Rune and Ulla Amlov; John and Brit Wennerstrom; Per-Olov Ahl; Wilhelm and Martina Lundgren; Emelle Foundations	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish state; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Lund University; Region Skane; Freemasons Lodge of Instruction EOS in Lund; King Gustav V and Queen Victoria's Foundation; Promobilia; Swedish Stroke Association; Goteborg Foundation for Neurological Research; Rune and Ulla Amlov; John and Brit Wennerstrom; Per-Olov Ahl; Wilhelm and Martina Lundgren; Emelle Foundations	This study was supported by the Swedish Research Council (K2011-65X-14605-09-6, K2010-61X-20378-04-3, and 2011-3891), the Swedish state (ALFGBG-148861), the Swedish Heart and Lung Foundation (20100256, 20100244 and 20100228), Lund University, Region Skane, the Freemasons Lodge of Instruction EOS in Lund, King Gustav V and Queen Victoria's Foundation, Promobilia, the Swedish Stroke Association, the Goteborg Foundation for Neurological Research, the Rune and Ulla Amlov, John and Brit Wennerstrom, Per-Olov Ahl, the Wilhelm and Martina Lundgren, and the Emelle Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Austin H, 2011, J THROMB HAEMOST, V9, P489, DOI 10.1111/j.1538-7836.2011.04185.x; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Cushman M, 2009, BLOOD, V114, P2878, DOI 10.1182/blood-2009-05-219915; de Moerloose P, 2007, SEMIN HEMATOL, V44, P106, DOI 10.1053/j.seminhematol.2007.01.008; Delluc A, 2010, THROMB HAEMOSTASIS, V103, P1161, DOI 10.1160/TH09-07-0430; Doggen CJM, 2006, BLOOD, V108, P4045, DOI 10.1182/blood-2005-12-023697; Flossmann E, 2004, STROKE, V35, P212, DOI 10.1161/01.STR.0000107187.84390.AA; Hallstrom B, 2007, ACTA NEUROL SCAND, V115, P49, DOI 10.1111/j.1600-0404.2006.00738.x; Jood K, 2005, STROKE, V36, P1383, DOI 10.1161/01.STR.0000169944.46025.09; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Kravtsov DV, 2009, BLOOD, V114, P452, DOI 10.1182/blood-2009-02-203604; Li CR, 2005, STROKE, V36, P234, DOI 10.1161/01.STR.0000152328.66493.0a; Li Y, 2009, J THROMB HAEMOST, V7, P1802, DOI 10.1111/j.1538-7836.2009.03544.x; Meijers JCM, 2000, NEW ENGL J MED, V342, P696, DOI 10.1056/NEJM200003093421004; Olsson S, 2011, EUR J NEUROL, V18, P1272, DOI 10.1111/j.1468-1331.2011.03377.x; Olsson S, 2012, STROKE, V43, P2278, DOI 10.1161/STROKEAHA.111.647446; Sabater-Lleal M, 2012, ARTERIOSCL THROM VAS, V32, P2008, DOI 10.1161/ATVBAHA.112.248492; Salomon O, 2003, J THROMB HAEMOST, V1, P658, DOI 10.1046/j.1538-7836.2003.00195.x; Salomon O, 2008, BLOOD, V111, P4113, DOI 10.1182/blood-2007-10-120139; Salomon O, 2011, THROMB HAEMOSTASIS, V105, P269, DOI 10.1160/TH10-05-0307; Schumacher WA, 2010, ARTERIOSCL THROM VAS, V30, P388, DOI 10.1161/ATVBAHA.109.197178; Siegerink B, 2010, CIRCULATION, V122, P1854, DOI 10.1161/CIRCULATIONAHA.110.943738; Smith NL, 2007, JAMA-J AM MED ASSOC, V297, P489, DOI 10.1001/jama.297.5.489; Souto JC, 2000, AM J HUM GENET, V67, P1452, DOI 10.1086/316903; Suri MFK, 2010, CEREBROVASC DIS, V29, P497, DOI 10.1159/000297966; Tanis B, 2006, EUR J HAEMATOL, V77, P67, DOI 10.1111/j.1600-0609.2006.00656.x; Undas A, 2011, THROMB RES, V128, pE62, DOI 10.1016/j.thromres.2011.06.010; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Woodruff RS, 2011, J THROMB THROMBOLYS, V32, P9, DOI 10.1007/s11239-011-0578-5; Yamashita A, 2006, J THROMB HAEMOST, V4, P1496, DOI 10.1111/j.1538-7836.2006.01973.x; Yang DT, 2006, AM J CLIN PATHOL, V126, P411, DOI 10.1309/QC259F09UNMKVP0R	32	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75286	10.1371/journal.pone.0075286	http://dx.doi.org/10.1371/journal.pone.0075286			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086496	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700069
J	Botanov, Y; Ilardi, SS				Botanov, Yevgeny; Ilardi, Stephen S.			The Acute Side Effects of Bright Light Therapy: A Placebo-Controlled Investigation	PLOS ONE			English	Article							SEASONAL AFFECTIVE-DISORDER; CONSENSUS REPORT; NONSEASONAL DEPRESSION; CIRCADIAN-RHYTHMS; CONTROLLED-TRIAL; MORNING LIGHT; DOUBLE-BLIND; SLEEP PHASE; PHOTOTHERAPY; MELATONIN	Despite the emergence of numerous clinical and non-clinical applications of bright light therapy (LT) in recent decades, the prevalence and severity of LT side effects have not yet been fully explicated. A few adverse LT effects -headache, eye strain, irritability, and nausea-have been consistently reported among depressed individuals and other psychiatric cohorts, but there exists little published evidence regarding LT side effects in non-clinical populations, who often undergo LT treatment of considerably briefer duration. Accordingly, in the present study we examined, in a randomized sample of healthy young adults, the acute side effects of exposure to a single 30-minute session of bright white light (10,000 lux) versus dim red light (< 500 lux). Across a broad range of potential side effects, repeated-measures analyses of variance revealed no significant group-by-time (Pre, Post) interactions. In other words, bright light exposure was not associated with a significantly higher incidence of any reported side effect than was the placebo control condition. Nevertheless, small but statistically significant increases in both eye strain and blurred vision were observed among both the LT and control groups. Overall, these results suggest that the relatively common occurrence of adverse side effects observed in the extant LT literature may not fully extend to non-clinical populations, especially for healthy young adults undergoing LT for a brief duration.	[Botanov, Yevgeny; Ilardi, Stephen S.] Univ Kansas, Dept Psychol, Lawrence, KS 66045 USA	University of Kansas	Botanov, Y (corresponding author), Univ Kansas, Dept Psychol, Lawrence, KS 66045 USA.	ybotanov@ku.edu	Botanov, Yevgeny/AAH-9507-2020					Ancoli-Israel S, 2002, J AM GERIATR SOC, V50, P282, DOI 10.1046/j.1532-5415.2002.50060.x; Boivin DB, 2002, J BIOL RHYTHM, V17, P266, DOI 10.1177/07430402017003010; Boulos Z, 1995, J BIOL RHYTHM, V10, P167, DOI 10.1177/074873049501000209; Braun DL, 1999, COMPR PSYCHIAT, V40, P442, DOI 10.1016/S0010-440X(99)90088-3; Brinkhuijsen M, 2003, J AFFECT DISORDERS, V74, P307, DOI 10.1016/S0165-0327(03)00003-X; Burgess HJ, 2002, SLEEP MED REV, V6, P407, DOI 10.1053/smrv.2001.0215; Cohen J.E., 1988, STAT POWER ANAL BEHA; Daansen PJ, 2010, NEUROENDOCRINOL LETT, V31, P290; DELTITO JA, 1991, J AFFECT DISORDERS, V23, P231, DOI 10.1016/0165-0327(91)90105-2; Eastman CI, 1995, J BIOL RHYTHM, V10, P157, DOI 10.1177/074873049501000208; Erickson K, 2005, AM J PSYCHIAT, V162, P2171, DOI 10.1176/appi.ajp.162.11.2171; Goel N, 2005, PSYCHOL MED, V35, P945, DOI 10.1017/S0033291705005027; Golden RN, 2005, AM J PSYCHIAT, V162, P656, DOI 10.1176/appi.ajp.162.4.656; KELLOGG JH, 2003, LIGHT THERAPEUTICS P; Kogan AO, 1998, AM J PSYCHIAT, V155, P293; Krasnik C, 2005, AM J OBSTET GYNECOL, V193, P658, DOI 10.1016/j.ajog.2005.01.055; Kripke DF, 1998, J AFFECT DISORDERS, V49, P109, DOI 10.1016/S0165-0327(98)00005-6; LABBATE LA, 1994, J CLIN PSYCHIAT, V55, P189; LACK L, 1993, SLEEP, V16, P436, DOI 10.1093/sleep/16.5.436; Lack L, 2005, SLEEP, V28, P616, DOI 10.1093/sleep/28.5.616; Lam RW, 2006, AM J PSYCHIAT, V163, P805, DOI 10.1176/appi.ajp.163.5.805; Lam RW, 1999, PSYCHIAT RES, V86, P185, DOI 10.1016/S0165-1781(99)00043-8; LAM RW, 1994, AM J PSYCHIAT, V151, P744; Lambert GW, 2002, LANCET, V360, P1840, DOI 10.1016/S0140-6736(02)11737-5; LEVITT AJ, 1993, AM J PSYCHIAT, V150, P650; LEWY AJ, 1980, SCIENCE, V210, P1267, DOI 10.1126/science.7434030; Neumeister A, 2001, PSYCHOL MED, V31, P1467, DOI 10.1017/S003329170105434z; Nowak L, 2011, WESTERN J NURS RES, V33, P933, DOI 10.1177/0193945910386248; Oren DA, 2002, AM J PSYCHIAT, V159, P666, DOI 10.1176/appi.ajp.159.4.666; OREN DA, 1991, COMPR PSYCHIAT, V32, P147, DOI 10.1016/0010-440X(91)90007-Y; OREN DA, 1991, J NEURAL TRANSM-GEN, V83, P85, DOI 10.1007/BF01244455; Rastad C, 2008, J AFFECT DISORDERS, V108, P291, DOI 10.1016/j.jad.2007.10.009; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; ROSENTHAL NE, 1990, SLEEP, V13, P354; Rybak YE, 2007, COMPR PSYCHIAT, V48, P562, DOI 10.1016/j.comppsych.2007.05.008; Sit D, 2007, BIPOLAR DISORD, V9, P918, DOI 10.1111/j.1399-5618.2007.00451.x; Strigo IA, 2008, ARCH GEN PSYCHIAT, V65, P1275, DOI 10.1001/archpsyc.65.11.1275; Strigo IA, 2008, PSYCHOSOM MED, V70, P338, DOI 10.1097/PSY.0b013e3181656a48; Terman M, 1995, J BIOL RHYTHM, V10, P135, DOI 10.1177/074873049501000206; Terman M, 2005, CNS SPECTRUMS, V10, P647, DOI 10.1017/S1092852900019611; Terman M, 1999, J CLIN PSYCHIAT, V60, P799; Thomas L, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-29; Vanderkooy JD, 2002, CAN J PSYCHIAT, V47, P174, DOI 10.1177/070674370204700208; VOLZ HP, 1991, PHARMACOPSYCHIATRY, V24, P141, DOI 10.1055/s-2007-1014458; WEHR TA, 1989, AM J PSYCHIAT, V146, P829; WETTERBERG L, 1978, J NEURAL TRANSM-SUPP, V13, P389; Willis GL, 2007, CHRONOBIOL INT, V24, P521, DOI 10.1080/07420520701420717; Wirz-Justice A, 2009, CHRONOTHERAPEUTICS A; Wirz-Justice A, 2011, J CLIN PSYCHIAT, V72, P986, DOI 10.4088/JCP.10m06188blu; Zimmerman M, 2010, J CLIN PSYCHIAT, V71, P484, DOI 10.4088/JCP.08m04978blu	50	15	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75893	10.1371/journal.pone.0075893	http://dx.doi.org/10.1371/journal.pone.0075893			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	226HG	24086658	Green Published, gold, Green Submitted			2022-12-27	WOS:000325025200068
J	Grube, MM; Koennecke, HC; Walter, G; Meisel, A; Sobesky, J; Nolte, CH; Wellwood, I; Heuschmann, PU				Grube, Maike Miriam; Koennecke, Hans-Christian; Walter, Georg; Meisel, Andreas; Sobesky, Jan; Nolte, Christian Hans; Wellwood, Ian; Heuschmann, Peter Ulrich		Berlin Stroke Register BSR	Influence of Acute Complications on Outcome 3 Months after Ischemic Stroke	PLOS ONE			English	Article							HOSPITAL MEDICAL COMPLICATIONS; QUALITY-OF-CARE; TERM MORTALITY; BARTHEL-INDEX; RANKIN SCALE; RISK-FACTORS; TRIAL; RELIABILITY; DEPENDENCY; PREDICTORS	Background: Early medical complications are potentially modifiable factors influencing in-hospital outcome. We investigated the influence of acute complications on mortality and poor outcome 3 months after ischemic stroke. Methods: Data were obtained from patients admitted to one of 13 stroke units of the Berlin Stroke Registry (BSR) who participated in a 3-months-follow up between June 2010 and September 2012. We examined the influence of the cumulative number of early in-hospital complications on mortality and poor outcome (death, disability or institutionalization) 3 months after stroke using multivariable logistic regression analyses and calculated attributable fractions to determine the impact of early complications on mortality and poor outcome. Results: A total of 2349 ischemic stroke patients alive at discharge from acute care were included in the analysis. Older age, stroke severity, pre-stroke dependency and early complications were independent predictors of mortality 3 months after stroke. Poor outcome was independently associated with older age, stroke severity, pre-stroke dependency, previous stroke and early complications. More than 60% of deaths and poor outcomes were attributed to age, pre-stroke dependency and stroke severity and in-hospital complications contributed to 12.3% of deaths and 9.1% of poor outcomes 3 months after stroke. Conclusion: The majority of deaths and poor outcomes after stroke were attributed to non-modifiable factors. However, early in-hospital complications significantly affect outcome in patients who survived the acute phase after stroke, underlining the need to improve prevention and treatment of complications in hospital.	[Grube, Maike Miriam; Meisel, Andreas; Sobesky, Jan; Nolte, Christian Hans; Wellwood, Ian] Charite, Neurol Klin, Ctr Stroke Res Berlin CSB, D-13353 Berlin, Germany; [Grube, Maike Miriam] Kings Coll London, Div Hlth & Social Care Res, London, England; [Koennecke, Hans-Christian] Vivantes Klinikum Friedrichshain, Berlin, Germany; [Walter, Georg] Vivantes Klinikum Spandau, Berlin, Germany; [Heuschmann, Peter Ulrich] Univ Wurzburg, Univ Hosp Wurzburg, Inst Clin Epidemiol & Biometry, Ctr Clin Studies,Comprehens Heart Failure Ctr, D-97070 Wurzburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; King's College London; University of Wurzburg	Grube, MM (corresponding author), Charite, Neurol Klin, Ctr Stroke Res Berlin CSB, D-13353 Berlin, Germany.	maike.grube@charite.de	Nolte, Christian/AAA-2651-2022	Nolte, Christian/0000-0001-5577-1775; Sobesky, Jan/0000-0001-5459-3655; Meisel, Andreas/0000-0001-7233-5342	Federal Ministry of Education and Research (BMBF) through the Center for Stroke Research Berlin [01 EO 0801]	Federal Ministry of Education and Research (BMBF) through the Center for Stroke Research Berlin	The study was supported by the Federal Ministry of Education and Research (BMBF, http://www.bmbf.de/) through the Center for Stroke Research Berlin (01 EO 0801). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KK, 2011, STROKE, V42, P2806, DOI 10.1161/STROKEAHA.111.619049; Appelros P, 2003, STROKE, V34, P122, DOI 10.1161/01.STR.0000047852.05842.3C; Balami JS, 2011, LANCET NEUROL, V10, P357, DOI 10.1016/S1474-4422(10)70313-6; Berger K, 1999, FORTSCHR NEUROL PSYC, V67, P81, DOI 10.1055/s-2007-993985; Bravata DM, 2003, STROKE, V34, P699, DOI 10.1161/01.STR.0000057578.26828.78; Diserens K, 2012, CLIN REHABIL, V26, P451, DOI 10.1177/0269215511425541; Grau AJ, 2001, STROKE, V32, P2559, DOI 10.1161/hs1101.098524; Grube MM, 2012, STROKE, V43, P3325, DOI 10.1161/STROKEAHA.112.669580; Hankey GJ, 2003, CEREBROVASC DIS, V16, P14, DOI 10.1159/000069936; Heuschmann PU, 2011, NEUROLOGY, V76, P159, DOI 10.1212/WNL.0b013e318206ca1e; Heuschmann PU, 2005, FORTSCHR NEUROL PSYC, V73, P74, DOI 10.1055/s-2004-830172; Hong KS, 2008, EUR J NEUROL, V15, P1324, DOI 10.1111/j.1468-1331.2008.02310.x; Ingeman A, 2008, MED CARE, V46, P63, DOI 10.1097/MLR.0b013e3181484b91; Ingeman A, 2011, STROKE, V42, P3214, DOI 10.1161/STROKEAHA.110.610881; Johnston KC, 1998, STROKE, V29, P447, DOI 10.1161/01.STR.29.2.447; Kelly AG, 2012, NEUROLOGY, V79, P941, DOI 10.1212/WNL.0b013e318266fc40; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Koennecke H-C, 2008, BERLINER SCHLAGANFAL, V9, P24; Kolominsky-Rabas PL, 2002, FORTSCHR NEUROL PSYC, V70, P657, DOI 10.1055/s-2002-35857; Koton S, 2010, NEUROEPIDEMIOLOGY, V34, P90, DOI 10.1159/000264826; Kumar S, 2010, LANCET NEUROL, V9, P105, DOI 10.1016/S1474-4422(09)70266-2; Middleton S, 2011, LANCET, V378, P1699, DOI 10.1016/S0140-6736(11)61485-2; Minnerup J, 2012, STROKE, V43, P295, DOI 10.1161/STROKEAHA.111.642363; Palnum KD, 2009, STROKE, V40, P1134, DOI 10.1161/STROKEAHA.108.543819; Ruckinger S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-7; Saposnik G, 2008, STROKE, V39, P2318, DOI 10.1161/STROKEAHA.107.510362; Schneider K, 2009, NERVENHEILKUNDE, V28, P114, DOI 10.1055/s-0038-1628584; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; Wang PL, 2013, CHINESE MED J-PEKING, V126, P1236, DOI 10.3760/cma.j.issn.0366-6999.20122573; Wang PL, 2012, CHINESE MED J-PEKING, V125, P2449, DOI 10.3760/cma.j.issn.0366-6999.2012.14.010; Ward A, 2005, EUR J NEUROL, V12, P264, DOI 10.1111/j.1468-1331.2004.00949.x	31	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75719	10.1371/journal.pone.0075719	http://dx.doi.org/10.1371/journal.pone.0075719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086621	Green Published, gold, Green Submitted			2022-12-27	WOS:000325025200060
J	Tellez, J; Van Vliet, K; Tseng, YS; Finn, JD; Tschernia, N; Almeida-Porada, G; Arruda, VR; Agbandje-McKenna, M; Porada, CD				Tellez, Joseph; Van Vliet, Kim; Tseng, Yu-Shan; Finn, Jonathan D.; Tschernia, Nick; Almeida-Porada, Graca; Arruda, Valder R.; Agbandje-McKenna, Mavis; Porada, Christopher D.			Characterization of Naturally-Occurring Humoral Immunity to AAV in Sheep	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS TYPE-2; ADENO-ASSOCIATED VIRUS; GENE-THERAPY; NEUTRALIZING ANTIBODIES; PREEXISTING IMMUNITY; VIRAL VECTORS; FACTOR-IX; LIVER; IDENTIFICATION; DELIVERY	AAV vectors have shown great promise for clinical gene therapy (GT), but pre-existing human immunity against the AAV capsid often limits transduction. Thus, testing promising AAV-based GT approaches in an animal model with similar pre-existing immunity could better predict clinical outcome. Sheep have long been used for basic biological and preclinical studies. Moreover, we have re-established a line of sheep with severe hemophilia A (HA). Given the impetus to use AAV-based GT to treat hemophilia, we characterized the pre-existing ovine humoral immunity to AAV. ELISA revealed naturally-occurring antibodies to AAV1, AAV2, AAV5, AAV6, AAV8, and AAV9. For AAV2, AAV8, and AAV9 these inhibit transduction in a luciferase-based neutralization assay. Epitope mapping identified peptides that were common to the capsids of all AAV serotypes tested (AAV2, AAV5, AAV8 and AAV9), with each animal harboring antibodies to unique and common capsid epitopes. Mapping using X-ray crystallographic AAV capsid structures demonstrated that these antibodies recognized both surface epitopes and epitopes located within regions of the capsid that are internal or buried in the capsid structure. These results suggest that sheep harbor endogenous AAV, which induces immunity to both intact capsid and to capsid epitopes presented following proteolysis during the course of infection. In conclusion, their clinically relevant physiology and the presence of naturally-occurring antibodies to multiple AAV serotypes collectively make sheep a unique model in which to study GT for HA, and other diseases, and develop strategies to circumvent the clinically important barrier of pre-existing AAV immunity.	[Tellez, Joseph; Tschernia, Nick] Univ Nevada, Dept Anim Biotechnol, Reno, NV 89557 USA; [Van Vliet, Kim; Tseng, Yu-Shan; Agbandje-McKenna, Mavis] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Finn, Jonathan D.; Arruda, Valder R.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Philadelphia, PA 19104 USA; [Almeida-Porada, Graca; Porada, Christopher D.] Wake Forest Inst Regenerat Med, Winston Salem, NC USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; State University System of Florida; University of Florida; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Wake Forest University	Porada, CD (corresponding author), Wake Forest Inst Regenerat Med, Winston Salem, NC USA.	cporada@wakehealth.edu	Van Vliet, Kim/AAK-7368-2021	Almeida-Porada, Maria da Graca/0000-0002-6715-865X; Van Vliet, Kim/0000-0001-7802-9514; Tschernia, Nicholas/0000-0002-2389-9974	Wake Forest University Health Sciences Translational Science Institute [20667]; NIH [R01 GM082946]; University of Florida College of Medicine Research Funds;  [NIH-HD43038];  [NIH- PO1HL64190]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043038] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL064190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082946] Funding Source: NIH RePORTER	Wake Forest University Health Sciences Translational Science Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida College of Medicine Research Funds; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH-HD43038 and Wake Forest University Health Sciences Translational Science Institute 20667 Clinical Pilot Award to CDP; NIH- PO1HL64190 to VRA; NIH R01 GM082946 and University of Florida College of Medicine Research Funds to MA-M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbandje-McKenna M, 2011, METHODS MOL BIOL, V807, P47, DOI 10.1007/978-1-61779-370-7_3; Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Bartel M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00204; Bell CL, 2012, J VIROL, V86, P7326, DOI 10.1128/JVI.00448-12; Bello AJ, 2012, MOL THER, V20, pS46; Binny Christopher J, 2012, Methods Mol Biol, V891, P109, DOI 10.1007/978-1-61779-873-3_6; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Bueler H, 1999, BIOL CHEM, V380, P613, DOI 10.1515/BC.1999.078; Carter PJ, 2000, INT J MOL MED, V6, P17; CLARKE JK, 1979, ARCH VIROL, V60, P171, DOI 10.1007/BF01348034; David AL, 2011, HUM GENE THER, V22, P419, DOI 10.1089/hum.2010.007; DiMattia MA, 2012, J VIROL, V86, P6947, DOI 10.1128/JVI.07232-11; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Excoffon KJDA, 2009, P NATL ACAD SCI USA, V106, P3865, DOI 10.1073/pnas.0813365106; Goncalves MAFV, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-43; Govindasamy L, 2006, J VIROL, V80, P11556, DOI 10.1128/JVI.01536-06; Grieger JC, 2005, ADV BIOCHEM ENG BIOT, V99, P119, DOI 10.1007/10_005; Gurda BL, 2012, J VIROL, V86, P7739, DOI 10.1128/JVI.00218-12; Herzog RW, 2007, MOL THER, V15, P649, DOI 10.1038/sj.mt.6300123; Hurlbut GD, 2010, MOL THER, V18, P1983, DOI 10.1038/mt.2010.175; Ito T, 2009, ANN CLIN BIOCHEM, V46, P508, DOI 10.1258/acb.2009.009077; Jimenez-Clavero MA, 2000, VIROLOGY, V270, P76, DOI 10.1006/viro.2000.0256; Karman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034684; Kern A, 2003, J VIROL, V77, P11072, DOI 10.1128/JVI.77.20.11072-11081.2003; Li C, 2012, GENE THER, V19, P288, DOI 10.1038/gt.2011.90; Li H, 2009, MOL THER, V17, P1215, DOI 10.1038/mt.2009.79; Lochrie MA, 2006, J VIROL, V80, P821, DOI 10.1128/JVI.80.2.821-834.2006; Lochrie MA, 2006, VIROLOGY, V353, P68, DOI 10.1016/j.virol.2006.05.023; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mariani JA, 2011, EUR J HEART FAIL, V13, P247, DOI 10.1093/eurjhf/hfq234; Mingozzi F, 2012, BLOOD, V120, p2050a; Mingozzi F, 2007, CURR GENE THER, V7, P316, DOI 10.2174/156652307782151425; Mitchell AM, 2010, CURR GENE THER, V10, P319; Moskalenko M, 2000, J VIROL, V74, P1761, DOI 10.1128/JVI.74.4.1761-1766.2000; Nam HJ, 2007, J VIROL, V81, P12260, DOI 10.1128/JVI.01304-07; Nathwani AC, 2002, BLOOD, V100, P1662, DOI 10.1182/blood-2002-02-0589; Nathwani A, 2010, BLOOD, V116, P114, DOI 10.1182/blood.V116.21.248.248; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Opie SR, 2003, J VIROL, V77, P6995, DOI 10.1128/JVI.77.12.6995-7006.2003; Ortolano S, 2012, RECENT PATENTS ENDOC, V6, P47, DOI 10.2174/187221412799015245; Popa-Wagner R, 2012, J VIROL, V86, P9163, DOI 10.1128/JVI.00282-12; Porada CD, 2010, J THROMB HAEMOST, V8, P276, DOI 10.1111/j.1538-7836.2009.03697.x; Rapti K, 2012, MOL THER, V20, P73, DOI 10.1038/mt.2011.177; Scallan CD, 2006, BLOOD, V107, P1810, DOI 10.1182/blood-2005-08-3229; Sharma A, 2010, EXP EYE RES, V91, P440, DOI 10.1016/j.exer.2010.06.020; Shin JH, 2012, HUM GENE THER, V23, P287, DOI 10.1089/hum.2011.125; Vandenberghe LH, 2007, CURR GENE THER, V7, P325, DOI 10.2174/156652307782151416; Veron P, 2012, J IMMUNOL, V188, P6418, DOI 10.4049/jimmunol.1200620; Wang JH, 2011, J MOL CELL CARDIOL, V50, P793, DOI 10.1016/j.yjmcc.2010.10.017; Wang LL, 2011, HUM GENE THER, V22, P1389, DOI 10.1089/hum.2011.031; Warrington KH, 2006, HUM GENET, V119, P571, DOI 10.1007/s00439-006-0165-6; White JD, 2011, GENE THER, V18, P546, DOI 10.1038/gt.2010.168; Wobus CE, 2000, J VIROL, V74, P9281, DOI 10.1128/JVI.74.19.9281-9293.2000; Wu P, 2000, J VIROL, V74, P8635, DOI 10.1128/JVI.74.18.8635-8647.2000; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899; Zadori Z, 2001, DEV CELL, V1, P291, DOI 10.1016/S1534-5807(01)00031-4	56	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75142	10.1371/journal.pone.0075142	http://dx.doi.org/10.1371/journal.pone.0075142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086458	gold, Green Submitted, Green Published			2022-12-27	WOS:000325025200029
J	Basseri, HR; Hajipirloo, HM; Bavani, MM; Whitten, MMA				Basseri, Hamid R.; Hajipirloo, Habib Mohamadzadeh; Bavani, Mulood Mohammadi; Whitten, Miranda M. A.			Comparative Susceptibility of Different Biological Forms of Anopheles stephensi to Plasmodium berghei ANKA Strain	PLOS ONE			English	Article							TRANSMISSION-BLOCKING VACCINES; MOSQUITO; GAMBIAE; MIDGUT; FALCIPARUM; INFECTIVITY; VIVAX; REFRACTORINESS; ANTIBODIES; CULICIDAE	Background: There are varying degrees of compatibility between malaria parasite-mosquito species, and understanding this compatibility may be crucial for developing effective transmission-blocking vaccines. This study investigates the compatibility of different biological forms of a malaria vector, Anopheles stephensi, to Plasmodium berghei ANKA strain. Methods: Several biologically different and allopatric forms of A. stephensi were studied. Three forms were isolated from different regions of southern Iran: the variety mysorensis, the intermediate form and the native type form, and an additional type form originated from India (Beech strain). The mosquitoes were experimentally infected with P. berghei to compare their susceptibility to parasitism. Anti-mosquito midgut antiserum was then raised in BALB/cs mice immunized against gut antigens from the most susceptible form of A. stephensi (Beech strain), and the efficacy of the antiserum was assessed in transmission-blocking assays conducted on the least susceptible mosquito biological form. Results: The susceptibility of different biological forms of A. stephensi mosquito to P. berghei was specifically inter-type varied. The Beech strain and the intermediate form were both highly susceptible to infection, with higher oocyst and sporozoite infection rates than intermediate and mysorensis forms. The oocyst infection, and particularly sporozite infection, was lowest in the mysorensis strain. Antiserum raised against midgut proteins of the Indian Beech type form blocked infection in this mosquito population, but it was ineffective at blocking both oocyst and sporozoite development in the permissive but geographically distant intermediate form mosquitoes. This suggests that a strong degree of incompatibility exists between the mosquito strains in terms of midgut protein(s) acting as putative ookinete receptors. Conclusions: The incompatibility in the midgut protein profiles between two biological forms of A. stephensi demonstrates a well-differentiated population structure according to geographical origin. Therefore, the design of potential transmission-blocking strategies should incorporate a more thorough understanding of intra-species variations in host-parasite interactions.	[Basseri, Hamid R.] Univ Tehran Med Sci, Sch Publ Hlth, Dept Med Entomol & Vector Control, Tehran, Iran; [Hajipirloo, Habib Mohamadzadeh; Bavani, Mulood Mohammadi] Urmia Univ Med Sci, Fac Med, Dept Parasitol & Mycol, Orumiyeh, Iran; [Whitten, Miranda M. A.] Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales	Tehran University of Medical Sciences; Urmia University of Medical Sciences; Swansea University	Hajipirloo, HM (corresponding author), Urmia Univ Med Sci, Fac Med, Dept Parasitol & Mycol, Orumiyeh, Iran.	habibmhaji@yahoo.com	Bavani, Mulood Mohammadi/AAV-7195-2021; mohammadi bavani, mulood/E-2897-2018; Hajipirloo, Habib Mohammadzadeh/H-2962-2017; Whitten, Miranda/P-8259-2015	Hajipirloo, Habib Mohammadzadeh/0000-0002-9071-7229; Whitten, Miranda/0000-0003-1930-5042	Tehran University of Medical Sciences	Tehran University of Medical Sciences(Tehran University of Medical Sciences)	This work was financially supported by a small grant from Tehran University of Medical Sciences. There are no other external funding sources for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adak T, 1999, T ROY SOC TROP MED H, V93, P573, DOI 10.1016/S0035-9203(99)90052-4; Alavi Y, 2003, INT J PARASITOL, V33, P933, DOI 10.1016/S0020-7519(03)00112-7; Almeida APG, 2002, J MED ENTOMOL, V39, P207, DOI 10.1603/0022-2585-39.1.207; [Anonymous], 2005, IRAN J PUBLIC HEALTH; Basseri H, 2010, J PARASITOL RES, V2010; Basseri HR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-131; BILLINGSLEY PF, 1992, J PARASITOL, V78, P430, DOI 10.2307/3283640; Billingsley PF, 2006, PARASITE IMMUNOL, V28, P143, DOI 10.1111/j.1365-3024.2006.00805.x; BURGESS RW, 1960, AM J TROP MED HYG, V9, P652, DOI 10.4269/ajtmh.1960.9.652; Catteruccia F, 2000, NATURE, V405, P959, DOI 10.1038/35016096; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; COLLINS WE, 1991, J AM MOSQUITO CONTR, V7, P569; Coluzzi M, 1971, Parassitologia, V13, P445; DAVIDSON G, 1961, B WORLD HEALTH ORGAN, V25, P209; Decaestecker E, 2007, NATURE, V450, P870, DOI 10.1038/nature06291; Dessens JT, 2001, INFECT IMMUN, V69, P4041, DOI 10.1128/IAI.69.6.4041-4047.2001; Dinglasan RR, 2008, TRENDS PARASITOL, V24, P364, DOI 10.1016/j.pt.2008.05.002; Dinglasan RR, 2007, P NATL ACAD SCI USA, V104, P15882, DOI 10.1073/pnas.0706340104; Dinglasan RR, 2007, P NATL ACAD SCI USA, V104, P13461, DOI 10.1073/pnas.0702239104; Dinglasan RR, 2005, INSECT BIOCHEM MOLEC, V35, P1, DOI 10.1016/j.ibmb.2004.09.005; Dybdahl MF, 2003, TRENDS ECOL EVOL, V18, P523, DOI 10.1016/S0169-5347(03)00223-4; Engelstadter J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000469; Ghosh AK, 2001, P NATL ACAD SCI USA, V98, P13278, DOI 10.1073/pnas.241491198; Grieco JP, 2005, J AM MOSQUITO CONTR, V21, P279, DOI 10.2987/8756-971X(2005)21[279:CSOTSO]2.0.CO;2; Hajipirloo HM, 2005, IRANIAN J PUBL HEAL, V34, P8; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Harris C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030849; Hume JCC, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-139; JEFFERY GEOFFREY M., 1950, JO UR NATL MALARIA SOC, V9, P349; LAL AA, 1994, INFECT IMMUN, V62, P316, DOI 10.1128/IAI.62.1.316-318.1994; Lavazec C, 2008, MICROBES INFECT, V10, P845, DOI 10.1016/j.micinf.2008.05.004; Lehane MJ, 1997, ANNU REV ENTOMOL, V42, P525, DOI 10.1146/annurev.ento.42.1.525; Leitner WW B-LE, 2010, MALARIA J, V27, P12; malERA Consultative Group on Vaccines, 2011, PLoS Med, V8, pe1000398, DOI 10.1371/journal.pmed.1000398; MANOUCHEHRI AV, 1976, TROP GEOGR MED, V28, P228; Mathias DK, 2012, INFECT IMMUN, V80, P1606, DOI 10.1128/IAI.06212-11; MEDLEY GF, 1993, PARASITOLOGY, V106, P441, DOI 10.1017/S0031182000076721; Nace D, 2004, J AM MOSQUITO CONTR, V20, P272; Parish LA, 2011, J PROTEOME RES, V10, P5150, DOI 10.1021/pr2006268; RAMSDALE C D, 1975, Parassitologia (Rome), V17, P39; Shahabuddin M, 2001, INSECT BIOCHEM MOLEC, V31, P231, DOI 10.1016/S0965-1748(00)00142-9; Sinden RE, 2004, INSECT BIOCHEM MOLEC, V34, P625, DOI 10.1016/j.ibmb.2004.03.015; Sinden RE, 2007, PLOS PATHOG, V3, P2005, DOI 10.1371/journal.ppat.0030195; Somboon P., 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P766; SUBBARAO SK, 1987, MED VET ENTOMOL, V1, P265, DOI 10.1111/j.1365-2915.1987.tb00353.x; SULEMAN M, 1990, J MED ENTOMOL, V27, P819, DOI 10.1093/jmedent/27.5.819; Vontas JG, 2004, PHYSIOL ENTOMOL, V29, P210, DOI 10.1111/j.0307-6962.2004.00410.x; Waters AP, 1997, J BIOL CHEM, V272, P3583, DOI 10.1074/jbc.272.6.3583; Zulueta J, 1968, MOSQ NEWS, V28, P5	49	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75413	10.1371/journal.pone.0075413	http://dx.doi.org/10.1371/journal.pone.0075413			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086525	Green Published, gold			2022-12-27	WOS:000326520200101
J	Nayak, P; Kumar, AMV; Claassens, M; Enarson, DA; Satyanarayana, S; Kundu, D; Khaparde, K; Agrawal, TK; Dapkekar, S; Chandraker, S; Nair, SA				Nayak, Priyakanta; Kumar, Ajay M. V.; Claassens, Mareli; Enarson, Donald A.; Satyanarayana, Srinath; Kundu, Debashish; Khaparde, Kshitij; Agrawal, Tarun K.; Dapkekar, Shankar; Chandraker, Sachin; Nair, Sreenivas Achuthan			Comparing Same Day Sputum Microscopy with Conventional Sputum Microscopy for the Diagnosis of Tuberculosis - Chhattisgarh, India	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS	Background: The World Health Organization (WHO) recommends same day sputum microscopy (spot-spot) in preference to conventional strategy (spot-morning) for the diagnosis of smear positive tuberculosis with the view that completing diagnosis on a single day may be more convenient to the patients and reduce pre-treatment losses to follow-up. Methods: We conducted a cross-sectional study in seven selected district level hospitals of Chhattisgarh State, India. During October 2012 - March 2013, two sputum specimens (spot-early morning) were collected from consecutively enrolled adult (>= 18 years) presumptive TB patients as per current national guidelines. In addition, a second sample was collected (one hour after the collection of first spot sample) from the same patients. All the samples were examined by ziehl-Neelsen (ZN) microscopy. McNemar's test was used to compare statistical differences in the proportion smear positive between the two approaches (spot-spot versus spot-morning). Results: Of 2551 presumptive TB patients, 69% were male. All patients provided the first spot specimen, 2361 (93%) provided the second spot specimen, and 2435 (96%) provided an early morning specimen. 72% of specimens were mucopurulent in conventional strategy as compared to 60% in same day strategy. The proportion of smear-positive patients diagnosed by same day microscopy was 14%, as compared to 17% by the conventional method (p<0.001). A total of 73 (16.9%) potential cases were missed by the same day method compared to only 2 (0.5%) by the conventional method. Conclusion: Same-day microscopy method missed 17% of smear-positive cases and contrary to prior perception, did not increase the proportion of suspects providing the second sample. These findings call for an urgent need to revisit the WHO recommendation of switching to same-day diagnosis over the current policy.	[Nayak, Priyakanta; Kundu, Debashish; Khaparde, Kshitij; Dapkekar, Shankar; Nair, Sreenivas Achuthan] WHO Country Off, Off World Hlth Org WHO Representat India, New Delhi, India; [Kumar, Ajay M. V.; Enarson, Donald A.; Satyanarayana, Srinath] South East Asia Reg Off, Int Union TB & Lung Dis Union, New Delhi, India; [Claassens, Mareli] Univ Stellenbosch, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, Cape Town, South Africa; [Agrawal, Tarun K.] State TB Off, Directorate Hlth Serv, Raipur, Madhya Pradesh, India; [Chandraker, Sachin] Intermediate Reference Lab, Raipur, Madhya Pradesh, India	World Health Organization; Stellenbosch University	Nayak, P (corresponding author), WHO Country Off, Off World Hlth Org WHO Representat India, New Delhi, India.	pikoo.2007@gmail.com	Claassens, Mareli/Y-3544-2019	Claassens, Mareli/0000-0002-5927-284X; Satyanarayana, Srinath/0000-0002-5420-2551; Nair, Sreenivas/0000-0002-2586-6797; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531	United States Agency for International Development (USAID)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	Funding for the operational research course was made possible from by the support of the American people through the United States Agency for International Development (USAID). Funders had no role in study design, data collection, analysis or interpretation of data. The contents of this paper do not necessarily reflect the views of USAID or the United States Government.	AITKHALED N, 2010, MANAGEMENT TUBERCULO, V6, P1; ANDREWS R H, 1959, Tubercle, V40, P155, DOI 10.1016/S0041-3879(59)80034-9; [Anonymous], 2012, GLOBAL TUBERCULOSIS, P1; Botha E, 2008, INT J TUBERC LUNG D, V12, P936; Cambanis A, 2006, INT J TUBERC LUNG D, V10, P230; Chandra T Jaya, 2012, Indian J Tuberc, V59, P141; Cuevas LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001057; Cuevas LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000443; Davis JL, 2013, LANCET INFECT DIS, V13, P147, DOI 10.1016/S1473-3099(12)70232-3; Hirao S, 2007, TROP MED INT HEALTH, V12, P1459, DOI 10.1111/j.1365-3156.2007.01952.x; HOBBY GL, 1973, ANTIMICROB AGENTS CH, V4, P94, DOI 10.1128/AAC.4.2.94; Myneedu V P, 2011, Indian J Tuberc, V58, P160; *NAT AIDS CONTR OR, 2013, TECHN REP IND HIV ES; Ramsay A, 2009, J TROP MED-US, V2009, DOI 10.1155/2009/398767; Squire SB, 2005, INT J TUBERC LUNG D, V9, P25; STOP PBP, 2006, INT J TUBERC LUNG D, V10, P240; STOP PBP, 2007, WHOHTMSTB200740, P1; WHO, 2011, WHO TECH REP SER, V959, P1	18	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74964	10.1371/journal.pone.0074964	http://dx.doi.org/10.1371/journal.pone.0074964			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086412	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200063
J	Pera, M; Camps, P; Munoz-Torrero, D; Perez, B; Badia, A; Guillen, MVC				Pera, Marta; Camps, Pelayo; Munoz-Torrero, Diego; Perez, Belen; Badia, Albert; Victoria Clos Guillen, M.			Undifferentiated and Differentiated PC12 Cells Protected by Huprines Against Injury Induced by Hydrogen Peroxide	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; RAT PHEOCHROMOCYTOMA CELLS; NERVE GROWTH-FACTOR; OXYGEN-GLUCOSE DEPRIVATION; GLOBAL CEREBRAL-ISCHEMIA; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; GLUTAMATE NEUROTOXICITY; MUSCARINIC RECEPTORS; SUPEROXIDE-DISMUTASE	Oxidative stress is implicated in the pathogenesis of neurodegenerative disorders and hydrogen peroxide (H2O2) plays a central role in the stress. Huprines, a group of potent acetylcholinesterase inhibitors (AChEIs), have shown a broad cholinergic pharmacological profile. Recently, it has been observed that huprine X (HX) improves cognition in non transgenic middle aged mice and shows a neuroprotective activity (increased synaptophysin expression) in 3xTg-AD mice. Consequently, in the present experiments the potential neuroprotective effect of huprines (HX, HY, HZ) has been analyzed in two different in vitro conditions: undifferentiated and NGF-differentiated PC12 cells. Cells were subjected to oxidative insult (H2O2, 200 mu M) and the protective effects of HX, HY and HZ (0.01 mM(-1) mu M) were analyzed after a pre-incubation period of 24 and 48 hours. All huprines showed protective effects in both undifferentiated and NGF-differentiated cells, however only in differentiated cells the effect was dependent on cholinergic receptors as atropine (muscarinic antagonist, 0.1 mu M) and mecamylamine (nicotinic antagonist, 100 mu M) reverted the neuroprotection action of huprines. The decrease in SOD activity observed after oxidative insult was overcome in the presence of huprines and this effect was not mediated by muscarinic or nicotinic receptors. In conclusion, huprines displayed neuroprotective properties as previously observed in in vivo studies. In addition, these effects were mediated by cholinergic receptors only in differentiated cells. However, a non-cholinergic mechanism, probably through an increase in SOD activity, seems to be also involved in the neuroprotective effects of huprines.	[Pera, Marta; Perez, Belen; Badia, Albert; Victoria Clos Guillen, M.] Univ Autonoma Barcelona, Inst Neurociencies, Dept Farmacol Terapeut & Toxicol, E-08193 Barcelona, Spain; [Camps, Pelayo; Munoz-Torrero, Diego] Univ Barcelona, Fac Farm, Quim Farmaceut Lab, Unitat Associada CSIC,Inst Biomed IBUB, E-08028 Barcelona, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona	Guillen, MVC (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Dept Farmacol Terapeut & Toxicol, E-08193 Barcelona, Spain.	Victoria.clos@uab.es	Muñoz-Torrero, Diego/K-9787-2014; Camps, Pelayo/D-4421-2014; Perez, Belen/K-7721-2014	Muñoz-Torrero, Diego/0000-0002-8140-8555; Camps, Pelayo/0000-0002-9633-3525; Perez, Belen/0000-0001-5801-1704; Pera, Marta/0000-0003-4317-6623	Ministerio de Ciencia e Innovacion [SAF 2006-04339, SAF 2009-10553, CTQ2008-03768/PPQ]; Generalitat de Catalunya [2009SGR1396]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	Funding for this study was provided by the Ministerio de Ciencia e Innovacion (SAF 2006-04339, SAF 2009-10553, CTQ2008-03768/PPQ) and the Generalitat de Catalunya (2009SGR1396). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike A, 2010, J MOL NEUROSCI, V40, P211, DOI 10.1007/s12031-009-9236-1; Alcala MM, 2005, NEUROSCI LETT, V379, P106, DOI 10.1016/j.neulet.2004.12.044; Almasieh M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.23; AMY CM, 1983, J NEUROSCI, V3, P1547; Arias E, 2004, NEUROPHARMACOLOGY, V46, P103, DOI 10.1016/S0028-3908(03)00317-4; Arias E, 2005, J PHARMACOL EXP THER, V315, P1346, DOI 10.1124/jpet.105.090365; Badia A, 1998, BIOORGAN MED CHEM, V6, P427, DOI 10.1016/S0968-0896(98)00015-7; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Bennett S, 2009, J ALZHEIMERS DIS, V17, P245, DOI 10.3233/JAD-2009-1041; Bianchetti A, 2006, AGING CLIN EXP RES, V18, P158, DOI 10.1007/BF03327433; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butterfield DA, 1997, CHEM RES TOXICOL, V10, P495, DOI 10.1021/tx960130e; BUTTERFIELD DA, 1994, BIOCHEM BIOPH RES CO, V200, P710, DOI 10.1006/bbrc.1994.1508; Camps P, 2000, J MED CHEM, V43, P4657, DOI 10.1021/jm000980y; Francis PT, 2005, TRENDS PHARMACOL SCI, V26, P104, DOI 10.1016/j.tips.2004.12.010; Giacobini E, 2000, ALZ DIS ASSOC DIS, V14, pS3, DOI 10.1097/00002093-200000001-00002; Giordano G, 2009, J NEUROCHEM, V109, P525, DOI 10.1111/j.1471-4159.2009.05969.x; Gorman AM, 2008, J CELL MOL MED, V12, P2263, DOI 10.1111/j.1582-4934.2008.00402.x; GREENE LA, 1981, J BIOL CHEM, V256, P6363; Hedberg MM, 2010, NEURODEGENER DIS, V7, P379, DOI 10.1159/000287954; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; JUMBLATT JE, 1982, NATURE, V297, P152, DOI 10.1038/297152a0; Kimura M, 2005, BRAIN RES, V1047, P72, DOI 10.1016/j.brainres.2005.04.014; Kita Y, 2013, PSYCHOPHARMACOLOGY, V225, P543, DOI 10.1007/s00213-012-2841-7; Kumar P, 2009, EUR J PHARMACOL, V615, P91, DOI 10.1016/j.ejphar.2009.04.058; Lorrio S, 2007, J PHARMACOL EXP THER, V322, P591, DOI 10.1124/jpet.107.122747; Markesbery WR, 1999, BRAIN PATHOL, V9, P133; Martorana A, 2010, CNS NEUROSCI THER, V16, P235, DOI 10.1111/j.1755-5949.2010.00175.x; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Min DY, 2012, NEUROSCI LETT, V510, P29, DOI 10.1016/j.neulet.2011.12.064; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mucke L, 2009, NATURE, V461, P895, DOI 10.1038/461895a; Nakamura S, 2001, ALCOHOL, V24, P79, DOI 10.1016/S0741-8329(01)00150-1; Nouspikel T, 2007, NEUROSCIENCE, V145, P1213, DOI 10.1016/j.neuroscience.2006.07.006; Pera M, 2006, BIOCHEM BIOPH RES CO, V346, P89, DOI 10.1016/j.bbrc.2006.04.187; Pera M, 2009, MOL CELL NEUROSCI, V40, P217, DOI 10.1016/j.mcn.2008.10.008; Picconi B, 2006, NEUROPHARMACOLOGY, V50, P917, DOI 10.1016/j.neuropharm.2006.01.002; Pratico D, 2004, J ALZHEIMERS DIS, V6, P171; Racchi M, 2004, PHARMACOL RES, V50, P441, DOI 10.1016/j.phrs.2003.12.027; Ratia M, 2013, NEURODEGENER DIS, V11, P129, DOI 10.1159/000336427; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; Roman S, 2005, BRAIN RES, V1061, P73, DOI 10.1016/j.brainres.2005.07.042; Roman S, 2004, NEUROPHARMACOLOGY, V46, P95, DOI 10.1016/j.neuropharm.2003.08.005; Roman S, 2002, NEUROSCI LETT, V325, P103, DOI 10.1016/S0304-3940(02)00245-8; Schneider Lon S, 2013, Continuum (Minneap Minn), V19, P339, DOI 10.1212/01.CON.0000429180.60095.d0; Shang YZ, 1999, ACTA PHARMACOL SIN, V20, P824; Stadelmann C, 1998, J NEUROPATH EXP NEUR, V57, P456, DOI 10.1097/00005072-199805000-00009; Takada Y, 2003, J PHARMACOL EXP THER, V306, P772, DOI 10.1124/jpet.103.050104; Takada-Takatori Y, 2006, EUR J PHARMACOL, V549, P19, DOI 10.1016/j.ejphar.2006.08.017; Takada-Takatori Y, 2006, NEUROPHARMACOLOGY, V51, P474, DOI 10.1016/j.neuropharm.2006.04.007; TISCHLER AS, 1975, NATURE, V258, P341, DOI 10.1038/258341a0; Wang R, 2006, ACTA PHARMACOL SIN, V27, P1, DOI 10.1111/j.1745-7254.2006.00255.x; Wang R, 2001, NEUROREPORT, V12, P2629, DOI 10.1097/00001756-200108280-00009; Wang ZF, 2002, ACTA PHARMACOL SIN, V23, P1193; Xiao XQ, 2000, J NEUROSCI RES, V61, P564; Yamashima T, 2013, PROG NEUROBIOL; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zhou J, 2001, NEUROREPORT, V12, P2073, DOI 10.1097/00001756-200107200-00007; Zhu Xiongwei, 2006, Current Alzheimer Research, V3, P393, DOI 10.2174/156720506778249470	60	13	13	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74344	10.1371/journal.pone.0074344	http://dx.doi.org/10.1371/journal.pone.0074344			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086337	gold, Green Published, Green Submitted			2022-12-27	WOS:000326520200029
J	Stevenson, LM; Dickson, H; Klanjscek, T; Keller, AA; McCauley, E; Nisbet, RM				Stevenson, Louise M.; Dickson, Helen; Klanjscek, Tin; Keller, Arturo A.; McCauley, Edward; Nisbet, Roger M.			Environmental Feedbacks and Engineered Nanoparticles: Mitigation of Silver Nanoparticle Toxicity to Chlamydomonas reinhardtii by Algal-Produced Organic Compounds	PLOS ONE			English	Article							ION-RELEASE KINETICS	The vast majority of nanotoxicity studies measures the effect of exposure to a toxicant on an organism and ignores the potentially important effects of the organism on the toxicant. We investigated the effect of citrate-coated silver nanoparticles (AgNPs) on populations of the freshwater alga Chlamydomonas reinhardtii at different phases of batch culture growth and show that the AgNPs are most toxic to cultures in the early phases of growth. We offer strong evidence that reduced toxicity occurs because extracellular dissolved organic carbon (DOC) compounds produced by the algal cells themselves mitigate the toxicity of AgNPs. We analyzed this feedback with a dynamic model incorporating algal growth, nanoparticle dissolution, bioaccumulation of silver, DOC production and DOC-mediated inactivation of nanoparticles and ionic silver. Our findings demonstrate how the feedback between aquatic organisms and their environment may impact the toxicity and ecological effects of engineered nanoparticles.	[Stevenson, Louise M.; Dickson, Helen; Klanjscek, Tin; McCauley, Edward; Nisbet, Roger M.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Klanjscek, Tin] Rudjer Boskovic Inst, Zagreb, Croatia; [Keller, Arturo A.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [McCauley, Edward] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of California System; University of California Santa Barbara; Rudjer Boskovic Institute; University of California System; University of California Santa Barbara; University of Calgary	Stevenson, LM (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	louise.stevenson@lifesci.ucsb.edu	Nisbet, Roger M/B-6951-2014	Stevenson, Louise/0000-0003-4967-9897; Klanjscek, Tin/0000-0002-9341-344X	US National Science Foundation; US Environmental Protection Agency [EF-0830117]; National Science Foundation [DGE-1144085]; Croatian Ministry for Science, Education and Sport [098-0982934-2719]	US National Science Foundation(National Science Foundation (NSF)); US Environmental Protection Agency(United States Environmental Protection Agency); National Science Foundation(National Science Foundation (NSF)); Croatian Ministry for Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia)	This research was supported by the US National Science Foundation (http://www.nsf.gov/) and the US Environmental Protection Agency (http://www.epa.gov/) under Cooperative Agreement Number EF-0830117, the National Science Foundation Graduate Research Fellowship (http://www.nsfgrfp.org/) under Grant No. DGE-1144085, and the Croatian Ministry for Science, Education and Sport (http://public.mzos.hr/) Grant 098-0982934-2719. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benn TM, 2008, ENVIRON SCI TECHNOL, V42, P4133, DOI 10.1021/es7032718; El Badawy AM, 2011, ENVIRON SCI TECHNOL, V45, P283, DOI 10.1021/es1034188; Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P7285, DOI 10.1021/es803259g; FOGG GE, 1965, PROC R SOC SER B-BIO, V162, P517, DOI 10.1098/rspb.1965.0054; Gao J, 2012, CHEMOSPHERE, V89, P96, DOI 10.1016/j.chemosphere.2012.04.024; Janes N, 1995, ENV TOXICOLOGY CHEM; Kaegi R, 2010, ENVIRON POLLUT, V158, P2900, DOI 10.1016/j.envpol.2010.06.009; Kennedy AJ, 2012, ENVIRON SCI TECHNOL, V46, P10772, DOI 10.1021/es302322y; Kilham SS, 1998, HYDROBIOLOGIA; Kim IG, 2002, BIOTECHNOL LETT, V24, P1299, DOI 10.1023/A:1019812202099; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kim JY, 2013, ECOTOX ENVIRON SAFE, V92, P57, DOI 10.1016/j.ecoenv.2013.02.004; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; Lee YJ, 2012, ENVIRON TOXICOL CHEM, V31, P155, DOI 10.1002/etc.717; Li X, 2012, ENVIRON SCI TECHNOL, V46, P5378, DOI 10.1021/es204531y; Li ZQ, 2010, ENVIRON SCI TECHNOL, V44, P3462, DOI 10.1021/es9031198; Liu JY, 2010, ENVIRON SCI TECHNOL, V44, P2169, DOI 10.1021/es9035557; McCauley E, 1999, NATURE, V402, P653, DOI 10.1038/45223; McCauley E, 2008, NATURE, V455, P1240, DOI 10.1038/nature07220; Miao AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015196; Miao AJ, 2009, ENVIRON POLLUT, V157, P3034, DOI 10.1016/j.envpol.2009.05.047; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Ostroumov SA, 2011, ECOLOGICA, V18, P3; Oukarroum A, 2012, ECOTOX ENVIRON SAFE, V78, P80, DOI 10.1016/j.ecoenv.2011.11.012; Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h; Perreault F, 2012, CHEMOSPHERE, V87, P1388, DOI 10.1016/j.chemosphere.2012.02.046; Piccapietra F, 2012, ENVIRON SCI TECHNOL, V46, P7390, DOI 10.1021/es300734m; Shrivastava S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/22/225103; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Studer AM, 2010, TOXICOL LETT, V197, P169, DOI 10.1016/j.toxlet.2010.05.012; Thio BJR, 2012, ENVIRON SCI TECHNOL, V46, P6985, DOI 10.1021/es203596w; Turner A, 2012, ECOTOXICOLOGY, V21, P148, DOI 10.1007/s10646-011-0774-2	33	49	50	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74456	10.1371/journal.pone.0074456	http://dx.doi.org/10.1371/journal.pone.0074456			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086348	Green Published, gold			2022-12-27	WOS:000326520200032
J	Tzartos, JS; Stergiou, C; Kilidireas, K; Zisimopoulou, P; Thomaidis, T; Tzartos, SJ				Tzartos, John S.; Stergiou, Christos; Kilidireas, Konstantinos; Zisimopoulou, Paraskevi; Thomaidis, Thomas; Tzartos, Socrates J.			Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; AQUAPORIN EXPRESSION; MYASTHENIA-GRAVIS; WATER CHANNELS; DIAGNOSIS; DISEASE; MULTICENTER; ANTIBODIES; MARKER; TISSUE	Autoantibodies against aquaporin-4 (AQP4), a water channel in CNS astrocytes, are detected in,50-80% of patients with neuromyelitis optica spectrum disorders (NMOsd), characterized by longitudinally extensive transverse myelitis (LETM) and/or optic neuritis. Although these autoantibodies present an invaluable biomarker for NMOsd and for the differential diagnosis of multiple sclerosis (MS), diagnosis of anti-AQP4-seronegative NMOsd remains challenging. We hypothesized that seronegative NMOsd patients might have autoantibodies against aquaporin-1 (AQP1), another water channel in CNS astrocytes. We initially developed a radioimmunoprecipitation assay to search for anti-AQP1 antibodies in sera from 632 individuals. Anti-AQP1 or anti-AQP4 autoantibodies were detected in 16.7% and 12%, respectively, of 348 patients with suspected NMOsd. Anti-AQP1 specificity was confirmed by competition, protein immunoblotting and ELISA assays, whereas epitope localization was studied by immunoadsorption on intact cells expressing AQP1 and peptide mapping experiments. Most anti-AQP1 autoantibodies were of the complement-activating IgG1 subclass and the majority bound to the extracellular domain of AQP1, suggesting a possible pathogenic role. Five out of 42 MS patients had anti-AQP1 antibodies, but 2 of them also had spinal cord lesions, while the anti-AQP1 antibodies in the other 3 bound to the cytoplasmic domain of AQP1. Anti-AQP1 antibodies were not detected in 100 healthy individuals or 142 patients with non-demyelinating neuroimmune diseases. Analysis of 17 anti-AQP1+/anti-AQP4-patients with suspected NMOsd showed that 5 had NMO and 11 had LETM. 12/17 of these sera bound predominantly to the extracellular AQP1 loop-A. Overall, we found that anti-AQP1 autoantibodies are present in a subgroup of patients with chronic demyelination in the CNS and similarities with anti-AQP4-seronegative NMOsd, offering a novel potential biomarker for CNS demyelination disorders.	[Tzartos, John S.; Stergiou, Christos; Zisimopoulou, Paraskevi; Tzartos, Socrates J.] Hellenic Pasteur Inst, Dept Biochem, Athens, Greece; [Tzartos, John S.; Thomaidis, Thomas] Gen Hosp Red Cross, Dept Neurol, Athens, Greece; [Kilidireas, Konstantinos] Natl & Kapodistrian Univ, Sch Med, Aeginit Hosp, Dept Neurol, Athens, Greece; [Tzartos, Socrates J.] Univ Patras, Dept Pharm, Patras, Greece	Athens Medical School; National & Kapodistrian University of Athens; University of Patras	Tzartos, JS (corresponding author), Hellenic Pasteur Inst, Dept Biochem, Athens, Greece.	jtzartos@gmail.com; tzartos@pasteur.gr	Zisimopoulou, P/B-4105-2017		Department of Biochemistry of the Hellenic Pasteur Institute; EU (European Social Fund); Greek national funds, through the Program "Education and Lifelong Learning" of the NSRF - Research Funding Programs: "Thales'' and "Aristeia''	Department of Biochemistry of the Hellenic Pasteur Institute; EU (European Social Fund)(European Social Fund (ESF)European Commission); Greek national funds, through the Program "Education and Lifelong Learning" of the NSRF - Research Funding Programs: "Thales'' and "Aristeia''	This work was supported by overheads of the Department of Biochemistry of the Hellenic Pasteur Institute and co-financed by the EU (European Social Fund) and Greek national funds, through the Program "Education and Lifelong Learning" of the NSRF - Research Funding Programs: "Thales'' and "Aristeia''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benga O, 2012, MOL ASPECTS MED, V33, P562, DOI 10.1016/j.mam.2012.03.008; Cabrera-Gomez JA, 2012, EUR J NEUROL, V19, P812, DOI 10.1111/j.1468-1331.2011.03565.x; Chang KH, 2012, MULT SCLER; Dolman D, 2005, J NEUROCHEM, V93, P825, DOI 10.1111/j.1471-4159.2005.03111.x; Gao JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046379; Iorio R, 2012, J AUTOIMMUN; Jarius S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-14; Kitley J, 2012, NEUROLOGY, V79, P1273, DOI 10.1212/WNL.0b013e31826aac4e; Leite MI, 2008, BRAIN, V131, P1940, DOI 10.1093/brain/awn092; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Marinelli RA, 1997, J BIOL CHEM, V272, P12984, DOI 10.1074/jbc.272.20.12984; Matiello M, 2008, NEUROLOGY, V70, P2197, DOI 10.1212/01.wnl.0000303817.82134.da; Matsuoka T, 2011, BRAIN PATHOL, V21, P516, DOI 10.1111/j.1750-3639.2011.00475.x; McKeon A, 2009, ARCH NEUROL-CHICAGO, V66, P1134, DOI 10.1001/archneurol.2009.178; Miller DH, 2008, MULT SCLER J, V14, P1157, DOI 10.1177/1352458508096878; Misu T, 2013, ACTA NEUROPATHOL, V125, P815, DOI 10.1007/s00401-013-1116-7; Moftakhar P, 2010, J NEUROPATH EXP NEUR, V69, P1201, DOI 10.1097/NEN.0b013e3181fd252c; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275; Perez E, 2007, BRAIN RES, V1128, P164, DOI 10.1016/j.brainres.2006.09.109; Pittock SJ, 2008, ARCH NEUROL-CHICAGO, V65, P629, DOI 10.1001/archneur.65.5.629; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P390, DOI 10.1001/archneur.63.3.390; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ribeiro MD, 2006, J NEUROSCI RES, V83, P1231, DOI 10.1002/jnr.20819; Satoh J, 2007, NEUROPATHOLOGY, V27, P245, DOI 10.1111/j.1440-1789.2007.00774.x; Siritho S, 2011, NEUROLOGY, V77, P827, DOI 10.1212/WNL.0b013e31822c61b1; Talbot NC, 2003, CELLS TISSUES ORGANS, V174, P117, DOI 10.1159/000071152; Trakas N, 2011, J NEUROIMMUNOL, V240, P79, DOI 10.1016/j.jneuroim.2011.09.007; Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13, DOI 10.1152/ajprenal.2000.278.1.F13; Waters PJ, 2012, NEUROLOGY, V78, P665, DOI 10.1212/WNL.0b013e318248dec1; Weinshenker BG, 2010, NEUROLOGY, V75, P1404, DOI 10.1212/WNL.0b013e3181f88382; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8	33	43	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74773	10.1371/journal.pone.0074773	http://dx.doi.org/10.1371/journal.pone.0074773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086369	gold, Green Submitted, Green Published			2022-12-27	WOS:000326520200040
J	Kenangalem, E; Waramori, G; Pontororing, GJ; Sandjaja; Tjitra, E; Maguire, G; Kelly, PM; Anstey, NM; Ralph, AP				Kenangalem, Enny; Waramori, Govert; Pontororing, Gysje J.; Sandjaja; Tjitra, Emiliana; Maguire, Graeme; Kelly, Paul M.; Anstey, Nicholas M.; Ralph, Anna P.			Tuberculosis Outcomes in Papua, Indonesia: The Relationship with Different Body Mass Index Characteristics between Papuan and Non-Papuan Ethnic Groups	PLOS ONE			English	Article							FACTORS INFLUENCING TIME; SPUTUM SMEAR CONVERSION; PULMONARY TUBERCULOSIS; WEIGHT-GAIN; MALNUTRITION; BIOMARKERS; SEVERITY; PROVINCE; DISEASE; CULTURE	Weight gain achieved during pulmonary tuberculosis (PTB) treatment is associated with the likelihood of bacteriological treatment success. It is recognised that weight and body mass index (BMI) characteristics differ between ethnic groups in health and illness states. However there has been no prior investigation of how ethnic differences in BMI might influence tuberculosis treatment outcome. Our aim was to investigate predictors of microbiological response to PTB treatment at the Tuberculosis Clinic in Timika, Papua Province, Indonesia and specifically, to determine the contribution of ethnicity. The population comprises two distinct ethnic groups - Asian (Non-Papuan) and Melanesian (Papuan). We conducted a prospective study of adults with smear-positive PTB. Treatment outcomes were 1- and 2-month sputum culture and time to microscopy conversion. Clinical measures included weight, BMI, chest radiograph, pulmonary function including forced expiratory volume in 1 second (FEV1) and haemoglobin. One hundred eighty six participants (83 Papuan, 103 non-Papuan Indonesians) were enrolled. At baseline, Papuans had higher mean weight and BMI than non-Papuans (50.0 kg versus 46.9 kg, p = 0.006 and 20.0 kg/m(2) versus 18.7 kg/m(2), p = 0.001 respectively). This was despite having lower mean haemoglobin (11.3 vs 13.1 g/dL, p < 0.0001), higher smoking and HIV rates (37% vs 21%, p = 0.02 and 20% vs 5%, p = 0.01 respectively) and longer median illness duration (3 vs 2 months, p = 0.04), but similar radiological severity (proportion with cavities 55% vs 57%, p = 0.7), sputum smear grade (p = 0.3) and mean % predicted FEV1 (63% vs 64%, p = 0.7). By 2 months, Papuans had gained still more weight (mean 5.9 vs 4.2 kg, p = 0.02), and were more likely to have negative sputum culture (49/56 vs 45/67, p = 0.02), in univariable and multivariable analyses controlling for other likely determinants of culture conversion. In conclusion, Papuans had better early microbiological outcome from PTB treatment, which may relate to better preservation of weight and greater early weight gain.	[Kenangalem, Enny; Pontororing, Gysje J.] Natl Inst Hlth Res & Dev Res Program, Menzies Sch Hlth Res, Timika, Papua Province, Indonesia; [Kenangalem, Enny] Dist Hlth Author, Timika, Papua Province, Indonesia; [Waramori, Govert] PT Freeport Indonesia, Publ Hlth & Malaria Control Dept, Timika, Papua Province, Indonesia; [Sandjaja; Tjitra, Emiliana] Natl Inst Hlth Res & Dev, Jakarta, Indonesia; [Maguire, Graeme] Baker IDI Heart & Diabet Inst, Alice Springs, NT, Australia; [Maguire, Graeme] James Cook Univ, Sch Med & Dent, Cairns, Qld, Australia; [Kelly, Paul M.] ACT Govt Hlth Directorate, Populat Hlth Div, Canberra, ACT, Australia; [Kelly, Paul M.] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Anstey, Nicholas M.; Ralph, Anna P.] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Anstey, Nicholas M.; Ralph, Anna P.] Charles Darwin Univ, Darwin, NT 0909, Australia; [Anstey, Nicholas M.; Ralph, Anna P.] Royal Darwin Hosp, Dept Infect Dis, Div Med, Darwin, NT, Australia	Freeport Indonesia; National Institute of Health Research & Development - Indonesia; Baker Heart and Diabetes Institute; James Cook University; Australian National University; Charles Darwin University; Menzies School of Health Research; Charles Darwin University	Ralph, AP (corresponding author), Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia.	anna.ralph@menzies.edu.au	Ralph, Anna/AAB-6103-2021		National Health and Medical Research Council (NHMRC) of Australia [605806, 496600]; Australian Respiratory Council; Royal Australasian College of Physicians Covance Award; Margaret Ross Chair in Indigenous Health	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Respiratory Council; Royal Australasian College of Physicians Covance Award; Margaret Ross Chair in Indigenous Health	Funding was provided by the National Health and Medical Research Council (NHMRC) of Australia (Grants 605806 and 496600; Scholarship to APR, Fellowships to APR, GPM, PMK, NMA), the Australian Respiratory Council, a Royal Australasian College of Physicians Covance Award to APR and the Margaret Ross Chair in Indigenous Health (GPM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardian M, 2007, INT J TUBERC LUNG D, V11, P1101; Bernabe-Ortiz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018474; Brian G, 2011, BRIT J NUTR, V105, P1539, DOI 10.1017/S0007114510005258; Brian G, 2011, ASIA-PAC J PUBLIC HE, V23, P34, DOI 10.1177/1010539510390665; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Chen XL, 2010, INT J EPIDEMIOL, V39, P1045, DOI 10.1093/ije/dyq081; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Junior DRD, 2008, BRAZ J INFECT DIS, V12, P226, DOI 10.1590/S1413-86702008000300013; Dominguez-Castellano A, 2003, INT J TUBERC LUNG D, V7, P432; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; Douglas NM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-135; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Guler M, 2007, INT J CLIN PRACT, V61, P231, DOI 10.1111/j.1742-1241.2006.01131.x; Handojo Tjandra, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P571; Hoa NB, 2013, INT J TUBERC LUNG D, V17, P61, DOI 10.5588/ijtld.12.0369; Khan A, 2006, AM J RESP CRIT CARE, V174, P344, DOI 10.1164/rccm.200511-1834OC; Krapp F, 2008, INT J TUBERC LUNG D, V12, P1153; Macallan DC, 1998, CLIN SCI, V94, P321, DOI 10.1042/cs0940321; Maertzdorf J, 2012, INT J TUBERC LUNG D, V16, P1140, DOI 10.5588/ijtld.12.0246; Maguire GP, 2009, INT J TUBERC LUNG D, V13, P1500; Martins N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4248; MITCHISON DA, 1993, AM REV RESPIR DIS, V147, P1062, DOI 10.1164/ajrccm/147.4.1062; Pasipanodya JG, 2007, CHEST, V132, P1591, DOI 10.1378/chest.07-0755; Pontororing GJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-362; Ralph AP, 2010, THORAX, V65, P863, DOI 10.1136/thx.2010.136242; RALPH AP, 2013, PLOS ONE IN PRESS; RALPH AP, 2013, J INFECT DIS; Rieder HL, 1996, TUBERCLE LUNG DIS, V77, P124, DOI 10.1016/S0962-8479(96)90026-X; SILVA CL, 1988, INFECT IMMUN, V56, P3067, DOI 10.1128/IAI.56.12.3067-3071.1988; Sinclair D, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006086.pub3; Telzak EE, 1997, CLIN INFECT DIS, V25, P666, DOI 10.1086/513772; Van Lettow M, 2004, INT J TUBERC LUNG D, V8, P211; Vasantha M, 2009, Indian J Tuberc, V56, P5; Visser ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029588; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; Wang JY, 2009, RESPIROLOGY, V14, P1012, DOI 10.1111/j.1440-1843.2009.01598.x; WHO, 2004, LANCET, V363, P902; World Health Organisation, 2002, WHOCDSTB2002308; World Health Organization, 2006, GLOB DAT BOD MASS IN; World Health Organization (WHO), 2010, GUIDELINES TREATMENT, V2nd; Yew WW, 2006, AM J RESP CRIT CARE, V174, P236, DOI 10.1164/rccm.200605-669ED	42	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76077	10.1371/journal.pone.0076077	http://dx.doi.org/10.1371/journal.pone.0076077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086690	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000325223900077
J	Sapkota, D; Costea, DE; Ibrahim, SO; Johannessen, AC; Bruland, O				Sapkota, Dipak; Costea, Daniela Elena; Ibrahim, Salah O.; Johannessen, Anne C.; Bruland, Ove			S100A14 Interacts with S100A16 and Regulates Its Expression in Human Cancer Cells	PLOS ONE			English	Article							YEAST 2-HYBRID SYSTEM; PROTEIN; FAMILY; CARCINOMA; CALCIUM; ROLES; DIFFERENTIATION; PROTEASOME; MTS1	Both S100A14 and S100A16 are members of the multifunctional S100 protein family. Formation of homo/heterodimers is considered to be one of the major mechanisms for S100 proteins to execute their diverse cellular functions. By employing a classical Yeast two hybrid (Y-2 H) screen, we identified S100A16 as the single interaction partner of S100A14. This interaction was verified by co-immunoprecipitation, double indirect immunofluorescence and double immunostaining in specimens of oral squamous cell carcinoma and normal oral mucosa. The functional significance of this interaction was examined by employing retroviral mediated over-expression and knock-down of these proteins in several cancer cell-lines. Over-expression and knock-down of S100A14 led to concomitant up-and down-regulation of S100A16 protein in the cell-lines examined. However, there was no up-regulation of S100A16 mRNA upon S100A14 over-expression, indicating that modulation of S100A16 expression was not due to enhanced transcriptional activity but possibly by post-transcriptional regulation. In contrary, over-expression of S100A16 was associated neither with the up-regulation of S100A14 mRNA nor its protein, suggesting a unidirectional regulation between S100A14 and S100A16. Cellular treatment with protein synthesis inhibitor cycloheximide demonstrated a time-dependent intracellular degradation of both S100A16 and S100A14 proteins. Additionally, regulation of S100A16 and S100A14 degradation was found to be independent of the classical proteasomal and lysosomal pathways of protein degradation. Further studies will therefore be necessary to understand the functional significance of this interaction and the mechanisms on how S100A14 is involved in the regulation of S100A16 expression.	[Sapkota, Dipak; Costea, Daniela Elena; Johannessen, Anne C.] Univ Bergen, Haukeland Univ Hosp, Gade Lab Pathol, Dept Clin Med, Bergen, Norway; [Ibrahim, Salah O.] Univ Bergen, Dept Clin Dent, Bergen, Norway; [Johannessen, Anne C.] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Bruland, Ove] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Sapkota, D (corresponding author), Univ Bergen, Haukeland Univ Hosp, Gade Lab Pathol, Dept Clin Med, Bergen, Norway.	Dipak.Sapkota@gades.uib.no	Johannessen, Anne Christine/B-8929-2017; Costea, Daniela Elena/AAB-9705-2020	Johannessen, Anne Christine/0000-0001-5403-2380; Costea, Daniela-Elena/0000-0001-7673-0358; Sapkota, Dipak/0000-0003-0061-825X	University of Bergen; Bergen Medical Research Foundation	University of Bergen; Bergen Medical Research Foundation	This study was funded by the University of Bergen (post-doctoral fund, DS) and Bergen Medical Research Foundation (DEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam PJ, 2003, J BIOL CHEM, V278, P6482, DOI 10.1074/jbc.M210184200; Babini E, 2011, J BIOL INORG CHEM, V16, P243, DOI 10.1007/s00775-010-0721-3; Bertini I, 2012, J BIOL INORG CHEM, V18, P1; Chan A, 2011, APPL IMMUNOHISTO M M, V19, P376, DOI 10.1097/PAI.0b013e31820251c0; Deloulme JC, 2003, MICROSC RES TECHNIQ, V60, P560, DOI 10.1002/jemt.10298; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Fuertes G, 2003, BIOCHEM J, V375, P75, DOI 10.1042/BJ20030282; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; HALACHMI D, 1993, FEBS LETT, V316, P73, DOI 10.1016/0014-5793(93)81739-M; Harper LJ, 2007, J ORAL PATHOL MED, V36, P594, DOI 10.1111/j.1600-0714.2007.00617.x; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Jin QE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019375; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; Lin P, 2000, P NATL ACAD SCI USA, V97, P674, DOI 10.1073/pnas.97.2.674; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V313, P237, DOI 10.1016/j.bbrc.2003.11.115; Novitskaya V, 2000, J BIOL CHEM, V275, P41278, DOI 10.1074/jbc.M007058200; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Pietas A, 2002, GENOMICS, V79, P513, DOI 10.1006/geno.2002.6744; Pillay CS, 2002, BIOCHEM J, V363, P417, DOI 10.1042/0264-6021:3630417; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; PRIME SS, 1990, J PATHOL, V160, P259, DOI 10.1002/path.1711600313; Renshaw S, 2007, IMMUNOHISTOCHEMISTRY; Sapkota D, 2008, J ORAL PATHOL MED, V37, P607, DOI 10.1111/j.1600-0714.2008.00683.x; Sapkota D, 2012, ORAL ONCOL, V48, P219, DOI 10.1016/j.oraloncology.2011.10.001; Sapkota D, 2011, EUR J CANCER, V47, P600, DOI 10.1016/j.ejca.2010.10.012; Skovronsky DM, 2000, BIOCHEMISTRY-US, V39, P810, DOI 10.1021/bi991728z; Tarabykina S, 2000, FEBS LETT, V475, P187, DOI 10.1016/S0014-5793(00)01652-5; TEIGELKAMP S, 1991, J BIOL CHEM, V266, P13462; Thomas GJ, 2001, J INVEST DERMATOL, V117, P67, DOI 10.1046/j.0022-202x.2001.01379.x; Wang HY, 2010, ONCOL REP, V23, P45, DOI 10.3892/or_00000604; Yang Q, 1999, EXP CELL RES, V246, P501, DOI 10.1006/excr.1998.4314; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297	33	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76058	10.1371/journal.pone.0076058	http://dx.doi.org/10.1371/journal.pone.0076058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086685	Green Published, Green Submitted, gold			2022-12-27	WOS:000325223900074
J	Lemay, DG; Pollard, KS; Martin, WF; Zadrowski, CF; Hernandez, J; Korf, I; German, JB; Rijnkels, M				Lemay, Danielle G.; Pollard, Katherine S.; Martin, William F.; Zadrowski, Courtneay Freeman; Hernandez, Joseph; Korf, Ian; German, J. Bruce; Rijnkels, Monique			From Genes to Milk: Genomic Organization and Epigenetic Regulation of the Mammary Transcriptome	PLOS ONE			English	Article							EXPRESSION; MOUSE; BIOINFORMATICS; IDENTIFICATION; NEIGHBORHOOD; PRINCIPLES; LACTATION; PATTERNS; DOMAINS	Even in genomes lacking operons, a gene's position in the genome influences its potential for expression. The mechanisms by which adjacent genes are co-expressed are still not completely understood. Using lactation and the mammary gland as a model system, we explore the hypothesis that chromatin state contributes to the co-regulation of gene neighborhoods. The mammary gland represents a unique evolutionary model, due to its recent appearance, in the context of vertebrate genomes. An understanding of how the mammary gland is regulated to produce milk is also of biomedical and agricultural importance for human lactation and dairying. Here, we integrate epigenomic and transcriptomic data to develop a comprehensive regulatory model. Neighborhoods of mammary-expressed genes were determined using expression data derived from pregnant and lactating mice and a neighborhood scoring tool, G-NEST. Regions of open and closed chromatin were identified by ChIP-Seq of histone modifications H3K36me3, H3K4me2, and H3K27me3 in the mouse mammary gland and liver tissue during lactation. We found that neighborhoods of genes in regions of uniquely active chromatin in the lactating mammary gland, compared with liver tissue, were extremely rare. Rather, genes in most neighborhoods were suppressed during lactation as reflected in their expression levels and their location in regions of silenced chromatin. Chromatin silencing was largely shared between the liver and mammary gland during lactation, and what distinguished the mammary gland was mainly a small tissue-specific repertoire of isolated, expressed genes. These findings suggest that an advantage of the neighborhood organization is in the collective repression of groups of genes via a shared mechanism of chromatin repression. Genes essential to the mammary gland's uniqueness are isolated from neighbors, and likely have less tolerance for variation in expression, properties they share with genes responsible for an organism's survival.	[Lemay, Danielle G.; Korf, Ian] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Martin, William F.; German, J. Bruce] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Gladstone Inst, Inst Human Genet, San Francisco, CA 94143 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Zadrowski, Courtneay Freeman; Hernandez, Joseph; Rijnkels, Monique] Baylor Coll Med, USDA ARS Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Baylor College of Medicine; United States Department of Agriculture (USDA)	Lemay, DG (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	dglemay@ucdavis.edu; rijnkel@bcm.edu		Lemay, Danielle/0000-0003-3318-0485	NIH [1R21HD05376, 1R03HD05609]; USDA [6200-51000-048]; California Dairy Research Foundation [09 GEB-01 NH]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA(United States Department of Agriculture (USDA)); California Dairy Research Foundation	Funding was provided by NIH (1R21HD05376, 1R03HD05609) to MR, USDA (6200-51000-048) to MR, and California Dairy Research Foundation (09 GEB-01 NH) to JBG, MR, and KSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; De S, 2009, GENOME RES, V19, P785, DOI 10.1101/gr.086165.108; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Harr B, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj010; Kabotyanski EB, 2009, J BIOL CHEM, V284, P22815, DOI 10.1074/jbc.M109.032490; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kress C, 2010, J MAMMARY GLAND BIOL, V15, P73, DOI 10.1007/s10911-010-9169-x; Lemay DG, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-253; Lemay DG, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-56; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108; Phillips-Cremins JE, 2013, MOL CELL, V50, P461, DOI 10.1016/j.molcel.2013.04.018; Pritchard C, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r26; Purmann A, 2007, GENOMICS, V89, P580, DOI 10.1016/j.ygeno.2007.01.010; Rijnkels M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053270; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; Rudolph MC, 2003, J MAMMARY GLAND BIOL, V8, P287, DOI 10.1023/B:JOMG.0000010030.73983.57; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; Sinha AU, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-82; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Turk R, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-57; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Yanai I, 2009, GENOME RES, V19, P2214, DOI 10.1101/gr.093815.109; Yu PF, 2013, GENOME RES, V23, P352, DOI 10.1101/gr.144949.112; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	34	13	13	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75030	10.1371/journal.pone.0075030	http://dx.doi.org/10.1371/journal.pone.0075030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086428	Green Published, Green Submitted, gold			2022-12-27	WOS:000325220000013
J	Attema, JL; Bert, AG; Lim, YY; Kolesnikoff, N; Lawrence, DM; Pillman, KA; Smith, E; Drew, PA; Khew-Goodall, Y; Shannon, F; Goodall, GJ				Attema, Joanne L.; Bert, Andrew G.; Lim, Yat-Yuen; Kolesnikoff, Natasha; Lawrence, David M.; Pillman, Katherine A.; Smith, Eric; Drew, Paul A.; Khew-Goodall, Yeesim; Shannon, Frances; Goodall, Gregory J.			Identification of an Enhancer That Increases miR-200b similar to 200a similar to 429 Gene Expression in Breast Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MIR-200 FAMILY; ACTIVE CHROMATIN; REPRESSORS ZEB1; NONCODING RNAS; FEEDBACK LOOP; TRANSCRIPTION; MICRORNAS; REGULATORS; PROMOTERS	The miR-200b similar to 200a similar to 429 gene cluster is a key regulator of EMT and cancer metastasis, however the transcription-based mechanisms controlling its expression during this process are not well understood. We have analyzed the miR-200b similar to 200a similar to 429 locus for epigenetic modifications in breast epithelial and mesenchymal cell lines using chromatin immunoprecipitation assays and DNA methylation analysis. We discovered a novel enhancer located approximately 5.1kb upstream of the miR-200b similar to 200a similar to 429 transcriptional start site. This region was associated with the active enhancer chromatin signature comprising H3K4me1, H3K27ac, RNA polymerase II and CpG dinucleotide hypomethylation. Luciferase reporter assays revealed the upstream enhancer stimulated the transcription of the miR-200b similar to 200a similar to 429 minimal promoter region approximately 27-fold in breast epithelial cells. Furthermore, we found that a region of the enhancer was transcribed, producing a short, GC-rich, mainly nuclear, non-polyadenylated RNA transcript designated miR-200b eRNA. Over-expression of miR-200b eRNA had little effect on miR-200b similar to 200a similar to 429 promoter activity and its production did not correlate with miR-200b similar to 200a similar to 429 gene expression. While additional investigations of miR-200b eRNA function will be necessary, it is possible that miR-200b eRNA may be involved in the regulation of miR-200b similar to 200a similar to 429 gene expression and silencing. Taken together, these findings reveal the presence of a novel enhancer, which contributes to miR-200b similar to 200a similar to 429 transcriptional regulation in epithelial cells.	[Attema, Joanne L.; Bert, Andrew G.; Lim, Yat-Yuen; Kolesnikoff, Natasha; Pillman, Katherine A.; Khew-Goodall, Yeesim; Goodall, Gregory J.] SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia; [Lim, Yat-Yuen; Goodall, Gregory J.] Univ Adelaide, Discipline Med, Adelaide, SA, Australia; [Lim, Yat-Yuen] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia; [Lawrence, David M.] Ctr Canc Biol, ACRF Canc Genom Facil, Adelaide, SA, Australia; [Smith, Eric] Univ Adelaide, Discipline Surg, Adelaide, SA, Australia; [Drew, Paul A.] Flinders Univ S Australia, Sch Nursing & Midwifery, Bedford Pk, SA 5042, Australia; [Shannon, Frances] Univ Canberra, Off Deputy Vice Chancellor Res, Bruce, ACT, Australia; [Attema, Joanne L.; Lawrence, David M.; Khew-Goodall, Yeesim; Goodall, Gregory J.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	Centre for Cancer Biology; SA Pathology; University of Adelaide; Universiti Malaya; Centre for Cancer Biology; University of Adelaide; Flinders University South Australia; University of Canberra; University of Adelaide	Attema, JL (corresponding author), SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia.	joanne.attema@health.sa.gov.au; greg.goodall@health.sa.gov.au	Smith, Eric/ABG-7104-2020; Lim, Yat Yuen/I-6495-2013; Smith, Eric/Y-1350-2019; Pillman, Katherine A/M-5723-2019	Lim, Yat Yuen/0000-0001-8617-6063; Smith, Eric/0000-0003-2958-3492; Pillman, Katherine A/0000-0002-5869-889X; Bert, Andrew/0000-0003-3876-1537; Drew, Paul/0000-0001-5661-4771; Lawrence, David/0000-0001-5464-5830	National Health and Medical Research Council [APP1008440]; Swedish Medical Research Council (Vetenskapsradet) [521-2009-2873]; Lund University Faculty of Medicine; Hemato-Linne Program; National Breast Cancer Foundation [CG-10-04] Funding Source: researchfish	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Swedish Medical Research Council (Vetenskapsradet)(Swedish Medical Research Council (SMRC)Swedish Research Council); Lund University Faculty of Medicine; Hemato-Linne Program; National Breast Cancer Foundation	This work was supported by a Project Grant APP1008440 from the National Health and Medical Research Council to GG and FS, and by funds from the Swedish Medical Research Council (Vetenskapsradet, 521-2009-2873), Lund University Faculty of Medicine and The Hemato-Linne Program to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertani S, 2011, MOL CELL, V43, P1040, DOI 10.1016/j.molcel.2011.08.019; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Boussouar F, 2008, CELL CYCLE, V7, P3499, DOI 10.4161/cc.7.22.6975; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Cao Q, 2011, CANCER CELL, V20, P187, DOI 10.1016/j.ccr.2011.06.016; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Flynn RA, 2012, CURR OPIN GENET DEV, V22, P172, DOI 10.1016/j.gde.2011.11.002; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Himes SR, 2001, J LEUKOCYTE BIOL, V70, P812; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Jin FL, 2011, TRANSCR-AUSTIN, V2, P226, DOI 10.4161/trns.2.5.17712; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Lefevre P, 2008, MOL CELL, V32, P129, DOI 10.1016/j.molcel.2008.07.023; Lim YY, 2013, J CELL SCI, V126, P2256, DOI 10.1242/jcs.122275; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Orom UA, 2011, CURR OPIN GENET DEV, V21, P194, DOI 10.1016/j.gde.2011.01.020; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Pike JW, 2011, J BONE MINER RES, V26, P1155, DOI 10.1002/jbmr.317; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Smallwood A, 2013, CURR OPIN CELL BIOL, V25, P387, DOI 10.1016/j.ceb.2013.02.005; Van Bortle K, 2012, ANNU REV CELL DEV BI, V28, P163, DOI 10.1146/annurev-cellbio-101011-155824; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Vrba L, 2011, GENOME RES, V21, P2026, DOI 10.1101/gr.123935.111; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Zentner GE, 2012, J BIOL CHEM, V287, P30888, DOI 10.1074/jbc.R111.296491	49	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75517	10.1371/journal.pone.0075517	http://dx.doi.org/10.1371/journal.pone.0075517			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086551	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700094
J	Finones, RR; Yeargin, J; Lee, M; Kaur, AP; Cheng, C; Sun, P; Wu, C; Nguyen, C; Wang-Rodriguez, J; Meyer, AN; Baird, SM; Donoghue, DJ; Haas, M				Finones, Rita R.; Yeargin, Jo; Lee, Melissa; Kaur, Aman Preet; Cheng, Clari; Sun, Paulina; Wu, Christopher; Nguyen, Catherine; Wang-Rodriguez, Jessica; Meyer, April N.; Baird, Stephen M.; Donoghue, Daniel J.; Haas, Martin			Early Human Prostate Adenocarcinomas Harbor Androgen-Independent Cancer Cells	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE-ACTIVITY; STEM-LIKE CELLS; EPITHELIAL-CELLS; PROSPECTIVE IDENTIFICATION; STEM/PROGENITOR CELLS; MALIGNANT PROSTATE; UROGENITAL SINUS; INITIATING CELLS; PROGENITOR CELLS; SIDE POPULATION	Although blockade of androgen receptor (AR) signaling represents the main treatment for advanced prostate cancer (PrCa), many patients progress to a lethal phenotype of "Castration-Resistant'' prostate cancer (CR-PrCa). With the hypothesis that early PrCa may harbor a population of androgen-unresponsive cancer cells as precursors to CR-recurrent disease, we undertook the propagation of androgen-independent cells from PrCa-prostatectomy samples of early, localized (Stage-I) cases. A collection of 120 surgical specimens from prostatectomy cases was established, among which 54 were adenocarcinomas. Hormone-free cell culture conditions were developed allowing routine propagation of cells expressing prostate basal cell markers and stem/progenitor cell markers, and which proliferated as spheres/spheroids in suspension cultures. Colonies of androgen-independent epithelial cells grew out from 30/43 (70%) of the adenocarcinoma cases studied in detail. Fluorescence microscopy and flow cytometry showed that CR-PrCa cells were positive for CD44, CD133, CK5/14, c-kit, integrin alpha 2b1, SSEA4, E-Cadherin and Aldehyde Dehydrogenase (ALDH). All 30 CR-PrCa cell cultures were also TERT-positive, but negative for TMPRSS2-ERG. Additionally, a subset of 22 of these CR-PrCa cell cultures was examined by orthotopic xenografting in intact and castrated SCID mice, generating histologically typical locally-invasive human PrCa or undifferentiated cancers, respectively, in 6-8 weeks. Cultured PrCa cells and orthotopically-induced in vivo cancers lacked PSA expression. We report here the propagation of Cancer Initiating Cells (CIC) directly from Stage I human PrCa tissue without selection or genetic manipulation. The propagation of stem/progenitor-like CR-PrCa cells derived from early human prostate carcinomas suggests the existence of a subpopulation of cells resistant to androgen-deprivation therapy and which may drive the subsequent emergence of disseminated CR-PrCa.	[Finones, Rita R.] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA; [Yeargin, Jo; Donoghue, Daniel J.; Haas, Martin] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Wang-Rodriguez, Jessica; Baird, Stephen M.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Kaur, Aman Preet; Cheng, Clari; Sun, Paulina; Wu, Christopher; Nguyen, Catherine; Haas, Martin] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Lee, Melissa; Meyer, April N.; Donoghue, Daniel J.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Donoghue, DJ (corresponding author), Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA.	ddonoghue@ucsd.edu			UC San Diego Foundation	UC San Diego Foundation	All funds were generously provided through the UC San Diego Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bastus NC, 2010, CANCER RES, V70, P9544, DOI 10.1158/0008-5472.CAN-10-1638; Bhatia B, 2008, J BIOL CHEM, V283, P27957, DOI 10.1074/jbc.M803467200; Bhatt RI, 2003, CYTOM PART A, V54A, P89, DOI 10.1002/cyto.a.10058; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Brown MD, 2007, PROSTATE, V67, P1384, DOI 10.1002/pros.20620; Buhler P, 2010, ONCOL REP, V23, P465, DOI 10.3892/or_00000656; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Collins AT, 2006, EUR J CANCER, V42, P1213, DOI 10.1016/j.ejca.2006.01.037; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Collins AT, 2001, J CELL SCI, V114, P3865; CUNHA GR, 1991, CANCER SURV, V11, P73; DEWINTER JAR, 1994, AM J PATHOL, V144, P735; Dhillon PK, 2009, CANCER EPIDEM BIOMAR, V18, P595, DOI 10.1158/1055-9965.EPI-08-0785; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; Eaton CL, 2010, PROSTATE, V70, P875, DOI 10.1002/pros.21121; Eirew P, 2012, STEM CELLS, V30, P344, DOI 10.1002/stem.1001; ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Guzman-Ramirez N, 2009, PROSTATE, V69, P1683, DOI 10.1002/pros.21018; HAYASHI N, 1993, EPITHELIAL CELL BIOL, V2, P66; Hayward SW, 2001, CANCER RES, V61, P8135; Kelly K, 2008, CELL RES, V18, P528, DOI 10.1038/cr.2008.50; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; KYPRIANOU N, 1988, ENDOCRINOLOGY, V122, P552, DOI 10.1210/endo-122-2-552; Lang SH, 2001, CELL GROWTH DIFFER, V12, P631; Lee SO, 2013, J MOL CELL BIOL, V5, P14, DOI 10.1093/jmcb/mjs042; Li H, 2008, EXP CELL RES, V314, P92, DOI 10.1016/j.yexcr.2007.08.011; Li XH, 2009, DIFFERENTIATION, V77, P95, DOI 10.1016/j.diff.2008.09.012; Maitland NJ, 2008, J CLIN ONCOL, V26, P2862, DOI 10.1200/JCO.2007.15.1472; Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; Marcato P, 2011, CELL CYCLE, V10, P1378, DOI 10.4161/cc.10.9.15486; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI 10.1517/17425255.4.6.697 ; Masters JR, 2008, PROSTATE CANCER P D, V11, P316, DOI 10.1038/pcan.2008.22; Mathew G, 2009, CELL CYCLE, V8, P1053, DOI 10.4161/cc.8.7.8043; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Norris PS, 1998, J VIROL METHODS, V75, P161, DOI 10.1016/S0166-0934(98)00108-6; Pascal Laura E, 2007, BMC Urol, V7, P6, DOI 10.1186/1471-2490-7-6; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Qin JC, 2012, CELL STEM CELL, V10, P556, DOI 10.1016/j.stem.2012.03.009; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Rajput AB, 2007, J CLIN PATHOL, V60, P1238, DOI 10.1136/jcp.2006.043810; Ruiz M, 2001, CLIN CANCER RES, V7, P4086; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Signoretti S, 2006, CELL CYCLE, V5, P138, DOI 10.4161/cc.5.2.2340; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tang DG, 2007, MOL CARCINOGEN, V46, P1, DOI 10.1002/mc.20255; Taubert I, 2011, CYTOTHERAPY, V13, P459, DOI 10.3109/14653249.2010.530652; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Wang XD, 2006, DEV BIOL, V290, P66, DOI 10.1016/j.ydbio.2005.11.009; Wei C, 2007, CANCER BIOL THER, V6, P763, DOI 10.4161/cbt.6.5.3996; WONG YC, 1992, ACTA ANAT, V143, P139; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Xin L, 2006, P NATL ACAD SCI USA, V103, P7789, DOI 10.1073/pnas.0602567103	62	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74438	10.1371/journal.pone.0074438	http://dx.doi.org/10.1371/journal.pone.0074438			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086346	Green Submitted, Green Published, gold			2022-12-27	WOS:000325218700025
J	Grasman, J				Grasman, Johan			Reconstruction of the Drive Underlying Food Intake and Its Control by Leptin and Dieting	PLOS ONE			English	Article							WEIGHT; KINETICS; PATTERNS	The intake of food and the expenditure of calories is modelled by a system of differential equations. The state variables are the amount of calories stored in adipose tissue and the level of plasma leptin. The model has as input a drive that controls the intake of food. This drive consists of a collective of physiological and psychological incentives to eat or to stop eating. An individual based approach is presented by which the parameters of the system can be set using data of a subject. The method of analysis is fully worked out using weight data of two persons. The model is prone to extensions by transferring incentives being part of the input to the collection of state variables.	Univ Wageningen & Res Ctr, Wageningen, Netherlands	Wageningen University & Research	Grasman, J (corresponding author), Univ Wageningen & Res Ctr, Wageningen, Netherlands.	johan.grasman@wur.nl						Amigo Isaac, 2007, Psychol Health Med, V12, P321, DOI 10.1080/13548500600621545; BLACK DR, 1991, INT J OBESITY, V15, P623; Chow CC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000045; Dardeno TA, 2010, FRONT NEUROENDOCRIN, V31, P377, DOI 10.1016/j.yfrne.2010.06.002; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Grasman J, 2009, ENCY COMPLEXITY S 18, V18, P7602; Grasman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047139; Klein S, 1996, DIABETES, V45, P984, DOI 10.2337/diabetes.45.7.984; Klok MD, 2007, OBES REV, V8, P21, DOI 10.1111/j.1467-789X.2006.00270.x; Leibel RL, 2008, INT J OBESITY, V32, pS98, DOI 10.1038/ijo.2008.245; Lowe MR, 2005, OBES RES, V13, P797, DOI 10.1038/oby.2005.90; Nicklas TA, 2001, J AM COLL NUTR, V20, P599, DOI 10.1080/07315724.2001.10719064; Pearcey SM, 2002, AM J CLIN NUTR, V76, P107, DOI 10.1093/ajcn/76.1.107; Peters J C, 2002, Obes Rev, V3, P69, DOI 10.1046/j.1467-789X.2002.00059.x; Pontzer H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040503; Prentice A. M., 2001, BNF Nutrition Bulletin, V26, P13, DOI 10.1046/j.1467-3010.2001.00100.x; Saad MF, 1997, J CLIN ENDOCR METAB, V82, P579, DOI 10.1210/jc.82.2.579; Speakman JR, 2011, DIS MODEL MECH, V4, P733, DOI 10.1242/dmm.008698; Tomiyama AJ, 2012, PHYSIOL BEHAV, V107, P34, DOI 10.1016/j.physbeh.2012.04.021; Wong SL, 2004, J CLIN ENDOCR METAB, V89, P2672, DOI 10.1210/jc.2003-031931; Woodworth RS., 1918, DYNAMIC PSYCHOL, DOI 10.7312/wood90908	21	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74997	10.1371/journal.pone.0074997	http://dx.doi.org/10.1371/journal.pone.0074997			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086420	Green Submitted, Green Published, gold			2022-12-27	WOS:000325218700047
J	Kushwaha, AK; Sangwan, NS; Trivedi, PK; Negi, AS; Misra, L; Sangwan, RS				Kushwaha, Amit Kumar; Sangwan, Neelam Singh; Trivedi, Prabodh Kumar; Negi, Arvind Singh; Misra, Laxminarain; Sangwan, Rajender Singh			Tropine Forming Tropinone Reductase Gene from Withania somnifera (Ashwagandha): Biochemical Characteristics of the Recombinant Enzyme and Novel Physiological Overtones of Tissue-Wide Gene Expression Patterns	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; MOLECULAR-CLONING; NATURAL-PRODUCTS; DIFFERENT STEREOSPECIFICITIES; CALYSTEGINE DISTRIBUTION; DATURA-STRAMONIUM; ROOT; BIOSYNTHESIS; PURIFICATION; DERIVATIVES	Withania somnifera is one of the most reputed medicinal plants of Indian systems of medicine synthesizing diverse types of secondary metabolites such as withanolides, alkaloids, withanamides etc. Present study comprises cloning and E. coli overexpression of a tropinone reductase gene (WsTR-I) from W. somnifera, and elucidation of biochemical characteristics and physiological role of tropinone reductase enzyme in tropane alkaloid biosynthesis in aerial tissues of the plant. The recombinant enzyme was demonstrated to catalyze NADPH-dependent tropinone to tropine conversion step in tropane metabolism, through TLC, GC and GC-MS-MS analyses of the reaction product. The functionally active homodimeric similar to 60 kDa enzyme catalyzed the reaction in reversible manner at optimum pH 6.7. Catalytic kinetics of the enzyme favoured its forward reaction (tropine formation). Comparative 3-D models of landscape of the enzyme active site contours and tropinone binding site were also developed. Tissue-wide and ontogenic stage-wise assessment of WsTR-I transcript levels revealed constitutive expression of the gene with relatively lower abundance in berries and young leaves. The tissue profiles of WsTR-I expression matched those of tropine levels. The data suggest that, in W. somnifera, aerial tissues as well possess tropane alkaloid biosynthetic competence. In vivo feeding of U-[C-14]-sucrose to orphan shoot (twigs) and [C-14]-chasing revealed substantial radiolabel incorporation in tropinone and tropine, confirming the de novo synthesizing ability of the aerial tissues. This inherent independent ability heralds a conceptual novelty in the backdrop of classical view that these tissues acquire the alkaloids through transportation from roots rather than synthesis. The TR-I gene expression was found to be up-regulated on exposure to signal molecules (methyl jasmonate and salicylic acid) and on mechanical injury. The enzyme's catalytic and structural properties as well as gene expression profiles are discussed with respect to their physiological overtones.	[Kushwaha, Amit Kumar; Sangwan, Neelam Singh; Negi, Arvind Singh; Misra, Laxminarain; Sangwan, Rajender Singh] CSIR CIMAP, Lucknow, Uttar Pradesh, India; [Trivedi, Prabodh Kumar] CSIR NBRI, Lucknow, Uttar Pradesh, India; [Sangwan, Rajender Singh] Govt India, Dept Biotechnol, Interim Facil, Bioproc Unit, Mohali, Punjab, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Department of Biotechnology (DBT) India; Center of Innovative & Applied Bioprocessing (CIAB)	Sangwan, RS (corresponding author), CSIR CIMAP, Lucknow, Uttar Pradesh, India.	sangwan.lab@gmail.com	Sangwan, Neelam/AAF-4010-2021; Negi, arvind singh/AAS-1530-2021	sangwan, Neelam singh/0000-0003-2761-702X; Kushwaha, Amit Kumar/0000-0003-0011-7738	New Millenium Indian Technology Leadership Initiative (NMITLI) of Govt. of India [SSP-97]; CSIR, India	New Millenium Indian Technology Leadership Initiative (NMITLI) of Govt. of India; CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the New Millenium Indian Technology Leadership Initiative (NMITLI) of Govt. of India (Project #SSP-97) and CSIR, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekkouche K, 2001, PHYTOCHEMISTRY, V58, P455, DOI 10.1016/S0031-9422(01)00283-7; Brock A, 2008, PLANT J, V54, P388, DOI 10.1111/j.1365-313X.2008.03422.x; Chatterjee S, 2010, PHYTOCHEMISTRY, V71, P1085, DOI 10.1016/j.phytochem.2010.04.001; Chaurasiya ND, 2012, PLANT CELL REP, V31, P1889, DOI 10.1007/s00299-012-1302-4; Chen LX, 2011, NAT PROD REP, V28, P705, DOI 10.1039/c0np00045k; Chen W, 2013, MOL BIOL REP, V40, P1145, DOI 10.1007/s11033-012-2156-0; Cheng X, 2013, J PLANT PHYSL, DOI 10.1016/j.jplph.2013.02.007; Cordell GA, 2001, PHYTOTHER RES, V15, P183, DOI 10.1002/ptr.890; Cordell GA, 2012, J NAT PROD, V75, P514, DOI 10.1021/np200803m; Dehghan E, 2013, PLANT PHYSL BIOCH, DOI 10.1016/j.plaphy.2013.05.007; DRAGER B, 1988, AGR BIOL CHEM TOKYO, V52, P2663; Geissler R, 2007, PLANT PHYSIOL, V143, P1493, DOI 10.1104/pp.106.095166; Griffin WJ, 2000, PHYTOCHEMISTRY, V53, P623, DOI 10.1016/S0031-9422(99)00475-6; Grynkiewicz G, 2008, PHARMACOL REP, V60, P439; Gupta P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062714; Gupta P, 2013, PROTOPLASMA, V250, P285, DOI 10.1007/s00709-012-0410-x; Gupta P, 2011, PLANT GROWTH REGUL, V65, P93, DOI 10.1007/s10725-011-9578-x; HASHIMOTO T, 1992, PLANT PHYSIOL, V100, P836, DOI 10.1104/pp.100.2.836; Jayaprakasam B, 2004, TETRAHEDRON, V60, P3109, DOI 10.1016/j.tet.2004.01.016; Kai GY, 2009, BIOTECHNOL APPL BIOC, V54, P177, DOI 10.1042/BA20090171; Kaiser H, 2006, PLANTA, V225, P127, DOI 10.1007/s00425-006-0335-8; Keiner R, 2002, PLANT MOL BIOL, V48, P299, DOI 10.1023/A:1013315110746; Keiner R, 2000, PLANT SCI, V150, P171, DOI 10.1016/S0168-9452(99)00184-3; Kushwaha AK, 2013, GENE, V516, P238, DOI 10.1016/j.gene.2012.11.091; Kushwaha S, 2012, PARASITE IMMUNOL, V34, P199, DOI 10.1111/j.1365-3024.2012.01352.x; Kushwaha S, 2012, VACCINE, V30, P1083, DOI 10.1016/j.vaccine.2011.12.031; Kutchan TM, 2008, ADV PL BIOCH MOL BIO, V1, P283, DOI 10.1016/S1755-0408(07)01010-7; Lal P, 2006, Z NATURFORSCH B, V61, P1143, DOI 10.1515/znb-2006-0914; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Madina BR, 2007, BBA-PROTEINS PROTEOM, V1774, P1199, DOI 10.1016/j.bbapap.2007.06.015; Majumdar DN, 1955, J IND I SCI A, V16A, P29; Mandal C, 2008, APOPTOSIS, V13, P1450, DOI 10.1007/s10495-008-0271-0; Mandal S, 2012, PLOS ONE, V7; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Misra L, 2005, PHYTOCHEMISTRY, V66, P2702, DOI 10.1016/j.phytochem.2005.10.001; Misra L, 2012, J ASIAN NAT PROD RES, V14, P39, DOI 10.1080/10286020.2011.622719; Mondal S, 2012, ADV EXP MED BIOL, V749, P295, DOI 10.1007/978-1-4614-3381-1_20; Mondal S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-239; Nakajima K, 1999, J BIOL CHEM, V274, P16563, DOI 10.1074/jbc.274.23.16563; Nakajima K, 1998, P NATL ACAD SCI USA, V95, P4876, DOI 10.1073/pnas.95.9.4876; Nakajima K, 1999, PLANT CELL PHYSIOL, V40, P1099, DOI 10.1093/oxfordjournals.pcp.a029494; NAKAJIMA K, 1993, P NATL ACAD SCI USA, V90, P9591, DOI 10.1073/pnas.90.20.9591; NAKAJIMA K, 1993, PLANT PHYSIOL, V103, P1465, DOI 10.1104/pp.103.4.1465; NAKAJIMA K, 1994, J BIOL CHEM, V269, P11695; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Ortholand JY, 2004, CURR OPIN CHEM BIOL, V8, P271, DOI 10.1016/j.cbpa.2004.04.011; Peacock SM, 1944, AM J BOT, V31, P463, DOI 10.2307/2437406; PORTSTEFFEN A, 1994, PHYTOCHEMISTRY, V37, P391, DOI 10.1016/0031-9422(94)85066-6; Sangwan RS, 2008, PHYSIOL PLANTARUM, V133, P278, DOI 10.1111/j.1399-3054.2008.01076.x; Sangwan RS, 2004, CURR SCI INDIA, V86, P461; SANGWAN RS, 1993, J PLANT PHYSIOL, V142, P129, DOI 10.1016/S0176-1617(11)80952-1; Sharma LK, 2007, ARCH BIOCHEM BIOPHYS, V460, P48, DOI 10.1016/j.abb.2007.01.024; Tuli R, 2010, ASHWAGANDHA WITHANIA; Wink M, 2003, PHYTOCHEMISTRY, V64, P3, DOI 10.1016/S0031-9422(03)00300-5; YAMADA Y, 1990, CURR PLANT SCI BIOT, V9, P547	56	25	27	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74777	10.1371/journal.pone.0074777	http://dx.doi.org/10.1371/journal.pone.0074777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086372	gold, Green Published, Green Submitted			2022-12-27	WOS:000325218700034
J	Sabri, A; Vandermoten, S; Leroy, PD; Haubruge, E; Hance, T; Thonart, P; De Pauw, E; Francis, F				Sabri, Ahmed; Vandermoten, Sophie; Leroy, Pascal D.; Haubruge, Eric; Hance, Thierry; Thonart, Philippe; De Pauw, Edwin; Francis, Frederic			Proteomic Investigation of Aphid Honeydew Reveals an Unexpected Diversity of Proteins	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PEA APHID; SUGAR COMPOSITION; ACYRTHOSIPHON-PISUM; NUTRITIONAL QUALITY; PHLOEM SAP; HYMENOPTERA; PLANT; SPECIFICITY; DETERMINES	Aphids feed on the phloem sap of plants, and are the most common honeydew-producing insects. While aphid honeydew is primarily considered to comprise sugars and amino acids, its protein diversity has yet to be documented. Here, we report on the investigation of the honeydew proteome from the pea aphid Acyrthosiphon pisum. Using a two-Dimensional Differential in-Gel Electrophoresis (2D-Dige) approach, more than 140 spots were isolated, demonstrating that aphid honeydew also represents a diverse source of proteins. About 66% of the isolated spots were identified through mass spectrometry analysis, revealing that the protein diversity of aphid honeydew originates from several organisms (i.e. the host aphid and its microbiota, including endosymbiotic bacteria and gut flora). Interestingly, our experiments also allowed to identify some proteins like chaperonin, GroEL and Dnak chaperones, elongation factor Tu (EF-Tu), and flagellin that might act as mediators in the plant-aphid interaction. In addition to providing the first aphid honeydew proteome analysis, we propose to reconsider the importance of this substance, mainly acknowledged to be a waste product, from the aphid ecology perspective.	[Vandermoten, Sophie; Leroy, Pascal D.; Haubruge, Eric; Francis, Frederic] Univ Liege, Lab Funct & Evolutionary Entomol, Gembloux, Belgium; [Sabri, Ahmed; Hance, Thierry] Catholic Univ Louvain, Earth & Life Inst, Biodivers Res Ctr, B-3000 Louvain, Belgium; [Thonart, Philippe] Univ Liege, Walloon Ctr Ind Biol, Liege, Belgium; [De Pauw, Edwin] Univ Liege, Dept Chem, Mass Spectrometry Lab, Liege, Belgium	University of Liege; Universite Catholique Louvain; University of Liege; University of Liege	Francis, F (corresponding author), Univ Liege, Lab Funct & Evolutionary Entomol, Gembloux, Belgium.	Frederic.Francis@ulg.ac.be		De Pauw, Edwin/0000-0003-3475-1315; Haubruge, Eric/0000-0002-8138-0476	Walloon Region Ministry Grant [WALEO2: SOLAPHIDRW/FUSAGX 061/6287]	Walloon Region Ministry Grant	This research was funded by the Walloon Region Ministry Grant (WALEO2: SOLAPHIDRW/FUSAGX 061/6287). The funders had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation.	Arakaki N, 1998, APPL ENTOMOL ZOOL, V33, P357, DOI 10.1303/aez.33.357; AUCLAIR JL, 1963, ANNU REV ENTOMOL, V8, P439, DOI 10.1146/annurev.en.08.010163.002255; Baumann P, 1996, CURR MICROBIOL, V32, P279, DOI 10.1007/s002849900050; Casas J, 2003, J ANIM ECOL, V72, P691, DOI 10.1046/j.1365-2656.2003.00740.x; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; CLOUTIER C, 1986, J INSECT PHYSIOL, V32, P263, DOI 10.1016/0022-1910(86)90037-5; DOUGLAS AE, 1993, ECOL ENTOMOL, V18, P31, DOI 10.1111/j.1365-2311.1993.tb01076.x; ELLIOTT NC, 1987, J KANSAS ENTOMOL SOC, V60, P25; England S, 1997, ENVIRON ENTOMOL, V26, P1437, DOI 10.1093/ee/26.6.1437; Evans EW, 2000, ENTOMOL EXP APPL, V94, P141, DOI 10.1023/A:1003914509181; Faria CA, 2008, BASIC APPL ECOL, V9, P286, DOI 10.1016/j.baae.2007.02.001; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fischer MK, 2002, J INSECT PHYSIOL, V48, P319, DOI 10.1016/S0022-1910(01)00179-2; Fischer MK, 2001, FUNCT ECOL, V15, P544, DOI 10.1046/j.0269-8463.2001.00550.x; Gilbert F, 1998, BIOL J LINN SOC, V63; Hansen AK, 2011, PROCEEDINGS OF THE N; HENDRIX DL, 1992, COMP BIOCHEM PHYS B, V101, P23, DOI 10.1016/0305-0491(92)90153-I; Hogervorst P, 2007, ENTOMOL EXP APPL, V122; IDOINE K, 1988, ENVIRON ENTOMOL, V17, P941, DOI 10.1093/ee/17.6.941; Kanzaki H, 2003, MOL PLANT PATHOL, V4, P383, DOI [10.1046/j.1364-3703.2003.00186.x, 10.1046/J.1364-3703.2003.00186.X]; Karley AJ, 2002, J EXP BIOL, V205, P3009; Kay A, 2002, ECOLOGY, V83, P1935, DOI 10.1890/0012-9658(2002)083[1935:AOFTTA]2.0.CO;2; Kay A, 2004, BEHAV ECOL, V15, P63, DOI 10.1093/beheco/arg106; Kloft W, 1985, WALDTRACHT UND WALDH; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Lee JC, 2004, ENTOMOL EXP APPL, V111, P189, DOI 10.1111/j.0013-8703.2004.00165.x; Leroy PD, 2011, ARTHROPOD-PLANT INTE, V5, P193, DOI 10.1007/s11829-011-9128-5; Lund PA, 2001, ADV MICROB PHYSIOL, V44, P93, DOI 10.1016/S0065-2911(01)44012-4; Malcolm S.B., 1990, Chemoecology, V1, P12, DOI 10.1007/BF01240581; MARKWELL TJ, 1993, NEW ZEAL J ECOL, V17, P85; Mittler T, 1958, J EXP BIOL, V35; Moller H, 1987, FOREST BIRD, V18, P14; Nomikou M, 2003, EXP APPL ACAROL, V31, P15, DOI 10.1023/B:APPA.0000005142.31959.e8; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Sabri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018847; Saheed SA, 2007, PHYSIOL PLANTARUM, V129, P429, DOI 10.1111/j.1399-3054.2006.00821.x; Sandstrom J, 2000, J INSECT PHYSIOL, V46, P33, DOI 10.1016/S0022-1910(99)00098-0; SASAKI T, 1990, J INSECT PHYSIOL, V36, P35, DOI 10.1016/0022-1910(90)90148-9; Shigenobu S, 2011, CELL MOL LIFE SCI, V68, P1297, DOI 10.1007/s00018-011-0645-2; Singh R, 2000, J ADV ZOOL, V21; Smith KM, 1926, ANN APPL BIOL, V13, P109, DOI 10.1111/j.1744-7348.1926.tb04254.x; SPILLER NJ, 1990, ENTOMOL EXP APPL, V55, P101, DOI 10.1007/BF00352570; Taguchi F, 2003, PLANT CELL PHYSIOL, V44, P342, DOI 10.1093/pcp/pcg042; Tsuchida T, 2002, MOL ECOL, V11, P2123, DOI 10.1046/j.1365-294X.2002.01606.x; Wackers F, 2005, SUITABILITY OF EXTRA; Wackers FL, 2000, OIKOS, V90, P197, DOI 10.1034/j.1600-0706.2000.900124.x; Waeckers F.L., 2003, IOBC-WPRS Bulletin, V26, P203; WAY MJ, 1963, ANNU REV ENTOMOL, V8, P307, DOI 10.1146/annurev.en.08.010163.001515; Wilkinson TL, 1997, J EXP BIOL, V200, P2137; Wilson ACC, 2010, INSECT MOL BIOL, V19, P249, DOI 10.1111/j.1365-2583.2009.00942.x; Woodring J, 2004, PHYSIOL ENTOMOL, V29, P311, DOI 10.1111/j.0307-6962.2004.00386.x; Yao I, 2002, ECOL ENTOMOL, V27, P745, DOI 10.1046/j.1365-2311.2002.00455.x; Yao I, 2001, OECOLOGIA, V128, P36, DOI 10.1007/s004420100633; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003; ZOEBELEIN G, 1955, Z ANG ENT, V38, P369	56	49	50	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74656	10.1371/journal.pone.0074656	http://dx.doi.org/10.1371/journal.pone.0074656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086359	Green Published, gold			2022-12-27	WOS:000325218700029
J	Inui, T; Chano, T; Takikita-Suzuki, M; Nishikawa, M; Yamamoto, G; Okabe, H				Inui, Takuma; Chano, Tokuhiro; Takikita-Suzuki, Mikiko; Nishikawa, Masanori; Yamamoto, Gaku; Okabe, Hidetoshi			Association of p62/SQSTM1 Excess and Oral Carcinogenesis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; SQUAMOUS-CELL CARCINOMA; CUL3-BASED E3 LIGASE; OXIDATIVE STRESS; PROXIMITY LIGATION; PROTEIN COMPLEXES; IN-SITU; KEAP1; ACTIVATION; EXPRESSION	p62/SQSTM1 (sequestosome1) has never been evaluated in oral epithelium. In order to clarify the role of p62/SQSTM1 in carcinogenesis in oral epithelium, both p62/SQSTM1 and Nrf2 were immunohistochemically evaluated in 54 carcinomas and 14 low grade dysplasias. p62/SQSTM1 knockdowns were also designed in oral cancer cells, and we analyzed the Nrf2 pathway, GSH contents and ROS accumulation. The association between p62/SQSTM1 excess and prognosis was addressed in a clinical cohort of oral carcinoma cases. p62/SQSTM1 excess was more obvious in carcinomas, but Nrf2 was abundant in almost all samples of the oral epithelium. In oral carcinoma cells, p62/SQSTM1 knockdown did not affect the Nrf2-Keap1 pathway but did significantly reduce GSH content with subsequent ROS accumulation, and caused cell growth inhibition in the irradiated condition. Finally, p62/SQSTM1 excess was associated with poor prognosis in a clinical cohort. In oral epithelial carcinogenesis, p62/SQSTM1 excess played a role in GSH induction rather than Nrf2 accumulation, and may cause resistance to cytotoxic stresses such as radiation or chemotherapy. Immunohistochemical evaluation of p62/SQSTM1 may be a potential significant marker to identify early carcinogenesis, chemo- radiotherapeutic resistance or poor prognosis of oral squamous cell carcinomas.	[Inui, Takuma; Chano, Tokuhiro; Takikita-Suzuki, Mikiko; Okabe, Hidetoshi] Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 52021, Japan; [Inui, Takuma; Nishikawa, Masanori; Yamamoto, Gaku] Shiga Univ Med Sci, Dept Oral & Maxillofacial Surg, Otsu, Shiga 52021, Japan	Shiga University of Medical Science; Shiga University of Medical Science	Chano, T (corresponding author), Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 52021, Japan.	chano@belle.shiga-med.ac.jp	Chano, Tokuhiro/F-5816-2018	Chano, Tokuhiro/0000-0002-9959-1183	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The study was partly supported by KAKENHI (Grant-in-Aid for Scientific Research) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. No additional external funding received for this study. The funding source had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript.	Arai A, 2011, CANCER RES, V71, P4598, DOI 10.1158/0008-5472.CAN-11-0320; Barnes L, 2005, PATHOLOGY GENETICS H; Biswas SK, 2009, MOL ASPECTS MED, V30, P60, DOI 10.1016/j.mam.2008.07.001; Bohn SK, 2006, CANCER LETT, V238, P240, DOI 10.1016/j.canlet.2005.07.027; Bui CB, 2011, BIOCHEM BIOPH RES CO, V412, P347, DOI 10.1016/j.bbrc.2011.07.101; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Forman HJ, 2003, BIOFACTORS, V17, P1, DOI 10.1002/biof.5520170101; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Holtzclaw WD, 2004, ADV ENZYME REGUL, V44, P335, DOI 10.1016/j.advenzreg.2003.11.013; Inoue D, 2012, CANCER SCI, V103, P760, DOI 10.1111/j.1349-7006.2012.02216.x; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kitamura H, 2006, HISTOPATHOLOGY, V48, P157, DOI 10.1111/j.1365-2559.2005.02313.x; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lu ML, 2001, AM J PATHOL, V159, P945, DOI 10.1016/S0002-9440(10)61770-1; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; OGUNBIYI OA, 1993, J CLIN PATHOL, V46, P23, DOI 10.1136/jcp.46.1.23; Qian Hong-liu, 2003, Zhonghua Bing Li Xue Za Zhi, V32, P329; Salzman R, 2010, INT J CLIN ONCOL; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Su YX, 2005, CLIN IMMUNOL, V116, P118, DOI 10.1016/j.clim.2005.04.004; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang JY, 1999, J EXP MED, V189, P1101, DOI 10.1084/jem.189.7.1101; Zieba A, 2010, CLIN CHEM, V56, P99, DOI 10.1373/clinchem.2009.134452; Zou X, 2012, J NUTR BIOCHEM, V23, P994, DOI 10.1016/j.jnutbio.2011.05.006	32	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e74398	10.1371/journal.pone.0074398	http://dx.doi.org/10.1371/journal.pone.0074398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086340	Green Published, gold, Green Submitted			2022-12-27	WOS:000325025200014
J	Lodi, S; Phillips, A; Fidler, S; Hawkins, D; Gilson, R; McLean, K; Fisher, M; Post, F; Johnson, AM; Walker-Nthenda, L; Dunn, D; Porter, K				Lodi, Sara; Phillips, Andrew; Fidler, Sarah; Hawkins, David; Gilson, Richard; McLean, Ken; Fisher, Martin; Post, Frank; Johnson, Anne M.; Walker-Nthenda, Louise; Dunn, David; Porter, Kholoud		UK Register HIV	Role of HIV Infection Duration and CD4 Cell Level at Initiation of Combination Anti-Retroviral Therapy on Risk of Failure	PLOS ONE			English	Article							DRUG-RESISTANCE MUTATIONS; INDIVIDUALS; PREDICTORS; COHORT	Background: The development of HIV drug resistance and subsequent virological failure are often cited as potential disadvantages of early cART initiation. However, their long-term probability is not known, and neither is the role of duration of infection at the time of initiation. Methods: Patients enrolled in the UK Register of HIV seroconverters were followed-up from cART initiation to last HIV-RNA measurement. Through survival analysis we examined predictors of virologic failure (2HIV-RNA >= 400 c/l while on cART) including CD4 count and HIV duration at initiation. We also estimated the cumulative probabilities of failure and drug resistance (from the available HIV nucleotide sequences) for early initiators (cART within 12 months of seroconversion). Results: Of 1075 starting cART at a median (IQR) CD4 count 272 (190,370) cells/mm(3) and HIV duration 3 (1,6) years, virological failure occurred in 163 (15%). Higher CD4 count at initiation, but not HIV infection duration at cART initiation, was independently associated with lower risk of failure (p=0.033 and 0.592 respectively). Among 230 patients initiating cART early, 97 (42%) discontinued it after a median of 7 months; cumulative probabilities of resistance and failure by 8 years were 7% (95% CI 4,11) and 19% (13,25), respectively. Conclusion: Although the rate of discontinuation of early cART in our cohort was high, the long-term rate of virological failure was low. Our data do not support early cART initiation being associated with increased risk of failure and drug resistance.	[Lodi, Sara; Walker-Nthenda, Louise; Dunn, David; Porter, Kholoud] UCL, MRC, London, England; [Lodi, Sara] Inst Salud Carlos III, Madrid, Spain; [Phillips, Andrew; Johnson, Anne M.] UCL, London, England; [Fidler, Sarah] Imperial Coll NHS Trust, London, England; [Hawkins, David] Chelsea & Westminster Hosp, London, England; [Gilson, Richard] Mortimer Market Ctr, London, England; [Gilson, Richard] Univ Coll London Hosp, London, England; [McLean, Ken] Charing Cross Hosp, London, England; [Fisher, Martin] Brighton & Sussex Univ Hosp Natl Hlth Serv Trust, Brighton, E Sussex, England; [Post, Frank] Kings Coll London, London, England	University of London; University College London; Instituto de Salud Carlos III; University of London; University College London; Imperial College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Imperial College London; University of London; King's College London	Porter, K (corresponding author), UCL, MRC, London, England.	kp@ctu.mrc.ac.uk	Phillips, Andrew N/B-4427-2008	Phillips, Andrew N/0000-0003-2384-4807; delpech, valerie/0000-0002-9952-8109; Ong, Edmund/0000-0002-6594-0509; Anderson, Jane/0000-0001-5294-8707; Fidler, Sarah/0000-0003-1676-7583; Johnson, Anne/0000-0003-1330-7100; Kennedy, Nicholas/0000-0003-1106-3827; Porter, Kholoud/0000-0002-9226-6206; Dunn, David/0000-0003-1836-4446; fox, Julie/0000-0002-0583-8019	Medical Research Council; MRC [MC_UU_12023/15, MC_U122886351] Funding Source: UKRI; Medical Research Council [MC_U122886351, MC_UU_12023/15] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10244] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The UK Register of HIV Seroconversion is funded by the Medical Research Council. No current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, HIV TESTING NEW HIV; Asboe D, 2012, HIV MED, V13, P1, DOI 10.1111/j.1468-1293.2011.00971.x; Audelin AM, 2009, ANTIVIR THER, V14, P995, DOI 10.3851/IMP1412; BABIKER AG, 2012, CLIN TRIALS, P1; Bannister WP, 2011, J ANTIMICROB CHEMOTH, V66, P901, DOI 10.1093/jac/dkr006; BERAL V, 1996, EPIDEMIOL INFECT, V117, P305; CLEMENTS M, 2003, ME HIV, V4, P332; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Department of agriculture forestry and fisheries, 2012, GUID US ANT AG HIV 1, P1; Dorrucci M, 2005, AIDS, V19, P331; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; *EUR AIDSCLINICAL, 2012, CLIN MAN TREATM HIV; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gupta R, 2008, CLIN INFECT DIS, V47, P712, DOI 10.1086/590943; Harrigan PR, 2010, CLIN INFECT DIS, V50, P1286, DOI 10.1086/651685; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Health Protection Agency, 2012, HIV UK 2012 REP; JAIN V, 2012, 19 INT C AIDS WASH D; Lodi S, 2010, AIDS, V24, P2697, DOI 10.1097/QAD.0b013e32833ef6c4; Miettinen O S, 1983, Stat Med, V2, P267, DOI 10.1002/sim.4780020222; Paredes R, 2000, ARCH INTERN MED, V160, P1123, DOI 10.1001/archinte.160.8.1123; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Pillay D, 2005, J INFECT DIS, V192, P967, DOI 10.1086/432763; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; *STANF U, 2011, HIV DRUG RES DAT; Uy J, 2009, JAIDS-J ACQ IMM DEF, V51, P450, DOI 10.1097/QAI.0b013e3181acb630; von Wyl V, 2012, CLIN INFECT DIS, V54, P131, DOI 10.1093/cid/cir728; WHO, 2010, ANT THER HIV INF AD; 2013, N ENGL J ME, V368, P207	30	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75608	10.1371/journal.pone.0075608	http://dx.doi.org/10.1371/journal.pone.0075608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086588	Green Published, gold			2022-12-27	WOS:000325025200055
J	Yin, AA; Zhang, LH; Cheng, JX; Dong, Y; Liu, BL; Han, N; Zhang, X				Yin, An-an; Zhang, Lu-hua; Cheng, Jin-xiang; Dong, Yu; Liu, Bo-lin; Han, Ning; Zhang, Xiang			Radiotherapy Plus Concurrent or Sequential Temozolomide for Glioblastoma in the Elderly: A Meta-Analysis	PLOS ONE			English	Article							HYPOFRACTIONATED RADIOTHERAPY; CONCOMITANT TEMOZOLOMIDE; ADJUVANT TEMOZOLOMIDE; PATIENTS OLDER; PHASE-II; MULTIFORME; RADIATION; SURVIVAL; AGE; CHEMOTHERAPY	Background: Many physicians are reluctant to treat elderly glioblastoma (GBM) patients as aggressively as younger patients, which is not evidence based due to the absence of validated data from primary studies. We conducted a meta-analysis to provide valid evidence for the use of the aggressive combination of radiotherapy (RT) and temozolomide (TMZ) in elderly GBM patients. Methods: A systematic literature search was conducted using the PubMed, EMBASE and Cochrane databases. Studies comparing combined RT/TMZ with RT alone in elderly patients (>= 65 years) with newly diagnosed GBM were eligible for inclusion. Results: No eligible randomized trials were identified. Alternatively, a meta-analysis of nonrandomized studies (NRSs) was performed, with 16 studies eligible for overall survival (OS) analysis and nine for progression-free survival (PFS) analysis. Combined RT/TMZ was shown to reduce the risk of death and progression in elderly GBM patients compared with RT alone (OS hazard ratio [HR] 0.59, 95% confidence interval [CI] 0.48-0.72; PFS: HR 0.58, 95% CI 0.41-0.84). Evaluable patients were reported to tolerate combined treatment but certain toxicities, and especially hematological toxicities, were more frequently observed. Limited data on O6-methylguanine-DNA methyltransferase (MGMT) promoter status and quality of life were reported. Conclusion: The meta-analysis of NRSs provided level 2a evidence (Oxford Centre for Evidence-Based Medicine) that combined RT/TMZ conferred a clear survival benefit on a selection of elderly GBM patients who had a favorable prognosis (e. g., extensive resection, favorable KPS). Toxicities were more frequent but acceptable. Future randomized trials are warranted to justify a definitive conclusion.	[Yin, An-an; Zhang, Lu-hua; Cheng, Jin-xiang; Liu, Bo-lin; Han, Ning; Zhang, Xiang] Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xijing Inst Clin Neurosci, Xian 710032, Shaanxi Provinc, Peoples R China; [Dong, Yu] Fourth Mil Med Univ, Dept Prosthodont, Sch Stomatol, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Zhang, X (corresponding author), Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xijing Inst Clin Neurosci, Xian 710032, Shaanxi Provinc, Peoples R China.	xzhang@fmmu.edu.cn	Han, Ning/K-3220-2017	Han, Ning/0000-0001-9177-6792; Yin, An-An/0000-0002-1888-5551	National Natural Science Foundation of China [81171087]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by National Natural Science Foundation of China (No: 81171087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel Karim K, 2012, NEURO ONCOL S3, V14, pi22; Abhinav K, 2013, CLIN NEUROL NEUROSUR, V115, P1375, DOI 10.1016/j.clineuro.2012.12.023; Ackerl MS, 2012, NEURO-ONCOLOGY, V14, P46; Balducci M, 2012, MED ONCOL, V29, P3478, DOI 10.1007/s12032-012-0263-3; Barker CA, 2012, J NEURO-ONCOL, V109, P391, DOI 10.1007/s11060-012-0906-4; Brandes AA, 2003, CANCER, V97, P657, DOI 10.1002/cncr.11097; Brandes AA, 2009, CANCER-AM CANCER SOC, V115, P3512, DOI 10.1002/cncr.24406; Cao JQ, 2012, J NEURO-ONCOL, V107, P395, DOI 10.1007/s11060-011-0766-3; Caroli M, 2011, EUR J CANCER, V47, pS581, DOI 10.1016/S0959-8049(11)72272-9; Cheng JX, 2009, NEURO-ONCOLOGY, V11, P41, DOI 10.1215/15228517-2008-050; Combs SE, 2008, INT J RADIAT ONCOL, V70, P987, DOI 10.1016/j.ijrobp.2007.07.2368; Dirier A, 2010, NEURO-ONCOLOGY, V12, P42; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ewelt C, 2011, J NEURO-ONCOL, V103, P611, DOI 10.1007/s11060-010-0429-9; Fiorentino A, 2013, AM J CLIN ONCOL; Fiorentino A, 2013, INT J NEUROSCI, V123, P133, DOI 10.3109/00207454.2012.744309; Fiorica F, 2010, ARCH GERONTOL GERIAT, V51, P31, DOI 10.1016/j.archger.2009.06.011; Floyd SR, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00122; Gerstein J, 2010, RADIOTHER ONCOL, V97, P382, DOI 10.1016/j.radonc.2010.06.014; Gerstner ER, 2009, NEUROLOGY, V73, P1509, DOI 10.1212/WNL.0b013e3181bf9907; Hashem SA, 2012, J MED IMAG RADIAT ON, V56, P204, DOI 10.1111/j.1754-9485.2011.02325.x; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Iwamoto FM, 2008, ANN NEUROL, V64, P628, DOI 10.1002/ana.21521; Kimple RJ, 2010, AM J CLIN ONCOL-CANC, V33, P265, DOI 10.1097/COC.0b013e3181a76a24; Kita D, 2009, NEUROEPIDEMIOLOGY, V33, P17, DOI 10.1159/000210017; Kushnir I, 2011, ISR MED ASSOC J, V13, P290; Laperriere N, 2010, RADIOTHER ONCOL, V96, pS34; Laperriere N, 2013, CANCER TREAT REV, V39, P350, DOI 10.1016/j.ctrv.2012.05.008; Lee JH, 2013, J CLIN NEUROSCI, V20, P503, DOI 10.1016/j.jocn.2012.03.044; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Malmstrom A, 2012, LANCET ONCOL, V13, P916, DOI 10.1016/S1470-2045(12)70265-6; Mangiola A, 2006, J NEURO-ONCOL, V76, P159, DOI 10.1007/s11060-005-4711-1; Minniti G, 2008, J NEURO-ONCOL, V88, P97, DOI 10.1007/s11060-008-9538-0; Minniti G, 2012, INT J RADIAT ONCOL, V83, P93, DOI 10.1016/j.ijrobp.2011.06.1992; Minniti G, 2011, J NEURO-ONCOL, V102, P311, DOI 10.1007/s11060-010-0324-4; Minniti G, 2009, J NEURO-ONCOL, V91, P95, DOI 10.1007/s11060-008-9689-z; Mishima K, 2010, NEURO-ONCOLOGY, V12, P46; Muni R, 2010, TUMORI J, V96, P60, DOI 10.1177/030089161009600110; Niyazi M, 2012, STRAHLENTHER ONKOL, V188, P154, DOI 10.1007/s00066-011-0026-7; Perry JR, 2012, J CLIN ONCOL S, V30, pS2104; Petretta M, 2011, AM J CARDIOL, V108, P1171, DOI 10.1016/j.amjcard.2011.06.022; Piccirilli M, 2006, TUMORI J, V92, P98, DOI 10.1177/030089160609200203; Pichlmeier U, 2008, NEURO-ONCOLOGY, V10, P1025, DOI 10.1215/15228517-2008-052; Reifenberger G, 2012, INT J CANCER, V131, P1342, DOI 10.1002/ijc.27385; Reyngold M, 2012, J NEURO-ONCOL, V110, P369, DOI 10.1007/s11060-012-0972-7; Saito K, 2011, NEURO-ONCOLOGY, V13, P44; Sharp HJ, 2011, INT J RADIAT ONCOL, V81, pS278, DOI 10.1016/j.ijrobp.2011.06.482; Sijben AE, 2008, J NEURO-ONCOL, V89, P97, DOI 10.1007/s11060-008-9593-6; Siu LL, 2007, NEW ENGL J MED, V356, P1575, DOI 10.1056/NEJMe078023; Smith S, 2011, ASIA PACIFIC J CL S4, V7, P76; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.NEU.0000346230.80425.3A, 10.1227/01.neu.0000317304.31579.17]; Stummer W, 2011, J NEURO-ONCOL, V103, P361, DOI 10.1007/s11060-010-0400-9; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tanaka S, 2013, J NEUROSURG, V118, P786, DOI 10.3171/2012.10.JNS112268; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; van den Bent MJ, 2005, EJC SUPPL, V3, P134; Weiss SE, 2010, INT J RADIAT ONCOL, V78, pS271, DOI 10.1016/j.ijrobp.2010.07.645; Wells G.A., NEWCASTLE OTTAWA SCA; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wick W, 2012, LANCET ONCOL, V13, P707, DOI 10.1016/S1470-2045(12)70164-X; Zachenhofer I, 2011, WIEN KLIN WOCHENSCHR, V123, P364, DOI 10.1007/s00508-011-1577-4	63	47	47	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e74242	10.1371/journal.pone.0074242	http://dx.doi.org/10.1371/journal.pone.0074242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086323	Green Submitted, Green Published, gold			2022-12-27	WOS:000325025200011
J	Zhao, YL; Zhang, L; Qiao, Y; Zhou, XL; Wu, GD; Wang, LJ; Peng, YH; Dong, XL; Huang, H; Si, LN; Zhang, XY; Zhang, L; Li, JH; Wang, W; Zhou, LY; Gao, X				Zhao, Yanli; Zhang, Lina; Qiao, Yu; Zhou, Xiaoling; Wu, Guodong; Wang, Lujing; Peng, Yahui; Dong, Xingli; Huang, Hui; Si, Lining; Zhang, Xueying; Zhang, Lei; Li, Jihong; Wang, Wei; Zhou, Lingyun; Gao, Xu			Heme Oxygenase-1 Prevents Cardiac Dysfunction in Streptozotocin-Diabetic Mice by Reducing Inflammation, Oxidative Stress, Apoptosis and Enhancing Autophagy	PLOS ONE			English	Article							SIGNALING PATHWAY; NADPH OXIDASE; CELL-DEATH; PROTECTIVE ROLE; GROWTH-FACTOR; CARDIOMYOPATHY; HEART; MECHANISMS; EXPRESSION; KINASE	Heme oxygenase-1 (HO-1) has been implicated in cardiac dysfunction, oxidative stress, inflammation, apoptosis and autophagy associated with heart failure, and atherosclerosis, in addition to its recognized role in metabolic syndrome and diabetes. Numerous studies have presented contradictory findings about the role of HO-1 in diabetic cardiomyopathy (DCM). In this study, we explored the role of HO-1 in myocardial dysfunction, myofibril structure, oxidative stress, inflammation, apoptosis and autophagy using a streptozotocin (STZ)-induced diabetes model in mice systemically overexpressing HO-1 (Tg-HO-1) or mutant HO-1 (Tg-mutHO-1). The diabetic mouse model was induced by multiple peritoneal injections of STZ. Two months after injection, left ventricular (LV) function was measured by echocardiography. In addition, molecular biomarkers related to oxidative stress, inflammation, apoptosis and autophagy were evaluated using classical molecular biological/biochemical techniques. Mice with DCM exhibited severe LV dysfunction, myofibril structure disarray, aberrant cardiac oxidative stress, inflammation, apoptosis, autophagy and increased levels of HO-1. In addition, we determined that systemic overexpression of HO-1 ameliorated left ventricular dysfunction, myofibril structure disarray, oxidative stress, inflammation, apoptosis and autophagy in DCM mice. Furthermore, serine/threonine-specific protein kinase (Akt) and AMP-activated protein kinase (AMPK) phosphorylation is normally inhibited in DCM, but overexpression of the HO-1 gene restored the phosphorylation of these kinases to normal levels. In contrast, the functions of HO-1 in DCM were significantly reversed by overexpression of mutant HO-1. This study underlines the unique roles of HO-1, including the inhibition of oxidative stress, inflammation and apoptosis and the enhancement of autophagy, in the pathogenesis of DCM.	[Zhao, Yanli; Zhang, Lina; Qiao, Yu; Zhou, Xiaoling; Wu, Guodong; Wang, Lujing; Peng, Yahui; Dong, Xingli; Huang, Hui; Zhang, Xueying; Zhang, Lei; Li, Jihong; Wang, Wei; Zhou, Lingyun; Gao, Xu] Harbin Med Univ, Dept Biochem, Harbin, Heilongjiang, Peoples R China; [Zhao, Yanli] Qinghai Univ, Coll Med, Dept Biochem, Xining, Qinghai, Peoples R China; [Gao, Xu] Harbin Med Univ, Minist Educ, Key Lab Cardiovasc Med Res, Harbin, Heilongjiang, Peoples R China; [Gao, Xu] Harbin Med Univ, State Prov Key Labs Biomed Pharmaceut China, Harbin, Heilongjiang, Peoples R China; [Si, Lining] Qinghai Univ, Sch Med, Affiliated Hosp, Dept Critical Care Med, Xining, Qinghai, Peoples R China; [Zhang, Lina] Daqing Oilfield Gen Hosp, Dept Clin Lab, Daqing, Heilongjiang, Peoples R China	Harbin Medical University; Qinghai University; Harbin Medical University; Harbin Medical University; Qinghai University	Zhou, LY (corresponding author), Harbin Med Univ, Dept Biochem, Harbin, Heilongjiang, Peoples R China.	zhoulingy@tom.com; gaoxu_671227@163.com	si, lining/GWD-0263-2022; zhao, yan/GWC-9174-2022; gao, xu/U-4765-2019; Dong, Xingli/AAH-8374-2021		National Natural Science Foundation of Regional China [81060162, 81001033]; Natural Science Foundation of Innovation Team of China [81121003]	National Natural Science Foundation of Regional China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Innovation Team of China	This work was supported by the National Natural Science Foundation of Regional China (No.81060162, No.81001033) and the Natural Science Foundation of Innovation Team of China (No.81121003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2004, AM J PHYSIOL-HEART C, V287, pH2468, DOI 10.1152/ajpheart.01187.2003; Abraham NG, 2003, CIRC RES, V93, P507, DOI 10.1161/01.RES.0000091828.36599.34; Aki T, 2003, ONCOGENE, V22, P8529, DOI 10.1038/sj.onc.1207197; Avogaro A, 2003, J CLIN ENDOCR METAB, V88, P1753, DOI 10.1210/jc.2002-021025; Bao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012371; Bodiga VL, 2013, HEART FAIL REV; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Bowman MAH, 2011, J HEART LUNG TRANSPL, V30, P1303, DOI 10.1016/j.healun.2011.06.004; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Cacciapaglia F, 2011, AUTOIMMUN REV, V10, P631, DOI 10.1016/j.autrev.2011.04.014; Cao J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00160; Cao J, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-37; Carchman EH, 2011, HEPATOLOGY, V53, P2053, DOI 10.1002/hep.24324; Chen David, 2008, Crit Care Med, V36, pS9, DOI 10.1097/01.CCM.0000297160.48694.90; Chen SL, 2004, FREE RADICAL RES, V38, P1301, DOI 10.1080/10715760400017228; Delucchi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039836; Deswal A, 2001, CIRCULATION, V103, P2055; Durante W, 2011, FRONT BIOSCI-LANDMRK, V16, P2372, DOI 10.2741/3860; El-Remessy AB, 2011, DIABETOLOGIA, V54, P1567, DOI 10.1007/s00125-011-2061-4; Falcao-Pires I, 2012, HEART FAIL REV, V17, P325, DOI 10.1007/s10741-011-9257-z; Fang ZY, 2004, ENDOCR REV, V25, P543, DOI 10.1210/er.2003-0012; Farhangkhoee H, 2003, J MOL CELL CARDIOL, V35, P1439, DOI 10.1016/j.yjmcc.2003.09.007; Fukazawa R, 2003, J MOL CELL CARDIOL, V35, P1473, DOI 10.1016/j.yjmcc.2003.09.012; Gallego M, 2009, CAN J PHYSIOL PHARM, V87, P77, DOI 10.1139/Y08-106; Gao X, 2011, EUR J PHARMACOL, V659, P199, DOI 10.1016/j.ejphar.2011.03.021; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Haines DD, 2012, ACTA PHYSIOL, V204, P487, DOI 10.1111/j.1748-1716.2011.02387.x; He CY, 2013, DIABETES, V62, P1270, DOI 10.2337/db12-0533; Hong F, 2001, LIFE SCI, V68, P1095, DOI 10.1016/S0024-3205(00)01012-2; Hsueh W, 2007, CIRC RES, V100, P1415, DOI 10.1161/01.RES.0000266449.37396.1f; Hui Y, 2012, J CARDIOVASC PHARM, V60, P474, DOI 10.1097/FJC.0b013e31826c1c13; Huynh K, 2013, FREE RADICAL BIO MED, V60, P307, DOI 10.1016/j.freeradbiomed.2013.02.021; Khong FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022777; Khullar M, 2010, CAN J PHYSIOL PHARM, V88, P233, DOI 10.1139/Y10-016; Kim AS, 2009, ACTA PHYSIOL, V196, P37, DOI 10.1111/j.1748-1716.2009.01978.x; Kim YM, 2011, ANTIOXID REDOX SIGN, V14, P137, DOI 10.1089/ars.2010.3153; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; KWAK JY, 1991, BIOCHIM BIOPHYS ACTA, V1076, P369, DOI 10.1016/0167-4838(91)90478-I; Lacombe VA, 2007, AM J PHYSIOL-REG I, V293, pR1787, DOI 10.1152/ajpregu.00059.2007; Lecour S, 2011, EUR HEART J, V32, P680, DOI 10.1093/eurheartj/ehq484; Lewis P, 2007, CIRCULATION, V115, P2178, DOI 10.1161/CIRCULATIONAHA.106.664250; Lorenzo O, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/652097; Luchner A, 2001, CARDIOVASC RES, V51, P601, DOI 10.1016/S0008-6363(01)00316-9; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Mano Y, 2011, CIRC J, V75, P1717, DOI 10.1253/circj.CJ-10-1199; Martinet W, 2007, TRENDS MOL MED, V13, P482, DOI 10.1016/j.molmed.2007.08.004; McCann FJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0049894, 10.1371/journal.pone.0052013]; Mougiakakos D, 2011, BLOOD, V117, P4826, DOI 10.1182/blood-2010-12-324038; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Octavia Y, 2012, FREE RADICAL BIO MED, V52, P291, DOI 10.1016/j.freeradbiomed.2011.10.482; Orozco LD, 2007, CIRC RES, V100, P1703, DOI 10.1161/CIRCRESAHA.107.151720; Pereira L, 2006, DIABETES, V55, P608, DOI 10.2337/diabetes.55.03.06.db05-1284; Rajesh M, 2012, DIABETES, V61, P716, DOI 10.2337/db11-0477; Rajesh M, 2010, J AM COLL CARDIOL, V56, P2115, DOI 10.1016/j.jacc.2010.07.033; Raphael J, 2006, J PHARMACOL EXP THER, V318, P186, DOI 10.1124/jpet.105.100537; Ren J, 2004, ENDOCRINE, V25, P73, DOI 10.1385/ENDO:25:2:073; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Schilling JD, 2012, AM J PHYSIOL-HEART C, V303, pH1366, DOI 10.1152/ajpheart.00111.2012; Selvaraju V, 2012, TOXICOL MECH METHOD, V22, P330, DOI 10.3109/15376516.2012.666648; Soliman H, 2012, AM J PHYSIOL-HEART C, V303, pH989, DOI 10.1152/ajpheart.00416.2012; Son SM, 2007, DIABETES RES CLIN PR, V77, pS65, DOI 10.1016/j.diabres.2007.01.036; Sun LA, 2011, J SURG RES, V166, pE187, DOI 10.1016/j.jss.2010.11.917; Van Linthout S, 2007, DIABETOLOGIA, V50, P1977, DOI 10.1007/s00125-007-0719-8; Wang GW, 2010, CIRCULATION, V121, P1912, DOI 10.1161/CIRCULATIONAHA.109.905471; Watanabe K, 2010, CURR CARDIOL REV, V6, P280, DOI 10.2174/157340310793566145; Wu ML, 2011, ANTIOXID REDOX SIGN, V15, P1835, DOI 10.1089/ars.2010.3726; Xie ZL, 2011, AUTOPHAGY, V7, P1254, DOI 10.4161/auto.7.10.16740; Xie ZL, 2011, DIABETES, V60, P1770, DOI 10.2337/db10-0351; Yoon YS, 2005, CIRCULATION, V111, P2073, DOI 10.1161/01.CIR.0000162472.52990.36; Yu XY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016239, 10.1371/journal.pone.0028397]; Zhou LY, 2011, ANAT REC, V294, P112, DOI 10.1002/ar.21284; Zou MH, 2013, AUTOPHAGY, V9, P624, DOI 10.4161/auto.23577	73	108	114	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75927	10.1371/journal.pone.0075927	http://dx.doi.org/10.1371/journal.pone.0075927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086665	Green Published, Green Submitted, gold			2022-12-27	WOS:000325025200071
J	Brameier, M; Ibing, W; Hofer, K; Montag, J; Stahl-Hennig, C; Motzkus, D				Brameier, Markus; Ibing, Wiebke; Hoefer, Katharina; Montag, Judith; Stahl-Hennig, Christiane; Motzkus, Dirk			Mapping the Small RNA Content of Simian Immunodeficiency Virions (SIV)	PLOS ONE			English	Article							SMALL NONCODING RNAS; VIRUS-LIKE PARTICLES; MESSENGER-RNA; T-CELLS; 7SL RNA; TRANSLATIONAL REPRESSION; REVERSE TRANSCRIPTION; HIV-1-INFECTED CELLS; STRUCTURAL DOMAIN; CELLULAR RNAS	Recent evidence indicates that regulatory small non-coding RNAs are not only components of eukaryotic cells and vesicles, but also reside within a number of different viruses including retroviral particles. Using ultra-deep sequencing we have comprehensively analyzed the content of simian immunodeficiency virions (SIV), which were compared to mock-control preparations. Our analysis revealed that more than 428,000 sequence reads matched the SIV (mac)239 genome sequence. Among these we could identify 12 virus-derived small RNAs (vsRNAs) that were highly abundant. Beside known retrovirus-enriched small RNAs, like 7SL-RNA, tRNA(Lys3) and tRNA(Lys) isoacceptors, we also identified defined fragments derived from small ILF3/NF90-associated RNA snaR-A14, that were enriched more than 50 fold in SIV. We also found evidence that small nucleolar RNAs U2 and U12 were underrepresented in the SIV preparation, indicating that the relative number or the content of co-isolated exosomes was changed upon infection. Our comprehensive atlas of SIV-incorporated small RNAs provides a refined picture of the composition of retrovirions, which gives novel insights into viral packaging.	[Brameier, Markus] German Primate Ctr, Primate Genet Lab, Gottingen, Germany; [Ibing, Wiebke; Hoefer, Katharina; Montag, Judith; Stahl-Hennig, Christiane; Motzkus, Dirk] German Primate Ctr, Unit Infect Models, Gottingen, Germany	Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ)	Motzkus, D (corresponding author), German Primate Ctr, Unit Infect Models, Gottingen, Germany.	dmotzkus@dpz.eu		, Judith/0000-0002-4663-6966; Hofer, Katharina/0000-0002-7472-9887	Department "Unit of Infection Models"	Department "Unit of Infection Models"	The funding was derived from the budget of the Department "Unit of Infection Models" headed by CSH at the German Primate Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDOVINI A, 1990, J VIROL, V64, P1920, DOI 10.1128/JVI.64.5.1920-1926.1990; Althaus CF, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-27; Bechtel J, 2005, J VIROL, V79, P10138, DOI 10.1128/JVI.79.16.10138-10146.2005; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; BRANLANT C, 1982, EMBO J, V1, P1259, DOI 10.1002/j.1460-2075.1982.tb00022.x; Bresnahan WA, 2000, SCIENCE, V288, P2373, DOI 10.1126/science.288.5475.2373; Cho HDD, 2002, J BIOL CHEM, V277, P3447, DOI 10.1074/jbc.M109559200; Cliffe AR, 2009, J VIROL, V83, P2321, DOI 10.1128/JVI.02303-08; Cullen BR, 2011, GENE DEV, V25, P1881, DOI 10.1101/gad.17352611; D'Souza V, 2005, NAT REV MICROBIOL, V3, P643, DOI 10.1038/nrmicro1210; DAS AT, 1995, J VIROL, V69, P3090, DOI 10.1128/JVI.69.5.3090-3097.1995; Das AT, 1997, J GEN VIROL, V78, P837, DOI 10.1099/0022-1317-78-4-837; Dettenhofer M, 1999, J VIROL, V73, P1460, DOI 10.1128/JVI.73.2.1460-1467.1999; Didierlaurent L, 2011, NUCLEIC ACIDS RES, V39, P8915, DOI 10.1093/nar/gkr577; Gabriely G, 2011, CANCER RES, V71, P3563, DOI 10.1158/0008-5472.CAN-10-3568; Greijer AE, 2000, J VIROL, V74, P9078, DOI 10.1128/JVI.74.19.9078-9082.2000; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hoque M, 2011, J MOL BIOL, V410, P917, DOI 10.1016/j.jmb.2011.03.060; Houzet L, 2007, NUCLEIC ACIDS RES, V35, P2695, DOI 10.1093/nar/gkm153; Huang J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705116200; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Hussain M, 2012, NUCLEIC ACIDS RES, V40, P2210, DOI 10.1093/nar/gkr848; JIANG M, 1993, J VIROL, V67, P3246, DOI 10.1128/JVI.67.6.3246-3253.1993; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Keene SE, 2010, J VIROL, V84, P9070, DOI 10.1128/JVI.00714-10; Kincaid RP, 2012, P NATL ACAD SCI USA, V109, P3077, DOI 10.1073/pnas.1116107109; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; Klase ZA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-15; KLEIMAN L, 1991, BIOCHEM BIOPH RES CO, V174, P1272, DOI 10.1016/0006-291X(91)91559-U; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Li ZH, 2012, NUCLEIC ACIDS RES, V40, P6787, DOI 10.1093/nar/gks307; LIAUTARD JP, 1982, J MOL BIOL, V162, P623, DOI 10.1016/0022-2836(82)90392-8; Lin J, 2007, J VIROL, V81, P12218, DOI 10.1128/JVI.01390-07; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Maute RL, 2013, P NATL ACAD SCI USA, V110, P1404, DOI 10.1073/pnas.1206761110; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Mussil B, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-77; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; NORLEY SG, 1993, BIOLOGICALS, V21, P251, DOI 10.1006/biol.1993.1082; Onafuwa-Nuga AA, 2006, RNA, V12, P542, DOI 10.1261/rna.2306306; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Parrott AM, 2007, NUCLEIC ACIDS RES, V35, P6249, DOI 10.1093/nar/gkm668; Parrott AM, 2011, NUCLEIC ACIDS RES, V39, P1485, DOI 10.1093/nar/gkq856; Pavon-Eternod M, 2010, RNA, V16, P267, DOI 10.1261/rna.1928110; Pederson T, 2010, RNA, V16, P1865, DOI 10.1261/rna.2266510; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; SALAHUDDIN SZ, 1983, VIROLOGY, V129, P51, DOI 10.1016/0042-6822(83)90395-1; Schopman NCT, 2012, VIRUS RES, V169, P438, DOI 10.1016/j.virusres.2012.06.017; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Sciortino MT, 2001, J VIROL, V75, P8105, DOI 10.1128/JVI.75.17.8105-8116.2001; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stahl-Hennig C, 1999, SCIENCE, V285, P1261, DOI 10.1126/science.285.5431.1261; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Wang SW, 2002, J VIROL, V76, P11853, DOI 10.1128/JVI.76.23.11853-11865.2002; WASSARMAN KM, 1992, MOL CELL BIOL, V12, P1276, DOI 10.1128/MCB.12.3.1276; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yeung ML, 2009, NUCLEIC ACIDS RES, V37, P6575, DOI 10.1093/nar/gkp707	69	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75063	10.1371/journal.pone.0075063	http://dx.doi.org/10.1371/journal.pone.0075063			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086438	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200078
J	Chen, R; Ren, SC; Meng, T; Aguilar, J; Sun, YH				Chen, Rui; Ren, Shancheng; Meng, Tong; Aguilar, Josephine; Sun, Yinghao			Impact of Glutathione-S-Transferases (GST) Polymorphisms and Hypermethylation of Relevant Genes on Risk of Prostate Cancer Biochemical Recurrence: A Meta-Analysis	PLOS ONE			English	Article							CPG ISLAND HYPERMETHYLATION; RADICAL PROSTATECTOMY; METHYLATION; MORTALITY; PROBABILITY; PROFILE; PTGS2; APC	Introduction: Accurate prediction of the biochemical recurrence (BCR) is critical for patients after intended curative therapy like radical prostatectomy (RP) or definitive radiotherapy for prostate cancer. Glutathione-S-transferases polymorphisms as well as hypermethylation of GSTP1 and functional genes in carcinogenesis, including tumor suppression gene (APC), hormone receptor that regulates cell growth and differentiation gene (RARbeta) were reported to be associated with BCR. Nevertheless, the reported results are inconsistent. To evaluate the relationship between glutathione-S-transferases polymorphisms and hypermethylation of these genes and the risk of prostate cancer BCR, we carried out a meta-analysis of the published studies. Methods and Materials: We performed a search in Medline, Embase and CNKI database with GST, APC, RARbeta in combination with single nucleotide polymorphism, hypermethylation, prostate cancer and recurrence. Languages were restricted to English and Chinese. Results: Our study included 4 case-control studies and 7 cohort studies including 12 data sets and 3,037 prostate cancer patients. We confirmed that APC hypermethylation is associated with a modest hazard for biochemical recurrence after RP (HR = 1.85, 95% CI = 1.12-3.06). We also suggest GSTP1 polymorphism and CpG hypermethylation tested in serum are associated with BCR (HR = 1.94, 95% CI = 1.13-3.34). We also identified a possible association between GSTM1 null polymorphism and prostate cancer biochemical recurrence risk with borderline significance (HR = 1.29, 95% CI = 0.97-1.71). Conclusion: To our knowledge, this is the first meta-analysis evaluating the relationship of polymorphisms and hypermethylation in GSTs and biochemical recurrence. GSTM1, GSTP1 polymorphisms and hypermethylation of GSTP1, APC may be potential biomarkers for the evaluation of the probability of BCR. Further studies are warranted to validate these findings in larger cohorts with longer follow-up.	[Chen, Rui; Ren, Shancheng; Sun, Yinghao] Second Mil Med Univ, Shanghai Changhai Hosp, Dept Urol, Shanghai, Peoples R China; [Meng, Tong] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Orthoped, Shanghai, Peoples R China; [Aguilar, Josephine] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	Naval Medical University; Naval Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sun, YH (corresponding author), Second Mil Med Univ, Shanghai Changhai Hosp, Dept Urol, Shanghai, Peoples R China.	sunyh@medmail.com.cn						Agalliu I, 2006, PROSTATE, V66, P1535, DOI 10.1002/pros.20491; Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Bastian PJ, 2007, EUR UROL, V51, P665, DOI 10.1016/j.eururo.2006.08.008; Bastian PJ, 2005, CLIN CANCER RES, V11, P4037, DOI 10.1158/1078-0432.CCR-04-2446; Busch J, 2012, BJU INT, V110, pE985, DOI 10.1111/j.1464-410X.2012.11279.x; Chiam K, 2012, CANC LETT; Chun FKH, 2007, WORLD J UROL, V25, P131, DOI 10.1007/s00345-007-0146-y; Cotignola J, 2012, PROSTATE CANC PROSTA; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dluzniewski PJ, 2012, CANCER EPIDEM BIOMAR, V21, P1774, DOI 10.1158/1055-9965.EPI-12-0458; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ellinger J, 2008, UROLOGY, V71, P161, DOI 10.1016/j.urology.2007.09.056; Ellinger J, 2008, PROSTATE, V68, P42, DOI 10.1002/pros.20651; Esteller M, 2001, CANCER RES, V61, P3225; Freedland SJ, 2005, JAMA-J AM MED ASSOC, V294, P433, DOI 10.1001/jama.294.4.433; Freedland SJ, 2003, UROLOGY, V61, P365, DOI 10.1016/S0090-4295(02)02268-9; Gsur A, 2001, INT J CANCER, V95, P152, DOI 10.1002/1097-0215(20010520)95:3<152::AID-IJC1026>3.0.CO;2-S; Han M, 2003, J UROLOGY, V169, P517, DOI 10.1016/S0022-5347(05)63946-8; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeronimo C, 2004, CLIN CANCER RES, V10, P8472, DOI 10.1158/1078-0432.CCR-04-0894; Liu LY, 2011, INT J CANCER, V129, P2454, DOI 10.1002/ijc.25908; Mahapatra S, 2012, CLIN CANCER RES, V18, P2882, DOI 10.1158/1078-0432.CCR-11-2090; MANTEL N, 1959, J NATL CANCER I, V22, P719; Nock NL, 2009, CANCER CAUSE CONTROL, V20, P1915, DOI 10.1007/s10552-009-9385-0; Phe V, 2010, BJU INT, V105, P1364, DOI 10.1111/j.1464-410X.2009.09167.x; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Rosenbaum E, 2005, CLIN CANCER RES, V11, P8321, DOI 10.1158/1078-0432.CCR-05-1183; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Stephenson AJ, 2006, JNCI-J NATL CANCER I, V98, P715, DOI 10.1093/jnci/djj190; Suardi N, 2008, CANCER-AM CANCER SOC, V112, P1254, DOI 10.1002/cncr.23293; Trock BJ, 2012, BJU INT, V110, P56, DOI 10.1111/j.1464-410X.2011.10718.x; Wei BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046982; Wiklund FE, 2009, CANCER EPIDEM BIOMAR, V18, P1659, DOI 10.1158/1055-9965.EPI-08-1148; Woodson K, 2006, EPIGENETICS-US, V1, P183, DOI 10.4161/epi.1.4.3530; Yegnasubramanian S, 2004, CANCER RES, V64, P1975, DOI 10.1158/0008-5472.CAN-03-3972	36	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74775	10.1371/journal.pone.0074775	http://dx.doi.org/10.1371/journal.pone.0074775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086370	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200041
J	Contreras-Ruiz, L; Regenfuss, B; Mir, FA; Kearns, J; Masli, S				Contreras-Ruiz, Laura; Regenfuss, Birgit; Mir, Fayaz Ahmad; Kearns, James; Masli, Sharmila			Conjunctival Inflammation in Thrombospondin-1 Deficient Mouse Model of Sjogren's Syndrome	PLOS ONE			English	Article							FLOW-CYTOMETRIC ANALYSIS; ROR-GAMMA-T; OCULAR SURFACE; DENDRITIC CELLS; CUTTING EDGE; EXPRESSION; LIGATION; RECEPTOR; PATHWAY; DISEASE	Lacrimal gland inflammation during autoimmune Sjogren's syndrome (SS) leads to ocular surface inflammation Keratoconjunctivitis sicca (KCS). This condition afflicts both the cornea and conjunctiva that form the ocular surface. Thrombospondin-1 (TSP-1) deficiency in mice results in lacrimal gland and corneal inflammation that resembles the human disease. In this study we report conjunctival pathology in this mouse model of SS. We found that TSP-1 null mice develop inflammation in the conjunctiva and associated loss of goblet cell function similar to that seen in patients with SS. Increased expression of Th1 (IFN-gamma, TNF-alpha) and Th17 (IL-6, IL-17A) inflammatory cytokines and related transcription factors (Tbet and ROR gamma t) were detected in TSP-1 null conjunctiva as well as their draining lymph nodes (LNs). The conjunctival inflammation was also accompanied by an increase in local lymphatic vessels. Interestingly, migration of antigen-bearing dendritic cells (DCs) from the ocular surface to the LNs was dependent on the TSP-1 available in the tissue. These results not only reveal potential immunopathogenic mechanisms underlying KCS in SS but also highlight the therapeutic potential of TSP-1.	Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA USA; Harvard Univ, Sch Med, Dept Ophthalmol, Massachusetts Eye & Ear, Boston, MA USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Masli, S (corresponding author), Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA.	smasli@bu.edu			National Institute of Health [EY015472]; NATIONAL EYE INSTITUTE [R01EY015472] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by National Institute of Health grant EY015472. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Argueso P, 2002, INVEST OPHTH VIS SCI, V43, P1004; Avice MN, 2000, J IMMUNOL, V165, P4624, DOI 10.4049/jimmunol.165.8.4624; Brignole F, 2000, INVEST OPHTH VIS SCI, V41, P1356; Calonge M, 2004, EXP EYE RES, V78, P457, DOI 10.1016/j.exer.2003.09.009; Chen L, 2005, INVEST OPHTH VIS SCI, V46, P4536, DOI 10.1167/iovs.05-0975; Cursiefen C, 2011, J EXP MED, V208, P1083, DOI 10.1084/jem.20092277; Doyen V, 2003, J EXP MED, V198, P1277, DOI 10.1084/jem.20030705; Grimbert P, 2006, J IMMUNOL, V177, P3534, DOI 10.4049/jimmunol.177.6.3534; HOFFMAN RW, 1984, ARTHRITIS RHEUM, V27, P157, DOI 10.1002/art.1780270206; HU YF, 1992, AM J PHYSIOL, V263, pE607, DOI 10.1152/ajpendo.1992.263.4.E607; Hyon JY, 2007, CORNEA, V26, pS13, DOI 10.1097/ICO.0b013e31812f6782; Jonsson R, 2011, IMMUNOL LETT, V141, P1, DOI 10.1016/j.imlet.2011.06.007; Kassan SS, 2004, ARCH INTERN MED, V164, P1275, DOI 10.1001/archinte.164.12.1275; Katsifis GE, 2007, CLIN REV ALLERG IMMU, V32, P252, DOI 10.1007/s12016-007-8011-8; Koufakis DI, 2006, INVEST OPHTH VIS SCI, V47, P541, DOI 10.1167/iovs.05-0804; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; Masli S, 2006, INT IMMUNOL, V18, P689, DOI 10.1093/intimm/dxl006; Nguyen CQ, 2007, J IMMUNOL, V179, P2318, DOI 10.4049/jimmunol.179.4.2318; Nguyen CQ, 2009, OCUL SURF, V7, P11, DOI 10.1016/S1542-0124(12)70289-6; PFLUGFELDER SC, 1990, OPHTHALMOLOGY, V97, P985; Pflugfelder SC, 1999, CURR EYE RES, V19, P201, DOI 10.1076/ceyr.19.3.201.5309; Pisella PJ, 2000, OPHTHALMOLOGY, V107, P1841, DOI 10.1016/S0161-6420(00)00347-X; Powell N, 2010, MUCOSAL IMMUNOL, V3, P567, DOI 10.1038/mi.2010.53; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; RAPHAEL M, 1988, HISTOPATHOLOGY, V13, P191, DOI 10.1111/j.1365-2559.1988.tb02024.x; Reynders A, 2011, EMBO J, V30, P2934, DOI 10.1038/emboj.2011.201; Saban DR, 2010, J IMMUNOL, V185, P4691, DOI 10.4049/jimmunol.1001133; Saeki H, 1999, J IMMUNOL, V162, P2472; Sarfati M, 2008, CURR DRUG TARGETS, V9, P842, DOI 10.2174/138945008785909310; Schlereth S, 2012, AM J PATHOL, V180, P2351, DOI 10.1016/j.ajpath.2012.02.015; Sekiyama E, 2006, INVEST OPHTH VIS SCI, V47, P1352, DOI 10.1167/iovs.05-1305; Stern ME, 2002, INVEST OPHTH VIS SCI, V43, P2609; Turpie B, 2009, AM J PATHOL, V175, P1136, DOI 10.2353/ajpath.2009.081058; Villani E, 2007, INVEST OPHTH VIS SCI, V48, P2017, DOI 10.1167/iovs.06-1129; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wakamatsu TH, 2010, INVEST OPHTH VIS SCI, V51, P144, DOI 10.1167/iovs.08-2722; Yoon KC, 2007, CORNEA, V26, P431, DOI 10.1097/ICO.0b013e31803dcda2; Yu DF, 2012, EXP EYE RES, V103, P22, DOI 10.1016/j.exer.2012.07.005; Zamiri P, 2005, INVEST OPHTH VIS SCI, V46, P908, DOI 10.1167/iovs.04-0362; Zhang XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036822	41	47	50	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75937	10.1371/journal.pone.0075937	http://dx.doi.org/10.1371/journal.pone.0075937			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086667	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200125
J	Lim, HC; Xie, L; Zhang, W; Li, R; Chen, ZC; Wu, GZ; Cui, SS; Tan, EK; Zeng, L				Lim, Han Chi; Xie, Li; Zhang, Wei; Li, Rong; Chen, Zhong-Can; Wu, Guang-Zhi; Cui, Shu-Sen; Tan, Eng King; Zeng, Li			Ribosomal S6 Kinase 2 (RSK2) Maintains Genomic Stability by Activating the Atm/p53-Dependent DNA Damage Pathway	PLOS ONE			English	Article							COFFIN-LOWRY-SYNDROME; ATAXIA-TELANGIECTASIA GENE; CELL-CYCLE; INTERACTING PROTEIN; C-ABL; ATM; PHOSPHORYLATION; REPAIR; P53; APOPTOSIS	Ribosomal S6 Kinase 2 (RSK2) is a member of the p90 RSK family of serine/threonine kinases, which are widely expressed and respond to many growth factors, peptide hormones, and neurotransmitters. Loss-of function mutations in the RPS6KA3 gene, which encodes the RSK2 protein, have been implicated in Coffin-Lowry Syndrome (CLS), an X-linked mental retardation disorder associated with cognitive deficits and behavioral impairments. However, the cellular and molecular mechanisms underlying this neurological disorder are not known. Recent evidence suggests that defective DNA damage signaling might be associated with neurological disorders, but the role of RSK2 in the DNA damage pathway remains to be elucidated. Here, we show that Adriamycin-induced DNA damage leads to the phosphorylation of RSK2 at Ser227 and Thr577 in the chromatin fraction, promotes RSK2 nuclear translocation, and enhances RSK2 and Atm interactions in the nuclear fraction. Furthermore, using RSK2 knockout mouse fibroblasts and RSK2-deficient cells from CLS patients, we demonstrate that ablation of RSK2 impairs the phosphorylation of Atm at Ser1981 and the phosphorylation of p53 at Ser18 (mouse) or Ser15 (human) in response to genotoxic stress. We also show that RSK2 affects p53-mediated downstream cellular events in response to DNA damage, that RSK2 knockout relieves cell cycle arrest at the G2/M phase, and that an increased number of cH2AX foci, which are associated with defects in DNA repair, are present in RSK2-deficient cells. Taken together, our findings demonstrated that RSK2 plays an important role in the DNA damage pathway that maintains genomic stability by mediating cell cycle progression and DNA repair.	[Lim, Han Chi; Xie, Li; Zhang, Wei; Zeng, Li] Natl Neurosci Inst, Res Dept, Neural Stem Cell Res Lab, Singapore, Singapore; [Li, Rong] ASTAR, Biomed Sci Inst BMSI, Ctr Expt Therapeut, Singapore, Singapore; [Li, Rong; Chen, Zhong-Can] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore; [Wu, Guang-Zhi; Cui, Shu-Sen] Jilin Univ, Dept Hand Surg, China Japan Union Hosp, Changchun 130023, Jinlin Province, Peoples R China; [Tan, Eng King] Natl Neurosci Inst, Res Dept, Singapore, Singapore; [Tan, Eng King] Natl Neurosci Inst, Dept Neurol, Singapore, Singapore; [Tan, Eng King; Zeng, Li] DUKE NUS Grad Med Sch, Neurosci & Behav Disorders Program, Singapore, Singapore	National Neuroscience Institute (NNI); Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; National University of Singapore; Jilin University; National Neuroscience Institute (NNI); National Neuroscience Institute (NNI); National University of Singapore	Zeng, L (corresponding author), Natl Neurosci Inst, Res Dept, Neural Stem Cell Res Lab, Singapore, Singapore.	Li_ZENG@nni.com.sg	Xie, Li/ABE-2011-2020	Xie, Li/0000-0002-5555-5762	Singapore Ministry of Health's National Medical Research Council [NMRC/1200/2009]	Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore)	This research is supported by the Singapore Ministry of Health's National Medical Research Council under its NMRC/1200/2009 to L.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ahles TA, 2007, NAT REV CANCER, V7, P192, DOI 10.1038/nrc2073; Allen DR, 2001, GENE DEV, V15, P554, DOI 10.1101/gad.869001; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Barlow C, 2000, P NATL ACAD SCI USA, V97, P871, DOI 10.1073/pnas.97.2.871; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Brown KD, 1997, P NATL ACAD SCI USA, V94, P1840, DOI 10.1073/pnas.94.5.1840; Cescutti R, 2010, EMBO J, V29, P3723, DOI 10.1038/emboj.2010.238; Chaturvedi D, 2006, MOL CELL BIOL, V26, P4586, DOI 10.1128/MCB.01422-05; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Cho YY, 2005, CANCER RES, V65, P3596, DOI 10.1158/0008-5472.CAN-04-3935; Collins I, 2001, MOL CELL BIOL, V21, P8437, DOI 10.1128/MCB.21.24.8437-8451.2001; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Dugani CB, 2010, DEV BIOL, V347, P348, DOI 10.1016/j.ydbio.2010.08.035; Eisinger-Mathason TSK, 2008, MOL CELL, V31, P722, DOI 10.1016/j.molcel.2008.06.025; ENOCH T, 1995, TRENDS BIOCHEM SCI, V20, P426, DOI 10.1016/S0968-0004(00)89093-3; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; HARPER JW, 1993, CELL, V75, P805; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Kesler SR, 2007, NEUROGENETICS, V8, P143, DOI 10.1007/s10048-007-0080-6; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Konat GW, 2008, METAB BRAIN DIS, V23, P325, DOI 10.1007/s11011-008-9100-y; Mehmood T, 2011, HUM GENET, V129, P255, DOI 10.1007/s00439-010-0918-0; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Norbury CJ, 2001, ANNU REV PHARMACOL, V41, P367, DOI 10.1146/annurev.pharmtox.41.1.367; O'Driscoll M, 2004, DNA REPAIR, V3, P1227, DOI 10.1016/j.dnarep.2004.03.025; Pereira PM, 2010, EUR J HUM GENET, V18, P627, DOI 10.1038/ejhg.2009.189; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Saykin AJ, 2006, NEUROLOGY, V67, P834, DOI 10.1212/01.wnl.0000234032.77541.a2; SELVAKUMARAN M, 1994, ONCOGENE, V9, P1791; She QB, 2002, J BIOL CHEM, V277, P24039, DOI 10.1074/jbc.M109907200; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Strachan RT, 2010, BIOCHEMISTRY-US, V49, P2657, DOI 10.1021/bi901921k; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; Wang X, 2011, CELL DEATH DIFFER, V18, P5, DOI 10.1038/cdd.2010.106; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Watson K, 2005, MOL PHARMACOL, V67, P757, DOI 10.1124/mol.104.004812; Wyman C, 2004, DNA REPAIR, V3, P827, DOI 10.1016/j.dnarep.2004.03.037; Zeng L, 2005, J BIOL CHEM, V280, P29374, DOI 10.1074/jbc.M503016200; Zeniou M, 2002, HUM MOL GENET, V11, P2929, DOI 10.1093/hmg/11.23.2929; Zhang YG, 2003, J BIOL CHEM, V278, P12650, DOI 10.1074/jbc.M210368200; Zhang YG, 2001, J BIOL CHEM, V276, P42534, DOI 10.1074/jbc.M106044200; Zhu F, 2011, CANCER RES, V71, P393, DOI 10.1158/0008-5472.CAN-10-2012; Zykova TA, 2007, CARCINOGENESIS, V28, P1543, DOI 10.1093/carcin/bgm070	48	14	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74334	10.1371/journal.pone.0074334	http://dx.doi.org/10.1371/journal.pone.0074334			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086335	gold, Green Published, Green Submitted			2022-12-27	WOS:000326520200028
J	Rajpara, N; Vinothkumar, K; Mohanty, P; Singh, AK; Singh, R; Sinha, R; Nag, D; Koley, H; Bhardwaj, AK				Rajpara, Neha; Vinothkumar, Kittappa; Mohanty, Priyabrata; Singh, Arun Kumar; Singh, Rajesh; Sinha, Ritam; Nag, Dhrubajyoti; Koley, Hemanta; Bhardwaj, Ashima Kushwaha			Synergistic Effect of Various Virulence Factors Leading to High Toxicity of Environmental V. cholerae Non-O1/Non-O139 Isolates Lacking ctx Gene : Comparative Study with Clinical Strains	PLOS ONE			English	Article							VIBRIO-CHOLERAE; MOLECULAR ANALYSIS; TOXIN GENE; NON-O1; O1; PROTEASE; OUTBREAK; PATHOGENICITY; DIARRHEA; HEMAGGLUTININ	Background: Vibrio cholerae non-O1/non-O139 serogroups have been reported to cause sporadic diarrhoea in humans. Cholera toxins have been mostly implicated for hypersecretion of ions and water into the small intestine. Though most of the V. cholerae non-O1/non-O139 strains lack these cholera toxins, several other innate virulence factors contribute towards their pathogenicity. The environmental isolates may thus act as reservoirs for potential spreading of these virulence genes in the natural environment which may cause the emergence of epidemic-causing organisms. Results: The environmental isolates of vibrios were obtained from water samples, zooplanktons and phytoplanktons, from a village pond in Gandhinagar, Gujarat, India. They were confirmed as Vibrio cholerae non-O1/non-O139 using standard biochemical and serotyping tests. PCR experiments revealed that the isolates lacked ctxA, ctxB, tcpA, zot and ace genes whereas other pathogenicity genes like toxR, rtxC, hlyA, hapA and prtV were detected in these isolates. Compared with epidemic strain V. cholerae O1 El Tor N16961, culture supernatants from most of these isolates caused higher cytotoxicity to HT29 cells and higher hemolytic, hemagglutinin and protease activities. In rabbit ileal loop assays, the environmental isolates showed only 2-4 folds lesser fluid accumulation in comparison to N16961 and a V. cholerae clinical isolate IDH02365 of 2009. Pulsed Field Gel electrophoresis and Random amplification of Polymorphic DNA indicated that these isolates showed considerable diversity and did not share the same clonal lineage even though they were derived from the same water source. All the isolates showed resistance to one or more antibiotics. Conclusion: Though these environmental isolates lacked the cholera toxins, they seem to have adopted other survival strategies by optimally utilising a diverse array of several other toxins. The current findings indicate the possibility that these isolates could cause some gastroenteric inflammation when ingested and may serve as progenitors for overt disease-causing organisms.	[Rajpara, Neha; Vinothkumar, Kittappa; Mohanty, Priyabrata; Bhardwaj, Ashima Kushwaha] Indian Inst Adv Res, Sch Biol Sci & Biotechnol, Dept Human Hlth & Dis, Gandhinagar, Gujarat, India; [Singh, Arun Kumar; Singh, Rajesh] Indian Inst Adv Res, Sch Biol Sci & Biotechnol, Dept Cell Biol, Gandhinagar, Gujarat, India; [Sinha, Ritam; Nag, Dhrubajyoti; Koley, Hemanta] Natl Inst Cholera & Enter Dis, Kolkata, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Bhardwaj, AK (corresponding author), Indian Inst Adv Res, Sch Biol Sci & Biotechnol, Dept Human Hlth & Dis, Gandhinagar, Gujarat, India.	ashima.bhardwaj@gmail.com			Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India [BT/PR/11634/INF/22/104/2008]; Puri Foundation for Education in India; Indian Council of Medical Research, New Delhi, India [AMR/49/11-ECDI, F/815/2011-ECD-II]; Gujarat State Biotechnology Mission [GSBTM/MD/PROJECTS/SSA/3386/2012-13]	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Puri Foundation for Education in India; Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR)); Gujarat State Biotechnology Mission	This work was partially supported by the grant BT/PR/11634/INF/22/104/2008 from the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India. The authors thankfully acknowledge the partial funding received from The Puri Foundation for Education in India. N.R. and P. M. are the recipients of Senior Research Fellowships from Indian Council of Medical Research, New Delhi, India with grant numbers AMR/49/11-ECDI and F/815/2011-ECD-II respectively. K. V. is recipient of Junior Research Fellowship from Gujarat State Biotechnology Mission GSBTM/MD/PROJECTS/SSA/3386/2012-13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P5137, DOI 10.1093/nar/20.19.5137; Bag PK, 2008, APPL ENVIRON MICROB, V74, P5635, DOI 10.1128/AEM.00029-08; BAGCHI K, 1993, J CLIN MICROBIOL, V31, P1315, DOI 10.1128/JCM.31.5.1315-1317.1993; Begum K, 2006, CELL MOL IMMUNOL, V3, P115; Bidinost C., 2004, Rev. argent. microbiol., V36, P158; Chakraborty R, 2005, J MED MICROBIOL, V54, P707, DOI 10.1099/jmm.0.45820-0; Chakraborty S, 2001, J MED MICROBIOL, V50, P879, DOI 10.1099/0022-1317-50-10-879; Chen Y, 2007, INFECT IMMUN, V75, P2645, DOI 10.1128/IAI.01317-06; Chow KH, 2001, J CLIN MICROBIOL, V39, P2594, DOI 10.1128/JCM.39.7.2594-2597.2001; CLSI, 2010, PERF STAND ANT SUSC; COLWELL RR, 1981, APPL ENVIRON MICROB, V41, P555, DOI 10.1128/AEM.41.2.555-558.1981; DALSGAARD A, 1995, J CLIN MICROBIOL, V33, P2715, DOI 10.1128/JCM.33.10.2715-2722.1995; DE SN, 1953, J PATHOL BACTERIOL, V66, P559, DOI 10.1002/path.1700660228; Dziejman M, 2005, P NATL ACAD SCI USA, V102, P3465, DOI 10.1073/pnas.0409918102; Dziejman M, 2002, P NATL ACAD SCI USA, V99, P1556, DOI 10.1073/pnas.042667999; Faruque SM, 2004, DNA CELL BIOL, V23, P723, DOI 10.1089/dna.2004.23.723; Faruque SM, 2003, INFECT IMMUN, V71, P1020, DOI 10.1128/IAI.71.2.1020-1025.2003; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Ghosh A, 2006, INFECT IMMUN, V74, P2937, DOI 10.1128/IAI.74.5.2937-2946.2006; HASAN NA, 2012, P NATL ACAD SCI USA, V109, pE2010, DOI DOI 10.1073/pnas.1207359109; HONDA T, 1987, INFECT IMMUN, V55, P451, DOI 10.1128/IAI.55.2.451-454.1987; HONDA T, 1989, INFECT IMMUN, V57, P2799, DOI 10.1128/IAI.57.9.2799-2803.1989; HUQ A, 1984, APPL ENVIRON MICROB, V48, P420, DOI 10.1128/AEM.48.2.420-424.1984; HUQ A, 1995, LANCET, V345, P1249, DOI 10.1016/S0140-6736(95)92038-2; ICHINOSE Y, 1987, INFECT IMMUN, V55, P1090, DOI 10.1128/IAI.55.5.1090-1093.1987; ISLAM MS, 1990, CAN J MICROBIOL, V36, P464, DOI 10.1139/m90-081; KARAOLIS DKR, 1995, J BACTERIOL, V177, P3191, DOI 10.1128/jb.177.11.3191-3198.1995; Khuntia HK, 2008, AM J TROP MED HYG, V78, P819, DOI 10.4269/ajtmh.2008.78.819; Koley H, 1999, J MED MICROBIOL, V48, P51, DOI 10.1099/00222615-48-1-51; Kumar P, 2009, J MED MICROBIOL, V58, P234, DOI 10.1099/jmm.0.002089-0; KUMAR P, 2005, INDIAN J COMMUN MED, V30, P146; Kumar P, 2008, APPL BIOCHEM BIOTECH, V151, P256, DOI 10.1007/s12010-008-8184-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mukhopadhyay AK, 2001, J BACTERIOL, V183, P4737, DOI 10.1128/JB.183.16.4737-4746.2001; Nandi B, 2000, J CLIN MICROBIOL, V38, P4145, DOI 10.1128/JCM.38.11.4145-4151.2000; OLSVIK O, 1993, J CLIN MICROBIOL, V31, P22, DOI 10.1128/JCM.31.1.22-25.1993; Parsons MB, 2007, FOODBORNE PATHOG DIS, V4, P285, DOI 10.1089/fpd.2007.0089; Rajpara N, 2009, INT J ANTIMICROB AG, V34, P220, DOI 10.1016/j.ijantimicag.2009.03.020; Rivera ING, 2001, APPL ENVIRON MICROB, V67, P2421, DOI 10.1128/AEM.67.6.2421-2429.2001; Rudra S, 1996, INDIAN J MED RES, V103, P71; Sharma C, 1998, J CLIN MICROBIOL, V36, P756, DOI 10.1128/JCM.36.3.756-763.1998; Shinoda S, 2011, BIOCONTROL SCI, V16, P1, DOI 10.4265/bio.16.1; Sikora AE, 2011, J BIOL CHEM, V286, P16555, DOI 10.1074/jbc.M110.211078; Singh DV, 1996, J MED MICROBIOL, V45, P35, DOI 10.1099/00222615-45-1-35; Singh DV, 2001, APPL ENVIRON MICROB, V67, P910, DOI 10.1128/AEM.67.2.910-921.2001; Syngkon A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013122; Thungapathra M, 2002, ANTIMICROB AGENTS CH, V46, P2948, DOI 10.1128/AAC.46.9.2948-2955.2002; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; WHO, 1987, WHOCDD833	49	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e76200	10.1371/journal.pone.0076200	http://dx.doi.org/10.1371/journal.pone.0076200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086707	gold, Green Published, Green Submitted			2022-12-27	WOS:000326520200130
J	Giezendanner, S; Walther, S; Razavi, N; Van Swam, C; Fisler, MS; Soravia, LM; Andreotti, J; Schwab, S; Jann, K; Wiest, R; Horn, H; Muller, TJ; Dierks, T; Federspiel, A				Giezendanner, Stephanie; Walther, Sebastian; Razavi, Nadja; Van Swam, Claudia; Fisler, Melanie Sarah; Soravia, Leila Maria; Andreotti, Jennifer; Schwab, Simon; Jann, Kay; Wiest, Roland; Horn, Helge; Mueller, Thomas Joerg; Dierks, Thomas; Federspiel, Andrea			Alterations of White Matter Integrity Related to the Season of Birth in Schizophrenia: A DTI Study	PLOS ONE			English	Article							PRENATAL IMMUNE CHALLENGE; RECENT-ONSET SCHIZOPHRENIA; BIPOLAR DISORDER; 1ST-EPISODE SCHIZOPHRENIA; CORPUS-CALLOSUM; STRUCTURAL ABNORMALITIES; GENERAL-POPULATION; VOXELWISE ANALYSIS; BRAIN; MRI	In schizophrenia there is a consistent epidemiological finding of a birth excess in winter and spring. Season of birth is thought to act as a proxy indicator for harmful environmental factors during foetal maturation. There is evidence that prenatal exposure to harmful environmental factors may trigger pathologic processes in the neurodevelopment, which subsequently increase the risk of schizophrenia. Since brain white matter alterations have repeatedly been found in schizophrenia, the objective of this study was to investigate whether white matter integrity was related to the season of birth in patients with schizophrenia. Thirty-four patients with schizophrenia and 33 healthy controls underwent diffusion tensor imaging. Differences in the fractional anisotropy maps of schizophrenia patients and healthy controls born in different seasons were analysed with tract-based spatial statistics. A significant main effect of season of birth and an interaction of group and season of birth showed that patients born in summer had significantly lower fractional anisotropy in widespread white matter regions than those born in the remainder of the year. Additionally, later age of schizophrenia onset was found in patients born in winter months. The current findings indicate a relationship of season of birth and white matter alterations in schizophrenia and consequently support the neurodevelopmental hypothesis of early pathological mechanisms in schizophrenia.	[Giezendanner, Stephanie; Walther, Sebastian; Razavi, Nadja; Van Swam, Claudia; Fisler, Melanie Sarah; Soravia, Leila Maria; Andreotti, Jennifer; Schwab, Simon; Jann, Kay; Horn, Helge; Mueller, Thomas Joerg; Dierks, Thomas; Federspiel, Andrea] Univ Bern, Univ Hosp Psychiat, Dept Psychiat Neurophysiol, Bern, Switzerland; [Wiest, Roland] Univ Bern, Inselspital, Univ Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland; [Wiest, Roland] Univ Bern, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern	Giezendanner, S (corresponding author), Univ Bern, Univ Hosp Psychiat, Dept Psychiat Neurophysiol, Bern, Switzerland.	giezendanner@puk.unibe.ch; federpsiel@puk.unibe.ch	Walther, Sebastian/E-3486-2010; Jann, Kay/AAF-2154-2020; Müller, Thomas/D-1212-2010; Schwab, Simon/ABI-8495-2020; Dierks, Thomas/B-7092-2012	Walther, Sebastian/0000-0003-4026-3561; Müller, Thomas/0000-0001-9315-8138; Schwab, Simon/0000-0002-1588-2689; Dierks, Thomas/0000-0002-4173-5308; Jann, Kay/0000-0003-3574-0538; Giezendanner, Stephanie/0000-0001-5660-9446; Soravia, Leila Maria/0000-0002-4924-7771	Swiss National Science Foundation [SNSF: 32003B-112578, SNSF: 2003B-124947]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by The Swiss National Science Foundation (http://www.snf.ch/D/Seiten/default.aspx) (SNSF: 32003B-112578 and SNSF: 2003B-124947). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson JLR, 2007, NONLINEAR REGISTRATI; Andreasen NC, 2011, BIOL PSYCHIAT, V70, P672, DOI 10.1016/j.biopsych.2011.05.017; [Anonymous], 2010, R LANG ENV STAT COMP; APA, 1994, DIAGN STAT MAN MENT; Ardekani BA, 2003, NEUROREPORT, V14, P2025, DOI 10.1097/00001756-200311140-00004; Barkovich AJ, 2000, AM J NEURORADIOL, V21, P1099; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; BOYD JH, 1986, SCHIZOPHRENIA BULL, V12, P173, DOI 10.1093/schbul/12.2.173; Brown AS, 2011, PROG NEUROBIOL, V93, P23, DOI 10.1016/j.pneurobio.2010.09.003; Cheung V, 2008, PSYCHOL MED, V38, P877, DOI 10.1017/S0033291707001808; DAMATO T, 1994, PSYCHIAT RES-NEUROIM, V55, P65, DOI 10.1016/0925-4927(94)90001-9; De Peri L, 2012, CURR PHARM DESIGN, V18, P486, DOI 10.2174/138161212799316253; DEGREEF G, 1988, BIOL PSYCHIAT, V24, P461, DOI 10.1016/0006-3223(88)90186-2; DeQuardo JR, 1996, SCHIZOPHR RES, V20, P275, DOI 10.1016/0920-9964(95)00003-8; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Fatemi SH, 2008, SCHIZOPHR RES, V99, P56, DOI 10.1016/j.schres.2007.11.018; Fatemi SH, 2009, SCHIZOPHR RES, V112, P46, DOI 10.1016/j.schres.2009.04.014; Fatemi SH, 2009, SCHIZOPHRENIA BULL, V35, P528, DOI 10.1093/schbul/sbn187; Fatemi SH, 2002, MOL PSYCHIATR, V7, P633, DOI 10.1038/sj.mp.4001046; Federspiel A, 2006, NEUROBIOL DIS, V22, P702, DOI 10.1016/j.nbd.2006.01.015; Frangou S, 1996, BRIT MED BULL, V52, P587; Fujiwara H, 2007, SCHIZOPHR RES, V95, P215, DOI 10.1016/j.schres.2007.05.044; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; Henze R, 2012, NEUROSCI LETT, V513, P178, DOI 10.1016/j.neulet.2012.02.032; Hori H, 2012, PSYCHIAT RES, V195, P69, DOI 10.1016/j.psychres.2011.07.028; Hubl D, 2004, ARCH GEN PSYCHIAT, V61, P658, DOI 10.1001/archpsyc.61.7.658; Kanaan R, 2009, BRIT J PSYCHIAT, V194, P236, DOI 10.1192/bjp.bp.108.054320; Karlsgodt KH, 2008, BIOL PSYCHIAT, V63, P512, DOI 10.1016/j.biopsych.2007.06.017; Kasprian G, 2008, NEUROIMAGE, V43, P213, DOI 10.1016/j.neuroimage.2008.07.026; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Knochel C, 2012, SCHIZOPHR RES, V140, P129, DOI 10.1016/j.schres.2012.06.001; Krabbendam L, 2005, SCHIZOPHRENIA BULL, V31, P795, DOI 10.1093/schbul/sbi060; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kubicki M, 2005, NEUROIMAGE, V26, P1109, DOI 10.1016/j.neuroimage.2005.03.026; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Li Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006354; Mamah D, 2010, PSYCHIAT RES-NEUROIM, V183, P144, DOI 10.1016/j.pscychresns.2010.04.013; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McGrath JJ, 2006, SCHIZOPHR RES, V81, P91, DOI 10.1016/j.schres.2005.07.017; Messias E, 2004, ARCH GEN PSYCHIAT, V61, P985, DOI 10.1001/archpsyc.61.10.985; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Meyer U, 2008, BRAIN BEHAV IMMUN, V22, P469, DOI 10.1016/j.bbi.2007.09.012; Mitelman SA, 2007, SCHIZOPHR RES, V92, P211, DOI 10.1016/j.schres.2006.12.029; Miyata J, 2010, SCHIZOPHR RES, V119, P232, DOI 10.1016/j.schres.2009.12.038; Mori S., 2005, MRI ATLAS HUMAN WHIT; Mori T, 2007, PSYCHIAT RES-NEUROIM, V154, P133, DOI 10.1016/j.pscychresns.2006.09.004; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nolte N, 1999, HUMAN BRAIN; O'Dwyer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037021; Patel S, 2011, SCHIZOPHR RES, V129, P149, DOI 10.1016/j.schres.2011.03.014; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Peters BD, 2008, NEUROPSYCHOBIOLOGY, V58, P19, DOI 10.1159/000154476; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Rapoport JL, 2011, INT J DEV NEUROSCI, V29, P251, DOI 10.1016/j.ijdevneu.2010.10.003; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; SACCHETTI E, 1992, BRIT J PSYCHIAT, V160, P390, DOI 10.1192/bjp.160.3.390; Sacchetti E., 1987, ETIOPATHOGENETIC HYP, P93; Seal ML, 2008, SCHIZOPHR RES, V101, P106, DOI 10.1016/j.schres.2007.12.489; Sigmundsson T, 2001, AM J PSYCHIAT, V158, P234, DOI 10.1176/appi.ajp.158.2.234; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Szeszko PR, 2008, NEUROPSYCHOPHARMACOL, V33, P976, DOI 10.1038/sj.npp.1301480; Tandon R, 2008, SCHIZOPHR RES, V102, P1, DOI 10.1016/j.schres.2008.04.011; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; Tochigi M, 2004, NEUROSCI LETT, V365, P120, DOI 10.1016/j.neulet.2004.04.064; Tochigi M, 2004, NEUROSCI RES, V48, P1, DOI 10.1016/j.neures.2003.09.002; Torrey EF, 1997, SCHIZOPHR RES, V28, P1, DOI 10.1016/S0920-9964(97)00092-3; Walterfang M, 2011, EXPERT REV NEUROTHER, V11, P971, DOI [10.1586/ern.11.76, 10.1586/ERN.11.76]; Walther S, 2011, NEUROBIOL DIS, V42, P276, DOI 10.1016/j.nbd.2011.01.017; Werring DJ, 2000, BRAIN, V123, P1667, DOI 10.1093/brain/123.8.1667; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; ZIPURSKY RB, 1987, BIOL PSYCHIAT, V22, P1288, DOI 10.1016/0006-3223(87)90040-0	75	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75508	10.1371/journal.pone.0075508	http://dx.doi.org/10.1371/journal.pone.0075508			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228WY	24086548	gold, Green Published, Green Submitted			2022-12-27	WOS:000325223900045
J	Tsuzuki, S; Morimoto, N; Hosokawa, S; Matsushita, T				Tsuzuki, Shinya; Morimoto, Nao; Hosokawa, Shinichi; Matsushita, Takeji			Associations of Maternal and Neonatal Serum Trace Element Concentrations with Neonatal Birth Weight	PLOS ONE			English	Article							MULTIPLE MICRONUTRIENT SUPPLEMENTATION; DOUBLE-BLIND; ZINC SUPPLEMENTATION; CONTROLLED-TRIAL; GROWTH; SELENIUM; NEPAL	Background: Trace elements play important nutritional roles in neonates. Our objective was to examine whether there are differences in maternal/neonatal serum trace element concentrations between mature infants and premature infants. Methods: During 2012, 44 infants born at National Center for Global Health and Medicine, Tokyo, Japan, were enrolled. Serum samples were collected to measure serum iron, zinc, copper, and selenium concentrations 5 days after birth. Maternal serum samples were obtained before delivery and cord blood was taken at delivery to measure the same trace elements. We compared the results between term group whose birth weight were >= 2500 g and gestational age were >= 37 weeks and premature group whose birth weight were <2500 g or gestational age were <37 weeks. Variables significantly different between two groups were included in linear regression models to identify significant predictors of birth weight. Values of P<0.05 were considered statistically significant. Results: Serum selenium concentrations were lower in premature group than in term group (43.3 +/- 7.0 mu g/L vs. 52.0 +/- 8.9 mu g/L, P = 0.001). Maternal serum selenium concentrations were also significantly lower in the mothers of premature group than in the mothers of term group (79.3 +/- 19.3 mu g/L vs. 94.1 +/- 18.1 mu g/L, P = 0.032). There were no significant differences in neonatal or maternal iron, zinc, or copper concentrations between two groups. Multivariate linear regression analysis showed that, except for gestational age, only maternal serum selenium was significantly associated with birth weight (P = 0.015). Conclusions: Serum selenium concentrations were lower in premature group and their mothers compared with the term group. The maternal serum selenium concentration was positively correlated with birth weight. These results suggest that maternal serum selenium concentration may influence neonatal birth weight.	[Tsuzuki, Shinya; Morimoto, Nao; Hosokawa, Shinichi; Matsushita, Takeji] Natl Ctr Global Hlth & Med, Dept Pediat, Tokyo, Japan	National Center for Global Health & Medicine - Japan	Tsuzuki, S (corresponding author), Natl Ctr Global Hlth & Med, Dept Pediat, Tokyo, Japan.	shinyatsuzuki@yahoo.co.jp	Tsuzuki, Shinya/S-7286-2019; Tsuzuki, Shinya/S-7286-2019	Tsuzuki, Shinya/0000-0002-8504-1244; Tsuzuki, Shinya/0000-0001-5732-846X	National Center for Global Health and Medicine [113-4]	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This work was supported by a grant for the National Center for Global Health and Medicine (113-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DARLOW BA, 1995, PEDIATRICS, V96, P314; GIMENEZ FG, 2003, AN PEDIATR, V59, P149; Haider BA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004905.pub3; Hiten DM, 2011, OXIDATIVE MED CELLUL; Iannotti LL, 2008, AM J CLIN NUTR, V88, P154, DOI 10.1093/ajcn/88.1.154; Kaestel P, 2005, EUR J CLIN NUTR, V59, P1081, DOI 10.1038/sj.ejcn.1602215; Khadem N, 2012, IRAN RED CRESCENT ME, V14, P240; Kon N, 2010, BRAIN DEV-JPN, V32, P849, DOI 10.1016/j.braindev.2009.12.003; Osendarp SJM, 2001, LANCET, V357, P1080, DOI 10.1016/S0140-6736(00)04260-4; Osrin D, 2005, LANCET, V365, P955, DOI 10.1016/S0140-6736(05)71084-9; Roberfroid D, 2008, AM J CLIN NUTR, V88, P1330, DOI 10.3945/ajcn.2008.26296; Shin YH, 2013, J KOREAN MED SCI, V28, P580, DOI 10.3346/jkms.2013.28.4.580; SOO TL, 1988, ARCH DIS CHILD, V63, P79, DOI 10.1136/adc.63.1.79; Sugiura T, 2005, ACTA PAEDIATR, V94, P1333, DOI 10.1080/08035250510027354; Vaidya A, 2008, LANCET, V371, P492, DOI 10.1016/S0140-6736(08)60172-5; Xinxo Sonela, 2013, Mater Sociomed, V25, P6, DOI 10.5455/msm.2013.25.6-8	16	27	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75627	10.1371/journal.pone.0075627	http://dx.doi.org/10.1371/journal.pone.0075627			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086594	gold, Green Published, Green Submitted			2022-12-27	WOS:000325223900051
J	Van Hemelrijck, M; Garmo, H; Michaelsson, K; Thorstenson, A; Akre, O; Stattin, P; Holmberg, L; Adolfsson, J				Van Hemelrijck, Mieke; Garmo, Hans; Michaelsson, Karl; Thorstenson, Andreas; Akre, Olof; Stattin, Par; Holmberg, Lars; Adolfsson, Jan			Mortality following Hip Fracture in Men with Prostate Cancer	PLOS ONE			English	Article							SKELETAL-RELATED EVENTS; OSTEOPOROTIC FRACTURE; BONE METASTASIS; RISK; SURVIVAL; REGISTER; SWEDEN; WOMEN	Background: Hip fractures are associated with increased mortality and are a known adverse effect of androgen deprivation therapy (ADT) for prostate cancer (PCa). It was our aim to evaluate how mortality after hip fracture is modified by PCa and ADT. Methods: PCa dataBase Sweden (PCBaSe 2.0) is based on the National PCa Register and also contains age and county-matched PCa-free men. We selected all men (n = 14,205) who had been hospitalized with a hip fracture between 2006 and 2010; 2,300 men had a prior PCa diagnosis of whom 1,518 (66%) were on ADT prior to date of fracture. Risk of death was estimated with cumulative incidence and standardized mortality ratios (SMRs) to make comparisons with the entire PCa population and the general population. Results: Cumulative incidences indicated that there was a higher risk of death following a hip fracture for PCa men on ADT than for PCa men not on ADT or PCa-free men, particularly in the first year. The SMRs showed that PCa men on ADT with a hip fracture were 2.44 times more likely to die than the comparison cohort of all PCa men (95% CI: 2.29-2.60). This risk was especially increased during the first month (5.64 (95% CI: 4.16-7.48)). In absolute terms, hip fractures were associated with 20 additional deaths per 1,000 person-years in PCa men not on ADT, but 30 additional deaths per 1,000 person-years for PCa men on ADT, compared to all PCa men. Conclusion: Hip fractures are associated with higher all-cause mortality in PCa men on ADT than in PCa men not on ADT or PCa-free men, especially within the first three months.	[Van Hemelrijck, Mieke; Garmo, Hans; Holmberg, Lars] Kings Coll London, Sch Med, Div Canc Studies, Canc Epidemiol Grp, London, England; [Van Hemelrijck, Mieke] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Garmo, Hans; Holmberg, Lars] Reg Canc Ctr, Uppsala, Sweden; [Michaelsson, Karl] Uppsala Univ, Dept Surg Sci, Sect Orthopaed, Uppsala, Sweden; [Thorstenson, Andreas] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Thorstenson, Andreas] Capio ST Gorans Hosp, Dept Surg, Urol Sect, Stockholm, Sweden; [Akre, Olof] Karolinska Inst, Clin Epidemiol Unit, Stockholm, Sweden; [Stattin, Par] Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden; [Stattin, Par] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10021 USA; [Holmberg, Lars] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Adolfsson, Jan] Karolinska Insititutet, CLINTEC Dept, Stockholm, Sweden	University of London; King's College London; Karolinska Institutet; Uppsala University; Karolinska Institutet; Saint Goran's Hospital; Karolinska Institutet; Umea University; Memorial Sloan Kettering Cancer Center; Uppsala University; Karolinska Institutet	Van Hemelrijck, M (corresponding author), Kings Coll London, Sch Med, Div Canc Studies, Canc Epidemiol Grp, London, England.	mieke.vanhemelrijck@kcl.ac.uk	Michaelsson, Karl/AAM-9094-2021	Adolfsson, Jan/0000-0003-2992-1869; Michaelsson, Karl/0000-0003-2815-1217; Van Hemelrijck, Mieke/0000-0002-7317-0858; Garmo, Hans/0000-0001-7181-7083	Swedish Research Council [825-2008-5910]; Swedish Council for Working Life and Social Research; Stockholm Cancer Society; Cancer Research-UK; Vasterbotten County Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Stockholm Cancer Society; Cancer Research-UK(Cancer Research UK); Vasterbotten County Council	Funding came from the Swedish Research Council 825-2008-5910, the Swedish Council for Working Life and Social Research, Stockholm Cancer Society, Cancer Research-UK and Vasterbotten County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson J, 2007, SCAND J UROL NEPHROL, V41, P456, DOI 10.1080/00365590701673625; Berglund A, 2011, J UROLOGY, V185, P833, DOI 10.1016/j.juro.2010.10.061; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Breslow N, 1987, IARC SCI PUBL, V82, P406; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; Conti Giario, 2008, Arch Ital Urol Androl, V80, P59; Cooperberg MR, 2009, JNCI-J NATL CANCER I, V101, P878, DOI 10.1093/jnci/djp122; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Gonzalez-Rozas M, 2012, AGING CLIN EXP RES, V24, P181; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Hagel E, 2009, SCAND J UROL NEPHROL, V43, P342, DOI 10.3109/00365590903024577; Hakimian P, 2008, BJU INT; Jones ME, 1998, AM J EPIDEMIOL, V148, P1012; Mohler J, 2010, J NATL COMPR CANC NE, V8, P162, DOI 10.6004/jnccn.2010.0012; Norgaard M, 2010, J UROLOGY, V184, P162, DOI 10.1016/j.juro.2010.03.034; Oefelein MG, 2002, J UROLOGY, V168, P1005, DOI 10.1016/S0022-5347(05)64561-2; Petrylak PJ, 2002, PROSTATE CANC PRINCI; Rothman KJGS., 2008, MEASURES EFFECT MEAS; Ryan CJ, 2007, CANCER-AM CANCER SOC, V110, P81, DOI 10.1002/cncr.22736; Sathiakumar N, 2011, PROSTATE CANCER P D, V14, P177, DOI 10.1038/pcan.2011.7; Sprenkle PC, 2007, CURR OPIN UROL, V17, P424, DOI 10.1097/MOU.0b013e3282f0ebef; The National Board of Health and Wealth Fare, 2010, SWED PRESCR DRUG REG; The National Board of Health and Welfare, 2007, STAT AR HLTH MED CAR; Thorstenson A, 2012, EUR J CANC; Thorstenson A, 2012, EUR J CANCER, V48, P1672, DOI 10.1016/j.ejca.2012.01.035; Valizadeh M, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-143; Van Hemelrijck M, 2012, INT J EPIDE IN PRESS; Van Hemelrijck M, 2010, J CLIN ONCOL, V28, P3448, DOI 10.1200/JCO.2010.29.1567; Van Hemelrijck M, 2010, LANCET ONCOL, V11, P450, DOI 10.1016/S1470-2045(10)70038-3; Zar N, 2008, EUR J CANCER, V44, P718, DOI 10.1016/j.ejca.2007.12.003	30	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74492	10.1371/journal.pone.0074492	http://dx.doi.org/10.1371/journal.pone.0074492			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086350	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900027
J	Gottardo, R; Bailer, RT; Korber, BT; Gnanakaran, S; Phillips, J; Shen, XY; Tomaras, GD; Turk, E; Imholte, G; Eckler, L; Wenschuh, H; Zerweck, J; Greene, K; Gao, HM; Berman, PW; Francis, D; Sinangil, F; Lee, C; Nitayaphan, S; Rerks-Ngarm, S; Kaewkungwal, J; Pitisuttithum, P; Tartaglia, J; Robb, ML; Michael, NL; Kim, JH; Zolla-Pazner, S; Haynes, BF; Mascola, JR; Self, S; Gilbert, P; Montefiori, DC				Gottardo, Raphael; Bailer, Robert T.; Korber, Bette T.; Gnanakaran, S.; Phillips, Joshua; Shen, Xiaoying; Tomaras, Georgia D.; Turk, Ellen; Imholte, Gregory; Eckler, Larry; Wenschuh, Holger; Zerweck, Johannes; Greene, Kelli; Gao, Hongmei; Berman, Phillip W.; Francis, Donald; Sinangil, Faruk; Lee, Carter; Nitayaphan, Sorachai; Rerks-Ngarm, Supachai; Kaewkungwal, Jaranit; Pitisuttithum, Punnee; Tartaglia, James; Robb, Merlin L.; Michael, Nelson L.; Kim, Jerome H.; Zolla-Pazner, Susan; Haynes, Barton F.; Mascola, John R.; Self, Steve; Gilbert, Peter; Montefiori, David C.			Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; DEPENDENT CELLULAR CYTOTOXICITY; RECOMBINANT GLYCOPROTEIN-120 VACCINE; CD4 BINDING-SITE; ENVELOPE PROTEIN; NEUTRALIZING ANTIBODIES; CONFORMATIONAL EPITOPE; TRANSMEMBRANE PROTEIN; BROAD NEUTRALIZATION	Neutralizing and non-neutralizing antibodies to linear epitopes on HIV-1 envelope glycoproteins have potential to mediate antiviral effector functions that could be beneficial to vaccine-induced protection. Here, plasma IgG responses were assessed in three HIV-1 gp120 vaccine efficacy trials (RV144, Vax003, Vax004) and in HIV-1-infected individuals by using arrays of overlapping peptides spanning the entire consensus gp160 of all major genetic subtypes and circulating recombinant forms (CRFs) of the virus. In RV144, where 31.2% efficacy against HIV-1 infection was seen, dominant responses targeted the C1, V2, V3 and C5 regions of gp120. An analysis of RV144 case-control samples showed that IgG to V2 CRF01_AE significantly inversely correlated with infection risk (OR=0.54, p=0.0042), as did the response to other V2 subtypes (OR=0.60-0.63, p=0.016-0.025). The response to V3 CRF01_AE also inversely correlated with infection risk but only in vaccine recipients who had lower levels of other antibodies, especially Env-specific plasma IgA (OR=0.49, p=0.007) and neutralizing antibodies (OR=0.5, p=0.008). Responses to C1 and C5 showed no significant correlation with infection risk. In Vax003 and Vax004, where no significant protection was seen, serum IgG responses targeted the same epitopes as in RV144 with the exception of an additional C1 reactivity in Vax003 and infrequent V2 reactivity in Vax004. In HIV-1 infected subjects, dominant responses targeted the V3 and C5 regions of gp120, as well as the immunodominant domain, heptad repeat 1 (HR-1) and membrane proximal external region (MPER) of gp41. These results highlight the presence of several dominant linear B cell epitopes on the HIV-1 envelope glycoproteins. They also generate the hypothesis that IgG to linear epitopes in the V2 and V3 regions of gp120 are part of a complex interplay of immune responses that contributed to protection in RV144.	[Gottardo, Raphael; Imholte, Gregory; Self, Steve; Gilbert, Peter] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Bailer, Robert T.; Turk, Ellen; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Korber, Bette T.; Gnanakaran, S.; Phillips, Joshua] Los Alamos Natl Lab, Los Alamos, NM USA; [Shen, Xiaoying; Tomaras, Georgia D.; Greene, Kelli; Gao, Hongmei; Haynes, Barton F.; Montefiori, David C.] Duke Univ, Med Ctr, Durham, NC 27710 USA; [Eckler, Larry; Wenschuh, Holger; Zerweck, Johannes] JPT Peptide Technol GmbH, Berlin, Germany; [Berman, Phillip W.] Univ Calif Santa Cruz, Baskin Sch Engn, Santa Cruz, CA 95064 USA; [Francis, Donald; Sinangil, Faruk; Lee, Carter] Global Solut Infect Dis, San Francisco, CA USA; [Nitayaphan, Sorachai] US Army Med Component, Dept Retrovirol, AFRIMS, Bangkok, Thailand; [Rerks-Ngarm, Supachai] Minist Publ Hlth, Dept Dis Control, Nonthaburi, Thailand; [Kaewkungwal, Jaranit] Mahidol Univ, Fac Trop Med, Ctr Excellence Biomed & Publ Hlth Informat BIOPHI, Bangkok, Thailand; [Pitisuttithum, Punnee] Mahidol Univ, Vaccine Trial Ctr, Bangkok 10700, Thailand; [Pitisuttithum, Punnee] Mahidol Univ, Dept Clin Trop Med, Bangkok 10700, Thailand; [Tartaglia, James] Sanofi Pasteur, Dept Res & Dev, Swiftwater, PA USA; [Robb, Merlin L.; Michael, Nelson L.; Kim, Jerome H.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Zolla-Pazner, Susan] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA; [Zolla-Pazner, Susan] NYU, Sch Med, New York, NY USA	Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Energy (DOE); Los Alamos National Laboratory; Duke University; University of California System; University of California Santa Cruz; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Ministry of Public Health - Thailand; Mahidol University; Mahidol University; Mahidol University; Sanofi-Aventis; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); New York University	Montefiori, DC (corresponding author), Duke Univ, Med Ctr, Durham, NC 27710 USA.	david.montefiori@duke.edu	Phillips, Joshua/AAZ-6380-2020; Gottardo, Raphael/HCH-3169-2022; Zolla-Pazner, Susan/S-1864-2019; Tomaras, Georgia/J-5041-2016; Mascola, John/AAI-7193-2021	Phillips, Joshua/0000-0002-4619-6083; Zolla-Pazner, Susan/0000-0002-0750-2666; Gnanakaran, S/0000-0002-9368-3044; Gottardo, Raphael/0000-0002-3867-0232; Korber, Bette/0000-0002-2026-5757; Kaewkungwal, Jaranit/0000-0001-7916-8460	Bill & Melinda Gates Foundation [38619]; U.S. Army Medical Research and Material Command (USAMRMC) [Y1-AI-2642-12]; National Institutes of Allergy and Infectious Diseases [Y1-AI-2642-12]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development [Y1-AI-2642-12]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; U.S. Department of Defense (DOD) [W81XWH-07-2-0067]; New York University School of Medicine [692526]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068635] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); U.S. Army Medical Research and Material Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense); New York University School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded in part by a grant from the Bill & Melinda Gates Foundation (#38619) to DCM as part of the Collaboration for AIDS Vaccine Discovery (www.cavd.org), and by an Interagency Agreement Y1-AI-2642-12 between U.S. Army Medical Research and Material Command (USAMRMC), the National Institutes of Allergy and Infectious Diseases, and by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development. This work was also supported by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD) and New York University School of Medicine (Contract No. 692526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfsen A, 2001, J IMMUNOL, V166, P6257, DOI 10.4049/jimmunol.166.10.6257; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binley JM, 1996, AIDS RES HUM RETROV, V12, P911, DOI 10.1089/aid.1996.12.911; Bomsel M, 1998, IMMUNITY, V9, P277, DOI 10.1016/S1074-7613(00)80610-X; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Diskin R, 2010, NAT STRUCT MOL BIOL, V17, P608, DOI 10.1038/nsmb.1796; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Falkowska E, 2012, J VIROL, V86, P4394, DOI 10.1128/JVI.06973-11; Ferrari G, 2011, J VIROL, V85, P7029, DOI 10.1128/JVI.00171-11; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Forthal DN, 2001, J VIROL, V75, P6953, DOI 10.1128/JVI.75.15.6953-6961.2001; FUNG MSC, 1992, J VIROL, V66, P848, DOI 10.1128/JVI.66.2.848-856.1992; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Gnanakaran S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000955; GNANN JW, 1987, J VIROL, V61, P2639, DOI 10.1128/JVI.61.8.2639-2641.1987; Gorny MK, 2000, J VIROL, V74, P6186, DOI 10.1128/JVI.74.13.6186-6192.2000; GOUDSMIT J, 1990, INTERVIROLOGY, V31, P327, DOI 10.1159/000150169; GRAHAM BS, 1994, J INFECT DIS, V170, P782, DOI 10.1093/infdis/170.4.782; GRIFFISS JM, 1983, J IMMUNOL, V130, P2882; Guilhaudis L, 2002, EUR J BIOCHEM, V269, P4860, DOI 10.1046/j.1432-1033.2002.03187.x; Haneuse S, 2011, J STAT SOFTW, V43, P1; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; Hochleitner EO, 2000, J IMMUNOL, V164, P4156, DOI 10.4049/jimmunol.164.8.4156; Holl V, 2006, BLOOD, V107, P4466, DOI 10.1182/blood-2005-08-3490; Holl V, 2006, J VIROL, V80, P6177, DOI 10.1128/JVI.02625-05; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huang YT, 2005, J IMMUNOL, V174, P4828, DOI 10.4049/jimmunol.174.8.4828; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Imholte GC, 2013, J IMMUNOL METHODS; JARVIS GA, 1991, J IMMUNOL, V147, P1962; JAVAHERIAN K, 1989, P NATL ACAD SCI USA, V86, P6768, DOI 10.1073/pnas.86.17.6768; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karasavvas N, 2012, AIDS RES HUM RETROV, V28, P1444, DOI 10.1089/aid.2012.0103; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; KOUP RA, 1989, J VIROL, V63, P584, DOI 10.1128/JVI.63.2.584-590.1989; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; MATHEW GD, 1981, INT J CANCER, V27, P175, DOI 10.1002/ijc.2910270208; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Moog C, 2013, MUCOSAL IMMUNOL, DOI [10.1038/mi.2013.23, DOI 10.1038/MI.2013.23.PUBMED:23591718.[]; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Mouquet H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024078; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nyambi PN, 2000, J VIROL, V74, P7096, DOI 10.1128/JVI.74.15.7096-7107.2000; Nyambi PN, 1998, J VIROL, V72, P9384, DOI 10.1128/JVI.72.11.9384-9391.1998; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; PALKER TJ, 1987, P NATL ACAD SCI USA, V84, P2479, DOI 10.1073/pnas.84.8.2479; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Pincus SH, 1997, J IMMUNOL, V158, P3511; PINCUS SH, 1993, J CLIN INVEST, V91, P1987, DOI 10.1172/JCI116420; PINCUS SH, 1992, AIDS RES HUM RETROV, V8, P1347, DOI 10.1089/aid.1992.8.1347; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Plotkin SA, 2008, CLIN VACC IMMUNOL, V17, P1055; Quan CP, 1998, EUR J IMMUNOL, V28, P4001, DOI 10.1002/(SICI)1521-4141(199812)28:12<4001::AID-IMMU4001>3.3.CO;2-T; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Smalls-Mantey A, 2012, J VIROL, V86, P8672, DOI 10.1128/JVI.00287-12; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; TYLER DS, 1990, J IMMUNOL, V145, P3276; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991; Yates NL, 2013, HIV 1 ENV V1 V UNPUB; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zolla-Pazner S, 2013, VACCINE INDUCE UNPUB; Zolla-Pazner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053629; ZOLLAPAZNER S, 1995, J VIROL, V69, P3807, DOI 10.1128/JVI.69.6.3807-3815.1995; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	93	185	190	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75665	10.1371/journal.pone.0075665	http://dx.doi.org/10.1371/journal.pone.0075665			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086607	Green Submitted, Green Published, gold			2022-12-27	WOS:000325220000034
J	Huang, TC; Wang, YC; Kao, CH				Huang, Tzung-Chi; Wang, Yao-Ching; Kao, Chia-Hung			Thoracic Tumor Volume Delineation in 4D-PET/CT by Low Dose Interpolated CT for Attenuation Correction	PLOS ONE			English	Article							4-DIMENSIONAL COMPUTED-TOMOGRAPHY; LUNG-CANCER; PET IMAGES; TARGET VOLUME; AVERAGE CT; RADIOTHERAPY; MOTION; 3D	Purpose: 4D-PET/CT imaging is an excellent solution for reducing the breathing-induced effects in both CT and PET images. In 4D-PET/CT, 4D-CT images are selected to match those of 4D-PET phase by phase and the corresponding phases are used for attenuation correction in 4D-PET. However, the high radiation dose that patients acquire while undergoing 4D-CT imaging for diagnostic purposes remains a concern. This study aims to assess low-dose interpolated CT (ICT) for PET attenuation correction (PETICT) in thoracic tumor volume delineation. Methods and Materials: Twelve thoracic cancer patients (10 esophageal and 2 lung cancer cases) were recruited. All patients underwent 4D-PET/CT scans. The optical flow method based on image intensity gradient was applied to calculate the motion displacement in three dimensions for each voxel on two original extreme CT phases in the respiratory cycle, end-inspiration and end-expiration. The interpolated CTs were generated from two phases of the original 4D-CT using motion displacement. Results: Tumor motion due to respiration was estimated in the anterior-posterior dimension, the lateral dimension and the superior-inferior dimension by the optical flow method. The PETICT and ICT (4D-PETICT/ICT) matched each other spatially in all the phases. The distortion of tumor shape and size resulting from respiratory motion artifacts were not observed in 4D-PETICT. The tumor volume measured by 4D-PETICT/ICT correlated to the tumor volume measured by 4D-PET/CT (p = 0.98). Conclusions: 4D-PETICT consistently represented the interpretation of FDG uptake as effectively as 4D-PET. 4D-PETICT/ICT is a low-dose alternative to 4D-CT and significantly improves the interpretation of PET and CT images, while solving the respiratory motion problem as effectively as 4D-PET/CT.	[Huang, Tzung-Chi] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Wang, Yao-Ching] China Med Univ Hosp, Div Radiat Oncol, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Huang, TC (corresponding author), China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.	tzungchi.huang@mail.cmu.edu.tw	huang, tzungchi/O-4434-2015		National Science Council of Taiwan [NSC 102-2221-E-039-010-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was financially supported by National Science Council of Taiwan (NSC 102-2221-E-039-010-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristophanous M, 2012, INT J RADIAT ONCOL, V82, pe99, DOI [10.1016/j.ijrobp.2010.12.060, DOI 10.1016/J.IJR0BP.2010.12.060]; Ashamalla H, 2005, INT J RADIAT ONCOL, V63, P1016, DOI 10.1016/j.ijrobp.2005.04.021; Britton KR, 2007, INT J RADIAT ONCOL, V68, P1036, DOI 10.1016/j.ijrobp.2007.01.021; Ekberg L, 1998, RADIOTHER ONCOL, V48, P71, DOI 10.1016/S0167-8140(98)00046-2; Huang TC, 2013, PLOS ONE, V8; Huang TC, 2011, PHYS MED BIOL, V56, P2559, DOI 10.1088/0031-9155/56/8/014; Liu HH, 2007, INT J RADIAT ONCOL, V68, P531, DOI 10.1016/j.ijrobp.2006.12.066; Messa C, 2006, Q J NUCL MED MOL IM, V50, P4; Mok G, 2011, IEEE T BIOMED ENG, V60, P1927; Nehmeh SA, 2004, MED PHYS, V31, P3179, DOI 10.1118/1.1809778; Nehmeh SA, 2002, J NUCL MED, V43, P876; Pan TS, 2005, J NUCL MED, V46, P1481; Park SJ, 2008, PHYS MED BIOL, V53, P3661, DOI 10.1088/0031-9155/53/13/018; Pevsner A, 2005, MED PHYS, V32, P2358, DOI 10.1118/1.1943809; Shimizu S, 2000, INT J RADIAT ONCOL, V46, P1127, DOI 10.1016/S0360-3016(99)00352-1; Wolthaus JWH, 2005, PHYS MED BIOL, V50, P1569, DOI 10.1088/0031-9155/50/7/017; Wu TH, 2010, NUCL INSTRUM METH A, V619, P361, DOI 10.1016/j.nima.2009.11.001; Yaremko B, 2005, PHYS MED BIOL, V50, P5969, DOI 10.1088/0031-9155/50/24/014; Zhang G, 2010, MED DOSIM, V35, P143, DOI 10.1016/j.meddos.2009.05.001	19	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75903	10.1371/journal.pone.0075903	http://dx.doi.org/10.1371/journal.pone.0075903			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086662	gold, Green Submitted, Green Published			2022-12-27	WOS:000325220000052
J	Lowther, AD; Harcourt, RG; Page, B; Goldsworthy, SD				Lowther, Andrew D.; Harcourt, Robert G.; Page, Bradley; Goldsworthy, Simon D.			Steady as He Goes: At-Sea Movement of Adult Male Australian Sea Lions in a Dynamic Marine Environment	PLOS ONE			English	Article							ANTARCTIC FUR SEALS; STABLE-ISOTOPES; NEW-ZEALAND; FORAGING BEHAVIOR; SURFACE TEMPERATURES; SATELLITE TELEMETRY; HABITAT SELECTION; ELEPHANT SEALS; STRATEGIES; ECOLOGY	The southern coastline of Australia forms part of the worlds' only northern boundary current system. The Bonney Upwelling occurs every austral summer along the south-eastern South Australian coastline, a region that hosts over 80% of the worlds population of an endangered endemic otariid, the Australian sea lion. We present the first data on the movement characteristics and foraging behaviour of adult male Australian sea lions across their South Australian range. Synthesizing telemetric, oceanographic and isotopic datasets collected from seven individuals enabled us to characterise individual foraging behaviour over an approximate two year time period. Data suggested seasonal variability in stable carbon and nitrogen isotopes that could not be otherwise explained by changes in animal movement patterns. Similarly, animals did not change their foraging patterns despite fine-scale spatial and temporal variability of the upwelling event. Individual males tended to return to the same colony at which they were tagged and utilized the same at-sea regions for foraging irrespective of oceanographic conditions or time of year. Our study contrasts current general assumptions that male otariid life history strategies should result in greater dispersal, with adult male Australian sea lions displaying central place foraging behaviour similar to males of other otariid species in the region.	[Lowther, Andrew D.; Goldsworthy, Simon D.] SARDI Aquat Sci, Threatened Endangered & Protected Species, Adelaide, SA, Australia; [Harcourt, Robert G.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia; [Page, Bradley] Dept Environm Water & Nat Resources, Sci Monitoring & Knowledge Branch, Adelaide, SA, Australia	Macquarie University	Lowther, AD (corresponding author), Norwegian Polar Res Inst, Biodivers Sect, Tromso, Norway.	Andrew.Lowther@npolar.no	Lowther, Andrew/T-2511-2019	Lowther, Andrew/0000-0003-4294-3157; Harcourt, Robert/0000-0003-4666-2934; Goldsworthy, Simon/0000-0003-4988-9085	Integrated Marine Observing System (IMOS); Australian Government through the National Collaborative Research Infrastructure Strategy; Super Science Initiative	Integrated Marine Observing System (IMOS); Australian Government through the National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science); Super Science Initiative	Funding was received from the Integrated Marine Observing System (IMOS) - IMOS is supported by the Australian Government through the National Collaborative Research Infrastructure Strategy and the Super Science Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnould JPY, 2007, AQUAT CONSERV, V17, pS53, DOI 10.1002/aqc.908; Arnould JPY, 2001, CAN J ZOOL, V79, P35, DOI 10.1139/cjz-79-1-35; Atkinson S, 1997, Rev Reprod, V2, P175, DOI 10.1530/revreprod/2.3.175; Aurioles D, 2006, MAR MAMMAL SCI, V22, P326, DOI 10.1111/j.1748-7692.2006.00023.x; Awkerman JA, 2007, CAN J ZOOL, V85, P273, DOI 10.1139/Z06-202; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Bailleul F, 2010, ECOLOGICAL MODELLING; Baylis AMM, 2008, CAN J ZOOL, V86, P774, DOI 10.1139/Z08-055; Bearhop S, 2006, MAR ECOL PROG SER, V311, P157, DOI 10.3354/meps311157; Boehme L, 2009, OCEAN SCI, V5, P685, DOI 10.5194/os-5-685-2009; Box GEP., 2008, TIME SERIES ANAL, DOI [10.1002/9781118619193, DOI 10.1002/9781118619193]; Boyd IL, 1998, CAN J FISH AQUAT SCI, V55, P845, DOI 10.1139/cjfas-55-4-845; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; BRAINERD KE, 1995, DEEP-SEA RES PT I, V42, P1521, DOI 10.1016/0967-0637(95)00068-H; Calenge C., 2011, HOME RANGE ESTIMATIO; CAMPAGNA C, 1995, J ZOOL, V236, P55, DOI 10.1111/j.1469-7998.1995.tb01784.x; Campagna C, 2001, J ZOOL, V255, P205, DOI 10.1017/S0952836901001285; Cherel Y, 2009, BIOL LETTERS, V5, P830, DOI 10.1098/rsbl.2009.0552; Crawford K, 2008, MAMMAL REV, V38, P87, DOI 10.1111/j.1365-2907.2008.00120.x; Crocker DE, 2001, J ZOOL, V254, P267, DOI 10.1017/S0952836901000784; Croll DA, 2005, MAR ECOL PROG SER, V289, P117, DOI 10.3354/meps289117; Cronin MA, 2008, J EXP MAR BIOL ECOL, V362, P43, DOI 10.1016/j.jembe.2008.05.010; de Bruyn PJN, 2009, MAR ECOL PROG SER, V394, P263, DOI 10.3354/meps08292; Field I, 2002, ANTARCTIC S IN PRESS, V13; Forero MG, 2003, SCI MAR, V67, P23, DOI 10.3989/scimar.2003.67s223; Freitas C, 2008, J APPL ECOL, V45, P1213, DOI 10.1111/j.1365-2664.2008.01505.x; Freitas C, 2009, MAR ECOL PROG SER, V375, P247, DOI 10.3354/meps07725; Freon P, 2000, REV FISH BIOL FISHER, V10, P183, DOI 10.1023/A:1016666108540; Gales NJ, 1997, MARINE MAMMAL RESEARCH IN THE SOUTHERN HEMISPHERE, VOL 1, P78; Gardner G, 1980, J R STAT SOC SER C A, V29, P311, DOI [10.2307/2346910, DOI 10.2307/2346910]; Gentry R.L., 1986, FUR SEALS MATERNAL S; Gentry RL, 1986, FUR SEALS MATERNAL S, P220; Georges JY, 2000, MAR ECOL PROG SER, V196, P291, DOI 10.3354/meps196291; Goldsworthy S, 2008, NEOPHOCA CINEREA IUC; Greaves DK, 2004, MAR MAMMAL SCI, V20, P296, DOI 10.1111/j.1748-7692.2004.tb01158.x; Guinet C, 1997, MAR ECOL PROG SER, V150, P11, DOI 10.3354/meps150011; Guinet C, 2001, MAR ECOL PROG SER, V219, P251, DOI 10.3354/meps219251; Hamer KC, 2009, J ANIM ECOL, V78, P880, DOI 10.1111/j.1365-2656.2009.01549.x; Hanson CE, 2005, MAR FRESHWATER RES, V56, P1011, DOI 10.1071/MF04288; Harcourt RG, 2002, MAR ECOL PROG SER, V227, P11, DOI 10.3354/meps227011; Hays GC, 2003, MAR ECOL PROG SER, V262, P305, DOI 10.3354/meps262305; Hindell MA, 2002, MAR ECOL PROG SER, V242, P275, DOI 10.3354/meps242275; Hindell MA, 1997, MAR MAMMAL SCI, V13, P219, DOI 10.1111/j.1748-7692.1997.tb00629.x; Hirons AC, 2001, CAN J ZOOL, V79, P1053, DOI 10.1139/z01-055; Hobson KA, 1996, CAN J FISH AQUAT SCI, V53, P528, DOI 10.1139/cjfas-53-3-528; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Huyer A, 2005, J MAR RES, V63, P901, DOI 10.1357/002224005774464238; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Kampf J, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019221; Kirkwood R, 2006, CAN J ZOOL, V84, P1781, DOI 10.1139/Z06-164; Klimley AP, 1999, MAR BIOL, V133, P307, DOI 10.1007/s002270050469; Langton Richard W., 1995, Reviews in Fisheries Science, V3, P201; Le Boeuf Burney J., 1994, P237; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; Longhlin TR, 1999, UASGCP REP, V99, P615; Lowther AD, 2011, MAR ECOL PROG SER, V443, P249, DOI 10.3354/meps09392; Lowther AD, 2010, MARINE MAMMAL SCI, V27; Mattern T, 2007, MAR ECOL PROG SER, V343, P295, DOI 10.3354/meps06954; McClatchie S, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2004JC002699; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; McDougall T., 2010, INT THERMODYNAMIC EQ; Menge BA, 2004, ECOL MONOGR, V74, P663, DOI 10.1890/03-4060; Menge BA, 2002, ECOL RES, V17, P1, DOI 10.1046/j.1440-1703.2002.00458.x; Middleton JF, 2007, PROG OCEANOGR, V75, P1, DOI 10.1016/j.pocean.2007.07.001; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nilsen JEO, 2006, PROG OCEANOGR, V70, P58, DOI 10.1016/j.pocean.2006.03.014; Nordstrom CA, 2012, DEEP SEA RES 2; OLSON DB, 1985, J MAR RES, V43, P113, DOI 10.1357/002224085788437325; Page B, 2005, MAR ECOL PROG SER, V304, P249, DOI 10.3354/meps304249; Page B, 2005, MAR ECOL PROG SER, V293, P283, DOI 10.3354/meps293283; Page B, 2006, MAR ECOL PROG SER, V323, P263, DOI 10.3354/meps323263; Phillips RA, 2009, OECOLOGIA, V160, P795, DOI 10.1007/s00442-009-1342-9; Pinaud D, 2008, J APPL ECOL, V45, P91, DOI 10.1111/j.1365-2664.2007.01370.x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Quillfeldt P, 2005, MAR ECOL PROG SER, V295, P295, DOI 10.3354/meps295295; Rochford D, 1977, REV POSSIBLE UPWELLI; Rudnick DL, 1999, SCIENCE, V283, P526, DOI 10.1126/science.283.5401.526; Schlitzer R, 2002, COMPUT GEOSCI-UK, V28, P1211, DOI 10.1016/S0098-3004(02)00040-7; Schneider D.C., 1990, Polar Research, V8, P17, DOI 10.1111/j.1751-8369.1990.tb00370.x; SCHOENHERR JR, 1991, CAN J ZOOL, V69, P583, DOI 10.1139/z91-088; Thompson D, 1998, J ZOOL, V246, P135, DOI 10.1111/j.1469-7998.1998.tb00142.x; Urbano F, 2010, PHILOS T R SOC B, V365, P2177, DOI 10.1098/rstb.2010.0081; Votier SC, 2011, MAR BIOL, V158, P355, DOI 10.1007/s00227-010-1563-9; Weise MJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027113; Weise MJ, 2010, ECOLOGY, V91, P1004, DOI 10.1890/08-1554.1; Whiteway T., 2009, AUSTR BATHYMETRY TOP, DOI DOI 10.4225/25/53D99B6581B9A; Wood SN, 2000, J ROY STAT SOC B, V62, P413, DOI 10.1111/1467-9868.00240	88	38	38	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74348	10.1371/journal.pone.0074348	http://dx.doi.org/10.1371/journal.pone.0074348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086338	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700023
J	Youssar, L; Gruning, BA; Gunther, S; Huttel, W				Youssar, Loubna; Gruening, Bjoern Andreas; Guenther, Stefan; Huettel, Wolfgang			Characterization and Phylogenetic Analysis of the Mitochondrial Genome of Glarea lozoyensis Indicates High Diversity within the Order Helotiales	PLOS ONE			English	Article							TRANSFER-RNA GENES; GROUP-I INTRON; HOMING ENDONUCLEASES; ZALERION-ARBORICOLA; EVOLUTION; SEQUENCE; DNA; FUNGI; PROGRAM; IDENTIFICATION	Background: Glarea lozoyensis is a filamentous fungus used for the industrial production of non-ribosomal peptide pneumocandin B-0. In the scope of a whole genome sequencing the complete mitochondrial genome of the fungus has been assembled and annotated. It is the first one of the large polyphyletic Helotiaceae family. A phylogenetic analysis was performed based on conserved proteins of the oxidative phosphorylation system in mitochondrial genomes. Results: The total size of the mitochondrial genome is 45,038 bp. It contains the expected 14 genes coding for proteins related to oxidative phosphorylation, two rRNA genes, six hypothetical proteins, three intronic genes of which two are homing endonucleases and a ribosomal protein rps3. Additionally there is a set of 33 tRNA genes. All genes are located on the same strand. Phylogenetic analyses based on concatenated mitochondrial protein sequences confirmed that G. lozoyensis belongs to the order of Helotiales and that it is most closely related to Phialocephala subalpina. However, a comparison with the three other mitochondrial genomes known from Helotialean species revealed remarkable differences in size, gene content and sequence. Moreover, it was found that the gene order found in P. subalpina and Sclerotinia sclerotiorum is not conserved in G. lozoyensis. Conclusion: The arrangement of genes and other differences found between the mitochondrial genome of G. lozoyensis and those of other Helotiales indicates a broad genetic diversity within this large order. Further mitochondrial genomes are required in order to determine whether there is a continuous transition between the different forms of mitochondrial genomes or G. lozoyensis belongs to a distinct subgroup within Helotiales.	[Youssar, Loubna; Gruening, Bjoern Andreas; Guenther, Stefan; Huettel, Wolfgang] Univ Freiburg, Inst Pharmaceut Sci, D-79106 Freiburg, Germany	University of Freiburg	Youssar, L (corresponding author), Univ Freiburg, Inst Pharmaceut Sci, Hugstetter Str 55, D-79106 Freiburg, Germany.	lyoussar@gmail.com	Günther, Stefan/AAY-8944-2020; Huettel, Wolfgang/B-3095-2016	Huttel, Wolfgang/0000-0002-7842-6365; Gruning, Bjorn/0000-0002-3079-6586	Alexander von Humboldt Research Fellowship; German Research Foundation (DFG); Albert Ludwigs University Freiburg	Alexander von Humboldt Research Fellowship(Alexander von Humboldt Foundation); German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	L.Y. was supported by an Alexander von Humboldt Research Fellowship. The project was supported partially by the German Research Foundation (DFG). The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Basse CW, 2010, CURR OPIN MICROBIOL, V13, P712, DOI 10.1016/j.mib.2010.09.003; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bertrand H, 2000, ANNU REV PHYTOPATHOL, V38, P397, DOI 10.1146/annurev.phyto.38.1.397; Bills GF, 1999, MYCOL RES, V103, P179, DOI 10.1017/S095375629800687X; Bullerwell CE, 2004, CURR OPIN MICROBIOL, V7, P528, DOI 10.1016/j.mib.2004.08.008; Bullerwell CE, 2003, NUCLEIC ACIDS RES, V31, P1614, DOI 10.1093/nar/gkg264; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; BURKE JM, 1987, NUCLEIC ACIDS RES, V15, P7217, DOI 10.1093/nar/15.18.7217; Cardoso MAG, 2007, YEAST, V24, P607, DOI 10.1002/yea.1500; Chevalier BS, 2001, NUCLEIC ACIDS RES, V29, P3757, DOI 10.1093/nar/29.18.3757; CLARKWALKER GD, 1992, INT REV CYTOL, V141, P89, DOI 10.1016/S0074-7696(08)62064-1; CUMMINGS DJ, 1990, CURR GENET, V17, P375, DOI 10.1007/BF00334517; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Duo A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-166; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; Edgell DR, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-22; Ferandon C, 2010, PLOS ONE, V18, P11; FOX TD, 1987, ANNU REV GENET, V21, P67, DOI 10.1146/annurev.ge.21.120187.000435; Gautheret D, 2001, J MOL BIOL, V313, P1003, DOI 10.1006/jmbi.2001.5102; Ghikas DV, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-174; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gray MW, 1999, CURR OPIN GENET DEV, V9, P678, DOI 10.1016/S0959-437X(99)00030-1; Guhan N, 2003, CRIT REV BIOCHEM MOL, V38, P199, DOI 10.1080/713609235; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jurica MS, 1999, CELL MOL LIFE SCI, V55, P1304, DOI 10.1007/s000180050372; Keating GM, 2003, DRUGS, V63, P2235, DOI 10.2165/00003495-200363200-00008; KIRK PM, 2001, DICT FUNGI; Kolesnikova OA, 2000, SCIENCE, V289, P1931, DOI 10.1126/science.289.5486.1931; Korab-Laskowska M, 1998, NUCLEIC ACIDS RES, V26, P138, DOI 10.1093/nar/26.1.138; Kouvelis VN, 2008, MYCOL RES, V112, P829, DOI 10.1016/j.mycres.2008.01.016; Kouvelis VN, 2004, FUNGAL GENET BIOL, V41, P930, DOI 10.1016/j.fgb.2004.07.003; LAMBOWITZ AM, 1990, TRENDS BIOCHEM SCI, V15, P440, DOI 10.1016/0968-0004(90)90283-H; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; LAZOWSKA J, 1980, CELL, V22, P333, DOI 10.1016/0092-8674(80)90344-X; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MASUREKAR PS, 1992, J ANTIBIOT, V45, P1867, DOI 10.7164/antibiotics.45.1867; OBrien EA, 2009, NUCLEIC ACIDS RES, V37, pD946, DOI 10.1093/nar/gkn819; Pantou MP, 2006, CURR GENET, V50, P125, DOI 10.1007/s00294-006-0079-9; Paquin B, 1996, J MOL BIOL, V255, P688, DOI 10.1006/jmbi.1996.0056; Paquin B, 1997, CURR GENET, V31, P380, DOI 10.1007/s002940050220; Pelaez F., 2011, Mycology - An International Journal on Fungal Biology, V2, P1, DOI 10.1080/21501203.2010.544334; Pellenz S, 2002, J MOL EVOL, V55, P302, DOI 10.1007/s00239-001-2327-4; Schafer B, 2003, CURR GENET, V43, P311, DOI 10.1007/s00294-003-0404-5; SCHWARTZ RE, 1992, J ANTIBIOT, V45, P1853, DOI 10.7164/antibiotics.45.1853; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; Sethuraman J, 2009, MOL BIOL EVOL, V26, P2299, DOI 10.1093/molbev/msp145; Sideris E G, 1988, Prog Clin Biol Res, V259, P13; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; van de Sande WWJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038654; van Diepeningen AD, 2010, MECH AGEING DEV, V131, P315, DOI 10.1016/j.mad.2010.03.001; Woo PCY, 2003, FEBS LETT, V555, P469, DOI 10.1016/S0014-5793(03)01307-3; Wu Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-238; Youssar L, 2012, EUKARYOT CELL, V11, P250, DOI 10.1128/EC.05302-11; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	65	7	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74792	10.1371/journal.pone.0074792	http://dx.doi.org/10.1371/journal.pone.0074792			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086376	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700038
J	Lin, XJ; Miao, P; Wang, JX; Yuan, FL; Guan, YJ; Tang, YH; He, XS; Wang, YT; Yang, GY				Lin, Xiaojie; Miao, Peng; Wang, Jixian; Yuan, Falei; Guan, Yongjing; Tang, Yaohui; He, Xiaosong; Wang, Yongting; Yang, Guo-Yuan			Surgery-Related Thrombosis Critically Affects the Brain Infarct Volume in Mice Following Transient Middle Cerebral Artery Occlusion	PLOS ONE			English	Article							POSTERIOR COMMUNICATING ARTERY; ACUTE ISCHEMIC-STROKE; BLOOD-FLOW; REPERFUSION; PERFUSION; MODEL; RATS; CRANIECTOMY; ANGIOGRAPHY; ANTAGONIST	Transient middle cerebral artery occlusion (tMCAO) model is widely used to mimic human focal ischemic stroke in order to study ischemia/reperfusion brain injury in rodents. In tMCAO model, intraluminal suture technique is widely used to achieve ischemia and reperfusion. However, variation of infarct volume in this model often requires large sample size, which hinders the progress of preclinical research. Our previous study demonstrated that infarct volume was related to the success of reperfusion although the reason remained unclear. The aim of present study is to explore the relationship between focal thrombus formation and model reproducibility with respect to infarct volume. We hypothesize that suture-induced thrombosis causes infarct volume variability due to insufficient reperfusion after suture withdrawal. Seventy-two adult male CD-1 mice underwent 90 minutes of tMCAO with or without intraperitoneal administration of heparin. Dynamic synchrotron radiation microangiography (SRA) and laser speckle contrast imaging (LSCI) were performed before and after tMCAO to observe the cerebral vascular morphology and to measure the cerebral blood flow in vivo. Infarct volume and neurological score were examined to evaluate severity of ischemic brain injury. We found that the rate of successful reperfusion was much higher in heparin-treated mice compared to that in heparin-free mice according to the result of SRA and LSCI at 1 and 3 hours after suture withdrawal (p<0.05). Pathological features and SRA revealed that thrombus formed in the internal carotid artery, middle cerebral artery or anterior cerebral artery, which blocked reperfusion following tMCAO. LSCI showed that cortical collateral circulation could be disturbed by thrombi. Our results demonstrated that suture-induced thrombosis was a critical element, which affects the success of reperfusion. Appropriate heparin management provides a useful approach for improving reproducibility of reperfusion model in mice.	[Lin, Xiaojie; Miao, Peng; Wang, Jixian; Yuan, Falei; Tang, Yaohui; He, Xiaosong; Wang, Yongting; Yang, Guo-Yuan] Shanghai Jiao Tong Univ, Neurosci & Neuroengn Ctr, Med X Res Inst, Shanghai 200030, Peoples R China; [Lin, Xiaojie; Miao, Peng; Wang, Jixian; Yuan, Falei; Tang, Yaohui; He, Xiaosong; Wang, Yongting; Yang, Guo-Yuan] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Guan, Yongjing] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Radiol, Shanghai 200030, Peoples R China; [Yang, Guo-Yuan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Neurol, Shanghai 200030, Peoples R China; [Miao, Peng] Shanghai Univ, Sch Commun & Informat Engn, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai University	Wang, YT (corresponding author), Shanghai Jiao Tong Univ, Neurosci & Neuroengn Ctr, Med X Res Inst, Shanghai 200030, Peoples R China.	yongting.wang@gmail.com; gyyang0626@gmail.com	Wang, Yongting/C-2916-2014; Tang, Yaohui/AAE-9746-2019	Tang, Yaohui/0000-0002-9603-2650; Miao, Peng/0000-0002-1919-2204	National Basic Research Program (973 Program) [2010CB834306]; National Natural Science Foundation of China [U1232205]; KC Wong Foundation	National Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); KC Wong Foundation	This study was supported by the National Basic Research Program (973 Program 2010CB834306 (GYY, YTW), the National Natural Science Foundation of China (Project #U1232205) and KC Wong Foundation (GYY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage GA, 2010, J CEREBR BLOOD F MET, V30, P1432, DOI 10.1038/jcbfm.2010.73; Ayata C, 2013, J CEREBR BLOOD F MET, V33, P954, DOI 10.1038/jcbfm.2013.38; Boas DA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3285504; Cai J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033366; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; DeFazio RA, 2012, J CEREBR BLOOD F MET, V32, P2012, DOI 10.1038/jcbfm.2012.102; Duong TQ, 2012, TRANSL STROKE RES, V3, P8, DOI 10.1007/s12975-011-0140-y; Furuya K, 2004, J NEUROSURG, V100, P97, DOI 10.3171/jns.2004.100.1.0097; Guan YJ, 2012, STROKE, V43, P888, DOI 10.1161/STROKEAHA.111.636456; Huang J, 2013, STROKE, V44, P190, DOI 10.1161/STROKEAHA.112.670299; KAWAMURA S, 1991, ACTA NEUROCHIR, V109, P126, DOI 10.1007/BF01403007; KAWAMURA S, 1994, SURG NEUROL, V41, P368, DOI 10.1016/0090-3019(94)90029-9; Kidoguchi K, 2006, STROKE, V37, P1856, DOI 10.1161/01.STR.0000226904.96059.a6; KUGE Y, 1995, STROKE, V26, P1655, DOI 10.1161/01.STR.26.9.1655; LAING RJ, 1993, STROKE, V24, P294, DOI 10.1161/01.STR.24.2.294; LINDSBERG PJ, 1991, ANN NEUROL, V30, P117, DOI 10.1002/ana.410300202; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lu HY, 2012, STROKE, V43, P838, DOI 10.1161/STROKEAHA.111.635235; MEMEZAWA H, 1995, BRAIN RES, V670, P48, DOI 10.1016/0006-8993(94)01251-C; Miao P, 2010, IEEE T BIO-MED ENG, V57, P1152, DOI 10.1109/TBME.2009.2037434; Miao P, 2010, OPT EXPRESS, V18, P218, DOI 10.1364/OE.18.000218; Moens AL, 2005, INT J CARDIOL, V100, P179, DOI 10.1016/j.ijcard.2004.04.013; Molina CA, 2011, STROKE, V42, pS16, DOI 10.1161/STROKEAHA.110.598763; Quartermain D, 2003, CEREBROVASC DIS, V16, P346, DOI 10.1159/000072556; Schmid-Elsaesser R, 1998, STROKE, V29, P2162, DOI 10.1161/01.STR.29.10.2162; Schwenke DO, 2008, J APPL PHYSIOL, V104, P88, DOI 10.1152/japplphysiol.00610.2007; Shah Zahoor Ahmad, 2006, J Stroke Cerebrovasc Dis, V15, P133, DOI 10.1016/j.jstrokecerebrovasdis.2006.04.002; Shen Q, 2004, J CEREBR BLOOD F MET, V24, P280, DOI 10.1097/01.WCB.0000110048.43905.E5; Shen Q, 2011, J CEREBR BLOOD F MET, V31, P2076, DOI 10.1038/jcbfm.2011.64; Shih YYI, 2012, RADIOLOGY, V264, P234, DOI 10.1148/radiol.12112033; Shuaib A, 2011, LANCET NEUROL, V10, P909, DOI 10.1016/S1474-4422(11)70195-8; Strong AJ, 2006, J CEREBR BLOOD F MET, V26, P645, DOI 10.1038/sj.jcbfm.9600240; Tanaka Y, 2011, J CEREBR BLOOD F MET, V31, P1403, DOI 10.1038/jcbfm.2010.228; Wang Z, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.12.125001; Yang GY, 1997, BRAIN RES, V751, P181, DOI 10.1016/S0006-8993(96)01277-2; YANG GY, 1994, STROKE, V25, P165, DOI 10.1161/01.STR.25.1.165; Yuan Falei, 2013, Front Biosci (Elite Ed), V5, P517; Yuan FL, 2012, J NEUROTRAUM, V29, P1499, DOI 10.1089/neu.2011.2105; Zhang H, 2010, J CEREBR BLOOD F MET, V30, P923, DOI 10.1038/jcbfm.2010.10; ZHAO Q, 1994, BRAIN RES, V649, P253, DOI 10.1016/0006-8993(94)91071-5; Zhou J, 2011, J CEREBR BLOOD F MET, V31, P924, DOI 10.1038/jcbfm.2010.171	41	33	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75561	10.1371/journal.pone.0075561	http://dx.doi.org/10.1371/journal.pone.0075561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086572	Green Published, Green Submitted, gold			2022-12-27	WOS:000325025200048
J	Hernandes, MS; Santos, GDR; Cafe-Mendes, CC; Lima, LS; Scavone, C; Munhoz, CD; Britto, LRG				Hernandes, Marina S.; Santos, Graziella D. R.; Cafe-Mendes, Cecilia C.; Lima, Larissa S.; Scavone, Cristoforo; Munhoz, Carolina D.; Britto, Luiz R. G.			Microglial Cells Are Involved in the Susceptibility of NADPH Oxidase Knockout Mice to 6-Hydroxy-Dopamine-Induced Neurodegeneration	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; TNF-ALPHA; PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; ACTIVATION; MODEL; MINOCYCLINE; DEGENERATION; GLUTATHIONE	We explored the impact of Nox-2 in modulating inflammatory-mediated microglial responses in the 6-hydroxydopamine (6-OHDA)-induced Parkinson's disease (PD) model. Nox1 and Nox2 gene expression were found to increase in striatum, whereas a marked increase of Nox2 expression was observed in substantia nigra (SN) of wild-type (wt) mice after PD induction. Gp91(phox-/-) 6-OHDA-lesioned mice exhibited a significant reduction in the apomorphine-induced rotational behavior, when compared to wt mice. Immunolabeling assays indicated that striatal 6-OHDA injections reduced the number of dopaminergic (DA) neurons in the SN of wt mice. In gp91(phox-/-) 6-OHDA-lesioned mice the DA degeneration was negligible, suggesting an involvement of Nox in 6-OHDA-mediated SN degeneration. Gp91(phox-/-) 6-OHDA-lesioned mice treated with minocycline, a tetracycline derivative that exerts multiple anti-inflammatory effects, including microglial inhibition, exhibited increased apomorphine-induced rotational behavior and degeneration of DA neurons after 6-OHDA injections. The same treatment also increased TNF-alpha release and potentiated NF-kappa B activation in the SN of gp91(phox-/-6-)OHDA-lesioned mice. Our results demonstrate for the first time that inhibition of microglial cells increases the susceptibility of gp91(phox-/-) 6-OHDA lesioned mice to develop PD. Blockade of microglia leads to NF-kappa B activation and TNF-alpha release into the SN of gp91(phox-/-) 6-OHDA lesioned mice, a likely mechanism whereby gp91(phox-/-) 6-OHDA lesioned mice may be more susceptible to develop PD after microglial cell inhibition. Nox2 adds an essential level of regulation to signaling pathways underlying the inflammatory response after PD induction.	[Hernandes, Marina S.; Santos, Graziella D. R.; Cafe-Mendes, Cecilia C.; Britto, Luiz R. G.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil; [Lima, Larissa S.; Scavone, Cristoforo; Munhoz, Carolina D.] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Hernandes, MS (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil.	marinash@icb.usp.br	Scavone, Cristoforo/ABB-8279-2021; Scavone, Cristoforo/AFK-9950-2022; Scavone, Cristoforo/C-1580-2012; Café-Mendes, Cecilia C/O-9432-2014; Munhoz, Carolina Demarchi/N-7219-2014	Scavone, Cristoforo/0000-0002-1206-0882; Scavone, Cristoforo/0000-0002-1206-0882; Scavone, Cristoforo/0000-0002-1206-0882; Munhoz, Carolina Demarchi/0000-0002-8656-5234	FAPESP; CNPq	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by the official brazilian agencies FAPESP and CNPq, in addition to the Applied Neuroscience Nucleus (NAPNA, University of Sao Paulo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2004, BBA-MOL CELL RES, V1742, P81, DOI 10.1016/j.bbamcr.2004.09.006; Babior BM, 2002, ANTIOXID REDOX SIGN, V4, P35, DOI 10.1089/152308602753625834; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Barcia C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.17; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Block ML, 2006, FASEB J, V20, P251, DOI 10.1096/fj.05-4553com; BOKA G, 1994, NEUROSCI LETT, V172, P151, DOI 10.1016/0304-3940(94)90684-X; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Choi DH, 2012, ANTIOXID REDOX SIGN, V16, P1033, DOI 10.1089/ars.2011.3960; Choi SH, 2012, J NEUROCHEM, V120, P292, DOI 10.1111/j.1471-4159.2011.07572.x; Ezcurra ALD, 2010, NEUROBIOL DIS, V37, P630, DOI 10.1016/j.nbd.2009.11.018; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Fox C, 2005, J CEREBR BLOOD F MET, V25, P1138, DOI 10.1038/sj.jcbfm.9600121; Gao HM, 2003, J NEUROSCI, V23, P6181; Gao HM, 2002, J NEUROCHEM, V81, P1285, DOI 10.1046/j.1471-4159.2002.00928.x; Glezer I, 2003, NEUROPHARMACOLOGY, V45, P1120, DOI 10.1016/S0028-3908(03)00279-X; Guerra MC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-128; He Y, 2001, BRAIN RES, V909, P187, DOI 10.1016/S0006-8993(01)02681-6; Henry CJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-15; Hernandes MS, 2010, NEUROSCIENCE, V170, P1249, DOI 10.1016/j.neuroscience.2010.07.065; Hernandes MS, 2012, CURR NEUROPHARMACOL, V10, P321, DOI 10.2174/157015912804143540; Hernandes MS, 2012, NEUROSCI LETT, V521, P104, DOI 10.1016/j.neulet.2012.05.051; Hussain AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039945; Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023; Ibi M, 2006, FREE RADICAL BIO MED, V40, P1785, DOI 10.1016/j.freeradbiomed.2006.01.009; Kawamoto EM, 2012, J NEUROSCI RES, V90, P213, DOI 10.1002/jnr.22745; Kim HJ, 2007, ANTIOXID REDOX SIGN, V9, P301, DOI 10.1089/ars.2006.1456; Kumar A, 2012, BRAIN RES, V1438, P48, DOI 10.1016/j.brainres.2011.12.028; Laurindo FRM, 2008, ANTIOXID REDOX SIGN, V10, P1101, DOI 10.1089/ars.2007.2011; LOEFFLER DA, 1994, CLIN NEUROPHARMACOL, V17, P370, DOI 10.1097/00002826-199408000-00009; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Mangano EN, 2012, NEUROBIOL AGING, V33, P1411, DOI 10.1016/j.neurobiolaging.2011.02.016; Molina-Luna K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007082; Moncunill G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052587; Munhoz CD, 2006, J NEUROSCI, V26, P3813, DOI 10.1523/JNEUROSCI.4398-05.2006; Nazemi S, 2012, PHARMACOL BIOCHEM BE, V102, P520, DOI 10.1016/j.pbb.2012.07.001; Paxinos G, 2007, MOUSE BRAIN STEREOTA; Pestana RRF, 2010, NEUROSCI LETT, V484, P187, DOI 10.1016/j.neulet.2010.08.049; Pranski EL, 2013, NEUROBIOL DIS, V54, P264, DOI 10.1016/j.nbd.2012.12.018; Rodriguez-Pallares J, 2007, J NEUROCHEM, V103, P145, DOI 10.1111/j.1471-4159.2007.04699.x; Rodriguez-Pallares J, 2008, NEUROBIOL DIS, V31, P58, DOI 10.1016/j.nbd.2008.03.003; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Soliman ML, 2013, J NEUROIMMUNE PHARM, V8, P287, DOI 10.1007/s11481-012-9426-4; Tarabin V, 2004, N-S ARCH PHARMACOL, V369, P563, DOI 10.1007/s00210-004-0938-1; Vallet P, 2005, NEUROSCIENCE, V132, P233, DOI 10.1016/j.neuroscience.2004.12.038; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Wu DC, 2003, P NATL ACAD SCI USA, V100, P6145, DOI 10.1073/pnas.0937239100; Zawada WM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-129; Zeevalk GD, 2005, ANTIOXID REDOX SIGN, V7, P1117, DOI 10.1089/ars.2005.7.1117; Zemke D, 2004, CLIN NEUROPHARMACOL, V27, P293, DOI 10.1097/01.wnf.0000150867.98887.3e; Zhang W, 2004, FASEB J, V18, P589, DOI 10.1096/fj.03-0983fje	51	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75532	10.1371/journal.pone.0075532	http://dx.doi.org/10.1371/journal.pone.0075532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086556	gold, Green Published, Green Submitted			2022-12-27	WOS:000326520200110
J	Kawamichi, H; Sasaki, AT; Matsunaga, M; Yoshihara, K; Takahashi, HK; Tanabe, HC; Sadato, N				Kawamichi, Hiroaki; Sasaki, Akihiro T.; Matsunaga, Masahiro; Yoshihara, Kazufumi; Takahashi, Haruka K.; Tanabe, Hiroki C.; Sadato, Norihiro			Medial Prefrontal Cortex Activation Is Commonly Invoked by Reputation of Self and Romantic Partners	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PERSPECTIVE-TAKING; BRAIN; OTHERS; FMRI; REPRESENTATION; METAANALYSIS; INFORMATION; ADJUSTMENT; EVOLUTION	The reputation of others influences partner selection in human cooperative behaviors through verbal reputation representation. Although the way in which humans represent the verbal reputations of others is a pivotal issue for social neuroscience, the neural correlates underlying the representation of verbal reputations of others are unclear. Humans primarily depend on self-evaluation when assessing reputation of self. Likewise, humans might primarily depend on self-evaluation of others when representing their reputation. As interaction promotes the formation of more nuanced, individualized impressions of an interaction partner, humans tend to form self-evaluations of persons with whom they are intimate in their daily life. Thus, we hypothesized that the representation of reputation of others is modulated by intimacy due to one's own evaluation formation of that person. To test this hypothesis, we conducted a functional magnetic resonance imaging experiment with 11 pairs of romantic partners while they viewed an evaluation of a target person (self, partner [intimate other], or stranger [non-intimate other]), made by other evaluators. When compared with strangers, viewing evaluations of self and partner activated overlapping regions in the medial prefrontal cortex. Verbal reputation of self-specific activation was found in the precuneus, which represents self-related processing. The data suggest that midline structures represent reputation of self. In addition, intimacy-modulated activation in the medial prefrontal cortex suggests that the verbal reputation of intimate others is represented similarly to reputation of self. These results suggest that the reputation representation in the medial prefrontal cortex is engaged by verbal reputation of self and intimate others stemming from both own and other evaluators' judgments.	[Kawamichi, Hiroaki; Takahashi, Haruka K.; Tanabe, Hiroki C.; Sadato, Norihiro] Natl Inst Physiol Sci, Dept Cerebral Res, Okazaki, Aichi 444, Japan; [Sasaki, Akihiro T.] Osaka City Univ, Dept Physiol, Grad Sch Med, Osaka, Japan; [Sasaki, Akihiro T.] RIKEN, Pathophysiol & Hlth Sci Team, Ctr Life Sci Technol, Kobe, Hyogo, Japan; [Matsunaga, Masahiro] Aichi Med Univ, Dept Hlth & Psychosocial Med, Sch Med, Nagakute, Aichi 48011, Japan; [Yoshihara, Kazufumi] Kyushu Univ, Grad Sch Med Sci, Dept Psychosomat Med, Fukuoka 812, Japan; [Takahashi, Haruka K.; Sadato, Norihiro] Grad Univ Adv Studies Sokendai, Dept Physiol Sci, Okazaki, Aichi, Japan; [Tanabe, Hiroki C.] Nagoya Univ, Grad Sch Environm Studies, Dept Social & Human Environm, Nagoya, Aichi 4648601, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Osaka Metropolitan University; RIKEN; Aichi Medical University; Kyushu University; Graduate University for Advanced Studies - Japan; Nagoya University	Kawamichi, H (corresponding author), Natl Inst Physiol Sci, Dept Cerebral Res, Okazaki, Aichi 444, Japan.	kawami@nips.ac.jp	Sasaki, Akihiro/AAH-9765-2021; Sasaki, Akihiro/C-3658-2017	Sasaki, Akihiro/0000-0002-2249-4975; Sasaki, Akihiro/0000-0002-2249-4975; Sadato, Norihiro/0000-0002-9786-3907; Kawamichi, Hiroaki/0000-0002-6172-8906; Takahashi, Haruka/0000-0002-6946-7982	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [23101507, 22101007]; Japan Society for the Promotion of Science [21220005, 23700505, 25750407, 23650224]	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was partly supported by Scientific Research on Innovative Areas grants no. 23101507 (H. K.) and no. 22101007 (H. C. T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT), by a Grant-in-Aid for Scientific Research (S) no. 21220005 (N.S.), by Grants-in-Aid for Young Scientists (B) no. 23700505 and no. 25750407 (H. K.), and by a Challenging Exploratory Research grant no. 23650224 (H. C. T.) from the Japan Society for the Promotion of Science. Part of this study is the result of "Development of biomarker candidates for social behavior" carried out under the strategic research program for brain sciences by the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Ames DR, 2004, J PERS SOC PSYCHOL, V87, P573, DOI 10.1037/0022-3514.87.5.573; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; ANDREASEN NC, 1995, AM J PSYCHIAT, V152, P1576; Apps MAJ, 2013, NEUROIMAGE, V64, P1, DOI 10.1016/j.neuroimage.2012.09.010; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; BEM DJ, 1967, PSYCHOL REV, V74, P183, DOI 10.1037/h0024835; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cooley C. H., 1902, HUMAN NATURE SOCIAL; Craik FIM, 1999, PSYCHOL SCI, V10, P26, DOI 10.1111/1467-9280.00102; D'Argembeau A, 2007, J COGNITIVE NEUROSCI, V19, P935, DOI 10.1162/jocn.2007.19.6.935; Eisenberger NI, 2011, J COGNITIVE NEUROSCI, V23, P3448, DOI 10.1162/jocn_a_00027; Epley N, 2004, J PERS SOC PSYCHOL, V87, P327, DOI 10.1037/0022-3514.87.3.327; FISKE ST, 1990, ADV EXP SOC PSYCHOL, V23, P1, DOI 10.1016/S0065-2601(08)60317-2; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Frith U, 2010, PHILOS T R SOC B, V365, P165, DOI 10.1098/rstb.2009.0160; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gobbini MI, 2004, NEUROIMAGE, V22, P1628, DOI 10.1016/j.neuroimage.2004.03.049; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hampton AN, 2008, P NATL ACAD SCI USA, V105, P6741, DOI 10.1073/pnas.0711099105; HERR PM, 1991, J CONSUM RES, V17, P454, DOI 10.1086/208570; Hynes CA, 2006, NEUROPSYCHOLOGIA, V44, P374, DOI 10.1016/j.neuropsychologia.2005.06.011; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Izuma K, 2010, SOC NEUROSCI-UK, V5, P133, DOI 10.1080/17470910903202559; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; KENNY DA, 1993, PSYCHOL BULL, V114, P145, DOI 10.1037/0033-2909.114.1.145; KINCH JW, 1963, AM J SOCIOL, V68, P481, DOI 10.1086/223404; Krienen FM, 2010, J NEUROSCI, V30, P13906, DOI 10.1523/JNEUROSCI.2180-10.2010; Lamm C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001292; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; RAUB W, 1990, AM J SOCIOL, V96, P626, DOI 10.1086/229574; Resnick P, 2000, COMMUN ACM, V43, P45, DOI 10.1145/355112.355122; RUBIN Z, 1970, J PERS SOC PSYCHOL, V16, P265, DOI 10.1037/h0029841; Schmitz TW, 2004, NEUROIMAGE, V22, P941, DOI 10.1016/j.neuroimage.2004.02.018; Seger CA, 2004, NEUROPSYCHOLOGIA, V42, P1168, DOI 10.1016/j.neuropsychologia.2004.02.003; Shamay-Tsoory SG, 2005, NEUROIMAGE, V27, P468, DOI 10.1016/j.neuroimage.2005.05.012; Tamir DI, 2010, P NATL ACAD SCI USA, V107, P10827, DOI 10.1073/pnas.1003242107; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257; van der Meer L, 2010, NEUROSCI BIOBEHAV R, V34, P935, DOI 10.1016/j.neubiorev.2009.12.004; Vanderwal T, 2008, NEUROIMAGE, V41, P1437, DOI 10.1016/j.neuroimage.2008.03.058; Wallace H.M., 2012, HDB SELF IDENTITY, P124; Whitfield-Gabrieli S, 2011, NEUROIMAGE, V55, P225, DOI 10.1016/j.neuroimage.2010.11.048; Zaki J, 2009, P NATL ACAD SCI USA, V106, P11382, DOI 10.1073/pnas.0902666106	52	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74958	10.1371/journal.pone.0074958	http://dx.doi.org/10.1371/journal.pone.0074958			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086409	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200061
J	Nars, A; Lafitte, C; Chabaud, M; Drouillard, S; Melida, H; Danoun, S; Le Costaouec, T; Rey, T; Benedetti, J; Bulone, V; Barker, DG; Bono, JJ; Dumas, B; Jacquet, C; Heux, L; Fliegmann, J; Bottin, A				Nars, Amaury; Lafitte, Claude; Chabaud, Mireille; Drouillard, Sophie; Melida, Hugo; Danoun, Saieda; Le Costaouec, Tinaig; Rey, Thomas; Benedetti, Julie; Bulone, Vincent; Barker, David George; Bono, Jean-Jacques; Dumas, Bernard; Jacquet, Christophe; Heux, Laurent; Fliegmann, Judith; Bottin, Arnaud			Aphanomyces euteiches Cell Wall Fractions Containing Novel Glucan-Chitosaccharides Induce Defense Genes and Nuclear Calcium Oscillations in the Plant Host Medicago truncatula	PLOS ONE			English	Article							CA2+ SPIKING; MOLECULAR-PATTERNS; CHITIN OLIGOMERS; PERCEPTION; OOMYCETE; PATHOGEN; ELICITORS; RESPONSES; PROTEINS; SYNTHASE	N-acetylglucosamine-based saccharides (chitosaccharides) are components of microbial cell walls and act as molecular signals during host-microbe interactions. In the legume plant Medicago truncatula, the perception of lipochitooligosaccharide signals produced by symbiotic rhizobia and arbuscular mycorrhizal fungi involves the Nod Factor Perception (NFP) lysin motif receptor-like protein and leads to the activation of the so-called common symbiotic pathway. In rice and Arabidopsis, lysin motif receptors are involved in the perception of chitooligosaccharides released by pathogenic fungi, resulting in the activation of plant immunity. Here we report the structural characterization of atypical chitosaccharides from the oomycete pathogen Aphanomyces euteiches, and their biological activity on the host Medicago truncatula. Using a combination of biochemical and biophysical approaches, we show that these chitosaccharides are linked to beta-1,6-glucans, and contain a beta-(1,3; 1,4)-glucan backbone whose beta-1,3-linked glucose units are substituted on their C-6 carbon by either glucose or N-acetylglucosamine residues. This is the first description of this type of structural motif in eukaryotic cell walls. Glucan-chitosaccharide fractions of A. euteiches induced the expression of defense marker genes in Medicago truncatula seedlings independently from the presence of a functional Nod Factor Perception protein. Furthermore, one of the glucan-chitosaccharide fractions elicited calcium oscillations in the nucleus of root cells. In contrast to the asymmetric oscillatory calcium spiking induced by symbiotic lipochitooligosaccharides, this response depends neither on the Nod Factor Perception protein nor on the common symbiotic pathway. These findings open new perspectives in oomycete cell wall biology and elicitor recognition and signaling in legumes.	[Nars, Amaury; Lafitte, Claude; Danoun, Saieda; Rey, Thomas; Benedetti, Julie; Dumas, Bernard; Jacquet, Christophe; Fliegmann, Judith; Bottin, Arnaud] Univ Toulouse UPS, Lab Rech Sci Vegetales, UMR 5546, Castanet Tolosan, France; [Nars, Amaury; Lafitte, Claude; Danoun, Saieda; Rey, Thomas; Benedetti, Julie; Dumas, Bernard; Jacquet, Christophe; Fliegmann, Judith; Bottin, Arnaud] CNRS, UMR5546, Castanet Tolosan, France; [Chabaud, Mireille; Benedetti, Julie; Barker, David George; Bono, Jean-Jacques; Fliegmann, Judith] INRA, Lab Interact Plantes Microorganismes, UMR 441, F-31326 Castanet Tolosan, France; [Chabaud, Mireille; Benedetti, Julie; Barker, David George; Bono, Jean-Jacques; Fliegmann, Judith] CNRS, Lab Interact Plantes Microorganismes, UMR 2594, Castanet Tolosan, France; [Drouillard, Sophie; Le Costaouec, Tinaig; Heux, Laurent] CNRS, CERMAV, Grenoble, France; [Melida, Hugo; Bulone, Vincent] AlbaNova Univ Ctr, Sch Biotechnol, Royal Inst Technol, Div Glycosci, Stockholm, Sweden	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Royal Institute of Technology	Bottin, A (corresponding author), Univ Toulouse UPS, Lab Rech Sci Vegetales, UMR 5546, Castanet Tolosan, France.	bottin@lrsv.ups-tlse.fr	Bulone, Vincent/C-8492-2019; BOTTIN, Arnaud/ABF-6872-2020; Rey, Thomas/AAF-4454-2019; Rey, Thomas/K-8969-2019; Mélida, Hugo/G-8779-2015; Dumas, Bernard/D-1751-2009; Bulone, Vincent/D-7469-2013; jacquet, Christophe/B-2563-2009	Bulone, Vincent/0000-0003-2809-4160; Rey, Thomas/0000-0002-9454-074X; Mélida, Hugo/0000-0003-1792-0113; Dumas, Bernard/0000-0002-4138-3533; jacquet, Christophe/0000-0002-7377-5638; Fliegmann, Judith/0000-0003-1021-8006	Region Midi-Pyrenees; CNRS [INEE 36]; French Agence Nationale de la Recherche [ANR-08-BLAN-0208-01]	Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); CNRS(Centre National de la Recherche Scientifique (CNRS)); French Agence Nationale de la Recherche(French National Research Agency (ANR))	This work is part of the "Laboratoire d'Excellence" (LABEX) entitled TULIP (ANR -10-LABX-41); it was funded by the Region Midi-Pyrenees, the CNRS (PhD grant INEE 36 to AN), and the French Agence Nationale de la Recherche (ANR-08-BLAN-0208-01 "Sympasignal"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; Asiegbu FO, 1996, EUR J FOREST PATHOL, V26, P315; Aziz A, 2007, J EXP BOT, V58, P1463, DOI 10.1093/jxb/erm008; Badreddine I, 2008, EUKARYOT CELL, V7, P1980, DOI 10.1128/EC.00091-08; BARTNICK.S, 1968, ANNU REV MICROBIOL, V22, P87, DOI 10.1146/annurev.mi.22.100168.000511; Beakes GW, 2012, PROTOPLASMA, V249, P3, DOI 10.1007/s00709-011-0269-2; Ben Amor B, 2003, PLANT J, V34, P495, DOI 10.1046/j.1365-313X.2003.01743.x; BERTKE CC, 1992, MYCOLOGIA, V84, P571, DOI 10.2307/3760323; BERTKE CC, 1992, BOT MAR, V35, P147, DOI 10.1515/botm.1992.35.2.147; Blank CE, 2011, J MOL EVOL, V73, P188, DOI 10.1007/s00239-011-9467-y; Blum M, 2012, PEST MANAG SCI, V68, P1171, DOI 10.1002/ps.3279; Blum M, 2012, FUNGAL BIOL-UK, V116, P529, DOI 10.1016/j.funbio.2012.02.003; Blum M, 2010, MOL PLANT PATHOL, V11, P227, DOI 10.1111/j.1364-3703.2009.00604.x; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; BULONE V, 1992, EXP MYCOL, V16, P8, DOI 10.1016/0147-5975(92)90037-R; Burton RA, 2009, MOL PLANT, V2, P873, DOI 10.1093/mp/ssp063; Cabib E, 2005, J BIOL CHEM, V280, P9170, DOI 10.1074/jbc.M414005200; CAMPOSTAKAKI GM, 1982, J GEN MICROBIOL, V128, P207; Chabaud M, 2011, NEW PHYTOL, V189, P347, DOI 10.1111/j.1469-8137.2010.03464.x; CHEONG JJ, 1991, PLANT CELL, V3, P127, DOI 10.1105/tpc.3.2.127; CHERIF M, 1993, CAN J MICROBIOL, V39, P213, DOI 10.1139/m93-030; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; DIETRICH SMC, 1975, AN ACAD BRAS CIENC, V47, P155; Djebali N, 2009, MOL PLANT MICROBE IN, V22, P1043, DOI 10.1094/MPMI-22-9-1043; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fliegmann J, 2004, J BIOL CHEM, V279, P1132, DOI 10.1074/jbc.M308552200; Fliegmann J, 2011, PLANT PHYSIOL BIOCH, V49, P709, DOI 10.1016/j.plaphy.2011.04.004; Fontaine T, 2000, J BIOL CHEM, V275, P41528; Francia D, 2011, PLANT PHYSIOL BIOCH, V49, P963, DOI 10.1016/j.plaphy.2011.04.008; FREY R., 1950, BER SCHWEIZ BOT GES, V60, P199; Gaulin E, 2007, MOL PLANT PATHOL, V8, P539, DOI [10.1111/j.1364-3703.2007.00413.x, 10.1111/j.1364-3703.2007.00413.X]; Gaulin E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001723; Genre A, 2013, NEW PHYTOL, V198, P179, DOI 10.1111/nph.12146; Gough C, 2011, MOL PLANT MICROBE IN, V24, P867, DOI 10.1094/MPMI-01-11-0019; Grenville-Briggs L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024500; Guerriero G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001070; Gust AA, 2012, TRENDS PLANT SCI, V17, P495, DOI 10.1016/j.tplants.2012.04.003; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Heux L, 2000, BIOMACROMOLECULES, V1, P746, DOI 10.1021/bm000070y; KOLLAR R, 1995, J BIOL CHEM, V270, P1170, DOI 10.1074/jbc.270.3.1170; Kombrink A, 2011, MICROBES INFECT, V13, P1168, DOI 10.1016/j.micinf.2011.07.010; Latge JP, 2010, CELL MICROBIOL, V12, P863, DOI 10.1111/j.1462-5822.2010.01474.x; Leclercq J, 2008, J PLANT PHYSIOL, V165, P766, DOI 10.1016/j.jplph.2007.02.008; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; LIN CC, 1970, ARCH MIKROBIOL, V72, P111, DOI 10.1007/BF00409517; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Melida H, 2013, EUKARYOT CELL, V12, P194, DOI 10.1128/EC.00288-12; Mithofer A, 2001, FEBS LETT, V508, P191, DOI 10.1016/S0014-5793(01)03054-X; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nars A, 2013, PLANT CELL REP, V32, P489, DOI 10.1007/s00299-012-1380-3; Navazio L, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-41; Nyamsuren O, 2003, PHYSIOL MOL PLANT P, V63, P17, DOI 10.1016/j.pmpp.2003.09.001; OKINAKA Y, 1995, PLANT PHYSIOL, V109, P839, DOI 10.1104/pp.109.3.839; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Pauly N, 2001, CELL CALCIUM, V30, P413, DOI 10.1054/ceca.2001.0250; Phillips AJ, 2008, TRENDS MICROBIOL, V16, P13, DOI 10.1016/j.tim.2007.10.013; Ranf S, 2011, PLANT J, V68, P100, DOI 10.1111/j.1365-313X.2011.04671.x; Rey T, 2013, NEW PHYTOL, V198, P875, DOI 10.1111/nph.12198; Ruiz-Herrera Jose, 2002, FEMS Yeast Research, V1, P247, DOI 10.1016/S1567-1356(01)00049-6; RUPLEY JA, 1964, BIOCHIM BIOPHYS ACTA, V83, P245, DOI 10.1016/0926-6526(64)90001-1; SELVENDRAN R R, 1985, P39; Shibuya N, 2001, PHYSIOL MOL PLANT P, V59, P223, DOI 10.1006/pmpp.2001.0364; Sieberer BJ, 2009, PLANT PHYSIOL, V151, P1197, DOI 10.1104/pp.109.142851; Silipo A, 2010, GLYCOBIOLOGY, V20, P406, DOI 10.1093/glycob/cwp201; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Vadassery J, 2009, PLANT J, V59, P193, DOI 10.1111/j.1365-313X.2009.03867.x; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; WALDMULLER T, 1992, PLANTA, V188, P498, DOI 10.1007/BF00197041; Werner S, 2002, FEMS MICROBIOL LETT, V208, P169, DOI 10.1111/j.1574-6968.2002.tb11077.x; Yim NH, 2008, BIOL PHARM BULL, V31, P1041, DOI 10.1248/bpb.31.1041; Zhang B, 2002, MOL PLANT MICROBE IN, V15, P963, DOI 10.1094/MPMI.2002.15.9.963; Zhu XH, 2010, EMBO J, V29, P1007, DOI 10.1038/emboj.2009.402	74	32	32	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75039	10.1371/journal.pone.0075039	http://dx.doi.org/10.1371/journal.pone.0075039			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086432	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200075
J	Stone, CM				Stone, Christopher M.			Transient Population Dynamics of Mosquitoes during Sterile Male Releases: Modelling Mating Behaviour and Perturbations of Life History Parameters	PLOS ONE			English	Article							ANOPHELES-GAMBIAE DIPTERA; DENGUE VECTOR MOSQUITO; AEDES-AEGYPTI; BODY-SIZE; DENSITY-DEPENDENCE; SPERM COMPETITION; FEMALE POLYGAMY; HOST-SEEKING; CULICIDAE; LARVAL	The release of genetically-modified or sterile male mosquitoes offers a promising form of mosquito-transmitted pathogen control, but the insights derived from our understanding of male mosquito behaviour have not fully been incorporated into the design of such genetic control or sterile-male release methods. The importance of aspects of male life history and mating behaviour for sterile-male release programmes were investigated by projecting a stage-structured matrix model over time. An elasticity analysis of transient dynamics during sterile-male releases was performed to provide insight on which vector control methods are likely to be most synergistic. The results suggest that high mating competitiveness and mortality costs of released males are required before the sterile-release method becomes ineffective. Additionally, if released males suffer a mortality cost, older males should be released due to their increased mating capacity. If released males are of a homogenous size and size-assortative mating occurs in nature, this can lead to an increase in the abundance of large females and reduce the efficacy of the population-suppression effort. At a high level of size-assortative mating, the disease transmission potential of the vector population increases due to male releases, arguing for the release of a heterogeneously-sized male population. The female population was most sensitive to perturbations of density-dependent components of larval mortality and female survivorship and fecundity. These findings suggest source reduction might be a particularly effective complement to mosquito control based on the sterile insect technique (SIT). In order for SIT to realize its potential as a key component of an integrated vector-management strategy to control mosquito-transmitted pathogens, programme design of sterile-male release programmes must account for the ecology, behaviour and life history of mosquitoes. The model used here takes a step in this direction and can easily be modified to investigate additional aspects of mosquito behaviour or species-specific ecology.	[Stone, Christopher M.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Stone, Christopher M.] Univ Basel, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Stone, CM (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.	c.stone@unibas.ch		Stone, Christopher/0000-0001-9535-2583	Bill & Melinda Gates Foundation [OPP1032350]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was partly supported by Bill & Melinda Gates Foundation project OPP1032350. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; Ameneshewa B, 1996, MED VET ENTOMOL, V10, P170, DOI 10.1111/j.1365-2915.1996.tb00724.x; Barclay HJ, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P147, DOI 10.1007/1-4020-4051-2_6; BARCLAY HJ, 1991, THEOR POPUL BIOL, V40, P105, DOI 10.1016/0040-5809(91)90048-K; Bargielowski I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026086; Beier JC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S4; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; BERRYMAN AA, 1967, CAN ENTOMOL, V99, P858, DOI 10.4039/Ent99858-8; Bonsall MB, 2010, ISR J ECOL EVOL, V56, P353, DOI 10.1560/IJEE.56.3-4.353; Boyer S, 2011, MED VET ENTOMOL, V25, P454, DOI 10.1111/j.1365-2915.2011.00962.x; Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042040; Caswell, 2000, MATRIX POPULATION MO; CASWELL H, 2008, DEMOGR RES, V18, P27; Caswell H, 2007, ECOL LETT, V10, P1, DOI 10.1111/j.1461-0248.2006.01001.x; Catteruccia F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S7; Charlwood JD, 2002, MED VET ENTOMOL, V16, P109, DOI 10.1046/j.0269-283x.2002.00342.x; CLEMENTS AN, 1981, J APPL ECOL, V18, P373, DOI 10.2307/2402401; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; DAME D, 2009, MALARIA J S2, pS2; Damiens D, 2012, J MED ENTOMOL, V49, P1001, DOI 10.1603/ME11289; Dao A, 2010, J MED ENTOMOL, V47, P769, DOI 10.1603/ME10052; DYE C, 1984, J ANIM ECOL, V53, P247, DOI 10.2307/4355; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Ferguson HM, 2005, TRENDS ECOL EVOL, V20, P202, DOI 10.1016/j.tree.2005.02.003; GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0; Gimnig JE, 2002, J MED ENTOMOL, V39, P162, DOI 10.1603/0022-2585-39.1.162; Godfray HCJ, 2013, J ANIM ECOL, V82, P15, DOI 10.1111/1365-2656.12003; GWADZ RW, 1970, MOSQ NEWS, V30, P355; Helinski MEH, 2012, BEHAV ECOL SOCIOBIOL, V66, P1131, DOI 10.1007/s00265-012-1365-9; Helinski MEH, 2012, AM J TROP MED HYG, V86, P635, DOI 10.4269/ajtmh.2012.11-0225; Klowden MJ, 2006, J INSECT PHYSIOL, V52, P679, DOI 10.1016/j.jinsphys.2006.03.006; KLOWDEN MJ, 1988, J AM MOSQUITO CONTR, V4, P73; KNIPLING EF, 1959, SCIENCE, V130, P902, DOI 10.1126/science.130.3380.902; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; LYIMO EO, 1993, MED VET ENTOMOL, V7, P328, DOI 10.1111/j.1365-2915.1993.tb00700.x; Maiga H, 2012, J VECTOR ECOL, V37, P289, DOI 10.1111/j.1948-7134.2012.00230.x; Muriu SM, 2013, J ANIM ECOL, V82, P166, DOI 10.1111/1365-2656.12002; NASCI RS, 1991, J MED ENTOMOL, V28, P522, DOI 10.1093/jmedent/28.4.522; Nghabi KR, 2008, ANIM BEHAV, V76, P105, DOI 10.1016/j.anbehav.2008.01.014; Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Pletcher SD, 2000, J GERONTOL A-BIOL, V55, pB381, DOI 10.1093/gerona/55.8.B381; Ponlawat A, 2009, AM J TROP MED HYG, V80, P395, DOI 10.4269/ajtmh.2009.80.395; ROGERS DJ, 1984, INSECT SCI APPL, V5, P419, DOI 10.1017/S1742758400008766; Roitberg BD, 2010, PHYSIOL ENTOMOL, V35, P46, DOI 10.1111/j.1365-3032.2009.00709.x; Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001; Snow J.W., 1988, P3; SPIELMAN A, 1967, BIOL BULL-US, V132, P404, DOI 10.2307/1539644; STEINWASCHER K, 1982, ENVIRON ENTOMOL, V11, P150, DOI 10.1093/ee/11.1.150; Stone CM, 2009, J MED ENTOMOL, V46, P1327, DOI 10.1603/033.046.0611; Stone CM, 2013, ECOL CONT VECTOR-BOR, V3, P35; Stone CM, 2012, AM J TROP MED HYG, V87, P727, DOI 10.4269/ajtmh.2012.12-0123; Styer LM, 2007, AM J TROP MED HYG, V76, P111, DOI 10.4269/ajtmh.2007.76.111; TAKKEN W, 1986, B ENTOMOL RES, V76, P275, DOI 10.1017/S0007485300014747; Takken W, 1998, J MED ENTOMOL, V35, P639, DOI 10.1093/jmedent/35.5.639; Thailayil J, 2011, P NATL ACAD SCI USA, V108, P13677, DOI 10.1073/pnas.1104738108; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Tripet F, 2003, AM J TROP MED HYG, V68, P1; VERHOEK BA, 1994, ENTOMOL EXP APPL, V72, P167, DOI 10.1007/BF02383551; Vreysen MJB, 2006, ANN ENTOMOL SOC AM, V99, P607, DOI 10.1603/0013-8746(2006)99[607:MOPMIA]2.0.CO;2; Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123; White SM, 2010, J APPL ECOL, V47, P1329, DOI 10.1111/j.1365-2664.2010.01880.x; WILLIAMS RW, 1980, MOSQ NEWS, V40, P597; Yakob L, 2008, J APPL ECOL, V45, P1258, DOI 10.1111/j.1365-2664.2008.01498.x	67	12	12	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e76228	10.1371/journal.pone.0076228	http://dx.doi.org/10.1371/journal.pone.0076228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086715	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000326520200134
J	Zhao, ZJ; Mai, ZL; Ou, LL; Duan, XL; Zeng, GH				Zhao, Zhijian; Mai, Zanlin; Ou, Lili; Duan, Xiaolu; Zeng, Guohua			Serum Estradiol and Testosterone Levels in Kidney Stones Disease with and without Calcium Oxalate Components in Naturally Postmenopausal Women	PLOS ONE			English	Article							SEX-HORMONES; REPLACEMENT THERAPY; ESTROGEN; EXPRESSION; EXCRETION; CITRATE; RISK	Objective: Epidemiological data reveal that the overall risk for kidney stones disease is lower for women compared to age-matched men. However, the beneficial effect for the female sex is lost upon menopause, a time corresponding to the onset of fall in estrogen levels. The aim of this study was to describe the serum estradiol (E2) and testosterone (T) characteristics of naturally postmenopausal women with kidney stones. Methods: 113 naturally postmenopausal women with newly diagnosed kidney stones (aged 57.4 +/- 4.98 years) and 84 age frequency matched stone-free controls (56.9 +/- 4.56 years) were validly recruited in the case-control study. The odds ratios (ORs) for the associations between sex hormones and kidney stones were estimated with logistic regression models, adjusting for demographic data and medical history. Patients were also stratified analyzed according to stone components (calcium oxalate stones [COS]; non-calcium oxalate stones [NCOS]). Results: Serum E2 (21.1 vs. 31.1 pg/ml) was significantly lower in kidney stones patients compared to controls. Post-hoc analysis demonstrated that this effect was driven by COS patients (p<0.001). According to tertiles of the E2 levels, a significant higher frequency of COS was seen in the lowest E2 group (p<0.001). Multiple logistic regression analysis identified E2 level as a strong factor that was independently associated with the risk for COS (per 1 SD increase, OR=0.951, 95% confidence interval [CI] = 0.919-0.985; highest: lowest tertile, OR=0.214, 95% CI = 0.069-0.665). However, serum T levels did not significantly differ among the groups. Conclusions: Naturally postmenopausal women with higher remaining estradiol levels appear less likely to suffer from kidney calcium oxalate stones. However, no correlation was found between serum T level and kidney stones. These findings support the hypothesis that higher postmenopausal endogenous estrogens may protect against kidney stones with ageing.	[Zhao, Zhijian; Mai, Zanlin; Ou, Lili; Duan, Xiaolu; Zeng, Guohua] Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Zhao, Zhijian; Mai, Zanlin; Ou, Lili; Duan, Xiaolu; Zeng, Guohua] Guangdong Key Lab Urol, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Zeng, GH (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Urol, Guangzhou, Guangdong, Peoples R China.	gzgyzgh@vip.tom.com			National Natural Science Foundation, China [81170652]; Science and Technology Education Department of the Ministry of Health, China [201002010]	National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC)); Science and Technology Education Department of the Ministry of Health, China	This work was financed by a grant from National Natural Science Foundation, China (No. 81170652) and Science and Technology Education Department of the Ministry of Health, China (No. 201002010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Curhan GC, 2001, KIDNEY INT, V59, P2290, DOI 10.1046/j.1523-1755.2001.0590062290.x; Dey J, 2002, J UROLOGY, V167, P169, DOI 10.1016/S0022-5347(05)65405-5; Fan J, 1999, J AM SOC NEPHROL, V10, pS376; Genazzani AD, 2007, DRUG AGING, V24, P173, DOI 10.2165/00002512-200724030-00001; Heller HJ, 2002, J UROLOGY, V168, P1923, DOI 10.1016/S0022-5347(05)64264-4; Hsu YJ, 2010, KIDNEY INT, V77, P601, DOI 10.1038/ki.2009.522; Iguchi M, 1999, KIDNEY INT, V56, P479, DOI 10.1046/j.1523-1755.1999.00586.x; JOHNSON CM, 1979, KIDNEY INT, V16, P624, DOI 10.1038/ki.1979.173; Lee YH, 1996, J UROLOGY, V156, P502, DOI 10.1016/S0022-5347(01)65914-7; Li JY, 2010, J UROLOGY, V184, P2360, DOI 10.1016/j.juro.2010.08.009; MARSHALL V, 1975, BRIT J UROL, V47, P117, DOI 10.1111/j.1464-410X.1975.tb03930.x; McEwen BS, 1999, J CLIN ENDOCR METAB, V84, P1790, DOI 10.1210/jc.84.6.1790; MCKANE WR, 1995, J CLIN ENDOCR METAB, V80, P3458, DOI 10.1210/jc.80.12.3458; NORDIN BE, J CLIN ENDOCRINOL ME, V60, P651; Nordin BEC, 1999, OSTEOPOROSIS INT, V9, P351, DOI 10.1007/s001980050158; Oz OK, 2007, J BONE MINER RES, V22, P1893, DOI 10.1359/JBMR.070808; PARKS JH, 1986, KIDNEY INT, V30, P85, DOI 10.1038/ki.1986.155; RANNEVIK G, 1995, MATURITAS, V21, P103, DOI 10.1016/0378-5122(94)00869-9; SCHEY HM, 1979, J UROLOGY, V122, P288, DOI 10.1016/S0022-5347(17)56370-3; SCHORR R, 1942, SCIENCE, V95, P606, DOI DOI 10.1126/SCIENCE.95.2476.606; Semins MJ, 2010, J UROLOGY, V183, P571, DOI 10.1016/j.juro.2009.09.085; SOUCIE JM, 1994, KIDNEY INT, V46, P893, DOI 10.1038/ki.1994.347; Taylor EN, 2005, JAMA-J AM MED ASSOC, V293, P455, DOI 10.1001/jama.293.4.455; Taylor EN, 2006, AM J KIDNEY DIS, V48, P905, DOI 10.1053/j.ajkd.2006.09.004; Van Abel M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022423.34922.2A; Watson JM, 2010, J ENDOUROL, V24, P1183, DOI 10.1089/end.2010.0113; Yoshihara H, 1999, J UROLOGY, V161, P668, DOI 10.1016/S0022-5347(01)61992-X; Yoshioka I, 2010, UROLOGY, V75, P907, DOI 10.1016/j.urology.2009.09.094	28	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75513	10.1371/journal.pone.0075513	http://dx.doi.org/10.1371/journal.pone.0075513			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086550	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200107
J	Guan, CQ; Meng, WJ; Yao, R; Glenberg, AM				Guan, Connie Qun; Meng, Wanjin; Yao, Ru; Glenberg, Arthur M.			The Motor System Contributes to Comprehension of Abstract Language	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; FMRI EVIDENCE; REPRESENTATIONS; MODULATION; INTEGRATION; SENTENCES; COGNITION; MOVEMENT; BEHAVIOR; IMAGERY	If language comprehension requires a sensorimotor simulation, how can abstract language be comprehended? We show that preparation to respond in an upward or downward direction affects comprehension of the abstract quantifiers "more and more" and "less and less" as indexed by an N400-like component. Conversely, the semantic content of the sentence affects the motor potential measured immediately before the upward or downward action is initiated. We propose that this bidirectional link between motor system and language arises because the motor system implements forward models that predict the sensory consequences of actions. Because the same movement (e. g., raising the arm) can have multiple forward models for different contexts, the models can make different predictions depending on whether the arm is raised, for example, to place an object or raised as a threat. Thus, different linguistic contexts invoke different forward models, and the predictions constitute different understandings of the language.	[Guan, Connie Qun] Univ Sci & Technol Beijing, Beijing 100083, Peoples R China; [Guan, Connie Qun; Meng, Wanjin] Florida State Univ, Tallahassee, FL 32306 USA; [Guan, Connie Qun; Meng, Wanjin] Florida Ctr Reading Res, Tallahassee, FL USA; [Meng, Wanjin; Yao, Ru] Natl Inst Educ Sci, Beijing, Peoples R China; [Glenberg, Arthur M.] Arizona State Univ, Tempe, AZ 85069 USA; [Glenberg, Arthur M.] Univ Wisconsin, Madison, WI USA	University of Science & Technology Beijing; State University System of Florida; Florida State University; Arizona State University; Arizona State University-Tempe; University of Wisconsin System; University of Wisconsin Madison	Glenberg, AM (corresponding author), Arizona State Univ, Tempe, AZ 85069 USA.	glenberg@asu.edu		Glenberg, Arthur/0000-0002-9281-3687	National Social Science Foundation Grant [13BYY070]; National Office for Education Sciences Planning Grant [DBA120179]; Engineering Research Institute Foundations of USTB Grant [YJ2012-019]; U.S. National Science Foundation grants [1020367, 1324807]	National Social Science Foundation Grant; National Office for Education Sciences Planning Grant; Engineering Research Institute Foundations of USTB Grant; U.S. National Science Foundation grants(National Science Foundation (NSF))	This research was supported by National Social Science Foundation Grant (13BYY070), National Office for Education Sciences Planning Grant (DBA120179), Engineering Research Institute Foundations of USTB Grant (YJ2012-019) to Connie Qun Guan. Arthur Glenberg was partially supported by U.S. National Science Foundation grants 1020367 and 1324807. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the U.S. National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman JM, 2001, ANN NY ACAD SCI, V935, P107, DOI 10.1111/j.1749-6632.2001.tb03476.x; Anderson ML, 2003, ARTIF INTELL, V149, P91, DOI 10.1016/S0004-3702(03)00054-7; Aravena P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011751; Arbib MA, 2008, J PHYSIOL-PARIS, V102, P4, DOI 10.1016/j.jphysparis.2008.03.001; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; BARRETT SE, 1990, BRAIN COGNITION, V14, P201, DOI 10.1016/0278-2626(90)90029-N; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bernardis P, 2008, EXP BRAIN RES, V184, P599, DOI 10.1007/s00221-007-1256-x; Boot I, 2011, EXP PSYCHOL, V58, P162, DOI 10.1027/1618-3169/a000082; Borghi A.M., 2009, P ANN C COGENTIVE SC, P2304; Borghi AM, 2010, NEUROPSYCHOLOGIA, V48, P63; Boroditsky L, 2002, PSYCHOL SCI, V13, P185, DOI 10.1111/1467-9280.00434; Boulenger V, 2006, J COGNITIVE NEUROSCI, V18, P1607, DOI 10.1162/jocn.2006.18.10.1607; Boulenger V, 2012, NEUROIMAGE, V59, P3502, DOI 10.1016/j.neuroimage.2011.11.011; Bubic A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00025; Chiel HJ, 1997, TRENDS NEUROSCI, V20, P553, DOI 10.1016/S0166-2236(97)01149-1; Clark A, 1998, ANALYSIS, V58, P7, DOI 10.1111/1467-8284.00096; Clark A, 1998, BEING THERE PUTTING; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Desai RH, 2011, J COGNITIVE NEUROSCI, V23, P2376, DOI 10.1162/jocn.2010.21596; Fodor J. A., 1975, LANGUAGE THOUGHT; Fodor J. A, 1983, MODULARITY MIND; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Gentilucci M, 2008, Q J EXP PSYCHOL, V61, P944, DOI 10.1080/17470210701625683; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Glenberg AM, 2008, Q J EXP PSYCHOL, V61, P905, DOI 10.1080/17470210701625550; Glenberg AM, 2012, CORTEX, V48, P905, DOI 10.1016/j.cortex.2011.04.010; Grush R, 2004, BEHAV BRAIN SCI, V27, P377, DOI 10.1017/S0140525X04000093; Guan CQ, J BEHAV PSYCHOL RES; Hatta A, 2009, NEUROSCI LETT, V459, P105, DOI 10.1016/j.neulet.2009.05.005; Havas DA, 2010, PSYCHOL SCI, V21, P895, DOI 10.1177/0956797610374742; Holcomb PJ, 1999, J EXP PSYCHOL LEARN, V25, P721, DOI 10.1037/0278-7393.25.3.721; Hurley S, 2004, PERSPECTIVES IMITATI; Ibanez A, 2010, NEUROSCI LETT, V471, P48, DOI 10.1016/j.neulet.2010.01.009; Kan IP, 2003, COGN NEUROPSYCHOL, V20, P525, DOI 10.1080/02643290244000257; Kiefer M, 2012, CORTEX, V48, P805, DOI 10.1016/j.cortex.2011.04.006; Kousta ST, 2011, J EXP PSYCHOL GEN, V140, P14, DOI 10.1037/a0021446; KRISTEVA R, 1990, ELECTROEN CLIN NEURO, V75, P410, DOI 10.1016/0013-4694(90)90086-Y; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Lakoff George, 2003, METAPHOR WE LIVE BY; Langston W, 2002, DISCOURSE PROCESS, V34, P281, DOI 10.1207/S15326950DP3403_3; Lesage E, 2012, CURR BIOL, V22, pR794, DOI 10.1016/j.cub.2012.07.006; Luu P, 2000, J NEUROSCI, V20, P464, DOI 10.1523/JNEUROSCI.20-01-00464.2000; McPherson WB, 1999, PSYCHOPHYSIOLOGY, V36, P53, DOI 10.1017/S0048577299971196; Noe Alva, 2002, VISION MIND SELECTED, P1; Pecher D., 2005, GROUNDING COGNITION; Pickering MJ, 2007, TRENDS COGN SCI, V11, P105, DOI 10.1016/j.tics.2006.12.002; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Raposo A, 2009, NEUROPSYCHOLOGIA, V47, P388, DOI 10.1016/j.neuropsychologia.2008.09.017; Richardson DC, 2003, COGNITIVE SCI, V27, P767, DOI 10.1016/S0364-0213(03)00064-8; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rueschemeyer SA, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00183; Sato M, 2008, BRAIN LANG, V105, P83, DOI 10.1016/j.bandl.2007.10.001; Schubert TW, 2005, J PERS SOC PSYCHOL, V89, P1, DOI 10.1037/0022-3514.89.1.1; Sell AJ, 2012, PSYCHON B REV, V19, P708, DOI 10.3758/s13423-012-0263-5; Sell AJ, 2011, BRAIN LANG, V117, P39, DOI 10.1016/j.bandl.2010.07.003; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; Slobounov S, 2002, CLIN NEUROPHYSIOL, V113, P1444, DOI 10.1016/S1388-2457(02)00195-5; Smith AL, 2006, BRAIN RES, V1071, P165, DOI 10.1016/j.brainres.2005.11.084; Speer NK, 2005, J MEM LANG, V53, P125, DOI 10.1016/j.jml.2005.02.009; TALMY L, 1988, COGNITIVE SCI, V12, P49, DOI 10.1016/0364-0213(88)90008-0; Van Petten C, 2006, BRAIN LANG, V97, P279, DOI 10.1016/j.bandl.2005.11.003; Varela F., 1991, EMBODIED MIND; West WC, 2002, COGNITIVE BRAIN RES, V13, P363, DOI 10.1016/S0926-6410(01)00129-X; West WC, 2000, J COGNITIVE NEUROSCI, V12, P1024, DOI 10.1162/08989290051137558; WHEELER Michael, 2005, RECONSTRUCTING COGNI; Willems RM, 2008, J COGNITIVE NEUROSCI, V20, P1235, DOI 10.1162/jocn.2008.20085; Willems RM, 2007, BRAIN LANG, V101, P278, DOI 10.1016/j.bandl.2007.03.004; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238; Yee E, 2013, PSYCHOL SCI, V24, P909, DOI 10.1177/0956797612464658	75	34	34	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75183	10.1371/journal.pone.0075183	http://dx.doi.org/10.1371/journal.pone.0075183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VP	24086463	Green Published, gold, Green Submitted			2022-12-27	WOS:000325220000015
J	Bohndiek, SE; Bodapati, S; Van De Sompel, D; Kothapalli, SR; Gambhir, SS				Bohndiek, Sarah E.; Bodapati, Sandhya; Van De Sompel, Dominique; Kothapalli, Sri-Rajasekhar; Gambhir, Sanjiv S.			Development and Application of Stable Phantoms for the Evaluation of Photoacoustic Imaging Instruments	PLOS ONE			English	Article							OPTICAL-PROPERTIES; MIMICKING PHANTOMS; TISSUE; DESIGN	Photoacoustic imaging combines the high contrast of optical imaging with the spatial resolution and penetration depth of ultrasound. This technique holds tremendous potential for imaging in small animals and importantly, is clinically translatable. At present, there is no accepted standard physical phantom that can be used to provide routine quality control and performance evaluation of photoacoustic imaging instruments. With the growing popularity of the technique and the advent of several commercial small animal imaging systems, it is important to develop a strategy for assessment of such instruments. Here, we developed a protocol for fabrication of physical phantoms for photoacoustic imaging from polyvinyl chloride plastisol (PVCP). Using this material, we designed and constructed a range of phantoms by tuning the optical properties of the background matrix and embedding spherical absorbing targets of the same material at different depths. We created specific designs to enable: routine quality control; the testing of robustness of photoacoustic signals as a function of background; and the evaluation of the maximum imaging depth available. Furthermore, we demonstrated that we could, for the first time, evaluate two small animal photoacoustic imaging systems with distinctly different light delivery, ultrasound imaging geometries and center frequencies, using stable physical phantoms and directly compare the results from both systems.	[Gambhir, Sanjiv S.] Stanford Univ, Bio X Program, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Radiol, Mol Imaging Program Stanford, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Gambhir, SS (corresponding author), Stanford Univ, Bio X Program, Sch Med, Stanford, CA 94305 USA.	sgambhir@stanford.edu	Bohndiek, Sarah/S-9416-2019	Bohndiek, Sarah/0000-0003-0371-8635	Center for Cancer Nanotechnology Excellence and Translation, an NCI-NIH U54 grant [1 U54-CA151459]; NATIONAL CANCER INSTITUTE [U54CA151459] Funding Source: NIH RePORTER	Center for Cancer Nanotechnology Excellence and Translation, an NCI-NIH U54 grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the Center for Cancer Nanotechnology Excellence and Translation, an NCI-NIH U54 grant (1 U54-CA151459). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarcay HG, 2012, BIOMED OPT EXPRESS, V3, P418, DOI 10.1364/BOE.3.000418; Bargo PR, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1921907; Beard PC, 2002, PHOTOACOUSTIC IMAGIN; Bykov AV, 2011, P SPIE OSA BIOMEDICA; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; Cook JR, 2011, BIOMED OPT EXPRESS, V2, P3193, DOI 10.1364/BOE.2.003193; Culjat MO, 2010, ULTRASOUND MED BIOL, V36, P861, DOI 10.1016/j.ultrasmedbio.2010.02.012; Ephrat P, 2010, MED PHYS, V37, P1619, DOI 10.1118/1.3352785; FIRBANK M, 1993, PHYS MED BIOL, V38, P847, DOI 10.1088/0031-9155/38/6/015; Guo ZJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.046009; Guo ZJ, 2009, MED PHYS, V36, P4084, DOI 10.1118/1.3187231; Haisch C, 2010, ANAL BIOANAL CHEM, V397, P1503, DOI 10.1007/s00216-010-3685-9; Hungr N, 2012, MED PHYS, V39, P2031, DOI 10.1118/1.3692179; Jokerst JV, 2012, ACS NANO, V6, P5920, DOI 10.1021/nn302042y; Kharine A, 2003, PHYS MED BIOL, V48, P357, DOI 10.1088/0031-9155/48/3/306; Kim B-M, 1996, P SOC PHOTO-OPT INS, P2681; Kircher MF, 2012, NAT MED, V18, P829, DOI 10.1038/nm.2721; Kothapalli SR, 2012, IEEE T BIO-MED ENG, V59, P1199, DOI 10.1109/TBME.2012.2183593; Kruger RA, 2010, MED PHYS, V37, P6096, DOI 10.1118/1.3497677; Laufer J, 2010, IEEE J SEL TOP QUANT, V16, P600, DOI 10.1109/JSTQE.2009.2032513; Levi J, 2010, J AM CHEM SOC, V132, P11264, DOI 10.1021/ja104000a; Madsen EL, 1998, ULTRASOUND MED BIOL, V24, P535, DOI 10.1016/S0301-5629(98)00013-1; Madsen EL, 2005, PHYS MED BIOL, V50, P5983, DOI 10.1088/0031-9155/50/24/015; Manohar S, 2004, J BIOMED OPT, V9, P1172, DOI 10.1117/1.1803548; Needles A, 2012, IEEE T ULTR IN PRESS; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]; Pogue BW, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2335429; Razansky D, 2009, MED PHYS, V36, P939, DOI 10.1118/1.3077120; Richter C, 2006, PROC SPIE, V6086, DOI 10.1117/12.650692; Spirou GM, 2005, PHYS MED BIOL, V50, pN141, DOI 10.1088/0031-9155/50/14/N01; Vernon ML, 1999, APPL OPTICS, V38, P4247, DOI 10.1364/AO.38.004247; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; WRAY S, 1988, BIOCHIM BIOPHYS ACTA, V933, P184, DOI 10.1016/0005-2728(88)90069-2; Zell K, 2007, PHYS MED BIOL, V52, pN475, DOI 10.1088/0031-9155/52/20/N02	34	81	85	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75533	10.1371/journal.pone.0075533	http://dx.doi.org/10.1371/journal.pone.0075533			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086557	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700097
J	Sreedevi, G; Prasad, YG; Prabhakar, M; Rao, GR; Vennila, S; Venkateswarlu, B				Sreedevi, Gudapati; Prasad, Yenumula Gerard; Prabhakar, Mathyam; Rao, Gubbala Ramachandra; Vennila, Sengottaiyan; Venkateswarlu, Bandi			Bioclimatic Thresholds, Thermal Constants and Survival of Mealybug, Phenacoccus solenopsis (Hemiptera: Pseudococcidae) in Response to Constant Temperatures on Hibiscus	PLOS ONE			English	Article							MACONELLICOCCUS-HIRSUTUS HEMIPTERA; INTRINSIC OPTIMUM TEMPERATURE; DEPENDENT DEVELOPMENT; LIFE-HISTORY; DIAMONDBACK MOTH; HOST PLANTS; RATE MODEL; COTTON; TINSLEY; REQUIREMENTS	Temperature-driven development and survival rates of the mealybug, Phenacoccus solenopsis Tinsley (Hemiptera: Pseudococcidae) were examined at nine constant temperatures (15, 20, 25, 27, 30, 32, 35 and 40 degrees C) on hibiscus (Hibiscus rosa-sinensis L.). Crawlers successfully completed development to adult stage between 15 and 35 degrees C, although their survival was affected at low temperatures. Two linear and four nonlinear models were fitted to describe developmental rates of P. solenopsis as a function of temperature, and for estimating thermal constants and bioclimatic thresholds (lower, optimum and upper temperature thresholds for development: T-min, T-opt and T-max, respectively). Estimated thresholds between the two linear models were statistically similar. Ikemoto and Takai's linear model permitted testing the equivalence of lower developmental thresholds for life stages of P. solenopsis reared on two hosts, hibiscus and cotton. Thermal constants required for completion of cumulative development of female and male nymphs and for the whole generation were significantly lower on hibiscus (222.2, 237.0, 308.6 degree-days, respectively) compared to cotton. Three nonlinear models performed better in describing the developmental rate for immature instars and cumulative life stages of female and male and for generation based on goodness-of-fit criteria. The simplified beta type distribution function estimated T-opt values closer to the observed maximum rates. Thermodynamic SSI model indicated no significant differences in the intrinsic optimum temperature estimates for different geographical populations of P. solenopsis. The estimated bioclimatic thresholds and the observed survival rates of P. solenopsis indicate the species to be high-temperature adaptive, and explained the field abundance of P. solenopsis on its host plants.	[Sreedevi, Gudapati; Prasad, Yenumula Gerard; Prabhakar, Mathyam; Rao, Gubbala Ramachandra; Venkateswarlu, Bandi] Cent Res Inst Dryland Agr, Div Crop Sci, Hyderabad, Andhra Pradesh, India; [Vennila, Sengottaiyan] Natl Ctr Integrated Pest Management, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Central Research Institute of Dryland Agriculture; Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre for Integrated Pest Management	Prasad, YG (corresponding author), Cent Res Inst Dryland Agr, Div Crop Sci, Hyderabad, Andhra Pradesh, India.	ygprasad@gmail.com		venkateswarlu, B/0000-0001-7654-8193	National Agricultural Innovation Project [(NAIP)-C4/ C2046]	National Agricultural Innovation Project	This work was supported by National Agricultural Innovation Project (NAIP)-C4/ C2046 sub project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akintola A. J., 2008, Agricultural Journal, V3, P1, DOI 10.3923/ijar.2008.1.26; Amarasekare KG, 2008, J ECON ENTOMOL, V101, P1798, DOI 10.1603/0022-0493-101.6.1798; Amjad Ali, 2012, Journal of Agricultural Research (Lahore), V50, P89; Arif MI, 2009, INT J AGRIC BIOL, V11, P163; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; CAMPBELL A, 1974, J APPL ECOL, V11, P431, DOI 10.2307/2402197; CAREY JR, 1984, ECOL ENTOMOL, V9, P261, DOI 10.1111/j.1365-2311.1984.tb00850.x; Charleston K., 2010, AUSTR COTTON GROWER, V31, P18; Chong JH, 2003, ANN ENTOMOL SOC AM, V96, P539, DOI 10.1603/0013-8746(2003)096[0539:TEOTDS]2.0.CO;2; Chong JH, 2008, ENVIRON ENTOMOL, V37, P323, DOI 10.1603/0046-225X(2008)37[323:LHOTMM]2.0.CO;2; Culik MP, 2005, ZOOTAXA, P1; Damos PT, 2008, J ECON ENTOMOL, V101, P1557, DOI 10.1603/0022-0493(2008)101[1557:TBAMOA]2.0.CO;2; Faraway J.J., 2005, LINEAR MODELS R; FUCHS TW, 1991, SOUTHWEST ENTOMOL, V16, P215; Gilbert N, 1996, CAN ENTOMOL, V128, P1, DOI 10.4039/Ent1281-1; Hameed A, 2012, PAK J ZOOL, V44, P685; Hodgson C, 2008, ZOOTAXA, P1; Ikemoto T, 2000, ENVIRON ENTOMOL, V29, P671, DOI 10.1603/0046-225X-29.4.671; Ikemoto T, 2005, ENVIRON ENTOMOL, V34, P1377, DOI 10.1603/0046-225X-34.6.1377; Ikemoto T, 2012, J INSECT SCI, V10, P1744; Institute SAS, 2009, PROC US MAN VERS 9 2; Jandricic SE, 2010, ENVIRON ENTOMOL, V39, P1631, DOI 10.1603/EN09351; Jarosik V, 2011, J ECON ENTOMOL, V104, P1870, DOI 10.1603/EC11247; Kontodimas DC, 2004, ENVIRON ENTOMOL, V33, P1, DOI 10.1603/0046-225X-33.1.1; Kuang XJ, 2012, INSECT SCI, V19, P121, DOI 10.1111/j.1744-7917.2011.01428.x; LACTIN DJ, 1995, ENVIRON ENTOMOL, V24, P68, DOI 10.1093/ee/24.1.68; Lu Yongyue, 2011, Scientific Research and Essays, V6, P6459; Ma J, 2011, PLANT QUARANTINE, V25, p5 ; Marchioro CA, 2011, NEOTROP ENTOMOL, V40, P533, DOI 10.1590/S1519-566X2011000500003; Prasad Y. G., 2011, Journal of Biological Control, V25, P198; Prasad YG, 2012, CROP PROT, V39, P81, DOI 10.1016/j.cropro.2012.03.027; Regniere J, 2012, J INSECT PHYSIOL, V58, P634, DOI 10.1016/j.jinsphys.2012.01.010; Serrano MS, 2002, FLA ENTOMOL, V85, P417, DOI 10.1653/0015-4040(2002)085[0417:EOHPAA]2.0.CO;2; Shi PJ, 2012, ENVIRON ENTOMOL, V41, P714, DOI 10.1603/EN12058; Shi PJ, 2011, ENVIRON ENTOMOL, V40, P462, DOI 10.1603/EN10265; Shi PJ, 2010, ENVIRON ENTOMOL, V39, P2033, DOI 10.1603/EN10136; Tinsley J.B., 1898, CAN ENTOMOL, V30, P47, DOI [DOI 10.4039/ENT3047-2, 10.4039/Ent3047-2]; Tran LT, 2012, ENVIRON ENTOMOL, V41, P1190, DOI 10.1603/EN12124; Trudgill DL, 2005, ANN APPL BIOL, V146, P1, DOI 10.1111/j.1744-7348.2005.04088.x; VANRIJN PCJ, 1995, B ENTOMOL RES, V85, P285, DOI 10.1017/S0007485300034386; Vennila S, 2011, TECHNICAL B NATL CTR, V26; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P208, DOI 10.1093/aesa/77.2.208; Wang YP, 2010, AGR FOREST ENTOMOL, V12, P403, DOI 10.1111/j.1461-9563.2010.00490.x; Wang Ying-Ying, 2012, Acta Entomologica Sinica, V55, P77; Williams D., 1992, MEALYBUGS CENTRAL S; WORNER SP, 1992, ENVIRON ENTOMOL, V21, P689, DOI 10.1093/ee/21.4.689; Wu San-An, 2009, Chinese Bulletin of Entomology, V46, P159; Zahiri B, 2010, ENVIRON ENTOMOL, V39, P177, DOI 10.1603/EN08239; Zalucki Myron P., 2005, Insect Science, V12, P45, DOI 10.1111/j.1672-9609.2005.00007.x	49	17	22	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75636	10.1371/journal.pone.0075636	http://dx.doi.org/10.1371/journal.pone.0075636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086597	Green Submitted, Green Published, gold			2022-12-27	WOS:000325218700105
J	Ferrer, T; Arechiga-Figueroa, IA; Shapiro, MS; Tristani-Firouzi, M; Sanchez-Chapula, JA				Ferrer, Tania; Arechiga-Figueroa, Ivan Arael; Shapiro, Mark S.; Tristani-Firouzi, Martin; Sanchez-Chapula, Jose A.			Tamoxifen Inhibition of Kv7.2/Kv7.3 Channels	PLOS ONE			English	Article							RECEPTOR-MEDIATED INHIBITION; POTASSIUM CHANNELS; K+ CURRENTS; PHOSPHATIDYLINOSITOL; PIP2; NEURONS; BLOCKS; CELLS; KCNQ2; GATE	KCNQ genes encode five Kv7 K+ channel subunits (Kv7.1-Kv7.5). Four of these (Kv7.2-Kv7.5) are expressed in the nervous system. Kv7.2 and Kv7.3 are the principal molecular components of the slow voltage-gated M-channel, which regulates neuronal excitability. In this study, we demonstrate that tamoxifen, an estrogen receptor antagonist used in the treatment of breast cancer, inhibits Kv7.2/Kv7.3 currents heterologously expressed in human embryonic kidney HEK-293 cells. Current inhibition by tamoxifen was voltage independent but concentration-dependent. The IC50 for current inhibition was 1.68 +/- 0.44 mu M. The voltage-dependent activation of the channel was not modified. Tamoxifen inhibited Kv7.2 homomeric channels with a higher potency (IC50 = 0.74 +/- 0.16 mu M). The mutation Kv7.2 R463E increases phosphatidylinositol-4,5-bisphosphate (PIP2) -channel interaction and diminished dramatically the inhibitory effect of tamoxifen compared with that for wild type Kv7.2. Conversely, the mutation Kv7.2 R463Q, which decreases PIP2 -channel interaction, increased tamoxifen potency. Similar results were obtained on the heteromeric Kv7.2 R463Q/Kv7.3 and Kv7.2 R463E/Kv7.3 channels, compared to Kv7.2/Kv7.3 WT. Overexpression of type 2A PI(4) P5-kinase (PIP5K 2A) significantly reduced tamoxifen inhibition of Kv7.2/Kv7.3 and Kv7.2 R463Q channels. Our results suggest that tamoxifen inhibited Kv7.2/Kv7.3 channels by interfering with PIP2-channel interaction because of its documented interaction with PIP2 and the similar effect of tamoxifen on various PIP2 sensitive channels.	[Ferrer, Tania; Arechiga-Figueroa, Ivan Arael; Sanchez-Chapula, Jose A.] Univ Colima, Ctr Univ Invest Biomed, Unidad Invest Carlos Mendez, Colima, Col Mexico, Mexico; [Shapiro, Mark S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Tristani-Firouzi, Martin] Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT USA; [Tristani-Firouzi, Martin] Univ Utah, Div Pediat Cardiol, Salt Lake City, UT USA	Colegio de Mexico; Universidad de Colima; University of Texas System; University of Texas Health San Antonio; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Ferrer, T (corresponding author), Univ Colima, Ctr Univ Invest Biomed, Unidad Invest Carlos Mendez, Colima, Col Mexico, Mexico.	tania@ucol.mx		ARECHIGA FIGUEROA, IVAN ARAEL/0000-0003-3124-7148	SEP-Conacyt (Mexico) [CB-2010-01-153394, CB-2008-01-105941]; FRABA (Mexico) [725/11]; National Institutes of Health (USA) [R01 NS043394]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043394] Funding Source: NIH RePORTER	SEP-Conacyt (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); FRABA (Mexico); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by SEP-Conacyt (Mexico) grant CB-2010-01-153394 and FRABA (Mexico) grant 725/11 (to T.F.), by SEP-CONACYT (Mexico) grant CB-2008-01-105941 (to J.A.S.-C.) and by National Institutes of Health (USA), grant R01 NS043394 (to M.S.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN SP, 1995, BRIT J PHARMACOL, V115, P1163, DOI 10.1111/j.1476-5381.1995.tb15019.x; ALLAN D, 1975, BIOCHEM J, V148, P471, DOI 10.1042/bj1480471; Allen MC, 1998, EUR J PHARMACOL, V354, P261, DOI 10.1016/S0014-2999(98)00454-3; Bender K, 2002, FEBS LETT, V529, P356, DOI 10.1016/S0014-5793(02)03426-9; Bian JS, 2004, AM J PHYSIOL-HEART C, V287, pH2154, DOI 10.1152/ajpheart.00120.2004; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Gomez-Posada JC, 2010, J NEUROSCI, V30, P9316, DOI 10.1523/JNEUROSCI.0851-10.2010; COEZY E, 1982, CANCER RES, V42, P317; COLE MP, 1971, BRIT J CANCER, V25, P270, DOI 10.1038/bjc.1971.33; CONRAD MJ, 1981, BIOCHEMISTRY-US, V20, P808, DOI 10.1021/bi00507a024; Cooper EC, 2001, EPILEPSIA, V42, P49, DOI 10.1046/j.1528-1157.2001.0420s5049.x; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; FRIEDMAN ZY, 1993, J PHARMACOL EXP THER, V267, P617; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; He JY, 2003, AM J PHYSIOL-HEART C, V285, pH661, DOI 10.1152/ajpheart.00686.2002; Hernandez CC, 2008, J GEN PHYSIOL, V132, P361, DOI 10.1085/jgp.200810007; Hernandez CC, 2009, J GEN PHYSIOL, V134, P437, DOI 10.1085/jgp.200910313; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; JORDAN VC, 1975, EUR J CANCER, V11, P205, DOI 10.1016/0014-2964(75)90119-X; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Liu XK, 1998, J PHARMACOL EXP THER, V287, P877; Lopez-Izquierdo A, 2010, EUR J PHARMACOL, V638, P33, DOI 10.1016/j.ejphar.2010.04.026; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; Ponce-Balbuena D, 2010, J PHARMACOL SCI, V113, P66, DOI 10.1254/jphs.10024FP; Ponce-Balbuena D, 2009, J PHARMACOL EXP THER, V331, P563, DOI 10.1124/jpet.109.156075; Punke MA, 2007, ANESTH ANALG, V104, P1256, DOI 10.1213/01.ane.0000260310.63117.a2; Robbins J, 2006, J NEUROSCI, V26, P7950, DOI 10.1523/JNEUROSCI.2138-06.2006; Roche JP, 2002, BRIT J PHARMACOL, V137, P1173, DOI 10.1038/sj.bjp.0704989; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suh BC, 2006, PFLUG ARCH EUR J PHY, V453, P293, DOI 10.1007/s00424-006-0092-3; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; Xiao J, 2003, NAT NEUROSCI, V6, P811, DOI 10.1038/nn1090; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; ZHANG JJ, 1994, J CLIN INVEST, V94, P1690, DOI 10.1172/JCI117514	37	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e76085	10.1371/journal.pone.0076085	http://dx.doi.org/10.1371/journal.pone.0076085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086693	Green Published, gold			2022-12-27	WOS:000325025200073
J	Xia, PC; Okumura, J; Yan, PP; Xie, MR; Wu, SL; Zhuang, MZ; Zheng, J; Zhang, CY; Zhang, MY; Kato, M; Cai, GX; Yamamoto, T				Xia, Pincang; Okumura, Junko; Yan, Pingping; Xie, Meirong; Wu, Shouli; Zhuang, Meizhu; Zheng, Jian; Zhang, Chunyang; Zhang, Mingya; Kato, Masaya; Cai, GuoXi; Yamamoto, Taro			Steps towards Preventive HIV Treatment in Fujian, China: Problems Identified via an Assessment of Initial Antiretroviral Therapy Provision	PLOS ONE			English	Article							INDIVIDUALS; FAILURE; COHORT; ADULTS	Background: At the end of 2009, a total of 501 AIDS patients were receiving antiretroviral therapy (ART) in Fujian Province in China, yet there were no assessments to determine treatment efficacy and HIV-1 preventive potency under the current health care delivery system. Methods: During the period of 2005-2009, we assessed the outcomes of initial ART by following up 381 patients for 12 months in Fujian Province. CD4(+) T-lymphocyte (CD4) count, plasma viral load (VL), and patient characteristics were analysed. The results were compared between 4 groups divided by the baseline CD4 values at the 25, 50 (median), and 75 percentiles. Findings: Over three-quarters of the subjects reported heterosexual contact as the probable route of transmission. After 12 months of ART, CD4 recovery varied between the 4 groups (P < 0.001), but VL sharply declined regardless of the baseline CD4 count (P = 0.136). Although this VL decline indicates the potency of ART as an HIV-1 prevention tool, the time between positive diagnosis and ART initiation suggests serious delay in both diagnosis and treatment; the medians of periods for the lowest and highest baseline CD4 quartiles were 1.2 and 9.6 months, respectively. Conclusion: Current limitations in VL determination make it difficult to assess the efficacy of initial ART, and delays in diagnosis and treatment suggest that subjects contributed to HIV-1 transmission while they were not receiving ART. The current National Free ART scheme does not provide free treatment for sexually transmitted infection (STI), and there is no link between ART and the STI care delivery system. This may interfere with the HIV-1 preventive potency of ART. We highly recommend establishing a collaborating mechanism with STI care, strengthening the VL determination system, and promoting HIV tests and early ART initiation.	[Xia, Pincang; Yan, Pingping; Xie, Meirong; Wu, Shouli; Zheng, Jian; Zhang, Chunyang; Zhang, Mingya] Fujian Ctr Dis Control & Prevent, Dept STDs & HIV AIDS Control & Prevent, Fuzhou, Fujian Province, Peoples R China; [Xia, Pincang; Okumura, Junko; Cai, GuoXi; Yamamoto, Taro] Nagasaki Univ, Inst Trop Med, Dept Int Hlth, Nagasaki 852, Japan; [Xia, Pincang; Okumura, Junko; Cai, GuoXi; Yamamoto, Taro] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki 852, Japan; [Zhuang, Meizhu] Beitang Dist Ctr Dis Control & Prevent, Dept Dis Control & Prevent, Wuxi, Jiangsu, Peoples R China; [Kato, Masaya] World Hlth Org Vietnam Country Off, Hanoi, Vietnam	Nagasaki University; Nagasaki University; World Health Organization	Okumura, J (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Int Hlth, Nagasaki 852, Japan.	jokumura@nagasaki-u.ac.jp	Okumura, Junko/AAX-6070-2020	Okumura, Junko/0000-0002-1744-7824; CAI, Guoxi/0000-0001-8551-5852	Japan China Sasakawa Medical Fellowship; Youth Foundation of the Fujian Center for Disease Control and Prevention	Japan China Sasakawa Medical Fellowship; Youth Foundation of the Fujian Center for Disease Control and Prevention	This study was supported by the Japan China Sasakawa Medical Fellowship and the Youth Foundation of the Fujian Center for Disease Control and Prevention. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett JA, 2001, AIDS, V15, P1369, DOI 10.1097/00002030-200107270-00006; Chen K, 2005, J CHINA AIDS STI, V11, P34; Chinese Centre for Disease Control and Prevention (Chinese CDC), 2007, CHIN FREE ARTS MAN 2; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Garnett GP, 2012, CURR OPIN HIV AIDS, V7, P157, DOI 10.1097/COH.0b013e3283504ab7; Granich R, 2011, CURR HIV RES, V9, P446, DOI 10.2174/157016211798038597; Gsponer T, 2012, AIDS, V26, P57, DOI 10.1097/QAD.0b013e32834e1b5f; Gutierrez F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000089; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Ministry of Health in People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2011, 2011 EST HIV AIDS EP; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Rojanawiwat A, 2009, JPN J INFECT DIS, V62, P32; State council office, 2006, CHIN ACT PLAN RED PR; UNAIDS, 2009, BACKGR INF EP RESP; Vernazza P, 2008, B MED SUISSES, V89, P165; WHO, 2010, ANT THER HIV INF AD; Yan Y, 2007, STRAITS SCI, V1, P75; Yao X, 2012, JAIDS-J ACQ IMM DEF, V60, P328, DOI 10.1097/QAI.0b013e31824f19f5; Zhang F., 2005, CHINA FREE ART MANUA	20	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e76483	10.1371/journal.pone.0076483	http://dx.doi.org/10.1371/journal.pone.0076483			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086744	Green Published, gold, Green Submitted			2022-12-27	WOS:000325025200076
J	Nakatani, Y; Suzuki, M; Tokunaga, M; Maeda, J; Sakai, M; Ishihara, H; Yoshinaga, T; Takenaka, O; Zhang, MR; Suhara, T; Higuchi, M				Nakatani, Yosuke; Suzuki, Michiyuki; Tokunaga, Masaki; Maeda, Jun; Sakai, Miyuki; Ishihara, Hiroki; Yoshinaga, Takashi; Takenaka, Osamu; Zhang, Ming-Rong; Suhara, Tetsuya; Higuchi, Makoto			A Small-Animal Pharmacokinetic/Pharmacodynamic PET Study of Central Serotonin 1A Receptor Occupancy by a Potential Therapeutic Agent for Overactive Bladder	PLOS ONE			English	Article							LOWER URINARY-TRACT; POSITRON-EMISSION-TOMOGRAPHY; 5-HT1A RECEPTORS; RATS; MICTURITION; ANTAGONIST; BRAIN; CYTOCHROME-P450; NAD-299; BINDING	Serotonin 1A (5-HT1A) receptors have been mechanistically implicated in micturition control, and there has been a need for an appropriate biomarker surrogating the potency of a provisional drug acting on this receptor system for developing a new therapeutic approach to overactive bladder (OAB). Here, we analyzed the occupancy of 5-HT1A receptors in living Sprague-Dawley rat brains by a novel candidate drug for OAB, E2110, using positron emission tomography (PET) imaging, and assessed the utility of a receptor occupancy (RO) assay to establish a pharmacodynamic index translatable between animals and humans. The plasma concentrations inducing 50% RO (EC50) estimated by both direct and effect compartment models were in good agreement. Dose-dependent therapeutic effects of E2110 on dysregulated micturition in different rat models of pollakiuria were also consistently explained by achievement of 5-HT1A RO by E2110 in a certain range (>= 60%). Plasma drug concentrations inducing this RO range and EC50 would accordingly be objective indices in comparing pharmacokinetics-RO relationships between rats and humans. These findings support the utility of PET RO and plasma pharmacokinetic assays with the aid of adequate mathematical models in determining the in vivo characteristics of a drug acting on 5-HT1A receptors and thereby counteracting OAB.	[Nakatani, Yosuke; Suzuki, Michiyuki; Sakai, Miyuki; Ishihara, Hiroki; Yoshinaga, Takashi; Takenaka, Osamu] Eisai & Co Ltd, Tsukuba Res Labs, Tsukuba, Ibaraki, Japan; [Nakatani, Yosuke; Suzuki, Michiyuki; Tokunaga, Masaki; Maeda, Jun; Zhang, Ming-Rong; Suhara, Tetsuya; Higuchi, Makoto] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba, Chiba, Japan; [Nakatani, Yosuke; Zhang, Ming-Rong; Suhara, Tetsuya; Higuchi, Makoto] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan	Eisai Co Ltd; National Institutes for Quantum Science & Technology; Tohoku University	Higuchi, M (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba, Chiba, Japan.	mhiguchi@nirs.go.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Japan Advanced Molecular Imaging Program from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanades S, 2011, J CEREBR BLOOD F MET, V31, P944, DOI 10.1038/jcbfm.2010.175; Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Andree B, 2003, PSYCHOPHARMACOLOGY, V167, P37, DOI 10.1007/s00213-002-1355-0; Chapple C, 2005, EUR UROL, V48, P5, DOI 10.1016/j.eururo.2005.02.024; Cheng CL, 2010, AM J PHYSIOL-RENAL, V298, pF771, DOI 10.1152/ajprenal.00266.2009; Chovan JP, 2007, XENOBIOTICA, V37, P459, DOI 10.1080/00498250701245250; de Groat WC, 2006, BRIT J PHARMACOL, V147, pS25, DOI 10.1038/sj.bjp.0706604; Kapur S, 2000, J PSYCHIATR NEUROSCI, V25, P161; KATO R, 1992, TOXICOL LETT, V64-5, P661, DOI 10.1016/0378-4274(92)90245-F; Kershen Richard T, 2004, Curr Urol Rep, V5, P359, DOI 10.1007/s11934-004-0083-x; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; LECCI A, 1992, J PHARMACOL EXP THER, V262, P181; Leonardi A, 1997, Application, Patent No. [WO 9731637-A1, 9731637]; McCarron JA, 1996, J LABELLED COMPD RAD, V38, P941, DOI 10.1002/(SICI)1099-1344(199610)38:10<941::AID-JLCR906>3.3.CO;2-P; Pehrson R, 2002, N-S ARCH PHARMACOL, V366, P528, DOI 10.1007/s00210-002-0650-y; Rabiner EA, 2002, J PHARMACOL EXP THER, V301, P1144, DOI 10.1124/jpet.301.3.1144; Raje S, 2008, CLIN PHARMACOL THER, V83, P86, DOI 10.1038/sj.clpt.6100232; Ramage AG, 2006, BRIT J PHARMACOL, V147, pS120, DOI 10.1038/sj.bjp.0706504; Saijo T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042589; Scheife R, 2005, CLIN THER, V27, P144, DOI 10.1016/j.clinthera.2005.02.014; Sheiner LB, 1979, CLIN PHARMACOL THER, V40, P86; Tai YC, 2005, J NUCL MED, V46, P455; Testa R, 1999, J PHARMACOL EXP THER, V290, P1258	23	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75040	10.1371/journal.pone.0075040	http://dx.doi.org/10.1371/journal.pone.0075040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086433	Green Submitted, gold, Green Published			2022-12-27	WOS:000326520200076
J	Pham, VL; Nakayama, M; Itoh, Y; Ishigaki, H; Kitano, M; Arikata, M; Ishida, H; Kitagawa, N; Shichinohe, S; Okamatsu, M; Sakoda, Y; Tsuchiya, H; Nakamura, S; Kida, H; Ogasawara, K				Van Loi Pham; Nakayama, Misako; Itoh, Yasushi; Ishigaki, Hirohito; Kitano, Mitsutaka; Arikata, Masahiko; Ishida, Hideaki; Kitagawa, Naoko; Shichinohe, Shintaro; Okamatsu, Masatoshi; Sakoda, Yoshihiro; Tsuchiya, Hideaki; Nakamura, Shinichiro; Kida, Hiroshi; Ogasawara, Kazumasa			Pathogenicity of Pandemic H1N1 Influenza A Virus in Immunocompromised Cynomolgus Macaques	PLOS ONE			English	Article							EXPERIMENTAL-INFECTION; CYCLOSPORIN-A; H5N1 VIRUS; CYCLOPHOSPHAMIDE; PATHOGENESIS; VACCINATION; IMMUNE; EPIDEMIOLOGY; TRANSMISSION; POPULATIONS	Pandemic (H1N1) 2009 influenza virus spread throughout the world since most people did not have immunity against the virus. In the post pandemic phase when many humans might possess immunity against the pandemic virus, one of the concerns is infection in immunocompromised people. Therefore, we used an immunosuppressed macaque model to examine pathogenicity of the pandemic (H1N1) 2009 virus under an immunocompromised condition. The virus in nasal samples of immunosuppressed macaques infected with the pandemic (H1N1) 2009 virus was detected longer after infection than was the virus in nasal samples of immunocompetent macaques. As expected, not only virus amounts but also virus propagation sites in the immunosuppressed macaques were larger than those in lungs of the immunocompetent macaques when they were infected with the pandemic virus. Immunosuppressed macaques possessed low levels of immune cells producing cytokines and chemokines, but levels of inflammatory cytokines/chemokine interleukin (IL)-6, IL-18, and monocyte chemotactic protein (MCP)-1 in lungs of the immunosuppressed macaques were higher than those in lungs of the immunocompetent macaques, though the differences were not statistically significant. Therefore, under an immunosuppressive condition, the pandemic influenza (H1N1) 2009 virus might cause more severe morbidity with high cytokine/chemokine production by the host innate immune system than that seen in macaques under the immunocompetent condition.	[Van Loi Pham; Nakayama, Misako; Itoh, Yasushi; Ishigaki, Hirohito; Kitano, Mitsutaka; Arikata, Masahiko; Ishida, Hideaki; Kitagawa, Naoko; Ogasawara, Kazumasa] Shiga Univ Med Sci, Dept Pathol, Div Pathol & Dis Regulat, Otsu, Shiga 52021, Japan; [Arikata, Masahiko] Shiga Univ Med Sci, Dept Otorhinolaryngol Head & Neck Surg, Otsu, Shiga 52021, Japan; [Tsuchiya, Hideaki; Nakamura, Shinichiro] Shiga Univ Med Sci, Res Ctr Anim Life Sci, Otsu, Shiga 52021, Japan; [Shichinohe, Shintaro; Okamatsu, Masatoshi; Sakoda, Yoshihiro; Kida, Hiroshi] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Microbiol Lab, Sapporo, Hokkaido, Japan; [Kida, Hiroshi] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science; Hokkaido University; Hokkaido University	Itoh, Y (corresponding author), Shiga Univ Med Sci, Dept Pathol, Div Pathol & Dis Regulat, Otsu, Shiga 52021, Japan.	yasushii@belle.shiga-med.ac.jp	Ishigaki, Hirohito/AAO-7458-2020; Shichinohe, Shintaro/C-7937-2017	Ishigaki, Hirohito/0000-0002-5249-8598; Shichinohe, Shintaro/0000-0002-8783-2103; Itoh, Yasushi/0000-0001-7462-2193; Nakayama, Misako/0000-0001-8611-0662	Regional Research and Development Resources Utilization Program, Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan; Research Center for Zoonosis Control, Hokkaido University; Japan Initiative for Global Research Network on Infectious Diseases; JSPS KAKENHI [22390076]	Regional Research and Development Resources Utilization Program, Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Center for Zoonosis Control, Hokkaido University; Japan Initiative for Global Research Network on Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Regional Research and Development Resources Utilization Program, Japan Science and Technology Agency, the Grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan, for Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University and the Japan Initiative for Global Research Network on Infectious Diseases, and Grant-in-Aid for Scientific Research (B) JSPS KAKENHI Grant number 22390076. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almansa Raquel, 2012, Enferm Infecc Microbiol Clin, V30 Suppl 4, P18, DOI 10.1016/S0213-005X(12)70100-3; [Anonymous], 2009, N ENGL J MED, V362; Arikata M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037220; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Brun-Buisson C, 2011, AM J RESP CRIT CARE, V183, P1200, DOI 10.1164/rccm.201101-0135OC; Buss JL, 2011, ANN TRANSPL, V16, P88; Carlson CM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001136; Chan MCW, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-102; CHERNAK E, 1995, CLIN INFECT DIS, V20, P170, DOI 10.1093/clinids/20.1.170; Cilloniz C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000604; Confalonieri M, 2012, Monaldi Arch Chest Dis, V77, P94; COOK RM, 1983, AGENTS ACTIONS, V13, P98, DOI 10.1007/BF01994290; Cooksley CD, 2005, CANCER-AM CANCER SOC, V104, P618, DOI 10.1002/cncr.21203; Cordero E, 2012, EUR J CLIN MICROBIOL, V31, P547, DOI 10.1007/s10096-011-1346-3; de la Rosa-Zamboni D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050116; Evseenko VA, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-77; Green LC, 2004, MICROBES INFECT, V6, P996, DOI 10.1016/j.micinf.2004.05.012; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Herfst S, 2010, VET PATHOL, V47, P1040, DOI 10.1177/0300985810374836; HUANG KL, 1983, INFECT IMMUN, V40, P421, DOI 10.1128/IAI.40.1.421-424.1983; HURD J, 1975, INFECT IMMUN, V11, P886, DOI 10.1128/IAI.11.5.886-889.1975; Ison MG, 2006, J INFECT DIS, V193, P760, DOI 10.1086/500465; Itoh Y, 2008, VACCINE, V26, P562, DOI 10.1016/j.vaccine.2007.11.031; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kao CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031162; Kawakami C, 2009, JPN J INFECT DIS, V62, P83; Kolappaswamy K, 2008, J AM ASSOC LAB ANIM, V47, P64; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Kozak W, 1998, ANN NY ACAD SCI, V856, P33, DOI 10.1111/j.1749-6632.1998.tb08310.x; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Lednicky JA, 1998, J VIROL, V72, P3980, DOI 10.1128/JVI.72.5.3980-3990.1998; Liu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037277; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Makkoch J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051275; Masri MA, 2003, MOL IMMUNOL, V39, P1073, DOI 10.1016/S0161-5890(03)00075-0; Mazzone PJ, 2001, EUR RESPIR J, V18, P971, DOI 10.1183/09031936.01.00215201; Meerveld-Eggink A, 2011, ANN ONCOL, V22, P2031, DOI 10.1093/annonc/mdq728; Morlighem JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018956; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Nakae H, 2003, PANCREAS, V26, P134, DOI 10.1097/00006676-200303000-00008; Nakajima N, 2013, MODERN PATHOL, V26, P357, DOI 10.1038/modpathol.2012.193; Nelli RK, 2012, J VIROL, V86, P9201, DOI 10.1128/JVI.00244-12; Nicholls JM, 2012, J VIROL METHODS, V179, P409, DOI 10.1016/j.jviromet.2011.11.006; Nilsberth C, 2009, ENDOCRINOLOGY, V150, P1850, DOI 10.1210/en.2008-0806; OHTAKI S, 1986, ACTA PATHOL JAPON, V36, P1537; Rerolle JP, 2004, SCAND J INFECT DIS, V36, P513, DOI 10.1080/00365540410020244; Sakabe S, 2011, J GEN VIROL, V92, P1428, DOI 10.1099/vir.0.030346-0; SCHILTKNECHT E, 1985, CELL IMMUNOL, V91, P227, DOI 10.1016/0008-8749(85)90046-2; Schroder C, 2006, TRANSPLANTATION, V81, P1165, DOI 10.1097/01.tp.0000203170.77195.e4; Schuurman HJ, 2005, TOXICOLOGY, V213, P1, DOI 10.1016/j.tox.2005.03.017; Shiino T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011057; Siberry GK, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/627974; SINGER SH, 1972, INFECT IMMUN, V5, P957, DOI 10.1128/IAI.5.6.957-960.1972; Soesman NMR, 2000, J MED VIROL, V61, P85, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;85::AID-JMV14&gt;3.0.CO;2-H; Sogawa H, 2008, TRANSPLANTATION, V86, P615, DOI 10.1097/TP.0b013e3181821bac; SOLBACH W, 1984, BLOOD, V64, P1022; Tan CS, 2009, J INFECT DIS, V199, P881, DOI 10.1086/597117; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; Van Reeth K, 2000, VET MICROBIOL, V74, P109, DOI 10.1016/S0378-1135(00)00171-1; Viasus Diego, 2012, Enferm Infecc Microbiol Clin, V30 Suppl 4, P54, DOI 10.1016/S0213-005X(12)70106-4; Wumba R, 2012, INT J GEN MED, V5, P603, DOI 10.2147/IJGM.S32344; Xu T, 2009, EUR RESPIR J, V33, P852, DOI 10.1183/09031936.00130507	62	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75910	10.1371/journal.pone.0075910	http://dx.doi.org/10.1371/journal.pone.0075910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086663	Green Submitted, gold, Green Published			2022-12-27	WOS:000326520200124
J	Wood, ACL; Rowden, AA; Compton, TJ; Gordon, DP; Probert, PK				Wood, Anna C. L.; Rowden, Ashley A.; Compton, Tanya J.; Gordon, Dennis P.; Probert, P. Keith			Habitat-Forming Bryozoans in New Zealand: Their Known and Predicted Distribution in Relation to Broad-Scale Environmental Variables and Fishing Effort	PLOS ONE			English	Article							DISTRIBUTION MODELS IMPLICATIONS; FOVEAUX STRAIT; SPECIES DISTRIBUTIONS; BIOGENIC REEFS; MARINE; PERFORMANCE; SHELF; CHEILOSTOMATA; CONSERVATION; BIODIVERSITY	Frame-building bryozoans occasionally occur in sufficient densities in New Zealand waters to generate habitat for other macrofauna. The environmental conditions necessary for bryozoans to generate such habitat, and the distributions of these species, are poorly known. Bryozoan-generated habitats are vulnerable to bottom fishing, so knowledge of species' distributions is essential for management purposes. To better understand these distributions, presence records were collated and mapped, and habitat suitability models were generated (Maxent, 1 km(2) grid) for the 11 most common habitat-forming bryozoan species: Arachnopusia unicornis, Cellaria immersa, Cellaria tenuirostris, Celleporaria agglutinans, Celleporina grandis, Cinctipora elegans, Diaperoecia purpurascens, Galeopsis porcellanicus, Hippomenella vellicata, Hornera foliacea, and Smittoidea maunganuiensis. The models confirmed known areas of habitat, and indicated other areas as potentially suitable. Water depth, vertical water mixing, tidal currents, and water temperature were useful for describing the distribution of the bryozoan species at broad scales. Areas predicted as suitable for multiple species were identified, and these 'hotspots' were compared to fishing effort data. This showed a potential conflict between fishing and the conservation of bryozoan-generated habitat. Fishing impacts are known from some sites, but damage to large areas of habitat-forming bryozoans is likely to have occurred throughout the study area. In the present study, spatial error associated with the use of historic records and the coarse native resolution of the environmental variables limited both the resolution at which the models could be interpreted and our understanding of the ecological requirements of the study species. However, these models show species distribution modelling has potential to further our understanding of habitat-forming bryozoan ecology and distribution. Importantly, comparisons between hotspots of suitable habitat and the distribution of bottom fishing in the study area highlight the need for management measures designed to mitigate the impact of seafloor disturbance on bryozoan-generated habitat in New Zealand waters.	[Wood, Anna C. L.; Probert, P. Keith] Univ Otago, Dept Marine Sci, Dunedin, New Zealand; [Rowden, Ashley A.; Compton, Tanya J.; Gordon, Dennis P.] Natl Inst Water & Atmospher Res, Wellington, New Zealand; [Compton, Tanya J.] Royal Netherlands Inst Sea Res, Dept Marine Ecol, Den Burg, Netherlands	University of Otago; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Wood, ACL (corresponding author), Univ Otago, Dept Marine Sci, Dunedin, New Zealand.	anna.wood@otago.ac.nz	Rowden, Ashley/ABG-6010-2020; Rowden, Ashley/O-9358-2019	Rowden, Ashley/0000-0003-2975-2524	NIWA's Coasts and Oceans Research Programme 2, Marine Biological Resources: Discovery and definition of the marine biota of New Zealand [2012/13 SCI]	NIWA's Coasts and Oceans Research Programme 2, Marine Biological Resources: Discovery and definition of the marine biota of New Zealand	AAR and DPG were funded by NIWA's Coasts and Oceans Research Programme 2, Marine Biological Resources: Discovery and definition of the marine biota of New Zealand (2012/13 SCI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2008, J EXP MAR BIOL ECOL, V366, P8, DOI 10.1016/j.jembe.2008.07.034; Allnutt TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028969; Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; ANDREWS PB, 1973, NEW ZEAL J GEOL GEOP, V16, P793, DOI 10.1080/00288306.1973.10555227; Arkema KK, 2009, MAR ECOL PROG SER, V388, P207, DOI 10.3354/meps08140; Auster PJ, 1998, CONSERV BIOL, V12, P1198, DOI 10.1046/j.1523-1739.1998.0120061198.x; Baird SJ, 2011, 73 MIN FISH; Batson PB, 2000, 200046  MIN FISH; Beentjes MP, 2010, 201029  MIN FISH; Beentjes MP, 2009, 200957 MIN FISH; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Boardman RS, 1992, MORPHOLOGY ANATOMY S, V70, P81; BRADSTOCK M, 1983, NEW ZEAL J MAR FRESH, V17, P159, DOI 10.1080/00288330.1983.9515993; Carter L., 1975, NEW ZEAL J MAR FRESH, V9, P423, DOI [10.1080/00288330.1975.9515579, DOI 10.1080/00288330.1975.9515579]; Cocito S, 2001, MEDITERRANEAN ECOSYSTEMS: STRUCTURES AND PROCESSES, P241; Compton TJ, 2013, J BIOGEOGR, V40, P75, DOI 10.1111/j.1365-2699.2012.02761.x; Cranfield HJ, 1999, AQUAT CONSERV, V9, P461, DOI 10.1002/(SICI)1099-0755(199909/10)9:5<461::AID-AQC353>3.0.CO;2-Z; Cranfield HJ, 2004, J SEA RES, V52, P109, DOI 10.1016/j.seares.2003.12.003; Cranfield HJ, 2003, CONT SHELF RES, V23, P1337, DOI 10.1016/S0278-4343(03)00122-5; Cryer M, 2000, DISTRIBUTION STRUCTU; Cuffey R. J, 1977, Proceedings int Coral Reef Symp, V3, P339; Cuffey RJ, 1979, ADV BRYOZOOLOGY, P345; Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483; Davies RWD, 2009, MAR POLICY, V33, P661, DOI 10.1016/j.marpol.2009.01.003; Department of Conservation and Ministry of Fisheries, 2011, BROAD SCALE GAP ANAL, V50; Dudik M, 2004, LECT NOTES COMPUT SC, V3120, P472, DOI 10.1007/978-3-540-27819-1_33; Edgar GJ, 2010, AQUAT CONSERV, V20, P297, DOI 10.1002/aqc.1079; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; FLEMING C. A., 1952, NEW ZEALAND JOUR SCI AND TECHNOL SER B, V34, P73; Froude VA, 2004, AREA BASED RESTRICTI, P169; GARNER D M, 1969, New Zealand Journal of Marine and Freshwater Research, V3, P201; Gordon DP, 1989, MARINE FAUNA NZ BRYO, P1; Gorman R, 2000, 6 INT WORKSH WAV HIN, P12; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Grange K.R., 2003, 4 MIN FISH, P22; Guisan A, 2007, ECOL MONOGR, V77, P615, DOI 10.1890/06-1060.1; Gutt J, 1998, POLAR BIOL, V20, P229, DOI 10.1007/s003000050300; Hadfield M, 2002, PHYS VARIABLES NZ MA, P64; Hageman SJ, 2003, PALAIOS, V18, P510, DOI 10.1669/0883-1351(2003)018<0510:PSOCBF>2.0.CO;2; Hageman SJ, 1995, AUST J EARTH SCI, V42, P571, DOI 10.1080/08120099508728226; Handley S, 2006, NEL2006002; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARGRAVE BT, 1973, J FISH RES BOARD CAN, V30, P1317, DOI 10.1139/f73-212; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Howell KL, 2011, BIOL CONSERV, V144, P2656, DOI 10.1016/j.biocon.2011.07.025; Jiang WM, 2002, AQUAT CONSERV, V12, P257, DOI 10.1002/aqc.495; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Jones CD, 2011, MAR POLICY, V35, P732, DOI 10.1016/j.marpol.2011.02.004; LAGAAIJ R., 1965, MICROPALEONTOLOGY, V11, P39, DOI 10.2307/1484817; Leathwick JR, 2009, DEV BENTHIC OPTIMISE; Lisbjerg D, 2000, J EXP MAR BIOL ECOL, V244, P285, DOI 10.1016/S0022-0981(99)00147-1; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lombardi C, 2008, J MAR BIOL ASSOC UK, V88, P711, DOI 10.1017/S0025315408001525; Mace J., 1981, CATCH, V8, P15; McKinney FK, 2000, CAH BIOL MAR, V41, P1; Michael KP, 2001, 200168 MIN FISH, P24; Millar CS, 2012, J NAT CONSERV, V20, P18, DOI 10.1016/j.jnc.2011.07.004; *MIN AGR PESC AL, 2010, SUP PROD AGR, P20; Ministry of Fisheries, 2010, NAT FISH PLAN DEEPW; Ministry of Fisheries, 2009, NZ MAX BEN US FISH E; Morgado EH, 2001, SCI MAR, V65, P173, DOI 10.3989/scimar.2001.65n3173; MORRIS PA, 1976, J PALEONTOL, V50, P1143; NELSON CS, 1988, SEDIMENT GEOL, V60, P301, DOI 10.1016/0037-0738(88)90126-1; Osborne PE, 2009, DIVERS DISTRIB, V15, P671, DOI 10.1111/j.1472-4642.2009.00572.x; Papes M, 2007, DIVERS DISTRIB, V13, P890, DOI 10.1111/j.1472-4642.2007.00392.x; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pinkerton M. H., 2005, CASE 2 CLIMATOLOGY N; Pinkerton MH, 2006, NEW ZEAL J MAR FRESH, V40, P227, DOI 10.1080/00288330.2006.9517417; PROBERT PK, 1979, NEW ZEAL J MAR FRESH, V13, P379, DOI 10.1080/00288330.1979.9515814; PROBERT PK, 1993, DEEP-SEA RES PT I, V40, P1003, DOI 10.1016/0967-0637(93)90086-I; Raes N, 2012, NAT CONSERVACAO, V10, P127, DOI 10.4322/natcon.2012.020; Rowden AA, 2004, BIODIVERS CONSERV, V13, P2695, DOI 10.1007/s10531-004-2143-4; Rowden AA, 2007, 200710 MIN FISH; Saxton F, 1980, CATCH, V7, P12; Seo C, 2009, BIOL LETTERS, V5, P39, DOI 10.1098/rsbl.2008.0476; Smith AM, 2001, PALAEOGEOGR PALAEOCL, V175, P201, DOI 10.1016/S0031-0182(01)00372-8; Smith F, 1999, ECOLOGY, V80, P51, DOI 10.2307/176979; Snelder TH, 2007, ENVIRON MANAGE, V39, P12, DOI 10.1007/s00267-005-0206-2; STEBBING AR, 1971, MAR BIOL, V9, P267, DOI 10.1007/BF00351389; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Taylor Paul D., 2000, P195, DOI 10.1017/CBO9780511535505.015; Taylor PD, 2004, NEW ZEAL J GEOL GEOP, V47, P57, DOI 10.1080/00288306.2004.9515037; Taylor PD, 2003, NEW ZEAL J MAR FRESH, V37, P653, DOI 10.1080/00288330.2003.9517196; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; Tracey DM, 2011, MAR ECOL PROG SER, V430, P1, DOI 10.3354/meps09164; Turner SJ, 1999, FISHERIES MANAG ECOL, V6, P401, DOI 10.1046/j.1365-2400.1999.00167.x; Uddstrom MJ, 1999, J GEOPHYS RES-OCEANS, V104, P20729, DOI 10.1029/1999JC900167; Uttley GH, 1972, NZ OCEANOGRAPHIC I M, p[57, 61]; VOOREN C M, 1975, New Zealand Journal of Marine and Freshwater Research, V9, P121; Walters RA, 2001, NEW ZEAL J MAR FRESH, V35, P567, DOI 10.1080/00288330.2001.9517023; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; WILLAN RC, 1981, NEW ZEAL J ZOOL, V8, P229, DOI 10.1080/03014223.1981.10427964; Wood ACL, 2012, AQUAT CONSERV, V22, P547, DOI 10.1002/aqc.2236	97	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75160	10.1371/journal.pone.0075160	http://dx.doi.org/10.1371/journal.pone.0075160			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086460	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200087
J	Chang, TY; Kuan, WC; Huang, KL; Chang, CH; Chang, YJ; Wong, HF; Lee, TH; Liu, HL				Chang, Ting-Yu; Kuan, Wan-Chun; Huang, Kuo-Lun; Chang, Chien-Hung; Chang, Yeu-Jhy; Wong, Ho-Fai; Lee, Tsong-Hai; Liu, Ho-Ling			Heterogeneous Cerebral Vasoreactivity Dynamics in Patients with Carotid Stenosis	PLOS ONE			English	Article							CEREBROVASCULAR REACTIVITY; HEMODYNAMIC-RESPONSE; ARTERY STENOSIS; BRAIN; STROKE; RISK; HYPERPERFUSION; RESERVE; LEVEL; MRI	Cerebral vasoreactivity (CVR) can be assessed by functional MRI (fMRI) using hypercapnia challenges. In normal subjects, studies have shown temporal variability of CVR blood oxygenation level-dependent responses among different brain regions. In the current study, we analyzed the variability of BOLD CVR dynamics by fMRI with a breath-holding task in 17 subjects with unilateral carotid stenosis before they received carotid stenting. Great heterogeneity of CVR dynamics was observed when comparing BOLD responses between ipsilateral and contralateral hemispheres in each patient, especially in middle cerebral artery (MCA) territories. While some subjects (n=12) had similar CVR responses between either hemisphere, the others (n=5) had a poorly correlated pattern of BOLD changes between ipsilateral and contralateral hemispheres. In the latter group, defined as impaired CVR, post-stenting perfusion tended to be more significantly increased. Our data provides the first observation of divergent temporal BOLD responses during breath holding in patients with carotid stenosis. The development of collateral circulation and the derangement of cerebral hemodynamics can be detected through this novel analysis of the different patterns of BOLD changes. The results also help in prediction of robust increase of perfusion or hyperperfusion after carotid stenting.	[Chang, Ting-Yu; Huang, Kuo-Lun; Chang, Chien-Hung; Chang, Yeu-Jhy; Lee, Tsong-Hai] Chang Gung Univ, Linkou Med Ctr, Chang Gung Mem Hosp, Dept Neurol,Stroke Ctr, Tao Yuan, Taiwan; [Chang, Ting-Yu; Huang, Kuo-Lun; Chang, Chien-Hung; Chang, Yeu-Jhy; Lee, Tsong-Hai] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Kuan, Wan-Chun; Liu, Ho-Ling] Chang Gung Univ, Dept Med Imaging & Radiol Sci, Tao Yuan, Taiwan; [Wong, Ho-Fai; Liu, Ho-Ling] Chang Gung Mem Hosp, Dept Med Imaging & Intervent, Tao Yuan, Taiwan; [Liu, Ho-Ling] Chang Gung Univ, Hlth Aging Res Ctr, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Lee, TH (corresponding author), Chang Gung Univ, Linkou Med Ctr, Chang Gung Mem Hosp, Dept Neurol,Stroke Ctr, Tao Yuan, Taiwan.	thlee@adm.cgmh.org.tw; hlaliu@mail.cgu.edu.tw	Lee, Tsong Hai/C-1235-2011	Chang, Ting-Yu/0000-0003-4642-7352	National Science Council of Taiwan [NSC99-2628-B-182-028-MY2]; Medical Research Project, Chang Gung Memorial Hospital [CMRPG390581]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Medical Research Project, Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by the National Science Council of Taiwan (NSC99-2628-B-182-028-MY2) and the Medical Research Project, Chang Gung Memorial Hospital (CMRPG390581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blockley NP, 2011, MAGN RESON MED, V65, P1278, DOI 10.1002/mrm.22719; Bokkers RPH, 2011, J NEUROL NEUROSUR PS, V82, P1011, DOI 10.1136/jnnp.2010.233338; Bokkers RPH, 2010, RADIOLOGY, V256, P201, DOI 10.1148/radiol.10091262; Bright MG, 2009, NEUROIMAGE, V48, P166, DOI 10.1016/j.neuroimage.2009.05.026; Cantin S, 2011, NEUROIMAGE, V58, P579, DOI 10.1016/j.neuroimage.2011.06.070; Carusone LM, 2002, AM J NEURORADIOL, V23, P1222; Chang C, 2008, NEUROIMAGE, V43, P90, DOI 10.1016/j.neuroimage.2008.06.030; Chang TY, 2009, AM J NEURORADIOL, V30, P1330, DOI 10.3174/ajnr.A1589; Derdeyn CP, 1999, NEUROLOGY, V53, P251, DOI 10.1212/WNL.53.2.251; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Furtner M, 2009, SLEEP MED, V10, P875, DOI 10.1016/j.sleep.2008.09.011; GIBBS JM, 1984, LANCET, V1, P310; Gupta A, 2012, STROKE, V43, P2884, DOI 10.1161/STROKEAHA.112.663716; Hajjar I, 2010, HYPERTENSION, V56, P859, DOI 10.1161/HYPERTENSIONAHA.110.160002; Hosoda K, 1998, NEUROSURGERY, V42, P988, DOI 10.1097/00006123-199805000-00019; Hosoda K, 2003, STROKE, V34, P1187, DOI 10.1161/01.STR.0000068781.31429.BE; Hosoda K, 2001, STROKE, V32, P1567, DOI 10.1161/01.STR.32.7.1567; Hsu YY, 2010, J MAGN RESON IMAGING, V31, P78, DOI 10.1002/jmri.22015; Kaku Y, 2004, AM J NEURORADIOL, V25, P1403; KLEINSCHMIDT A, 1995, STROKE, V26, P106, DOI 10.1161/01.STR.26.1.106; Lavi S, 2006, AM J PHYSIOL-HEART C, V291, pH1856, DOI 10.1152/ajpheart.00014.2006; Leoni RF, 2008, NEUROIMAGE, V41, P1192, DOI 10.1016/j.neuroimage.2008.03.035; Liebeskind DS, 2003, STROKE, V34, P2279, DOI 10.1161/01.STR.0000086465.41263.06; Lythgoe DJ, 1999, MAGN RESON IMAGING, V17, P495, DOI 10.1016/S0730-725X(98)00211-2; Markus H, 2001, BRAIN, V124, P457, DOI 10.1093/brain/124.3.457; Murphy K, 2011, NEUROIMAGE, V54, P369, DOI 10.1016/j.neuroimage.2010.07.059; Novak V, 2011, DIABETES CARE, V34, P2438, DOI 10.2337/dc11-0969; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Romero JR, 2009, CURR CARDIOL REV, V5, P279, DOI 10.2174/157340309789317887; Silvestrini M, 2000, JAMA-J AM MED ASSOC, V283, P2122, DOI 10.1001/jama.283.16.2122; Silvestrini M, 2006, STROKE, V37, P1010, DOI 10.1161/01.STR.0000206439.62025.97; Tanaka H, 2006, AM J NEURORADIOL, V27, P1770; Tong YJ, 2011, NEUROIMAGE, V56, P2047, DOI 10.1016/j.neuroimage.2011.03.071; van der Zande FHR, 2005, NEURORADIOLOGY, V47, P114, DOI 10.1007/s00234-004-1274-3; Vesely A, 2001, MAGNET RESON MED, V45, P1011, DOI 10.1002/mrm.1134; Zhang R, 2002, CIRCULATION, V106, P1814, DOI 10.1161/01.CIR.0000031798.07790.FE; Ziyeh S, 2005, STROKE, V36, P751, DOI 10.1161/01.STR.0000157593.03470.3d	38	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76072	10.1371/journal.pone.0076072	http://dx.doi.org/10.1371/journal.pone.0076072			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086687	Green Published, Green Submitted, gold			2022-12-27	WOS:000325223900075
J	Gehrie, EA; Nian, H; Young, PP				Gehrie, Eric A.; Nian, Hui; Young, Pampee P.			Brown Recluse Spider Bite Mediated Hemolysis: Clinical Features, a Possible Role for Complement Inhibitor Therapy, and Reduced RBC Surface Glycophorin A as a Potential Biomarker of Venom Exposure	PLOS ONE			English	Article							LOXOSCELES-RECLUSA; HUMAN-ERYTHROCYTES; ANEMIA; ECULIZUMAB	Background: The venom of Loxosceles reclusa (Brown Recluse spider) can cause a severe, life-threatening hemolysis in humans for which no therapy is currently available in the USA beyond supportive measures. Because this hemolysis is uncommon, relatively little is known about its clinical manifestation, diagnosis, or management. Here, we aimed to clarify the clinical details of envenomation, to determine the efficacy of the complement inhibitor eculizumab to prevent the hemolysis in vitro, and to investigate markers of exposure to Brown Recluse venom. Study Design and Methods: We performed a 10-year chart review of cases of Brown Recluse spider bite-mediated hemolysis at our institution. We also designed an in vitro assay to test the efficacy of eculizumab to inhibit hemolysis of venom exposed red blood cells. Finally, we compared levels of CD55, CD59 and glycophorin A on venom exposed versus venom-nave cells. Results: Most victims of severe Brown Recluse spider mediated hemolysis at our institution are children and follow an unpredictable clinical course. Brown Recluse spider bite mediated hemolysis is reduced by 79.2% (SD=18.8%) by eculizumab in vitro. Erythrocyte glycophorin A, but not CD55 or CD59, is reduced after red blood cells are incubated with venom in vitro. Conclusion: Taken together, our laboratory data and clinical observations indicate that L. reclusa venom exposure results in non-specific antibody and complement fixation on red blood cells, resulting in complement mediated hemolysis that is curtailed by the complement inhibitor eculizumab in vitro. Glycophorin A measurement by flow cytometry may help to identify victims of L. reclusa envenomation.	[Gehrie, Eric A.; Young, Pampee P.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Nian, Hui] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Young, Pampee P.] Tennessee Valley Vet Affairs Hosp, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Young, PP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.	pampee.young@vanderbilt.edu	Gehrie, Eric Abraham/H-9196-2019	Gehrie, Eric Abraham/0000-0002-5354-3899	Vanderbilt University Medical Center Department of Pathology, Microbiology and Immunology, Vanderbilt CTSA grant from NCRR/NIH [1UL1RR024975-01]; vial of eculizumab from Alexion Pharmaceuticals, Inc; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER	Vanderbilt University Medical Center Department of Pathology, Microbiology and Immunology, Vanderbilt CTSA grant from NCRR/NIH; vial of eculizumab from Alexion Pharmaceuticals, Inc; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported in part by a Clinical and Translational Enhancement Award from the Vanderbilt University Medical Center Department of Pathology, Microbiology and Immunology, Vanderbilt CTSA grant 1UL1RR024975-01 from NCRR/NIH, and by a research grant and a vial of eculizumab from Alexion Pharmaceuticals, Inc, www.alxn.com (all to EG and PYY). The funders had no role in study design, data collection and analysis, or decision to publish. The manuscript was reviewed by Alexion prior to submission but no changes were requested or required.	Algren DA, 2011, ANN EMERG MED, V57, P419, DOI 10.1016/j.annemergmed.2010.10.020; BRADY MT, 2011, AAP NEWS, V32, P1; Brain M, 2010, TRANSFUSION, V50, P292, DOI 10.1111/j.1537-2995.2009.02445.x; BRUCE LJ, 1994, BLOOD, V84, P916; DANKBAR DT, 1987, TRANSFUSION, V27, P534; de Roodt AR, 2007, CLIN TOXICOL, V45, P678, DOI 10.1080/15563650701397001; Dowling MM, 2012, BLOOD, V120, P3891, DOI 10.1182/blood-2012-01-406314; Elbahlawan LM, 2005, PEDIATR EMERG CARE, V21, P177; Fu S, 2004, AM J TRANSPLANT, V4, P65, DOI 10.1046/j.1600-6143.2003.00293.x; FUTRELL JM, 1979, AM J PATHOL, V95, P675; FUTRELL JM, 1979, TOXICON, V17, P355, DOI 10.1016/0041-0101(79)90263-0; Garratty G, 1997, VOX SANG, V72, P124, DOI 10.1046/j.1423-0410.1997.7220124.x; Garratty G, 1995, BLOOD, V86, P260; HARDMAN JT, 1983, TRANSFUSION, V23, P233, DOI 10.1046/j.1537-2995.1983.23383224902.x; Hostetler MA, 2003, J EMERG MED, V25, P277, DOI 10.1016/S0736-4679(03)00202-6; Kurpiewski G, 1981, Int J Tissue React, V3, P39; Lane L, 2011, PEDIATR DERMATOL, V28, P685, DOI 10.1111/j.1525-1470.2010.01302.x; Lee S, 2005, BIOCHEM J, V391, P317, DOI 10.1042/BJ20050043; Lonze BE, 2010, NEW ENGL J MED, V362, P1744, DOI 10.1056/NEJMc0910965; McDade J, 2010, J PEDIATR-US, V156, P155, DOI 10.1016/j.jpeds.2009.07.021; MCGLASSON DL, 2010, CLIN LAB SCI, V22, P216; MORGAN BB, 1977, TOXICON, V16, P85; PHARMACEUTICALS A, 2011, PACK INS SOL EC; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Roth A, 2009, BLOOD, V113, P3885, DOI 10.1182/blood-2009-01-196329; SHENKELBRUNNER H, 2000, HUMAN BLOOD GROUPS C, P304; Stoecker William V, 2009, Mo Med, V106, P425; Swanson DL, 2006, CLIN DERMATOL, V24, P213, DOI 10.1016/j.clindermatol.2005.11.006; Swanson DL, 2005, NEW ENGL J MED, V352, P700, DOI 10.1056/NEJMra041184; Tambourgi DV, 2010, TOXICON, V56, P1113, DOI 10.1016/j.toxicon.2010.01.021; Tambourgi DV, 2005, J INVEST DERMATOL, V124, P725, DOI 10.1111/j.0022-202X.2005.23654.x; TAMBOURGI DV, 1995, J IMMUNOL, V155, P4459; Tambourgi DV, 2000, BLOOD, V95, P683, DOI 10.1182/blood.V95.2.683; TANNER MJA, 1976, BIOCHEM J, V153, P271, DOI 10.1042/bj1530271; Vetter RS, 2011, TOXICON, V58, P623, DOI 10.1016/j.toxicon.2011.09.009; Vetter RS, 2009, SOUTH MED J, V102, P518, DOI 10.1097/SMJ.0b013e3181a0abb3; Wright SW, 1997, ANN EMERG MED, V30, P28, DOI 10.1016/S0196-0644(97)70106-9	37	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76558	10.1371/journal.pone.0076558	http://dx.doi.org/10.1371/journal.pone.0076558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086749	Green Published, Green Submitted, gold			2022-12-27	WOS:000325223900105
J	Grashorn, W; Sprenger, C; Forkmann, K; Wrobel, N; Bingel, U				Grashorn, Wiebke; Sprenger, Christian; Forkmann, Katarina; Wrobel, Nathalie; Bingel, Ulrike			Age-Dependent Decline of Endogenous Pain Control: Exploring the Effect of Expectation and Depression	PLOS ONE			English	Article							NOXIOUS INHIBITORY CONTROLS; SUBNUCLEUS-RETICULARIS-DORSALIS; HOSPITAL ANXIETY; SEX-DIFFERENCES; MODULATION; INVOLVEMENT; ACTIVATION; ANALGESIA; GENDER; HORN	Although chronic pain affects all age ranges, it is particularly common in the elderly. One potential explanation for the high prevalence of chronic pain in the older population is impaired functioning of the descending pain inhibitory system which can be studied in humans using conditioned pain modulation (CPM) paradigms. In this study we investigated (i) the influence of age on CPM and (ii) the role of expectations, depression and gender as potential modulating variables of an age-related change in CPM. 64 healthy volunteers of three different age groups (young = 20-40 years, middle-aged = 41-60 years, old = 61-80 years) were studied using a classical CPM paradigm that combined moderate heat pain stimuli to the right forearm as test stimuli (TS) and immersion of the contralateral foot into ice water as the conditioning stimulus (CS). The CPM response showed an age-dependent decline with strong CPM responses in young adults but no significant CPM responses in middle-aged and older adults. These age-related changes in CPM responses could not be explained by expectations of pain relief or depression. Furthermore, changes in CPM responses did not differ between men and women. Our results strongly support the notion of a genuine deterioration of descending pain inhibitory mechanisms with age.	[Grashorn, Wiebke; Forkmann, Katarina; Wrobel, Nathalie; Bingel, Ulrike] Univ Med Ctr Hamburg Eppendorf UKE, Dept Neurol, Hamburg, Germany; [Sprenger, Christian; Bingel, Ulrike] Univ Med Ctr Hamburg Eppendorf UKE, Dept Syst Neurosci, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Grashorn, W (corresponding author), Univ Med Ctr Hamburg Eppendorf UKE, Dept Neurol, Hamburg, Germany.	w.grashorn@uke.uni-hamburg.de			German Research Foundation [SFB 936/1]; Federal Ministry of Education and Research [01GQ0808]; LIIRA Grant by Pfizer	German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); LIIRA Grant by Pfizer	This work was supported by grants from the German Research Foundation (SFB 936/1), the Federal Ministry of Education and Research (01GQ0808) and the LIIRA Grant by Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt-Nielsen L, 2008, PAIN, V140, P465, DOI 10.1016/j.pain.2008.09.027; Arnow BA, 2006, PSYCHOSOM MED, V68, P262, DOI 10.1097/01.psy.0000204851.15499.fc; Baad-Hansen L, 2005, PAIN, V116, P359, DOI 10.1016/j.pain.2005.05.006; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Bie BH, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-37; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BOUHASSIRA D, 1992, BRAIN RES, V595, P353, DOI 10.1016/0006-8993(92)91071-L; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; CHETELAT G, 2013, NEUROIMAGE; CHITOUR D, 1982, BRAIN RES, V236, P329, DOI 10.1016/0006-8993(82)90718-1; CORMIER S, 2012, J PAIN; Dickstein DL, 2007, AGING CELL, V6, P275, DOI 10.1111/j.1474-9726.2007.00289.x; Eaton WW, 1997, ARCH GEN PSYCHIAT, V54, P993; Edwards RR, 2003, PAIN, V101, P155, DOI 10.1016/S0304-3959(02)00324-X; Eippert F, 2009, NEURON, V63, P533, DOI 10.1016/j.neuron.2009.07.014; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Fotenos AF, 2008, ARCH NEUROL-CHICAGO, V65, P113, DOI 10.1001/archneurol.2007.27; France CR, 1999, PAIN, V81, P77, DOI 10.1016/S0304-3959(98)00272-3; Gibson SJ, 2004, CLIN J PAIN, V20, P227, DOI 10.1097/00002508-200407000-00004; Gibson Stephen J, 2007, Expert Rev Neurother, V7, P627, DOI 10.1586/14737175.7.6.627; Goffaux P, 2007, PAIN, V130, P137, DOI 10.1016/j.pain.2006.11.011; Granot M, 2008, PAIN, V136, P142, DOI 10.1016/j.pain.2007.06.029; Lariviere M, 2007, CLIN J PAIN, V23, P506, DOI 10.1097/AJP.0b013e31806a23e8; Lautenbacher S, 2012, PAIN MED, V13, pS44, DOI 10.1111/j.1526-4637.2012.01326.x; LEBARS D, 1992, PAIN, V48, P13, DOI 10.1016/0304-3959(92)90126-V; LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Moont R, 2011, PAIN, V152, P1469, DOI 10.1016/j.pain.2011.01.036; Nir RR, 2012, PAIN, V153, P170, DOI 10.1016/j.pain.2011.10.010; Piche M, 2009, J NEUROSCI, V29, P14236, DOI 10.1523/JNEUROSCI.2341-09.2009; Popescu A, 2010, PAIN, V150, P309, DOI 10.1016/j.pain.2010.05.013; Potvin S, 2009, J PAIN, V10, P969, DOI 10.1016/j.jpain.2009.03.013; PRICE DD, 1988, PAIN, V34, P245, DOI 10.1016/0304-3959(88)90119-4; Pud D, 2009, PAIN, V144, P16, DOI 10.1016/j.pain.2009.02.015; Quiton RL, 2007, PAIN, V132, pS134, DOI 10.1016/j.pain.2007.09.001; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Riley JL, 2010, PAIN, V150, P153, DOI 10.1016/j.pain.2010.04.020; Sandrini G, 2006, CEPHALALGIA, V26, P782, DOI 10.1111/j.1468-2982.2006.01130.x; SCHOUENBORG J, 1985, BRAIN RES, V328, P23, DOI 10.1016/0006-8993(85)91318-6; Sprenger C, 2011, PAIN, V152, P428, DOI 10.1016/j.pain.2010.11.018; Tamnes CK, 2013, NEUROIMAGE, V68, P63, DOI 10.1016/j.neuroimage.2012.11.039; Tauscher J, 2001, NEUROPSYCHOPHARMACOL, V24, P522, DOI 10.1016/S0893-133X(00)00227-X; Tousignant-Laflamme Y, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/693912; Tracey I, 2012, CELL, V148, P1308, DOI 10.1016/j.cell.2012.03.004; Villanueva L, 1996, PAIN, V67, P231, DOI 10.1016/0304-3959(96)03121-1; Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013; Washington LL, 2000, PAIN, V89, P89, DOI 10.1016/S0304-3959(00)00352-3; Yarnitsky D, 2008, PAIN, V138, P22, DOI 10.1016/j.pain.2007.10.033; Yarnitsky D, 2012, PAIN, V153, P1193, DOI 10.1016/j.pain.2012.02.021; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	50	42	43	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75629	10.1371/journal.pone.0075629	http://dx.doi.org/10.1371/journal.pone.0075629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086595	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900052
J	Chang, TS; Chang, CM; Ho, HC; Su, YC; Chen, LF; Chou, P; Lee, CC				Chang, Ting-Shou; Chang, Chun-Ming; Ho, Hsu-Chieh; Su, Yu-Chieh; Chen, Li-Fu; Chou, Pesus; Lee, Ching-Chih			Impact of Young Age on the Prognosis for Oral Cancer: A Population-Based Study in Taiwan	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; NECK-CANCER; HEAD; TONGUE; CAVITY; RISK; SURVIVAL; VOLUME	Background: Oral cancer leads to a considerable use of health care resources. Wide resection of the tumor and reconstruction with a pedicle flap/free flap is widely used. This study was conducted to investigate if young age at the time of diagnosis of oral cancer requiring this treatment confers a worse prognosis. Methods: A total of 2339 patients who underwent resections for oral cancer from 2004 to 2005 were identified from The Taiwan National Health Insurance Research Database. Survival analysis, Cox proportional regression model, propensity scores, and sensitivity test were used to evaluate the association between 5-year survival rates and age. Results: In the Cox proportional regression model, the older age group (>65 years) had the worst survival rate (hazard ratio [HR], 1.80; 95% confidence interval [CI], 1.45-2.22; P<0.001). When analyzed using the propensity scores, the adjusted 5-year survival rates were also poorer for oral cancer patients with older age (>65 years), compared to those with younger age (<45 years) (P<0.001). In sensitivity test, the adjusted hazard ratio remained no statistically elevated in the younger age group (<45 years). Conclusions: For those oral cancer patients who underwent wide excision and reconstruction, young age did not confer a worse prognosis using a Cox proportional regression model, propensity scores or sensitivity test. Young oral cancer patients may be treated using general guidelines and do not require more aggressive treatment.	[Chang, Ting-Shou] Kaohsiung Vet Gen Hosp, Dept Otolaryngol, Kaohsiung, Taiwan; [Chang, Chun-Ming] Buddhist Dalin Tzu Chi Gen Hosp, Dept Surg, Chiayi, Taiwan; [Chou, Pesus; Lee, Ching-Chih] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Chou, Pesus; Lee, Ching-Chih] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Ho, Hsu-Chieh; Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Su, Yu-Chieh] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Chiayi, Taiwan; [Ho, Hsu-Chieh; Su, Yu-Chieh; Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Chen, Li-Fu] Natl Yang Ming Univ Hosp, Dept Emergency, Taipei, Taiwan	Kaohsiung Veterans General Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University	Lee, CC (corresponding author), Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan.	hematcd@hotmail.com	Su, Yu-Chieh/M-7867-2013	Su, Yu-Chieh/0000-0002-1771-9017				AMSTERDAM JT, 1982, J SURG ONCOL, V19, P65, DOI 10.1002/jso.2930190202; Bhattacharya J, 2007, NBER TECHNICAL WORKI; CARNIOL PJ, 1982, ANN OTO RHINOL LARYN, V91, P152, DOI 10.1177/000348948209100206; Chen CY, 2007, PEDIATRICS, V119, pE435, DOI 10.1542/peds.2006-1477; Chen CJ, 2002, JPN J CLIN ONCOL, V32, pS66, DOI 10.1093/jjco/hye138; Chen HP, 2013, GUT, V62, P606, DOI 10.1136/gutjnl-2011-301708; CLARK RM, 1982, AM J SURG, V144, P459, DOI 10.1016/0002-9610(82)90423-8; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Friedlander PL, 1998, HEAD NECK-J SCI SPEC, V20, P363, DOI 10.1002/(SICI)1097-0347(199808)20:5<363::AID-HED1>3.3.CO;2-X; Gilroy JS, 2005, HEAD NECK-J SCI SPEC, V27, P269, DOI 10.1002/hed.20145; Hafkamp HC, 2004, ACTA OTO-LARYNGOL, V124, P520, DOI 10.1080/00016480310016893; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; KASSIM KH, 1988, ORAL SURG ORAL MED O, V65, P445, DOI 10.1016/0030-4220(88)90359-3; Lacy PD, 2000, OTOLARYNG HEAD NECK, V122, P253, DOI 10.1016/S0194-5998(00)70249-X; Lee CC, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-92; Lingen MW, 2000, HEAD NECK-J SCI SPEC, V22, P328, DOI 10.1002/1097-0347(200007)22:4<328::AID-HED3>3.0.CO;2-R; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; MCGREGOR GI, 1983, AM J SURG, V146, P88, DOI 10.1016/0002-9610(83)90265-9; Mignogna MD, 2004, EUR J CANCER PREV, V13, P139, DOI 10.1097/00008469-200404000-00008; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pitman KT, 2000, HEAD NECK-J SCI SPEC, V22, P297, DOI 10.1002/(SICI)1097-0347(200005)22:3<297::AID-HED14>3.0.CO;2-3; Pytynia KB, 2004, ARCH OTOLARYNGOL, V130, P869, DOI 10.1001/archotol.130.7.869; Roohan PJ, 1998, AM J PUBLIC HEALTH, V88, P454, DOI 10.2105/AJPH.88.3.454; RUBIN DB, 1993, MED CARE, V31, pYS103, DOI 10.1097/00005650-199305001-00017; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Sasaki T, 2005, J ORAL PATHOL MED, V34, P129, DOI 10.1111/j.1600-0714.2004.00291.x; SCHANTZ SP, 1989, JAMA-J AM MED ASSOC, V262, P3313, DOI 10.1001/jama.262.23.3313; SON YH, 1985, CANCER-AM CANCER SOC, V55, P441, DOI 10.1002/1097-0142(19850115)55:2<441::AID-CNCR2820550225>3.0.CO;2-5; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605; Vargas H, 2000, LARYNGOSCOPE, V110, P1623, DOI 10.1097/00005537-200010000-00009; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Yang YH, 2005, J ORAL PATHOL MED, V34, P596, DOI 10.1111/j.1600-0714.2005.00266.x; Zheng YX, 2001, CARCINOGENESIS, V22, P1195, DOI 10.1093/carcin/22.8.1195; zur Hausen H, 2009, VIROLOGY, V392, P1, DOI 10.1016/j.virol.2009.06.001	35	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75855	10.1371/journal.pone.0075855	http://dx.doi.org/10.1371/journal.pone.0075855			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086646	Green Submitted, gold, Green Published			2022-12-27	WOS:000325220000048
J	Rudra, S; Skibbens, RV				Rudra, Soumya; Skibbens, Robert V.			Chl1 DNA Helicase Regulates Scc2 Deposition Specifically during DNA-Replication in Saccharomyces cerevisiae	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; DE-LANGE-SYNDROME; WARSAW BREAKAGE SYNDROME; ROBERTS-SYNDROME; BUDDING YEAST; S-PHASE; ESTABLISHMENT FACTOR; NIPPED-B; BIOCHEMICAL-CHARACTERIZATION; ACETYLTRANSFERASE ACTIVITY	The conserved family of cohesin proteins that mediate sister chromatid cohesion requires Scc2, Scc4 for chromatin-association and Eco1/Ctf7 for conversion to a tethering competent state. A popular model, based on the notion that cohesins form huge ring-like structures, is that Scc2, Scc4 function is essential only during G1 such that sister chromatid cohesion results simply from DNA replisome passage through pre-loaded cohesin rings. In such a scenario, cohesin deposition during G1 is temporally uncoupled from Eco1-dependent establishment reactions that occur during S-phase. Chl1 DNA helicase (homolog of human ChlR1/DDX11 and BACH1/BRIP1/FANCJ helicases implicated in Fanconi anemia, breast and ovarian cancer and Warsaw Breakage Syndrome) plays a critical role in sister chromatid cohesion, however, the mechanism through which Chl1 promotes cohesion remains poorly understood. Here, we report that Chl1 promotes Scc2 loading unto DNA such that both Scc2 and cohesin enrichment to chromatin are defective in chl1 mutant cells. The results further show that both Chl1 expression and chromatin-recruitment are tightly regulated through the cell cycle, peaking during S-phase. Importantly, kinetic ChIP studies reveals that Chl1 is required for Scc2 chromatin-association specifically during S-phase, but not during G1. Despite normal chromatin enrichment of both Scc2 and cohesin during G1, chl1 mutant cells exhibit severe chromosome segregation and cohesion defects - revealing that G1-loaded cohesins is insufficient to promote cohesion. Based on these findings, we propose a new model wherein S-phase cohesin loading occurs during DNA replication and in concert with both cohesion establishment and chromatin assembly reactions - challenging the notion that DNA replication fork navigates through or around pre-loaded cohesin rings.	[Rudra, Soumya; Skibbens, Robert V.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	Lehigh University	Skibbens, RV (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	rvs3@lehigh.edu		Skibbens, Robert/0000-0003-4216-8306	National Institute of General Medical Sciences [2R15GM083269-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM110631, R15GM083269] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	RVS is supported by an award from the National Institute of General Medical Sciences (2R15GM083269-02). Any opinions, findings, and conclusions or recommendations expressed in this study are those of the authors and do not necessarily reflect the views of the National Institutes of General Medical Sciences or Lehigh University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann J, 1997, J BIOL CHEM, V272, P3823, DOI 10.1074/jbc.272.6.3823; [Anonymous], ANNU REV CELL DEV BI, V24, P105, DOI [10.1146/annurev.cellbio.24.110707.175350, DOI 10.1146/ANNUREV.CELLBI0.24.110707.175350.PUBMED:18616427]; Bellows AM, 2003, NUCLEIC ACIDS RES, V31, P6334, DOI 10.1093/nar/gkg811; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Bernard P, 2006, CURR BIOL, V16, P875, DOI 10.1016/j.cub.2006.03.037; Borges V, 2013, CHROMOSOMA, V122, P121, DOI 10.1007/s00412-013-0396-y; Bylund GO, 2005, MOL CELL BIOL, V25, P5445, DOI 10.1128/MCB.25.13.5445-5455.2005; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cantor SB, 2006, CELL CYCLE, V5, P164, DOI 10.4161/cc.5.2.2338; Capo-Chichi JM, 2013, HUM MUTAT, V34, P103, DOI 10.1002/humu.22226; Chen ZM, 2012, G3-GENES GENOM GENET, V2, P1161, DOI 10.1534/g3.112.003327; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Deardorff MA, 2012, AM J HUM GENET, V90, P1014, DOI 10.1016/j.ajhg.2012.04.019; Dorsett D, 2011, CURR OPIN GENET DEV, V21, P199, DOI 10.1016/j.gde.2011.01.018; Farina A, 2008, J BIOL CHEM, V283, P20925, DOI 10.1074/jbc.M802696200; Gartenberg M, 2009, CHROMOSOME RES, V17, P229, DOI 10.1007/s10577-008-9012-z; Gause M, 2010, MOL CELL BIOL, V30, P4940, DOI 10.1128/MCB.00642-10; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; GERRING SL, 1990, EMBO J, V9, P4347, DOI 10.1002/j.1460-2075.1990.tb07884.x; Gillis LA, 2004, AM J HUM GENET, V75, P610, DOI 10.1086/424698; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Gordillo M, 2008, HUM MOL GENET, V17, P2172, DOI 10.1093/hmg/ddn116; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Guacci V, 2012, MOL BIOL CELL, V23, P729, DOI 10.1091/mbc.E11-08-0696; Gupta R, 2007, BLOOD, V110, P2390, DOI 10.1182/blood-2006-11-057273; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Heidinger-Pauli JM, 2010, CURR BIOL, V20, P957, DOI 10.1016/j.cub.2010.04.018; Hirota Y, 2000, NUCLEIC ACIDS RES, V28, P917, DOI 10.1093/nar/28.4.917; Hou FJ, 2005, MOL BIOL CELL, V16, P3908, DOI 10.1091/mbc.E04-12-1063; Huang CE, 2005, PHILOS T ROY SOC B, V360, P537, DOI 10.1098/rstb.2004.1609; Inoue A, 2007, CELL CYCLE, V6, P1646, DOI 10.4161/cc.6.13.4411; Inoue A, 2011, EXP CELL RES, V317, P2522, DOI 10.1016/j.yexcr.2011.08.006; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Kenna MA, 2003, MOL CELL BIOL, V23, P2999, DOI 10.1128/MCB.23.8.2999-3007.2003; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Kogut I, 2009, GENE DEV, V23, P2345, DOI 10.1101/gad.1819409; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Laha S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-83; Laloraya S, 2000, J CELL BIOL, V151, P1047, DOI 10.1083/jcb.151.5.1047; Leman AR, 2013, GENES-BASEL, V4, P1, DOI 10.3390/genes4010001; Leman AR, 2010, J CELL SCI, V123, P660, DOI 10.1242/jcs.057984; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468; Maradeo ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015381; Maradeo ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004707; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Mc Intyre J, 2007, EMBO J, V26, P3783, DOI 10.1038/sj.emboj.7601793; McNairn AJ, 2009, CHROMOSOME RES, V17, P155, DOI 10.1007/s10577-008-9007-9; Megee PC, 1999, MOL CELL, V4, P445, DOI 10.1016/S1097-2765(00)80347-0; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MILES J, 1992, MOL CELL BIOL, V12, P5724, DOI 10.1128/MCB.12.12.5724; Milutinovich M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030012; Mockel C, 2012, NUCLEIC ACIDS RES, V40, P914, DOI 10.1093/nar/gkr749; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Morita A, 2012, DEV GROWTH DIFFER, V54, P588, DOI 10.1111/j.1440-169X.2012.01362.x; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Ocampo-Hafalla MT, 2011, J CELL SCI, V124, P685, DOI 10.1242/jcs.073866; Ogiwara H, 2007, BIOCHEM BIOPH RES CO, V354, P222, DOI 10.1016/j.bbrc.2006.12.185; Onn I, 2011, P NATL ACAD SCI USA, V108, P12198, DOI 10.1073/pnas.1107504108; Parish JL, 2006, J CELL SCI, V119, P4857, DOI 10.1242/jcs.03262; Peng M, 2006, ONCOGENE, V25, P2245, DOI 10.1038/sj.onc.1209257; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Rudra S, 2013, J CELL SCI, V126, P31, DOI 10.1242/jcs.116566; Rudra S, 2012, CELL CYCLE, V11, P2114, DOI 10.4161/cc.20547; Schiller CB, 2012, NAT STRUCT MOL BIOL, V19, P693, DOI 10.1038/nsmb.2323; Schule B, 2005, AM J HUM GENET, V77, P1117, DOI 10.1086/498695; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Skibbens RV, 2008, INT REV CEL MOL BIO, V269, P283, DOI 10.1016/S1937-6448(08)01005-8; Skibbens RV, 2007, J CELL SCI, V120, P2471, DOI 10.1242/jcs.011999; Skibbens RV, 2010, TRENDS CELL BIOL, V20, P507, DOI 10.1016/j.tcb.2010.06.003; Skibbens RV, 2000, GENOME RES, V10, P1664, DOI 10.1101/gr.153600; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Skibbens RV, 2004, GENETICS, V166, P33, DOI 10.1534/genetics.166.1.33; Song JH, 2012, J BIOL CHEM, V287, P34325, DOI 10.1074/jbc.M112.400192; Suhasini AN, 2013, MUTAT RES-REV MUTAT, V752, P138, DOI 10.1016/j.mrrev.2012.12.004; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; van der Lelij P, 2010, AM J HUM GENET, V86, P262, DOI 10.1016/j.ajhg.2010.01.008; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Warren CD, 2004, MOL BIOL CELL, V15, P1724, DOI 10.1091/mbc.E03-09-0637; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049; Whelan G, 2012, NUCLEUS-PHILA, V3, P330, DOI 10.4161/nucl.20440; Williams BC, 2003, CURR BIOL, V13, P2025, DOI 10.1016/j.cub.2003.11.018; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu YL, 2012, NUCLEIC ACIDS RES, V40, P4247, DOI 10.1093/nar/gks039; Wu YL, 2012, J BIOL CHEM, V287, P1007, DOI 10.1074/jbc.M111.276022; Xiong B, 2010, ANNU REV BIOCHEM, V79, P131, DOI 10.1146/annurev-biochem-061708-092640; Zhang B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005232; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zheng L, 2011, J MOL CELL BIOL, V3, P23, DOI 10.1093/jmcb/mjq048	109	33	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75435	10.1371/journal.pone.0075435	http://dx.doi.org/10.1371/journal.pone.0075435			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086532	Green Published, gold, Green Submitted			2022-12-27	WOS:000325220000021
J	Tweya, H; Feldacker, C; Estill, J; Jahn, A; Ng'ambi, W; Ben-Smith, A; Keiser, O; Bokosi, M; Egger, M; Speight, C; Gumulira, J; Phiri, S				Tweya, Hannock; Feldacker, Caryl; Estill, Janne; Jahn, Andreas; Ng'ambi, Wingston; Ben-Smith, Anne; Keiser, Olivia; Bokosi, Mphatso; Egger, Matthias; Speight, Colin; Gumulira, Joe; Phiri, Sam			Are They Really Lost? "True" Status and Reasons for Treatment Discontinuation among HIV Infected Patients on Antiretroviral Therapy Considered Lost to Follow Up in Urban Malawi	PLOS ONE			English	Article							OUTCOMES; MORTALITY; LILONGWE; PROGRAMS; FAILURE; ART	Introduction: Patients who are lost to follow-up (LTFU) while on antiretroviral therapy (ART) pose challenges to the long-term success of ART programs. We describe the extent to which patients considered LTFU are misclassified as true disengagement from care when they are still alive on ART and explain reasons for ART discontinuation using our active tracing program to further improve ART retention programs and policies. Methods: We identified adult ART patients who missed clinic appointment by more than 3 weeks between January 2006 and December 2010, assuming that such patients would miss their doses of antiretroviral drugs. Patients considered LTFU who consented during ART registration were traced by phone or home visits; true ART status after tracing was documented. Reasons for ART discontinuation were also recorded for those who stopped ART. Results: Of the 4,560 suspected LTFU cases, 1,384 (30%) could not be traced. Of the 3,176 successfully traced patients, 952 (30%) were dead and 2,224 (70%) were alive, of which 2,183 (99.5%) started ART according to phone-based self-reports or physical verification during in-person interviews. Of those who started ART, 957 (44%) stopped ART and 1,226 (56%) reported still taking ART at the time of interview by sourcing drugs from another clinic, using alternative ART sources or making brief ART interruptions. Among 940 cases with reasons for ART discontinuations, failure to remember (17%), too weak/sick (12%), travel (46%), and lack of transport to the clinic (16%) were frequently cited; reasons differed by gender. Conclusion: The LTFU category comprises sizeable proportions of patients still taking ART that may potentially bias retention estimates and misdirect resources at the clinic and national levels if not properly accounted for. Clinics should consider further decentralization efforts, increasing drug allocations for frequent travels, and improving communication on patient transfers between clinics to increase retention and adherence.	[Tweya, Hannock] Int Union TB & Lung Dis, Paris, France; [Tweya, Hannock; Feldacker, Caryl; Ng'ambi, Wingston; Bokosi, Mphatso; Speight, Colin; Gumulira, Joe; Phiri, Sam] Lighthouse Trust, Lilongwe, Malawi; [Tweya, Hannock; Estill, Janne; Keiser, Olivia; Egger, Matthias] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Feldacker, Caryl; Jahn, Andreas] Univ Washington, Int Training & Educ Ctr Hlth, Seattle, WA 98195 USA; [Jahn, Andreas] Minist Hlth, Dept HIV andAIDS, Cent Monitoring & Evaluat Div, Lilongwe, Malawi; [Ben-Smith, Anne] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA USA	University of Bern; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tweya, H (corresponding author), Int Union TB & Lung Dis, Paris, France.	h_tweya@lighthouse.org.mw	Jahn, Andreas/ABB-7796-2020	Jahn, Andreas/0000-0003-4645-1600; Keiser, Olivia/0000-0001-8191-2789; Egger, Matthias/0000-0001-7462-5132; Feldacker, Caryl/0000-0002-8152-6754	International Union Against Tuberculosis and Lung Disease, Paris, France; US Department of Health and Human Services, Health Resources and Services Administration (HRSA) [U91HA06801]; Swiss National Science Foundation	International Union Against Tuberculosis and Lung Disease, Paris, France; US Department of Health and Human Services, Health Resources and Services Administration (HRSA)(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Hannock Tweya is supported as an Operational Research Fellow by the International Union Against Tuberculosis and Lung Disease, Paris, France. Caryl Feldacker was supported with funding from Cooperative Agreement U91HA06801 from the US Department of Health and Human Services, Health Resources and Services Administration (HRSA). Olivia Keiser is supported by a PROSPER grant from the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker F, 2008, J AMBUL CARE MANAG, V31, P128, DOI 10.1097/01.JAC.0000314703.34795.44; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Castelnuovo B, 2009, INT J STD AIDS, V20, P123, DOI 10.1258/ijsa.2008.008174; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Douglas GP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000319; Egger M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000390; Feldacker C, 2011, SOC SCI MED, V72, P717, DOI 10.1016/j.socscimed.2011.01.003; Geng EH, 2013, JAIDS-J ACQ IMM DEF, V63, pE64, DOI 10.1097/QAI.0b013e31828af5a6; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Luebbert J, 2012, CLIN INFECT DIS, V55, P441, DOI 10.1093/cid/cis438; Maskew M, 2007, SAMJ S AFR MED J, V97, P853; Miller CM, 2010, TROP MED INT HEALTH, V15, P48, DOI 10.1111/j.1365-3156.2010.02514.x; MoH, 2006, GUID US ANT THER MAL; MOH, 2012, INT HIV PROGR REP JU; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Roura M, 2009, AIDS PATIENT CARE ST, V23, P203, DOI 10.1089/apc.2008.0129; Tweya H, 2010, TROP MED INT HEALTH, V15, P82, DOI 10.1111/j.1365-3156.2010.02509.x; Van Cutsem G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014684; Ware NC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001369; Weigel R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-31; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	23	54	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75761	10.1371/journal.pone.0075761	http://dx.doi.org/10.1371/journal.pone.0075761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086627	Green Published, Green Submitted, gold			2022-12-27	WOS:000325220000041
J	Willems, MCM; van der Vliet, JA; Lomme, RMLM; Hendriks, T				Willems, Martine C. M.; van der Vliet, J. Adam; Lomme, Roger M. L. M.; Hendriks, Thijs			Tacrolimus Does Not Affect Early Wound Healing in a Rodent Model of Bowel Anastomoses and Abdominal Wall Closure	PLOS ONE			English	Article							TRANSPLANT RECIPIENTS; KIDNEY-TRANSPLANTATION; SIROLIMUS; COMPLICATIONS; RAT; STRENGTH	Background: Use of immunosuppressant drugs has been associated with complications in wound healing. The calcineurin inhibitor tacrolimus is thought to have a relatively low complication rate, but preclinical research has yielded contradictory data, prompting the current comprehensive study Methods: Three groups of 33 male Wistar rats received a daily subcutaneous dose of 0,5, 2 or 5 mg/kg tacrolimus. A control group received saline. On day 0 a resection of 1 cm ileum and 1 cm colon was performed, and end-to-end anastomoses were constructed. Ten rats of each group were killed on day 3 and day 5 and the remaining animals on day 7. Both anastomoses and the wound in the abdominal wall were analyzed. Wound strength was the primary outcome parameter. Results: Mean strength of the abdominal wall increased significantly over time in all groups (p<0.0001). Both the breaking strength and the bursting pressure of the ileum and colon anastomoses followed the same pattern. No differences were observed between control and experimental groups. In addition, no consistent differences were found between groups regarding wound hydroxyproline content and the activities of matrix metalloproteinase-2 and -9. Conclusion: Tacrolimus does not affect early wound healing.	[Willems, Martine C. M.; van der Vliet, J. Adam; Lomme, Roger M. L. M.; Hendriks, Thijs] Radboud Univ Nijmegen, Med Ctr, Dept Surg, Div Vasc & Transplantat Surg, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Willems, MCM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Surg, Div Vasc & Transplantat Surg, NL-6525 ED Nijmegen, Netherlands.	mwillems@flevoziekenhuis.nl	Lomme, Roger/P-6623-2015; van der Vliet, J. Adam/L-4721-2015	Lomme, Roger/0000-0002-4856-9234	UMCN St Radboud University	UMCN St Radboud University	The research was funded by the UMCN St Radboud University. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anil Kumar, 2005, TRANSPLANTATION, V80, P807, DOI [10.1097/01.tp.0000173378.28790.0b, DOI 10.1097/01.TP.0000173378.28790.0B.PUBMED:16210969]; Bouzas-Mosquera A, 2008, TRANSPL P, V40, P3027, DOI 10.1016/j.transproceed.2008.09.021; Dean PG, 2004, TRANSPLANTATION, V77, P1555, DOI 10.1097/01.TP.0000123082.31092.53; DEWAARD JWD, 1995, BRIT J CANCER, V72, P456, DOI 10.1038/bjc.1995.355; Grim SA, 2006, TRANSPLANT P, V38, P3520, DOI 10.1016/j.transproceed.2006.10.065; Kapoor A, 2008, DRUGS, V68, P11, DOI 10.2165/00003495-200868001-00003; Kita J, 1999, TRANSPLANT P, V31, P2789, DOI 10.1016/S0041-1345(99)00568-0; Kiyama T, 2002, WOUND REPAIR REGEN, V10, P308, DOI 10.1046/j.1524-475X.2002.t01-1-10506.x; Kobashigawa JA, 2006, AM J TRANSPLANT, V6, P1377, DOI 10.1111/j.1600-6143.2006.01290.x; Kuppahally S, 2006, AM J TRANSPLANT, V6, P986, DOI 10.1111/j.1600-6143.2006.01282.x; Raptis D, 2012, INT J COLORECTAL DIS, V27, P299, DOI 10.1007/s00384-011-1337-y; Schaffer M, 2005, J INVEST SURG, V18, P71, DOI 10.1080/08941930590926294; Schaffer MR, 1998, TRANSPLANTATION, V65, P813; Siemonsma MA, 2003, SURGERY, V133, P268, DOI 10.1067/msy.2003.27; Staatz CE, 2004, CLIN PHARMACOKINET, V43, P623, DOI 10.2165/00003088-200443100-00001; Vliet JAD, 2006, TRANSPLANTATION, V82, P1477, DOI 10.1097/01.tp.0000246078.09845.9c; Vicari-Christensen M, 2009, PROG TRANSPLANT, V19, P277, DOI 10.7182/prtr.19.3.22u4114wn0l01140; Wasserberg N, 2004, WORLD J SURG, V28, P69, DOI 10.1007/s00268-003-7028-2; Webster A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003961.pub2; Willems MCM, 2010, WOUND REPAIR REGEN, V18, P98, DOI 10.1111/j.1524-475X.2009.00558.x; Wszola M, 2013, TRANSPLANTATION, V95, P878, DOI 10.1097/TP.0b013e318281b953	21	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76348	10.1371/journal.pone.0076348	http://dx.doi.org/10.1371/journal.pone.0076348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086731	Green Published, gold, Green Submitted			2022-12-27	WOS:000325220000064
J	Braithwaite, I; Stewart, AW; Hancox, RJ; Beasley, R; Murphy, R; Mitchell, EA				Braithwaite, Irene; Stewart, Alistair W.; Hancox, Robert J.; Beasley, Richard; Murphy, Rinki; Mitchell, Edwin A.		ISAAC Phase Three Study Grp	The Worldwide Association between Television Viewing and Obesity in Children and Adolescents: Cross Sectional Study	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY; CHILDHOOD OBESITY; BIRTH COHORT; MEDIA USE; OVERWEIGHT; PREVALENCE; HEALTH; YOUTH; TIME	Background: Studies exploring the effect of television viewing on obesity throughout childhood are conflicting. Most studies have been confined to single high-income countries. Our aim was to examine the association between television viewing habits and Body Mass Index (BMI) in adolescents and children in a multicentre worldwide sample. Methods: In the International Study of Asthma and Allergies in Children Phase Three, adolescents aged between 12 and 15 years completed questionnaires which included questions on television viewing habits, height and weight. Parents/guardians of children aged between 5 and 8 years completed the same questionnaire on behalf of their children. The questionnaire asked "During a normal week, how many hours a day (24 hours) do you (does your child) watch television?'' Responses were categorised as; "short" (<1 hour), "moderate" (1 to <= 3 hours), "long" (3 to <= 5 hours) and "prolonged" (>5 hours). Findings: 207,672 adolescents from 37 countries and 77,003 children from 18 countries provided data. Daily television viewing in excess of one hour was reported in 89% of adolescents and 79% of children. Compared with adolescents in the short viewing group, those in the moderate, long and prolonged groups had BMIs that were 0.14 kg/m(2), 0.21 kg/m(2), 0.30 kg/m(2) and 0.08 kg/m(2), 0.16 kg/m(2) and 0.17 kg/m(2) larger for females and males respectively (both P<0.001). Compared with children in the short viewing group, those in the moderate, long and prolonged groups had BMIs that were 0.24 kg/m(2), 0.34 kg/m(2), 0.36 kg/m(2) and 0.19 kg/m(2), 0.32 kg/m(2) and 0.36 kg/m(2) larger for females and males respectively (both P<0.001). Interpretation: Increased television viewing hours were positively associated with BMI in both adolescents and children with an apparent dose response effect. These findings extend the evidence that television viewing contributes to increased BMI in childhood.	[Braithwaite, Irene; Beasley, Richard] Med Res Inst New Zealand, Wellington, New Zealand; [Stewart, Alistair W.] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand; [Hancox, Robert J.] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand; [Murphy, Rinki] Univ Auckland, Dept Med, Fac Med & Hlth Sci, Auckland, New Zealand; [Mitchell, Edwin A.] Univ Auckland, Dept Paediat Child & Youth Hlth, Fac Med & Hlth Sci, Auckland 1, New Zealand	Medical Research Institute Of New Zealand; University of Auckland; University of Otago; University of Auckland; University of Auckland	Braithwaite, I (corresponding author), Med Res Inst New Zealand, Wellington, New Zealand.	Irene.braithwaite@mrinz.ac.nz	Ellwood, Philippa/G-7555-2015; Masjedi, Mohammad Reza/J-9776-2017; Beasley, Richard/AAH-3908-2019; Braithwaite, Irene/G-2045-2014; Braithwaite, Irene/L-2811-2019	Ellwood, Philippa/0000-0002-1994-4023; Masjedi, Mohammad Reza/0000-0002-6871-382X; Beasley, Richard/0000-0003-0337-406X; Braithwaite, Irene/0000-0001-5327-3027; Braithwaite, Irene/0000-0001-5327-3027; Garcia-Marcos, Luis/0000-0002-0925-3851	Cure Kids (NZ)	Cure Kids (NZ)	Professor E. Mitchell and Dr. I. Braithwaite were supported by Cure Kids (NZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RE, 1998, JAMA-J AM MED ASSOC, V279, P938, DOI 10.1001/jama.279.12.938; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; BERNARD L, 1995, J AM DIET ASSOC, V95, P800, DOI 10.1016/S0002-8223(95)00221-9; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; DIETZ WH, 1985, PEDIATRICS, V75, P807; Eisenmann JC, 2008, INT J OBESITY, V32, P613, DOI 10.1038/sj.ijo.0803800; Ellwood P, 2005, INT J TUBERC LUNG D, V9, P10; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Hancox RJ, 2006, INT J OBESITY, V30, P171, DOI 10.1038/sj.ijo.0803071; Hancox RJ, 2004, LANCET, V364, P257, DOI 10.1016/S0140-6736(04)16675-0; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Jago R, 2005, AM J PREV MED, V28, P447, DOI 10.1016/j.amepre.2005.02.007; Maher C, 2012, ACTA PAEDIATR, V101, P1170, DOI 10.1111/j.1651-2227.2012.02804.x; Marshall SJ, 2006, J ADOLESCENCE, V29, P333, DOI 10.1016/j.adolescence.2005.08.016; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; McMurray RG, 2000, OBES RES, V8, P130, DOI 10.1038/oby.2000.14; Parsons TJ, 2008, EUR J CLIN NUTR, V62, P1355, DOI 10.1038/sj.ejcn.1602884; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; Report of a WHO Consultation, 2000, WHO TECH REP SER, P1; Rey-Lopez JP, 2008, NUTR METAB CARDIOVAS, V18, P242, DOI 10.1016/j.numecd.2007.07.008; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; Rudolf MCJ, 2001, BRIT MED J, V322, P1094, DOI 10.1136/bmj.322.7294.1094; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Viner RM, 2005, J PEDIATR-US, V147, P429, DOI 10.1016/j.jpeds.2005.05.005; Viner RM, 2005, BRIT MED J, V330, P1354, DOI 10.1136/bmj.38453.422049.E0; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Wang Y, 2009, OBES REV, V10, P456, DOI 10.1111/j.1467-789X.2009.00568.x; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747	30	68	69	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74263	10.1371/journal.pone.0074263	http://dx.doi.org/10.1371/journal.pone.0074263			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086327	gold, Green Published, Green Submitted			2022-12-27	WOS:000325218700021
J	He, J; Stewart, K; Kinnell, HL; Anderson, RA; Childs, AJ				He, Jing; Stewart, Kayleigh; Kinnell, Hazel L.; Anderson, Richard A.; Childs, Andrew J.			A Developmental Stage-Specific Switch from DAZL to BOLL Occurs during Fetal Oogenesis in Humans, but Not Mice	PLOS ONE			English	Article							GERM-CELL DEVELOPMENT; RNA-BINDING PROTEIN; IN-VIVO; FAMILY PROTEINS; PUMILIO-2 PUM2; REGULATOR DAZL; HUMAN OVARY; DIFFERENTIATION; TRANSLATION; GENE	The Deleted in Azoospermia gene family encodes three germ cell-specific RNA-binding proteins (DAZ, DAZL and BOLL) that are essential for gametogenesis in diverse species. Targeted disruption of Boll in mice causes male-specific spermiogenic defects, but females are apparently fertile. Overexpression of human BOLL promotes the derivation of germ cell-like cells from genetically female (XX), but not male (XY) human ES cells however, suggesting a functional role for BOLL in regulating female gametogenesis in humans. Whether BOLL is expressed during oogenesis in mammals also remains unclear. We have therefore investigated the expression of BOLL during fetal oogenesis in humans and mice. We demonstrate that BOLL protein is expressed in the germ cells of the human fetal ovary, at a later developmental stage than, and almost mutually-exclusive to, the expression of DAZL. Strikingly, BOLL is downregulated, and DAZL re-expressed, as primordial follicles form, revealing BOLL expression to be restricted to a narrow window during fetal oogenesis. By quantifying the extent of co-expression of DAZL and BOLL with markers of meiosis, we show that this window likely corresponds to the later stages of meiotic prophase I. Finally, we demonstrate that Boll is also transiently expressed during oogenesis in the fetal mouse ovary, but is simultaneously co-expressed within the same germ cells as Dazl. These data reveal significant similarities and differences between the expression of BOLL homologues during oogenesis in humans and mice, and raise questions as to the validity of the Boll(-/-) mouse as a model for understanding BOLL function during human oogenesis.	[He, Jing; Stewart, Kayleigh; Kinnell, Hazel L.; Anderson, Richard A.; Childs, Andrew J.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Childs, Andrew J.] Univ London, Royal Vet Coll, Dept Comparat Biomed Sci, London, England	University of Edinburgh; University of London; University of London Royal Veterinary College	Childs, AJ (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.	achilds@rvc.ac.uk		Childs, Andrew/0000-0003-3937-4037	Medical Research Foundation [354FRG]; Medical Research Council [G1100357]; University of Edinburgh Darwin Scholarship; Society for Reproduction and Fertility Summer Vacation Scholarship; MRC [G1100357, G1002033, G1002118] Funding Source: UKRI; Medical Research Council [G1002033, G1002118] Funding Source: researchfish	Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Edinburgh Darwin Scholarship; Society for Reproduction and Fertility Summer Vacation Scholarship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Foundation [grant 354FRG to AJC] and the Medical Research Council [grant G1100357 to RAA]. J.H. is supported by a University of Edinburgh Darwin Scholarship and K.S. is the recipient of a Society for Reproduction and Fertility Summer Vacation Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-136; Bendsen E, 2006, HUM REPROD, V21, P30, DOI 10.1093/humrep/dei280; Chen J, 2011, GENE DEV, V25, P755, DOI 10.1101/gad.2028911; Childs AJ, 2012, STEM CELLS DEV, V21, P2343, DOI 10.1089/scd.2011.0730; Childs AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020249; Childs AJ, 2010, STEM CELLS, V28, P1368, DOI 10.1002/stem.440; Collier B, 2005, EMBO J, V24, P2656, DOI 10.1038/sj.emboj.7600738; Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0; Fox M, 2005, GENOMICS, V85, P92, DOI 10.1016/j.ygeno.2004.10.003; Fulton N, 2005, J CLIN ENDOCR METAB, V90, P4664, DOI 10.1210/jc.2005-0219; Gill ME, 2011, P NATL ACAD SCI USA, V108, P7443, DOI 10.1073/pnas.1104501108; Hamer G, 2004, BIOL REPROD, V70, P1206, DOI 10.1095/biolreprod.103.024950; Hartley PS, 2002, J CLIN ENDOCR METAB, V87, P3417, DOI 10.1210/jc.87.7.3417; Hartshorne GM, 2009, MOL HUM REPROD, V15, P805, DOI 10.1093/molehr/gap055; Haston KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005654; He Jing, 2013, Methods Mol Biol, V957, P59, DOI 10.1007/978-1-62703-191-2_4; Jenkins HT, 2011, P NATL ACAD SCI USA, V108, P18266, DOI 10.1073/pnas.1105211108; Jiao XF, 2002, BIOL REPROD, V66, P475, DOI 10.1095/biolreprod66.2.475; Karashima T, 2000, DEVELOPMENT, V127, P1069; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kim B, 2012, DEVELOPMENT, V139, P568, DOI 10.1242/dev.075846; Le Bouffant R, 2010, HUM REPROD, V25, P2579, DOI 10.1093/humrep/deq195; Lee KH, 2006, EMBO J, V25, P4263, DOI 10.1038/sj.emboj.7601304; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; Lin YF, 2005, DEV BIOL, V288, P309, DOI 10.1016/j.ydbio.2005.06.032; Maegawa S, 2002, GENES CELLS, V7, P971, DOI 10.1046/j.1365-2443.2002.00576.x; Maines JZ, 1999, NAT CELL BIOL, V1, P171, DOI 10.1038/11091; Mandon-Pepin B, 2003, BIOL REPROD, V68, P985, DOI 10.1095/biolreprod.102.008557; McNeilly JR, 2000, ENDOCRINOLOGY, V141, P4284, DOI 10.1210/en.141.11.4284; Paredes A, 2005, ENDOCRINOLOGY, V146, P5267, DOI 10.1210/en.2005-0965; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo RA, 2000, BIOL REPROD, V63, P1490, DOI 10.1095/biolreprod63.5.1490; Reynolds N, 2005, HUM MOL GENET, V14, P3899, DOI 10.1093/hmg/ddi414; Reynolds N, 2007, RNA, V13, P974, DOI 10.1261/rna.465507; Roig I, 2004, CHROMOSOMA, V113, P22, DOI 10.1007/s00412-004-0290-8; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Saunders PTK, 2003, REPRODUCTION, V126, P589, DOI 10.1530/rep.0.1260589; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Schrans-Stassen BHGJ, 2001, BIOL REPROD, V65, P771, DOI 10.1095/biolreprod65.3.771; Shah C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001022; Stoop H, 2005, HUM REPROD, V20, P1466, DOI 10.1093/humrep/deh800; Tingen C, 2009, MOL HUM REPROD, V15, P795, DOI 10.1093/molehr/gap073; Urano J, 2005, MOL REPROD DEV, V71, P290, DOI 10.1002/mrd.20270; Vangompel Michael J W, 2011, Spermatogenesis, V1, P36; VanGompel MJW, 2010, HUM MOL GENET, V19, P2360, DOI 10.1093/hmg/ddq109; Xu EYJ, 2003, HUM MOL GENET, V12, P169, DOI 10.1093/hmg/ddg017; Yu YH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-96; Zeng M, 2008, BMB REP, V41, P300, DOI 10.5483/BMBRep.2008.41.4.300; Zeng M, 2009, MOL BIOL REP, V36, P2399, DOI 10.1007/s11033-009-9470-1; Zheng P, 2010, BIOL REPROD, V82, P543, DOI 10.1095/biolreprod.109.079590	51	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e73996	10.1371/journal.pone.0073996	http://dx.doi.org/10.1371/journal.pone.0073996			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086306	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700016
J	Kono, AK; Higashi, M; Morisaki, H; Morisaki, T; Naito, H; Sugimura, K				Kono, Atsushi K.; Higashi, Masahiro; Morisaki, Hiroko; Morisaki, Takayuki; Naito, Hiroaki; Sugimura, Kazuro			Prevalence of Dural Ectasia in Loeys-Dietz Syndrome: Comparison with Marfan Syndrome and Normal Controls	PLOS ONE			English	Article							BETA RECEPTOR; MUTATIONS; DIAGNOSIS; FEATURES; CRITERIA; TGFBR2; MR	Background and Purpose: Dural ectasia is well recognized in Marfan syndrome (MFS) as one of the major diagnostic criteria, but the exact prevalence of dural ectasia is still unknown in Loeys-Dietz syndrome (LDS), which is a recently discovered connective tissue disease. In this study, we evaluated the prevalence of dural ectasia in LDS according by using qualitative and quantitative methods and compared our findings with those for with MFS and normal controls. Material and Methods: We retrospectively studied 10 LDS (6 males, 4 females, mean age 36.3 years) and 20 MFS cases (12 males, 8 females, mean age 37.1 years) and 20 controls (12 males, 8 females, mean age 36.1 years) both qualitatively and quantitatively using axial CT images and sagittal multi-planar reconstruction images of the lumbosacral region. For quantitative examination, we adopted two methods: method-1 (anteroposterior dural diameter of S1> L4) and method-2 (ratio of anteroposterior dural diameter/vertebral body diameter>cutoff values). The prevalence of dural ectasia among groups was compared by using Fisher's exact test and the Tukey-Kramer test. Results: In LDS patients, the qualitative method showed 40% of dural ectasia, the quantitative method-1 50%, and the method-2 70%. In MFS patients, the corresponding prevalences were 50%, 75%, and 85%, and in controls, 0%, 0%, and 5%. Both LDS and MFS had a significantly wider dura than controls. Conclusions: While the prevalence of dural ectasia varied depending on differences in qualitative and quantitative methods, LDS as well as MFS, showed, regardless of method, a higher prevalence of dural ectasia than controls. This finding should help the differentiation of LDS from controls.	[Kono, Atsushi K.; Sugimura, Kazuro] Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo 657, Japan; [Higashi, Masahiro; Naito, Hiroaki] Natl Cardiovasc Res Ctr, Dept Radiol, Suita, Osaka, Japan; [Morisaki, Hiroko; Morisaki, Takayuki] Natl Cardiovasc Res Ctr, Dept Biosci, Suita, Osaka, Japan	Kobe University; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan	Kono, AK (corresponding author), Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo 657, Japan.	akono@med.kobe-u.ac.jp	Kono, Atsushi/N-2697-2019	Kono, Atsushi/0000-0002-0963-7433	Ministry of Health, Labour and Welfare	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	Dr Hiroko Morisaki received a Health Labour Sciences Research Grant (Research on Measures for Intractable Diseases) from the Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn NU, 2000, GENET MED, V2, P173, DOI 10.1097/00125817-200005000-00003; Akutsu K, 2007, CIRC J, V71, P1305, DOI 10.1253/circj.71.1305; De Paepe A, 1999, LANCET, V354, P878, DOI 10.1016/S0140-6736(99)00168-3; DIETZ HC, 1991, GENOMICS, V9, P355, DOI 10.1016/0888-7543(91)90264-F; Fattori R, 1999, LANCET, V354, P910, DOI 10.1016/S0140-6736(98)12448-0; Habermann CR, 2005, RADIOLOGY, V234, P535, DOI 10.1148/radiol.2342031497; Kono AK, 2010, JPN J RADIOL, V28, P273, DOI 10.1007/s11604-010-0420-6; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Lundby R, 2009, AM J NEURORADIOL, V30, P1534, DOI 10.3174/ajnr.A1620; Oosterhof T, 2001, RADIOLOGY, V220, P514, DOI 10.1148/radiology.220.2.r01au08514; OREN M, 1977, DIS COLON RECTUM, V20, P492, DOI 10.1007/BF02586588; PYERITZ RE, 1988, AM J HUM GENET, V43, P726; Rodrigues VJ, 2009, AM J NEURORADIOL, V30, P1614, DOI 10.3174/ajnr.A1651; Rose PS, 2000, GENET MED, V2, P278, DOI 10.1097/00125817-200009000-00002; Singh KK, 2006, HUM MUTAT, V27, P770, DOI 10.1002/humu.20354; Soylen B, 2009, NEURORADIOLOGY, V51, P397, DOI 10.1007/s00234-009-0508-9	18	12	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75264	10.1371/journal.pone.0075264	http://dx.doi.org/10.1371/journal.pone.0075264			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086486	gold, Green Submitted, Green Published			2022-12-27	WOS:000325218700066
J	Albertin, W; da Silva, T; Rigoulet, M; Salin, B; Masneuf-Pomarede, I; de Vienne, D; Sicard, D; Bely, M; Marullo, P				Albertin, Warren; da Silva, Telma; Rigoulet, Michel; Salin, Benedicte; Masneuf-Pomarede, Isabelle; de Vienne, Dominique; Sicard, Delphine; Bely, Marina; Marullo, Philippe			The Mitochondrial Genome Impacts Respiration but Not Fermentation in Interspecific Saccharomyces Hybrids	PLOS ONE			English	Article							BAYANUS VAR. UVARUM; OXIDATIVE PHOSPHORYLATIONS; DNA MOLECULES; YEAST; CEREVISIAE; WINE; INHERITANCE; EVOLUTION; SEQUENCE; FITNESS	In eukaryotes, mitochondrial DNA (mtDNA) has high rate of nucleotide substitution leading to different mitochondrial haplotypes called mitotypes. However, the impact of mitochondrial genetic variant on phenotypic variation has been poorly considered in microorganisms because mtDNA encodes very few genes compared to nuclear DNA, and also because mitochondrial inheritance is not uniparental. Here we propose original material to unravel mitotype impact on phenotype: we produced interspecific hybrids between S. cerevisiae and S. uvarum species, using fully homozygous diploid parental strains. For two different interspecific crosses involving different parental strains, we recovered 10 independent hybrids per cross, and allowed mtDNA fixation after around 80 generations. We developed PCR-based markers for the rapid discrimination of S. cerevisiae and S. uvarum mitochondrial DNA. For both crosses, we were able to isolate fully isogenic hybrids at the nuclear level, yet possessing either S. cerevisiae mtDNA (Sc-mtDNA) or S. uvarum mtDNA (Su-mtDNA). Under fermentative conditions, the mitotype has no phenotypic impact on fermentation kinetics and products, which was expected since mtDNA are not necessary for fermentative metabolism. Alternatively, under respiratory conditions, hybrids with Sc-mtDNA have higher population growth performance, associated with higher respiratory rate. Indeed, far from the hypothesis that mtDNA variation is neutral, our work shows that mitochondrial polymorphism can have a strong impact on fitness components and hence on the evolutionary fate of the yeast populations. We hypothesize that under fermentative conditions, hybrids may fix stochastically one or the other mt-DNA, while respiratory environments may increase the probability to fix Sc-mtDNA.	[Albertin, Warren; Masneuf-Pomarede, Isabelle; Bely, Marina; Marullo, Philippe] Univ Bordeaux, ISW, EA 4577, Unite Rech Enol, Villenave Dornon, France; [Albertin, Warren; Masneuf-Pomarede, Isabelle] Bordeaux Sci Agro, Gradignan, France; [da Silva, Telma] INRA, UMR 0320, UMR Genet Vegetale 8120, Gif Sur Yvette, France; [Rigoulet, Michel; Salin, Benedicte] CNRS, Inst Biochem & Genet Cell, UMR 5095, Bordeaux, France; [Rigoulet, Michel; Salin, Benedicte] Univ Bordeaux, IBGC, UMR 5095, Bordeaux, France; [de Vienne, Dominique; Sicard, Delphine] Univ Paris 11, UMR 0320, UMR Genet Vegetale 8120, Gif Sur Yvette, France; [Marullo, Philippe] BIOLAFFORT, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS)	Marullo, P (corresponding author), Univ Bordeaux, ISW, EA 4577, Unite Rech Enol, Villenave Dornon, France.	philippe.marullo@u-bordeaux2.fr		Sicard, Delphine/0000-0002-6570-3212; Marullo, Philippe/0000-0002-3594-5173; Albertin, Warren/0000-0002-7385-9882; Masneuf-Pomarede, Isabelle/0000-0002-8806-8944				Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Aigle M, 1984, AM SOC BREW CHEM, V42, P1; Albertin W, 2009, J EVOLUTION BIOL, V22, P2157, DOI 10.1111/j.1420-9101.2009.01828.x; Albertin W, 2011, APPL ENVIRON MICROB, V77, P2772, DOI 10.1128/AEM.02547-10; Ballard JWO, 2010, MOL ECOL, V19, P1523, DOI 10.1111/j.1365-294X.2010.04594.x; BEAUVOIT B, 1993, EUR J BIOCHEM, V214, P163, DOI 10.1111/j.1432-1033.1993.tb17909.x; BELLIS M, 1987, NUCLEIC ACIDS RES, V15, P6749, DOI 10.1093/nar/15.16.6749; Belloch C, 2000, INT J SYST EVOL MICR, V50, P405, DOI 10.1099/00207713-50-1-405; Blein-Nicolas M, 2013, MOL BIOL EVOL, V30, P1368, DOI 10.1093/molbev/mst050; Bolnick DI, 2008, GENETICS, V178, P1037, DOI 10.1534/genetics.107.081364; Borneman AR, 2012, FEMS YEAST RES, V12, P88, DOI 10.1111/j.1567-1364.2011.00773.x; Burger G, 2013, GENOME BIOL EVOL, V5, P418, DOI 10.1093/gbe/evt008; Burgess KS, 2004, AM J BOT, V91, P1802, DOI 10.3732/ajb.91.11.1802; Burton RS, 2007, GENE, V403, P53, DOI 10.1016/j.gene.2007.07.026; Chou JY, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000432; De Vero L, 2003, ANN MICROBIOL, V53, P219; Dejean L, 2000, BBA-BIOENERGETICS, V1457, P45, DOI 10.1016/S0005-2728(00)00053-0; delaBastide PY, 1997, APPL ENVIRON MICROB, V63, P3426, DOI 10.1128/AEM.63.9.3426-3431.1997; Demuyter C, 2004, J APPL MICROBIOL, V97, P1140, DOI 10.1111/j.1365-2672.2004.02394.x; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Devin A, 2006, J BIOL CHEM, V281, P26779, DOI 10.1074/jbc.M604800200; DOHMEN RJ, 1991, YEAST, V7, P691, DOI 10.1002/yea.320070704; Dowling DK, 2008, TRENDS ECOL EVOL, V23, P546, DOI 10.1016/j.tree.2008.05.011; DUBOURDIEU D, 1987, Connaissance de la Vigne et du Vin, V21, P267; Dujon B., 1981, MOL BIOL YEAST SACCH, P505; Emelyanov VV, 2003, EUR J BIOCHEM, V270, P1599, DOI 10.1046/j.1432-1033.2003.03499.x; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; Fernandez AI, 2008, J ANIM SCI, V86, P1283, DOI 10.2527/jas.2007-0568; Fernandez-Espinar MT, 2000, ANTON LEEUW INT J G, V78, P87; Fontanillas P, 2005, MOL ECOL, V14, P661, DOI 10.1111/j.1365-294X.2004.02414.x; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Groth C, 2000, MOL BIOL EVOL, V17, P1833, DOI 10.1093/oxfordjournals.molbev.a026284; Hadjivasiliou Z, 2012, P ROY SOC B-BIOL SCI, V279, P1865, DOI 10.1098/rspb.2011.1871; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hutter A, 1998, APPL MICROBIOL BIOT, V49, P511, DOI 10.1007/s002530051206; James AC, 2003, GENETICS, V164, P187; Johnson JA, 2003, MOL ECOL, V12, P3335, DOI 10.1046/j.1365-294X.2003.02013.x; Kitagaki H, 2007, J BIOSCI BIOENG, V104, P227, DOI 10.1263/jbb.104.227; Langkjaer RB, 2003, NUCLEIC ACIDS RES, V31, P3081, DOI 10.1093/nar/gkg423; Lee HY, 2008, CELL, V135, P1065, DOI 10.1016/j.cell.2008.10.047; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Marcuello A, 2009, MITOCHONDRION, V9, P27, DOI 10.1016/j.mito.2008.10.002; Marinoni G, 1999, J BACTERIOL, V181, P6488, DOI 10.1128/JB.181.20.6488-6496.1999; Marullo P, 2006, FEMS YEAST RES, V6, P268, DOI 10.1111/j.1567-1364.2006.00034.x; Marullo P, 2004, FEMS YEAST RES, V4, P711, DOI 10.1016/j.femsyr.2004.01.006; Marullo P, 2009, FEMS YEAST RES, V9, P1148, DOI 10.1111/j.1567-1364.2009.00550.x; MAZAT JP, 1986, BIOCHIM BIOPHYS ACTA, V849, P7, DOI 10.1016/0005-2728(86)90090-3; McCauley DE, 2003, MOL ECOL, V12, P777, DOI 10.1046/j.1365-294X.2003.01764.x; McCullough MJ, 1998, J CLIN MICROBIOL, V36, P1035, DOI 10.1128/JCM.36.4.1035-1038.1998; Meadows Robin, 2010, PLoS Biol, V8, pe1000433, DOI 10.1371/journal.pbio.1000433; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Montiel-Sosa F, 2006, GENE, V368, P21, DOI 10.1016/j.gene.2005.09.015; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Nakao Y, 2009, DNA RES, V16, P115, DOI 10.1093/dnares/dsp003; Naumov GI, 2000, RES MICROBIOL, V151, P683, DOI 10.1016/S0923-2508(00)90131-1; Niemi AK, 2005, EUR J HUM GENET, V13, P965, DOI 10.1038/sj.ejhg.5201438; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; OConnorCox ESC, 1996, J I BREWING, V102, P19, DOI 10.1002/j.2050-0416.1996.tb00890.x; Pichaud N, 2012, J BIOENERG BIOMEMBR, P1; Pichaud N, 2012, EVOLUTION, V66, P3189, DOI 10.1111/j.1558-5646.2012.01683.x; Prochazka E, 2012, FEMS YEAST RES, V12, P819, DOI 10.1111/j.1567-1364.2012.00833.x; Pulvirenti A, 2000, ANN MICROBIOL, V50, P61; Pulvirenti A, 2005, CAN J MICROBIOL, V51, P759, DOI [10.1139/W05-062, 10.1139/w05-062]; Rainieri S, 2008, FEMS YEAST RES, V8, P586, DOI 10.1111/j.1567-1364.2008.00363.x; Rand DM, 2006, GENETICS, V172, P329, DOI 10.1534/genetics.105.046698; RIGOULET M, 1987, EUR J BIOCHEM, V168, P275, DOI 10.1111/j.1432-1033.1987.tb13417.x; Rosenfeld E, 2002, YEAST, V19, P1299, DOI 10.1002/yea.918; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANFORD JC, 1982, EUPHYTICA, V31, P1, DOI 10.1007/BF00028300; SANFORD JC, 1979, AM POTATO J, V56, P531, DOI 10.1007/BF02855968; Serra A, 2005, INT J FOOD MICROBIOL, V104, P257, DOI 10.1016/j.ijfoodmicro.2005.03.006; Solieri L, 2008, YEAST, V25, P485, DOI 10.1002/yea.1600; Solieri L, 2010, TRENDS MICROBIOL, V18, P521, DOI 10.1016/j.tim.2010.08.001; Spirek M, 2000, CURR GENET, V38, P202, DOI 10.1007/s002940000155; Sulo P, 2003, FEMS YEAST RES, V4, P97, DOI 10.1016/S1567-1356(03)00109-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ter Linde JJM, 2002, YEAST, V19, P825, DOI 10.1002/yea.879; Tieleman BI, 2009, P ROY SOC B-BIOL SCI, V276, P1685, DOI 10.1098/rspb.2008.1946; Tiffin P, 2001, P ROY SOC B-BIOL SCI, V268, P861, DOI 10.1098/rspb.2000.1578; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; Van Leeuwen T, 2008, P NATL ACAD SCI USA, V105, P5980, DOI 10.1073/pnas.0802224105; VEZINHET F, 1990, APPL MICROBIOL BIOT, V32, P568, DOI 10.1007/BF00173729; Wallin IE, 1923, AM NAT, V57, P255, DOI 10.1086/279919; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; WILLIAM J, 1995, TRENDS ECOL EVOL, V10, P485, DOI 10.1016/S0169-5347(00)89195-8; Yashin AI, 2000, J GERONTOL A-BIOL, V55, pB319, DOI 10.1093/gerona/55.7.B319; Zeyl C, 2005, EVOLUTION, V59, P910; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	92	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75121	10.1371/journal.pone.0075121	http://dx.doi.org/10.1371/journal.pone.0075121			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086452	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200083
J	Landa, I; Boullosa, C; Inglada-Perez, L; Sastre-Perona, A; Pastor, S; Velazquez, A; Mancikova, V; Ruiz-Llorente, S; Schiavi, F; Marcos, R; Malats, N; Opocher, G; Diaz-Uriarte, R; Santisteban, P; Valencia, A; Robledo, M				Landa, Inigo; Boullosa, Cesar; Inglada-Perez, Lucia; Sastre-Perona, Ana; Pastor, Susana; Velazquez, Antonia; Mancikova, Veronika; Ruiz-Llorente, Sergio; Schiavi, Francesca; Marcos, Ricard; Malats, Nuria; Opocher, Giuseppe; Diaz-Uriarte, Ramon; Santisteban, Pilar; Valencia, Alfonso; Robledo, Mercedes			An Epistatic Interaction between the PAX8 and STK17B Genes in Papillary Thyroid Cancer Susceptibility	PLOS ONE			English	Article							CARCINOMA CELL-LINE; DEGREE RELATIVES; RISK; ASSOCIATION; RECEPTOR; DISEASE; TSHR; POLYMORPHISMS; POPULATION; EXPRESSION	Papillary Thyroid Cancer (PTC) is a heterogeneous and complex disease; susceptibility to PTC is influenced by the joint effects of multiple common, low-penetrance genes, although relatively few have been identified to date. Here we applied a rigorous combined approach to assess both the individual and epistatic contributions of genetic factors to PTC susceptibility, based on one of the largest series of thyroid cancer cases described to date. In addition to identifying the involvement of TSHR variation in classic PTC, our pioneer study of epistasis revealed a significant interaction between variants in STK17B and PAX8. The interaction was detected by MD-MBR (p = 0.00010) and confirmed by other methods, and then replicated in a second independent series of patients (MD-MBR p = 0.017). Furthermore, we demonstrated an inverse correlation between expression of PAX8 and STK17B in a set of cell lines derived from human thyroid carcinomas. Overall, our work sheds additional light on the genetic basis of thyroid cancer susceptibility, and suggests a new direction for the exploration of the inherited genetic contribution to disease using association studies.	[Landa, Inigo; Inglada-Perez, Lucia; Mancikova, Veronika; Robledo, Mercedes] Spanish Natl Canc Res Ctr, Hereditary Endocrine Canc Grp, Madrid, Spain; [Boullosa, Cesar; Valencia, Alfonso] Spanish Natl Canc Res Ctr, Struct & Computat Biol Grp, Madrid, Spain; [Inglada-Perez, Lucia; Robledo, Mercedes] Ctr Invest Biomed Red Enfermedades Raras, Madrid, Spain; [Sastre-Perona, Ana; Ruiz-Llorente, Sergio; Santisteban, Pilar] Autonomous Univ Madrid, CSIC, Inst Invest Biomed Alberto Sols, E-28049 Madrid, Spain; [Pastor, Susana; Velazquez, Antonia; Marcos, Ricard] Autonomous Univ Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain; [Pastor, Susana; Velazquez, Antonia; Marcos, Ricard] Ctr Invest Biomed Red Epidemiol & Salud Publ, Madrid, Spain; [Ruiz-Llorente, Sergio] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Schiavi, Francesca; Opocher, Giuseppe] Veneto Inst Oncol, Familial Canc Clin & Oncoendocrinol, Padua, Italy; [Malats, Nuria] Spanish Natl Canc Res Ctr, Genet & Mol Epidemiol Grp, Madrid, Spain; [Opocher, Giuseppe] Univ Padua, Dept Med & Surg Sci, Padua, Italy; [Diaz-Uriarte, Ramon] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Dept Bioquim, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Memorial Sloan Kettering Cancer Center; IRCCS Istituto Oncologico Veneto (IOV); Centro Nacional de Investigaciones Oncologicas (CNIO); University of Padua; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Santisteban, P (corresponding author), Autonomous Univ Madrid, CSIC, Inst Invest Biomed Alberto Sols, E-28049 Madrid, Spain.	psantisteban@iib.uam.es; avalencia@cnio.es; mrobledo@cnio.es	Malats, Nuria/H-7041-2015; Pastor, Susana/H-7545-2015; Marcos, Ricard/G-9671-2015; Robledo, Mercedes/O-2230-2013; Santisteban, Pilar/E-7829-2016; Valencia, Alfonso/I-3127-2015; Landa, Iñigo/AAK-8789-2020; Sastre-Perona, Ana/AAC-1202-2021; Diaz-Uriarte, Ramon/M-5517-2013; Opocher, Giuseppe/F-3950-2014; inglada-perez, lucia/H-5378-2015; Valencia, Alfonso/AAN-9230-2020; Schiavi, Francesca/AAB-9908-2022; Inglada-Perez, Lucia/Z-3020-2019	Malats, Nuria/0000-0003-2538-3784; Pastor, Susana/0000-0003-2454-5163; Marcos, Ricard/0000-0001-7891-357X; Robledo, Mercedes/0000-0001-6256-5902; Santisteban, Pilar/0000-0002-2758-796X; Valencia, Alfonso/0000-0002-8937-6789; Landa, Iñigo/0000-0002-2817-8295; Diaz-Uriarte, Ramon/0000-0002-6637-9039; Opocher, Giuseppe/0000-0002-9845-9623; Valencia, Alfonso/0000-0002-8937-6789; Schiavi, Francesca/0000-0001-8529-4455; Ruiz-Llorente, Sergio/0000-0002-5003-1759; INGLADA, LUCIA/0000-0001-9523-2717; Inglada-Perez, Lucia/0000-0001-9814-4368	Fondo de Investigaciones Sanitarias (FIS) [PI11/01359]; Red Tematica de Investigacion Cooperativa en Cancer; Instituto de Salud Carlos III [RD12/0030/0060, RD12/0036/0050]; Comunidad de Madrid [S2011/BMD-2328 TIRONET]; European Regional Development Fund; FIS [FI07/00326, CD05-0055]; FPI [BES-2008-006332]; Centro de Investigacion Biomedica en Red de Enfermedades Raras; Spanish Ministry of Economy and Innovation [BIO2009-12458]; Generalitat de Catalunya, CIRIT [2009SGR-725]	Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); Red Tematica de Investigacion Cooperativa en Cancer; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Comunidad de Madrid(Comunidad de Madrid); European Regional Development Fund(European Commission); FIS(Instituto de Salud Carlos III); FPI(Spanish Government); Centro de Investigacion Biomedica en Red de Enfermedades Raras; Spanish Ministry of Economy and Innovation(Spanish Government); Generalitat de Catalunya, CIRIT(Generalitat de Catalunya)	This work was supported by Grants from the Fondo de Investigaciones Sanitarias (FIS) project PI11/01359 (to MR), the Red Tematica de Investigacion Cooperativa en Cancer, the Instituto de Salud Carlos III, RD12/0030/0060 (to PS), RD12/0036/0050 (to NM) and S2011/BMD-2328 TIRONET from the Comunidad de Madrid (to MR and PS), and European Regional Development Fund. IL is supported by FIS grant FI07/00326; CB is supported by the FPI grant BES-2008-006332; LI-P is supported by Centro de Investigacion Biomedica en Red de Enfermedades Raras, and AS-P is a predoctoral fellows of the FPU program (MICINN) respectively. SR-LL is a postdoctoral fellow of the FIS (contract # CD05-0055). RDU is supported by project BIO2009-12458 from the Spanish Ministry of Economy and Innovation. RM, SP and AV are supported by the Generalitat de Catalunya, CIRIT (2009SGR-725). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjadj E, 2009, LANCET ONCOL, V10, P181, DOI 10.1016/S1470-2045(09)70020-8; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Brand OJ, 2009, HUM MOL GENET, V18, P1704, DOI 10.1093/hmg/ddp087; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Calle ML, 2008, STAT MED, V27, P6532, DOI 10.1002/sim.3431; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Davies TF, 2010, THYROID, V20, P727, DOI 10.1089/thy.2010.1638; Dechairo BM, 2005, EUR J HUM GENET, V13, P1223, DOI 10.1038/sj.ejhg.5201485; DeLellis R, 2004, PATHOLOGY GENETICS T; Dimas AS, 2009, CURR OPIN GENET DEV, V19, P586, DOI 10.1016/j.gde.2009.10.012; ESTOUR B, 1989, VIRCHOWS ARCH B, V57, P167, DOI 10.1007/BF02899078; FABIEN N, 1994, CANCER, V73, P2206, DOI 10.1002/1097-0142(19940415)73:8<2206::AID-CNCR2820730828>3.0.CO;2-M; Ferlay J, 2010, INT J CANC; FUSCO A, 1987, MOL CELL BIOL, V7, P3365, DOI 10.1128/MCB.7.9.3365; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Gu LQ, 2010, CLIN ENDOCRINOL, V72, P248, DOI 10.1111/j.1365-2265.2009.03617.x; Gudmundsson J, 2009, NAT GENET; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Heldin N E, 1991, Thyroidology, V3, P127; Hemminki K, 2004, INT J CANCER, V111, P944, DOI 10.1002/ijc.20355; Hiratani H, 2005, J CLIN ENDOCR METAB, V90, P2898, DOI 10.1210/jc.2004-2148; Ii M, 2011, MUTAT RES-FUND MOL M, V714, P33, DOI 10.1016/j.mrfmmm.2011.06.007; ISHIZAKA Y, 1989, JPN J CANCER RES, V80, P1149, DOI 10.1111/j.1349-7006.1989.tb01645.x; Jones AM, 2012, J MED GENET, V49, P158, DOI 10.1136/jmedgenet-2011-100586; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Kong M, 2011, PSYCHIAT GENET, V21, P37, DOI 10.1097/YPG.0b013e3283413496; Landa I, 2011, J MOL ENDOCRINOL, V47, pR43, DOI 10.1530/JME-11-0005; Landa I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000637; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Lonn S, 2007, CANCER EPIDEM BIOMAR, V16, P174, DOI 10.1158/1055-9965.EPI-06-0665; Macchia PE, 1998, NAT GENET, V19, P83, DOI 10.1038/ng0598-83; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; Matakidou A, 2004, CARCINOGENESIS, V25, P369, DOI 10.1093/carcin/bgh027; Miller DJ, 2009, BIOINFORMATICS, V25, P2478, DOI 10.1093/bioinformatics/btp435; Milne RL, 2009, JNCI-J NATL CANCER I, V101, P1012, DOI 10.1093/jnci/djp167; Montero-Conde C, 2008, ONCOGENE, V27, P1554, DOI 10.1038/sj.onc.1210792; Moore JH, 2005, NAT GENET, V37, P13, DOI 10.1038/ng0105-13; Musani SK, 2007, HUM HERED, V63, P67, DOI 10.1159/000099179; Naushad SM, 2010, MOL BIOL REP; Ohno M, 1999, MOL CELL BIOL, V19, P2051; Pal T, 2001, J CLIN ENDOCR METAB, V86, P5307, DOI 10.1210/jc.86.11.5307; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ruiz-Llorente S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-147; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Snitkin ES, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001294; Sturgis EM, 2009, THYROID, V19, P1031, DOI 10.1089/thy.2009.1597; Takahashi M, 2010, HUM MOL GENET, V19, P2516, DOI 10.1093/hmg/ddq123; Van Steen K, 2012, BRIEF BIOINFORM, V13, P1, DOI 10.1093/bib/bbr012; Wan X, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-13; Wu SH, 2010, CLIN CHIM ACTA, V411, P1705, DOI 10.1016/j.cca.2010.07.007; Yang C, 2009, BIOINFORMATICS, V25, P504, DOI 10.1093/bioinformatics/btn652; ZANNINI M, 1992, MOL CELL BIOL, V12, P4230, DOI 10.1128/MCB.12.9.4230; Zhang X, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-1; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395	55	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74765	10.1371/journal.pone.0074765	http://dx.doi.org/10.1371/journal.pone.0074765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086368	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200039
J	Paez-Colasante, X; Seaberg, B; Martinez, TL; Kong, L; Sumner, CJ; Rimer, M				Paez-Colasante, Ximena; Seaberg, Bonnie; Martinez, Tara L.; Kong, Lingling; Sumner, Charlotte J.; Rimer, Mendell			Improvement of Neuromuscular Synaptic Phenotypes without Enhanced Survival and Motor Function in Severe Spinal Muscular Atrophy Mice Selectively Rescued in Motor Neurons	PLOS ONE			English	Article							MOUSE MODEL; GENE-EXPRESSION; SMN EXPRESSION; PROTEIN; MUSCLE; JUNCTIONS; RESTORATION; SMN-DELTA-7; DEFECTS; ABSENCE	In the inherited childhood neuromuscular disease spinal muscular atrophy (SMA), lower motor neuron death and severe muscle weakness result from the reduction of the ubiquitously expressed protein survival of motor neuron (SMN). Although SMA mice recapitulate many features of the human disease, it has remained unclear if their short lifespan and motor weakness are primarily due to cell-autonomous defects in motor neurons. Using Hb9(Cre) as a driver, we selectively raised SMN expression in motor neurons in conditional SMA Delta 7 mice. Unlike a previous study that used choline acetyltransferase (ChAT(Cre+)) as a driver on the same mice, and another report that used Hb9(Cre) as a driver on a different line of conditional SMA mice, we found no improvement in survival, weight, motor behavior and presynaptic neurofilament accumulation. However, like in ChAT(Cre+) mice, we detected rescue of endplate size and mitigation of neuromuscular junction (NMJ) denervation status. The rescue of endplate size occurred in the absence of an increase in myofiber size, suggesting endplate size is determined by the motor neuron in these animals. Real time-PCR showed that the expression of spinal cord SMN transcript was sharply reduced in Hb9(Cre+) SMA mice relative to ChAT(Cre+) SMA mice. This suggests that our lack of overall phenotypic improvement is most likely due to an unexpectedly poor recombination efficiency driven by Hb9(Cre). Nonetheless, the low levels of SMN were sufficient to rescue two NMJ structural parameters indicating that these motor neuron cell autonomous phenotypes are very sensitive to changes in motoneuronal SMN levels. Our results directly suggest that even those therapeutic interventions with very modest effects in raising SMN in motor neurons may provide mitigation of neuromuscular phenotypes in SMA patients.	[Paez-Colasante, Ximena; Seaberg, Bonnie; Rimer, Mendell] Texas A&M Hlth Sci Ctr, Coll Med, Dept Neurosci & Expt Therapeut, Bryan, TX USA; [Paez-Colasante, Ximena; Rimer, Mendell] Texas A&M Inst Neurosci, Bryan, TX USA; [Martinez, Tara L.; Kong, Lingling; Sumner, Charlotte J.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Sumner, Charlotte J.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Johns Hopkins University; Johns Hopkins University	Rimer, M (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Neurosci & Expt Therapeut, Bryan, TX USA.	mjrimer@medicine.tamhsc.edu		Paez-Colasante, Ximena/0000-0001-8005-3302	National Institutes of Health (NIH) [1R03NS071141]; Texas Brain and Spine Institute, Bryan, Texas; National Institute of Neurological Disorders and Stroke (NINDS) [R01NS062869]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062869, R03NS071141] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Brain and Spine Institute, Bryan, Texas; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health (NIH) Grant 1R03NS071141 to M.R. X.P.-C. was supported in part by a stipend from the Texas Brain and Spine Institute, Bryan, Texas. C.J.S was supported by National Institute of Neurological Disorders and Stroke (NINDS) grant R01NS062869. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaynick WA, 2011, CELL, V146, P178, DOI 10.1016/j.cell.2011.06.038; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P2660; Bowerman M, 2012, NEUROMUSCULAR DISORD, V22, P263, DOI 10.1016/j.nmd.2011.09.007; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; El-Khodor BF, 2008, EXP NEUROL, V212, P29, DOI 10.1016/j.expneurol.2008.02.025; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Gavrilina TO, 2008, HUM MOL GENET, V17, P1063, DOI 10.1093/hmg/ddm379; Gogliotti RG, 2012, J NEUROSCI, V32, P3818, DOI 10.1523/JNEUROSCI.5775-11.2012; Hamilton G, 2013, TRENDS MOL MED, V19, P40, DOI 10.1016/j.molmed.2012.11.002; Hammond SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015887; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kolb SJ, 2011, ARCH NEUROL-CHICAGO, V68, P979, DOI 10.1001/archneurol.2011.74; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lee AJH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046353; Lee YI, 2011, DEV BIOL, V356, P432, DOI 10.1016/j.ydbio.2011.05.667; Li XM, 2008, NAT NEUROSCI, V11, P262, DOI 10.1038/nn2053; Ling KKY, 2012, HUM MOL GENET, V21, P185, DOI 10.1093/hmg/ddr453; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutz CM, 2011, J CLIN INVEST, V121, P3029, DOI 10.1172/JCI57291; Martinez TL, 2012, J NEUROSCI, V32, P8703, DOI 10.1523/JNEUROSCI.0204-12.2012; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Oberdoerffer P, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng140; Park GH, 2010, J NEUROSCI, V30, P12005, DOI 10.1523/JNEUROSCI.2208-10.2010; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; Porensky PN, 2012, HUM MOL GENET, V21, P1625, DOI 10.1093/hmg/ddr600; Schreml J, 2013, EUR J HUM GENET, V21, P643, DOI 10.1038/ejhg.2012.222; Torres-Benito L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026164; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Zagoraiou L, 2009, NEURON, V64, P645, DOI 10.1016/j.neuron.2009.10.017	34	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75866	10.1371/journal.pone.0075866	http://dx.doi.org/10.1371/journal.pone.0075866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086650	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200123
J	Tran, TD; Biggs, BA; Tran, T; Simpson, JA; Hanieh, S; Dwyer, T; Fisher, J				Thach Duc Tran; Biggs, Beverley-Ann; Tuan Tran; Simpson, Julie Anne; Hanieh, Sarah; Dwyer, Terence; Fisher, Jane			Impact on Infants' Cognitive Development of Antenatal Exposure to Iron Deficiency Disorder and Common Mental Disorders	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; TERM-FOLLOW-UP; CHILD-DEVELOPMENT; MATERNAL STRESS; POSTNATAL DEPRESSION; DEVELOPING-COUNTRIES; INCOME COUNTRIES; PREGNANCY; FETAL; GROWTH	Objectives: The aim of this study was to examine the effects of antenatal exposure to iron deficiency anemia (IDA) and common mental disorders (CMD) on cognitive development of 6 months old infants in a developing country. Methods: A prospective population-based study in a rural province in Vietnam, which enrolled pregnant women at 12-20 weeks gestation and followed them up with their infants until six months postpartum. Criteria for IDA were Hb < 11 g/dL and serum ferritin <15 ng/mL. CMD symptoms were assessed by the Edinburgh Postnatal Depression Scale-Vietnam validation. Infant cognitive development was assessed by Bayley Scales of Infant and Toddler Development, 3rd Ed. Path analyses were performed to determine the direct and indirect, partly or fully mediated, causal effects of the antenatal exposures. Results: A total of 497 pregnant women were recruited, of those 378 women provided complete data which were included in the analyses. Statistically significant direct adverse effects of persistent antenatal IDA (estimated difference of -11.62 points; 95% CI -23.01 to -0.22) and antenatal CMD (-4.80 points; 95% CI: -9.40 to -0.20) on infant Bayley cognitive scores at six months were found. Higher birthweight, household wealth, and self-rated sufficient supply of breastmilk were associated with higher cognitive scores. Maternal age >30 years and primiparity had an indirect adverse effect on infants' Bayley cognitive scores. Conclusions: These findings suggest that antenatal IDA and CMD both have adverse effects on child cognitive development, which if unrecognized and unaddressed are likely to be lasting. It is crucial that both these risks are considered by policy makers, clinicians, and researchers seeking to improve child cognitive function in developing countries.	[Thach Duc Tran; Tuan Tran] Res & Training Ctr Community Dev, Hanoi, Vietnam; [Thach Duc Tran; Fisher, Jane] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Womens Hlth Gender & Soc, Melbourne, Vic, Australia; [Thach Duc Tran; Fisher, Jane] Monash Univ, Sch Publ Hlth & Prevent Med, Jean Hailes Res Unit, Melbourne, Vic 3004, Australia; [Biggs, Beverley-Ann; Hanieh, Sarah] Univ Melbourne, Royal Melbourne Hosp, Dept Med RMH WH, Melbourne, Vic 3050, Australia; [Simpson, Julie Anne] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Dwyer, Terence] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia	University of Melbourne; Monash University; Royal Melbourne Hospital; University of Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Tran, TD (corresponding author), Res & Training Ctr Community Dev, Hanoi, Vietnam.	indthach@yahoo.com	TRAN, THACH DUC/H-7734-2014; Mireku, Michael/D-5262-2016; Simpson, Julie A/P-7299-2014; Fisher, Jane/I-1569-2014	TRAN, THACH DUC/0000-0002-4686-8601; Simpson, Julie/0000-0002-2660-2013; Biggs, Beverley-Ann/0000-0002-2961-9793; Tran, Tuan/0000-0002-4947-9169; Fisher, Jane/0000-0002-1959-6807	Australian Research Council [DP0986594]; University of Melbourne	Australian Research Council(Australian Research Council); University of Melbourne(University of Melbourne)	The study was funded by Australian Research Council Discovery Project Grant DP0986594. TDT is supported by a University of Melbourne International Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LH, 2001, J NUTR, V131, p581S, DOI 10.1093/jn/131.2.581S; Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; Amin SB, 2010, J PEDIATR-US, V156, P377, DOI 10.1016/j.jpeds.2009.09.049; Barker DJP, 2002, TRENDS ENDOCRIN MET, V13, P364, DOI 10.1016/S1043-2760(02)00689-6; Bayley N, 1993, BAYLEY SCALES INFANT; Bergman K, 2007, J AM ACAD CHILD PSY, V46, P1454, DOI 10.1097/chi.0b013e31814a62f6; Bergman K, 2010, BIOL PSYCHIAT, V67, P1026, DOI 10.1016/j.biopsych.2010.01.002; Black MM, 2007, J CHILD PSYCHOL PSYC, V48, P764, DOI 10.1111/j.1469-7610.2007.01752.x; Brown RW, 1996, ENDOCRINOLOGY, V137, P794, DOI 10.1210/en.137.2.794; Buitelaar JK, 2003, NEUROBIOL AGING, V24, pS53, DOI 10.1016/S0197-4580(03)00050-2; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; DALLMAN PR, 1986, ANNU REV NUTR, V6, P13, DOI 10.1146/annurev.nu.06.070186.000305; Deave T, 2008, BJOG-INT J OBSTET GY, V115, P1043, DOI 10.1111/j.1471-0528.2008.01752.x; deRegnier R-A, 2010, WILEY BLACKWELL HDB; Desai M, 2005, AM J PHYSIOL-REG I, V288, pR91, DOI 10.1152/ajpregu.00340.2004; DiPietro JA, 2006, CHILD DEV, V77, P573, DOI 10.1111/j.1467-8624.2006.00891.x; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Field T, 2011, INFANT BEHAV DEV, V34, P1, DOI 10.1016/j.infbeh.2010.09.008; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Fisher J, 2011, B WORLD HEALTH ORGAN, V89, P813, DOI 10.2471/BLT.11.089763; Fisher J, 2010, B WORLD HEALTH ORGAN, V88, P737, DOI 10.2471/BLT.09.067066; Fleming RE, 2002, J PEDIATR-US, V140, P145, DOI 10.1067/mpd.2002.121931; Galler JR, 2000, J CHILD PSYCHOL PSYC, V41, P747, DOI 10.1017/S0021963099005910; Garcia-Moreno C, 2005, SCIENCE, V310, P1282, DOI 10.1126/science.1121400; Geelhoed D, 2006, ACTA OBSTET GYN SCAN, V85, P49, DOI 10.1080/00016340500334794; Gibson RS, 2008, J NUTR, V138, P581, DOI 10.1093/jn/138.3.581; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Gulmezoglu AM, 1996, J PERINAT MED, V24, P687, DOI 10.1515/jpme.1996.24.6.687; Hadley C, 2008, ANN HUM BIOL, V35, P259, DOI 10.1080/03014460802043624; Hernandez-Martinez C, 2011, EARLY HUM DEV, V87, P165, DOI 10.1016/j.earlhumdev.2010.12.006; Jaleel R, 2008, J SURG PAK, V13, P147; Kidanto HL, 2009, SAMJ S AFR MED J, V99, P98; Kline RB, 2011, METHODOLOGY SOCIAL S, pxvi; Laplante DP, 2004, PEDIATR RES, V56, P400, DOI 10.1203/01.PDR.0000136281.34035.44; Laungani P, 2000, INT J HLTH PROMOTION, V38, P86, DOI DOI 10.1080/14635240.2000.10806156; Lone FW, 2004, TROP MED INT HEALTH, V9, P486, DOI 10.1111/j.1365-3156.2004.01222.x; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; Lugo-Gil J, 2008, CHILD DEV, V79, P1065, DOI 10.1111/j.1467-8624.2008.01176.x; Marahatta R, 2007, Nepal Med Coll J, V9, P270; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Mulder EJH, 2002, EARLY HUM DEV, V70, P3, DOI 10.1016/S0378-3782(02)00075-0; Murray L., 2010, WILEY BLACKWELL HDB, V2, P192, DOI [10.1002/9781444327588.ch8, DOI 10.1002/9781444327588.CH8]; National Institute of Nutrition/UNICEF, 2011, REV NUTR SIT VIET NA; O'Connor TG, 2002, J AM ACAD CHILD PSY, V41, P1470, DOI 10.1097/00004583-200212000-00019; Parsons AG, 2008, BRIT J NUTR, V99, P1133, DOI 10.1017/S0007114507853359; Patel V, 2003, ARCH DIS CHILD, V88, P34, DOI 10.1136/adc.88.1.34; Pearl J., 2009, CAUSALITY MODELS REA; Petraglia F, 1996, ENDOCR REV, V17, P156, DOI 10.1210/er.17.2.156; Riggins T, 2009, DEVELOPMENTAL SCI, V12, P209, DOI 10.1111/j.1467-7687.2008.00757.x; Rioux FM, 2011, CAN J DIET PRACT RES, V72, P76, DOI 10.3148/72.2.2011.76; Servili C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-693; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; Tamura T, 2002, J PEDIATR-US, V140, P165, DOI 10.1067/mpd.2002.120688; Tran T, 2004, COMMUNITY BASED EVID; Tran TD, 2011, J AFFECT DISORDERS, V133, P281, DOI 10.1016/j.jad.2011.03.038; Trinh Lieu Thi Thuy, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P927; VanderWeele TJ, 2012, AM J EPIDEMIOL, V176, P608, DOI 10.1093/aje/kws213; Wachs TD, 2005, DEV PSYCHOBIOL, V46, P141, DOI 10.1002/dev.20049; Wadhwa PD, 2005, PSYCHONEUROENDOCRINO, V30, P724, DOI 10.1016/j.psyneuen.2005.02.004; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; WHO/UNICEF/ICCIDD, 2001, WHONHD011 UNICEFICCI; World Health Organization, 2001, IR DEF AN ASS PREV C; Zhou SJ, 2006, AM J CLIN NUTR, V83, P1112, DOI 10.1093/ajcn/83.5.1112; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5	65	31	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74876	10.1371/journal.pone.0074876	http://dx.doi.org/10.1371/journal.pone.0074876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086390	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200048
J	Wootton, JT; Forester, JD				Wootton, J. Timothy; Forester, James D.			Complex Population Dynamics in Mussels Arising from Density-Linked Stochasticity	PLOS ONE			English	Article							ECOLOGICAL TIME-SERIES; ENVIRONMENTAL STOCHASTICITY; INTERTIDAL COMMUNITY; SPECIES INTERACTIONS; NATURAL DISTURBANCE; LARGE HERBIVORES; MARKOV-MODELS; SOAY SHEEP; CHAOS; NOISE	Population fluctuations are generally attributed to the deterministic consequences of strong non-linear interactions among organisms, or the effects of random stochastic environmental variation superimposed upon the deterministic skeleton describing population change. Analysis of the population dynamics of the mussel Mytilus californianus taken in 16 plots over 18-years found no evidence that these processes explained observed strong fluctuations. Instead, population fluctuations arose because environmental stochasticity varied with abundance, which we term density-linked stochasticity. This phenomenon arises from biologically relevant mechanisms: recruitment variation and transmission of disturbance among neighboring individuals. Density-linked stochasticity is probably present frequently in populations, as it arises naturally from several general ecological processes, including stage structure variation with density, ontogenetic niche shifts, and local transmission of stochastic perturbations. More thoroughly characterizing and interpreting deviations from the mean behavior of a system will lead to better ecological prediction and improved insight into the important processes affecting populations and ecosystems.	[Wootton, J. Timothy; Forester, James D.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Wootton, JT (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	twootton@uchicago.edu	Forester, James/A-3298-2012; Wootton, J. Timothy/F-3191-2015	Forester, James/0000-0002-5392-9556; Wootton, J. Timothy/0000-0002-7715-0344	Andrew W. Mellon Foundation; U.S.EPA STAR Center for Integrating Statistics and the Environmental Sciences at the University of Chicago; National Science Foundation [OCE 0117801, OCE 0452687, DEB 0919420]; Division Of Environmental Biology [0919420] Funding Source: National Science Foundation	Andrew W. Mellon Foundation; U.S.EPA STAR Center for Integrating Statistics and the Environmental Sciences at the University of Chicago; National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported in part by the Andrew W. Mellon Foundation, the U.S.EPA STAR Center for Integrating Statistics and the Environmental Sciences at the University of Chicago, and National Science Foundation Grants OCE 0117801, OCE 0452687 and DEB 0919420. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JC, 1993, NATURE, V364, P229, DOI 10.1038/364229a0; Amarasekare P, 2004, AM NAT, V164, P310, DOI 10.1086/422858; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Berlow EL, 1999, NATURE, V398, P330, DOI 10.1038/18672; Bertness MD, 1997, ECOLOGY, V78, P1976, DOI 10.1890/0012-9658(1997)078[1976:TROPII]2.0.CO;2; BIGGS BJF, 1995, J PHYCOL, V31, P233, DOI 10.1111/j.0022-3646.1995.00233.x; Bjornstad ON, 2001, NATURE, V409, P1001, DOI 10.1038/35059003; Bloomfield P., 1976, FOURIER ANAL TIME SE; Broitman BR, 2008, ECOL MONOGR, V78, P403, DOI 10.1890/06-1805.1; Burnham K.P., 2007, MODEL SELECTION INFE, V2nd; Burton PJ, 2002, SILVA FENN, V36, P329, DOI 10.14214/sf.566; Calder WA., 1984, SIZE FUNCTION LIFE H; Caswell, 2000, MATRIX POPULATION MO; CHENG B, 1992, J ROY STAT SOC B MET, V54, P427; Chesson P, 1997, AM NAT, V150, P519, DOI 10.1086/286080; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Coulson T, 2008, ECOLOGY, V89, P1661, DOI 10.1890/07-1099.1; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Coulson T, 2004, TRENDS ECOL EVOL, V19, P359, DOI 10.1016/j.tree.2004.05.008; Crowder M.J., 1978, J R STAT SOC C-APPL, V27, P34, DOI DOI 10.2307/2346223; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; Denny MW, 2004, ECOL MONOGR, V74, P513, DOI 10.1890/03-4043; DWYER G, 1991, ECOLOGY, V72, P559, DOI 10.2307/2937196; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; ELLNER S, 1995, AM NAT, V145, P343, DOI 10.1086/285744; Ellner SP, 1998, AM NAT, V151, P425, DOI 10.1086/286130; Fraterrigo JM, 2008, ECOL LETT, V11, P756, DOI 10.1111/j.1461-0248.2008.01191.x; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Greenman JV, 2003, AM NAT, V161, P225, DOI 10.1086/345784; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; HASSELL MP, 1975, J ANIM ECOL, V44, P283, DOI 10.2307/3863; HASTINGS A, 1991, ECOLOGY, V72, P896, DOI 10.2307/1940591; Ives AR, 1998, ECOLOGY, V79, P1039, DOI 10.1890/0012-9658(1998)079[1039:CDISTM]2.0.CO;2; IVES AR, 1995, ECOLOGY, V76, P926, DOI 10.2307/1939357; Kendall BE, 1998, ECOL APPL, V8, P184, DOI 10.2307/2641320; Kilpatrick AM, 2003, NATURE, V422, P65, DOI 10.1038/nature01471; Krkosek M, 2011, P ROY SOC B-BIOL SCI, V278, P2060, DOI 10.1098/rspb.2010.2335; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Malamud BD, 1998, SCIENCE, V281, P1840, DOI 10.1126/science.281.5384.1840; MAY RM, 1974, SCIENCE, V186, P645, DOI 10.1126/science.186.4164.645; MAY RM, 1976, AM NAT, V110, P573, DOI 10.1086/283092; MAY RM, 1973, ECOLOGY, V54, P315, DOI 10.2307/1934339; Menge BA, 2009, ECOL MONOGR, V79, P379, DOI 10.1890/08-2086.1; Minnich RA, 1997, INT J WILDLAND FIRE, V7, P221, DOI 10.1071/WF9970221; MORRIS WF, 1990, ECOLOGY, V71, P1849, DOI 10.2307/1937593; NICHOLSON AJ, 1957, COLD SPRING HARB SYM, V22, P153, DOI 10.1101/SQB.1957.022.01.017; PAINE R T, 1974, Oecologia (Berlin), V15, P93, DOI 10.1007/BF00345739; PAINE RT, 1981, ECOL MONOGR, V51, P145, DOI 10.2307/2937261; PETERSEN JH, 1984, J EXP MAR BIOL ECOL, V82, P147, DOI 10.1016/0022-0981(84)90100-X; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; POSSINGHAM HP, 1994, AM NAT, V143, P563, DOI 10.1086/285620; POWER ME, 1987, AM MIDL NAT, V117, P333, DOI 10.2307/2425975; Richards SA, 1999, P ROY SOC B-BIOL SCI, V266, P2383, DOI 10.1098/rspb.1999.0935; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Rier ST, 2006, HYDROBIOLOGIA, V561, P131, DOI 10.1007/s10750-005-1610-6; ROBLES C, 1995, ECOLOGY, V76, P565, DOI 10.2307/1941214; Rohani P, 2002, AM NAT, V159, P469, DOI 10.1086/339467; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; ROUGHGARDEN J, 1985, ECOLOGY, V66, P54, DOI 10.2307/1941306; SAUER JR, 1983, J WILDLIFE MANAGE, V47, P31, DOI 10.2307/3808049; SCHAFFER WM, 1985, ECOLOGY, V66, P93, DOI 10.2307/1941309; SPRUGEL DG, 1981, SCIENCE, V211, P390, DOI 10.1126/science.211.4480.390; Stenseth NC, 2004, P ROY SOC B-BIOL SCI, V271, P1985, DOI 10.1098/rspb.2004.2794; STRONG DR, 1986, TRENDS ECOL EVOL, V1, P39, DOI 10.1016/0169-5347(86)90071-6; Suchanek T. H., 1979, THESIS U WASHINGTON; TAYLOR LR, 1980, J ANIM ECOL, V49, P209, DOI 10.2307/4285; TURCHIN P, 1990, NATURE, V344, P660, DOI 10.1038/344660a0; TURCHIN P, 1992, ECOLOGY, V73, P289, DOI 10.2307/1938740; Vogel S., 1988, LIFES DEVICES PHYS W; Volterra V, 1926, NATURE, V118, P558, DOI 10.1038/118558a0; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; WHITE PS, 1979, BOT REV, V45, P229, DOI 10.1007/BF02860857; Wootton JT, 2013, B MAR SCI, V89, P337, DOI 10.5343/bms.2011.1125; Wootton JT, 2010, ECOLOGY, V91, P42, DOI 10.1890/08-1868.1; WOOTTON JT, 1993, ECOLOGY, V74, P195, DOI 10.2307/1939514; Wootton JT, 2004, ECOL LETT, V7, P653, DOI 10.1111/j.1461-0248.2004.00621.x; Wootton JT, 2001, ECOLOGY, V82, P580, DOI 10.2307/2679881; Wootton JT, 2001, NATURE, V413, P841, DOI 10.1038/35101595; Worrall JJ, 2005, J ECOL, V93, P178, DOI 10.1111/j.1365-2745.2004.00937.x; Yoccoz NG, 2006, CLIMATE RES, V32, P139, DOI 10.3354/cr032139	83	5	5	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75700	10.1371/journal.pone.0075700	http://dx.doi.org/10.1371/journal.pone.0075700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086617	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200119
J	Zhang, LL; Guo, S; Schwab, JH; Nielsen, GP; Choy, E; Ye, SN; Zhang, Z; Mankin, H; Hornicek, FJ; Duan, ZF				Zhang, Linlin; Guo, Shang; Schwab, Joseph H.; Nielsen, G. Petur; Choy, Edwin; Ye, Shunan; Zhang, Zhan; Mankin, Henry; Hornicek, Francis J.; Duan, Zhenfeng			Tissue Microarray Immunohistochemical Detection of Brachyury Is Not a Prognostic Indicator in Chordoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR BRACHYURY; CANCER; TARGET; EXPRESSION; GENE	Brachyury is a marker for notochord-derived tissues and neoplasms, such as chordoma. However, the prognostic relevance of brachyury expression in chordoma is still unknown. The improvement of tissue microarray technology has provided the opportunity to perform analyses of tumor tissues on a large scale in a uniform and consistent manner. This study was designed with the use of tissue microarray to determine the expression of brachyury. Brachyury expression in chordoma tissues from 78 chordoma patients was analyzed by immunohistochemical staining of tissue microarray. The clinicopathologic parameters, including gender, age, location of tumor and metastatic status were evaluated. Fifty-nine of 78 (75.64%) tumors showed nuclear staining for brachyury, and among them, 29 tumors (49.15%) showed 1+ (<= 30% positive cells) staining, 15 tumors (25.42%) had 2+ (31% to 60% positive cells) staining, and 15 tumors (25.42%) demonstrated 3+ (61% to 100% positive cells) staining. Brachyury nuclear staining was detected more frequently in sacral chordomas than in chordomas of the mobile spine. However, there was no significant relationship between brachyury expression and other clinical variables. By Kaplan-Meier analysis, brachyury expression failed to produce any significant relationship with the overall survival rate. In conclusion, brachyury expression is not a prognostic indicator in chordoma.	[Zhang, Linlin; Guo, Shang; Schwab, Joseph H.; Choy, Edwin; Ye, Shunan; Zhang, Zhan; Mankin, Henry; Hornicek, Francis J.; Duan, Zhenfeng] Massachusetts Gen Hosp, Ctr Sarcoma & Connect Tissue Oncol, Sarcoma Biol Lab, Boston, MA 02114 USA; [Zhang, Linlin; Zhang, Zhan] Zhengzhou Univ, Affiliated Hosp 3, Dept Pathol, Zhengzhou 450052, Peoples R China; [Nielsen, G. Petur] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Guo, Shang] Shanghai Jiao Tong Univ, Dept Orthopaed, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China	Harvard University; Massachusetts General Hospital; Zhengzhou University; Harvard University; Massachusetts General Hospital; Shanghai Jiao Tong University	Duan, ZF (corresponding author), Massachusetts Gen Hosp, Ctr Sarcoma & Connect Tissue Oncol, Sarcoma Biol Lab, Boston, MA 02114 USA.	zduan@partners.org	zhang, linlin/ABE-9743-2021	zhang, linlin/0000-0003-0204-7972	Stephan L. Harris Fund; Jennifer Hunter Yates Foundation	Stephan L. Harris Fund; Jennifer Hunter Yates Foundation	This project was supported by a grant from the Stephan L. Harris Fund and the Jennifer Hunter Yates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Barresi V, 2012, AM J SURG PATHOL, V36, P1052, DOI 10.1097/PAS.0b013e31824f4ce3; Bydon M, 2012, EXPERT OPIN THER TAR; Chugh R, 2007, ONCOLOGIST, V12, P1344, DOI 10.1634/theoncologist.12-11-1344; Franco R, 2011, EXPERT REV ANTICANC, V11, P859, DOI [10.1586/ERA.11.65, 10.1586/era.11.65]; Hamilton DH, 2012, SEMIN ONCOL, V39, P358, DOI 10.1053/j.seminoncol.2012.02.005; HEALEY JH, 1989, ORTHOP CLIN N AM, V20, P417; Huang B, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.208; Jambhekar NA, 2010, ARCH PATHOL LAB MED, V134, P1181, DOI 10.1043/2009-0476-OA.1; Kilic N, 2011, EUR J CANCER, V47, P1080, DOI 10.1016/j.ejca.2010.11.015; Le LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018846; Nelson AC, 2012, J PATHOL, V228, P274, DOI 10.1002/path.4082; Palena C, 2007, CLIN CANCER RES, V13, P2471, DOI 10.1158/1078-0432.CCR-06-2353; Pinder SE, 2013, J CLIN PATHOL, V66, P169, DOI 10.1136/jclinpath-2012-201091; Presneau N, 2011, J PATHOL, V223, P327, DOI 10.1002/path.2816; Roselli M, 2012, CLIN CANCER RES, V18, P3868, DOI 10.1158/1078-0432.CCR-11-3211; Satoh N, 2012, EVOL DEV, V14, P56, DOI 10.1111/j.1525-142X.2011.00522.x; Shen J, 2011, J CLIN NEUROSCI, V18, P96, DOI 10.1016/j.jocn.2010.03.066; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Simon R, 2010, METHODS MOL BIOL, V664, P1, DOI 10.1007/978-1-60761-806-5_1; Vujovic S, 2006, J PATHOL, V209, P157, DOI 10.1002/path.1969; Walcott BP, 2012, LANCET ONCOL, V13, pE69, DOI 10.1016/S1470-2045(11)70337-0; Yang C, 2010, SPINE, V35, P1257, DOI 10.1097/BRS.0b013e3181c2a8b0; Yang XHR, 2009, NAT GENET, V41, P1176, DOI 10.1038/ng.454	24	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75851	10.1371/journal.pone.0075851	http://dx.doi.org/10.1371/journal.pone.0075851			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086644	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200122
J	Alho, I; Costa, L; Bicho, M; Coelho, C				Alho, Irina; Costa, Luis; Bicho, Manuel; Coelho, Constanca			Low Molecular Weight Protein Tyrosine Phosphatase Isoforms Regulate Breast Cancer Cells Migration through a RhoA Dependent Mechanism	PLOS ONE			English	Article							RECEPTOR; GROWTH; EPHA2; ACP1	Low molecular weight protein tyrosine phosphatase (LMW-PTP) has been associated with cell proliferation control through dephosphorylation and inactivation of growth factor receptors such as PDGF-R and EphA2, and with cellular adhesion and migration through p190RhoGap and RhoA. We aim to clarify the role of two main LMW-PTP isoforms in breast cancer tumorigenesis. We used a siRNA-mediated loss-of-function in MDA-MB-435 breast cancer cell line to study the role of the two main LMW-PTP isoforms, fast and slow, in breast cancer tumorigenesis and migration. Our results show that the siRNAs directed against total LMW-PTP and LMW-PTP slow isoform enhanced cell motility in an invasive breast cancer cell line, MDA-MB-435, with no changes in the proliferation and invasive potential of cells. The total LMW-PTP knockdown caused a more pronounced increase of cell migration. Suppression of total LMW-PTP decreased RhoA activation and suppression of the LMW-PTP slow isoform caused a small but significant increase in RhoA activation. We propose that the increase or decrease in RhoA activation induces changes in stress fibers formation and consequently alter the adhesive and migratory potential of cells. These findings suggest that the two main isoforms of LMW-PTP may act differentially, with the fast isoform having a more prominent role in tumor cell migration. In addition, our results highlight functional specificity among LMW-PTP isoforms, suggesting hitherto unknown roles for these proteins in breast cancer biology. Novel therapeutic approaches targeting LMW-PTP, considering the expression of these two isoforms and not LMW-PTP as a whole, should be investigated.	[Alho, Irina; Bicho, Manuel; Coelho, Constanca] Fac Med Lisbon, Ctr Cardiol, Genet Lab, Lisbon, Portugal; [Alho, Irina; Costa, Luis] Fac Med Lisbon, Inst Mol Med, Lisbon, Portugal; [Costa, Luis] Ctr Hosp Lisboa Norte, Hosp Santa Maria, Dept Oncol, Med Oncol Serv, Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria	Coelho, C (corresponding author), Fac Med Lisbon, Ctr Cardiol, Genet Lab, Lisbon, Portugal.	constancacoelho@fm.ul.pt	Costa, Luis AM/E-5117-2015	Bicho, Manuel/0000-0002-5773-5687; Coelho, Constanca/0000-0002-5331-2257; Duarte, Irina/0000-0002-3190-7479; Costa, Luis/0000-0002-4782-7318	Fundacao para a Ciencia e Tecnologia, FCT [SFRH/BD/44716/2008]	Fundacao para a Ciencia e Tecnologia, FCT(Portuguese Foundation for Science and Technology)	Irina Alho is supported by Fundacao para a Ciencia e Tecnologia, FCT grant: SFRH/BD/44716/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alho I, 2013, ANTICANCER RES, V33, P1983; Balcerczyk A, 2005, BIOCHEM PHARMACOL, V69, P1263, DOI 10.1016/j.bcp.2005.01.010; BOTTINI E, 1995, HUM GENET, V96, P629, DOI 10.1007/BF00210290; Brantley-Sieders DM, 2004, J CELL SCI, V117, P2037, DOI 10.1242/jcs.01061; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Chiarugi P, 2004, ONCOGENE, V23, P3905, DOI 10.1038/sj.onc.1207508; CHIARUGI P, 1995, FEBS LETT, V372, P49, DOI 10.1016/0014-5793(95)00947-8; DISSING J, 1991, J BIOL CHEM, V266, P20619; Fang BW, 2008, J CELL SCI, V121, P358, DOI 10.1242/jcs.017145; Ferreira PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044312; Malentacchi F, 2005, BIOCHEM BIOPH RES CO, V334, P875, DOI 10.1016/j.bbrc.2005.06.176; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Raugei G, 2002, CELL MOL LIFE SCI, V59, P941, DOI 10.1007/s00018-002-8481-z; Souza ACS, 2009, CELL MOL LIFE SCI, V66, P1140, DOI 10.1007/s00018-008-8501-8; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; Taddei ML, 2006, INT J CANCER, V118, P2082, DOI 10.1002/ijc.21602; Taddei ML, 2002, CANCER RES, V62, P6489; Walker-Daniels J, 2003, AM J PATHOL, V162, P1037, DOI 10.1016/S0002-9440(10)63899-0	19	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76307	10.1371/journal.pone.0076307	http://dx.doi.org/10.1371/journal.pone.0076307			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086724	gold, Green Published, Green Submitted			2022-12-27	WOS:000325223900095
J	Alhabib, S; Feder, G; Horwood, J				Alhabib, Samia; Feder, Gene; Horwood, Jeremy			English to Arabic Translation of the Composite Abuse Scale (CAS): A Multi-Method Approach	PLOS ONE			English	Article							GENERAL-PRACTICE; WIFE ABUSE; PREVALENCE; WOMEN; SOCIETY	Background: The composite abuse scale (CAS) is a comprehensive tool used to measure intimate partner violence (IPV). The aim of the present study is to translate the CAS from English to Arabic. Methods: The translation of the CAS was conducted in four stages using a multi-method approach: 1) preliminary forward translation, 2) discussion with a panel of bilingual experts, 3) focus groups discussion, and 4) back-translation of the CAS. The discussion included a linguistic validation by a comparison of the Arabic translation with the original English by assessing conceptual and content equivalence. Findings: In all the stages of translation, there was an agreement to remove the question from the CAS that asked women about the use of objects in the vagina. Wording, format and order of the items were refined according to comments and suggestions made by the experts' panel and focus groups' members. The back-translated CAS showed similar wording and language of the original English version. Conclusions: The Arabic version of the CAS will help to measure the problem of IPV among Saudi women and possibly other Arabic-speaking women in future studies. This is important, particularly, in longitudinal studies or intervention studies among abused women and it allows a comparison of the results of studies from different cultures. However, further validations studies are needed to ensure accurate and equivalent Arabic translation of the CAS.	[Alhabib, Samia; Feder, Gene] Univ Bristol, Sch Social & Community Med, Ctr Acad Primary Care, Bristol, Avon, England; [Horwood, Jeremy] Univ Bristol, Sch Social & Community Med, NIHR Sch Primary Care Res, Bristol Randomised Trials Collaborat,Ctr Acad Pri, Bristol, Avon, England	University of Bristol; University of Bristol	Alhabib, S (corresponding author), Univ Bristol, Sch Social & Community Med, Ctr Acad Primary Care, Bristol, Avon, England.	smalhabib@yahoo.com	Horwood, Jeremy/AAH-2941-2019	Horwood, Jeremy/0000-0001-7092-4960; Feder, Gene/0000-0002-7890-3926	University of Bristol; National Institute for Health Research [RP-PG-0108-10084] Funding Source: researchfish	University of Bristol; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was sponsored by the University of Bristol. No current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A M, 2005, East Mediterr Health J, V11, P164; ALhabib S, 2010, J FAM VIOLENCE, V15, P1; Almosaed N., 2004, J MUSLIM MINOR AFF, V24, P67, DOI [DOI 10.1080/1360200042000212124, 10.1080/1360200042000212124]; American Educational Research Association, 1999, STAND ED PSYCH TEST; Azzam IJ, 2000, J CULTURE        JUN; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Catford C., 1965, LINGUISTIC THEORY TR, P49; Douki S, 2003, Arch Womens Ment Health, V6, P165, DOI 10.1007/s00737-003-0170-x; Gharaibeh M, 2002, GUIDANCE COUNSELING, V18, P2; Haj-Yahia MM, 2000, J FAM VIOLENCE, V15, P347, DOI 10.1023/A:1007554229592; Haj-Yahia MM, 2000, FAM PROCESS, V39, P237, DOI 10.1111/j.1545-5300.2000.39207.x; Hegarty K, 2008, COMPOSITE ABUSE SCAL; Hegarty Kelsey, 2005, Violence Vict, V20, P529, DOI 10.1891/vivi.2005.20.5.529; Khawaja M, 2005, J EPIDEMIOL COMMUN H, V59, P840, DOI 10.1136/jech.2004.031625; Lokhmatkina NV, 2010, FAM PRACT, V27, P625, DOI 10.1093/fampra/cmq044; Newmark P, 1981, APPROACHES TRANSLATI, P36; Nord C, 1991, TEXT ANAL TRANSLATIO, P30; Oweis A, 2010, MATERN CHILD HLTH J, V14, P437, DOI 10.1007/s10995-009-0465-2; Oweis A, 2009, J TRANSCULT NURS, V20, P69, DOI 10.1177/1043659608325848; Prosman GJ, 2011, FAM PRACT, V28, P267, DOI 10.1093/fampra/cmq117; Rietveld L, 2010, J PSYCHOSOM OBST GYN, V31, P3, DOI [10.3109/01674820903556388, DOI 10.3109/01674820903556388.PUBMED:20121462]; Van de Vijver FJR, 1997, METHODS DATA ANAL CR, P15; Vinay J.P., 1958, COMP STYLISTICS FREN	23	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75244	10.1371/journal.pone.0075244	http://dx.doi.org/10.1371/journal.pone.0075244			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VC	24086478	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700060
J	Blattmann, T; Boch, S; Turke, M; Knop, E				Blattmann, Tamara; Boch, Steffen; Tuerke, Manfred; Knop, Eva			Gastropod Seed Dispersal: An Invasive Slug Destroys Far More Seeds in Its Gut than Native Gastropods	PLOS ONE			English	Article							CONSEQUENCES; ECOLOGY; PLANTS; ANT	Seed dispersal is one of the most important mechanisms shaping biodiversity, and animals are one of the key dispersal vectors. Animal seed dispersal can directly or indirectly be altered by invasive organisms through the establishment of new or the disruption of existing seed dispersal interactions. So far it is known for a few gastropod species that they ingest and defecate viable plant seeds and consequently act as seed dispersers, referred to as gastropodochory. In a multi-species experiment, consisting of five different plant species and four different gastropod species, we tested with a fully crossed design whether gastropodochory is a general mechanism across native gastropod species, and whether it is altered by the invasive alien slug species Arion lusitanicus. Specifically, we hypothesized that a) native gastropod species consume the seeds from all tested plant species in equal numbers (have no preference), b) the voracious invasive alien slug A. lusitanicus - similarly to its herbivore behaviour - consumes a higher amount of seeds than native gastropods, and that c) seed viability is equal among different gastropod species after gut passage. As expected all tested gastropod species consumed all tested plant species. Against our expectation there was a difference in the amount of consumed seeds, with the largest and native mollusk Helix pomatia consuming most seeds, followed by the invasive slug and the other gastropods. Seed damage and germination rates did not differ after gut passage through different native species, but seed damage was significantly higher after gut passage through the invasive slug A. lusitanicus, and their germination rates were significantly reduced.	[Blattmann, Tamara; Knop, Eva] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Boch, Steffen] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Boch, Steffen] Univ Bern, Bot Garden, Bern, Switzerland; [Tuerke, Manfred] Tech Univ Munich, Dept Ecol & Ecosyst Management, Freising Weihenstephan, Germany	University of Bern; University of Bern; University of Bern; Technical University of Munich	Knop, E (corresponding author), Univ Bern, Inst Ecol & Evolut, Bern, Switzerland.	eva.knop@iee.unibe.ch	Boch, Steffen/L-5436-2016; Knop, Eva/D-2298-2018	Knop, Eva/0000-0001-9402-2216; Turke, Manfred/0000-0002-8957-5454	German Federal Ministry of Education and Research (BMBF) [FKZ: 01LL09 170-LEGATO]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	MT was financed by the German Federal Ministry of Education and Research (BMBF; FKZ: 01LL09 170-LEGATO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benvenuti S, 2007, WEED BIOL MANAG, V7, P141, DOI 10.1111/j.1445-6664.2007.00249.x; Boch S, 2013, OECOLOGIA; Boch S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018770; Bogon K, 1990, LANDSCHNECKEN BIOL O; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Calvino-Cancela M, 2012, PLANT ECOL, V213, P663, DOI 10.1007/s11258-012-0030-8; Carney SE, 2003, OECOLOGIA, V135, P576, DOI 10.1007/s00442-003-1200-0; Castro SA, 2008, J ARID ENVIRON, V72, P1164, DOI 10.1016/j.jaridenv.2007.12.012; Christian CE, 2001, NATURE, V413, P635, DOI 10.1038/35098093; Cowie Robert H., 2003, P93; CSCF, 2011, VERBR TIER; DERKSEN DA, 1994, WEED SCI, V42, P184, DOI 10.1017/S0043174500080255; Gelman A, 2009, DATA ANAL USING REGR; Gervais JA, 1998, AM MIDL NAT, V140, P103, DOI 10.1674/0003-0031(1998)140[0103:TPFSDB]2.0.CO;2; Hansen DM, 2010, ECOGRAPHY, V33, P272, DOI 10.1111/j.1600-0587.2010.06305.x; Honek A, 2009, AGR ECOSYST ENVIRON, V134, P126, DOI 10.1016/j.agee.2009.06.001; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Kappes H, 2009, LANDSCAPE ECOL, V24, P685, DOI 10.1007/s10980-009-9342-z; KLOTZ S, 2003, BIOLFLOR DATENBANK B; Knop E, 2012, P ROY SOC B-BIOL SCI, V279, P4668, DOI 10.1098/rspb.2012.1564; Levin SA, 2003, ANNU REV ECOL EVOL S, V34, P575, DOI 10.1146/annurev.ecolsys.34.011802.132428; Lopez-Darias M, 2008, J ARID ENVIRON, V72, P926, DOI 10.1016/j.jaridenv.2007.12.006; McConkey KR, 2012, BIOL CONSERV, V146, P1, DOI 10.1016/j.biocon.2011.09.018; Muir AM, 1997, SEED PREDATION DISPE; Muller-Schneider P., 1971, Folia Geobotanica et Phytotaxonomica, V6, P407; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Petren K, 1996, ECOLOGY, V77, P118, DOI 10.2307/2265661; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Quinteiro J, 2005, J ZOOL SYST EVOL RES, V43, P139, DOI 10.1111/j.1439-0469.2005.00307.x; Rabitsch W, 2009, HDB ALIEN SPECIES EU; Rodriguez-Cabal MA, 2009, BIOL LETTERS, V5, P499, DOI 10.1098/rsbl.2009.0297; Schlaepfer DR, 2010, NEW PHYTOL, V185, P1087, DOI 10.1111/j.1469-8137.2009.03114.x; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; SCHUPP EW, 1993, VEGETATIO, V108, P15; Team R. D. C, 2011, R LANG ENV STAT COMP; Traveset A, 2012, P ROY SOC B-BIOL SCI, V279, P3298, DOI 10.1098/rspb.2012.0535; Turke M, 2012, AM NAT, V179, P124, DOI 10.1086/663195; Turke M, 2010, OECOLOGIA, V163, P681, DOI 10.1007/s00442-010-1612-6; Turner H, 1998, ATLAS MOLLUSKEN SCHW; White EM, 2006, DIVERS DISTRIB, V12, P443, DOI 10.1111/j.1366-9516.2006.00265.x; Winkler E, 2001, EVOL ECOL, V15, P281, DOI 10.1023/A:1016080714200	42	14	16	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75243	10.1371/journal.pone.0075243	http://dx.doi.org/10.1371/journal.pone.0075243			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086477	Green Submitted, Green Published, gold			2022-12-27	WOS:000325218700059
J	Cui, Q; Zhang, QL; Takahashi, H				Cui, Qian; Zhang, Qinglin; Takahashi, Hidehiko			The Neural Mechanism of Encountering Misjudgment by the Justice System	PLOS ONE			English	Article							FUNCTIONAL MAGNETIC-RESONANCE; ROSTRAL ANTERIOR CINGULATE; DECISION-MAKING; DETECTING DECEPTION; REWARD PREDICTION; FRONTAL-CORTEX; BRAIN ACTIVITY; LIE-DETECTION; ERROR; STRIATUM	Although misjudgment is an issue of primary concern to the justice system and public safety, the response to misjudgment by the human brain remains unclear. We used fMRI to record neural activity in participants that encountered four possible judgments by the justice system with two basic components: whether the judgment was right or wrong [accuracy: right vs. wrong (misjudgment)] and whether the judgment was positive or negative [valence: positive vs. negative]. As hypothesized, the rostral ACC specifically processes the accuracy of judgment, being more active for misjudgment than for right judgment, while the striatum was uniquely responsible for the valence of judgment, being recruited to a larger extent by positive judgment compared to negative judgment. Furthermore, the activity in the rACC for positive misjudgments was positively correlated with that for negative misjudgments, which confirmed the misjudgment-specificity of the rACC. These results demonstrate that the brain can distinguish a misjudgment from a right judgment and regard a misjudgment as an emotionally arousing stimulus, independent of whether it is positive or negative, while positive judgment is considered as hedonic information, regardless of whether it is right or wrong. Our study is the first to reveal the neural mechanism that underlies judgment processing. This mechanism may constitute the basis of future studies to develop a novel marker for the detection of lies.	[Cui, Qian; Zhang, Qinglin] Southwest Univ, Fac Psychol, Chongqing, Peoples R China; [Cui, Qian; Takahashi, Hidehiko] Kyoto Univ, Dept Psychiat, Grad Sch Med, Kyoto, Japan; [Cui, Qian; Zhang, Qinglin] Southwest Univ, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China	Southwest University - China; Kyoto University; Southwest University - China	Zhang, QL (corresponding author), Southwest Univ, Fac Psychol, Chongqing, Peoples R China.	zhangql@swu.edu.cn; hidehiko@kuhp.kyoto-u.ac.jp		Takahashi, Hidehiko/0000-0002-5102-1982	Takeda Science Foundation; Casio Science Foundation; Brain Science Foundation; National Natural Science Foundation of China [30970892, 31170983];  [23120009];  [23680045]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Casio Science Foundation; Brain Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ; 	This study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas: Prediction and Decision Making (23120009); a Grant-in-Aid for Young Scientist A (23680045); a research grant from Takeda Science Foundation, a research grant from Casio Science Foundation; a research grant from Brain Science Foundation; and the National Natural Science Foundation of China (30970892, 31170983). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Conti R. P., 1999, J CREDIBILITY ASSESS, V2, P14; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley HD, 2005, NEUROIMAGE, V27, P885, DOI 10.1016/j.neuroimage.2005.05.047; Davatzikos C, 2005, NEUROIMAGE, V28, P663, DOI 10.1016/j.neuroimage.2005.08.009; de Bruijn ERA, 2009, J NEUROSCI, V29, P12183, DOI 10.1523/JNEUROSCI.1751-09.2009; De Cremer D, 2007, ADV PSYCHOL JUSTICE, Vviii; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Elliott R, 2003, J NEUROSCI, V23, P303; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Furman HP, 2003, COLO LAW, V32, P11; GEHRING WJ, 1992, J EXP PSYCHOL HUMAN, V18, P198, DOI 10.1037/0096-1523.18.1.198; Gould Jon B., 2010, J CRIM LAW CRIM, V100, P2010; Gudjonsson G.H., 2012, NEW ENGLAND LAW REV, V46, P689; Gudjonsson Gisli H, 2003, Crim Behav Ment Health, V13, P159, DOI 10.1002/cbm.539; Hakun JG, 2008, NEUROCASE, V14, P59, DOI 10.1080/13554790801992792; Hogan AM, 2006, BRAIN, V129, P2177, DOI 10.1093/brain/awl160; Jocham G, 2009, J NEUROSCI, V29, P7489, DOI 10.1523/JNEUROSCI.0349-09.2009; Kiehl KA, 2000, PSYCHOPHYSIOLOGY, V37, P216, DOI 10.1111/1469-8986.3720216; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Kozel F Andrew, 2009, Open Forensic Sci J, V2, P6; Kozel FA, 2009, J FORENSIC SCI, V54, P220, DOI 10.1111/j.1556-4029.2008.00927.x; Kozel FA, 2005, BIOL PSYCHIAT, V58, P605, DOI 10.1016/j.biopsych.2005.07.040; Kozel FA, 2004, J NEUROPSYCH CLIN N, V16, P295, DOI 10.1176/appi.neuropsych.16.3.295; Kozel FA, 2004, BEHAV NEUROSCI, V118, P852, DOI 10.1037/0735-7044.118.4.852; Langleben DD, 2008, LEGAL CRIMINOL PSYCH, V13, P1, DOI 10.1348/135532507X251641; Langleben DD, 2002, NEUROIMAGE, V15, P727, DOI 10.1006/nimg.2001.1003; Laurens KR, 2003, BRAIN, V126, P610, DOI 10.1093/brain/awg056; Leo R. A., 2009, J PSYCHIAT LAW, V38, P9; Leo RA., 2005, J CONTEMP CRIM JUST, V21, P201, DOI DOI 10.1177/104398620527747S; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mobbs D, 2003, NEURON, V40, P1041, DOI 10.1016/S0896-6273(03)00751-7; Nee DE, 2011, NEUROIMAGE, V54, P528, DOI 10.1016/j.neuroimage.2010.08.027; O'Doherty JP, 2007, ANN NY ACAD SCI, V1104, P35, DOI 10.1196/annals.1390.022; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Ricciardelli R, 2009, CAN J CRIMINOL CRIM, V51, P411, DOI 10.3138/cjccj.51.3.411; Shane MS, 2008, NEUROIMAGE, V42, P450, DOI 10.1016/j.neuroimage.2007.12.067; Sip KE, 2008, TRENDS COGN SCI, V12, P48, DOI 10.1016/j.tics.2007.11.008; Spence SA, 2004, J ROY SOC MED, V97, P6, DOI 10.1258/jrsm.97.1.6; Spence SA, 2001, NEUROREPORT, V12, P2849, DOI 10.1097/00001756-200109170-00019; Swanner JK, 2010, LAW HUMAN BEHAV, V34, P418, DOI 10.1007/s10979-009-9212-x; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; Takahashi H, 2008, CEREB CORTEX, V18, P898, DOI 10.1093/cercor/bhm120; Takahashi H, 2009, SCIENCE, V323, P937, DOI 10.1126/science.1165604; Taylor SF, 2006, J NEUROSCI, V26, P4063, DOI 10.1523/JNEUROSCI.4709-05.2006; Ullsperger M, 2006, J COGNITIVE NEUROSCI, V18, P651, DOI 10.1162/jocn.2006.18.4.651; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; van't Wout M, 2006, EXP BRAIN RES, V169, P564, DOI 10.1007/s00221-006-0346-5; Wolpe PR, 2005, AM J BIOETHICS, V5, P39, DOI 10.1080/15265160590923367; Yoshida K, 2012, NAT NEUROSCI, V15, P1307, DOI 10.1038/nn.3180; 1991, BMJ, V302, P1194	54	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75434	10.1371/journal.pone.0075434	http://dx.doi.org/10.1371/journal.pone.0075434			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086531	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700087
J	Peng, QX; Cai, HB; Sun, XG; Li, X; Mo, ZX; Shi, J				Peng, Qiuxian; Cai, Hongbing; Sun, Xuegang; Li, Xin; Mo, Zhixian; Shi, Jue			Alocasia cucullata Exhibits Strong Antitumor Effect In Vivo by Activating Antitumor Immunity	PLOS ONE			English	Article							CANCER; CELLS; IMMUNOTHERAPY; GLIOBLASTOMA; INFLAMMATION; MACROPHAGES; MIGRATION; RANTES	Chinese herbal medicines have long been used to treat various illnesses by modulating the human immune response. In this study, we investigate the immuno-modulating effect and antitumor activity of Alocasia Cucullata (AC), a Chinese herb traditionally used to treat infection and cancer. We found that the whole water extract of AC roots could significantly attenuate tumor growth in mouse tumor models. The median survival time of the AC-treated mice was 43 days, 16 days longer than that of the control group. Moreover, the AC-treated mice showed substantially higher induction of key antitumor cytokines, such as IL-2, IFN-gamma, and TNF-alpha, indicating that AC may exert antitumor effect by activating antitumor immunity. To further pinpoint the cellular and molecular mechanism of AC, we studied the dose response of a human monocytic cell line, THP-1, to the whole water extract of AC. Treatment of the AC extract significantly induced THP-1 differentiation into macrophage-like cells and the differentiated THP-1 showed expression of specific macrophage surface markers, such as CD11b and CD14, as well as productions of antitumor cytokines, e.g. IFN-gamma and TNF-alpha. Our data thus point to AC as potentially a new, alternative immuno-modulating herbal remedy for anticancer treatment.	[Peng, Qiuxian; Cai, Hongbing; Sun, Xuegang; Li, Xin; Mo, Zhixian; Shi, Jue] Southern Med Univ, Sch Chinese Med, Guangzhou, Guangdong, Peoples R China; [Peng, Qiuxian; Shi, Jue] Hong Kong Baptist Univ, Ctr Quantitat Syst Biol, Dept Phys, Hong Kong, Hong Kong, Peoples R China; [Peng, Qiuxian; Shi, Jue] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Hong Kong, Peoples R China	Southern Medical University - China; Hong Kong Baptist University; Hong Kong Baptist University	Mo, ZX (corresponding author), Southern Med Univ, Sch Chinese Med, Guangzhou, Guangdong, Peoples R China.	cherrymo@fimmu.com; jshi@hkbu.edu.hk	Shi, Jue/J-9714-2014	Shi, Jue/0000-0003-4061-3496; Mo, Zhixian/0000-0002-4100-7298	faculty research fund of HKBU [FRG2/09-10/019]; Special Program for Key Basic Research of the Ministry of Science and Technology China [2006CB708516]; Guangzhou Municipal research grant [201300000152]	faculty research fund of HKBU; Special Program for Key Basic Research of the Ministry of Science and Technology China; Guangzhou Municipal research grant	The work was supported by faculty research fund of HKBU #FRG2/09-10/019) to J. Shi, the Special Program for Key Basic Research of the Ministry of Science and Technology China (No. 2006CB708516) to Z. Mo and the Guangzhou Municipal research grant (#201300000152) to H. Cai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Candolfi M, 2011, NEOPLASIA, V13, P947, DOI 10.1593/neo.11024; Chow KKH, 2013, MOL THER, V21, P629, DOI 10.1038/mt.2012.210; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Diesner SC, 2012, THER DELIV, V3, P377, DOI 10.4155/TDE.11.146; Fiorenza S, 2012, J IMMUNOL, V189, P5622, DOI 10.4049/jimmunol.1200709; Gao YH, 2005, J MED FOOD, V8, P159, DOI 10.1089/jmf.2005.8.159; Ghosh AK, 2012, CANCER LETT, V324, P91, DOI 10.1016/j.canlet.2012.05.002; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guo J, 2002, GENE THER, V9, P793, DOI 10.1038/sj.gt.3301688; Hou XueWen, 1998, Journal of South China Agricultural University, V19, P106; Ina K, 2013, ANTI-CANCER AGENT ME, V13, P681, DOI 10.2174/1871520611313050002; Kaur A, 2005, BIOTECHNOL LETT, V27, P1815, DOI 10.1007/s10529-005-3559-y; [雷霄 Lei Xiao], 2012, [中国医药工业杂志, Chinese Journal of Pharmaceuticals], V43, P340; Lesterhuis WJ, 2011, NAT REV DRUG DISCOV, V10, P591, DOI 10.1038/nrd3500; MEGYERI P, 1990, J LEUKOCYTE BIOL, V47, P70, DOI 10.1002/jlb.47.1.70; Overwijk WW, 2011, CURR PROTOC IMMUNOL; Ramakrishnan R, 2011, CANCER IMMUNOL IMMUN, V60, P419, DOI 10.1007/s00262-010-0930-1; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tundup S, 2012, ANN NY ACAD SCI, V1253, pE1, DOI 10.1111/j.1749-6632.2012.06618.x; Wettergren Y, 2012, CANCER-AM CANCER SOC, V118, P2935, DOI 10.1002/cncr.26595; Yang XY, 2010, VACCINE, V28, P737, DOI 10.1016/j.vaccine.2009.10.065; Yoon TJ, 2008, APPL MICROBIOL BIOT, V80, P1087, DOI 10.1007/s00253-008-1607-y; Yoshino Shigefumi, 2008, Gan To Kagaku Ryoho, V35, P2239; Zang YCQ, 2000, BRAIN, V123, P1874, DOI 10.1093/brain/123.9.1874; Zhu KJ, 2000, CHINESE MED J-PEKING, V113, P1124	26	12	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75328	10.1371/journal.pone.0075328	http://dx.doi.org/10.1371/journal.pone.0075328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086508	gold, Green Published, Green Submitted			2022-12-27	WOS:000325218700076
J	Kalani, K; Agarwal, J; Alam, S; Khan, F; Pal, A; Srivastava, SK				Kalani, Komal; Agarwal, Jyoti; Alam, Sarfaraz; Khan, Feroz; Pal, Anirban; Srivastava, Santosh Kumar			In Silico and In Vivo Anti-Malarial Studies of 18 beta Glycyrrhetinic Acid from Glycyrrhiza glabra	PLOS ONE			English	Article							FALCIPARUM LACTATE-DEHYDROGENASE; PLASMODIUM-FALCIPARUM; OLEANOLIC ACID; PHARMACOLOGY; DERIVATIVES; DOCKING; MALARIA; MICE	Malaria is one of the most prevailing fatal diseases causing between 1.2 and 2.7 million deaths all over the world each year. Further, development of resistance against the frontline anti-malarial drugs has created an alarming situation, which requires intensive drug discovery to develop new, more effective, affordable and accessible anti-malarial agents possessing novel modes of action. Over the past few years triterpenoids from higher plants have shown a wide range of anti-malarial activities. As a part of our drug discovery program for anti-malarial agents from Indian medicinal plants, roots of Glycyrrhiza glabra were chemically investigated, which resulted in the isolation and characterization of 18 beta-glycyrrhetinic acid (GA) as a major constituent. The in vitro studies against P. falciparum showed significant (IC50 1.69 mu g/ml) anti-malarial potential for GA. Similarly, the molecular docking studies showed adequate docking (LibDock) score of 71.18 for GA and 131.15 for standard anti-malarial drug chloroquine. Further, in silico pharmacokinetic and drug-likeness studies showed that GA possesses drug-like properties. Finally, in vivo evaluation showed a dose dependent anti-malarial activity ranging from 68-100% at doses of 62.5-250mg/kg on day 8. To the best of our knowledge this is the first ever report on the anti-malarial potential of GA. Further work on optimization of the anti-malarial lead is under progress.	[Kalani, Komal; Srivastava, Santosh Kumar] CSIR Cent Inst Med & Aromat Plants, Dept Med Chem, Lucknow, Uttar Pradesh, India; [Agarwal, Jyoti; Pal, Anirban] CSIR Cent Inst Med & Aromat Plants, Mol Bioprospect Dept, Lucknow, Uttar Pradesh, India; [Alam, Sarfaraz; Khan, Feroz] CSIR Cent Inst Med & Aromat Plants, Metab & Struct Biol Dept, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP)	Pal, A (corresponding author), CSIR Cent Inst Med & Aromat Plants, Mol Bioprospect Dept, Lucknow, Uttar Pradesh, India.	drapaul@gmail.com; santoshkumar_1955@yahoo.com	Alam, Sarfaraz/H-2802-2019; Pal, Anirban/AAG-9077-2020; Alam, Sarfaraz/A-9180-2012; Khan, Feroz/AHC-3474-2022	Alam, Sarfaraz/0000-0002-7246-8687; Alam, Sarfaraz/0000-0002-7246-8687; Khan, Feroz/0000-0002-2704-5925; Pal, Anirban/0000-0003-2688-7714	CSIR-network [BSC-0121]	CSIR-network(Council of Scientific & Industrial Research (CSIR) - India)	The funding source is CSIR-network project BSC-0121 and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, EMAHMPC5711222010; Boniface PK, 2013, J ETHNOPHARMACOL, V145, P373, DOI 10.1016/j.jep.2012.10.025; Cimanga RK, 2006, PHARM BIOL, V44, P677, DOI 10.1080/13880200601009123; Daily JP, 2006, J CLIN PHARMACOL, V46, P1487, DOI 10.1177/0091270006294276; Gao DW, 2012, INT J NANOMED, V7, P3517, DOI 10.2147/IJN.S31725; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gautam R, 2009, MED RES REV, V29, P767, DOI 10.1002/med.20156; Harwood JL, 1996, BBA-LIPID LIPID MET, V1301, P7, DOI 10.1016/0005-2760(95)00242-1; Kalani K, 2013, BIOORG MED CHEM LETT, V23, P2566, DOI 10.1016/j.bmcl.2013.02.115; Khare C.P., 2004, ENCY INDIAN MED PLAN; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; MACIAS A, 1994, MECH DEVELOP, V46, P15, DOI 10.1016/0925-4773(94)90034-5; Nick A, 1995, J ETHNOPHARMACOL, V49, P147, DOI 10.1016/0378-8741(95)01315-6; Penna-Coutinho J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021237; Qidwai T, 2012, CURR PHARM DESIGN, V18, P6133, DOI 10.2174/138161212803582397; Ramalhete C, 2011, BIOORGAN MED CHEM, V19, P7474, DOI 10.1016/j.bmc.2011.10.044; Ramalhete C, 2010, BIOORGAN MED CHEM, V18, P5254, DOI 10.1016/j.bmc.2010.05.054; Read JA, 1999, J BIOL CHEM, V274, P10213, DOI 10.1074/jbc.274.15.10213; Roy KK, 2011, CHEM BIOL DRUG DES, V78, P483, DOI 10.1111/j.1747-0285.2011.01158.x; Sen D, 2013, J ADV PHARM TECHNOL, V4, P50, DOI 10.4103/2231-4040.107501; Sessions RB, 1997, PROTEIN ENG, V10, P301, DOI 10.1093/protein/10.4.301; SINGH GB, 1992, J PHARM PHARMACOL, V44, P456, DOI 10.1111/j.2042-7158.1992.tb03646.x; Srivastava V, 2005, BIOORGAN MED CHEM, V13, P5892, DOI 10.1016/j.bmc.2005.05.066; Takenaka T, 2001, BJU INT, V88, P7; W.H.O, 2012, ORLD MAL REP 2012; Zhu YM, 2001, BIOORG MED CHEM LETT, V11, P3115, DOI 10.1016/S0960-894X(01)00647-3	26	55	55	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e74761	10.1371/journal.pone.0074761	http://dx.doi.org/10.1371/journal.pone.0074761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086367	gold, Green Published, Green Submitted			2022-12-27	WOS:000325025200016
J	Chen, BD; Wang, WD; Shen, T; Qi, RM				Chen, Beidong; Wang, Wendong; Shen, Tao; Qi, Ruomei			Thioredoxin1 Downregulates Oxidized Low-Density Lipoprotein-Induced Adhesion Molecule Expression via Smad3 Protein	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; ENDOTHELIAL-CELLS; APOPTOSIS; INHIBITOR; BINDING; ATHEROSCLEROSIS; RESPONSIVENESS; ATHEROGENESIS; DISRUPTION	Atherosclerosis is a chronic inflammation disease that is initiated by endothelial cell injury. Oxidized low-density lipoprotein (ox-LDL) is directly associated with chronic vascular inflammation. To understand whether thioredoxin1 (Trx1) participates in an antiinflammatory defense mechanism in atherosclerosis, we investigated the effect of Trx1 on the expression of two adhesion molecules, vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1), in human umbilical vein endothelial cells (HUVECs). Thioredoxin1 and dominant-negative mutant thioredoxin1 (TD) were transiently overexpressed using adenovirus vector gene transfer. Our data showed that Trx1 overexpression suppressed ox-LDL-induced adhesion molecule expression in HUVECs. The overexpression of Trx1 promoted ox-LDL-induced Smad3 phosphorylation and nuclear translocation. A co-immunoprecipitation assay indicated that Smad3 continued to interact with Trx1 with or without ox-LDL stimulation. These results suggest that Trx1 inherently suppresses VCAM-1 and ICAM-1 expression in vascular endothelia and may prevent the initiation of atherosclerosis by attenuating adhesion molecule expression. The enhancement of Smad3 phosphorylation and nuclear expression appears to be primarily responsible for the Trx1-induced downregulation of adhesion molecules.	[Qi, Ruomei] Beijing Inst Geriatr, Key Lab Geriatr, Beijing, Peoples R China; Beijing Hosp, Minist Hlth, Beijing, Peoples R China	Beijing Hospital	Qi, RM (corresponding author), Beijing Inst Geriatr, Key Lab Geriatr, Beijing, Peoples R China.	ruomeiqi@163.com	Wang, Wendong/O-7502-2018	Wang, Wendong/0000-0001-9104-1622	National Natural Science Foundation of China [30900627, 81270379, 81200221]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (no. 30900627, 81270379, 81200221). The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Chen BD, 2010, AM J PHYSIOL-CELL PH, V298, pC1170, DOI 10.1152/ajpcell.00223.2009; Chen CL, 2007, J CELL SCI, V120, P3509, DOI 10.1242/jcs.006916; Chen HJ, 2001, CIRC RES, V89, P1155, DOI 10.1161/hh2401.100598; CHUNG BH, 1980, J LIPID RES, V21, P284; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Fan Jianglin, 2003, J Atheroscler Thromb, V10, P63; Feinberg MW, 2005, PANMINERVA MED, V47, P169; Guo LL, 2012, J CELL PHYSIOL, V227, P3185, DOI 10.1002/jcp.24005; Hashimoto S, 1999, BIOCHEM BIOPH RES CO, V258, P443, DOI 10.1006/bbrc.1999.0658; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kaplan ZS, 2011, HEMATOL-AM SOC HEMAT, P51, DOI 10.1182/asheducation-2011.1.51; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Lutz M, 2002, CELL SIGNAL, V14, P977, DOI 10.1016/S0898-6568(02)00058-X; Massague J, 2000, GENE DEV, V14, P627; Masutani H, 2005, CELL DEATH DIFFER, V12, P991, DOI 10.1038/sj.cdd.4401625; Miranda-Vizuete A, 2001, J BIOL CHEM, V276, P31567, DOI 10.1074/jbc.M101760200; Miyazono K, 2000, CYTOKINE GROWTH F R, V11, P15, DOI 10.1016/S1359-6101(99)00025-8; Moustakas A, 2001, J CELL SCI, V114, P4359; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Norata GD, 2005, CIRCULATION, V111, P2805, DOI 10.1161/CIRCULATIONAHA.104.472886; OBLONG JE, 1994, J BIOL CHEM, V269, P11714; Powis G, 2000, FREE RADICAL BIO MED, V29, P312, DOI 10.1016/S0891-5849(00)00313-0; Powis G, 2001, ANNU REV BIOPH BIOM, V30, P421, DOI 10.1146/annurev.biophys.30.1.421; ROBERTS AB, 1993, GROWTH FACTORS, V8, P1; Robertson AKL, 2003, J CLIN INVEST, V112, P1342, DOI 10.1172/JCI200318607; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sakamoto Y, 2005, ATHEROSCLEROSIS, V183, P85, DOI 10.1016/j.atherosclerosis.2005.02.032; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Watanabe R, 2010, PHARMACOL THERAPEUT, V127, P261, DOI 10.1016/j.pharmthera.2010.04.004; Watson JA, 1999, BIOCHEM J, V343, P301, DOI 10.1042/0264-6021:3430301; World CJ, 2006, J MOL MED-JMM, V84, P997, DOI 10.1007/s00109-006-0109-6; Yakmovych I, 2001, FASEB J, V15, P553; Yamawaki H, 2003, CIRC RES, V93, P1029, DOI 10.1161/01.RES.0000102869.39150.23; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang R, 2004, CIRC RES, V94, P1483, DOI 10.1161/01.RES.0000130525.37646.a7; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	45	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e76226	10.1371/journal.pone.0076226	http://dx.doi.org/10.1371/journal.pone.0076226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086714	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200133
J	Jordanovski, D; Herwartz, C; Pawlowski, A; Taute, S; Frommolt, P; Steger, G				Jordanovski, Darko; Herwartz, Christine; Pawlowski, Anna; Taute, Stefanie; Frommolt, Peter; Steger, Gertrud			The Hypoxia-Inducible Transcription Factor ZNF395 Is Controlled by I kappa B Kinase-Signaling and Activates Genes Involved in the Innate Immune Response and Cancer	PLOS ONE			English	Article							PAPILLOMAVIRUS BINDING-FACTOR; CELL-LINE; EXPRESSION; PROTEIN; PHOSPHORYLATION; ALPHA; BETA; INHIBITION; TARGET; FAMILY	Activation of the hypoxia inducible transcription factor HIF and the NF-kappa B pathway promotes inflammation-mediated tumor progression. The cellular transcription factor ZNF395 has repeatedly been found overexpressed in various human cancers, particularly in response to hypoxia, implying a functional relevance. To understand the biological activity of ZNF395, we identified target genes of ZNF395 through a genome-wide expression screen. Induced ZNF395 expression led to the upregulation of genes known to play a role in cancer as well as a subset of interferon (IFN)-stimulated genes (ISG) involved in antiviral responses such as IFIT1/ISG56, IFI44 and IFI16. In cells that lack ZNF395, the IFN-alpha-mediated stimulation of these factors was impaired, demonstrating that ZNF395 is required for the full induction of these antiviral genes. Transient transfections revealed that ZNF395-mediated activation of the IFIT1/ISG56 promoter depends on the two IFN-stimulated response elements within the promoter and on the DNA-binding domain of ZNF395, a so-called C-clamp. We also show that I kappa B alpha kinase (IKK)-signaling is necessary to allow ZNF395 to activate transcription and simultaneously enhances its proteolytic degradation. Thus, ZNF395 becomes activated at the level of protein modification by IKK. Moreover, we confirm that the expression of ZNF395 is induced by hypoxia. Our results characterize ZNF395 as a novel factor that contributes to the maximal stimulation of a subset of ISGs. This transcriptional activity depends on IKK signaling further supporting a role of ZNF395 in the innate immune response. Given these results it is possible that under hypoxic conditions, elevated levels of ZNF395 may support inflammation and cancer progression by activating the target genes involved in the innate immune response and cancer.	[Jordanovski, Darko; Herwartz, Christine; Pawlowski, Anna; Taute, Stefanie; Steger, Gertrud] Univ Cologne, Inst Virol, D-50931 Cologne, Germany; [Frommolt, Peter] CECAD Cologne, Bioinformat Core Facil, Cologne, Germany; [Frommolt, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne	Steger, G (corresponding author), Univ Cologne, Inst Virol, D-50931 Cologne, Germany.	Gertrud.Steger@uni-koeln.de	Frommolt, Peter/L-9656-2016	Frommolt, Peter/0000-0002-1966-8014	Deutsche Forschungsgemeinschaft [STE604/5-1]; Deutsche Krebshilfe; Koeln Fortune Program / Faculty of Medicine, University of Cologne, Germany [220/2010]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Koeln Fortune Program / Faculty of Medicine, University of Cologne, Germany	This work was supported by the Deutsche Forschungsgemeinschaft (grant to G. Steger, number STE604/5-1), the Deutsche Krebshilfe and the Koeln Fortune Program / Faculty of Medicine, University of Cologne, Germany, grant number 220/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atcha FA, 2007, MOL CELL BIOL, V27, P8352, DOI 10.1128/MCB.02132-06; Blazkova H, 2007, CELL CYCLE, V6, P2531, DOI 10.4161/cc.6.20.4807; Boeckle S, 2002, VIROLOGY, V293, P103, DOI 10.1006/viro.2001.1231; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Chang HM, 2004, P NATL ACAD SCI USA, V101, P9578, DOI 10.1073/pnas.0400567101; Chariot A, 2009, TRENDS CELL BIOL, V19, P404, DOI 10.1016/j.tcb.2009.05.006; Chefetz I, 2008, J INVEST DERMATOL, V128, P1423, DOI 10.1038/sj.jid.5701203; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Dalgin GS, 2007, CANCER INFORM, V3, P65; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Fardin P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-185; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Gariano GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002498; Geiger K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026465; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Hallen LC, 2007, J INTERF CYTOK RES, V27, P675, DOI 10.1089/jir.2007.0021; Hertoghs KML, 2010, J CLIN INVEST, V120, P4077, DOI 10.1172/JCI42758; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Hong SW, 2009, MOL CELLS, V27, P243, DOI 10.1007/s10059-009-0030-2; Hoverter NP, 2012, MOL CELL BIOL, V32, P3648, DOI 10.1128/MCB.06769-11; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Hufbauer M, 2010, VIROLOGY, V403, P128, DOI 10.1016/j.virol.2010.04.013; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang YD, 2003, MOL CANCER RES, V1, P453; JORDANOVSKI D, 2012, HUNTINGTONS DIS CORE; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim SS, 2010, PATHOLOGY, V42, P50, DOI 10.3109/00313020903434421; KITAMURA A, 1994, EUR J BIOCHEM, V224, P877, DOI 10.1111/j.1432-1033.1994.00877.x; KOONG AC, 1994, CANCER RES, V54, P1425; Lal A, 2001, JNCI-J NATL CANCER I, V93, P1337, DOI 10.1093/jnci/93.17.1337; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Ludlow LEA, 2005, EXP CELL RES, V308, P1, DOI 10.1016/j.yexcr.2005.03.032; Mendez O, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-133; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Muller A, 2002, J VIROL, V76, P11042, DOI 10.1128/JVI.76.21.11042-11053.2002; Murat A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005947; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PURDIE KJ, 1993, CANCER RES, V53, P5328; Rehtanz M, 2004, MOL CELL BIOL, V24, P2153, DOI 10.1128/MCB.24.5.2153-2168.2004; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rotger M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000781; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Sichtig N, 2007, ARCH BIOCHEM BIOPHYS, V467, P67, DOI 10.1016/j.abb.2007.08.015; Sichtig N, 2007, ARCH BIOCHEM BIOPHYS, V464, P90, DOI 10.1016/j.abb.2007.04.017; Skubitz KM, 2006, J LAB CLIN MED, V147, P250, DOI 10.1016/j.lab.2006.04.001; Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Tanaka K, 2004, J BIOL CHEM, V279, P7275, DOI 10.1074/jbc.M310726200; Tsuji K, 2010, CANCER GENET CYTOGEN, V198, P118, DOI 10.1016/j.cancergencyto.2010.01.004; Tsukahara T, 2004, CANCER RES, V64, P5442, DOI 10.1158/0008-5472.CAN-04-0522; Tsukahara T, 2009, CANCER SCI, V100, P47, DOI 10.1111/j.1349-7006.2008.00991.x; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Wallmen B, 2012, NUCLEIC ACIDS RES, V40, P9455, DOI 10.1093/nar/gks690; Wu JQ, 2008, VIROLOGY, V380, P124, DOI 10.1016/j.virol.2008.06.039; Xia YF, 2009, P NATL ACAD SCI USA, V106, P2629, DOI 10.1073/pnas.0812256106; Yabe H, 2008, ONCOL REP, V19, P129; Yang CK, 2006, J BIOL CHEM, V281, P3389, DOI 10.1074/jbc.M510403200	64	20	22	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74911	10.1371/journal.pone.0074911	http://dx.doi.org/10.1371/journal.pone.0074911			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086395	gold, Green Published, Green Submitted			2022-12-27	WOS:000326520200052
J	Klinger, CM; Klute, MJ; Dacks, JB				Klinger, Christen M.; Klute, Mary J.; Dacks, Joel B.			Comparative Genomic Analysis of Multi-Subunit Tethering Complexes Demonstrates an Ancient Pan-Eukaryotic Complement and Sculpting in Apicomplexa	PLOS ONE			English	Article							TOXOPLASMA-GONDII; ENDOPLASMIC-RETICULUM; SM PROTEIN; SECRETORY ORGANELLE; PARASITES INSIGHTS; MALARIA PARASITES; GARP COMPLEX; COG COMPLEX; LIFE-CYCLE; CIS-GOLGI	Apicomplexa are obligate intracellular parasites that cause tremendous disease burden world-wide. They utilize a set of specialized secretory organelles in their invasive process that require delivery of components for their biogenesis and function, yet the precise mechanisms underpinning such processes remain unclear. One set of potentially important components is the multi-subunit tethering complexes (MTCs), factors increasingly implicated in all aspects of vesicle-target interactions. Prompted by the results of previous studies indicating a loss of membrane trafficking factors in Apicomplexa, we undertook a bioinformatic analysis of MTC conservation. Building on knowledge of the ancient presence of most MTC proteins, we demonstrate the near complete retention of MTCs in the newly available genomes for Guillardia theta and Bigelowiella natans. The latter is a key taxonomic sampling point as a basal sister taxa to the group including Apicomplexa. We also demonstrate an ancient origin of the CORVET complex subunits Vps8 and Vps3, as well as the TRAPPII subunit Tca17. Having established that the lineage leading to Apicomplexa did at one point possess the complete eukaryotic complement of MTC components, we undertook a deeper taxonomic investigation in twelve apicomplexan genomes. We observed excellent conservation of the VpsC core of the HOPS and CORVET complexes, as well as the core TRAPP subunits, but sparse conservation of TRAPPII, COG, Dsl1, and HOPS/CORVET-specific subunits. However, those subunits that we did identify appear to be expressed with similar patterns to the fully conserved MTC proteins, suggesting that they may function as minimal complexes or with analogous partners. Strikingly, we failed to identify any subunits of the exocyst complex in all twelve apicomplexan genomes, as well as the dinoflagellate Perkinsus marinus. Overall, we demonstrate reduction of MTCs in Apicomplexa and their ancestors, consistent with modification during, and possibly pre-dating, the move from free-living marine algae to deadly human parasites.	[Klinger, Christen M.; Klute, Mary J.; Dacks, Joel B.] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada	University of Alberta	Dacks, JB (corresponding author), Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada.	dacks@ualberta.ca	Klinger, Christen/V-7761-2019; Dacks, Joel/AAE-3308-2021	Klinger, Christen/0000-0002-4699-4851; Dacks, Joel/0000-0003-4520-5694	Alberta Innovates Technology Futures; NSERC; Alberta Innovates Health Solutions; Women's and Children Health Research Institute	Alberta Innovates Technology Futures; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates Health Solutions; Women's and Children Health Research Institute	This work was supported by a New Faculty Award from Alberta Innovates Technology Futures and an NSERC Discovery grant. JBD is the Canada Research Chair in Evolutionary Cell Biology. CMK is supported by studentships from Alberta Innovates Health Solutions and the Women's and Children Health Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adung'a VO, 2013, TRAFFIC, V14, P440, DOI 10.1111/tra.12040; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2007, INT REV CYTOL, V262, P1, DOI 10.1016/S0074-7696(07)62001-4; Angers CG, 2011, SEMIN CELL DEV BIOL, V22, P18, DOI 10.1016/j.semcdb.2010.07.003; Aoki T, 2009, MOL BIOL CELL, V20, P2639, DOI 10.1091/mbc.E08-11-1104; Arasaki K, 2006, MOL BIOL CELL, V17, P2780, DOI 10.1091/mbc.E05-10-0973; Ayong L, 2007, MOL BIOCHEM PARASIT, V152, P113, DOI 10.1016/j.molbiopara.2006.12.007; Bachvaroff TR, 2011, J EUKARYOT MICROBIOL, V58, P223, DOI 10.1111/j.1550-7408.2011.00555.x; Balderhaar HJK, 2013, J CELL SCI, V126, P1307, DOI 10.1242/jcs.107805; Barrowman J, 2010, NAT REV MOL CELL BIO, V11, P759, DOI 10.1038/nrm2999; Bartfai R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001223; Baum J, 2008, TRENDS PARASITOL, V24, P557, DOI 10.1016/j.pt.2008.08.006; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; Bock R, 2004, PARASITOLOGY, V129, pS247, DOI 10.1017/S0031182004005190; Breinich MS, 2009, CURR BIOL, V19, P277, DOI 10.1016/j.cub.2009.01.039; Brocker C, 2010, CURR BIOL, V20, pR943, DOI 10.1016/j.cub.2010.09.015; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Cabrera M, 2010, J CELL BIOL, V191, P845, DOI 10.1083/jcb.201004092; Cai HQ, 2005, J CELL BIOL, V171, P823, DOI 10.1083/jcb.200505145; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; Cai YY, 2008, CELL, V133, P1202, DOI 10.1016/j.cell.2008.04.049; Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006; Chan GKT, 2000, NAT CELL BIOL, V2, P944, DOI 10.1038/35046598; Choi C, 2011, TRAFFIC, V12, P715, DOI 10.1111/j.1600-0854.2011.01181.x; Civril F, 2010, STRUCTURE, V18, P616, DOI 10.1016/j.str.2010.02.014; Curtis BA, 2012, NATURE, V492, P59, DOI 10.1038/nature11681; Danne JC, 2013, MOL BIOL EVOL, V30, P123, DOI 10.1093/molbev/mss205; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Daugschies A, 2005, J VET MED B, V52, P417, DOI 10.1111/j.1439-0450.2005.00894.x; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Dubey JP, 2011, VET PARASITOL, V180, P90, DOI 10.1016/j.vetpar.2011.05.031; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elias M, 2012, J CELL SCI, V125, P2500, DOI 10.1242/jcs.101378; Famulski JK, 2008, J CELL BIOL, V180, P507, DOI 10.1083/jcb.200708021; Fauquenoy S, 2008, MOL CELL PROTEOMICS, V7, P891, DOI 10.1074/mcp.M700391-MCP200; Field HI, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-141; Finger FP, 1997, MOL BIOL CELL, V8, P647, DOI 10.1091/mbc.8.4.647; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Foulquier F, 2007, HUM MOL GENET, V16, P717, DOI 10.1093/hmg/ddl476; Gabaldon T, 2010, PHILOS T R SOC B, V365, P765, DOI 10.1098/rstb.2009.0240; Gonzalez NH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025316; Gubbels MJ, 2012, INT J PARASITOL, V42, P1071, DOI 10.1016/j.ijpara.2012.09.009; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hirose H, 2004, EMBO J, V23, P1267, DOI 10.1038/sj.emboj.7600135; Hu K, 2006, PLOS PATHOG, V2, P121, DOI 10.1371/journal.ppat.0020013; Janouskovec J, 2012, CURR BIOL, V22, pR518, DOI 10.1016/j.cub.2012.04.047; Jin Y, 2011, DEV CELL, V21, P1156, DOI 10.1016/j.devcel.2011.10.009; Joiner KA, 2002, J CELL BIOL, V157, P557, DOI 10.1083/jcb.200112144; Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003; Kats LM, 2008, TRAFFIC, V9, P176, DOI 10.1111/j.1600-0854.2007.00681.x; Kissinger JC, 2003, NUCLEIC ACIDS RES, V31, P234, DOI 10.1093/nar/gkg072; Klinger CM, 2013, CURR OPIN MICROBIOL, V16, P424, DOI 10.1016/j.mib.2013.07.015; Koumandou VL, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-29; Kremer K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003213; Langsley G, 2008, MICROBES INFECT, V10, P462, DOI 10.1016/j.micinf.2008.01.017; Laufman O, 2009, EMBO J, V28, P2006, DOI 10.1038/emboj.2009.168; Lees JA, 2010, NAT STRUCT MOL BIOL, V17, P1292, DOI 10.1038/nsmb.1917; Leung KF, 2008, TRAFFIC, V9, P1698, DOI 10.1111/j.1600-0854.2008.00797.x; Liendo A, 2000, MICROBES INFECT, V2, P137, DOI 10.1016/S1286-4579(00)00274-4; Liu JL, 2012, PROTOPLASMA, V249, P587, DOI 10.1007/s00709-011-0330-1; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Meiringer CTA, 2011, J BIOL CHEM, V286, P25039, DOI 10.1074/jbc.M110.215327; Miller VJ, 2012, TRAFFIC, V13, P891, DOI 10.1111/j.1600-0854.2012.01338.x; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Morgera F, 2012, MOL BIOL CELL, V23, P337, DOI 10.1091/mbc.E11-08-0670; Morrison DA, 2009, TRENDS PARASITOL, V25, P375, DOI 10.1016/j.pt.2009.05.010; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nevin WD, 2009, PARASITOL INT, V58, P86, DOI 10.1016/j.parint.2008.12.002; Ngo HM, 2003, J BIOL CHEM, V278, P5343, DOI 10.1074/jbc.M208291200; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; O'Connor RM, 2011, AIDS, V25, P549, DOI 10.1097/QAD.0b013e3283437e88; Obornik M, 2009, INT J PARASITOL, V39, P1, DOI 10.1016/j.ijpara.2008.07.010; Obornik M, 2012, PROTIST, V163, P306, DOI 10.1016/j.protis.2011.09.001; Obornik M, 2011, PROTIST, V162, P115, DOI 10.1016/j.protis.2010.02.004; Okamoto N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034900; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Parussini F, 2010, MOL MICROBIOL, V76, P1340, DOI 10.1111/j.1365-2958.2010.07181.x; Pelletier L, 2002, NATURE, V418, P548, DOI 10.1038/nature00946; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Perez-Victoria FJ, 2008, MOL BIOL CELL, V19, P2350, DOI 10.1091/mbc.E07-11-1189; Perez-Victoria FJ, 2009, MOL CELL BIOL, V29, P5251, DOI 10.1128/MCB.00495-09; Perez-Victoria FJ, 2010, MOL BIOL CELL, V21, P3386, DOI 10.1091/mbc.E10-05-0392; Perry RJ, 2009, EUKARYOT CELL, V8, P830, DOI 10.1128/EC.00024-09; Plemel RL, 2011, MOL BIOL CELL, V22, P1353, DOI 10.1091/mbc.E10-03-0260; Ren Y, 2009, CELL, V139, P1119, DOI 10.1016/j.cell.2009.11.002; Richard D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000328; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruiz-Trillo I, 2007, TRENDS GENET, V23, P113, DOI 10.1016/j.tig.2007.01.005; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Sacher M, 2008, TRAFFIC, V9, P2032, DOI 10.1111/j.1600-0854.2008.00833.x; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; Schluter A, 2006, MOL BIOL EVOL, V23, P838, DOI 10.1093/molbev/msj103; Schmitt HD, 2010, TRENDS CELL BIOL, V20, P257, DOI 10.1016/j.tcb.2010.02.001; Shestakova A, 2007, J CELL BIOL, V179, P1179, DOI 10.1083/jcb.200705145; Sivaram MVS, 2005, BIOCHEMISTRY-US, V44, P6302, DOI 10.1021/bi048008z; Sloves PJ, 2012, CELL HOST MICROBE, V11, P515, DOI 10.1016/j.chom.2012.03.006; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Spang A, 2012, TRAFFIC, V13, P908, DOI 10.1111/j.1600-0854.2012.01362.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Striepen B, 2001, MOL BIOCHEM PARASIT, V113, P45, DOI 10.1016/S0166-6851(00)00379-0; Struck NS, 2008, MOL MICROBIOL, V67, P1320, DOI 10.1111/j.1365-2958.2008.06125.x; Templeton TJ, 2004, GENOME RES, V14, P1686, DOI 10.1101/gr.2615304; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Tripathi A, 2009, NAT STRUCT MOL BIOL, V16, P114, DOI 10.1038/nsmb.1548; Wang S, 2004, J BIOL CHEM, V279, P35958, DOI 10.1074/jbc.M313778200; Weir W, 2011, INT J PARASITOL, V41, P193, DOI 10.1016/j.ijpara.2010.08.004; White NJ, 2008, CLIN INFECT DIS, V46, P172, DOI 10.1086/524889; Williams BC, 2003, MOL BIOL CELL, V14, P1379, DOI 10.1091/mbc.E02-09-0624; Yamasaki A, 2009, MOL BIOL CELL, V20, P4205, DOI 10.1091/mbc.E09-05-0387; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007; YU S, 2012, CELL MOL LIFE SCI; ZONG M, 2012, PLOS ONE, V7, P76278, DOI DOI 10.1371/J0URNAL.P0NE.0029995.PUBMED:22279557	114	36	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76278	10.1371/journal.pone.0076278	http://dx.doi.org/10.1371/journal.pone.0076278			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086721	gold, Green Submitted, Green Published			2022-12-27	WOS:000325223900093
J	Liu, XT; Han, SZ; Wang, ZH; Gelernter, J; Yang, BZ				Liu, Xiangtao; Han, Shizhong; Wang, Zuoheng; Gelernter, Joel; Yang, Bao-Zhu			Variant Callers for Next-Generation Sequencing Data: A Comparison Study	PLOS ONE			English	Article							MAPREDUCE; FRAMEWORK; GENOTYPE; FORMAT	Next generation sequencing (NGS) has been leading the genetic study of human disease into an era of unprecedented productivity. Many bioinformatics pipelines have been developed to call variants from NGS data. The performance of these pipelines depends crucially on the variant caller used and on the calling strategies implemented. We studied the performance of four prevailing callers, SAMtools, GATK, glftools and Atlas2, using single-sample and multiple-sample variant-calling strategies. Using the same aligner, BWA, we built four single-sample and three multiple-sample calling pipelines and applied the pipelines to whole exome sequencing data taken from 20 individuals. We obtained genotypes generated by Illumina Infinium HumanExome v1.1 Beadchip for validation analysis and then used Sanger sequencing as a "gold-standard" method to resolve discrepancies for selected regions of high discordance. Finally, we compared the sensitivity of three of the single-sample calling pipelines using known simulated whole genome sequence data as a gold standard. Overall, for single-sample calling, the called variants were highly consistent across callers and the pairwise overlapping rate was about 0.9. Compared with other callers, GATK had the highest rediscovery rate (0.9969) and specificity (0.99996), and the Ti/Tv ratio out of GATK was closest to the expected value of 3.02. Multiple-sample calling increased the sensitivity. Results from the simulated data suggested that GATK outperformed SAMtools and glfSingle in sensitivity, especially for low coverage data. Further, for the selected discrepant regions evaluated by Sanger sequencing, variant genotypes called by exome sequencing versus the exome array were more accurate, although the average variant sensitivity and overall genotype consistency rate were as high as 95.87% and 99.82%, respectively. In conclusion, GATK showed several advantages over other variant callers for general purpose NGS analyses. The GATK pipelines we developed perform very well.	[Liu, Xiangtao; Han, Shizhong; Gelernter, Joel; Yang, Bao-Zhu] Yale Univ, Sch Med, Dept Psychiat, Div Human Genet, New Haven, CT 06520 USA; [Liu, Xiangtao; Han, Shizhong; Gelernter, Joel; Yang, Bao-Zhu] VA CT Hlth Care Ctr, West Haven, CT USA; [Wang, Zuoheng] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Gelernter, Joel] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Gelernter, Joel] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University	Yang, BZ (corresponding author), Yale Univ, Sch Med, Dept Psychiat, Div Human Genet, New Haven, CT 06520 USA.	bao-zhu.yang@yale.edu		Han, Shizhong/0000-0002-5114-6742; Gelernter, Joel/0000-0002-4067-1859	National Institutes of Health (NIH) [DA030976, DA12849, DA12690, DA18432, AA017535, DA028909, AA11330, MH64122]; VA MERIT award; Clinical and Translational Science Award (CTSA) [KL2 RR024138]; NIDA career development award [DA24758]; Brain and Behavior Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH064122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011330, R01AA017535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012690, R01DA030976, K01DA024758, R01DA018432, RC2DA028909, R01DA012849] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA MERIT award(US Department of Veterans Affairs); Clinical and Translational Science Award (CTSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDA career development award; Brain and Behavior Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors are grateful to the funding agencies for support in part by National Institutes of Health (NIH) grants DA030976, DA12849, DA12690, DA18432, AA017535, DA028909, AA11330, MH64122, and a VA MERIT award, the Clinical and Translational Science Award (CTSA) KL2 RR024138 (ZW), and NIDA career development award DA24758 (BZY), and Brain and Behavior Research Foundation Young Investigator Award (BZY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AB LAB, 2010, AB LAB GLF TOOLS; ABECASIS GR, 2012, EXOME CHIP DESIGN; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andrews S., 2012, FASTQC; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bao SY, 2011, J HUM GENET, V56, P406, DOI 10.1038/jhg.2011.43; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; HOMER N, 2012, DWGSIM; Ji HP, 2012, GENOME MED, V4, DOI 10.1186/gm306; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Martin ER, 2010, BIOINFORMATICS, V26, P2803, DOI 10.1093/bioinformatics/btq526; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Pattnaik S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030080; Ruffalo M, 2011, BIOINFORMATICS, V27, P2790, DOI 10.1093/bioinformatics/btr477; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WYSOKER A, 2011, ICARDTOOLS 1 5 3	23	99	107	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75619	10.1371/journal.pone.0075619	http://dx.doi.org/10.1371/journal.pone.0075619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086590	Green Submitted, Green Published, gold			2022-12-27	WOS:000325223900050
J	Matsumoto, Y; Niimi, N; Kohyama, K				Matsumoto, Yoh; Niimi, Naoko; Kohyama, Kuniko			Development of a New DNA Vaccine for Alzheimer Disease Targeting a Wide Range of A beta Species and Amyloidogenic Peptides	PLOS ONE			English	Article							IMMUNIZATION; MODEL	It has recently been determined that not only A beta oligomers, but also other A beta species and amyloidogenic peptides are neurotoxic in Alzheimer disease (AD) and play a pivotal role in AD pathogenesis. In the present study, we attempted to develop new DNA vaccines targeting a wide range of A beta species. For this purpose, we first performed in vitro assays with newly developed vaccines to evaluate A beta production and A beta secretion abilities and then chose an IgL-A beta x4-Fc-IL-4 vaccine (designated YM3711) for further studies. YM3711 was vaccinated to mice, rabbits and monkeys to evaluate anti-A beta species antibody-producing ability and A beta reduction effects. It was found that YM3711 vaccination induced significantly higher levels of antibodies not only to A beta 1-42 but also to AD-related molecules including A beta pE3-42, A beta oligomers and A beta fibrils. Importantly, YM3711 significantly reduced these A beta species in the brain of model mice. Binding and competition assays using translated YM3711 protein products clearly demonstrated that a large part of antibodies induced by YM3711 vaccination are directed at conformational epitopes of the A beta complex and oligomers. Taken together, we demonstrate that YM3711 is a powerful DNA vaccine targeting a wide range of AD-related molecules and is worth examining in preclinical and clinical trials.	[Matsumoto, Yoh; Niimi, Naoko; Kohyama, Kuniko] Tokyo Metropolitan Inst Neurosci, Dept Mol Neuropathol, Tokyo, Japan; [Matsumoto, Yoh; Niimi, Naoko; Kohyama, Kuniko] Tokyo Metropolitan Inst Neurosci, Dept Immunotherapy Dev, Tokyo, Japan	Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science	Matsumoto, Y (corresponding author), Tokyo Metropolitan Inst Neurosci, Dept Mol Neuropathol, Tokyo, Japan.	matsumoto-yo@igakuken.or.jp		Niimi, Naoko/0000-0001-9222-1596	Health and Labor Sciences Research Grants for Research on Psychiatric and Neurological Diseases and Mental Health; Japan Society for the Promotion of Science; "Welfare and Health Fund" of the Tokyo Metropolitan Government	Health and Labor Sciences Research Grants for Research on Psychiatric and Neurological Diseases and Mental Health; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); "Welfare and Health Fund" of the Tokyo Metropolitan Government	This study was supported in part by Health and Labor Sciences Research Grants for Research on Psychiatric and Neurological Diseases and Mental Health and by Grants-in-Aid from the Japan Society for the Promotion of Science. Y. M. was also supported by the "Welfare and Health Fund" of the Tokyo Metropolitan Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christensen DZ, 2010, ACTA NEUROPATHOL, V119, P555, DOI 10.1007/s00401-010-0666-1; Citron M, 2002, NAT NEUROSCI, V5, P1055, DOI 10.1038/nn940; Fonte J, 2001, J ALZHEIMERS DIS, V3, P209; Ghiso J, 2006, BRAIN PATHOL, V16, P71; Goni F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013391; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haass C, 2010, CELL, V142, P356, DOI 10.1016/j.cell.2010.07.032; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jang H, 2010, J PHYS CHEM B, V114, P9445, DOI 10.1021/jp104073k; Janus C, 2000, NEUROBIOL AGING, V21, P541, DOI 10.1016/S0197-4580(00)00107-X; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Okura Y, 2006, P NATL ACAD SCI USA, V103, P9619, DOI 10.1073/pnas.0600966103; Okura Y, 2009, HUM VACCINES, V5, P373, DOI 10.4161/hv.5.6.7815; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Rocha S, 2009, BIOCHEM BIOPH RES CO, V380, P397, DOI 10.1016/j.bbrc.2009.01.090; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Serrano-Pozo A, 2010, BRAIN, V133, P1312, DOI 10.1093/brain/awq056; St George-Hyslop PH, 2008, LANCET, V372, P180, DOI 10.1016/S0140-6736(08)61047-8; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Wirths O, 2010, J NEURAL TRANSM, V117, P85, DOI 10.1007/s00702-009-0314-x; Wisniewski T, 2010, EXPERT REV VACCINES, V9, P1441, DOI [10.1586/erv.10.131, 10.1586/ERV.10.131]; Wisniewski T, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S5	32	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75203	10.1371/journal.pone.0075203	http://dx.doi.org/10.1371/journal.pone.0075203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086465	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900036
J	Tripurani, SK; Wee, G; Lee, KB; Smith, GW; Wang, L; Yao, JB				Tripurani, Swamy K.; Wee, Gabbine; Lee, Kyung-Bon; Smith, George W.; Wang, Lei; Yao, Jianbo			MicroRNA-212 Post-Transcriptionally Regulates Oocyte-Specific Basic-Helix-Loop-Helix Transcription Factor, Factor in the Germline Alpha (FIGLA), during Bovine Early Embryogenesis	PLOS ONE			English	Article							EARLY EMBRYONIC-DEVELOPMENT; MESSENGER-RNA; GENE-EXPRESSION; MATURATION; PROFILES; BIOGENESIS; TRANSITION; MIR-212; MIR-132; ACTIN	Factor in the germline alpha (FIGLA) is an oocyte-specific basic helix-loop-helix transcription factor essential for primordial follicle formation and expression of many genes required for folliculogenesis, fertilization and early embryonic survival. Here we report the characterization of bovine FIGLA gene and its regulation during early embryogenesis. Bovine FIGLA mRNA expression is restricted to gonads and is detected in fetal ovaries harvested as early as 90 days of gestation. FIGLA mRNA and protein are abundant in germinal vesicle and metaphase II stage oocytes, as well as in embryos from pronuclear to eight-cell stage but barely detectable at morula and blastocyst stages, suggesting that FIGLA might be a maternal effect gene. Recent studies in zebrafish and mice have highlighted the importance of non-coding small RNAs (microRNAs) as key regulatory molecules targeting maternal mRNAs for degradation during embryonic development. We hypothesized that FIGLA, as a maternal transcript, is regulated by microRNAs during early embryogenesis. Computational predictions identified a potential microRNA recognition element (MRE) for miR-212 in the 3' UTR of the bovine FIGLA mRNA. Bovine miR-212 is expressed in oocytes and tends to increase in four-cell and eight-cell stage embryos followed by a decline at morula and blastocyst stages. Transient transfection and reporter assays revealed that miR-212 represses the expression of FIGLA in a MRE dependent manner. In addition, ectopic expression of miR-212 mimic in bovine early embryos dramatically reduced the expression of FIGLA protein. Collectively, our results demonstrate that FIGLA is temporally regulated during bovine early embryogenesis and miR-212 is an important negative regulator of FIGLA during the maternal to zygotic transition in bovine embryos.	[Tripurani, Swamy K.; Wang, Lei; Yao, Jianbo] W Virginia Univ, Lab Anim Biotechnol & Genom, Div Anim & Nutr Sci, Morgantown, WV 26506 USA; [Wee, Gabbine; Lee, Kyung-Bon; Smith, George W.] Michigan State Univ, Lab Mammalian Reprod Biol & Genom, E Lansing, MI 48824 USA; [Wee, Gabbine; Lee, Kyung-Bon; Smith, George W.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Smith, George W.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA	West Virginia University; Michigan State University; Michigan State University; Michigan State University	Yao, JB (corresponding author), W Virginia Univ, Lab Anim Biotechnol & Genom, Div Anim & Nutr Sci, Morgantown, WV 26506 USA.	jianbo.yao@mail.wvu.edu			National Research Initiative Competitive Grant, USDA National Institute of Food and Agriculture [2008-35203-19094]; Agriculture and Food Research Initiative, Competitive Grant, USDA National Institute of Food and Agriculture [2009-65203-05706]; West Virginia Agricultural and Forestry Experiment Station (Hatch project) [427]	National Research Initiative Competitive Grant, USDA National Institute of Food and Agriculture; Agriculture and Food Research Initiative, Competitive Grant, USDA National Institute of Food and Agriculture; West Virginia Agricultural and Forestry Experiment Station (Hatch project)	This work was supported by National Research Initiative Competitive Grant #2008-35203-19094 from the USDA National Institute of Food and Agriculture (GWS), Agriculture and Food Research Initiative, Competitive Grant #2009-65203-05706 from the USDA National Institute of Food and Agriculture (JY) and funds from the West Virginia Agricultural and Forestry Experiment Station (Hatch project No. 427). It is published with the approval of the director of the West Virginia Agricultural and Forestry Experiment Station as scientific paper No. 3188. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Andreu-Vieyra C, 2006, TRENDS ENDOCRIN MET, V17, P136, DOI 10.1016/j.tem.2006.03.010; BACHVAROVA R, 1985, DEV BIOL, V108, P325, DOI 10.1016/0012-1606(85)90036-3; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bayne RAL, 2004, MOL HUM REPROD, V10, P373, DOI 10.1093/molehr/gah056; Begemann G, 2008, ZEBRAFISH, V5, P111, DOI 10.1089/zeb.2008.0528; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bettegowda A, 2006, MOL REPROD DEV, V73, P267, DOI 10.1002/mrd.20333; Bettegowda A, 2007, FRONT BIOSCI-LANDMRK, V12, P3713, DOI 10.2741/2346; Bortvin Alex, 2004, BMC Developmental Biology, V4; Brevini TAL, 2004, MOL REPROD DEV, V69, P375, DOI 10.1002/mrd.20140; Fiedler SD, 2008, BIOL REPROD, V79, P1030, DOI 10.1095/biolreprod.108.069690; Foygel K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004109; Gibs R, 2006, BOVINE GENOMIC SEQUE, P1; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gougelet A, 2011, INT J CANCER, V129, P680, DOI 10.1002/ijc.25715; Hu W, 2010, MOL CELL BIOL, V30, P3661, DOI 10.1128/MCB.00201-10; Huntriss J, 2002, MOL HUM REPROD, V8, P1087, DOI 10.1093/molehr/8.12.1087; Joshi S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-67; Kanamori A, 2000, MOL REPROD DEV, V55, P31, DOI 10.1002/(SICI)1098-2795(200001)55:1&lt;31::AID-MRD5&gt;3.0.CO;2-7; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Liang LF, 1997, DEVELOPMENT, V124, P4939; Lingenfelter BM, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-40; Lund E, 2009, RNA, V15, P2351, DOI 10.1261/rna.1882009; Onichtchouk D, 2003, DEV DYNAM, V228, P393, DOI 10.1002/dvdy.10392; PAYNTON BV, 1988, DEV BIOL, V129, P304, DOI 10.1016/0012-1606(88)90377-6; Pennetier S, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-26; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Roberts RM, 2009, SCIENCE, V324, P468, DOI 10.1126/science.1168521; Rusinov V, 2005, NUCLEIC ACIDS RES, V33, pW696, DOI 10.1093/nar/gki364; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Spruce T, 2010, DEV CELL, V19, P207, DOI 10.1016/j.devcel.2010.07.014; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Tejomurtula J, 2009, BIOL REPROD, V81, P333, DOI 10.1095/biolreprod.109.077396; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; Tripurani SK, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-25; Tripurani SK, 2011, ENDOCRINOLOGY, V152, P1013, DOI 10.1210/en.2010-1134; Tripurani SK, 2010, ANIM REPROD SCI, V120, P16, DOI 10.1016/j.anireprosci.2010.03.001; Ucar A, 2010, NAT GENET, V42, P1101, DOI 10.1038/ng.709; Villalba A, 2011, CURR OPIN GENET DEV, V21, P452, DOI 10.1016/j.gde.2011.04.006; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wada R, 2010, INT J CANCER, V127, P1106, DOI 10.1002/ijc.25126; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Wang WX, 2011, ACTA NEUROPATHOL, V121, P193, DOI 10.1007/s00401-010-0756-0; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; Yurttas P, 2008, DEVELOPMENT, V135, P2627, DOI 10.1242/dev.016329; Zhao H, 2008, AM J HUM GENET, V82, P1342, DOI 10.1016/j.ajhg.2008.04.018	60	24	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76114	10.1371/journal.pone.0076114	http://dx.doi.org/10.1371/journal.pone.0076114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086699	Green Submitted, Green Published, gold			2022-12-27	WOS:000325223900083
J	Zago, M; Sheridan, JA; Nair, P; de Souza, AR; Gallouzi, IE; Rousseau, S; Di Marco, S; Hamid, Q; Eidelman, DH; Baglole, CJ				Zago, Michela; Sheridan, Jared A.; Nair, Parameswaran; de Souza, Angela Rico; Gallouzi, Imed-Eddine; Rousseau, Simon; Di Marco, Sergio; Hamid, Qutayba; Eidelman, David H.; Baglole, Carolyn J.			Aryl Hydrocarbon Receptor-Dependent Retention of Nuclear HuR Suppresses Cigarette Smoke-Induced Cyclooxygenase-2 Expression Independent of DNA-Binding	PLOS ONE			English	Article							CONTAINING MESSENGER-RNAS; HUMAN LUNG FIBROBLASTS; AH DIOXIN RECEPTOR; GENE-EXPRESSION; PROTEIN HUR; 3'-UNTRANSLATED REGION; PROSTAGLANDIN E-2; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; POSTTRANSCRIPTIONAL REGULATION; MEDIATED TRANSCRIPTION	The aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor that responds to man-made environmental toxicants, has emerged as an endogenous regulator of cyclooxygenase-2 (Cox-2) by a mechanism that is poorly understood. In this study, we first used AhR-deficient (AhR(-/-)) primary pulmonary cells, together with pharmacological tools to inhibit new RNA synthesis, to show that the AhR is a prominent factor in the destabilization of Cox-2 mRNA. The destabilization of Cox-2 mRNA and subsequent suppression of cigarette smoke-induced COX-2 protein expression by the AhR was independent of its ability to bind the dioxin response element (DRE), thereby differentiating the DRE-driven toxicological AhR pathway from its anti-inflammatory abilities. We further describe that the AhR destabilizes Cox-2 mRNA by sequestering HuR within the nucleus. The role of HuR in AhR stabilization of Cox-2 mRNA was confirmed by knockdown of HuR, which resulted in rapid Cox-2 mRNA degradation. Finally, in the lungs of AhR(-/-) mice exposed to cigarette smoke, there was little Cox-2 mRNA despite robust COX-2 protein expression, a finding that correlates with almost exclusive cytoplasmic HuR within the lungs of AhR(-/-) mice. Therefore, we propose that the AhR plays an important role in suppressing the expression of inflammatory proteins, a function that extends beyond the ability of the AhR to respond to man-made toxicants. These findings open the possibility that a DRE-independent AhR pathway may be exploited therapeutically as an anti-inflammatory target.	[Zago, Michela; Sheridan, Jared A.; Rousseau, Simon; Hamid, Qutayba; Eidelman, David H.; Baglole, Carolyn J.] McGill Univ, Dept Med, Montreal, PQ, Canada; [de Souza, Angela Rico; Rousseau, Simon; Hamid, Qutayba; Eidelman, David H.; Baglole, Carolyn J.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Gallouzi, Imed-Eddine; Di Marco, Sergio] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Gallouzi, Imed-Eddine; Di Marco, Sergio] McGill Univ, Goodman Canc Ctr, Montreal, PQ, Canada; [Nair, Parameswaran] McMaster Univ, Dept Med, Hamilton, ON, Canada	McGill University; McGill University; McGill University; McGill University; McMaster University	Baglole, CJ (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	Carolyn.baglole@McGill.ca		Di Marco, Sergio/0000-0002-4039-0600; Rousseau, Simon/0000-0002-8773-575X	American Thoracic Society; Department of Medicine of McGill University; Research Institute of the McGill University Health Centre; Canada Foundation for Innovation-Leaders Opportunities Fund; Natural Sciences and Engineering Research Council of Canada; Fonds de recherche du Quebec-Sante (FRQ-S); Meakins-Christie Post-Doctoral Fellowship Award; Canada Research Chair in Airway Inflammometry	American Thoracic Society; Department of Medicine of McGill University; Research Institute of the McGill University Health Centre; Canada Foundation for Innovation-Leaders Opportunities Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de recherche du Quebec-Sante (FRQ-S); Meakins-Christie Post-Doctoral Fellowship Award; Canada Research Chair in Airway Inflammometry(Canada Research Chairs)	This work was supported by the American Thoracic Society Research Grant; the Department of Medicine of McGill University; the Research Institute of the McGill University Health Centre; the Canada Foundation for Innovation-Leaders Opportunities Fund and the Natural Sciences and Engineering Research Council of Canada. CJB was supported by a salary award from the Fonds de recherche du Quebec-Sante (FRQ-S). MZ is the recipient of a Meakins-Christie Post-Doctoral Fellowship Award. Dr Nair is supported by a Canada Research Chair in Airway Inflammometry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2009, EMBO J, V28, P1271, DOI 10.1038/emboj.2009.67; Anderson P, 2004, J LEUKOCYTE BIOL, V76, P42, DOI 10.1189/jlb.1103536; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; APPLEBY SB, 1994, BIOCHEM J, V302, P723, DOI 10.1042/bj3020723; Atasoy U, 1998, J CELL SCI, V111, P3145; Baglole CJ, 2008, J BIOL CHEM, V283, P28944, DOI 10.1074/jbc.M800685200; Baglole CJ, 2008, AM J PHYSIOL-LUNG C, V295, pL624, DOI 10.1152/ajplung.90215.2008; Baglole CJ, 2006, AM J PHYSIOL-LUNG C, V291, pL19, DOI 10.1152/ajplung.00306.2005; Baglole CJ, 2005, METH MOLEC MED, V117, P115; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Beauchamp P, 2010, CELL DEATH DIFFER, V17, P1588, DOI 10.1038/cdd.2010.34; Blaxall BC, 2000, MOL CARCINOGEN, V28, P76; Bonelli MA, 2004, EXP GERONTOL, V39, P423, DOI 10.1016/j.exger.2003.12.004; Bunger MK, 2008, TOXICOL SCI, V106, P83, DOI 10.1093/toxsci/kfn149; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Cha HJ, 2011, HEPATO-GASTROENTEROL, V58, P790; Chang XQ, 2007, MOL CELL BIOL, V27, P6127, DOI 10.1128/MCB.00323-07; Chen Y, 2008, RESPIROLOGY, V13, P1014, DOI 10.1111/j.1440-1843.2008.01365.x; Cheng YH, 2012, TOXICOL APPL PHARM, V259, P293, DOI 10.1016/j.taap.2012.01.005; Cho YC, 2004, TOXICOL APPL PHARM, V199, P220, DOI 10.1016/j.taap.2003.12.025; CHRISTOU M, 1995, MOL CELL ENDOCRINOL, V115, P41, DOI 10.1016/0303-7207(95)03668-W; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Clark A, 2000, ARTHRITIS RES, V2, P172, DOI 10.1186/ar83; Cok SJ, 2003, J BIOL CHEM, V278, P36157, DOI 10.1074/jbc.M302547200; de Souza AR, 2011, J BIOL CHEM, V286, P43214, DOI 10.1074/jbc.M111.258764; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Dixon DA, 2000, J BIOL CHEM, V275, P11750, DOI 10.1074/jbc.275.16.11750; Dong B, 2010, BIOCHEM PHARMACOL, V79, P487, DOI 10.1016/j.bcp.2009.08.031; Eltom SE, 1998, CARCINOGENESIS, V19, P1437, DOI 10.1093/carcin/19.8.1437; EMA M, 1994, J BIOCHEM-TOKYO, V116, P845, DOI 10.1093/oxfordjournals.jbchem.a124605; Fan JS, 2011, J IMMUNOL, V186, P2482, DOI 10.4049/jimmunol.0903634; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; FernandezSalguero PM, 1997, VET PATHOL, V34, P605, DOI 10.1177/030098589703400609; Furness SGB, 2007, FEBS LETT, V581, P3616, DOI 10.1016/j.febslet.2007.04.011; Gasiewicz TA, 1996, BIOCHEM PHARMACOL, V52, P1787, DOI 10.1016/S0006-2952(96)00600-4; Guyot E, 2012, DRUG DISCOV TODAY; HAYASHI S, 1994, CARCINOGENESIS, V15, P801, DOI 10.1093/carcin/15.5.801; Hel Z, 1998, NUCLEIC ACIDS RES, V26, P2803, DOI 10.1093/nar/26.11.2803; Henry EC, 2006, ARCH BIOCHEM BIOPHYS, V450, P67, DOI 10.1016/j.abb.2006.02.008; Henry EC, 1999, MOL PHARMACOL, V55, P716; Henry EC, 2010, TOXICOL SCI, V114, P90, DOI 10.1093/toxsci/kfp285; Hestermann EV, 2003, MOL CELL BIOL, V23, P7920, DOI 10.1128/MCB.23.21.7920-7925.2003; HYMAN RW, 1970, J MOL BIOL, V50, P421, DOI 10.1016/0022-2836(70)90202-0; Ikuta T, 2004, J BIOL CHEM, V279, P19209, DOI 10.1074/jbc.M310492200; Jeyaraj SC, 2006, AM J PHYSIOL-RENAL, V291, pF1255, DOI 10.1152/ajprenal.00440.2005; Kim SH, 2006, MOL PHARMACOL, V69, P1871, DOI 10.1124/mol.105.021832; LANDERS JP, 1991, BIOCHEM J, V276, P273, DOI 10.1042/bj2760273; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lin WN, 2011, BRIT J PHARMACOL, V163, P1691, DOI 10.1111/j.1476-5381.2011.01312.x; LOFROTH G, 1988, TOXICOL LETT, V42, P131, DOI 10.1016/0378-4274(88)90070-7; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Marlowe JL, 2008, MOL BIOL CELL, V19, P3263, DOI 10.1091/mbc.E08-04-0359; Martey CA, 2004, AM J PHYSIOL-LUNG C, V287, pL981, DOI 10.1152/ajplung.00239.2003; Meisner NC, 2010, ADV EXP MED BIOL, V700, P106, DOI 10.1007/978-1-4419-7823-3_10; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Montuschi P, 2003, THORAX, V58, P585, DOI 10.1136/thorax.58.7.585; Mukhopadhyay D, 2003, MOL CELL, V11, P113, DOI 10.1016/S1097-2765(03)00012-1; Murray IA, 2011, MOL PHARMACOL, V79, P508, DOI 10.1124/mol.110.069369; Murray IA, 2010, CHEM RES TOXICOL, V23, P955, DOI 10.1021/tx100045h; Natarajan G, 2008, AM J PHYSIOL-GASTR L, V294, pG1235, DOI 10.1152/ajpgi.00037.2008; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nowotarski SL, 2010, J BIOL CHEM, V285, P31885, DOI 10.1074/jbc.M110.148767; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Okey Allan B, 2005, Toxicol Appl Pharmacol, V207, P43, DOI 10.1016/j.taap.2004.12.028; Patel RD, 2009, LAB INVEST, V89, P695, DOI 10.1038/labinvest.2009.24; POLAND A, 1976, J BIOL CHEM, V251, P4936; Puga A, 1997, BIOCHEM PHARMACOL, V54, P1287, DOI 10.1016/S0006-2952(97)00417-6; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; Racky J, 2004, ARCH BIOCHEM BIOPHYS, V421, P91, DOI 10.1016/j.abb.2003.10.005; Roemer E, 2004, TOXICOLOGY, V195, P31, DOI 10.1016/j.tox.2003.08.006; Rowlands JC, 1997, CRIT REV TOXICOL, V27, P109, DOI 10.3109/10408449709021615; Rustemeier K, 2002, FOOD CHEM TOXICOL, V40, P93, DOI 10.1016/S0278-6915(01)00085-0; Safe S, 1999, Expert Opin Investig Drugs, V8, P1385, DOI 10.1517/13543784.8.9.1385; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Sengupta S, 2003, J BIOL CHEM, V278, P25227, DOI 10.1074/jbc.M301813200; Sgantzis N, 2011, DEV BIOL, V354, P267, DOI 10.1016/j.ydbio.2011.04.003; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Song JS, 2002, P NATL ACAD SCI USA, V99, P14694, DOI 10.1073/pnas.232562899; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; Thatcher TH, 2007, AM J PATHOL, V170, P855, DOI 10.2353/ajpath.2007.060391; van der Giessen K, 2007, MOL BIOL CELL, V18, P2619, DOI 10.1091/mbc.E07-02-0167; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vogel CFA, 2007, MOL ENDOCRINOL, V21, P2941, DOI 10.1210/me.2007-0211; von Roretz C, 2011, WIRES RNA, V2, P336, DOI 10.1002/wrna.55; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Zhao B, 2010, TOXICOL SCI, V117, P393, DOI 10.1093/toxsci/kfq217	89	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74953	10.1371/journal.pone.0074953	http://dx.doi.org/10.1371/journal.pone.0074953			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086407	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900033
J	Geiler-Samerotte, KA; Hashimoto, T; Dion, MF; Budnik, BA; Airoldi, EM; Drummond, DA				Geiler-Samerotte, Kerry A.; Hashimoto, Tatsunori; Dion, Michael F.; Budnik, Bogdan A.; Airoldi, Edoardo M.; Drummond, D. Allan			Quantifying Condition-Dependent Intracellular Protein Levels Enables High-Precision Fitness Estimates	PLOS ONE			English	Article							GROWTH-RATE; CELL-CYCLE; YEAST; MASS; SELECTION	Countless studies monitor the growth rate of microbial populations as a measure of fitness. However, an enormous gap separates growth-rate differences measurable in the laboratory from those that natural selection can distinguish efficiently. Taking advantage of the recent discovery that transcript and protein levels in budding yeast closely track growth rate, we explore the possibility that growth rate can be more sensitively inferred by monitoring the proteomic response to growth, rather than growth itself. We find a set of proteins whose levels, in aggregate, enable prediction of growth rate to a higher precision than direct measurements. However, we find little overlap between these proteins and those that closely track growth rate in other studies. These results suggest that, in yeast, the pathways that set the pace of cell division can differ depending on the growth-altering stimulus. Still, with proper validation, protein measurements can provide high-precision growth estimates that allow extension of phenotypic growth-based assays closer to the limits of evolutionary selection.	[Drummond, D. Allan] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Geiler-Samerotte, Kerry A.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Hashimoto, Tatsunori; Airoldi, Edoardo M.] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; [Dion, Michael F.; Budnik, Bogdan A.; Airoldi, Edoardo M.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Airoldi, Edoardo M.] Broad Inst Harvard & MIT, Cambridge, MA USA	University of Chicago; New York University; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Geiler-Samerotte, KA (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	kas25@nyu.edu	Budnik, Bogdan/AGG-8824-2022; Drummond, D. Allan/A-1250-2015; Budnik, Bogdan/AAH-9987-2019	Budnik, Bogdan/0000-0003-3622-2003; Drummond, D. Allan/0000-0001-7018-7059; Airoldi, Edoardo/0000-0002-3512-0542; Dion, Michael/0000-0002-0434-4236	National Institutes of Health [1R01GM088344-01, P50GM068763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096193, P50GM068763, R01GM088344] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants 1R01GM088344-01 and P50GM068763. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi EM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000257; Akashi H, 2012, GENETICS, V192, P15, DOI 10.1534/genetics.112.140178; Aparicio F, 2005, PLANT PHYSIOL, V138, P529, DOI 10.1104/pp.104.058958; Blomberg A, 2011, CURR OPIN BIOTECH, V22, P94, DOI 10.1016/j.copbio.2010.10.013; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Bryan AK, 2010, P NATL ACAD SCI USA, V107, P999, DOI 10.1073/pnas.0901851107; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Geiler-Samerotte KA, 2011, P NATL ACAD SCI USA, V108, P680, DOI 10.1073/pnas.1017570108; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Godin M, 2010, NAT METHODS, V7, P387, DOI [10.1038/nmeth.1452, 10.1038/NMETH.1452]; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Lee MV, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.48; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Picotti P, 2010, NAT METHODS, V7, P43, DOI [10.1038/NMETH.1408, 10.1038/nmeth.1408]; Slavov N, 2011, MOL BIOL CELL, V22, P1997, DOI 10.1091/mbc.E11-02-0132; Sugio A, 2009, PLANT CELL, V21, P642, DOI 10.1105/tpc.108.062596	21	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75320	10.1371/journal.pone.0075320	http://dx.doi.org/10.1371/journal.pone.0075320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086506	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700074
J	Polidarova, L; Sladek, M; Novakova, M; Parkanova, D; Sumova, A				Polidarova, Lenka; Sladek, Martin; Novakova, Marta; Parkanova, Daniela; Sumova, Alena			Increased Sensitivity of the Circadian System to Temporal Changes in the Feeding Regime of Spontaneously Hypertensive Rats - A Potential Role for Bmal2 in the Liver	PLOS ONE			English	Article							FOOD-ANTICIPATORY ACTIVITY; TRANSCRIPTION FACTOR; INSULIN-RESISTANCE; GENE-EXPRESSION; DAILY RHYTHMS; PPAR-GAMMA; CLOCK; IDENTIFICATION; ENTRAINMENT; MECHANISM	The mammalian timekeeping system generates circadian oscillations that rhythmically drive various functions in the body, including metabolic processes. In the liver, circadian clocks may respond both to actual feeding conditions and to the metabolic state. The temporal restriction of food availability to improper times of day (restricted feeding, RF) leads to the development of food anticipatory activity (FAA) and resets the hepatic clock accordingly. The aim of this study was to assess this response in a rat strain exhibiting complex pathophysiological symptoms involving spontaneous hypertension, an abnormal metabolic state and changes in the circadian system, i.e., in spontaneously hypertensive rats (SHR). The results revealed that SHR were more sensitive to RF compared with control rats, developing earlier and more pronounced FAA. Whereas in control rats, the RF only redistributed the activity profiles into two bouts (one corresponding to FAA and the other corresponding to the dark phase), in SHR the RF completely phase-advanced the locomotor activity according to the time of food presentation. The higher behavioral sensitivity to RF was correlated with larger phase advances of the hepatic clock in response to RF in SHR. Moreover, in contrast to the controls, RF did not suppress the amplitude of the hepatic clock oscillation in SHR. In the colon, no significant differences in response to RF between the two rat strains were detected. The results suggested the possible involvement of the Bmal2 gene in the higher sensitivity of the hepatic clock to RF in SHR because, in contrast to the Wistar rats, the rhythm of Bmal2 expression was advanced similarly to that of Bmal1 under RF. Altogether, the data demonstrate a higher behavioral and circadian responsiveness to RF in the rat strain with a cardiovascular and metabolic pathology and suggest a likely functional role for the Bmal2 gene within the circadian clock.	[Polidarova, Lenka; Sladek, Martin; Novakova, Marta; Parkanova, Daniela; Sumova, Alena] Acad Sci Czech Republ, Inst Physiol, Dept Neurohumoral Regulat, Vvi, Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Sumova, A (corresponding author), Acad Sci Czech Republ, Inst Physiol, Dept Neurohumoral Regulat, Vvi, Prague, Czech Republic.	sumova@biomed.cas.cz	Sumova, Alena/C-3390-2012; Polidarova, Lenka/K-3550-2017; Sládek, Martin/C-3383-2012	Sumova, Alena/0000-0003-4126-5470; Polidarova, Lenka/0000-0001-9087-6388; Sládek, Martin/0000-0002-9744-9386	Czech Science Foundation [P303110668];  [RVO:67985823]	Czech Science Foundation(Grant Agency of the Czech Republic); 	The study was supported by the Czech Science Foundation, grant No. P303110668, and by Research Project RVO:67985823. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Alessi MC, 2006, ARTERIOSCL THROM VAS, V26, P2200, DOI 10.1161/01.ATV.0000242905.41404.68; BOLLES RC, 1962, J COMP PHYSIOL PSYCH, V55, P760, DOI 10.1037/h0046716; Bozek K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004882; Carneiro BTS, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00083; Challet E, 1997, J BIOL RHYTHM, V12, P65, DOI 10.1177/074873049701200108; COLEMAN GJ, 1982, PHYSIOL BEHAV, V29, P107, DOI 10.1016/0031-9384(82)90373-0; Cui H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017339; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dardente H, 2007, BIOCHEM J, V402, P525, DOI 10.1042/BJ20060827; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Djordjevic J, 2007, GEN COMP ENDOCR, V153, P217, DOI 10.1016/j.ygcen.2007.02.004; Dolinsky VW, 2010, HYPERTENSION, V56, P412, DOI 10.1161/HYPERTENSIONAHA.110.154732; DRUCKERCOLIN R, 1984, BRAIN RES, V311, P353, DOI 10.1016/0006-8993(84)90099-4; Escobar C, 1998, AM J PHYSIOL-REG I, V274, pR1309, DOI 10.1152/ajpregu.1998.274.5.R1309; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gachon F, 2011, P NATL ACAD SCI USA, V108, P4794, DOI 10.1073/pnas.1002862108; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; HONMA KI, 1983, PHYSIOL BEHAV, V30, P905, DOI 10.1016/0031-9384(83)90256-1; Hoogerwerf WA, 2007, GASTROENTEROLOGY, V133, P1250, DOI 10.1053/j.gastro.2007.07.009; Hung MS, 2006, HUM MOL GENET, V15, P2732, DOI 10.1093/hmg/ddl209; Ikeda M, 2000, BIOCHEM BIOPH RES CO, V275, P493, DOI 10.1006/bbrc.2000.3248; Imaki T, 1998, J NEUROENDOCRINOL, V10, P635, DOI 10.1046/j.1365-2826.1998.00249.x; Kawai M, 2010, NAT REV ENDOCRINOL, V6, P629, DOI 10.1038/nrendo.2010.155; Kawai M, 2010, P NATL ACAD SCI USA, V107, P10508, DOI 10.1073/pnas.1000788107; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Lee HM, 2011, P NATL ACAD SCI USA, V108, P16451, DOI 10.1073/pnas.1107178108; Lee YH, 2013, EXP PHYSIOL, V98, P1145, DOI 10.1113/expphysiol.2013.072298; Li ZF, 2010, PEPTIDES, V31, P297, DOI 10.1016/j.peptides.2009.11.018; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Maemura K, 2000, J BIOL CHEM, V275, P36847, DOI 10.1074/jbc.C000629200; Masri S, 2012, ANN NY ACAD SCI, V1264, P103, DOI 10.1111/j.1749-6632.2012.06649.x; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; MISTLBERGER RE, 1995, BEHAV NEUROSCI, V109, P790, DOI 10.1037/0735-7044.109.4.790; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; Murakami Y, 2008, GASTROENTEROLOGY, V135, P1636, DOI 10.1053/j.gastro.2008.07.073; NAGAI K, 1978, BRAIN RES, V142, P384, DOI 10.1016/0006-8993(78)90648-0; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Ohno T, 2007, NUCLEIC ACIDS RES, V35, P648, DOI 10.1093/nar/gkl868; Pendergast JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004860; Pravenec M, 2008, HYPERTENSION, V51, P148, DOI 10.1161/HYPERTENSIONAHA.107.100743; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Sasaki M, 2009, J BIOL CHEM, V284, P25149, DOI 10.1074/jbc.M109.040758; Schmutz I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021325; Schoenhard JA, 2002, AM J PHYSIOL-CELL PH, V283, pC103, DOI 10.1152/ajpcell.00541.2001; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shi SQ, 2013, CURR BIOL, V23, P372, DOI 10.1016/j.cub.2013.01.048; Shi SQ, 2010, CURR BIOL, V20, P316, DOI 10.1016/j.cub.2009.12.034; Silver R, 2010, SLEEP BIOL RHYTHMS, V8, P120, DOI 10.1111/j.1479-8425.2010.00438.x; Sladek M, 2004, P NATL ACAD SCI USA, V101, P6231, DOI 10.1073/pnas.0401149101; Sladek M, 2007, GASTROENTEROLOGY, V133, P1240, DOI 10.1053/j.gastro.2007.05.053; Sladek M, 2007, AM J PHYSIOL-REG I, V292, pR1224, DOI 10.1152/ajpregu.00184.2006; Sladek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046951; STEPHAN FK, 1989, J BIOL RHYTHM, V4, P467, DOI 10.1177/074873048900400406; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P346, DOI 10.1016/S0163-1047(79)90415-1; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Svoboda DS, 2012, J PROTEOMICS, V75, P1752, DOI 10.1016/j.jprot.2011.12.011; SWISLOCKI A, 1993, AM J MED SCI, V306, P282, DOI 10.1097/00000441-199311000-00002; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takasu NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048892; Tong X, 2010, J BIOL CHEM, V285, P36401, DOI 10.1074/jbc.M110.172866; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104	72	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75690	10.1371/journal.pone.0075690	http://dx.doi.org/10.1371/journal.pone.0075690			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086613	Green Submitted, Green Published, gold			2022-12-27	WOS:000325218700109
J	Salmeron, C; de la Serrana, DG; Jimenez-Amilburu, V; Fontanillas, R; Navarro, I; Johnston, IA; Gutierrez, J; Capilla, E				Salmeron, Cristina; de la Serrana, Daniel Garcia; Jimenez-Amilburu, Vanesa; Fontanillas, Ramon; Navarro, Isabel; Johnston, Ian A.; Gutierrez, Joaquim; Capilla, Encarnacion			Characterisation and Expression of Calpain Family Members in Relation to Nutritional Status, Diet Composition and Flesh Texture in Gilthead Sea Bream (Sparus aurata)	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; BASS DICENTRARCHUS-LABRAX; MUSCLE-SPECIFIC CALPAIN; SKELETAL-MUSCLE; ATLANTIC SALMON; GROWTH DYNAMICS; MU-CALPAIN; TENDERNESS; FISH; QUALITY	Calpains are non-lysosomal calcium-activated neutral proteases involved in a wide range of cellular processes including muscle proteolysis linked to post-mortem flesh softening. The aims of this study were (a) to characterise several members of the calpain system in gilthead sea bream and (b) to examine their expression in relation to nutritional status and muscle tenderisation. We identified the complete open reading frame of gilthead sea bream calpains1-3, sacapn1, sacapn2, sacapn3, and two paralogs of the calpain small subunit1, sacapns1a and sacapns1b. Proteins showed 63-90% sequence identity compared with sequences from mammals and other teleost fishes, and the characteristic domain structure of vertebrate calpains. Transcripts of sacapn1, sacapn2, sacapns1a and sacapns1b had a wide tissue distribution, whereas sacapn3 was almost exclusively detected in skeletal muscle. Next, we assessed transcript expression in skeletal muscle following alteration of nutritional status by (a) fasting and re-feeding or (b) feeding four experimental diets with different carbohydrate-to-protein ratios. Fasting significantly reduced plasma glucose and increased free fatty acids and triglycerides, together with a significant increase in sacapns1b expression. Following 7 days of re-feeding, plasma parameters returned to fed values and sacapn1, sacapn2, sacapns1a and sacapns1b expression was significantly reduced. Furthermore, an increase in dietary carbohydrate content (11 to 39%) diminished growth but increased muscle texture, which showed a significant correlation with decreased sacapn1 and sacapns1a expression, whilst the other calpains remained unaffected. This study has demonstrated that calpain expression is modulated by nutritional status and diet composition in gilthead sea bream, and that the expression of several calpain members is correlated with muscle texture, indicating their potential use as molecular markers for flesh quality in aquaculture production.	[Salmeron, Cristina; Jimenez-Amilburu, Vanesa; Navarro, Isabel; Gutierrez, Joaquim; Capilla, Encarnacion] Univ Barcelona, Fac Biol, Dept Physiol & Immunol, Barcelona, Spain; [de la Serrana, Daniel Garcia; Johnston, Ian A.] Univ St Andrews, Scottish Oceans Inst, Sch Biol, St Andrews, Fife, Scotland; [Fontanillas, Ramon] Skretting Aquaculture Res Ctr, Stavanger, Norway	University of Barcelona; University of St Andrews	Capilla, E (corresponding author), Univ Barcelona, Fac Biol, Dept Physiol & Immunol, Barcelona, Spain.	ecapilla@ub.edu	Navarro, Isabel/L-9318-2014; Johnston, Ian A/D-6592-2013; Gutierrez, Joaquim/H-2836-2015; Johnston, Ian A./AAE-2044-2019; Salmeron, Cristina/CAG-8357-2022; Garcia de la serrana, Daniel/R-9956-2018; Fontanillas, Ramon/AAR-6368-2021; Capilla, Encarnación/L-6143-2014	Navarro, Isabel/0000-0002-2641-0361; Johnston, Ian A/0000-0002-7796-5754; Gutierrez, Joaquim/0000-0002-3126-2236; Garcia de la serrana, Daniel/0000-0001-6630-3379; Fontanillas, Ramon/0000-0002-1572-8171; Capilla, Encarnación/0000-0002-0863-9728; Sanyal, Subhabrata/0000-0003-2590-2732; Salmeron, Cristina/0000-0003-2259-3807	MICINN [AGL2009-12427, AGL2010-17324]; Catalonian Government [2009SGR-00402]; Xarxa de Referencia d'R+D+I en Aquicultura; European Union [FP7-222719]	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Catalonian Government; Xarxa de Referencia d'R+D+I en Aquicultura; European Union(European Commission)	EC is a Ramon y Cajal researcher fellow from the "Ministerio de Ciencia e Innovaci" (MICINN). This work was supported by funds from the MICINN (AGL2009-12427 and AGL2010-17324), the Catalonian Government (2009SGR-00402) and the "Xarxa de Referencia d'R+D+I en Aquicultura" and the European Union through the project LIFECYCLE (FP7-222719). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami-Durante H, 2010, AQUACULTURE, V303, P50, DOI 10.1016/j.aquaculture.2010.03.012; APROMAR, 2012, LA ACUICULTURA MARIN; Beckmann JS, 2008, NEUROMUSCULAR DISORD, V18, P913, DOI 10.1016/j.nmd.2008.08.005; Bonnal C, 2001, MAR BIOTECHNOL, V3, P172, DOI 10.1007/s101260000059; Casas E, 2006, J ANIM SCI, V84, P520, DOI 10.2527/2006.843520x; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Cleveland BM, 2012, AQUACULTURE, V338, P228, DOI 10.1016/j.aquaculture.2012.01.032; de la Serrana DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051884; de la Serrana DG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-181; de Morree A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011940; Dutt P, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-3; EMORI Y, 1986, J BIOL CHEM, V261, P9472; Enes P, 2011, REV FISH SCI, V19, P201, DOI 10.1080/10641262.2011.579363; FAUCONNEAU B, 1993, SCI ALIMENT, V13, P173; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Geesink GH, 2006, J ANIM SCI, V84, P2834, DOI 10.2527/jas.2006-122; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Grigorakis K, 2003, AQUACULTURE, V225, P109, DOI 10.1016/S0044-8486(03)00283-7; Hunter R, 1987, THE MEASUREMENT OF A; Hurling R, 1996, J TEXTURE STUD, V27, P679, DOI 10.1111/j.1745-4603.1996.tb01001.x; Ibarz A, 2011, J COMP PHYSIOL B, V181, P209, DOI 10.1007/s00360-010-0516-4; Ilian MA, 2001, J AGR FOOD CHEM, V49, P1990, DOI 10.1021/jf0010026; Ilian MA, 2001, J ANIM SCI, V79, P122; Jekely G, 1999, J MOL EVOL, V49, P272, DOI 10.1007/PL00006549; JOHNSTON IA, 1980, J COMP PHYSIOL, V135, P147, DOI 10.1007/BF00691204; Johnston IA, 1998, J EXP BIOL, V201, P623; Johnston IA, 2004, AQUACULTURE, V237, P281, DOI 10.1016/j.aquaculture.2004.04.026; Johnston IA, 2002, AQUACULTURE, V210, P259, DOI 10.1016/S0044-8486(01)00862-6; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kemp CM, 2010, MEAT SCI, V84, P248, DOI 10.1016/j.meatsci.2009.06.008; KIESSLING A, 1991, AQUACULTURE, V93, P335, DOI 10.1016/0044-8486(91)90225-V; KOOHMARAIE M, 1987, MEAT SCI, V19, P187, DOI 10.1016/0309-1740(87)90056-8; Lepage SE, 2008, DEV DYNAM, V237, P819, DOI 10.1002/dvdy.21459; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Albors O, 2008, AQUACULTURE, V277, P39, DOI 10.1016/j.aquaculture.2008.02.015; Macqueen DJ, 2010, MOL BIOL EVOL, V27, P1886, DOI 10.1093/molbev/msq071; Macqueen DJ, 2010, GENE, V453, P45, DOI 10.1016/j.gene.2010.01.002; Martin CI, 2005, J EXP BIOL, V208, P2083, DOI 10.1242/jeb.01605; Martin SAM, 2002, PFLUG ARCH EUR J PHY, V445, P257, DOI 10.1007/s00424-002-0916-8; Nagaraj NS, 2006, J FOOD BIOCHEM, V30, P269, DOI 10.1111/j.1745-4514.2006.00066.x; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nathanailides C., 1996, Aquaculture Research, V27, P885, DOI 10.1046/j.1365-2109.1996.t01-1-00819.x; Navarro Isabel, 1995, Biochemistry and Molecular Biology of Fishes, V4, P393; Ono Y, 2004, J BIOL CHEM, V279, P2761, DOI 10.1074/jbc.M308789200; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Page BT, 2002, J ANIM SCI, V80, P3077; Parr T, 1999, J ANIM SCI, V77, P661; Preziosa E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059404; Ravulapalli R, 2005, BIOCHEM J, V388, P585, DOI 10.1042/BJ20041821; Reinhardt A, 1998, NUCLEIC ACIDS RES, V26, P2230, DOI 10.1093/nar/26.9.2230; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Salem M, 2005, COMP BIOCHEM PHYS B, V141, P488, DOI 10.1016/j.cbpc.2005.05.012; Salem M, 2005, COMP BIOCHEM PHYS B, V140, P63, DOI 10.1016/j.cbpc.2004.09.007; Salem M, 2004, ANIM BIOTECHNOL, V15, P145, DOI [10.1081/ABIO-200036706, 10.1081/labt-200036706]; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; Suarez MD, 2009, AQUACULTURE, V288, P106, DOI 10.1016/j.aquaculture.2008.11.007; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TOTLAND GK, 1987, AQUACULTURE, V66, P299, DOI 10.1016/0044-8486(87)90115-3; Valente LMP, 2011, FOOD CONTROL, V22, P708, DOI 10.1016/j.foodcont.2010.11.001; vandenHemelGrooten HNA, 1997, J ANIM SCI, V75, P968	61	46	47	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75349	10.1371/journal.pone.0075349	http://dx.doi.org/10.1371/journal.pone.0075349			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086513	Green Submitted, Green Published, gold			2022-12-27	WOS:000325218700079
J	Wampole, ME; Kairys, JC; Mitchell, EP; Ankeny, ML; Thakur, ML; Wickstrom, E				Wampole, Matthew E.; Kairys, John C.; Mitchell, Edith P.; Ankeny, Martha L.; Thakur, Mathew L.; Wickstrom, Eric			Consistent Surgeon Evaluations of Three-Dimensional Rendering of PET/CT Scans of the Abdomen of a Patient with a Ductal Pancreatic Mass	PLOS ONE			English	Article							CONTRAST-ENHANCED CT; F-18-FDG PET/CT; COLORECTAL-CANCER; NONENHANCED CT; FDG-PET; SEGMENTATION; REGISTRATION; CARCINOMA; THERAPY	Two-dimensional (2D) positron emission tomography (PET) and computed tomography (CT) are used for diagnosis and evaluation of cancer patients, requiring surgeons to look through multiple planar images to comprehend the tumor and surrounding tissues. We hypothesized that experienced surgeons would consistently evaluate three-dimensional (3D) presentation of CT images overlaid with PET images when preparing for a procedure. We recruited six Jefferson surgeons to evaluate the accuracy, usefulness, and applicability of 3D renderings of the organs surrounding a malignant pancreas prior to surgery. PET/CT and contrast-enhanced CT abdominal scans of a patient with a ductal pancreatic mass were segmented into 3D surface renderings, followed by co-registration.Version A used only the PET/CT image, while version B used the contrast-enhanced CT scans co-registered with the PET images. The six surgeons answered 15 questions covering a) the ease of use and accuracy of models, b) how these models, with/without PET, changed their understanding of the tumor, and c) what are the best applications of the 3D visualization, on a scale of 1 to 5. The six evaluations revealed a statistically significant improvement from version A (score 3.6 +/- 0.5) to version B (score 4.4 +/- 0.4). A paired-samples t-test yielded t(14) = -28.964, p < 0.001. Across the surgeon cohort, contrast-enhanced CT fused with PET provided a more lifelike presentation than standard CT, increasing the usefulness of the presentation. The experienced surgeons consistently reported positive reactions to 3D surface renderings of fused PET and contrast-enhanced CT scans of a pancreatic cancer and surrounding organs. Thus, the 3D presentation could be a useful preparative tool for surgeons prior to making the first incision. This result supports proceeding to a larger surgeon cohort, viewing prospective 3D images from multiple types of cancer.	[Wampole, Matthew E.; Wickstrom, Eric] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Kairys, John C.] Thomas Jefferson Univ, Dept Surg, Philadelphia, PA 19107 USA; [Mitchell, Edith P.] Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA 19107 USA; [Ankeny, Martha L.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Thakur, Mathew L.] Thomas Jefferson Univ, Dept Radiol, Philadelphia, PA 19107 USA; [Kairys, John C.; Mitchell, Edith P.; Thakur, Mathew L.; Wickstrom, Eric] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University; Jefferson University; Jefferson University; Jefferson University	Wickstrom, E (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	eric@tesla.jci.tju.edu	wampole, matthew/AAF-9443-2019	Thakur, Mathew/0000-0003-2409-039X	United States Army Medical Research and Materiel Command (USAMRMC)/Telemedicine and Advanced Technology Research Center (TATRC) grant [W81XWH-09-1-0577]; National Institutes of Health (NIH) [CA148565]; NATIONAL CANCER INSTITUTE [R01CA148565] Funding Source: NIH RePORTER	United States Army Medical Research and Materiel Command (USAMRMC)/Telemedicine and Advanced Technology Research Center (TATRC) grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by United States Army Medical Research and Materiel Command (USAMRMC)/Telemedicine and Advanced Technology Research Center (TATRC) grant W81XWH-09-1-0577 and National Institutes of Health (NIH) grant CA148565 to E.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard J, 2007, STUD HEALTH TECHNOL, V125, P13; Antoch G, 2004, J NUCL MED, V45, p56S; Bueno G, 2011, INT J COMPUT ASS RAD, V6, P341, DOI 10.1007/s11548-010-0513-9; Calhoun PS, 1999, RADIOGRAPHICS, V19, P745, DOI 10.1148/radiographics.19.3.g99ma14745; Camara O, 2003, 3 IASTED INT C VIS I, P516; Delbeke Dominique, 2005, HPB (Oxford), V7, P166, DOI 10.1080/13651820510028909; DOERR RJ, 1991, ANN SURG, V214, P118, DOI 10.1097/00000658-199108000-00005; Erdt M, 2011, I S BIOMED IMAGING, P2076, DOI 10.1109/ISBI.2011.5872821; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fishman EK, 2006, RADIOGRAPHICS, V26, P905, DOI 10.1148/rg.263055186; Gao H-J, 2008, 2 INT C BIOINF BIOM, P16; HEATH DG, 1995, RADIOGRAPHICS, V15, P1001, DOI 10.1148/radiographics.15.4.7569120; Jadvar H, 2001, ABDOM IMAGING, V26, P254, DOI 10.1007/s002610000159; Kitajima K, 2008, EUR J NUCL MED MOL I, V35, P1439, DOI 10.1007/s00259-008-0776-3; Linguraru MG, 2010, MED PHYS, V37, P771, DOI 10.1118/1.3284530; Lundtrom C, 2005, IEEE COMPUT GRAPH, P263; Miura Fumihiko, 2006, HPB (Oxford), V8, P337, DOI 10.1080/13651820500540949; Murakami K, 2011, WORLD J CLIN ONCOL, V2, P229, DOI 10.5306/wjco.v2.i5.229; Nguyen NQ, 2011, J GASTROEN HEPATOL, V26, P613, DOI 10.1111/j.1440-1746.2011.06625.x; Pfannenberg AC, 2007, EUR J NUCL MED MOL I, V34, P36, DOI 10.1007/s00259-006-0186-3; Roach M, 2011, J SURG ONCOL, V103, P587, DOI 10.1002/jso.21805; Satava RM, 2008, WORLD J SURG, V32, P141, DOI 10.1007/s00268-007-9374-y; Schwier M, 2011, INT J COMPUT ASSIST; Shimizu A, 2010, INT J COMPUT ASS RAD, V5, P85, DOI 10.1007/s11548-009-0384-0; Shimizu A, 2007, INT J COMPUT ASS RAD, V2, P135, DOI 10.1007/s11548-007-0135-z; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Soyka JD, 2008, J NUCL MED, V49, P354, DOI 10.2967/jnumed.107.048249; Strasberg SM, 2010, J SURG ONCOL, V102, P955, DOI 10.1002/jso.21729; Strobel K, 2008, J NUCL MED, V49, P1408, DOI 10.2967/jnumed.108.051466; Tateishi U, 2007, EUR J NUCL MED MOL I, V34, P1627, DOI 10.1007/s00259-007-0455-9; Tatsumi M, 2011, INT J CLIN ONCOL, V16, P408, DOI 10.1007/s10147-011-0202-x; Wickstrom E, 2011, STUD HEALTH TECHNOL, V163, P691, DOI 10.3233/978-1-60750-706-2-691; Zhang JQY, 2005, PROC SPIE, V5744, P123, DOI 10.1117/12.595517; Zhang JQY, 2005, J COMPUT INF SCI ENG, V5, P283, DOI 10.1115/1.2052828; Zhou ZM, 2006, POSTGRAD MED J, V82, P392, DOI 10.1136/pgmj.2005.039230	35	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75237	10.1371/journal.pone.0075237	http://dx.doi.org/10.1371/journal.pone.0075237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086475	Green Published, gold, Green Submitted			2022-12-27	WOS:000325025200031
J	Dryden-Peterson, S; Jayeoba, O; Hughes, MD; Jibril, H; McIntosh, K; Modise, TA; Asmelash, A; Powis, KM; Essex, M; Shapiro, RL; Lockman, S				Dryden-Peterson, Scott; Jayeoba, Oluwemimo; Hughes, Michael D.; Jibril, Haruna; McIntosh, Kenneth; Modise, Taolo A.; Asmelash, Aida; Powis, Kathleen M.; Essex, Max; Shapiro, Roger L.; Lockman, Shahin			Cotrimoxazole Prophylaxis and Risk of Severe Anemia or Severe Neutropenia in HAART-Exposed, HIV-Uninfected Infants	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; ANTIRETROVIRAL THERAPY; AFRICAN ADULTS; COTE-DIVOIRE; PREVENTION; ZIDOVUDINE; WOMEN; PREGNANCY; BOTSWANA; REGIMENS	Background: Prophylactic cotrimoxazole is recommended for infants born to HIV-infected mothers. However, cotrimoxazole may increase the risk of severe anemia or neutropenia. Methods: We compared the proportion of HIV-exposed uninfected (HIV-EU) infants experiencing incident severe anemia (and separately, severe neutropenia) between a prospective cohort receiving prophylactic cotrimoxazole from 1 to 6 months vs. infants from two prior trials who did not receive cotrimoxazole. Infants were from rural and urban communities in southern Botswana. Results: A total of 1705 HIV-EU infants were included. Among these 645 (37.8%) were fed with iron-supplemented formula from birth. Severe anemia developed in 87 (5.1%) infants, and severe neutropenia in 164 (9.6%) infants. In an analysis stratified by infant feeding method, there were no significant differences in the risk of severe anemia by prophylactic cotrimoxazole exposure-risk difference, -0.69% (95% confidence interval [CI] -2.1 to 0.76%). Findings were similar in multivariable analysis, adjusted odds ratio (aOR) 0.35 (95% CI 0.07 to 1.65). There were also no significant differences observed for severe neutropenia by cotrimoxazole exposure, risk difference 2.0% (95% CI -1.3 to 5.2%) and aOR 0.80 (95% CI 0.33 to 1.93). Conclusions: Severe anemia and severe neutropenia were infrequent among HIV-exposed uninfected infants receiving cotrimoxazole from 1-6 months of age. Concerns regarding hematologic toxicity should not limit the use of prophylactic cotrimoxazole in HIV-exposed uninfected infants.	[Dryden-Peterson, Scott; Lockman, Shahin] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Dryden-Peterson, Scott; Jayeoba, Oluwemimo; Modise, Taolo A.; Asmelash, Aida; Powis, Kathleen M.; Essex, Max; Shapiro, Roger L.; Lockman, Shahin] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Dryden-Peterson, Scott; McIntosh, Kenneth; Powis, Kathleen M.; Essex, Max; Shapiro, Roger L.; Lockman, Shahin] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Hughes, Michael D.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Jibril, Haruna] Minist Hlth, Dept Publ Hlth, Gaborone, Botswana; [McIntosh, Kenneth] Boston Childrens Hosp, Div Infect Dis, Boston, MA USA; [Powis, Kathleen M.] Massachusetts Gen Hosp, Dept Internal Med, Boston, MA 02114 USA; [Powis, Kathleen M.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Shapiro, Roger L.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Botswana-Harvard AIDS Institute Partnership; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center	Dryden-Peterson, S (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.	scott_peterson@post.harvard.edu	Powis, Kathleen/AAU-5123-2021	Dryden-Peterson, Scott/0000-0002-8487-9731	Harvard University Center for AIDS Research (CFAR), a National Institutes of Health (NIH) [P30 AI060354]; NIH; NIAID; NCI; NICHD; NHLBI; NIDA; NIMH; NIA; MCCAM; FIC; OAR; Fogarty International Center [R24 TW007988]; Burroughs Wellcome Fund/American Society of Tropical Medicine and Hygiene; Harvard Institute for Global Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD070774] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI091434, P30AI060354] Funding Source: NIH RePORTER	Harvard University Center for AIDS Research (CFAR), a National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MCCAM; FIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); OAR; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Burroughs Wellcome Fund/American Society of Tropical Medicine and Hygiene(Burroughs Wellcome Fund); Harvard Institute for Global Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work supported by a research grant from the Harvard University Center for AIDS Research (CFAR), a National Institutes of Health (NIH)-funded program (P30 AI060354) which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, MCCAM, FIC, and OAR, and career development grants (to S. D. P) from the Fogarty International Center (R24 TW007988), Burroughs Wellcome Fund/American Society of Tropical Medicine and Hygiene, and the Harvard Institute for Global Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizire J, 2012, AIDS, V26, P325, DOI 10.1097/QAD.0b013e32834e892c; Botswana Ministry of Health, 2008, BOTSW 2008 NAT HIV A; BROWN MS, 1988, DEV NEONATAL HEMATOL; Bunders MJ, 2005, ACTA PAEDIATR, V94, P1571, DOI 10.1080/08035250510042951; Chatziioannou A., 2009, PUBLIC HEALTH NUTR, P1; Coutsoudis A, 2010, B WORLD HEALTH ORGAN, V88, P949, DOI 10.2471/BLT.10.076422; Dryden-Peterson S, 2011, JAIDS-J ACQ IMM DEF, V58, P353, DOI 10.1097/QAI.0b013e31822d4063; Dryden-Peterson S, 2011, JAIDS-J ACQ IMM DEF, V56, P428, DOI 10.1097/QAI.0b013e31820bd2b6; Feiterna-Sperling C, 2007, JAIDS-J ACQ IMM DEF, V45, P43, DOI 10.1097/QAI.0b013e318042d5e3; Fernandez Ibieta M, 2008, An Pediatr (Barc), V69, P533; Hwan W, 2008, AIDS, V22, P1633, DOI 10.1097/QAD.0b013e328307a029; IMRIE KR, 1995, BONE MARROW TRANSPL, V15, P267; Kourtis Athena P, 2005, J Int Assoc Physicians AIDS Care (Chic), V4, P73, DOI 10.1177/1545109705282591; Lahoz R, 2009, PEDIAT INFECT DIS J; Le Chenadec J, 2003, AIDS, V17, P2053, DOI 10.1097/00002030-200309260-00006; Moh R, 2005, ANTIVIR THER, V10, P615; Mwinga K, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-49; NIH DoA, 2009, DIV AIDS TABL GRAD S; OBRIEN RT, 1971, J PEDIATR-US, V79, P132, DOI 10.1016/S0022-3476(71)80076-8; Pacheco SE, 2006, J INFECT DIS, V194, P1089, DOI 10.1086/507645; Palombi L, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000279708.09180.f5; Powis KM, 2011, J INFECT DIS, V204, P506, DOI 10.1093/infdis/jir307; Powis KM, 2011, JAIDS-J ACQ IMM DEF, V56, P131, DOI 10.1097/QAI.0b013e3181ffa4f5; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Ssali F, 2006, ANTIVIR THER, V11, P741; Tapp H, 1997, J PAEDIATR CHILD H, V33, P166, DOI 10.1111/j.1440-1754.1997.tb01022.x; Toure S, 2006, T ROY SOC TROP MED H, V100, P785, DOI 10.1016/j.trstmh.2005.11.008; Wells J, 2006, JAIDS-J ACQ IMM DEF, V42, P460, DOI 10.1097/01.qai.0000224975.45091.a5; WHO, 2001, IRON DEFICIENCY ANAE; WHO UNAIDS UNICEF, 2008, UN ACC SCAL PRIOR HI; WOODS WG, 1984, J PEDIATR-US, V105, P639, DOI 10.1016/S0022-3476(84)80439-4; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization (WHO), 2006, GUID COTR PROPH HIV	33	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74171	10.1371/journal.pone.0074171	http://dx.doi.org/10.1371/journal.pone.0074171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086319	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200024
J	Trouvay, M; Palazon, G; Berger, F; Volney, B; Blanchet, D; Faway, E; Donato, D; Legrand, E; Carme, B; Musset, L				Trouvay, Melanie; Palazon, Georges; Berger, Franck; Volney, Beatrice; Blanchet, Denis; Faway, Emilie; Donato, Damien; Legrand, Eric; Carme, Bernard; Musset, Lise			High Performance of Histidine-Rich Protein 2 Based Rapid Diagnostic Tests in French Guiana Are Explained by the Absence of pfhrp2 Gene Deletion in P. falciparum	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; SEQUENCE VARIATION; MALARIA; DIVERSITY; PARASITES; RESISTANCE; PFCRT; VIVAX	Background: Care for malaria patients in endemic areas has been improved through the increasing use of Rapid Diagnostic Tests (RDTs). Most RDTs target the histidine-rich protein-2 antigen (PfHRP2) to detect P. falciparum, as it is abundant and shows great heat stability. However, their use in South America has been widely questioned following a recent publication that pinpoints the high prevalence of Peruvian field isolates lacking the gene encoding this protein. In the remote rural health centers of French Guiana, RDTs are the main diagnosis tools. Therefore, a study of PfHRP2 RDT performances and pfhrp2 genotyping was conducted to determine whether a replacement of the current pLDH-based kit could be considered. Methods: The performance study compared the SD Malaria Ag test P. f/PanH kit with the current gold standard diagnosis by microscopy. The prevalence of pfhrp2 and pfhrp3 deletions were evaluated from 221 P. falciparum isolates collected between 2009 and 2011 in French Guiana. Results: Between January 2010 and August 2011, 960 suspected cases of malaria were analyzed using microscopy and RDTs. The sensitivity of the SD Malaria Ag test P. f/PanH for detection of P. falciparum was 96.8% (95% CI: 90.9-99.3), and 86.0% (95% CI: 78.9-91.5) for the detection of P. vivax. No isolates (95% CI: 0-4.5) lacking either exon of the pfhrp2 gene were identified among the 221 P. falciparum isolates analyzed, but 7.4% (95% CI: 2.8-15.4) lacked the exon 2 part of the pfhrp3 gene. Conclusions: Field isolates lacking either exon of the pfhrp2 gene are absent in this western part of South America. Despite its sensibility to detect P. vivax, the SD Malaria Ag test P. f/PanH kit is a satisfying alternative to microscopy in remote health centers, where it is difficult to provide highly skilled microscopists and to maintain the necessary equipment.	[Trouvay, Melanie; Volney, Beatrice; Faway, Emilie; Donato, Damien; Legrand, Eric; Musset, Lise] Inst Pasteur Guyane, Parasitol Lab, Ctr Natl Reference Chimioresistance Paludisme, Cayenne, French Guiana, France; [Palazon, Georges; Blanchet, Denis; Carme, Bernard] Univ Antilles Guyane, Lab Hosp Univ Parasitol & Mycol Med, Equipe Accueil 3593, Unite Format & Rech Med, Cayenne, French Guiana, France; [Berger, Franck] Inst Pasteur Guyane, Unite Epidemiol, Cayenne, French Guiana, France		Musset, L (corresponding author), Inst Pasteur Guyane, Parasitol Lab, Ctr Natl Reference Chimioresistance Paludisme, Cayenne, French Guiana, France.	lisemusset@gmail.com		Faway, Emilie/0000-0003-3406-1103; Legrand, Eric/0000-0003-4725-0712; Blanchet, Denis/0000-0003-3270-2093	French Ministry of Health (InVS agency, Paris)	French Ministry of Health (InVS agency, Paris)	This project was supported by the French Ministry of Health (InVS agency, Paris). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GOOD PRACT SEL PROC; [Anonymous], 2011, MAL RAP DIAGN TEST P; [Anonymous], 2009, MAL RAP DIAGN TEST P; [Anonymous], 2012, MAL RAP DIAGN TEST P; Ariey F, 1999, AM J TROP MED HYG, V61, P978, DOI 10.4269/ajtmh.1999.61.978; AVILA Priscilla Elisangela, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P293, DOI 10.1590/S0036-46652002000500012; Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; Baker J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022593; Baker J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-129; Bell D, 2006, NAT REV MICROBIOL, pS34, DOI [10.1038/nrmico1524, 10.1038/nrmicro1524]; Berger F, 2012, AM J TROP MED HYG, V86, P591, DOI 10.4269/ajtmh.2012.11-0582; Carme B, 2005, TROP MED INT HEALTH, V10, P154, DOI 10.1111/j.1365-3156.2004.01365.x; Carme B, 2009, Med Trop (Mars), V69, P19; Carme B, 2002, CONS C MAL TRET FREN; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Gillet P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-271; Griffing S, 2010, ANTIMICROB AGENTS CH, V54, P1572, DOI 10.1128/AAC.01243-09; Houze S, 2011, J CLIN MICROBIOL, V49, P2694, DOI 10.1128/JCM.00281-11; Houze S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-211; Lee N, 2012, J CLIN MICROBIOL, V50, P1397, DOI 10.1128/JCM.06533-11; Lee N, 2006, J CLIN MICROBIOL, V44, P2773, DOI 10.1128/JCM.02557-05; Legrand E, 2012, ANTIMICROB AGENTS CH, V56, P1382, DOI 10.1128/AAC.05280-11; Maltha J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043094; Mariette N, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-219; Ochola LB, 2006, LANCET INFECT DIS, V6, P582, DOI 10.1016/S1473-3099(06)70579-5; Palmer CJ, 1998, J CLIN MICROBIOL, V36, P203, DOI 10.1128/JCM.36.1.203-206.1998; Pava Z, 2010, AM J TROP MED HYG, V83, P834, DOI 10.4269/ajtmh.2010.10-0075; Peek R, 2005, AM J TROP MED HYG, V73, P833, DOI 10.4269/ajtmh.2005.73.833; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; World Health Organization, 2018, MAL RAP DIAGN TEST P	31	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74269	10.1371/journal.pone.0074269	http://dx.doi.org/10.1371/journal.pone.0074269			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086328	Green Published, gold			2022-12-27	WOS:000326520200026
J	Young, D; Mayer, F; Vidotto, N; Schweizer, T; Berth, R; Abramowski, D; Shimshek, DR; van der Putten, PH; Schmid, P				Young, Douglas; Mayer, Franziska; Vidotto, Nella; Schweizer, Tatjana; Berth, Ramon; Abramowski, Dorothee; Shimshek, Derya R.; van der Putten, P. Herman; Schmid, Peter			Mutant Huntingtin Gene-Dose Impacts on Aggregate Deposition, DARPP32 Expression and Neuroinflammation in HdhQ150 Mice	PLOS ONE			English	Article							IN MOUSE MODEL; MICROGLIAL ACTIVATION; INTRANUCLEAR INCLUSIONS; MONOCLONAL-ANTIBODIES; TRINUCLEOTIDE REPEAT; NEUROTROPHIC FACTOR; CAG REPEAT; DISEASE; PROTEIN; EXON-1	Huntington's disease (HD) is an autosomal dominant, progressive and fatal neurological disorder caused by an expansion of CAG repeats in exon-1 of the huntingtin gene. The encoded poly-glutamine stretch renders mutant huntingtin prone to aggregation. HdhQ150 mice genocopy a pathogenic repeat (similar to 150 CAGs) in the endogenous mouse huntingtin gene and model predominantly pre-manifest HD. Treating early is likely important to prevent or delay HD, and HdhQ150 mice may be useful to assess therapeutic strategies targeting pre-manifest HD. This requires appropriate markers and here we demonstrate, that pre-symptomatic HdhQ150 mice show several dramatic mutant huntingtin gene-dose dependent pathological changes including: (i) an increase of neuronal intra-nuclear inclusions (NIIs) in brain, (ii) an increase of extranuclear aggregates in dentate gyrus, (iii) a decrease of DARPP32 protein and (iv) an increase in glial markers of neuroinflammation, which curiously did not correlate with local neuronal mutant huntingtin inclusion-burden. HdhQ150 mice developed NIIs also in all retinal neuron cell-types, demonstrating that retinal NIIs are not specific to human exon-1 R6 HD mouse models. Taken together, the striking and robust mutant huntingtin gene-dose related changes in aggregate-load, DARPP32 levels and glial activation markers should greatly facilitate future testing of therapeutic strategies in the HdhQ150 HD mouse model.	[Young, Douglas; Mayer, Franziska; Vidotto, Nella; Schweizer, Tatjana; Berth, Ramon; Abramowski, Dorothee; Shimshek, Derya R.; van der Putten, P. Herman; Schmid, Peter] Novartis Pharma AG, Novartis Inst BioMed Res, Basel, Switzerland	Novartis	Shimshek, DR (corresponding author), Novartis Pharma AG, Novartis Inst BioMed Res, Basel, Switzerland.	derya.shimshek@novartis.com; PeSchmid@aol.com		Shimshek, Derya/0000-0001-8602-7850				Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Arrasate M, 2012, EXP NEUROL, V238, P1, DOI 10.1016/j.expneurol.2011.12.013; Baldo B, 2012, CHEM BIOL, V19, P264, DOI 10.1016/j.chembiol.2011.12.020; Batcha AH, 2012, NEUROBIOL DIS, V45, P887, DOI 10.1016/j.nbd.2011.12.004; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Bayram-Weston Z, 2012, BRAIN RES BULL, V88, P189, DOI 10.1016/j.brainresbull.2011.03.014; Benn CL, 2005, HUM MOL GENET, V14, P3065, DOI 10.1093/hmg/ddi340; Bibb JA, 2000, P NATL ACAD SCI USA, V97, P6809, DOI 10.1073/pnas.120166397; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hadzi TC, 2012, NEUROLOGY, V79, P1708, DOI 10.1212/WNL.0b013e31826e9a5d; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Helmlinger D, 2002, HUM MOL GENET, V11, P3351, DOI 10.1093/hmg/11.26.3351; Heng MY, 2007, J NEUROSCI, V27, P8989, DOI 10.1523/JNEUROSCI.1830-07.2007; Heng MY, 2010, HUM MOL GENET, V19, P3702, DOI 10.1093/hmg/ddq285; Hickey MA, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-12; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Krauss S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2514; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Legleiter J, 2009, J BIOL CHEM, V284, P21647, DOI 10.1074/jbc.M109.016923; Li Y, 2012, P NATL ACAD SCI USA, V109, P15491, DOI 10.1073/pnas.1212899109; Lloret A, 2006, HUM MOL GENET, V15, P2015, DOI 10.1093/hmg/ddl125; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marcellin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044457; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Moller T, 2010, J NEURAL TRANSM, V117, P1001, DOI 10.1007/s00702-010-0430-7; Moffitt H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008025; Pavese N, 2006, NEUROLOGY, V66, P1638, DOI 10.1212/01.wnl.0000222734.56412.17; Petrasch-Parwez E, 2005, ACTA NEUROPATHOL, V110, P523, DOI 10.1007/s00401-005-1092-7; Petrasch-Parwez E, 2004, J COMP NEUROL, V479, P181, DOI 10.1002/cne.20327; Politis M, 2011, HUM BRAIN MAPP, V32, P258, DOI 10.1002/hbm.21008; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Runne H, 2008, J NEUROSCI, V28, P9723, DOI 10.1523/JNEUROSCI.3044-08.2008; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Simmons DA, 2007, GLIA, V55, P1074, DOI 10.1002/glia.20526; Squitieri F, 2003, BRAIN, V126, P946, DOI 10.1093/brain/awg077; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Tai YF, 2007, BRAIN, V130, P1759, DOI 10.1093/brain/awm044; Tai YF, 2007, BRAIN RES BULL, V72, P148, DOI 10.1016/j.brainresbull.2006.10.029; Thomas EA, 2011, HUM MOL GENET, V20, P1049, DOI 10.1093/hmg/ddq548; van Dellen A, 2000, NEUROREPORT, V11, P3751, DOI 10.1097/00001756-200011270-00032; Vonsattel Jean Paul G, 2011, Handb Clin Neurol, V100, P83, DOI 10.1016/B978-0-444-52014-2.00004-5; Wang CE, 2008, HUM MOL GENET, V17, P2738, DOI 10.1093/hmg/ddn175; Wang YL, 2005, NEUROSCI RES, V53, P241, DOI 10.1016/j.neures.2005.06.021; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Weiss A, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-11; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	59	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75108	10.1371/journal.pone.0075108	http://dx.doi.org/10.1371/journal.pone.0075108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086450	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200082
J	Shaw, PG; Chaerkady, R; Wang, T; Vasilatos, S; Huang, Y; Van Houten, B; Pandey, A; Davidson, NE				Shaw, Patrick G.; Chaerkady, Raghothama; Wang, Tao; Vasilatos, Shauna; Huang, Yi; Van Houten, Bennett; Pandey, Akhilesh; Davidson, Nancy E.			Integrated Proteomic and Metabolic Analysis of Breast Cancer Progression	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; AMINO-ACIDS; EXPRESSION; HYPOXIA; MCF10AT; MODEL; RESPIRATION; IMPAIRMENT; GROWTH; CELLS	One of the most persistent hallmarks of cancer biology is the preference of tumor cells to derive energy through glycolysis as opposed to the more efficient process of oxidative phosphorylation (OXPHOS). However, little is known about the molecular cascades by which oncogenic pathways bring about this metabolic switch. We carried out a quantitative proteomic and metabolic analysis of the MCF10A derived cell line model of breast cancer progression that includes parental cells and derivatives representing three different tumor grades of Ras-driven cancer with a common genetic background. A SILAC (Stable Isotope Labeling by Amino acids in Cell culture) labeling strategy was used to quantify protein expression in conjunction with subcellular fractionation to measure dynamic subcellular localization in the nucleus, cytosol and mitochondria. Protein expression and localization across cell lines were compared to cellular metabolic rates as a measure of oxidative phosphorylation (OXPHOS), glycolysis and cellular ATP. Investigation of the metabolic capacity of the four cell lines revealed that cellular OXPHOS decreased with breast cancer progression independently of mitochondrial copy number or electron transport chain protein expression. Furthermore, glycolytic lactate secretion did not increase in accordance with cancer progression and decreasing OXPHOS capacity. However, the relative expression and subcellular enrichment of enzymes critical to lactate and pyruvate metabolism supported the observed extracellular acidification profiles. This analysis of metabolic dysfunction in cancer progression integrated with global protein expression and subcellular localization is a novel and useful technique for determining organelle-specific roles of proteins in disease.	[Shaw, Patrick G.; Wang, Tao; Vasilatos, Shauna; Huang, Yi; Van Houten, Bennett; Davidson, Nancy E.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Davidson, Nancy E.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Wang, Tao; Vasilatos, Shauna; Huang, Yi; Van Houten, Bennett; Davidson, Nancy E.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Shaw, Patrick G.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD USA; [Chaerkady, Raghothama; Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA; [Chaerkady, Raghothama; Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Pandey, A (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA.	pandey@jhmi.edu; davidsonne@upmc.edu	Pandey, Akhilesh/B-4127-2009; Van Houten, Bennett/K-2284-2019; Huang, Yi/AAW-7892-2021	Pandey, Akhilesh/0000-0001-9943-6127; Huang, Yi/0000-0002-9982-117X	Breast Cancer Research Foundation; NCI [T32 CA09110, U54 RR 020839]; NIH roadmap grant for Technology Centers of Networks and Pathways [U54 GM103250]; National Heart, Lung and Blood Institute [HHSN268201000032C]; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH roadmap grant for Technology Centers of Networks and Pathways(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was partially supported by the Breast Cancer Research Foundation, NCI Training Grant T32 CA09110, U54 RR 020839, an NIH roadmap grant for Technology Centers of Networks and Pathways (U54 GM103250) and a contract from the National Heart, Lung and Blood Institute (HHSN268201000032C) to A.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayley JP, 2010, CURR OPIN GENET DEV, V20, P324, DOI 10.1016/j.gde.2010.02.008; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066; Buchanan NS, 2007, INT J ONCOL, V31, P941; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Choong LY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011030; Cox B, 2006, NAT PROTOC, V1, P1872, DOI 10.1038/nprot.2006.273; Dawson PJ, 1996, AM J PATHOL, V148, P313; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Hansen WJ, 2002, MOL CELL BIOL, V22, P1947, DOI 10.1128/MCB.22.6.1947-1960.2002; Harsha HC, 2008, NAT PROTOC, V3, P505, DOI 10.1038/nprot.2008.2; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kadota M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009201; Kim SH, 2009, INT J CANCER, V124, P2813, DOI 10.1002/ijc.24278; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; Lee JJ, 2010, CARCINOGENESIS, V31, P427, DOI 10.1093/carcin/bgp326; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lim S, 2009, J PROTEOME RES, V8, P4062, DOI 10.1021/pr900430n; Liu YV, 2007, CELL CYCLE, V6, P656, DOI 10.4161/cc.6.6.3981; Marella NV, 2009, CANCER RES, V69, P5946, DOI 10.1158/0008-5472.CAN-09-0420; Moelans CB, 2010, MODERN PATHOL, V23, P1029, DOI 10.1038/modpathol.2010.84; NIEMINEN AL, 1994, AM J PHYSIOL, V267, pC67, DOI 10.1152/ajpcell.1994.267.1.C67; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Shen J, 2010, MITOCHONDRION, V10, P62, DOI 10.1016/j.mito.2009.09.004; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; SOULE HD, 1990, CANCER RES, V50, P6075; Sun CH, 2010, J CELL PHYSIOL, V225, P673, DOI 10.1002/jcp.22262; von Lintig FC, 2000, BREAST CANCER RES TR, V62, P51, DOI 10.1023/A:1006491619920; Wang JB, 2009, J CELL SCI, V122, P2024, DOI 10.1242/jcs.044644; WARBURG O, 1956, SCIENCE, V124, P269; Worsham MJ, 2006, BREAST CANCER RES TR, V96, P177, DOI 10.1007/s10549-005-9077-8; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yang D, 2010, CANCER BIOL THER, V9, P122, DOI 10.4161/cbt.9.2.10379	41	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76220	10.1371/journal.pone.0076220	http://dx.doi.org/10.1371/journal.pone.0076220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086712	gold, Green Published, Green Submitted			2022-12-27	WOS:000325223900087
J	Stres, B; Sul, WJ; Murovec, B; Tiedje, JM				Stres, Blaz; Sul, Woo Jun; Murovec, Bostjan; Tiedje, James M.			Recently Deglaciated High-Altitude Soils of the Himalaya: Diverse Environments, Heterogenous Bacterial Communities and Long-Range Dust Inputs from the Upper Troposphere	PLOS ONE			English	Article							SIZE DISTRIBUTION; MICROBIAL COMMUNITIES; CHEMICAL-COMPOSITION; TIBETAN PLATEAU; ICE CORES; SEA-LEVEL; DEPOSITION; MICROORGANISMS; PRECIPITATION; AEROSOLS	Background: The Himalaya with its altitude and geographical position forms a barrier to atmospheric transport, which produces much aqueous-particle monsoon precipitation and makes it the largest continuous ice-covered area outside polar regions. There is a paucity of data on high-altitude microbial communities, their native environments and responses to environmental-spatial variables relative to seasonal and deglaciation events. Methodology/Principal Findings: Soils were sampled along altitude transects from 5000 m to 6000 m to determine environmental, spatial and seasonal factors structuring bacterial communities characterized by 16 S rRNA gene deep sequencing. Dust traps and fresh-snow samples were used to assess dust abundance and viability, community structure and abundance of dust associated microbial communities. Significantly different habitats among the altitude-transect samples corresponded to both phylogenetically distant and closely-related communities at distances as short as 50 m showing high community spatial divergence. High within-group variability that was related to an order of magnitude higher dust deposition obscured seasonal and temporal rearrangements in microbial communities. Although dust particle and associated cell deposition rates were highly correlated, seasonal dust communities of bacteria were distinct and differed significantly from recipient soil communities. Analysis of closest relatives to dust OTUs, HYSPLIT back-calculation of airmass trajectories and small dust particle size (4-12 mu m) suggested that the deposited dust and microbes came from distant continental, lacustrine and marine sources, e. g. Sahara, India, Caspian Sea and Tibetan plateau. Cyanobacteria represented less than 0.5% of microbial communities suggesting that the microbial communities benefitted from (co)deposited carbon which was reflected in the psychrotolerant nature of dust-particle associated bacteria. Conclusions/Significance: The spatial, environmental and temporal complexity of the high-altitude soils of the Himalaya generates ongoing disturbance and colonization events that subject heterogeneous microniches to stochastic colonization by far away dust associated microbes and result in the observed spatially divergent bacterial communities.	[Stres, Blaz] Univ Ljubljana, Dept Anim Sci, Domzale, Slovenia; [Sul, Woo Jun; Tiedje, James M.] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA; [Sul, Woo Jun] Chung Ang Univ, Dept Syst Biotechnol, Anseong, South Korea; [Murovec, Bostjan] Univ Ljubljana, Fac Elect Engn, Ljubljana, Slovenia	University of Ljubljana; Michigan State University; Chung Ang University; University of Ljubljana	Tiedje, JM (corresponding author), Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA.	tiedjej@msu.edu	Stres, Blaz/AAF-7279-2020; Sul, Woo Jun/A-9291-2012	Stres, Blaz/0000-0003-2972-2907; Sul, Woo Jun/0000-0002-7016-1454	U.S. Department of Energy, Office of Science [DE-SC000460]; World Class University program through the National Research Foundation of Korea; Ministry of Education, Science and Technology [R33-10076]; Slovenian Research Agency [PO-0562-0481]	U.S. Department of Energy, Office of Science(United States Department of Energy (DOE)); World Class University program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The authors acknowledge financial support from the U.S. Department of Energy, Office of Science, grant DE-SC000460, the World Class University program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R33-10076) and Slovenian Research Agency contract PO-0562-0481. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato P, 2007, FEMS MICROBIOL ECOL, V59, P242, DOI 10.1111/j.1574-6941.2006.00199.x; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bahadur J, 1993, IAHS PUBL, V218; Bardgett RD, 2007, BIOLOGY LETT, V3, P487, DOI 10.1098/rsbl.2007.0242; Barros AP, 2004, NAT HAZARD EARTH SYS, V4, P29, DOI 10.5194/nhess-4-29-2004; Bhattarai BK, 2011, ADV ATMOS SCI, V28, P789, DOI 10.1007/s00376-010-9222-0; Bloem J., 1995, MOL MICROBIAL ECOLOG, P1; Bonasoni P, 2010, ATMOS CHEM PHYS, V10, P7515, DOI 10.5194/acp-10-7515-2010; Carrico CM, 2003, ATMOS ENVIRON, V37, P2811, DOI 10.1016/S1352-2310(03)00197-3; Chatterjee A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011122; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Creamean JM, 2013, SCIENCE, V339, P1572, DOI 10.1126/science.1227279; Das PK, 1972, MONSOONS; Decesari S, 2009, ATMOS CHEM PHYS DISC, V9, P25487, DOI DOI 10.5194/ACPD-9-25487-2009; DeLeon-Rodriguez N, 2013, P NATL ACAD SCI USA, V110, P2575, DOI 10.1073/pnas.1212089110; Formenti P, 2011, ATMOS CHEM PHYS, V11, P8231, DOI 10.5194/acp-11-8231-2011; Gilbert B, 2010, J APPL ECOL, V47, P1071, DOI 10.1111/j.1365-2664.2010.01861.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hara K, 2012, ATMOS ENVIRON, V47, P20, DOI 10.1016/j.atmosenv.2011.11.050; Hidy GM, 2003, ATMOS ENVIRON, V37, P1231, DOI 10.1016/S1352-2310(02)01024-5; Huneeus N, 2011, ATMOS CHEM PHYS, V11, P7781, DOI 10.5194/acp-11-7781-2011; Jacob T, 2012, NATURE, V482, P514, DOI 10.1038/nature10847; Kansakar SR, 2004, INT J CLIMATOL, V24, P1645, DOI 10.1002/joc.1098; Kastovska K, 2005, MICROB ECOL, V50, P396, DOI 10.1007/s00248-005-0246-4; Kellenberg TW, 2006, OBJECT ORIENTED LAND; Kessler MA, 2003, SCIENCE, V299, P380, DOI 10.1126/science.1077309; King AJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1055; Kok JF, 2011, P NATL ACAD SCI USA, V108, P1016, DOI 10.1073/pnas.1014798108; Lang TJ, 2004, J METEOROL SOC JPN, V82, P829, DOI 10.2151/jmsj.2004.829; Lee HN, 2006, WATER AIR SOIL POLL, V169, P137, DOI 10.1007/s11270-006-1895-8; Liu Y, 2009, FRONT EARTH SCI CHIN, V3, P80, DOI [DOI 10.1007/S11707-009-0016-6, 10.1007/s11707-009-0016-6]; Liu Z, 2008, ATMOS CHEM PHYS, V8, P5045, DOI 10.5194/acp-8-5045-2008; Matsuoka N, 2001, EARTH-SCI REV, V55, P107, DOI 10.1016/S0012-8252(01)00057-5; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mori I, 2002, ATMOS ENVIRON, V36, P4569, DOI 10.1016/S1352-2310(02)00489-2; Mori I, 2003, ATMOS ENVIRON, V37, P4253, DOI 10.1016/S1352-2310(03)00535-1; Morris CE, 2011, BIOGEOSCIENCES, V8, P17, DOI 10.5194/bg-8-17-2011; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Nickling W.G., 2009, GEOMORPHOLOGY DESERT, P517; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Sapkota A, 2007, HOLOCENE, V17, P561, DOI 10.1177/0959683607078981; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt SK, 2008, P ROY SOC B-BIOL SCI, V275, P2793, DOI 10.1098/rspb.2008.0808; Schutte UME, 2010, MOL ECOL, V19, P54, DOI 10.1111/j.1365-294X.2009.04479.x; Schutte UME, 2009, ISME J, V3, P1258, DOI 10.1038/ismej.2009.71; Singh S, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004854; Smith DJ, 2012, MICROB ECOL, V64, P973, DOI 10.1007/s00248-012-0088-9; Smith TW, 2010, ECOGRAPHY, V33, P648, DOI 10.1111/j.1600-0587.2009.06105.x; Stres B, 2010, FEMS MICROBIOL ECOL, V74, P323, DOI 10.1111/j.1574-6941.2010.00951.x; Sul WJ, 2011, P NATL ACAD SCI USA, V108, P14637, DOI 10.1073/pnas.1111435108; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Thomas JK, 2005, OVERVIEW GLACIERS GL; WAKE CP, 1994, TELLUS B, V46, P220, DOI 10.1034/j.1600-0889.1994.t01-2-00005.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Wu GJ, 2010, TELLUS B, V62, P197, DOI [10.1111/j.1600-0889.2010.00457.x, 10.1111/J.1600-0889.2010.00457.x]; Wu GJ, 2009, J GLACIOL, V55, P859, DOI 10.3189/002214309790152492; Xiang SR, 2009, FEMS MICROBIOL ECOL, V70, P165, DOI 10.1111/j.1574-6941.2009.00759.x; Yamaguchi N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00525; Yoshimura Y, 1997, ARCTIC ALPINE RES, V29, P126, DOI 10.2307/1551843	64	46	48	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76440	10.1371/journal.pone.0076440	http://dx.doi.org/10.1371/journal.pone.0076440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086740	Green Published, gold, Green Submitted			2022-12-27	WOS:000325220000066
J	Venhoranta, H; Pausch, H; Wysocki, M; Szczerbal, I; Hanninen, R; Taponen, J; Uimari, P; Flisikowski, K; Lohi, H; Fries, R; Switonski, M; Andersson, M				Venhoranta, Heli; Pausch, Hubert; Wysocki, Michal; Szczerbal, Izabela; Hanninen, Reetta; Taponen, Juhani; Uimari, Pekka; Flisikowski, Krzysztof; Lohi, Hannes; Fries, Ruedi; Switonski, Marek; Andersson, Magnus			Ectopic KIT Copy Number Variation Underlies Impaired Migration of Primordial Germ Cells Associated with Gonadal Hypoplasia in Cattle (Bos taurus)	PLOS ONE			English	Article							WHITE COAT COLOR; C-KIT; PHENOTYPE; INDICUS; BULLS; TOOL; XY	Impaired migration of primordial germ cells during embryonic development causes hereditary gonadal hypoplasia in both sexes of Northern Finncattle and Swedish Mountain cattle. The affected gonads exhibit a lack of or, in rare cases, a reduced number of germ cells. Most affected animals present left-sided gonadal hypoplasia. However, right-sided and bilateral cases are also found. This type of gonadal hypoplasia prevails in animals with white coat colour. Previous studies indicated that gonadal hypoplasia is inherited in an autosomal recessive fashion with incomplete penetrance. In order to identify genetic regions underlying gonadal hypoplasia, a genome-wide association study (GWAS) and a copy number variation (CNV) analysis were performed with 94 animals, including 21 affected animals, using bovine 777,962 SNP arrays. The GWAS and CNV results revealed two significantly associated regions on bovine chromosomes (BTA) 29 and 6, respectively (P=2.19 x 10(-13) and P=5.65 x 10(-6)). Subsequent cytogenetic and PCR analyses demonstrated that homozygosity of a similar to 500 kb chromosomal segment translocated from BTA6 to BTA29 (Cs-29 allele) is the underlying genetic mechanism responsible for gonadal hypoplasia. The duplicated segment includes the KIT gene that is known to regulate the migration of germ cells and precursors of melanocytes. This duplication is also one of the two translocations associated with colour sidedness in various cattle breeds.	[Venhoranta, Heli; Taponen, Juhani; Andersson, Magnus] Univ Helsinki, Dept Prod Anim Med, Saarentaus, Finland; [Pausch, Hubert; Wysocki, Michal; Fries, Ruedi] Tech Univ Munich, Chair Anim Breeding, Freising Weihenstephan, Germany; [Szczerbal, Izabela; Switonski, Marek] Univ Life Sci, Dept GeneticsandAnim Breeding, Poznan, Poland; [Hanninen, Reetta; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Res Programs Unit, Helsinki, Finland; [Hanninen, Reetta; Lohi, Hannes] Folkhalsan Res Inst, Helsinki, Finland; [Uimari, Pekka] Agrifood Res Finland, MTT, Biotechnol & Food Res, Jokioinen, Finland; [Flisikowski, Krzysztof] Tech Univ Munich, Chair Livestock Biotechnol, Freising Weihenstephan, Germany	University of Helsinki; Technical University of Munich; Poznan University of Life Sciences; University of Helsinki; Folkhalsan Research Center; Natural Resources Institute Finland (Luke); Technical University of Munich	Venhoranta, H (corresponding author), Univ Helsinki, Dept Prod Anim Med, Saarentaus, Finland.	heli.venhoranta@helsinki.fi	Pausch, Hubert/B-7637-2018; Lohi, Hannes/F-4596-2011; Szczerbal, Izabela/AFM-9268-2022; Pausch, Hubert/U-5934-2019	Lohi, Hannes/0000-0003-1087-5532; Pausch, Hubert/0000-0002-0501-6760; Fries, Ruedi/0000-0002-4657-1787; Uimari, Pekka/0000-0002-5349-3932; Szczerbal, Izabela/0000-0002-4238-0414; Switonski, Marek/0000-0003-2539-9508	Academy of Finland; Finnish Veterinary Foundation; Orion-Farmos research foundation; Emil Aaltonen Foundation; Niemi Foundation; German Federal Ministry of Education and Research within the AgroClustEr "Synbreed - Synergistic plant and animal breeding"	Academy of Finland(Academy of Finland); Finnish Veterinary Foundation; Orion-Farmos research foundation; Emil Aaltonen Foundation; Niemi Foundation; German Federal Ministry of Education and Research within the AgroClustEr "Synbreed - Synergistic plant and animal breeding"	Funding from the Academy of Finland, Finnish Veterinary Foundation, Orion-Farmos research foundation, Emil Aaltonen Foundation and Niemi Foundation is highly appreciated. HP was funded by the German Federal Ministry of Education and Research within the AgroClustEr "Synbreed - Synergistic plant and animal breeding". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 1999, EQUINE VET J, V31, P336, DOI 10.1111/j.2042-3306.1999.tb03813.x; Bernex F, 1996, DEVELOPMENT, V122, P3023; Bidarkar Sandeep S, 2005, Semin Pediatr Surg, V14, P118, DOI 10.1053/j.sempedsurg.2005.01.008; Brenig B, 2013, ANIM GENET, V44, P450, DOI 10.1111/age.12029; BUEHR M, 1993, DEV DYNAM, V198, P182, DOI 10.1002/aja.1001980304; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Durkin K, 2012, NATURE, V482, P81, DOI 10.1038/nature10757; Eriksson K, 1943, LUND HAKAN OHLSSONS, V155; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Haase B, 2009, ANIM GENET, V40, P623, DOI 10.1111/j.1365-2052.2009.01893.x; KAY GW, 1985, S AFR J ANIM SCI, V15, P58; KAY GW, 1992, J REPROD FERTIL, V96, P537; Lachman HM, 2007, AM J MED GENET B, V144B, P259, DOI 10.1002/ajmg.b.30498; Lagerlof N., 1961, Zuchthygiene, Fortpflanzungsstorungen und Besamung der Haustiere, V5, P141; LAGERLOF N, 1953, CORNELL VET, V43, P64; LAGERLOF N, 1953, CORNELL VET, V43, P52; LAUVERGNE JJ, 1970, J HERED, V61, P43, DOI 10.1093/oxfordjournals.jhered.a108031; Makinen A, 1999, EQUINE VET J, V31, P346, DOI 10.1111/j.2042-3306.1999.tb03829.x; Marklund S, 1998, GENOME RES, V8, P826, DOI 10.1101/gr.8.8.826; Moller MJ, 1996, MAMM GENOME, V7, P822, DOI 10.1007/s003359900244; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; OGAWA M, 1993, DEVELOPMENT, V117, P1089; Olson T, 1999, GENETICS OF CATTLE, P33; Palmieri C, 2011, THERIOGENOLOGY, V75, P393, DOI 10.1016/j.theriogenology.2010.09.020; Pretorius A, 1979, AFRIKANERBEES JOERNA, V25, P40; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Romagnoli S, 2006, VET CLIN N AM-SMALL, V36, P573, DOI 10.1016/j.cvsm.2005.12.007; Rozen S, 2000, Methods Mol Biol, V132, P365; Settergren I, 1964, STOCKH ALMQVIST WIKS, V108; Tarbashevich K, 2010, CURR OPIN CELL BIOL, V22, P715, DOI 10.1016/j.ceb.2010.09.005; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weksberg R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-180; Wriedt C, 1925, J HERED, V16, P51, DOI 10.1093/oxfordjournals.jhered.a102551; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	37	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75659	10.1371/journal.pone.0075659	http://dx.doi.org/10.1371/journal.pone.0075659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086604	Green Published, Green Submitted, gold			2022-12-27	WOS:000325220000032
J	Larsen, KK; Christensen, B; Sondergaard, J; Vestergaard, M				Larsen, Karen Kjaer; Christensen, Bo; Sondergaard, Jens; Vestergaard, Mogens			Depressive Symptoms and Risk of New Cardiovascular Events or Death in Patients with Myocardial Infarction: A Population-Based Longitudinal Study Examining Health Behaviors and Health Care Interventions	PLOS ONE			English	Article							ACUTE CORONARY SYNDROME; PROGNOSTIC ASSOCIATION; COLLABORATIVE CARE; HOSPITAL ANXIETY; MORTALITY; MORBIDITY; RECOMMENDATIONS; REHABILITATION; EPIDEMIOLOGY; METAANALYSIS	Background: Depressive symptoms is associated with adverse cardiovascular outcomes in patients with myocardial infarction (MI), but the underlying mechanisms are unclear and it remains unknown whether subgroups of patients are at a particularly high relative risk of adverse outcomes. We examined the risk of new cardiovascular events and/or death in patients with depressive symptoms following first-time MI taking into account other secondary preventive factors. We further explored whether we could identify subgroups of patients with a particularly high relative risk of adverse outcomes. Methods and Results: We conducted a prospective population-based cohort study of 897 patients discharged with first-time MI between 1 January 2009 and 31 December 2009, and followed up until 31 July 2012. Depressive symptoms were found in 18.6% using the Hospital Anxiety and Depression Scale (HADS-D >= 8). A total of 239 new cardiovascular events, 95 deaths, and 288 composite events (239 new cardiovascular events and 49 deaths) occurred during 1,975 person-years of follow-up. Event-free survival was evaluated using Cox regression analysis. Compared to the 730 patients without depressive symptoms (HADS-D<8), the 167 patients with depressive symptoms (HADS-D >= 8) had age-and sex-adjusted hazard ratios [HR] (95% confidence interval [CI]) of 1.53 (95% CI, 1.14-2.05) for a new cardiovascular event, 3.10 (95% CI, 2.04-4.71) for death and 1.77 (95% CI, 1.36-2.31) for a composite event. The associations were attenuated when adjusted for disease severity, comorbid conditions and physical inactivity; HR = 1.17 (95% CI, 0.85-1.61) for a new cardiovascular event, HR = 2.01 (95% CI, 1.28-3.16) for death, and HR = 1.33 (95% CI, 1.00-1.76) for a composite event. No subgroups of patients had a particularly high risk of adverse outcomes. Conclusions: Depressive symptoms following first-time MI was an independent prognostic risk factor for death, but not for new cardiovascular events. We found no subgroups of patients with a particularly high relative risk of adverse outcomes.	[Larsen, Karen Kjaer; Christensen, Bo; Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Sect Gen Med Practice, Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Aarhus, Denmark; [Sondergaard, Jens] Univ Southern Denmark, Dept Publ Hlth, Res Unit Gen Practice, Odense, Denmark	Aarhus University; Aarhus University; University of Southern Denmark	Larsen, KK (corresponding author), Aarhus Univ, Dept Publ Hlth, Sect Gen Med Practice, Aarhus, Denmark.	kkl@alm.au.dk	Vestergaard, Mogens/M-9333-2014; Søndergaard, Jens js/F-3031-2013	Vestergaard, Mogens/0000-0001-8830-2174; Søndergaard, Jens js/0000-0002-1629-1864	Tryg Foundation [7844-07]; Danish Health Insurance Faoundation [2010B013]; Lundbeck Foundation; Lundbeck Foundation [R155-2012-11280] Funding Source: researchfish	Tryg Foundation; Danish Health Insurance Faoundation; Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Tryg Foundation (grant number 7844-07), the Danish Health Insurance Faoundation (grant number 2010B013), and the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1960, BMJ-BRIT MED J, V2, P1665; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Baumeister H, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008012.pub3; Blumenthal JA, 2012, J AM COLL CARDIOL, V60, P1053, DOI 10.1016/j.jacc.2012.04.040; Carney RM, 2005, ARCH INTERN MED, V165, P1486, DOI 10.1001/archinte.165.13.1486; Carney RM, 2002, J PSYCHOSOM RES, V53, P897, DOI 10.1016/S0022-3999(02)00311-2; Carstensen B, 2011, SCAND J PUBLIC HEALT, V39, P58, DOI 10.1177/1403494811404278; CASE RB, 1992, JAMA-J AM MED ASSOC, V267, P515, DOI 10.1001/jama.267.4.515; Danish Society of Cardiology, NAT GUID CARD CARD R; Davidson KW, 2010, ARCH INTERN MED, V170, P600, DOI 10.1001/archinternmed.2010.29; Druss BG, 2000, JAMA-J AM MED ASSOC, V283, P506, DOI 10.1001/jama.283.4.506; Frasure-Smith N, 2000, CIRCULATION, V101, P1919, DOI 10.1161/01.CIR.101.16.1919; Frasure-Smith N, 1999, PSYCHOSOM MED, V61, P26, DOI 10.1097/00006842-199901000-00006; Frasure-Smith N, 2007, BIOL PSYCHIAT, V62, P302, DOI 10.1016/j.biopsych.2006.09.029; FRASURESMITH N, 1995, HEALTH PSYCHOL, V14, P388, DOI 10.1037/0278-6133.14.5.388; Giannuzzi P, 2003, EUR HEART J, V24, P1273, DOI 10.1016/S0195-668X(03)00198-2; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Glassman AH, 2006, ARCH GEN PSYCHIAT, V63, P283, DOI 10.1001/archpsyc.63.3.283; Green LA, 2009, ANN FAM MED, V7, P71, DOI 10.1370/afm.918; Joensen AM, 2009, J CLIN EPIDEMIOL, V62, P188, DOI 10.1016/j.jclinepi.2008.03.005; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; LADWIG KH, 1991, EUR HEART J, V12, P959; Larsen KK, 2011, SCAND J PRIM HEALTH, V29, P210, DOI 10.3109/02813432.2011.629147; Larsen KK, 2010, CIRCULATION, V122, P2388, DOI 10.1161/CIRCULATIONAHA.110.956136; Larsen KK, 2012, EUR J PREV CARDIOL; Lauzon C, 2003, CAN MED ASSOC J, V168, P547; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Martin CR, 2003, PSYCHIAT RES, V120, P85, DOI 10.1016/S0165-1781(03)00162-8; Meijer A, 2011, GEN HOSP PSYCHIAT, V33, P203, DOI 10.1016/j.genhosppsych.2011.02.007; National Collaborating Centre for Mental Health, 2010, DEPR AD CHRON PHYS H; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; Olsson I, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-46; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Rumsfeld JS, 2005, AM HEART J, V150, P961, DOI 10.1016/j.ahj.2005.02.036; Shiotani I, 2002, J CARDIOVASC RISK, V9, P153, DOI 10.1097/00043798-200206000-00004; Smolderen KG, 2009, CIRC-CARDIOVASC QUAL, V2, P328, DOI 10.1161/CIRCOUTCOMES.109.868588; Sorensen C, 2006, ACTA PSYCHIAT SCAND, V113, P290, DOI 10.1111/j.1600-0447.2006.00777.x; Spijkerman T, 2005, GEN HOSP PSYCHIAT, V27, P411, DOI 10.1016/j.genhosppsych.2005.05.007; Statistics Denmark, 1991, IDA INT DAT LAB MARK; Taylor CB, 2005, ARCH GEN PSYCHIAT, V62, P792, DOI 10.1001/archpsyc.62.7.792; Thombs BD, 2006, J GEN INTERN MED, V21, P30, DOI 10.1111/j.1525-1497.2005.00269.x; Thombs BD, 2007, PSYCHOSOMATICS, V48, P185, DOI 10.1176/appi.psy.48.3.185; Thombs BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052654; Tylee A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-58; van Melle JP, 2004, PSYCHOSOM MED, V66, P814, DOI 10.1097/01.psy.0000146294.82810.9c; VESTBO J, 1988, AM REV RESPIR DIS, V137, P1114, DOI 10.1164/ajrccm/137.5.1114; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zuidersma M, 2013, INT J CARDIOL, V167, P2775, DOI 10.1016/j.ijcard.2012.07.002	50	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74393	10.1371/journal.pone.0074393	http://dx.doi.org/10.1371/journal.pone.0074393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VC	24086339	Green Published, gold			2022-12-27	WOS:000325218700024
J	Sommer, K; Sander, AL; Albig, M; Weber, R; Henrich, D; Frank, J; Marzi, I; Jakob, H				Sommer, Katharina; Sander, Anna Lena; Albig, Michael; Weber, Roxane; Henrich, Dirk; Frank, Johannes; Marzi, Ingo; Jakob, Heike			Delayed Wound Repair in Sepsis Is Associated with Reduced Local Pro-Inflammatory Cytokine Expression	PLOS ONE			English	Article								Sepsis is one of the main causes for morbidity and mortality in hospitalized patients. Moreover, sepsis associated complications involving impaired wound healing are common. Septic patients often require surgical interventions that in-turn may lead to further complications caused by impaired wound healing. We established a mouse model to the study delayed wound healing during sepsis distant to the septic focus point. For this reason cecal ligation and puncture (CLP) was combined with the creation of a superficial wound on the mouse ear. Control animals received the same procedure without CPL. Epithelialization was measured every second day by direct microscopic visualization up to complete closure of the wound. As interplay of TNF-alpha, TGF-beta, matrix metalloproteinases (MMP), and tissue inhibitors of metalloproteinases (TIMP) is important in wound healing in general, TNF-alpha, TGF-beta, MMP7, and TIMP1 were assessed immunohistochemical in samples of wounded ears harvested on days 2, 6, 10 and 16 after wounding. After induction of sepsis, animals showed a significant delay in wound epithelialization from day 2 to 12 compared to control animals. Complete wound healing was attained after mean 12.2 +/- standard deviation (SD) 3.0 days in septic animals compared to 8.7 +/- SD 1.7 days in the control group. Septic animals showed a significant reduction in local pro-inflammatory cytokine level of TNF-alpha on day 2 and day 6 as well as a reduced expression of TGF-beta on day 2 in wounds. A significant lower expression of MMP7 as well as TIMP1 was also observed on day 2 after wounding. The induction of sepsis impairs wound healing distant to the septic focus point. We could demonstrate that expression of important cytokines for wound repair is deregulated after induction of sepsis. Thus restoring normal cytokine response locally in wounds could be a good strategy to enhance wound repair in sepsis.	[Sommer, Katharina; Sander, Anna Lena; Albig, Michael; Weber, Roxane; Henrich, Dirk; Frank, Johannes; Marzi, Ingo; Jakob, Heike] Hosp Johann Wolfgang Goethe Univ, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Sommer, K (corresponding author), Hosp Johann Wolfgang Goethe Univ, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany.	katharina.sommer@kgu.de			"Patenschaftsmodell" of the Johann Wolfgang Goethe-University, Frankfurt am Main, Germany	"Patenschaftsmodell" of the Johann Wolfgang Goethe-University, Frankfurt am Main, Germany	This work was partly supported by the "Patenschaftsmodell" of the Johann Wolfgang Goethe-University, Frankfurt am Main, Germany. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker John H., 1994, Wound Repair and Regeneration, V2, P138, DOI 10.1046/j.1524-475X.1994.20208.x; BARRIERE SL, 1995, CRIT CARE MED, V23, P376, DOI 10.1097/00003246-199502000-00026; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; Dunn L, 2013, JOVE-J VIS EXP, DOI 10.3791/50265; Faler Byron J, 2006, Perspect Vasc Surg Endovasc Ther, V18, P55, DOI 10.1177/153100350601800123; Frank J, 2003, EUR J TRAUMA, V29, P208; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; GREENHALGH DG, 1987, SURGERY, V102, P306; Kanno E, 2011, WOUND REPAIR REGEN, V19, P608, DOI 10.1111/j.1524-475X.2011.00721.x; Koskela M, 2009, CRIT CARE, V13, DOI 10.1186/cc7932; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Maish G, 1998, J SURG RES, V78, P108, DOI 10.1006/jsre.1998.5315; Marti Guy P., 2008, V423, P383, DOI 10.1007/978-1-59745-194-9_30; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Meng W, 2012, CRIT CARE, V16, DOI 10.1186/cc11442; Moali C, 2009, EUR J DERMATOL, V19, P552, DOI 10.1684/ejd.2009.0770; RAPALA K, 1991, EUR SURG RES, V23, P261, DOI 10.1159/000129163; Rico RM, 2002, J SURG RES, V102, P193, DOI 10.1006/jsre.2001.6316; Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; STEENFOS HH, 1994, SCAND J PLAST RECONS, V28, P95, DOI 10.3109/02844319409071186; Toriseva M, 2009, CELL MOL LIFE SCI, V66, P203, DOI 10.1007/s00018-008-8388-4; Wang XJ, 2006, J INVEST DERM SYMP P, V11, P112, DOI 10.1038/sj.jidsymp.5650004; Weinstein DA, 2010, J AM ACAD DERMATOL, V63, P146, DOI 10.1016/j.jaad.2009.08.004; Wolfe RR, 1999, EUR J CLIN NUTR, V53, pS136, DOI 10.1038/sj.ejcn.1600754	25	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e73992	10.1371/journal.pone.0073992	http://dx.doi.org/10.1371/journal.pone.0073992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086305	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700015
J	Moon, SH; Kim, SM; Park, SJ; Kim, H; Bae, D; Choi, YS; Chung, HM				Moon, Sung-Hwan; Kim, Sun-Mi; Park, Soon-Jung; Kim, Hojin; Bae, Daekyeong; Choi, Yong-Soo; Chung, Hyung-Min			Development of a Xeno-Free Autologous Culture System for Endothelial Progenitor Cells Derived from Human Umbilical Cord Blood	PLOS ONE			English	Article							INDUCED PLURIPOTENT STEM; MOUSE MODEL; NEOVASCULARIZATION; TRANSPLANTATION; DIFFERENTIATION; IDENTIFICATION; PRECURSOR; SERUM	Despite promising preclinical outcomes in animal models, a number of challenges remain for human clinical use. In particular, expanding a large number of endothelial progenitor cells (EPCs) in vitro in the absence of animal-derived products is the most critical hurdle remaining to be overcome to ensure the safety and efficiency of human therapy. To develop in vitro culture conditions for EPCs derived from human cord blood (hCB-EPCs), we isolated extracts (UCE) and collagen (UC-collagen) from umbilical cord tissue to replace their animal-derived counterparts. UC-collagen and UCE efficiently supported the attachment and proliferation of hCB-EPCs in a manner comparable to that of animal-derived collagen in the conventional culture system. Our developed autologous culture system maintained the typical characteristics of hCB-EPCs, as represented by the expression of EPC-associated surface markers. In addition, the therapeutic potential of hCB-EPCs was confirmed when the transplantation of hCB-EPCs cultured in this autologous culture system promoted limb salvage in a mouse model of hindlimb ischemia and was shown to contribute to attenuating muscle degeneration and fibrosis. We suggest that the umbilical cord represents a source for autologous biomaterials for the in vitro culture of hCB-EPCs. The main characteristics and therapeutic potential of hCB-EPCs were not compromised in developed autologous culture system. The absence of animal-derived products in our newly developed in vitro culture removes concerns associated with secondary contamination. Thus, we hope that this culture system accelerates the realization of therapeutic applications of autologous hCB-EPCs for human vascular diseases.	[Moon, Sung-Hwan; Park, Soon-Jung; Chung, Hyung-Min] Konkuk Univ, Sch Med, Dept Stem Cell Biol, Seoul, South Korea; [Kim, Sun-Mi; Kim, Hojin; Choi, Yong-Soo] CHA Univ, Dept Appl Biosci, Songnam, South Korea; [Park, Soon-Jung; Bae, Daekyeong; Choi, Yong-Soo; Chung, Hyung-Min] CHA Bio & Diostech Co Ltd, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Pochon Cha University	Choi, YS (corresponding author), CHA Univ, Dept Appl Biosci, Songnam, South Korea.	yschoi@cha.ac.kr; stemchung@gmail.com		Choi, Yong-Soo/0000-0001-8445-8067; Moon, Sunghwan/0000-0003-1858-0261	Bio & Medical Technology Development Program of the National Research Foundation (NRF); South Korean government (MEST) [2011-0019487]	Bio & Medical Technology Development Program of the National Research Foundation (NRF)(National Research Foundation of Korea); South Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF), which is funded by the South Korean government (MEST) (No. 2011-0019487). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; BELTRAMI CA, 1994, CIRCULATION, V89, P151, DOI 10.1161/01.CIR.89.1.151; Bompais H, 2004, BLOOD, V103, P2577, DOI 10.1182/blood-2003-08-2770; Cho SW, 2007, CIRCULATION, V116, P2409, DOI 10.1161/CIRCULATIONAHA.106.687038; Choi JS, 2009, J CONTROL RELEASE, V139, P2, DOI 10.1016/j.jconrel.2009.05.034; Choi KD, 2012, CELL REP, V2, P553, DOI 10.1016/j.celrep.2012.08.002; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Escobedo-Lucea C, 2010, METHODS MOL BIOL, V584, P55, DOI 10.1007/978-1-60761-369-5_3; Fadini GP, 2008, DIABETOLOGIA, V51, P1091, DOI 10.1007/s00125-008-1021-0; Finney MR, 2006, BIOL BLOOD MARROW TR, V12, P585, DOI 10.1016/j.bbmt.2005.12.037; GIARD DJ, 1987, IN VITRO CELL DEV B, V23, P691, DOI 10.1007/BF02620982; Hattori F, 2012, TRANSPLANT REV-ORLAN, V26, P223, DOI 10.1016/j.trre.2011.09.003; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kawamoto A, 2009, STEM CELLS, V27, P2857, DOI 10.1002/stem.207; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Losordo DW, 2007, CIRCULATION, V115, P3165, DOI 10.1161/CIRCULATIONAHA.106.687376; Mallon BS, 2006, INT J BIOCHEM CELL B, V38, P1063, DOI 10.1016/j.biocel.2005.12.014; Masuda H, 2003, CARDIOVASC RES, V58, P390, DOI 10.1016/S0008-6363(02)00785-X; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; Moon SH, 2011, BIOMATERIALS, V32, P6445, DOI 10.1016/j.biomaterials.2011.05.026; Okano S, 2006, AM J VET RES, V67, P1020, DOI 10.2460/ajvr.67.6.1020; Pearl JI, 2011, CELL STEM CELL, V8, P309, DOI 10.1016/j.stem.2011.01.012; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Shin KS, 2010, CELL PROLIFERAT, V43, P435, DOI 10.1111/j.1365-2184.2010.00693.x; Sobolewski K, 1997, BIOL NEONATE, V71, P11; Suarez Y, 2007, J IMMUNOL, V179, P7488, DOI 10.4049/jimmunol.179.11.7488; van der Valk J, 2010, TOXICOL IN VITRO, V24, P1053, DOI 10.1016/j.tiv.2010.03.016; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wang XG, 2007, J AM COLL CARDIOL, V49, P1566, DOI 10.1016/j.jacc.2006.12.037; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zisch AH, 2004, CURR OPIN BIOTECH, V15, P424, DOI 10.1016/j.copbio.2004.08.005	33	8	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75224	10.1371/journal.pone.0075224	http://dx.doi.org/10.1371/journal.pone.0075224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086472	Green Published, gold, Green Submitted			2022-12-27	WOS:000325025200030
J	Wang, Q; Xiang, B; Deng, W; Wu, JY; Li, ML; Ma, XH; Wang, YC; Jiang, LJ; McAlonan, G; Chua, SE; Sham, PC; Hu, X; Li, T				Wang, Qiang; Xiang, Bo; Deng, Wei; Wu, Junyao; Li, Mingli; Ma, Xiaohong; Wang, Yingcheng; Jiang, Lijun; McAlonan, Grainne; Chua, Siew E.; Sham, Pak C.; Hu, Xun; Li, Tao			Genome-Wide Association Analysis with Gray Matter Volume as a Quantitative Phenotype in First-Episode Treatment-Naive Patients with Schizophrenia	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; CYTOARCHITECTONIC MAPS; ONSET SCHIZOPHRENIA; COMMON VARIANTS; ABNORMALITIES; GENETICS; GENES; HIPPOCAMPAL; THROMBOXANE; INFARCTION	Reduced Gray matter (GM) volume is a core feature of schizophrenia. Mapping genes that is associated with the heritable disease-related phenotypes may be conducive to elucidate the pathogenesis of schizophrenia. This study aims to identify the common genetic variants that underlie the deficits of GM volume in schizophrenia. High-resolution T1 images and whole genome genotyping data were obtained from 74 first-episode treatment-naive patients with schizophrenia and 51 healthy controls in the Mental Health Centre of the West China Hospital, Sichuan University. All participants were scanned using a 3T MR imaging system and were genotyped using the HumanHap660 Bead Array. Reduced GM volumes in three brain areas including left hOC3v in the collateral sulcus of visual cortex (hOC3vL), left cerebellar vermis lobule 10 (vermisL10) and right cerebellar vermis lobule 10 (vermisR10) were found in patients with schizophrenia. There was a group by genotype interaction when genotypes from genome-wide scan were subsequently considered in the case-control analyses. SNPs from three genes or chromosomal regions (TBXAS1, PIK3C2G and HS3ST5) were identified to predict the changes of GM volume in hOC3vL, vermisL10 and vermisR10. These results also highlighted the usefulness of endophenotype in exploring the pathogenesis of neuropsychiatric diseases such as schizophrenia although further independent replication studies are needed in the future.	[Wang, Qiang; Deng, Wei; Li, Mingli; Ma, Xiaohong; Wang, Yingcheng; Jiang, Lijun; Li, Tao] Sichuan Univ, West China Hosp, Mental Hlth Ctr, Chengdu 610064, Sichuan, Peoples R China; [Xiang, Bo; Wu, Junyao; Ma, Xiaohong; Wang, Yingcheng; Li, Tao] Sichuan Univ, West China Hosp, Psychiat Lab, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China; [Chua, Siew E.; Sham, Pak C.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [McAlonan, Grainne] Kings Coll London, Inst Psychiat, Dept Forens & Neurodev Sci, London, England; [Hu, Xun] Sichuan Univ, West China Hosp, Biobank, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University; University of Hong Kong; University of London; King's College London; Sichuan University	Hu, X (corresponding author), Sichuan Univ, West China Hosp, Biobank, Chengdu 610064, Sichuan, Peoples R China.	hxxhu99@163.com; litaohx@scu.edu.cn	Deng, Wei/AAU-9945-2020; Deng, Wei/GWC-9207-2022; McAlonan, Grainne/G-1541-2011	McAlonan, Grainne/0000-0002-4466-2343; Li, Tao/0000-0003-3831-901X; Ma, Xiaohong/0000-0003-2627-9946	National Nature Science Foundation of China [81130024, 30530300, 30125014, 30971056, 81271479]; National Basic Research Program of China (973 Program) [2007CB512301]; Ph.D. Programs Foundation of Ministry of Education of China [20110181110014]; National Key Technology R & D Program of the Ministry of Science and Technology of China [2012BAI01B06]; NARSAD Independent Investigator Award; Wellcome Trust (International Collaborative award)	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); National Key Technology R & D Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); NARSAD Independent Investigator Award(NARSAD); Wellcome Trust (International Collaborative award)(Wellcome Trust)	This work was partly funded by National Nature Science Foundation of China (81130024, 30530300 and 30125014, T. L.); the National Basic Research Program of China (973 Program 2007CB512301, T. L.), the Ph.D. Programs Foundation of Ministry of Education of China (20110181110014, T. L.), National Key Technology R & D Program of the Ministry of Science and Technology of China during the 12th Five-Year Plan (2012BAI01B06, T. L.), NARSAD Independent Investigator Award (T. L.), and the Wellcome Trust (International Collaborative award to T. L. and D. A. C.); National Nature Science Foundation of China (30971056 and 81271479, Q. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Brown GG, 2011, PSYCHIAT RES-NEUROIM, V194, P149, DOI 10.1016/j.pscychresns.2011.05.005; Brun CC, 2009, NEUROIMAGE, V48, P37, DOI 10.1016/j.neuroimage.2009.05.022; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Dutt A, 2009, PSYCHOL MED, V39, P1783, DOI 10.1017/S0033291709990316; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; Fornito A, 2009, SCHIZOPHR RES, V108, P104, DOI 10.1016/j.schres.2008.12.011; GOTTESMAN II, 1987, SCHIZOPHRENIA BULL, V13, P23, DOI 10.1093/schbul/13.1.23; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Ho BC, 2011, ARCH GEN PSYCHIAT, V68, P128, DOI 10.1001/archgenpsychiatry.2010.199; Hu MR, 2013, SCHIZOPHR RES, V144, P37, DOI 10.1016/j.schres.2012.12.018; Jacobson S, 2010, NEUROIMAGE, V49, P1875, DOI 10.1016/j.neuroimage.2009.09.015; Jungerius BJ, 2008, MOL PSYCHIATR, V13, P1060, DOI 10.1038/sj.mp.4002080; Kakeda S, 2010, NEURORADIOLOGY, V52, P711, DOI 10.1007/s00234-010-0717-2; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Leung M, 2011, SCHIZOPHRENIA BULL, V37, P199, DOI 10.1093/schbul/sbp099; Li MX, 2009, BIOINFORMATICS, V25, P1449, DOI 10.1093/bioinformatics/btp183; Maloku E, 2011, NEUROPSYCHOPHARMACOL, V36, P1366, DOI 10.1038/npp.2011.21; Matsuo K, 2009, NEUROPSYCHOPHARMACOL, V34, P1904, DOI 10.1038/npp.2009.23; McGuffin P, 1999, NEW ENGL J MED, V341, P370; Miyata J, 2009, SCHIZOPHR RES, V111, P78, DOI 10.1016/j.schres.2009.03.010; Mochizuki H, 2003, J BIOL CHEM, V278, P26780, DOI 10.1074/jbc.M301861200; Owen MJ, 2004, MOL PSYCHIATR, V9, P14, DOI 10.1038/sj.mp.4001444; Park SA, 2009, BMB REP, V42, P200, DOI 10.5483/BMBRep.2009.42.4.200; Penttila J, 2008, J AM ACAD CHILD PSY, V47, P1125, DOI 10.1097/CHI.0b013e3181825aa7; Pomarol-Clotet E, 2010, MOL PSYCHIATR, V15, P823, DOI 10.1038/mp.2009.146; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P96, DOI 10.1093/schbul/sbn155; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rametti G, 2010, SCHIZOPHR RES, V121, P66, DOI 10.1016/j.schres.2010.05.016; Rasser PE, 2010, NEUROIMAGE, V53, P1175, DOI 10.1016/j.neuroimage.2010.07.018; Rijsdijk FV, 2005, PSYCHOL MED, V35, P1399, DOI 10.1017/S0033291705005167; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rottschy C, 2007, HUM BRAIN MAPP, V28, P1045, DOI 10.1002/hbm.20348; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Stein JL, 2010, NEUROIMAGE, V53, P1160, DOI 10.1016/j.neuroimage.2010.02.032; Takao H, 2010, J MAGN RESON IMAGING, V31, P221, DOI 10.1002/jmri.22017; Tsujita Y, 2000, ATHEROSCLEROSIS, V153, P261, DOI 10.1016/S0021-9150(00)00593-1; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Voets NL, 2008, NEUROIMAGE, V43, P665, DOI 10.1016/j.neuroimage.2008.08.013; Watson DR, 2012, BEHAV BRAIN RES, V227, P91, DOI 10.1016/j.bbr.2011.10.034; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979	49	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75083	10.1371/journal.pone.0075083	http://dx.doi.org/10.1371/journal.pone.0075083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086445	Green Published, Green Submitted, gold			2022-12-27	WOS:000325025200024
J	Errington, TM; Macara, IG				Errington, Timothy M.; Macara, Ian G.			Depletion of the Adaptor Protein NCK Increases UV-Induced p53 Phosphorylation and Promotes Apoptosis	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; ATM; IDENTIFICATION; EXPRESSION; DOMAIN; INHIBITION; REVEALS; BINDING; BREAKS; GENES	The cellular response to DNA damage requires the coordination of many proteins involved in diverse molecular processes. Discrete molecular pathways are becoming increasingly well understood, but the interconnectivity and coordination of multiple pathways remains less clear. We now show that NCK, an adapter protein involved in cytoskeletal responses to tyrosine kinase receptor signaling, accumulates in the nucleus in response to DNA damage and this translocation can be blocked by specific inhibition of the ATR protein kinase. Strikingly, HeLa cells depleted of NCK undergo apoptosis shortly after UV irradiation, as monitored by caspase-3 cleavage and PARP cleavage. This rapid, hyperactive apoptosis in NCK depleted cells might be p53 dependent, because loss of NCK also increased UV-induced p53 phosphorylation. Importantly, depletion of SOCS7, which is necessary for NCK nuclear translocation, phenocopies NCK depletion, indicating the nuclear accumulation of NCK is responsible for these molecular events. There are two NCK isoforms that have mostly redundant functions, and although NCK2 appears to have a greater contribution, depletion of NCK1 or NCK2, led to increased p53 phosphorylation and early apoptosis after UV exposure. These data reveal a novel function for NCK in regulating p53 phosphorylation and apoptosis, and provide evidence for interconnectedness of growth factor signaling proteins and the DNA damage response.	[Errington, Timothy M.] Univ Virginia, Sch Med, Dept Microbiol, Ctr Cell Signaling, Charlottesville, VA 22908 USA; [Macara, Ian G.] Vanderbilt Univ, Ctr Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA	University of Virginia; Vanderbilt University	Macara, IG (corresponding author), Vanderbilt Univ, Ctr Med, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37232 USA.	ian.g.macara@vanderbilt.edu		Errington, Tim/0000-0002-4959-5143	National Institutes of Health, DHHS [RO1GM50526]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066306, R01GM050526] Funding Source: NIH RePORTER	National Institutes of Health, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, DHHS, through grant RO1GM50526. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bladt F, 2003, MOL CELL BIOL, V23, P4586, DOI 10.1128/MCB.23.13.4586-4597.2003; Braverman LE, 1999, J BIOL CHEM, V274, P5542, DOI 10.1074/jbc.274.9.5542; Buday L, 1999, BBA-REV BIOMEMBRANES, V1422, P187, DOI 10.1016/S0304-4157(99)00005-2; Chen LY, 2003, MOL CELL BIOL, V23, P7108, DOI 10.1128/MCB.23.20.7108-7121.2003; Chen M, 1998, J BIOL CHEM, V273, P25171, DOI 10.1074/jbc.273.39.25171; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Dogusan Z, 2000, J NEUROIMMUNOL, V109, P34, DOI 10.1016/S0165-5728(00)00300-3; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hussain S. Perwez, 2006, Journal of Nippon Medical School, V73, P54; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kirch HC, 1999, ONCOGENE, V18, P2728, DOI 10.1038/sj.onc.1202626; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; Kremer BE, 2007, CELL, V130, P837, DOI 10.1016/j.cell.2007.06.053; Labelle-Cote M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-443; Lal A, 2005, MOL CELL PROBE, V19, P385, DOI 10.1016/j.mcp.2005.06.007; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; LEHMANN JM, 1990, NUCLEIC ACIDS RES, V18, P1048, DOI 10.1093/nar/18.4.1048; Lettau M, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-1; Liu WJ, 2008, CARCINOGENESIS, V29, P263, DOI 10.1093/carcin/bgm251; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Matuoka K, 1997, BIOCHEM BIOPH RES CO, V239, P488, DOI 10.1006/bbrc.1997.7492; McCarty JH, 1998, BIOESSAYS, V20, P913, DOI 10.1002/(SICI)1521-1878(199811)20:11<913::AID-BIES6>3.0.CO;2-T; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; RICHARDS SA, 1995, J BIOL CHEM, V270, P14405, DOI 10.1074/jbc.270.24.14405; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sarkaria JN, 1998, CANCER RES, V58, P4375; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Smith JA, 2005, CANCER RES, V65, P1027; Tomimatsu N, 2009, EMBO REP, V10, P629, DOI 10.1038/embor.2009.60; Ward IM, 2001, J BIOL CHEM, V276, P47755, DOI 10.1074/jbc.C100587200	37	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e76204	10.1371/journal.pone.0076204	http://dx.doi.org/10.1371/journal.pone.0076204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086708	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200131
J	Gil-Mohapel, J; Brocardo, PS; Choquette, W; Gothard, R; Simpson, JM; Christie, BR				Gil-Mohapel, Joana; Brocardo, Patricia S.; Choquette, Will; Gothard, Russ; Simpson, Jessica M.; Christie, Brian R.			Hippocampal Neurogenesis Levels Predict WATERMAZE Search Strategies in the Aging Brain	PLOS ONE			English	Article							GENERATED GRANULE CELLS; TRANSGENIC MOUSE MODEL; AGE-RELATED DECLINE; DENTATE GYRUS; ADULT NEUROGENESIS; SYNAPTIC PLASTICITY; LIFE-SPAN; DIETARY RESTRICTION; VOLUNTARY EXERCISE; PRENATAL STRESS	The hippocampus plays a crucial role in the formation of spatial memories, and it is thought that adult hippocampal neurogenesis may participate in this form of learning. To better elucidate the relationship between neurogenesis and spatial learning, we examined both across the entire life span of mice. We found that cell proliferation, neuronal differentiation, and neurogenesis significantly decrease with age, and that there is an abrupt reduction in these processes early on, between 1.5-3 months of age. After this, the neurogenic capacity continues to decline steadily. The initial abrupt decline in adult neurogenesis was paralleled by a significant reduction in Morris Water Maze performance, however overall learning and memory remained constant thereafter. Further analysis of the search strategies employed revealed that reductions in neurogenesis in the aging brain were strongly correlated with the adoption of spatially imprecise search strategies. Overall, performance measures of learning and memory in the Morris Water Maze were maintained at relatively constant levels in aging animals due to an increase in the use of spatially imprecise search strategies.	[Gil-Mohapel, Joana; Brocardo, Patricia S.; Choquette, Will; Gothard, Russ; Simpson, Jessica M.; Christie, Brian R.] Univ Victoria, Isl Med Program, Div Med Sci, Victoria, BC, Canada; [Choquette, Will; Simpson, Jessica M.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Gothard, Russ] Univ Victoria, Dept Psychol, Victoria, BC, Canada; [Christie, Brian R.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Christie, Brian R.] Univ British Columbia, Program Neurosci, Vancouver, BC V5Z 1M9, Canada; [Christie, Brian R.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	University of Victoria; University of Victoria; University of Victoria; University of British Columbia; University of British Columbia; University of British Columbia	Christie, BR (corresponding author), Univ Victoria, Isl Med Program, Div Med Sci, Victoria, BC, Canada.	brain64@uvic.ca	Brocardo, Patricia S/N-8522-2016; Christie, Brian Ross/AAF-3766-2019; Gil-Mohapel, Joana/AAP-8871-2021; S Brocardo, Patricia/N-7407-2018	Christie, Brian Ross/0000-0002-6830-0160; Gil-Mohapel, Joana/0000-0003-4982-1662; S Brocardo, Patricia/0000-0002-1680-5909	Natural Sciences and Engineering Research Council of Canada (NSERC); Michael Smith Foundation for Health Research (MSFHR); Canadian Bureau for International Education; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; National Counsel of Technological and Scientific Development, Brazil); NSERC; MSFHR; Canadian Institutes of Health Research (CIHR); Canada Foundation for Innovation (CFI)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Canadian Bureau for International Education; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; National Counsel of Technological and Scientific Development, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); MSFHR(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation)	J.G.M. acknowledges postdoctoral funding from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Michael Smith Foundation for Health Research (MSFHR). P. S. B. acknowledges post-doctoral funding from the Canadian Bureau for International Education and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; National Counsel of Technological and Scientific Development, Brazil). J.M.S. was supported by scholarships from NSERC and MSFHR. B. R. C. is a Michael Smith Senior Scholar and is supported by grants from NSERC, the Canadian Institutes of Health Research (CIHR), MSFHR, and the Canada Foundation for Innovation (CFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg MAI, 2000, J NEUROSCI, V20, P2896; Alpar A, 2010, BRAIN RES, V1330, P9, DOI 10.1016/j.brainres.2010.03.026; ALTMAN J, 1962, SCIENCE, V135, P1127, DOI 10.1126/science.135.3509.1127; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Amrein I, 2010, BRAIN RES, V1328, P12, DOI 10.1016/j.brainres.2010.02.075; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; Bizon JL, 2004, AGING CELL, V3, P227, DOI 10.1111/j.1474-9728.2004.00099.x; Bohbot VD, 2007, HIPPOCAMPUS, V17, P863, DOI 10.1002/hipo.20313; Bondolfi L, 2004, NEUROBIOL AGING, V25, P333, DOI 10.1016/S0197-4580(03)00083-6; Brocardo P., 2012, NEUROGENESIS RES NEW, P1; BROCARDO PS, 2012, COGNITIVE BEHAV THER, P37; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Bruel-Jungerman E, 2007, REV NEUROSCIENCE, V18, P93; Brunet JF, 1999, BIOESSAYS, V21, P313, DOI 10.1002/(SICI)1521-1878(199904)21:4<313::AID-BIES7>3.0.CO;2-C; Burgess N, 2002, Q J EXP PSYCHOL-A, V55, P1057, DOI 10.1080/02724980244000224; Cameron HA, 1998, CURR OPIN NEUROBIOL, V8, P677, DOI 10.1016/S0959-4388(98)80099-8; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Christie BR, 2006, HIPPOCAMPUS, V16, P199, DOI 10.1002/hipo.20151; Clapcote SJ, 2004, BEHAV BRAIN RES, V152, P35, DOI 10.1016/j.bbr.2003.09.030; Cooper-Kuhn CM, 2002, DEV BRAIN RES, V134, P13, DOI 10.1016/S0165-3806(01)00243-7; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Drapeau E, 2007, J NEUROSCI, V27, P6037, DOI 10.1523/JNEUROSCI.1031-07.2007; Ehninger D, 2008, CELL TISSUE RES, V331, P243, DOI 10.1007/s00441-007-0478-3; EICHENBAUM H, 1990, J NEUROSCI, V10, P3531; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Epp JR, 2010, HIPPOCAMPUS, V20, P866, DOI 10.1002/hipo.20692; Epp JR, 2009, HIPPOCAMPUS, V19, P1040, DOI 10.1002/hipo.20546; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Flurkey K, 2007, MOUSE BIOMEDICAL RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; GILMOHAPEL J, 2010, ADULT NEUROGENESIS C, P125; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Harrist A, 2004, SYNAPSE, V54, P200, DOI 10.1002/syn.20081; Hattiangady B, 2008, NEUROBIOL AGING, V29, P129, DOI 10.1016/j.neurobiolaging.2006.09.015; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Jabes A, 2010, EUR J NEUROSCI, V31, P273, DOI 10.1111/j.1460-9568.2009.07061.x; James LE, 2001, PSYCHOL SCI, V12, P485, DOI 10.1111/1467-9280.00390; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Kannangara TS, 2011, NEUROBIOL AGING, V32, P2279, DOI 10.1016/j.neurobiolaging.2009.12.025; Kannangara TS, 2009, HIPPOCAMPUS, V19, P889, DOI 10.1002/hipo.20514; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kee N, 2007, NAT PROTOC, V2, P3033, DOI 10.1038/nprot.2007.415; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1998, NAT MED, V4, P555, DOI 10.1038/nm0598-555; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; KEMPERMANN G, 2006, ADULT NEUROGENESIS S; Kerr AL, 2010, NEUROSCIENCE, V171, P214, DOI 10.1016/j.neuroscience.2010.08.008; Klempin F, 2007, EUR ARCH PSY CLIN N, V257, P271, DOI 10.1007/s00406-007-0731-5; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Koehl M, 2009, EUR J NEUROSCI, V29, P635, DOI 10.1111/j.1460-9568.2009.06608.x; Kronenberg G, 2006, NEUROBIOL AGING, V27, P1505, DOI 10.1016/j.neurobiolaging.2005.09.016; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lassalle JM, 2000, NEUROBIOL LEARN MEM, V73, P243, DOI 10.1006/nlme.1999.3931; Lazic SE, 2012, NEUROBIOL AGING, V33, P1664, DOI 10.1016/j.neurobiolaging.2011.03.008; Lazic SE, 2012, J R SOC INTERFACE, V9, P907, DOI 10.1098/rsif.2011.0510; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Leuner B, 2004, J NEUROSCI, V24, P7477, DOI 10.1523/JNEUROSCI.0204-04.2004; Leuner B, 2007, P NATL ACAD SCI USA, V104, P17169, DOI 10.1073/pnas.0708228104; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Limoli CL, 2004, RADIAT RES, V161, P17, DOI 10.1667/RR3112; Lipp HP, 1998, CURR OPIN NEUROBIOL, V8, P272, DOI 10.1016/S0959-4388(98)80151-7; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Manda K, 2009, J PINEAL RES, V46, P71, DOI 10.1111/j.1600-079X.2008.00632.x; Manev H, 2001, EUR J PHARMACOL, V411, P67, DOI 10.1016/S0014-2999(00)00904-3; Martinez-Canabal A, 2013, HIPPOCAMPUS, V23, P66, DOI 10.1002/hipo.22054; Meziane H, 2007, GENES BRAIN BEHAV, V6, P192, DOI 10.1111/j.1601-183X.2006.00249.x; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Morgenstern NA, 2008, J PHYSIOL-LONDON, V586, P3751, DOI 10.1113/jphysiol.2008.154807; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Nixon K, 2004, J NEUROSCI, V24, P9714, DOI 10.1523/JNEUROSCI.3063-04.2004; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pleasure SJ, 2000, J NEUROSCI, V20, P6095, DOI 10.1523/JNEUROSCI.20-16-06095.2000; Rao MS, 2006, AGING CELL, V5, P545, DOI 10.1111/j.1474-9726.2006.00243.x; Redish AD, 1998, NEURAL COMPUT, V10, P73, DOI 10.1162/089976698300017908; Rivas-Arancibia S, 2010, TOXICOL SCI, V113, P187, DOI 10.1093/toxsci/kfp252; Rodriguez JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002935; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Sharma V.K., 2009, J BIOSCI TECH, V1, P15; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Simon M, 2005, BRAIN RES, V1049, P244, DOI 10.1016/j.brainres.2005.05.006; Simpson JM, 2011, NEUROBIOL DIS, V41, P249, DOI 10.1016/j.nbd.2010.09.012; Siwak-Tapp CT, 2007, NEUROBIOL LEARN MEM, V88, P249, DOI 10.1016/j.nlm.2007.05.001; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Speisman RB, 2013, BRAIN BEHAV IMMUN, V28, P25, DOI 10.1016/j.bbi.2012.09.013; Speisman RB, 2013, NEUROBIOL AGING, V34, P263, DOI 10.1016/j.neurobiolaging.2012.05.023; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; UND V, 2007, CELL TISSUE RES, V329, P409; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Wolfer DP, 1998, EUR J NEUROSCI, V10, P708, DOI 10.1046/j.1460-9568.1998.00089.x; Wu CW, 2008, J APPL PHYSIOL, V105, P1585, DOI 10.1152/japplphysiol.90775.2008; Xavier GF, 2009, PROG NEURO-PSYCHOPH, V33, P762, DOI 10.1016/j.pnpbp.2009.03.036; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	117	74	76	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75125	10.1371/journal.pone.0075125	http://dx.doi.org/10.1371/journal.pone.0075125			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086453	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200084
J	Hiblot, J; Gotthard, G; Elias, M; Chabriere, E				Hiblot, Julien; Gotthard, Guillaume; Elias, Mikael; Chabriere, Eric			Differential Active Site Loop Conformations Mediate Promiscuous Activities in the Lactonase SsoPox	PLOS ONE			English	Article							QUORUM-QUENCHING LACTONASE; RAY DIFFRACTION ANALYSIS; DIRECTED EVOLUTION; THERMOSTABLE PHOSPHOTRIESTERASE; SULFOLOBUS-SOLFATARICUS; STRUCTURAL BASIS; CRYSTALLIZATION; HOMOLOG; MODEL	Enzymes are proficient catalysts that enable fast rates of Michaelis-complex formation, the chemical step and products release. These different steps may require different conformational states of the active site that have distinct binding properties. Moreover, the conformational flexibility of the active site mediates alternative, promiscuous functions. Here we focused on the lactonase SsoPox from Sulfolobus solfataricus. SsoPox is a native lactonase endowed with promiscuous phosphotriesterase activity. We identified a position in the active site loop (W263) that governs its flexibility, and thereby affects the substrate specificity of the enzyme. We isolated two different sets of substitutions at position 263 that induce two distinct conformational sampling of the active loop and characterized the structural and kinetic effects of these substitutions. These sets of mutations selectively and distinctly mediate the improvement of the promiscuous phosphotriesterase and oxo-lactonase activities of SsoPox by increasing active-site loop flexibility. These observations corroborate the idea that conformational diversity governs enzymatic promiscuity and is a key feature of protein evolvability.	[Hiblot, Julien; Gotthard, Guillaume; Chabriere, Eric] Univ Mediterranee, URMITE, Fac Med, CNRS IRD,UMR 6236, Marseille, France; [Elias, Mikael] Weizmann Inst Sci Biol Chem, Rehovot, Israel	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Elias, M (corresponding author), Weizmann Inst Sci Biol Chem, Rehovot, Israel.	mikael.elias@gmx.fr; eric.chabriere@univmed.fr	Hiblot, Julien/AAA-4452-2020; Elias, Mikael/AAH-9385-2021	Hiblot, Julien/0000-0002-7883-8079; Elias, Mikael/0000-0003-0406-7539	Direction Generale de l'Armement (DGA), France [REI. 2009 34 0045]; Vaincre La Mucoviscidose, France; DGA; IEF Marie Curie program [252836]	Direction Generale de l'Armement (DGA), France; Vaincre La Mucoviscidose, France; DGA; IEF Marie Curie program	This work was granted by Direction Generale de l'Armement (DGA), France (REI. 2009 34 0045) and Vaincre La Mucoviscidose, France. JH and GG are PhD students granted by DGA. ME is a fellow supported by the IEF Marie Curie program (grant No. 252836). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Afriat-Jurnou L, 2012, BIOCHEMISTRY-US, V51, P6047, DOI 10.1021/bi300694t; Amara N, 2011, CHEM REV, V111, P195, DOI 10.1021/cr100101c; Ashani Y, 2010, CHEM-BIOL INTERACT, V187, P362, DOI 10.1016/j.cbi.2010.02.039; Ben-David M, 2013, J MOL BIOL, V425, P1028, DOI 10.1016/j.jmb.2013.01.009; Ben-David M, 2012, J MOL BIOL, V418, P181, DOI 10.1016/j.jmb.2012.02.042; Chow JY, 2010, J BIOL CHEM, V285, P40911, DOI 10.1074/jbc.M110.177139; Chow JY, 2009, BIOCHEMISTRY-US, V48, P4344, DOI 10.1021/bi9004045; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Del Vecchio P, 2009, EXTREMOPHILES, V13, P461, DOI 10.1007/s00792-009-0231-9; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DELLUSGUR E, 2013, J MOL BIOL; Dickschat JS, 2010, NAT PROD REP, V27, P343, DOI 10.1039/b804469b; Duan K, 2007, J BACTERIOL, V189, P4827, DOI 10.1128/JB.00043-07; DUMAS DP, 1989, J BIOL CHEM, V264, P19659; Elias M, 2008, J MOL BIOL, V379, P1017, DOI 10.1016/j.jmb.2008.04.022; Elias M, 2007, ACTA CRYSTALLOGR F, V63, P553, DOI 10.1107/S1744309107023512; Elias M, 2012, J BIOL CHEM, V287, P11, DOI 10.1074/jbc.R111.257329; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gotthard G, 2011, ACTA CRYSTALLOGR F, V67, P354, DOI 10.1107/S1744309110053819; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gupta RD, 2011, NAT CHEM BIOL, V7, P120, DOI [10.1038/nchembio.510, 10.1038/NCHEMBIO.510]; Hawwa R, 2009, ARCH BIOCHEM BIOPHYS, V488, P109, DOI 10.1016/j.abb.2009.06.005; Hawwa R, 2009, J MOL BIOL, V393, P36, DOI 10.1016/j.jmb.2009.06.083; Hiblot J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047028; Hiblot J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00779; Hou L, 2007, J BIOL CHEM, V282, P23264, DOI 10.1074/jbc.M700868200; Jackson CJ, 2009, P NATL ACAD SCI USA, V106, P21631, DOI 10.1073/pnas.0907548106; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; KOSHLAND DE, 1994, ANGEW CHEM INT EDIT, V33, P2375; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merone L, 2005, EXTREMOPHILES, V9, P297, DOI 10.1007/s00792-005-0445-4; Merone L, 2010, BIORESOURCE TECHNOL, V101, P9204, DOI 10.1016/j.biortech.2010.06.102; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NG FS, 2010, APPL ENV MICROBIOL; Popat R, 2008, BRIT MED BULL, V87, P63, DOI 10.1093/bmb/ldn030; Porzio E, 2007, BIOCHIMIE, V89, P625, DOI 10.1016/j.biochi.2007.01.007; Roodveldt C, 2005, BIOCHEMISTRY-US, V44, P12728, DOI 10.1021/bi051021e; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Sigman JA, 2005, BIOCHEM J, V388, P255, DOI 10.1042/BJ20041481; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tokuriki N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2246; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xiang DF, 2009, BIOCHEMISTRY-US, V48, P2237, DOI 10.1021/bi802274f; XUE B, 2012, BIOCHEMISTRY-US, V51, P10120, DOI DOI 10.1021/BI3011829.PUBMED:23088324	49	57	60	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75272	10.1371/journal.pone.0075272	http://dx.doi.org/10.1371/journal.pone.0075272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086491	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200095
J	Sominskaya, I; Skrastina, D; Petrovskis, I; Dishlers, A; Berza, I; Mihailova, M; Jansons, J; Akopjana, I; Stahovska, I; Dreilina, D; Ose, V; Pumpens, P				Sominskaya, Irina; Skrastina, Dace; Petrovskis, Ivars; Dishlers, Andris; Berza, Ieva; Mihailova, Maria; Jansons, Juris; Akopjana, Inara; Stahovska, Irina; Dreilina, Dzidra; Ose, Velta; Pumpens, Paul			A VLP Library of C-Terminally Truncated Hepatitis B Core Proteins: Correlation of RNA Encapsidation with a Th1/Th2 Switch in the Immune Responses of Mice	PLOS ONE			English	Article							VIRUS CORE; CAPSID PROTEIN; ESCHERICHIA-COLI; ANTIGEN; PARTICLES; EXPRESSION; SURFACE; DOMAIN; CELLS; GENE	An efficient pBR327-and Ptrp-based E. coli expression system was used to generate a large-scale library of virus like particles (VLP) formed by recombinant hepatitis B virus (HBV) core (HBc) protein derivatives. To construct the library, the gene of HBc protein of the genotype D/subtype ayw2 virus was gradually truncated from the 3'-end and twenty-two HBc variants (with truncation up to 139 aa) were expressed at high levels. The proteins were purified by salt precipitation and gel filtration. Background RNA binding was observed for VLPs formed by HBc1-149, which lacked all C-terminal Arg blocks, and the addition of three Arg residues (HBc1-152) only slightly increased RNA binding. The presence of two Arg blocks (proteins HBc1-162 and HBc1-163) resulted in approximately half of the typical level of RNA binding, and the presence of three blocks (protein HBc1-171) led to approximately 85% of the typical level of binding. Only a small increase in the level of RNA binding was found for the HBc1-175 VLPs, which contained all four Arg blocks but lacked the last 8 aa of the full-length HBc protein. VLPs containing high levels of RNA had higher antigenicity according to an ELISA with anti-HBc mAbs than the VLPs formed by HBc variants without C-terminal Arg blocks and lacking RNA. The results indicate that the VLPs were stabilised by nucleic acids. The immunogenicity in BALB/c mice was comparable for VLPs formed by different HBc proteins, but a clear switch from a Th1 response to a Th2 response occurred after the loss of encapsidated RNA. We did not observe significant differences in lymphocyte proliferation in vitro for the tested VLP variants; however, the loss of RNA encapsidation correlated with a decreased level of IFN-gamma induction, which is a measure of the potential CTL activity of immunogens.	[Sominskaya, Irina; Skrastina, Dace; Petrovskis, Ivars; Dishlers, Andris; Berza, Ieva; Mihailova, Maria; Jansons, Juris; Akopjana, Inara; Stahovska, Irina; Dreilina, Dzidra; Ose, Velta; Pumpens, Paul] Latvian Biomed Res & Study Ctr, Dept Prot Engn, Riga, Latvia	Latvian Biomedical Research & Study Centre	Dishlers, A (corresponding author), Latvian Biomed Res & Study Ctr, Dept Prot Engn, Riga, Latvia.	Irina@biomed.lu.lv	Jansons, Juris/AAJ-6158-2020; Pumpens, Paul/A-2163-2008	Jansons, Juris/0000-0003-0845-4392; Petrovskis, Ivars/0000-0002-1382-3466; Sominska, Irina/0000-0002-1932-369X; Dishlers, Andris/0000-0002-0112-3948	ERAF [2010/0224/2DP/2.1.1.1.0/10/APIA/VIAA/164 2010/0211/2DP/2.1.1.1.0/10/APIA/VIAA/048.]	ERAF	This work was supported by grants ERAF Nr. (2010/0224/2DP/2.1.1.1.0/10/APIA/VIAA/164 and 2010/0211/2DP/2.1.1.1.0/10/APIA/VIAA/048.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAMES B, 1993, VIROLOGY, V194, P597, DOI 10.1006/viro.1993.1299; BICHKO V, 1993, MOL IMMUNOL, V30, P221, DOI 10.1016/0161-5890(93)90051-C; BICHKO V, 1985, FEBS LETT, V185, P208, DOI 10.1016/0014-5793(85)80771-7; BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; BORISOVA GP, 1984, DOKL AKAD NAUK SSSR+, V279, P1245; BORISOVA GP, 1988, DOKL AKAD NAUK SSSR+, V298, P1474; BUNDULE MA, 1990, DOKL AKAD NAUK SSSR+, V312, P993; Cao TH, 2001, J VIROL, V75, P6359, DOI 10.1128/JVI.75.14.6359-6366.2001; Cardinale D, 2012, TRENDS BIOTECHNOL, V30, P369, DOI 10.1016/j.tibtech.2012.04.001; Cooper A, 2005, J IMMUNOL, V175, P3165, DOI 10.4049/jimmunol.175.5.3165; CROWTHER RA, 1994, CELL, V77, P943, DOI 10.1016/0092-8674(94)90142-2; DISLERS A, 2008, DISIERS A; EDMAN JC, 1981, NATURE, V291, P503, DOI 10.1038/291503a0; Freivalds J, 2011, PROTEIN EXPRES PURIF, V75, P218, DOI 10.1016/j.pep.2010.09.010; GALLINA A, 1989, J VIROL, V63, P4645, DOI 10.1128/JVI.63.11.4645-4652.1989; HATTON T, 1992, J VIROL, V66, P5232, DOI 10.1128/JVI.66.9.5232-5241.1992; HILDITCH CM, 1990, J GEN VIROL, V71, P2755, DOI 10.1099/0022-1317-71-11-2755; Kann M, 1999, J CELL BIOL, V145, P45, DOI 10.1083/jcb.145.1.45; KENNEY JM, 1995, STRUCTURE, V3, P1009, DOI 10.1016/S0969-2126(01)00237-4; KNISKERN PJ, 1986, GENE, V46, P135, DOI 10.1016/0378-1119(86)90177-0; LANFORD RE, 1990, VIROLOGY, V176, P222, DOI 10.1016/0042-6822(90)90247-O; Lee BO, 2009, J IMMUNOL, V182, P6670, DOI 10.4049/jimmunol.0803683; MACHIDA A, 1989, MOL IMMUNOL, V26, P413; MACHIDA A, 1991, J VIROL, V65, P6024, DOI 10.1128/JVI.65.11.6024-6030.1991; Mechtcheriakova IA, 2006, J VIROL METHODS, V131, P10, DOI 10.1016/j.jviromet.2005.06.020; Milich DR, 1997, P NATL ACAD SCI USA, V94, P14648, DOI 10.1073/pnas.94.26.14648; MILICH DR, 1995, J VIROL, V69, P2776, DOI 10.1128/JVI.69.5.2776-2785.1995; MISSALE G, 1993, J EXP MED, V177, P751, DOI 10.1084/jem.177.3.751; MIYANOHARA A, 1986, J VIROL, V59, P176, DOI 10.1128/JVI.59.1.176-180.1986; NASSAL M, 1988, GENE, V66, P279, DOI 10.1016/0378-1119(88)90364-2; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; OUCHTERLONY O, 1949, ACTA PATHOL MIC SC, V26, P507; PASEK M, 1979, NATURE, V282, P575, DOI 10.1038/282575a0; Pumpens Paul, 2009, P205; PUSHKO P, 1994, VIROLOGY, V202, P912, DOI 10.1006/viro.1994.1413; Pushko P, 2013, INTERVIROLOGY, V56, P141, DOI 10.1159/000346773; Riedl P, 2002, EUR J IMMUNOL, V32, P1709, DOI 10.1002/1521-4141(200206)32:6<1709::AID-IMMU1709>3.0.CO;2-D; Riedl P, 2002, J IMMUNOL, V168, P4951, DOI 10.4049/jimmunol.168.10.4951; Rolland D, 2001, J CHROMATOGR B, V753, P51, DOI 10.1016/S0378-4347(00)00538-7; Roseman AM, 2012, J MOL BIOL, V423, P63, DOI 10.1016/j.jmb.2012.06.032; Roseman AM, 2005, P NATL ACAD SCI USA, V102, P15821, DOI 10.1073/pnas.0504874102; SEIFER M, 1994, J VIROL, V68, P5548, DOI 10.1128/JVI.68.9.5548-5555.1994; Skrastina D, 2008, VACCINE, V26, P1972, DOI 10.1016/j.vaccine.2008.02.030; Sominskaya I, 2010, CLIN VACCINE IMMUNOL, V17, P1027, DOI 10.1128/CVI.00468-09; TAKEHARA K, 1988, J GEN VIROL, V69, P2763, DOI 10.1099/0022-1317-69-11-2763; Tsuda S, 1998, VOX SANG, V74, P148, DOI 10.1046/j.1423-0410.1998.7430148.x; Vanlandschoot P, 2005, J GEN VIROL, V86, P75, DOI 10.1099/vir.0.80580-0; Watts NR, 2002, EMBO J, V21, P876, DOI 10.1093/emboj/21.5.876; Weigand K, 2010, J GEN VIROL, V91, P59, DOI 10.1099/vir.0.013698-0; Whitacre DC, 2009, EXPERT REV VACCINES, V8, P1565, DOI 10.1586/ERV.09.121; WINGFIELD PT, 1995, BIOCHEMISTRY-US, V34, P4919, DOI 10.1021/bi00015a003; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5; Zeltins A, 2013, MOL BIOTECHNOL, V53, P92, DOI 10.1007/s12033-012-9598-4; ZHOU S, 1992, P NATL ACAD SCI USA, V89, P10046, DOI 10.1073/pnas.89.21.10046; Zlotnick A, 1996, BIOCHEMISTRY-US, V35, P7412, DOI 10.1021/bi9604800	55	25	30	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75938	10.1371/journal.pone.0075938	http://dx.doi.org/10.1371/journal.pone.0075938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086668	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200126
J	Capderrey, C; Kaufmann, B; Jean, P; Malard, F; Konecny-Dupre, L; Lefebure, T; Douady, CJ				Capderrey, Cecile; Kaufmann, Bernard; Jean, Pauline; Malard, Florian; Konecny-Dupre, Lara; Lefebure, Tristan; Douady, Christophe J.			Microsatellite Development and First Population Size Estimates for the Groundwater Isopod Proasellus walteri	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; GENETIC-STRUCTURE; N-E; TEMPORAL-CHANGES; MIGRATION RATES; CONSERVATION; DIVERSITY; EVOLUTION; PHYLOGEOGRAPHY; FISHES	Effective population size (N-e) is one of the most important parameters in, ecology, evolutionary and conservation biology; however, few studies of N-e in surface freshwater organisms have been published to date. Even fewer studies have been carried out in groundwater organisms, although their evolution has long been considered to be particularly constrained by small N-e. In this study, we estimated the contemporary effective population size of the obligate groundwater isopod: Proasellus walteri (Chappuis, 1948). To this end, a genomic library was enriched for microsatellite motifs and sequenced using 454 GS-FLX technology. A total of 54,593 reads were assembled in 10,346 contigs or singlets, of which 245 contained candidate microsatellite sequences with suitable priming sites. Ninety-six loci were tested for amplification, polymorphism and multiplexing properties, of which seven were finally selected for N-e estimation. Linkage disequilibrium and approximate Bayesian computation methods revealed that N-e in this small interstitial groundwater isopod could reach large sizes (> 585 individuals). Our results suggest that environmental conditions in groundwater, while often referred to as extreme, are not necessarily associated with small N-e.	[Capderrey, Cecile; Kaufmann, Bernard; Jean, Pauline; Malard, Florian; Konecny-Dupre, Lara; Lefebure, Tristan; Douady, Christophe J.] Univ Lyon 1, CNRS, Ecol Hydrosyst Nat & Anthropises UMR5023, F-69622 Villeurbanne, France; [Douady, Christophe J.] Inst Univ France, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut Universitaire de France	Douady, CJ (corresponding author), Univ Lyon 1, CNRS, Ecol Hydrosyst Nat & Anthropises UMR5023, F-69622 Villeurbanne, France.	christophe.douady@univ-lyon1.fr	Douady, Christophe J/N-1357-2014; Lefebure, Tristan/A-6489-2009; Douady, Christophe/N-3069-2019; Capderrey, Cécile/ACB-8991-2022	Douady, Christophe J/0000-0002-4503-8040; Lefebure, Tristan/0000-0003-3923-8166; Douady, Christophe/0000-0002-4503-8040; Kaufmann, Bernard/0000-0001-9097-3452	French Water Agency Rhone-Mediterranee-Corse; Agence Nationale de la Recherche [ANR-08-JCJC-0120- 01]; Institut Universitaire de France; European Commission [226874]	French Water Agency Rhone-Mediterranee-Corse; Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut Universitaire de France; European Commission(European CommissionEuropean Commission Joint Research Centre)	This research was funded by the French Water Agency Rhone-Mediterranee-Corse; the Agence Nationale de la Recherche (ANR-08-JCJC-0120- 01, "DEEP"); the Institut Universitaire de France; and the European Commission (7th EU Framework Programme, Contract No. 226874, BioFresh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araguas RM, 2012, FRESHWATER BIOL, V57, P143, DOI 10.1111/j.1365-2427.2011.02705.x; Ardren WR, 2003, MOL ECOL, V12, P35, DOI 10.1046/j.1365-294X.2003.01705.x; AVISE JC, 1972, EVOLUTION, V26, P1, DOI 10.1111/j.1558-5646.1972.tb00170.x; Beebee TJC, 2007, FRESHWATER BIOL, V52, P2101, DOI 10.1111/j.1365-2427.2007.01834.x; Belkhir K, 1996, 5171 CNRS UMR U MONT; Borowsky RL, 2001, MOL ECOL, V10, P2799, DOI 10.1046/j.0962-1083.2001.01409.x; BOU C, 1967, CR ACAD SCI D NAT, V265, P369; Buhay JE, 2005, MOL ECOL, V14, P4259, DOI 10.1111/j.1365-294X.2005.02755.x; Buhay JE, 2007, MOL PHYLOGENET EVOL, V42, P435, DOI 10.1016/j.ympev.2006.07.014; Calvignac S, 2011, MITOCHONDRION, V11, P246, DOI 10.1016/j.mito.2010.10.004; Carreras-Carbonell J, 2008, CONSERV GENET, V9, P181, DOI 10.1007/s10592-007-9322-2; Chapman DD, 2003, CONSERV GENET, V4, P415, DOI 10.1023/A:1024771215616; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Clemento AJ, 2009, CONSERV GENET, V10, P1321, DOI 10.1007/s10592-008-9712-0; Dawnay N, 2011, CONSERV GENET, V12, P731, DOI 10.1007/s10592-010-0179-4; Dillman CB, 2007, SYSTEMATICS SPECIES; Djuikwo-Teukeng FF, 2011, INFECT GENET EVOL, V11, P17, DOI 10.1016/j.meegid.2010.10.018; England PR, 2010, CONSERV GENET, V11, P2425, DOI 10.1007/s10592-010-0112-x; Ewing G, 2006, MOL BIOL EVOL, V23, P988, DOI 10.1093/molbev/msj111; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Ficetola GF, 2010, ANIM CONSERV, V13, P82, DOI 10.1111/j.1469-1795.2009.00306.x; Finlay JB, 2006, ANIM CONSERV, V9, P375, DOI 10.1111/j.1469-1795.2006.00046.x; Frankham R, 2009, INTRO CONSERVATION G; Gossmann TI, 2011, GENETICS, V189, P1389, DOI 10.1534/genetics.111.132654; Gow JL, 2011, EVOL APPL, V4, P763, DOI 10.1111/j.1752-4571.2011.00198.x; Guzik MT, 2009, MOL ECOL, V18, P3683, DOI 10.1111/j.1365-294X.2009.04296.x; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; Hinaux H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053553; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jehle R, 2005, J EVOLUTION BIOL, V18, P619, DOI 10.1111/j.1420-9101.2004.00864.x; Jones JW, 2009, THESIS VIRGINIA STAT; Kane T.C., 1994, P245; Kingman J., 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Lance SL, 2010, CONSERV GENET RESOUR, V2, P139, DOI 10.1007/s12686-010-9195-4; Leberg P, 2005, J WILDLIFE MANAGE, V69, P1385, DOI 10.2193/0022-541X(2005)69[1385:GAFETE]2.0.CO;2; Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7; Massa-Gallucci A, 2010, CONSERV GENET, V11, P1689, DOI 10.1007/s10592-010-0061-4; Morvan C, 2013, SYST BIOL, V62, P512, DOI 10.1093/sysbio/syt015; NEI M, 1981, GENETICS, V98, P625; Osborne MJ, 2010, MOL ECOL, V19, P2832, DOI 10.1111/j.1365-294X.2010.04695.x; Ostergaard S, 2003, MOL ECOL, V12, P3123, DOI 10.1046/j.1365-294X.2003.01976.x; Palumbi Stephen R., 1996, P205; Phillipsen IC, 2011, EVOLUTION, V65, P2927, DOI 10.1111/j.1558-5646.2011.01356.x; Primmer CR, 2005, J AVIAN BIOL, V36, P348; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sbordoni MC, 1996, J ZOOL SYST EVOL RES, V34, P75; Sbordoni Valerio, 2005, P447; Schwartz M, 1999, J ADV MATER, V31, P2; Scribner KT, 1997, MOL ECOL, V6, P701, DOI 10.1046/j.1365-294X.1997.00238.x; Serbezov D, 2012, GENETICS, V191, P579, DOI 10.1534/genetics.111.136580; Shama LNS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-278; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Stoch F, 2010, HYDROBIOLOGIA, V653, P217, DOI 10.1007/s10750-010-0356-y; Tallmon DA, 2004, GENETICS, V167, P977, DOI 10.1534/genetics.103.026146; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Taylor EB, 2012, CAN J ZOOL, V90, P291, DOI 10.1139/Z11-135; Trouve S, 2005, J EVOLUTION BIOL, V18, P358, DOI 10.1111/j.1420-9101.2004.00831.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; Wang JL, 2001, GENET RES, V78, P243, DOI 10.1017/S0016672301005286; Wang JL, 2003, GENETICS, V163, P429; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Waples RS, 2002, MOL ECOL, V11, P1029, DOI 10.1046/j.1365-294X.2002.01504.x; WAPLES RS, 1989, GENETICS, V121, P379; Watts PC, 2007, J ANIM ECOL, V76, P790, DOI 10.1111/j.1365-2656.2007.01249.x; Wright S, 1931, GENETICS, V16, P0097; Zeller M, 2008, J EVOLUTION BIOL, V21, P1755, DOI 10.1111/j.1420-9101.2008.01589.x	73	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76213	10.1371/journal.pone.0076213	http://dx.doi.org/10.1371/journal.pone.0076213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086709	Green Submitted, Green Published, gold			2022-12-27	WOS:000325223900085
J	Mallela, J; Lewis, SE; Croke, B				Mallela, Jennie; Lewis, Stephen E.; Croke, Barry			Coral Skeletons Provide Historical Evidence of Phosphorus Runoff on the Great Barrier Reef	PLOS ONE			English	Article							INNER-SHELF; FLOOD PLUMES; SEDIMENT; GROWTH; NITROGEN; RECORDS; AUSTRALIA; PHOSPHATE; DECLINE; REGION	Recently, the inshore reefs of the Great Barrier Reef have declined rapidly because of deteriorating water quality. Increased catchment runoff is one potential culprit. The impacts of land-use on coral growth and reef health however are largely circumstantial due to limited long-term data on water quality and reef health. Here we use a 60 year coral core record to show that phosphorus contained in the skeletons (P/Ca) of long-lived, near-shore Porites corals on the Great Barrier Reef correlates with annual records of fertiliser application and particulate phosphorus loads in the adjacent catchment. Skeletal P/Ca also correlates with Ba/Ca, a proxy for fluvial sediment loading, again linking near-shore phosphorus records with river runoff. Coral core records suggest that phosphorus levels increased 8 fold between 1949 and 2008 with the greatest levels coinciding with periods of high fertiliser-phosphorus use. Periods of high P/Ca correspond with intense agricultural activity and increased fertiliser application in the river catchment following agricultural expansion and replanting after cyclone damage. Our results demonstrate how coral P/Ca records can be used to assess terrestrial nutrient loading of vulnerable near-shore reefs.	[Mallela, Jennie] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Mallela, Jennie] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Lewis, Stephen E.] James Cook Univ, TropWATER, Catchment Reef Res Grp, Townsville, Qld 4811, Australia; [Croke, Barry] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Croke, Barry] Australian Natl Univ, Dept Math, Canberra, ACT, Australia	Australian National University; Australian National University; James Cook University; Australian National University; Australian National University	Mallela, J (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia.	jennie.mallela@anu.edu.au	Lewis, Stephen E/P-7205-2016; Croke, Barry/A-2275-2008	Lewis, Stephen E/0000-0002-6929-6626; Croke, Barry/0000-0001-9216-1554; Mallela, Jennie/0000-0002-7811-6850	Marine and Tropical Science Facility (MTSRF) awarded; ARC DECRA awarded	Marine and Tropical Science Facility (MTSRF) awarded; ARC DECRA awarded(Australian Research Council)	Funding for this work was provided by: 1) The Marine and Tropical Science Facility (MTSRF) awarded to JM & SL:Project 3.7.2 Connectivity and risk: tracing materials from the upper catchment to the Reef, and 2) ARC DECRA awarded to JM: http://www.arc.gov.au/ncgp/decra.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibert C, 2003, GEOCHIM COSMOCHIM AC, V67, P231, DOI 10.1016/S0016-7037(02)01055-4; Alibert C, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004263; [Anonymous], 2010, HIST MON DAT TULL RI; Armour JD, 2009, MAR FRESHWATER RES, V60, P1091, DOI 10.1071/MF08345; BOM, 2010, CLIM DAT ONL BUR MET; Brodie J, 2007, 0607 ACTFR J COOK U; Brodie J, 2012, MAR POLLUT BULL, V65, P267, DOI 10.1016/j.marpolbul.2011.12.011; Burke L., 2011, REEFS RISK REVISITED; Chen TR, 2011, MAR POLLUT BULL, V62, P2114, DOI 10.1016/j.marpolbul.2011.07.014; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Devlin M, 2009, MAR FRESHWATER RES, V60, P1109, DOI 10.1071/MF08343; DODGE RE, 1984, MAR POLLUT BULL, V15, P178, DOI 10.1016/0025-326X(84)90317-5; Dunn JG, 2012, J EXP MAR BIOL ECOL, V411, P34, DOI 10.1016/j.jembe.2011.10.013; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Ferrier-Pages C, 2000, CORAL REEFS, V19, P103, DOI 10.1007/s003380000078; Filippelli GM, 2008, ELEMENTS, V4, P89, DOI 10.2113/GSELEMENTS.4.2.89; Furnas M., 2003, CATCHMENTS CORALS TE; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; HUNTER CL, 1995, B MAR SCI, V57, P501; KINSEY DW, 1979, LIMNOL OCEANOGR, V24, P935, DOI 10.4319/lo.1979.24.5.0935; KNUTSON DW, 1972, SCIENCE, V177, P270, DOI 10.1126/science.177.4045.270; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kroon FJ, 2012, MAR POLLUT BULL, V65, P167, DOI 10.1016/j.marpolbul.2011.10.018; Kumarsingh K, 1998, MAR POLLUT BULL, V36, P1012, DOI 10.1016/S0025-326X(98)00086-1; LaVigne M, 2010, GEOCHIM COSMOCHIM AC, V74, P1282, DOI 10.1016/j.gca.2009.11.002; LaVigne M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031926; Lewis SE, 2012, MAR POLLUT BULL, V65, P306, DOI 10.1016/j.marpolbul.2011.09.030; Lough JM, 2002, CORAL REEFS, V21, P333, DOI 10.1007/s00338-002-0253-6; Mallela J, 2011, CORAL REEFS, V30, P813, DOI 10.1007/s00338-011-0757-z; Mallela J, 2007, CORAL REEFS, V26, P53, DOI DOI 10.1007/S00338-006-0168-8; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; Mitchell AW, 2001, WATER SCI TECHNOL, V43, P99, DOI 10.2166/wst.2001.0516; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Perry CT, 2011, MAR GEOL, V289, P60, DOI 10.1016/j.margeo.2011.09.012; PULS J, 1996, HEMICELLULOSES HEMIC, P1; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Roff G., 2013, P R SOC LOND B, V280; SHOTYK W, 1995, J CHROMATOGR A, V706, P209, DOI 10.1016/0021-9673(94)01153-6; Sweatman H. P. A., 2007, MARINE TROPICAL SCI; Thompson A, 2011, REEF RESCUE MARINE M, P128; Whinney JC, 2007, PHYS CONDITIONS MARG; Wolanski E, 2005, ESTUAR COAST SHELF S, V65, P153, DOI 10.1016/j.ecss.2005.06.003; Wolanski E, 2008, ESTUAR COAST SHELF S, V77, P755, DOI 10.1016/j.ecss.2007.10.014; Zhang FF, 2011, ANAL CHEM, V83, P7870, DOI 10.1021/ac2017663	44	20	22	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75663	10.1371/journal.pone.0075663	http://dx.doi.org/10.1371/journal.pone.0075663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086606	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000325223900056
J	Cheng, KF; Chen, JH				Cheng, Kuang-Fu; Chen, Jin-Hua			Detecting Rare Variants in Case-Parents Association Studies	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENOTYPE RELATIVE RISKS; LINKAGE DISEQUILIBRIUM; COMMON VARIANTS; HDL CHOLESTEROL; CANDIDATE-GENE; PLASMA-LEVELS; DISEASE; SUSCEPTIBILITY; HAPLOTYPES	Despite the success of genome-wide association studies (GWASs) in detecting common variants (minor allele frequency >= 0.05) many suggested that rare variants also contribute to the genetic architecture of diseases. Recently, researchers demonstrated that rare variants can show a strong stratification which may not be corrected by using existing methods. In this paper, we focus on a case-parents study and consider methods for testing group-wise association between multiple rare (and common) variants in a gene region and a disease. All tests depend on the numbers of transmitted mutant alleles from parents to their diseased children across variants and hence they are robust to the effect of population stratification. We use extensive simulation studies to compare the performance of four competing tests: the largest single-variant transmission disequilibrium test (TDT), multivariable test, combined TDT, and a likelihood ratio test based on a random-effects model. We find that the likelihood ratio test is most powerful in a wide range of settings and there is no negative impact to its power performance when common variants are also included in the analysis. If deleterious and protective variants are simultaneously analyzed, the likelihood ratio test was generally insensitive to the effect directionality, unless the effects are extremely inconsistent in one direction.	[Cheng, Kuang-Fu; Chen, Jin-Hua] Taipei Med Univ, Ctr Biostat, Taipei, Taiwan; [Cheng, Kuang-Fu; Chen, Jin-Hua] Taipei Med Univ, Dept Epidemiol, Taipei, Taiwan; [Cheng, Kuang-Fu] Natl Cent Univ, Grad Inst Stat, Chungli 32054, Taiwan	Taipei Medical University; Taipei Medical University; National Central University	Cheng, KF (corresponding author), Taipei Med Univ, Ctr Biostat, Taipei, Taiwan.	Kfcheng@tmu.edu.tw			National Science Council, Taiwan [NSC100-2118-M-039-001-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported in part by the National Science Council, Taiwan (NSC100-2118-M-039-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Azzopardi D, 2008, CANCER RES, V68, P358, DOI 10.1158/0008-5472.CAN-07-5733; Bird TD, 2005, NEW ENGL J MED, V352, P862, DOI 10.1056/NEJMp058027; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Brunham LR, 2006, ANNU REV NUTR, V26, P105, DOI 10.1146/annurev.nutr.26.061505.111214; Chen JH, 2011, STAT MED, V30, P291, DOI 10.1002/sim.4092; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Iyengar Sudha K, 2007, Methods Mol Biol, V376, P71; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Ku CS, 2010, J HUM GENET, V55, P195, DOI 10.1038/jhg.2010.19; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015., 10.1016/j.ajhg.2011.07.015]; Lunetta KL, 2000, AM J HUM GENET, V66, P605, DOI 10.1086/302782; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; SCHAID DJ, 1993, AM J HUM GENET, V53, P1114; Scherag A, 2002, HUM HERED, V54, P210, DOI 10.1159/000070666; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Shi M, 2007, AM J HUM GENET, V81, P53, DOI 10.1086/518670; Siegmund KD, 2000, AM J HUM GENET, V67, P244, DOI 10.1086/302973; Slatter TL, 2008, CLIN GENET, V73, P179, DOI 10.1111/j.1399-0004.2007.00940.x; Smith DJ, 2002, HUM MOL GENET, V11, P2455, DOI 10.1093/hmg/11.20.2455; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Spirin V, 2007, AM J HUM GENET, V81, P1298, DOI 10.1086/522497; Sun FZ, 1999, AM J EPIDEMIOL, V150, P97; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zhang ZG, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-65; Zhao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031134	41	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e74310	10.1371/journal.pone.0074310	http://dx.doi.org/10.1371/journal.pone.0074310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086332	Green Published, Green Submitted, gold			2022-12-27	WOS:000325220000007
J	Hoogeboom, TJ; van Meeteren, NLU; Kim, RH; Stevens-Lapsley, JE				Hoogeboom, Thomas J.; van Meeteren, Nico L. U.; Kim, Raymond H.; Stevens-Lapsley, Jennifer E.			Linear and Curvilinear Relationship between Knee Range of Motion and Physical Functioning in People with Knee Osteoarthritis: A Cross-Sectional Study	PLOS ONE			English	Article							HIP; ARTHROPLASTY; PERFORMANCE; LIMITATIONS; FLEXION; STRENGTH; OUTCOMES; GAIT; GO	Background: Knee range of motion (KROM) is associated with the ability to perform daily activities in people with knee OA. However, this association is weak, possibly through the use of linear analyses. Curvilinear associations appear much more relevant, as these allow the determination of relevant clinical thresholds in KROM. The goal of this study is to assess the curvilinear association between KROM and daily activities (self-reported and observed) in people with knee osteoarthritis (OA). Methods: Demographic, functional and KROM (flexion and extension) data were collected from a convenience sample of people with knee OA awaiting total knee arthroplasty. Self-reported functioning was measured by use of the Knee Osteoarthritis Outcomes Scale and observed functioning with the timed up and go and six-minute walk test. The presence of curvilinear relationships between KROM and measures of functioning were tested by generalized additive modeling, piecewise regression modeling and receiver operated curves. Results: Data from 110 participants (mean age +/- standard deviation: 65 +/- 9 and female: 54%) with knee OA were evaluated. Statistical modeling did not reveal linear nor curvilinear associations between KROM and self-reported or observed measures of functioning; except for statistical significant associations between reduced knee flexion and major difficulties standing (p<=0.01). However, further modeling did not provide convincing evidence for relevant clinical associations and thresholds. Conclusions: No clinically relevant relationship between KROM and self-reported or observed measures of physical functioning could be established, indicating that the limitations in range of motion in the affected knee OA alone do not contribute to poorer functional performance.	[Hoogeboom, Thomas J.; Stevens-Lapsley, Jennifer E.] Univ Colorado, Dept Phys Med & Rehabil, Phys Therapy Program, Denver, CO 80202 USA; [Hoogeboom, Thomas J.; van Meeteren, Nico L. U.] Maastricht Univ, Med Ctr, Caphri Res Sch, Maastricht, Netherlands; [Hoogeboom, Thomas J.; van Meeteren, Nico L. U.] Ctr Care Technol Res CCTR, Maastricht, Netherlands; [van Meeteren, Nico L. U.] TNO Hlth Living, Leiden, Netherlands; [Kim, Raymond H.] Porter Adventist Hosp, Dept Orthoped, Denver, CO USA	University of Colorado System; University of Colorado Denver; Maastricht University; Netherlands Organization Applied Science Research	Hoogeboom, TJ (corresponding author), Univ Colorado, Dept Phys Med & Rehabil, Phys Therapy Program, Denver, CO 80202 USA.	thomashoogeboom@gmail.com	Hoogeboom, Thomas J/G-8767-2015	Hoogeboom, Thomas J/0000-0003-2103-419X; Stevens-Lapsley, Jennifer/0000-0002-8118-378X				Bieleman HJ, 2010, INT ARCH OCC ENV HEA, V83, P913, DOI 10.1007/s00420-010-0541-3; Brown K, 2009, J STRENGTH COND RES, V23, P436, DOI 10.1519/JSC.0b013e318198fc13; Cook TM, 1997, J ORTHOP SPORT PHYS, V25, P236, DOI 10.2519/jospt.1997.25.4.236; Ferrucci L, 1997, J GERONTOL A-BIOL, V52, pM275, DOI 10.1093/gerona/52A.5.M275; Holla JFM, 2010, ARTHRIT CARE RES, V62, P1415, DOI 10.1002/acr.20263; JETTE AM, 1995, PHYS THER, V75, P965, DOI 10.1093/ptj/75.11.965; Jette AM, 2001, PHYS THER, V81; Jette AM, 2001, PHYS THER, V81, P3; Kennedy DM, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-3; Konrat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033559; Lenssen AF, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-83; Meneghini RM, 2007, J ARTHROPLASTY, V22, P47, DOI 10.1016/j.arth.2007.03.031; Miner AL, 2003, J ARTHROPLASTY, V18, P286, DOI 10.1054/arth.2003.50046; Norkin CC., 2003, MEASUREMENT JOINT MO; OBERG T, 1994, J REHABIL RES DEV, V31, P199; Park KK, 2007, J BONE JOINT SURG BR, V89B, P604, DOI 10.1302/0301-620X.89B5.18117; Pisters MF, 2012, OSTEOARTHR CARTILAGE, V20, P503, DOI 10.1016/j.joca.2012.02.002; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Roos Ewa M, 2003, Health Qual Life Outcomes, V1, P17, DOI 10.1186/1477-7525-1-17; Royston P., 1998, STATA TECH B, V42, P38; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Steultjens MPM, 2000, RHEUMATOLOGY, V39, P955, DOI 10.1093/rheumatology/39.9.955; Stevens-Lapsley JE, 2012, J ARTHROPLASTY, V27, P1812, DOI 10.1016/j.arth.2012.02.016; Stevens-Lapsley JE, 2012, PHYS THER, V92, P210, DOI 10.2522/ptj.20110124; van Dijk GM, 2010, ARCH PHYS MED REHAB, V91, P58, DOI 10.1016/j.apmr.2009.08.147; van Dijk GM, 2009, DISABIL REHABIL, V31, P1685, DOI 10.1080/09638280902736809; WINTER DA, 1983, PHYS THER, V63, P331, DOI 10.1093/ptj/63.3.331; Zhang W, 2010, ANN RHEUM DIS, V69, P483, DOI 10.1136/ard.2009.113100	28	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76173	10.1371/journal.pone.0076173	http://dx.doi.org/10.1371/journal.pone.0076173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086704	Green Published, gold, Green Submitted			2022-12-27	WOS:000325220000062
J	Landesmann, JB; Gundel, PE; Martinez-Ghersa, MA; Ghersa, CM				Landesmann, Jennifer B.; Gundel, Pedro E.; Alejandra Martinez-Ghersa, M.; Ghersa, Claudio M.			Ozone Exposure of a Weed Community Produces Adaptive Changes in Seed Populations of Spergula arvensis	PLOS ONE			English	Article							(SEMI-)NATURAL VEGETATION; EVOLUTIONARY RESPONSES; CLIMATE-CHANGE; ELEVATED CO2; PLANT; DORMANCY; QUALITY; GERMINATION; IMPACT; YIELD	Tropospheric ozone is one of the major drivers of global change. This stress factor alters plant growth and development. Ozone could act as a selection pressure on species communities composition, but also on population genetic background, thus affecting life history traits. Our objective was to evaluate the consequences of prolonged ozone exposure of a weed community on phenotypic traits of Spergula arvensis linked to persistence. Specifically, we predicted that the selection pressure exerted by high ozone concentrations as well as the concomitant changes in the weed community would drive population adaptive changes which will be reflected on seed germination, dormancy and longevity. In order to test seed viability and dormancy level, we conducted germination experiments for which we used seeds produced by S. arvensis plants grown within a weed community exposed to three ozone treatments during four years (0, 90 and 120 ppb). We also performed a soil seed bank experiment to test seed longevity with seeds coming from both the four-year ozone exposure experiment and from a short-term treatment conducted at ambient and added ozone concentrations. We found that prolonged ozone exposure produced changes in seed germination, dormancy and longevity, resulting in three S. arvensis populations. Seeds from the 90 ppb ozone selection treatment had the highest level of germination when stored at 75% RH and 25 degrees C and then scarified. These seeds showed the lowest dormancy level when being subjected to 5 degrees C/5% RH and 25 degrees C/75% followed by 5% RH storage conditions. Furthermore, ozone exposure increased seed persistence in the soil through a maternal effect. Given that tropospheric ozone is an important pollutant in rural areas, changes in seed traits due to ozone exposure could increase weed persistence in fields, thus affecting weed-crop interactions, which could ultimately reduce crop production.	[Landesmann, Jennifer B.] Univ Nacl Comahue, INIBIOMA CONICET, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina; [Landesmann, Jennifer B.; Gundel, Pedro E.; Alejandra Martinez-Ghersa, M.; Ghersa, Claudio M.] IFEVA CONICET, Fac Agron UBA, Catedra Ecol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Landesmann, JB (corresponding author), Univ Nacl Comahue, INIBIOMA CONICET, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina.	jennifer.landesmann@gmail.com	Gundel, Pedro/A-5314-2013	Gundel, Pedro/0000-0003-3246-0282	UBACYT [G073]; FONCYT [PICT 2010 1573]	UBACYT; FONCYT(FONCyT)	This research was funded by UBACYT G073 and FONCYT PICT 2010 1573. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anav A, 2011, GLOBAL CHANGE BIOL, V17, P2342, DOI 10.1111/j.1365-2486.2010.02387.x; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2008, INT RUL SEED TEST, P1; ASHMORE MR, 1991, ANN BOT-LONDON, V67, P39, DOI 10.1093/oxfordjournals.aob.a088207; Bailly C, 2004, SEED SCI RES, V14, P93, DOI 10.1079/SSR2004159; Barbo DN, 1998, NEW PHYTOL, V138, P653, DOI 10.1046/j.1469-8137.1998.00138.x; Baskin J.M., 1998, SEEDS ECOLOGY BIOGEO; Baskin Jerry M., 2000, Plant Species Biology, V15, P139, DOI 10.1046/j.1442-1984.2000.00034.x; Benech-Arnold RL, 2000, FIELD CROP RES, V67, P105, DOI 10.1016/S0378-4290(00)00087-3; Berg MP, 2010, GLOBAL CHANGE BIOL, V16, P587, DOI 10.1111/j.1365-2486.2009.02014.x; Black VJ, 2010, ENVIRON EXP BOT, V69, P121, DOI 10.1016/j.envexpbot.2010.04.006; Bogo H, 1999, ATMOS ENVIRON, V33, P2587, DOI 10.1016/S1352-2310(98)00270-2; Booker F, 2009, J INTEGR PLANT BIOL, V51, P337, DOI 10.1111/j.1744-7909.2008.00805.x; Bosac C, 1998, J PLANT PHYSIOL, V153, P127, DOI 10.1016/S0176-1617(98)80055-2; BOUWMEESTER HJ, 1993, CAN J BOT, V71, P64, DOI 10.1139/b93-008; Crawley M.J., 2007, R BOOK; Darbah JNT, 2008, ENVIRON POLLUT, V155, P446, DOI 10.1016/j.envpol.2008.01.033; Fenner M., 2005, ECOLOGY SEEDS; Galloway LF, 2001, AM J BOT, V88, P832, DOI 10.2307/2657035; Grantz DA, 2006, CROP SCI, V46, P1879, DOI 10.2135/cropsci2005.06.0167; Gundel PE, 2008, EUR J AGRON, V28, P606, DOI 10.1016/j.eja.2008.01.004; Hayes F, 2007, ENVIRON POLLUT, V146, P754, DOI 10.1016/j.envpol.2006.06.011; HOGSETT WE, 1985, ATMOS ENVIRON, V19, P1135, DOI 10.1016/0004-6981(85)90198-2; Iriti M, 2009, J AGR FOOD CHEM, V57, P201, DOI 10.1021/jf802819m; Kangasjarvi J, 2005, PLANT CELL ENVIRON, V28, P1021, DOI 10.1111/j.1365-3040.2005.01325.x; LEFOHN AS, 1986, ATMOS ENVIRON, V20, P361, DOI 10.1016/0004-6981(86)90039-9; Leisner CP, 2012, GLOBAL CHANGE BIOL, V18, P606, DOI 10.1111/j.1365-2486.2011.02535.x; Lyons TM, 1997, NEW PHYTOL, V136, P503, DOI 10.1046/j.1469-8137.1997.00773.x; Martinez-Ghersa Maria A., 2000, Plant Species Biology, V15, P127, DOI 10.1046/j.1442-1984.2000.00033.x; Mendoza R, 2008, THESIS BUENOS AIRES; Merritt DJ, 2003, AUST J BOT, V51, P85, DOI 10.1071/BT02040; Mills G, 2007, ENVIRON POLLUT, V146, P736, DOI 10.1016/j.envpol.2006.04.005; Mills G, 2011, GLOBAL CHANGE BIOL, V17, P592, DOI 10.1111/j.1365-2486.2010.02217.x; Mortimer AM, 1997, PESTIC SCI, V51, P299, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;299::AID-PS653&gt;3.0.CO;2-I; Ooi MKJ, 2009, GLOBAL CHANGE BIOL, V15, P2375, DOI 10.1111/j.1365-2486.2009.01887.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pfleeger TG, 2010, AGR ECOSYST ENVIRON, V138, P116, DOI 10.1016/j.agee.2010.04.009; ROBERTS HA, 1982, WEED RES, V22, P13, DOI 10.1111/j.1365-3180.1982.tb00137.x; Salamin N, 2010, TRENDS ECOL EVOL, V25, P692, DOI 10.1016/j.tree.2010.09.009; Schnell RC, 2009, NAT GEOSCI, V2, P120, DOI 10.1038/NGEO415; Skelly DK, 2007, CONSERV BIOL, V21, P1353, DOI 10.1111/j.1523-1739.2007.00764.x; TRAINER M, 1987, NATURE, V329, P705, DOI 10.1038/329705a0; VANSTADE.J, 1973, J EXP BOT, V24, P662, DOI 10.1093/jxb/24.4.662; Vingarzan R, 2004, ATMOS ENVIRON, V38, P3431, DOI 10.1016/j.atmosenv.2004.03.030; Voigt W, 2007, GLOBAL CHANGE BIOL, V13, P1710, DOI 10.1111/j.1365-2486.2007.01398.x; WAGNER LK, 1988, AM J BOT, V75, P465, DOI 10.2307/2444211; Walck JL, 2011, GLOBAL CHANGE BIOL, V17, P2145, DOI 10.1111/j.1365-2486.2010.02368.x; WARWICK MA, 1984, WEED RES, V24, P261, DOI 10.1111/j.1365-3180.1984.tb01563.x; Way DA, 2010, GLOBAL CHANGE BIOL, V16, P1046, DOI 10.1111/j.1365-2486.2009.02007.x; Zhaozhong F, 2008, GLOBAL CHANGE BIOL, V14, P2696	50	10	10	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75820	10.1371/journal.pone.0075820	http://dx.doi.org/10.1371/journal.pone.0075820			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086640	Green Published, gold, Green Submitted			2022-12-27	WOS:000325220000045
J	Binder, E; Bermudez-Silva, FJ; Andre, C; Elie, M; Romero-Zerbo, SY; Leste-Lasserre, T; Belluomo, I; Duchampt, A; Clark, S; Aubert, A; Mezzullo, M; Fanelli, F; Pagotto, U; Laye, S; Mithieux, G; Cota, D				Binder, Elke; Bermudez-Silva, Francisco J.; Andre, Caroline; Elie, Melissa; Romero-Zerbo, Silvana Y.; Leste-Lasserre, Thierry; Belluomo, Ilaria; Duchampt, Adeline; Clark, Samantha; Aubert, Agnes; Mezzullo, Marco; Fanelli, Flaminia; Pagotto, Uberto; Laye, Sophie; Mithieux, Gilles; Cota, Daniela			Leucine Supplementation Protects from Insulin Resistance by Regulating Adiposity Levels	PLOS ONE			English	Article							WEIGHT-LOSS; MAMMALIAN TARGET; ENERGY-BALANCE; AMINO-ACIDS; MICE; OBESITY; FAT; CHOLESTEROL; SENSITIVITY; HOMEOSTASIS	Background: Leucine supplementation might have therapeutic potential in preventing diet-induced obesity and improving insulin sensitivity. However, the underlying mechanisms are at present unclear. Additionally, it is unclear whether leucine supplementation might be equally efficacious once obesity has developed. Methodology/Principal Findings: Male C57BL/6J mice were fed chow or a high-fat diet (HFD), supplemented or not with leucine for 17 weeks. Another group of HFD-fed mice (HFD-pairfat group) was food restricted in order to reach an adiposity level comparable to that of HFD-Leu mice. Finally, a third group of mice was exposed to HFD for 12 weeks before being chronically supplemented with leucine. Leucine supplementation in HFD-fed mice decreased body weight and fat mass by increasing energy expenditure, fatty acid oxidation and locomotor activity in vivo. The decreased adiposity in HFD-Leu mice was associated with increased expression of uncoupling protein 3 (UCP-3) in the brown adipose tissue, better insulin sensitivity, increased intestinal gluconeogenesis and preservation of islets of Langerhans histomorphology and function. HFD-pairfat mice had a comparable improvement in insulin sensitivity, without changes in islets physiology or intestinal gluconeogenesis. Remarkably, both HFD-Leu and HFD-pairfat mice had decreased hepatic lipid content, which likely helped improve insulin sensitivity. In contrast, when leucine was supplemented to already obese animals, no changes in body weight, body composition or glucose metabolism were observed. Conclusions/Significance: These findings suggest that leucine improves insulin sensitivity in HFD-fed mice by primarily decreasing adiposity, rather than directly acting on peripheral target organs. However, beneficial effects of leucine on intestinal gluconeogenesis and islets of Langerhans's physiology might help prevent type 2 diabetes development. Differently, metabolic benefit of leucine supplementation is lacking in already obese animals, a phenomenon possibly related to the extent of the obesity before starting the supplementation.	[Binder, Elke; Bermudez-Silva, Francisco J.; Andre, Caroline; Elie, Melissa; Romero-Zerbo, Silvana Y.; Leste-Lasserre, Thierry; Belluomo, Ilaria; Clark, Samantha; Cota, Daniela] INSERM, Neuroctr Magendie Physiopathol Plasticite Neurona, U862, Bordeaux, France; [Binder, Elke; Bermudez-Silva, Francisco J.; Andre, Caroline; Elie, Melissa; Romero-Zerbo, Silvana Y.; Leste-Lasserre, Thierry; Belluomo, Ilaria; Clark, Samantha] Univ Bordeaux, Neuroctr Magendie Physiopathol Plasticite Neurona, U862, Bordeaux, France; [Bermudez-Silva, Francisco J.; Romero-Zerbo, Silvana Y.] IBIMA Hosp Carlos Haya, Lab Invest, Malaga, Spain; [Duchampt, Adeline; Mithieux, Gilles] INSERM, U855, F-69008 Lyon, France; [Duchampt, Adeline; Mithieux, Gilles; Cota, Daniela] Univ Lyon, Lyon, France; [Duchampt, Adeline; Mithieux, Gilles] Univ Lyon 1, F-69622 Villeurbanne, France; [Aubert, Agnes; Laye, Sophie] Univ Bordeaux, UMR 1286, Bordeaux, France; [Aubert, Agnes; Laye, Sophie] INRA, UMR 1286, Bordeaux, France; [Mezzullo, Marco; Fanelli, Flaminia; Pagotto, Uberto] Univ Bologna, Dept Clin Med, S Orsola Malpighi Hosp, Endocrinol Unit, Bologna, Italy; [Mezzullo, Marco; Fanelli, Flaminia; Pagotto, Uberto] Univ Bologna, Dept Clin Med, S Orsola Malpighi Hosp, Ctr Ric Biomed Applicata, Bologna, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Universidad de Malaga; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite de Bordeaux; INRAE; UDICE-French Research Universities; Universite de Bordeaux; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Cota, D (corresponding author), INSERM, Neuroctr Magendie Physiopathol Plasticite Neurona, U862, Bordeaux, France.	daniela.cota@inserm.fr	Belluomo, Ilaria/AAL-7855-2021; Laye, Sophie/AAX-2501-2020; Bermudez-Silva, Francisco-Javier/Q-6920-2016	Laye, Sophie/0000-0002-3843-1012; Bermudez-Silva, Francisco-Javier/0000-0003-3133-9691; Gilles, Mithieux/0000-0003-3579-8529; MEZZULLO, MARCO/0000-0001-6748-3041; Romero-Zerbo, Silvana-Yanina/0000-0002-6737-992X; Cota, Daniela/0000-0002-6909-2156	INSERM; Aquitaine Region; Ajinomoto 3ARP research program; EquipEx OptoPath [ANR-10-EQPX-08]; European Community [FP7-People2009-IEF-251494]; Fondation Recherche Medicale; National System of Health (Instituto de Salud Carlos III) [CP07/00283]; BAE from Instituto de Salud Carlos III [BA09/90066];  [ANR-2010-1414-01]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Aquitaine Region(Region Nouvelle-Aquitaine); Ajinomoto 3ARP research program; EquipEx OptoPath; European Community(European Commission); Fondation Recherche Medicale; National System of Health (Instituto de Salud Carlos III)(Instituto de Salud Carlos III); BAE from Instituto de Salud Carlos III(Instituto de Salud Carlos III); 	This work was supported by INSERM, Aquitaine Region, Ajinomoto 3ARP research program, ANR-2010-1414-01 and EquipEx OptoPath ANR-10-EQPX-08 (to DC), European Community's Seventh Framework Programme FP7-People2009-IEF-251494 (DC and EB) and Fondation Recherche Medicale. FJBS is recipient of a research contract from the National System of Health (Instituto de Salud Carlos III; CP07/00283) and of a BAE from Instituto de Salud Carlos III (BA09/90066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre C, 2012, P NUTR SOC, V71, P502, DOI 10.1017/S0029665112000754; Blouet C, 2012, CELL METAB, V16, P579, DOI 10.1016/j.cmet.2012.10.003; Bruckbauer A, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-77; Cardinal P, 2012, ENDOCRINOLOGY, V153, P4136, DOI 10.1210/en.2012-1405; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Eller LK, 2013, J NUTR BIOCHEM, V24, P1285, DOI 10.1016/j.jnutbio.2012.10.004; HA J, 1994, J BIOL CHEM, V269, P22162; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; Hardy OT, 2012, CURR OPIN ENDOCRINOL, V19, P81, DOI 10.1097/MED.0b013e3283514e13; HAYEK A, 1979, DIABETES, V28, P565, DOI 10.2337/diabetes.28.6.565; Himms-Hagen J, 2001, EXP BIOL MED, V226, P78, DOI 10.1177/153537020122600204; Hinault C, 2004, FASEB J, V18, P1894, DOI 10.1096/fj.03-1409fje; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Larsen TM, 2010, NEW ENGL J MED, V363, P2102, DOI 10.1056/NEJMoa1007137; Li HL, 2012, AM J PHYSIOL-ENDOC M, V303, pE1234, DOI 10.1152/ajpendo.00198.2012; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Mithieux G, 2009, CURR OPIN CLIN NUTR, V12, P419, DOI 10.1097/MCO.0b013e32832c4d6a; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Pitman JL, 2011, J LIPID RES, V52, P1775, DOI 10.1194/jlr.M017277; Popkin BM, 2007, NAT REV CANCER, V7, P61, DOI 10.1038/nrc2029; Proud CG, 2007, BIOCHEM SOC T, V35, P1187, DOI 10.1042/BST0351187; Proulx K, 2008, DIABETES, V57, P3231, DOI 10.2337/db07-1690; Qin LQ, 2011, J NUTR, V141, P249, DOI 10.3945/jn.110.128520; Rajas F, 2000, DIABETES, V49, P1165, DOI 10.2337/diabetes.49.7.1165; SENER A, 1980, NATURE, V288, P187, DOI 10.1038/288187a0; Tuduri E, 2009, DIABETES, V58, P1616, DOI 10.2337/db08-1787; Van Schaftingen E, 2002, BIOCHEM J, V362, P513, DOI 10.1042/0264-6021:3620513; Vaughan RA, 2013, AMINO ACIDS; Westerterp-Plantenga MS, 2012, BRIT J NUTR, V108, pS105, DOI 10.1017/S0007114512002589; Wisse BE, 2007, SCIENCE, V318, P928, DOI 10.1126/science.1148032; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123	31	50	61	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74705	10.1371/journal.pone.0074705	http://dx.doi.org/10.1371/journal.pone.0074705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086364	gold, Green Published, Green Submitted			2022-12-27	WOS:000325218700031
J	Jaiswara, R; Nandi, D; Balakrishnan, R				Jaiswara, Ranjana; Nandi, Diptarup; Balakrishnan, Rohini			Examining the Effectiveness of Discriminant Function Analysis and Cluster Analysis in Species Identification of Male Field Crickets Based on Their Calling Songs	PLOS ONE			English	Article							NEURAL-NETWORK ANALYSIS; ACOUSTIC IDENTIFICATION; CHARACTER DISPLACEMENT; CHORUS FROGS; CHIROPTERA; BOUNDARIES; BAT; RECOGNITION; TAXONOMY; RECORDINGS	Traditional taxonomy based on morphology has often failed in accurate species identification owing to the occurrence of cryptic species, which are reproductively isolated but morphologically identical. Molecular data have thus been used to complement morphology in species identification. The sexual advertisement calls in several groups of acoustically communicating animals are species-specific and can thus complement molecular data as non-invasive tools for identification. Several statistical tools and automated identifier algorithms have been used to investigate the efficiency of acoustic signals in species identification. Despite a plethora of such methods, there is a general lack of knowledge regarding the appropriate usage of these methods in specific taxa. In this study, we investigated the performance of two commonly used statistical methods, discriminant function analysis (DFA) and cluster analysis, in identification and classification based on acoustic signals of field cricket species belonging to the subfamily Gryllinae. Using a comparative approach we evaluated the optimal number of species and calling song characteristics for both the methods that lead to most accurate classification and identification. The accuracy of classification using DFA was high and was not affected by the number of taxa used. However, a constraint in using discriminant function analysis is the need for a priori classification of songs. Accuracy of classification using cluster analysis, which does not require a priori knowledge, was maximum for 6-7 taxa and decreased significantly when more than ten taxa were analysed together. We also investigated the efficacy of two novel derived acoustic features in improving the accuracy of identification. Our results show that DFA is a reliable statistical tool for species identification using acoustic signals. Our results also show that cluster analysis of acoustic signals in crickets works effectively for species classification and identification.	[Jaiswara, Ranjana; Nandi, Diptarup; Balakrishnan, Rohini] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Balakrishnan, R (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India.	rohini@ces.iisc.ernet.in	Jaiswara, Ranjana/ABE-3428-2020; Balakrishnan, Rohini/Z-5881-2019	Jaiswara, Ranjana/0000-0002-2672-3093	Ministry of Environment and Forests, Government of India	Ministry of Environment and Forests, Government of India(Ministry of Environment, Forest and Climate Change (MoEFCC), Government of India)	This work was supported by Ministry of Environment and Forests, Government of India (http://envfor.nic.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo MA, 2009, ECOL INFORM, V4, P206, DOI 10.1016/j.ecoinf.2009.06.005; Angulo A, 2008, ZOOL J LINN SOC-LOND, V152, P59, DOI 10.1111/j.1096-3642.2007.00338.x; Bailey W.J., 1991, ACOUSTIC BEHAV INSEC; BALFOORT HW, 1992, J PLANKTON RES, V14, P575, DOI 10.1093/plankt/14.4.575; BLAIR WF, 1964, Q REV BIOL, V39, P333, DOI 10.1086/404323; BLAIR WF, 1974, AM ZOOL, V14, P1119; BODDY L, 1994, CYTOMETRY, V15, P283, DOI 10.1002/cyto.990150403; Brandes TS, 2006, J ACOUST SOC AM, V120, P2950, DOI 10.1121/1.2355479; Britzke ER, 2010, J FISH WILDL MANAG, V1, P136, DOI 10.3996/072010-JFWM-025; Chesmore David, 2004, An. Acad. Bras. Ciênc., V76, P436, DOI 10.1590/S0001-37652004000200037; Chopard L, 1969, FAUNA INDIA ADJACENT, P421; Crawley MJ, 2007, R BOOK, P953; Do MT, 1999, B ENTOMOL RES, V89, P217, DOI 10.1017/S0007485399000334; Fagerlund S, 2007, EURASIP J ADV SIG PR, DOI 10.1155/2007/38637; Ferreira RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015363; FOUQUETTE MJ, 1975, SYST ZOOL, V24, P16, DOI 10.2307/2412694; Fukui D, 2004, ZOOL SCI, V21, P947, DOI 10.2108/zsj.21.947; GASTON KJ, 1992, NATURE, V356, P281, DOI 10.1038/356281a0; Gauld ID, 2000, DRIVING MISS DAISY P, P303; Godfray HCJ, 2002, NATURE, V417, P17, DOI 10.1038/417017a; GOTTLIEB G, 1974, J COMP PHYSIOL PSYCH, V87, P1038, DOI 10.1037/h0037601; Haralabous J, 1996, ICES J MAR SCI, V53, P173, DOI 10.1006/jmsc.1996.0019; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Herr A, 1997, COMPLEXITY INT, V4, P1; Heyer WR, 1984, VARIATION SYSTEMATIC; Horne JK, 2000, FISH OCEANOGR, V9, P356, DOI 10.1046/j.1365-2419.2000.00143.x; Jaiswara R, 2012, ZOOL J LINN SOC-LOND, V164, P285, DOI 10.1111/j.1096-3642.2011.00769.x; Knapp S, 2007, NATURE, V446, P261, DOI 10.1038/446261a; Kogan JA, 1998, J ACOUST SOC AM, V103, P2185, DOI 10.1121/1.421364; Korneliussen RJ, 2009, ICES J MAR SCI, V66, P1111, DOI 10.1093/icesjms/fsp119; Lawson GL, 2001, ICES J MAR SCI, V58, P275, DOI 10.1006/jmsc.2000.1009; LeFeuvre P, 2000, FISH RES, V47, P137, DOI 10.1016/S0165-7836(00)00165-X; Lemmon EM, 2007, MOL PHYLOGENET EVOL, V44, P1068, DOI 10.1016/j.ympev.2007.04.010; Lewontin RC, 1966, SYST ZOOL, V15, P141, DOI DOI 10.2307/2411632; Martins I. A., 2003, Braz. J. Biol., V63, P507, DOI 10.1590/S1519-69842003000300017; Metrani Sapna, 2005, Journal of Orthoptera Research, V14, P1, DOI 10.1665/1082-6467(2005)14[1:TUOSAM]2.0.CO;2; Nickerson CM, 2006, J ACOUST SOC AM, V120, P1111, DOI 10.1121/1.2211509; Oswald JN, 2003, MAR MAMMAL SCI, V19, P20, DOI 10.1111/j.1748-7692.2003.tb01090.x; Otte D., 1983, MONOGRAPHS OF THE ACADEMY OF NATURAL SCIENCES OF PHILADELPHIA, V22, P1; Parsons S, 2000, J EXP BIOL, V203, P2641; Proudlove G, 2003, TRENDS ECOL EVOL, V18, P272, DOI 10.1016/S0169-5347(03)00095-8; R Core Team, 2021, R LANGUAGE ENV STAT; Ramasindrazana B, 2011, BIOL J LINN SOC, V104, P284, DOI 10.1111/j.1095-8312.2011.01740.x; ROY D, 1993, J BIOSCIENCE, V18, P381, DOI 10.1007/BF02702996; Russo D, 2002, J ZOOL, V258, P91, DOI 10.1017/S0952836902001231; Rydell J, 2002, J ZOOL, V257, P27, DOI 10.1017/S0952836902000626; Scalabrin C, 1996, ICES J MAR SCI, V53, P181, DOI 10.1006/jmsc.1996.0020; SCHNEIDER H, 1984, Z ZOOL SYST EVOL, V22, P349; Scoble MJ, 2004, PHILOS T R SOC B, V359, P699, DOI 10.1098/rstb.2003.1456; Shaw KL, 1999, MOL PHYLOGENET EVOL, V11, P332, DOI 10.1006/mpev.1998.0558; Simmonds EJ, 1996, ICES J MAR SCI, V53, P189; Trifa VM, 2008, J ACOUST SOC AM, V123, P2424, DOI 10.1121/1.2839017; Vredenburg VT, 2007, J ZOOL, V271, P361, DOI 10.1111/j.1469-7998.2006.00258.x; WALKER TJ, 1962, EVOLUTION, V16, P407, DOI 10.2307/2406176; WILCZYNSKI W, 1993, J COMP PHYSIOL A, V172, P425, DOI 10.1007/BF00213524; Zakharia ME, 1996, ICES J MAR SCI, V53, P203, DOI 10.1006/jmsc.1996.0023	57	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75930	10.1371/journal.pone.0075930	http://dx.doi.org/10.1371/journal.pone.0075930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086666	gold, Green Published, Green Submitted			2022-12-27	WOS:000325218700116
J	Liu, L; Yuan, GZ; Cheng, ZH; Zhang, GF; Liu, XW; Zhang, HF				Liu, Liang; Yuan, Guozhen; Cheng, Zaohuo; Zhang, Guofu; Liu, Xiaowei; Zhang, Huifang			Identification of the mRNA Expression Status of the Dopamine D2 Receptor and Dopamine Transporter in Peripheral Blood Lymphocytes of Schizophrenia Patients	PLOS ONE			English	Article							QUANTITATIVE RT-PCR; PRESYNAPTIC DOPAMINE; TYROSINE-HYDROXYLASE; PARKINSONS-DISEASE; MONONUCLEAR-CELLS; IN-VIVO; BINDING; BRAIN; DIFFERENTIATION; POLYMORPHISM	The aim of this study was to detect the mRNA expression levels of the dopamine D2 receptor (DRD2) and dopamine transporter (DAT) in peripheral blood leukocytes (PBLs) of schizophrenia patients and to explore the relationship between the mRNA expression levels and the clinical symptoms of schizophrenia. The research included 25 cases of acute schizophrenia patients, 27 cases of chronic schizophrenia patients, and 30 healthy controls. In every case, we measured the mRNA levels of DRD2 and DAT in PBLs by real-time quantitative reverse transcription-polymerase chain reaction (real-time RT-PCR), and we evaluated the patients' clinical symptoms using the Positive and Negative Syndrome Scale (PANSS). DRD2 mRNA levels in PBLs of acute schizophrenia patients, chronic schizophrenia patients, and healthy controls were 0.32 +/- 0.13, 0.37 +/- 0.19, and 0.34 +/- 0.09, respectively, and the difference was not significant. DAT mRNA levels in PBLs of the abovementioned groups were 0.48 +/- 0.24, 0.58 +/- 0.21 and 0.39 +/- 0.24, respectively (F = 4.330, P = 0.017), and comparisons between every group showed that DAT mRNA levels in PBLs of chronic schizophrenia patients were significantly higher than those in healthy controls (MS interclass = 0.198, p = 0.005). The correlation between DRD2 mRNA levels in PBLs and the positive symptom points of PANSS in acute schizophrenia patients was significant (r = 0.443, p = 0.044). In conclusion, DRD2 mRNA levels in PBLs are correlated with positive symptoms in acute schizophrenia patients, and DAT mRNA levels in PBLs of chronic schizophrenia patients are over-expressed.	[Liu, Liang; Yuan, Guozhen; Cheng, Zaohuo; Zhang, Guofu; Liu, Xiaowei; Zhang, Huifang] Nanjing Med Univ, Wuxi Mental Hlth Ctr, Clin Psychiat Dept, Wuxi, Peoples R China	Nanjing Medical University	Cheng, ZH (corresponding author), Nanjing Med Univ, Wuxi Mental Hlth Ctr, Clin Psychiat Dept, Wuxi, Peoples R China.	chengzaohuo@yahoo.cn	zhang, hui/GXH-6098-2022; Zhang, Hui/HHN-8494-2022		Natural Science Foundation of Jiangsu Province, China [BK2008108]; "333" Projects Foundation of Jiangsu Province, China	Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); "333" Projects Foundation of Jiangsu Province, China	This research was supported by grants from Natural Science Foundation of Jiangsu Province, China (BK2008108), and "333" Projects Foundation of Jiangsu Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Amenta F, 2001, J NEUROIMMUNOL, V117, P133, DOI 10.1016/S0165-5728(01)00317-4; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Basu S, 2000, J NEUROIMMUNOL, V102, P113, DOI 10.1016/S0165-5728(99)00176-9; Buttarelli FR, 2011, CURR NEUROPHARMACOL, V9, P278, DOI 10.2174/157015911795596612; Carlsson A, 2001, SCIENCE, V294, P1021, DOI 10.1126/science.1066969; Chinese Society of Psychiatry, 2001, CHIN CLASS DIAGN CRI; Ferrari M, 2004, BIOCHEM PHARMACOL, V67, P865, DOI 10.1016/j.bcp.2003.10.004; Fusar-Poli P, 2013, SCHIZOPHRENIA BULL, V39, P22, DOI 10.1093/schbul/sbr111; Goodarzi A, 2009, EUR J PHARMACOL, V615, P218, DOI 10.1016/j.ejphar.2009.04.060; Gordon J, 2003, TRENDS IMMUNOL, V24, P438, DOI 10.1016/S1471-4906(03)00176-5; Ilani T, 2001, P NATL ACAD SCI USA, V98, P625, DOI 10.1073/pnas.021535398; Ilani T, 2004, FASEB J, V18, DOI 10.1096/fj.04-1652fje; Kirillova GP, 2008, J NEUROSCI METH, V174, P272, DOI 10.1016/j.jneumeth.2008.07.018; Laakso A, 2001, SCHIZOPHR RES, V52, P115, DOI 10.1016/S0920-9964(00)00095-5; Liu L, 2010, PSYCHIAT RES, V176, P1, DOI 10.1016/j.psychres.2008.10.024; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Mane A, 2011, PSYCHIAT RES-NEUROIM, V194, P79, DOI 10.1016/j.pscychresns.2011.03.004; Marazziti D, 2010, PSYCHIAT RES, V175, P54, DOI 10.1016/j.psychres.2009.03.009; McKenna F, 2002, J NEUROIMMUNOL, V132, P34, DOI 10.1016/S0165-5728(02)00280-1; Mill J, 2002, AM J MED GENET, V114, P975, DOI 10.1002/ajmg.b.10948; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nagai Y, 1996, NEUROLOGY, V46, P791, DOI 10.1212/WNL.46.3.791; Nakano K, 2008, BIOCHEM BIOPH RES CO, V373, P286, DOI 10.1016/j.bbrc.2008.06.012; Nakano K, 2009, INT IMMUNOL, V21, P645, DOI 10.1093/intimm/dxp033; Ohara K, 1998, PSYCHIAT RES, V81, P117, DOI 10.1016/S0165-1781(98)00092-4; Peleg-Raibstein D, 2008, BEHAV BRAIN RES, V191, P190, DOI 10.1016/j.bbr.2008.03.037; Rollins B, 2010, AM J MED GENET B, V153B, P919, DOI 10.1002/ajmg.b.31062; Sarkar C, 2010, BRAIN BEHAV IMMUN, V24, P525, DOI 10.1016/j.bbi.2009.10.015; Sjoholm H, 2004, PSYCHOPHARMACOLOGY, V173, P27, DOI 10.1007/s00213-003-1700-y; Tandon Rajiv, 2013, Clin Schizophr Relat Psychoses, V7, P16, DOI 10.3371/CSRP.TA.032513; Tenn CC, 2003, SCHIZOPHR RES, V64, P103, DOI 10.1016/S0920-9964(03)00009-4; Wandinger KP, 1999, J NEUROIMMUNOL, V98, P214, DOI 10.1016/S0165-5728(99)00093-4; Wonodi I, 2009, AM J MED GENET B, V150B, P282, DOI 10.1002/ajmg.b.30811; Yao YR, 2008, J PSYCHIATR RES, V42, P639, DOI 10.1016/j.jpsychires.2007.07.011; Zhan L, 2011, NEUROPATH APPL NEURO, V37, P206, DOI 10.1111/j.1365-2990.2010.01128.x; Zvara A, 2005, DIS MARKERS, V21, P61, DOI 10.1155/2005/275318	37	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75259	10.1371/journal.pone.0075259	http://dx.doi.org/10.1371/journal.pone.0075259			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086483	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700064
J	Loop, MS; Kent, ST; Al-Hamdan, MZ; Crosson, WL; Estes, SM; Estes, MG; Quattrochi, DA; Hemmings, SN; Wadley, VG; McClure, LA				Loop, Matthew Shane; Kent, Shia T.; Al-Hamdan, Mohammad Z.; Crosson, William L.; Estes, Sue M.; Estes, Maurice G., Jr.; Quattrochi, Dale A.; Hemmings, Sarah N.; Wadley, Virginia G.; McClure, Leslie A.			Fine Particulate Matter and Incident Cognitive Impairment in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort	PLOS ONE			English	Article							AIR-POLLUTION EXPOSURE; VASCULAR RISK-FACTORS; UNITED-STATES; BRAIN INFLAMMATION; INDIVIDUALS; ASSOCIATION; AEROSOL; HEART; CHILDREN; DECLINE	Studies of the effect of air pollution on cognitive health are often limited to populations living near cities that have air monitoring stations. Little is known about whether the estimates from such studies can be generalized to the U.S. population, or whether the relationship differs between urban and rural areas. To address these questions, we used a satellite-derived estimate of fine particulate matter (PM2.5) concentration to determine whether PM2.5 was associated with incident cognitive impairment in a geographically diverse, biracial US cohort of men and women (n = 20,150). A 1-year mean baseline PM2.5 concentration was estimated for each participant, and cognitive status at the most recent follow-up was assessed over the telephone using the Six-Item Screener (SIS) in a subsample that was cognitively intact at baseline. Logistic regression was used to determine whether PM2.5 was related to the odds of incident cognitive impairment. A 10 mu g/m(3) increase in PM2.5 concentration was not reliably associated with an increased odds of incident impairment, after adjusting for temperature, season, incident stroke, and length of follow-up [OR (95% CI): 1.26 (0.97, 1.64)]. The odds ratio was attenuated towards 1 after adding demographic covariates, behavioral factors, and known comorbidities of cognitive impairment. A 10 mu g/m(3) increase in PM2.5 concentration was slightly associated with incident impairment in urban areas (1.40 [1.06-1.85]), but this relationship was also attenuated after including additional covariates in the model. Evidence is lacking that the effect of PM2.5 on incident cognitive impairment is robust in a heterogeneous US cohort, even in urban areas.	[Loop, Matthew Shane; McClure, Leslie A.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Kent, Shia T.] Univ Alabama Birmingham, Dept Environm Hlth Sci, Birmingham, AL 35294 USA; [Al-Hamdan, Mohammad Z.; Crosson, William L.; Estes, Sue M.; Estes, Maurice G., Jr.; Hemmings, Sarah N.] NASA Marshall Space Flight Ctr, Univ Space Res Assoc, Huntsville, AL USA; [Quattrochi, Dale A.] NASA Marshall Space Flight Ctr, Earth Sci Off, Huntsville, AL USA; [Wadley, Virginia G.] Univ Alabama Birmingham, Sch Med, Div Gerontol Geriatr & Palliat Care, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; Universities Space Research Association (USRA); National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; University of Alabama System; University of Alabama Birmingham	Loop, MS (corresponding author), Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA.	loop2@uab.edu	McClure, Leslie/P-2929-2015	Loop, Matthew/0000-0001-9442-4573	National Institute of Neurological Disorders and Stroke [U01NS41588]; National Institutes of Health Heart, Lung and Blood Institute [T32HL079888]; National Aeronautics and Space Administration [NNX09AV81G]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL079888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by federal grants from National Institute of Neurological Disorders and Stroke (U01NS41588, http://www.ninds.nih.gov/), National Institutes of Health Heart, Lung and Blood Institute (T32HL079888, http://www.nhlbi.nih.gov/), and National Aeronautics and Space Administration (NNX09AV81G, http://www.nasa.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hamdan MZ, 2014, GEOCARTO INT, V29, P85, DOI 10.1080/10106049.2012.715209; Al-Hamdan MZ, 2009, J AIR WASTE MANAGE, V59, P865, DOI 10.3155/1047-3289.59.7.865; Blacker D, 2007, ARCH NEUROL-CHICAGO, V64, P862, DOI 10.1001/archneur.64.6.862; Calderon-Garciduenas L, 2004, TOXICOL PATHOL, V32, P650, DOI 10.1080/01926230490520232; Calderon-Garciduenas L, 2003, TOXICOL PATHOL, V31, P524, DOI 10.1080/01926230390226645; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Calderon-Garciduenas L, 2007, TOXICOL PATHOL, V35, P154, DOI 10.1080/01926230601059985; Callahan CM, 2002, MED CARE, V40, P771, DOI 10.1097/00005650-200209000-00007; Campbell A, 2005, NEUROTOXICOLOGY, V26, P133, DOI 10.1016/j.neuro.2004.08.003; Chen JC, 2009, NEUROTOXICOLOGY, V30, P231, DOI 10.1016/j.neuro.2008.12.011; Cosgrove BA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003118; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Duron E, 2008, VASC HEALTH RISK MAN, V4, P363; Euser SM, 2008, EPIDEMIOLOGY, V19, P440, DOI 10.1097/EDE.0b013e31816a1d31; Freire C, 2010, J EPIDEMIOL COMMUN H, V64, P223, DOI 10.1136/jech.2008.084574; Gryparis A, 2009, BIOSTATISTICS, V10, P258, DOI 10.1093/biostatistics/kxn033; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Heal MR, 2012, CHEM SOC REV, V41, P6606, DOI 10.1039/c2cs35076a; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Hu ZY, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-26; Hu ZY, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-27; Kumar N, 2010, ENVIRON HEALTH PERSP, V118, pA109, DOI 10.1289/ehp.0901732; Liu W, 2005, ATMOS ENVIRON, V39, P4453, DOI 10.1016/j.atmosenv.2005.03.048; Martuzevicius D, 2004, ATMOS ENVIRON, V38, P1091, DOI 10.1016/j.atmosenv.2003.11.015; MELCHIOR LA, 1993, EDUC PSYCHOL MEAS, V53, P1117, DOI 10.1177/0013164493053004024; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; Power MC, 2011, ENVIRON HEALTH PERSP, V119, P682, DOI 10.1289/ehp.1002767; Puett RC, 2009, ENVIRON HEALTH PERSP, V117, P1697, DOI 10.1289/ehp.0900572; Pullicino PM, 2008, J CARD FAIL, V14, P290, DOI 10.1016/j.cardfail.2008.01.003; Ranft U, 2009, ENVIRON RES, V109, P1004, DOI 10.1016/j.envres.2009.08.003; Steffens DC, 2006, AM J GERIAT PSYCHIAT, V14, P401, DOI 10.1097/01.JGP.0000194646.65031.3f; Suglia SF, 2008, AM J EPIDEMIOL, V167, P280, DOI 10.1093/aje/kwm308; Tamura MK, 2008, AM J KIDNEY DIS, V52, P227, DOI 10.1053/j.ajkd.2008.05.004; Tsivgoulis G, 2009, NEUROLOGY, V73, P589, DOI 10.1212/WNL.0b013e3181b38969; Unverzagt FW, 2011, NEUROLOGY, V77, P1729, DOI 10.1212/WNL.0b013e318236ef23; Wadley VG, 2007, STROKE, V38, P1143, DOI 10.1161/01.STR.0000259676.75552.38; Wadley VG, 2011, ANN NEUROL, V70, P229, DOI 10.1002/ana.22432; Wellenius GA, 2012, ARCH INTERN MED, V172, P229, DOI 10.1001/archinternmed.2011.732; Weuve J, 2012, ARCH INTERN MED, V172, P219, DOI 10.1001/archinternmed.2011.683; Wilber ST, 2005, ACAD EMERG MED, V12, P612, DOI 10.1111/j.1553-2712.2005.tb00915.x; Zhang H, 2009, J AIR WASTE MANAGE, V59, P1358, DOI 10.3155/1047-3289.59.11.1358	41	62	66	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75001	10.1371/journal.pone.0075001	http://dx.doi.org/10.1371/journal.pone.0075001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086422	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700049
J	Nair, M; Ariana, P; Ohuma, EO; Gray, R; De Stavola, B; Webster, P				Nair, Manisha; Ariana, Proochista; Ohuma, Eric O.; Gray, Ron; De Stavola, Bianca; Webster, Premila			Effect of the Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA) on Malnutrition of Infants in Rajasthan, India: A Mixed Methods Study	PLOS ONE			English	Article							FOOD INSECURITY; DEFINITION; NUTRITION; MORTALITY; IMPACT	Objectives: Analyse the effect of the Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA), a wage-for-employment policy of the Indian Government, on infant malnutrition and delineate the pathways through which MGNREGA affects infant malnutrition. Hypothesis: MGNREGA could reduce infant malnutrition through positive effects on household food security and infant feeding. Method: Mixed methods using cross-sectional study and focus group discussions conducted in Dungarpur district, Rajasthan, India. Participants: Infants aged 1 to <12 months and their mothers/caregivers. Final sample 528 households with 1056 participants, response rate 89.6%. Selected households were divided into MGNREGA-households and non-MGNREGA-households based on participation in MGNREGA between August-2010 and September-2011. Outcomes: Infant malnutrition measured using anthropometric indicators - underweight, stunting, and wasting (WHO criteria). Results: We included 528 households with 1,056 participants. Out of 528, 281 households took part in MGNREGA between August'10, and September'11. Prevalence of wasting was 39%, stunting 24%, and underweight 50%. Households participating in MGNREGA were less likely to have wasted infants (OR 0.57, 95% CI 0.37-0.89, p = 0.014) and less likely to have underweight infants (OR 0.48, 95% CI 0.30-0.76, p = 0.002) than non-participating households. Stunting did not differ significantly between groups. We did 11 focus group discussions with 62 mothers. Although MGNREGA reduced starvation, it did not provide the desired benefits because of lower than standard wages and delayed payments. Results from path analysis did not support existence of an effect through household food security and infant feeding, but suggested a pathway of effect through low birth-weight. Conclusion: Participation in MGNREGA was associated with reduced infant malnutrition possibly mediated indirectly via improved birth-weight rather than by improved infant feeding. Addressing factors such as lack of mothers' knowledge and inappropriate feeding practices, over and above the social and economic policies, is key in efforts to reduce infant malnutrition.	[Nair, Manisha; Gray, Ron] Univ Oxford, NPEU, Nuffield Dept Populat Hlth, Oxford, England; [Ariana, Proochista; Webster, Premila] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Ariana, Proochista] Univ Oxford, Dept Int Dev, Oxford, England; [Ohuma, Eric O.] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England; [De Stavola, Bianca] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [De Stavola, Bianca] London Sch Hyg & Trop Med, Fac Epidemiol & Publ Hlth, London WC1, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Nair, M (corresponding author), Univ Oxford, NPEU, Nuffield Dept Populat Hlth, Oxford, England.	manisha.nair@npeu.ox.ac.uk		De Stavola, Bianca Lucia/0000-0001-7853-0528; Nair, Manisha/0000-0003-0660-5054	Weidenfeld Scholarship; Department of Public Health, University of Oxford, UK	Weidenfeld Scholarship; Department of Public Health, University of Oxford, UK	This paper is from the PhD thesis of MN funded by the Weidenfeld Scholarship and Leadership Programme and Department of Public Health, University of Oxford, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBI R, 1988, Food and Nutrition Bulletin, V10, P51; Asparouhov T., 2010, MPLUS TECHNICAL APPE; BAQUI AH, 1991, INT J EPIDEMIOL, V20, P1057, DOI 10.1093/ije/20.4.1057; Bawdekar M, 2008, J BIOSOC SCI, V40, P771, DOI 10.1017/S0021932008002757; Beauducel A, 2006, STRUCT EQU MODELING, V13, P186, DOI 10.1207/s15328007sem1302_2; Burchi F, 2010, ECON HUM BIOL, V8, P331, DOI 10.1016/j.ehb.2010.05.010; Charmarbagwala R, 2004, DETERMINANTS CHILD H; Chitnis S., 1997, POLITICS BACKWARDNES; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; DEONIS M, 1993, B WORLD HEALTH ORGAN, V71, P703; Dev SM, 2011, WP2011004 I GANDH I; Frongillo EA, 1997, J NUTR, V127, P2302, DOI 10.1093/jn/127.12.2302; Galanter Marc, 1984, COMPETING EQUALITIES; Government of Rajasthan and Planning Commission of India, 2009, DUNG DISTR HUM DEV R; Gulliford MC, 2005, J CLIN EPIDEMIOL, V58, P246, DOI 10.1016/j.jclinepi.2004.08.012; Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.21427/D7CF7R; International Institute for Population Sciences, 2011, DISTR LEV HOUS FAC S; International Institute for Population Sciences (IIPS), 2007, NAT FAM HLTH SURV NF; Jha R, 2011, J ASIAN ECON, V22, P189, DOI 10.1016/j.asieco.2010.11.004; Kenny DA, 2003, STRUCT EQU MODELING, V10, P333, DOI 10.1207/S15328007SEM1003_1; Khera R., 2011, BATTLE EMPLOYMENT GU; Mascie-Taylor CGN, 2010, B WORLD HEALTH ORGAN, V88, P854, DOI 10.2471/BLT.10.080994; Naandi Foundation, 2011, HUNGAMA FIGHT HUNG M; Nair M, 2011, B WORLD HEALTH ORGAN, V89, P778, DOI 10.2471/BLT.11.093799; Paul KH, 2011, FOOD NUTR BULL, V32, P244, DOI 10.1177/156482651103200308; PELLETIER DL, 1994, J NUTR, V124, pS2047; Planning Commission, 2002, 10 5 YEAR PLAN 2002; Senarath U, 2012, MATERN CHILD NUTR, V8, P5, DOI 10.1111/j.1740-8709.2011.00371.x; Swindale A., 2006, FHI 360FANTA; United Nations Children Fund (UNICEF), 2007, WAT ENV SAN CHILDR W; Uppal V., 2009, IS NREGS SAFETY NET; Vasconcelos AGG, 1998, ANN EPIDEMIOL, V8, P262, DOI 10.1016/S1047-2797(97)00213-5; Vesel L, 2010, B WORLD HEALTH ORGAN, V88, P39, DOI 10.2471/BLT.08.057901; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WATERLOW JC, 1972, BRIT MED J, V3, P566, DOI 10.1136/bmj.3.5826.566; Webb P, 1995, EMPLOYMENT POVERTY R; WHO, 2006, WHO CHILD GROWTH STA; WHO/ UNICEF, 2009, WHO CHILD GROWTH STA; World Health Organization, 2010, IND ASS INF YOUNG CH	39	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75089	10.1371/journal.pone.0075089	http://dx.doi.org/10.1371/journal.pone.0075089			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VC	24086447	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700052
J	Panda, SP; Guntur, AR; Polusani, SR; Fajardo, RJ; Gakunga, PT; Roman, LJ; Masters, BS				Panda, Satya P.; Guntur, Anyonya R.; Polusani, Srikanth R.; Fajardo, Roberto J.; Gakunga, Peter T.; Roman, Linda J.; Masters, Bettie Sue			Conditional Deletion of Cytochrome P450 Reductase in Osteoprogenitor Cells Affects Long Bone and Skull Development in Mice Recapitulating Antley-Bixler Syndrome: Role of a Redox Enzyme in Development	PLOS ONE			English	Article							P450 OXIDOREDUCTASE; PKC-DELTA; MOUSE; GROWTH; EXPRESSION; OSTEOBLAST; GENE; DIFFERENTIATION; KNOCKOUT; DEFECTS	NADPH-cytochrome P450 oxidoreductase (POR) is the primary electron donor for cytochromes P450, dehydrocholesterol reductase, heme oxygenase, and squalene monooxygenase. Human patients with specific mutations in POR exhibit severe developmental malformations including disordered steroidogenesis, sexual ambiguities and various bone defects, similar to those seen in patients with Antley-Bixler syndrome (ABS). To probe the role of POR during bone development, we generated a conditional knockout mouse (CKO) by cross breeding Por(lox/lox) and Dermo1 Cre mice. CKO mice were smaller than their littermate controls and exhibited significant craniofacial and long bone abnormalities. Differential staining of the CKO mice skull bases shows premature fusion of the sphenooccipital and basioccipital-exoccipital synchondroses. Class III malocclusion was noted in adult knockout mice with an unusual overgrowth of the lower incisors. Shorter long bones were observed along with a reduction in the bone volume fraction, measured by microCT, in the Por-deleted mice compared to age-and sex-matched littermate controls. Concerted up-or down-regulation of proteins in the FGF signaling pathway observed by immunohistochemistry in the tibia samples of CKO mice compared to wild type controls shows a decrease in the FGF signaling pathway. To our knowledge, this is the first report of a mouse model that recapitulates both skull and long bone defects upon Por deletion, offering an approach to study the sequelae of POR mutations. This unique model demonstrates that P450 metabolism in bone itself is potentially important for proper bone development, and that an apparent link exists between the POR and FGF signaling pathways, begging the question of how an oxidation-reduction flavoprotein affects developmental and cellular signaling processes.	[Panda, Satya P.; Guntur, Anyonya R.; Polusani, Srikanth R.; Roman, Linda J.; Masters, Bettie Sue] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Fajardo, Roberto J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Orthoped, San Antonio, TX 78229 USA; [Gakunga, Peter T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Dev Dent, Div Orthodont, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Panda, SP (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.	panda@uthscsa.edu; masters@uthscsa.edu	Polusani, Srikanth R/H-7318-2015	polusani, Srikanth/0000-0002-7186-0345	NIH [GM081568]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081568] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Grant GM081568 to BSM and SPP and BSM is The Robert A. Welch Distinguished Professor in Chemistry (AQ-0012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2009, ENDOCRINOLOGY, V150, P2732, DOI 10.1210/en.2009-0043; Alam J, 2002, ANTIOXID REDOX SIGN, V4, P559, DOI 10.1089/15230860260220049; Antley R, 1975, Birth Defects Orig Artic Ser, V11, P397; Auchus RJ, 2001, ENDOCRIN METAB CLIN, V30, P101, DOI 10.1016/S0889-8529(08)70021-5; Cheng JB, 2003, J BIOL CHEM, V278, P38084, DOI 10.1074/jbc.M307028200; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dobrowolski R, 2009, HUM MOL GENET, V18, P2899, DOI 10.1093/hmg/ddp227; Eswarakumar VP, 2004, P NATL ACAD SCI USA, V101, P12555, DOI 10.1073/pnas.0405031101; Eswarakumar VP, 2002, DEVELOPMENT, V129, P3783; Fang C, 2012, NEUROSCIENCE, V218, P170, DOI 10.1016/j.neuroscience.2012.05.027; Fang C, 2008, DRUG METAB DISPOS, V36, P1722, DOI 10.1124/dmd.108.021881; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; Guntur AR, 2011, DEVELOPMENT, V138, P1433, DOI 10.1242/dev.058016; Horvat S, 2011, DRUG METAB REV, V43, P69, DOI 10.3109/03602532.2010.540580; Huang NW, 2005, AM J HUM GENET, V76, P729, DOI 10.1086/429417; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Keber R, 2011, J BIOL CHEM, V286, P29086, DOI 10.1074/jbc.M111.253245; Kolpakova-Hart E, 2008, DEV BIOL, V321, P407, DOI 10.1016/j.ydbio.2008.07.005; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Laurita J, 2011, DEV DYNAM, V240, P2584, DOI 10.1002/dvdy.22752; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Lee CH, 2011, EUR J PHARMACOL, V668, P383, DOI 10.1016/j.ejphar.2011.06.059; Liu ZH, 2007, DEV BIOL, V302, P80, DOI 10.1016/j.ydbio.2006.08.071; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Makarenkova H, 1999, DEV BIOL, V207, P380, DOI 10.1006/dbio.1998.9171; Masters BS, 2006, DRUG METAB REV, V38, P209, DOI 10.1080/03602530600570065; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Melville H, 2010, AM J MED GENET A, V152A, P3007, DOI 10.1002/ajmg.a.33703; Nagata M, 2011, BONE, V48, P847, DOI 10.1016/j.bone.2010.11.014; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Niger C, 2012, AM J PHYSIOL-CELL PH, V302, pC1035, DOI 10.1152/ajpcell.00262.2011; Opperman L.A., 2005, SEMIN ORTHOD, V11, P199, DOI [10.1053/j.sodo.2005.07.004, DOI 10.1053/J.SODO.2005.07.004, DOI 10.1053/J.S0D0.2005.07.004]; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Otto DME, 2003, MOL CELL BIOL, V23, P6103, DOI 10.1128/MCB.23.17.6103-6116.2003; Polusani SR, 2011, BIOCHEM BIOPH RES CO, V411, P490, DOI 10.1016/j.bbrc.2011.06.132; Ribes V, 2007, DEV BIOL, V303, P66, DOI 10.1016/j.ydbio.2006.10.032; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; Schmidt K, 2009, MOL CELL BIOL, V29, P2716, DOI 10.1128/MCB.01638-08; Seo HS, 2007, DEV BIOL, V310, P304, DOI 10.1016/j.ydbio.2007.07.040; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Sinha KM, 2013, J CELL BIOCHEM, V114, P975, DOI 10.1002/jcb.24439; Stavridis MP, 2010, DEVELOPMENT, V137, P881, DOI 10.1242/dev.043117; Takahashi H, 1997, ENDOCR RES, V23, P95, DOI 10.1080/07435809709031845; Tou LQ, 2001, MOL CELL ENDOCRINOL, V183, P71, DOI 10.1016/S0303-7207(01)00594-9; Tsuchiya Yoshiko, 2004, Bull Tokyo Dent Coll, V45, P87, DOI 10.2209/tdcpublication.45.87; Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003; Twigg SRF, 2009, DEV DYNAM, V238, P331, DOI 10.1002/dvdy.21790; Weng Y, 2007, CANCER RES, V67, P7825, DOI 10.1158/0008-5472.CAN-07-1006; Wu L, 2005, J PHARMACOL EXP THER, V312, P35, DOI 10.1124/jpet.104.073353; Wu L, 2003, GENESIS, V36, P177, DOI 10.1002/gene.10214; Yeh LCC, 1996, ENDOCRINOLOGY, V137, P1921, DOI 10.1210/en.137.5.1921; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zhang QY, 2009, DRUG METAB DISPOS, V37, P651, DOI 10.1124/dmd.108.025429	55	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75638	10.1371/journal.pone.0075638	http://dx.doi.org/10.1371/journal.pone.0075638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086598	Green Submitted, gold, Green Published			2022-12-27	WOS:000325218700106
J	Elustondo, PA; Angelova, PR; Kawalec, M; Michalak, M; Kurcok, P; Abramov, AY; Pavlov, EV				Elustondo, Pia A.; Angelova, Plamena R.; Kawalec, Michal; Michalak, Michal; Kurcok, Piotr; Abramov, Andrey Y.; Pavlov, Evgeny V.			Polyhydroxybutyrate Targets Mammalian Mitochondria and Increases Permeability of Plasmalemmal and Mitochondrial Membranes	PLOS ONE			English	Article							INORGANIC POLYPHOSPHATE; (R)-3-HYDROXYBUTANOIC ACID; ESCHERICHIA-COLI; LIPID-BILAYERS; CHANNEL; CELLS; IDENTIFICATION; METABOLISM; TRANSPORT; CA2+	Poly(3-hydroxybutyrate) (PHB) is a polyester of 3-hydroxybutyric acid (HB) that is ubiquitously present in all organisms. In higher eukaryotes PHB is found in the length of 10 to 100 HB units and can be present in free form as well as in association with proteins and inorganic polyphosphate. It has been proposed that PHB can mediate ion transport across lipid bilayer membranes. We investigated the ability of PHB to interact with living cells and isolated mitochondria and the effects of these interactions on membrane ion transport. We performed experiments using a fluorescein derivative of PHB (fluo-PHB). We found that fluo-PHB preferentially accumulated inside the mitochondria of HeLa cells. Accumulation of fluo-PHB induced mitochondrial membrane depolarization. This membrane depolarization was significantly delayed by the inhibitor of the mitochondrial permeability transition pore - Cyclosporin A. Further experiments using intact cells as well as isolated mitochondria confirmed that the effects of PHB directly linked to its ability to facilitate ion transport, including calcium, across the membranes. We conclude that PHB demonstrates ionophoretic properties in biological membranes and this effect is most profound in mitochondria due to the selective accumulation of the polymer in this organelle.	[Elustondo, Pia A.; Pavlov, Evgeny V.] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada; [Kawalec, Michal; Michalak, Michal; Kurcok, Piotr] Polish Acad Sci, Ctr Polymer & Carbon Mat, Zabrze, Poland; [Angelova, Plamena R.; Abramov, Andrey Y.] UCL Inst Neurol, London, England	Dalhousie University; Polish Academy of Sciences; Centre of Polymer & Carbon Materials of the Polish Academy of Sciences; University of London; University College London	Pavlov, EV (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada.	evgeny.pavlov@dal.ca	Kawalec, Michal/H-3918-2011; Michalak, Michal/O-4975-2019; Kurcok, Piotr/B-5773-2016; Michalak, Michał/D-4543-2016; Stroh, Plamena/K-4444-2013; Abramov, Andrey/AAC-6712-2019; Abramov, Andrey Y/H-9053-2012	Kawalec, Michal/0000-0002-5760-3756; Michalak, Michal/0000-0001-6306-3744; Kurcok, Piotr/0000-0002-8748-1649; Michalak, Michał/0000-0001-6306-3744; Stroh, Plamena/0000-0003-4596-9117; Abramov, Andrey/0000-0002-7646-7235; Abramov, Andrey Y/0000-0002-7646-7235	Heart and Stroke Foundation of Nova Scotia; Natural Sciences and Engineering Research Council of Canada	Heart and Stroke Foundation of Nova Scotia; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Heart and Stroke Foundation of Nova Scotia and Natural Sciences and Engineering Research Council of Canada (to EP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2003, CELL CALCIUM, V33, P101, DOI 10.1016/S0143-4160(02)00203-8; Abramov AY, 2001, BBA-BIOMEMBRANES, V1512, P98, DOI 10.1016/S0005-2736(01)00307-8; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Cao CK, 2013, CELL REP, V4, P302, DOI 10.1016/j.celrep.2013.06.022; Das S, 1999, MACROMOLECULES, V32, P8781, DOI 10.1021/ma991105t; Das S, 1997, P NATL ACAD SCI USA, V94, P9075, DOI 10.1073/pnas.94.17.9075; Elustondo P, 2012, CHEM BIODIVERS, V9, P2597, DOI 10.1002/cbdv.201200294; Fritz MG, 1999, MACROMOLECULES, V32, P574, DOI 10.1021/ma981256g; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gee PJ, 2002, HELV CHIM ACTA, V85, P618, DOI 10.1002/1522-2675(200202)85:2<618::AID-HLCA618>3.0.CO;2-Q; Gunter TE, 2009, BBA-BIOENERGETICS, V1787, P1291, DOI 10.1016/j.bbabio.2008.12.011; Kawalec M, 2012, REACT FUNCT POLYM, V72, P509, DOI 10.1016/j.reactfunctpolym.2012.04.013; KESSLER RJ, 1977, P NATL ACAD SCI USA, V74, P2241, DOI 10.1073/pnas.74.6.2241; Pavlov E, 2005, BIOPHYS J, V88, P2614, DOI 10.1529/biophysj.104.057281; Pavlov E, 2010, J BIOL CHEM, V285, P9420, DOI 10.1074/jbc.M109.013011; Piddubnyak V, 2004, BIOMATERIALS, V25, P5271, DOI 10.1016/j.biomaterials.2003.12.029; Reusch RN, 2003, ACTA DIABETOL, V40, P91; REUSCH RN, 1989, P SOC EXP BIOL MED, V191, P377; REUSCH RN, 1988, P NATL ACAD SCI USA, V85, P4176, DOI 10.1073/pnas.85.12.4176; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Seebach D, 1999, INT J BIOL MACROMOL, V25, P217, DOI 10.1016/S0141-8130(99)00037-9; SEEBACH D, 1994, EUR J BIOCHEM, V224, P317, DOI 10.1111/j.1432-1033.1994.00317.x; Smithen M, 2013, CELL CALCIUM, V54, P86, DOI 10.1016/j.ceca.2013.04.006; Trainer MA, 2006, APPL MICROBIOL BIOT, V71, P377, DOI 10.1007/s00253-006-0354-1; Wood-Kaczmar A, 2013, ADV EXP MED BIOL, V961, P241, DOI 10.1007/978-1-4614-4756-6_20; Zakharian E, 2007, BIOPHYS J, V92, P588, DOI 10.1529/biophysj.106.095273; Zakharian E, 2004, BIOCHEM BIOPH RES CO, V322, P1059, DOI 10.1016/j.bbrc.2004.08.027; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404; Zamaraeva MV, 1997, CELL CALCIUM, V22, P235, DOI 10.1016/S0143-4160(97)90062-2; Zawidlak-Wegrzynska B, 2010, EUR J MED CHEM, V45, P1833, DOI 10.1016/j.ejmech.2010.01.020	31	32	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75812	10.1371/journal.pone.0075812	http://dx.doi.org/10.1371/journal.pone.0075812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086638	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200121
J	Geiger, MF; McCrary, JK; Schliewen, UK				Geiger, Matthias F.; McCrary, Jeffrey K.; Schliewen, Ulrich K.			Crater Lake Apoyo Revisited - Population Genetics of an Emerging Species Flock	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; MIDAS CICHLID COMPLEX; SYMPATRIC SPECIATION; TELEOSTEI CICHLIDAE; GENOMIC SIGNATURES; AMPHILOPHUS SPP.; SEXUAL SELECTION; WATER TURBIDITY; EVOLUTION; FISH	The polytypic Nicaraguan Midas cichlids (Amphilophus cf. citrinellus) have been established as a model system for studying the mechanisms of speciation and patterns of diversification in allopatry and sympatry. The species assemblage in Crater Lake Apoyo has been accepted as a textbook example for sympatric speciation. Here, we present a first comprehensive data set of population genetic (mtDNA & AFLPs) proxies of species level differentiation for a representative set of individuals of all six endemic Amphilophus species occurring in Crater Lake Apoyo. AFLP genetic differentiation was partitioned into a neutral and non-neutral component based on outlier-loci detection approaches, and patterns of species divergence were explored with Bayesian clustering methods. Substantial levels of admixture between species were detected, indicating different levels of reproductive isolation between the six species. Analysis of neutral genetic variation revealed several A. zaliosus as being introgressed by an unknown contributor, hereby rendering the sympatrically evolving L. Apoyo flock polyphyletic. This is contrasted by the mtDNA analysis delivering a clear monophyly signal with Crater Lake Apoyo private haplotypes characterising all six described species, but also demonstrating different demographic histories as inferred from pairwise mismatch distributions.	[Geiger, Matthias F.; Schliewen, Ulrich K.] Zool Staatssammlung Munchen, ZSM, Dept Ichthyol, Bavarian State Collect Zool, Munich, Germany; [McCrary, Jeffrey K.] Laguna de Apoyo Nat Reserve, Fdn Nicaraguense Prodesarrollo Comunitario Integr, Estn Biol, Masaya, Nicaragua		Geiger, MF (corresponding author), Zool Staatssammlung Munchen, ZSM, Dept Ichthyol, Bavarian State Collect Zool, Munich, Germany.	matthias.f.geiger@t-online.de	Geiger, Matthias/S-3459-2017	Geiger, Matthias/0000-0003-2403-0805	FUNDECI/GAIA; DAAD; LMU; Bavarian Elite Aid Act (BayEFG)	FUNDECI/GAIA; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); LMU; Bavarian Elite Aid Act (BayEFG)	This work was supported in part by FUNDECI/GAIA (www.gaianicaragua.org) and by grants provided to MFG by DAAD (www.daad.de), LMU (www.lmu.de) and the Bavarian Elite Aid Act (BayEFG, www.elitenetzwerk.bayern.de). Additional support for molecular analyses was provided by the DNA Bank Network (www.dnabank-network.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida CR, 2003, EVOL ECOL RES, V5, P739; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BANIC, 1999, ENCUENTRO, V51, P80; BARLOW GW, 1977, BEHAV ECOL SOCIOBIOL, V2, P49, DOI 10.1007/BF00299288; BARLOW GW, 1978, BIOL BEHAV, V3, P137; BARLOW GW, 1976, INVESTIGATIONS ICHTH; Barluenga M, 2004, MOL ECOL, V13, P2061, DOI 10.1111/j.1365-294X.2004.02211.x; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Barluenga M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-326; Barreto FS, 2008, EVOLUTION, V62, P226, DOI 10.1111/j.1558-5646.2007.00285.x; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Bolnick DI, 2007, ANNU REV ECOL EVOL S, V38, P459, DOI 10.1146/annurev.ecolsys.38.091206.095804; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Burke JM, 2001, ANNU REV GENET, V35, P31, DOI 10.1146/annurev.genet.35.102401.085719; Butlin RK, 2009, HEREDITY, V102, P1, DOI 10.1038/hdy.2008.97; Butlin R, 2012, TRENDS ECOL EVOL, V27, P27, DOI 10.1016/j.tree.2011.09.002; Butlin RK, 2010, GENETICA, V138, P409, DOI 10.1007/s10709-008-9321-3; Caballero A, 2008, GENETICS, V179, P539, DOI 10.1534/genetics.107.083246; *CIRA UNAN MAN, 2008, PLAN INF LAG AP MAN; Coyne J.A., 2004, SPECIATION; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Donaldson KA, 1999, MOL PHYLOGENET EVOL, V13, P208, DOI 10.1006/mpev.1999.0625; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Elmer KR, 2010, MOL ECOL, V19, P197, DOI 10.1111/j.1365-294X.2009.04488.x; Elmer KR, 2013, EVOLUTION, V67, P281, DOI 10.1111/j.1558-5646.2012.01755.x; Elmer KR, 2011, TRENDS ECOL EVOL, V26, P298, DOI 10.1016/j.tree.2011.02.008; Elmer KR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-60; Elmer KR, 2009, EVOLUTION, V63, P2750, DOI 10.1111/j.1558-5646.2009.00736.x; Engstrom-Ost J, 2007, BEHAV ECOL, V18, P393, DOI 10.1093/beheco/arl097; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Feulner Philine G.D., 2009, Communicative & Integrative Biology, V2, P329; Fitzpatrick BM, 2008, J EVOLUTION BIOL, V21, P1452, DOI 10.1111/j.1420-9101.2008.01611.x; Foll M, 2008, GENETICS, V179, P927, DOI 10.1534/genetics.107.084541; Gaggiotti OE, 2000, P ROY SOC B-BIOL SCI, V267, P81, DOI 10.1098/rspb.2000.0970; GAVRILETS S, 2004, MONOGR POPUL BIOL, V41; Geiger MF, 2010, P BIOL SOC WASH, V123, P159, DOI 10.2988/09-20.1; Geiger MF, 2010, MOL PHYLOGENET EVOL, V56, P1011, DOI 10.1016/j.ympev.2010.05.015; Gross BL, 2004, AM NAT, V164, P145, DOI 10.1086/422223; Henning F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-171; Herder F, 2008, EVOLUTION, V62, P2178, DOI 10.1111/j.1558-5646.2008.00447.x; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jarvenpaa M, 2004, P ROY SOC B-BIOL SCI, V271, P2361, DOI 10.1098/rspb.2004.2870; Kautt AF, 2012, MOL ECOL, V21, P4770, DOI 10.1111/j.1365-294X.2012.05738.x; Kawata M, 2000, EVOL ECOL RES, V2, P897; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Kondrashov AS, 1999, NATURE, V400, P351, DOI 10.1038/22514; LINK W, 1995, THEOR APPL GENET, V90, P27, DOI 10.1007/BF00220992; Losos JB, 2010, EVOLUTION DARWIN 1 1; Mallet J, 2009, J EVOLUTION BIOL, V22, P2332, DOI 10.1111/j.1420-9101.2009.01816.x; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Martin CH, 2012, AM NAT, V180, pE90, DOI 10.1086/667586; Mayr E, 1942, SYSTEMATICS ORIGIN S; MCCRARY JK, 2008, REV NICARAGNENSE BIO, V1, P43; McKaye K.R., 1976, INVESTIGATIONS ICHTH; Nagl S, 1998, P NATL ACAD SCI USA, V95, P14238, DOI 10.1073/pnas.95.24.14238; Nielsen EE, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-276; Nolte AW, 2005, P ROY SOC B-BIOL SCI, V272, P2379, DOI 10.1098/rspb.2005.3231; Oleksiak MF, 2010, J FISH BIOL, V76, P1067, DOI 10.1111/j.1095-8649.2010.02563.x; Perez GAC, 2007, MOL PHYLOGENET EVOL, V43, P91, DOI 10.1016/j.ympev.2006.08.012; Perez-Figueroa A, 2010, J EVOLUTION BIOL, V23, P2267, DOI 10.1111/j.1420-9101.2010.02093.x; Pfennig KS, 2007, SCIENCE, V318, P965, DOI 10.1126/science.1146035; Posada D., 2004, COLLAPSE VER 1 2 TOO; Pritchard JK, 2000, GENETICS, V155, P945; Recknagel H, 2013, G3-GENES GENOM GENET, V3, P65, DOI 10.1534/g3.112.003897; Rican O, 2008, MOL PHYLOGENET EVOL, V49, P941, DOI 10.1016/j.ympev.2008.07.022; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Ripa J, 2009, EVOL ECOL, V23, P31, DOI 10.1007/s10682-008-9267-z; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Salazar C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000930; Sato A, 2003, MOL BIOL EVOL, V20, P1448, DOI 10.1093/molbev/msg151; SCHENEKAR T, 2011, HEREDITY, DOI DOI 10.1038/HDY.2011.48.PUBMED:21731052; Schliewen UK, 2006, NATURE, V444, pE12, DOI 10.1038/nature05419; Schluter PM, 2006, MOL ECOL NOTES, V6, P569, DOI 10.1111/j.1471-8286.2006.01225.x; SCHMIDT DL, 1994, NATURE, V368, P39, DOI 10.1038/368039a0; Seehausen O, 2006, CURR BIOL, V16, pR334, DOI 10.1016/j.cub.2006.03.080; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; SMITH JM, 1966, AM NAT, V100, P637, DOI 10.1086/282457; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Smith TB, 1997, SCIENCE, V276, P1855, DOI 10.1126/science.276.5320.1855; Stauffer JR, 2008, P BIOL SOC WASH, V121, P117, DOI 10.2988/06-37.1; Stelkens RB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-283; Streelman JT, 2003, TRENDS ECOL EVOL, V18, P126; SUSSMAN D, 1985, J VOLCANOL GEOTH RES, V24, P249, DOI 10.1016/0377-0273(85)90072-1; Taylor EB, 2006, MOL ECOL, V15, P343, DOI 10.1111/j.1365-294X.2005.02794.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TURNER GF, 1995, P ROY SOC B-BIOL SCI, V260, P287, DOI 10.1098/rspb.1995.0093; van Doorn GS, 2009, SCIENCE, V326, P1704, DOI 10.1126/science.1181661; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson AB, 2000, P ROY SOC B-BIOL SCI, V267, P2133, DOI 10.1098/rspb.2000.1260; Wolf JBW, 2010, PHILOS T R SOC B, V365, P1717, DOI 10.1098/rstb.2010.0023	104	8	8	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74901	10.1371/journal.pone.0074901	http://dx.doi.org/10.1371/journal.pone.0074901			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086393	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200050
J	Gulden, E; Ihira, M; Ohashi, A; Reinbeck, AL; Freudenberg, MA; Kolb, H; Burkart, V				Guelden, Elke; Ihira, Masaru; Ohashi, Atsushi; Reinbeck, Anna Lena; Freudenberg, Marina A.; Kolb, Hubert; Burkart, Volker			Toll-Like Receptor 4 Deficiency Accelerates the Development of Insulin-Deficient Diabetes in Non-Obese Diabetic Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; INNATE IMMUNITY; AUTOIMMUNE-THYROIDITIS; NITRIC-OXIDE; BETA-CELLS; TLR4; LPS; ACTIVATION; PROTEIN	Background/Objective: Toll-like receptors (TLR) mediate the recognition of microbial constituents and stress-induced endogenous ligands by the immune system. They may also be involved in the maintenance or break down of tolerance against autologous antigens. The aim of our investigation was to study the consequence of TLR4 deficiency on the development of insulin-deficient diabetes in the NOD mouse. Methods: The TLR4 defect of the C57BL/10ScN mouse was backcrossed onto the NOD background and the effect of TLR4 deficiency on diabetes development was analysed by in vivo and in vitro studies. Results: Compared to animals with wildtype TLR4 expression (TLR4(+/+)), female NOD mice carrying a homozygous TLR4 defect (TLR4(-/-)), showed significant acceleration of diabetes development, with a younger age at diabetes onset (TLR4(+/+) 177 +/- 22 d, TLR-/- : 118 +/- 21 d; p < 0.01). Pancreata of 120 d old TLR4(-/-) NOD mice revealed increased proportions of islets with advanced stages of immune cell infiltration compared to TLR4(+/+) mice (p < 0.05). TLR4 deficiency did not affect the susceptibility of islet cells to the beta cell damaging mediators nitric oxide or the inflammatory cytokines tumor necrosis factor alpha, interleukin-1 beta and interferon gamma. The lack of TLR4 further had no effect on the frequency of regulatory T-cells but reduced their capacity to inhibit T-cell proliferation. Conclusions: Our findings demonstrate that TLR4 deficiency results in an acceleration of diabetes development and immune cell infiltration of islets in NOD mice. We conclude that TLR4 is involved in the progression of the insulitis process thereby controlling the development of insulin-deficient diabetes in NOD mice.	[Guelden, Elke; Ihira, Masaru; Ohashi, Atsushi; Reinbeck, Anna Lena; Kolb, Hubert; Burkart, Volker] Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Freudenberg, Marina A.] Max Planck Inst Immunbiol & Epigenet, Dept Dev Immunol, Freiburg, Germany	Deutsches Diabetes-Zentrum (DDZ); Max Planck Society	Burkart, V (corresponding author), Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany.	burkart@ddz.uni-duesseldorf.de		Freudenberg, Marina Alexandra/0000-0001-5894-1805	Deutsche Forschungsgemeinschaft; Deutsche Diabetes-Gesellschaft; Bundesministerium fur Bildung und Forschung to the Deutsches Zentrum fur Diabetesforschung (DZD e.V.)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Diabetes-Gesellschaft; Bundesministerium fur Bildung und Forschung to the Deutsches Zentrum fur Diabetesforschung (DZD e.V.)(Federal Ministry of Education & Research (BMBF))	This work was supported in part by grants from the Deutsche Forschungsgemeinschaft, the Deutsche Diabetes-Gesellschaft, and from the Bundesministerium fur Bildung und Forschung to the Deutsches Zentrum fur Diabetesforschung (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi-Roodsaz S, 2007, ARTHRITIS RHEUM, V56, P2957, DOI 10.1002/art.22848; Aumeunier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011484; Beutler B, 2001, DRUG METAB DISPOS, V29, P474; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Brandhorst D, 2003, CELL TRANSPLANT, V12, P859, DOI 10.3727/000000003771000200; Brusko T, 2009, CELL BIOCH BIOPHYS, V48, P165; Burkart V, 2000, J BIOL CHEM, V275, P19521, DOI 10.1074/jbc.M002265200; Burkart V, 1999, NAT MED, V5, P314, DOI 10.1038/6535; Burkart V, 1996, IMMUNOBIOLOGY, V195, P601, DOI 10.1016/S0171-2985(96)80025-8; Buschard K, 2011, APMIS, V119, P1, DOI 10.1111/j.1600-0463.2011.02765.x; CAMPBELL IL, 1988, J IMMUNOL, V141, P2325; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Caramalho I, 2011, SCAND J IMMUNOL, V74, P585, DOI 10.1111/j.1365-3083.2011.02627.x; Caricilli AM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001212; Chan JY, 2011, DIABETOLOGIA, V54, P1766, DOI 10.1007/s00125-011-2139-z; Collison LW, 2011, METHODS MOL BIOL, V707, P21, DOI 10.1007/978-1-61737-979-6_2; Dai J, 2007, J IMMUNOL, V178, P3219, DOI 10.4049/jimmunol.178.5.3219; Devaraj Sridevi, 2010, Expert Rev Endocrinol Metab, V5, P19; Freudenberg MA, 2008, IMMUNOBIOLOGY, V213, P193, DOI 10.1016/j.imbio.2007.11.008; Garay-Malpartida HM, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-18; Habich C, 2002, J IMMUNOL, V168, P569, DOI 10.4049/jimmunol.168.2.569; Huurman VAL, 2008, CLIN EXP IMMUNOL, V152, P488, DOI 10.1111/j.1365-2249.2008.03656.x; Jahromi MM, 2007, CELL MOL LIFE SCI, V64, P865, DOI 10.1007/s00018-007-6469-4; Jiang DH, 2010, ANAT REC, V293, P982, DOI 10.1002/ar.21102; Kang YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049994; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kerfoot SM, 2004, J IMMUNOL, V173, P7070, DOI 10.4049/jimmunol.173.11.7070; Kim HS, 2007, IMMUNITY, V27, P321, DOI 10.1016/j.immuni.2007.06.010; Kim HS, 2009, CURR MOL MED, V9, P30, DOI 10.2174/156652409787314471; Kong YCM, 2009, AUTOIMMUN REV, V9, P28, DOI 10.1016/j.autrev.2009.02.034; Liu B, 2006, J IMMUNOL, V177, P6880, DOI 10.4049/jimmunol.177.10.6880; Marshak-Rothstein A, 2004, J ENDOTOXIN RES, V10, P247, DOI 10.1179/096805104225005850; Martin S, 1999, HORM METAB RES, V31, P636, DOI 10.1055/s-2007-978812; Martin SF, 2008, J EXP MED, V205, P2151, DOI 10.1084/jem.20070509; McGettrick AF, 2004, MOL IMMUNOL, V41, P577, DOI 10.1016/j.molimm.2004.04.006; Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951; Pasare C, 2004, MICROBES INFECT, V6, P1382, DOI 10.1016/j.micinf.2004.08.018; Pasare C, 2003, CURR OPIN IMMUNOL, V15, P677, DOI 10.1016/j.coi.2003.09.002; Pavlovic D, 2000, EUR CYTOKINE NETW, V11, P267; Poltorak A, 2001, J IMMUNOL, V167, P2106, DOI 10.4049/jimmunol.167.4.2106; Poltorak A, 2000, J ENDOTOXIN RES, V6, P51, DOI 10.1177/09680519000060010701; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pozzilli P, 2009, ENDOCRINOL NUTR S4, V56, P50; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Saemann MD, 2005, J CLIN INVEST, V115, P468, DOI 10.1172/JCI200522720; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Schulthess FT, 2009, CELL METAB, V9, P125, DOI 10.1016/j.cmet.2009.01.003; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Tree TIM, 2006, ANN NY ACAD SCI, V1079, P9, DOI 10.1196/annals.1375.002; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Vives-Pi M, 2003, CLIN EXP IMMUNOL, V133, P208, DOI 10.1046/j.1365-2249.2003.02211.x; Wagner H, 2006, ADV IMMUNOL, V91, P159, DOI 10.1016/S0065-2776(06)91004-9; Wei WZ, 2005, CANCER RES, V65, P8471, DOI 10.1158/0008-5472.CAN-05-0934; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wong FS, 2008, ANN NY ACAD SCI, V1150, P146, DOI 10.1196/annals.1447.039	60	41	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75385	10.1371/journal.pone.0075385	http://dx.doi.org/10.1371/journal.pone.0075385			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086519	gold, Green Submitted, Green Published			2022-12-27	WOS:000326520200098
J	Jongsma, MLA; Meulenbroek, RGJ; Okely, J; Baas, CM; van der Lubbe, RHJ; Steenbergen, B				Jongsma, Marijtje L. A.; Meulenbroek, Ruud G. J.; Okely, Judith; Baas, C. Marjolein; van der Lubbe, Rob H. J.; Steenbergen, Bert			Effects of Hand Orientation on Motor Imagery - Event Related Potentials Suggest Kinesthetic Motor Imagery to Solve the Hand Laterality Judgment Task	PLOS ONE			English	Article							MENTAL ROTATION; EMBODIED COGNITION; STROKE; VOLUNTARY	Motor imagery (MI) refers to the process of imagining the execution of a specific motor action without actually producing an overt movement. Two forms of MI have been distinguished: visual MI and kinesthetic MI. To distinguish between these forms of MI we employed an event related potential (ERP) study to measure interference effects induced by hand orientation manipulations in a hand laterality judgement task. We hypothesized that this manipulation should only affect kinesthetic MI but not visual MI. The ERPs elicited by rotated hand stimuli contained the classic rotation related negativity (RRN) with respect to palm view stimuli. We observed that laterally rotated stimuli led to a more marked RRN than medially rotated stimuli. This RRN effect was observed when participants had their hands positioned in either a straight (control) or an inward rotated posture, but not when their hands were positioned in an outward rotated posture. Posture effects on the ERP-RRN have not previously been studied. Apparently, a congruent hand posture (hands positioned in an outward rotated fashion) facilitates the judgement of the otherwise more demanding laterally rotated hand stimuli. These ERP findings support a kinesthetic interpretation of MI involved in solving the hand laterality judgement task. The RRN may be used as a non-invasive marker for kinesthetic MI and seems useful in revealing the covert behavior of MI in e. g. rehabilitation programs.	[Jongsma, Marijtje L. A.; Baas, C. Marjolein; Steenbergen, Bert] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [van der Lubbe, Rob H. J.] Univ Twente, NL-7500 AE Enschede, Netherlands; [Meulenbroek, Ruud G. J.; Okely, Judith] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Donders Ctr Cognit, NL-6525 ED Nijmegen, Netherlands; [van der Lubbe, Rob H. J.] Univ Finance & Management, Dept Cognit Psychol, Warsaw, Poland	Radboud University Nijmegen; University of Twente; Radboud University Nijmegen; University of Finance & Management Warsaw	Jongsma, MLA (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands.	m.jongsma@donders.ru.nl	Meulenbroek, Ruud/D-4781-2009; van+der+Lubbe, Rob/AAJ-8120-2020	Meulenbroek, Ruud/0000-0002-5099-3771; Steenbergen, Bert/0000-0001-8863-2624; van der Lubbe, Rob/0000-0003-3658-0345	Netherlands Scientific Research NWO Brain & Cognition program	Netherlands Scientific Research NWO Brain & Cognition program	The research was funded by the Netherlands Scientific Research NWO Brain & Cognition program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNETT J, 1995, NEUROPSYCHOLOGIA, V33, P1395, DOI 10.1016/0028-3932(95)00072-B; ASHTON R, 1978, ACTA PSYCHOL, V42, P253, DOI 10.1016/0001-6918(78)90001-X; Bruyer R, 2011, PSYCHOL BELG, V51, P5, DOI 10.5334/pb-51-1-5; de Lange FP, 2006, NEUROIMAGE, V33, P609, DOI 10.1016/j.neuroimage.2006.07.017; de Vries S, 2007, J REHABIL MED, V39, P5, DOI 10.2340/16501977-0020; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Dietrich A, 2008, METHODS, V45, P319, DOI 10.1016/j.ymeth.2008.04.004; Dijkerman HC, 2004, CLIN REHABIL, V18, P538, DOI 10.1191/0269215504cr769oa; Funk M, 2005, DEVELOPMENTAL SCI, V8, P402, DOI 10.1111/j.1467-7687.2005.00428.x; Grafton ST, 2009, ANN NY ACAD SCI, V1156, P97, DOI 10.1111/j.1749-6632.2009.04425.x; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Ionta S, 2009, EXP BRAIN RES, V195, P207, DOI 10.1007/s00221-009-1770-0; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Liu KP, 2004, ARCH PHYS MED REHAB, V85, P1403, DOI 10.1016/j.apmr.2003.12.035; Lust JM, 2006, CHILD CARE HLTH DEV, V32, P649, DOI 10.1111/j.1365-2214.2006.00683.x; Mahon BZ, 2008, J PHYSIOL-PARIS, V102, P59, DOI 10.1016/j.jphysparis.2008.03.004; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Nine G., 1994, J CLIN NEUROPHYSIOL, V11, P40, DOI DOI 10.1097/00004691-199401000-00010.PUBMED:8195426; Page SJ, 2005, ARCH PHYS MED REHAB, V86, P399, DOI 10.1016/j.apmr.2004.10.002; Page SJ, 2001, CLIN REHABIL, V15, P233, DOI 10.1191/026921501672063235; Page SJ, 2011, CLIN REHABIL, V25, P627, DOI 10.1177/0269215510395793; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; PARSONS LM, 1987, COGNITIVE PSYCHOL, V19, P178, DOI 10.1016/0010-0285(87)90011-9; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; Porro CA, 1996, J NEUROSCI, V16, P7688; ROLAND PE, 1982, J NEUROPHYSIOL, V48, P467, DOI 10.1152/jn.1982.48.2.467; RUGG MD, 1995, OX PSYCH S, P27; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; Shenton JT, 2004, NEUROSCI LETT, V370, P19, DOI 10.1016/j.neulet.2004.07.053; Sirigu A, 2001, J COGNITIVE NEUROSCI, V13, P910, DOI 10.1162/089892901753165827; Steenbergen B, 2009, DEV MED CHILD NEUROL, V51, P690, DOI 10.1111/j.1469-8749.2009.03371.x; Stinear CM, 2006, EXP BRAIN RES, V168, P157, DOI 10.1007/s00221-005-0078-y; ter Horst AC, 2012, PSYCHOPHYSIOLOGY, V49, P566, DOI 10.1111/j.1469-8986.2011.01322.x; ter Horst AC, 2011, EXP BRAIN RES, V212, P635, DOI 10.1007/s00221-011-2748-2; ter Horst AC, 2010, EXP BRAIN RES, V203, P347, DOI 10.1007/s00221-010-2235-1; Thayer ZC, 2006, PSYCHOPHYSIOLOGY, V43, P401, DOI 10.1111/j.1469-8986.2006.00404.x; Vannuscorps G, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00299; Vingerhoets G, 2002, NEUROIMAGE, V17, P1623, DOI 10.1006/nimg.2002.1290; YUE G, 1992, J NEUROPHYSIOL, V67, P1114, DOI 10.1152/jn.1992.67.5.1114; Zimmermann M, 2012, CEREB CORTEX, V22, P122, DOI 10.1093/cercor/bhr098; ZIMMERMANNSCHLA.A, 2008, J NEUROENG REHABIL, V5, P5, DOI DOI 10.1186/1743-0003-5-5	42	16	17	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76515	10.1371/journal.pone.0076515	http://dx.doi.org/10.1371/journal.pone.0076515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228WY	24086747	gold, Green Published, Green Submitted			2022-12-27	WOS:000325223900104
J	Osthoff, M; Yong, HMA; Dean, MM; Eisen, DP				Osthoff, Michael; Yong, Hue Mun Au; Dean, Melinda M.; Eisen, Damon P.			Significance of Mannose-Binding Lectin Deficiency and Nucleotide-Binding Oligomerization Domain 2 Polymorphisms in Staphylococcus aureus Bloodstream Infections: A Case-Control Study	PLOS ONE			English	Article							GENETIC-VARIANTS; CROHNS-DISEASE; BACTEREMIA; MORTALITY; SEPSIS; NOD2; OPSONOPHAGOCYTOSIS; ACTIVATION; PNEUMONIA; SEVERITY	Background: Pathways coordinated by innate pattern recognition receptors like mannose-binding lectin (MBL) and nucleotide-binding oligomerization domain 2 (NOD2) are among the first immune responses to Staphylococcus aureus (S. aureus) bloodstream infections (BSI) in animal models, but human data are limited. Here, we investigated the role of MBL deficiency and NOD2 mutations in the predisposition to and severity of S. aureus BSI. Patients and Methods: A matched case-control study was undertaken involving 70 patients with S. aureus BSI and 70 age-and sex-matched hospitalized controls. MBL levels, MBL2 and NOD2 polymorphisms were analyzed. Results: After adjusting for potential confounders, MBL deficiency (<0.5 mu g/ml) was found less frequently in cases than controls (26 vs. 41%, OR 0.4, 95% confidence interval (CI) 0.20-0.95, p=0.04) as were low producing MBL genotypes (11 vs. 23%, OR 0.2, 95% CI 0.08-0.75, p=0.01), whereas NOD2 polymorphisms were similarly distributed. Cases with NOD2 polymorphisms had less organ dysfunction as shown by a lower SOFA score (median 2.5 vs. 4.5, p=0.02), whereas only severe MBL deficiency (<0.1 mu g/ml) was associated with life-threatening S. aureus BSI (OR 5.6, 95% CI 1.25-24.85, p=0.02). Conclusions: Contrary to animal model data, our study suggests MBL deficiency may confer protection against acquiring S. aureus BSI. NOD2 mutations were less frequently associated with multi-organ dysfunction. Further human studies of the innate immune response in S. aureus BSI are needed to identify suitable host targets in sepsis treatment.	[Osthoff, Michael; Eisen, Damon P.] Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3050, Australia; [Osthoff, Michael; Yong, Hue Mun Au; Eisen, Damon P.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3010, Australia; [Dean, Melinda M.] Australian Red Cross Blood Serv, Kelvin Grove, Qld, Australia	Royal Melbourne Hospital; Royal Melbourne Hospital; University of Melbourne; Australian Red Cross Blood Service	Eisen, DP (corresponding author), Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3050, Australia.	Damon.Eisen@mh.org.au	eisen, damon/AAC-7433-2019	Eisen, Damon/0000-0002-8987-4358; Osthoff, Michael/0000-0001-5439-957X	University of Melbourne, Department of Medicine	University of Melbourne, Department of Medicine	This work was supported by the University of Melbourne, Department of Medicine funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blot SI, 2002, ARCH INTERN MED, V162, P2229, DOI 10.1001/archinte.162.19.2229; Brenmoehl J, 2007, INTENS CARE MED, V33, P1541, DOI 10.1007/s00134-007-0722-z; Brouwer N, 2008, J IMMUNOL, V180, P4124, DOI 10.4049/jimmunol.180.6.4124; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Cavanaugh JA, 2003, ANN HUM GENET, V67, P35, DOI 10.1046/j.1469-1809.2003.00006.x; Deshmukh HS, 2009, INFECT IMMUN, V77, P1376, DOI 10.1128/IAI.00940-08; Eisen DP, 2008, CLIN INFECT DIS, V47, P510, DOI 10.1086/590006; Eisen DP, 2006, FEMS IMMUNOL MED MIC, V48, P274, DOI 10.1111/j.1574-695X.2006.00144.x; Eisen DP, 2003, CLIN INFECT DIS, V37, P1496, DOI 10.1086/379324; Elliott T, 2011, GUT, V60, pA61, DOI 10.1136/gut.2011.239301.121; Ferdinands JM, 2011, EMERG INFECT DIS, V17, P2294, DOI 10.3201/eid1712.111002; Fidler KJ, 2004, INTENS CARE MED, V30, P1438, DOI 10.1007/s00134-004-2303-8; Fode P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032315; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; Gillrie MR, 2010, EUR J IMMUNOL, V40, P1639, DOI 10.1002/eji.200939929; Henckaerts L, 2009, CRIT CARE MED, V37, P192, DOI 10.1097/CCM.0b013e31819263d8; Herpers BL, 2009, CLIN EXP IMMUNOL, V156, P488, DOI 10.1111/j.1365-2249.2009.03929.x; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Jongerius I, 2007, J EXP MED, V204, P2461, DOI 10.1084/jem.20070818; Kapetanovic R, 2010, MICROBES INFECT, V12, P759, DOI 10.1016/j.micinf.2010.05.003; Minchinton RM, 2002, SCAND J IMMUNOL, V56, P630, DOI 10.1046/j.1365-3083.2002.01167.x; Moreira LO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00328; Naber CK, 2009, CLIN INFECT DIS, V48, pS231, DOI 10.1086/598189; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Neth O, 2002, J IMMUNOL, V169, P4430, DOI 10.4049/jimmunol.169.8.4430; Noskin GA, 2005, ARCH INTERN MED, V165, P1756, DOI 10.1001/archinte.165.15.1756; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Park KH, 2010, J BIOL CHEM, V285, P27167, DOI 10.1074/jbc.M110.141309; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rose WE, 2012, J INFECT DIS, V206, P1604, DOI 10.1093/infdis/jis552; Shi L, 2004, J EXP MED, V199, P1379, DOI 10.1084/jem.20032207; Smithson A, 2008, CLIN INFECT DIS, V47, P1492, DOI 10.1086/593106; Styers David, 2006, Ann Clin Microbiol Antimicrob, V5, P2; Sutherland AM, 2005, CRIT CARE MED, V33, P638, DOI [10.1097/01.CCM.0000156242.44356.C5, 10.1097/01.ccm.0000156242.44356.c5]; van Belkum A, 2007, MICROBES INFECT, V9, P1471, DOI 10.1016/j.micinf.2007.08.003; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vuononvirta J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026198; Wehrhahn MC, 2012, J INFECT DIS, V205, P1840, DOI 10.1093/infdis/jis279	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76218	10.1371/journal.pone.0076218	http://dx.doi.org/10.1371/journal.pone.0076218			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086711	Green Published, Green Accepted, gold			2022-12-27	WOS:000325223900086
J	Rizvi, A; Hasan, SS; Naseem, I				Rizvi, Asim; Hasan, S. Saif; Naseem, Imrana			Selective Cytotoxic Action and DNA Damage by Calcitriol-Cu(II) Interaction: Putative Mechanism of Cancer Prevention	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; CELLULAR-DNA; COPPER; ACID; PROOXIDANT; BREAKAGE; BINDING	Background: Vitamin D is known to play an important role in cancer-prevention. One of the features associated with the onset of malignancy is the elevation of Cu (II) levels. The mode of cancer-prevention mediated by calcitriol, the biologically active form of vitamin D, remain largely unknown. Methods: Using exogenously added Cu (II) to stimulate a malignancy like condition in a novel cellular system of rabbit calcitriol overloaded lymphocytes, we assessed lipid peroxidation, protein carbonylation, DNA damage and consequent apoptosis. Free radical mediators were identified using free radical scavengers and the role of Cu (II) in the reaction was elucidated using chelators of redox active cellular metal ions. Results: Lipid peroxidation and protein carbonylation (markers of oxidative stress), consequent DNA fragmentation and apoptosis were observed due to calcitriol-Cu (II) interaction. Hydroxyl radicals, hydrogen peroxide and superoxide anions mediate oxidative stress produced during this interaction. Amongst cellular redox active metals, copper was found to be responsible for this reaction. Conclusion: This is the first report implicating Cu (II) and calcitriol interaction as the cause of selective cytotoxic action of calcitriol against malignant cells. We show that this interaction leads to the production of oxidative stress due to free radical production and consequent DNA fragmentation, which leads to apoptosis. A putative mechanism is presented to explain this biological effect.	[Rizvi, Asim; Naseem, Imrana] Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh, Uttar Pradesh, India; [Hasan, S. Saif] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Aligarh Muslim University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Rizvi, A (corresponding author), Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh, Uttar Pradesh, India.	rizvirizviasim@gmail.com	Hasan, Syed Saif/A-3400-2015	Hasan, Syed Saif/0000-0002-0759-7511; Rizvi, Asim/0000-0003-0771-0227	UGC-CSIR Junior Research Fellowship from the Government of India	UGC-CSIR Junior Research Fellowship from the Government of India	AR received a UGC-CSIR Junior Research Fellowship from the Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEGRETTO EA, 1985, J BIOL CHEM, V260, P139; ALLEGRETTO EA, 1987, J BIOL CHEM, V262, P1312; Barsony J, 1997, J BIOL CHEM, V272, P5774, DOI 10.1074/jbc.272.9.5774; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Chibber S, 2012, MED CHEM RES, V21, P2379, DOI 10.1007/s00044-011-9758-2; Chibber S, 2011, TUMOR BIOL, V32, P881, DOI 10.1007/s13277-011-0189-y; Christakos S, 2010, ENDOCRIN METAB CLIN, V39, P243, DOI 10.1016/j.ecl.2010.02.002; Ebad E, 1998, PROG CLIN BIOL RES, V259, P167; Garland CF, 2009, ANN EPIDEMIOL, V19, P468, DOI 10.1016/j.annepidem.2009.03.021; Garland CF, 2006, AM J PUBLIC HEALTH, V96, P252, DOI 10.2105/AJPH.2004.045260; Hadi SM, 2007, SEMIN CANCER BIOL, V17, P370, DOI 10.1016/j.semcancer.2007.04.002; Hadi SM, 2000, IUBMB LIFE, V50, P167, DOI 10.1080/152165400300001471; Hasan SS, 2013, IUBMB LIFE, V65, P787, DOI 10.1002/iub.1199; Hassan I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036273; KAGAWA TF, 1991, J BIOL CHEM, V266, P20175; Koren R, 2001, CANCER RES, V61, P1439; Lowndes SA, 2005, J MAMMARY GLAND BIOL, V10, P299, DOI 10.1007/s10911-006-9003-7; Moran PO, 2005, FRON BIO, V10, P2723, DOI DOI 10.2741/1731; Mukhopadhyay B, 2010, J BIOL CHEM, V285, P19002, DOI 10.1074/jbc.M109.068460; Nakagawa K, 2010, J HEALTH SCI, V53, P591, DOI [10.1248/jhs.53.591, DOI 10.1248/JHS.53.591]; Narvaez CJ, 2001, J BIOL CHEM, V276, P9101, DOI 10.1074/jbc.M006876200; Nasulewiez A, 2004, J TRACE ELEM MED BIO, V18, P1, DOI 10.1016/j.jtemb.2004.02.004; Orlov I, 2012, EMBO J, V31, P291, DOI 10.1038/emboj.2011.445; PIKE JW, 1984, J BIOL CHEM, V259, P1167; RAMANATHAN R, 1994, FREE RADICAL BIO MED, V16, P43, DOI 10.1016/0891-5849(94)90241-0; Shaffer PL, 2005, BIOCHEMISTRY-US, V44, P2678, DOI 10.1021/bi0477182; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; STUDZINSKI GP, 1995, CANCER RES, V55, P4014; Ting HJ, 2012, CANCER RES, V72, P958, DOI 10.1158/0008-5472.CAN-11-0042; Ullah MF, 2011, CANCER CHEMOTH PHARM, V67, P103, DOI 10.1007/s00280-010-1290-4; YOSHIDA D, 1993, J NEURO-ONCOL, V16, P109, DOI 10.1007/BF01324697; Zowczak M, 2001, BIOL TRACE ELEM RES, V82, P1, DOI 10.1385/BTER:82:1-3:001	32	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76191	10.1371/journal.pone.0076191	http://dx.doi.org/10.1371/journal.pone.0076191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086705	gold, Green Published, Green Submitted			2022-12-27	WOS:000325223900084
J	Jelen, S; Ulhoi, BP; Larsen, A; Frokiaer, J; Nielsen, S; Rutzler, M				Jelen, Sabina; Ulhoi, Benedicte Parm; Larsen, Agnete; Frokiaer, Jorgen; Nielsen, Soren; Rutzler, Michael			AQP9 Expression in Glioblastoma Multiforme Tumors Is Limited to a Small Population of Astrocytic Cells and CD15(+)/CalB(+) Leukocytes	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; MOLECULAR CHARACTERIZATION; GLIOMAS REVEALS; STEM-CELLS; AQUAPORIN-9; BRAIN; CD14; MARKER; WATER; DIFFERENTIATION	Aquaporin-9 (AQP9) is a membrane protein channel that is permeable to a range of small solutes, including glycerol, urea and nucleobases. Expression of AQP9 in normal brain is limited, while widespread AQP9 expression has previously been reported in human glioblastoma. However, the specific cellular expression of AQP9 in glioblastoma remains unclear. In this study, we have examined microarrays to corroborate AQP9 mRNA expression in glioma. These analyses suggested that AQP9 mRNA expression in glioblastoma is primarily explained by tumor infiltration with AQP9 expressing leukocytes. Immunolabeling confirmed that within tumor regions, AQP9 was expressed in CD15(+) and Calgranulin B+ leukocytes, but also in larger cells that morphologically resembled glioma cells. Specificity of immunoreagents was tested in recombinant cell lines, leukocyte preparations, and sections of normal human brain and liver tissue. Apparent AQP9(+) glioma cells were frequently observed in proximity to blood vessels, where brain tumor stem cells have been observed previously. A fraction of these larger AQP9 expressing cells co-expressed the differentiated astrocyte marker GFAP. AQP9 expressing glioma cells were negative for the brain tumor stem cell marker CD15, but were observed in proximity to CD15(+) glioma cells. AQP9 expression may therefore require signals of the perivascular tumor environment or alternatively it may be restricted to a population of glioma stem cell early progenitor cells.	[Jelen, Sabina; Nielsen, Soren; Rutzler, Michael] Aarhus Univ, Water & Salt Res Ctr, Dept Biomed, Aarhus, Denmark; [Ulhoi, Benedicte Parm] Aarhus Univ Hosp, Dept Pathol, DK-8000 Aarhus, Denmark; [Larsen, Agnete] Aarhus Univ, Dept Biomed Pharmacol, Aarhus, Denmark; [Frokiaer, Jorgen] Aarhus Univ, Inst Clin Med, Water & Salt Res Ctr, Aarhus, Denmark; [Rutzler, Michael] Lund Univ, Ctr Mol Prot Sci, Dept Biochem & Struct Biol, Lund, Sweden	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Lund University	Rutzler, M (corresponding author), Aarhus Univ, Water & Salt Res Ctr, Dept Biomed, Aarhus, Denmark.	michael.rutzler@biochemistry.lu.se	Rutzler, Michael/ABE-7914-2020	Rutzler, Michael/0000-0001-5597-8880; Frokiaer, Jorgen/0000-0002-6206-8065; Larsen, Agnete/0000-0001-8765-8443	Lundbeck Foundation [R17A1742]; Marie Curie Research Training Network; Nordic Research Grant for Water Imbalance Related Disorders; Danish National Research Foundation	Lundbeck Foundation(Lundbeckfonden); Marie Curie Research Training Network(European Commission); Nordic Research Grant for Water Imbalance Related Disorders; Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by The Lundbeck Foundation Grant R17A1742 (http://lundbeckfonden.dk/), a Marie Curie Research Training Network grant (http://ec.europa.eu/research/fp6/index_en.cfm?p = 10_curie), a Nordic Research Grant for Water Imbalance Related Disorders (http://www.cmbn.no/wired/). The Water and Salt Research Center was established and funded by The Danish National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado T, 2007, J BIOL CHEM, V282, P6854, DOI 10.1074/jbc.M608900200; Arcienega II, 2010, NEUROSCIENCE, V167, P1103, DOI 10.1016/j.neuroscience.2010.02.059; Badaut J, 2004, NEUROSCIENCE, V128, P27, DOI 10.1016/j.neuroscience.2004.05.042; Badaut J, 2001, J CEREBR BLOOD F MET, V21, P477, DOI 10.1097/00004647-200105000-00001; Brescia P, 2012, J ONCOL, V2012, DOI 10.1155/2012/376894; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Charles NA, 2010, CELL STEM CELL, V6, P6, DOI 10.1016/j.stem.2009.12.005; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; EDGEWORTH J, 1991, J BIOL CHEM, V266, P7706; Elkjaer ML, 2000, BIOCHEM BIOPH RES CO, V276, P1118, DOI 10.1006/bbrc.2000.3505; FEARNS C, 1995, J EXP MED, V181, P857, DOI 10.1084/jem.181.3.857; Fossdal G, 2012, SCI WORLD J, DOI 10.1100/2012/915176; FREY EA, 1992, J EXP MED, V176, P1665, DOI 10.1084/jem.176.6.1665; GRIFFIN JD, 1981, J CLIN INVEST, V68, P932, DOI 10.1172/JCI110348; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V244, P268, DOI 10.1006/bbrc.1998.8252; Jelen S, 2011, J BIOL CHEM, V286, P44319, DOI 10.1074/jbc.M111.297002; Jersmann HPA, 2001, INFECT IMMUN, V69, P479, DOI 10.1128/IAI.69.1.479-485.2001; Kitai R, 2010, BRAIN TUMOR PATHOL, V27, P17, DOI 10.1007/s10014-009-0261-0; Kotliarov Y, 2006, CANCER RES, V66, P9428, DOI 10.1158/0008-5472.CAN-06-1691; Liu HF, 2007, BIOINFORMATICS, V23, P2385, DOI 10.1093/bioinformatics/btm360; Mao XG, 2009, TRANSL ONCOL, V2, P247, DOI 10.1593/tlo.09136; Margareto J, 2007, J MOL NEUROSCI, V32, P53, DOI 10.1007/s12031-007-0008-5; Mylonakou MN, 2009, J NEUROSCI RES, V87, P1310, DOI 10.1002/jnr.21952; Nauseef William M., 2007, V412, P15, DOI 10.1007/978-1-59745-467-4_2; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Rodriguez A, 2011, J CLIN ENDOCR METAB, V96, pE586, DOI 10.1210/jc.2010-1408; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; Saper CB, 2003, J COMP NEUROL, V465, P161, DOI 10.1002/cne.10858; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Schittenhelm J, 2011, HISTOPATHOLOGY, V58, P739, DOI 10.1111/j.1365-2559.2011.03801.x; Shervington A, 2008, CANCER INVEST, V26, P535, DOI 10.1080/07357900801904140; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Sugawara K, 2002, LAB INVEST, V82, P345, DOI 10.1038/labinvest.3780428; Tan G, 2008, J INT MED RES, V36, P777, DOI 10.1177/147323000803600420; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Tsukaguchi H, 1999, AM J PHYSIOL-RENAL, V277, pF685, DOI 10.1152/ajprenal.1999.277.5.F685; VANDERMEULEN JDM, 1978, NEUROPATH APPL NEURO, V4, P177; VELASCO ME, 1980, CANCER, V45, P484, DOI 10.1002/1097-0142(19800201)45:3<484::AID-CNCR2820450312>3.0.CO;2-9; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Ward RJ, 2009, CANCER RES, V69, P4682, DOI 10.1158/0008-5472.CAN-09-0342; Warth A, 2007, APPL IMMUNOHISTO M M, V15, P193, DOI 10.1097/01.pai.0000213110.05108.e9; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	47	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75764	10.1371/journal.pone.0075764	http://dx.doi.org/10.1371/journal.pone.0075764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086629	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700111
J	Nickels, S; Vrieling, A; Seibold, P; Heinz, J; Obi, N; Flesch-Janys, D; Chang-Claude, J				Nickels, Stefan; Vrieling, Alina; Seibold, Petra; Heinz, Judith; Obi, Nadia; Flesch-Janys, Dieter; Chang-Claude, Jenny			Mortality and Recurrence Risk in Relation to the Use of Lipid-Lowering Drugs in a Prospective Breast Cancer Patient Cohort	PLOS ONE			English	Article							STATIN USE; THERAPY	Lipid-lowering drugs are used for the prevention of cardiovascular diseases. Statins are the most commonly used lipid-lowering drugs. Evidence from preclinical and observational studies suggests that statins might improve the prognosis of breast cancer patients. We analyzed data from the German MARIEplus study, a large prospective population-based cohort of patients aged 50 and older, who were diagnosed with breast cancer between 2001 and 2005. For overall mortality, breast-cancer specific mortality, and non-breast-cancer mortality, we included 3189 patients with invasive breast cancer stage I-IV, and for recurrence risk 3024 patients with breast cancer stage I-III. We used Cox proportional hazards models to assess the association with self-reported lipid-lowering drug use at recruitment. We stratified by study region, tumor grade, and estrogen/progesterone receptor status, and adjusted for age, tumor size, nodal status, metastases (stage I-IV only), menopausal hormone treatment, mode of detection, radiotherapy, and smoking. Mortality analyses were additionally adjusted for cardiovascular disease, diabetes mellitus and body-mass index. During a median follow-up of 5.3 years, 404 of 3189 stage I-IV patients died, and 286 deaths were attributed to breast cancer. Self-reported use of lipid-lowering drugs was non-significantly associated with increased non-breast cancer mortality (Hazard ratio (HR) 1.49, 95% confidence interval (CI) 0.88-2.52) and increased overall mortality (HR 1.21, 95% CI 0.87-1.69) whereas no association with breast cancer-specific mortality was found (HR 1.04, 0.67-1.60). Restricted to stage I-III breast cancer patients, 387 recurrences occurred during a median follow-up of 5.4 years. We found lipid-lowering drug use to be non-significantly associated with a reduced risk of recurrence (HR 0.83, 95% CI 0.54-1.24) and of breast cancer-specific mortality (HR 0.89, 95% CI 0.52-1.49). Although compatible with previous findings of an improved prognosis associated with statin use, our results do not provide clear supportive evidence for an association with lipid-lowering drug use due to imprecise estimates.	[Nickels, Stefan; Vrieling, Alina; Seibold, Petra; Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Vrieling, Alina] Radboud Univ Nijmegen Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands; [Heinz, Judith; Obi, Nadia; Flesch-Janys, Dieter] Univ Med Ctr Hamburg Eppendorf, Dept Canc Epidemiol, Clin Canc Registry, Hamburg, Germany; [Flesch-Janys, Dieter] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometr & Epidemiol, Hamburg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Radboud University Nijmegen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Chang-Claude, J (corresponding author), German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany.	j.chang-claude@dkfz.de	Vrieling, Alina/A-2725-2016	Vrieling, Alina/0000-0002-8178-2125	Deutsche Krebshilfe [108253/108419]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by the Deutsche Krebshilfe, Project numbers 108253/108419. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern TP, 2011, JNCI-J NATL CANCER I, V103, P1461, DOI 10.1093/jnci/djr291; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Calip GS, 2013, BREAST CANC RES TREA; Chae YK, 2011, CANCER INVEST, V29, P585, DOI 10.3109/07357907.2011.616252; Ewertz M, 2011, J CLIN ONCOL, V29, P25, DOI 10.1200/JCO.2010.29.7614; Fiesch-Janys D, 2008, INT J CANCER, V123, P933, DOI 10.1002/ijc.23655; Gopalan A, 2013, CANCER LETT, V329, P9, DOI 10.1016/j.canlet.2012.08.031; Holmes MD, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3336; Jakobisiak M, 2003, INT J ONCOL, V23, P1055; Katz MS, 2005, NAT CLIN PRACT ONCOL, V2, P82, DOI 10.1038/ncponc0097; Kwan ML, 2008, BREAST CANCER RES TR, V109, P573, DOI 10.1007/s10549-007-9683-8; Latry P, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-46; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Ozdemir BH, 2004, AM J CLIN PATHOL, V122, P696, DOI 10.1309/HW2MYB5TVF4AMOY4; Protani M, 2010, BREAST CANCER RES TR, V123, P627, DOI 10.1007/s10549-010-0990-0; Schwabe U., 2010, ARZNEIVERORDNUNGS RE; Therneau T.M., 2000, MODELING SURVIVAL DA; Undela K, 2012, BREAST CANCER RES TR, V135, P261, DOI 10.1007/s10549-012-2154-x; Vaklavas C, 2011, PHARMACOL THERAPEUT, V130, P177, DOI 10.1016/j.pharmthera.2011.01.009	21	42	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75088	10.1371/journal.pone.0075088	http://dx.doi.org/10.1371/journal.pone.0075088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086446	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700051
J	Tobar, A; Ori, Y; Benchetrit, S; Milo, G; Herman-Edelstein, M; Zingerman, B; Lev, N; Gafter, U; Chagnac, A				Tobar, Ana; Ori, Yaacov; Benchetrit, Sydney; Milo, Gai; Herman-Edelstein, Michal; Zingerman, Boris; Lev, Netta; Gafter, Uzi; Chagnac, Avry			Proximal Tubular Hypertrophy and Enlarged Glomerular and Proximal Tubular Urinary Space in Obese Subjects with Proteinuria	PLOS ONE			English	Article							INDEPENDENT RISK-FACTOR; BODY-MASS INDEX; METABOLIC SYNDROME; RENAL HEMODYNAMICS; STRUCTURAL-CHANGES; DIABETES-MELLITUS; MECHANICAL-STRESS; GROWTH-FACTORS; KIDNEY; HYPERFILTRATION	Background: Obesity is associated with glomerular hyperfiltration, increased proximal tubular sodium reabsorption, glomerular enlargement and renal hypertrophy. A single experimental study reported an increased glomerular urinary space in obese dogs. Whether proximal tubular volume is increased in obese subjects and whether their glomerular and tubular urinary spaces are enlarged is unknown. Objective: To determine whether proximal tubules and glomerular and tubular urinary space are enlarged in obese subjects with proteinuria and glomerular hyperfiltration. Methods: Kidney biopsies from 11 non-diabetic obese with proteinuria and 14 non-diabetic lean patients with a creatinine clearance above 50 ml/min and with mild or no interstitial fibrosis were retrospectively analyzed using morphometric methods. The cross-sectional area of the proximal tubular epithelium and lumen, the volume of the glomerular tuft and of Bowman's space and the nuclei number per tubular profile were estimated. Results: Creatinine clearance was higher in the obese than in the lean group (P=0.03). Proteinuria was similarly increased in both groups. Compared to the lean group, the obese group displayed a 104% higher glomerular tuft volume (P=0.001), a 94% higher Bowman's space volume (P=0.003), a 33% higher cross-sectional area of the proximal tubular epithelium (P=0.02) and a 54% higher cross-sectional area of the proximal tubular lumen (P=0.01). The nuclei number per proximal tubular profile was similar in both groups, suggesting that the increase in tubular volume is due to hypertrophy and not to hyperplasia. Conclusions: Obesity-related glomerular hyperfiltration is associated with proximal tubular epithelial hypertrophy and increased glomerular and tubular urinary space volume in subjects with proteinuria. The expanded glomerular and urinary space is probably a direct consequence of glomerular hyperfiltration. These effects may be involved in the pathogenesis of obesity-related renal disease.	[Tobar, Ana] Rabin Med Ctr, Dept Pathol, Petah Tiqwa, Israel; [Ori, Yaacov; Milo, Gai; Herman-Edelstein, Michal; Zingerman, Boris; Lev, Netta; Gafter, Uzi; Chagnac, Avry] Rabin Med Ctr, Dept Hypertens & Nephrol, Petah Tiqwa, Israel; [Benchetrit, Sydney] Meir Med Ctr, Dept Nephrol, Kefar Sava, Israel; [Tobar, Ana; Ori, Yaacov; Benchetrit, Sydney; Milo, Gai; Zingerman, Boris; Lev, Netta; Gafter, Uzi; Chagnac, Avry] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Chagnac, A (corresponding author), Rabin Med Ctr, Dept Hypertens & Nephrol, Petah Tiqwa, Israel.	Chagnac@clalit.org.il						Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; BANK N, 1990, J CLIN INVEST, V86, P309, DOI 10.1172/JCI114700; Baumgartl HJ, 1998, NEPHROL DIAL TRANSPL, V13, P630, DOI 10.1093/ndt/13.3.630; Bayliss G, 2012, CURR DIABETES REP, V12, P440, DOI 10.1007/s11892-012-0288-1; Bonnet F, 2001, AM J KIDNEY DIS, V37, P720, DOI 10.1016/S0272-6386(01)80120-7; Chagnac A, 2000, AM J PHYSIOL-RENAL, V278, pF817, DOI 10.1152/ajprenal.2000.278.5.F817; Chagnac A, 2003, J AM SOC NEPHROL, V14, P1480, DOI 10.1097/01.ASN.0000068462.38661.89; Chagnac A, 2008, NEPHROL DIAL TRANSPL, V23, P3946, DOI 10.1093/ndt/gfn379; Chen HM, 2006, AM J KIDNEY DIS, V48, P772, DOI 10.1053/j.ajkd.2006.07.025; Chiarelli F, 2009, HORM METAB RES, V41, P585, DOI 10.1055/s-0029-1220752; COHEN AH, 1975, AM J PATHOL, V81, P117; D'Agati VD, 2008, KIDNEY INT, V73, P909, DOI 10.1038/ki.2008.42; Darouich S, 2011, ULTRASTRUCT PATHOL, V35, P176, DOI 10.3109/01913123.2011.584657; Du ZP, 2004, P NATL ACAD SCI USA, V101, P13068, DOI 10.1073/pnas.0405179101; Endlich N, 2001, J AM SOC NEPHROL, V12, P413, DOI 10.1681/ASN.V123413; Gonzalez E, 2005, KIDNEY INT, V68, P263, DOI 10.1111/j.1523-1755.2005.00401.x; Goumenos DS, 2009, NEPHROL DIAL TRANSPL, V24, P3732, DOI 10.1093/ndt/gfp329; HANNEDOUCHE TP, 1990, KIDNEY INT, V37, P1126, DOI 10.1038/ki.1990.95; Henegar JR, 2001, J AM SOC NEPHROL, V12, P1211, DOI 10.1681/ASN.V1261211; Hirschberg R, 2005, CURR OPIN NEPHROL HY, V14, P43, DOI 10.1097/00041552-200501000-00008; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; KASISKE BL, 1986, ARCH INTERN MED, V146, P1105, DOI 10.1001/archinte.146.6.1105; Kataoka H, 2012, CLIN EXP NEPHROL, V16, P706, DOI 10.1007/s10157-012-0613-7; Kato S, 2009, CLIN EXP NEPHROL, V13, P332, DOI 10.1007/s10157-009-0169-3; Krikken JA, 2007, KIDNEY INT, V71, P260, DOI 10.1038/sj.ki.5002011; Kriz W, 2005, KIDNEY INT, V67, P404, DOI 10.1111/j.1523-1755.2005.67097.x; Lawson ML, 1996, DIABETES, V45, P51, DOI 10.2337/diabetes.45.1.51; Meier-Kriesche HU, 2002, TRANSPLANTATION, V73, P70, DOI 10.1097/00007890-200201150-00013; MORTENSEN JB, 1980, SCAND J CLIN LAB INV, V40, P695, DOI DOI 10.3109/00365518009095584.PUBMED:7280549; NAGATA M, 1992, KIDNEY INT, V42, P148, DOI 10.1038/ki.1992.272; OSTERBY R, 1986, CLIN ENDOCRINOL META, V15, P733, DOI 10.1016/S0300-595X(86)80072-X; Pecly IMD, 2006, INT J CLIN PRACT, V60, P1198, DOI 10.1111/j.1742-1241.2006.01037.x; Porter LE, 1998, HYPERTENSION, V32, P144, DOI 10.1161/01.HYP.32.1.144; Praga M, 2005, NEPHROL DIAL TRANSPL, V20, P2594, DOI 10.1093/ndt/gfi201; Rea DJ, 2006, KIDNEY INT, V70, P1636, DOI 10.1038/sj.ki.5001799; REISIN E, 1987, J HYPERTENS, V5, P397; RIBSTEIN J, 1995, HYPERTENSION, V26, P610, DOI 10.1161/01.HYP.26.4.610; Ritz E, 2011, CURR OPIN NEPHROL HY, V20, P44, DOI 10.1097/MNH.0b013e3283414ca1; Serra A, 2008, KIDNEY INT, V73, P947, DOI 10.1038/sj.ki.5002796; SEYERHANSEN K, 1980, DIABETOLOGIA, V18, P501; Sonomura K, 2012, KIDNEY INT, V81, P449, DOI 10.1038/ki.2011.403; Strazzullo P, 2006, J HYPERTENS, V24, P1633, DOI 10.1097/01.hjh.0000239300.48130.07; Thomson SC, 2001, J CLIN INVEST, V107, P217, DOI 10.1172/JCI10963; Tsuboi N, 2012, CLIN J AM SOC NEPHRO, V7, P735, DOI 10.2215/CJN.07270711; Vallon V, 1999, J AM SOC NEPHROL, V10, P2569; Vallon V, 2003, J AM SOC NEPHROL, V14, P530, DOI 10.1097/01.ASN.0000051700.07403.27; VERANI RR, 1992, AM J KIDNEY DIS, V20, P629, DOI 10.1016/S0272-6386(12)70230-5; Wahba IM, 2007, CLIN J AM SOC NEPHRO, V2, P550, DOI 10.2215/CJN.04071206; Weibel ER., 1979, STEREOLOGICAL METHOD, P44; Wuerzner G, 2010, AM J KIDNEY DIS, V56, P303, DOI 10.1053/j.ajkd.2010.03.017; Zerbini G, 2006, DIABETES, V55, P2620, DOI 10.2337/db06-0592	51	56	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75547	10.1371/journal.pone.0075547	http://dx.doi.org/10.1371/journal.pone.0075547			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086563	gold, Green Submitted, Green Published			2022-12-27	WOS:000325218700098
J	Zhong, W; Hua, BZ				Zhong, Wen; Hua, Baozhen			Mating Behaviour and Copulatory Mechanism in the Scorpionfly Neopanorpa longiprocessa (Mecoptera: Panorpidae)	PLOS ONE			English	Article							RESOURCE-DEFENSE POLYGYNY; MALE-FEMALE CONFLICT; SEXUAL SELECTION; MALE GENITALIA; POSTGENITAL SEGMENTS; ANIMAL GENITALIA; SPERM TRANSFER; NUPTIAL GIFTS; NOTAL ORGAN; INSECTA	Sexual conflict during copulation may drive morphological and behavioral evolution in insects. Although nuptial feeding behaviour is well studied in Panorpa, whether this behaviour is universal in Panorpidae remains unknown. The scorpionfly Neopanorpa longiprocessa Hua & Chou, 1997 was investigated for its mating behaviour, functional morphology of the notal organ, and external genitalia using light microscopy and scanning electron microscopy. The results show that the mating behaviour is not associated with nuptial feeding in N. longiprocessa. The morphological basis of this non-nuptial copulation is likely related to the developed notal organ of the male. The notal organ serves a function to seize wings of the female during copulation. Only males that succeed in seizing the female with the notal organ are able to establish genital contact and copulate. The male genitalia exhibit distinct species-specific modification. The epandrium (tergum IX) has evolved a pair of ventral bulbs to grasp the subgenital plate of the female. The hypandrium (sternum IX) has a pair of dorsal processes to control the abdominal end of the female. These results indicate that nuptial feeding is not a universal behaviour in Panorpidae. Presumably, these grasping apparatuses compensate the scorpionflies that fail to provide nuptial gifts, as exemplified by N. longiprocessa.	[Zhong, Wen; Hua, Baozhen] Northwest A&F Univ, Entomol Museum, Key Lab Plant Protect Resources & Pest Management, State Key Lab Crop Stress Biol Arid Areas,Minist, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Hua, BZ (corresponding author), Northwest A&F Univ, Entomol Museum, Key Lab Plant Protect Resources & Pest Management, State Key Lab Crop Stress Biol Arid Areas,Minist, Yangling, Shaanxi, Peoples R China.	huabzh@nwsuaf.edu.cn			National Natural Science Foundation of China [31172125]; Ministry of Science and Technology of China (MOST) [2006FY120100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China (MOST)(Ministry of Science and Technology, China)	This research was financially supported by the National Natural Science Foundation of China (grant no. 31172125) and the Ministry of Science and Technology of China (MOST grant no. 2006FY120100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist G, 1997, BIOL J LINN SOC, V60, P365; Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; Arnqvist G, 1998, GENET RES, V71, P193, DOI 10.1017/S0016672398003279; BYERS GEORGE W., 1963, ANN ENTOMOL SOC AMER, V56, P142; Byers George W., 1994, Annals of Carnegie Museum, V63, P185; BYERS GEORGE W., 1954, ANN ENT SOC AMER, V47, P484; BYERS GEORGE W., 1965, PACIFIC INSECTS, V7, P705; BYERS GW, 1983, ANNU REV ENTOMOL, V28, P203, DOI 10.1146/annurev.en.28.010183.001223; CARPENTER FRANK M., 1931, PSYCHE, V38, P41, DOI 10.1155/1931/43706; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Chau H.C.-S., 1978, University of Kansas Science Bulletin, V51, P341; CHENG F. Y., 1957, BULL MUS COMP ZOOL HARVARD UNIV, V116, P1; Crampton G. C., 1922, Transactions of the American Entomological Society, V48, P207; CRAMPTON G. C., 1931, PSYCHE, V38, P1, DOI 10.1155/1931/28135; Eberhard WG, 2004, EVOLUTION, V58, P1947; Eberhard WG, 2004, ANN ENTOMOL SOC AM, V97, P1007, DOI 10.1603/0013-8746(2004)097[1007:FMOTMG]2.0.CO;2; Eberhard WG, 2004, BIOL REV, V79, P121, DOI 10.1017/S1464793103006237; Eberhard WG, 2003, TRENDS ECOL EVOL, V18, P438, DOI 10.1016/S0169-5347(03)00180-0; Eberhard W, 2010, GENETICA, V138, P5, DOI 10.1007/s10709-009-9358-y; Engels S, 2008, J ZOOL SYST EVOL RES, V46, P133, DOI 10.1111/j.1439-0469.2007.00438.x; Engels S, 2006, BEHAV ECOL, V17, P628, DOI 10.1093/beheco/ark007; Engqvist L, 2003, ETHOLOGY, V109, P911, DOI 10.1046/j.1439-0310.2003.00937.x; Engqvist L, 2001, P ROY SOC B-BIOL SCI, V268, P729, DOI 10.1098/rspb.2000.1423; Engqvist L, 2007, EVOL ECOL, V21, P801, DOI 10.1007/s10682-006-9152-6; Engqvist L, 2007, EVOLUTION, V61, P1489, DOI 10.1111/j.1558-5646.2007.00107.x; Engqvist L, 2007, ECOL ENTOMOL, V32, P327, DOI 10.1111/j.1365-2311.2006.00835.x; Engqvist L, 2007, BEHAV ECOL SOCIOBIOL, V61, P703, DOI 10.1007/s00265-006-0300-3; Engqvist L, 2007, EVOL ECOL, V21, P49, DOI 10.1007/s10682-006-9123-y; Engqvist L, 2011, BEHAV ECOL, V22, P345, DOI 10.1093/beheco/arq211; Grell Karl Gottlieb, 1942, ZOOL JAHRB ABT ANAT U ONTOG TIERE, V67, P513; Gullan PJ, 2010, INSECTS OUTLINE ENTO; Gwynne DT, 2008, ANNU REV ENTOMOL, V53, P83, DOI 10.1146/annurev.ento.53.103106.093423; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; Hua Baozheng, 1997, Entomotaxonomia, V19, P273; Hua Baozheng, 1997, Entomotaxonomia, V19, P213; ISSIKI SYUTI, 1933, JAPANESE JOUR ZOOL, V4, P315; Kock D, 2008, J ZOOL SYST EVOL RES, V46, P137, DOI 10.1111/j.1439-0469.2007.00454.x; Kock D, 2006, BEHAV ECOL SOCIOBIOL, V60, P528, DOI 10.1007/s00265-006-0196-y; Kock D, 2007, J CHEM ECOL, V33, P1249, DOI 10.1007/s10886-007-9304-3; Kock D, 2009, BEHAV ECOL, V20, P639, DOI 10.1093/beheco/arp043; Kullmann H, 2005, ZOOL ANZ, V244, P1, DOI 10.1016/j.jcz.2004.12.003; Kullmann H, 2009, ECOL ENTOMOL, V34, P153, DOI 10.1111/j.1365-2311.2008.01039.x; Lewis S, 2011, CURR BIOL, V21, pR644, DOI 10.1016/j.cub.2011.05.046; Ma N, 2012, SYST BIODIVERS, V10, P159, DOI 10.1080/14772000.2012.683459; Ma N, 2011, ACTA ZOOL-STOCKHOLM, V92, P398, DOI 10.1111/j.1463-6395.2010.00474.x; Ma N, 2011, EUR J ENTOMOL, V108, P493, DOI 10.14411/eje.2011.064; Ma N, 2010, MICRON, V41, P931, DOI 10.1016/j.micron.2010.07.008; MICKOLEIT G, 1976, ZOOMORPHOLOGIE, V85, P133, DOI 10.1007/BF00995408; MICKOLEIT G, 1975, Z MORPHOL TIERE, V80, P97; MICKOLEIT G, 1971, Z MORPHOL TIERE, V69, P1, DOI 10.1007/BF00294385; Missoweit M, 2008, EVOL ECOL, V22, P689, DOI 10.1007/s10682-007-9191-7; Missoweit M, 2007, ANIM BEHAV, V74, P1207, DOI 10.1016/j.anbehav.2006.10.028; MIYAKE T, 1913, J COLL AGR IMPERIAL, V4, P265; Palmer Christopher M., 2010, Terrestrial Arthropod Reviews, V3, P111, DOI 10.1163/187498310X519716; Parker GA, 2006, PHILOS T R SOC B, V361, P235, DOI 10.1098/rstb.2005.1785; PENNY N D, 1979, Acta Amazonica, V9, P365; Potter E., 1938, T ROY ENT SOC LONDON, V87, P467; Sauer KP, 1998, NATURWISSENSCHAFTEN, V85, P219, DOI 10.1007/s001140050487; Sirot LK, 2003, FLA ENTOMOL, V86, P124, DOI 10.1653/0015-4040(2003)086[0124:TEOIMS]2.0.CO;2; SNODGRASS R. E., 1957, SMITHSONIAN MISC COLL, V135, P1; Stockley P, 1997, TRENDS ECOL EVOL, V12, P154, DOI 10.1016/S0169-5347(97)01000-8; THORNHILL R, 1976, AM NAT, V110, P153, DOI 10.1086/283055; THORNHILL R, 1980, ANIM BEHAV, V28, P52, DOI 10.1016/S0003-3472(80)80007-8; THORNHILL R, 1979, ENVIRON ENTOMOL, V8, P886, DOI 10.1093/ee/8.5.886; THORNHILL R, 1981, ANNU REV ECOL SYST, V12, P355, DOI 10.1146/annurev.es.12.110181.002035; THORNHILL R, 1992, ANIM BEHAV, V44, P867, DOI 10.1016/S0003-3472(05)80583-4; Thornhill R, 1973, GREAT LAKES ENTOMOL, V6, P47; Thornhill R, 1991, BEHAV ECOL, V2, P156, DOI 10.1093/beheco/2.2.156; Vahed K, 1998, BIOL REV, V73, P43, DOI 10.1017/S0006323197005112; WILLMANN R, 1981, Z ZOOL SYST EVOL, V19, P153; WILLMANN R, 1981, Z ZOOL SYST EVOL, V19, P96	71	28	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74781	10.1371/journal.pone.0074781	http://dx.doi.org/10.1371/journal.pone.0074781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086373	Green Submitted, gold, Green Published			2022-12-27	WOS:000325218700035
J	Abu-Farha, M; Tiss, A; Abubaker, J; Khadir, A; Al-Ghimlas, F; Al-Khairi, I; Baturcam, E; Cherian, P; Elkum, N; Hammad, M; John, J; Kavalakatt, S; Warsame, S; Behbehani, K; Dermime, S; Dehbi, M				Abu-Farha, Mohamed; Tiss, Ali; Abubaker, Jehad; Khadir, Abdelkrim; Al-Ghimlas, Fahad; Al-Khairi, Irina; Baturcam, Engin; Cherian, Preethi; Elkum, Naser; Hammad, Maha; John, Jeena; Kavalakatt, Sina; Warsame, Samia; Behbehani, Kazem; Dermime, Said; Dehbi, Mohammed			Proteomics Analysis of Human Obesity Reveals the Epigenetic Factor HDAC4 as a Potential Target for Obesity	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; IIA HISTONE DEACETYLASES; NF-KAPPA-B; INSULIN-RESISTANCE; ADIPOSE-TISSUE; METABOLIC SYNDROME; GENE-EXPRESSION; UP-REGULATION; LYSINE ACETYLATION; SKELETAL-MUSCLE	Sedentary lifestyle and excessive energy intake are prominent contributors to obesity; a major risk factors for the development of insulin resistance, type 2 diabetes and cardiovascular diseases. Elucidating the molecular mechanisms underlying these chronic conditions is of relevant importance as it might lead to the identification of novel anti-obesity targets. The purpose of the current study is to investigate differentially expressed proteins between lean and obese subjects through a shot-gun quantitative proteomics approach using peripheral blood mononuclear cells (PBMCs) extracts as well as potential modulation of those proteins by physical exercise. Using this approach, a total of 47 proteins showed at least 1.5 fold change between lean and obese subjects. In obese, the proteomic profiling before and after 3 months of physical exercise showed differential expression of 38 proteins. Thrombospondin 1 (TSP1) was among the proteins that were upregulated in obese subjects and then decreased by physical exercise. Conversely, the histone deacetylase 4 (HDAC4) was downregulated in obese subjects and then induced by physical exercise. The proteomic data was further validated by qRT-PCR, Western blot and immunohistochemistry in both PBMCs and adipose tissue. We also showed that HDAC4 levels correlated positively with maximum oxygen consumption (V-O2 (Max)) but negatively with body mass index, percent body fat, and the inflammatory chemokine RANTES. In functional assays, our data indicated that ectopic expression of HDAC4 significantly impaired TNF-alpha-dependent activation of NF-kappa B, establishing thus a link between HDAC4 and regulation of the immune system. Together, the expression pattern of HDAC4 in obese subjects before and after physical exercise, its correlation with various physical, clinical and metabolic parameters along with its inhibitory effect on NF-kappa B are suggestive of a protective role of HDAC4 against obesity. HDAC4 could therefore represent a potential therapeutic target for the control and management of obesity and presumably insulin resistance.	[Abu-Farha, Mohamed; Tiss, Ali; Abubaker, Jehad; Khadir, Abdelkrim; Al-Khairi, Irina; Baturcam, Engin; Cherian, Preethi; Hammad, Maha; John, Jeena; Kavalakatt, Sina; Warsame, Samia; Behbehani, Kazem; Dehbi, Mohammed] Dasman Diabet Inst, Dept Biomed Res, Kuwait, Kuwait; [Al-Ghimlas, Fahad; Behbehani, Kazem] Dasman Diabet Inst, Fitness & Rehabil Ctr, Kuwait, Kuwait; [Elkum, Naser; Behbehani, Kazem] Dasman Diabet Inst, Dept Biostat & Epidemiol, Kuwait, Kuwait; [Dermime, Said] King Fahad Specialist Hosp Dammam, Biomed Res Facil, Dammam, Saudi Arabia; [Dehbi, Mohammed] Qatar Biomed Res Inst, Genom Med & Syst Biol Res Ctr, Doha, Qatar	Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Biomedical Research Institute (QBRI)	Dehbi, M (corresponding author), Dasman Diabet Inst, Dept Biomed Res, Kuwait, Kuwait.	mdehbi@qf.org.qa	Tiss, Ali/L-6656-2019; Elkum, Naser/AAU-5555-2020; Dermime, Said/P-2448-2019	Tiss, Ali/0000-0002-3024-5370; Elkum, Naser/0000-0002-0457-0444; Dermime, Said/0000-0002-5526-7496; kavalakatt, sina/0000-0003-3795-1881; Abu-Farha, Mohamed/0000-0001-8357-1252; Abubaker, Jehad/0000-0003-0681-7305; Hammad, Maha/0000-0002-8974-8255	Kuwait Foundation for the Advancement of Sciences [RA-2010-003]	Kuwait Foundation for the Advancement of Sciences(Kuwait Foundation for the Advancement of Sciences (KFAS))	This work was supported by the Kuwait Foundation for the Advancement of Sciences under project (RA-2010-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubaker J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069217; Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Al Rashdan I, 2010, ANGIOLOGY, V61, P42, DOI 10.1177/0003319709333226; al-Haj L, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-20; Alessi MC, 2000, DIABETES, V49, P1374, DOI 10.2337/diabetes.49.8.1374; Bendinelli P, 2009, MOL CANCER RES, V7, P1328, DOI 10.1158/1541-7786.MCR-08-0548; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Bruce CR, 2003, DIABETES, V52, P2338, DOI 10.2337/diabetes.52.9.2338; Burns B, 2010, HUM MOL GENET, V19, P4026, DOI 10.1093/hmg/ddq317; Castro-Chavez F, 2003, DIABETES, V52, P2666, DOI 10.2337/diabetes.52.11.2666; Chatterjee TK, 2011, J BIOL CHEM, V286, P27836, DOI 10.1074/jbc.M111.262964; Chavez RJ, 2012, AM J PHYSIOL-CELL PH, V303, pC179, DOI 10.1152/ajpcell.00008.2012; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Chen Y, 2011, NAT NEUROSCI, V14, P437, DOI 10.1038/nn.2780; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chu F, 2008, AGING CELL, V7, P516, DOI 10.1111/j.1474-9726.2008.00403.x; Dixon Anne E, 2010, Proc Am Thorac Soc, V7, P325, DOI 10.1513/pats.200903-013ST; Dong CH, 2011, HUM GENET, V129, P209, DOI 10.1007/s00439-010-0916-2; Esemuede N, 2004, J SURG RES, V122, P135, DOI 10.1016/j.jss.2004.05.015; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Ghebeh H, 2007, INT J CANCER, V121, P751, DOI 10.1002/ijc.22703; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Hooper PL, 2009, CELL STRESS CHAPERON, V14, P113, DOI 10.1007/s12192-008-0073-x; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Huey KA, 2008, J APPL PHYSIOL, V105, P1830, DOI 10.1152/japplphysiol.90955.2008; Iyer A, 2012, IMMUNOL CELL BIOL, V90, P39, DOI 10.1038/icb.2011.99; Kaiser C, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-23; Kimura K, 2012, DIABETES, V61, P61, DOI 10.2337/db10-1684; Kurucz I, 2002, DIABETES, V51, P1102, DOI 10.2337/diabetes.51.4.1102; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Lenoir O, 2011, DIABETES, V60, P2861, DOI 10.2337/db11-0440; Li YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026656; Liu HM, 2009, CHEM-BIOL INTERACT, V179, P81, DOI 10.1016/j.cbi.2008.12.003; Liu ZX, 2011, NUCLEIC ACIDS RES, V39, pD1029, DOI 10.1093/nar/gkq939; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majdzadeh N, 2008, DEV NEUROBIOL, V68, P1076, DOI 10.1002/dneu.20637; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; Matsuoka H, 2007, BIOCHEM PHARMACOL, V74, P465, DOI 10.1016/j.bcp.2007.05.002; McGee SL, 2009, J PHYSIOL-LONDON, V587, P5951, DOI 10.1113/jphysiol.2009.181065; McGinnes RA, 2012, MED J AUSTRALIA, V196, P567, DOI 10.5694/mja12.10353; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Mitchell NS, 2011, PSYCHIAT CLIN N AM, V34, P717, DOI 10.1016/j.psc.2011.08.005; Pallavi R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00318; Pandeya N, 2009, AUST NZ J PUBL HEAL, V33, P312, DOI 10.1111/j.1753-6405.2009.00401.x; Perez-Perez R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030326; Perez-Perez R, 2012, J PROTEOMICS, V75, P783, DOI 10.1016/j.jprot.2011.09.016; Perez-Perez R, 2009, J PROTEOME RES, V8, P1682, DOI 10.1021/pr800942k; Prior MJ, 2011, J PROTEOME RES, V10, P4970, DOI 10.1021/pr200446r; Ramis JM, 2002, CELL MOL LIFE SCI, V59, P1960, DOI 10.1007/PL00012518; Ross R, 2009, OBESITY, V17, pS1, DOI 10.1038/oby.2009.381; Samad F, 1997, MOL MED, V3, P37, DOI 10.1007/BF03401666; Shakespear MR, 2011, TRENDS IMMUNOL, V32, P335, DOI 10.1016/j.it.2011.04.001; Sun XJ, 2009, J BIOL CHEM, V284, P21881, DOI 10.1074/jbc.M109.019091; Vallerie SN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001007; Varma V, 2008, DIABETES, V57, P432, DOI 10.2337/db07-0840; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Wang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018939; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Weems JC, 2012, DIABETES, V61, P1404, DOI 10.2337/db11-0737; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Williams SR, 2010, AM J HUM GENET, V87, P219, DOI 10.1016/j.ajhg.2010.07.011; Ye J, 2009, INT J OBESITY, V33, P54, DOI 10.1038/ijo.2008.229; Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113; Zhou H, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.O111.008425	67	64	68	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75342	10.1371/journal.pone.0075342	http://dx.doi.org/10.1371/journal.pone.0075342			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086512	gold, Green Published, Green Submitted			2022-12-27	WOS:000325025200040
J	Freeley, SJ; Giorgini, A; Tulone, C; Popat, RJ; Horsfield, C; Robson, MG				Freeley, Simon J.; Giorgini, Angela; Tulone, Calogero; Popat, Reena J.; Horsfield, Catherine; Robson, Michael G.			Toll-Like Receptor 2 or Toll-Like Receptor 4 Deficiency Does Not Modify Lupus in MRLlpr Mice	PLOS ONE			English	Article							IMMUNE-COMPLEX GLOMERULONEPHRITIS; INTRINSIC RENAL-CELLS; ACTIVATE B-CELLS; MURINE LUPUS; MEDIATED GLOMERULONEPHRITIS; INDUCTION; STIMULATION; ENGAGEMENT; EXPRESSION; NEPHRITIS	Systemic lupus erythematosus is an autoimmune disease with a high morbidity and nephritis is a common manifestation. Previous studies in murine lupus models have suggest a role for Toll-like receptor 2 and 4. We examined the role of these molecules in MRL lpr mice which is one of the most established and robust murine models. We compared disease parameters in Toll-like receptor 2 or Toll-like receptor 4 deficient mice with their littermate controls. We found no difference in the severity of glomerulonephritis as assessed by histology, serum creatinine and albuminuria when Toll-like receptor 2 or Toll-like receptor 4 deficient MRLlpr mice were compared with Toll-like receptor sufficient controls. We also found similar levels of anti-dsDNA and anti-ssDNA antibodies. These results show that Toll-like receptor 2 and Toll-like receptor 4 do not play a significant role in MRLlpr mice, and therefore they may not be important in human lupus.	[Freeley, Simon J.; Giorgini, Angela; Tulone, Calogero; Popat, Reena J.; Robson, Michael G.] Kings Coll London, MRC, Ctr Transplantat, London, England; [Horsfield, Catherine] Guys & St Thomas NHS Fdn Trust, Dept Histopathol, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Robson, MG (corresponding author), Kings Coll London, MRC, Ctr Transplantat, London, England.	Michael.robson@kcl.ac.uk		Robson, Michael/0000-0002-1192-1353	Genzyme Renal Innovations Program; Sir Jules Thorn Charitable Trust; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; King's College Hospital NHS Foundation Trust; Medical Research Council [MR/J006742/1] Funding Source: researchfish	Genzyme Renal Innovations Program(Sanofi-AventisGenzyme Corporation); Sir Jules Thorn Charitable Trust; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College Hospital NHS Foundation Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Genzyme Renal Innovations Program and the Sir Jules Thorn Charitable Trust. The authors acknowledge financial support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. The authors also acknowledge the support of the MRC Centre for Transplantation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2008, EUR J IMMUNOL, V38, P1795, DOI 10.1002/eji.200838478; Berland R, 2006, IMMUNITY, V25, P429, DOI 10.1016/j.immuni.2006.07.014; Brown HJ, 2007, J AM SOC NEPHROL, V18, P1732, DOI 10.1681/ASN.2006060634; Brown HJ, 2006, J IMMUNOL, V177, P1925, DOI 10.4049/jimmunol.177.3.1925; Brown HJ, 2006, J AM SOC NEPHROL, V17, P1931, DOI 10.1681/ASN.2005111167; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Giorgini A, 2010, AM J PATHOL, V177, P644, DOI 10.2353/ajpath.2010.091279; HANG L, 1983, J EXP MED, V157, P874, DOI 10.1084/jem.157.3.874; Lartigue A, 2009, J IMMUNOL, V183, P6207, DOI 10.4049/jimmunol.0803219; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Moreth K, 2010, J CLIN INVEST, V120, P4251, DOI 10.1172/JCI42213; Patole PS, 2006, NEPHROL DIAL TRANSPL, V21, P3062, DOI 10.1093/ndt/gfl336; Pawar RD, 2006, J AM SOC NEPHROL, V17, P141, DOI 10.1681/ASN.2005070714; Peng SL, 1996, BIOTECHNIQUES, V21, P362; Summers SA, 2010, J AUTOIMMUN, V35, P291, DOI 10.1016/j.jaut.2010.05.004; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696	19	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e74112	10.1371/journal.pone.0074112	http://dx.doi.org/10.1371/journal.pone.0074112			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086313	Green Published, gold, Green Submitted			2022-12-27	WOS:000325025200009
J	Labonte, D; Thies, E; Pechmann, Y; Groffen, AJ; Verhage, M; Smit, AB; van Kesteren, RE; Kneussel, M				Labonte, Dorthe; Thies, Edda; Pechmann, Yvonne; Groffen, Alexander J.; Verhage, Matthijs; Smit, August B.; van Kesteren, Ronald E.; Kneussel, Matthias			TRIM3 Regulates the Motility of the Kinesin Motor Protein KIF21B	PLOS ONE			English	Article							RING FINGER PROTEIN; POSTTRANSLATIONAL MODIFICATIONS; E3 LIGASE; TRANSPORT; CARGO; PHOSPHORYLATION; SUSCEPTIBILITY; LOCALIZATION; MICROTUBULES; REPLICATION	Kinesin superfamily proteins (KIFs) are molecular motors that transport cellular cargo along the microtubule cytoskeleton. KIF21B is a neuronal kinesin that is highly enriched in dendrites. The regulation and specificity of microtubule transport involves the binding of motors to individual cargo adapters and accessory proteins. Moreover, posttranslational modifications of either the motor protein, their cargos or tubulin regulate motility, cargo recognition and the binding or unloading of cargos. Here we show that the ubiquitin E3 ligase TRIM3, also known as BERP, interacts with KIF21B via its RBCC domain. TRIM3 is found at intracellular and Golgi-derived vesicles and colocalizes with the KIF21B motor in neurons. Trim3 gene deletion in mice and TRIM3 overexpression in cultured neurons both suggested that the E3-ligase function of TRIM3 is not involved in KIF21B degradation, however TRIM3 depletion reduces the motility of the motor. Together, our data suggest that TRIM3 is a regulator in the modulation of KIF21B motor function.	[Labonte, Dorthe; Thies, Edda; Pechmann, Yvonne; Kneussel, Matthias] Univ Med Ctr Hamburg Eppendorf, ZMNH, Ctr Mol Neurobiol, Dept Mol Neurogenet, Hamburg, Germany; [Groffen, Alexander J.; Verhage, Matthijs; Smit, August B.; van Kesteren, Ronald E.] Vrije Univ Amsterdam, Dept Mol & Cellular Neurobiol, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands	University of Hamburg; University Medical Center Hamburg-Eppendorf; Vrije Universiteit Amsterdam	Kneussel, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, ZMNH, Ctr Mol Neurobiol, Dept Mol Neurogenet, Hamburg, Germany.	matthias.kneussel@zmnh.uni-hamburg.de	van Kesteren, Ronald E/E-2505-2014; Groffen, A.J.A./C-1118-2009	Groffen, A.J.A./0000-0003-0046-4027; verhage, matthijs/0000-0002-6085-7503; Kneussel, Matthias/0000-0003-4900-366X; van Kesteren, Ronald/0000-0002-9592-3777	Deutsche Forschungsgemeinschaft DFG [KN556/4-2, DFG KN556/6-1, GRK1459]; EU-FP7 SYNSYS [HEALTH-2009-2.1.2-1]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); EU-FP7 SYNSYS	Supported by grants of the Deutsche Forschungsgemeinschaft DFG KN556/4-2, DFG KN556/6-1 and GRK1459 to MK and by HEALTH-2009-2.1.2-1 EU-FP7 SYNSYS to REvK and ABS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Cheung CC, 2010, P NATL ACAD SCI USA, V107, P11883, DOI 10.1073/pnas.1006529107; Cho KI, 2009, EMBO REP, V10, P480, DOI 10.1038/embor.2009.29; Chu Y, 2011, ONCOGENE, V30, P1108, DOI 10.1038/onc.2010.462; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; Danoy P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001195; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; El-Husseini AE, 1999, J BIOL CHEM, V274, P19771, DOI 10.1074/jbc.274.28.19771; El-Husseini AED, 2000, BIOCHEM BIOPH RES CO, V267, P906, DOI 10.1006/bbrc.1999.2045; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Friedman DS, 1999, NAT CELL BIOL, V1, P293, DOI 10.1038/13008; Fuhrmann JC, 2002, J NEUROSCI, V22, P5393; Goris A, 2010, J MED GENET, V47, P775, DOI 10.1136/jmg.2009.075911; Guillaud L, 2008, NAT CELL BIOL, V10, P19, DOI 10.1038/ncb1665; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Heisler FF, 2011, NEURON, V70, P66, DOI 10.1016/j.neuron.2011.03.008; Hirokawa N, 2004, EXP CELL RES, V301, P50, DOI 10.1016/j.yexcr.2004.08.010; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Huang CJ, 2012, MOL CELL BIOCHEM, V360, P121, DOI 10.1007/s11010-011-1050-8; Hung AY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009842; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kapitein LC, 2010, CURR BIOL, V20, P290, DOI 10.1016/j.cub.2009.12.052; Loiseau P, 2010, DEVELOPMENT, V137, P2763, DOI 10.1242/dev.048108; Maas C, 2009, P NATL ACAD SCI USA, V106, P8731, DOI 10.1073/pnas.0812391106; Mandelkow EM, 2003, NEUROBIOL AGING, V24, P1079, DOI 10.1016/j.neurobiolaging.2003.04.007; Marszalek JR, 1999, J CELL BIOL, V145, P469, DOI 10.1083/jcb.145.3.469; McCauley JL, 2010, HUM MOL GENET, V19, P953, DOI 10.1093/hmg/ddp542; Mosesson Y, 2009, DEV CELL, V16, P687, DOI 10.1016/j.devcel.2009.03.015; Napolitano LM, 2012, IUBMB LIFE, V64, P64, DOI 10.1002/iub.580; Napolitano LM, 2011, BIOCHEM J, V434, P309, DOI 10.1042/BJ20101487; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; REXACH MF, 1994, J CELL BIOL, V126, P1133, DOI 10.1083/jcb.126.5.1133; Rieser E, 2013, TRENDS BIOCHEM SCI, V38, P94, DOI 10.1016/j.tibs.2012.11.007; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Shin SM, 2012, NAT NEUROSCI, V15, P1655, DOI 10.1038/nn.3259; Sun FN, 2011, EMBO J, V30, P3416, DOI 10.1038/emboj.2011.229; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Yan Q, 2005, MOL BIOL CELL, V16, P2470, DOI 10.1091/mbc.e04-11-1014; Ying HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009168	46	25	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75603	10.1371/journal.pone.0075603	http://dx.doi.org/10.1371/journal.pone.0075603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086586	Green Submitted, gold, Green Published			2022-12-27	WOS:000325025200054
J	Bai, TT; Xie, WB; Zhou, PP; Wu, ZL; Xiao, WC; Zhou, L; Sun, J; Ruan, XL; Li, HP				Bai, Ting-Ting; Xie, Wan-Bin; Zhou, Ping-Ping; Wu, Zi-Lin; Xiao, Wen-Chao; Zhou, Ling; Sun, Jie; Ruan, Xiao-Lei; Li, Hua-Ping			Transcriptome and Expression Profile Analysis of Highly Resistant and Susceptible Banana Roots Challenged with Fusarium oxysporum f. sp cubense Tropical Race 4	PLOS ONE			English	Article							DISEASE RESISTANCE; DEFENSE RESPONSES; GENE-EXPRESSION; INNATE IMMUNITY; CELL-DEATH; ARABIDOPSIS; WILT; TOLERANCE; PATHOGENS; CHANNEL	Banana wilt disease, caused by the fungal pathogen Fusarium oxysporum f. sp. cubense 4 (Foc4), is regarded as one of the most devastating diseases worldwide. Cavendish cultivar 'Yueyoukang 1' was shown to have significantly lower disease severity and incidence compared with susceptible cultivar 'Brazilian' in greenhouse and field trials. De novo sequencing technology was previously performed to investigate defense mechanism in middle resistant 'Nongke No 1' banana, but not in highly resistant cultivar 'Yueyoukang 1'. To gain more insights into the resistance mechanism in banana against Foc4, Illumina Solexa sequencing technology was utilized to perform transcriptome sequencing of 'Yueyoukang 1' and 'Brazilian' and characterize gene expression profile changes in the both two cultivars at days 0.5, 1, 3, 5 and 10 after infection with Foc4. The results showed that more massive transcriptional reprogramming occurs due to Foc4 treatment in 'Yueyoukang 1' than 'Brazilian', especially at the first three time points, which suggested that 'Yueyoukang 1' had much faster defense response against Foc4 infection than 'Brazilian'. Expression patterns of genes involved in 'Plant-pathogen interaction' and 'Plant hormone signal transduction' pathways were analyzed and compared between the two cultivars. Defense genes associated with CEBiP, BAK1, NB-LRR proteins, PR proteins, transcription factor and cell wall lignification were expressed stronger in 'Yueyoukang 1' than 'Brazilian', indicating that these genes play important roles in banana against Foc4 infection. However, genes related to hypersensitive reaction (HR) and senescence were up-regulated in ` Brazilian' but down-regulated in 'Yueyoukang 1', which suggested that HR and senescence may contribute to Foc4 infection. In addition, the resistance mechanism in highly resistant 'Yueyoukang 1' was found to differ from that in middle resistant 'Nongke No 1' banana. These results explain the resistance in the highly resistant cultivar and provide more insights in understanding the compatible and incompatible interactions between banana and Foc4.	[Bai, Ting-Ting; Xie, Wan-Bin; Zhou, Ping-Ping; Wu, Zi-Lin; Xiao, Wen-Chao; Zhou, Ling; Sun, Jie; Li, Hua-Ping] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Bai, Ting-Ting; Xie, Wan-Bin; Zhou, Ping-Ping; Wu, Zi-Lin; Xiao, Wen-Chao; Zhou, Ling; Sun, Jie; Ruan, Xiao-Lei; Li, Hua-Ping] South China Agr Univ, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University	Li, HP (corresponding author), South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China.	huaping@scau.edu.cn		Wu, Zilin/0000-0002-3313-262X	earmarked fund for Modern Agro-Industry Technology Research System [CAR-32-05]	earmarked fund for Modern Agro-Industry Technology Research System	The study was supported by the earmarked fund for Modern Agro-Industry Technology Research System (CAR-32-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Balague C, 2003, PLANT CELL, V15, P365, DOI 10.1105/tpc.006999; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; BECKMAN CH, 1990, FUSARIUM WILT OF BANANA, P93; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Chen XW, 2011, TRENDS PLANT SCI, V16, P451, DOI 10.1016/j.tplants.2011.04.003; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Deller S, 2011, J PLANT PHYSIOL, V168, P63, DOI 10.1016/j.jplph.2010.05.024; Di Pietro A, 2003, MOL PLANT PATHOL, V4, P315, DOI [10.1046/j.1364-3703.2003.00180.x, 10.1046/J.1364-3703.2003.00180.X]; Ekengren SK, 2003, PLANT J, V36, P905, DOI 10.1046/j.1365-313X.2003.01944.x; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Grant JJ, 2000, PLANT PHYSIOL, V124, P21, DOI 10.1104/pp.124.1.21; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; He YH, 2002, PLANT PHYSIOL, V128, P876, DOI 10.1104/pp.010843; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; Hwang SC, 2004, PLANT DIS, V88, P580, DOI 10.1094/PDIS.2004.88.6.580; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kemmerling B, 2007, CURR BIOL, V17, P1116, DOI 10.1016/j.cub.2007.05.046; Kesarwani M, 2007, PLANT PHYSIOL, V144, P336, DOI 10.1104/pp.106.095299; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Kurusu T, 2005, PLANT J, V42, P798, DOI 10.1111/j.1365-313X.2005.02415.x; Li CY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-374; Li CY, 2011, EUR J PLANT PATHOL, V131, P327, DOI 10.1007/s10658-011-9811-5; [刘文清 LIU Wen-qing], 2010, [广东农业科学, Guangdong Agricultural Sciences], V37, P110; Lu GY, 2011, EUR J PLANT PATHOL, V131, P585, DOI 10.1007/s10658-011-9833-z; Lu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043447; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Moeder W, 2011, MOL PLANT, V4, P442, DOI 10.1093/mp/ssr018; Monshausen GB, 2009, PLANT CELL, V21, P2341, DOI 10.1105/tpc.109.068395; Pandelova I, 2009, MOL PLANT, V2, P1067, DOI 10.1093/mp/ssp045; Ploetz RC, 2003, DIS TROPICAL FRUIT C, P109; Schenk PM, 2005, PLANT PHYSIOL BIOCH, V43, P997, DOI 10.1016/j.plaphy.2005.09.002; Shah J, 2005, ANNU REV PHYTOPATHOL, V43, P229, DOI 10.1146/annurev.phyto.43.040204.135951; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Shimizu T, 2010, PLANT J, V64, P204, DOI 10.1111/j.1365-313X.2010.04324.x; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; SMYTH GK, 2004, STAT APPL GENETICS M, V3; STOVER RH, 1962, 4 COMM MYC I; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Thatcher LF, 2009, PLANT J, V58, P927, DOI 10.1111/j.1365-313X.2009.03831.x; VAJNA L, 1985, PHYTOPATHOL Z, V114, P338; Van den Berg N, 2007, MOL PLANT PATHOL, V8, P333, DOI 10.1111/J.1364-3703.2007.00389.X; Wang Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-650; Wu JA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-234; Xu CX, 2011, ACTA HORTIC, V897, P301; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x	52	66	80	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e73945	10.1371/journal.pone.0073945	http://dx.doi.org/10.1371/journal.pone.0073945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086302	gold, Green Published, Green Submitted			2022-12-27	WOS:000326520200016
J	Mudvari, P; Ohshiro, K; Nair, V; Horvath, A; Kumar, R				Mudvari, Prakriti; Ohshiro, Kazufumi; Nair, Vasudha; Horvath, Anelia; Kumar, Rakesh			Genomic Insights into Triple-Negative and HER2-Positive Breast Cancers Using Isogenic Model Systems	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; MOLECULAR PORTRAITS; CATHEPSIN-B; IDENTIFICATION; PROGRESSION; CARCINOMAS; PREDICTOR; PROFILES; PATTERNS; SUBTYPES	Introduction: In general, genomic signatures of breast cancer subtypes have little or no overlap owing to the heterogeneous genetic backgrounds of study samples. Thus, obtaining a reliable signature in the context of isogenic nature of the cells has been challenging and the precise contribution of isogenic triple negative breast cancer (TNBC) versus non-TNBC remains poorly defined. Methods: We established isogenic stable cell lines representing TNBC and Human Epidermal Growth Factor Receptor 2 positive (HER2+) breast cancers by introducing HER2 in TNBC cell lines MDA-MB-231 and MDA-MB-468. We examined protein level expression and functionality of the transfected receptor by treatment with an antagonist of HER2. Using microarray profiling, we obtained a comprehensive gene list of differentially expressed between TNBC and HER2+ clones. We identified and validated underlying isogenic components using qPCR and also compared results with expression data from patients with similar breast cancer subtypes. Results: We identified 544 and 1087 statistically significant differentially expressed genes between isogenic TNBC and HER2+ samples in MDA-MB-231 and MDA-MB-468 backgrounds respectively and a shared signature of 49 genes. By comparing results from MDA-MB-231 and MDA-MB-468 backgrounds with two patient microarray datasets, we identified 17 and 22 common genes with same expression trend respectively. Additionally, we identified 56 and 78 genes from MDA-MB-231 and MDA-MB-468 comparisons respectively present in our published RNA-seq data. Conclusions: Using our unique model system, we have identified an isogenic gene expression signature between TNBC and HER2+ breast cancer. A portion of our results was also verified in patient data samples, indicating an existence of isogenic element associated with HER2 status between genetically heterogeneous breast cancer samples. These findings may potentially contribute to the development of molecular platform that would be valuable for diagnostic and therapeutic decision for TNBC and in distinguishing it from HER2+ subtype.	[Mudvari, Prakriti; Horvath, Anelia; Kumar, Rakesh] George Washington Univ, Sch Med & Hlth Sci, McCormick Genom & Prote Ctr, Washington, DC 20052 USA; [Mudvari, Prakriti; Ohshiro, Kazufumi; Nair, Vasudha; Horvath, Anelia; Kumar, Rakesh] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20052 USA	George Washington University; George Washington University	Kumar, R (corresponding author), George Washington Univ, Sch Med & Hlth Sci, McCormick Genom & Prote Ctr, Washington, DC 20052 USA.	bcmrxk@gwu.edu	Kumar, Rakesh/ABD-1065-2020	Kumar, Rakesh/0000-0001-7664-0803	McCormick Genomic and Proteomics Center	McCormick Genomic and Proteomics Center	This work is supported by the McCormick Genomic and Proteomics Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2011, BREAST CANC FACTS FI; Barker HE, 2011, CANCER RES, V71, P1561, DOI 10.1158/0008-5472.CAN-10-2868; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Bertucci F, 2004, ONCOGENE, V23, P2564, DOI 10.1038/sj.onc.1207361; Boyle P, 2012, ANN ONCOL S, V23, P12, DOI [10.1093/annonc/mds187, DOI 10.1093/ANN0NC/MDS187.PUBMED:23012306]; Cadenas C, 2012, BBA-MOL CELL BIOL L, V1821, P1256, DOI 10.1016/j.bbalip.2011.11.008; Chen JQ, 2009, BBA-REV CANCER, V1796, P162, DOI 10.1016/j.bbcan.2009.06.003; CLARKE R, 1990, ANN ONCOL, V1, P401, DOI 10.1093/oxfordjournals.annonc.a057790; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Espinoza I, 2011, MOL CANCER THER, V10, P732, DOI 10.1158/1535-7163.MCT-10-0836; Eswaran J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00264; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Guedj M, 2012, ONCOGENE, V31, P1196, DOI 10.1038/onc.2011.301; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irvin WJ, 2008, EUR J CANCER, V44, P2799, DOI 10.1016/j.ejca.2008.09.034; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; LEONESSA F, 1992, ACTA ONCOL, V31, P115, DOI 10.3109/02841869209088890; Leygue E, 1998, CANCER RES, V58, P1348; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nouh MA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-1; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rafn B, 2012, MOL CELL, V45, P764, DOI 10.1016/j.molcel.2012.01.029; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vincent-Salomon A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1666; Watson CJ, 2009, J MAMMARY GLAND BIOL, V14, P171, DOI 10.1007/s10911-009-9126-8	35	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74993	10.1371/journal.pone.0074993	http://dx.doi.org/10.1371/journal.pone.0074993			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086418	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200068
J	Gao, DF; Ning, N; Wang, CX; Wang, YH; Li, Q; Meng, Z; Liu, Y; Li, Q				Gao, Dengfeng; Ning, Ning; Wang, Congxia; Wang, Yuhuan; Li, Qing; Meng, Zhe; Liu, Yang; Li, Qiang			Dairy Products Consumption and Risk of Type 2 Diabetes: Systematic Review and Dose-Response Meta-Analysis	PLOS ONE			English	Review							TRANS-PALMITOLEIC ACID; DIETARY WHEY-PROTEIN; MAGNESIUM INTAKE; VITAMIN-D; MEN; MELLITUS; CALCIUM; DISEASE; MILK; FOOD	Background: The consumption of dairy products may influence the risk of type 2 diabetes mellitus (T2DM), but inconsistent findings have been reported. Moreover, large variation in the types of dairy intake has not yet been fully explored. Methods and Results: We conducted a systematic review and meta-analysis to clarify the dose-response association of dairy products intake and T2DM risk. We searched PubMed, EMBASE and Scopus for studies of dairy products intake and T2DM risk published up to the end of October 2012. Random-effects models were used to estimate summary relative risk (RR) statistics. Dose-response relations were evaluated using data from different dairy products in each study. We included 14 articles of cohort studies that reported RR estimates and 95% confidence intervals (95% CIs) of T2DM with dairy products intake. We found an inverse linear association of consumption of total dairy products (13 studies), low-fat dairy products (8 studies), cheese (7 studies) and yogurt (7 studies) and risk of T2DM. The pooled RRs were 0.94 (95% CI 0.91-0.97) and 0.88 (0.84-0.93) for 200 g/day total and low-fat dairy consumption, respectively. The pooled RRs were 0.80 (0.69-0.93) and 0.91 (0.82-1.00) for 30 g/d cheese and 50 g/d yogurt consumption, respectively. We also found a nonlinear association of total and low-fat dairy intake and T2DM risk, and the inverse association appeared to be strongest within 200 g/d intake. Conclusion: A modest increase in daily intake of dairy products such as low fat dairy, cheese and yogurt may contribute to the prevention of T2DM, which needs confirmation in randomized controlled trials.	[Gao, Dengfeng; Ning, Ning; Wang, Congxia; Li, Qing; Meng, Zhe; Liu, Yang] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Cardiol, Xian 710049, Shaanxi, Peoples R China; [Gao, Dengfeng] Xi An Jiao Tong Univ, Minist Educ, Key Lab Environm & Genes Related Dis, Xian 710049, Shaanxi, Peoples R China; [Wang, Yuhuan] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Endocrinol, Xian 710049, Shaanxi, Peoples R China; [Li, Qiang] Xi An Jiao Tong Univ, Sch Med, Dept Epidemiol, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Gao, DF (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Cardiol, Xian 710049, Shaanxi, Peoples R China.	gaomedic@163.com			National Natural Science Foundation of China [30900617]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from National Natural Science Foundation of China (no. 30900617 to D. Gao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azadbakht L, 2005, DIABETES CARE, V28, P2823, DOI 10.2337/diacare.28.12.2823; Belin RJ, 2007, MAGNESIUM RES, V20, P107; Beulens JWJ, 2010, DIABETES CARE, V33, P1699, DOI 10.2337/dc09-2302; Bodner-Montville J AJ, 2006, J FOOD COMPOS ANAL, V19, P7; Carter Patrice, 2010, BMJ, V341, pc4229, DOI 10.1136/bmj.c4229; Choi HK, 2005, ARCH INTERN MED, V165, P997, DOI 10.1001/archinte.165.9.997; Dong JY, 2011, DIABETES CARE, V34, P2116, DOI 10.2337/dc11-0518; Elwood PC, 2007, J EPIDEMIOL COMMUN H, V61, P695, DOI 10.1136/jech.2006.053157; Elwood PC, 2010, LIPIDS, V45, P925, DOI 10.1007/s11745-010-3412-5; Ericson U, 2013, BRIT J NUTR, V109, P1143, DOI 10.1017/S0007114512003017; German JB, 2009, EUR J NUTR, V48, P191, DOI 10.1007/s00394-009-0002-5; GRANTHAM N, 2012, PUBLIC HEALTH NUTR, V7, P1; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Guariguata L, 2011, DIABETES RES CLIN PR, V94, P322, DOI 10.1016/j.diabres.2011.10.040; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Jakubowicz D, 2013, J NUTR BIOCHEM, V24, P1, DOI 10.1016/j.jnutbio.2012.07.008; Khan H, 2013, P NUTR SOC, V72, P89, DOI 10.1017/S0029665112002765; Kirii K, 2009, DIABETOLOGIA, V52, P2542, DOI 10.1007/s00125-009-1554-x; Kirii K, 2010, J AM COLL NUTR, V29, P99, DOI 10.1080/07315724.2010.10719822; Kratz M, 2012, EUR J NUTR; Lakerveld Jeroen, 2008, BMC Endocr Disord, V8, P6, DOI 10.1186/1472-6823-8-6; Liu SM, 2006, DIABETES CARE, V29, P1579, DOI 10.2337/dc06-0256; Lopez-Ridaura R, 2004, DIABETES CARE, V27, P134, DOI 10.2337/diacare.27.1.134; Louie JC, 2012, NUTR METAB CARDIOVAS; Malik VS, 2011, AM J CLIN NUTR, V94, P854, DOI 10.3945/ajcn.110.009621; Margolis KL, 2011, J NUTR, V141, P1969, DOI 10.3945/jn.111.143339; Montonen J, 2005, EUR J CLIN NUTR, V59, P441, DOI 10.1038/sj.ejcn.1602094; Mozaffarian D, 2013, AM J CLIN NUTR, V97, P854, DOI 10.3945/ajcn.112.045468; Mozaffarian D, 2010, ANN INTERN MED, V153, P790, DOI 10.7326/0003-4819-153-12-201012210-00005; Niu K, 2012, EUR J NUTR; Orsini N BR, 2006, STATA J, V17; Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265; Pittas AG, 2006, DIABETES CARE, V29, P650, DOI 10.2337/diacare.29.03.06.dc05-1961; Polonsky KS, 2012, NEW ENGL J MED, V367, P1332, DOI 10.1056/NEJMra1110560; Riserus U, 2002, DIABETES CARE, V25, P1516, DOI 10.2337/diacare.25.9.1516; Schurgers LJ, 2000, HAEMOSTASIS, V30, P298; Sluijs I, 2012, AM J CLIN NUTR, V96, P382, DOI 10.3945/ajcn.111.021907; Soedamah-Muthu SS, 2013, BRIT J NUTR, V109, P718, DOI 10.1017/S0007114512001845; Song YQ, 2013, DIABETES CARE, V36, P1422, DOI 10.2337/dc12-0962; Sousa GTD, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-67; Straka RJ, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-53; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Struijk EA, 2012, NUTR METAB CARDIOVAS; THOMPSON SG, 1994, BMJ-BRIT MED J, V309, P1351, DOI 10.1136/bmj.309.6965.1351; Tong X, 2011, EUR J CLIN NUTR, V65, P1027, DOI 10.1038/ejcn.2011.62; van Dam RM, 2006, DIABETES CARE, V29, P2238, DOI 10.2337/dc06-1014; Villegas R, 2009, AM J CLIN NUTR, V89, P1059, DOI 10.3945/ajcn.2008.27182; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wong WCW, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-23; Woodward M, 2003, DIABETES CARE, V26, P360; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	51	69	73	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e73965	10.1371/journal.pone.0073965	http://dx.doi.org/10.1371/journal.pone.0073965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086304	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900020
J	Gaultney, RA; Gonzalez, T; Floden, AM; Brissette, CA				Gaultney, Robert A.; Gonzalez, Tammy; Floden, Angela M.; Brissette, Catherine A.			BB0347, from the Lyme Disease Spirochete Borrelia burgdorferi, Is Surface Exposed and Interacts with the CS1 Heparin-Binding Domain of Human Fibronectin	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; ANAPLASMA-PHAGOCYTOPHILUM; SERUM ANTIBODIES; UNITED-STATES; HOST-CELLS; PROTEIN; EXPRESSION; ADHESIN; IDENTIFICATION; PLASMINOGEN	The causative agent of Lyme disease, Borrelia burgdorferi, codes for several known fibronectin-binding proteins. Fibronectin a common the target of diverse bacterial pathogens, and has been shown to be essential in allowing for the development of certain disease states. Another borrelial protein, BB0347, has sequence similarity with these other known fibronectin-binding proteins, and may be important in Lyme disease pathogenesis. Herein, we perform an initial characterization of BB0347 via the use of molecular and biochemical techniques. We found that BB0347 is expressed, produced, and presented on the outer surface of intact B. burgdorferi. We also demonstrate that BB0347 has the potential to be important in Lyme disease progression, and have begun to characterize the nature of the interaction between human fibronectin and this bacterial protein. Further work is needed to define the role of this protein in the borrelial infection process.	[Gaultney, Robert A.; Gonzalez, Tammy; Floden, Angela M.; Brissette, Catherine A.] Univ N Dakota, Sch Med & Hlth Sci, Edwin C James Med Res Facil, Dept Microbiol & Immunol, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks	Brissette, CA (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Edwin C James Med Res Facil, Dept Microbiol & Immunol, Grand Forks, ND 58201 USA.	catherine.brissette@med.und.edu		Brissette, Catherine/0000-0003-0792-1403	NIH/NIAID [1K22AI093671-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI093671] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH/NIAID 1K22AI093671-01 to CAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano A, 2003, J PERIODONTOL, V74, P90, DOI 10.1902/jop.2003.74.1.90; Aquino RS, 2010, PROG MOL BIOL TRANSL, V93, P373, DOI 10.1016/S1877-1173(10)93016-0; Balzer S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-26; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Behera AK, 2008, CELL MICROBIOL, V10, P320, DOI 10.1111/j.1462-5822.2007.01043.x; Boone TJ, 2011, MICROB PATHOGENESIS, V51, P255, DOI 10.1016/j.micpath.2011.06.005; Brissette CA, 2008, INT J MED MICROBIOL, V298, P257, DOI 10.1016/j.ijmm.2007.09.004; Brissette CA, 2009, INFECT IMMUN, V77, P2802, DOI 10.1128/IAI.00227-09; Bunikis I, 2011, J MICROBIOL METH, V86, P243, DOI 10.1016/j.mimet.2011.05.004; Busscher HJ, 2008, LANGMUIR, V24, P10968, DOI 10.1021/la8016968; CARROLL JA, 2010, CURR PROTOC MICROBIO, V12; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Chan KF, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-157; Chenail AM, 2012, J BACTERIOL, V194, P4570, DOI 10.1128/JB.00661-12; Coburn J, 2005, MOL MICROBIOL, V57, P1182, DOI 10.1111/j.1365-2958.2005.04759.x; COUCHMAN JR, 1990, J INVEST DERMATOL, V94, pS7, DOI 10.1111/1523-1747.ep12874973; Dabo SM, 2006, INFECT IMMUN, V74, P2513, DOI 10.1128/IAI.74.5.2513-2521.2006; Dhanoa A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-270; Dickerson MT, 2012, BIOCONJUGATE CHEM, V23, P184, DOI 10.1021/bc200436x; Edwards AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018899; Floden AM, 2013, CLIN VACCINE IMMUNOL, V20, P892, DOI 10.1128/CVI.00758-12; Floden AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027502; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gilmore RD, 2000, INFECT IMMUN, V68, P411, DOI 10.1128/IAI.68.1.411-414.2000; Goldstein SF, 1996, J BACTERIOL, V178, P6539, DOI 10.1128/jb.178.22.6539-6545.1996; Hallstrom T, 2010, J INFECT DIS, V202, P490, DOI 10.1086/653825; Hamer-Barrera R, 2004, CAN J VET RES, V68, P33; Hauck CR, 2006, CURR OPIN MICROBIOL, V9, P5, DOI 10.1016/j.mib.2005.12.002; Hoen AG, 2009, P NATL ACAD SCI USA, V106, P15013, DOI 10.1073/pnas.0903810106; Hu LT, 2012, ANN INTERN MED, V157, DOI [10.7326/0003-4819-157-3-201208070-01002, 10.7326/0003-4819-157-3-20120807-01002]; Hyde JA, 2011, MOL MICROBIOL, V82, P99, DOI 10.1111/j.1365-2958.2011.07801.x; Jaenson TGT, 2011, TICKS TICK-BORNE DIS, V2, P44, DOI 10.1016/j.ttbdis.2010.10.006; Joh D, 1999, MATRIX BIOL, V18, P211, DOI 10.1016/S0945-053X(99)00025-6; Keller TE, 2012, GENOME BIOL EVOL, V4, P80, DOI 10.1093/gbe/evr129; KENEDY MR, 2012, FEMS IMMUNOL MED MIC; Kingsley RA, 2004, MOL MICROBIOL, V52, P345, DOI 10.1111/j.1365-2958.2004.03995.x; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; Kumru OS, 2011, J BACTERIOL, V193, P5759, DOI 10.1128/JB.05622-11; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Liu CY, 2012, FEMS MICROBIOL LETT, V337, P104, DOI 10.1111/1574-6968.12013; Liu RM, 2005, ANTICANCER RES, V25, P2129; Livengood JA, 2006, MICROBES INFECT, V8, P2832, DOI 10.1016/j.micinf.2006.08.014; MA Y, 1991, INFECT IMMUN, V59, P671, DOI 10.1128/IAI.59.2.671-678.1991; Magnarelli LA, 2013, J WILDLIFE DIS, V49, P294, DOI 10.7589/2012-06-172; Magnarelli LA, 2012, J WILDLIFE DIS, V48, P12, DOI 10.7589/0090-3558-48.1.12; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Margos G, 2012, APPL ENVIRON MICROB, V78, P6059, DOI 10.1128/AEM.00231-12; McElroy MC, 2002, INFECT IMMUN, V70, P3865, DOI 10.1128/IAI.70.7.3865-3873.2002; McNabb Scott J. N., 2006, Morbidity and Mortality Weekly Report, V55, P1; Mendes-Giannini MJS, 2005, FEMS IMMUNOL MED MIC, V45, P383, DOI 10.1016/j.femsim.2005.05.014; Moreillon P, 2002, INFECT DIS CLIN N AM, V16, P297, DOI 10.1016/S0891-5520(01)00009-5; Morgan-Kiss RM, 2002, P NATL ACAD SCI USA, V99, P7373, DOI 10.1073/pnas.122227599; Moriarty TJ, 2012, MOL MICROBIOL, V86, P1116, DOI 10.1111/mmi.12045; Motaleb MA, 2000, P NATL ACAD SCI USA, V97, P10899, DOI 10.1073/pnas.200221797; Nogueira SV, 2012, INFECT IMMUN, V80, P82, DOI 10.1128/IAI.05671-11; Onder O, 2012, J BIOL CHEM, V287, P16860, DOI 10.1074/jbc.M111.290775; Ostfeld RS, 2006, PLOS BIOL, V4, P1058, DOI 10.1371/journal.pbio.0040145; Ouyang ZM, 2010, J BACTERIOL, V192, P1965, DOI 10.1128/JB.01616-09; Pinne M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006071; Probert WS, 1998, MOL MICROBIOL, V30, P1003, DOI 10.1046/j.1365-2958.1998.01127.x; Rejmanek D, 2012, MICROBIOL-SGM, V158, P2632, DOI 10.1099/mic.0.059808-0; Roger P, 1999, EUR RESPIR J, V13, P1301, DOI 10.1183/09031936.99.13613109; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Shinji H, 2011, INFECT IMMUN, V79, P2215, DOI 10.1128/IAI.00133-11; Sinha B, 2000, INFECT IMMUN, V68, P6871, DOI 10.1128/IAI.68.12.6871-6878.2000; Sridhar S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-598; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Steere AC, 2011, CLIN INFECT DIS, V52, pS259, DOI 10.1093/cid/ciq117; Stevenson B, 2006, WIEN KLIN WOCHENSCHR, V118, P643, DOI 10.1007/s00508-006-0690-2; Stewart PE, 2004, APPL ENVIRON MICROB, V70, P5973, DOI 10.1128/AEM.70.10.5973-5979.2004; Tegtmeyer N, 2010, J BIOL CHEM, V285, P23513, DOI 10.1074/jbc.M109.096214; Torelli R, 2012, J INFECT DIS, V206, P952, DOI 10.1093/infdis/jis440; Verma SK, 2012, WORLD J MICROB BIOT, V28, P2487, DOI 10.1007/s11274-012-1056-8; Wang HM, 2012, ASIAN PAC J CANCER P, V13, P613, DOI 10.7314/APJCP.2012.13.2.613; WILSKE B, 1993, INFECT IMMUN, V61, P2182, DOI 10.1128/IAI.61.5.2182-2191.1993; Wu J, 2011, INFECT IMMUN, V79, P1338, DOI 10.1128/IAI.01188-10; Xu HJ, 2010, INFECT IMMUN, V78, P2910, DOI 10.1128/IAI.00372-10	78	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75643	10.1371/journal.pone.0075643	http://dx.doi.org/10.1371/journal.pone.0075643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086600	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900053
J	Jin, QF; Wang, ZY; Yan, F; Deng, ZT; Ni, F; Wu, JR; Shandas, R; Liu, X; Zheng, HR				Jin, Qiaofeng; Wang, Zhiyong; Yan, Fei; Deng, Zhiting; Ni, Fei; Wu, Junru; Shandas, Robin; Liu, Xin; Zheng, Hairong			A Novel Cationic Microbubble Coated with Stearic Acid-Modified Polyethylenimine to Enhance DNA Loading and Gene Delivery by Ultrasound	PLOS ONE			English	Article							TRANSFECTION IN-VITRO; CONTRAST AGENTS; DESTRUCTION; PLASMID; CELLS; CAVITATION; EXPRESSION; THERAPY; DRUG; CANCER	A novel cationic microbubble (MB) for improvement of the DNA loading capacity and the ultrasound-mediated gene delivery efficiency has been developed; it has been prepared with commercial lipids and a stearic acid modified polyethylenimine 600 (Stearic-PEI600) polymer synthesized via acylation reaction of branched PEI600 and stearic acid mediated by N, N'-carbonyldiimidazole (CDI). The MBs' concentration, size distribution, stability and zeta potential (zeta-potential) were measured and the DNA loading capacity was examined as a function of the amount of Stearic-PEI600. The gene transfection efficiency and cytotoxicity were also examined using breast cancer MCF-7 cells via the reporter plasmid pCMV-Luc, encoding the firefly luciferase gene. The results showed that the Stearic-PEI600 polymer caused a significant increase in magnitude of zeta-potential of MBs. The addition of DNA into cationic MBs can shift zeta-potentials from positive to negative values. The DNA loading capacity of the MBs grew linearly from (5+/-0.2) x 10(-3) pg/mu m(2) to (20+/-1.8) x 10(-3) pg/mu m(2) when Stearic-PEI600 was increased from 5 mol% to 30 mol%. Transfection of MCF-7 cells using 5% PEI600 MBs plus ultrasound exposure yielded 5.76+/-2.58 x 10(3) p/s/cm(2)/sr average radiance intensity, was 8.97- and 7.53-fold higher than those treated with plain MBs plus ultrasound (6.41+/-5.82) x 10(2) p/s/cm(2)/sr, (P < 0.01) and PEI600 MBs without ultrasound (7.65+/-6.18) x 10(2) p/s/cm(2)/sr, (P < 0.01), respectively. However, the PEI600 MBs showed slightly higher cytotoxicity than plain MBs. The cells treated with PEI600-MBs and plain MBs plus ultrasound showed 59.5+/-6.1% and 71.4+/-7.1% cell viability, respectively. In conclusion, our study demonstrated that the novel cationic MBs were able to increase DNA loading capacity and gene transfection efficiency and could be potentially applied in targeted gene delivery and therapy.	[Jin, Qiaofeng; Wang, Zhiyong; Yan, Fei; Deng, Zhiting; Ni, Fei; Liu, Xin; Zheng, Hairong] Chinese Acad Sci, Paul C Lauterbur Res Ctr Biomed Imaging, Inst Biomed & Hlth Engn, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Wu, Junru] Univ Vermont, Dept Phys, Burlington, VT 05405 USA; [Shandas, Robin] Univ Colorado Denver, Dept Bioengn, Aurora, CO USA; [Liu, Xin] Chinese Acad Sci, Shenzhen Key Lab MRI, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; University of Vermont; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Yan, F (corresponding author), Chinese Acad Sci, Paul C Lauterbur Res Ctr Biomed Imaging, Inst Biomed & Hlth Engn, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China.	fei.yan@siat.ac.cn; hr.zheng@siat.ac.cn	Jin, Qiaofeng/GXH-7164-2022	Jin, Qiaofeng/0000-0002-6086-0630; Shandas, Robin/0000-0002-9473-7542	National Basic Research Program 973 from Ministry of Science and Technology, China [2012CB733800, 2011CB707903, 2010CB732604]; National Science Foundation [61020106008, 30900749]; HAS fund of the University of Vermont, USA	National Basic Research Program 973 from Ministry of Science and Technology, China; National Science Foundation(National Science Foundation (NSF)); HAS fund of the University of Vermont, USA	The work was supported by National Basic Research Program 973 (Grant Nos. 2012CB733800, 2011CB707903, and 2010CB732604) from Ministry of Science and Technology, China, National Science Foundation Grants (Grant Nos. 61020106008 and 30900749). The work of J. Wu was partially supported by HAS fund of the University of Vermont, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SP, 1997, ULTRASOUND MED BIOL, V23, P953, DOI 10.1016/S0301-5629(97)00025-2; Bekeredjian R, 2005, ULTRASOUND MED BIOL, V31, P687, DOI 10.1016/j.ultrasmedbio.2004.08.002; Bekeredjian R, 2003, CIRCULATION, V108, P1022, DOI 10.1161/01.CIR.0000084535.35435.AE; Borden MA, 2006, LANGMUIR, V22, P4291, DOI 10.1021/la052841v; Borden MA, 2005, IEEE T ULTRASON FERR, V52, P1992, DOI 10.1109/TUFFC.2005.1561668; Borden MA, 2007, LANGMUIR, V23, P9401, DOI 10.1021/la7009034; Chandrashekhar C, 2013, ACTA BIOMATER, V9, P4985, DOI 10.1016/j.actbio.2012.09.015; Chen SY, 2006, P NATL ACAD SCI USA, V103, P8469, DOI 10.1073/pnas.0602921103; Chen ZY, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-152; Christiansen JP, 2003, ULTRASOUND MED BIOL, V29, P1759, DOI 10.1016/S0301-5629(03)00976-1; Daigeler A, 2010, ULTRASOUND MED BIOL, V36, P1893, DOI 10.1016/j.ultrasmedbio.2010.08.009; De Temmerman ML, 2011, BIOMATERIALS, V32, P9128, DOI 10.1016/j.biomaterials.2011.08.024; Deshpande MC, 2007, J CONTROL RELEASE, V118, P126, DOI 10.1016/j.jconrel.2006.12.010; Feshitan JA, 2009, J COLLOID INTERF SCI, V329, P316, DOI 10.1016/j.jcis.2008.09.066; Frenkel PA, 2002, ULTRASOUND MED BIOL, V28, P817, DOI 10.1016/S0301-5629(02)00518-5; Godbey WT, 2000, J BIOMED MATER RES, V51, P321, DOI 10.1002/1097-4636(20000905)51:3<321::AID-JBM5>3.3.CO;2-I; Karshafian R, 2009, ULTRASOUND MED BIOL, V35, P847, DOI 10.1016/j.ultrasmedbio.2008.10.013; Kimmel Eitan, 2006, Critical Reviews in Biomedical Engineering, V34, P105, DOI 10.1615/CritRevBiomedEng.v34.i2.10; Lawrie A, 2000, GENE THER, V7, P2023, DOI 10.1038/sj.gt.3301339; Lentacker I, 2006, LANGMUIR, V22, P7273, DOI 10.1021/la0603828; Lentacker I, 2010, MOL THER, V18, P101, DOI 10.1038/mt.2009.160; Lum AFH, 2006, J CONTROL RELEASE, V111, P128, DOI 10.1016/j.jconrel.2005.11.006; Lungwitz U, 2005, EUR J PHARM BIOPHARM, V60, P247, DOI 10.1016/j.ejpb.2004.11.011; Maeda H, 2001, J CONTROL RELEASE, V74, P47, DOI 10.1016/S0168-3659(01)00309-1; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Min SH, 2006, J GENE MED, V8, P1425, DOI 10.1002/jgm.973; Morille M, 2008, BIOMATERIALS, V29, P3477, DOI 10.1016/j.biomaterials.2008.04.036; Nomikou N, 2012, ACTA BIOMATER, V8, P1273, DOI 10.1016/j.actbio.2011.09.010; Pollard H, 1998, J BIOL CHEM, V273, P7507, DOI 10.1074/jbc.273.13.7507; Qiu YY, 2010, J CONTROL RELEASE, V145, P40, DOI 10.1016/j.jconrel.2010.04.010; Sirsi SR, 2012, THERANOSTICS, V2, P1208, DOI 10.7150/thno.4306; Sirsi SR, 2012, J CONTROL RELEASE, V157, P224, DOI 10.1016/j.jconrel.2011.09.071; Sun L, 2013, BIOMATERIALS, V34, P2107, DOI 10.1016/j.biomaterials.2012.11.041; Suvasini R, 2008, CANCER BIOL THER, V7, P225, DOI 10.4161/cbt.7.2.5796; Suzuki J, 2010, J AM COLL CARDIOL, V55, P904, DOI 10.1016/j.jacc.2009.09.054; Tlaxca JL, 2010, ULTRASOUND MED BIOL, V36, P1907, DOI 10.1016/j.ultrasmedbio.2010.05.014; Tse MT, 2009, INT J PHARMACEUT, V370, P33, DOI 10.1016/j.ijpharm.2008.11.006; Ulasov I, 2013, PLOS ONE, V8; Unger EC, 2001, PROG CARDIOVASC DIS, V44, P45, DOI 10.1053/pcad.2001.26443; Wan Q, 2013, NANOSCALE, V5, P744, DOI 10.1039/c2nr32438e; Wang DS, 2012, RADIOLOGY, V264, P721, DOI 10.1148/radiol.12112368; Wu J, 2008, ADV DRUG DELIVER REV, V60, P1103, DOI 10.1016/j.addr.2008.03.009; Yan F, 2012, ULTRASOUND MED BIOL, V38, P670, DOI 10.1016/j.ultrasmedbio.2011.12.025; Zarnitsyn VG, 2004, ULTRASOUND MED BIOL, V30, P527, DOI 10.1016/j.ultrasmedbio.2004.01.008; Zhou Q, 2012, INT J NANOMED, V5819	45	28	28	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76544	10.1371/journal.pone.0076544	http://dx.doi.org/10.1371/journal.pone.0076544			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086748	Green Submitted, Green Published, gold			2022-12-27	WOS:000325220000068
J	Kroon, J; Tol, S; van Amstel, S; Elias, JA; Fernandez-Borja, M				Kroon, Jeffrey; Tol, Simon; van Amstel, Sven; Elias, Judith A.; Fernandez-Borja, Mar			The Small GTPase RhoB Regulates TNF alpha Signaling in Endothelial Cells	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; TUMOR-NECROSIS-FACTOR; MESSENGER-RNA; TRANSCRIPTIONAL ACTIVATION; EARLY ENDOSOMES; KINASE PATHWAY; GENE RHOB; EXPRESSION; TRAFFICKING; BINDING	The inflammatory response of endothelial cells triggered by cytokines such as TNF alpha and IL1 beta plays a pivotal role in innate immunity. Upon pro-inflammatory cytokine stimulation, endothelial cells produce chemokines and cytokines that attract and activate leukocytes, and express high levels of leukocyte adhesion molecules. This process is mediated by intracellular signaling cascades triggered by activation of e. g. the TNF alpha receptor (TNFR) that lead to the activation of the NFkB transcription factor and of MAP kinases, which in turn activate inflammatory gene transcription. We found that the small GTPase RhoB was strongly and rapidly upregulated in primary human endothelial cells by TNF alpha, IL1 beta and LPS. We subsequently investigated the role of RhoB in the regulation of TNFR signaling in endothelial cells by silencing RhoB expression with siRNA. We provide evidence that the TNF alpha-induced activation of p38 MAP kinase is strongly dependent on RhoB, but not on RhoA, while JNK activation is regulated by both RhoB and RhoA. Consistent with the important role of p38 MAP kinase in inflammation, we demonstrate that loss of RhoB impairs TNF alpha-induced ICAM-1 expression and reduces cell production of IL6 and IL8. In addition, we show that RhoB silencing alters the intracellular traffic of TNF alpha after endocytosis. Since RhoB is a known regulator of the intracellular traffic of membrane receptors, our data suggest that RhoB controls TNF alpha signaling through the regulation of the TNFR traffic.	[Kroon, Jeffrey; Tol, Simon; van Amstel, Sven; Elias, Judith A.; Fernandez-Borja, Mar] Univ Amsterdam, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands	University of Amsterdam	Fernandez-Borja, M (corresponding author), Univ Amsterdam, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands.	m.fernandez@sanquin.nl	Kroon, Jeffrey/AAL-2588-2021; kim, hyangah/T-1669-2019	Kroon, Jeffrey/0000-0001-9983-6614; 	Landsteiner Foundation for Blood Transfusion [112]	Landsteiner Foundation for Blood Transfusion	M. Fernandez-Borja was funded by project 112 from the Landsteiner Foundation for Blood Transfusion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; Adini I, 2003, GENE DEV, V17, P2721, DOI 10.1101/gad.1134603; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Canguilhem B, 2005, J BIOL CHEM, V280, P43257, DOI 10.1074/jbc.M508650200; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Dodeller F, 2008, J BIOL CHEM, V283, P21487, DOI 10.1074/jbc.M801908200; Engel ME, 1998, J BIOL CHEM, V273, P9921, DOI 10.1074/jbc.273.16.9921; Fernandez-Borja M, 2005, J CELL SCI, V118, P2661, DOI 10.1242/jcs.02384; FRITZ G, 1995, J BIOL CHEM, V270, P25172, DOI 10.1074/jbc.270.42.25172; Fritz G, 2001, NUCLEIC ACIDS RES, V29, P792, DOI 10.1093/nar/29.3.792; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Huang M, 2007, ARTERIOSCL THROM VAS, V27, P2597, DOI 10.1161/ATVBAHA.107.154211; JAHNER D, 1991, MOL CELL BIOL, V11, P3682; Kajimoto H, 2007, CIRCULATION, V115, P1777, DOI 10.1161/CIRCULATIONAHA.106.649566; Kamon H, 2006, EMBO J, V25, P4108, DOI 10.1038/sj.emboj.7601286; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Kim BK, 2011, CARCINOGENESIS, V32, P254, DOI 10.1093/carcin/bgq244; Kim DM, 2010, APOPTOSIS, V15, P1540, DOI 10.1007/s10495-010-0531-7; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kraan TCTMV, 1997, J IMMUNOL, V158, P5560; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lajoie-Mazenc I, 2008, J BIOL CHEM, V283, P4155, DOI 10.1074/jbc.M709639200; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Liao W, 2008, CURR BIOL, V18, P641, DOI 10.1016/j.cub.2008.04.017; Llado A, 2008, MOL BIOL CELL, V19, P17, DOI 10.1091/mbc.E07-05-0411; Mahul-Mellier AL, 2008, J BIOL CHEM, V283, P34954, DOI 10.1074/jbc.M803140200; Mannam P, 2013, J IMMUNOL, V190, P1264, DOI 10.4049/jimmunol.1202012; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Neel NF, 2007, J CELL SCI, V120, P1559, DOI 10.1242/jcs.03437; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Nwariaku FE, 2003, J APPL PHYSIOL, V95, P1889, DOI 10.1152/japplphysiol.00225.2003; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Rolfe BE, 2005, ATHEROSCLEROSIS, V183, P1, DOI 10.1016/j.atherosclerosis.2005.04.023; Rondanino C, 2007, TRAFFIC, V8, P932, DOI 10.1111/j.1600-0854.2007.00575.x; Saklatvala J, 2003, BIOCHEM SOC SYMP, V70, P95, DOI 10.1042/bss0700095; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Sandilands E, 2007, EMBO REP, V8, P1162, DOI 10.1038/sj.embor.7401097; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Su X, 2008, BBA-MOL CELL RES, V1783, P1623, DOI 10.1016/j.bbamcr.2008.04.009; Teramoto H, 1996, J BIOL CHEM, V271, P25731, DOI 10.1074/jbc.271.42.25731; TSUJIMOTO M, 1985, P NATL ACAD SCI USA, V82, P7626, DOI 10.1073/pnas.82.22.7626; Wallar BJ, 2007, EXP CELL RES, V313, P560, DOI 10.1016/j.yexcr.2006.10.033; Westmark CJ, 2005, ONCOGENE, V24, P502, DOI 10.1038/sj.onc.1208224; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Woo CH, 2006, BIOCHEM BIOPH RES CO, V351, P972, DOI 10.1016/j.bbrc.2006.10.154; Wysk M, 1999, P NATL ACAD SCI USA, V96, P3763, DOI 10.1073/pnas.96.7.3763	51	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75031	10.1371/journal.pone.0075031	http://dx.doi.org/10.1371/journal.pone.0075031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086429	gold, Green Published, Green Submitted			2022-12-27	WOS:000325220000014
J	Qian, H				Qian, Hong			Environmental Determinants of Woody Plant Diversity at a Regional Scale in China	PLOS ONE			English	Article							AVIAN SPECIES RICHNESS; GLOBAL PATTERNS; CLIMATIC GRADIENTS; SOUTHERN AFRICA; TREE; ENERGY; AVAILABILITY; MODELS; SPACE	Understanding what drives the geographic variation of species richness across the globe is a fundamental goal of ecology and biogeography. Environmental variables have been considered as drivers of global diversity patterns but there is no consensus among ecologists on what environmental variables are primary drivers of the geographic variation of species richness. Here, I examine the relationship of woody plant species richness at a regional scale in China with sixteen environmental variables representing energy availability, water availability, energy-water balance, seasonality, and habitat heterogeneity. I found that temperature seasonality is the best predictor of woody species richness in China. Other important environmental variables include annual precipitation, mean temperature of the coldest month, and potential evapotranspiration. The best model explains 85% of the variation in woody plant species richness at the regional scale in China.	Illinois State Museum, Res & Collect Ctr, Springfield, IL USA		Qian, H (corresponding author), Illinois State Museum, Res & Collect Ctr, Springfield, IL USA.	hqian@museum.state.il.us						Ahn C-H, 1994, PHOTOGRAMM REMOTE SE, V33, P12; Boucher-Lalonde V, 2012, GLOBAL ECOL BIOGEOGR, V21, P1157, DOI 10.1111/j.1466-8238.2012.00764.x; Buckley LB, 2007, P ROY SOC B-BIOL SCI, V274, P1167, DOI 10.1098/rspb.2006.0436; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CONNELL JH, 1964, AM NAT, V98, P399, DOI 10.1086/282335; Cooperative Group of the Flora of Anhui, 1986, FLOR ANH, V1-5; CURRIE DJ, 1987, NATURE, V329, P326, DOI 10.1038/329326a0; Davies RG, 2007, GLOBAL ECOL BIOGEOGR, V16, P220, DOI 10.1111/j.1466-8238.2007.00282.x; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Evans KL, 2006, GLOBAL ECOL BIOGEOGR, V15, P372, DOI 10.1111/j.1466-822x.2006.00228.x; FANG JY, 2010, ATLAS WOODY PLANTS C; Flora Reipublicae Popularis Sinicae Editorial Committee, 1959, FLORA REIPUBLICAE PO, V1-80; Francis AP, 2003, AM NAT, V161, P523, DOI 10.1086/368223; Fu L. G, 1999, HIGHER PLANTS CHINA, V2-13; Giam X, 2010, BIOL CONSERV, V143, P1594, DOI 10.1016/j.biocon.2010.04.019; Hortal J, 2008, J BIOGEOGR, V35, P1202, DOI 10.1111/j.1365-2699.2007.01850.x; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Latham Roger Earl, 1993, P294; Montoya D, 2007, ECOGRAPHY, V30, P173, DOI 10.1111/j.0906-7590.2007.04873.x; Moore JL, 2002, P ROY SOC B-BIOL SCI, V269, P1645, DOI 10.1098/rspb.2002.2075; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Normand S, 2011, P ROY SOC B-BIOL SCI, V278, P3644, DOI 10.1098/rspb.2010.2769; O'Brien EM, 1998, ECOGRAPHY, V21, P495, DOI 10.1111/j.1600-0587.1998.tb00441.x; O'Brien EM, 2000, OIKOS, V89, P588, DOI 10.1034/j.1600-0706.2000.890319.x; OBRIEN EM, 1993, J BIOGEOGR, V20, P181, DOI 10.2307/2845670; PALMER MW, 1994, FOLIA GEOBOT PHYTOTX, V29, P511, DOI 10.1007/BF02883148; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Qian H, 2008, J BIOGEOGR, V35, P1362, DOI 10.1111/j.1365-2699.2008.01901.x; Qian H, 2007, CONSERV BIOL, V21, P937, DOI 10.1111/j.1523-1739.2007.00692.x; Qian H, 2012, PLANT ECOL, V213, P749, DOI 10.1007/s11258-012-0038-0; Qian H, 2011, GLOBAL ECOL BIOGEOGR, V20, P362, DOI 10.1111/j.1466-8238.2010.00590.x; Qian H, 2010, ECOLOGY, V91, P1172, DOI 10.1890/09-0620.1; Raes N, 2009, ECOGRAPHY, V32, P180, DOI 10.1111/j.1600-0587.2009.05800.x; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; ROSENZWEIG ML, 1968, AM NAT, V102, P67, DOI 10.1086/282523; Shafer SL, 2001, ECOSYSTEMS, V4, P200, DOI 10.1007/s10021-001-0004-5; Wang ZH, 2011, P ROY SOC B-BIOL SCI, V278, P2122, DOI 10.1098/rspb.2010.1897; Wiens JJ, 2006, AM NAT, V168, P579, DOI 10.1086/507882; Wright David H., 1993, P66; Wu C-Y, 1994, FLORA CHINA, V4-25; Zheng W., 1983, SYLVA SINICA	41	30	39	7	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75832	10.1371/journal.pone.0075832	http://dx.doi.org/10.1371/journal.pone.0075832			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086642	Green Published, Green Submitted, gold			2022-12-27	WOS:000325220000047
J	Sharma, A; Prasongwattana, V; Cha'on, U; Selmi, C; Hipkaeo, W; Boonnate, P; Pethlert, S; Titipungul, T; Intarawichian, P; Waraasawapati, S; Puapiroj, A; Sitprija, V; Reungjui, S				Sharma, Amod; Prasongwattana, Vitoon; Cha'on, Ubon; Selmi, Carlo; Hipkaeo, Wiphawi; Boonnate, Piyanard; Pethlert, Supattra; Titipungul, Tanin; Intarawichian, Piyapharom; Waraasawapati, Sakda; Puapiroj, Anucha; Sitprija, Visith; Reungjui, Sirirat			Monosodium Glutamate (MSG) Consumption Is Associated with Urolithiasis and Urinary Tract Obstruction in Rats	PLOS ONE			English	Article							CHINESE ADULTS; KIDNEY; METABOLISM; CALCIUM; CITRATE; PH; OVERWEIGHT; NUTRITION; PHOSPHATE; EXCRETION	Background: The peritoneal injection of monosodium glutamate (MSG) can induce kidney injury in adult rats but the effects of long-term oral intake have not been determined. Methods: We investigated the kidney histology and function in adult male Wistar rats that were fed ad libitum with a standard rat chow pellet and water with or without the addition of 2 mg/g body weight MSG/day in drinking water (n=10 per group). Both MSG-treated and control animals were sacrificed after 9 months when renal function parameters, blood and urine electrolytes, and tissue histopathology were determined. Results: MSG-treated rats were more prone to kidney stone formation, as represented by the alkaline urine and significantly higher activity product of calcium phosphate. Accordingly, 3/10 MSG-treated rats developed kidney stones over 9 months versus none of the control animals. Further, 2/10 MSG-treated rats but none (0/10) of the controls manifested hydronephrosis. MSG-treated rats had significantly higher levels of serum creatinine and potassium including urine output volume, urinary excretion sodium and citrate compared to controls. In contrast, MSG-treated rats had significantly lower ammonium and magnesium urinary excretion. Conclusion: Oral MSG consumption appears to cause alkaline urine and may increase the risks of kidney stones with hydronephrosis in rats. Similar effects in humans must be verified by dedicated studies.	[Sharma, Amod; Prasongwattana, Vitoon; Cha'on, Ubon; Boonnate, Piyanard; Pethlert, Supattra] Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen, Thailand; [Selmi, Carlo] Humanitas Clin & Res Ctr, Milan, Italy; [Selmi, Carlo] Univ Milan, BIOMETRA Dept, Milan, Italy; [Hipkaeo, Wiphawi] Khon Kaen Univ, Fac Med, Dept Anat, Khon Kaen, Thailand; [Titipungul, Tanin] Mahasarakham Hosp, Dept Pathol, Maha Sarakham, Thailand; [Intarawichian, Piyapharom; Waraasawapati, Sakda; Puapiroj, Anucha] Khon Kaen Univ, Fac Med, Dept Pathol, Khon Kaen, Thailand; [Sitprija, Visith] Queen Saovabha Mem Inst, Bangkok, Thailand; [Reungjui, Sirirat] Khon Kaen Univ, Fac Med, Dept Internal Med, Khon Kaen, Thailand	Khon Kaen University; University of Milan; Khon Kaen University; Khon Kaen University; Khon Kaen University	Cha'on, U (corresponding author), Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen, Thailand.	ubocha@kku.ac.th	sharma, amod/ABT-8672-2022; Selmi, Carlo/ABG-4899-2021; Sharma, Amod/AAA-3679-2022	Selmi, Carlo/0000-0002-0323-0376; Sharma, Amod/0000-0002-2860-7790	Research and Technology affairs division, Khon Kaen University; Faculty of Medicine [I54139, I56124]	Research and Technology affairs division, Khon Kaen University; Faculty of Medicine	UC received the grants from the Research and Technology affairs division, Khon Kaen University, under incubation research project and the invitation research fund from the Faculty of Medicine (I54139 and I56124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2004, SPECTROSC SPECT ANAL, V24, P1016; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bellisle F, 1999, NEUROSCI BIOBEHAV R, V23, P423, DOI 10.1016/S0149-7634(98)00043-8; BRENNAN S, 1988, AM J PHYSIOL, V255, pF301, DOI 10.1152/ajprenal.1988.255.2.F301; CHANEY AL, 1962, CLIN CHEM, V8, P130; Chauvin MF, 1997, J BIOL CHEM, V272, P4705, DOI 10.1074/jbc.272.8.4705; Cheema-Dhadli S, 2002, AM J PHYSIOL-RENAL, V282, pF1049, DOI 10.1152/ajprenal.00006.2001; Chevassus H, 2002, BRIT J CLIN PHARMACO, V53, P641, DOI 10.1046/j.1365-2125.2002.01596.x; Collison KS, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-58; Collison KS, 2010, PHYSIOL BEHAV, V99, P334, DOI 10.1016/j.physbeh.2009.11.010; DEGROOT AP, 1988, FOOD CHEM TOXICOL, V26, P425, DOI 10.1016/0278-6915(88)90053-1; GOLDENBERG H, 1966, CLIN CHEM, V12, P871; GRUNERT RR, 1950, J NUTR, V42, P609, DOI 10.1093/jn/42.4.609; Halpern BP, 2000, J NUTR, V130, p910S, DOI 10.1093/jn/130.4.910S; He K, 2008, OBESITY, V16, P1875, DOI 10.1038/oby.2008.274; He K, 2011, AM J CLIN NUTR, V93, P1328, DOI 10.3945/ajcn.110.008870; Hediger MA, 1999, AM J PHYSIOL-RENAL, V277, pF487, DOI 10.1152/ajprenal.1999.277.4.F487; Roson MI, 2011, J NEPHROL, V24, P119, DOI 10.5301/JN.2010.5824; Insawang T, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-50; Kamel KS, 2007, NEPHROL DIAL TRANSPL, V22, P424, DOI 10.1093/ndt/gfl588; KAUFMAN AM, 1988, AM J PHYSIOL, V255, pF182, DOI 10.1152/ajprenal.1988.255.1.F182; LEVIN M, 1989, MINER ELECTROL METAB, V15, P214; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; OHARA I, 1977, PHYSIOL BEHAV, V19, P627, DOI 10.1016/0031-9384(77)90037-3; Ortiz GG, 2006, BIOMED PHARMACOTHER, V60, P86, DOI 10.1016/j.biopha.2005.07.012; Paul MVS, 2012, TOXICOL MECH METHOD, V22, P625, DOI 10.3109/15376516.2012.714008; PETRARULO M, 1995, CLIN CHEM, V41, P1518; PETTERSSON BA, 1984, KIDNEY INT, V26, P122, DOI 10.1038/ki.1984.145; Rao GN, 2002, TOXICOL PATHOL, V30, P651, DOI 10.1080/01926230290166733; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sampson N, 2011, MOL ENDOCRINOL, V25, P503, DOI 10.1210/me.2010-0340; Shi ZM, 2011, J HYPERTENS, V29, P846, DOI 10.1097/HJH.0b013e328344da8e; Shi ZM, 2010, BRIT J NUTR, V104, P457, DOI 10.1017/S0007114510000760; SLOT C, 1965, SCAND J CLIN LAB INV, V17, P381, DOI 10.3109/00365516509077065; STEGINK LD, 1973, J NUTR, V103, P1146, DOI 10.1093/jn/103.8.1146; Thomas M, 2010, PHYSIOL BEHAV, V99, P334, DOI [10.1016/j.physbeh.2009.11.010, DOI 10.1016/J.PHYSBEH.2009.11.010.PUBMED:19945473]; Thu Hien VT, 2012, PUBLIC HEALTH NUTR, P1; TISELIUS HG, 1984, EUR UROL, V10, P191; Tucker MJ, 2003, DIS WISTAR RAT; Vercoutere B, 2004, BIOCHEM J, V378, P485, DOI 10.1042/BJ20031088; VINAY P, 1986, KIDNEY INT, V29, P68, DOI 10.1038/ki.1986.9; Wagner CA, 2010, J NEPHROL, V23, pS165; Walker R, 2000, J NUTR, V130, p1049S, DOI 10.1093/jn/130.4.1049S; WYBENGA DR, 1971, CLIN CHEM, V17, P891; Yatabe MS, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-160	46	20	20	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75546	10.1371/journal.pone.0075546	http://dx.doi.org/10.1371/journal.pone.0075546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086562	gold, Green Published, Green Submitted			2022-12-27	WOS:000325220000026
J	Wajid, A; White, F; Karim, MS				Wajid, Abdul; White, Franklin; Karim, Mehtab S.			Community Health Workers and Health Care Delivery: Evaluation of a Women's Reproductive Health Care Project in a Developing Country	PLOS ONE			English	Article							ANTENATAL CARE; QUALITY; PATIENT	Background: As part of the mid-term evaluation of a Women's Health Care Project, a study was conducted to compare the utilization of maternal and neonatal health (MNH) services in two areas with different levels of service in Punjab, Pakistan. Methods: A cross-sectional survey was conducted to interview Married Women of Reproductive Age (MWRA). Information was collected on MWRA knowledge regarding danger signs during pregnancy, delivery, postnatal periods, and MNH care seeking behavior. After comparing MNH service utilization, the two areas were compared using a logistic regression model, to identify the association of different factors with the intervention after controlling for socio-demographic, economic factors and distance of the MWRA residence to a health care facility. Results: The demographic characteristics of women in the two areas were similar, although socioeconomic status as indicated by level of education and better household amenities, was higher in the intervention area. Consequently, on univariate analysis, utilization of MNH services: antenatal care, TT vaccination, institutional delivery and use of modern contraceptives were higher in the intervention than control area. Nonetheless, multivariable analysis controlling for confounders such as socioeconomic status revealed that utilization of antenatal care services at health centers and TT vaccination during pregnancy are significantly associated with the intervention. Conclusions: Our findings suggest positive changes in health care seeking behavior of women and families with respect to MNH. Some aspects of care still require attention, such as knowledge about danger signs and neonatal care, especially umbilical cord care. Despite overall success achieved so far in response to the Millennium Development Goals, over the past two decades decreases in maternal mortality are far from the 2015 target. This report identifies some of the key factors to improving MNH and serves as an interim measure of a national and global challenge that remains a work in progress.	[Wajid, Abdul] Michigan State Univ, Coll Human Med, E Lansing, MI 48824 USA; [White, Franklin] Univ Victoria, Sch Publ Hlth & Social Policy, Victoria, BC V8W 2Y2, Canada; [White, Franklin] Dalhousie Univ, Halifax, NS B3H 3J5, Canada; [White, Franklin] Pacific Hlth & Dev Sci Inc, Victoria, BC, Canada; [Karim, Mehtab S.] George Mason Univ, Sch Publ Policy, Arlington, VA USA	Michigan State University; Michigan State University College of Human Medicine; University of Victoria; Dalhousie University; George Mason University	Wajid, A (corresponding author), Michigan State Univ, Coll Human Med, E Lansing, MI 48824 USA.	wajid_ab@yahoo.com	Wajid, Abdul/AAN-1011-2020	Wajid, Abdul/0000-0001-9594-620X	United Nations Population Fund (UNFPA) Islamabad as part of evaluation of the Women's Reproductive Health Care Project	United Nations Population Fund (UNFPA) Islamabad as part of evaluation of the Women's Reproductive Health Care Project	This study was funded by the United Nations Population Fund (UNFPA) Islamabad as part of evaluation of the Women's Reproductive Health Care Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya LB, 2000, HEALTH POLICY PLANN, V15, P223, DOI 10.1093/heapol/15.2.223; Akin JS, 1999, HEALTH POLICY PLANN, V14, P135, DOI 10.1093/heapol/14.2.135; [Anonymous], 2008, NAT PROGR FAM PLANN; [Anonymous], 1995, WORD PROC DAT STAT P; Arif MS, 2006, CHANGES KNOWLEDGE BE; Babalola S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-43; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Brazier E, 2009, SOC SCI MED, V69, P682, DOI 10.1016/j.socscimed.2009.06.023; Campbell SM, 2000, SOC SCI MED, V51, P1611, DOI 10.1016/S0277-9536(00)00057-5; Couillet M, 2007, J OBSTET GYNAECOL, V27, P688, DOI 10.1080/01443610701629080; du Monde Medecins, 1996, WOMENS HLTH CARE PRO; Fatmi Z, 2002, J Pak Med Assoc, V52, P138; Government of Pakistan, 2000, DISTR CENS REP RY KH; Griffiths P, 2001, J BIOSOC SCI, V33, P339, DOI 10.1017/S002193200100339X; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Hasan I J, 2002, J Pak Med Assoc, V52, P148; Lady Health Worker Programme, 2009, EXT EV NAT PROGR FAM; Liu JX, 2008, ANN FAM MED, V6, P124, DOI 10.1370/afm.794; Magadi MA, 2000, SOC SCI MED, V51, P551, DOI 10.1016/S0277-9536(99)00495-5; Matsumura M., 2001, ASIA PAC POPULAT J, V16, P23, DOI DOI 10.18356/E8A4C9ED-EN; Midhet F, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-30; Mikhail BI, 1999, WESTERN J NURS RES, V21, P335, DOI 10.1177/019394599902100305; Mushi D, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-14; Mwaniki P K, 2002, East Afr Med J, V79, P184; Nikiema L, 2010, J HEALTH POPUL NUTR, V28, P67, DOI 10.3329/jhpn.v28i1.4525; Rashida G, 2006, PROJECT OVERVIEW SAF; Sabih F, 2010, EMJH, V16; Scheaffer R.L., 1996, ELEMENTARY SURVEY SA; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Sitzia J, 1997, SOC SCI MED, V45, P1829, DOI 10.1016/S0277-9536(97)00128-7; SPSS, 1999, SPSS 10 0 WIND; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Thind A, 2005, TROP DOCT, V35, P75, DOI 10.1258/0049475054036977; van Eijk Anna M, 2006, Reprod Health, V3, P2, DOI 10.1186/1742-4755-3-2; World Health Organization, TRENDS MAT MORT 1990	35	7	7	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75476	10.1371/journal.pone.0075476	http://dx.doi.org/10.1371/journal.pone.0075476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VC	24086541	gold, Green Published, Green Submitted			2022-12-27	WOS:000325218700090
J	Choi, JS; Kim, YA; Kang, YU; Kim, CS; Bae, EH; Ma, SK; Ahn, YK; Jeong, MH; Kim, SW				Choi, Joon Seok; Kim, Young A.; Kang, Yong Un; Kim, Chang Seong; Bae, Eun Hui; Ma, Seong Kwon; Ahn, Young-Keun; Jeong, Myung Ho; Kim, Soo Wan			Clinical Impact of Hospital-Acquired Anemia in Association with Acute Kidney Injury and Chronic Kidney Disease in Patients with Acute Myocardial Infarction	PLOS ONE			English	Article							ERYTHROPOIETIN DEFICIENCY; CARDIOVASCULAR OUTCOMES; RENAL-FUNCTION; MORTALITY; RISK	Background: Hospital-acquired anemia (HAA) is common in patients with acute myocardial infarction (AMI) and is an independent indicator of long-term mortality in these patients. However, limited information exists regarding the development and prognostic impact of HAA associated with acute kidney injury (AKI) and chronic kidney disease (CKD) in AMI patients. Methods and Results: We retrospectively analyzed 2,289 patients with AMI, and excluded those with anemia at admission. The study population included 1,368 patients, of whom 800 (58.5%) developed HAA. Age, Hgb level at admission, Length of hospital stay, documented in-hospital bleeding and use of glycoprotein IIb/IIIa inhibitor, presence of CKD and occurrence of AKI were significantly associated with the development of HAA. HAA was significantly associated with higher 3-year mortality (4.8% and 11.4% for non-HAA and HAA patients, respectively; P < 0.001). After adjustment for multivariable confounders, the risk for long-term mortality was increased in HAA patients with AKI and/or CKD but not in HAA patients without AKI and/or CKD, compared to non-HAA patients (HAA patients without AKI and CKD, hazard ratio [HR]: 1.34, 95% confidence interval [CI]: 0.70-2.56; HAA patients with either AKI or CKD, HR: 2.80, 95% CI: 1.37-5.73; HAA patients with AKI and CKD, HR: 3.25, 95% CI: 1.28-8.24; compared with the non-HAA group). Conclusion: AKI and CKD were strongly associated with the development of HAA in AMI patients. HAA, when accompanied by AKI or CKD, is an independent risk predictor for long-term mortality in AMI patients.	[Choi, Joon Seok; Kim, Young A.; Kang, Yong Un; Kim, Chang Seong; Bae, Eun Hui; Ma, Seong Kwon; Kim, Soo Wan] Chonnam Natl Univ, Sch Med, Dept Internal Med, Div Nephrol, Gwangju, South Korea; [Ahn, Young-Keun; Jeong, Myung Ho] Chonnam Natl Univ, Cardiovasc Res Inst, Gwangju, South Korea	Chonnam National University; Chonnam National University	Kim, SW (corresponding author), Chonnam Natl Univ, Sch Med, Dept Internal Med, Div Nephrol, Gwangju, South Korea.	skimw@chonnam.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0009743]; National Research Foundation of Korea (NRF) grant (MRC for Gene Regulation) [2011-0030132]; Korea government (MSIP)	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF) grant (MRC for Gene Regulation)(National Research Foundation of Korea); Korea government (MSIP)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0009743), and by the National Research Foundation of Korea (NRF) grant (MRC for Gene Regulation, 2011-0030132) funded by the Korea government (MSIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Falluji N, 2002, AM HEART J, V144, P636, DOI 10.1067/mhj.2002.124351; AlFaleh HF, 2013, INT J CARDIOL, V167, P866, DOI 10.1016/j.ijcard.2012.01.097; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Amin AP, 2010, AM HEART J, V160, P1065, DOI 10.1016/j.ahj.2010.08.007; Anand I, 2004, CIRCULATION, V110, P149, DOI 10.1161/01.CIR.0000134279.79571.73; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Babitt JL, 2012, J AM SOC NEPHROL, V23, P1631, DOI 10.1681/ASN.2011111078; Bae EH, 2012, AM J KIDNEY DIS, V59, P795, DOI 10.1053/j.ajkd.2012.01.016; COTES PM, 1982, BRIT J HAEMATOL, V50, P427, DOI 10.1111/j.1365-2141.1982.tb01938.x; Davies MJ, 1997, NEW ENGL J MED, V336, P1312, DOI 10.1056/NEJM199705013361809; DAVIES MJ, 1993, BRIT HEART J, V69, P377; du Cheyron D, 2005, INTENS CARE MED, V31, P1529, DOI 10.1007/s00134-005-2739-5; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Erslev AJ, 1997, KIDNEY INT, V51, P622, DOI 10.1038/ki.1997.91; GARCIA JF, 1982, J LAB CLIN MED, V99, P624; HALES M, 1994, RENAL FAILURE, V16, P125, DOI 10.3109/08860229409044854; Langston RD, 2003, KIDNEY INT, V64, P1398, DOI 10.1046/j.1523-1755.2003.00200.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LIPKIN GW, 1989, LANCET, V1, P1029; MCGONIGLE RJS, 1984, KIDNEY INT, V25, P437, DOI 10.1038/ki.1984.36; Montalescot G, 2007, EUR HEART J, V28, P1409, DOI 10.1093/eurheartj/ehm031; NIELSEN OJ, 1990, J INTERN MED, V227, P373, DOI 10.1111/j.1365-2796.1990.tb00175.x; NIELSEN OJ, 1989, LANCET, V1, P624; Nutritional Anaemias, 1968, WHO TECH REP SER, V405, P5; O'Riordan E, 2000, NEPHROL DIAL TRANSPL, V15, P19, DOI 10.1093/oxfordjournals.ndt.a027971; Sabatine MS, 2005, CIRCULATION, V111, P2042, DOI 10.1161/01.CIR.0000162477.70955.5F; Salisbury AC, 2011, AM J CARDIOL, V108, P949, DOI 10.1016/j.amjcard.2011.05.026; Salisbury AC, 2011, AM HEART J, V162, P300, DOI 10.1016/j.ahj.2011.05.021; Salisbury AC, 2010, CIRC-CARDIOVASC QUAL, V3, P337, DOI 10.1161/CIRCOUTCOMES.110.957050; TAHNKJOHNSON ME, 1993, AM J CARDIOL, V71, P869, DOI 10.1016/0002-9149(93)90842-Z; Wu WC, 2001, NEW ENGL J MED, V345, P1230, DOI 10.1056/NEJMoa010615; 2012, KIDNEY INT, pS1	32	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75583	10.1371/journal.pone.0075583	http://dx.doi.org/10.1371/journal.pone.0075583			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086579	Green Published, Green Submitted, gold			2022-12-27	WOS:000325025200053
J	Lee, CH; Kim, TH; Lee, JH; Oh, SJ; Yoo, JY; Kwon, HS; Kim, YI; Ferguson, SD; Ahn, JY; Ku, BJ; Fazleabas, AT; Lim, JM; Jeong, JW				Lee, Chae Hyun; Kim, Tae Hoon; Lee, Jae Hee; Oh, Seo Jin; Yoo, Jung-Yoon; Kwon, Hyo Suk; Kim, Young Im; Ferguson, Susan D.; Ahn, Ji Yeon; Ku, Bon Jeong; Fazleabas, Asgerally T.; Lim, Jeong Mook; Jeong, Jae-Wook			Extracellular Signal-Regulated Kinase 1/2 Signaling Pathway Is Required for Endometrial Decidualization in Mice and Human	PLOS ONE			English	Article							BINDING-PROTEIN-BETA; PROGESTERONE-RECEPTOR; STROMAL CELLS; C/EBP-BETA; C-FOS; IMPLANTATION; ACTIVATOR; DIFFERENTIATION; PROLIFERATION; ESTROGEN	Decidualization is a crucial change required for successful embryo implantation and the maintenance of pregnancy. During this process, endometrial stromal cells differentiate into decidual cells in response to the ovarian steroid hormones of early pregnancy. Extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) are known to regulate cell proliferation and apoptosis in multiple cell types, including uterine endometrial cells. Aberrant activation of ERK1/2 has recently been implicated in the pathological processes of endometriosis and endometrial cancer. However, the function of ERK1/2 signaling during implantation and decidualization is still unknown. To determine the role and regulation of ERK1/2 signaling during implantation and decidualization, we examine ERK1/2 signaling in the mouse uterus during early pregnancy using immunostaining and qPCR. Interestingly, levels of phospho-ERK1/2 were highest within decidual cells located at the implantation sites. Expression levels of ERK1/2 target genes were also significantly higher at implantation sites, when compared to either inter-implantation sites. To determine if ERK1/2 signaling is also important during human endometrial decidualization, we examined levels of phospho-ERK1/2 in cultured human endometrial stromal cells during in vitro decidualization. Following treatment with a well-established decidualization-inducing steroidogenic cocktail, levels of phospho-ERK1/2 were markedly increased. Treatment with the ERK1/2 inhibitor, U0126, significantly decreased the expression of the known decidualization marker genes, IGFBP1 and PRL as well as inhibited the induction of known ERK1/2 target genes; FOS, MSK1, STAT1, and STAT3. Interestingly, the phosphorylation level of CCAAT/enhancer binding protein beta(C/EBP beta), a protein previously shown to be critical for decidualization, was significantly reduced in this model. These results suggest that ERK1/2 signaling is required for successful decidualization in mice as well as human endometrial stromal cells and implicates C/EBP beta as a downstream target of ERK1/2.	[Lee, Chae Hyun; Kim, Tae Hoon; Lee, Jae Hee; Oh, Seo Jin; Yoo, Jung-Yoon; Ferguson, Susan D.; Fazleabas, Asgerally T.; Jeong, Jae-Wook] Michigan State Univ, Coll Human Med, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI USA; [Lee, Chae Hyun; Lim, Jeong Mook] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Oh, Seo Jin; Kwon, Hyo Suk; Kim, Young Im; Ahn, Ji Yeon; Fazleabas, Asgerally T.; Lim, Jeong Mook; Jeong, Jae-Wook] Seoul Natl Univ, WCU Biomodulat Program, Seoul, South Korea; [Ahn, Ji Yeon] Seoul Natl Univ Hosp, Canc Res Inst, Seoul 110744, South Korea; [Ku, Bon Jeong] Chungnam Natl Univ, Sch Med, Dept Internal Med, Taejon, South Korea	Michigan State University; Michigan State University College of Human Medicine; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Chungnam National University	Lim, JM (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	limjm@snu.ac.kr; JaeWook.Jeong@hc.msu.edu		Ku, Bon Jeong/0000-0002-3414-8949; Yoo, Jung-Yoon/0000-0001-9366-3863	National Institutes of Health [R01HD057873]; American Cancer Society Research Scholar Grant [RSG-12-084-01-TBG]; World Class University program [R31-10056]; National Research Foundation of Korea; Ministry of Education, Science and Technology; National Institute of Child Health cooperative agreement [U54HD40093]; Specialized Cooperative Centers Program in Reproduction and Infertility Research; Ministry of Education, Science and Technology, Republic of Korea [20120006091]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057873] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD040093] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P50CA098258] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar Grant(American Cancer Society); World Class University program; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Institute of Child Health cooperative agreement; Specialized Cooperative Centers Program in Reproduction and Infertility Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank the Human Female Reproductive Tract Biopository and the Spectrum Health Medical Group, Department of Obstetrics, Gynecology and Reproductive Biology and Women's Health (Elizabeth Leary M.D., Calvin Leazenby M.D. and Diana Bitner M.D.) for their help in obtaining human endometrial tissue samples. This work was supported by National Institutes of Health Grant R01HD057873, American Cancer Society Research Scholar Grant RSG-12-084-01-TBG and World Class University program (R31-10056) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (to JWJ), and the National Institute of Child Health cooperative agreement U54HD40093 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research (to ATF) and this study was also supported by a grant from the Ministry of Education, Science and Technology, Republic of Korea No. 20120006091 (to JML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avruch J, 2001, RECENT PROG HORM RES, V56, P127, DOI 10.1210/rp.56.1.127; BAKER DJ, 1992, BIOL REPROD, V47, P492, DOI 10.1095/biolreprod47.3.492; Banerjee P, 2009, ENDOCRINOLOGY, V150, P4326, DOI 10.1210/en.2009-0394; Brosens JJ, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.037; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Chalmers CJ, 2007, CELL SIGNAL, V19, P695, DOI 10.1016/j.cellsig.2006.09.001; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Christian M, 2002, MOL ENDOCRINOL, V16, P141, DOI 10.1210/me.16.1.141; Duncan SA, 1997, DEV DYNAM, V208, P190, DOI 10.1002/(SICI)1097-0177(199702)208:2<190::AID-AJA6>3.0.CO;2-D; Fan HY, 2011, MOL ENDOCRINOL, V25, P253, DOI 10.1210/me.2010-0318; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Fazleabas AT, 2002, MOL CELL ENDOCRINOL, V186, P143, DOI 10.1016/S0303-7207(01)00655-4; Franco HL, 2011, FASEB J, V25, P1176, DOI 10.1096/fj.10-175349; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Hsu YL, 2013, ONCOGENE, V32, P4436, DOI 10.1038/onc.2012.444; IRWIN JC, 1991, ENDOCRINOLOGY, V129, P2385, DOI 10.1210/endo-129-5-2385; Jeong JW, 2010, BIOL REPROD, V83, P396, DOI 10.1095/biolreprod.109.083154; Kannan A, 2010, REPROD SCI, V17, P434, DOI 10.1177/1933719110361384; Karpovich N, 2005, J CLIN ENDOCR METAB, V90, P1607, DOI 10.1210/jc.2004-0868; Kim JJ, 1998, BIOL REPROD, V59, P160, DOI 10.1095/biolreprod59.1.160; Klemmt PAB, 2006, FERTIL STERIL, V85, P564, DOI 10.1016/j.fertnstert.2005.08.046; Laird S, 2006, REPROD BIOMED ONLINE, V13, P13, DOI 10.1016/S1472-6483(10)62011-1; Lee JH, 2013, FASEB J, V27, P2553, DOI 10.1096/fj.12-225664; Lee KY, 2004, REPRODUCTION, V128, P679, DOI 10.1530/rep.1.00340; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Liang XH, 2010, ENDOCRINOLOGY, V151, P5007, DOI 10.1210/en.2010-0170; Liu TY, 2002, BIOL REPROD, V67, P114, DOI 10.1095/biolreprod67.1.114; LOCKWOOD CJ, 1994, ANN NY ACAD SCI, V734, P57, DOI 10.1111/j.1749-6632.1994.tb21736.x; Mantena SR, 2006, P NATL ACAD SCI USA, V103, P1870, DOI 10.1073/pnas.0507261103; Mormile R, 2013, ARCH GYNECOL OBSTET, V287, P837, DOI 10.1007/s00404-012-2587-9; Pohnke Y, 1999, J BIOL CHEM, V274, P24808, DOI 10.1074/jbc.274.35.24808; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Ryan I P, 1997, Obstet Gynecol Surv, V52, P365, DOI 10.1097/00006254-199706000-00021; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; SCHATZ F, 1993, J CLIN ENDOCR METAB, V77, P621, DOI 10.1210/jc.77.3.621; Tamm K, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-150; Velarde MC, 2009, ENDOCRINOLOGY, V150, P4701, DOI 10.1210/en.2009-0389; Wang W, 2012, MOL ENDOCRINOL, V26, P2016, DOI 10.1210/me.2012-1169; Wang W, 2010, ENDOCRINOLOGY, V151, P3929, DOI 10.1210/en.2009-1437; Wetendorf M, 2012, MOL CELL ENDOCRINOL, V357, P108, DOI 10.1016/j.mce.2011.10.028; Yotova IY, 2011, HUM REPROD, V26, P885, DOI 10.1093/humrep/der010; Zarich N, 2006, MOL BIOL CELL, V17, P3591, DOI 10.1091/mbc.E05-12-1104; Zhang L, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-75; Zhao YC, 2013, ENDOCRINOLOGY, V154, P1349, DOI 10.1210/en.2012-2026	47	25	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75282	10.1371/journal.pone.0075282	http://dx.doi.org/10.1371/journal.pone.0075282			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086495	Green Submitted, Green Published, gold			2022-12-27	WOS:000325025200037
J	Nghe, P; Boulineau, S; Gude, S; Recouvreux, P; van Zon, JS; Tans, SJ				Nghe, Philippe; Boulineau, Sarah; Gude, Sebastian; Recouvreux, Pierre; van Zon, Jeroen S.; Tans, Sander J.			Microfabricated Polyacrylamide Devices for the Controlled Culture of Growing Cells and Developing Organisms	PLOS ONE			English	Article							MICROFLUIDIC DEVICE; ESCHERICHIA-COLI; SINGLE-CELL; GENE-REGULATION; CHEMOSTAT; BACTERIAL; POLY(DIMETHYLSILOXANE); EXPRESSION; HYDROGELS; FRACTURE	The ability to spatially confine living cells or small organisms while dynamically controlling their aqueous environment is important for a host of microscopy applications. Here, we show how polyacrylamide layers can be patterned to construct simple microfluidic devices for this purpose. We find that polyacrylamide gels can be molded like PDMS into micron-scale structures that can enclose organisms, while being permeable to liquids, and transparent to allow for microscopic observation. We present a range of chemostat-like devices to observe bacterial and yeast growth, and C. elegans nematode development. The devices can integrate PDMS layers and allow for temporal control of nutrient conditions and the presence of drugs on a minute timescale. We show how spatial confinement of motile C. elegans enables for time-lapse microscopy in a parallel fashion.	[Nghe, Philippe; Boulineau, Sarah; Gude, Sebastian; Recouvreux, Pierre; van Zon, Jeroen S.; Tans, Sander J.] FOM Inst AMOLF, Amsterdam, Netherlands	AMOLF	Tans, SJ (corresponding author), FOM Inst AMOLF, Amsterdam, Netherlands.	tans@amolf.nl	Tans, Sander/AAS-2901-2020; Nghe, Philippe/AAB-3575-2019; van Zon, Jeroen/C-8313-2018; Nghe, Philippe/M-3065-2015	Nghe, Philippe/0000-0003-3690-4610; van Zon, Jeroen/0000-0002-6021-2924; Nghe, Philippe/0000-0003-3690-4610; Recouvreux, Pierre/0000-0002-0747-5821; Gude, Sebastian/0000-0003-0688-5025	Nederlandse Organisatie voor Wetenschappelijke Onderzoek (NWO)	Nederlandse Organisatie voor Wetenschappelijke Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO))	This work is part of the research program of the Stichting voor Fundamenteel Onderzoek der Materie (FOM), which is financially supported by the Nederlandse Organisatie voor Wetenschappelijke Onderzoek (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 2010, NANO LETT, V10, P3379, DOI 10.1021/nl101204e; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173; Beg QK, 2007, P NATL ACAD SCI USA, V104, P12663, DOI 10.1073/pnas.0609845104; Ben-Yakar A, 2009, CURR OPIN NEUROBIOL, V19, P561, DOI 10.1016/j.conb.2009.10.010; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; Bonn D, 1998, SCIENCE, V280, P265, DOI 10.1126/science.280.5361.265; Brahmasandra SN, 2001, ELECTROPHORESIS, V22, P300, DOI 10.1002/1522-2683(200101)22:2<300::AID-ELPS300>3.0.CO;2-F; Brenner S, 1974, AENORHABDITIS ELEGAN, P71; Breslauer DN, 2006, MOL BIOSYST, V2, P97, DOI 10.1039/b515632g; Bringmann H, 2011, J NEUROSCI METH, V201, P78, DOI 10.1016/j.jneumeth.2011.07.013; Burnham MR, 2006, BIOMATERIALS, V27, P5883, DOI 10.1016/j.biomaterials.2006.08.001; Caulfield MJ, 2003, POLYMER, V44, P1331, DOI 10.1016/S0032-3861(03)00003-X; Charvin G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001468; Cheng SY, 2007, LAB CHIP, V7, P763, DOI 10.1039/b618463d; Chi WJ, 2012, APPL MICROBIOL BIOT, V94, P917, DOI 10.1007/s00253-012-4023-2; Cho HJ, 2007, PLOS BIOL, V5, P2614, DOI 10.1371/journal.pbio.0050302; Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022; Crank J., 1956, MATH DIFFUSION; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Ducret A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007282; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Groisman A, 2005, NAT METHODS, V2, P685, DOI 10.1038/NMETH784; Hoog JL, 2011, J CELL SCI, V124, P693, DOI 10.1242/jcs.072967; Hung PJ, 2005, BIOTECHNOL BIOENG, V89, P1, DOI 10.1002/bit.20289; Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Kwon HJ, 2011, POLYM ENG SCI, V51, P1078, DOI 10.1002/pen.21923; Lee JN, 2004, LANGMUIR, V20, P11684, DOI 10.1021/la048562+; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Liu JK, 2008, ELECTROPHORESIS, V29, P2241, DOI 10.1002/elps.200700608; Long Z, 2013, LAB CHIP, V13, P947, DOI 10.1039/c2lc41196b; Mannik J, 2009, P NATL ACAD SCI USA, V106, P14861, DOI 10.1073/pnas.0907542106; Mather W, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.208101; McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q; Mih JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019929; Moffitt JR, 2012, LAB CHIP, V12, P1487, DOI 10.1039/c2lc00009a; Moorthy J, 2007, ANAL CHEM, V79, P5322, DOI 10.1021/ac070226l; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Podbilewicz B, 2006, COLD SPRING HARBOR P; Regehr KJ, 2009, LAB CHIP, V9, P2132, DOI 10.1039/b903043c; Robert L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.12; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Takeuchi S, 2005, NANO LETT, V5, P1819, DOI 10.1021/nl0507360; Tanaka Y, 2000, EUR PHYS J E, V3, P395, DOI 10.1007/s101890070010; Tran PT, 2004, METHODS, V33, P220, DOI 10.1016/j.ymeth.2003.11.017; Tse JR, 2010, CURR PROTOC CELL BIO, V47, DOI [10.1002/0471143030.cb1016-47, DOI 10.1002/0471143030.CB1016-47]; Tuson HH, 2012, CHEM COMMUN, V48, P1595, DOI 10.1039/c1cc14705f; Walker GM, 2004, LAB CHIP, V4, P91, DOI 10.1039/b311214d; Walters EM, 2004, METH MOL B, V254, P375; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wong I, 2010, LAB CHIP, V10, P2710, DOI 10.1039/c004719h; Zaari N, 2004, ADV MATER, V16, P2133, DOI 10.1002/adma.200400883	61	18	19	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75537	10.1371/journal.pone.0075537	http://dx.doi.org/10.1371/journal.pone.0075537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086559	Green Published, gold			2022-12-27	WOS:000325025200045
J	Xu, B; Chakraborty, R; Eilers, M; Dakshinamurti, S; O'Neil, JD; Smith, SO; Bhullar, RP; Chelikani, P				Xu, Bing; Chakraborty, Raja; Eilers, Markus; Dakshinamurti, Shyamala; O'Neil, Joe D.; Smith, Steven O.; Bhullar, Rajinder P.; Chelikani, Prashen			High-Level Expression, Purification and Characterization of a Constitutively Active Thromboxane A2 Receptor Polymorphic Variant	PLOS ONE			English	Article							A(2); GLYCOSYLATION; RHODOPSIN	G protein-coupled receptors (GPCRs) exhibit some level of basal signaling even in the absence of a bound agonist. This basal or constitutive signaling can have important pathophysiological roles. In the past few years, a number of high resolution crystal structures of GPCRs have been reported, including two crystal structures of constitutively active mutants (CAM) of the dim-light receptor, rhodopsin. The structural characterizations of CAMs are impeded by the lack of proper expression systems. The thromboxane A2 receptor (TP) is a GPCR that mediates vasoconstriction and promotes thrombosis in response to the binding of thromboxane. Here, we report on the expression and purification of a genetic variant and CAM in TP, namely A160T, using tetracycline-inducible HEK293S-TetR and HEK293S (GnTI(-))-TetR cell lines. Expression of the TP and the A160T genes in these mammalian cell lines resulted in a 4-fold increase in expression to a level of 15.8 +/- 0.3 pmol of receptor/mg of membrane protein. The receptors expressed in the HEK293S (GnTI(-))-TetR cell line showed homogeneous glycosylation. The functional yield of the receptors using a single step affinity purification was 45 mu g/10(6) cells. Temperature-dependent secondary structure changes of the purified TP and A160T receptors were characterized using circular dichroism (CD) spectropolarimetry. The CD spectra shows that the loss of activity or thermal sensitivity that was previously observed for the A160T mutant, is not owing to large unfolding of the protein but rather to a more subtle effect. This is the first study to report on the successful high-level expression, purification, and biophysical characterization of a naturally occurring, diffusible ligand activated GPCR CAM.	[Xu, Bing; Chakraborty, Raja; Bhullar, Rajinder P.; Chelikani, Prashen] Univ Manitoba, Dept Oral Biol, Winnipeg, MB, Canada; [Eilers, Markus; Smith, Steven O.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Dakshinamurti, Shyamala] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada; [Dakshinamurti, Shyamala; Chelikani, Prashen] Univ Manitoba, Manitoba Inst Child Hlth, Winnipeg, MB, Canada; [O'Neil, Joe D.] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Manitoba; University of Manitoba; University of Manitoba	Chelikani, P (corresponding author), Univ Manitoba, Dept Oral Biol, Winnipeg, MB, Canada.	chelikan@cc.umanitoba.ca	Xu, Bing/AAB-6608-2019; O'Neil, Joe/R-2356-2019; Smith, Steven/HDM-9496-2022; Chakraborty, Raja/L-6316-2017	O'Neil, Joe/0000-0002-5917-0392; Chelikani, Prashen/0000-0003-1129-7957	Natural Sciences and Engineering Research Council of Canada [RGPIN 356285]; Manitoba Health Research Coucnil; Heart and Stroke Foundation of Manitoba; National Institutes of Health [GM 41412]; Heart and Stroke Foundation of Canada; MICH/MHRC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041412] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Manitoba Health Research Coucnil; Heart and Stroke Foundation of Manitoba; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); MICH/MHRC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Discovery grant (RGPIN 356285) from the Natural Sciences and Engineering Research Council of Canada to PC, and an operating grants from the Manitoba Health Research Coucnil to PC, from the Heart and Stroke Foundation of Manitoba to RB and the National Institutes of Health (GM 41412) to SOS. An MMSF/MHRC Dr. F.W. DuVal Clinical Research Professorship to SD, a New Investigator Award from Heart and Stroke Foundation of Canada to PC, and a MICH/MHRC graduate studentship to RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capra V, 2004, MOL PHARMACOL, V66, P880, DOI 10.1124/mol.104.001487; Chakraborty R, 2013, MOL CELL BIOL, V33, P184, DOI 10.1128/MCB.00725-12; Chakraborty R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029996; Chelikani P, 2006, PROTEIN SCI, V15, P1433, DOI 10.1110/ps.062080006; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Kazius J, 2008, HUM MUTAT, V29, P39, DOI 10.1002/humu.20638; Kelley LP, 2003, BBA-GEN SUBJECTS, V1621, P192, DOI 10.1016/S0304-4165(03)00059-X; KINSELLA BT, 1994, J BIOL CHEM, V269, P29914; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Oates J, 2012, BBA-BIOMEMBRANES, V1818, P2228, DOI 10.1016/j.bbamem.2012.04.010; Pawate S, 1998, J BIOL CHEM, V273, P22753, DOI 10.1074/jbc.273.35.22753; RAYCHOWDHURY MK, 1994, J BIOL CHEM, V269, P19256; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Ruan KH, 2008, BIOCHEMISTRY-US, V47, P6819, DOI 10.1021/bi702501g; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009	19	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e76481	10.1371/journal.pone.0076481	http://dx.doi.org/10.1371/journal.pone.0076481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086743	Green Submitted, Green Published, gold			2022-12-27	WOS:000326520200137
J	Greenbaum, A; Akbari, N; Feizi, A; Luo, W; Ozcan, A				Greenbaum, Alon; Akbari, Najva; Feizi, Alborz; Luo, Wei; Ozcan, Aydogan			Field-Portable Pixel Super-Resolution Colour Microscope	PLOS ONE			English	Article							WIDE-FIELD; DIGITAL HOLOGRAPHY; IMAGE-RECONSTRUCTION; PHASE RETRIEVAL; 3D TRACKING; REAL-TIME; CHIP; POINT; TELEMEDICINE	Based on partially-coherent digital in-line holography, we report a field-portable microscope that can render lensfree colour images over a wide field-of-view of e. g., >20 mm(2). This computational holographic microscope weighs less than 145 grams with dimensions smaller than 17x6x5 cm, making it especially suitable for field settings and point-of-care use. In this lensfree imaging design, we merged a colorization algorithm with a source shifting based multi-height pixel super-resolution technique to mitigate 'rainbow' like colour artefacts that are typical in holographic imaging. This image processing scheme is based on transforming the colour components of an RGB image into YUV colour space, which separates colour information from brightness component of an image. The resolution of our super-resolution colour microscope was characterized using a USAF test chart to confirm sub-micron spatial resolution, even for reconstructions that employ multi-height phase recovery to handle dense and connected objects. To further demonstrate the performance of this colour microscope Papanicolaou (Pap) smears were also successfully imaged. This field-portable and wide-field computational colour microscope could be useful for tele-medicine applications in resource poor settings.	[Greenbaum, Alon; Akbari, Najva; Luo, Wei; Ozcan, Aydogan] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA; [Feizi, Alborz; Ozcan, Aydogan] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Ozcan, Aydogan] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA; [Ozcan, Aydogan] Univ Calif Los Angeles, Sch Med, Dept Surg, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ozcan, A (corresponding author), Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA.	ozcan@ucla.edu	Ozcan, Aydogan/I-2608-2013; Luo, Wei/I-7660-2017	Ozcan, Aydogan/0000-0002-0717-683X; Feizi, Alborz/0000-0001-6960-7028; Luo, Wei/0000-0002-4828-0721	Presidential Early Career Award for Scientists and Engineers (PECASE); ARO Life Sciences Division; ARO Young Investigator Award; NSF CAREER Award; ONR Young Investigator Award; NIH Director's New Innovator Award from the Office of The Director, NIH [DP2OD006427]; NSF BISH program [0754880, 0930501]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006427] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [0954482] Funding Source: National Science Foundation	Presidential Early Career Award for Scientists and Engineers (PECASE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARO Life Sciences Division; ARO Young Investigator Award; NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); ONR Young Investigator Award; NIH Director's New Innovator Award from the Office of The Director, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF BISH program; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	A. Ozcan gratefully acknowledges the support of the Presidential Early Career Award for Scientists and Engineers (PECASE), ARO Life Sciences Division, ARO Young Investigator Award, NSF CAREER Award, the ONR Young Investigator Award, and the NIH Director's New Innovator Award DP2OD006427 from the Office of The Director, NIH. The authors also acknowledge the support of the NSF BISH program (under Awards # 0754880 and 0930501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LJ, 2001, OPT COMMUN, V199, P65, DOI 10.1016/S0030-4018(01)01556-5; Almoro P, 2006, APPL OPTICS, V45, P8596, DOI 10.1364/AO.45.008596; Baker JJ, 2002, DIAGN CYTOPATHOL, V27, P185, DOI 10.1002/dc.10158; Balsam J, 2011, LAB CHIP, V11, P941, DOI [10.1039/c0lc00431f, 10.1039/c01c00431f]; Biener G, 2011, LAB CHIP, V11, P2738, DOI 10.1039/c1lc20169g; Bishara W, 2011, LAB CHIP, V11, P1276, DOI 10.1039/c0lc00684j; Bishara W, 2010, OPT EXPRESS, V18, P11181, DOI 10.1364/OE.18.011181; Brady DJ, 2009, OPT EXPRESS, V17, P13040, DOI 10.1364/OE.17.013040; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Celebi ME, 2013, COLOR MED IMAGE ANAL; Choi K, 2010, APPL OPTICS, V49, pH1, DOI 10.1364/AO.49.0000H1; Cui XQ, 2008, P NATL ACAD SCI USA, V105, P10670, DOI 10.1073/pnas.0804612105; Elad M, 2001, IEEE T IMAGE PROCESS, V10, P1187, DOI 10.1109/83.935034; Farsiu S, 2006, IEEE T IMAGE PROCESS, V15, P141, DOI 10.1109/TIP.2005.860336; Ferraro P, 2008, J DISP TECHNOL, V4, P97, DOI 10.1109/JDT.2007.900936; Gallegos D, 2013, LAB CHIP, V13, P2124, DOI 10.1039/c3lc40991k; Garcia-Sucerquia J, 2006, OPT LETT, V31, P1211, DOI 10.1364/OL.31.001211; Garcia-Sucerquia J, 2012, OPT LETT, V37, P1724, DOI 10.1364/OL.37.001724; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Goldberg BD, 2009, OPT EXPRESS, V17, P3619, DOI 10.1364/OE.17.003619; Goodman J. W., 2005, INTRO FOURIER OPTICS; Gorocs Z, 2010, P SOC PHOTO-OPT INS, V7316; Greenbaum A, 2013, OPT EXPRESS, V21, P12469, DOI 10.1364/OE.21.012469; Greenbaum A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01717; Greenbaum A, 2012, NAT METHODS, V9, P889, DOI 10.1038/nmeth.2114; Greenbaum A, 2012, LAB CHIP, V12, P1242, DOI 10.1039/c2lc21072j; Greenbaum A, 2012, OPT EXPRESS, V20, P3129, DOI 10.1364/OE.20.003129; Hardie RC, 1998, OPT ENG, V37, P247, DOI 10.1117/1.601623; Iftimia NV, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1921509; Isikman SO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045044; Isikman SO, 2010, LAB CHIP, V10, P1109, DOI 10.1039/c001200a; Jack K., 2011, VIDEO DEMYSTIFIED HD; Javidi B, 2005, OPT LETT, V30, P144, DOI 10.1364/OL.30.000144; Kikuchi Y, 2010, OPT LETT, V35, P1548, DOI 10.1364/OL.35.001548; Kim SB, 2011, LAB CHIP, V11, P1801, DOI [10.1039/c1lc20098d, 10.1039/c11c20098d]; Kumar K, 2008, BIOMED MICRODEVICES, V10, P653, DOI 10.1007/s10544-008-9176-5; LAI G, 1991, J OPT SOC AM A, V8, P822, DOI 10.1364/JOSAA.8.000822; Levin A, 2004, ACM T GRAPHIC, V23, P689, DOI 10.1145/1015706.1015780; Louis KS, 2011, METHODS MOL BIOL, V740, P7, DOI 10.1007/978-1-61779-108-6_2; Martinez AW, 2008, ANAL CHEM, V80, P3699, DOI 10.1021/ac800112r; McLeod E, 2013, LAB CHIP, V13, P2028, DOI 10.1039/c3lc50222h; Memmolo P, 2012, OPT EXPRESS, V20, P28485, DOI 10.1364/OE.20.028485; Miller AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011890; Mudanyali O, 2013, NAT PHOTONICS, V7, P247, DOI [10.1038/nphoton.2012.337, 10.1038/NPHOTON.2012.337]; Mudanyali O, 2010, LAB CHIP, V10, P2419, DOI 10.1039/c004829a; Mudanyali O, 2010, LAB CHIP, V10, P1417, DOI 10.1039/c000453g; Myers FB, 2008, LAB CHIP, V8, P2015, DOI 10.1039/b812343h; Pamplona VF, 2011, ACM T GRAPHIC, V30, DOI 10.1145/1964921.1964942; Park SC, 2003, IEEE SIGNAL PROC MAG, V20, P21, DOI 10.1109/MSP.2003.1203207; Paturzo M, 2011, J DISP TECHNOL, V7, P24, DOI 10.1109/JDT.2010.2087007; Pelagotti A, 2012, OPT EXPRESS, V20, P4830, DOI 10.1364/OE.20.004830; Ramachandraiah H, 2013, LAB CHIP, V13, P1578, DOI 10.1039/c3lc41360h; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Shaffer E, 2012, J MICROSC-OXFORD, V245, P49, DOI 10.1111/j.1365-2818.2011.03543.x; Stern A, 2008, J OPT SOC AM A, V25, P736, DOI 10.1364/JOSAA.25.000736; Su TW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01664; Su TW, 2012, P NATL ACAD SCI USA, V109, P16018, DOI 10.1073/pnas.1212506109; Su TW, 2010, ANAL CHEM, V82, P8307, DOI 10.1021/ac101845q; Toge H, 2008, P SPIE, V6912; Wang J, 2006, BIOSENS BIOELECTRON, V21, P1887, DOI 10.1016/j.bios.2005.10.027; Xia P, 2011, APPL OPTICS, V50, pH177, DOI 10.1364/AO.50.00H177; Zhang Y, 2003, OPT EXPRESS, V11, P3234, DOI 10.1364/OE.11.003234; Zhu HY, 2013, LAB CHIP, V13, P51, DOI [10.1039/c2lc40864c, 10.1039/c21c40864c]; Zhu HY, 2011, ANAL CHEM, V83, P6641, DOI 10.1021/ac201587a; Zhu HY, 2011, LAB CHIP, V11, P315, DOI [10.1039/c0lc00358a, 10.1039/c01c00358a]	65	73	76	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76475	10.1371/journal.pone.0076475	http://dx.doi.org/10.1371/journal.pone.0076475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086742	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900102
J	Rowley, J; Fonov, V; Wu, O; Eskildsen, SF; Schoemaker, D; Wu, LY; Mohades, S; Shin, M; Sziklas, V; Cheewakriengkrai, L; Shmuel, A; Dagher, A; Gauthier, S; Rosa-Neto, P				Rowley, Jared; Fonov, Vladimir; Wu, Ona; Eskildsen, Simon Fristed; Schoemaker, Dorothee; Wu, Liyong; Mohades, Sara; Shin, Monica; Sziklas, Viviane; Cheewakriengkrai, Laksanun; Shmuel, Amir; Dagher, Alain; Gauthier, Serge; Rosa-Neto, Pedro		Alzheimer's Dis Neuroimaging Initi	White Matter Abnormalities and Structural Hippocampal Disconnections in Amnestic Mild Cognitive Impairment and Alzheimer's Disease	PLOS ONE			English	Article							DIFFUSION-TENSOR; MICROGLIAL ACTIVATION; POSTERIOR CINGULATE; UNCINATE FASCICULUS; TRACT INTEGRITY; DAMAGE; MRI; CORTEX; REGISTRATION; VALIDATION	The purpose of this project was to evaluate white matter degeneration and its impact on hippocampal structural connectivity in patients with amnestic mild cognitive impairment, non-amnestic mild cognitive impairment and Alzheimer's disease. We estimated white matter fractional anisotropy, mean diffusivity and hippocampal structural connectivity in two independent cohorts. The ADNI cohort included 108 subjects [25 cognitively normal, 21 amnestic mild cognitive impairment, 47 non-amnestic mild cognitive impairment and 15 Alzheimer's disease]. A second cohort included 34 subjects [15 cognitively normal and 19 amnestic mild cognitive impairment] recruited in Montreal. All subjects underwent clinical and neuropsychological assessment in addition to diffusion and T1 MRI. Individual fractional anisotropy and mean diffusivity maps were generated using FSL-DTIfit. In addition, hippocampal structural connectivity maps expressing the probability of connectivity between the hippocampus and cortex were generated using a pipeline based on FSL-probtrackX. Voxel-based group comparison statistics of fractional anisotropy, mean diffusivity and hippocampal structural connectivity were estimated using Tract-Based Spatial Statistics. The proportion of abnormal to total white matter volume was estimated using the total volume of the white matter skeleton. We found that in both cohorts, amnestic mild cognitive impairment patients had 27-29% white matter volume showing higher mean diffusivity but no significant fractional anisotropy abnormalities. No fractional anisotropy or mean diffusivity differences were observed between non-amnestic mild cognitive impairment patients and cognitively normal subjects. Alzheimer's disease patients had 66.3% of normalized white matter volume with increased mean diffusivity and 54.3% of the white matter had reduced fractional anisotropy. Reduced structural connectivity was found in the hippocampal connections to temporal, inferior parietal, posterior cingulate and frontal regions only in the Alzheimer's group. The severity of white matter degeneration appears to be higher in advanced clinical stages, supporting the construct that these abnormalities are part of the pathophysiological processes of Alzheimer's disease.	[Rowley, Jared; Schoemaker, Dorothee; Wu, Liyong; Mohades, Sara; Shin, Monica; Cheewakriengkrai, Laksanun; Gauthier, Serge; Rosa-Neto, Pedro] McGill Univ, MCSA, Translat Neuroimaging Lab, Montreal, PQ, Canada; [Wu, Liyong] Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing, Peoples R China; [Shmuel, Amir; Dagher, Alain; Rosa-Neto, Pedro] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada; [Fonov, Vladimir; Sziklas, Viviane] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Wu, Ona] Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Eskildsen, Simon Fristed] Aarhus Univ, Ctr Functionally Integrat Neurosci, Aarhus, Denmark	McGill University; Capital Medical University; McGill University; McGill University; Aarhus University	Rosa-Neto, P (corresponding author), McGill Univ, MCSA, Translat Neuroimaging Lab, Montreal, PQ, Canada.	Pedro.Rosa@mcgill.ca	wu, liyong/GVT-7509-2022; Eskildsen, Simon/K-3934-2019; Fonov, Vladimir/AAG-9572-2019; ROSA-NETO, PEDRO/F-5077-2015	Eskildsen, Simon/0000-0003-4242-9158; Fonov, Vladimir/0000-0003-3402-7749; Rowley, Jared/0000-0001-9690-7683; ROSA-NETO, PEDRO/0000-0001-9116-1376; Wu, Ona/0000-0002-5509-9461	Canadian institutes of Health Research (CIHR) [MOP-11-51-31]; Alzheimer's Association [NIRG-08-92090]; National Nature Science Foundation of China (NSFC) [3070024]; Beijing Scientific and Technological New Star Program [2007B069]; Nussia & Andre Aisenstadt Foundation; Fonds de la recherche en sante du Quebec; Scotia Bank Trust; Alzheimer's disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NIH [P30 AG010129, K01 AG030514]; NATIONAL INSTITUTE ON AGING [U01AG024904, K01AG030514, P30AG010129] Funding Source: NIH RePORTER	Canadian institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alzheimer's Association(Alzheimer's Association); National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Beijing Scientific and Technological New Star Program; Nussia & Andre Aisenstadt Foundation; Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Scotia Bank Trust; Alzheimer's disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The MCSA data, analysis and writing of this paper were supported by Canadian institutes of Health Research (CIHR) (MOP-11-51-31); Alzheimer's Association (NIRG-08-92090); National Nature Science Foundation of China (NSFC) (3070024); Beijing Scientific and Technological New Star Program (2007B069); Nussia & Andre Aisenstadt Foundation, Fonds de la recherche en sante du Quebec, and the Scotia Bank Trust. Additionally, data collection and sharing for this project was funded by the Alzheimer's disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association, Alzheimer's Drug Discovery Foundation, BioClinica, Inc., Biogen Idec Inc., Bristol-Myers Squibb Company, Eisai Inc., Elan Pharmaceuticals, Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd. and its affiliated company, Genentech, Inc., GE Healthcare, Innogenetics, N.V., IXICO Ltd., Janssen Alzheimer Immunotherapy Research & Development, LLC., Johnson & Johnson Pharmaceutical Research & Development LLC., Medpace, Inc., Merck & Co., Inc., Meso Scale Diagnostics, LLC., NeuroRx Research, Novartis Pharmaceuticals Corporation, Pfizer Inc., Piramal Imaging, Servier, Synarc Inc., and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are Rev November 7, 2012 facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129 and K01 AG030514. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2011, RADIOLOGY, V258, P853, DOI 10.1148/radiol.10101284; Aisen PS, 2010, ALZHEIMERS DEMENT, V6, P239, DOI 10.1016/j.jalz.2010.03.006; AUGUSTINACK JC, 2013, NEUROIMAGE, P2414; Barbas H, 1995, HIPPOCAMPUS, V5, P511, DOI 10.1002/hipo.450050604; Bartzokis G, 2003, ARCH NEUROL-CHICAGO, V60, P393, DOI 10.1001/archneur.60.3.393; Beattie BL, 2007, CAN J NEUROL SCI, V34, pS27, DOI 10.1017/S0317167100005527; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; BERG L, 1988, PSYCHOPHARMACOL BULL, V24, P637; Blatt GJ, 1998, J COMP NEUROL, V392, P92, DOI 10.1002/(SICI)1096-9861(19980302)392:1<92::AID-CNE7>3.0.CO;2-K; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Bozzali M, 2002, J NEUROL NEUROSUR PS, V72, P742, DOI 10.1136/jnnp.72.6.742; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bruckner G, 1999, NEUROSCIENCE, V92, P791, DOI 10.1016/S0306-4522(99)00071-8; Cagnin A, 2006, ACTA NEUROL SCAND, V114, P107, DOI 10.1111/j.1600-0404.2006.00694.x; Carter SF, 2012, J NUCL MED, V53, P37, DOI 10.2967/jnumed.110.087031; Charlton RA, 2006, NEUROLOGY, V66, P217, DOI 10.1212/01.wnl.0000194256.15247.83; Chen TF, 2009, HUM BRAIN MAPP, V30, P3826, DOI 10.1002/hbm.20810; Cho H, 2008, J KOREAN MED SCI, V23, P477, DOI 10.3346/jkms.2008.23.3.477; Choi SJ, 2005, J GERIATR PSYCH NEUR, V18, P12, DOI 10.1177/0891988704271763; Chua TC, 2008, CURR OPIN NEUROL, V21, P83, DOI 10.1097/WCO.0b013e3282f4594b; Chua TC, 2009, AM J GERIAT PSYCHIAT, V17, P602, DOI 10.1097/JGP.0b013e3181a76e0b; Clerx L, 2012, J ALZHEIMERS DIS, V29, P405, DOI 10.3233/JAD-2011-110797; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Collins DL, 1997, INT J PATTERN RECOGN, V11, P1271, DOI 10.1142/S0218001497000597; DELAMONTE SM, 1989, ANN NEUROL, V25, P450, DOI 10.1002/ana.410250506; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Duan JH, 2006, SURG RADIOL ANAT, V28, P150, DOI 10.1007/s00276-006-0111-2; Duvernoy H. M, 2005, HUMAN HIPPOCAMPUS FU; Eskildsen SF, 2012, NEUROIMAGE, V59, P2362, DOI 10.1016/j.neuroimage.2011.09.012; Fellgiebel A, 2004, DEMENT GERIATR COGN, V18, P101, DOI 10.1159/000077817; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Giorgio A, 2010, NEUROIMAGE, V49, P94, DOI 10.1016/j.neuroimage.2009.08.003; GOLDMANRAKIC PS, 1984, NEUROSCIENCE, V12, P719, DOI 10.1016/0306-4522(84)90166-0; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; Gouw AA, 2008, BRAIN, V131, P3286, DOI 10.1093/brain/awn265; Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208; Ibrahim I, 2009, NEUROENDOCRINOL LETT, V30, P39; INSAUSTI R, 2004, INSAUSTI HIPPOCAMPAL; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; JENKINSON M, 2005, ET2 MR BASED ESTIMAT; Kiuchi K, 2009, BRAIN RES, V1287, P184, DOI 10.1016/j.brainres.2009.06.052; KRSTIC D, 2012, NAT REV NEUROL; Lucas JA, 1998, J CLIN EXP NEUROPSYC, V20, P194, DOI 10.1076/jcen.20.2.194.1173; Lue LF, 2001, GLIA, V35, P72, DOI 10.1002/glia.1072; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; Miller A. K., 2008, NEUROPATHOL APPL NEU, V6, P119; Morris R, 1999, J COMP NEUROL, V407, P183, DOI 10.1002/(SICI)1096-9861(19990503)407:2<183::AID-CNE3>3.0.CO;2-N; Mufson EJ, 2012, ACTA NEUROPATHOL, V123, P13, DOI 10.1007/s00401-011-0884-1; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Dwyer L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021745; Okello A, 2009, NEUROLOGY, V72, P56, DOI 10.1212/01.wnl.0000338622.27876.0d; Parente DB, 2008, AM J ROENTGENOL, V190, P1369, DOI 10.2214/AJR.07.2617; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petersen RC, 2006, ARCH NEUROL-CHICAGO, V63, P665, DOI 10.1001/archneur.63.5.665; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Rose SE, 2000, J NEUROL NEUROSUR PS, V69, P528, DOI 10.1136/jnnp.69.4.528; Salat DH, 2010, NEUROBIOL AGING, V31, P244, DOI 10.1016/j.neurobiolaging.2008.03.013; Schmidt M., 1996, W PSYCHOL SERVICES; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; SELTZER B, 1979, BRAIN RES, V179, P157, DOI 10.1016/0006-8993(79)90499-2; SEXTON CE, 2009, BIOL PSYCHIAT; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stahl R, 2007, RADIOLOGY, V243, P483, DOI 10.1148/radiol.2432051714; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Stricker NH, 2009, NEUROIMAGE, V45, P10, DOI 10.1016/j.neuroimage.2008.11.027; Takahashi E, 2007, NEUROIMAGE, V34, P827, DOI 10.1016/j.neuroimage.2006.10.009; Taoka T, 2006, AM J NEURORADIOL, V27, P1040; Teipel SJ, 2007, NEUROIMAGE, V34, P985, DOI 10.1016/j.neuroimage.2006.07.047; TIERNEY MC, 1988, NEUROLOGY, V38, P359, DOI 10.1212/WNL.38.3.359; Ukmar M, 2008, RADIOL MED, V113, P915, DOI 10.1007/s11547-008-0286-1; Villain N, 2008, J NEUROSCI, V28, P6174, DOI 10.1523/JNEUROSCI.1392-08.2008; Villain N, 2010, BRAIN, V133, P3301, DOI 10.1093/brain/awq203; Vollmar C, 2010, NEUROIMAGE, V51, P1384, DOI 10.1016/j.neuroimage.2010.03.046; Wang DS, 2004, NEUROSCI RES, V48, P93, DOI 10.1016/j.neures.2003.10.002; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wechsler D., 1984, WMS R WECHSLER MEMOR; Yasmin H, 2008, NEURORADIOLOGY, V50, P293, DOI 10.1007/s00234-007-0353-7; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; Zhuang L, 2010, NEUROIMAGE, V53, P16, DOI 10.1016/j.neuroimage.2010.05.068; Zijdenbos A, 1998, LECT NOTES COMPUT SC, V1496, P439, DOI 10.1007/BFb0056229	89	22	23	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74776	10.1371/journal.pone.0074776	http://dx.doi.org/10.1371/journal.pone.0074776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086371	gold, Green Published, Green Submitted			2022-12-27	WOS:000325223900030
J	Mazzola, V; Vuilleumier, P; Latorre, V; Petito, A; Gallese, V; Popolizio, T; Arciero, G; Bondolfi, G				Mazzola, Viridiana; Vuilleumier, Patrik; Latorre, Valeria; Petito, Annamaria; Gallese, Vittorio; Popolizio, Teresa; Arciero, Giampiero; Bondolfi, Guido			Effects of Emotional Contexts on Cerebello-Thalamo-Cortical Activity during Action Observation	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTEX EXCITABILITY; MEDIAL TEMPORAL-LOBE; FUNCTIONAL TOPOGRAPHY; PREFRONTAL CORTEX; SUPPLEMENTARY; CONNECTIVITY; METAANALYSIS; INHIBITION; RESPONSES	Several studies investigated the neural and functional mechanisms underlying action observation in contexts with objects. However, actions seen in everyday life are often embedded in emotional contexts. The neural systems integrating emotion cues in action observation are still poorly understood. Previous findings suggest that the processing of both action and emotion information recruits motor control areas within the cerebello-thalamo-cortical pathways. It is therefore hard to determine whether social emotional contexts influence action processing via a direct modulation of motor representations coding for the observed action or via the affective state and implicit motor preparedness elicited in observers in response to emotional contexts. Here we designed a novel fMRI task to identify neural networks engaged by the affective appraisal of a grasping action seen in two different emotional contexts, while keeping the action kinematics constant. Results confirmed that observing the same acts of grasping but in different emotional contexts modulated activity in supplementary motor area, ventrolateral thalamus, anterior cerebellum. Moreover, changes in functional connectivity between left supplementary motor area and parahippocampus in different emotional contexts suggested a direct neural pathway through which emotional contexts may drive the neural motor system. Taken together, these findings shed new light on the malleability of motor system as a function of emotional contexts.	[Mazzola, Viridiana] Univ Geneva, Swiss Ctr Affect Sci CISA, Geneva, Switzerland; [Vuilleumier, Patrik] Univ Geneva, Dept Neurol, Univ Hosp, Lab Behav Neurol & Imaging Cognit, Geneva, Switzerland; [Vuilleumier, Patrik] Univ Geneva, Sch Med, Dept Neurosci, CH-1211 Geneva, Switzerland; [Latorre, Valeria; Arciero, Giampiero] Inst Postrationalist Psychol IPRA, Rome, Italy; [Petito, Annamaria; Arciero, Giampiero] Univ Foggia, Dept Med Sci, Inst Psychiat & Clin Psychol, Foggia, Italy; [Gallese, Vittorio; Arciero, Giampiero] Univ Parma, Dept Neurosci, Physiol Sect, I-43100 Parma, Italy; [Gallese, Vittorio; Arciero, Giampiero] Italian Inst Technol IIT, Brain Ctr Social & Motor Cognit, Parma, Italy; [Popolizio, Teresa; Arciero, Giampiero] Casa Sollievo Sofferenza IRCCSS, Dept Neuroradiol, Foggia, Italy; [Arciero, Giampiero; Bondolfi, Guido] Univ Hosp Geneva, Dept Mental Hlth & Psychiat, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Foggia; University of Parma; Istituto Italiano di Tecnologia - IIT; IRCCS Casa Sollievo Della Sofferenza; University of Geneva	Mazzola, V (corresponding author), Univ Geneva, Swiss Ctr Affect Sci CISA, Geneva, Switzerland.	Viridiana.Mazzola@unige.ch	Vuilleumier, Patrik/AAJ-1839-2021; Gallese, Vittorio/ABD-5097-2021	Vuilleumier, Patrik/0000-0002-8198-9214; Gallese, Vittorio/0000-0003-4815-3607				Adolphs R, 2010, NEURON, V65, P752, DOI 10.1016/j.neuron.2010.03.006; Arciero G, 1989, EVOLUTIONARY EPISTEM; Arciero G., 2009, SELFHOOD IDENTITY PE; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Baumann O, 2012, NEUROIMAGE, V61, P805, DOI 10.1016/j.neuroimage.2012.03.044; Bermejo-Pareja F, 2011, NAT REV NEUROL, V7, P273, DOI 10.1038/nrneurol.2011.44; Boy F, 2010, CURR BIOL, V20, P1779, DOI 10.1016/j.cub.2010.09.003; Boy F, 2010, EXP BRAIN RES, V206, P441, DOI 10.1007/s00221-010-2417-x; Carbon M, 2011, BRAIN, V134, P1416, DOI 10.1093/brain/awr060; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Chang SE, 2011, CEREB CORTEX, V21, P2507, DOI 10.1093/cercor/bhr028; Coelho CM, 2010, NEUROSCI LETT, V481, P135, DOI 10.1016/j.neulet.2010.03.027; Cojan Y, 2009, NEUROIMAGE, V47, P1026, DOI 10.1016/j.neuroimage.2009.05.023; Coombes SA, 2009, COGN AFFECT BEHAV NE, V9, P380, DOI 10.3758/CABN.9.4.380; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Dinomais M, 2009, NEUROREPORT, V20, P1351, DOI 10.1097/WNR.0b013e328330cd43; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Edwards MJ, 2012, BRAIN, V135, P3495, DOI 10.1093/brain/aws129; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Ekman P., 1976, PICTURES FACIAL AFFE; Ekman P., 1999, HDB COGN EMOT, V98, P16; Ferri F, 2013, PONE, V8, P54091, DOI [10.1371/journal.pone.0054091, DOI 10.1371/J0URNAL.P0NE.0054091.PUBMED:23349792]; Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238; Frijda N. H., 1986, EMOTIONS STUDIES EMO; Frijda NH, 1995, PSYCHOL FACIAL EXPRE; Frith C, 2010, NEURON, V65, P739, DOI 10.1016/j.neuron.2010.03.015; Gallese V, 2011, TRENDS COGN SCI, V15, P512, DOI 10.1016/j.tics.2011.09.003; Griffiths PE, 2008, CAMBRIDGE HDB SITUAT; Grosbras MH, 2006, CEREB CORTEX, V16, P1087; Grosbras MH, 2012, HUM BRAIN MAPP, V33, P431, DOI 10.1002/hbm.21222; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P91, DOI 10.1111/j.1469-8986.2006.00487.x; Hinde R. A., 1985, DEV EXPRESSIVE BEHAV, P103; HINDE RA, 1985, ANIM BEHAV, V33, P985, DOI 10.1016/S0003-3472(85)80032-4; HORNE MK, 1995, PROG NEUROBIOL, V46, P199, DOI 10.1016/0301-0082(95)00002-D; Howard LR, 2011, J NEUROSCI, V31, P5253, DOI 10.1523/JNEUROSCI.6055-10.2011; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Kelly RM, 2003, J NEUROSCI, V23, P8432; Keysers C, 2009, CURR OPIN NEUROBIOL, V19, P666, DOI 10.1016/j.conb.2009.10.006; Kveraga K, 2011, P NATL ACAD SCI USA, V108, P3389, DOI 10.1073/pnas.1013760108; Lench HC, 2011, PSYCHOL BULL, V137, P834, DOI 10.1037/a0024244; Middleton FA, 2001, J NEUROSCI, V21, P700, DOI 10.1523/JNEUROSCI.21-02-00700.2001; Mullally SL, 2011, J NEUROSCI, V31, P7441, DOI 10.1523/JNEUROSCI.0267-11.2011; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Neef NE, 2011, CORTEX, V47, P945, DOI 10.1016/j.cortex.2010.06.007; Oliveri M, 2003, EXP BRAIN RES, V149, P214, DOI 10.1007/s00221-002-1346-8; Paulhus D. L., 2007, HDB RES METHODS PERS; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Pichon S, 2012, CEREB CORTEX, V22, P274, DOI 10.1093/cercor/bhr060; Ramnani N, 2006, NAT REV NEUROSCI, V7, P511, DOI 10.1038/nrn1953; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Sabatinelli D, 2011, NEUROIMAGE, V54, P2524, DOI 10.1016/j.neuroimage.2010.10.011; Sagaspe P, 2011, NEUROIMAGE, V55, P1825, DOI 10.1016/j.neuroimage.2011.01.027; Schutter DJLG, 2008, PSYCHOPHYSIOLOGY, V45, P345, DOI 10.1111/j.1469-8986.2007.00635.x; Shmuelof L, 2006, J NEUROSCI, V26, P9736, DOI 10.1523/JNEUROSCI.1836-06.2006; Singer T, 2012, NEUROIMAGE, V61, P437, DOI 10.1016/j.neuroimage.2012.01.109; Smith SD, 2011, NEUROIMAGE, V58, P269, DOI 10.1016/j.neuroimage.2011.06.004; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Spraker MB, 2007, J NEUROPHYSIOL, V98, P821, DOI 10.1152/jn.00239.2007; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Sumner P, 2008, NEUROSCIENTIST, V14, P474, DOI 10.1177/1073858408314435; Sumner P, 2007, NEURON, V54, P697, DOI 10.1016/j.neuron.2007.05.016; Talairach J., 1998, COPLANAR STEREOTAXIC; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Tamietto M, 2009, P NATL ACAD SCI USA, V106, P17661, DOI 10.1073/pnas.0908994106; Torriero S, 2011, J COGNITIVE NEUROSCI, V23, P338, DOI 10.1162/jocn.2010.21471; van Loon AM, 2010, COGN AFFECT BEHAV NE, V10, P174, DOI 10.3758/CABN.10.2.174; Voon V, 2010, BRAIN, V133, P1526, DOI 10.1093/brain/awq054; Vuilleumier P, 2001, BRAIN, V124, P1077, DOI 10.1093/brain/124.6.1077; Wager TD, 2003, NEUROIMAGE, V18, P293, DOI 10.1016/S1053-8119(02)00046-0; Wardak C, 2011, J NEUROSCI, V31, P5181, DOI 10.1523/JNEUROSCI.0006-11.2011; Wolbers T, 2011, CURR BIOL, V21, P984, DOI 10.1016/j.cub.2011.04.038	78	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75912	10.1371/journal.pone.0075912	http://dx.doi.org/10.1371/journal.pone.0075912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086664	Green Published, gold			2022-12-27	WOS:000325220000053
J	Sinha, D; Gupta, MK; Patel, HK; Ranjan, A; Sonti, RV				Sinha, Dipanwita; Gupta, Mahesh Kumar; Patel, Hitendra Kumar; Ranjan, Ashish; Sonti, Ramesh V.			Cell Wall Degrading Enzyme Induced Rice Innate Immune Responses Are Suppressed by the Type 3 Secretion System Effectors XopN, XopQ, XopX and XopZ of Xanthomonas oryzae pv. oryzae	PLOS ONE			English	Article							GENOME SEQUENCE; III EFFECTOR; PSEUDOMONAS-SYRINGAE; TRIGGERED IMMUNITY; PLANT IMMUNITY; DANGER SIGNALS; VIRULENCE; CAMPESTRIS; ARABIDOPSIS; DEFENSE	Innate immune responses are induced in plants and animals through perception of Damage Associated Molecular Patterns. These immune responses are suppressed by pathogens during infection. A number of studies have focussed on identifying functions of plant pathogenic bacteria that are involved in suppression of Pathogen Associated Molecular Pattern induced immune responses. In comparison, there is very little information on functions used by plant pathogens to suppress Damage Associated Molecular Pattern induced immune responses. Xanthomonas oryzae pv. oryzae, a gram negative bacterial pathogen of rice, secretes hydrolytic enzymes such as LipA (Lipase/Esterase) that damage rice cell walls and induce innate immune responses. Here, we show that Agrobacterium mediated transient transfer of the gene for XopN, a X. oryzae pv. oryzae type 3 secretion (T3S) system effector, results in suppression of rice innate immune responses induced by LipA. A xopN(-) mutant of X. oryzae pv. oryzae retains the ability to suppress these innate immune responses indicating the presence of other functionally redundant proteins. In transient transfer assays, we have assessed the ability of 15 other X. oryzae pv. oryzae T3S secreted effectors to suppress rice innate immune responses. Amongst these proteins, XopQ, XopX and XopZ are suppressors of LipA induced innate immune responses. A mutation in any one of the xopN, xopQ, xopX or xopZ genes causes partial virulence deficiency while a xopN(-) xopX(-) double mutant exhibits a greater virulence deficiency. A xopN(-) xopQ(-) xopX(-) xopZ(-) quadruple mutant of X. oryzae pv. oryzae induces callose deposition, an innate immune response, similar to a X. oryzae pv. oryzae T3S(-) mutant in rice leaves. Overall, these results indicate that multiple T3S secreted proteins of X. oryzae pv. oryzae can suppress cell wall damage induced rice innate immune responses.	[Sinha, Dipanwita; Gupta, Mahesh Kumar; Patel, Hitendra Kumar; Ranjan, Ashish; Sonti, Ramesh V.] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Sonti, RV (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	sonti@ccmb.res.in	Ranjan, Ashish/I-5058-2019	Ranjan, Ashish/0000-0002-6711-2088	Department of Biotechnology (DBT), Government of India; Council of Scientific and Industrial Research (CSIR); DBT; CSIR	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); DBT(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants to RVS from the Department of Biotechnology (DBT), Government of India and the Plant-Microbe and Soil Interactions project of the Council of Scientific and Industrial Research (CSIR). DS and MKG were supported by doctoral and post-doctoral fellowships, respectively, from the DBT. AR was supported by a doctoral fellowship from CSIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto-Tomiyama C, 2012, MOL PLANT MICROBE IN, V25, P505, DOI 10.1094/MPMI-06-11-0167; ALBERSHEIM P, 1969, ANNU REV PHYTOPATHOL, V7, P171, DOI 10.1146/annurev.py.07.090169.001131; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aparna G, 2009, PLANT CELL, V21, P1860, DOI 10.1105/tpc.109.066886; Bartetzko V, 2009, MOL PLANT MICROBE IN, V22, P655, DOI 10.1094/MPMI-22-6-0655; BESTWICK CS, 1995, PLANT PHYSIOL, V108, P503, DOI 10.1104/pp.108.2.503; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Cheng YF, 2004, PLANT PHYSIOL, V135, P1020, DOI 10.1104/pp.104.044495; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Cunha C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00286; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DARVILL AG, 1984, ANNU REV PLANT PHYS, V35, P243, DOI 10.1146/annurev.pp.35.060184.001331; Furutani A, 2009, MOL PLANT MICROBE IN, V22, P96, DOI 10.1094/MPMI-22-1-0096; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Giska F, 2013, PLANT PHYSIOL, V161, P2049, DOI 10.1104/pp.112.209023; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; HOOD EE, 1986, J BACTERIOL, V168, P1291, DOI 10.1128/jb.168.3.1291-1301.1986; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Huffaker A, 2006, P NATL ACAD SCI USA, V103, P10098, DOI 10.1073/pnas.0603727103; INNES RW, 1988, J BACTERIOL, V170, P3793, DOI 10.1128/jb.170.9.3793-3802.1988; Jha G, 2007, MOL PLANT MICROBE IN, V20, P31, DOI 10.1094/MPMI-20-0031; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Kim JG, 2003, J BACTERIOL, V185, P3155, DOI 10.1128/JB.185.10.3155-3166.2003; Kim JG, 2008, PLANT CELL, V20, P1915, DOI 10.1105/tpc.108.058529; Kim JG, 2009, PLANT CELL, V21, P1305, DOI 10.1105/tpc.108.063123; LEACH JE, 1990, MOL PLANT MICROBE IN, V3, P238, DOI 10.1094/MPMI-3-238; Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206; Li W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059684; Metz M, 2005, PLANT J, V41, P801, DOI 10.1111/j.1365-313X.2005.02338.x; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Ochiai H, 2005, JARQ-JPN AGR RES Q, V39, P275, DOI 10.6090/jarq.39.275; Pandey A, 2010, J BACTERIOL, V192, P3187, DOI 10.1128/JB.01558-09; Pennell RI, 1997, PLANT CELL, V9, P1157, DOI 10.1105/tpc.9.7.1157; Pieretti I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-616; Rajeshwari R, 2005, MOL PLANT MICROBE IN, V18, P830, DOI 10.1094/MPMI-18-0830; Ray SK, 2000, MOL PLANT MICROBE IN, V13, P394, DOI 10.1094/MPMI.2000.13.4.394; Roden J, 2004, MOL PLANT MICROBE IN, V17, P633, DOI 10.1094/MPMI.2004.17.6.633; Roden JA, 2004, P NATL ACAD SCI USA, V101, P16624, DOI 10.1073/pnas.0407383101; RYAN CA, 1991, ANNU REV PLANT PHYS, V42, P651, DOI 10.1146/annurev.pp.42.060191.003251; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Sambrook J., 2002, MOL CLONING LAB MANU; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schulze S, 2012, NEW PHYTOL, V195, P894, DOI 10.1111/j.1469-8137.2012.04210.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Song CF, 2010, MOL PLANT MICROBE IN, V23, P893, DOI 10.1094/MPMI-23-7-0893; Swords KMM, 1996, J BACTERIOL, V178, P4661, DOI 10.1128/jb.178.15.4661-4669.1996; Taylor KW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002768; Wang LF, 2007, MOL PLANT PATHOL, V8, P491, DOI 10.1111/J.1364-3703.2007.00409.X; Windgassen M, 2000, FEMS MICROBIOL LETT, V193, P201, DOI 10.1016/S0378-1097(00)00476-6; Zhao S, 2013, WORLD J MICROB BIOT, V29, P733, DOI 10.1007/s11274-012-1229-5	54	48	49	6	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75867	10.1371/journal.pone.0075867	http://dx.doi.org/10.1371/journal.pone.0075867			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086651	gold, Green Published, Green Submitted			2022-12-27	WOS:000325220000049
J	Andriantahina, F; Liu, XL; Huang, H				Andriantahina, Farafidy; Liu, Xiaolin; Huang, Hao			Genetic Map Construction and Quantitative Trait Locus (QTL) Detection of Growth-Related Traits in Litopenaeus vannamei for Selective Breeding Applications	PLOS ONE			English	Article							PACIFIC WHITE SHRIMP; LINKAGE MAP; AFLP; MICROSATELLITES; GENOME; PERFORMANCE; SOFTWARE; MARKERS; SSR	Growth is a priority trait from the point of view of genetic improvement. Molecular markers linked to quantitative trait loci (QTL) have been regarded as useful for marker-assisted selection (MAS) in complex traits as growth. Using an intermediate F-2 cross of slow and fast growth parents, a genetic linkage map of Pacific whiteleg shrimp, Litopenaeus vannamei, based on amplified fragment length polymorphisms (AFLP) and simple sequence repeats (SSR) markers was constructed. Meanwhile, QTL analysis was performed for growth-related traits. The linkage map consisted of 451 marker loci (429 AFLPs and 22 SSRs) which formed 49 linkage groups with an average marker space of 7.6 cM; they spanned a total length of 3627.6 cM, covering 79.50% of estimated genome size. 14 QTLs were identified for growth-related traits, including three QTLs for body weight (BW), total length (TL) and partial carapace length (PCL), two QTLs for body length (BL), one QTL for first abdominal segment depth (FASD), third abdominal segment depth (TASD) and first abdominal segment width (FASW), which explained 2.62 to 61.42% of phenotypic variation. Moreover, comparison of linkage maps between L. vannamei and Penaeus japonicus was applied, providing a new insight into the genetic base of QTL affecting the growth-related traits. The new results will be useful for conducting MAS breeding schemes in L. vannamei.	[Andriantahina, Farafidy; Liu, Xiaolin] Northwest A&F Univ, Shaanxi Key Lab Mol Biol Agr, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Huang, Hao] Hainan Guangtai Ocean Breeding Co Ltd, Haikou, Peoples R China	Northwest A&F University - China	Liu, XL (corresponding author), Northwest A&F Univ, Shaanxi Key Lab Mol Biol Agr, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	liuxiaolin@nwsuaf.edu.cn			Northwest A&F University, China [XNY2013-4]; National Ministry of Agricultural Science and Technology, China [2012GB2E200361]; National Fundamental Research Program, China [2006AA10A406]	Northwest A&F University, China; National Ministry of Agricultural Science and Technology, China; National Fundamental Research Program, China	This research work was supported by the collaborative project of Northwest A&F University, China (XNY2013-4), National Ministry of Agricultural Science and Technology, China (2012GB2E200361), and National Fundamental Research Program, China (2006AA10A406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriantahina F, 2013, MAR BIOTECHNOL, V15, P399, DOI 10.1007/s10126-013-9500-9; Andriantahina F, 2013, CHIN J OCEANOL LIMN, V31, P534, DOI 10.1007/s00343-013-2220-1; Andriantahina F, 2012, CHIN J OCEANOL LIMN, V30, P200, DOI 10.1007/s00343-012-1066-2; Andriantahina F, 2012, AQUACULTURE, V324, P194, DOI 10.1016/j.aquaculture.2011.10.026; ARMSTRONG KC, 1982, CAN J GENET CYTOL, V24, P735, DOI 10.1139/g82-079; Ball AO, 1998, MOL ECOL, V7, P1251; CHAKRAVARTI A, 1991, GENETICS, V128, P175; Du ZQ, 2010, ANIM GENET, V41, P286, DOI 10.1111/j.1365-2052.2009.02002.x; Hwang TY, 2009, DNA RES, V16, P213, DOI 10.1093/dnares/dsp010; Kasha K J, 1970, Nature, V225, P874, DOI 10.1038/225874a0; Kiani SP, 2009, PLANT BREEDING, V128, P363, DOI 10.1111/j.1439-0523.2009.01628.x; Kocher TD, 1998, GENETICS, V148, P1225; Li L, 2005, AQUACULTURE, V245, P63, DOI 10.1016/j.aquaculture.2004.12.015; Li YT, 2006, AQUACULTURE, V258, P198, DOI 10.1016/j.aquaculture.2006.04.027; Liu B, 2010, CHIN J OCEANOL LIMN, V28, P815, DOI 10.1007/s00343-010-9915-3; [刘萍 Liu Ping], 2004, [海洋水产研究, Marine Fisheries Research], V25, P80; Liu ZJ, 2003, GENETICS, V165, P687; [罗云 Luo Yun], 2010, [渔业科学进展, Progress in Fishery Sciences], V31, P56; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Maneeruttanarungroj C, 2006, ANIM GENET, V37, P363, DOI 10.1111/j.1365-2052.2006.01493.x; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Meehan D, 2003, MAR BIOTECHNOL, V5, P311, DOI 10.1007/s10126-002-0092-z; NAG DK, 1989, NATURE, V340, P318, DOI 10.1038/340318a0; Ng SHS, 2005, GENOMICS, V86, P396, DOI 10.1016/j.ygeno.2005.06.001; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez-Ramos I, 2012, SCI WORLD J, DOI 10.1100/2012/369802; Sekino M, 2007, GENETICS, V175, P945, DOI 10.1534/genetics.106.065839; Upadyayula N, 2006, THEOR APPL GENET, V112, P592, DOI 10.1007/s00122-005-0133-x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang J., 2012, AFR J BIOTECHNOL, V11, P7874; Wang S., 2007, WINDOWS QTL CARTOGRA; Wilson K, 2002, AQUACULTURE, V204, P297, DOI 10.1016/S0044-8486(01)00842-0; Woram RA, 2003, GENOME RES, V13, P272, DOI 10.1101/gr.578503; Xia JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-135; Yu ZN, 2003, BIOL BULL-US, V204, P327, DOI 10.2307/1543603; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang LS, 2007, GENETICA, V131, P37, DOI 10.1007/s10709-006-9111-8; [张天时 ZHANG Tianshi], 2006, [海洋水产研究, Marine Fisheries Research], V27, P34	39	42	44	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75206	10.1371/journal.pone.0075206	http://dx.doi.org/10.1371/journal.pone.0075206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086466	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700057
J	Beer, B; Erb, R; Pavlic, M; Ulmer, H; Giacomuzzi, S; Riemer, Y; Oberacher, H				Beer, Beate; Erb, Robert; Pavlic, Marion; Ulmer, Hanno; Giacomuzzi, Salvatore; Riemer, Yvonne; Oberacher, Herbert			Association of Polymorphisms in Pharmacogenetic Candidate Genes (OPRD1, GAL, ABCB1, OPRM1) with Opioid Dependence in European Population: A Case-Control Study	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE GENE; P-GLYCOPROTEIN; SEQUENCE VARIATIONS; HEROIN-ADDICTION; GALANIN; VARIANTS; ALLELE; OPIATE; ABUSE	It is becoming increasingly evident that genetic variants contribute to the development of opioid addiction. An elucidation of these genetic factors is crucial for a better understanding of this chronic disease and may help to develop novel therapeutic strategies. In recent years, several candidate genes were implicated in opioid dependence. However, most study findings have not been replicated and additional studies are required before reported associations can be considered robust. Thus, the major objective of this study was to replicate earlier findings and to identify new genetic polymorphisms contributing to the individual susceptibility to opioid addiction, respectively. Therefore, a candidate gene association study was conducted including 142 well-phenotyped long-term opioid addicts undergoing opioid maintenance therapy and 142 well-matched healthy controls. In both study groups, 24 single nucleotide polymorphisms predominantly located in pharmacogenetic candidate genes have been genotyped using an accurate mass spectrometry based method. The most significant associations with opioid addiction (remaining significant after adjustment for multiple testing) were observed for the rs948854 SNP in the galanin gene (GAL, p = 0.001) and the rs2236861 SNP in the delta opioid receptor gene (OPRD1, p = 0.001). Moreover, an association of the ATP binding cassette transporter 1 (ABCB1) variant rs1045642 and the Mu Opioid receptor (OPRM1) variant rs9479757 with opioid addiction was observed. The present study provides further support for a contribution of GAL and OPRD1 variants to the development of opioid addiction. Furthermore, our results indicate a potential contribution of OPRM1 and ABCB1 SNPs to the development of this chronic relapsing disease. Therefore it seems important that these genes are addressed in further addiction related studies.	[Beer, Beate; Erb, Robert; Pavlic, Marion; Oberacher, Herbert] Med Univ Innsbruck, Inst Legal Med, A-6020 Innsbruck, Austria; [Ulmer, Hanno] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, A-6020 Innsbruck, Austria; [Giacomuzzi, Salvatore; Riemer, Yvonne] Med Univ Innsbruck, Dept Gen Psychiat, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Oberacher, H (corresponding author), Med Univ Innsbruck, Inst Legal Med, A-6020 Innsbruck, Austria.	herbert.oberacher@i-med.ac.at	Ulmer, Hanno/S-6615-2019; Parson, Walther/AAD-6845-2020	Ulmer, Hanno/0000-0001-5911-1002; Oberacher, Herbert/0000-0002-0963-8268	Anniversary Fund of the Oesterreichische Nationalbank [13253]	Anniversary Fund of the Oesterreichische Nationalbank	This study was funded by the Anniversary Fund of the Oesterreichische Nationalbank (http://www.oenb.at/de/ueber_die_oenb/foerderung/jubilaeumsfonds/jubilaeumsfonds.jsp; grant number: 13253). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Carrion Oscar, 2012, Curr Drug Abuse Rev, V5, P178; Bart G, 2004, MOL PSYCHIATR, V9, P547, DOI 10.1038/sj.mp.4001504; Beer B, 2012, ANALYST, V137, P5325, DOI 10.1039/c2an35440c; Beer B, 2011, ANAL BIOANAL CHEM, V400, P2361, DOI 10.1007/s00216-010-4597-4; Brandstatter A, 2007, FORENSIC SCI INT, V166, P164, DOI 10.1016/j.forsciint.2006.05.006; Cascorbi I, 2011, HANDB EXP PHARMACOL, V201, P261, DOI 10.1007/978-3-642-14541-4_6; Coller JK, 2006, CLIN PHARMACOL THER, V80, P682, DOI 10.1016/j.clpt.2006.09.011; Crettol S, 2006, CLIN PHARMACOL THER, V80, P668, DOI 10.1016/j.clpt.2006.09.012; de Klerk Onno L., 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P197; Farre M, 2002, DRUG ALCOHOL DEPEN, V65, P283, DOI 10.1016/S0376-8716(01)00171-5; Fonseca F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019527; Fujii T, 2012, J PSYCHIATR RES, V46, P555, DOI 10.1016/j.jpsychires.2012.01.012; Gelernter Joel, 2010, Dialogues Clin Neurosci, V12, P77; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Hattersley AT, 2005, LANCET, V366, P1315, DOI 10.1016/S0140-6736(05)67531-9; Ho MK, 2010, CLIN PHARMACOL THER, V88, P779, DOI 10.1038/clpt.2010.175; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Huang CJ, 2008, ANAESTHESIA, V63, P1288, DOI 10.1111/j.1365-2044.2008.05760.x; Hung CC, 2011, PHARMACOGENOMICS, V12, P1525, DOI [10.2217/PGS.11.96, 10.2217/pgs.11.96]; Kadiev E, 2008, EXPERT OPIN DRUG MET, V4, P77, DOI 10.1517/17425255.4.1.77 ; Kim RB, 2001, CLIN PHARMACOL THER, V70, P189, DOI 10.1067/mcp.2001.117412; Kreek MJ, 2005, PHARMACOL REV, V57, P1, DOI 10.1124/pr.57.1.1; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; Le Merrer J, 2009, PHYSIOL REV, V89, P1379, DOI 10.1152/physrev.00005.2009; Levran O, 2008, GENES BRAIN BEHAV, V7, P720, DOI 10.1111/j.1601-183X.2008.00410.x; Levran O, 2008, HUM MOL GENET, V17, P2219, DOI 10.1093/hmg/ddn122; Levran O, 2012, HUM GENET, V131, P823, DOI 10.1007/s00439-012-1172-4; Li MD, 2009, NAT REV GENET, V10, P225, DOI 10.1038/nrg2536; Li T, 2002, AM J MED GENET, V114, P329, DOI 10.1002/ajmg.10200; Lotsch J, 2009, PHARMACOL THERAPEUT, V124, P168, DOI 10.1016/j.pharmthera.2009.06.010; Mroziewicz Margaret, 2010, Addict Sci Clin Pract, V5, P17; Nelson EC, 2014, ADDICT BIOL, V19, P111, DOI 10.1111/j.1369-1600.2012.00445.x; Oberacher H, 2005, ANAL CHEM, V77, P4999, DOI 10.1021/ac050399f; Picciotto MR, 2010, EXPERIENTIA SUPPL, V102, P195, DOI 10.1007/978-3-0346-0228-0_14; Terman GW, 2004, BRIT J PHARMACOL, V141, P55, DOI 10.1038/sj.bjp.0705595; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; Unschuld PG, 2008, J AFFECT DISORDERS, V105, P177, DOI 10.1016/j.jad.2007.05.006; Unschuld PG, 2010, NEUROPSYCHOPHARMACOL, V35, P1583, DOI 10.1038/npp.2010.30; Vandenbergh DJ, 1997, AM J MED GENET, V74, P439, DOI 10.1002/(SICI)1096-8628(19970725)74:4<439::AID-AJMG16>3.0.CO;2-J; Yuferov V, 2010, ANN NY ACAD SCI, V1187, P184, DOI 10.1111/j.1749-6632.2009.05275.x; Zhang H, 2008, MOL PSYCHIATR, V13, P531, DOI 10.1038/sj.mp.4002035; ZHANG L, 2008, BEHAV BRAIN FUNCT, V2, P28; Zheng HX, 2002, HUM IMMUNOL, V63, P765, DOI 10.1016/S0198-8859(02)00426-3; Zhou SF, 2008, XENOBIOTICA, V38, P802, DOI 10.1080/00498250701867889 	44	45	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75359	10.1371/journal.pone.0075359	http://dx.doi.org/10.1371/journal.pone.0075359			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086514	gold, Green Published, Green Submitted			2022-12-27	WOS:000325218700080
J	Brander, SM; Connon, RE; He, GC; Hobbs, JA; Smalling, KL; Teh, SJ; White, JW; Werner, I; Denison, MS; Cherr, GN				Brander, Susanne M.; Connon, Richard E.; He, Guochun; Hobbs, James A.; Smalling, Kelly L.; Teh, Swee J.; White, J. Wilson; Werner, Inge; Denison, Michael S.; Cherr, Gary N.			From 'Omics to Otoliths: Responses of an Estuarine Fish to Endocrine Disrupting Compounds across Biological Scales	PLOS ONE			English	Article							IN-VITRO; SEX DETERMINATION; MENIDIA-MENIDIA; GENE-EXPRESSION; TREATMENT-PLANT; DELTA SMELT; WATER; MODEL; EXPOSURE; TEMPERATURE	Endocrine disrupting chemicals (EDCs) cause physiological abnormalities and population decline in fishes. However, few studies have linked environmental EDC exposures with responses at multiple tiers of the biological hierarchy, including population-level effects. To this end, we undertook a four-tiered investigation in the impacted San Francisco Bay estuary with the Mississippi silverside (Menidia audens), a small pelagic fish. This approach demonstrated links between different EDC sources and fish responses at different levels of biological organization. First we determined that water from a study site primarily impacted by ranch run-off had only estrogenic activity in vitro, while water sampled from a site receiving a combination of urban, limited ranch run-off, and treated wastewater effluent had both estrogenic and androgenic activity. Secondly, at the molecular level we found that fish had higher mRNA levels for estrogen-responsive genes at the site where only estrogenic activity was detected but relatively lower expression levels where both estrogenic and androgenic EDCs were detected. Thirdly, at the organism level, males at the site exposed to both estrogens and androgens had significantly lower mean gonadal somatic indices, significantly higher incidence of severe testicular necrosis and altered somatic growth relative to the site where only estrogens were detected. Finally, at the population level, the sex ratio was significantly skewed towards males at the site with measured androgenic and estrogenic activity. Our results suggest that mixtures of androgenic and estrogenic EDCs have antagonistic and potentially additive effects depending on the biological scale being assessed, and that mixtures containing androgens and estrogens may produce unexpected effects. In summary, evaluating EDC response at multiple tiers is necessary to determine the source of disruption (lowest scale, i.e. cell line) and what the ecological impact will be (largest scale, i.e. sex ratio).	[Brander, Susanne M.; Cherr, Gary N.] Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA; [Brander, Susanne M.; He, Guochun; Denison, Michael S.; Cherr, Gary N.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Brander, Susanne M.; White, J. Wilson] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA; [Connon, Richard E.; Teh, Swee J.] Univ Calif Davis, Dept Anat Physiol & Cell Biol, Sch Vet Med, Davis, CA 95616 USA; [Hobbs, James A.] Univ Calif Davis, Dept Wildlife Fisheries & Conservat Biol, Davis, CA 95616 USA; [Smalling, Kelly L.] US Geol Survey, Sacramento, CA USA; [Werner, Inge] Eawag Ecole Polytech Fed Lausanne, Swiss Ctr Appl Ecotoxicol, Dubendorf, Switzerland; [Cherr, Gary N.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of North Carolina; University of North Carolina Wilmington; University of California System; University of California Davis; University of California System; University of California Davis; United States Department of the Interior; United States Geological Survey; University of California System; University of California Davis	Brander, SM (corresponding author), Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA.	branders@uncw.edu		Smalling, Kelly/0000-0002-1214-4920	Delta Science [R/SF-27, SCI-05-C111]; National Science Foundation [GK-12, 0841297]; Sacramento Regional County Sanitation District; Interagency Ecological Program, Sacramento, California [4600008070]; National Institutes of Environmental Health Sciences [P42-ES004699]; California Department of Fish and Wildlife [E1183010]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699] Funding Source: NIH RePORTER	Delta Science; National Science Foundation(National Science Foundation (NSF)); Sacramento Regional County Sanitation District; Interagency Ecological Program, Sacramento, California; National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); California Department of Fish and Wildlife; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from Delta Science (Pre-Doctoral Fellowship R/SF-27 to SMB and grant no. SCI-05-C111), the National Science Foundation (GK-12 Pre-Doctoral Fellowship to SMB, grant no. 0841297), the Sacramento Regional County Sanitation District, and the Interagency Ecological Program, Sacramento, California (Contract No. 4600008070 to IW), a Superfund Research Grant from the National Institutes of Environmental Health Sciences (P42-ES004699 to M. Denison), and continuing funding from the California Department of Fish and Wildlife (Contract No. E1183010 to REC and SMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RG, 2007, ENVIRON SCI TECHNOL, V41, P1317, DOI 10.1021/es0621593; Ahn KC, 2008, ENVIRON HEALTH PERSP, V116, P1203, DOI 10.1289/ehp.11200; Anderson SL, 2006, MAR ENVIRON RES, V62, pS317, DOI 10.1016/j.marenvres.2006.04.011; Ankley GT, 2008, AQUAT TOXICOL, V88, P69, DOI 10.1016/j.aquatox.2008.03.005; Ankley GT, 2010, AQUAT TOXICOL, V99, P389, DOI 10.1016/j.aquatox.2010.05.020; [Anonymous], 2008, SAN FRANCISCO ESTUAR; Banks JE, 2010, RISK ANAL, V30, P175, DOI 10.1111/j.1539-6924.2009.01349.x; BARKMAN RC, 1987, J FISH BIOL, V31, P683, DOI 10.1111/j.1095-8649.1987.tb05271.x; Blazer VS, 2002, FISH PHYSIOL BIOCHEM, V26, P85, DOI 10.1023/A:1023332216713; Bogers R, 2006, AQUAT TOXICOL, V80, P119, DOI 10.1016/j.aquatox.2006.07.020; Brander SM, 2012, ENV TOXICOLOGY CHEM; Brander SM, 2013, MONITORING WATER QUALITY: POLLUTION ASSESSMENT, ANALYSIS, AND REMEDIATION, P103, DOI 10.1016/B978-0-444-59395-5.00005-4; Brander SM, 2012, ECOTOXICOLOGY, V21, P1272, DOI 10.1007/s10646-012-0879-2; Brander SM, 2009, ENVIRON TOXICOL CHEM, V28, P1493, DOI 10.1897/08-374.1; Braun AM, 2003, BIOL REPROD, V69, P1642, DOI 10.1095/biolreprod.103.015479; BUCKLAND ST, 1984, BIOMETRICS, V40, P811, DOI 10.2307/2530926; Chang H, 2011, WATER RES, V45, P732, DOI 10.1016/j.watres.2010.08.046; Clements William H., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P113, DOI 10.1023/A:1009927612391; Connon RE, 2011, AQUAT TOXICOL, V105, P369, DOI 10.1016/j.aquatox.2011.07.002; CONOVER DO, 1981, SCIENCE, V213, P577, DOI 10.1126/science.213.4507.577; CONOVER DO, 1990, SCIENCE, V250, P1556, DOI 10.1126/science.250.4987.1556; Crago J, 2011, CHEMOSPHERE, V82, P1669, DOI 10.1016/j.chemosphere.2010.11.011; Dang ZC, 2011, TOXICOL LETT, V202, P36, DOI 10.1016/j.toxlet.2011.01.016; Denslow Nancy, 2007, P255, DOI 10.1007/978-1-4020-6235-3_10; Doyle MA, 2011, J ENV MONITORING, V13; Duffy TA, 2010, J EXP ZOOL PART A, V313A, P421, DOI 10.1002/jez.612; Duffy TA, 2009, MAR ECOL PROG SER, V380, P245, DOI 10.3354/meps07928; Feyrer F, 2007, CAN J FISH AQUAT SCI, V64, P723, DOI 10.1139/F07-048; Filby AL, 2007, ENVIRON HEALTH PERSP, V115, P1704, DOI 10.1289/ehp.10443; Giudice BD, 2011, ENVIRON TOXICOL CHEM, V30, P2220, DOI 10.1002/etc.631; Green MR, 2012, MOL CLONING LAB MANU, V1; Gurney WSC, 2006, ENVIRON HEALTH PERSP, V114, P122, DOI 10.1289/ehp.8064; Gutjahr-Gobell RE, 2005, ECOTOXICOLOGY ENV SA, V63, P244; Harris CA, 2011, ENV HLTH PERSPECT, V119; Heinze G, 2003, COMPUT METH PROG BIO, V71, P181, DOI 10.1016/S0169-2607(02)00088-3; Hladik ML, 2008, B ENVIRON CONTAM TOX, V80, P139, DOI 10.1007/s00128-007-9332-2; Hobbs JA, 2007, FISH B-NOAA, V105, P30; Houtman CJ, 2004, ENVIRON TOXICOL CHEM, V23, P32, DOI 10.1897/02-544; Houtman CJ, 2007, ENVIRON TOXICOL CHEM, V26, P898, DOI 10.1897/06-326R.1; HUBBS C, 1976, COPEIA, P386; Jeffries MKS, 2011, AQUAT TOXICOL, V105, P189, DOI 10.1016/j.aquatox.2011.04.008; Johnson R, 2009, OECD GUIDAN IN PRESS; KENNEDY WJ, 1971, ANN MATH STAT, V42, P1273, DOI 10.1214/aoms/1177693240; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Knapp R, 2011, BIOL LETTERS, V7, P150, DOI 10.1098/rsbl.2010.0514; Kolodziej EP, 2003, ENVIRON TOXICOL CHEM, V22, P2622, DOI 10.1897/03-42; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; LEDREAN Y, 1995, MOL CELL ENDOCRINOL, V109, P27, DOI 10.1016/0303-7207(95)03482-M; Leon A, 2007, AQUAT TOXICOL, V82, P195, DOI 10.1016/j.aquatox.2007.02.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Metcalfe CD, 2001, ENVIRON TOXICOL CHEM, V20, P297, DOI [10.1897/1551-5028(2001)020&lt;0297:EPOCDI&gt;2.0.CO;2, 10.1002/etc.5620200210]; MIDDAUGH DP, 1992, COPEIA, P53; Miller DH, 2007, ENVIRON TOXICOL CHEM, V26, P521, DOI 10.1897/06-318R.1; Moyle P.B., 2002, INLAND FISHES CALIFO; NICHOLS FH, 1986, SCIENCE, V231, P567, DOI 10.1126/science.231.4738.567; Nimrod AC, 1998, AQUAT TOXICOL, V44, P141, DOI 10.1016/S0166-445X(98)00062-9; O'Rear T. A., 2009, TRENDS FISH POPULATI; Orton F, 2009, ENVIRON SCI TECHNOL, V43, P2144, DOI 10.1021/es8028928; Paulos P, 2010, AQUAT TOXICOL, V99, P256, DOI 10.1016/j.aquatox.2010.05.001; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pottinger TG, 2010, ENVIRON INT, V37, P158; R Development Core Team, 2012, R LANG ENV STAT COMP; Rempel MA, 2008, INT REV CEL MOL BIO, V267, P207, DOI 10.1016/S1937-6448(08)00605-9; Rempel MA, 2006, AQUAT TOXICOL, V77, P241, DOI 10.1016/j.aquatox.2005.12.007; Rogers JM, 2000, IN VITRO MOL TOXICOL, V13, P67; Rose WL, 2005, ENVIRON TOXICOL CHEM, V24, P2612, DOI 10.1897/04-516R.1; Sanchez W, 2011, ENVIRON INT, V37, P1342, DOI 10.1016/j.envint.2011.06.002; Scholz NL, 2012, BIOSCIENCE, V62, P428, DOI 10.1525/bio.2012.62.4.13; Scholz S, 2008, MOL CELL ENDOCRINOL, V293, P57, DOI 10.1016/j.mce.2008.06.008; Segner H, 2009, COMP BIOCHEM PHYS C, V149, P187, DOI 10.1016/j.cbpc.2008.10.099; Seki M, 2006, ENVIRON TOXICOL CHEM, V25, P2742, DOI 10.1897/05-647R.1; Singh PB, 2008, CHEMOSPHERE, V72, P422, DOI 10.1016/j.chemosphere.2008.02.026; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tamura H, 2006, BIOORGAN MED CHEM, V14, P7160, DOI 10.1016/j.bmc.2006.06.064; Thomas P, 2011, P ROYAL SOC B; Tilton F, 2002, AQUAT TOXICOL, V61, P211, DOI 10.1016/S0166-445X(02)00058-9; Van der Linden SC, 2008, ENVIRON SCI TECHNOL, V42, P5814, DOI 10.1021/es702897y; Velasco-Santamaria YM, 2010, MAR ENVIRON RES, V69, pS67, DOI 10.1016/j.marenvres.2009.09.009; Yamahira K, 2003, COPEIA, P155, DOI 10.1643/0045-8511(2003)003[0155:IVITDS]2.0.CO;2; Zeilinger J, 2009, ENVIRON TOXICOL CHEM, V28, P2663, DOI 10.1897/08-485.1	80	32	33	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74251	10.1371/journal.pone.0074251	http://dx.doi.org/10.1371/journal.pone.0074251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086325	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700019
J	Kim, SH; Kim, JY; Choi, Y; Nguyen, HH; Song, MK; Chang, J				Kim, So-Hee; Kim, Joo Young; Choi, Youngjoo; Nguyen, Huan H.; Song, Man Ki; Chang, Jun			Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection	PLOS ONE			English	Article							A VIRUS; SINGLE MUCOSAL; IMMUNITY; IMMUNIZATION; MICE; ANTIBODIES; RESPONSES; VACCINES; PROTEIN; NASAL	Influenza vaccines that target the highly variable surface glycoproteins hemagglutinin and neuraminidase cause inconvenience of having vaccination every year. For this reason, development of universal vaccines targeting conserved viral components is needed. In this study, we generated recombinant adenovirus (rAd) vaccine encoding nucleoprotein (NP) of A/PR/8/34 influenza virus, designated rAd/NP BALB/c mice were immunized intranasally or sublingually with rAd/NP vaccine and subsequently challenged with lethal doses of heterologous as well as homologous influenza viruses. We found that intranasal immunization of rAd/NP elicited strong mucosal IgA responses as well as stronger CD8 T-cell responses toward immunodominant K-d-restricted NP147-155 epitope than sublingual immunization. Importantly, only single intranasal but not sublingual immunization of rAd/NP provides potent protection against both homologous and heterologous influenza virus challenges. These results suggest that recombinant rAd/ NP could be a universal vaccine candidate for mucosal administration against influenza virus.	[Kim, So-Hee; Kim, Joo Young; Choi, Youngjoo; Chang, Jun] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea; [Nguyen, Huan H.; Song, Man Ki] Int Vaccine Inst, Div Sci Lab, Seoul, South Korea	Ewha Womans University; International Vaccine Institute	Chang, J (corresponding author), Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea.	tcell@ewha.ac.kr	Kim, Jooyoung/R-5839-2018	Kim, Jooyoung/0000-0003-4846-6259; CHANG, JUN/0000-0002-8423-5987	TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea) which part of Korea Healthcare technology R&D Project by Ministry of Health & Welfare, Republic of Korea [A103001]	TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea) which part of Korea Healthcare technology R&D Project by Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea) which part of Korea Healthcare technology R&D Project by Ministry of Health & Welfare, Republic of Korea (Grant No. : A103001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2001, J CLIN IMMUNOL, V21, P227, DOI 10.1023/A:1011087132180; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436; Crowe SR, 2003, J EXP MED, V198, P399, DOI 10.1084/jem.20022151; Croyle MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003548; Dai C, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2755; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hillaire MLB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/939860; Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032226; Kim S, 2010, VACCINE, V28, P3801, DOI 10.1016/j.vaccine.2010.03.032; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; Kurono Y, 1999, J INFECT DIS, V180, P122, DOI 10.1086/314827; LaMere MW, 2011, J IMMUNOL, V186, P4331, DOI 10.4049/jimmunol.1003057; Lemiale F, 2003, J VIROL, V77, P10078, DOI 10.1128/JVI.77.18.10078-10087.2003; LIEW FY, 1984, EUR J IMMUNOL, V14, P350, DOI 10.1002/eji.1830140414; Lo CY, 2008, VACCINE, V26, P2062, DOI 10.1016/j.vaccine.2008.02.047; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; MOLDOVEANU Z, 1995, VACCINE, V13, P1006, DOI 10.1016/0264-410X(95)00016-T; Pabst R, 2008, TRENDS IMMUNOL, V29, P206, DOI 10.1016/j.it.2008.02.006; Park Min-Hee, 2012, Immune Netw, V12, P261, DOI 10.4110/in.2012.12.6.261; Pedersen GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026973; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Price GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013162; Shim BS, 2013, J MICROBIOL, V51, P130, DOI 10.1007/s12275-013-2399-z; Shim BS, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-215; Soboleski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021937; Song JH, 2008, P NATL ACAD SCI USA, V105, P1644, DOI 10.1073/pnas.0708684105; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; Tretyakova I, 2013, VIROLOGY, V442, P67, DOI 10.1016/j.virol.2013.03.027; Tutykhina IL, 2011, J MOL MED, V89, P331, DOI 10.1007/s00109-010-0696-0; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Van Kampen KR, 2005, VACCINE, V23, P1029, DOI 10.1016/j.vaccine.2004.07.043; van Riet E, 2012, VACCINE, V30, P5893, DOI 10.1016/j.vaccine.2012.04.109; WALKER RI, 1994, VACCINE, V12, P387, DOI 10.1016/0264-410X(94)90112-0; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785; YEWDELL JW, 1981, J IMMUNOL, V126, P1814; Zhang JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022605; Zhou DM, 2010, MOL THER, V18, P2182, DOI 10.1038/mt.2010.202	44	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75460	10.1371/journal.pone.0075460	http://dx.doi.org/10.1371/journal.pone.0075460			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086536	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700088
J	Lee, NM; Lucke, J; Hall, WD; Meurk, C; Boyle, FM; Carter, A				Lee, Natalia M.; Lucke, Jayne; Hall, Wayne D.; Meurk, Carla; Boyle, Frances M.; Carter, Adrian			Public Views on Food Addiction and Obesity: Implications for Policy and Treatment	PLOS ONE			English	Article							NEUROBIOLOGY; DISORDER; HEALTH; BRAIN; MEDICALIZATION; OPINION; STIGMA; SUGAR; TAXES	Background: According to their advocates, neurobiological explanations of overeating, or "food addiction", have the potential to impact public understanding and treatment of obesity. In this study, we examine the public's acceptance of the concept of food addiction as an explanation of overeating and assess its effects upon their attitudes toward obese persons and the treatment of obesity. Methods and Findings: We conducted an online survey of 479 adults from the US (n = 215) and Australia (n = 264). There was substantial support for the idea of food addiction, particularly among obese participants. Over half favoured treating obesity as a type of addiction. Psychotherapy was believed to be the most effective treatment and educational and support programs were the preferred policies to address food addiction. There was very little support for increasing taxes on obesogenic foods. Despite the strong support for seeing obesity as a form of addiction, respondents still saw obesity as primarily the result of personal choices and emphasized the need for individuals to take responsibility for their eating. Conclusions: Our sample of the general public strongly supported the idea of obesity as a form of food addiction; but this did not translate into support of clinical and public health policies that experts believe are most likely to reduce the prevalence of obesity. The reasons for the apparent disjunction between support for food addiction and a strong emphasis on personal choice for weight warrant further examination.	[Lee, Natalia M.; Boyle, Frances M.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Lucke, Jayne; Hall, Wayne D.; Meurk, Carla; Carter, Adrian] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Hall, Wayne D.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Carter, A (corresponding author), Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia.	adrian.carter@uq.edu.au	Lucke, Jayne C/A-5538-2008; Hall, Wayne D/A-3283-2008; Meurk, Carla/A-7571-2013; Carter, Adrian/AAG-2830-2020; Carter, Adrian N/A-1282-2008; Boyle, Fran/F-9139-2012	Lucke, Jayne C/0000-0002-2885-5292; Hall, Wayne D/0000-0003-1984-0096; Meurk, Carla/0000-0002-5792-5229; Carter, Adrian/0000-0002-3593-0772; Carter, Adrian N/0000-0002-3593-0772; Boyle, Fran/0000-0003-1665-2137	National Health and Medical Research Fellowships [628935, 569738]	National Health and Medical Research Fellowships	This work was supported by National Health and Medical Research Fellowships to Dr. Carter (Grant No. 628935) and Professor Wayne Hall (Grant No. 569738). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 2012, PHYSIOL BEHAV, V107, P126, DOI 10.1016/j.physbeh.2012.05.005; Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; [Anonymous], 2011, CENS POP HOUS; Australian Bureau of Statistics, 2011, OV OB AD AUSTR SNAPS; Avena NM, 2012, NUTRITION, V28, P341, DOI 10.1016/j.nut.2011.11.002; Avena NM, 2011, PSYCHIAT ANN, V41, P478, DOI 10.3928/00485713-20110921-06; Berghmans R, 2009, THEOR MED BIOETH, V30, P311, DOI 10.1007/s11017-009-9103-7; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; Carter A, 2012, ADDICTION NEUROETHICS: THE ETHICS OF ADDICTION NEUROSCIENCE RESEARCH AND TREATMENT, P1; CDC.gov, 2012, OV OB; Di Leone RJ, 2012, NAT NEUROSCI, V15, P1330, DOI 10.1038/nn.3202; Easter MM, 2012, SOC SCI MED, V75, P1408, DOI 10.1016/j.socscimed.2012.05.042; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gearhardt AN, 2012, ANNU REV CLIN PSYCHO, V8, P405, DOI 10.1146/annurev-clinpsy-032511-143129; Gearhardt AN, 2011, ADDICTION, V106, P1208, DOI 10.1111/j.1360-0443.2010.03301.x; GREEN DP, 1989, PUBLIC OPIN QUART, V53, P1, DOI 10.1086/269138; Halpern CH, 2011, ACTA NEUROCHIR, V153, P2293, DOI 10.1007/s00701-011-1166-3; Kennett GA, 2010, PHARMACOL BIOCHEM BE, V97, P63, DOI 10.1016/j.pbb.2010.07.020; Lee NM, 2012, EMBO REP, V13, P785, DOI 10.1038/embor.2012.115; Lee S, 2004, SOC SCI MED, V58, P1709, DOI 10.1016/S0277-9536(03)00340-X; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Luty J, 2006, PSYCHIATR BULL, V30, P257, DOI 10.1192/pb.30.7.257; Moreno C, 2011, CURR PHARM DESIGN, V17, P1128, DOI 10.2174/138161211795656701; Pescosolido BA, 2010, AM J PSYCHIAT, V167, P1321, DOI 10.1176/appi.ajp.2010.09121743; Pisapia JM, 2013, AM J BIOETH IN PRESS; Puhl RM, 2011, OBESITY, V19, P74, DOI 10.1038/oby.2010.126; Salant T, 2006, SOC SCI MED, V62, P2445, DOI 10.1016/j.socscimed.2005.10.021; Sikorski C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-661; U.S. Census Bureau, 2010, AM COMM SURV; Volkow ND, 2007, AM J PSYCHIAT, V164, P708, DOI 10.1176/appi.ajp.164.5.708; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; World Health Organization, 2014, 311 WHO; Yanamadala S, 2012, PUBLIC HEALTH NUTR, V15, P1331, DOI 10.1017/S1368980012003187; Ziauddeen H, 2012, NAT REV NEUROSCI, V13, P279, DOI 10.1038/nrn3212	34	35	36	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74836	10.1371/journal.pone.0074836	http://dx.doi.org/10.1371/journal.pone.0074836			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VC	24086382	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700042
J	Tang, FM; Sally, B; Ciszewski, C; Abadie, V; Curran, SA; Groh, V; FitzGerald, O; Winchester, RJ; Jabri, B				Tang, Fangming; Sally, Benjamin; Ciszewski, Cezary; Abadie, Valerie; Curran, Shane A.; Groh, Veronika; FitzGerald, Oliver; Winchester, Robert J.; Jabri, Bana			Interleukin 15 Primes Natural Killer Cells to Kill via NKG2D and cPLA2 and This Pathway Is Active in Psoriatic Arthritis	PLOS ONE			English	Article							CELIAC-DISEASE; NK CELLS; T-CELLS; CYTOKINE SECRETION; MAST-CELLS; RECEPTORS; TISSUE; IL-15; CTL; IMMUNOPATHOLOGY	NK cells are large granular lymphocytes that form a critical component of the innate immune system, whose functions include the killing of cells expressing stress-induced molecules. It is increasingly accepted that despite being considered prototypical effector cells, NK cells require signals to reach their full cytotoxic potential. We previously showed that IL-15 is capable of arming CD8 effector T cells to kill independently of their TCR via NKG2D in a cPLA2-dependent process. As NK cells also express NKG2D, we wanted to investigate whether this pathway functioned in an analogous manner and if resting NK cells could be primed to the effector phase by IL-15. Furthermore, to establish relevance to human disease we studied a possible role for this pathway in the pathogenesis of psoriatic arthritis, since there are aspects of this disease that suggest a potential effector role for the innate immune system. We found that PsA patients had upregulated IL-15 and MIC in their affected synovial tissues, and that this unique inflammatory environment enabled NK cell activation and killing via NKG2D and cPLA2. Moreover, we were able to reproduce the phenotype of joint NK cells from blood NK cells by incubating them with IL-15. Altogether, these findings suggest a destructive role for NK cells when activated by environmental stress signals during the pathogenesis of PsA and demonstrate that IL-15 is capable of priming resting NK cells in tissues to the effector phase.	[Tang, Fangming; Sally, Benjamin; Ciszewski, Cezary; Abadie, Valerie; Curran, Shane A.; Jabri, Bana] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Sally, Benjamin] Columbia Univ, Dept Microbiol & Immunol, New York, NY USA; [Curran, Shane A.; Winchester, Robert J.] Columbia Univ, Dept Med, New York, NY USA; [Groh, Veronika] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [FitzGerald, Oliver] Univ Coll Dublin, Dept Rheumatol, St Vincents Univ Hosp, Dublin 2, Ireland; [FitzGerald, Oliver] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland	University of Chicago; Columbia University; Columbia University; Fred Hutchinson Cancer Center; University College Dublin; Saint Vincent's University Hospital; University College Dublin	Jabri, B (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	bjabri@bsd.uchicago.edu		FitzGerald, Oliver/0000-0002-6607-6070	 [R01 DK067180];  [R01 DK058727]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058727, R01DK067180] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R01 DK067180 and R01 DK058727. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allez M, 2007, GASTROENTEROLOGY, V132, P2346, DOI 10.1053/j.gastro.2007.03.025; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bowness P, 2011, J IMMUNOL, V186, P2672, DOI 10.4049/jimmunol.1002653; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Costello PJ, 2001, J IMMUNOL, V166, P2878, DOI 10.4049/jimmunol.166.4.2878; Curran SA, 2004, J IMMUNOL, V172, P1935, DOI 10.4049/jimmunol.172.3.1935; Dai ZP, 2009, J EXP MED, V206, P793, DOI 10.1084/jem.20081648; de Matos CT, 2007, IMMUNOLOGY, V122, P291, DOI 10.1111/j.1365-2567.2007.02638.x; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; FitzGerald O, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2580; Gladman DD, 2005, ANN RHEUM DIS, V64, P14, DOI 10.1136/ard.2004.032482; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; McGonagle D, 2009, CURR OPIN RHEUMATOL, V21, P340, DOI 10.1097/BOR.0b013e32832c6ab9; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Noordenbos T, 2012, ARTHRITIS RHEUM-US, V64, P99, DOI 10.1002/art.33396; Perricone R, 2008, AUTOIMMUN REV, V7, P384, DOI 10.1016/j.autrev.2008.03.002; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Robertson MJ, 1996, EXP HEMATOL, V24, P406; Tang FM, 2009, J EXP MED, V206, P707, DOI 10.1084/jem.20071887; Ueno N, 2011, J BIOL CHEM, V286, P37249, DOI 10.1074/jbc.M111.290312; Villadsen LS, 2003, J CLIN INVEST, V112, P1571, DOI 10.1172/JCI200318986; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Winchester R, 2012, ARTHRITIS RHEUM-US, V64, P1134, DOI 10.1002/art.33415; Yokomizo T, 2011, ADV ENZYME REGUL, V51, P59, DOI 10.1016/j.advenzreg.2010.08.002	29	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76292	10.1371/journal.pone.0076292	http://dx.doi.org/10.1371/journal.pone.0076292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086722	Green Submitted, Green Published, gold			2022-12-27	WOS:000325218700123
J	Zhu, JN; Chen, R; Fu, YH; Lin, QX; Huang, S; Guo, LL; Zhang, MZ; Deng, CY; Zou, X; Zhong, SL; Yang, M; Zhuang, J; Yu, XY; Shan, ZX				Zhu, Jie-Ning; Chen, Ren; Fu, Yong-Heng; Lin, Qiu-Xiong; Huang, Shuai; Guo, Lin-Lin; Zhang, Meng-Zhen; Deng, Chun-Yu; Zou, Xiao; Zhong, Shi-Long; Yang, Min; Zhuang, Jian; Yu, Xi-Yong; Shan, Zhi-Xin			Smad3 Inactivation and MiR-29b Upregulation Mediate the Effect of Carvedilol on Attenuating the Acute Myocardium Infarction-Induced Myocardial Fibrosis in Rat	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; CARDIAC FIBROBLASTS; PULMONARY-FIBROSIS; OXIDATIVE STRESS; MICRORNAS; EXPRESSION; DISEASE; MODEL; ANTIOXIDANT; MORBIDITY	Carvedilol, a nonselective beta-adrenoreceptor antagonist, protects against myocardial injury induced by acute myocardium infarction (AMI). The mechanisms underlying the anti-fibrotic effects of carvedilol are unknown. Recent studies have revealed the critical role of microRNAs (miRNAs) in a variety of cardiovascular diseases. This study investigated whether miR-29b is involved in the cardioprotective effect of carvedilol against AMI-induced myocardial fibrosis. Male SD rats were randomized into several groups: the sham surgery control, left anterior descending (LAD) surgery-AMI model, AMI plus low-dose carvedilol treatment (1 mg/kg per day, CAR-L), AMI plus medium-dose carvedilol treatment (5 mg/kg per day, CAR-M) and AMI plus high-dose carvedilol treatment (10 mg/kg per day, CAR-H). Cardiac remodeling and impaired heart function were observed 4 weeks after LAD surgery treatment; the observed cardiac remodeling, decreased ejection fraction, and fractional shortening were rescued in the CAR-M and CAR-H groups. The upregulated expression of Col1a1, Col3a1, and alpha-SMA mRNA was significantly reduced in the CAR-M and CAR-H groups. Moreover, the downregulated miR-29b was elevated in the CAR-M and CAR-H groups. The in vitro study showed that Col1a1, Col3a1, and alpha-SMA were downregulated and miR-29b was upregulated by carvedilol in a dose-dependent manner in rat cardiac fibroblasts. Inhibition of ROS-induced Smad3 activation by carvedilol resulted in downregulation of Col1a1, Col3a1, and alpha-SMA and upregulation of miR-29b derived from the miR-29b-2 precursor. Enforced expression of miR-29b significantly suppressed Col1a1, Col3a1, and alpha-SMA expression. Taken together, we found that smad3 inactivation and miR-29b upregulation contributed to the cardioprotective activity of carvedilol against AMI-induced myocardial fibrosis.	[Zhu, Jie-Ning; Chen, Ren; Fu, Yong-Heng; Lin, Qiu-Xiong; Huang, Shuai; Guo, Lin-Lin; Zhang, Meng-Zhen; Deng, Chun-Yu; Zou, Xiao; Zhong, Shi-Long; Yang, Min; Zhuang, Jian; Yu, Xi-Yong; Shan, Zhi-Xin] Guangdong Acad Med Sci, Guangdong Prov Cardiovasc Inst, Guangdong Gen Hosp, Dept Med Res, Guangzhou, Guangdong, Peoples R China; [Shan, Zhi-Xin] Southern Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China	Yu, XY (corresponding author), Guangdong Acad Med Sci, Guangdong Prov Cardiovasc Inst, Guangdong Gen Hosp, Dept Med Res, Guangzhou, Guangdong, Peoples R China.	yuxycn@hotmail.com; zhixinshan@aliyun.com	Guo, Linlin/AAA-6196-2022	Guo, Linlin/0000-0001-5529-0971; Shan, zhi xin/0000-0001-6086-5565	National Natural Science Foundation of China [81070102, 81071635, 81120108003, 81270222, 81273516]; Natural Science Foundation of Guangdong Province [S2011020005911, S2012010009453]; National Key Basic Research Program (NKBRP) of China [2012CB526602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National Key Basic Research Program (NKBRP) of China(National Basic Research Program of China)	This research was supported by the National Natural Science Foundation of China (No. 81070102, 81071635, 81120108003, 81270222, 81273516). This work was also supported by Natural Science Foundation of Guangdong Province (No. S2011020005911, S2012010009453) and the National Key Basic Research Program (NKBRP) of China (No. 2012CB526602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen-Scarabelli C, 2012, AM J CARDIOVASC DRUG, V12, P391, DOI 10.2165/11636090-000000000-00000; Colucci WS, 1996, CIRCULATION, V94, P2800, DOI 10.1161/01.CIR.94.11.2800; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Feng YL, 2011, SCI CHINA LIFE SCI, V54, P1113, DOI 10.1007/s11427-011-4257-8; FEUERSTEIN GZ, 1995, EUR HEART J, V16, P38, DOI 10.1093/eurheartj/16.suppl_F.38; Fu YH, 2009, METHOD FIND EXP CLIN, V31, P367, DOI 10.1358/mf.2009.31.6.1393631; Gao F, 2008, ANTIOXID REDOX SIGN, V10, P343, DOI 10.1089/ars.2007.1908; Karp X, 2005, SCIENCE, V310, P1288, DOI 10.1126/science.1121566; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P237, DOI 10.1152/physiolgenomics.00141.2011; Li B, 2006, INT J CARDIOL, V111, P247, DOI 10.1016/j.ijcard.2005.08.065; Lijnen PJ, 2012, CARDIOVASC THER, V30, pe1, DOI 10.1111/j.1755-5922.2010.00205.x; Lotze U, 2002, J CARDIOVASC PHARM, V39, P576, DOI 10.1097/00005344-200204000-00014; Lowes BD, 1999, AM J CARDIOL, V83, P1201, DOI 10.1016/S0002-9149(99)00059-4; Nanjo S, 2006, INT HEART J, V47, P607, DOI 10.1536/ihj.47.607; Packer M, 2002, CIRCULATION, V106, P2194, DOI 10.1161/01.CIR.0000035653.72855.BF; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Senior R, 1999, AM HEART J, V137, P646, DOI 10.1016/S0002-8703(99)70217-6; Shan ZX, 2009, BIOCHEM BIOPH RES CO, V381, P597, DOI 10.1016/j.bbrc.2009.02.097; Shi B, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-11; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vaughan DE, 1995, EUR HEART J, V16, P31, DOI 10.1093/eurheartj/16.suppl_K.31; Wang RJ, 2006, J PHARMACOL EXP THER, V318, P45, DOI 10.1124/jpet.105.099903; Wei S, 2000, J AM COLL CARDIOL, V36, P276, DOI 10.1016/S0735-1097(00)00671-9; Wong VY, 2001, BRIT J PHARMACOL, V134, P977, DOI 10.1038/sj.bjp.0704329; Xiao J, 2012, MOL THER, V20, P1251, DOI 10.1038/mt.2012.36; YUE TL, 1992, J PHARMACOL EXP THER, V263, P92; Zhang JL, 2009, CHINESE MED J-PEKING, V122, P2372, DOI 10.3760/cma.j.issn.0366-6999.2009.19.033; Zhu HY, 2012, CARDIOVASC RES, V94, P284, DOI 10.1093/cvr/cvr291; Zhuang XF, 2009, J INT MED RES, V37, P1354, DOI 10.1177/147323000903700510; Zmijewski JW, 2005, AM J PHYSIOL-HEART C, V289, pH852, DOI 10.1152/ajpheart.00015.2005	37	49	51	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75557	10.1371/journal.pone.0075557	http://dx.doi.org/10.1371/journal.pone.0075557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086569	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700101
J	Jansen, D; Zerbi, V; Arnoldussen, IAC; Wiesmann, M; Rijpma, A; Fang, XTT; Dederen, PJ; Mutsaers, MPC; Broersen, LM; Lutjohann, D; Miller, M; Joosten, LAB; Heerschap, A; Kiliaan, AJ				Jansen, Diane; Zerbi, Valerio; Arnoldussen, Ilse A. C.; Wiesmann, Maximilian; Rijpma, Anne; Fang, Xiaotian T.; Dederen, Pieter J.; Mutsaers, Martina P. C.; Broersen, Laus M.; Luetjohann, Dieter; Miller, Malgorzata; Joosten, Leo A. B.; Heerschap, Arend; Kiliaan, Amanda J.			Effects of Specific Multi-Nutrient Enriched Diets on Cerebral Metabolism, Cognition and Neuropathology in A beta PPswe-PS1dE9 Mice	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACID; MAGNETIC-RESONANCE-SPECTROSCOPY; MORRIS WATER MAZE; APP/PS1 TRANSGENIC MICE; MICROTUBULE-ASSOCIATED PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; BRAIN CHOLESTEROL-SYNTHESIS; SPATIAL MEMORY DEFICIT; NERVE GROWTH-FACTOR; AGE-RELATED-CHANGES	Recent studies have focused on the use of multi-nutrient dietary interventions in search of alternatives for the treatment and prevention of Alzheimer's disease (AD). In this study we investigated to which extent long-term consumption of two specific multi-nutrient diets can modulate AD-related etiopathogenic mechanisms and behavior in 11-12-month-old A beta PPswe-PS1dE9 mice. Starting from 2 months of age, male A beta PP-PS1 mice and wild-type littermates were fed either a control diet, the DHA+EPA+UMP (DEU) diet enriched with uridine monophosphate (UMP) and the omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), or the Fortasyn (R) Connect (FC) diet enriched with the DEU diet plus phospholipids, choline, folic acid, vitamins and antioxidants. We performed behavioral testing, proton magnetic resonance spectroscopy, immunohistochemistry, biochemical analyses and quantitative real-time PCR to gain a better understanding of the potential mechanisms by which these multi-nutrient diets exert protective properties against AD. Our results show that both diets were equally effective in changing brain fatty acid and cholesterol profiles. However, the diets differentially affected AD-related pathologies and behavioral measures, suggesting that the effectiveness of specific nutrients may depend on the dietary context in which they are provided. The FC diet was more effective than the DEU diet in counteracting neurodegenerative aspects of AD and enhancing processes involved in neuronal maintenance and repair. Both diets elevated interleukin-1 beta mRNA levels in A beta PP-PS1 and wild-type mice. The FC diet additionally restored neurogenesis in A beta PP-PS1 mice, decreased hippocampal levels of unbound choline-containing compounds in wild-type and A beta PP-PS1 animals, suggesting diminished membrane turnover, and decreased anxiety-related behavior in the open field behavior. In conclusion, the current data indicate that specific multi-nutrient diets can influence AD-related etiopathogenic processes. Intervention with the FC diet might be of interest for several other neurodegenerative and neurological disorders.	[Jansen, Diane; Zerbi, Valerio; Arnoldussen, Ilse A. C.; Wiesmann, Maximilian; Rijpma, Anne; Fang, Xiaotian T.; Dederen, Pieter J.; Mutsaers, Martina P. C.; Kiliaan, Amanda J.] Radboud Univ Nijmegen, Med Ctr, Dept Anat, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Broersen, Laus M.] Danone Res, Ctr Specialised Nutr, Nutricia Adv Med Nutr, Wageningen, Netherlands; [Luetjohann, Dieter] Univ Clin Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany; [Miller, Malgorzata; Joosten, Leo A. B.] Radboud Univ Nijmegen, Dept Gen Internal Med, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, NL-6525 ED Nijmegen, Netherlands; [Heerschap, Arend] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Danone Nutricia; University of Bonn; Radboud University Nijmegen; Radboud University Nijmegen	Kiliaan, AJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Anat, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	A.Kiliaan@anat.umcn.nl	Fang, Xiaotian/AAV-9272-2021; Joosten, Leo AB/H-3138-2015; Wiesmann, Maximilian/C-5482-2012; Heerschap, Arend/G-5228-2010; Kiliaan, Amanda J/D-8778-2012; Zerbi, Valerio/K-3405-2018; Arnoldussen, Ilse A.C./H-4421-2015; Wiesmann, Maximilian/AAW-1627-2021; Rijpma, Anne/P-8251-2015; Rijpma, Anne/ABA-7746-2021; Dederen, Pieter.J.W.C/E-1899-2016	Fang, Xiaotian/0000-0001-9706-1122; Joosten, Leo AB/0000-0001-6166-9830; Wiesmann, Maximilian/0000-0002-1412-398X; Arnoldussen, Ilse A.C./0000-0002-7395-5284; Wiesmann, Maximilian/0000-0002-1412-398X; Rijpma, Anne/0000-0001-9411-5404; Zerbi, Valerio/0000-0001-7984-9565	European Community's Seventh Framework Programme (FP7) [211696]	European Community's Seventh Framework Programme (FP7)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no211696 (LipiDiDiet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackl N, 2005, NEUROSCI LETT, V384, P23, DOI 10.1016/j.neulet.2005.04.035; Arendash GW, 2007, NEUROSCIENCE, V149, P286, DOI 10.1016/j.neuroscience.2007.08.018; Barberger-Gateau P, 2002, BRIT MED J, V325, P932, DOI 10.1136/bmj.325.7370.932; Barcelo-Coblijn G, 2003, P NATL ACAD SCI USA, V100, P11321, DOI 10.1073/pnas.1734008100; Basu A, 2004, J NEUROSCI RES, V78, P151, DOI 10.1002/jnr.20266; Bhatia HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028451; Bjorkhem I, 2006, J INTERN MED, V260, P493, DOI 10.1111/j.1365-2796.2006.01725.x; Block W, 2002, AMINO ACIDS, V23, P317, DOI 10.1007/s00726-001-0144-0; Boekhoorn K, 2006, NEUROBIOL DIS, V24, P1, DOI 10.1016/j.nbd.2006.04.017; Bonnet E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003487; BOURRE JM, 1989, J NUTR, V119, P1880, DOI 10.1093/jn/119.12.1880; Braak E, 1999, EUR ARCH PSY CLIN N, V249, P14; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Broersen LM, 2013, J ALZHEIMERS DIS, V33, P177, DOI 10.3233/JAD-2012-112039; Calder PC, 2001, LIPIDS, V36, P1007, DOI 10.1007/s11745-001-0812-7; Carrie I, 2002, NUTR NEUROSCI, V5, P43, DOI 10.1080/10284150290007074; Cavassila S, 2001, NMR BIOMED, V14, P278, DOI 10.1002/nbm.701; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Chen SQ, 2012, BEHAV BRAIN RES, V235, P1, DOI 10.1016/j.bbr.2012.07.016; Chen SQ, 2009, DEMENT GERIATR COGN, V28, P558, DOI 10.1159/000261646; Chiu CC, 2008, PROG NEURO-PSYCHOPH, V32, P1538, DOI 10.1016/j.pnpbp.2008.05.015; Choi IY, 2003, NEUROCHEM RES, V28, P987, DOI 10.1023/A:1023370104289; Conte V, 2004, J NEUROCHEM, V90, P758, DOI 10.1111/j.1471-4159.2004.02560.x; Cuppini R, 2002, INT J VITAM NUTR RES, V72, P170, DOI 10.1024/0300-9831.72.3.170; Dangour AD, 2010, AM J CLIN NUTR, V91, P1725, DOI 10.3945/ajcn.2009.29121; Das UN, 2008, PROSTAG LEUKOTR ESS, V78, P11, DOI 10.1016/j.plefa.2007.10.006; De Bruin NMWJ, 2003, NEUROBIOL LEARN MEM, V80, P63, DOI 10.1016/S1074-7427(03)00024-8; De La Torre JC, 2002, ANN NY ACAD SCI, V977, P196; DEBRUIN JPC, 1994, BRAIN RES, V652, P323, DOI 10.1016/0006-8993(94)90243-7; Dedeoglu A, 2004, BRAIN RES, V1012, P60, DOI 10.1016/j.brainres.2004.02.079; Demars M, 2010, J NEUROSCI RES, V88, P2103, DOI 10.1002/jnr.22387; Depino A, 2005, J NEUROIMMUNOL, V168, P96, DOI 10.1016/j.jneuroim.2005.07.009; Doody RS, 2003, J CLIN PSYCHIAT, V64, P11; Dyall SC, 2010, J NEUROSCI RES, V88, P2091, DOI 10.1002/jnr.22390; Enciu AM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-75; Eriksson C, 1999, NEUROSCIENCE, V93, P915, DOI 10.1016/S0306-4522(99)00178-5; Farina N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002854.pub3; Farkas T, 2000, P NATL ACAD SCI USA, V97, P6362, DOI 10.1073/pnas.120157297; Fedorova I, 2006, PROSTAG LEUKOTR ESS, V75, P271, DOI 10.1016/j.plefa.2006.07.006; Ferretti L, 2001, J GERIATR PSYCH NEUR, V14, P52, DOI 10.1177/089198870101400111; Figueiredo CP, 2011, J ALZHEIMERS DIS, V24, P61, DOI 10.3233/JAD-2010-101320; Fontani G, 2005, EUR J CLIN INVEST, V35, P691, DOI 10.1111/j.1365-2362.2005.01570.x; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Frederick BD, 2004, PROG NEURO-PSYCHOPH, V28, P1313, DOI 10.1016/j.pnpbp.2004.08.013; Freund-Levi Y, 2008, INT J GERIATR PSYCH, V23, P161, DOI 10.1002/gps.1857; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Fujii A, 1996, GEN PHARMACOL, V27, P995, DOI 10.1016/0306-3623(95)02072-1; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Geleijnse JM, 2002, J HYPERTENS, V20, P1493, DOI 10.1097/00004872-200208000-00010; GINSBERG L, 1993, BRAIN RES, V615, P355, DOI 10.1016/0006-8993(93)90050-W; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Goodfellow J, 2000, J AM COLL CARDIOL, V35, P265, DOI 10.1016/S0735-1097(99)00548-3; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; Griffith HR, 2008, ALZHEIMERS DEMENT, V4, P421, DOI 10.1016/j.jalz.2008.04.008; Grossberg GT, 2003, J CLIN PSYCHIAT, V64, P3; Guerrero AL, 1999, NEUROREPORT, V10, P1689, DOI 10.1097/00001756-199906030-00012; Hamilton A, 2012, BRAIN RES, V1449, P83, DOI 10.1016/j.brainres.2012.02.015; Harris WS, 1997, AM J CLIN NUTR, V65, P1611; Harris WS, 1997, AM J CLIN NUTR, V65, P1645, DOI 10.1093/ajcn/65.5.1645S; Heverin M, 2005, J LIPID RES, V46, P1047, DOI 10.1194/jlr.M500024-JLR200; Heverin M, 2004, J LIPID RES, V45, P186, DOI 10.1194/jlr.M300320-JLR200; HIGGINS GA, 1991, MOL BRAIN RES, V9, P143, DOI 10.1016/0169-328X(91)90139-O; Holguin S, 2008, FASEB J, V22, P3938, DOI 10.1096/fj.08-112425; Holguin S, 2008, BEHAV BRAIN RES, V191, P11, DOI 10.1016/j.bbr.2008.02.042; Hooijmans CR, 2009, NEUROBIOL DIS, V33, P482, DOI 10.1016/j.nbd.2008.12.002; Horrocks LA, 2004, PROSTAG LEUKOTR ESS, V70, P361, DOI 10.1016/j.plefa.2003.12.011; Huang W, 2001, NEUROLOGY, V57, P626, DOI 10.1212/WNL.57.4.626; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jansen D, 2014, BRAIN STRUCT FUNCT, V219, P1841, DOI 10.1007/s00429-013-0606-7; Jansen D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063643; Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104; Joseph JA, 1998, J NEUROSCI, V18, P8047; Juric DM, 2001, INT J DEV NEUROSCI, V19, P675, DOI 10.1016/S0736-5748(01)00044-2; Kalmijn S, 1997, ANN NEUROL, V42, P776, DOI 10.1002/ana.410420514; Kamphuis PJGH, 2011, J NUTR HEALTH AGING, V15, P720, DOI 10.1007/s12603-011-0105-6; Kantarci K, 2007, BRIT J RADIOL, V80, pS146, DOI 10.1259/bjr/60346217; Kantarci K, 2004, NEUROLOGY, V63, P1393; Kavanagh T, 2004, PROSTAG LEUKOTR ESS, V70, P391, DOI 10.1016/j.plefa.2003.12.014; Kawakita E, 2006, NEUROSCIENCE, V139, P991, DOI 10.1016/j.neuroscience.2006.01.021; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kitajka K, 2002, P NATL ACAD SCI USA, V99, P2619, DOI 10.1073/pnas.042698699; Kotani S, 2006, NEUROSCI RES, V56, P159, DOI 10.1016/j.neures.2006.06.010; Lalonde R, 2005, NEUROSCI LETT, V390, P87, DOI 10.1016/j.neulet.2005.08.028; Lalonde R, 2012, NEUROSCI BIOBEHAV R, V36, P1357, DOI 10.1016/j.neubiorev.2012.02.011; Lalonde R, 2004, NEUROSCI LETT, V369, P156, DOI 10.1016/j.neulet.2004.07.069; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Lavie CJ, 2009, J AM COLL CARDIOL, V54, P585, DOI 10.1016/j.jacc.2009.02.084; Lazarov O, 2010, TRENDS NEUROSCI, V33, P569, DOI 10.1016/j.tins.2010.09.003; Lazarov O, 2010, EXP NEUROL, V223, P267, DOI 10.1016/j.expneurol.2009.08.009; Leaf A, 2003, CIRCULATION, V107, P2646, DOI 10.1161/01.CIR.0000069566.78305.33; Lee JH, 2008, MAYO CLIN PROC, V83, P324, DOI 10.4065/83.3.324; LOCASCIO JJ, 1995, ARCH NEUROL-CHICAGO, V52, P1087, DOI 10.1001/archneur.1995.00540350081020; Lovasic L, 2005, GENES BRAIN BEHAV, V4, P197, DOI 10.1111/j.1601-183X.2004.00104.x; Lutjohann D, 2004, STEROIDS, V69, P431, DOI 10.1016/j.steroids.2004.03.012; Lutjohann D, 2002, J LIPID RES, V43, P1078, DOI 10.1194/jlr.M200071-JLR200; MacKay S, 1996, ARCH NEUROL-CHICAGO, V53, P167, DOI 10.1001/archneur.1996.00550020079018; MALOUF M, 2003, COCHRANE DB SYST REV; Malouf R, 2003, Cochrane Database Syst Rev, pCD004393, DOI 10.1002/14651858.CD004393; Malouf R, 2003, COCHRANE DB SYST REV, V2003; Marjanska M, 2005, P NATL ACAD SCI USA, V102, P11906, DOI 10.1073/pnas.0505513102; Mason JL, 2001, J NEUROSCI, V21, P7046, DOI 10.1523/JNEUROSCI.21-18-07046.2001; Matousek SB, 2012, J NEUROIMMUNE PHARM, V7, P156, DOI 10.1007/s11481-011-9331-2; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; MEYERHOFF DJ, 1994, ANN NEUROL, V36, P40; Mlynarik V, 2012, J ALZHEIMERS DIS, V31, pS87, DOI 10.3233/JAD-2012-112072; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mrak RE, 2005, NEUROBIOL AGING, V26, P349, DOI 10.1016/j.neurobiolaging.2004.05.010; Naliwaiko K, 2004, NUTR NEUROSCI, V7, P91, DOI 10.1080/10284150410001704525; Niidome T, 2008, NEUROREPORT, V19, P1361, DOI 10.1097/WNR.0b013e32830e6dd6; O'Leary TP, 2009, BEHAV BRAIN RES, V201, P120, DOI 10.1016/j.bbr.2009.01.039; Oberg J, 2008, NEUROBIOL AGING, V29, P1423, DOI 10.1016/j.neurobiolaging.2007.03.002; Oksman M, 2006, NEUROBIOL DIS, V23, P563, DOI 10.1016/j.nbd.2006.04.013; Okuda N, 2005, ATHEROSCLEROSIS, V178, P371, DOI 10.1016/j.atherosclerosis.2004.09.007; Pfefferbaum A, 1999, MAGNET RESON MED, V41, P276, DOI 10.1002/(SICI)1522-2594(199902)41:2<276::AID-MRM10>3.0.CO;2-8; Proescholdt MG, 2002, NEUROSCIENCE, V112, P731, DOI 10.1016/S0306-4522(02)00048-9; Pugh PL, 2007, BEHAV BRAIN RES, V178, P18, DOI 10.1016/j.bbr.2006.11.044; Puolivali J, 2002, NEUROBIOL DIS, V9, P339, DOI 10.1006/nbdi.2002.0481; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rogers PJ, 2008, BRIT J NUTR, V99, P421, DOI 10.1017/S0007114507801097; Rose SE, 1999, MAGN RESON IMAGING, V17, P291, DOI 10.1016/S0730-725X(98)00168-4; Rusanen M, 2011, ARCH INTERN MED, V171, P333, DOI 10.1001/archinternmed.2010.393; Sacks FM, 2002, AM J MED, V113, P13, DOI 10.1016/S0002-9343(01)00987-1; Savelkoul PJM, 2012, J NEUROCHEM, V120, P631, DOI 10.1111/j.1471-4159.2011.07616.x; Scheltens P, 2012, J ALZHEIMERS DIS, V31, P225, DOI 10.3233/JAD-2012-121189; Scheltens P, 2010, ALZHEIMERS DEMENT, V6, P1, DOI 10.1016/j.jalz.2009.10.003; Schipper P, 2011, BEHAV PHARMACOL, V22, P324, DOI 10.1097/FBP.0b013e328347881b; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuff N, 1997, NEUROLOGY, V49, P1513, DOI 10.1212/WNL.49.6.1513; Shaftel SS, 2007, J NEUROSCI, V27, P9301, DOI 10.1523/JNEUROSCI.1418-07.2007; Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450; Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7; Shrivastava R, 2005, NUTR NEUROSCI, V8, P317, DOI 10.1080/10284150500510242; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Skoog I, 2006, NEUROL RES, V28, P605, DOI 10.1179/016164106X130506; Small BJ, 2003, ACTA NEUROL SCAND, V107, P29, DOI 10.1034/j.1600-0404.107.s179.6.x; Solomon A, 2009, DEMENT GERIATR COGN, V28, P75, DOI 10.1159/000231980; Song C, 2004, J LIPID RES, V45, P1112, DOI [10.1194/jlr.M300526-JLR200, 10.1194/jlr.M300526-JLr200]; Song C, 2008, J NUTR, V138, P954, DOI 10.1093/jn/138.5.954; Streijger F, 2005, BEHAV BRAIN RES, V157, P219, DOI 10.1016/j.bbr.2004.07.002; STRIJBOS PJLM, 1995, J NEUROSCI, V15, P3468; Takeuchi T, 2003, BRAIN RES, V964, P136, DOI 10.1016/S0006-8993(02)04113-6; Tanabe Y, 2004, CLIN EXP PHARMACOL P, V31, P700, DOI 10.1111/j.1440-1681.2004.04068.x; Taniuchi N, 2007, NEUROREPORT, V18, P1801, DOI 10.1097/WNR.0b013e3282f1c9e9; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; Teather LA, 2003, PROG NEURO-PSYCHOPH, V27, P711, DOI 10.1016/S0278-5846(03)00086-1; Teri L, 1999, J GERONTOL A-BIOL, V54, pM348, DOI 10.1093/gerona/54.7.M348; Thelen KM, 2006, J PHARMACOL EXP THER, V316, P1146, DOI 10.1124/jpet.105.094136; Van Dam D, 2006, NEUROBIOL LEARN MEM, V85, P164, DOI 10.1016/j.nlm.2005.09.006; van de Rest O, 2008, NEUROLOGY, V71, P430, DOI 10.1212/01.wnl.0000324268.45138.86; van Gelder BM, 2007, AM J CLIN NUTR, V85, P1142, DOI 10.1093/ajcn/85.4.1142; Vela JM, 2002, MOL CELL NEUROSCI, V20, P489, DOI 10.1006/mcne.2002.1127; von Arnim CAF, 2010, NUTRITION, V26, P694, DOI 10.1016/j.nut.2009.11.009; von Kienlin M, 2005, NEUROBIOL DIS, V18, P32, DOI 10.1016/j.nbd.2004.09.005; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Watanabe T, 2012, NEUROBIOL LEARN MEM, V97, P289, DOI 10.1016/j.nlm.2012.01.006; WELSH K, 1991, ARCH NEUROL-CHICAGO, V48, P278, DOI 10.1001/archneur.1991.00530150046016; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Wiesmann M, 2013, J ALZHEIMERS DIS, DOI [10.3223/JAD-130179, DOI 10.3223/JAD-130179]; Wu LY, 2012, CAN J NEUROL SCI, V39, P436, DOI 10.1017/S0317167100013949; Wurtman RJ, 2008, METABOLISM, V57, pS6, DOI 10.1016/j.metabol.2008.07.007; Wurtman RJ, 2006, BRAIN RES, V1088, P83, DOI 10.1016/j.brainres.2006.03.019; WURTMAN RJ, 1985, NEUROCHEM INT, V7, P369, DOI 10.1016/0197-0186(85)90127-5; Xu W, 2010, J NEUROSCI RES, V88, P3155, DOI 10.1002/jnr.22479; Yaffe K, 2007, CURR ALZHEIMER RES, V4, P123, DOI 10.2174/156720507780362191; Yamada K, 1999, EUR J NEUROSCI, V11, P83, DOI 10.1046/j.1460-9568.1999.00408.x; Zhang XM, 2012, NUTR NEUROSCI, V15, P55, DOI 10.1179/1476830511Y.0000000025	172	34	34	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75393	10.1371/journal.pone.0075393	http://dx.doi.org/10.1371/journal.pone.0075393			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086523	Green Published, gold, Green Submitted			2022-12-27	WOS:000325025200041
J	De Ridder, KAA; Pape, K; Johnsen, R; Holmen, TL; Westin, S; Bjorngaard, JH				De Ridder, Karin A. A.; Pape, Kristine; Johnsen, Roar; Holmen, Turid Lingaas; Westin, Steinar; Bjorngaard, Johan Hakon			Adolescent Health and High School Dropout: A Prospective Cohort Study of 9000 Norwegian Adolescents (The Young-HUNT)	PLOS ONE			English	Article							HUMAN-CAPITAL ACCUMULATION; CHILD MENTAL-HEALTH; EDUCATIONAL-ATTAINMENT; DISORDERS; ADULTHOOD; CONSEQUENCES; TRAJECTORIES; INEQUALITIES; POPULATION; OVERWEIGHT	Background: High school dropout is of major concern in the western world. Our aims were to estimate the risk of school dropout in adolescents following chronic somatic disease, somatic symptoms, psychological distress, concentration difficulties, insomnia or overweight and to assess to which extent the family contributes to the association between health and school dropout. Methods: A population of 8950 school-attending adolescents (13-21 years) rated their health in the Young-HUNT 1 Study (90% response rate) in 1995-1997. High school dropout or completion, was defined with the Norwegian National Education Database in the calendar year the participant turned 24 years old. Parental socioeconomic status was defined by using linkages to the National Education Database, the National Insurance Administration and the HUNT2 Survey. We used logistic regression to estimate odds ratios and risk differences of high school dropout, both in the whole population and among siblings within families differentially exposed to health problems. Results: All explored health dimensions were strongly associated with high school dropout. In models adjusted for parental socioeconomic status, the risk differences of school dropout according to health exposures varied between 3.6% (95% CI 1.7 to 5.5) for having >= 1 somatic disease versus none and 11.7% (6.3 to 17.0) for being obese versus normal weight. The results from the analyses comparing differentially exposed siblings, confirmed these results with the exception of weaker associations for somatic diseases and psychological distress. School dropout was strongly clustered within families (family level conditional intraclass correlation 0.42). Conclusions: Adolescent health problems are markers for high school dropout, independent of parental socioeconomic status. Although school dropout it strongly related to family-level factors, also siblings with poor health have reduced opportunity to complete high school compared to healthy siblings. Public health policy should focus on ensuring young people with poor health the best attainable education.	[De Ridder, Karin A. A.; Pape, Kristine; Johnsen, Roar; Westin, Steinar; Bjorngaard, Johan Hakon] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [De Ridder, Karin A. A.] Nord Trondelag Hlth Trust, Levanger Hosp, Dept Phys Med & Rehabil, Levanger, Norway; [Holmen, Turid Lingaas] Norwegian Univ Sci & Technol, HUNT Res Ctr, Dept Publ Hlth & Gen Practice, Levanger, Norway; [Bjorngaard, Johan Hakon] Univ Trondheim Hosp, St Olavs Hosp, Forens Dept, Trondheim, Norway; [Bjorngaard, Johan Hakon] Univ Trondheim Hosp, St Olavs Hosp, Res Ctr Broset, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	De Ridder, KAA (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway.	karin.de.ridder@ntnu.no	De Ridder, Karin/AAH-6973-2019		Norwegian University of Science and Technology; Research Council of Norway; Liaison Committee	Norwegian University of Science and Technology; Research Council of Norway(Research Council of Norway); Liaison Committee	KDR and KP are financed by the Norwegian University of Science and Technology. JHB is financed by the by the Research Council of Norway and the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison PD, 2009, FIXED EFFECTS REGRES, P28; Boyle MH, 2007, CHILD DEV, V78, P168, DOI 10.1111/j.1467-8624.2007.00991.x; Breslau J, 2008, J PSYCHIATR RES, V42, P708, DOI 10.1016/j.jpsychires.2008.01.016; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Crosnoe R, 2004, J HEALTH SOC BEHAV, V45, P393, DOI 10.1177/002214650404500403; Currie J, 2006, J HEALTH ECON, V25, P1094, DOI 10.1016/j.jhealeco.2006.03.001; De Ridder KAA, 2012, J EPIDEMIOL COMMUN H, V66, P995, DOI 10.1136/jech-2011-200047; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Elstad JI, 2003, SOC SCI MED, V57, P1475, DOI 10.1016/S0277-9536(02)00514-2; Fletcher J, 2008, J HEALTH ECON, V27, P794, DOI 10.1016/j.jhealeco.2007.10.010; Fletcher JM, 2008, HEALTH ECON, V17, P1215, DOI 10.1002/hec.1319; Fletcher JM, 2012, HEALTH AFFAIR, V31, P27, DOI 10.1377/hlthaff.2011.0862; Fletcher JM, 2010, HEALTH ECON, V19, P855, DOI 10.1002/hec.1526; Fujiwara T, 2009, INT J EPIDEMIOL, V38, P1310, DOI 10.1093/ije/dyp226; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; Haas SA, 2008, J HEALTH SOC BEHAV, V49, P178, DOI 10.1177/002214650804900205; Holmen TL, 2014, INT J EPIDEMIOL, V43, P536, DOI 10.1093/ije/dys232; Huurre T, 2006, EDUC RES-UK, V48, P41, DOI 10.1080/00131880500498438; Huurre T, 2005, SOC PSYCH PSYCH EPID, V40, P580, DOI 10.1007/s00127-005-0930-1; Jackson MI, 2009, DEMOGRAPHY, V46, P671, DOI 10.1353/dem.0.0078; Kendler KS, 2001, ARCH GEN PSYCHIAT, V58, P1005, DOI 10.1001/archpsyc.58.11.1005; KESSLER RC, 1995, AM J PSYCHIAT, V152, P1026; Koivusilta L, 2003, SOC SCI MED, V57, P577, DOI 10.1016/S0277-9536(02)00405-7; Krokstad S., 2002, NOR EPIDEMIOL, V12, P19; Le F, 2013, SOC SCI MED, V76, P57, DOI 10.1016/j.socscimed.2012.10.005; Marmot MG, 2003, PERSPECT BIOL MED, V46, pS9, DOI 10.1353/pbm.2003.0056; Maslow GR, 2011, J ADOLESCENT HEALTH, V49, P206, DOI 10.1016/j.jadohealth.2010.12.001; McLeod JD, 2007, AM J SOCIOL, V113, P653, DOI 10.1086/521849; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Needham BL, 2009, J ADOLESCENT HEALTH, V45, P179, DOI 10.1016/j.jadohealth.2008.12.015; Needham BL, 2004, SOC PROBL, V51, P569, DOI 10.1525/sp.2004.51.4.569; OECD, 2012, EQ QUAL ED SUPP DISS; Osler M, 2007, INT J EPIDEMIOL, V36, P77, DOI 10.1093/ije/dyl266; Pingault JB, 2011, AM J PSYCHIAT, V168, P1164, DOI 10.1176/appi.ajp.2011.10121732; PLESS IB, 1993, PEDIATRICS, V91, P1131; Polderman TJC, 2010, ACTA PSYCHIAT SCAND, V122, P271, DOI 10.1111/j.1600-0447.2010.01568.x; Power C, 1996, BRIT MED J, V313, P449; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Ravens-Sieberer U, 2009, INT J PUBLIC HEALTH, V54, P151, DOI 10.1007/s00038-009-5406-8; Rouse CE, 2006, FUTURE CHILD, V16, P99, DOI 10.1353/foc.2006.0018; Strand BH, 2003, NORD J PSYCHIAT, V57, P113, DOI 10.1080/08039480310000932; TAMBS K, 1993, ACTA PSYCHIAT SCAND, V87, P364, DOI 10.1111/j.1600-0447.1993.tb03388.x; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; WEST P, 1991, SOC SCI MED, V32, P373, DOI 10.1016/0277-9536(91)90338-D	44	42	42	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74954	10.1371/journal.pone.0074954	http://dx.doi.org/10.1371/journal.pone.0074954			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	246EK	24086408	gold, Green Submitted, Green Published			2022-12-27	WOS:000326520200060
J	Valvo, G; Baldini, S; Brachini, F; Apicella, F; Cosenza, A; Ferrari, AR; Guerrini, R; Muratori, F; Romano, MF; Santorelli, FM; Tancredi, R; Sicca, F				Valvo, Giulia; Baldini, Sara; Brachini, Francesca; Apicella, Fabio; Cosenza, Angela; Ferrari, Anna Rita; Guerrini, Renzo; Muratori, Filippo; Romano, Maria Francesca; Santorelli, Filippo M.; Tancredi, Raffaella; Sicca, Federico			Somatic Overgrowth Predisposes to Seizures in Autism Spectrum Disorders	PLOS ONE			English	Article							HEAD CIRCUMFERENCE; INTELLECTUAL DISABILITY; EEG ABNORMALITIES; 1ST YEAR; EPILEPSY; CHILDREN; GROWTH; REGRESSION; LIFE; METAANALYSIS	Background: Comorbidity of Autism Spectrum Disorders with seizures or abnormal EEG (Autism-Epilepsy Phenotype) suggests shared pathomechanisms, and might be a starting point to identify distinct populations within the clinical complexity of the autistic spectrum. In this study, we tried to assess whether distinct subgroups, having distinctive clinical hallmarks, emerge from this comorbid condition. Methods: Two-hundred and six individuals with idiopathic Autism Spectrum Disorders were subgrouped into three experimental classes depending on the presence of seizures and EEG abnormalities. Neurobehavioral, electroclinical and auxological parameters were investigated to identify differences among groups and features which increase the risk of seizures. Our statistical analyses used ANOVA, post-hoc multiple comparisons, and the Chi-squared test to analyze continuous and categorical variables. A correspondence analysis was also used to decompose significant Chi-squared and reduce variables dimensions. Results: The high percentage of children with seizures (28.2% of our whole cohort) and EEG abnormalities (64.1%) confirmed that the prevalence of epilepsy in Autism Spectrum Disorders exceeds that of the general population. Seizures were associated with severe intellectual disability, and not with autism severity. Interestingly, tall stature (without macrocephaly) was significantly associated with EEG abnormalities or later onset seizures. However, isolated macrocephaly was equally distributed among groups or associated with early onset seizures when accompanied by tall stature. Conclusions: Tall stature seems to be a phenotypic "biomarker" of susceptibility to EEG abnormalities or late epilepsy in Autism Spectrum Disorders and, when concurring with macrocephaly, predisposes to early onset seizures. Growth pattern might act as an endophenotypic marker in Autism-Epilepsy comorbidity, delineating distinct pathophysiological subtypes and addressing personalized diagnostic work-up and therapeutic approaches.	[Valvo, Giulia; Baldini, Sara; Brachini, Francesca; Ferrari, Anna Rita; Guerrini, Renzo; Sicca, Federico] IRCCS Stella Maris Fdn, Epilepsy Neurophysiol & Neurogenet Unit, Pisa, Italy; [Apicella, Fabio; Cosenza, Angela; Muratori, Filippo; Tancredi, Raffaella] IRCCS Stella Maris Fdn, Dev Psychiat Unit, Pisa, Italy; [Guerrini, Renzo] Univ Florence, A Meyer Pediat Hosp, Child Neurol Unit, Florence, Italy; [Romano, Maria Francesca] St Anna Sch Adv Studies, Inst Econ, Pisa, Italy; [Santorelli, Filippo M.] IRCCS Stella Maris Fdn, Mol Med Unit, Pisa, Italy	IRCCS Fondazione Stella Maris; IRCCS Fondazione Stella Maris; University of Florence; Scuola Superiore Sant'Anna; IRCCS Fondazione Stella Maris	Sicca, F (corresponding author), IRCCS Stella Maris Fdn, Epilepsy Neurophysiol & Neurogenet Unit, Pisa, Italy.	federico.sicca@inpe.unipi.it	Sicca, Federico/J-7768-2016; Baldini, Sara/J-6456-2016; Santorelli, Filippo M/ABE-5124-2020; Bargagna, Stefania/AAB-7603-2019; Muratori, Filippo/K-3187-2018; Ferrari, Anna Rita/AAB-9899-2019; Cosenza, Angela/ABI-6504-2020; Tancredi, Raffaella/C-3868-2018; Apicella, Fabio/ABF-4304-2020; Romano, Maria Francesca/G-7717-2011	Sicca, Federico/0000-0002-4917-5253; Baldini, Sara/0000-0001-8330-0452; Santorelli, Filippo M/0000-0002-1359-9062; Bargagna, Stefania/0000-0001-6430-9494; Muratori, Filippo/0000-0001-9598-0096; Ferrari, Anna Rita/0000-0002-5397-6184; Cosenza, Angela/0000-0001-7971-5735; Tancredi, Raffaella/0000-0003-3517-4919; Apicella, Fabio/0000-0001-7390-3241; Romano, Maria Francesca/0000-0001-8933-125X; Guerrini, Renzo/0000-0002-7272-7079	Telethon - Italy [GGP11188]	Telethon - Italy(Fondazione Telethon)	The financial support of Telethon - Italy (http://www.telethon.it/en; Grant no. GGP11188) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiet C, 2008, BIOL PSYCHIAT, V64, P577, DOI 10.1016/j.biopsych.2008.04.030; Baird G, 2008, J AUTISM DEV DISORD, V38, P1827, DOI 10.1007/s10803-008-0571-9; Barnard-Brak L, 2011, PEDIATR NEUROL, V44, P97, DOI 10.1016/j.pediatrneurol.2010.09.011; Berg AT, 2012, EPILEPSY BEHAV, V23, P193, DOI 10.1016/j.yebeh.2012.01.015; Berg AT, 2011, J CHILD NEUROL, V26, P540, DOI 10.1177/0883073810384869; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Brooks-Kayal A, 2010, BRAIN DEV-JPN, V32, P731, DOI 10.1016/j.braindev.2010.04.010; Cacciari E, 2006, J ENDOCRINOL INVEST, V29, P581, DOI 10.1007/BF03344156; Canitano R, 2005, J CHILD NEUROL, V20, P27, DOI 10.1177/08830738050200010401; Chawarska K, 2011, ARCH GEN PSYCHIAT, V68, P1021, DOI 10.1001/archgenpsychiatry.2011.106; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Cuccaro ML, 2012, J AUTISM DEV DISORD, V42, P1630, DOI 10.1007/s10803-011-1402-y; Dementieva YA, 2005, PEDIATR NEUROL, V32, P102, DOI 10.1016/j.pediatrneurol.2004.08.005; Deonna T, 2006, EPILEPSIA, V47, P79, DOI 10.1111/j.1528-1167.2006.00697.x; Dissanayake C, 2006, DEV PSYCHOPATHOL, V18, P381, DOI 10.1017/S0954579406060202; Giannotti F, 2008, J AUTISM DEV DISORD, V38, P1888, DOI 10.1007/s10803-008-0584-4; Hara H, 2007, BRAIN DEV-JPN, V29, P486, DOI 10.1016/j.braindev.2006.12.012; Hrdlicka M, 2004, EUR CHILD ADOLES PSY, V13, P209, DOI 10.1007/s00787-004-0353-7; Hua X, 2013, HUM BRAIN MAPP, V34, P425, DOI 10.1002/hbm.21441; Lainhart JE, 2006, AM J MED GENET A, V140A, P2257, DOI 10.1002/ajmg.a.31465; Muratori F, 2012, RES AUTISM SPECT DIS, V6, P442, DOI 10.1016/j.rasd.2011.07.004; NELLHAUS G, 1968, PEDIATRICS, V41, P106; Parmeggiani A, 2002, BRAIN DEV-JPN, V24, P296, DOI 10.1016/S0387-7604(02)00063-3; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; Sicca F, 2011, NEUROBIOL DIS, V43, P239, DOI 10.1016/j.nbd.2011.03.016; Spence SJ, 2009, PEDIATR RES, V65, P599, DOI 10.1203/PDR.0b013e31819e7168; Torrey EF, 2004, BIOL PSYCHIAT, V56, P892, DOI 10.1016/j.biopsych.2004.09.014; Tuchman R, 2002, LANCET NEUROL, V1, P352, DOI 10.1016/S1474-4422(02)00160-6; Tuchman RF, 1997, PEDIATRICS, V99, P560, DOI 10.1542/peds.99.4.560; Tuchman R, 2011, CURR NEUROL NEUROSCI, V11, P428, DOI 10.1007/s11910-011-0195-x; Tuchman R, 2010, BRAIN DEV-JPN, V32, P709, DOI 10.1016/j.braindev.2010.04.008; Tuchman R, 2009, BRAIN DEV-JPN, V31, P95, DOI 10.1016/j.braindev.2008.09.009; Turk J, 2009, ACTA PAEDIATR, V98, P675, DOI 10.1111/j.1651-2227.2008.01184.x; van Daalen E, 2007, PEDIATR NEUROL, V37, P324, DOI 10.1016/j.pediatrneurol.2007.06.006; WONG V, 1993, J CHILD NEUROL, V8, P316, DOI 10.1177/088307389300800405; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002	37	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75015	10.1371/journal.pone.0075015	http://dx.doi.org/10.1371/journal.pone.0075015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086423	gold, Green Published, Green Submitted			2022-12-27	WOS:000326520200070
J	Cheng, G; Palanisamy, AP; Evans, ZP; Sutter, AG; Jin, L; Singh, I; May, H; Schmidt, MG; Chavin, KD				Cheng, Gang; Palanisamy, Arun P.; Evans, Zachary P.; Sutter, Alton G.; Jin, Lan; Singh, Inderjit; May, Harold; Schmidt, Michael G.; Chavin, Kenneth D.			Cerulenin Blockade of Fatty Acid Synthase Reverses Hepatic Steatosis in ob/ob Mice	PLOS ONE			English	Article							UNCOUPLING PROTEIN-2 EXPRESSION; BREAST-CANCER CELLS; PPAR-GAMMA; MESSENGER-RNA; FOOD-INTAKE; MOUSE HEPATOCYTES; UP-REGULATION; BODY-WEIGHT; LIVER; INHIBITION	Fatty liver or hepatic steatosis is a common health problem associated with abnormal liver function and increased susceptibility to ischemia/reperfusion injury. The objective of this study was to investigate the effect of the fatty acid synthase inhibitor cerulenin on hepatic function in steatotic ob/ob mice. Different dosages of cerulenin were administered intraperitoneally to ob/ob mice for 2 to 7 days. Body weight, serum AST/ALT, hepatic energy state, and gene expression patterns in ob/ob mice were examined. We found that cerulenin treatment markedly improved hepatic function in ob/ob mice. Serum AST/ALT levels were significantly decreased and hepatic ATP levels increased in treated obese mice compared to obese controls, accompanied by fat depletion in the hepatocyte. Expression of peroxisome proliferator-activated receptors alpha and gamma and uncoupling protein 2 were suppressed with cerulenin treatment and paralleled changes in AST/ALT levels. Hepatic glutathione content were increased in some cases and apoptotic activity in the steatotic livers was minimally changed with cerulenin treatment. In conclusion, these results demonstrate that fatty acid synthase blockade constitutes a novel therapeutic strategy for altering hepatic steatosis at non-stressed states in obese livers.	[Cheng, Gang; Palanisamy, Arun P.; Evans, Zachary P.; Sutter, Alton G.; Jin, Lan; Chavin, Kenneth D.] Med Univ S Carolina, Dept Surg, Div Transplant Surg, Charleston, SC 29425 USA; [Singh, Inderjit] Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; [May, Harold; Schmidt, Michael G.] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Palanisamy, AP (corresponding author), Med Univ S Carolina, Dept Surg, Div Transplant Surg, Charleston, SC 29425 USA.	arunp@musc.edu	Sutter, Alton/GWV-3369-2022; Palanisamy, Arun/I-7712-2019; Palanisamy, Arun/L-2019-2014	Palanisamy, Arun/0000-0002-7793-0682; Palanisamy, Arun/0000-0002-7793-0682; Schmidt, Michael G/0000-0002-7794-7265	National Institutes of Health [DK069369]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS022576, R01NS022576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by a grant from the National Institutes of Health, number DK069369. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, J GASTROEN HEPATOL, V17, pS186, DOI 10.1046/j.1440-1746.17.s1.10.x; Angulo Paul, 2005, Rev Gastroenterol Mex, V70 Suppl 3, P52; Armeni T, 2000, J SURG RES, V88, P207, DOI 10.1006/jsre.1999.5781; Asselah T, 2006, GUT, V55, P123, DOI 10.1136/gut.2005.069757; BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q; Basaranoglu M, 2013, WORLD J GASTROENTERO, V19, P1158, DOI 10.3748/wjg.v19.i8.1158; Begriche K, 2013, HEPATOLOGY; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Boelsterli UA, 2002, BIOCHEM PHARMACOL, V63, P1, DOI 10.1016/S0006-2952(01)00817-6; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Chavin KD, 2004, AM J TRANSPLANT, V4, P1440, DOI 10.1111/j.1600-6143.2004.00546.x; Chavin KD, 1999, J BIOL CHEM, V274, P5692, DOI 10.1074/jbc.274.9.5692; Cheng G, 2003, BIOCHEM BIOPH RES CO, V308, P573, DOI 10.1016/S0006-291X(03)01409-8; Cho WS, 2009, TOXICOL APPL PHARM, V236, P16, DOI 10.1016/j.taap.2008.12.023; Cortez-Pinto H, 1999, GASTROENTEROLOGY, V116, P1184, DOI 10.1016/S0016-5085(99)70022-3; DAGNOLO G, 1973, BIOCHIM BIOPHYS ACTA, V326, P155, DOI 10.1016/0005-2760(73)90241-5; de Las Heras N, 2013, NUTR METAB CARDIOVAS; Deepa PR, 2013, NUTR CANCER, V65, P311, DOI 10.1080/01635581.2013.748923; Della Corte C, 2012, J ADOLESCENT HEALTH, V51, P305, DOI 10.1016/j.jadohealth.2012.01.010; Dongiovanni P, 2013, PPAR RES, V2013, DOI 10.1155/2013/452061; Dridi S, 2006, AM J PHYSIOL-REG I, V291, pR138, DOI 10.1152/ajpregu.00899.2005; Evans ZP, 2009, TRANSPL P, V41, P4094, DOI 10.1016/j.transproceed.2009.09.055; Evans ZP, 2012, AM J PHYSIOL-GASTR L, V302, pG336, DOI 10.1152/ajpgi.00049.2011; Falck-Ytter Y, 2001, SEMIN LIVER DIS, V21, P17, DOI 10.1055/s-2001-12926; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fink BD, 2005, AM J PHYSIOL-ENDOC M, V288, pE71, DOI 10.1152/ajpendo.00332.2004; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gres S, 2013, MOL NUTR FOOD RES; Guan LL, 2012, ZHONGHUA GAN ZANG BI, V20, P131; Kimura K, 1999, FEBS LETT, V457, P75, DOI 10.1016/S0014-5793(99)00987-4; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Makimura H, 2001, DIABETES, V50, P733, DOI 10.2337/diabetes.50.4.733; Malnick SDH, 2003, QJM-INT J MED, V96, P699, DOI 10.1093/qjmed/hcg120; Tirado-Velez JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046484; Marques AR, 2004, BRIT J CANCER, V91, P732, DOI 10.1038/sj.bjc.6601989; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Medvedev AV, 2001, J BIOL CHEM, V276, P10817, DOI 10.1074/jbc.M010587200; Memon RA, 2000, ENDOCRINOLOGY, V141, P4021, DOI 10.1210/en.141.11.4021; Menendez JA, 2004, P NATL ACAD SCI USA, V101, P10715, DOI 10.1073/pnas.0403390101; Nadig SN, 2004, J GASTROINTEST SURG, V8, P695, DOI 10.1016/j.gassur.2004.04.002; Nakatani T, 2002, J BIOL CHEM, V277, P9562, DOI 10.1074/jbc.M110132200; Nardo B, 2001, TRANSPLANTATION, V71, P1816, DOI 10.1097/00007890-200106270-00018; NOMURA S, 1972, J ANTIBIOT, V25, P365, DOI 10.7164/antibiotics.25.365; Pizer ES, 1996, CANCER RES, V56, P2745; Price AC, 2001, J BIOL CHEM, V276, P6551, DOI 10.1074/jbc.M007101200; Rahimian R, 2001, MOL CELL BIOCHEM, V224, P29, DOI 10.1023/A:1011927113563; Rashid A, 1999, HEPATOLOGY, V29, P1131, DOI 10.1002/hep.510290428; Ronnett GV, 2006, OBESITY, V14, P201; Shimokawa T, 1998, BIOCHEM BIOPH RES CO, V251, P374, DOI 10.1006/bbrc.1998.9479; Spiegelman BM, 2000, INT J OBESITY, V24, pS8, DOI 10.1038/sj.ijo.0801492; Suzuki S, 2013, BIOCHEM BIOPH RES CO, V432, P92, DOI 10.1016/j.bbrc.2013.01.080; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Thupari JN, 2001, BIOCHEM BIOPH RES CO, V285, P217, DOI 10.1006/bbrc.2001.5146; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Van der Lee KAJM, 2000, FASEB J, V14, P495, DOI 10.1096/fasebj.14.3.495; Viguerie-Bascands N, 1999, BIOCHEM BIOPH RES CO, V256, P138, DOI 10.1006/bbrc.1999.0303	59	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75980	10.1371/journal.pone.0075980	http://dx.doi.org/10.1371/journal.pone.0075980			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086674	Green Submitted, Green Published, gold			2022-12-27	WOS:000325223900069
J	Manni, S; Brancalion, A; Mandato, E; Tubi, LQ; Colpo, A; Pizzi, M; Cappellesso, R; Zaffino, F; Di Maggio, SA; Cabrelle, A; Marino, F; Zambello, R; Trentin, L; Adami, F; Gurrieri, C; Semenzato, G; Piazza, F				Manni, Sabrina; Brancalion, Alessandra; Mandato, Elisa; Tubi, Laura Quotti; Colpo, Anna; Pizzi, Marco; Cappellesso, Rocco; Zaffino, Fortunato; Di Maggio, Speranza Antonia; Cabrelle, Anna; Marino, Filippo; Zambello, Renato; Trentin, Livio; Adami, Fausto; Gurrieri, Carmela; Semenzato, Gianpietro; Piazza, Francesco			Protein Kinase CK2 Inhibition Down Modulates the NF-kappa B and STAT3 Survival Pathways, Enhances the Cellular Proteotoxic Stress and Synergistically Boosts the Cytotoxic Effect of Bortezomib on Multiple Myeloma and Mantle Cell Lymphoma Cells	PLOS ONE			English	Article							PROTEASOME INHIBITORS; THERAPEUTIC TARGET; SIGNALING PATHWAY; INDUCED APOPTOSIS; CANCER-CELLS; ACTIVATION; PHOSPHORYLATION; EXPRESSION; PROLIFERATION; TRANSCRIPTION	CK2 is a pivotal pro-survival protein kinase in multiple myeloma that may likely impinge on bortezomib-regulated cellular pathways. In the present study, we investigated CK2 expression in multiple myeloma and mantle cell lymphoma, two bortezomib-responsive B cell tumors, as well as its involvement in bortezomib-induced cytotoxicity and signaling cascades potentially mediating bortezomib resistance. In both tumors, CK2 expression correlated with that of its activated targets NF-kappa B and STAT3 transcription factors. Bortezomib-induced proliferation arrest and apoptosis were significantly amplified by the simultaneous inhibition of CK2 with two inhibitors (CX-4945 and K27) in multiple myeloma and mantle cell lymphoma cell lines, in a model of multiple myeloma bone marrow microenvironment and in cells isolated from patients. CK2 inhibition empowered bortezomib-triggered mitochondrial-dependent cell death. Phosphorylation of NF-kappa B p65 on Ser529 (a CK2 target site) and rise of the levels of the endoplasmic reticulum stress kinase/endoribonuclease Ire1 alpha were markedly reduced upon CK2 inhibition, as were STAT3 phospho Ser727 levels. On the contrary, CK2 inhibition increased phospho Ser51 eIF2 alpha levels and enhanced the bortezomib-dependent accumulation of poly-ubiquitylated proteins and of the proteotoxic stress-associated chaperone Hsp70. Our data suggest that CK2 over expression in multiple myeloma and mantle cell lymphoma cells might sustain survival signaling cascades and can antagonize bortezomib-induced apoptosis at different levels. CK2 inhibitors could be useful in bortezomib-based combination therapies.	[Manni, Sabrina; Brancalion, Alessandra; Mandato, Elisa; Tubi, Laura Quotti; Colpo, Anna; Zaffino, Fortunato; Di Maggio, Speranza Antonia; Zambello, Renato; Trentin, Livio; Adami, Fausto; Gurrieri, Carmela; Semenzato, Gianpietro; Piazza, Francesco] Univ Padua, Dept Med, Hematol & Clin Immunol Branch, Padua, Italy; [Manni, Sabrina; Brancalion, Alessandra; Mandato, Elisa; Tubi, Laura Quotti; Colpo, Anna; Zaffino, Fortunato; Cabrelle, Anna; Zambello, Renato; Trentin, Livio; Gurrieri, Carmela; Semenzato, Gianpietro; Piazza, Francesco] Venetian Inst Mol Med, Hematol Malignancies Unit, Myeloma & Lymphoma Pathobiol Lab, Padua, Italy; [Pizzi, Marco; Cappellesso, Rocco; Marino, Filippo] Univ Padua, Dept Med, Gen Pathol & Cytopathol Unit, Padua, Italy	University of Padua; Veneto Institute Molecular Medicine; University of Padua	Semenzato, G (corresponding author), Univ Padua, Dept Med, Hematol & Clin Immunol Branch, Padua, Italy.	g.semenzato@unipd.it; francesco.piazza@unipd.it	SEMENZATO, GIANPIETRO C/J-7727-2016; mandato, elisa/AGI-6364-2022; Manni, Sabrina/AAE-9182-2021; Zambello, Renato/AAB-5280-2022; TRENTIN, LIVIO/J-7676-2016; Piazza, Francesco/AAD-1600-2019; Cappellesso, Rocco/L-5463-2016; Piazza, Francesco/K-6695-2016; gurrieri, carmela/AAA-5365-2022; Adami, Fernando/D-3855-2012; TRENTIN, LIVIO/L-6678-2019; Pizzi, Marco/H-6273-2016	SEMENZATO, GIANPIETRO C/0000-0002-6061-4595; mandato, elisa/0000-0002-7443-2821; Zambello, Renato/0000-0002-8799-5324; TRENTIN, LIVIO/0000-0003-1222-6149; Piazza, Francesco/0000-0002-2831-623X; Cappellesso, Rocco/0000-0002-0480-3412; Piazza, Francesco/0000-0002-2831-623X; Adami, Fernando/0000-0003-1918-3364; TRENTIN, LIVIO/0000-0003-1222-6149; Pizzi, Marco/0000-0003-4006-7317; COLPO, ANNA/0000-0001-8286-4336; gurrieri, carmela/0000-0001-8233-6007; MANNI, SABRINA/0000-0001-6804-0680	Ministero dell'Istruzione, dell' Universita e della Ricerca Scientifica (MIUR) [RBFR086EW9]; University of Padova [CPDA114940/11]; Associazione Italiana per la Ricerca sul Cancro (A.I.R.C.)	Ministero dell'Istruzione, dell' Universita e della Ricerca Scientifica (MIUR)(Ministry of Education, Universities and Research (MIUR)); University of Padova; Associazione Italiana per la Ricerca sul Cancro (A.I.R.C.)(Fondazione AIRC per la ricerca sul cancro)	This study was supported by a grant from the Ministero dell'Istruzione, dell' Universita e della Ricerca Scientifica (MIUR; www.miur.it) no RBFR086EW9 (FIRB "Futuro in Ricerca") and from a University of Padova (www.unipd.it) grant no CPDA114940/11 "Progetti di Ricerca di Ateneo" to Francesco Piazza and from the Associazione Italiana per la Ricerca sul Cancro (A.I.R.C., Milan; www.airc.it) to Gianpietro Semenzato. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird TA, 1997, J BIOL CHEM, V272, P32606, DOI 10.1074/jbc.272.51.32606; Bjorling-Poulsen M, 2005, ONCOGENE, V24, P6194, DOI 10.1038/sj.onc.1208762; Buac D, 2013, CURR PHARM DESIGN, V19, P4025, DOI 10.2174/1381612811319220012; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Cenci S, 2007, FEBS LETT, V581, P3652, DOI 10.1016/j.febslet.2007.04.031; Cortelazzo S, 2012, CRIT REV ONCOL HEMAT, V82, P78, DOI 10.1016/j.critrevonc.2011.05.001; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Fassan M, 2010, J CLIN PATHOL, V63, P692, DOI 10.1136/jcp.2010.078253; Fassina A, 2012, LAB INVEST, V92, P1574, DOI 10.1038/labinvest.2012.129; Ferguson AD, 2010, FEBS LETT; Gomez-Bougie P, 2007, CANCER RES, V67, P5418, DOI 10.1158/0008-5472.CAN-06-4322; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Harvey EJ, 2007, ARTERIOSCL THROM VAS, V27, P806, DOI 10.1161/01.ATV.0000258867.79411.96; Hessenauer A, 2011, CELL SIGNAL, V23, P145, DOI 10.1016/j.cellsig.2010.08.014; Hideshima T, 2003, BLOOD, V101, P1530, DOI 10.1182/blood-2002-08-2543; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; Holkova B, 2012, BEST PRACT RES CL HA, V25, P133, DOI 10.1016/j.beha.2012.04.007; Hosoi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040144; Hoster E, 2008, BLOOD, V111, P558, DOI 10.1182/blood-2007-06-095331; Ishikawa H, 2003, LEUKEMIA LYMPHOMA, V44, P1477, DOI 10.1080/1042819031000097339; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; Koprivnikar JL, 2012, FUTURE ONCOL, V8, P359, DOI [10.2217/FON.12.23, 10.2217/fon.12.23]; Lai R, 2003, J PATHOL, V199, P84, DOI 10.1002/path.1253; Lawasut P, 2012, CURR HEMATOL MALIG R, V7, P258, DOI 10.1007/s11899-012-0141-2; Manni S, 2012, CLIN CANCER RES, V18, P1888, DOI 10.1158/1078-0432.CCR-11-1789; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Mitsiades CS, 2009, SEMIN HEMATOL, V46, P166, DOI 10.1053/j.seminhematol.2009.02.003; Miyata Y, 2004, ANN NY ACAD SCI, V1030, P150, DOI 10.1196/annals.1329.019; Miyata Y, 2009, CELL MOL LIFE SCI, V66, P1840, DOI 10.1007/s00018-009-9152-0; Mujtaba T, 2011, DISCOV MED, V12, P471; Navas TA, 2006, LEUKEMIA, V20, P1017, DOI 10.1038/sj.leu.2404200; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Padgett CS, 2010, EJC SUPPL, V8, P131, DOI 10.1016/S1359-6349(10)72121-2; Piazza F, 2012, LEUKEMIA, V26, P1174, DOI 10.1038/leu.2011.385; Piazza F, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-526; Piazza FA, 2006, BLOOD, V108, P1698, DOI 10.1182/blood-2005-11-013672; Prowald A, 1997, FEBS LETT, V408, P99, DOI 10.1016/S0014-5793(97)00399-2; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Romieu-Mourez R, 2002, CANCER RES, V62, P6770; Roue G, 2011, BLOOD, V117, P1270, DOI 10.1182/blood-2010-04-278853; Ruzzene M, 2009, BIOCH BIOPHYS ACTA; Ruzzene M, 2010, BBA-PROTEINS PROTEOM, V1804, P499, DOI 10.1016/j.bbapap.2009.07.018; Sarno S, 2011, CURR TOP MED CHEM, V11, P1340, DOI 10.2174/156802611795589638; Schewe DM, 2009, CANCER RES, V69, P1545, DOI 10.1158/0008-5472.CAN-08-3858; Schneider CC, 2012, CELL SIGNAL, V24, P1797, DOI 10.1016/j.cellsig.2012.05.006; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Timofeeva OA, 2006, ONCOGENE, V25, P7555, DOI 10.1038/sj.onc.1209742; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; Wang H, 2010, CELL SIGNAL, V22, P1717, DOI 10.1016/j.cellsig.2010.06.012; Yared MA, 2005, ARCH PATHOL LAB MED, V129, P990; Zhang L, 2012, BLOOD, V120, P3783, DOI 10.1182/blood-2012-04-424630; Zheng Y, 2011, BLOOD, V118, P156, DOI 10.1182/blood-2010-01-266320	55	61	62	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75280	10.1371/journal.pone.0075280	http://dx.doi.org/10.1371/journal.pone.0075280			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086494	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900041
J	Pelisson, PF; Bel-Venner, MC; Giron, D; Menu, F; Venner, S				Pelisson, Pierre-Francois; Bel-Venner, Marie-Claude; Giron, David; Menu, Frederic; Venner, Samuel			From Income to Capital Breeding: When Diversified Strategies Sustain Species Coexistence	PLOS ONE			English	Article							ALLOCATION; ENERGY; ACQUISITION; PHYSIOLOGY; DICHOTOMY; EVOLUTION; CURCULIO; BREEDERS	There is empirical evidence of many diversified ways for energy to be acquired and allocated to reproduction, notably with strategies ranging from strict income breeding (females fueling their gametes with energy gained concomitantly during reproduction) to strict capital breeding (females storing nutrients prior reproduction). Until now, the question of whether diversification of these strategies might impact the way communities are organized has not been considered. Here, we suggest that diversified resource allocation strategies among competing species may contribute to their coexistence. We examined this hypothesis by focusing on communities composed of four phytophagous insect species that coexist and compete for egg-laying sites. From wild-caught females, we determined precisely the breeding period of each species and we described their resource acquisition and allocation to reproduction dynamics. We quantified in each species the total amount of larval energy stored by newly-emerging females and then monitored the total energy budget of females caught in the field before and throughout their breeding period. We found that the four sibling weevil species are markedly segregated along the income-capital-breeding continuum, which is correlated with clear time partitioning in their laying activity. Our results suggest that diversified resource allocation strategies might contribute to time partitioning of plant resources exploitation and thus indirectly to their coexistence. This work should further encourage studies examining the extent to which competitive coexistence might be affected by diversification of income-capital breeding strategies together with the intensity of interspecific competition, and considering the divergent evolution of these strategies.	[Pelisson, Pierre-Francois; Bel-Venner, Marie-Claude; Menu, Frederic; Venner, Samuel] Univ Lyon, Lyon, France; [Pelisson, Pierre-Francois; Bel-Venner, Marie-Claude; Menu, Frederic; Venner, Samuel] Univ Lyon, CNRS, UMR5558, Lab Biometrie & Biol Evolut, Villeurbanne, France; [Pelisson, Pierre-Francois] Univ Libre Bruxelles, Biol Control & Spatial Ecol Lab LUBIES, Brussels, Belgium; [Giron, David] Univ Tours, CNRS, UMR 7261, Inst Rech Biol Insecte, Tours, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Tours	Pelisson, PF (corresponding author), Univ Lyon, Lyon, France.	pfpelisson@gmail.com; Samuel.Venner@univ-lyon1.fr	MENU, Frédéric/C-3107-2016; Venner, Samuel/ABC-7739-2020; Giron, David/B-9108-2013	Venner, Samuel/0000-0001-7127-3733; Giron, David/0000-0001-8356-0983	French National Research Agency (ANR: CoCoReCo project) [JC09_470585]; CNRS	French National Research Agency (ANR: CoCoReCo project)(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was funded by the French National Research Agency (ANR: CoCoReCo project JC09_470585) and by the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R, 2000, J ANIM ECOL, V69, P672, DOI 10.1046/j.1365-2656.2000.00425.x; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; BOGGS CL, 1992, FUNCT ECOL, V6, P508, DOI 10.2307/2390047; Bonnet X, 1998, OIKOS, V83, P333, DOI 10.2307/3546846; Bonnet-Masimbert M., 1984, Pollinisation et productions vegetales, P219; Boyd IL, 2000, FUNCT ECOL, V14, P623, DOI 10.1046/j.1365-2435.2000.t01-1-00463.x; Casas J, 2005, ECOLOGY, V86, P545, DOI 10.1890/04-0812; Cecich RA, 1999, CAN J FOREST RES, V29, P1817, DOI 10.1139/cjfr-29-12-1817; Chesson P, 2004, OECOLOGIA, V141, P236, DOI 10.1007/s00442-004-1551-1; Coutin R., 1992, Memoires de la Societe Royale Belge d'Entomologie, V35, P259; Giron D, 2003, ECOL LETT, V6, P273, DOI 10.1046/j.1461-0248.2003.00429.x; Hoffmann A, 1986, F D FRAN SOC SCI NAT, V59, P1090; Houston AI, 2007, BEHAV ECOL, V18, P241, DOI 10.1093/beheco/arl080; Hughes J, 2004, MOL PHYLOGENET EVOL, V32, P601, DOI 10.1016/j.ympev.2004.02.007; Jervis MA, 2001, J ANIM ECOL, V70, P442, DOI 10.1046/j.1365-2656.2001.00507.x; Jervis MA, 2008, ANNU REV ENTOMOL, V53, P361, DOI 10.1146/annurev.ento.53.103106.093433; Johnson RA, 2006, INSECT SOC, V53, P316, DOI 10.1007/s00040-006-0874-9; Jonsson KI, 1997, OIKOS, V78, P57, DOI 10.2307/3545800; KARASOV WH, 1986, TRENDS ECOL EVOL, V1, P101, DOI 10.1016/0169-5347(86)90034-0; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Kemp DJ, 2003, AM NAT, V162, P290, DOI 10.1086/376890; Klaassen M, 2006, ARDEA, V94, P371; Mathias A, 2013, THEOR POPUL BIOL, V84, P56, DOI 10.1016/j.tpb.2012.11.009; Meijer T, 1999, IBIS, V141, P399, DOI 10.1111/j.1474-919X.1999.tb04409.x; Pelisson PF, 2011, ENTOMOL EXP APPL, V138, P77, DOI 10.1111/j.1570-7458.2010.01077.x; PELISSON PF, 2011, THESIS, P260; Pelisson PF, 2012, FUNCT ECOL, V26, P198, DOI 10.1111/j.1365-2435.2011.01925.x; PERRIN N, 1993, ANNU REV ECOL SYST, V24, P379, DOI 10.1146/annurev.es.24.110193.002115; SORK VL, 1993, ECOLOGY, V74, P528, DOI 10.2307/1939313; Stearns S.C., 1992, pi; Stephens PA, 2009, ECOLOGY, V90, P2057, DOI 10.1890/08-1369.1; Tammaru T, 1996, OIKOS, V77, P561, DOI 10.2307/3545946; Thoren LM, 1998, J ECOL, V86, P501, DOI 10.1046/j.1365-2745.1998.00276.x; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Varpe O, 2009, OIKOS, V118, P363, DOI 10.1111/j.1600-0706.2008.17036.x; Venner S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018039; Warner DA, 2008, J ANIM ECOL, V77, P1242, DOI 10.1111/j.1365-2656.2008.01442.x; Wessels FJ, 2010, J INSECT PHYSIOL, V56, P1269, DOI 10.1016/j.jinsphys.2010.03.033; WILLIAMSON MJ, 1966, FOREST SCI, V12, P19	39	15	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76086	10.1371/journal.pone.0076086	http://dx.doi.org/10.1371/journal.pone.0076086			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086694	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900080
J	Ziakas, PD; Thapa, R; Rice, LB; Mylonakis, E				Ziakas, Panayiotis D.; Thapa, Rachana; Rice, Louis B.; Mylonakis, Eleftherios			Trends and Significance of VRE Colonization in the ICU: A Meta-Analysis of Published Studies	PLOS ONE			English	Article							VANCOMYCIN-RESISTANT ENTEROCOCCI; INTENSIVE-CARE-UNIT; BLOOD-STREAM INFECTION; GRAM-NEGATIVE BACILLI; STAPHYLOCOCCUS-AUREUS; RISK-FACTORS; SECULAR TRENDS; ACQUISITION; CARRIAGE; SURVEILLANCE	Background: The burden and significance of vancomycin-resistant enterococci (VRE) colonization in the ICU is not clearly understood. Methods: We searched PubMed and EMBASE up to May 2013 for studies reporting the prevalence of VRE upon admission to the ICU and performed a meta-analysis to assess rates and trends of VRE colonization. We calculated the prevalence of VRE on admission and the acquisition (colonization and/or infection) rates to estimate time trends and the impact of colonization on ensuing VRE infections. Findings: Across 37 studies (62,959 patients at risk), the estimated prevalence of VRE on admission to the ICU was 8.8% (7.1-10.6). Estimates were more consistent when cultures were obtained within 24 hours from admission. The VRE acquisition rate was 8.8% (95% CI 6.9-11.0) across 26 evaluable studies (35,364 patients at risk). Across US studies, VRE acquisition rate was 10.2% (95% CI 7.7-13.0) and demonstrated significant decline in annual trends. We used the US estimate of colonization on admission [12.3% (10.5-14.3)] to evaluate the impact of VRE colonization on admission in overall VRE prevalence. We demonstrated that VRE colonization on admission is a major determinant of the overall VRE burden in the ICU. Importantly, among colonized patients (including admitted and/or acquired cases) the VRE infection rates vary widely from 0-45% (with the risk of VRE bacteremia being reported from 0-16%) and <2% among those without a proven colonization. Conclusion: In summary, up to 10.6% of patients admitted in the ICU are colonized with VRE on admission and a similar percentage will acquire VRE during their ICU stay. Importantly, colonization on admission is a major determinant of VRE dynamics in the ICU and the risk of VRE-related infections is close related to colonization.	[Ziakas, Panayiotis D.; Thapa, Rachana; Mylonakis, Eleftherios] Rhode Isl Hosp, Div Infect Dis, Providence, RI 02903 USA; [Ziakas, Panayiotis D.; Thapa, Rachana; Mylonakis, Eleftherios] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Rice, Louis B.] Brown Univ, Warren Alpert Med Sch, Dept Med, Providence, RI 02912 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University	Mylonakis, E (corresponding author), Rhode Isl Hosp, Div Infect Dis, Providence, RI 02903 USA.	emylonakis@lifespan.org		Ziakas, Panayiotis/0000-0002-5943-8635				Austin DJ, 1999, P NATL ACAD SCI USA, V96, P6908, DOI 10.1073/pnas.96.12.6908; Baden LR, 2001, CLIN INFECT DIS, V33, P1654, DOI 10.1086/323762; Bonten MJM, 1998, CRIT CARE MED, V26, P2001, DOI 10.1097/00003246-199812000-00029; Bonten MJM, 1996, LANCET, V348, P1615, DOI 10.1016/S0140-6736(96)02331-8; Borg MA, 2012, J HOSP INFECT, V81, P251, DOI 10.1016/j.jhin.2012.05.001; Bourdon N, 2011, J ANTIMICROB CHEMOTH, V66, P713, DOI 10.1093/jac/dkq524; Climo MW, 2013, NEW ENGL J MED, V368, P533, DOI 10.1056/NEJMoa1113849; Climo MW, 2009, CRIT CARE MED, V37, P1858, DOI 10.1097/CCM.0b013e31819ffe6d; Batistao DWD, 2012, MEM I OSWALDO CRUZ, V107, P57, DOI 10.1590/S0074-02762012000100008; Dan M, 1999, J HOSP INFECT, V43, P231, DOI 10.1053/jhin.1998.0641; de Jonge E, 2003, LANCET, V362, P1011, DOI 10.1016/S0140-6736(03)14409-1; DEKRAKER ME, 2012, CLIN MICROBIOL INFEC; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doyle JS, 2011, SEMIN RESP CRIT CARE, V32, P115, DOI 10.1055/s-0031-1275525; Drees M, 2008, INFECT CONT HOSP EP, V29, P709, DOI 10.1086/589582; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Freire-Moran L, 2011, DRUG RESIST UPDATE, V14, P118, DOI 10.1016/j.drup.2011.02.003; Furuno JP, 2005, EMERG INFECT DIS, V11, P1539, DOI 10.3201/eid1110.050508; Gardiner D, 2002, INFECT CONT HOSP EP, V23, P466, DOI 10.1086/502087; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Grabsch EA, 2012, J HOSP INFECT, V82, P234, DOI 10.1016/j.jhin.2012.08.010; Grayson ML, 1999, MED J AUSTRALIA, V171, P133, DOI 10.5694/j.1326-5377.1999.tb123564.x; Harris AD, 2004, INFECT CONT HOSP EP, V25, P105, DOI 10.1086/502358; Hendrix CW, 2001, ANN SURG, V233, P259, DOI 10.1097/00000658-200102000-00016; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Ho PL, 2003, CRIT CARE MED, V31, P1175, DOI 10.1097/01.CCM.0000059437.01924.97; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huang SS, 2011, CRIT CARE, V15, DOI 10.1186/cc10445; Huskins WC, 2011, NEW ENGL J MED, V364, P1407, DOI 10.1056/NEJMoa1000373; Kim YJ, 2012, AM J INFECT CONTROL, V40, P1018, DOI 10.1016/j.ajic.2012.01.009; Lambiase A, 2007, INFECTION, V35, P428, DOI 10.1007/s15010-007-6288-4; Lin MY, 2010, CRIT CARE MED, V38, pS335, DOI 10.1097/CCM.0b013e3181e6ab12; Littvik A. M., 2006, Rev. argent. microbiol., V38, P28; Marin ME, 2001, INFECT CONT HOSP EP, V22, P332, DOI 10.1086/503402; Martinez JA, 2003, ARCH INTERN MED, V163, P1905, DOI 10.1001/archinte.163.16.1905; Mascini EM, 2003, J CLIN MICROBIOL, V41, P5377, DOI 10.1128/JCM.41.12.5377-5383.2003; Matar MJ, 2006, AM J INFECT CONTROL, V34, P534, DOI 10.1016/j.ajic.2006.04.205; Meyer E, 2010, CRIT CARE, V14, DOI 10.1186/cc9062; Minhas P, 2011, CRIT CARE MED, V39, P2322, DOI 10.1097/CCM.0b013e3182227222; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Olivier CN, 2008, INFECT CONT HOSP EP, V29, P404, DOI 10.1086/587647; Ostrowsky BE, 1999, ARCH INTERN MED, V159, P1467, DOI 10.1001/archinte.159.13.1467; Padiglione AA, 2000, EMERG INFECT DIS, V6, P534, DOI 10.3201/eid0605.000514; Padiglione AA, 2003, ANTIMICROB AGENTS CH, V47, P2492, DOI 10.1128/AAC.47.8.2492-2498.2003; Pan SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047297; Patel R, 2001, LIVER TRANSPLANT, V7, P27, DOI 10.1053/jlts.2001.20784; Peta M, 2006, CLIN MICROBIOL INFEC, V12, P163, DOI 10.1111/j.1469-0691.2005.01331.x; Pogorzelska M, 2012, AM J INFECT CONTROL, V40, P96, DOI 10.1016/j.ajic.2011.10.002; Puzniak LA, 2002, CLIN INFECT DIS, V35, P18, DOI 10.1086/340739; Ramsey AM, 2009, INFECT CONT HOSP EP, V30, P184, DOI 10.1086/593956; Rucker G, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-79; Safdar N, 2002, ANN INTERN MED, V136, P834, DOI 10.7326/0003-4819-136-11-200206040-00013; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; SALGADO CD, 2008, AM J INFECT CONTROL, V36; Sandiumenge A, 2012, CURR OPIN PULM MED, V18, P187, DOI 10.1097/MCP.0b013e328351f974; Shadel BN, 2006, INFECT CONT HOSP EP, V27, P1068, DOI 10.1086/507960; Slaughter S, 1996, ANN INTERN MED, V125, P448, DOI 10.7326/0003-4819-125-6-199609150-00004; Song Joon Young, 2005, Korean Journal of Internal Medicine, V20, P55; Song JY, 2009, AM J INFECT CONTROL, V37, P734, DOI 10.1016/j.ajic.2008.09.025; Sutter ST, 2010, CLIN INFECT DIS, V51, P678, DOI 10.1086/655824; Top J, 2008, FEMS IMMUNOL MED MIC, V52, P297, DOI 10.1111/j.1574-695X.2008.00383.x; Vernon MO, 2006, ARCH INTERN MED, V166, P306, DOI 10.1001/archinte.166.3.306; Warren DK, 2003, INFECT CONT HOSP EP, V24, P257, DOI 10.1086/502199; Weinstock DM, 2007, BIOL BLOOD MARROW TR, V13, P615, DOI 10.1016/j.bbmt.2007.01.078; Werner G, 2008, Euro Surveill, V13; Wibbenmeyer L, 2009, J BURN CARE RES, V30, P648, DOI 10.1097/BCR.0b013e3181abff7e; Winston LG, 2004, AM J INFECT CONTROL, V32, P462, DOI 10.1016/j.ajic.2004.07.004; Yeh KM, 2004, MICROB DRUG RESIST, V10, P177, DOI 10.1089/1076629041310091; Yoon YK, 2012, J ANTIMICROB CHEMOTH, V67, P2963, DOI 10.1093/jac/dks303; Zuckerman RA, 1999, INFECT CONT HOSP EP, V20, P685, DOI 10.1086/501565	72	56	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75658	10.1371/journal.pone.0075658	http://dx.doi.org/10.1371/journal.pone.0075658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086603	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900055
J	Liu, J; Zhang, RX; Chen, F; Yu, CC; Sun, Y; Jia, CL; Zhang, LJ; Salahuddin, T; Li, XD; Lang, JT; Song, XC				Liu, Jun; Zhang, Renxia; Chen, Fei; Yu, Cuicui; Sun, Yan; Jia, Chuanliang; Zhang, Lijing; Salahuddin, Taufiq; Li, Xiaodong; Lang, Juntian; Song, Xicheng			MGMT Leu84Phe Polymorphism Contributes to Cancer Susceptibility: Evidence from 44 Case-Control Studies	PLOS ONE			English	Article							DNA-REPAIR GENES; SQUAMOUS-CELL CARCINOMA; ENZYME O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; SINGLE-NUCLEOTIDE POLYMORPHISMS; ACID SUBSTITUTION POLYMORPHISMS; SNP-SNP INTERACTIONS; LUNG-CANCER; COLORECTAL-CANCER; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; PROSTATE-CANCER	Background: O-6-methylguanine-DNA methyltransferase is one of the few proteins to directly remove alkylating agents in the human DNA direct reversal repair pathway. A large number of case-control studies have been conducted to explore the association between MGMT Leu84Phe polymorphism and cancer risk. However, the results were not consistent. Methods: We carried out a meta-analysis of 44 case-control studies to clarify the association between the Leu84Phe polymorphism and cancer risk. Results: Overall, significant association of the T allele with cancer susceptibility was verified with meta-analysis under a recessive genetic model (P<0.001, OR=1.30, 95% CI 1.24-1.50) and TT versus CC comparison (P=0.001, OR=1.29, 95% CI 1.12-1.50). In subgroup analysis, a significant increased risk was found for lung cancer (TT versus CC, P=0.027, OR=1.67, 95% CI 1.06-2.63; recessive genetic model, P=0.32, OR=1.64, 95% CI 1.04-2.58), whereas risk of colorectal cancer was significantly low under a dominant genetic model (P=0.019, OR=0.84, 95% CI 0.72-0.97). Additionally, a significant association between TT genetic model and total cancer risk was found in the Caucasian population (TT versus CC, P=0.014, OR=1.29, 95% CI 1.05-1.59; recessive genetic model, P=0.009, OR=1.31, 95% CI 1.07-1.61), but not in the Asian population. An increased risk for lung cancer was also verified in the Caucasian population (TT versus CC, P=0.035, OR=1.62, 95% CI 1.04-2.53; recessive genetic model, P=0.048, OR=1.57, 95% CI 1.01-2.45). Conclusions: These results suggest that MGMT Leu84Phe polymorphism might contribute to the susceptibility of certain cancers.	[Liu, Jun; Chen, Fei] Sichuan Univ, Dept Otolaryngol Head & Neck Surg, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Renxia; Yu, Cuicui] Qingdao Univ, Sch Med, Yuhuangding Hosp, Dept Anesthesia, Yantai, Shandong, Peoples R China; [Sun, Yan; Jia, Chuanliang; Zhang, Lijing; Song, Xicheng] Qingdao Univ, Sch Med, Yuhuangding Hosp, Dept Otolaryngol Head & Neck Surg, Yantai, Shandong, Peoples R China; [Jia, Chuanliang] Binzhou Med Sch, Yantai, Shandong, Peoples R China; [Zhang, Lijing] Qingdao Med Sch, Qingdao, Shandong, Peoples R China; [Salahuddin, Taufiq] Wake Forest Sch Med, Winston Salem, NC USA; [Li, Xiaodong] 3rdPeoples Hosp Jinan, Jinan, Shandong, Peoples R China; [Lang, Juntian] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China	Sichuan University; Qingdao University; Qingdao University; Binzhou Medical University; Wake Forest University; Naval Medical University	Lang, JT (corresponding author), Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China.	wolfjt3610@hotmail.com; songxicheng@126.com	, 刀客/ABG-3664-2020	Liu, Jun/0000-0003-4800-7749	Science and Technical Development Foundation of Shandong Province, China [2011YD18014]; Doctoral Program of Shandong Province, China [2007BS03009]; Science and Technical Development Foundation of Yantai, China [2008142-21]	Science and Technical Development Foundation of Shandong Province, China; Doctoral Program of Shandong Province, China; Science and Technical Development Foundation of Yantai, China	This work was supported by Science and Technical Development Foundation of Shandong Province (2011YD18014), China, Doctoral Program of Shandong Province (2007BS03009), China, and Science and Technical Development Foundation of Yantai (2008142-21), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalliu I, 2010, CANCER CAUSE CONTROL, V21, P289, DOI 10.1007/s10552-009-9461-5; Akbari MR, 2009, CANCER RES, V69, P7994, DOI 10.1158/0008-5472.CAN-09-1149; BARTSCH H, 1984, CARCINOGENESIS, V5, P1381, DOI 10.1093/carcin/5.11.1381; Bigler J, 2005, CANCER EPIDEM BIOMAR, V14, P2501, DOI 10.1158/1055-9965.EPI-05-0270; Bye H, 2011, CARCINOGENESIS, V32, P1855, DOI 10.1093/carcin/bgr211; Chae MH, 2006, MOL CARCINOGEN, V45, P239, DOI 10.1002/mc.20171; Chuang LY, 2012, EUR J CANCER PREV, V21, P336, DOI 10.1097/CEJ.0b013e32834e31f6; CITRON M, 1991, CANCER RES, V51, P4131; Crosbie PAJ, 2008, INT J CANCER, V122, P791, DOI 10.1002/ijc.23059; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doecke J, 2008, INT J CANCER, V123, P174, DOI 10.1002/ijc.23410; Dong XQ, 2012, MOL CARCINOGEN, V51, P491, DOI 10.1002/mc.20817; Egyhazi S, 2002, Hum Mutat, V20, P408, DOI 10.1002/humu.9078; Felini MJ, 2007, NEUROEPIDEMIOLOGY, V29, P55, DOI 10.1159/000108919; Goodman JE, 2006, INT J CANCER, V118, P1790, DOI 10.1002/ijc.21523; Gu F, 2009, BRIT J DERMATOL, V161, P209, DOI 10.1111/j.1365-2133.2009.09219.x; Hall J, 2007, CARCINOGENESIS, V28, P665, DOI 10.1093/carcin/bgl160; Han JL, 2006, CARCINOGENESIS, V27, P2281, DOI 10.1093/carcin/bgl099; Han JL, 2006, PHARMACOGENET GENOM, V16, P469, DOI 10.1097/01.fpc.0000215065.21718.4c; Hazra A, 2008, CANCER EPIDEM BIOMAR, V17, P311, DOI 10.1158/1055-9965.EPI-07-0195; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hu ZB, 2007, HUM MUTAT, V28, P431, DOI 10.1002/humu.20462; Huang JY, 2007, CARCINOGENESIS, V28, P1314, DOI 10.1093/carcin/bgm003; Huang SH, 2010, J ORAL PATHOL MED, V39, P645, DOI 10.1111/j.1600-0714.2009.00880.x; Huang WY, 2005, CANCER EPIDEM BIOMAR, V14, P1747, DOI 10.1158/1055-9965.EPI-05-0162; Huang WY, 2005, CARCINOGENESIS, V26, P1354, DOI 10.1093/carcin/bgi084; Hung RJ, 2007, CANCER EPIDEM BIOMAR, V16, P2736, DOI 10.1158/1055-9965.EPI-07-0494; IMAI Y, 1995, CARCINOGENESIS, V16, P2441; Inoue R, 2003, NEUROL RES, V25, P875, DOI 10.1179/016164103771954005; Jiao L, 2006, CANCER DETECT PREV, V30, P284, DOI 10.1016/j.cdp.2006.05.002; Khatami F, 2009, ASIAN PAC J CANCER P, V10, P1183; Kietthubthew S, 2006, INT J HYG ENVIR HEAL, V209, P21, DOI 10.1016/j.ijheh.2005.06.002; Krzesniak M, 2004, ANN HUM GENET, V68, P300, DOI 10.1046/j.1529-8817.2004.00079.x; Li CP, 2005, CANCER LETT, V227, P49, DOI 10.1016/j.canlet.2005.03.043; LINDAHL T, 1988, ANNU REV BIOCHEM, V57, P133, DOI 10.1146/annurev.bi.57.070188.001025; Liu YH, 2009, CANCER EPIDEM BIOMAR, V18, P204, DOI 10.1158/1055-9965.EPI-08-0632; Loh YH, 2011, CANCER EPIDEMIOL, V35, P369, DOI 10.1016/j.canep.2010.09.011; Loh YH, 2010, DNA REPAIR, V9, P421, DOI 10.1016/j.dnarep.2010.01.002; Ma WJ, 2010, WORLD J GASTROENTERO, V16, P641, DOI 10.3748/wjg.v16.i5.641; Macaskill P, 2001, STAT MED, V20, P641, DOI 10.1002/sim.698; Margison GP, 2003, CARCINOGENESIS, V24, P625, DOI 10.1093/carcin/bgg005; McKean-Cowdin R, 2009, CANCER EPIDEM BIOMAR, V18, P1118, DOI 10.1158/1055-9965.EPI-08-1078; Moreno V, 2006, CLIN CANCER RES, V12, P2101, DOI 10.1158/1078-0432.CCR-05-1363; NATARAJAN AT, 1992, MUTAGENESIS, V7, P83, DOI 10.1093/mutage/7.1.83; O'Mara TA, 2011, TWIN RES HUM GENET, V14, P328, DOI 10.1375/twin.14.4.328; Oh HK, 1996, BIOCHEMISTRY-US, V35, P12259, DOI 10.1021/bi9603635; Palli D, 2010, MUTAGENESIS, V25, P569, DOI 10.1093/mutage/geq042; Ricceri F, 2010, DNA REPAIR, V9, P191, DOI 10.1016/j.dnarep.2009.12.002; Ritchey JD, 2005, CANCER EPIDEM BIOMAR, V14, P1703, DOI 10.1158/1055-9965.EPI-04-0809; SAMSON L, 1992, MOL MICROBIOL, V6, P825, DOI 10.1111/j.1365-2958.1992.tb01533.x; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schwender H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051880; Shen J, 2005, CARCINOGENESIS, V26, P2131, DOI 10.1093/carcin/bgi179; Shen M, 2007, HAEMATOLOGICA, V92, P1180, DOI 10.3324/haematol.11324; Stern MC, 2007, CANCER EPIDEM BIOMAR, V16, P2363, DOI 10.1158/1055-9965.EPI-07-0268; Teo AKC, 2001, MOL CELL BIOL, V21, P7105, DOI 10.1128/MCB.21.20.7105-7114.2001; Tranah GJ, 2006, CANCER CAUSE CONTROL, V17, P721, DOI 10.1007/s10552-006-0005-y; Wang L, 2006, CANCER EPIDEM BIOMAR, V15, P2364, DOI 10.1158/1055-9965.EPI-06-0437; Yang Fan, 2009, Zhonghua Xue Ye Xue Za Zhi, V30, P622; Yang MH, 2004, LUNG CANCER, V44, P281, DOI 10.1016/j.lungcan.2003.12.003; Zawlik I, 2009, NEUROEPIDEMIOLOGY, V32, P21, DOI 10.1159/000170088; Zhang MD, 2008, CANCER EPIDEM BIOMAR, V17, P2123, DOI 10.1158/1055-9965.EPI-07-2735; Zhang ZD, 2010, DNA REPAIR, V9, P558, DOI 10.1016/j.dnarep.2010.02.006; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048; Zintzaras E, 2008, J CLIN EPIDEMIOL, V61, P634, DOI 10.1016/j.jclinepi.2007.12.011	67	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75367	10.1371/journal.pone.0075367	http://dx.doi.org/10.1371/journal.pone.0075367			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086516	Green Submitted, Green Published, gold			2022-12-27	WOS:000325220000017
J	Rossello, FJ; Tothill, RW; Britt, K; Marini, KD; Falzon, J; Thomas, DM; Peacock, CD; Marchionni, L; Li, J; Bennett, S; Tantoso, E; Brown, T; Chan, P; Martelotto, LG; Watkins, DN				Rossello, Fernando J.; Tothill, Richard W.; Britt, Kara; Marini, Kieren D.; Falzon, Jeanette; Thomas, David M.; Peacock, Craig D.; Marchionni, Luigi; Li, Jason; Bennett, Samara; Tantoso, Erwin; Brown, Tracey; Chan, Philip; Martelotto, Luciano G.; Watkins, D. Neil			Next-Generation Sequence Analysis of Cancer Xenograft Models	PLOS ONE			English	Article							CELL LUNG-CANCER; INTEGRATIVE GENOMICS VIEWER; BREAST-CANCER; RNA-SEQ; PANCREATIC-CANCER; IN-VITRO; METASTASIS; INFORMATION; EXPLORATION; EVOLUTION	Next-generation sequencing (NGS) studies in cancer are limited by the amount, quality and purity of tissue samples. In this situation, primary xenografts have proven useful preclinical models. However, the presence of mouse-derived stromal cells represents a technical challenge to their use in NGS studies. We examined this problem in an established primary xenograft model of small cell lung cancer (SCLC), a malignancy often diagnosed from small biopsy or needle aspirate samples. Using an in silico strategy that assign reads according to species-of-origin, we prospectively compared NGS data from primary xenograft models with matched cell lines and with published datasets. We show here that low-coverage whole-genome analysis demonstrated remarkable concordance between published genome data and internal controls, despite the presence of mouse genomic DNA. Exome capture sequencing revealed that this enrichment procedure was highly species-specific, with less than 4% of reads aligning to the mouse genome. Human-specific expression profiling with RNA-Seq replicated array-based gene expression experiments, whereas mouse-specific transcript profiles correlated with published datasets from human cancer stroma. We conclude that primary xenografts represent a useful platform for complex NGS analysis in cancer research for tumours with limited sample resources, or those with prominent stromal cell populations.	[Rossello, Fernando J.; Marini, Kieren D.; Martelotto, Luciano G.; Watkins, D. Neil] Monash Univ, Monash Inst Med Res, Clayton, Vic, Australia; [Tothill, Richard W.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Tothill, Richard W.] Peter MacCallum Canc Ctr, Mol Genom Core Facil, East Melbourne, Vic, Australia; [Britt, Kara] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Britt, Kara; Thomas, David M.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Falzon, Jeanette; Bennett, Samara; Brown, Tracey] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Thomas, David M.] Peter MacCallum Canc Ctr, Dept Canc Med, East Melbourne, Vic, Australia; [Peacock, Craig D.; Marchionni, Luigi] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Li, Jason] Peter MacCallum Canc Ctr, Bioinformat Core Facil, East Melbourne, Vic, Australia; [Li, Jason] Univ Melbourne, Dept Mech Engn, Parkville, Vic 3052, Australia; [Tantoso, Erwin] Partek SG Private Ltd, Singapore, Singapore; [Chan, Philip] Monash Univ, Monash eRes Ctr, Clayton, Vic, Australia; [Martelotto, Luciano G.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Monash University; University of Melbourne; Peter Maccallum Cancer Center; Monash University; Peter Maccallum Cancer Center; University of Melbourne; Monash University; Peter Maccallum Cancer Center; Johns Hopkins University; Johns Hopkins Medicine; Peter Maccallum Cancer Center; University of Melbourne; Monash University; Memorial Sloan Kettering Cancer Center	Martelotto, LG (corresponding author), Monash Univ, Monash Inst Med Res, Clayton, Vic, Australia.	martelol@mskcc.org; neil.watkins@monash.edu	Martelotto, Luciano/D-1946-2015; Rossello, Fernando/B-1208-2015; Marchionni, Luigi/S-6774-2017; Thomas, David/AAD-2877-2019; Britt, Kara/B-2437-2013	Martelotto, Luciano/0000-0002-9625-1183; Rossello, Fernando/0000-0003-3885-8777; Marchionni, Luigi/0000-0002-7336-8071; Thomas, David/0000-0002-2527-5428; Tothill, Richard William/0000-0003-4522-1184; Britt, Kara/0000-0001-6069-7856; Tantoso, Erwin/0000-0002-7946-6297; Li, Jason/0000-0002-1150-3549	National Health and Medical Research Council of Australia [546204]; Victorian Government Operational Infrastructure Support Program; Victorian Cancer Agency	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government Operational Infrastructure Support Program; Victorian Cancer Agency	Funding for this work was provided by the National Health and Medical Research Council of Australia (Project Grant 546204), the Victorian Government Operational Infrastructure Support Program, and the Victorian Cancer Agency. Funding for open access charge: Victorian Cancer Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Casey T, 2009, BREAST CANCER RES TR, V114, P47, DOI 10.1007/s10549-008-9982-8; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; Decaudin D, 2011, ANTI-CANCER DRUG, V22, P827, DOI 10.1097/CAD.0b013e3283475f70; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Ge HY, 2011, BIOINFORMATICS, V27, P1922, DOI 10.1093/bioinformatics/btr310; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JW, 2012, BIOINFORMATICS, V28, P1272, DOI 10.1093/bioinformatics/bts128; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Raskatov JA, 2012, P NATL ACAD SCI USA, V109, P16041, DOI 10.1073/pnas.1214267109; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Song S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045835; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	34	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e74432	10.1371/journal.pone.0074432	http://dx.doi.org/10.1371/journal.pone.0074432			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086345	Green Published, Green Submitted, gold			2022-12-27	WOS:000325220000010
J	Zhang, DJ; Wang, XM; Wang, M; Li, JH; Guo, XY; Chong, K; Xu, YY				Zhang, Dajian; Wang, Xiaomin; Wang, Min; Li, Junhua; Guo, Xiaoyu; Chong, Kang; Xu, Yunyuan			Ectopic Expression of WUS in Hypocotyl Promotes Cell Division via GRP23 in Arabidopsis	PLOS ONE			English	Article							WUSCHEL GENE; SHOOT; CYTOKININ; PROTEIN; GROWTH; AUXIN; CYCLE; FATE; GIBBERELLINS; TOLERANCE	WUSCHEL (WUS) is essential for preventing stem cell differentiation in Arabidopsis. Here we report that in addition to its functions in meristematic stem cell maintenance, WUS is involved in the regulation of cell division. The WUS gain-of-function mutant, stem ectopic flowers (sef), displayed elongated hypocotyls, whereas the loss-of-function wus-1 mutant had shortened hypocotyls. The long hypocotyl in sef was due to the presence of more cells, rather than increased cell elongation. Microscopic observation, flow cytometry assays, quantitative RT-PCR (qRT-PCR), and histochemical staining of CycB1;1::GUS supported the hypothesis that ectopic cell division occurred in the sef hypocotyls after germination. Both immunoblot and qRT-PCR results showed that WUS was ectopically expressed in sef hypocotyls. Luciferase activity, chromatin immunoprecipitation (ChIP) and electrophoretic mobility shift assay (EMSA) showed that GLUTAMINE-RICH PROTEIN 23 (GRP23) expression can be activated by WUS and that GRP23 is a direct target gene of WUS. The phenotypes of 35S::GRP23 plants and GRP23 knockdown lines supported the notion that GRP23 mediates the effects of WUS on hypocotyl length. Together, our data suggest that ectopic expression of WUS in hypocotyl controls cell division through its target gene GRP23.	[Zhang, Dajian; Wang, Xiaomin; Wang, Min; Li, Junhua; Guo, Xiaoyu; Chong, Kang; Xu, Yunyuan] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing, Peoples R China; [Zhang, Dajian] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xu, YY (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing, Peoples R China.	xuyy@ibcas.ac.cn			National Science Foundation of China for Innovative Research Groups [31121065]	National Science Foundation of China for Innovative Research Groups(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the National Science Foundation of China for Innovative Research Groups (31121065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowler C, 2004, PLANT J, V39, P776, DOI 10.1111/j.1365-313X.2004.02169.x; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Buechel S, 2010, EUR J CELL BIOL, V89, P279, DOI 10.1016/j.ejcb.2009.11.016; Busch W, 2010, DEV CELL, V18, P849, DOI 10.1016/j.devcel.2010.03.012; Cheng ZJ, 2013, PLANT PHYSIOL, V161, P240, DOI 10.1104/pp.112.203166; Chickarmane VS, 2012, P NATL ACAD SCI USA, V109, P4002, DOI 10.1073/pnas.1200636109; Clouse SD, 1996, PLANT J, V10, P1, DOI 10.1046/j.1365-313X.1996.10010001.x; Collett CE, 2000, PLANT PHYSIOL, V124, P553, DOI 10.1104/pp.124.2.553; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; Cowling RJ, 1999, J EXP BOT, V50, P1351, DOI 10.1093/jexbot/50.337.1351; Dewitte W, 2003, ANNU REV PLANT BIOL, V54, P235, DOI 10.1146/annurev.arplant.54.031902.134836; Ding YH, 2006, PLANT CELL, V18, P815, DOI 10.1105/tpc.105.039495; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; Gordon SP, 2009, P NATL ACAD SCI USA, V106, P16529, DOI 10.1073/pnas.0908122106; Gutierrez C, 2005, NAT CELL BIOL, V7, P535, DOI 10.1038/ncb0605-535; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Jing YJ, 2013, PLANT CELL, V25, P242, DOI 10.1105/tpc.112.105742; Laux T, 1996, DEVELOPMENT, V122, P87; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Lenhard M, 2002, DEVELOPMENT, V129, P3195; Li JJ, 2011, PLANT CELL, V23, P4411, DOI 10.1105/tpc.111.092684; Lin RC, 2007, SCIENCE, V318, P1302, DOI 10.1126/science.1146281; Lohmann JU, 2001, CELL, V105, P793, DOI 10.1016/S0092-8674(01)00384-1; Ma QB, 2009, PLANT PHYSIOL, V150, P244, DOI 10.1104/pp.108.133454; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; MCNELLIS TW, 1995, PLANT CELL, V7, P1749, DOI 10.1105/tpc.7.11.1749; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sablowski R, 2009, P NATL ACAD SCI USA, V106, P16016, DOI 10.1073/pnas.0909300106; Saibo NJM, 2003, PLANT J, V33, P989, DOI 10.1046/j.1365-313X.2003.01684.x; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Sosso D, 2012, PLANT CELL, V24, P676, DOI 10.1105/tpc.111.091074; Xu YY, 2005, PLANT MOL BIOL, V57, P773, DOI 10.1007/s11103-005-0952-9; Yadav RK, 2011, GENE DEV, V25, P2025, DOI 10.1101/gad.17258511; Yanagisawa S, 2003, NATURE, V425, P521, DOI 10.1038/nature01984; Yu H, 2008, PLANT CELL, V20, P1134, DOI 10.1105/tpc.108.058263; Zuo JR, 2002, PLANT J, V30, P349, DOI 10.1046/j.1365-313X.2002.01289.x	40	2	3	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75773	10.1371/journal.pone.0075773	http://dx.doi.org/10.1371/journal.pone.0075773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086632	Green Published, Green Submitted, gold			2022-12-27	WOS:000325220000043
J	Basile, AJ; Horiuchi, K; Panella, AJ; Laven, J; Kosoy, O; Lanciotti, RS; Venkateswaran, N; Biggerstaff, BJ				Basile, Alison J.; Horiuchi, Kalanthe; Panella, Amanda J.; Laven, Janeen; Kosoy, Olga; Lanciotti, Robert S.; Venkateswaran, Neeraja; Biggerstaff, Brad J.			Multiplex Microsphere Immunoassays for the Detection of IgM and IgG to Arboviral Diseases	PLOS ONE			English	Article							WEST-NILE-VIRUS; MONOCLONAL-ANTIBODIES; ENCEPHALITIS; IDENTIFICATION; FLAVIVIRUS; INFECTIONS; ANTIGEN	Serodiagnosis of arthropod-borne viruses (arboviruses) at the Division of Vector-Borne Diseases, CDC, employs a combination of individual enzyme-linked immunosorbent assays and microsphere immunoassays (MIAs) to test for IgM and IgG, followed by confirmatory plaque-reduction neutralization tests. Based upon the geographic origin of a sample, it may be tested concurrently for multiple arboviruses, which can be a cumbersome task. The advent of multiplexing represents an opportunity to streamline these types of assays; however, because serologic cross-reactivity of the arboviral antigens often confounds results, it is of interest to employ data analysis methods that address this issue. Here, we constructed 13-virus multiplexed IgM and IgG MIAs that included internal and external controls, based upon the Luminex platform. Results from samples tested using these methods were analyzed using 8 different statistical schemes to identify the best way to classify the data. Geographic batteries were also devised to serve as a more practical diagnostic format, and further samples were tested using the abbreviated multiplexes. Comparative error rates for the classification schemes identified a specific boosting method based on logistic regression "Logitboost" as the classification method of choice. When the data from all samples tested were combined into one set, error rates from the multiplex IgM and IgG MIAs were <5% for all geographic batteries. This work represents both the most comprehensive, validated multiplexing method for arboviruses to date, and also the most systematic attempt to determine the most useful classification method for use with these types of serologic tests.	[Basile, Alison J.; Horiuchi, Kalanthe; Panella, Amanda J.; Laven, Janeen; Kosoy, Olga; Lanciotti, Robert S.; Biggerstaff, Brad J.] Ctr Dis Control, Div Vector Borne Dis, Ft Collins, CO 80521 USA; [Venkateswaran, Neeraja] Radix Biosolut, Georgetown, TX USA		Basile, AJ (corresponding author), Ctr Dis Control, Div Vector Borne Dis, Ft Collins, CO 80521 USA.	Ajj1@cdc.gov		Basile, Alison Jane/0000-0002-5646-1557	CDC, DVBD	CDC, DVBD	CDC, DVBD is a federally funded national public health Lab (USCDC) and the work presented was supported by this federal funding. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.	Adjemian J, 2012, VECTOR-BORNE ZOONOT, V12, P922, DOI 10.1089/vbz.2011.0917; Beaty BC., 1995, VIRAL RICKETTSIAL CH, P189; Briese T, 1999, LANCET, V354, P1261, DOI 10.1016/S0140-6736(99)04576-6; Centers for Disease Control and Prevention, 2012, NAT NOT DIS COND CUR; Chang GJJ, 2003, VIROLOGY, V306, P170, DOI 10.1016/S0042-6822(02)00028-4; Core R Team, 2012, R LANG ENV STAT COMP; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; Hastie T., 2008, ELEMENTS STAT LEARNI; Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114; HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830; Hunt AR, 2001, J VIROL METHODS, V97, P133, DOI 10.1016/S0166-0934(01)00346-9; Johnson AJ, 2005, CLIN DIAGN LAB IMMUN, V12, P566, DOI 10.1128/CDLI.12.5.566-574.2005; Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000; Johnson AJ, 2007, CLIN VACCINE IMMUNOL, V14, P1084, DOI 10.1128/CVI.00115-07; Jokela P, 2012, J VIROL METHODS, V182, P82, DOI 10.1016/j.jviromet.2012.03.015; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Lammie PJ, 2012, INT J PARASITOL, V42, P797, DOI 10.1016/j.ijpara.2012.07.002; LUDWIG GV, 1991, MICROB PATHOGENESIS, V11, P411, DOI 10.1016/0882-4010(91)90037-B; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; Martins TB, 2008, AM J CLIN PATHOL, V129, P34, DOI 10.1309/65VKWVNAQ38PHMGQ; Monath TP, 2008, ANTIVIR RES, V78, P116, DOI 10.1016/j.antiviral.2007.10.009; Prince HE, 2013, J CLIN LAB ANAL, V27, P27, DOI 10.1002/jcla.21557; Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130; Roberson JA, 2007, J CLIN MICROBIOL, V45, P3167, DOI 10.1128/JCM.01143-07; ROEHRIG JT, 1983, VIROLOGY, V128, P118, DOI 10.1016/0042-6822(83)90323-9; ROEHRIG JT, 1990, AM J TROP MED HYG, V42, P394, DOI 10.4269/ajtmh.1990.42.394; Roehrig JT, 1986, TOGAVIRIDAE FLAVIVIR, P251; van der Wal FJ, 2012, J VIROL METHODS, V183, P99, DOI 10.1016/j.jviromet.2012.03.008; Zubach V, 2012, J CLIN MICROBIOL, V50, P460, DOI 10.1128/JCM.06090-11	29	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75670	10.1371/journal.pone.0075670	http://dx.doi.org/10.1371/journal.pone.0075670			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086608	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700107
J	Petrie, JG; Ohmit, SE; Cowling, BJ; Johnson, E; Cross, RT; Malosh, RE; Thompson, MG; Monto, AS				Petrie, Joshua G.; Ohmit, Suzanne E.; Cowling, Benjamin J.; Johnson, Emileigh; Cross, Rachel T.; Malosh, Ryan E.; Thompson, Mark G.; Monto, Arnold S.			Influenza Transmission in a Cohort of Households with Children: 2010-2011	PLOS ONE			English	Article							PANDEMIC INFLUENZA; UNITED-STATES; A H1N1; VACCINE EFFECTIVENESS; VIRUS; ILLNESS; INFECTION; SEASON; CIRCULATION; PREVENTION	Background: Households play a major role in community spread of influenza and are potential targets for mitigation strategies. Methods: We enrolled and followed 328 households with children during the 2010-2011 influenza season; this season was characterized by circulation of influenza A (H3N2), A (H1N1)pdm09 and type B viruses. Specimens were collected from subjects with acute respiratory illnesses and tested for influenza in real-time reverse transcriptase polymerase chain reaction (RT-PCR) assays. Influenza cases were classified as community-acquired or household-acquired, and transmission parameters estimated. Results: Influenza was introduced to 78 (24%) households and transmission to exposed household members was documented in 23 households. Transmission was more likely in younger households (mean age <22 years) and those not reporting home humidification, but was not associated with household vaccination coverage. The secondary infection risk (overall 9.7%) was highest among young children (<9 years) and varied substantially by influenza type/subtype with the highest risk for influenza A (H3N2). The serial interval (overall 3.2 days) also varied by influenza type and was longest for influenza B. Duration of symptomatic illness was shorter in children compared with adults, and did not differ by influenza vaccination status. Discussion: Prospective study of households with children over a single influenza season identified differences in household transmission by influenza type/subtype, subject age, and home humidification, suggesting possible targets for interventions to reduce transmission.	[Petrie, Joshua G.; Ohmit, Suzanne E.; Johnson, Emileigh; Cross, Rachel T.; Malosh, Ryan E.; Monto, Arnold S.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Cowling, Benjamin J.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Thompson, Mark G.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	University of Michigan System; University of Michigan; University of Hong Kong; Centers for Disease Control & Prevention - USA	Ohmit, SE (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	sohmit@umich.edu	Cowling, Benjamin John/C-4263-2009	Cowling, Benjamin John/0000-0002-6297-7154	Centers for Disease Control and Prevention; University of Michigan [U01 IP000170]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097150] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Centers for Disease Control and Prevention through a cooperative agreement with the University of Michigan (U01 IP000170).	Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; Boelle PY, 2011, INFLUENZA OTHER RESP, V5, P306, DOI 10.1111/j.1750-2659.2011.00234.x; Calatayud L, 2010, EPIDEMIOL INFECT, V138, P183, DOI 10.1017/S0950268809991191; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Cauchemez S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003061; Committee on Modeling Community Containment for Pandemic Influenza and Institute of Medicine, 2006, MOD COMM CONT PAND I; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Cowling BJ, 2009, EPIDEMIOLOGY, V20, P344, DOI 10.1097/EDE.0b013e31819d1092; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Hayden FG, 2000, NEW ENGL J MED, V343, P1282, DOI 10.1056/NEJM200011023431801; Howard PF, 2013, INFLUENZA OTHER RESP, V7, P330, DOI 10.1111/j.1750-2659.2012.00395.x; Lau LLH, 2012, EPIDEMIOLOGY, V23, P531, DOI 10.1097/EDE.0b013e31825588b8; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Loustalot F, 2011, CLIN INFECT DIS, V52, pS146, DOI 10.1093/cid/ciq057; MONTO AS, 1994, EPIDEMIOL REV, V16, P351, DOI 10.1093/oxfordjournals.epirev.a036158; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Ng S, 2010, CLIN INFECT DIS, V50, P707, DOI 10.1086/650458; Nukiwa-Souma N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033046; Ohmit SE, 2006, CLIN INFECT DIS, V43, P564, DOI 10.1086/506352; Ohmit SE, 2013, CLIN INFECT DIS, V56, P1363, DOI 10.1093/cid/cit060; Papenburg J, 2010, CLIN INFECT DIS, V51, P1033, DOI 10.1086/656582; Petrie JG, 2011, J INFECT DIS, V203, P1309, DOI 10.1093/infdis/jir015; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Skowronski DM, 2012, CLIN INFECT DIS, V55, P332, DOI 10.1093/cid/cis431; Sugimoto JD, 2011, EPIDEMIOLOGY, V22, P180, DOI 10.1097/EDE.0b013e3182060ca5; Treanor JJ, 2012, CLIN INFECT DIS, V55, P951, DOI 10.1093/cid/cis574	31	53	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75339	10.1371/journal.pone.0075339	http://dx.doi.org/10.1371/journal.pone.0075339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086511	Green Submitted, gold, Green Published			2022-12-27	WOS:000325218700078
J	Wang, FL; Chen, F; Huo, XQ; Xu, RB; Wu, L; Wang, JM; Lu, C				Wang, Fengliang; Chen, Fei; Huo, Xiqian; Xu, Ruobing; Wu, Liang; Wang, Jianming; Lu, Cheng			A Neglected Issue on Sexual Well-Being following Breast Cancer Diagnosis and Treatment among Chinese Women	PLOS ONE			English	Article							HEALTH-SERVICES RESEARCH; BODY-IMAGE; PSYCHOSOCIAL ADJUSTMENT; MIXED METHODS; DYSFUNCTION; SURVIVORS; RECONSTRUCTION; EXPERIENCES; STRATEGIES; MANAGEMENT	Background: Changes to sexual well-being can be one of the most problematic quality of life issues following the diagnosis and treatment of breast cancer. The objectives of the present study were to evaluate changes to sexual well-being following breast cancer, to expand upon the existing body of knowledge pertaining to breast cancer and sexuality, and to provide the necessary information for implementing future interventions that may help improve the quality of life in breast cancer patients. Methods: This study was mixed with qualitative and quantitative designs. Twenty patients with breast cancer were recruited for in-depth interviews. The central questions covered a patient's cancer experience and perceptions of sexual activities following breast cancer. According to the findings of the qualitative study, we performed a quantitative study using a structured questionnaire to collect data on patient's experience and attitude to sexual well-being following breast cancer diagnosis and treatment. Results: Based on the qualitative analysis, seven main themes emerged: (1) Decrease in sexual frequency; (2) Lack of sexual interest; (3) Menopausal symptoms; (4) Body image changes; (5) Effects on marital relationship; (6) Misconceptions about sex; (7) The need for professional consultation. Results from the quantitative study further supported the findings from the qualitative analysis, where changes to sexual well-being were common following cancer diagnosis and treatment and it was a neglected issue among Chinese women. Conclusions: The present study highlights the significant changes to sexual well-being following breast cancer, in addition to the lack of knowledge and misconceptions of sexual activity among patients. Addressing these problems will help improve a patient's quality of life. The findings of this study could help healthcare professionals recognize the sexual issues faced by women with breast cancer and ultimately promote a healthy life.	[Wang, Fengliang; Chen, Fei; Lu, Cheng] Nanjing Med Univ, Dept Breast, Nanjing Matern & Child Hlth Hosp, Nanjing, Jiangsu, Peoples R China; [Chen, Fei; Huo, Xiqian; Xu, Ruobing; Wu, Liang; Wang, Jianming] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wang, JM (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	jmwang@njmu.edu.cn; lucheng66@126.com		Wang, Jianming/0000-0002-9151-284X	National Natural Science Foundation of China [81172501]; Key University Science Research Project of Jiangsu Province [12KJA330001]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key University Science Research Project of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by National Natural Science Foundation of China (81172501), Key University Science Research Project of Jiangsu Province (12KJA330001), and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barni S, 1997, ANN ONCOL, V8, P149, DOI 10.1023/A:1008298615272; Di Gen-hong, 2007, Zhonghua Zhongliu Zazhi, V29, P62; Dizon DS, 2009, BREAST J, V15, P500, DOI 10.1111/j.1524-4741.2009.00766.x; Downs-Holmes Catherine, 2011, Nurse Pract, V36, P20, DOI 10.1097/01.NPR.0000407602.29522.d7; Fang SY, 2013, BREAST CANCER RES TR, V137, P13, DOI 10.1007/s10549-012-2349-1; Fergus KD, 2002, J HEALTH PSYCHOL, V7, P303, DOI 10.1177/1359105302007003223; Fobair P, 2006, PSYCHO-ONCOL, V15, P579, DOI 10.1002/pon.991; Gao ES, 2012, J ADOLESCENT HEALTH, V50, pS12, DOI 10.1016/j.jadohealth.2011.12.002; Hughes Mary K, 2008, Semin Oncol Nurs, V24, P91, DOI 10.1016/j.soncn.2008.02.003; Katz A, 2011, AM J NURS, V111, P63, DOI 10.1097/01.NAJ.0000396560.09620.19; Kinsinger SW, 2011, PSYCHOL HEALTH, V26, P1571, DOI 10.1080/08870446.2010.533771; Krychman ML, 2012, J SEX MED, V9, P5, DOI 10.1111/j.1743-6109.2011.02566.x; Krychman ML, 2006, GYNECOL ONCOL, V101, P380, DOI 10.1016/j.ygyno.2006.03.001; Lenahan PM, 2004, CLIN FAMILY PRACTICE, V6, P955; Loprinzi CL, 2008, LANCET ONCOL, V9, P993, DOI 10.1016/S1470-2045(08)70256-0; Maguire P, 1998, BRIT MED J, V316, P1086; Moreira H, 2013, J PSYCHOSOC ONCOL, V31, P282, DOI 10.1080/07347332.2013.778934; Rowe P, 2011, PHYSIOTHER CAN, V63, P453, DOI 10.3138/ptc.2010-41; Sbitti Y, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-29; SCHOVER LR, 1995, CANCER-AM CANCER SOC, V75, P54, DOI 10.1002/1097-0142(19950101)75:1<54::AID-CNCR2820750111>3.0.CO;2-I; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Stead ML, 2003, CURR OPIN OBSTET GYN, V15, P57, DOI 10.1097/00001703-200302000-00009; Takahashi M, 2005, SOC SCI MED, V61, P1278, DOI 10.1016/j.socscimed.2005.01.013; Ussher JM, 2013, J ADV NURS, V69, P327, DOI 10.1111/j.1365-2648.2012.06010.x; Ussher JM, 2012, CANCER NURS, V35, P456, DOI 10.1097/NCC.0b013e3182395401; White JL, 2012, ONCOL NURS FORUM, V39, P210, DOI 10.1188/12.ONF.210-217; Wilmoth MC, 2011, ONCOL NURS FORUM, V38, P699, DOI 10.1188/11.ONF.699-708; Wisdom JP, 2012, HEALTH SERV RES, V47, P721, DOI 10.1111/j.1475-6773.2011.01344.x; Yeh CJ, 2007, COUNS PSYCHOL, V35, P369, DOI 10.1177/0011000006292596; Zhang Bao-ning, 2005, Zhonghua Zhongliu Zazhi, V27, P680; Zhang WQ, 2013, MED CARE, V51, pe51, DOI 10.1097/MLR.0b013e31824642fd	31	11	14	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74473	10.1371/journal.pone.0074473	http://dx.doi.org/10.1371/journal.pone.0074473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VC	24086349	gold, Green Published, Green Submitted			2022-12-27	WOS:000325218700026
J	Abdelmoaty, S; Wigerblad, G; Bas, DB; Codeluppi, S; Fernandez-Zafra, T; El-Awady, ES; Moustafa, Y; Abdelhamid, AES; Brodin, E; Svensson, CI				Abdelmoaty, Sally; Wigerblad, Gustaf; Bas, Duygu B.; Codeluppi, Simone; Fernandez-Zafra, Teresa; El-Awady, El-Sayed; Moustafa, Yasser; Abdelhamid, Alaa El-din S.; Brodin, Ernst; Svensson, Camilla I.			Spinal Actions of Lipoxin A(4) and 17(R)-Resolvin D1 Attenuate Inflammation-Induced Mechanical Hypersensitivity and Spinal TNF Release	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; RESOLVIN D1; FACTOR-ALPHA; CYTOKINE PRODUCTION; INDUCED ARTHRITIS; GLIAL ACTIVATION; GENE-EXPRESSION; PAIN BEHAVIOR; CORD-INJURY	Lipoxins and resolvins have anti-inflammatory and pro-resolving actions and accumulating evidence indicates that these lipid mediators also attenuate pain-like behavior in a number of experimental models of inflammation and tissue injury-induced pain. The present study was undertaken to assess if spinal administration of lipoxin A(4) (LXA4) or 17 (R)-resolvin D1 (17(R)-RvD1) attenuates mechanical hypersensitivity in the carrageenan model of peripheral inflammation in the rat. Given the emerging role of spinal cytokines in the generation and maintenance of inflammatory pain we measured cytokine levels in the cerebrospinal fluid (CSF) after LXA4 or 17(R)-RvD1 administration, and the ability of these lipid metabolites to prevent stimuli-induced release of cytokines from cultured primary spinal astrocytes. We found that intrathecal bolus injection of LXA4 and17(R)-RvD1 attenuated inflammation-induced mechanical hypersensitivity without reducing the local inflammation. Furthermore, both LXA4 and 17(R)-RvD1 reduced carrageenan-induced tumor necrosis factor (TNF) release in the CSF, while only 17(R)-RvD1attenuated LPS and IFN-gamma-induced TNF release in astrocyte cell culture. In conclusion, this study demonstrates that lipoxins and resolvins potently suppress inflammation-induced mechanical hypersensitivity, possibly by attenuating cytokine release from spinal astrocytes. The inhibitory effect of lipoxins and resolvins on spinal nociceptive processing puts them in an intriguing position in the search for novel pain therapeutics.	[Abdelmoaty, Sally; Wigerblad, Gustaf; Bas, Duygu B.; Brodin, Ernst; Svensson, Camilla I.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Codeluppi, Simone; Fernandez-Zafra, Teresa] Karolinska Inst, Dept Mol Biochem & Biophys, Stockholm, Sweden; [Abdelmoaty, Sally; El-Awady, El-Sayed; Moustafa, Yasser] Suez Canal Univ, Fac Pharm, Dept Pharmacol & Toxicol, Ismailia, Egypt; [Abdelhamid, Alaa El-din S.] Suez Canal Univ, Fac Med, Dept Clin Pathol, Ismailia, Egypt	Karolinska Institutet; Karolinska Institutet; Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Suez Canal University	Svensson, CI (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.	camilla.svensson@ki.se	Svensson, Camilla/C-9511-2014; Moustafa, Yasser/AAS-1212-2021; codeluppi, simone/I-4143-2012	Svensson, Camilla/0000-0001-7980-4631; Moustafa, Yasser/0000-0001-5394-5559; codeluppi, simone/0000-0002-7053-0520; abdelhamid, alaa eldin/0000-0002-4764-5573	EU [224882]; Swedish Research Council [2007-5750]; Swedish Association for Strategic Research; Egyptian Ministry of Higher Education	EU(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Association for Strategic Research; Egyptian Ministry of Higher Education(Science and Technology Development Fund (STDF))	This work was supported by: EU (Marie Curie International Reintergration grants-No.224882) to CIS, Swedish Research Council(No.2007-5750) to CIS, Swedish Association for Strategic Research (CIS) and the Egyptian Ministry of Higher Education (PhD scholarship to SA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel A, 2003, J IMMUNOL, V170, P6266, DOI 10.4049/jimmunol.170.12.6266; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Bang S, 2012, BRIT J PHARMACOL, V165, P683, DOI 10.1111/j.1476-5381.2011.01568.x; Bang S, 2010, BRIT J PHARMACOL, V161, P707, DOI 10.1111/j.1476-5381.2010.00909.x; Boyle DL, 2003, ARTHRITIS RES THER, V5, pR352, DOI 10.1186/ar1004; Brandenburg LO, 2007, J NEUROCHEM, V101, P718, DOI 10.1111/j.1471-4159.2006.04351.x; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Choi JI, 2010, PAIN, V149, P243, DOI 10.1016/j.pain.2010.02.008; CHUNG IY, 1990, J IMMUNOL, V144, P2999; Codeluppi S, 2011, J NEUROSCI METH, V197, P118, DOI 10.1016/j.jneumeth.2011.02.011; Conte FP, 2010, BRIT J PHARMACOL, V161, P911, DOI 10.1111/j.1476-5381.2010.00950.x; Decker Y, 2009, AM J PHYSIOL-CELL PH, V296, pC1420, DOI 10.1152/ajpcell.00380.2008; Feng QX, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-148; Filep JG, 2005, PROSTAG LEUKOTR ESS, V73, P257, DOI 10.1016/j.plefa.2005.05.014; GARRISON CJ, 1991, BRAIN RES, V565, P1, DOI 10.1016/0006-8993(91)91729-K; Gwak YS, 2008, PAIN, V138, P410, DOI 10.1016/j.pain.2008.01.021; Halonen SK, 2006, J NEUROIMMUNOL, V175, P19, DOI 10.1016/j.jneuroim.2006.02.015; Hashimoto A, 2007, J RHEUMATOL, V34, P2144; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Hu S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-278; Huang LA, 2011, PAIN, V152, P557, DOI 10.1016/j.pain.2010.11.021; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Jozsef L, 2002, P NATL ACAD SCI USA, V99, P13266, DOI 10.1073/pnas.202296999; Koistinaho M, 2002, GLIA, V40, P175, DOI 10.1002/glia.10151; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Lafortune L, 1996, J NEUROPATH EXP NEUR, V55, P515, DOI 10.1097/00005072-199605000-00003; Le YY, 2000, J NEUROIMMUNOL, V111, P102, DOI 10.1016/S0165-5728(00)00373-8; LEE SC, 1993, J IMMUNOL, V150, P2659; LI D, 2013, MUCOSAL IMMUNOL, P62912; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Lima-Garcia JF, 2011, BRIT J PHARMACOL, V164, P278, DOI 10.1111/j.1476-5381.2011.01345.x; MALIPIERO UV, 1990, J IMMUNOL, V144, P3816; McMahon SB, 2009, NEURON, V64, P46, DOI 10.1016/j.neuron.2009.09.033; Menezes-de-Lima O, 2006, PROSTAG OTH LIPID M, V80, P123, DOI 10.1016/j.prostaglandins.2006.05.016; Milligan ED, 2005, EUR J NEUROSCI, V21, P2136, DOI 10.1111/j.1460-9568.2005.04057.x; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Niederberger E, 2008, FASEB J, V22, P3432, DOI 10.1096/fj.08-109355; Norling LV, 2012, ARTERIOSCL THROM VAS, V32, P1970, DOI 10.1161/ATVBAHA.112.249508; Ohira T, 2010, J BIOL CHEM, V285, P3451, DOI 10.1074/jbc.M109.044131; Park CK, 2011, J NEUROSCI, V31, P18433, DOI 10.1523/JNEUROSCI.4192-11.2011; Pollock J, 2002, NEUROPHARMACOLOGY, V42, P93, DOI 10.1016/S0028-3908(01)00163-0; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Saito O, 2010, BRIT J PHARMACOL, V160, P1754, DOI 10.1111/j.1476-5381.2010.00811.x; Saklatvala J, 1999, BIOCHEM SOC SYMP, P63; SAWADA M, 1989, BRAIN RES, V491, P394, DOI 10.1016/0006-8993(89)90078-4; Schafers M, 2008, NEUROSCI LETT, V437, P188, DOI 10.1016/j.neulet.2008.03.052; Schafers Maria, 2007, Expert Rev Neurother, V7, P1613, DOI 10.1586/14737175.7.11.1613; Semple BD, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-67; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2011, CURR TOP MED CHEM, V11, P629; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Sun T, 2012, EUR J PAIN, V16, P18, DOI 10.1016/j.ejpain.2011.05.005; Svensson CI, 2007, J EXP MED, V204, P245, DOI 10.1084/jem.20061826; Sweitzer SM, 1999, BRAIN RES, V829, P209, DOI 10.1016/S0006-8993(99)01326-8; Tawfik VL, 2007, BRAIN BEHAV IMMUN, V21, P238, DOI 10.1016/j.bbi.2006.07.001; Vale ML, 2003, J PHARMACOL EXP THER, V304, P102, DOI 10.1124/jpet.102.038703; Wang YP, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-95; Wu SH, 2008, INFLAMM RES, V57, P430, DOI 10.1007/s00011-008-7147-1; Xu MX, 2013, CNS NEUROSCI THER, V19, P235, DOI 10.1111/cns.12069; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Yu CG, 2003, J PAIN, V4, P129, DOI 10.1054/jpai.2003.11; Zhang RX, 2008, PAIN, V135, P232, DOI 10.1016/j.pain.2007.05.023	68	57	58	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75543	10.1371/journal.pone.0075543	http://dx.doi.org/10.1371/journal.pone.0075543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086560	Green Published, Green Submitted, gold			2022-12-27	WOS:000325025200046
J	Yoon, J; Matsuo, E; Yamada, D; Mizuno, H; Morimoto, T; Miyakawa, H; Kinoshita, S; Ishimoto, H; Kamikouchi, A				Yoon, Jeonghyeon; Matsuo, Eriko; Yamada, Daichi; Mizuno, Hiroshi; Morimoto, Takako; Miyakawa, Hiroyoshi; Kinoshita, Setsuo; Ishimoto, Hiroshi; Kamikouchi, Azusa			Selectivity and Plasticity in a Sound-Evoked Male-Male Interaction in Drosophila	PLOS ONE			English	Article							COURTSHIP SONGS; BEHAVIORAL-CHARACTERISTICS; HABITUATION; MEMORY; MELANOGASTER; MUTATIONS; GENES; COMMUNICATION; EVOLUTION	During courtship, many animals, including insects, birds, fish, and mammals, utilize acoustic signals to transmit information about species identity. Although auditory communication is crucial across phyla, the neuronal and physiologic processes are poorly understood. Sound-evoked chaining behavior, a display of homosexual courtship behavior in Drosophila males, has long been used as an excellent model for analyzing auditory behavior responses, outcomes of acoustic perception and higher-order brain functions. Here we developed a new method, termed ChaIN (Chain Index Numerator), in which we use a computer-based auto detection system for chaining behavior. The ChaIN system can systematically detect the chaining behavior induced by a series of modified courtship song playbacks. Two evolutionarily related Drosophila species, Drosophila melanogaster and Drosophila simulans, exhibited dramatic selective increases in chaining behavior when exposed to specific auditory cues, suggesting that auditory discrimination processes are involved in the acceleration of chaining behavior. Prolonged monotonous pulse sounds containing courtship song components also induced high intense chaining behavior. Interestingly, the chaining behavior was gradually suppressed over time when song playback continued. This behavioral change is likely to be a plastic behavior and not a simple sensory adaptation or fatigue, because the suppression was released by applying a different pulse pattern. This behavioral plasticity is not a form of habituation because different modality stimuli did not recover the behavioral suppression. Intriguingly, this plastic behavior partially depended on the cAMP signaling pathway controlled by the rutabaga adenylyl cyclase gene that is important for learning and memory. Taken together, this study demonstrates the selectivity and behavioral kinetics of the sound-induced interacting behavior of Drosophila males, and provides a basis for the systematic analysis of genes and neural circuits underlying complex acoustic behavior.	[Yoon, Jeonghyeon; Matsuo, Eriko; Yamada, Daichi; Ishimoto, Hiroshi; Kamikouchi, Azusa] Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648601, Japan; [Mizuno, Hiroshi; Morimoto, Takako; Miyakawa, Hiroyoshi] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 19203, Japan; [Kinoshita, Setsuo] ProMed Co Ltd, Shinjuku Ku, Tokyo, Japan; [Kamikouchi, Azusa] JST, PRESTO, Chiyoda Ku, Tokyo, Japan	Nagoya University; Tokyo University of Pharmacy & Life Sciences; Japan Science & Technology Agency (JST)	Kamikouchi, A (corresponding author), Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648601, Japan.	kamikouchi@bio.nagoya-u.ac.jp	Ishimoto, Hiroshi/AAV-1923-2021	Ishimoto, Hiroshi/0000-0002-8859-6931; Kamikouchi, Azusa/0000-0003-1552-6892	Human Frontier Science Program; Japan Science and Technology Agency; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Mitsubishi Foundation; Grants-in-Aid for Scientific Research [25640010] Funding Source: KAKEN	Human Frontier Science Program(Human Frontier Science Program); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Human Frontier Science Program; PRESTO program "Decoding and controlling brain information" from the Japan Science and Technology Agency; Grant-in-Aid for Young Scientists from Japan Society for the Promotion of Science; a Grant-in-Aid for Scientific Research on Innovative Areas "Systems Molecular Ethology" from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; and Research Grants in the Natural Sciences from the Mitsubishi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETCLARK HC, 1971, NATURE, V234, P255, DOI 10.1038/234255a0; BENNETCLARK HC, 1969, ANIM BEHAV, V17, P755, DOI 10.1016/S0003-3472(69)80023-0; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; CROSSLEY SA, 1995, ANIM BEHAV, V50, P827, DOI 10.1016/0003-3472(95)80142-1; Dalton P, 2000, CHEM SENSES, V25, P487, DOI 10.1093/chemse/25.4.487; Das S, 2011, P NATL ACAD SCI USA, V108, pE646, DOI 10.1073/pnas.1106411108; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; DUERR JS, 1982, P NATL ACAD SCI-BIOL, V79, P3646, DOI 10.1073/pnas.79.11.3646; Eberl DF, 1997, P NATL ACAD SCI USA, V94, P14837, DOI 10.1073/pnas.94.26.14837; Engel JE, 1996, J NEUROSCI, V16, P3486; Engel JE, 2009, NEUROBIOL LEARN MEM, V92, P166, DOI 10.1016/j.nlm.2008.08.003; EWING AW, 1968, BEHAVIOUR, V31, P288, DOI 10.1163/156853968X00298; Fiala Andre, 2003, Sci STKE, V2003, pPL6, DOI 10.1126/stke.2003.174.pl6; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Harris C, 1988, P 4 ALV VIS C, P147, DOI DOI 10.5244/C.2.23; HOIKKALA A, 1987, EVOLUTION, V41, P827, DOI 10.1111/j.1558-5646.1987.tb05856.x; HOY RR, 1988, SCIENCE, V240, P217, DOI 10.1126/science.3127882; Inagaki HK, 2010, NAT PROTOC, V5, P26, DOI 10.1038/nprot.2009.206; Jonsson T, 2011, FLY, V5, P29, DOI 10.4161/fly.5.1.13713; Kamikouchi A, 2006, J COMP NEUROL, V499, P317, DOI 10.1002/cne.21075; Kamikouchi A, 2010, NAT PROTOC, V5, P1229, DOI 10.1038/nprot.2010.85; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; KYRIACOU CP, 1980, P NATL ACAD SCI-BIOL, V77, P6729, DOI 10.1073/pnas.77.11.6729; KYRIACOU CP, 1986, SCIENCE, V232, P494, DOI 10.1126/science.3083506; Lehnert BP, 2013, NEURON, V77, P115, DOI 10.1016/j.neuron.2012.11.030; Menda G, 2011, J EXP BIOL, V214, P2864, DOI 10.1242/jeb.055202; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Paranjpe P, 2012, LEARN MEMORY, V19, P627, DOI 10.1101/lm.026641.112; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Riabinina O, 2011, CURR BIOL, V21, P658, DOI 10.1016/j.cub.2011.03.001; Ritchie MG, 1999, ANIM BEHAV, V58, P649, DOI 10.1006/anbe.1999.1167; SCHILCHER FV, 1975, BEHAV GENET, V5, P395, DOI 10.1007/BF01073208; Tauber E, 2003, BEHAV PROCESS, V64, P197, DOI 10.1016/S0376-6357(03)00135-9; Tootoonian S, 2012, J NEUROSCI, V32, P787, DOI 10.1523/JNEUROSCI.5104-11.2012; WHEELER DA, 1988, BEHAV GENET, V18, P675, DOI 10.1007/BF01066850; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967	39	22	21	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e74289	10.1371/journal.pone.0074289	http://dx.doi.org/10.1371/journal.pone.0074289			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086330	Green Published, Green Submitted, gold			2022-12-27	WOS:000325025200013
J	Scheepers, C; Mohr, S; Fischer, MH; Roberts, AM				Scheepers, Christoph; Mohr, Sibylle; Fischer, Martin H.; Roberts, Andrew M.			Listening to Limericks: A Pupillometry Investigation of Perceivers' Expectancy	PLOS ONE			English	Article							PROCESSING LOAD; RESPONSES	What features of a poem make it captivating, and which cognitive mechanisms are sensitive to these features? We addressed these questions experimentally by measuring pupillary responses of 40 participants who listened to a series of Limericks. The Limericks ended with either a semantic, syntactic, rhyme or metric violation. Compared to a control condition without violations, only the rhyme violation condition induced a reliable pupillary response. An anomaly-rating study on the same stimuli showed that all violations were reliably detectable relative to the control condition, but the anomaly induced by rhyme violations was perceived as most severe. Together, our data suggest that rhyme violations in Limericks may induce an emotional response beyond mere anomaly detection.	[Scheepers, Christoph; Mohr, Sibylle] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Fischer, Martin H.] Univ Potsdam, Dept Psychol, Potsdam, Germany; [Roberts, Andrew M.] Univ Dundee, Sch Humanities, Dundee, Scotland	University of Glasgow; University of Potsdam; University of Dundee	Scheepers, C (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	Christoph.Scheepers@glasgow.ac.uk	Fischer, Martin H./D-9965-2017; Mohr, Sibylle/AAG-6191-2021	Fischer, Martin H./0000-0003-3818-7272; Mohr, Sibylle/0000-0002-9089-6327	School of Humanities at the University of Dundee; AHRC [AH/G013721/1] Funding Source: UKRI; Arts and Humanities Research Council [AH/G013721/1] Funding Source: researchfish	School of Humanities at the University of Dundee; AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	This research was part funded by a small grant from the School of Humanities at the University of Dundee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ashby J, 2005, COGNITION, V96, pB89, DOI 10.1016/j.cognition.2004.12.006; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Carminati MN, 2006, POETICS, V34, P204, DOI 10.1016/j.poetic.2006.05.001; Engelhardt PE, 2010, Q J EXP PSYCHOL, V63, P639, DOI 10.1080/17470210903469864; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Gray T, 1965, POEMS GRAY COLLINS G; Hanauer D., 2001, PSYCHOL SOCIOLOGY LI, P107, DOI DOI 10.1075/UPAL.35.08HAN; Hoorn J. F., 1996, ADV DISC PROCESS, P339; Janisse M.P., 1977, PUPILLOMETRY PSYCHOL; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Lea RB, 2008, PSYCHOL SCI, V19, P709, DOI 10.1111/j.1467-9280.2008.02146.x; Legman Gershon, 1988, LIMERICK; McGann Jerome, 1980, BYRON COMPLETE POETI, VI, P320; Partala T, 2003, INT J HUM-COMPUT ST, V59, P185, DOI 10.1016/S1071-5819(03)00017-X; Scheepers C, 2004, ON-LINE STUDY OF SENTENCE COMPREHENSION, P167; Schrott R, 2011, GEHIRN GEDICHT; Short Mick, 1996, EXPLORING LANGUAGE P	17	22	22	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74986	10.1371/journal.pone.0074986	http://dx.doi.org/10.1371/journal.pone.0074986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	246EK	24086417	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200067
J	Rossetti, V; Ammann, TW; Thurnheer, T; Bagheri, HC; Belibasakis, GN				Rossetti, Valentina; Ammann, Thomas W.; Thurnheer, Thomas; Bagheri, Homayoun C.; Belibasakis, Georgios N.			Phenotypic Diversity of Multicellular Filamentation in Oral Streptococci	PLOS ONE			English	Article							SULFUR BACTERIA; COMMUNITIES; SURVIVAL; GROWTH	Filamentous multicellular bacteria are among the most ancient multicellular organisms. They inhabit a great variety of environments and are present in the human body, including the oral cavity. Beside the selective advantages related to the larger size achieved through filamentation, the development of multicellular bacteria can be also driven by simple ecological factors such as birth and death rates at the cellular level. In order to extend earlier results obtained in aquatic species, we investigate the filamentation process of four different strains of oral streptococci, namely S. mutans, S. salivarius, S. oralis and S. anginosus. The results indicate differences in the capacities of different streptococcus species to form filaments, manifested in terms of length and the time-scale of filament elongation. The filamentation pattern of these oral streptococci resembles that of aquatic bacteria, whereby filaments reach a peak length during exponential growth and become short when the population reaches a steady state. Hence, this study validates that multicellularity can be an emergent property of filamentous bacteria of different ecological niches, and that phenotypic differences in filamentation can occur within species of the same genus, in this case oral streptococci. Moreover, given the role that specific oral streptococci can play in the etiology of oral diseases, these results can possibly open new perspectives in the study of the virulence properties of these species.	[Rossetti, Valentina; Bagheri, Homayoun C.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Ammann, Thomas W.; Thurnheer, Thomas; Belibasakis, Georgios N.] Univ Zurich, Inst Oral Biol, Sect Oral Microbiol & Immunol, Zurich, Switzerland; [Rossetti, Valentina] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich	Rossetti, V (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	valentina.rossetti@uzh.ch	Belibasakis, Georgios/AAL-3159-2020	Belibasakis, Georgios/0000-0002-8164-0653; Bagheri, Homayoun/0000-0002-2495-7785; Thurnheer, Thomas/0000-0002-8615-8209	University of Zurich	University of Zurich	This work has been supported by the University of Zurich (www.uzh.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DG, 2000, CURR OPIN MICROBIOL, V3, P618, DOI 10.1016/S1369-5274(00)00150-8; Berman-Frank I, 2003, RES MICROBIOL, V154, P157, DOI 10.1016/S0923-2508(03)00029-9; Bibby BG, 1939, J BACTERIOL, V38, P263, DOI 10.1128/JB.38.3.263-274.1939; Bonner John Tyler, 1998, Integrative Biology, V1, P27; BURTON JP, 2013, J MED MICROBIOL; Carlsson J, 1968, Odontol Revy, V19, P137; Carlsson J, 1967, Odontol Revy, V18, P55; FISHER LE, 1993, J DENT RES, V72, P1191, DOI 10.1177/00220345930720080501; Gallardo VA, 2007, INT MICROBIOL, V10, P97, DOI 10.2436/20.1501.01.14; Guggenheim B, 2001, J DENT RES, V80, P363, DOI 10.1177/00220345010800011201; Ishijima SA, 2012, APPL ENVIRON MICROB, V78, P2190, DOI 10.1128/AEM.07055-11; Jorgensen BB, 1999, FEMS MICROBIOL ECOL, V28, P301, DOI 10.1016/S0168-6496(98)00122-6; Justice SS, 2008, NAT REV MICROBIOL, V6, P162, DOI 10.1038/nrmicro1820; Kaiser D, 2001, ANNU REV GENET, V35, P103, DOI 10.1146/annurev.genet.35.102401.090145; KAUFMAN J, 1989, INFECT IMMUN, V57, P331, DOI 10.1128/IAI.57.2.331-337.1989; Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002; KOMAREK J, 2005, SUSSWASSERFLORA MITT, V2; LANCY P, 1980, INFECT IMMUN, V29, P663; LANCY P, 1983, INFECT IMMUN, V40, P303, DOI 10.1128/IAI.40.1.303-309.1983; LISTGARTEN MA, 1976, J PERIODONTOL, V47, P139, DOI 10.1902/jop.1976.47.3.139; Paerl HW, 2000, ENVIRON MICROBIOL, V2, P11, DOI 10.1046/j.1462-2920.2000.00071.x; Rosen DA, 2007, PLOS MED, V4, P1949, DOI 10.1371/journal.pmed.0040329; Rossetti V, 2011, J R SOC INTERFACE, V8, P1772, DOI 10.1098/rsif.2011.0102; Rossetti V, 2010, J THEOR BIOL, V262, P23, DOI 10.1016/j.jtbi.2009.09.009; Schaudinn C, 2009, J AM DENT ASSOC, V140, P978, DOI 10.14219/jada.archive.2009.0307; Smith EG, 2012, J DENT RES, V91, P133, DOI 10.1177/0022034511415415; Stinson MW, 2003, INFECT IMMUN, V71, P2365, DOI 10.1128/IAI.71.5.2365-2372.2003; TAKAZOE I, 1963, J DENT RES, V42, P681, DOI 10.1177/00220345630420021601; Tannock GW, 1999, ANTON LEEUW INT J G, V76, P265, DOI 10.1023/A:1002038308506; Wescombe PA, 2012, FUTURE MICROBIOL, V7, P1355, DOI [10.2217/FMB.12.113, 10.2217/fmb.12.113]; Whiley RA, 1998, ORAL MICROBIOL IMMUN, V13, P195, DOI 10.1111/j.1399-302X.1998.tb00698.x; Whitton B.A., 2000, ECOLOGY CYANOBACTERI	33	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76221	10.1371/journal.pone.0076221	http://dx.doi.org/10.1371/journal.pone.0076221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086713	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000325223900088
J	Yu-Wai-Man, C; Smith, FE; Firbank, MJ; Guthrie, G; Guthrie, S; Gorman, GS; Taylor, RW; Turnbull, DM; Griffiths, PG; Blamire, AM; Chinnery, PF; Yu-Wai-Man, P				Yu-Wai-Man, Cynthia; Smith, Fiona E.; Firbank, Michael J.; Guthrie, Grant; Guthrie, Stuart; Gorman, Grainne S.; Taylor, Robert W.; Turnbull, Douglass M.; Griffiths, Philip G.; Blamire, Andrew M.; Chinnery, Patrick F.; Yu-Wai-Man, Patrick			Extraocular Muscle Atrophy and Central Nervous System Involvement in Chronic Progressive External Ophthalmoplegia	PLOS ONE			English	Article							MITOCHONDRIAL DISEASE; MR; MUTATIONS; MYOPATHY; SPECTRUM; BRAIN	Background: Chronic progressive external ophthalmoplegia (CPEO) is a classical mitochondrial ocular disorder characterised by bilateral progressive ptosis and ophthalmoplegia. These ocular features can develop either in isolation or in association with other prominent neurological deficits (CPEO+). Molecularly, CPEO can be classified into two distinct genetic subgroups depending on whether patients harbour single, large-scale mitochondrial DNA (mtDNA) deletions or multiple mtDNA deletions secondary to a nuclear mutation disrupting mtDNA replication or repair. The aim of this magnetic resonance imaging (MRI) study was to investigate whether the ophthalmoplegia in CPEO is primarily myopathic in origin or whether there is evidence of contributory supranuclear pathway dysfunction. Methods: Ten age-matched normal controls and twenty patients with CPEO were recruited nine patients with single, large-scale mtDNA deletions and eleven patients with multiple mtDNA deletions secondary to mutations in POLG, PEO1, OPA1, and RRM2B. All subjects underwent a standardised brain and orbital MRI protocol, together with proton magnetic resonance spectroscopy in two voxels located within the parietal white matter and the brainstem. Results: There was evidence of significant extraocular muscle atrophy in patients with single or multiple mtDNA deletions compared with controls. There was no significant difference in metabolite concentrations between the patient and control groups in both the parietal white matter and brainstem voxels. Volumetric brain measurements revealed marked cortical and cerebellar atrophy among patients with CPEO+ phenotypes. Conclusion: The results of this study support a primary myopathic aetiology for the progressive limitation of eye movements that develops in CPEO.	[Yu-Wai-Man, Cynthia; Guthrie, Grant; Guthrie, Stuart; Griffiths, Philip G.; Yu-Wai-Man, Patrick] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Smith, Fiona E.; Blamire, Andrew M.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Smith, Fiona E.; Blamire, Andrew M.] Newcastle Univ, Newcastle Magnet Resonance Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Firbank, Michael J.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Gorman, Grainne S.; Turnbull, Douglass M.; Chinnery, Patrick F.] Royal Victoria Infirm, Dept Neurol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Gorman, Grainne S.; Taylor, Robert W.; Turnbull, Douglass M.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Chinnery, Patrick F.; Yu-Wai-Man, Patrick] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Yu-Wai-Man, P (corresponding author), Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	Patrick.Yu-Wai-Man@ncl.ac.uk	Blamire, Andrew/AAU-6100-2021; Firbank, Michael J/K-3335-2012	Firbank, Michael J/0000-0002-9536-0185; Chinnery, Patrick/0000-0002-7065-6617; Blamire, Andrew/0000-0002-8749-1257; Yu-Wai-Man, Cynthia/0000-0003-4868-5187; Gorman, Grainne/0000-0002-7585-3409; Turnbull, Doug/0000-0002-8878-9901	Newcastle Joint Research Executive Scientific Committee (JRESC); Medical Research Council (MRC, UK); Wellcome Trust; Medical Research Council [G0700718, MR/K000608/1, G0701386, G1002570] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10011] Funding Source: researchfish; MRC [MR/K000608/1, G0701386, G1002570, G0700718] Funding Source: UKRI	Newcastle Joint Research Executive Scientific Committee (JRESC); Medical Research Council (MRC, UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by research grants from the Newcastle Joint Research Executive Scientific Committee (JRESC), the Medical Research Council (MRC, UK), and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlow TJ, 1998, AM J NEURORADIOL, V19, P95; DAROFF RB, 1966, NEUROLOGY, V16, P161, DOI 10.1212/WNL.16.2_Part_1.161; Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002; Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b; Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f; Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659; Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088; Kapeller P, 1996, J NEUROL SCI, V135, P126, DOI 10.1016/0022-510X(95)00290-I; Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d; Man CYW, 2006, EYE, V20, P564, DOI 10.1038/sj.eye.6701924; MATTHEWS PM, 1993, NEUROLOGY, V43, P2484, DOI 10.1212/WNL.43.12.2484; McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2; Ortube MC, 2006, J AAPOS, V10, P414, DOI 10.1016/j.jaapos.2006.04.012; Palin EJH, 2013, BRAIN, V136, P2379, DOI 10.1093/brain/awt160; Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488; Taherian K, 2007, EYE, V21, P639, DOI 10.1038/sj.eye.6702296; VIVIAN AJ, 1993, EYE, V7, P565, DOI 10.1038/eye.1993.123; WRAY SH, 1995, AM J NEURORADIOL, V16, P1167; Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007; Yu-Wai-Man P, 2012, BRIT J OPHTHALMOL, V96, P1536, DOI 10.1136/bjophthalmol-2012-302566	20	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75048	10.1371/journal.pone.0075048	http://dx.doi.org/10.1371/journal.pone.0075048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086434	Green Submitted, gold, Green Published			2022-12-27	WOS:000325223900035
J	Lemaitre, C; Mahjoub-Messai, F; Dupont, D; Caro, V; Diancourt, L; Bingen, E; Bidet, P; Bonacorsi, S				Lemaitre, Chloe; Mahjoub-Messai, Farah; Dupont, Damien; Caro, Valerie; Diancourt, Laure; Bingen, Edouard; Bidet, Philippe; Bonacorsi, Stephane			A Conserved Virulence Plasmidic Region Contributes to the Virulence of the Multiresistant Escherichia coli Meningitis Strain S286 Belonging to Phylogenetic Group C	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; NEONATAL MENINGITIS; PATHOGENICITY ISLAND; CHI-7122 O78K80H9; BETA-LACTAMASE; YOUNG INFANTS; AVIAN ORIGIN; DNA-SEQUENCE; IDENTIFICATION; UROSEPSIS	Recent isolation of the non-K1 Escherichia coli neonatal meningitis strain S286, belonging to phylogroup C, which is closely related to major group B1, and producing an extended-spectrum beta-lactamase, encouraged us to seek the genetic determinants responsible for its virulence. We show that S286 belongs to the sequence O type ST23(O78) and harbors 4 large plasmids. The largest one, pS286colV (similar to 120 kb), not related to resistance, contains genes characteristic of a Conserved Virulence Plasmidic (CVP) region initially identified in B2 extra-intestinal avian pathogenic E. coli (APEC) strains and in the B2 neonatal meningitis E. coli strain S88. The sequence of this CVP region has a strong homology (98%) with that of the recently sequenced plasmid pChi7122-1 of the O78 APEC strain Chi7122. A CVP plasmid-cured variant of S286 was less virulent than the wild type strain in a neonatal rat sepsis model with a significant lower level of bacteremia at 24 h (4.1 +/- 1.41 versus 2.60 +/- 0.16 log CFU/ml, p = 0.001) and mortality. However, the mortality in the model of adult mice was comparable between wild type and variant indicating that pS286colV is not sufficient by itself to fully explain the virulence of S286. Gene expression analysis of pS286colV in iron depleted environment was very close to that of pS88, suggesting that genes of CVP region may be expressed similarly in two very different genetic backgrounds (group C versus group B2). Screening a collection of 178 human A/B1 extraintestinal pathogenic E. coli (ExPEC) strains revealed that the CVP region is highly prevalent (23%) and MLST analysis indicated that these CVP positive strains belong to several clusters and mostly to phylogroup C. The virulence of S286 is explained in part by the presence of CVP region and this region has spread in different clusters of human A/B1 ExPEC, especially in group C.	[Lemaitre, Chloe; Mahjoub-Messai, Farah; Dupont, Damien; Bingen, Edouard; Bidet, Philippe; Bonacorsi, Stephane] Univ Paris Diderot, Sorbonne Paris Cite, Equipe Ccueil EA3105, Paris, France; [Lemaitre, Chloe; Mahjoub-Messai, Farah; Dupont, Damien; Bingen, Edouard; Bidet, Philippe; Bonacorsi, Stephane] Hop Robert Debre, AP HP, Microbiol Lab, F-75019 Paris, France; [Caro, Valerie; Diancourt, Laure] Inst Pasteur, Genotyping Pathogens & Publ Hlth, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bonacorsi, S (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Equipe Ccueil EA3105, Paris, France.	stephane.bonacorsi@rdb.aphp.fr	Bonacorsi, Stéphane/HGB-3185-2022		Fondation pour la Recherche Medicale	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported in part by the "Fondation pour la Recherche Medicale" for CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Bidet P, 2007, J INFECT DIS, V196, P297, DOI 10.1086/518897; Bingen-Bidois M, 2002, INFECT IMMUN, V70, P3216, DOI 10.1128/IAI.70.6.3216-3226.2002; Bonacorsi S, 2005, J UROLOGY, V173, P195, DOI 10.1097/01.ju.0000148606.07267.7d; Bonacorsi S, 2003, J INFECT DIS, V187, P1895, DOI 10.1086/375347; Bonacorsi S, 2009, INT J MED MICROBIOL, V299, P402, DOI 10.1016/j.ijmm.2009.04.001; BORTOLUSSI R, 1978, INFECT IMMUN, V22, P480, DOI 10.1128/IAI.22.2.480-485.1978; Christenson JK, 2009, MICROBIOL-SGM, V155, P1645, DOI 10.1099/mic.0.026666-0; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Crossman LC, 2010, J BACTERIOL, V192, P5822, DOI 10.1128/JB.00710-10; Dissanayake DRA, 2008, VET MICROBIOL, V132, P355, DOI 10.1016/j.vetmic.2008.05.024; Dozois CM, 2003, P NATL ACAD SCI USA, V100, P247, DOI 10.1073/pnas.232686799; Dozois CM, 2000, INFECT IMMUN, V68, P4145, DOI 10.1128/IAI.68.7.4145-4154.2000; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Fricke WF, 2009, APPL ENVIRON MICROB, V75, P5963, DOI 10.1128/AEM.00786-09; Grimaldi D, 2010, J CLIN MICROBIOL, V48, P3794, DOI 10.1128/JCM.00491-10; Hacker J., 2003, Acta Microbiologica et Immunologica Hungarica, V50, P321, DOI 10.1556/AMicr.50.2003.4.1; Houdouin V, 2008, ARCH PEDIATRIE, V15, pS138, DOI 10.1016/S0929-693X(08)75497-6; Houdouin V, 2002, INFECT IMMUN, V70, P5865, DOI 10.1128/IAI.70.10.5865-5869.2002; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Jeziorowski A, 2007, J BACTERIOL, V189, P7045, DOI 10.1128/JB.00243-07; Johnson JR, 2008, J CLIN MICROBIOL, V46, P3906, DOI 10.1128/JCM.00949-08; Johnson JR, 2003, INFECT DIS CLIN N AM, V17, P261, DOI 10.1016/S0891-5520(03)00027-8; JOHNSON JR, 1988, INFECT IMMUN, V56, P405, DOI 10.1128/IAI.56.2.405-412.1988; Johnson JR, 2005, J INFECT DIS, V191, P46, DOI 10.1086/426450; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Johnson TJ, 2006, J BACTERIOL, V188, P5975, DOI 10.1128/JB.00204-06; Johnson TJ, 2010, INFECT IMMUN, V78, P1931, DOI 10.1128/IAI.01174-09; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Johnson TJ, 2008, J CLIN MICROBIOL, V46, P3987, DOI 10.1128/JCM.00816-08; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LASSITER HA, 1992, J INFECT DIS, V166, P53, DOI 10.1093/infdis/166.1.53; Lassiter HA, 1997, PEDIATR RES, V42, P128, DOI 10.1203/00006450-199707000-00020; Lemaitre C, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-115; Li GW, 2011, INFECT IMMUN, V79, P1951, DOI 10.1128/IAI.01230-10; Liu B, 2010, VET MICROBIOL, V142, P373, DOI 10.1016/j.vetmic.2009.10.019; Logue CM, 2012, APPL ENVIRON MICROB, V78, P5824, DOI 10.1128/AEM.07869-11; Mahjoub-Messai F, 2011, J INFECT DIS, V203, P1844, DOI 10.1093/infdis/jir189; Mellata M, 2010, INFECT IMMUN, V78, P1528, DOI 10.1128/IAI.00981-09; Mellata M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004232; Moissenet D, 2010, J CLIN MICROBIOL, V48, P2459, DOI 10.1128/JCM.00529-10; Mora A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-132; Morales Cesar, 2004, Foodborne Pathog Dis, V1, P160; Moulin-Schouleur M, 2007, J CLIN MICROBIOL, V25, P25; Moulin-Schouleur M, 2006, J CLIN MICROBIOL, V44, P3484, DOI 10.1128/JCM.00548-06; Negre VL, 2004, INFECT IMMUN, V72, P1216, DOI 10.1128/IAI.72.2.1216-1220.2004; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Olesen B, 2012, J CLIN MICROBIOL, V50, P3703, DOI 10.1128/JCM.01909-12; Peigne C, 2009, INFECT IMMUN, V77, P2272, DOI 10.1128/IAI.01333-08; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Plainvert C, 2007, J BACTERIOL, V189, P8528, DOI 10.1128/JB.01013-07; Rodriguez-Siek KE, 2005, MICROBIOL-SGM, V151, P2097, DOI 10.1099/mic.0.27499-0; Ruppe E, 2006, J CLIN MICROBIOL, V44, P4204, DOI 10.1128/JCM.00918-06; Russo TA, 1999, INFECT IMMUN, V67, P5306, DOI 10.1128/IAI.67.10.5306-5314.1999; Sabri M, 2006, MICROBIOL-SGM, V152, P745, DOI 10.1099/mic.0.28682-0; Snyder JA, 2004, INFECT IMMUN, V72, P6373, DOI 10.1128/IAI.72.11.6373-6381.2004; Southern E, 2006, NAT PROTOC, V1, P518, DOI 10.1038/nprot.2006.73; SUGIMURA K, 1988, J BACTERIOL, V170, P5625, DOI 10.1128/jb.170.12.5625-5632.1988; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Tivendale KA, 2010, INFECT IMMUN; Tivendale KA, 2009, MICROBIOL-SGM, V155, P450, DOI 10.1099/mic.0.023143-0; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406	67	32	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e74423	10.1371/journal.pone.0074423	http://dx.doi.org/10.1371/journal.pone.0074423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086343	Green Published, gold, Green Submitted			2022-12-27	WOS:000325220000009
J	Li, G; Shu, ZH; Wang, YQ				Li, Guang; Shu, ZongHuang; Wang, Yiquan			Year-Round Reproduction and Induced Spawning of Chinese Amphioxus, Branchiostoma belcheri, in Laboratory	PLOS ONE			English	Article							DEUTEROSTOME PHYLOGENY; DEVELOPMENTAL BIOLOGY; CHORDATE AMPHIOXUS; 2 LANCELETS; EVOLUTION; VERTEBRATES; GENOME; LANCEOLATUM; DIVERSITY; INSIGHTS	Amphioxus is a best candidate for studying the evolutionary and developmental mechanisms of vertebrates, because of its vertebrate-like but much simpler morphology, embryonic development and genome structure. Producing live amphioxus embryos throughout the year is an ideal for comparative evolution and developmental studies. However, all amphioxus species have distinct breeding seasons in the wild and laboratory. We recently found that Chinese amphioxus B. belcheri could reproduce repeatedly beyond its natural breeding season when reared under proper conditions. In this study, we were able to extend further and produce embryos throughout the year from October 2011 to October 2012. We found all examined animals had spawned repeatedly during the examined period. In addition, both lancelets B. belcheri and B. japonicum could be induced to spawn by heat-shock method, although the induced spawning efficiency was not as high as that observed in the European lancelet. In general, we have succeeded in producing B. belcheri embryos almost daily throughout the year. This advancement will provide essential embryonic material for evolutionary and developmental studies, and have great implications for the cultivation and spawning induction of other amphioxus species.	[Li, Guang; Shu, ZongHuang; Wang, Yiquan] Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China; [Li, Guang; Wang, Yiquan] Xiamen Univ, Shenzhen Res Inst, Shenzhen, Peoples R China	Xiamen University; Xiamen University	Wang, YQ (corresponding author), Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China.	wangyq@xmu.edu.cn			Natural Science Foundation of Fujian Province of China [2011J05097]; National High Technology Research and Development Program of China [2008AA092602]; National Natural Science Foundation of China [30830023, 31101631]; Social Development and Technological Project by Department of Science and Technology of Shenzhen [JSF201006290026A]	Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Development and Technological Project by Department of Science and Technology of Shenzhen	This work was supported by the Natural Science Foundation of Fujian Province of China (No. 2011J05097), the National High Technology Research and Development Program of China (No. 2008AA092602), the National Natural Science Foundation of China (No. 30830023 and No. 31101631) and Social Development and Technological Project by the Department of Science and Technology of Shenzhen (No. JSF201006290026A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaster-Jones L, 2012, BRIEF FUNCT GENOMICS, V11, P118, DOI 10.1093/bfgp/els006; Bertrand S, 2011, DEVELOPMENT, V138, P4819, DOI 10.1242/dev.066720; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Candiani S, 2012, BRIEF FUNCT GENOMICS, V11, P107, DOI 10.1093/bfgp/els004; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Fuentes M, 2004, J EXP ZOOL PART B, V302B, P384, DOI 10.1002/jez.b.20025; Fuentes M, 2007, J EXP ZOOL PART B, V308B, P484, DOI 10.1002/jez.b.21179; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; Gee H, 2001, SYST ASSOC SPEC VOL, V61, P1; Holland LZ, 2004, CELL MOL LIFE SCI, V61, P2290, DOI 10.1007/s00018-004-4075-2; HOLLAND ND, 1989, BIOL BULL-US, V176, P111, DOI 10.2307/1541578; Koop Demian, 2008, Birth Defects Research, V84, P175, DOI 10.1002/bdrc.20128; Li G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050838; Li WY, 2013, ZOOL SCI, V30, P83, DOI 10.2108/zsj.30.83; Paps J, 2012, BRIEF FUNCT GENOMICS, V11, P177, DOI 10.1093/bfgp/els012; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Stokes D, 1991, INVERTEBRA BIOL, V115, P349; Theodosiou M, 2011, J EXP ZOOL PART B, V316B, P263, DOI 10.1002/jez.b.21397; TURBEVILLE JM, 1994, MOL BIOL EVOL, V11, P648; Wang Yi-quan, 2006, Zoological Research, V27, P631; Wang Yi-quan, 2005, Zoological Research, V26, P666; Wu SC, 1986, ADV SCI CHINA BIOL, P231; Xu QS, 2005, J EXP ZOOL PART B, V304B, P259, DOI 10.1002/jez.b.21036; Yu JK, 2009, COLD SPRING HARB PRO, V2009; Zhang QJ, 2007, J EXP ZOOL PART B, V308B, P464, DOI 10.1002/jez.b.21172; Zhang QJ, 2006, ZOOL SCI, V23, P573, DOI 10.2108/zsj.23.573	29	27	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75461	10.1371/journal.pone.0075461	http://dx.doi.org/10.1371/journal.pone.0075461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086537	Green Published, gold			2022-12-27	WOS:000325220000022
J	Chen, J; Lee, EJ; Jing, LF; Christoforou, N; Leong, KW; Setton, LA				Chen, Jun; Lee, Esther J.; Jing, Liufang; Christoforou, Nicolas; Leong, Kam W.; Setton, Lori A.			Differentiation of Mouse Induced Pluripotent Stem Cells (iPSCs) into Nucleus Pulposus-Like Cells In Vitro	PLOS ONE			English	Article							HUMAN INTERVERTEBRAL-DISK; PROTEIN GENE-EXPRESSION; NEURAL GANGLIOSIDE GD2; MATRIX INTERACTIONS; CHONDROCYTE TRANSPLANTATION; NOTOCHORDAL CELLS; END-PLATE; DEGENERATION; PHENOTYPE; GROWTH	A large percentage of the population may be expected to experience painful symptoms or disability associated with intervertebral disc (IVD) degeneration - a condition characterized by diminished integrity of tissue components. Great interest exists in the use of autologous or allogeneic cells delivered to the degenerated IVD to promote matrix regeneration. Induced pluripotent stem cells (iPSCs), derived from a patient's own somatic cells, have demonstrated their capacity to differentiate into various cell types although their potential to differentiate into an IVD cell has not yet been demonstrated. The overall objective of this study was to assess the possibility of generating iPSC-derived nucleus pulposus (NP) cells in a mouse model, a cell population that is entirely derived from notochord. This study employed magnetic activated cell sorting (MACS) to isolate a CD24(+) iPSC subpopulation. Notochordal cell-related gene expression was analyzed in this CD24(+) cell fraction via real time RT-PCR. CD24(+) iPSCs were then cultured in a laminin-rich culture system for up to 28 days, and the mouse NP phenotype was assessed by immunostaining. This study also focused on producing a more conducive environment for NP differentiation of mouse iPSCs with addition of low oxygen tension and notochordal cell conditioned medium (NCCM) to the culture platform. iPSCs were evaluated for an ability to adopt an NP-like phenotype through a combination of immunostaining and biochemical assays. Results demonstrated that a CD24(+) fraction of mouse iPSCs could be retrieved and differentiated into a population that could synthesize matrix components similar to that in native NP. Likewise, the addition of a hypoxic environment and NCCM induced a similar phenotypic result. In conclusion, this study suggests that mouse iPSCs have the potential to differentiate into NP-like cells and suggests the possibility that they may be used as a novel cell source for cellular therapy in the IVD.	[Chen, Jun; Setton, Lori A.] Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC 27705 USA; [Lee, Esther J.; Jing, Liufang; Christoforou, Nicolas; Leong, Kam W.; Setton, Lori A.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA	Duke University; Duke University	Chen, J (corresponding author), Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC 27705 USA.	junchen@duke.edu	Leong, Kam/O-9302-2019; Leong, Kam W/A-7270-2009	Leong, Kam/0000-0002-8133-4955; Leong, Kam W/0000-0002-8133-4955; Setton, Lori/0000-0001-5992-4206	NIH [R01AR057410, R01EB002263, R01AR047442, R01HL083008]; AOSpine Foundation; FAMRI Young Clinical Scientist Award; Pratt Undergraduate Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057410, R01AR047442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002263] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AOSpine Foundation; FAMRI Young Clinical Scientist Award; Pratt Undergraduate Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported by NIH under grants R01AR057410, R01EB002263, R01AR047442, R01HL083008, AOSpine Foundation, FAMRI Young Clinical Scientist Award (NC), and a Pratt Undergraduate Research Fellowship (EJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RD, 2012, J ORTHOP RES, V30, P482, DOI 10.1002/jor.21534; Allon Aliza A, 2009, SAS J, V3, P41, DOI 10.1016/SASJ-2009-0005-NT; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Boyd LM, 2008, ARTHRITIS RHEUM, V58, P164, DOI 10.1002/art.23231; Boyd LM, 2004, SPINE, V29, P2217, DOI 10.1097/01.brs.0000142747.90488.1d; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; Chen J, 2002, BIOCHEM BIOPH RES CO, V293, P932, DOI 10.1016/S0006-291X(02)00314-5; Chen J, 2009, CONNECT TISSUE RES, V50, P294, DOI 10.3109/03008200802714925; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Choi KS, 2011, P NATL ACAD SCI USA, V108, P9484, DOI 10.1073/pnas.1007566108; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; Christoforou N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065963; Crevensten G, 2004, ANN BIOMED ENG, V32, P430, DOI 10.1023/B:ABME.0000017545.84833.7c; Dahia CL, 2009, SPINE, V34, P447, DOI 10.1097/BRS.0b013e3181990c64; Dahia CL, 2009, SPINE, V34, P456, DOI 10.1097/BRS.0b013e3181913e98; Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109; Erwin WM, 2006, ARTHRITIS RHEUM-US, V54, P3859, DOI 10.1002/art.22258; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Fujita N, 2005, BIOCHEM BIOPH RES CO, V338, P1890, DOI 10.1016/j.bbrc.2005.10.166; Gai H, 2009, CELL BIOL INT, V33, P1184, DOI 10.1016/j.cellbi.2009.08.008; Ganey T, 2003, SPINE, V28, P2609, DOI 10.1097/01.BRS.0000097891.63063.78; Gilchrist CL, 2011, EUR CELLS MATER, V21, P523, DOI 10.22203/eCM.v021a39; Gilchrist CL, 2007, J ORTHOP RES, V25, P829, DOI 10.1002/jor.20343; Gilchrist CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027170; Gilson A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2931; GOTZ W, 1995, CELL TISSUE RES, V280, P455; Gruber HE, 2002, SPINE, V27, P1626, DOI 10.1097/00007632-200208010-00007; HERRMANN BG, 1994, TRENDS GENET, V10, P280, DOI 10.1016/0168-9525(90)90011-T; hon BH, 2011, HUMAN UMBILICAL CORD, P36; HUMZAH MD, 1988, ANAT RECORD, V220, P337, DOI 10.1002/ar.1092200402; Jiang W, 2011, STEM CELLS, V29, P609, DOI 10.1002/stem.608; Kandel R, 2008, EUR SPINE J, V17, pS480, DOI 10.1007/s00586-008-0746-2; Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Kim MJ, 2011, ARTHRITIS RHEUM-US, V63, P3010, DOI 10.1002/art.30488; Korecki CL, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt18; Li XD, 2005, CONNECT TISSUE RES, V46, P75, DOI 10.1080/03008200590954104; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Longo U. G., 2012, STEM CELLS INT, V2012, DOI DOI 10.1155/2012/921053-921057; Luo X, 2004, SPINE; Ma W, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-90; Maier JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055528; Martinez C, 2007, BLOOD, V109, P4245, DOI 10.1182/blood-2006-08-039347; Masuda Koichi, 2004, Spine J, V4, p330S, DOI 10.1016/j.spinee.2004.07.028; McCann MR, 2012, DIS MODEL MECH, V5, P73, DOI 10.1242/dmm.008128; Meisel HJ, 2007, BIOMOL ENG, V24, P5, DOI 10.1016/j.bioeng.2006.07.002; Nishimura K, 1998, SPINE, V23, P1531, DOI 10.1097/00007632-199807150-00006; Nomura T, 2001, CLIN ORTHOP RELAT R, P94; OEGEMA TR, 1993, CLIN SPORT MED, V12, P419; Pattappa G, 2012, J ANAT, V221, P480, DOI 10.1111/j.1469-7580.2012.01521.x; Purmessur D, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3344; Richardson SM, 2008, BIOMATERIALS, V29, P85, DOI 10.1016/j.biomaterials.2007.09.018; Risbud MV, 2010, DEV DYNAM, V239, P2141, DOI 10.1002/dvdy.22350; Risbud MV, 2004, SPINE, V29, P2627, DOI 10.1097/01.brs.0000146462.92171.7f; ROBERTS S, 1991, SPINE, V16, P1030, DOI 10.1097/00007632-199109000-00003; Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9; Sakai D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2226; Sakai D, 2008, EUR SPINE J, V17, pS452, DOI 10.1007/s00586-008-0743-5; Setton LA, 2007, REGENERATION REPLACE; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052020; TROUT JJ, 1982, TISSUE CELL, V14, P359, DOI 10.1016/0040-8166(82)90033-7; von Furstenberg RJ, 2011, AM J PHYSIOL-GASTR L, V300, pG409, DOI 10.1152/ajpgi.00453.2010; Wei YY, 2012, EUR CELLS MATER, V23, P1; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Xu J, 2009, CELL PHYSIOL BIOCHEM, V23, P415, DOI 10.1159/000218188; Yu J, 2002, BIOCHEM SOC T, V30, P848, DOI 10.1042/bst0300848	70	41	43	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75548	10.1371/journal.pone.0075548	http://dx.doi.org/10.1371/journal.pone.0075548			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086564	gold, Green Published, Green Submitted			2022-12-27	WOS:000325218700099
J	Havermans, C; Sonet, G; d'Acoz, CD; Nagy, ZT; Martin, P; Brix, S; Riehl, T; Agrawal, S; Held, C				Havermans, Charlotte; Sonet, Gontran; d'Acoz, Cedric d'Udekem; Nagy, Zoltan T.; Martin, Patrick; Brix, Saskia; Riehl, Torben; Agrawal, Shobhit; Held, Christoph			Genetic and Morphological Divergences in the Cosmopolitan Deep-Sea Amphipod Eurythenes gryllus Reveal a Diverse Abyss and a Bipolar Species	PLOS ONE			English	Article							NECROPHAGOUS AMPHIPOD; SCAVENGING AMPHIPODS; POPULATION-STRUCTURE; VERTICAL-DISTRIBUTION; BATHYMETRIC PATTERNS; MITOCHONDRIAL-DNA; CRUSTACEA; DIFFERENTIATION; RATES; BIODIVERSITY	Eurythenes gryllus is one of the most widespread amphipod species, occurring in every ocean with a depth range covering the bathyal, abyssal and hadal zones. Previous studies, however, indicated the existence of several genetically and morphologically divergent lineages, questioning the assumption of its cosmopolitan and eurybathic distribution. For the first time, its genetic diversity was explored at the global scale (Arctic, Atlantic, Pacific and Southern oceans) by analyzing nuclear (28S rDNA) and mitochondrial (COI, 16S rDNA) sequence data using various species delimitation methods in a phylogeographic context. Nine putative species-level clades were identified within E. gryllus. A clear distinction was observed between samples collected at bathyal versus abyssal depths, with a genetic break occurring around 3,000 m. Two bathyal and two abyssal lineages showed a widespread distribution, while five other abyssal lineages each seemed to be restricted to a single ocean basin. The observed higher diversity in the abyss compared to the bathyal zone stands in contrast to the depth-differentiation hypothesis. Our results indicate that, despite the more uniform environment of the abyss and its presumed lack of obvious isolating barriers, abyssal populations might be more likely to show population differentiation and undergo speciation events than previously assumed. Potential factors influencing species' origins and distributions, such as hydrostatic pressure, are discussed. In addition, morphological findings coincided with the molecular clades. Of all specimens available for examination, those of the bipolar bathyal clade seemed the most similar to the 'true' E. gryllus. We present the first molecular evidence for a bipolar distribution in a macro-benthic deep-sea organism.	[Havermans, Charlotte; Martin, Patrick] Royal Belgian Inst Nat Sci, Direct Nat Environm, Brussels, Belgium; [Sonet, Gontran; d'Acoz, Cedric d'Udekem; Nagy, Zoltan T.; Martin, Patrick] Royal Belgian Inst Nat Sci, Direct Taxon & Phylogeny, Brussels, Belgium; [Havermans, Charlotte] Catholic Univ Louvain, Biodivers Res Ctr, Earth & Life Inst, B-3000 Louvain, Belgium; [Brix, Saskia; Riehl, Torben] Bioctr Grindel, Senckenberg Res Inst, Ctr Marine Biodivers Res, Hamburg, Germany; [Agrawal, Shobhit; Held, Christoph] Alfred Wegener Inst Helmholtz Ctr Polar & Marine, Sect Funct Ecol, Bremerhaven, Germany	Royal Belgian Institute of Natural Sciences; Royal Belgian Institute of Natural Sciences; Universite Catholique Louvain; Senckenberg Gesellschaft fur Naturforschung (SGN); University of Hamburg; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Havermans, C (corresponding author), Royal Belgian Inst Nat Sci, Direct Nat Environm, Brussels, Belgium.	chavermans@naturalsciences.be	Nagy, Zoltan T./C-6737-2011; Riehl, Torben/C-3711-2013; Martin, Patrick/V-9708-2019	Nagy, Zoltan T./0000-0002-8455-040X; Martin, Patrick/0000-0002-6033-8412; Havermans, Charlotte/0000-0002-1126-4074; Riehl, Torben/0000-0002-7363-4421	Belgian Science Policy Office and Scientific Research Program on Antarctica; project BIANZO II; Belgian Science Policy Office [WI/36/H04, MO/36/022]; Antarctic Science Bursary; DFG [HE 3391/5-1, SPP 1158]	Belgian Science Policy Office and Scientific Research Program on Antarctica; project BIANZO II; Belgian Science Policy Office(Belgian Federal Science Policy Office); Antarctic Science Bursary; DFG(German Research Foundation (DFG))	This work was supported by the Belgian Science Policy Office and Scientific Research Program on Antarctica, with the project BIANZO II. The first author was supported by an Action II grant (contract number WI/36/H04) and CUA by an Action I grant (contract number MO/36/022) of the Belgian Science Policy Office. GS and ZTN are part of the Joint Experimental Molecular Unit, also supported by the Belgian Science Policy Office. Part of the molecular work was funded by an Antarctic Science Bursary to the first author. SA and C Held were supported by the DFG grant HE 3391/5-1 within the SPP 1158. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Samples were collected during the expeditions ANDEEP I, II, III, ANT-XIII-8, ANT XXVII-3, ARK XIX-3 aboard RV Polarstern, the expedition DIVA-3 aboard RV Meteor and a cruise aboard RV Jan Mayen.	ALTABET MA, 1991, NATURE, V354, P136, DOI 10.1038/354136a0; Baird HP, 2011, MOL ECOL, V20, P3439, DOI 10.1111/j.1365-294X.2011.05173.x; Bano N, 2004, APPL ENVIRON MICROB, V70, P781, DOI 10.1128/AEM.70.2.781-789.2004; Barnard J. L., 1961, Galathea Report, V5, P23; Birky CW, 2005, HYDROBIOLOGIA, V546, P29, DOI 10.1007/s10750-005-4097-2; Blankenship LE, 2006, DEEP-SEA RES PT I, V53, P48, DOI 10.1016/j.dsr.2005.09.006; Blankenship LE, 2007, LIMNOL OCEANOGR, V52, P1685, DOI 10.4319/lo.2007.52.4.1685; BOWMAN T E, 1972, Crustaceana (Leiden), V23, P187, DOI 10.1163/156854072X00363; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; Brandt A, 2012, POL POLAR RES, V33, P139, DOI 10.2478/v10183-012-0012-5; Brinkmeyer R, 2003, APPL ENVIRON MICROB, V69, P6610, DOI 10.1128/AEM.69.11.6610-6619.2003; Brix Saskia, 2011, Zootaxa, V2838, P79; BROWN A, 2012, BIOGEOSCIENCES DISCU, V9, pC1; Brown A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028562; BUCKLIN A, 1987, DEEP-SEA RES, V34, P1795, DOI 10.1016/0198-0149(87)90054-9; CHRISTIANSEN B, 1990, MAR ECOL PROG SER, V66, P35, DOI 10.3354/meps066035; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; CORFIELD R, 2003, SILENT LANDSCAPE SCI; CRAME JA, 1993, J BIOGEOGR, V20, P145, DOI 10.2307/2845668; DUFFY GA, 2012, BIOGEOSCIENCES DISCU, V9, P7831; Escobar-Briones E, 2010, REV MEX BIODIVERS, V81, pS177; ETTER RJ, 1992, NATURE, V360, P576, DOI 10.1038/360576a0; Etter RJ, 2005, EVOLUTION, V59, P1479, DOI 10.1111/j.0014-3820.2005.tb01797.x; Etter RJ, 1999, DEEP-SEA RES PT I, V46, P1095, DOI 10.1016/S0967-0637(98)00100-9; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; France SC, 1996, MOL MAR BIOL BIOTECH, V5, P304; France SC, 1996, MAR BIOL, V126, P633, DOI 10.1007/BF00351330; FRANCE SC, 1994, MAR BIOL, V118, P67, DOI 10.1007/BF00699220; GRASSLE JF, 1992, AM NAT, V139, P313, DOI 10.1086/285329; HARGRAVE BT, 1985, DEEP-SEA RES, V32, P443, DOI 10.1016/0198-0149(85)90090-1; Havermans C, 2011, DEEP-SEA RES PT II, V58, P230, DOI 10.1016/j.dsr2.2010.09.028; Havermans C, 2010, MOL PHYLOGENET EVOL, V55, P202, DOI 10.1016/j.ympev.2009.10.025; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Held C, 2003, ANTARCTIC BIOLOGY IN A GLOBAL CONTEXT, PROCEEDINGS, P135; HESSLER RR, 1967, DEEP-SEA RES, V14, P65; Hou ZG, 2007, MOL PHYLOGENET EVOL, V45, P596, DOI 10.1016/j.ympev.2007.06.006; Howell KL, 2004, MAR BIOL, V144, P977, DOI 10.1007/s00227-003-1248-8; Hunt Brian, 2010, PLoS ONE, V5, P1, DOI 10.1371/journal.pone.0009835; INGRAM CL, 1987, DEEP-SEA RES, V34, P1889, DOI 10.1016/0198-0149(87)90090-2; INGRAM CL, 1983, DEEP-SEA RES, V30, P683, DOI 10.1016/0198-0149(83)90017-1; Jamieson AJ, 2011, DEEP-SEA RES PT I, V58, P49, DOI 10.1016/j.dsr.2010.11.003; Kanzaki N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043865; Katho K., 2002, NUCLEIC ACIDS RES, V30, P3059, DOI [10.1093/nar/gkf436, DOI 10.1093/NAR/GKF436]; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kojima S, 2001, MAR ECOL PROG SER, V217, P135, DOI 10.3354/meps217135; Kuklinski P, 2010, MAR ECOL PROG SER, V401, P15, DOI 10.3354/meps08446; Laakmann S, 2012, MOL PHYLOGENET EVOL, V65, P535, DOI 10.1016/j.ympev.2012.07.007; Lorz AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032365; Madsen F. J., 1961, Galathea Report, V4, P177; MANTYLA AW, 1983, DEEP-SEA RES, V30, P805, DOI 10.1016/0198-0149(83)90002-X; Menzel L, 2011, DEEP-SEA RES PT I, V58, P839, DOI 10.1016/j.dsr.2011.05.008; Miller K, 2011, TLS-TIMES LIT SUPPL, P6; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Palumbi Stephen R., 1991, Molecular Marine Biology and Biotechnology, V1, P27; PATERSON GLJ, 1995, DEEP-SEA RES PT I, V42, P1199, DOI 10.1016/0967-0637(95)00041-4; Pawlowski J, 2007, MOL ECOL, V16, P4089, DOI 10.1111/j.1365-294X.2007.03465.x; Pawlowski J, 2008, POLAR BIOL, V31, P1205, DOI 10.1007/s00300-008-0459-3; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Premke K, 2009, VIE MILIEU, V59, P251; Premke K, 2003, J EXP MAR BIOL ECOL, V285, P283, DOI 10.1016/S0022-0981(02)00533-6; Premke K, 2006, MAR ECOL PROG SER, V325, P121, DOI 10.3354/meps325121; Quattro JM, 2001, MAR BIOL, V139, P1107; Raupach MJ, 2007, DEEP-SEA RES PT II, V54, P1820, DOI 10.1016/j.dsr2.2007.07.009; Raupach MJ, 2006, ANTARCT SCI, V18, P191, DOI 10.1017/S0954102006000228; Rex M.A., 1983, DEEP SEA BIOL SEA, V8, P453; REX MA, 2010, DEEP SEA BIODIVERSIT, P199; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schuller M, 2011, POLAR BIOL, V34, P549, DOI 10.1007/s00300-010-0913-x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Senna Andre R., 2009, Nauplius, V17, P81; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; SMITH KL, 1984, DEEP-SEA RES, V31, P1179, DOI 10.1016/0198-0149(84)90057-8; SOMERO GN, 1992, ANNU REV PHYSIOL, V54, P557, DOI 10.1146/annurev.ph.54.030192.003013; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Takeuchi I, 1998, MAR ECOL PROG SER, V163, P285, DOI 10.3354/meps163285; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thoen HH, 2011, POLAR BIOL, V34, P83, DOI 10.1007/s00300-010-0861-5; Thurston MH, 2002, J MAR BIOL ASSOC UK, V82, P205, DOI 10.1017/S0025315402005374; Uriz MJ, 2011, POLAR BIOL, V34, P243, DOI 10.1007/s00300-010-0876-y; Zardus JD, 2006, MOL ECOL, V15, P639, DOI 10.1111/j.1365-294X.2005.02832.x	83	107	110	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74218	10.1371/journal.pone.0074218	http://dx.doi.org/10.1371/journal.pone.0074218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086322	Green Published, gold			2022-12-27	WOS:000325218700018
J	Jalbert, E; Crawford, TQ; D'Antoni, ML; Keating, SM; Norris, PJ; Nakamoto, BK; Seto, T; Parikh, NI; Shikuma, CM; Ndhlovu, LC; Barbour, JD				Jalbert, Emilie; Crawford, Timothy Q.; D'Antoni, Michelle L.; Keating, Sheila M.; Norris, Philip J.; Nakamoto, Beau K.; Seto, Todd; Parikh, Nisha I.; Shikuma, Cecilia M.; Ndhlovu, Lishomwa C.; Barbour, Jason D.			IL-1B Enriched Monocytes Mount Massive IL-6 Responses to Common Inflammatory Triggers among Chronically HIV-1 Infected Adults on Stable Anti-Retroviral Therapy at Risk for Cardiovascular Disease	PLOS ONE			English	Article							FLOW-CYTOMETRY; HIV; INFECTION; EXPRESSION; TNF; INTERLEUKIN-1; MACROPHAGES; ACTIVATION; INITIATION; IL-1-BETA	Chronic infection by HIV increases the risk of cardiovascular disease (CVD) despite effective antiretroviral therapy (ART). The mechanisms linking HIV to CVD have yet to be fully elucidated. High plasma levels of the pro-inflammatory cytokine IL-6, which may be triggered by IL-1 beta, is a biomarker of CVD risk in HIV-negative adults, and of all-cause mortality in HIV disease. Monocytes play a pivotal role in atherosclerosis, and may be major mediators of HIV-associated inflammation. We therefore hypothesized that monocytes from HIV-infected adults would display high inflammatory responses. Employing a 10-color flow cytometry intracellular cytokine staining assay, we directly assessed cytokine and chemokine responses of monocytes from the cryopreserved peripheral blood of 33 chronically HIV-1 infected subjects. Participants were 45 years or older, on virologically suppressive ART and at risk for CVD. This group was compared to 14 HIV-negative subjects matched for age and gender, with similar CVD risk. We simultaneously detected intracellular expression of IL-1 beta, IL-6, IL-8 and TNF in blood monocytes in the basal state and after stimulation by triggers commonly found in the blood of treated, chronically HIV-infected subjects: lipopolysaccharide (LPS) and oxidized low-density lipoprotein (oxLDL). In the absence of stimulation, monocytes from treated HIV-infected subjects displayed a high frequency of cells producing IL-1 beta (median 19.5%), compared to low levels in HIV-uninfected persons (0.9% p<0.0001). IL-8, which is induced by IL-1 beta, was also highly expressed in the HIV-infected group in the absence of stimulation, 43.7% compared to 1.9% in HIV-uninfected subjects, p<0.0001. Strikingly, high basal expression of IL-1 beta by monocytes predicted high IL-6 levels in the plasma, and high monocyte IL-6 responses in HIV-infected subjects. Hyper-inflammatory IL-1 beta enriched monocytes may be a major source of IL-6 production and systemic inflammation in HIV-infected adults, and may contribute to the risk for all-cause mortality and cardiovascular disease in treated HIV infection.	[Jalbert, Emilie; Crawford, Timothy Q.; D'Antoni, Michelle L.; Seto, Todd; Parikh, Nisha I.; Shikuma, Cecilia M.; Ndhlovu, Lishomwa C.; Barbour, Jason D.] Hawaii Ctr HIV AIDS, Honolulu, HI 96813 USA; [Jalbert, Emilie; Crawford, Timothy Q.; D'Antoni, Michelle L.; Ndhlovu, Lishomwa C.; Barbour, Jason D.] Univ Hawaii, John A Burns Sch Med, Dept Trop Med, Honolulu, HI 96822 USA; [Keating, Sheila M.; Norris, Philip J.] Blood Syst Res Inst, San Francisco, CA USA; [Keating, Sheila M.; Norris, Philip J.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Norris, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Nakamoto, Beau K.; Shikuma, Cecilia M.] Univ Hawaii, John A Burns Sch Med, Dept Med, Honolulu, HI 96822 USA; [Nakamoto, Beau K.] Straub Clin & Hosp, Honolulu, HI USA; [Seto, Todd; Parikh, Nisha I.] Queens Med Ctr, Honolulu, HI USA	University of Hawaii System; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Hawaii System; The Queen's Medical Center	Barbour, JD (corresponding author), Hawaii Ctr HIV AIDS, Honolulu, HI 96813 USA.	jbarbour@hawaii.edu	n, l/AAX-3992-2020	Keating, Sheila/0000-0002-8324-3694; Ndhlovu, Lishomwa/0000-0001-5427-4187; Jalbert, Emilie/0000-0001-7056-5275	NIH [R01HL095135]; Dean's Office of the John A. Burns School of Medicine; Vice Chancellor's Office for Research and Graduate Education of the University of Hawaii Manoa; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dean's Office of the John A. Burns School of Medicine; Vice Chancellor's Office for Research and Graduate Education of the University of Hawaii Manoa; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The authors thank the NIH R01HL095135 for funding support to C. S. and support from the Dean's Office of the John A. Burns School of Medicine, and the Vice Chancellor's Office for Research and Graduate Education of the University of Hawaii Manoa, to J.D.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autissier P, 2010, CYTOM PART A, V77A, P410, DOI 10.1002/cyto.a.20859; Baker J, 2013, 20 C RETR OPP INF 3; Baker JV, 2011, AIDS, V25, P2133, DOI 10.1097/QAD.0b013e32834be088; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Berg KE, 2012, CIRC-CARDIOVASC GENE, V5, P122, DOI 10.1161/CIRCGENETICS.111.960385; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Boulware DR, 2011, J INFECT DIS, V203, P1637, DOI 10.1093/infdis/jir134; CalzadaWack JC, 1996, J INFLAMM, V46, P78; DINARELLO CA, 1984, NEW ENGL J MED, V311, P1413; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Dutertre CA, 2012, BLOOD, V120, P2259, DOI 10.1182/blood-2012-03-418681; Esser S, 2013, CLIN RES CARDIOL, V102, P203, DOI 10.1007/s00392-012-0519-0; Funderburg NT, 2012, BLOOD, V120, P4599, DOI 10.1182/blood-2012-05-433946; Funderburg NT, 2010, BLOOD, V115, P161, DOI 10.1182/blood-2009-03-210179; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hsue PY, 2012, J INFECT DIS, V205, pS375, DOI 10.1093/infdis/jis200; Jalbert E, 2013, CYTOM PART A, V83A, P280, DOI 10.1002/cyto.a.22257; Longenecker C, 2013, HIV MED; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Ordovas JM, 2010, NAT REV CARDIOL, V7, P510, DOI 10.1038/nrcardio.2010.104; Ratto-Kim S, 2008, J NEUROIMMUNOL, V195, P100, DOI 10.1016/j.jneuroim.2007.11.021; Robbins CS, 2010, CELL MOL LIFE SCI, V67, P2685, DOI 10.1007/s00018-010-0375-x; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shikuma CM, 2012, AIDS RES HUM RETROV, V28, P793, DOI [10.1089/aid.2011.0086, 10.1089/AID.2011.0086]; Shive CL, 2012, JAIDS-J ACQ IMM DEF, V61, P145, DOI 10.1097/QAI.0b013e31825ddbbf; Siedlar M, 2000, IMMUNOBIOLOGY, V202, P11, DOI 10.1016/S0171-2985(00)80047-9; TOSATO G, 1990, BLOOD, V75, P1305, DOI 10.1182/blood.V75.6.1305.1305; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605	33	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75500	10.1371/journal.pone.0075500	http://dx.doi.org/10.1371/journal.pone.0075500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086545	Green Submitted, gold, Green Published			2022-12-27	WOS:000325218700091
J	Khan, MMH; Zanuzdana, A; Kraemer, A				Khan, Md Mobarak Hossain; Zanuzdana, Arina; Kraemer, Alexander			Levels, Trends and Disparities in Public-Health-Related Indicators among Reproductive-Age Women in Bangladesh by Urban-Rural and Richest-Poorest Groups, 1993-2011	PLOS ONE			English	Article							MATERNAL HEALTH; CARE SERVICES; DETERMINANTS; MARRIAGE; POVERTY; MALNUTRITION; INEQUITIES; OVERWEIGHT; FERTILITY; AUTONOMY	Background And Objectives: Although Bangladesh has already achieved noticeable progress in the field of development and health, disparities in public health indicators for several markers are still reported. To assess public health development in Bangladesh during the last two decades, firstly, we analysed levels, trends and disparities in public-health-related indicators by rural versus urban as well as by the richest versus poorest group of women who have ever been married. Secondly, using the most recent data set we performed multiple analyses to check whether urban-rural and richest-poorest disparities were still significant. Methods: The analysis was based on six nationally representative data sets from the Bangladesh Demographic and Health Surveys (BDHS) conducted in 1993-94 (n=9,640), 1996-1997 (n=9,127), 1999-2000 (n=10,544), 2004 (n=11,440), 2007 (n=10,996) and 2011 (n=17,749). The outcome variables were six selected public-health-related indicators. We performed various types of analyses, including multiple logistic regressions. Results: The trend of all indicators except being overweight (1993-2011) displayed gradual improvements for both markers. However, the urban and richest groups revealed a better situation than their counterparts in both simple and multiple analyses. Disparities between richest-poorest groups were more pronounced than urban-rural disparities. For instance, the prevalence of delivery at any healthcare facility in 2011 was 20.4% in rural areas and 46.5% in urban areas, whereas it was 9.1% in the poorest group and 57.6% in the richest group. Conclusion: The public health sector in Bangladesh has achieved some successes over the last two decades. However, urban-rural and richest-poorest disparities are still considerable and therefore more public health strategies and efforts are clearly needed for the rural and poorest groups of women in order to reduce these gaps further.	[Khan, Md Mobarak Hossain; Zanuzdana, Arina; Kraemer, Alexander] Univ Bielefeld, Sch Publ Hlth, Dept Publ Hlth Med, D-33615 Bielefeld, Germany	University of Bielefeld	Khan, MMH (corresponding author), Univ Bielefeld, Sch Publ Hlth, Dept Publ Hlth Med, D-33615 Bielefeld, Germany.	mobarak.khan@uni-bielefeld.de	Kraemer, Alexander/F-8832-2016	Kraemer, Alexander/0000-0003-2774-7860				Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; Ahmed SM, 1998, J BIOSOC SCI, V30, P349, DOI 10.1017/S0021932098003496; Ahmed SM, 2000, SOC SCI MED, V51, P361, DOI 10.1016/S0277-9536(99)00461-X; [Anonymous], 2008, LANCET, V371, P2008; *BANK WORLD, 2008, BANK WORLD BANGL DEV, V22; *BANK WORLD, 2007, 14 BANK WORLD, V14; Bankole A, 1998, J BIOSOC SCI, V30, P439, DOI 10.1017/S0021932098004398; Bhuiya A, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-29; Chakraborty N, 2003, HEALTH PROMOT INT, V18, P327, DOI 10.1093/heapro/dag414; Chowdhury AMR, 2007, LANCET, V370, P1292, DOI 10.1016/S0140-6736(07)61554-2; Corsi DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025120; CSDH, 2008, CLOS GAP GEN HLTH EQ; Fikree FF, 2004, BMJ-BRIT MED J, V328, P823, DOI 10.1136/bmj.328.7443.823; *GOB, 2005, MILL DEV GOALS; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Howe LD, 2009, J EPIDEMIOL COMMUN H, V63, P871, DOI 10.1136/jech.2009.088021; Jancloes M, 1998, WORLD HEALTH FORUM, V19, P182; Jankovic J, 2010, EUR J PUBLIC HEALTH, V20, P389, DOI 10.1093/eurpub/ckp189; Jejeebhoy SJ, 2001, POPUL DEV REV, V27, P687, DOI 10.1111/j.1728-4457.2001.00687.x; Jones GW, 2007, POPUL DEV REV, V33, P453, DOI 10.1111/j.1728-4457.2007.00180.x; Kabir MA, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1170, DOI 10.1177/1010539512437401; Kamal SMM, 2012, J HEALTH POPUL NUTR, V30, P317; Karim F, 2006, PUBLIC HEALTH, V120, P193, DOI 10.1016/j.puhe.2005.08.016; Khan MMH, 2012, J PUBLIC HEALTH-UK, V34, P261, DOI 10.1093/pubmed/fdr108; Khan MMH, 2009, SINGAP MED J, V50, P804; Khan MMH, 2011, B WORLD HEALTH ORGAN, V89, P583, DOI 10.2471/BLT.11.087429; KHAN MMH, 2005, J HLTH POPUL DEV CTR, P1; Koblinsky M, 2008, J HEALTH POPUL NUTR, V26, P280; *MACR INT, 2012, EM HLTH SURV; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; MARTIN TC, 1995, STUD FAMILY PLANN, V26, P187, DOI 10.2307/2137845; Milton AH, 2010, ASIA-PAC J PUBLIC HE, V22, P110, DOI 10.1177/1010539509350913; MITRA S, 1997, BANGLADESH DEMOGRAPH; MITRA SNA, 1994, BANGLADESH DEMOGRAPH; NIPORT M, 2005, BANGL DEM HLTH SURV; NIPORT M, 2001, ANGL DEM HLTH SURV 1; NIPORT M, 2009, BANGL DEM HLTH SURV; NIPORT Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; Nuraini E, 2005, Asia Pac J Public Health, V17, P3, DOI 10.1177/101053950501700102; Pathak PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013593; Rahman MH, 2008, J BIOSOC SCI, V40, P19, DOI 10.1017/S0021932007002258; Rahman Redwanur M, 2006, BMC Int Health Hum Rights, V6, P4, DOI 10.1186/1472-698X-6-4; Raj A, 2009, LANCET, V373, P1883, DOI 10.1016/S0140-6736(09)60246-4; Razzaque Abdur, 2007, Int J Equity Health, V6, P4, DOI 10.1186/1475-9276-6-4; Romaniuk A, 2011, POPUL DEV REV, V37, P1, DOI 10.1111/j.1728-4457.2011.00388.x; Rubayet S, 2012, HEALTH POLICY PLANN, V27, P40, DOI 10.1093/heapol/czs044; Schuler SR, 2006, SOC SCI MED, V62, P2826, DOI 10.1016/j.socscimed.2005.11.004; Senarath U, 2009, ASIA-PAC J PUBLIC HE, V21, P137, DOI 10.1177/1010539509331590; Shafique S, 2007, INT J EPIDEMIOL, V36, P449, DOI 10.1093/ije/dyl306; Sicchia SR, 2006, CAN J PUBLIC HEALTH, V97, P69, DOI 10.1007/BF03405219; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Singh A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030947, 10.1371/journal.pone.0044728, 10.1371/journal.pone.0039812, 10.1371/journal.pone.0044931]; Streatfield PK, 2008, J HEALTH POPUL NUTR, V26, P261; Trinh LTT, 2006, PUBLIC HEALTH REP, V121, P468, DOI 10.1177/003335490612100417; van Eijk Anna M, 2006, Reprod Health, V3, P2, DOI 10.1186/1742-4755-3-2; Victora CG, 2010, HEALTH POLICY PLANN, V25, P253, DOI 10.1093/heapol/czp065; Wagstaff A, 2002, B WORLD HEALTH ORGAN, V80, P97; Westoff CF, 2011, POPUL DEV REV, V37, P749, DOI 10.1111/j.1728-4457.2011.00455.x	58	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75261	10.1371/journal.pone.0075261	http://dx.doi.org/10.1371/journal.pone.0075261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VC	24086485	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700065
J	Ma, JX; Trop, S; Baer, S; Rakhmanaliev, E; Arany, Z; Dumoulin, P; Zhang, H; Romano, J; Coppens, I; Levitsky, V; Levitskaya, J				Ma, Jinxia; Trop, Stefanie; Baer, Samantha; Rakhmanaliev, Elian; Arany, Zita; Dumoulin, Peter; Zhang, Hao; Romano, Julia; Coppens, Isabelle; Levitsky, Victor; Levitskaya, Jelena			Dynamics of the Major Histocompatibility Complex Class I Processing and Presentation Pathway in the Course of Malaria Parasite Development in Human Hepatocytes: Implications for Vaccine Development	PLOS ONE			English	Article							CD8(+) T-CELLS; PLASMODIUM CIRCUMSPOROZOITE PROTEIN; VIRAL IMMUNE EVASION; BERGHEI LIVER STAGES; ENDOPLASMIC-RETICULUM; MEMORY; STAGE; STRATEGIES; EFFECTOR; ESCAPE	Control of parasite replication exerted by MHC class I restricted CD8+ T-cells in the liver is critical for vaccination-induced protection against malaria. While many intracellular pathogens subvert the MHC class I presentation machinery, its functionality in the course of malaria replication in hepatocytes has not been characterized. Using experimental systems based on specific identification, isolation and analysis of human hepatocytes infected with P. berghei ANKA GFP or P. falciparum 3D7 GFP sporozoites we demonstrated that molecular components of the MHC class I pathway exhibit largely unaltered expression in malaria-infected hepatocytes until very late stages of parasite development. Furthermore, infected cells showed no obvious defects in their capacity to upregulate expression of different molecular components of the MHC class I machinery in response to pro-inflammatory lymphokines or trigger direct activation of allo-specific or peptide-specific human CD8+ T-cells. We further demonstrate that ectopic expression of circumsporozoite protein does not alter expression of critical genes of the MHC class I pathway and its response to pro-inflammatory cytokines. In addition, we identified supra-cellular structures, which arose at late stages of parasite replication, possessed the characteristic morphology of merosomes and exhibited nearly complete loss of surface MHC class I expression. These data have multiple implications for our understanding of natural T-cell immunity against malaria and may promote development of novel, efficient anti-malaria vaccines overcoming immune escape of the parasite in the liver.	[Ma, Jinxia; Trop, Stefanie; Baer, Samantha; Rakhmanaliev, Elian; Arany, Zita; Dumoulin, Peter; Zhang, Hao; Romano, Julia; Coppens, Isabelle; Levitskaya, Jelena] Johns Hopkins Univ, W Harry Feinstone Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Levitsky, Victor] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Levitskaya, J (corresponding author), Johns Hopkins Univ, W Harry Feinstone Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	jelevits@jhsph.edu		Romano, Julia/0000-0001-8956-7377	JHMRI pilot grant "Alterations of the MHC class I processing and presentation pathway at the liver stage of malaria infection"; JHMRI postdoctoral fellowship	JHMRI pilot grant "Alterations of the MHC class I processing and presentation pathway at the liver stage of malaria infection"; JHMRI postdoctoral fellowship	This work was supported by the JHMRI pilot grant "Alterations of the MHC class I processing and presentation pathway at the liver stage of malaria infection" and JHMRI postdoctoral fellowship awarded to Jinxia Ma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulghani J, 2010, EXPERT OPIN THER TAR, V14, P1091, DOI 10.1517/14728222.2010.519701; Abele R, 2011, ESSAYS BIOCHEM, V50, P249, DOI [10.1042/BSE0500249, 10.1042/bse0500249]; Lin AF, 2007, CELL MOL IMMUNOL, V4, P91; Alto NM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006114; Balam S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051875; Basta S, 2003, VIRAL IMMUNOL, V16, P231, DOI 10.1089/088282403322396064; Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Berridge MJ, 1997, CRIT REV IMMUNOL, V17, P155, DOI 10.1615/CritRevImmunol.v17.i2.30; Bongfen SE, 2007, J IMMUNOL, V178, P7054, DOI 10.4049/jimmunol.178.11.7054; Butler NS, 2012, TRENDS IMMUNOL, V33, P247, DOI 10.1016/j.it.2012.02.001; Chakravarty S, 2008, INFECT IMMUN, V76, P3628, DOI 10.1128/IAI.00471-08; Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; Chinnaiyan A M, 1997, Semin Immunol, V9, P69, DOI 10.1006/smim.1996.0055; Cockburn IA, 2007, CURR OPIN IMMUNOL, V19, P424, DOI 10.1016/j.coi.2007.05.008; Cockburn IA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001318; Cockburn IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000877; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; Ewen CL, 2012, CELL DEATH DIFFER, V19, P28, DOI 10.1038/cdd.2011.153; Frevert U, 1998, EMBO J, V17, P3816, DOI 10.1093/emboj/17.14.3816; Fruh K, 1999, IMMUNOL REV, V168, P157, DOI 10.1111/j.1600-065X.1999.tb01290.x; Fruh K, 2002, VIRUS RES, V88, P55, DOI 10.1016/S0168-1702(02)00120-X; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Graewe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002224; Greenwood B, 2011, PHILOS T R SOC B, V366, P2733, DOI 10.1098/rstb.2011.0076; Gruhler A, 2000, TRAFFIC, V1, P306, DOI 10.1034/j.1600-0854.2000.010403.x; Hafalla JCR, 2007, J INFECT DIS, V196, P1827, DOI 10.1086/522965; Hafalla JC, 2011, IMMUNOL REV, V240, P297, DOI 10.1111/j.1600-065X.2010.00988.x; Hoves S, 2010, J LEUKOCYTE BIOL, V87, P237, DOI 10.1189/jlb.0909608; Jobe O, 2007, J INFECT DIS, V196, P599, DOI 10.1086/519743; Johnston JB, 2003, J VIROL, V77, P6093, DOI 10.1128/JVI.77.11.6093-6100.2003; Kamp W, 2000, EUR J CLIN INVEST, V30, P740; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Levitsky V, 1997, J IMMUNOL, V159, P5383; Levitsky V, 1996, J EXP MED, V183, P915, DOI 10.1084/jem.183.3.915; Levitsky V, 2002, VIRUS RES, V88, P71, DOI 10.1016/S0168-1702(02)00121-1; Lopez JA, 2012, TRENDS IMMUNOL, V33, P406, DOI 10.1016/j.it.2012.04.001; Lorenzo ME, 2001, SEMIN IMMUNOL, V13, P1, DOI 10.1006/smim.2000.0290; Morrot A, 2004, IMMUNOL REV, V201, P291, DOI 10.1111/j.0105-2896.2004.00175.x; Nagata S, 1996, Prog Mol Subcell Biol, V16, P87; Renggli J, 1997, PARASITE IMMUNOL, V19, P145, DOI 10.1046/j.1365-3024.1997.d01-190.x; Ressing ME, 2005, J IMMUNOL, V174, P6829, DOI 10.4049/jimmunol.174.11.6829; Reyes-Sandoval A, 2011, J IMMUNOL, V187, P1347, DOI 10.4049/jimmunol.1100302; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Rock KL, 1996, IMMUNOL TODAY, V17, P131, DOI 10.1016/0167-5699(96)80605-0; Sattabongkot J, 2006, AM J TROP MED HYG, V74, P708, DOI 10.4269/ajtmh.2006.74.708; Sayers TJ, 2011, CANCER IMMUNOL IMMUN, V60, P1173, DOI 10.1007/s00262-011-1008-4; Schwenk RJ, 2011, TRENDS PARASITOL, V27, P306, DOI 10.1016/j.pt.2011.02.002; Sijts A., 2001, Current Molecular Medicine (Hilversum), V1, P665, DOI 10.2174/1566524013363230; Singh AP, 2007, CELL, V131, P492, DOI 10.1016/j.cell.2007.09.013; Sinnis P, 2007, PARASITOL INT, V56, P171, DOI 10.1016/j.parint.2007.04.002; Talman AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009156; Trimnell A, 2009, J IMMUNOL, V183, P5870, DOI 10.4049/jimmunol.0900302; Tse SW, 2011, MEM I OSWALDO CRUZ, V106, P172, DOI 10.1590/S0074-02762011000900022; van Endert PM, 1999, CURR OPIN IMMUNOL, V11, P82, DOI 10.1016/S0952-7915(99)80015-6; vanParijs L, 1996, CURR OPIN IMMUNOL, V8, P355, DOI 10.1016/S0952-7915(96)80125-7; Vitoria M, 2009, AM J CLIN PATHOL, V131, P844, DOI 10.1309/AJCP5XHDB1PNAEYT; Voskoboinik I, 2010, IMMUNOL REV, V235, P35, DOI 10.1111/j.0105-2896.2010.00896.x; Vossen MTM, 2002, IMMUNOGENETICS, V54, P527, DOI 10.1007/s00251-002-0493-1; WHO Malaria Policy Advisory Committee and Secretariat, 2012, Malar J, V11, P424, DOI 10.1186/1475-2875-11-424; Wiertz E, 1997, IMMUNOL LETT, V57, P213, DOI 10.1016/S0165-2478(97)00073-4; Yewdell JW, 1998, J IMMUNOTHER, V21, P127, DOI 10.1097/00002371-199803000-00006	62	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75321	10.1371/journal.pone.0075321	http://dx.doi.org/10.1371/journal.pone.0075321			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086507	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700075
J	Silveira, CB; Cardoso, AM; Coutinho, FH; Lima, JL; Pinto, LH; Albano, RM; Clementino, MM; Martins, OB; Vieira, RP				Silveira, Cynthia B.; Cardoso, Alexander M.; Coutinho, Felipe H.; Lima, Joyce L.; Pinto, Leonardo H.; Albano, Rodolpho M.; Clementino, Maysa M.; Martins, Orlando B.; Vieira, Ricardo P.			Tropical Aquatic Archaea Show Environment-Specific Community Composition	PLOS ONE			English	Article							PHYLOGENETIC DIVERSITY; MICROBIAL ECOLOGY; LAKE; ATLANTIC; SEDIMENT; GENOME; SEA; CRENARCHAEOTA; WIDESPREAD; EVOLUTION	The Archaea domain is ubiquitously distributed and extremely diverse, however, environmental factors that shape archaeal community structure are not well known. Aquatic environments, including the water column and sediments harbor many new uncultured archaeal species from which metabolic and ecological roles remain elusive. Some environments are especially neglected in terms of archaeal diversity, as is the case of pristine tropical areas. Here we investigate the archaeal composition in marine and freshwater systems from IIha Grande, a South Atlantic tropical environment. All sampled habitats showed high archaeal diversity. No OTUs were shared between freshwater, marine and mangrove sediment samples, yet these environments are interconnected and geographically close, indicating environment-specific community structuring. Group II Euryarchaeota was the main clade in marine samples, while the new putative phylum Thaumarchaeota and LDS/RCV Euryarchaeota dominated freshwaters. Group III Euryarchaeota, a rare clade, was also retrieved in reasonable abundance in marine samples. The archaeal community from mangrove sediments was composed mainly by members of mesophilic Crenarchaeota and by a distinct clade forming a sister-group to Crenarchaeota and Thaumarchaeota. Our results show strong environment-specific community structuring in tropical aquatic Archaea, as previously seen for Bacteria.	[Silveira, Cynthia B.; Coutinho, Felipe H.; Lima, Joyce L.; Pinto, Leonardo H.; Martins, Orlando B.; Vieira, Ricardo P.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio de Janeiro, Brazil; [Silveira, Cynthia B.; Coutinho, Felipe H.] Univ Fed Rio de Janeiro, Dept Genet, Rio de Janeiro, Brazil; [Cardoso, Alexander M.] Ctr Univ Estadual Zona Oeste UEZO, Rio De Janeiro, Brazil; [Cardoso, Alexander M.] INMETRO, Inst Nacl Metrol Qualidade & Tecnol, Rio De Janeiro, Brazil; [Albano, Rodolpho M.] Univ Estado Rio De Janeiro, Dept Bioquim, Rio De Janeiro, Brazil; [Clementino, Maysa M.] Fundacao Oswaldo Cruz FIOCRUZ, Inst Nacl Controle Qualidade Saude, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Centro Universitario Estadual da Zona Oeste; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz	Silveira, CB (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio de Janeiro, Brazil.	cynthiabsilveira@gmail.com; alexandercardoso@uezo.rj.gov.br	Cardoso, Alexander/S-6687-2017; Clementino, Maysa/C-1944-2009; Cardoso, Alexander/AAX-2505-2021; Coutinho, Felipe Hernandes/R-3714-2019	Cardoso, Alexander/0000-0003-2974-0232; Coutinho, Felipe Hernandes/0000-0001-6430-7069; Silveira, Cynthia/0000-0002-9533-5588; Albano, Rodolpho/0000-0002-0643-901X	FAPERJ; FIOCRUZ; CNPq	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FIOCRUZ; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support was provided by FAPERJ, FIOCRUZ and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Barberan A, 2011, MOL ECOL, V20, P1988, DOI 10.1111/j.1365-294X.2011.05057.x; Bergauer K, 2013, FEMS MICROBIOL ECOL, V84, P461, DOI 10.1111/1574-6941.12073; Bernardes MC, 2012, BRAZ J BIOL, V72, P761, DOI 10.1590/S1519-69842012000400011; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Bowman JP, 2003, APPL ENVIRON MICROB, V69, P2463, DOI 10.1128/AEM.69.5.2463-2483.2003; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Bruce T, 2010, MICROB ECOL, V60, P840, DOI 10.1007/s00248-010-9750-2; BUCKLES L, 2013, ENV MICROBIOL; Cao HP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076946, 10.1371/journal.pone.0052853]; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Crump BC, 2000, FEMS MICROBIOL ECOL, V31, P231, DOI 10.1016/S0168-6496(99)00102-6; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Dorador C, 2010, FEMS MICROBIOL ECOL, V73, P291, DOI 10.1111/j.1574-6941.2010.00891.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fuhrman JA, 2002, ANTON LEEUW INT J G, V81, P521, DOI 10.1023/A:1020513506777; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Galand PE, 2006, AQUAT MICROB ECOL, V44, P115, DOI 10.3354/ame044115; Ghai R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023785; Glissmann K, 2004, MICROB ECOL, V48, P389, DOI 10.1007/s00248-003-2027-2; Gupta RS, 2011, ANTON LEEUW INT J G, V99, P133, DOI 10.1007/s10482-010-9488-3; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Jurgens G, 2000, FEMS MICROBIOL ECOL, V34, P45, DOI 10.1111/j.1574-6941.2000.tb00753.x; Karl DM, 2002, NATURE, V415, P590, DOI 10.1038/415590b; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kubo K, 2012, ISME J, V6, P1949, DOI 10.1038/ismej.2012.37; Lliros M, 2008, FEMS MICROBIOL ECOL, V66, P331, DOI 10.1111/j.1574-6941.2008.00583.x; Lliros M, 2010, APPL ENVIRON MICROB, V76, P6853, DOI 10.1128/AEM.02864-09; Lopez-Garcia P, 2001, ENVIRON MICROBIOL, V3, P72, DOI 10.1046/j.1462-2920.2001.00162.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; Mendes LW, 2012, RES MICROBIOL, V163, P366, DOI 10.1016/j.resmic.2012.05.005; MN H, 2013, P NATL ACAD SCI USA, V110, P6004, DOI DOI 10.1073/PNAS.1216863110.PUBMED:23536290; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nunoura T, 2011, NUCLEIC ACIDS RES, V39, P3204, DOI 10.1093/nar/gkq1228; Nusslein B, 2001, ENVIRON MICROBIOL, V3, P460, DOI 10.1046/j.1462-2920.2001.00215.x; Offre P, 2013, ANNU REV MICROBIOL, V67, P437, DOI 10.1146/annurev-micro-092412-155614; OGRAM A, 1987, J MICROBIOL METH, V7, P57, DOI 10.1016/0167-7012(87)90025-X; OLSEN GJ, 1986, ANNU REV MICROBIOL, V40, P337, DOI 10.1146/annurev.mi.40.100186.002005; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; Ravenschlag K, 1999, APPL ENVIRON MICROB, V65, P3982; Robertson CE, 2005, CURR OPIN MICROBIOL, V8, P638, DOI 10.1016/j.mib.2005.10.003; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schleper C, 2005, NAT REV MICROBIOL, V3, P479, DOI 10.1038/nrmicro1159; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2004, APPL ENVIRON MICROB, V70, P5485, DOI 10.1128/AEM.70.9.5485-5492.2004; Siboni N, 2008, ENVIRON MICROBIOL, V10, P2979, DOI 10.1111/j.1462-2920.2008.01718.x; Silveira CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017789; Somboonna N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S29; Taib N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058950; Tamames J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-85; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turque AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015774; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vieira RP, 2007, MICROB ECOL, V54, P460, DOI 10.1007/s00248-007-9261-y; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Wang YF, 2013, APPL MICROBIOL BIOT, V97, P7015, DOI 10.1007/s00253-012-4430-4; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	69	10	10	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76321	10.1371/journal.pone.0076321	http://dx.doi.org/10.1371/journal.pone.0076321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086729	Green Submitted, Green Published, gold			2022-12-27	WOS:000325218700126
J	Xu, GH; Yang, JJ; Li, GQ				Xu, Guanghua; Yang, Junjie; Li, Guoqing			Simulating Society Transitions: Standstill, Collapse and Growth in an Evolving Network Model	PLOS ONE			English	Article							EVOLUTIONARY MODEL; MAYA CIVILIZATION; DYNASTIC CYCLE; COMPLEXITY; SYSTEMS	We developed a model society composed of various occupations that interact with each other and the environment, with the capability of simulating three widely recognized societal transition patterns: standstill, collapse and growth, which are important compositions of society evolving dynamics. Each occupation is equipped with a number of inhabitants that may randomly flow to other occupations, during which process new occupations may be created and then interact with existing ones. Total population of society is associated with productivity, which is determined by the structure and volume of the society. We ran the model under scenarios such as parasitism, environment fluctuation and invasion, which correspond to different driving forces of societal transition, and obtained reasonable simulation results. This work adds to our understanding of societal evolving dynamics as well as provides theoretical clues to sustainable development.	[Xu, Guanghua; Yang, Junjie] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Xu, Guanghua; Yang, Junjie] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Guoqing] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China	Li, GQ (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China.	liguoqing@nwsuaf.edu.cn						[Anonymous], 2001, PANARCHY UNDERSTANDI; [Anonymous], 1990, COLLAPSE COMPLEX SOC; [Anonymous], 2001, TIME GOES IND REVOLU; Bak P., 1996, NATURE WORKS SCI SEL; Berman A., 1979, NONNEGATIVE MATRICES; Buchanan M., 2000, UBIQUITY SCI HIST WH; Curry A, 2010, J FUTURES STUD, V14, P75; Danilevsky N. Ya., 1895, RUSSIA EUROPE LOOK C; De Carolis E, 2003, VESUVIUS A D 79 DEST; Diamond J., 2011, COLLAPSE SOC CHOOSE; Dittrich P, 2001, ARTIF LIFE, V7, P225, DOI 10.1162/106454601753238636; Feichtinger G, 1996, CHAOS SOLITON FRACT, V7, P257, DOI 10.1016/0960-0779(95)00011-9; Gotts NM, 2007, ECOL SOC, V12; Green DG, 2009, UNIFYING THEMES COMP; Grimm V, 2006, CONTRIB ECON, P139, DOI 10.1007/3-7908-1721-X_7; Hanel R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036110; Haug GH, 2003, SCIENCE, V299, P1731, DOI 10.1126/science.1080444; Holling CS, 2001, ECOSYSTEMS, V4, P390, DOI 10.1007/s10021-001-0101-5; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Jain S, 2002, P NATL ACAD SCI USA, V99, P2055, DOI 10.1073/pnas.032618499; Jain S, 1998, PHYS REV LETT, V81, P5684, DOI 10.1103/PhysRevLett.81.5684; Jin Guantao, 1992, XINGSHENG YU WEIJI L; Levin S., 1999, FRAGILE DOMINION; Levin SA, 2005, BIOSCIENCE, V55, P1075, DOI 10.1641/0006-3568(2005)055[1075:SATEOC]2.0.CO;2; Liu C, 1981, REASONS PERPETUATING; LOVELOCK J E, 1991, P3; Medina-Elizalde M, 2012, SCIENCE, V335, P956, DOI 10.1126/science.1216629; Nefedov S. A., 2004, SOCIAL EVOLUTION HIS, V3, P69; Paperin G, 2011, J ROYAL SOC INTERFAC; Railsback S.F., 2011, AGENT BASED INDIVIDU; Saeed K, 2007, J OPERATIONAL RES SO, V59, P1289; Schultz TW., 1993, ORIGINS INCREASING R; Schumpeter, 2006, HIST EC ANAL; SCHUSTER P, 1983, J THEOR BIOL, V100, P533, DOI 10.1016/0022-5193(83)90445-9; Smith A., 1976, INQUIRY NATURE CAUSE; Thurner S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/7/075029; Thurner S, 2010, PHYSICA A, V389, P747, DOI 10.1016/j.physa.2009.10.030; TURCHIN P, 2008, SECULAR CYCLES; Turchin P, 2006, SOC EVOL HIST, V5, P112; Turchin P, 2009, ANN NY ACAD SCI, V1162, P1, DOI 10.1111/j.1749-6632.2009.04447.x; USHER D, 1989, AM ECON REV, V79, P1031; Weeks B, 2004, P COMPL SYST SUMM SC	42	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75433	10.1371/journal.pone.0075433	http://dx.doi.org/10.1371/journal.pone.0075433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086530	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700086
J	Morris, VA; Zhang, AL; Yang, TM; Stirewalt, DL; Ramamurthy, R; Meshinchi, S; Oehler, VG				Morris, Valerie A.; Zhang, Ailin; Yang, Taimei; Stirewalt, Derek L.; Ramamurthy, Ranjani; Meshinchi, Soheil; Oehler, Vivian G.			MicroRNA-150 Expression Induces Myeloid Differentiation of Human Acute Leukemia Cells and Normal Hematopoietic Progenitors	PLOS ONE			English	Article							C-MYB; GRANULOCYTIC DIFFERENTIATION; TRANSCRIPTION FACTORS; MYELOGENOUS LEUKEMIA; GENE-EXPRESSION; DOWN-REGULATION; LINE; MIR-150; ESTABLISHMENT; ALPHA	In acute myeloid leukemia (AML) and blast crisis (BC) chronic myeloid leukemia (CML) normal differentiation is impaired. Differentiation of immature stem/progenitor cells is critical for normal blood cell function. MicroRNAs (miRNAs or miRs) are small non-coding RNAs that interfere with gene expression by degrading messenger RNAs (mRNAs) or blocking protein translation. Aberrant miRNA expression is a feature of leukemia and miRNAs also play a significant role in normal hematopoiesis and differentiation. We have identified miRNAs differentially expressed in AML and BC CML and identified a new role for miR-150 in myeloid differentiation. Expression of miR-150 is low or absent in BC CML and AML patient samples and cell lines. We have found that expression of miR-150 in AML cell lines, CD34+ progenitor cells from healthy individuals, and primary BC CML and AML patient samples at levels similar to miR-150 expression in normal bone marrow promotes myeloid differentiation of these cells. MYB is a direct target of miR-150, and we have identified that the observed phenotype is partially mediated by MYB. In AML cell lines, differentiation of miR-150 expressing cells occurs independently of retinoic acid receptor a (RARA) signaling. High-throughput gene expression profiling (GEP) studies of the AML cell lines HL60, PL21, and THP-1 suggest that activation of CEPBA, CEBPE, and cytokines associated with myeloid differentiation in miR-150 expressing cells as compared to control cells contributes to myeloid differentiation. These data suggest that miR-150 promotes myeloid differentiation, a previously uncharacterized role for this miRNA, and that absent or low miR-150 expression contributes to blocked myeloid differentiation in acute leukemia cells.	[Morris, Valerie A.; Zhang, Ailin; Yang, Taimei; Stirewalt, Derek L.; Meshinchi, Soheil; Oehler, Vivian G.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Morris, Valerie A.; Oehler, Vivian G.] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Ramamurthy, Ranjani] Univ Washington, Dept Med, Seattle, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Oehler, VG (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	voehler@u.washington.edu		zhang, ailin/0000-0001-9598-3772; Morris, Valerie/0000-0002-0355-7379	National Institute of Health [R01 CA140371]; American Society of Hematology (Scholar Award); Institute of Translational Health Sciences, University of Washington [2UL1TR000423]; Hope Foundation (SWOG Development Award) [T32 HL 7093-36)]; NATIONAL CANCER INSTITUTE [R01CA140371] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000423] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology (Scholar Award); Institute of Translational Health Sciences, University of Washington; Hope Foundation (SWOG Development Award); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by grants from the National Institute of Health (R01 CA140371), the American Society of Hematology (Scholar Award (www. ash. org)), the Institute of Translational Health Sciences, University of Washington (2UL1TR000423), and the Hope Foundation (SWOG Development Award) [VGO]; a NIH Hematology Training Grant (2 T32 HL 7093-36) [VAM]; and by resources from and use of facilities at the Fred Hutchinson Cancer Research Center, Seattle, Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167; Alemdehy MF, 2012, BLOOD, V119, P4723, DOI 10.1182/blood-2011-10-386359; APFEL C, 1992, P NATL ACAD SCI USA, V89, P7129, DOI 10.1073/pnas.89.15.7129; Bedi R, 2009, BLOOD, V113, P317, DOI 10.1182/blood-2008-02-139741; Bezman NA, 2011, J EXP MED, V208, P2717, DOI 10.1084/jem.20111386; Bianchi E, 2010, BLOOD, V116, pE99, DOI 10.1182/blood-2009-08-238311; Bissels U., 2011, HAEMATOLOGICA, V97, P160, DOI [DOI 10.3324/HAEMAT0L.2011.051730.PUBMED:22058204, 10.3324/haematol.2011.051730]; Breccia M, 2012, EXPERT OPIN PHARMACO, V13, P1031, DOI 10.1517/14656566.2012.677436; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; De Marchis ML, 2009, LEUKEMIA, V23, P856, DOI 10.1038/leu.2008.372; Delgado MD, 2013, CLIN TRANSL ONCOL, V15, P87, DOI 10.1007/s12094-012-0926-8; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; El Gazzar M, 2012, IMMUNOL CELL BIOL, V90, P587, DOI 10.1038/icb.2011.74; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; FERRARI S, 1990, CELL GROWTH DIFFER, V1, P543; Gao SM, 2011, LEUKEMIA LYMPHOMA, V52, P2365, DOI 10.3109/10428194.2011.601476; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Ghani S, 2011, BLOOD, V118, P2275, DOI 10.1182/blood-2011-02-335141; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Hahn CK, 2009, CANCER CELL, V16, P281, DOI 10.1016/j.ccr.2009.08.018; Halene S, 2010, EXP HEMATOL, V38, P90, DOI 10.1016/j.exphem.2009.11.004; Huang XQ, 2011, BLOOD, V117, P2157, DOI 10.1182/blood-2010-08-302711; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jiang X, 2012, CANCER CELL, V22, P524, DOI 10.1016/j.ccr.2012.08.028; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kaplan IM, 2011, J IMMUNOL, V186, P2826, DOI 10.4049/jimmunol.1002806; KOEFFLER HP, 1978, SCIENCE, V200, P1153, DOI 10.1126/science.306682; Koschmieder S, 2009, J CLIN ONCOL, V27, P619, DOI 10.1200/JCO.2008.17.9812; KUBONISHI I, 1983, International Journal of Cell Cloning, V1, P105; KUBONISHI I, 1984, BLOOD, V63, P254; Kuchenbauer F, 2011, BLOOD, V118, P3350, DOI 10.1182/blood-2010-10-312454; LANGE B, 1987, BLOOD, V70, P192; LANOTTE M, 1991, BLOOD, V77, P1080; Laslo P, 2008, SEMIN IMMUNOL, V20, P228, DOI 10.1016/j.smim.2008.08.003; Li YH, 2013, BLOOD, V121, P499, DOI 10.1182/blood-2012-07-444729; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Li ZJ, 2012, BLOOD, V119, P2314, DOI 10.1182/blood-2011-10-386235; Lidonnici MR, 2008, BLOOD, V111, P4771, DOI 10.1182/blood-2007-08-105072; LIEBERMANN DA, 1994, STEM CELLS, V12, P352, DOI 10.1002/stem.5530120402; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Machova Polakova K, 2011, MOL CANCER, V10, P41, DOI DOI 10.1186/1476-4598-10-41; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Marcucci G, 2011, BLOOD, V117, P1121, DOI 10.1182/blood-2010-09-191312; Marcucci G, 2011, J CLIN ONCOL, V29, P475, DOI 10.1200/JCO.2010.30.2554; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; NGUYEN HQ, 1993, CELL, V72, P197, DOI 10.1016/0092-8674(93)90660-I; O'Connell RM, 2011, BLOOD, V118, P2960, DOI 10.1182/blood-2011-03-291971; Oehler VG, 2009, BLOOD, V114, P3299, DOI 10.1182/blood-2008-07-170282; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Petriv OI, 2010, P NATL ACAD SCI USA, V107, P15443, DOI 10.1073/pnas.1009320107; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Sanz MA, 2011, J CLIN ONCOL, V29, P495, DOI 10.1200/JCO.2010.32.1067; SEIGNEURIN D, 1987, EXP HEMATOL, V15, P822; Senyuk V, 2013, P NATL ACAD SCI USA, V110, P5594, DOI 10.1073/pnas.1302645110; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Tabe Y, 2012, PPAR RES, V2012, DOI 10.1155/2012/483656; Tano N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023114; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Walz C, 2012, BLOOD, V119, P3550, DOI 10.1182/blood-2011-12-397554; Wang XS, 2012, BLOOD, V119, P4992, DOI 10.1182/blood-2011-10-385716; Watanabe A, 2011, LEUKEMIA, V25, P1324, DOI 10.1038/leu.2011.81; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890; Zhao HW, 2009, BLOOD, V113, P505, DOI 10.1182/blood-2008-01-136218; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104; Zuber J, 2011, GENE DEV, V25, P1628, DOI 10.1101/gad.17269211	73	47	50	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75815	10.1371/journal.pone.0075815	http://dx.doi.org/10.1371/journal.pone.0075815			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086639	Green Submitted, gold, Green Published			2022-12-27	WOS:000325025200064
J	Avanzino, L; Pelosin, E; Martino, D; Abbruzzese, G				Avanzino, Laura; Pelosin, Elisa; Martino, Davide; Abbruzzese, Giovanni			Motor Timing Deficits in Sequential Movements in Parkinson Disease Are Related to Action Planning: A Motor Imagery Study	PLOS ONE			English	Article							MENTAL REPRESENTATION; TIME REPRODUCTION; NEURAL-NETWORKS; MODULATION; FACILITATION; DISSOCIATION; CEREBELLUM; INTERVALS; ROTATION; DECLINE	Timing of sequential movements is altered in Parkinson disease (PD). Whether timing deficits in internally generated sequential movements in PD depends also on difficulties in motor planning, rather than merely on a defective ability to materially perform the planned movement is still undefined. To unveil this issue, we adopted a modified version of an established test for motor timing, i.e. the synchronization-continuation paradigm, by introducing a motor imagery task. Motor imagery is thought to involve mainly processes of movement preparation, with reduced involvement of end-stage movement execution-related processes. Fourteen patients with PD and twelve matched healthy volunteers were asked to tap in synchrony with a metronome cue (SYNC) and then, when the tone stopped, to keep tapping, trying to maintain the same rhythm (CONT-EXE) or to imagine tapping at the same rhythm, rather than actually performing it (CONT-MI). We tested both a sub-second and a supra-second inter-stimulus interval between the cues. Performance was recorded using a sensor-engineered glove and analyzed measuring the temporal error and the interval reproduction accuracy index. PD patients were less accurate than healthy subjects in the supra-second time reproduction task when performing both continuation tasks (CONT-MI and CONT-EXE), whereas no difference was detected in the synchronization task and on all tasks involving a sub-second interval. Our findings suggest that PD patients exhibit a selective deficit in motor timing for sequential movements that are separated by a supra-second interval and that this deficit may be explained by a defect of motor planning. Further, we propose that difficulties in motor planning are of a sufficient degree of severity in PD to affect also the motor performance in the supra-second time reproduction task.	[Avanzino, Laura] Univ Genoa, Dept Expt Med, Sect Human Physiol, Genoa, Italy; [Avanzino, Laura] Univ Genoa, Ctr Polifunz Sci Motorie, Genoa, Italy; [Pelosin, Elisa; Abbruzzese, Giovanni] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy; [Martino, Davide] South London NHS Trust, Queen Elizabeth Hosp, London, England; [Martino, Davide] Kings Coll Hosp London, London, England; [Martino, Davide] Queen Mary Univ London, Ctr Neurosci & Trauma, London, England	University of Genoa; University of Genoa; University of Genoa; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; Queen Mary University London	Avanzino, L (corresponding author), Univ Genoa, Dept Expt Med, Sect Human Physiol, Genoa, Italy.	lavanzino76@gmail.com	Avanzino, Laura/K-6623-2016; Pelosin, Elisa/AAA-9637-2019	Pelosin, Elisa/0000-0002-9880-2241; AVANZINO, LAURA/0000-0001-6286-1509				Abbruzzese G, 2003, MOVEMENT DISORD, V18, P231, DOI 10.1002/mds.10327; Battaglia F, 2006, CLIN NEUROPHYSIOL, V117, P1009, DOI 10.1016/j.clinph.2006.01.008; Buch ER, 2012, BRAIN, V135, P596, DOI 10.1093/brain/awr331; Crammond DJ, 1997, TRENDS NEUROSCI, V20, P54, DOI 10.1016/S0166-2236(96)30019-2; Cunnington R, 1997, BRAIN, V120, P1339, DOI 10.1093/brain/120.8.1339; Decety J, 1996, BEHAV BRAIN RES, V72, P127; Decety J, 1996, COGNITIVE BRAIN RES, V3, P87, DOI 10.1016/0926-6410(95)00033-X; Deiber MP, 1998, NEUROIMAGE, V7, P73, DOI 10.1006/nimg.1997.0314; Elsinger CL, 2003, J INT NEUROPSYCH SOC, V9, P1088, DOI 10.1017/S1355617703970123; Fourkas AD, 2008, CEREB CORTEX, V18, P2382, DOI 10.1093/cercor/bhn005; Gallese V., 2005, PHENOMENOLOGY COGNIT, V4, P23, DOI [10.1007/s11097-005-4737-z, DOI 10.1007/S11097-005-4737-Z]; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Gonzalez B, 2005, BEHAV NEUROSCI, V119, P622, DOI 10.1037/0735-7044.119.2.622; Harrington DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017461; Harrington DL, 1998, NEUROPSYCHOLOGY, V12, P3, DOI 10.1037/0894-4105.12.1.3; Helmich RC, 2007, NEUROPSYCHOLOGIA, V45, P2201, DOI 10.1016/j.neuropsychologia.2007.02.024; Helmich RC, 2012, HUM BRAIN MAPP, V33, P1763, DOI 10.1002/hbm.21318; Heremans E, 2012, NEUROREHAB NEURAL RE, V26, P27, DOI 10.1177/1545968311411055; Heremans E, 2009, BRAIN RES, V1278, P50, DOI 10.1016/j.brainres.2009.04.041; Hetu S, 2013, NEUROSCI BIOBEHAV R, V37, P930, DOI 10.1016/j.neubiorev.2013.03.017; HUSAROVA I, J NEUROIMAGING; Ionta S, 2007, EXP BRAIN RES, V183, P1, DOI 10.1007/s00221-007-1020-2; Ivry RB, 2002, ANN NY ACAD SCI, V978, P302, DOI 10.1111/j.1749-6632.2002.tb07576.x; IVRY RB, 1988, EXP BRAIN RES, V73, P167, DOI 10.1007/BF00279670; Jahanshahi M, 2010, BRAIN, V133, P727, DOI 10.1093/brain/awq012; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P51, DOI 10.1016/S0926-6410(00)00022-7; Jones CRG, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00081; Kasess CH, 2008, NEUROIMAGE, V40, P828, DOI 10.1016/j.neuroimage.2007.11.040; Koch G, 2008, NEUROPSYCHOLOGIA, V46, P1305, DOI 10.1016/j.neuropsychologia.2007.12.005; Koch G, 2009, PHILOS T R SOC B, V364, P1907, DOI 10.1098/rstb.2009.0018; Konczak J, 2012, BRAIN, V135, P3371, DOI 10.1093/brain/aws265; Kuhn AA, 2006, BRAIN, V129, P695, DOI 10.1093/brain/awh715; Lacourse MG, 2005, NEUROIMAGE, V27, P505, DOI 10.1016/j.neuroimage.2005.04.025; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Madan CR, 2012, COGN PROCESS, V13, P211, DOI 10.1007/s10339-012-0438-z; McAuley JD, 2006, J EXP PSYCHOL GEN, V135, P348, DOI 10.1037/0096-3445.135.3.348; McIntosh GC, 1997, J NEUROL NEUROSUR PS, V62, P22, DOI 10.1136/jnnp.62.1.22; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Meck WH, 2002, BRAIN COGNITION, V48, P195, DOI 10.1006/brcg.2001.1313; Michelon P, 2006, J NEUROPHYSIOL, V95, P811, DOI 10.1152/jn.00488.2005; Nair DG, 2003, COGNITIVE BRAIN RES, V15, P250, DOI 10.1016/S0926-6410(02)00197-0; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parsons LM, 2001, ACTA PSYCHOL, V107, P155, DOI 10.1016/S0001-6918(01)00023-3; PASTOR MA, 1992, BRAIN, V115, P211, DOI 10.1093/brain/115.1.211; Penhune VB, 1998, J COGNITIVE NEUROSCI, V10, P752, DOI 10.1162/089892998563149; Personnier P, 2010, NEUROSCI LETT, V476, P146, DOI 10.1016/j.neulet.2010.04.017; Petit LS, 2003, BRAIN COGNITION, V51, P95, DOI 10.1016/S0278-2626(02)00526-2; Rochester L, 2009, MOVEMENT DISORD, V24, P839, DOI 10.1002/mds.22400; ROSENBAUM DA, 1993, J MOTOR BEHAV, V25, P217, DOI 10.1080/00222895.1993.9942051; Saimpont A, 2013, J MOTOR BEHAV, V45, P21, DOI 10.1080/00222895.2012.740098; Samuel M, 2001, NEUROREPORT, V12, P821, DOI 10.1097/00001756-200103260-00040; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Skoura X, 2008, CORTEX, V44, P1271, DOI 10.1016/j.cortex.2007.07.008; Spencer RMC, 2005, BRAIN COGNITION, V58, P84, DOI 10.1016/j.bandc.2004.09.010; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; STEPHAN KM, 1995, J NEUROPHYSIOL, V73, P373, DOI 10.1152/jn.1995.73.1.373; Szameitat AJ, 2007, NEUROIMAGE, V34, P702, DOI 10.1016/j.neuroimage.2006.09.033; Thobois S, 2000, NEUROLOGY, V55, P996, DOI 10.1212/WNL.55.7.996; Torta DME, 2010, J NEUROL, V257, P1356, DOI 10.1007/s00415-010-5532-5; Tremblay F, 2008, EXP BRAIN RES, V185, P249, DOI 10.1007/s00221-007-1150-6; Witt ST, 2008, NEUROIMAGE, V42, P343, DOI 10.1016/j.neuroimage.2008.04.025; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X; Wolpert DM, 2001, TRENDS COGN SCI, V5, P487, DOI 10.1016/S1364-6613(00)01773-3	63	19	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75454	10.1371/journal.pone.0075454	http://dx.doi.org/10.1371/journal.pone.0075454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086534	Green Submitted, Green Published, gold			2022-12-27	WOS:000326520200102
J	Hayoz, S; Cubano, L; Maldonado, H; Bychkov, R				Hayoz, Sebastien; Cubano, Luis; Maldonado, Hector; Bychkov, Rostislav			Protein Kinase A and C Regulate Leak Potassium Currents in Freshly Isolated Vascular Myocytes from the Aorta	PLOS ONE			English	Article							SMOOTH-MUSCLE; ARTERIAL STIFFNESS; CHANNEL DIVERSITY; K+ CURRENT; FUNCTIONAL-CHARACTERISTICS; DEPENDENT ACTIVATION; INDUCED VASODILATION; PULSE PRESSURE; CAMP ANALOGS; INHIBITION	We tested the hypothesis that protein kinase A (PKA) inhibits K2P currents activated by protein kinase C (PKC) in freshly isolated aortic myocytes. PDBu, the PKC agonist, applied extracellularly, increased the amplitude of the K2P currents in the presence of the "cocktail'' of K+ channel blockers. Go 6976 significantly reduced the increase of the K2P currents by PDBu suggesting the involvement of either alpha or beta isoenzymes of PKC. We found that forskolin, or membrane permeable cAMP, did not inhibit K2P currents activated by the PKC. However, when PKA agonists were added prior to PDBu, they produced a strong decrease in the K2P current amplitudes activated by PKC. Inhibition of PDBu-elicited K2P currents by cAMP agonists was not prevented by the treatment of vascular smooth muscle cells with PKA antagonists (H-89 and Rp-cAMPs). Zn2+ and Hg2+ inhibited K2P currents in one population of cells, produced biphasic responses in another population, and increased the amplitude of the PDBu-elicited K+ currents in a third population of myocytes, suggesting expression of several K2P channel types. We found that cAMP agonists inhibited biphasic responses and increase of amplitude of the PDBu-elicited K2P currents produced by Zn2+ and Hg-2. 6-Bnz-cAMp produced a significantly altered pH sensitivity of PDBu-elicited K2P-currents, suggesting the inhibition of alkaline-activated K2P-currents. These results indicate that 6-Bnz-cAMP and other cAMP analogs may inhibit K2P currents through a PKA-independent mechanism. cAMP analogs may interact with unidentified proteins involved in K2P channel regulation. This novel cellular mechanism could provide insights into the interplay between PKC and PKA pathways that regulate vascular tone.	[Hayoz, Sebastien] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA; [Hayoz, Sebastien; Cubano, Luis; Maldonado, Hector; Bychkov, Rostislav] Univ Cent Caribe, Dept Pharmacol, Bayamon, PR USA	Michigan State University	Bychkov, R (corresponding author), Univ Cent Caribe, Dept Pharmacol, Bayamon, PR USA.	rostislav.bychkov@uccaribe.edu		Maldonado, Hector/0000-0003-4585-3165	National Institutes of Health [SC2 NHLBI (HL107237)]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [SC2HL107237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the grant SC2 NHLBI (HL107237) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello EA, 1996, AM J PHYSIOL-HEART C, V271, pH109, DOI 10.1152/ajpheart.1996.271.1.H109; Barman SA, 2004, AM J PHYSIOL-LUNG C, V286, pL149, DOI 10.1152/ajplung.00207.2003; Berg AP, 2007, J NEUROPHYSIOL, V97, P1546, DOI 10.1152/jn.01090.2006; Besana A, 2004, J BIOL CHEM, V279, P33154, DOI 10.1074/jbc.M403525200; Blondeau N, 2007, CIRC RES, V101, P176, DOI 10.1161/CIRCRESAHA.107.154443; Bockenhauer D, 2001, NAT NEUROSCI, V4, P486, DOI 10.1038/87434; Boland LM, 1999, AM J PHYSIOL-CELL PH, V277, pC100, DOI 10.1152/ajpcell.1999.277.1.C100; Bonnet S, 2007, PHARMACOL THERAPEUT, V115, P56, DOI 10.1016/j.pharmthera.2007.03.014; Buckler KJ, 2010, ADV EXP MED BIOL, V661, P15, DOI 10.1007/978-1-60761-500-2_2; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Bychkov R, 1998, J PHARMACOL EXP THER, V285, P293; Chae YJ, 2010, ANESTHESIOLOGY, V113, P1326, DOI 10.1097/ALN.0b013e3181f90ca5; Chemin J, 2003, EMBO J, V22, P5403, DOI 10.1093/emboj/cdg528; Chen XD, 2006, P NATL ACAD SCI USA, V103, P3422, DOI 10.1073/pnas.0507710103; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; CLARK JM, 1985, ARTERIOSCLEROSIS, V5, P19, DOI 10.1161/01.ATV.5.1.19; Clarke CE, 2008, J BIOL CHEM, V283, P16985, DOI 10.1074/jbc.M801368200; Czirjak G, 2006, MOL PHARMACOL, V69, P1024, DOI 10.1124/mol.105.018556; Czirjak G, 2001, AM J PHYSIOL-CELL PH, V281, pC700, DOI 10.1152/ajpcell.2001.281.2.C700; Dart AM, 2001, J AM COLL CARDIOL, V37, P975, DOI 10.1016/S0735-1097(01)01108-1; Dingemans KP, 2000, ANAT REC, V258, P1; Enyeart JA, 2010, MOL PHARMACOL, V77, P469, DOI 10.1124/mol.109.061861; Enyedi P, 2012, MOL CELL ENDOCRINOL, V353, P75, DOI 10.1016/j.mce.2011.11.009; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Fanchaouy M, 2007, CELL CALCIUM, V41, P41, DOI 10.1016/j.ceca.2006.04.030; Fanchaouy M, 2005, CELL CALCIUM, V37, P25, DOI 10.1016/j.ceca.2004.06.008; Farand P, 2007, MICROVASC RES, V73, P95, DOI 10.1016/j.mvr.2006.10.005; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Fujita T, 2002, J BIOL CHEM, V277, P22191, DOI 10.1074/jbc.M110364200; Garry A, 2007, EMBO REP, V8, P354, DOI 10.1038/sj.embor.7400916; GLASS DB, 1989, J BIOL CHEM, V264, P14579; Gu WL, 2002, J PHYSIOL-LONDON, V539, P657, DOI 10.1113/jphysiol.2001.013432; Gurney A, 2009, EUR BIOPHYS J BIOPHY, V38, P305, DOI 10.1007/s00249-008-0326-8; Hayoz S, 2009, ACTA PHYSIOL, V195, P247, DOI 10.1111/j.1748-1716.2008.01884.x; Hayoz S, 2007, AM J PHYSIOL-CELL PH, V292, pC1502, DOI 10.1152/ajpcell.00522.2006; HIDAKA H, 1991, METHOD ENZYMOL, V201, P328; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Hwang SJ, 2008, J PHYSIOL-LONDON, V586, P1169, DOI 10.1113/jphysiol.2007.148718; Iacovelli L, 2001, MOL PHARMACOL, V60, P924, DOI 10.1124/mol.60.5.924; Ivins JK, 2004, J NEUROSCI, V24, P1212, DOI 10.1523/JNEUROSCI.4689-03.2004; Kang DW, 2006, AM J PHYSIOL-CELL PH, V291, pC649, DOI 10.1152/ajpcell.00047.2006; Keshavaprasad B, 2005, ANESTH ANALG, V101, P1042, DOI 10.1213/01.ane.0000168447.87557.5a; Kim JS, 2005, J PHARMACOL EXP THER, V314, P618, DOI 10.1124/jpet.105.084418; Lindner M, 2011, J PHYSIOL-LONDON, V589, P3149, DOI 10.1113/jphysiol.2011.208983; Liu HY, 2008, J GEN PHYSIOL, V132, P279, DOI 10.1085/jgp.200810003; Lloyd EE, 2009, EXP BIOL MED, V234, P1493, DOI 10.3181/0903-RM-110; Lotshaw DP, 2007, CELL BIOCHEM BIOPHYS, V47, P209, DOI 10.1007/s12013-007-0007-8; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mathie A, 2007, J PHYSIOL-LONDON, V578, P377, DOI 10.1113/jphysiol.2006.121582; Michelakis ED, 1997, CAN J PHYSIOL PHARM, V75, P889, DOI 10.1139/cjpp-75-7-889; Murbartian J, 2005, J BIOL CHEM, V280, P30175, DOI 10.1074/jbc.M503862200; Namiranian K, 2010, AM J PHYSIOL-REG I, V299, pR461, DOI 10.1152/ajpregu.00057.2010; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Nilius B, 2012, TRENDS NEUROSCI, V35, P477, DOI 10.1016/j.tins.2012.04.002; Noel J, 2011, CHANNELS, V5, P400, DOI 10.4161/chan.5.5.16469; Olschewski A, 2006, CIRC RES, V98, P1072, DOI 10.1161/01.RES.0000219677.12988.e9; Poels MMF, 2012, STROKE, V43, P2637, DOI 10.1161/STROKEAHA.111.642264; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Purves GI, 2009, J PHYSIOL-LONDON, V587, P3639, DOI 10.1113/jphysiol.2009.173534; Rabkin SW, 2012, J ALZHEIMERS DIS, V32, P541, DOI 10.3233/JAD-2012-120757; Rahm AK, 2012, BRIT J PHARMACOL, V166, P764, DOI 10.1111/j.1476-5381.2011.01813.x; Sabbadini M, 2009, J MOL BIOL, V385, P1331, DOI 10.1016/j.jmb.2008.11.048; Safar ME, 2012, CURR HYPERTENS REP, V14, P339, DOI 10.1007/s11906-012-0272-9; Salamanca DA, 2005, BIOCHEM PHARMACOL, V70, P1537, DOI 10.1016/j.bcp.2005.07.017; Schubert R, 1999, AM J PHYSIOL-CELL PH, V276, pC648, DOI 10.1152/ajpcell.1999.276.3.C648; Serir K, 2006, BRIT J PHARMACOL, V147, P45, DOI 10.1038/sj.bjp.0706432; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Veale EL, 2007, MOL PHARMACOL, V71, P1666, DOI 10.1124/mol.106.033241; Vega-Saenz de Miera E, 2001, J NEUROPHYSIOL, V86, P130, DOI 10.1152/jn.2001.86.1.130; Xu FL, 2007, J NEUROCHEM, V101, P1284, DOI 10.1111/j.1471-4159.2007.04468.x	70	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75077	10.1371/journal.pone.0075077	http://dx.doi.org/10.1371/journal.pone.0075077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086441	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200079
J	Im-Aram, A; Farrand, L; Bae, SM; Song, G; Song, YS; Han, JY; Tsang, BK				Im-aram, Akechai; Farrand, Lee; Bae, Seung-Min; Song, Gwonhwa; Song, Yong Sang; Han, Jae Yong; Tsang, Benjamin K.			The mTORC2 Component Rictor Contributes to Cisplatin Resistance in Human Ovarian Cancer Cells	PLOS ONE			English	Article							X-LINKED INHIBITOR; AKT PHOSPHORYLATION; DOWN-REGULATION; COMPLEX 2; P53; APOPTOSIS; PATHWAY; CHEMORESISTANCE; UBIQUITINATION; PKC	Resistance to cisplatin-based therapy is a major cause of treatment failure in human ovarian cancer. A better understanding of the mechanisms of cisplatin resistance will offer new insights for novel therapeutic strategies for this deadly disease. Akt and p53 are determinants of cisplatin sensitivity. Rictor is a component of mTOR protein kinase complex 2, which is required for Akt phosphorylation (Ser473) and full activation. However, the precise role of rictor and the relationship between rictor and p53 in cisplatin resistance remains poorly understood. Here, using sensitive wild-type p53 (OV2008 and A2780s), resistant wild-type p53 (C13* and OVCAR433), and p53 compromised (A2780cp, OCC1, and SKOV-3) ovarian cancer cells, we have demonstrated that (i) rictor is a determinant of cisplatin resistance in chemosensitive human ovarian cancer cells; (ii) cisplatin down-regulates rictor content by caspase-3 cleavage and proteasomal degradation; (iii) rictor down-regulation sensitizes chemo-resistant ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner; (iv) rictor suppresses cisplatin-induced apoptosis and confers resistance by activating and stabilizing Akt. These findings extend current knowledge on the molecular and cellular basis of cisplatin resistance and provide a rationale basis for rictor as a potential therapeutic target for chemo-resistant ovarian cancer.	[Im-aram, Akechai; Farrand, Lee; Bae, Seung-Min; Song, Gwonhwa; Song, Yong Sang; Han, Jae Yong; Tsang, Benjamin K.] Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, World Class Univ Biomodulat Major, Seoul, South Korea; [Tsang, Benjamin K.] Univ Ottawa, Dept Obstet & Gynecol, Ottawa, ON, Canada; [Tsang, Benjamin K.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Tsang, Benjamin K.] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada; [Tsang, Benjamin K.] Ottawa Hosp Res Inst, Chron Dis Program, Ottawa, ON, Canada	Seoul National University (SNU); University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Tsang, BK (corresponding author), Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, World Class Univ Biomodulat Major, Seoul, South Korea.	btsang@ohri.ca	Song, Gwonhwa/H-3647-2015; gwonhwa, song/H-3208-2015	Tsang, Benjamin K./0000-0003-1213-3946; SONG, YONGSANG/0000-0001-7115-4021	World Class University (WCU) program through the Ministry of Education, Science and Technology; National Research Foundation of Korea [R31-10056]; Canadian Institutes of Health Research [M0P-126144]	World Class University (WCU) program through the Ministry of Education, Science and Technology; National Research Foundation of Korea(National Research Foundation of Korea); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the World Class University (WCU) program through the Ministry of Education, Science and Technology and funded by the National Research Foundation of Korea (R31-10056) and by the Canadian Institutes of Health Research (M0P-126144). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini MR, 2010, ONCOGENE, V29, P11, DOI 10.1038/onc.2009.300; Abedini MR, 2008, CANCER RES, V68, P4511, DOI 10.1158/0008-5472.CAN-08-0673; Abedini MR, 2004, ONCOGENE, V23, P6997, DOI 10.1038/sj.onc.1207925; Ali AY, 2011, ONCOGENE, V29, P1; Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Back JH, 2012, PHOTOCHEM PHOTOBIOL, V88, P1165, DOI 10.1111/j.1751-1097.2012.01097.x; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Fraser M, 2006, ONCOGENE, V25, P2203, DOI 10.1038/sj.onc.1209251; Fraser M, 2003, CANCER RES, V63, P7081; Fraser M, 2008, INT J CANCER, V122, P534, DOI 10.1002/ijc.23086; Fu L, 2009, CANCER RES, V69, P8967, DOI 10.1158/0008-5472.CAN-09-2190; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Guppy AE, 2005, CLIN ONCOL-UK, V17, P399, DOI 10.1016/j.clon.2005.05.009; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hietakangas V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-282; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jiang BH, 2008, DRUG RESIST UPDATE, V11, P63, DOI 10.1016/j.drup.2008.03.001; Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P23, DOI 10.1016/S0027-5107(01)00141-5; Kmet LM, 2003, CANCER, V97, P389, DOI 10.1002/cncr.11064; Li H, 2012, BREAST CANC RES TR, V2, P1; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; Moll UM, 2003, MOL CANCER RES, V1, P1001; No JH, 2011, GYNECOL ONCOL, V121, P8, DOI 10.1016/j.ygyno.2010.12.364; Peng DJ, 2010, BIOCHEM BIOPH RES CO, V394, P600, DOI 10.1016/j.bbrc.2010.03.029; Perego P, 2003, INT J CANCER, V105, P617, DOI 10.1002/ijc.11140; Roulin D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-57; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sasaki H, 2000, CANCER RES, V60, P5659; Schuijer M, 2003, HUM MUTAT, V21, P285, DOI 10.1002/humu.10181; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Woo MG, 2012, J BIOL CHEM, V287, P3963, DOI 10.1074/jbc.M111.314765; Wu YT, 2011, J BIOL CHEM, V286, P14190, DOI 10.1074/jbc.M111.219923; Yang X, 2008, BRIT J CANCER, V98, P803, DOI 10.1038/sj.bjc.6604223; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Zhang F, 2010, CANCER RES, V70, P9360, DOI 10.1158/0008-5472.CAN-10-0207; Zhang HY, 2009, EUR J OBSTET GYN R B, V146, P81, DOI 10.1016/j.ejogrb.2009.04.035	44	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75455	10.1371/journal.pone.0075455	http://dx.doi.org/10.1371/journal.pone.0075455			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086535	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200103
J	Mi, RS; Wang, XJ; Li, CH; Huang, Y; Zhou, P; Li, ZF; Lei, MT; Cai, JZ; Chen, ZG				Mi, Rongsheng; Wang, Xiaojuan; Li, Chunhua; Huang, Yan; Zhou, Peng; Li, Zhengfeng; Lei, Mengtong; Cai, Jinzhong; Chen, Zhaoguo			Prevalence and Genetic Characterization of Cryptosporidium in Yaks in Qinghai Province of China	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; DAIRY CALVES; SUBTYPE ANALYSIS; SUBGENOTYPE ANALYSIS; CATTLE; HUMANS; PARVUM; GIARDIA; SPP.; GENOTYPES	The objective of this study was to determine the prevalence, species and subtypes of Cryptosporidium infecting yaks in the Qinghai Province of Northwestern China. The prevalence of Cryptosporidium spp. was detected by microscopy and nested-PCR. A total of 586 fecal samples were collected from yaks in 6 counties, of which 142 (24.2%) samples tested positive for Cryptosporidium. The small subunit (SSU) rRNA gene of fifty-five samples were amplified and sequenced successfully and demonstrated that Cryptosporidium bovis (31/55, 56.4%) was the most common species, followed by C. parvum (16/55, 29.1%) and C. ryanae (5/55, 9.0%). Mixed infections of C. parvum and C. bovis (n = 2), C. ryanae and C. bovis (n = 1) were also detected. All three species were found in yaks ranging in age from <1 year, 1-2 years, to >2 years. Cryptosporidium was most commonly detected in spring (28.4%), followed by summer (20.9%), then winter (17.5%). Cryptosporidium parvum positive samples were subtyped using the 60 kDa glycoprotein (gp60) gene. Subtypes IIaA15G2R1 (n = 8), IIaA16G2R1 (n = 2), IIaA14G1R1 (n = 1), IIaA14G2R1 (n = 1) and IIaA16G3R1 (n = 1) were detected. All of these subtypes are zoonotic, and may pose a potential threat to human health.	[Mi, Rongsheng; Wang, Xiaojuan; Huang, Yan; Zhou, Peng; Li, Zhengfeng; Chen, Zhaoguo] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Minist Agr, Key Lab Anim Parasitol, Shanghai, Peoples R China; [Li, Chunhua; Lei, Mengtong; Cai, Jinzhong] Qinghai Acad Anim & Vet Sci, Vet Res Inst, Lab Plateau Vet Parasitol, Xining, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Qinghai University	Cai, JZ (corresponding author), Qinghai Acad Anim & Vet Sci, Vet Res Inst, Lab Plateau Vet Parasitol, Xining, Peoples R China.	caijinz@vip.sina.com; zhaoguochen@shvri.ac.cn			National S & T Major Program [2012ZX10004220-008]; Shanghai Municipal Agriculture Commission [2005-3-4]; Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China [2012JB16, 2013JB13]	National S & T Major Program; Shanghai Municipal Agriculture Commission; Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China	This study was supported in part by National S & T Major Program (Grant No. 2012ZX10004220-008), Shanghai Municipal Agriculture Commission (Grant No. 2005-3-4) and Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China (Grant Nos. 2012JB16 and 2013JB13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2006, PARASITOL RES, V99, P303, DOI 10.1007/s00436-006-0140-0; Almawly J, 2013, VET PARASITOL; Alves M, 2003, J CLIN MICROBIOL, V41, P2744, DOI 10.1128/JCM.41.6.2744-2747.2003; Amer S, 2013, VET PARASITOL, V191, P123, DOI 10.1016/j.vetpar.2012.08.015; Bornay-Llinares FJ, 1999, APPL ENVIRON MICROB, V65, P1455; Brook EJ, 2009, VET J, V179, P378, DOI 10.1016/j.tvjl.2007.10.023; Budu-Amoako E, 2012, VET PARASITOL, V184, P1, DOI 10.1016/j.vetpar.2011.10.027; Chen ZG, 2011, VET PARASITOL, V181, P113, DOI 10.1016/j.vetpar.2011.04.037; Dou C, 2007, ANIM HUSBANDRY FEED, P14; Fayer R, 2006, VET PARASITOL, V135, P105, DOI 10.1016/j.vetpar.2005.08.003; Fayer R, 2007, VET PARASITOL, V145, P260, DOI 10.1016/j.vetpar.2006.12.009; Fayer R, 2010, VET PARASITOL, V170, P187, DOI 10.1016/j.vetpar.2010.02.040; Feng YY, 2007, VET PARASITOL, V144, P1, DOI 10.1016/j.vetpar.2006.10.001; Feng YY, 2012, VET PARASITOL, V185, P309, DOI 10.1016/j.vetpar.2011.09.025; Follet J, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-116; Geurden T, 2007, PARASITOLOGY, V134, P1981, DOI 10.1017/S0031182007003460; Hamnes IS, 2006, VET PARASITOL, V140, P204, DOI 10.1016/j.vetpar.2006.03.024; Helmy YA, 2013, VET PARASITOL, V193, P15, DOI 10.1016/j.vetpar.2012.12.015; Herges GR, 2012, APPL ENVIRON MICROB, V78, P8096, DOI 10.1128/AEM.02105-12; Ikarashi M, 2013, VET PARASITOL; Imre K, 2011, VET PARASITOL, V181, P321, DOI 10.1016/j.vetpar.2011.04.042; Jex AR, 2008, ELECTROPHORESIS, V29, P4119, DOI 10.1002/elps.200800422; Kang'ethe EK, 2012, TROP ANIM HEALTH PRO, V44, pS25, DOI 10.1007/s11250-012-0202-5; Karanis P, 2007, PARASITOL RES, V101, P1575, DOI 10.1007/s00436-007-0681-x; King BJ, 2007, PARASITOLOGY, V134, P309, DOI 10.1017/S0031182006001491; Kvac M, 2011, VET PARASITOL, V177, P378, DOI 10.1016/j.vetpar.2010.11.048; Langkjaer RB, 2007, PARASITOLOGY, V134, P339, DOI 10.1017/S0031182006001533; Learmonth JJ, 2003, WATER SCI TECHNOL, V47, P21, DOI 10.2166/wst.2003.0150; Liu AQ, 2009, PARASITOL RES, V105, P797, DOI 10.1007/s00436-009-1457-2; Long RJ, 1999, PREV VET MED, V38, P195, DOI 10.1016/S0167-5877(98)00125-1; Ma L, 2011, ACTA ECOL ANIM DOMAS, V32, P47; Maikai BV, 2011, VET PARASITOL, V178, P241, DOI 10.1016/j.vetpar.2010.12.048; Murakoshi F, 2013, J VET MED SCI; Murakoshi F, 2012, VET PARASITOL, V187, P123, DOI 10.1016/j.vetpar.2011.12.011; Nazemalhosseini-Mojarad E, 2011, VET PARASITOL, V179, P250, DOI 10.1016/j.vetpar.2011.01.051; Nydam DV, 2002, PARASITOL RES, V88, P797, DOI 10.1007/s00436-002-0665-9; Peng MM, 2003, PARASITOL RES, V90, P175, DOI 10.1007/s00436-003-0834-5; Quilez J, 2008, PARASITOLOGY, V135, P1613, DOI 10.1017/S0031182008005088; Rieux A, 2012, VET PARASITOL; Rossignol JF, 2010, EXP PARASITOL, V124, P45, DOI 10.1016/j.exppara.2009.07.005; Nguyen ST, 2012, PARASITOL RES, V111, P1817, DOI 10.1007/s00436-012-3038-z; Santin M, 2004, VET PARASITOL, V122, P103, DOI 10.1016/j.vetpar.2004.03.020; Silva C. A. T., 2012, EPIDEMIOL INFECT, P1; Silverlas C, 2013, INT J PARASITOL, V43, P155, DOI 10.1016/j.ijpara.2012.10.009; Silverlas C, 2010, VET PARASITOL, V169, P289, DOI 10.1016/j.vetpar.2010.01.003; Smith HV, 2005, VET REC, V156, P710, DOI 10.1136/vr.156.22.710; Soba B, 2008, PARASITOLOGY, V135, P1263, DOI 10.1017/S0031182008004800; Sulaiman IM, 2005, J CLIN MICROBIOL, V43, P2805, DOI 10.1128/JCM.43.6.2805-2809.2005; Sun WC, 2011, B ENVIRON CONTAM TOX, V86, P653, DOI 10.1007/s00128-011-0282-3; Szonyi B, 2010, PARASITOL RES, V107, P317, DOI 10.1007/s00436-010-1864-4; Trotz-Williams LA, 2006, PARASITOL RES, V99, P346, DOI 10.1007/s00436-006-0157-4; Wang RJ, 2011, PARASITOL INT, V60, P1, DOI 10.1016/j.parint.2010.09.002; Wang RJ, 2011, J CLIN MICROBIOL, V49, P1077, DOI 10.1128/JCM.02194-10; Wielinga PR, 2008, INT J PARASITOL, V38, P809, DOI 10.1016/j.ijpara.2007.10.014; Xiao LH, 2001, J INFECT DIS, V183, P492, DOI 10.1086/318090; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P3386; Xiao LH, 2008, INT J PARASITOL, V38, P1239, DOI 10.1016/j.ijpara.2008.03.006; Xiao LH, 2007, PARASITOL RES, V100, P701, DOI 10.1007/s00436-006-0337-2; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Xiao LH, 2009, EUKARYOT CELL, V8, P429, DOI 10.1128/EC.00295-08; ZHANG J, 2006, CHIN QINGHAI J ANIM, V36, P16; Zhang WZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054857; Zhao GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060112; Zhou Chun-xiang, 2009, Chinese Journal of Zoonoses, V25, P389	64	44	48	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74985	10.1371/journal.pone.0074985	http://dx.doi.org/10.1371/journal.pone.0074985			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086416	gold, Green Published			2022-12-27	WOS:000326520200066
J	Park, JW; Shin, MK; Pitot, HC; Lambert, PF				Park, Jung Wook; Shin, Myeong-Kyun; Pitot, Henry C.; Lambert, Paul F.			High Incidence of HPV-Associated Head and Neck Cancers in FA Deficient Mice Is Associated with E7's Induction of DNA Damage through Its Inactivation of Pocket Proteins	PLOS ONE			English	Article							PAPILLOMAVIRUS TYPE-16 E6; SQUAMOUS-CELL CARCINOMAS; FANCONI-ANEMIA; S-PHASE; PATHWAY; GENE; LINK; RB; ONCOPROTEIN; SUPPRESSOR	Fanconi anemia (FA) patients are highly susceptible to solid tumors at multiple anatomical sites including head and neck region. A subset of head and neck cancers (HNCs) is associated with 'high-risk' HPVs, particularly HPV16. However, the correlation between HPV oncogenes and cancers in FA patients is still unclear. We previously learned that FA deficiency in mice predisposes HPV16 E7 transgenic mice to HNCs. To address HPV16 E6's oncogenic potential under FA deficiency in HNCs, we utilized HPV16 E6-transgenic mice (K14E6) and HPV16 E6/E7-bi-transgenic mice (K14E6E7) on genetic backgrounds sufficient or deficient for one of the fanc genes, fancD2 and monitored their susceptibility to HNCs. K14E6 mice failed to develop tumor. However, E6 and fancD2-deficiency accelerated E7-driven tumor development in K14E6E7 mice. The increased tumor incidence was more correlated with E7-driven DNA damage than proliferation. We also found that deficiency of pocket proteins, pRb, p107, and p130 that are well-established targets of E7, could recapitulate E7's induction of DNA damage. Our findings support the hypothesis that E7 induces HPV-associated HNCs by promoting DNA damage through the inactivation of pocket proteins, which explains why a deficiency in DNA damage repair would increase susceptibility to E7-driven cancer. Our results further demonstrate the unexpected finding that FA deficiency does not predispose E6 transgenic mice to HNCs, indicating a specificity in the synergy between FA deficiency and HPV oncogenes in causing HNCs.	[Park, Jung Wook; Shin, Myeong-Kyun; Pitot, Henry C.; Lambert, Paul F.] Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Lambert, PF (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, 1400 Univ Ave, Madison, WI 53706 USA.	lambert@oncology.wisc.edu		Park, Jung Wook/0000-0003-4798-9621	National Institutes of Health (NIH) [CA098428, CA022443]; NATIONAL CANCER INSTITUTE [P01CA022443, P30CA014520, R01CA098428] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The source of funding for this work was National Institutes of Health (NIH) (CA098428, CA022443). NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter BP, 2013, INT J CANCER, V133, P1513, DOI 10.1002/ijc.28157; Begum S, 2005, CLIN CANCER RES, V11, P5694, DOI 10.1158/1078-0432.CCR-05-0587; Birkeland AC, 2011, ARCH OTOLARYNGOL, V137, P930, DOI 10.1001/archoto.2011.154; Crossan GP, 2012, J PATHOL, V226, P326, DOI 10.1002/path.3002; Duensing S, 2002, CANCER RES, V62, P7075; Duensing S, 2002, ONCOGENE, V21, P6241, DOI 10.1038/sj.onc.1205709; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fernandez-Capetillo O, 2003, CELL CYCLE, V2, P426, DOI 10.4161/cc.2.5.509; Gillison ML, 2004, LANCET, V363, P1488, DOI 10.1016/S0140-6736(04)16194-1; Gillison ML, 2004, SEMIN ONCOL, V31, P744, DOI 10.1053/j.seminoncol.2004.09.011; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Herber R, 1996, J VIROL, V70, P1873, DOI 10.1128/JVI.70.3.1873-1881.1996; Ho VM, 2009, ONCOGENE, V28, P1393, DOI 10.1038/onc.2008.491; Hoskins EE, 2008, ONCOGENE, V27, P4798, DOI 10.1038/onc.2008.121; Hoskins EE, 2009, ONCOGENE, V28, P674, DOI 10.1038/onc.2008.416; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Huh KW, 2005, P NATL ACAD SCI USA, V102, P11492, DOI 10.1073/pnas.0505337102; Jabbar S, 2010, VIROLOGY, V407, P60, DOI 10.1016/j.virol.2010.08.003; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kutler DI, 2003, J NATL CANCER I, V95, P1718, DOI 10.1093/jnci/djg091; Kutler DI, 2003, ARCH OTOLARYNGOL, V129, P106, DOI 10.1001/archotol.129.1.106; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; Lowy DR, 2003, JNCI-J NATL CANCER I, V95, P1648, DOI 10.1093/jnci/djg125; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; Park JW, 2010, CANCER RES, V70, P9959, DOI 10.1158/0008-5472.CAN-10-1291; Pichierri P, 2004, CELL CYCLE, V3, P698; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Riley RR, 2003, CANCER RES, V63, P4862; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Rosenberg PS, 2003, BLOOD, V101, P822, DOI 10.1182/blood-2002-05-1498; Rosenberg PS, 2005, BLOOD, V105, P67, DOI 10.1182/blood-2004-04-1652; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; Shai A, 2010, CANCER RES, V70, P5064, DOI 10.1158/0008-5472.CAN-09-3307; Shin MK, 2012, CANCER RES, V72, P5418, DOI 10.1158/0008-5472.CAN-12-2083; Shin MK, 2012, CANCER RES, V72, P1280, DOI 10.1158/0008-5472.CAN-11-2833; Simpson DS, 2009, CANCER RES, V69, P8733, DOI 10.1158/0008-5472.CAN-09-1359; Song SY, 1999, J VIROL, V73, P5887, DOI 10.1128/JVI.73.7.5887-5893.1999; Spardy N, 2007, J VIROL, V81, P13265, DOI 10.1128/JVI.01121-07; Strati K, 2007, CANCER RES, V67, P11585, DOI 10.1158/0008-5472.CAN-07-3007; Strati K, 2006, P NATL ACAD SCI USA, V103, P14152, DOI 10.1073/pnas.0606698103; Sun A, 2007, J CELL BIOCHEM, V102, P1400, DOI 10.1002/jcb.21609; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Tribius S, 2011, CANCER LETT, V304, P71, DOI 10.1016/j.canlet.2011.02.002; van Zeeburg HJT, 2008, J NATL CANCER I, V100, P1649, DOI 10.1093/jnci/djn366	52	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75056	10.1371/journal.pone.0075056	http://dx.doi.org/10.1371/journal.pone.0075056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086435	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200077
J	Ross, OA; Soto-Ortolaza, AI; Heckman, MG; Verbeeck, C; Serie, DJ; Rayaprolu, S; Rich, SS; Nalls, MA; Singleton, A; Guerreiro, R; Kinsella, E; Wszolek, ZK; Brott, TG; Brown, RD; Worrall, BB; Meschia, JF				Ross, Owen A.; Soto-Ortolaza, Alexandra I.; Heckman, Michael G.; Verbeeck, Christophe; Serie, Daniel J.; Rayaprolu, Sruti; Rich, Stephen S.; Nalls, Michael A.; Singleton, Andrew; Guerreiro, Rita; Kinsella, Emma; Wszolek, Zbigniew K.; Brott, Thomas G.; Brown, Robert D., Jr.; Worrall, Bradford B.; Meschia, James F.			NOTCH3 Variants and Risk of Ischemic Stroke	PLOS ONE			English	Article							CADASIL; MUTATION; ARTERIOPATHY; INFARCTS; GENE	Background: Mutations within the NOTCH3 gene cause cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). CADASIL mutations appear to be restricted to the first twenty-four exons, resulting in the gain or loss of a cysteine amino acid. The role of other exonic NOTCH3 variation not involving cysteine residues and mutations in exons 25-33 in ischemic stroke remains unresolved. Methods: All 33 exons of NOTCH3 were sequenced in 269 Caucasian probands from the Siblings With Ischemic Stroke Study (SWISS), a 70-center North American affected sibling pair study and 95 healthy Caucasian control subjects. Variants identified by sequencing in the SWISS probands were then tested for association with ischemic stroke using US Caucasian controls collected at the Mayo Clinic (n=654), and further assessed in a Caucasian (n=802) and African American (n=298) patient-control series collected through the Ischemic Stroke Genetics Study (ISGS). Results: Sequencing of the 269 SWISS probands identified one (0.4%) with small vessel type stroke carrying a known CADASIL mutation (p. R558C; Exon 11). Of the 19 common NOTCH3 variants identified, the only variant significantly associated with ischemic stroke after multiple testing adjustment was p. R1560P (rs78501403; Exon 25) in the combined SWISS and ISGS Caucasian series (Odds Ratio [OR] 0.50, P=0.0022) where presence of the minor allele was protective against ischemic stroke. Although only significant prior to adjustment for multiple testing, p.T101T (rs3815188; Exon 3) was associated with an increased risk of small-vessel stroke (OR: 1.56, P=0.008) and p.P380P (rs61749020; Exon 7) was associated with decreased risk of large-vessel stroke (OR: 0.35, P=0.047) in Caucasians. No significant associations were observed in the small African American series. Conclusion: Cysteine-affecting NOTCH3 mutations are rare in patients with typical ischemic stroke, however our observation that common NOTCH3 variants may be associated with risk of ischemic stroke warrants further study.	[Ross, Owen A.; Soto-Ortolaza, Alexandra I.; Verbeeck, Christophe; Rayaprolu, Sruti] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Heckman, Michael G.; Serie, Daniel J.] Mayo Clin, Biostat Sect, Jacksonville, FL 32224 USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Gen, Charlottesville, VA USA; [Nalls, Michael A.; Singleton, Andrew; Guerreiro, Rita; Kinsella, Emma] Natl Inst Hlth, Natl Inst Aging, Neurogenet Lab, Bethesda, MD USA; [Guerreiro, Rita] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Guerreiro, Rita] Inst Neurol, Reta Lilla Weston Labs, London WC1N 3BG, England; [Guerreiro, Rita] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Kinsella, Emma] Cardiff Univ, Sch Med, Cardiff, Wales; [Wszolek, Zbigniew K.; Brott, Thomas G.; Meschia, James F.] Mayo Clin, Coll Med, Dept Neurol, Jacksonville, FL 32224 USA; [Brown, Robert D., Jr.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Worrall, Bradford B.] Univ Virginia, Dept Neurol, Charlottesville, VA USA	Mayo Clinic; Mayo Clinic; University of Virginia; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London; University of London; University College London; Universidade de Coimbra; Cardiff University; Mayo Clinic; Mayo Clinic; University of Virginia	Ross, OA (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	ross.owen@mayo.edu	Sander-Effron, Samuel/AAX-2231-2020; Wszolek, Zbigniew K./AAB-1431-2019; Resource Center, NINDS Human Genetics/AGF-2474-2022; Singleton, Andrew B/C-3010-2009; Meschia, James/GPP-1636-2022; Guerreiro, Rita J L/A-1327-2011	Meschia, James/0000-0002-4475-8142; Guerreiro, Rita/0000-0001-5879-3486; Ross, Owen/0000-0003-4813-756X; Rich, Stephen/0000-0003-3872-7793; Rayaprolu, Sruti/0000-0002-5212-3745	James and Ester King Foundation New Investigator Award from the Department of Health, Florida State; American Heart Association (AHA); Myron and Jane Hanley Award in Stroke Research; National Institute of Neurological Disorders and Stroke (NINDS) [R01 NS39987]; Marriott Disease Risk and Regenerative Medicine Initiative Award in Individualized Medicine; NINDS [R01 NS42733]; National Institutes of Health (NIH) /NINDS [P50 NS072187]; Mayo Clinic Center for Regenerative Medicine; Dystonia Medical Research Foundation; Intramural Research Program of the National Institute on Aging, NIH, Department of Health and Human Services [Z01 AG000950-06]; UK Motor Neurone Disease Association [6057]; Wellcome Trust/MRC Joint Call in Neurodegeneration award [WT089698]; UCL/Institute of Neurology; University of Sheffield; MRC Protein Phosphorylation Unit at the University of Dundee; Alzheimer's Research UK; MRC [MC_G1000735] Funding Source: UKRI; Medical Research Council [MC_G1000735] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS072187, R01NS042733, R01NS039987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000950] Funding Source: NIH RePORTER	James and Ester King Foundation New Investigator Award from the Department of Health, Florida State; American Heart Association (AHA)(American Heart Association); Myron and Jane Hanley Award in Stroke Research; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Marriott Disease Risk and Regenerative Medicine Initiative Award in Individualized Medicine; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health (NIH) /NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Mayo Clinic Center for Regenerative Medicine; Dystonia Medical Research Foundation; Intramural Research Program of the National Institute on Aging, NIH, Department of Health and Human Services; UK Motor Neurone Disease Association; Wellcome Trust/MRC Joint Call in Neurodegeneration award(Wellcome TrustUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCL/Institute of Neurology; University of Sheffield; MRC Protein Phosphorylation Unit at the University of Dundee(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	OAR is a recipient of a James and Ester King Foundation New Investigator Award from the Department of Health, Florida State. OAR is also funded by the American Heart Association (AHA) and the Myron and Jane Hanley Award in Stroke Research. The Siblings with Ischemic Stroke Study was funded by a grant from the National Institute of Neurological Disorders and Stroke (NINDS) (R01 NS39987; JFM, PI) and by a Marriott Disease Risk and Regenerative Medicine Initiative Award in Individualized Medicine. The Ischemic Stroke Genetics Study (ISGS) was funded by a grant from the NINDS (R01 NS42733). ZKW is partially supported by the National Institutes of Health (NIH) /NINDS P50 NS072187, Mayo Clinic Center for Regenerative Medicine, and Dystonia Medical Research Foundation. This work was supported in part by the Intramural Research Program of the National Institute on Aging, NIH, Department of Health and Human Services, project number Z01 AG000950-06; the UK Motor Neurone Disease Association grant 6057 to John Hardy and Richard Orrell and Alzheimer's Research UK funding to John Hardy. This work was supported in part by the Wellcome Trust/MRC Joint Call in Neurodegeneration award (WT089698) to the UK Parkinson's Disease Consortium (UKPDC) whose members are from the UCL/Institute of Neurology, the University of Sheffield and the MRC Protein Phosphorylation Unit at the University of Dundee and a fellowship from Alzheimer's Research UK to Dr. Guerreiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; Arboleda-Velasquez JF, 2008, P NATL ACAD SCI USA, V105, P4856, DOI 10.1073/pnas.0709867105; BARRETT JC, 2009, COLD SPRING HARB PRO, P71; DICHGANS M, 2003, STROKE GENETICS, P165; DUDOIT S, 2004, STAT APPL GENET 0614, P3; Federico A, 2005, NEUROL SCI, V26, P117, DOI 10.1007/s10072-005-0444-3; Fouillade C, 2008, HUM MUTAT, V29, P452, DOI 10.1002/humu.9527; Guerreiro RJ, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.009; Guidetti D, 2006, CLIN EXP HYPERTENS, V28, P271, DOI 10.1080/10641960600549223; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kalimo H, 2002, BRAIN PATHOL, V12, P371; Meschia JF, 2011, NAT REV NEUROL, V7, P369, DOI 10.1038/nrneurol.2011.80; Pescini F, 2008, J NEUROL SCI, V267, P170, DOI 10.1016/j.jns.2007.10.017; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ross OA, 2007, CURR DRUG TARGETS, V8, P850; Schmidt H, 2011, BRAIN, V134, P3384, DOI 10.1093/brain/awr252; Vikelis M, 2007, SWISS MED WKLY, V137, P323	19	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75035	10.1371/journal.pone.0075035	http://dx.doi.org/10.1371/journal.pone.0075035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086431	gold, Green Published, Green Submitted			2022-12-27	WOS:000326520200074
J	Byrne, LC; Khalid, F; Lee, T; Zin, EA; Greenberg, KP; Visel, M; Schaffer, DV; Flannery, JG				Byrne, Leah C.; Khalid, Fakhra; Lee, Trevor; Zin, Emilia A.; Greenberg, Kenneth P.; Visel, Meike; Schaffer, David V.; Flannery, John G.			AAV-Mediated, Optogenetic Ablation of Muller Glia Leads to Structural and Functional Changes in the Mouse Retina	PLOS ONE			English	Article							TYPE-2; TRANSDUCTION; CELLS	Muller glia, the primary glial cell in the retina, provide structural and metabolic support for neurons and are essential for retinal integrity. Muller cells are closely involved in many retinal degenerative diseases, including macular telangiectasia type 2, in which impairment of central vision may be linked to a primary defect in Muller glia. Here, we used an engineered, Muller-specific variant of AAV, called ShH10, to deliver a photo-inducibly toxic protein, KillerRed, to Muller cells in the mouse retina. We characterized the results of specific ablation of these cells on visual function and retinal structure. ShH10-KillerRed expression was obtained following intravitreal injection and eyes were then irradiated with green light to induce toxicity. Induction of KillerRed led to loss of Muller cells and a concomitant decrease of Muller cell markers glutamine synthetase and cellular retinaldehyde-binding protein, reduction of rhodopsin and cone opsin, and upregulation of glial fibrillary acidic protein. Loss of Muller cells also resulted in retinal disorganization, including thinning of the outer nuclear layer and the photoreceptor inner and outer segments. High resolution imaging of thin sections revealed displacement of photoreceptors from the ONL, formation of rosette-like structures and the presence of phagocytic cells. Furthermore, Muller cell ablation resulted in increased area and volume of retinal blood vessels, as well as the formation of tortuous blood vessels and vascular leakage. Electrophysiologic measures demonstrated reduced retinal function, evident in decreased photopic and scotopic electroretinogram amplitudes. These results show that loss of Muller cells can cause progressive retinal degenerative disease, and suggest that AAV delivery of an inducibly toxic protein in Muller cells may be useful to create large animal models of retinal dystrophies.	[Byrne, Leah C.; Khalid, Fakhra; Lee, Trevor; Zin, Emilia A.; Visel, Meike; Flannery, John G.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Byrne, Leah C.; Khalid, Fakhra; Lee, Trevor; Zin, Emilia A.; Visel, Meike; Schaffer, David V.; Flannery, John G.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Greenberg, Kenneth P.] Spiral Devices LLC, Berkeley, CA USA; [Schaffer, David V.] Univ Calif Berkeley, Dept Chem Engn, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Flannery, JG (corresponding author), Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA.	flannery@berkeley.edu		Flannery, John/0000-0002-0720-8897; Araujo Zin, Emilia/0000-0002-1275-3697; Byrne, Leah/0000-0002-3229-4993	NIH; Foundation Fighting Blindness; MacTel Project; Howard Hughes Medical Institute	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); MacTel Project; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was funded by the following agencies: the NIH, the Foundation Fighting Blindness (http://www.blindness.org/), the MacTel Project (https://web.emmes.com/study/mactel/index.htm), and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Del Bene F, 2010, SCIENCE, V330, P669, DOI 10.1126/science.1192949; Dubois-Dauphin M, 2000, NEUROSCIENCE, V95, P9; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Klein R, 2010, AM J OPHTHALMOL, V150, P55, DOI 10.1016/j.ajo.2010.02.013; Klimczak RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007467; Koerber JT, 2009, MOL THER, V17, P2088, DOI 10.1038/mt.2009.184; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Len ACL, 2012, J PROTEOME RES, V11, P537, DOI 10.1021/pr200889t; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Li YJ, 2007, DIABETES, V56, P656, DOI 10.2337/db06-0999; Narayanan R, 2013, GRAEF ARCH CLIN EXP, V251, P1311, DOI 10.1007/s00417-012-2191-5; Nishikiori N, 2007, DIABETES, V56, P1333, DOI 10.2337/db06-1431; Otteson DC, 2010, INVEST OPHTH VIS SCI, V51, P5991, DOI 10.1167/iovs.10-5395; Petrs-Silva H, 2009, MOL THER, V17, P463, DOI 10.1038/mt.2008.269; Powner MB, 2013, OPHTHALMOLOGY, DOI [10.1016/j.ophtha.2013.04.013, DOI 10.1016/J.0PHTHA.2013.04.013.PUBMED:23769334]; Powner MB, 2011, BRIT J OPHTHALMOL, V95, P1316, DOI 10.1136/bjo.2011.204222; Powner MB, 2010, OPHTHALMOLOGY, V117, P2407, DOI 10.1016/j.ophtha.2010.04.001; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Sallo FB, 2012, INVEST OPHTH VIS SCI, V53, P7889, DOI 10.1167/iovs.12-10765; Shen WY, 2012, J NEUROSCI, V32, P15715, DOI 10.1523/JNEUROSCI.2841-12.2012; Shen WY, 2011, INVEST OPHTH VIS SCI, V52, P119, DOI 10.1167/iovs.10-6033; Shen WY, 2010, J NEUROSCI RES, V88, P1485, DOI 10.1002/jnr.22317; Shibuya T, 2012, J PHOTOCH PHOTOBIO B, V117, P1, DOI 10.1016/j.jphotobiol.2012.08.005; Shirmanova MV, 2013, J BIOPHOTONICS, V6, P283, DOI 10.1002/jbio.201200056; TOUT S, 1993, NEUROSCIENCE, V55, P291, DOI 10.1016/0306-4522(93)90473-S; Yin L, 2011, INVEST OPHTH VIS SCI, V52, P2775, DOI 10.1167/iovs.10-6250	28	44	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76075	10.1371/journal.pone.0076075	http://dx.doi.org/10.1371/journal.pone.0076075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086689	gold, Green Submitted, Green Published			2022-12-27	WOS:000325223900076
J	Gupta, A; Shrivastava, N; Grover, P; Singh, A; Mathur, K; Verma, V; Kaur, C; Chaudhary, VK				Gupta, Amita; Shrivastava, Nimisha; Grover, Payal; Singh, Ajay; Mathur, Kapil; Verma, Vaishali; Kaur, Charanpreet; Chaudhary, Vijay K.			A Novel Helper Phage Enabling Construction of Genome-Scale ORF-Enriched Phage Display Libraries	PLOS ONE			English	Article							OPEN READING FRAMES; FILAMENTOUS PHAGE; SURFACE EXPRESSION; CDNA LIBRARIES; GENE; ANTIBODIES; SELECTION; PROTEINS; ASSAY; M13	Phagemid-based expression of cloned genes fused to the gIIIP coding sequence and rescue using helper phages, such as VCSM13, has been used extensively for constructing large antibody phage display libraries. However, for randomly primed cDNA and gene fragment libraries, this system encounters reading frame problems wherein only one of 18 phages display the translated foreign peptide/protein fused to phagemid-encoded gIIIP. The elimination of phages carrying out-of-frame inserts is vital in order to improve the quality of phage display libraries. In this study, we designed a novel helper phage, AGM13, which carries trypsin-sensitive sites within the linker regions of gIIIP. This renders the phage highly sensitive to trypsin digestion, which abolishes its infectivity. For open reading frame (ORF) selection, the phagemid-borne phages are rescued using AGM13, so that clones with in-frame inserts express fusion proteins with phagemid-encoded trypsin-resistant gIIIP, which becomes incorporated into the phages along with a few copies of AGM13-encoded trypsin-sensitive gIIIP. In contrast, clones with out-of-frame inserts produce phages carrying only AGM13-encoded trypsin-sensitive gIIIP. Trypsin treatment of the phage population renders the phages with out-of-frame inserts non-infectious, whereas phages carrying in-frame inserts remain fully infectious and can hence be enriched by infection. This strategy was applied efficiently at a genome scale to generate an ORF-enriched whole genome fragment library from Mycobacterium tuberculosis, in which nearly 100% of the clones carried in-frame inserts after selection. The ORF-enriched libraries were successfully used for identification of linear and conformational epitopes for monoclonal antibodies specific to mycobacterial proteins.	[Gupta, Amita] Univ Delhi South Campus, Dept Microbiol, New Delhi, India; [Shrivastava, Nimisha; Grover, Payal; Singh, Ajay; Mathur, Kapil; Verma, Vaishali; Kaur, Charanpreet; Chaudhary, Vijay K.] Univ Delhi South Campus, Dept Biochem, New Delhi, India	University of Delhi; University of Delhi	Gupta, A (corresponding author), Univ Delhi South Campus, Dept Microbiol, Benito Juarez Rd, New Delhi, India.	amitagupta@south.du.ac.in; vkchaudhary@south.du.ac.in	Verma, Vaishali/ABH-2408-2021	Verma, Vaishali/0000-0001-5076-7435	Department of Science and Technology; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, India	Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Department of Science and Technology to AG and Department of Biotechnology, Government of India to VKC. NS, VV are recipient of Research Fellowship from Council of Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN Y, J STRUCT BIOL, V175, P189; ARMSTRONG J, 1981, FEBS LETT, V135, P167, DOI 10.1016/0014-5793(81)80969-6; BHARDWAJ D, 1995, J IMMUNOL METHODS, V179, P165, DOI 10.1016/0022-1759(94)00280-A; BREITLING F, 1991, GENE, V104, P147, DOI 10.1016/0378-1119(91)90244-6; Caberoy NB, 2010, J MOL RECOGNIT, V23, P74, DOI 10.1002/jmr.983; CRAMERI R, 1994, EUR J BIOCHEM, V226, P53, DOI 10.1111/j.1432-1033.1994.tb20025.x; D'Angelo S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S1-S5; DINIRO R, NUCL ACIDS RES, V38, pE110; Fack F, 1997, J IMMUNOL METHODS, V206, P43, DOI 10.1016/S0022-1759(97)00083-5; Faix PH, 2004, BIOTECHNIQUES, V36, P1018, DOI 10.2144/04366RR03; Goletz S, 2002, J MOL BIOL, V315, P1087, DOI 10.1006/jmbi.2001.5314; Gupta A, 2009, MABS, V1, P268, DOI 10.4161/mabs.1.3.8231; HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133; Hust M, 2006, BIOTECHNIQUES, V41, P335, DOI 10.2144/000112225; JESPERS LS, 1995, BIO-TECHNOL, V13, P378, DOI 10.1038/nbt0495-378; Johnston SA, 1997, VACCINE, V15, P808, DOI 10.1016/S0264-410X(96)00276-9; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Kudva IT, 2006, MOL CELL PROTEOMICS, V5, P1514, DOI 10.1074/mcp.T600013-MCP200; Kugler J, 2008, APPL MICROBIOL BIOT, V80, P447, DOI 10.1007/s00253-008-1576-1; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Liu JW, 2006, PROTEIN EXPRES PURIF, V47, P258, DOI 10.1016/j.pep.2005.11.019; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Maxwell KL, 1999, PROTEIN SCI, V8, P1908, DOI 10.1110/ps.8.9.1908; Rollins SM, 2005, CELL MICROBIOL, V7, P1, DOI 10.1111/j.1462-5822.2004.00477.x; Rondot S, 2001, NAT BIOTECHNOL, V19, P75, DOI 10.1038/83567; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Zacchi P, 2003, GENOME RES, V13, P980, DOI 10.1101/gr.861503	28	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75212	10.1371/journal.pone.0075212	http://dx.doi.org/10.1371/journal.pone.0075212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086469	Green Submitted, Green Published, gold			2022-12-27	WOS:000325223900039
J	Gurha, P; Wang, TN; Larimore, AH; Sassi, Y; Abreu-Goodger, C; Ramirez, MO; Reddy, AK; Engelhardt, S; Taffet, GE; Wehrens, XHT; Entman, ML; Rodriguez, A				Gurha, Priyatansh; Wang, Tiannan; Larimore, Ashley H.; Sassi, Yassine; Abreu-Goodger, Cei; Ramirez, Maricela O.; Reddy, Anilkumar K.; Engelhardt, Stefan; Taffet, George E.; Wehrens, Xander H. T.; Entman, Mark L.; Rodriguez, Antony			microRNA-22 Promotes Heart Failure through Coordinate Suppression of PPAR/ERR-Nuclear Hormone Receptor Transcription	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; MESSENGER-RNA; ERR-ALPHA; GAMMA; GENE; DISEASE; STRESS; MUSCLE; METABOLISM; MECHANISMS	Increasing evidence suggests that microRNAs are intimately involved in the pathophysiology of heart failure. MicroRNA-22 (miR-22) is a muscle-enriched miRNA required for optimum cardiac gene transcription and adaptation to hemodynamic stress by pressure overload in mice. Recent evidence also suggests that miR-22 induces hypertrophic growth and it is oftentimes upregulated in end stage heart failure. However the scope of mRNA targets and networks of miR-22 in the heart failure remained unclear. We analyzed transgenic mice with enhanced levels of miR-22 expression in adult cardiomyocytes to identify important pathophysiologic targets of miR-22. Our data shows that forced expression of miR-22 induces a pro-hypertrophic gene expression program, and it elicits contractile dysfunction leading to cardiac dilation and heart failure. Increased expression of miR-22 impairs the Ca2+ transient, Ca2+ loading into the sarcoplasmic reticulum plus it interferes with transcription of estrogen related receptor (ERR) and PPAR downstream genes. Mechanistically, miR-22 postranscriptionally inhibits peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha), PPAR alpha and sirtuin 1 (SIRT1) expression via a synergistic circuit, which may account for deleterious actions of unchecked miR-22 expression on the heart.	[Gurha, Priyatansh; Larimore, Ashley H.; Ramirez, Maricela O.; Rodriguez, Antony] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Wang, Tiannan; Wehrens, Xander H. T.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Sassi, Yassine; Engelhardt, Stefan] Tech Univ Munich, Inst Pharmacol & Toxicol, D-80290 Munich, Germany; [Sassi, Yassine; Engelhardt, Stefan] Munich Heart Alliance, Munich, Germany; [Abreu-Goodger, Cei] CINVESTAV, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico; [Ramirez, Maricela O.; Rodriguez, Antony] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; [Reddy, Anilkumar K.; Taffet, George E.; Entman, Mark L.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Technical University of Munich; Munich Heart Alliance; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Baylor College of Medicine; Baylor College of Medicine	Rodriguez, A (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	micromax@gmail.com	Reddy, Anilkumar/GLS-1391-2022; Abreu-Goodger, Cei/A-1268-2010; Engelhardt, Stefan/AAA-9329-2019; Wehrens, Xander/AAQ-9574-2020	Abreu-Goodger, Cei/0000-0001-8302-9893; Engelhardt, Stefan/0000-0001-5378-8661; Wehrens, Xander/0000-0001-5044-672X; Sassi, Yassine/0000-0002-7807-1728; Gurha, Priyatansh/0000-0003-4867-7785	American Heart Association, National and a Gillson-Longenbaugh Foundation award; National Institutes of Health (NIH) [HL089792]; Hankamer Foundation; NIH [K25 HL73041, R01 HL22512, HL089598, HL091947]; Fondation Leducq (Alliance for CaMKII Signaling in Heart); NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011795] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL022512, R01HL091947, R01HL089792, R01HL089598, K25HL073041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002182] Funding Source: NIH RePORTER	American Heart Association, National and a Gillson-Longenbaugh Foundation award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hankamer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq (Alliance for CaMKII Signaling in Heart); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	A.R. was supported by the American Heart Association, National and a Gillson-Longenbaugh Foundation award. M.L.E. was supported by National Institutes of Health (NIH) grant HL089792 and also by the Hankamer Foundation; A.K.R. was supported by NIH grants, K25 HL73041 and R01 HL22512; X.W. was supported by NIH grants HL089598 and HL091947 and the Fondation Leducq (Alliance for CaMKII Signaling in Heart). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat R, 2009, J BIOL CHEM, V284, P21872, DOI 10.1074/jbc.M109.022749; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Crawford PA, 2013, J MOL CELL CARDIOL, V55, P130, DOI 10.1016/j.yjmcc.2012.06.008; Diwan A, 2007, PHYSIOLOGY, V22, P56, DOI 10.1152/physiol.00033.2006; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gurha P, 2012, CIRCULATION, V125, P2751, DOI 10.1161/CIRCULATIONAHA.111.044354; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Jentzsch C, 2012, J MOL CELL CARDIOL, V52, P13, DOI 10.1016/j.yjmcc.2011.07.010; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Madrazo JA, 2008, J MOL CELL CARDIOL, V44, P968, DOI 10.1016/j.yjmcc.2008.03.021; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Oka S, 2011, CELL METAB, V14, P598, DOI 10.1016/j.cmet.2011.10.001; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Sucharov C, 2008, J MOL CELL CARDIOL, V45, P185, DOI 10.1016/j.yjmcc.2008.04.014; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Voigt N, 2012, CIRCULATION, V125, P2059, DOI 10.1161/CIRCULATIONAHA.111.067306; Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100	28	65	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75882	10.1371/journal.pone.0075882	http://dx.doi.org/10.1371/journal.pone.0075882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086656	Green Submitted, Green Published, gold			2022-12-27	WOS:000325223900067
J	Lee, YJ; Kim, NK; Yang, JY; Noh, JH; Lee, SS; Ko, KS; Rhee, BD; Kim, DJ				Lee, Yun Jeong; Kim, Na Kyung; Yang, Ju Yean; Noh, Jung Hyun; Lee, Sung-Soon; Ko, Kyung Soo; Rhee, Byoung Doo; Kim, Dong-Jun			Low Pulmonary Function in Individuals with Impaired Fasting Glucose: The 2007-2009 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							RESTRICTIVE VENTILATORY DYSFUNCTION; LUNG-FUNCTION; INSULIN-RESISTANCE; METABOLIC SYNDROME; ASSOCIATION; HEART; HYPERGLYCEMIA; DIAGNOSIS; DISEASE	Objective: To investigate the association between fasting plasma glucose level and pulmonary function. Research Design and Methods: Nutritional information, pulmonary function data, and laboratory test data from 9,223 subjects from the fourth Korea National Health and Nutrition Examination Survey were examined. The participants were divided into five groups according to fasting plasma glucose (FPG) level: normal fasting glucose (NFG) 1, FPG <90 mg/dl; NFG2, FPG 90-99 mg/dl; impaired fasting glucose (IFG) 1: FPG 100-109 mg/dl; IFG2, FPG 110-125 mg/dl; and diabetes, FPG >= 126 mg/dl and/or current anti-diabetes medications. Results: After adjustment for several variables, the percentage of predicted forced vital capacity(FVC%) decreased with increasing fasting plasma glucose level in both sexes[men: (mean +/- SEM) 92.0 +/- 0.3 in NFG1; 91.9 +/- 0.3 in NFG2; 92.0 +/- 0.4 in IFG1; 90.2 +/- 0.7 in IFG2; and 89.9 +/- 0.5 in diabetes, P = 0.004; women: 93.7 +/- 0.3 in NFG1; 93.7 +/- 0.3 in NFG2; 93.1 +/- 0.5 in IFG1; 91.1 +/- 0.9 in IFG2; and 90.7 +/- 0.6 in diabetes, P<0.001]. A logistic regression analysis found that IFG2 and diabetes were independently associated with the lowest quintile of predicted FVC% (IFG2: odds ratio [95% CI], 1.50 [1.18-1.89], P = 0.001; diabetes: 1.56 [1.30-1.88], P<0.001) using NFG1 as a control. Conclusions: The current data suggest that forced vital capacity may begin to decrease in the higher range of IFG.	[Lee, Yun Jeong; Yang, Ju Yean; Noh, Jung Hyun; Lee, Sung-Soon; Ko, Kyung Soo; Rhee, Byoung Doo; Kim, Dong-Jun] Inje Univ, Coll Med, Dept Internal Med, Busan, South Korea; [Kim, Na Kyung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, Seoul, South Korea	Inje University; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, DJ (corresponding author), Inje Univ, Coll Med, Dept Internal Med, Busan, South Korea.	djkim@paik.ac.kr	Noh, Junghyun/AAU-8113-2020	Noh, Junghyun/0000-0002-7964-0515	Inje University	Inje University	This work was supported by a 2012 Inje University research grant. The relevant grant number is one. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Bongaerts BWC, 2012, DIABETES CARE, V35, P1891, DOI 10.2337/dc11-2028; Choi JK, 2005, TUBERC RESPIR DIS, V58, P230, DOI 10.4046/trd.2005.58.3.230; Davis TME, 2000, DIABETES RES CLIN PR, V50, P153, DOI 10.1016/S0168-8227(00)00166-2; Davis WA, 2004, DIABETES CARE, V27, P752, DOI 10.2337/diacare.27.3.752; Fimognari FL, 2007, J GERONTOL A-BIOL, V62, P760, DOI 10.1093/gerona/62.7.760; Ford ES, 2004, DIABETES CARE, V27, P2966, DOI 10.2337/diacare.27.12.2966; Fox CS, 2005, DIABETES CARE, V28, P2436, DOI 10.2337/diacare.28.10.2436; Gabir MM, 2000, DIABETES CARE, V23, P1113, DOI 10.2337/diacare.23.8.1113; Hickson DA, 2011, LUNG, V189, P311, DOI 10.1007/s00408-011-9296-1; Kim HK, 2011, EXP CLIN ENDOCR DIAB, V119, P47, DOI 10.1055/s-0030-1268467; Klein OL, 2010, DIABETIC MED, V27, P977, DOI 10.1111/j.1464-5491.2010.03073.x; Ko SH, 2011, DIABETES METAB J, V35, P431, DOI 10.4093/dmj.2011.35.5.431; Lawlor DA, 2004, DIABETOLOGIA, V47, P195, DOI 10.1007/s00125-003-1310-6; Lazarus R, 1998, EUR RESPIR J, V12, P641, DOI 10.1183/09031936.98.12030641; Lin WY, 2006, OBESITY, V14, P1654, DOI 10.1038/oby.2006.190; Litonjua AA, 2005, RESP MED, V99, P1583, DOI 10.1016/j.rmed.2005.03.023; McKeever TM, 2005, AM J EPIDEMIOL, V161, P546, DOI 10.1093/aje/kwi076; Nakajima K, 2008, CHEST, V134, P712, DOI 10.1378/chest.07-3003; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; Oda Eiji, 2009, Environmental Health and Preventive Medicine, V14, P284, DOI 10.1007/s12199-009-0098-5; Oda E, 2009, DIABETES RES CLIN PR, V85, P111, DOI 10.1016/j.diabres.2009.04.011; Oh JY, 2008, DIABETES RES CLIN PR, V80, P463, DOI 10.1016/j.diabres.2008.01.022; SANDLER M, 1990, ARCH INTERN MED, V150, P1385, DOI 10.1001/archinte.150.7.1385; Thyagarajan B, 2006, INT J EPIDEMIOL, V35, P1001, DOI 10.1093/ije/dyl049; Walter RE, 2003, AM J RESP CRIT CARE, V167, P911, DOI 10.1164/rccm.2203022; Yeh HC, 2008, DIABETES CARE, V31, P741, DOI 10.2337/dc07-1464	27	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76244	10.1371/journal.pone.0076244	http://dx.doi.org/10.1371/journal.pone.0076244			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086719	Green Published, Green Submitted, gold			2022-12-27	WOS:000325223900091
J	Yang, WH; Liu, SC; Tsai, CH; Fong, YC; Wang, SJ; Chang, YS; Tang, CH				Yang, Wei-Hung; Liu, Shan-Chi; Tsai, Chun-Hao; Fong, Yi-Chin; Wang, Shoou-Jyi; Chang, Yung-Sen; Tang, Chih-Hsin			Leptin Induces IL-6 Expression through OBRl Receptor Signaling Pathway in Human Synovial Fibroblasts	PLOS ONE			English	Article							NF-KAPPA-B; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; ARTICULAR-CARTILAGE; INTERLEUKIN-6; OSTEOARTHRITIS; AKT; BINDING; CELLS; FLUID	Background: Leptin, an adipocyte-secreted hormone that centrally regulates weight control, may exert proinflammatory effects in the joint, depending on the immune response. Leptin is abundantly expressed in osteoarthritis (OA) cartilage and synovium. However, the relationship between leptin and interleukin-6 (IL-6) in OA synovial fibroblasts (OASFs) remains obscure. Methodology/Principal Findings: Stimulation of OASFs with leptin induced IL-6 expression in a concentration-and time-dependent manner. OASFs expressed the long (OBRl) and short (OBRs) isoforms of the leptin receptor. However, OBRl, but not OBRs, antisense oligonucleotide (AS-ODN) abolished the leptin-mediated increase of IL-6 expression. Transfection with insulin receptor substrate (IRS)-1 siRNA decreased leptin-induced IL-6 production. In addition, pretreatment of cells with PI3K, Akt, or AP-1 inhibitor also inhibited the potentiating action of leptin. Leptin-induced AP-1 activation was inhibited by OBRl, IRS-1, PI3K, or Akt inhibitors and siRNAs. Conclusions/Significance: Our results showed that leptin activates the OBRl receptor, which in turn activates IRS-1, PI3K, Akt, and AP-1 pathway, leading to up-regulation of IL-6 expression.	[Yang, Wei-Hung; Chang, Yung-Sen] Taichung Hosp, Dept Orthoped Surg, Dept Hlth Execut Yuan, Taichung, Taiwan; [Yang, Wei-Hung] Natl Taichung Univ Sci & Technol, Dept Nursing, Taichung, Taiwan; [Yang, Wei-Hung; Fong, Yi-Chin] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan; [Yang, Wei-Hung] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Liu, Shan-Chi] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Tsai, Chun-Hao] China Med Univ, Dept Med, Taichung, Taiwan; [Tsai, Chun-Hao] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Tsai, Chun-Hao; Fong, Yi-Chin] China Med Univ Hosp, Dept Orthoped Surg, Taichung, Taiwan; [Wang, Shoou-Jyi] Chang Hua Hosp, Dept Orthoped Surg, Dept Hlth Execut Yuan, Puhsin, Changhua County, Taiwan; [Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan; [Tang, Chih-Hsin] Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan	National Taichung University of Science & Technology; China Medical University Taiwan; National Chung Hsing University; National Chung Hsing University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Tang, CH (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.	chtang@mail.cmu.edu.tw	Tang, Chih Hsin/O-5212-2015; Tsai, Chun-Hao/H-3140-2013	Tang, Chih Hsin/0000-0002-7113-8352; Tsai, Chun-Hao/0000-0002-4428-3132	National Science Council of Taiwan [NSC99-2320-B-039-003-MY3, 100-2320-B-039-028-MY3]; Department of Health Executive Yuan [DOH10220]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Department of Health Executive Yuan	This study was supported by grants from the National Science Council of Taiwan (NSC99-2320-B-039-003-MY3; 100-2320-B-039-028-MY3) and Department of Health Executive Yuan (DOH10220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Attoub S, 2000, FASEB J, V14, P2329, DOI 10.1096/fj.00-0162; Attur M, 2013, CURR OPIN RHEUMATOL, V25, P136, DOI 10.1097/BOR.0b013e32835a9381; Bao JP, 2010, MOL BIOL REP, V37, P3265, DOI 10.1007/s11033-009-9911-x; Busso N, 2002, J IMMUNOL, V168, P875, DOI 10.4049/jimmunol.168.2.875; Cawston TE, 1998, ARTHRITIS RHEUM-US, V41, P1760, DOI 10.1002/1529-0131(199810)41:10<1760::AID-ART8>3.0.CO;2-M; Chattopadhyay M, 2011, DIABETES, V60, P1483, DOI 10.2337/db10-0869; Chiu YC, 2009, J IMMUNOL, V183, P2785, DOI 10.4049/jimmunol.0802826; Del Rey MJ, 2010, ARTHRITIS RHEUM-US, V62, P3584, DOI 10.1002/art.27750; Dumond H, 2003, ARTHRITIS RHEUM, V48, P3118, DOI 10.1002/art.11303; Elmquist JK, 1998, NAT NEUROSCI, V1, P445, DOI 10.1038/2164; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Gkretsi V, 2011, PROG LIPID RES, V50, P133, DOI 10.1016/j.plipres.2010.11.001; GRAEVE L, 1993, CLIN INVESTIGATOR, V71, P664; Grassl C, 1999, J AM SOC NEPHROL, V10, P1466; Grimble RF, 1998, NUTRITION, V14, P634, DOI 10.1016/S0899-9007(98)00010-0; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Huang CY, 2012, ARTHRITIS RHEUM-US, V64, P3344, DOI 10.1002/art.34557; Kaneko S, 2000, CYTOKINES CELL MOL T, V6, P71, DOI 10.1080/13684730050515796; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Ku JH, 2009, CLIN RHEUMATOL, V28, P1431, DOI 10.1007/s10067-009-1242-8; Liu JF, 2013, BBA-MOL CELL RES, V1833, P966, DOI 10.1016/j.bbamcr.2012.12.023; Livshits G, 2009, ARTHRITIS RHEUM-US, V60, P2037, DOI 10.1002/art.24598; Marks R, 2002, ARTHRITIS RES, V4, P112, DOI 10.1186/ar387; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Metlakunta AS, 2011, AM J PHYSIOL-REG I, V300, pR1185, DOI 10.1152/ajpregu.00794.2010; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Palmer G, 2003, ANN RHEUM DIS, V62, P913, DOI 10.1136/ard.62.10.913; Pelletier JP, 2010, ANN RHEUM DIS, V69, P2095, DOI 10.1136/ard.2009.122002; Persson E, 2005, BONE, V37, P513, DOI 10.1016/j.bone.2005.04.043; Poree B, 2008, J BIOL CHEM, V283, P4850, DOI 10.1074/jbc.M706387200; Presle N, 2006, OSTEOARTHR CARTILAGE, V14, P690, DOI 10.1016/j.joca.2006.01.009; Rowan AD, 2001, ARTHRITIS RHEUM-US, V44, P1620, DOI 10.1002/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B; Russo VC, 2004, ENDOCRINOLOGY, V145, P4103, DOI 10.1210/en.2003-1767; Samuels J, 2008, BULL HOSP JT DIS, V66, P244; Schaffler A, 2003, JAMA-J AM MED ASSOC, V290, P1709, DOI 10.1001/jama.290.13.1709-c; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Simopoulou T, 2007, OSTEOARTHR CARTILAGE, V15, P872, DOI 10.1016/j.joca.2007.01.018; Sui YH, 2009, ARTHRITIS RHEUM-US, V60, P2985, DOI 10.1002/art.24857; Sweeney G, 2002, CELL SIGNAL, V14, P655, DOI 10.1016/S0898-6568(02)00006-2; Tang CH, 2007, J IMMUNOL, V179, P5483, DOI 10.4049/jimmunol.179.8.5483; Tang CH, 2007, J IMMUNOL, V179, P1292, DOI 10.4049/jimmunol.179.2.1292; Tang CH, 2010, ARTHRITIS RHEUM-US, V62, P3615, DOI 10.1002/art.27755; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tong KM, 2008, CELL SIGNAL, V20, P1478, DOI 10.1016/j.cellsig.2008.04.003; Vecchione C, 2002, DIABETES, V51, P168, DOI 10.2337/diabetes.51.1.168; Zarkesh-Esfahani H, 2001, J IMMUNOL, V167, P4593, DOI 10.4049/jimmunol.167.8.4593; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	48	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75551	10.1371/journal.pone.0075551	http://dx.doi.org/10.1371/journal.pone.0075551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086566	gold, Green Published, Green Submitted			2022-12-27	WOS:000325223900046
J	Yeh, HH; Chang, WT; Lu, KC; Lai, WW; Liu, HS; Su, WC				Yeh, Hsuan-Heng; Chang, Wen-Tsan; Lu, Kuang-Chu; Lai, Wu-Wei; Liu, Hsiao-Sheng; Su, Wu-Chou			Upregulation of Tissue Factor by Activated Stat3 Contributes to Malignant Pleural Effusion Generation via Enhancing Tumor Metastasis and Vascular Permeability in Lung Adenocarcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; FACTOR EXPRESSION; PULMONARY METASTASIS; CANCER; COAGULATION; ANGIOGENESIS; PROGRESSION; SURVIVAL; CELLS; GLIOBLASTOMA	Malignant pleural effusion (MPE) is a poor prognostic sign for patients with lung cancer. Tissue factor (TF) is a coagulation factor that participates in angiogenesis and vascular permeability and is abundant in MPE. We previously demonstrated that autocrine IL-6-activated Stat3 contributes to tumor metastasis and upregulation of VEGF, resulting in the generation of MPE in lung adenocarcinoma. In this study, we found IL-6-triggered Stat3 activation also induces TF expression. By using pharmacologic inhibitors, it was shown that JAK2 kinase, but not Src kinase, contributed to autocrine IL-6-induced TF expression. Inhibition of Stat3 activation by dominant negative Stat3 (S3D) in lung adenocarcinoma suppressed TF-induced coagulation, anchorage-independent growth in vitro, and tumor growth in vivo. Consistently, knockdown of TF expression by siRNA resulted in a reduction of anchorage-independent growth of lung adenocarcinoma cells. Inhibition of TF expression also decreased the adhesion ability of cancer cells in normal lung tissues. In the nude mouse model, both lung metastasis and MPE generation were decreased when PC14PE6/AS2-siTF cells (TF expression was silenced) were intravenously injected. PC14PE6/AS2-siTF cells also produced less malignant ascites through inhibition of vascular permeability. In summary, we showed that TF expression plays a pivotal role in the pathogenesis of MPE generation via regulating of tumor metastasis and vascular permeability in lung adenocarcinoma bearing activated Stat3.	[Yeh, Hsuan-Heng; Chang, Wen-Tsan; Lu, Kuang-Chu; Liu, Hsiao-Sheng; Su, Wu-Chou] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Yeh, Hsuan-Heng; Su, Wu-Chou] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Ctr Canc, Tainan 70101, Taiwan; [Chang, Wen-Tsan; Lu, Kuang-Chu] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Lai, Wu-Wei] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Surg, Tainan 70101, Taiwan; [Liu, Hsiao-Sheng] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Su, Wu-Chou] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70101, Taiwan; [Liu, Hsiao-Sheng] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Liu, HS (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan.	a713@mail.ncku.edu.tw; sunnysu@mail.ncku.edu.tw	, 賴吾為/T-8615-2019	, 賴吾為/0000-0001-9174-8310; Su, Wu-Chou/0000-0003-2953-4105; Liu, Hsiao-Sheng/0000-0003-0576-7203	Department of Health, Taiwan, R.O.C. [DOH102-TD-C-111-003, DOH102-TD-B-111-002, DOH101-TD-PB-111-TM024]	Department of Health, Taiwan, R.O.C.	This work was supported by the grants DOH102-TD-C-111-003, DOH102-TD-B-111-002 and DOH101-TD-PB-111-TM024 from Department of Health, Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1999, P NATL ACAD SCI USA, V96, P8663, DOI 10.1073/pnas.96.15.8663; Alexandrakis MG, 2000, ONCOL REP, V7, P1327; Amarzguioui M, 2006, CLIN CANCER RES, V12, P4055, DOI 10.1158/1078-0432.CCR-05-2482; ANDERSON CB, 1974, CANCER-AM CANCER SOC, V33, P916, DOI 10.1002/1097-0142(197404)33:4<916::AID-CNCR2820330405>3.0.CO;2-U; Antony VB, 2001, EUR RESPIR J, V18, P402, DOI 10.1183/09031936.01.00225601; Belting M, 2005, ARTERIOSCL THROM VAS, V25, P1545, DOI 10.1161/01.ATV.0000171155.05809.bf; Belting M, 2004, NAT MED, V10, P502, DOI 10.1038/nm1037; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; BROMBERG ME, 1995, P NATL ACAD SCI USA, V92, P8205, DOI 10.1073/pnas.92.18.8205; Buettner R, 2002, CLIN CANCER RES, V8, P945; Camerer E, 1996, THROMB RES, V81, P1, DOI 10.1016/0049-3848(95)00209-X; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Dorfleutner A, 2004, MOL BIOL CELL, V15, P4416, DOI 10.1091/mbc.E03-09-0640; Friedl J, 2002, BLOOD, V100, P1334, DOI 10.1182/blood.V100.4.1334.h81602001334_1334_1339; Gieseler F, 2007, THROMB HAEMOSTASIS, V97, P1023, DOI 10.1160/TH06-12-0712; Gil-Bernabe AM, 2012, BLOOD, V119, P3164, DOI 10.1182/blood-2011-08-376426; Hsu IL, 2009, LUNG CANCER, V65, P371, DOI 10.1016/j.lungcan.2008.12.007; Im JH, 2004, CANCER RES, V64, P8613, DOI 10.1158/0008-5472.CAN-04-2078; Kasthuri RS, 2009, J CLIN ONCOL, V27, P4834, DOI 10.1200/JCO.2009.22.6324; Krikun G, 2000, MOL ENDOCRINOL, V14, P393, DOI 10.1210/me.14.3.393; Liu HS, 2008, NEOPLASIA, V10, P52, DOI 10.1593/neo.07691; Liu Y, 2011, CANCER RES, V71, P6492, DOI 10.1158/0008-5472.CAN-11-1145; MACKMAN N, 1990, P NATL ACAD SCI USA, V87, P2254, DOI 10.1073/pnas.87.6.2254; MACKMAN N, 1995, FASEB J, V9, P883, DOI 10.1096/fasebj.9.10.7615158; MEMON A, 1981, Current Problems in Cancer, V5, P1, DOI 10.1016/S0147-0272(81)80012-8; Milsom CC, 2008, CANCER RES, V68, P10068, DOI 10.1158/0008-5472.CAN-08-2067; Moschos C, 2009, NEOPLASIA, V11, P298, DOI 10.1593/neo.81480; Mueller BM, 1998, J CLIN INVEST, V101, P1372, DOI 10.1172/JCI930; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Provencal M, 2009, CARCINOGENESIS, V30, P1089, DOI 10.1093/carcin/bgp085; Regina S, 2009, CLIN CHEM, V55, P1834, DOI 10.1373/clinchem.2009.123695; Rickles FR, 2003, CHEST, V124, p58S, DOI 10.1378/chest.124.3_suppl.58S; Rong Y, 2006, CANCER RES, V66, P7067, DOI 10.1158/0008-5472.CAN-06-0346; Rong Y, 2009, CANCER RES, V69, P2540, DOI 10.1158/0008-5472.CAN-08-1547; Sawada M, 1999, BRIT J CANCER, V79, P472, DOI 10.1038/sj.bjc.6690073; Shigemori C, 1998, THROMB HAEMOSTASIS, V80, P894; Stathopoulos GT, 2008, JNCI-J NATL CANCER I, V100, P1464, DOI 10.1093/jnci/djn325; Stathopoulos GT, 2007, CANCER RES, V67, P9825, DOI 10.1158/0008-5472.CAN-07-1064; Stathopoulos GT, 2006, AM J RESP CELL MOL, V34, P142, DOI 10.1165/rcmb.2005-0130OC; Ueno T, 2000, BRIT J CANCER, V83, P164; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; Versteeg HH, 2006, SEMIN THROMB HEMOST, V32, P24, DOI 10.1055/s-2006-933337; Wang XL, 2004, INT J CANCER, V112, P994, DOI 10.1002/ijc.20527; Yano S, 2000, AM J PATHOL, V157, P1893, DOI 10.1016/S0002-9440(10)64828-6; Yeh HH, 2006, ONCOGENE, V25, P4300, DOI 10.1038/sj.onc.1209464; Yu JL, 2005, BLOOD, V105, P1734, DOI 10.1182/blood-2004-05-2042; ZHANG YM, 1994, J CLIN INVEST, V94, P1320, DOI 10.1172/JCI117451	47	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75287	10.1371/journal.pone.0075287	http://dx.doi.org/10.1371/journal.pone.0075287			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086497	Green Submitted, gold, Green Published			2022-12-27	WOS:000325223900042
J	Angoulvant, F; Rouault, A; Prot-Labarthe, S; Boizeau, P; Skurnik, D; Morin, L; Mercier, JC; Alberti, C; Bourdon, O				Angoulvant, Francois; Rouault, Anne; Prot-Labarthe, Sonia; Boizeau, Priscilla; Skurnik, David; Morin, Laurence; Mercier, Jean-Christophe; Alberti, Corinne; Bourdon, Olivier			Randomized Controlled Trial of Parent Therapeutic Education on Antibiotics to Improve Parent Satisfaction and Attitudes in a Pediatric Emergency Department	PLOS ONE			English	Article							PATIENT SATISFACTION; OTITIS-MEDIA; INFECTIONS; INTERVENTIONS; ADHERENCE; COMMUNITY; CHILDREN; COMMUNICATION; NONCOMPLIANCE; EXPECTATIONS	Objective: To evaluate therapeutic education delivered in a pediatric emergency department to improve parents' satisfaction and attitudes about judicious antibiotic use. Methods: In an emergency department of a tertiary pediatric hospital, children aged 1 month to 6 years and discharged with an oral antibiotic prescription for an acute respiratory or urinary tract infection were randomized to a patient therapeutic education on antibiotic use (intervention group) or fever control (control group) delivered to the parents (in the presence of the children) by a pharmacist trained in therapeutic education. Education consisted in a 30-minute face-to-face session with four components: educational diagnosis, educational contract, education, and evaluation. The main outcome measure was parent satisfaction about information on antibiotics received at the hospital, as assessed by a telephone interview on day 14. The secondary outcome was attitudes about antibiotic use evaluated on day 14 and at month 6. Results: Of the 300 randomized children, 150 per arm, 259 were evaluated on day 14. Parent satisfaction with information on antibiotics was higher in the intervention group (125/129, 96.9%, versus 108/130, 83.0%; P=0.002, exact Fisher test). Intervention: Group parents had higher proportions of correct answers on day 14 to questions on attitudes about judicious antibiotic use than did control-group parents (P=0.017, Mann-Whitney U test). Conclusion: Therapeutic education delivered by a clinical pharmacist in the pediatric emergency department holds promise for improving the use of antibiotics prescribed to pediatric outpatients.	[Angoulvant, Francois; Morin, Laurence; Mercier, Jean-Christophe] Univ Paris Diderot, Hop Robert Debre, AP HP, Sorbonne Paris Cite Serv Accueil Urgences Pediat, Paris, France; [Angoulvant, Francois; Boizeau, Priscilla; Alberti, Corinne] Univ Paris Diderot, Hop Robert Debre, AP HP,INSERM CIE5, Sorbonne Paris Cite,Unite Epidemiol Clin, Paris, France; [Rouault, Anne; Prot-Labarthe, Sonia; Bourdon, Olivier] Univ Paris 05, Hop Robert Debre, AP HP, Fac Pharm,Dept Pharm, Paris, France; [Rouault, Anne; Bourdon, Olivier] Univ Paris 13 Bobigny, Sorbonne Paris Cite, Lab Pedag Sante,EA 3412, Paris, France; [Skurnik, David] Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Skurnik, David] Harvard Univ, Sch Med, Boston, MA USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Angoulvant, F (corresponding author), Univ Paris Diderot, Hop Robert Debre, AP HP, Sorbonne Paris Cite Serv Accueil Urgences Pediat, Paris, France.	francois.angoulvant@rdb.aphp.fr	Bourdon, Olivier/AHA-7107-2022	Skurnik, David/0000-0002-4205-9639	Assistance Publique-Hopitaux de Paris	Assistance Publique-Hopitaux de Paris	AR was supported by educational grants from the Assistance Publique-Hopitaux de Paris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder SC, 2005, AM J HEALTH EDUC, V36, P132, DOI 10.1080/19325037.2005.10608174; Altman Douglas G, 2009, Open Med, V3, pe51; Ammentorp J, 2005, ARCH PEDIAT ADOL MED, V159, P127, DOI 10.1001/archpedi.159.2.127; Andrews T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030334; Angoulvant F, 2012, EUR J CLIN MICROBIOL, V31, P1295, DOI 10.1007/s10096-011-1442-4; Autorite de Sante Haute, 2007, THER PAT ED TPE DEF; Azria R., 2012, Medecine et Maladies Infectieuses, V42, P460, DOI 10.1016/j.medmal.2012.02.004; Barrows H., 1980, PROBLEM BASED LEARNI; Bordley WC, 2002, AMBUL PEDIATR, V2, P306, DOI 10.1367/1539-4409(2002)002<0306:ORAEMS>2.0.CO;2; Boudreaux ED, 2004, J EMERG MED, V26, P13, DOI 10.1016/j.jemermed.2003.04.003; Cesarz JL, 2013, ANN EMERG MED, V61, P209, DOI 10.1016/j.annemergmed.2012.04.011; Chao JH, 2008, PEDIATRICS, V121, pE1352, DOI 10.1542/peds.2007-2278; Dagan R, 2009, PEDIATR INFECT DIS J, V28, pS119, DOI 10.1097/INF.0b013e3181b6d7d5; Dajani AS, 1996, PEDIATRICS, V97, P976; de Sande-Bruinsma NV, 2008, EMERG INFECT DIS, V14, P1722, DOI 10.3201/eid1411.070467; Dommergues MA, 2012, SCAND J INFECT DIS, V44, P495, DOI 10.3109/00365548.2012.669840; Dowell SF, 1997, AM FAM PHYSICIAN, V55, P1647; Finch RG, 2004, LANCET INFECT DIS, V4, P44, DOI 10.1016/S1473-3099(03)00860-0; Finkelstein JA, 2001, PEDIATRICS, V108, pU113; Gonzales R, 2001, CLIN INFECT DIS, V33, P757, DOI 10.1086/322627; Goossens H, 2006, EUR J CLIN PHARMACOL, V62, P373, DOI 10.1007/s00228-005-0094-7; Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; HALL JA, 1988, MED CARE, V26, P657, DOI 10.1097/00005650-198807000-00002; Isaacman DJ, 1997, PEDIATR EMERG CARE, V13, P256, DOI 10.1097/00006565-199708000-00004; Kardas P, 2005, INT J ANTIMICROB AG, V26, P106, DOI 10.1016/j.ijantimicag.2005.04.017; Laos CM, 2012, ACAD EMERG MED, V19, P274, DOI 10.1111/j.1553-2712.2012.01289.x; Lieberman JM, 2003, PEDIATR INFECT DIS J, V22, P1143, DOI 10.1097/01.inf.0000101851.57263.63; Mangione-Smith R, 2001, ARCH PEDIAT ADOL MED, V155, P800, DOI 10.1001/archpedi.155.7.800; Matsui D, 2000, ARCH PEDIAT ADOL MED, V154, P195, DOI 10.1001/archpedi.154.2.195; May L, 2013, ANN EMERG MED, V62, P69, DOI 10.1016/j.annemergmed.2012.09.002; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V59, P727, DOI 10.1093/jac/dkl558; Otters HBM, 2004, J ANTIMICROB CHEMOTH, V53, P361, DOI 10.1093/jac/dkh062; Pechere JC, 2007, INT J ANTIMICROB AG, V29, P245, DOI 10.1016/j.ijantimicag.2006.09.026; Price EL, 2011, PATIENT EDUC COUNS, V85, P493, DOI 10.1016/j.pec.2011.02.005; Rega PP, 2012, ACAD EMERG MED, V19, P313, DOI 10.1111/j.1553-2712.2012.01293.x; Rosman SL, 2012, PEDIATR EMERG CARE, V28, P22, DOI 10.1097/PEC.0b013e31823ed6e4; Sabuncu E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000084; Salazar ML, 2012, CLIN PEDIATR, V51, P632, DOI 10.1177/0009922812439243; Schindler C, 2003, PHARMACOEPIDEM DR S, V12, P113, DOI 10.1002/pds.786; Schnellinger M, 2010, PEDIATRICS, V125, P990, DOI 10.1542/peds.2009-2916; Sixsmith DM, 1997, ACAD EMERG MED, V4, P301, DOI 10.1111/j.1553-2712.1997.tb03553.x; Spahr CD, 2006, ACAD EMERG MED, V13, P1280, DOI 10.1197/j.aem.2006.06.059; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Thomas EJ, 1996, ANN EMERG MED, V27, P49, DOI 10.1016/S0196-0644(96)70296-2; WHO, 2001, WHO GLOB STRAT CONT; World Health Organization, 1998, THER PAT ED; Wroth TH, 2006, J AM BOARD FAM MED, V19, P478, DOI 10.3122/jabfm.19.5.478; Wu YP, 2008, J PEDIATR PSYCHOL, V33, P789, DOI 10.1093/jpepsy/jsn009	48	9	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75590	10.1371/journal.pone.0075590	http://dx.doi.org/10.1371/journal.pone.0075590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086581	Green Published, gold, Green Submitted			2022-12-27	WOS:000325220000030
J	Gardberg, M; Kaipio, K; Lehtinen, L; Mikkonen, P; Heuser, VD; Talvinen, K; Iljin, K; Kampf, C; Uhlen, M; Grenman, R; Koivisto, M; Carpen, O				Gardberg, Maria; Kaipio, Katja; Lehtinen, Laura; Mikkonen, Piia; Heuser, Vanina D.; Talvinen, Kati; Iljin, Kristiina; Kampf, Caroline; Uhlen, Mathias; Grenman, Reidar; Koivisto, Mari; Carpen, Olli			FHOD1, a Formin Upregulated in Epithelial-Mesenchymal Transition, Participates in Cancer Cell Migration and Invasion	PLOS ONE			English	Article							INVADOPODIA FORMATION; PROTEIN FHOD1; CARCINOMA-CELLS; DOMAIN; ROCK; TISSUES; FMNL2; RAC	Cancer cells can obtain their ability to invade and metastasise by undergoing epithelial-to-mesenchymal transition (EMT). Exploiting this mechanism of cellular plasticity, malignant cells can remodel their actin cytoskeleton and down-regulate proteins needed for cell-cell contacts. The mechanisms of cytoskeletal reorganisation resulting in mesenchymal morphology and increased invasive potential are poorly understood. Actin nucleating formins have been implicated as key players in EMT. Here, we analysed which formins are altered in squamous cell carcinoma related EMT. FHOD1, a poorly studied formin, appeared to be markedly upregulated upon EMT. In human tissues FHOD1 was primarily expressed in mesenchymal cells, with little expression in epithelia. However, specimens from oral squamous cell cancers demonstrated consistent FHOD1 upregulation in mesenchymally transformed cells at the invasive edge. This upregulation was confirmed in an oral squamous carcinoma model, where FHOD1 expression was markedly increased upon EMT in a PI3K signalling dependent manner. In the EMT cells FHOD1 contributed to the spindle-shaped morphology and mesenchymal F-actin organization. Furthermore, functional assays demonstrated that FHOD1 contributes to cell migration and invasion. Finally, FHOD1 depletion reduced the ability of EMT cancer cells to form invadopodia and to degrade extracellular matrix. Our results indicate that FHOD1 participates in cytoskeletal changes in EMT. In addition, we show that FHOD1 upregulation occurs during cancer cell EMT in vivo, which indicates that FHOD1 may contribute to tumour progression.	[Gardberg, Maria; Kaipio, Katja; Lehtinen, Laura; Mikkonen, Piia; Heuser, Vanina D.; Talvinen, Kati; Carpen, Olli] Univ Turku, Dept Pathol, Turku, Finland; [Gardberg, Maria; Kaipio, Katja; Lehtinen, Laura; Mikkonen, Piia; Heuser, Vanina D.; Talvinen, Kati; Carpen, Olli] Turku Univ Hosp, FIN-20520 Turku, Finland; [Iljin, Kristiina] VTT Tech Res Ctr Finland, Turku, Finland; [Iljin, Kristiina] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Kampf, Caroline] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Uhlen, Mathias] Royal Inst Technol, Sci Life Lab, Stockholm, Sweden; [Uhlen, Mathias] Royal Inst Technol, Albanova Univ Ctr, Stockholm, Sweden; [Grenman, Reidar] Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, FIN-20520 Turku, Finland; [Grenman, Reidar] Turku Univ Hosp, Dept Med Biochem & Genet, FIN-20520 Turku, Finland; [Grenman, Reidar] Univ Turku, Turku, Finland; [Koivisto, Mari] Univ Turku, Dept Biostat, Turku, Finland	University of Turku; University of Turku; VTT Technical Research Center Finland; University of Turku; Uppsala University; Royal Institute of Technology; Royal Institute of Technology; University of Turku; University of Turku; University of Turku; University of Turku	Gardberg, M (corresponding author), Univ Turku, Dept Pathol, Turku, Finland.	maria.gardberg@utu.fi	Uhlen, Mathias/AAV-8746-2021; Uhlen, Mathias/B-3262-2016	Uhlen, Mathias/0000-0002-4858-8056; Dahlstrom-Heuser, Vanina/0000-0002-7044-4649; Iljin, Kristiina/0000-0002-5161-0584	Academy of Finland; Finska Lakaresallskapet; Sigrid Juselius Foundation; K Albin Johansson Foundation; Finnish Cancer Organizations; Turku University Hospital Research Funds; National Graduate School of Clinical Investigation	Academy of Finland(Academy of Finland); Finska Lakaresallskapet; Sigrid Juselius Foundation(Sigrid Juselius Foundation); K Albin Johansson Foundation; Finnish Cancer Organizations; Turku University Hospital Research Funds; National Graduate School of Clinical Investigation	This research was supported by funding from The Academy of Finland, Finska Lakaresallskapet, Sigrid Juselius Foundation, K Albin Johansson Foundation, The Finnish Cancer Organizations and Turku University Hospital Research Funds. Maria Gardberg is a Ph.D. student supported by the National Graduate School of Clinical Investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Chen C, 2012, CANC LETT IN PRESS; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Gardberg M, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-55; Gasteier JE, 2003, J BIOL CHEM, V278, P38902, DOI 10.1074/jbc.M306229200; Gill MB, 2004, J CELL SCI, V117, P2709, DOI 10.1242/jcs.01113; Haikonen J, 2003, INT J CANCER, V103, P784, DOI 10.1002/ijc.10890; Hwang YS, 2012, ARCH ORAL BIOL, V57, P335, DOI 10.1016/j.archoralbio.2011.08.019; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Koka S, 2003, J CELL SCI, V116, P1745, DOI 10.1242/jcs.00386; Krisanaprakornkit S, 2012, ONCOLOGY, V2012; Li YF, 2010, MOL CANCER RES, V8, P1579, DOI 10.1158/1541-7786.MCR-10-0081; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Pignatelli J, 2012, J CELL BIOL, V197, P421, DOI 10.1083/jcb.201108143; Rath N, 2012, EMBO REP, V13, P900, DOI 10.1038/embor.2012.127; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Schonichen A, 2006, J BIOL CHEM, V281, P5084, DOI 10.1074/jbc.M509226200; Schonichen A, 2013, J CELL SCI IN PRESS; Sibony-Benyamini H, 2012, EUR J CELL BIOL, V91, P896, DOI 10.1016/j.ejcb.2012.04.001; Takeya R, 2008, EMBO J, V27, P618, DOI 10.1038/emboj.2008.7; Takkunen M, 2006, J HISTOCHEM CYTOCHEM, V54, P1263, DOI 10.1369/jhc.6A6958.2006; Takkunen M, 2010, J CELL MOL MED, V14, P1569, DOI 10.1111/j.1582-4934.2009.00868.x; Wang YP, 2004, J BIOL CHEM, V279, P24420, DOI 10.1074/jbc.M313823200	27	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e74923	10.1371/journal.pone.0074923	http://dx.doi.org/10.1371/journal.pone.0074923			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086398	Green Published, Green Submitted, gold			2022-12-27	WOS:000325220000011
J	Thibault, V; Laperche, S; Thiers, V; Sayon, S; Letort, MJ; Delarocque-Astagneau, E; Antona, D				Thibault, Vincent; Laperche, Syria; Thiers, Valerie; Sayon, Sophie; Letort, Marie-Jose; Delarocque-Astagneau, Elisabeth; Antona, Denise			Molecular Epidemiology and Clinical Characteristics of Hepatitis B Identified through the French Mandatory Notification System	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE SEQUENCES; IGM ANTI-HBC; QUANTITATIVE-ANALYSIS; FULMINANT-HEPATITIS; VIRUS-INFECTIONS; CORE ANTIGEN; MUTATIONS; FRANCE; GENOTYPES; VACCINATION	Background & Aims: Strains responsible for acute hepatitis B infections (AHB) in France have not been characterized. This study was first designed to analyze the molecular epidemiology of AHB and second to describe the differences between AHB and chronic hepatitis B (CHB) exacerbations. Methods: This prospective study was based on the French mandatory notification system for AHB. 147 samples corresponding to declared cases were shipped to a central laboratory for classification as AHB or CHB according to the level of anti-HBc IgM and anti-HBc avidity. Results: Based on biological marker values and file examination, 75 cases (59%) were classified as AHB. Independently of the acute or chronic status, genotype A (57%), D (22%) and E (14%) were the most prevalent and no phylogenetic clustering was observed among HBV sequences (n=68). Precore or basal core-promoter variants were not particularly associated with disease severity but were more prevalent in CHB. No antiviral resistant strains or immune-escape HBsAg was observed. HBV viral loads in AHB or CHB were comparable but with opposite distributions. ALT levels reached 10 times the upper normal value in 94% of AHB but only in 24% of CHB. Conclusions: After rigorous classification, no major difference at the genetic level was found between HBV strains isolated from AHB and CHB. Absence of potentially deleterious variant detection is reassuring. When based upon HBsAg and anti-HBc IgM determination, AHB notification may falsely include more than 40% CHB, leading to an important risk of bias in national surveillance programs of AHB.	[Thibault, Vincent; Sayon, Sophie] Hop La Pitie Salpetriere, Assistance Publ APHP, Virol Lab, Paris, France; [Thibault, Vincent; Sayon, Sophie] Univ Paris 06, Paris, France; [Laperche, Syria] Natl Inst Blood Transfus, Natl Reference Ctr Hepatitis B&C Blood Transfus, Paris, France; [Thiers, Valerie] Inst Pasteur, Dept Virol, Paris, France; [Letort, Marie-Jose; Antona, Denise] Natl Inst Publ Hlth Surveillance, Inst Veille Sanit, Dept Infect Dis, St Maurice, France; [Delarocque-Astagneau, Elisabeth] Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France; [Delarocque-Astagneau, Elisabeth] Inst Pasteur, Pharmacoepidemiol & Infect Dis Unit, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institute of Public Health Surveillance; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Thibault, V (corresponding author), Hop La Pitie Salpetriere, Assistance Publ APHP, Virol Lab, Paris, France.	vincent.thibault@psl.aphp.fr	THIBAULT, Vincent/J-7193-2015; delarocque-astagneau, elisabeth/E-4706-2016; THIBAULT, Vincent/AAB-5241-2020	THIBAULT, Vincent/0000-0001-6517-2901; delarocque-astagneau, elisabeth/0000-0002-5129-9300; THIBAULT, Vincent/0000-0001-6517-2901	ANRS (Agence Nationale de Recherche sur le Sida et les hepatites virales) [06286-CSS7-2006 2]	ANRS (Agence Nationale de Recherche sur le Sida et les hepatites virales)(ANRSFrench National Research Agency (ANR))	This study was supported by a grant (06286-CSS7-2006 2) from ANRS (Agence Nationale de Recherche sur le Sida et les hepatites virales). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antona D, 2009, HEPATITIS B INFECT E, P20; Balinska MA, 2009, J CLIN VIROL, V46, P202, DOI 10.1016/j.jcv.2009.07.024; Colloredo G, 1996, J HEPATOL, V25, P644, DOI 10.1016/S0168-8278(96)80233-9; Ganne-Carrie N, 2006, J MED VIROL, V78, P335, DOI 10.1002/jmv.20545; GERLICH WH, 1986, J CLIN MICROBIOL, V24, P288, DOI 10.1128/JCM.24.2.288-293.1986; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Gunther S, 1998, J CLIN MICROBIOL, V36, P531; Halfon P, 2006, J VIRAL HEPATITIS, V13, P329, DOI 10.1111/j.1365-2893.2005.00692.x; Han Y, 2009, J GASTROEN HEPATOL, V24, P1417, DOI 10.1111/j.1440-1746.2009.05864.x; Hayashi K, 2008, J GASTROENTEROL, V43, P558, DOI 10.1007/s00535-008-2197-2; Hunt CM, 2000, HEPATOLOGY, V31, P1037, DOI 10.1053/he.2000.6709; Ismail AM, 2011, INTERVIROLOGY; Kajiya Y, 2001, DIGEST DIS SCI, V46, P509, DOI 10.1023/A:1005582812466; Kanada A, 2007, INTERVIROLOGY, V50, P394, DOI 10.1159/000110651; Kao JH, 2007, HEPATOL INT, V1, P415, DOI 10.1007/s12072-007-9033-2; Klompas M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002626; Lada O, 2006, J VIROL, V80, P2968, DOI 10.1128/JVI.80.6.2968-2975.2006; Lai MW, 2012, GASTROENTEROLOGY, V143, P400, DOI 10.1053/j.gastro.2012.05.002; LEMON SM, 1981, J INFECT DIS, V143, P803, DOI 10.1093/infdis/143.6.803; LIANG TJ, 1994, J CLIN INVEST, V93, P550, DOI 10.1172/JCI117006; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu BM, 2010, ANTIVIR RES, V85, P512, DOI 10.1016/j.antiviral.2009.12.006; Liu CJ, 2004, J MED VIROL, V72, P545, DOI 10.1002/jmv.20024; Ly TD, 2006, J CLIN MICROBIOL, V44, P2321, DOI 10.1128/JCM.00121-06; Meffre C, 2010, J MED VIROL, V82, P546, DOI 10.1002/jmv.21734; Muhlbacher A, 2008, MED MICROBIOL IMMUN, V197, P55, DOI 10.1007/s00430-007-0059-9; Orenbuch-Harroch E, 2008, WORLD J GASTROENTERO, V14, P7133, DOI 10.3748/wjg.14.7133; Ozasa A, 2006, HEPATOLOGY, V44, P326, DOI 10.1002/hep.21249; PAPAEVANGELOU G, 1984, J MED VIROL, V13, P393, DOI 10.1002/jmv.1890130411; Ramsay ME, 1998, VACCINE, V16, pS76, DOI 10.1016/S0264-410X(98)00303-X; Rodella A, 2006, J CLIN VIROL, V37, P206, DOI 10.1016/j.jcv.2006.06.011; Servant-Delmas A, 2010, TRANSFUSION, V50, P2607, DOI 10.1111/j.1537-2995.2010.02725.x; Sloan RD, 2009, J CLIN VIROL, V44, P157, DOI 10.1016/j.jcv.2008.11.010; Tamada Y, 2012, GUT, V61, P765, DOI 10.1136/gutjnl-2011-300832; Terkmani H, 2005, HEPATOLOGY, V42, p717A; Trimoulet P, 2007, GASTROEN CLIN BIOL, V31, P1088, DOI 10.1016/S0399-8320(07)78341-0; van Houdt R, 2007, J MED VIROL, V79, P895, DOI 10.1002/jmv.20820; Xu ZH, 2010, J CLIN VIROL, V48, P270, DOI 10.1016/j.jcv.2010.05.010; Zhang DK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-271	39	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75267	10.1371/journal.pone.0075267	http://dx.doi.org/10.1371/journal.pone.0075267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086488	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700067
J	Wang, L; Rao, CM; Gao, K; Li, YH; Fu, ZH; Bi, H; Wang, JZ				Wang, Lan; Rao, Chunming; Gao, Kai; Li, Yonghong; Fu, Zhihao; Bi, Hua; Wang, Junzhi			Development of a Reference Standard of Escherichia coli DNA for Residual DNA Determination in China	PLOS ONE			English	Article							QUANTITATION; ASSAY; PROTEINS	This collaborative study developed the first national Escherichia coli (E. coli) DNA reference standard for standardizing quantitative residual DNA assay methods, fluorescence dye (PicoGreen) and quantitative PCR (q-PCR), which were widely employed to measure residual DNA contents of prokaryotic-derived recombinant products. High purity of E. coli strain BL21 was extracted by the cetyl triethyl ammonium bromide (CTAB)/phenol chloroform method, analyzed by UV-visible spectrophotometry and electrophoresis, diluted with tris-EDTA (TE) buffer and manually dispensed. Then, with a cooperative calibration among six laboratories, including five manufacturers and one national control laboratory, the concentration of E. coli DNA standard solution was determined as 96.2 mu g/mL (95% C.I: 95.5-96.9 mu g/mL, CV 3.4%). The candidate showed excellent stability both from accelerated degradation study and real time stability study. The applicability study showed that the E. coli DNA reference could reach the sensitivity of 0.781 ng/mL and 1 fg/mu L, respectively, in fluorescent dye and q-PCR assay, and also had good linearity and precision. The consistency of the reference could meet the requirements of the national reference standard. As a conclusion, the candidate material was suitable to serve as a China national standard for E. coli residual DNA determination. The successful establishment of the E. coli DNA standard will facilitate the standardization of quantitative methods for testing residual host cell DNA.	[Wang, Lan; Rao, Chunming; Gao, Kai; Li, Yonghong; Fu, Zhihao; Bi, Hua; Wang, Junzhi] Natl Inst Food & Drug Control, Beijing, Peoples R China	National Institute of Food & Drug Control - China	Wang, JZ (corresponding author), Natl Inst Food & Drug Control, Beijing, Peoples R China.	wangjz_nifdc@163.com			National Science and Technology Major Project [2012ZX09304010]; National High Technology Research and Development Program of China [SS2012AA020406]	National Science and Technology Major Project; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was financially supported by grants from the National Science and Technology Major Project (No. 2012ZX09304010) and the National High Technology Research and Development Program of China (No. SS2012AA020406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAMPBELL PJ, 1974, J BIOL STAND, V2, P249, DOI 10.1016/0092-1157(74)90033-X; Cao S, 2012, HUM VACC IMMUNOTHER, V9, P1; Desjardins P, 2010, J VIS EXP, V22; European Commission, 2006, COMM REG EC NO 1881, P5; European Union, 2001, CPMPBWP114300 EUR UN; Gao K, 2012, BIOLOGICALS, V40, P151, DOI 10.1016/j.biologicals.2011.08.013; Health Canada, 2013, GUID SPONS INF SUBM, P7; Ji XY, 2002, BIOTECHNIQUES, V32, P1162, DOI 10.2144/02325dd06; Kang MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028661; Kline MC, 2009, ANAL BIOANAL CHEM, V394, P1183, DOI 10.1007/s00216-009-2782-0; Knezevic I, 2010, BIOLOGICALS, V38, P162, DOI 10.1016/j.biologicals.2009.08.019; KUNG VT, 1990, ANAL BIOCHEM, V187, P220, DOI 10.1016/0003-2697(90)90447-H; Niimi S, 2002, BIOLOGICALS, V30, P69, DOI 10.1006/biol.2001.0318; Nissom PM, 2007, BIOLOGICALS, V35, P211, DOI 10.1016/j.biologicals.2006.09.001; Rathore AS, 2003, J PHARMACEUT BIOMED, V32, P1199, DOI 10.1016/S0731-7085(03)00157-2; Singer VL, 1997, ANAL BIOCHEM, V249, P228, DOI 10.1006/abio.1997.2177; U.S. Food and Drug Administration, 2013, QUAL CONS DEM BIOS R, P10; US Food and Drug Administration, 1997, POINTS CONS MAN TEST; WHO, 2013, GUID EV SIM BIOTH PR; WHO Expert Committee on Biological Standardization, 2006, WHO TECH REP SER, V932, p[v, 1]	20	4	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74166	10.1371/journal.pone.0074166	http://dx.doi.org/10.1371/journal.pone.0074166			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086318	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700017
J	Huan, XL; Shi, JH; Lim, LZ; Mitra, S; Zhu, WL; Qin, HN; Pasquale, EB; Song, JX				Huan, Xuelu; Shi, Jiahai; Lim, Liangzhong; Mitra, Sayantan; Zhu, Wanlong; Qin, Haina; Pasquale, Elena B.; Song, Jianxing			Unique Structure and Dynamics of the EphA5 Ligand Binding Domain Mediate Its Binding Specificity as Revealed by X-ray Crystallography, NMR and MD Simulations	PLOS ONE			English	Article							EPHRIN-BINDING; CRYSTAL-STRUCTURE; CONFORMATIONAL SELECTION; RECEPTOR SPECIFICITY; BACKBONE DYNAMICS; PROTEIN DYNAMICS; NERVOUS-SYSTEM; RELAXATION; COMPLEX; EXPRESSION	The 16 EphA and EphB receptors represent the largest family of receptor tyrosine kinases, and their interactions with 9 ephrin-A and ephrin-B ligands initiate bidirectional signals controlling many physiological and pathological processes. Most interactions occur between receptor and ephrins of the same class, and only EphA4 can bind all A and B ephrins. To understand the structural and dynamic principles that enable Eph receptors to utilize the same jellyroll beta-sandwich fold to bind ephrins, the VAPB-MSP domain, peptides and small molecules, we have used crystallography, NMR and molecular dynamics (MD) simulations to determine the first structure and dynamics of the EphA5 ligand-binding domain (LBD), which only binds ephrin-A ligands. Unexpectedly, despite being unbound, the high affinity ephrin-binding pocket of EphA5 resembles that of other Eph receptors bound to ephrins, with a helical conformation over the J-K loop and an open pocket. The openness of the pocket is further supported by NMR hydrogen/deuterium exchange data and MD simulations. Additionally, the EphA5 LBD undergoes significant picosecond-nanosecond conformational exchanges over the loops, as revealed by NMR and MD simulations, but lacks global conformational exchanges on the microsecond-millisecond time scale. This is markedly different from the EphA4 LBD, which shares 74% sequence identity and 87% homology. Consequently, the unbound EphA5 LBD appears to comprise an ensemble of open conformations that have only small variations over the loops and appear ready to bind ephrin-A ligands. These findings show how two proteins with high sequence homology and structural similarity are still able to achieve distinctive binding specificities through different dynamics, which may represent a general mechanism whereby the same protein fold can serve for different functions. Our findings also suggest that a promising strategy to design agonists/antagonists with high affinity and selectivity might be to target specific dynamic states of the Eph receptor LBDs.	[Huan, Xuelu; Song, Jianxing] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Shi, Jiahai; Lim, Liangzhong; Zhu, Wanlong; Qin, Haina; Song, Jianxing] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore; [Mitra, Sayantan; Pasquale, Elena B.] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Pasquale, Elena B.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Song, Jianxing] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; National University of Singapore	Song, JX (corresponding author), Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore.	bchsj@nus.edu.sg	Song, Jianxing/H-8026-2012; Zhu, Wan Long/GYA-3382-2022; Shi, Jiahai/AAH-1103-2019; Qin, Haina/AAB-7486-2020; shi, jiahai/D-7650-2013	Shi, Jiahai/0000-0002-6467-8289; shi, jiahai/0000-0002-6467-8289; Haina, Qin/0000-0002-9175-8014; Song, Jianxing/0000-0003-0224-6322; zhu, Wanlong/0000-0003-0025-6674	National Medical Research Council of Singapore (NMRC) [R-154-000-382-213 (NMRC/1216/2009)]; Ministry of Education of Singapore (MOE) [MOE 2011-T2-1-096]; National Institutes of Health (NIH) [P01CA138390]; NATIONAL CANCER INSTITUTE [P01CA138390] Funding Source: NIH RePORTER	National Medical Research Council of Singapore (NMRC)(National Medical Research Council, Singapore); Ministry of Education of Singapore (MOE)(Ministry of Education, Singapore); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants: National Medical Research Council of Singapore (NMRC) grant R-154-000-382-213 (NMRC/1216/2009) and Ministry of Education of Singapore (MOE) Tier 2 Grant MOE 2011-T2-1-096 to JXS; and National Institutes of Health (NIH) grant P01CA138390 to EBP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2002, SEMIN CELL DEV BIOL, V13, P55, DOI 10.1006/scdb.2001.0289; Akaneya Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012486; Almog N, 2009, CANCER RES, V69, P836, DOI 10.1158/0008-5472.CAN-08-2590; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bowden TA, 2009, STRUCTURE, V17, P1386, DOI 10.1016/j.str.2009.07.018; Chrencik JE, 2006, STRUCTURE, V14, P321, DOI 10.1016/j.str.2005.11.011; Chrencik JE, 2007, J BIOL CHEM, V282, P36505, DOI 10.1074/jbc.M706340200; Chrencik JE, 2006, J BIOL CHEM, V281, P28185, DOI 10.1074/jbc.M605766200; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P7387, DOI 10.1021/bi00484a006; Cooper MA, 2009, J COMP NEUROL, V514, P310, DOI 10.1002/cne.22030; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; DINGLEY AJ, 1995, J BIOMOL NMR, V6, P321; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Fu DY, 2010, HUM PATHOL, V41, P48, DOI 10.1016/j.humpath.2009.06.007; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; Giaginis C, 2010, PATHOL ONCOL RES, V16, P267, DOI 10.1007/s12253-009-9221-6; Giorgio C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018128; Heroult M, 2006, EXP CELL RES, V312, P642, DOI 10.1016/j.yexcr.2005.10.028; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Himanen JP, 1998, NATURE, V396, P486, DOI 10.1038/24904; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Himanen JP, 2009, EMBO REP, V10, P722, DOI 10.1038/embor.2009.91; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kimura K, 2011, P NATL ACAD SCI USA, V108, P9981, DOI 10.1073/pnas.1107592108; Kober P, 2011, MOL CARCINOGEN, V50, P846, DOI 10.1002/mc.20763; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Lamberto I, 2012, BIOCHEM J, V445, P47, DOI 10.1042/BJ20120408; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liu JX, 2008, BIOPHYS J, V95, P4803, DOI 10.1529/biophysj.107.125641; Long D, 2008, J AM CHEM SOC, V130, P2432, DOI 10.1021/ja710477h; Lua SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027072; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; Ma BY, 2002, PROTEIN SCI, V11, P184, DOI 10.1110/ps.21302; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; Mamiya PC, 2008, BRAIN RES, V1205, P91, DOI 10.1016/j.brainres.2008.02.047; Masterson LR, 2011, J MOL BIOL, V412, P155, DOI 10.1016/j.jmb.2011.06.041; Murai KK, 2003, MOL CELL NEUROSCI, V24, P1000, DOI 10.1016/j.mcn.2003.08.006; Noberini R, 2008, J BIOL CHEM, V283, P29461, DOI 10.1074/jbc.M804103200; Noberini R, 2011, CHEM BIOL DRUG DES, V78, P667, DOI 10.1111/j.1747-0285.2011.01199.x; Numachi Y, 2007, NEUROSCI LETT, V424, P116, DOI 10.1016/j.neulet.2007.07.025; Nussinov R, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2004, NAT NEUROSCI, V7, P417, DOI 10.1038/nn0504-417; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pejovic T, 2009, TRANSL ONCOL, V2, P341, DOI 10.1593/tlo.09199; Petty A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042120; Qin HN, 2008, J BIOL CHEM, V283, P29473, DOI 10.1074/jbc.M804114200; Qin HN, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-2; Qin HN, 2010, J BIOL CHEM, V285, P644, DOI 10.1074/jbc.M109.064824; Seiradake E, 2010, NAT STRUCT MOL BIOL, V17, P398, DOI 10.1038/nsmb.1782; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; Shi JH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001084; Shi JH, 2010, BIOCHEMISTRY-US, V49, P3887, DOI 10.1021/bi902057a; Singla N, 2010, BIOCHEM BIOPH RES CO, V399, P555, DOI 10.1016/j.bbrc.2010.07.109; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Sun Bingsheng, 2008, Cancer Biol Ther, V7, P387; Tsuda H, 2008, CELL, V133, P963, DOI 10.1016/j.cell.2008.04.039; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Wu JC, 2010, J CANCER RES CLIN, V136, P595, DOI 10.1007/s00432-009-0695-0; Zhou RP, 1997, CELL TISSUE RES, V290, P251, DOI 10.1007/s004410050929	69	14	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e74040	10.1371/journal.pone.0074040	http://dx.doi.org/10.1371/journal.pone.0074040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086308	Green Published, Green Submitted, gold			2022-12-27	WOS:000325025200008
J	Odaka, C; Loranger, A; Takizawa, K; Ouellet, M; Tremblay, MJ; Murata, S; Inoko, A; Inagaki, M; Marceau, N				Odaka, Chikako; Loranger, Anne; Takizawa, Kazuya; Ouellet, Michel; Tremblay, Michel J.; Murata, Shigeo; Inoko, Akihito; Inagaki, Masaki; Marceau, Normand			Keratin 8 Is Required for the Maintenance of Architectural Structure in Thymus Epithelium	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; MEDULLARY EPITHELIUM; MONOCLONAL-ANTIBODIES; DESMOSOMAL ADHESION; APOPTOTIC CELLS; MURINE THYMUS; MOUSE; EXPRESSION; PROTEIN; DESMOPLAKIN	Keratins (Ks), the intermediate filament (IF) proteins of epithelia, are coordinately expressed as pairs in a cell-lineage and differentiation manner. Cortical thymic epithelial cells (cTECs) predominantly express the simple epithelium keratin 8/18 (K8/K18) pair, whereas medullary thymic epithelial cells (mTECs) express the stratified epithelium K5/K14 pair, with TECs exhibiting K5 and K8 at the cortico-medullary junction in mature thymus. In the work reported here, we used wild-type (WT) and K8-knockout (K8-null) mice to address the contribution of K8/K18 IFs in the maintenance of the thymic epithelial structure. K8-null thymus maintained the differential cell segregation at the cortex versus the medulla observed in WT thymus, and the distribution of immature thymocytes at the cortex. The K8/K18 loss did not affect thymocyte development. However, it massively perturbed the TEC morphology both at the cortex and the medulla, along with a prominent depletion of cTECs. Such tissue alterations coincided with an increase in apoptosis and a reduced expression of Albatross (Fas-binding factor-1), also known for its capacity to bind K8/18 IFs. In addition, the K8/K18 loss affected the distribution of K5/K14-positive mTECs, but not their differentiation status. Together, the results indicate that K8/K18 IFs constitute key promoters of the thymic epithelium integrity.	[Odaka, Chikako; Takizawa, Kazuya] Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Tokyo, Japan; [Loranger, Anne; Marceau, Normand] Univ Laval, Ctr Rech Canc, Quebec City, PQ, Canada; [Loranger, Anne; Ouellet, Michel; Tremblay, Michel J.; Marceau, Normand] CHU Quebec, Ctr Rech, Quebec City, PQ, Canada; [Ouellet, Michel; Tremblay, Michel J.] Univ Laval, Ctr Rech Infectiol, Quebec City, PQ, Canada; [Murata, Shigeo] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Prot Metab, Tokyo, Japan; [Inoko, Akihito; Inagaki, Masaki] Aichi Canc Ctr, Res Inst, Div Biochem, Nagoya, Aichi 464, Japan	National Institute of Infectious Diseases (NIID); Laval University; Laval University; Laval University; University of Tokyo; Aichi Cancer Center	Odaka, C (corresponding author), Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Tokyo, Japan.	odaka@nih.go.jp	Ouellet, Michel/C-9942-2015; Inagaki, Masaki/B-9920-2016; Murata, Shigeo/A-1426-2010; Ouellet, Michel/ABC-3759-2020	Ouellet, Michel/0000-0002-2353-7535; Murata, Shigeo/0000-0002-3177-3503; Ouellet, Michel/0000-0002-2353-7535; Inoko, Akihito/0000-0002-6739-2948	National Sciences and Engineering Council of Canada [312270]; Canadian Institutes of Health Research [MOP15529]; Grants-in-Aid for Scientific Research [23247035] Funding Source: KAKEN	National Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the National Sciences and Engineering Council of Canada (312270) and the Canadian Institutes of Health Research (MOP15529). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; Baribault H, 1992, GENE DEV, V7, P1991; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x; Bravo-Nuevo A, 2011, INT IMMUNOL, V23, P593, DOI 10.1093/intimm/dxr064; BRULET P, 1980, P NATL ACAD SCI-BIOL, V77, P4113, DOI 10.1073/pnas.77.7.4113; Candi E, 2007, P NATL ACAD SCI USA, V104, P11999, DOI 10.1073/pnas.0703458104; Caulin C, 2000, J CELL BIOL, V149, P17, DOI 10.1083/jcb.149.1.17; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; DEGERMANN S, 1994, J IMMUNOL, V152, P3254; FARR AG, 1985, J IMMUNOL, V134, P2971; Farr AG, 2002, IMMUNOL REV, V189, P20, DOI 10.1034/j.1600-065X.2002.18903.x; GARROD DR, 1999, ADV MOL CEL, V28, P165; Gilbert S, 2001, J CELL BIOL, V154, P763, DOI 10.1083/jcb.200102130; Godsel LM, 2005, J CELL BIOL, V171, P1045, DOI 10.1083/jcb.200510038; Habtezion A, 2011, P NATL ACAD SCI USA, V108, P1445, DOI 10.1073/pnas.1010833108; Irla M, 2010, TRENDS IMMUNOL, V31, P71, DOI 10.1016/j.it.2009.11.002; JACKSON BW, 1980, DIFFERENTIATION, V17, P161, DOI 10.1111/j.1432-0436.1980.tb01093.x; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; LANE EB, 1982, EMBO J, V1, P1365, DOI 10.1002/j.1460-2075.1982.tb01324.x; LEE MG, 1994, J IMMUNOL, V152, P5653; Loranger A, 1997, AM J PATHOL, V151, P1673; Loranger A, 2006, EXP CELL RES, V312, P4108, DOI 10.1016/j.yexcr.2006.09.031; Marceau N, 2004, METHOD CELL BIOL, V78, P95; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Odaka C, 2006, CELL TISSUE RES, V325, P13, DOI 10.1007/s00441-005-0139-3; Odaka C, 1999, J IMMUNOL, V163, P5346; Odaka C, 2002, CELL DEATH DIFFER, V9, P104, DOI 10.1038/sj/cdd/4400941; Odaka C, 2009, J HISTOCHEM CYTOCHEM, V57, P373, DOI 10.1369/jhc.2008.952895; Oriolo AS, 2007, EXP CELL RES, V313, P2255, DOI 10.1016/j.yexcr.2007.02.030; Oshima RG, 1996, CANCER METAST REV, V15, P445, DOI 10.1007/BF00054012; REISNER Y, 1976, CELL IMMUNOL, V25, P129, DOI 10.1016/0008-8749(76)90103-9; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; ROUSE RV, 1988, J HISTOCHEM CYTOCHEM, V36, P1511, DOI 10.1177/36.12.2461413; Runswick SK, 2001, NAT CELL BIOL, V3, P823, DOI 10.1038/ncb0901-823; Schmidt T, 2000, BBA-GENE STRUCT EXPR, V1493, P249, DOI 10.1016/S0167-4781(00)00163-9; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sugimoto M, 2008, J CELL BIOL, V183, P19, DOI 10.1083/jcb.200803133; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076	44	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75101	10.1371/journal.pone.0075101	http://dx.doi.org/10.1371/journal.pone.0075101			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086449	gold, Green Submitted, Green Published			2022-12-27	WOS:000325025200025
J	Gessaroli, E; Santelli, E; di Pellegrino, G; Frassinetti, F				Gessaroli, Erica; Santelli, Erica; di Pellegrino, Giuseppe; Frassinetti, Francesca			Personal Space Regulation in Childhood Autism Spectrum Disorders	PLOS ONE			English	Article							NEURAL CIRCUITRY; AMYGDALA; CHILDREN; OXYTOCIN; DISTANCE; FEAR; INDIVIDUALS; IMPAIRMENTS; ADOLESCENTS; RESPONSES	People appropriately adjust the distance between themselves and others during social interaction, and they may feel discomfort and move away when another person intrudes on their personal space. In the present study, we investigated personal space in children with persistent difficulties in the domain of social behavior, such as children with autism spectrum disorders (ASD), and in children with typical development (TD). The stop-distance paradigm was used to derive estimates of interpersonal distance, before and after a brief interaction with an unfamiliar adult confederate. The results showed that ASD children felt comfortable at a greater distance compared to TD children. Moreover, personal space shrunk after interaction with the confederate in TD children, but it failed to do so in ASD children. These findings reveal that autism deeply affects the regulation of personal space, influencing both its size and flexibility.	[Gessaroli, Erica; di Pellegrino, Giuseppe; Frassinetti, Francesca] Univ Bologna, Dept Psychol, Bologna, Italy; [Gessaroli, Erica; Frassinetti, Francesca] Fdn Salvatore Maugeri, Clin Lavoro & Riabilitaz, Ist Ricovero & Cura Carattere Sci, Mantua, Castel Goffredo, Italy; [Santelli, Erica] Ctr Autismo, Reggio Emilia, Italy; [di Pellegrino, Giuseppe] Ctr Studies & Res Cognit Neurosci, Cesena, Italy	University of Bologna; Istituti Clinici Scientifici Maugeri IRCCS	di Pellegrino, G (corresponding author), Univ Bologna, Dept Psychol, Bologna, Italy.	g.dipellegrino@unibo.it; francesc.frassinetti@unibo.it	FRASSINETTI, FRANCESCA/ABI-1533-2020; di Pellegrino, Giuseppe/AAC-7149-2022; Frassinetti, Francesca/K-1474-2016	FRASSINETTI, FRANCESCA/0000-0001-6810-2861; di Pellegrino, Giuseppe/0000-0001-7080-4758; Frassinetti, Francesca/0000-0001-6810-2861	University of Bologna (Ricerca Fondamentale Orientata); Ministero Istruzione Universita e Ricerca [2010XPMFW4_009]	University of Bologna (Ricerca Fondamentale Orientata); Ministero Istruzione Universita e Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the University of Bologna (Ricerca Fondamentale Orientata) to FF and GdP, and from the Ministero Istruzione Universita e Ricerca (PRIN 2010, protocol number: 2010XPMFW4_009) to GdP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2001, J COGNITIVE NEUROSCI, V13, P232, DOI 10.1162/089892901564289; Aiello JR, 1987, HDB ENV PSYCHOL, P359; Amaral DG, 2003, GENES BRAIN BEHAV, V2, P295, DOI 10.1034/j.1601-183X.2003.00043.x; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; ARGYLE M, 1965, SOCIOMETRY, V28, P289, DOI 10.2307/2786027; BACHEVALIER J, 1994, NEUROPSYCHOLOGIA, V32, P627, DOI 10.1016/0028-3932(94)90025-6; BARHAIM Y, 2002, ATTACH HUM DEV, V4, DOI DOI 10.1080/14616730210123111.PUBMED:12065031; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Baron-Cohen S., 1993, UNDERSTANDING OTHER; Ben Shalom D, 2006, J AUTISM DEV DISORD, V36, P395, DOI 10.1007/s10803-006-0077-2; Bernier R, 2005, J AUTISM DEV DISORD, V35, P575, DOI 10.1007/s10803-005-0002-0; Bolte S, 2008, J AUTISM DEV DISORD, V38, P776, DOI 10.1007/s10803-007-0443-8; CASSIDY J, 1994, CHILD DEV, V65, P971, DOI 10.2307/1131298; Corbett BA, 2006, PSYCHONEUROENDOCRINO, V31, P59, DOI 10.1016/j.psyneuen.2005.05.011; Cristani M., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P290, DOI 10.1109/PASSAT/SocialCom.2011.32; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Deus Valentina, 2006, Psychiatr Danub, V18, P150; DOSEY MA, 1969, J PERS SOC PSYCHOL, V11, P93, DOI 10.1037/h0027040; Emery NJ, 2001, BEHAV NEUROSCI, V115, P515, DOI 10.1037/0735-7044.115.3.515; FEIN D, 1986, J AM ACAD CHILD PSY, V25, P198, DOI 10.1016/S0002-7138(09)60227-2; FELIPE NJ, 1966, SOC PROBL, V14, P206, DOI 10.1525/sp.1966.14.2.03a00080; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P845, DOI 10.1016/j.neuropsychologia.2005.09.009; Hall E.T., 1966, HIDDEN DIMENSION, V609; Happe F, 1996, BRAIN, V119, P1377, DOI 10.1093/brain/119.4.1377; HAYDUK LA, 1981, CAN J BEHAV SCI, V13, P274, DOI 10.1037/h0081182; HAYDUK LA, 1981, CAN J BEHAV SCI, V13, P87, DOI 10.1037/h0081114; HAYDUK LA, 1983, PSYCHOL BULL, V94, P293, DOI 10.1037/0033-2909.94.2.293; Hirstein W, 2001, P ROY SOC B-BIOL SCI, V268, P1883, DOI 10.1098/rspb.2001.1724; HOROWITZ MJ, 1964, ARCH GEN PSYCHIAT, V11, P651; Howard MA, 2000, NEUROREPORT, V11, P2931, DOI 10.1097/00001756-200009110-00020; Kennedy D. P., 2010, INT M AUT RES IMFAR; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Kleinhans NM, 2009, AM J PSYCHIAT, V166, P467, DOI 10.1176/appi.ajp.2008.07101681; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Kluver H, 1938, J PSYCHOL, V5, P33; LITTLE KB, 1965, J EXP SOC PSYCHOL, V1, P237, DOI 10.1016/0022-1031(65)90028-4; LOMRANZ J, 1975, DEV PSYCHOL, V11, P541, DOI 10.1037/0012-1649.11.5.541; Lord C, 2005, J AUTISM DEV DISORD, V35, P695, DOI 10.1007/s10803-005-0017-6; Markram K, 2008, NEUROPSYCHOPHARMACOL, V33, P901, DOI 10.1038/sj.npp.1301453; Mason WA, 2006, EMOTION, V6, P73, DOI 10.1037/1528-3542.6.1.73; Parsons S, 2004, J AUTISM DEV DISORD, V34, P449, DOI 10.1023/B:JADD.0000037421.98517.8d; RICHER JM, 1976, ACTA PSYCHIAT SCAND, V53, P193, DOI 10.1111/j.1600-0447.1976.tb00074.x; ROGERS AL, 1977, PSYCHOTHER-THEOR RES, V14, P41, DOI 10.1037/h0087490; Scheele D, 2012, J NEUROSCI, V32, P16074, DOI 10.1523/JNEUROSCI.2755-12.2012; Schulkin J, 2007, BRAIN COGNITION, V65, P87, DOI 10.1016/j.bandc.2006.02.009; Schumann CM, 2009, BIOL PSYCHIAT, V66, P942, DOI 10.1016/j.biopsych.2009.07.007; SOMMER R, 1959, SOCIOMETRY, V22, P247, DOI 10.2307/2785668; Sommer Robert, 1969, PERSONAL SPACE BEHAV, P12; Swartz J.R., 2011, J AM ACAD CHILD ADOL, V52, P84; Volkmar F. R., 2000, ASPERGER SYNDROME, P25; Vranic A, 2003, ENVIRON BEHAV, V35, P550, DOI 10.1177/0013916503035004006; Watson O. M., 1970, PROXEMIC BEHAV CROSS; Weng SJ, 2011, J CHILD PSYCHOL PSYC, V52, P296, DOI 10.1111/j.1469-7610.2010.02317.x; WING L, 1979, J AUTISM DEV DISORD, V9, P11, DOI 10.1007/BF01531288	56	58	59	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74959	10.1371/journal.pone.0074959	http://dx.doi.org/10.1371/journal.pone.0074959			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	246EK	24086410	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200062
J	Hanauske-Abel, HM; Saxena, D; Palumbo, PE; Hanauske, AR; Luchessi, AD; Cambiaghi, TD; Hoque, M; Spino, M; Gandolfi, DD; Heller, DS; Singh, S; Park, MH; Cracchiolo, BM; Tricta, F; Connelly, J; Popowicz, AM; Cone, RA; Holland, B; Pe'ery, T; Mathews, MB				Hanauske-Abel, Hartmut M.; Saxena, Deepti; Palumbo, Paul E.; Hanauske, Axel-Rainer; Luchessi, Augusto D.; Cambiaghi, Tavane D.; Hoque, Mainul; Spino, Michael; Gandolfi, Darlene D'Alliessi; Heller, Debra S.; Singh, Sukhwinder; Park, Myung Hee; Cracchiolo, Bernadette M.; Tricta, Fernando; Connelly, John; Popowicz, Anthony M.; Cone, Richard A.; Holland, Bart; Pe'ery, Tsafi; Mathews, Michael B.			Drug-Induced Reactivation of Apoptosis Abrogates HIV-1 Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INITIATION-FACTOR 5A; ACTIVE ANTIRETROVIRAL THERAPY; INTRACELLULAR LABILE IRON; CD4(+) T-CELLS; BLOOD MONONUCLEAR-CELLS; TYPE-1 TAT PROTEIN; GENE-EXPRESSION; IN-VITRO; MOTEXAFIN GADOLINIUM	HIV-1 blocks apoptosis, programmed cell death, an innate defense of cells against viral invasion. However, apoptosis can be selectively reactivated in HIV-infected cells by chemical agents that interfere with HIV-1 gene expression. We studied two globally used medicines, the topical antifungal ciclopirox and the iron chelator deferiprone, for their effect on apoptosis in HIV-infected H9 cells and in peripheral blood mononuclear cells infected with clinical HIV-1 isolates. Both medicines activated apoptosis preferentially in HIV-infected cells, suggesting that the drugs mediate escape from the viral suppression of defensive apoptosis. In infected H9 cells, ciclopirox and deferiprone enhanced mitochondrial membrane depolarization, initiating the intrinsic pathway of apoptosis to execution, as evidenced by caspase-3 activation, poly(ADP-ribose) polymerase proteolysis, DNA degradation, and apoptotic cell morphology. In isolate-infected peripheral blood mononuclear cells, ciclopirox collapsed HIV-1 production to the limit of viral protein and RNA detection. Despite prolonged monotherapy, ciclopirox did not elicit breakthrough. No viral re-emergence was observed even 12 weeks after drug cessation, suggesting elimination of the proviral reservoir. Tests in mice predictive for cytotoxicity to human epithelia did not detect tissue damage or activation of apoptosis at a ciclopirox concentration that exceeded by orders of magnitude the concentration causing death of infected cells. We infer that ciclopirox and deferiprone act via therapeutic reclamation of apoptotic proficiency (TRAP) in HIV-infected cells and trigger their preferential elimination. Perturbations in viral protein expression suggest that the antiretroviral activity of both drugs stems from their ability to inhibit hydroxylation of cellular proteins essential for apoptosis and for viral infection, exemplified by eIF5A. Our findings identify ciclopirox and deferiprone as prototypes of selectively cytocidal antivirals that eliminate viral infection by destroying infected cells. A drug-based drug discovery program, based on these compounds, is warranted to determine the potential of such agents in clinical trials of HIV-infected patients.	[Hanauske-Abel, Hartmut M.; Luchessi, Augusto D.; Cambiaghi, Tavane D.; Hoque, Mainul; Pe'ery, Tsafi; Mathews, Michael B.] Rutgers State Univ, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07102 USA; [Hanauske-Abel, Hartmut M.; Saxena, Deepti; Palumbo, Paul E.] Rutgers State Univ, New Jersey Med Sch, Dept Pediat, Newark, NJ 07102 USA; [Hanauske-Abel, Hartmut M.; Cracchiolo, Bernadette M.] Rutgers State Univ, Dept Obstet Gynecol & Womens Hlth, New Jersey Med Sch, Newark, NJ 07102 USA; [Hanauske, Axel-Rainer] Asklepios Clin St George, Ctr Oncol, Hamburg, Germany; [Hanauske, Axel-Rainer] Asklepios Clin St George, Med Clin 3, Hamburg, Germany; [Spino, Michael] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Spino, Michael; Tricta, Fernando; Connelly, John] ApoPharma Inc, Toronto, ON, Canada; [Gandolfi, Darlene D'Alliessi] Manhattanville Coll, Dept Chem, Purchase, NY USA; [Heller, Debra S.; Singh, Sukhwinder] Rutgers State Univ, New Jersey Med Sch, Dept Pathol & Lab Med, Newark, NJ 07102 USA; [Park, Myung Hee] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, Bethesda, MD USA; [Popowicz, Anthony M.] Rockefeller Univ, Dept Informat Technol, New York, NY 10021 USA; [Cone, Richard A.] Johns Hopkins Univ, Dept Biophys, Baltimore, MD USA; [Holland, Bart] Rutgers State Univ, Dept Prevent Med & Community Hlth, New Jersey Med Sch, Newark, NJ 07102 USA; [Pe'ery, Tsafi] Rutgers State Univ, Dept Med, New Jersey Med Sch, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Asklepios Klinik St. Georg; Asklepios Klinik St. Georg; University of Toronto; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Rockefeller University; Johns Hopkins University; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Hanauske-Abel, HM (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07102 USA.	hanaushm@njms.rutgers.edu; mathews@njms.rutgers.edu	Luchessi, Augusto Ducati/Y-7400-2019	Luchessi, Augusto Ducati/0000-0003-2080-3524; Heller, Debra/0000-0002-8378-4642; Singh, Sukhwinder/0000-0002-7061-0096	Foundation of UMDNJ; National Institutes of Health [HD-1457, AI034552, AI060403]; National Institutes of Health (NIH-NIDCR); State of New Jersey, through its Commission on Cancer Research [05-2405-CCR-EO]; Pediatric AIDS Clinical Trials Group, the National Institutes of Health; DAIDS [202PVCL05]; Foundation IND Synergen; The State of SApoundo Paulo Research Foundation (FAPESP) [08/50355-1, 04/040181-6]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD001457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034552, R21AI060403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000608] Funding Source: NIH RePORTER	Foundation of UMDNJ; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH-NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); State of New Jersey, through its Commission on Cancer Research; Pediatric AIDS Clinical Trials Group, the National Institutes of Health; DAIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Foundation IND Synergen; The State of SApoundo Paulo Research Foundation (FAPESP); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant from the Foundation of UMDNJ to MBM and HMHA. The BIRCWH (Building Interdisciplinary Research Careers in Women's Health) Program of the National Institutes of Health (HD-1457), in which HMHA was a Scholar, supported this study. MBM and TP were funded by the National Institutes of Health (AI034552 and AI060403). MHP and ECW were supported by the Intramural Research Program of the National Institutes of Health (NIH-NIDCR); BMC by the State of New Jersey, through its Commission on Cancer Research (05-2405-CCR-EO); PEP by the Pediatric AIDS Clinical Trials Group, the National Institutes of Health, and DAIDS (202PVCL05); and ARH by the Foundation IND Synergen. ADL and TDC were recipients of grants (08/50355-1 and 04/040181-6) from The State of SA o pound Paulo Research Foundation (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBRUZZESE A, 1991, BIOCHIM BIOPHYS ACTA, V1077, P159, DOI 10.1016/0167-4838(91)90053-3; ABRAMOVITCH RA, 1975, J HETEROCYCLIC CHEM, V12, P683, DOI 10.1002/jhet.5570120414; ACTG Laboratory Technologist Committee, 2004, PREP PHA STIM UN DON; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; ALREFAIE FN, 1995, BRIT J HAEMATOL, V91, P224, DOI 10.1111/j.1365-2141.1995.tb05274.x; Andrus L, 1998, BIOCHEM PHARMACOL, V55, P1807, DOI 10.1016/S0006-2952(98)00053-7; Arokium H, 2009, J VIROL, V83, P11283, DOI 10.1128/JVI.00756-09; Arunagiri C, 1997, APOPTOSIS, V2, P69, DOI 10.1023/A:1026487609215; BALZARINI J, 1995, P NATL ACAD SCI USA, V92, P5470, DOI 10.1073/pnas.92.12.5470; Balzarini J, 2001, AIDS RES HUM RETROV, V17, P1625, DOI 10.1089/088922201753342031; Barros LF, 2001, COMP BIOCHEM PHYS A, V130, P401, DOI 10.1016/S1095-6433(01)00438-X; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Bennasser Y, 2002, FASEB J, V16, P546, DOI 10.1096/fj.01-0775com; Berro R, 2007, J BIOL CHEM, V282, P8207, DOI 10.1074/jbc.M606324200; Bevec D, 1996, SCIENCE, V271, P1858, DOI 10.1126/science.271.5257.1858; BEVEC D, 1994, P NATL ACAD SCI USA, V91, P10829, DOI 10.1073/pnas.91.23.10829; Bhavsar H, 2008, NATL J INTEGR RES ME, V2, P47; Biglione S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-47; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Breuer D, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-94; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Calzada AA, 2013, EXP HEMATOL, V41, P253, DOI 10.1016/j.exphem.2012.10.013; Calzado MA, 2000, CLIN EXP IMMUNOL, V120, P317, DOI 10.1046/j.1365-2249.2000.01203.x; Cano VSP, 2010, AMINO ACIDS, V38, P479, DOI 10.1007/s00726-009-0407-8; Caraglia M, 2003, J BIOCHEM, V133, P757, DOI 10.1093/jb/mvg097; Carambula SF, 2002, ENDOCRINOLOGY, V143, P1495, DOI 10.1210/en.143.4.1495; Casey L, 2010, CYTOKINE, V51, P1, DOI 10.1016/j.cyto.2010.02.018; Chaston TB, 2003, AM J HEMATOL, V73, P200, DOI 10.1002/ajh.10348; CHEN BK, 1994, J VIROL, V68, P654, DOI 10.1128/JVI.68.2.654-660.1994; Chen J, 2005, APOPTOSIS, V10, P1131, DOI 10.1007/s10495-005-0887-2; CHOW YK, 1993, NATURE, V361, P650, DOI 10.1038/361650a0; Chun TW, 2010, AIDS, V24, P2803, DOI 10.1097/QAD.0b013e328340a239; Clement PMJ, 2002, INT J CANCER, V100, P491, DOI 10.1002/ijc.10515; Cohen AR, 2000, BRIT J HAEMATOL, V108, P305; COHEN EA, 1990, J VIROL, V64, P3097, DOI 10.1128/JVI.64.6.3097-3099.1990; Cohen SBA, 1997, IMMUNOLOGY, V92, P1, DOI 10.1046/j.1365-2567.1997.00348.x; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; Conti L, 2000, J IMMUNOL, V165, P3293, DOI 10.4049/jimmunol.165.6.3293; Cosenza MA, 2004, NEUROPATH APPL NEURO, V30, P478, DOI 10.1111/j.1365-2990.2004.00563.x; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Cracchiolo BM, 2004, GYNECOL ONCOL, V94, P217, DOI 10.1016/j.ygyno.2004.03.018; Debatin KMFS, 2006, APOPTOSIS CANC THERA; Debebe Z, 2007, VIROLOGY, V367, P324, DOI 10.1016/j.virol.2007.06.011; Debebe Z, 2011, MOL PHARMACOL, V79, P185, DOI 10.1124/mol.110.069062; Decker RH, 2001, CELL DEATH DIFFER, V8, P715, DOI 10.1038/sj.cdd.4400868; Deshmane SL, 2009, J BIOL CHEM, V284, P11364, DOI 10.1074/jbc.M809266200; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Eberhard Y, 2009, BLOOD, V114, P3064, DOI 10.1182/blood-2009-03-209965; Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0; Fakih S, 2009, J PHARM SCI-US, V98, P2212, DOI 10.1002/jps.21583; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Galen BT, 2007, J INFECT DIS, V195, P1332, DOI 10.1086/513279; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Garcia F, 2003, AIDS, V17, P43, DOI 10.1097/00002030-200301030-00007; Gee K, 2006, J BIOL CHEM, V281, P31647, DOI 10.1074/jbc.M512109200; Georgiou NA, 2002, EUR J CLIN INVEST, V32, P91, DOI 10.1046/j.1365-2362.2002.0320s1091.x; Georgiou NA, 2000, J INFECT DIS, V181, P484, DOI 10.1086/315223; Giri MS, 2009, J IMMUNOL, V182, P4459, DOI 10.4049/jimmunol.0801450; Glickstein H, 2005, BLOOD, V106, P3242, DOI 10.1182/blood-2005-02-0460; Glickstein H, 2006, BLOOD, V108, P3195, DOI 10.1182/blood-2006-05-020867; GOUGEON ML, 1991, CR ACAD SCI III-VIE, V312, P529; GROUX H, 1991, CR ACAD SCI III-VIE, V312, P599; GUNZLER V, 1986, BIOCHIM BIOPHYS ACTA, V873, P38, DOI 10.1016/0167-4838(86)90187-1; Gupta AK, 2001, INT J DERMATOL, V40, P305, DOI 10.1046/j.1365-4362.2001.01156.x; Halicka HD, 2000, EXP CELL RES, V260, P248, DOI 10.1006/excr.2000.5027; Hanauske-Abel H. M., 1996, HEPATOLOGY TXB LIVER, P465; Hanauske-Abel HM, 2003, CURR MED CHEM, V10, P1005, DOI 10.2174/0929867033457601; HANAUSKEABEL HM, 1994, BBA-MOL CELL RES, V1221, P115, DOI 10.1016/0167-4889(94)90003-5; HANAUSKEABEL HM, 1995, FEBS LETT, V366, P92, DOI 10.1016/0014-5793(95)00493-S; HANAUSKEABEL HM, 1982, J THEOR BIOL, V94, P421, DOI 10.1016/0022-5193(82)90320-4; Harrigan PR, 1999, AIDS, V13, pF59, DOI 10.1097/00002030-199905280-00001; Hart RA, 2002, VIROLOGY, V304, P97, DOI 10.1006/viro.2002.1659; Hashemy SI, 2006, J BIOL CHEM, V281, P10691, DOI 10.1074/jbc.M511373200; Hasselmann DO, 2001, CLIN CHEM, V47, P1488; Hauber I, 2005, J CLIN INVEST, V115, P76, DOI 10.1172/JCI200521949; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hay S, 2002, J GEN VIROL, V83, P1547, DOI 10.1099/0022-1317-83-7-1547; Hinkula J, 2009, VACCINE, V27, P6424, DOI 10.1016/j.vaccine.2009.06.016; Hirasawa K, 2000, BIOCHEM BIOPH RES CO, V273, P1025, DOI 10.1006/bbrc.2000.3056; Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103; HOFFMAN BD, 1991, CYTOMETRY, V12, P26, DOI 10.1002/cyto.990120105; Hoque M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-90; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; HUNT J, 1979, BRIT J HAEMATOL, V41, P69, DOI 10.1111/j.1365-2141.1979.tb03682.x; Hussain SRA, 2008, BLOOD, V111, P3190, DOI 10.1182/blood-2007-10-115733; Huyghe P, 2004, ONCOL RES, V14, P235, DOI 10.3727/000000003772505362; Jacotot E, 2001, J EXP MED, V193, P509, DOI 10.1084/jem.193.4.509; Jacquel A, 2003, FASEB J, V17, P2160, DOI 10.1096/fj.03-0322fje; Jasiulionis MG, 2007, CELL BIOCHEM FUNCT, V25, P109, DOI 10.1002/cbf.1351; Jin BF, 2003, ONCOGENE, V22, P4819, DOI 10.1038/sj.onc.1206738; Johansson U, 2007, J IMMUNOL, V179, P1711, DOI 10.4049/jimmunol.179.3.1711; Jonckheere H, 1998, AIDS RES HUM RETROV, V14, P249, DOI 10.1089/aid.1998.14.249; Jones K, 2011, MED INDIA; Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; Kogan M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-25; KONTOGHIORGHES GJ, 1990, CLIN PHARMACOL THER, V48, P255, DOI 10.1038/clpt.1990.147; Kubota S, 1996, J VIROL, V70, P1282, DOI 10.1128/JVI.70.2.1282-1287.1996; Lafeuillade Alain, 2002, HIV Clin Trials, V3, P263; Larrosa PNF, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-19; LAZDINS JK, 1991, LANCET, V338, P1341, DOI 10.1016/0140-6736(91)92651-H; Le Rouzic E, 2008, J BIOL CHEM, V283, P21686, DOI 10.1074/jbc.M710298200; Lee SK, 2009, J ORAL PATHOL MED, V38, P792, DOI 10.1111/j.1600-0714.2009.00809.x; Li QS, 2009, J IMMUNOL, V183, P1975, DOI 10.4049/jimmunol.0803222; Linden T, 2003, FASEB J, V17, P761, DOI 10.1096/fj.02-0586fje; LORI F, 1994, SCIENCE, V266, P801, DOI 10.1126/science.7973634; Lukmantara AY, 2013, BIOORG MED CHEM LETT, V23, P967, DOI 10.1016/j.bmcl.2012.12.044; Lum JJ, 2003, CURR HIV RES, V1, P261, DOI 10.2174/1570162033485203; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; MAJAMAA K, 1986, J BIOL CHEM, V261, P7819; MAJAMAA K, 1984, EUR J BIOCHEM, V138, P239, DOI 10.1111/j.1432-1033.1984.tb07907.x; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; MALLEY SD, 1994, P NATL ACAD SCI USA, V91, P11017, DOI 10.1073/pnas.91.23.11017; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Masutani H, 2005, CELL DEATH DIFFER, V12, P991, DOI 10.1038/sj.cdd.4401625; Mathur M, 2008, INDIAN J MED MICROBI, V26, P205, DOI 10.4103/0255-0857.40552; MCCAFFREY TA, 1995, J CLIN INVEST, V95, P446, DOI 10.1172/JCI117684; McLean JE, 2008, CURR PHARM DESIGN, V14, P198; MELLORS JW, 1995, ANTIMICROB AGENTS CH, V39, P1087, DOI 10.1128/AAC.39.5.1087; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Minden MD, 2012, 54 ASH ANN M ATL GA; Montagnier L, 2009, ANGEW CHEM INT EDIT, V48, P5815, DOI 10.1002/anie.200902130; Moris A, 2004, BLOOD, V103, P2648, DOI 10.1182/blood-2003-07-2532; Muthumani K, 2002, J BIOL CHEM, V277, P37820, DOI 10.1074/jbc.M205313200; Muthumani K, 2002, ONCOGENE, V21, P4613, DOI 10.1038/sj.onc.1205549; Muthumani K, 2009, CURR HIV RES, V7, P144, DOI 10.2174/157016209787581481; Neidig ML, 2006, J INORG BIOCHEM, V100, P2108, DOI 10.1016/j.jinorgbio.2006.08.021; Nekhai S, 2013, FUTURE VIROL, V8, P301, DOI 10.2217/FVL.13.6; Nenoff P, 1999, MYCOSES, V42, P55, DOI 10.1046/j.1439-0507.1999.00268.x; Neumann AU, 1999, AIDS, V13, P677, DOI 10.1097/00002030-199904160-00008; New EJ, 2013, DALTON T, V42, P3210, DOI 10.1039/c2dt31933k; Niewerth M, 2003, ANTIMICROB AGENTS CH, V47, P1805, DOI 10.1128/AAC.47.6.1805-1817.2003; Nonaka M, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-20; Norris PJ, 2006, AIDS RES HUM RETROV, V22, P757, DOI 10.1089/aid.2006.22.757; Nunez R, 2010, CELL DEATH DIFFER, V17, P1665, DOI 10.1038/cdd.2010.96; Okada Y, 2001, COMP BIOCHEM PHYS A, V130, P377, DOI 10.1016/S1095-6433(01)00424-X; Okamoto M, 1996, ANTIVIR RES, V31, P69, DOI 10.1016/0166-3542(96)00946-1; Orsilles MA, 2006, APMIS, V114, P55, DOI 10.1111/j.1600-0463.2006.apm_108.x; Paintsil Elijah, 2009, AIDS Res Ther, V6, P5, DOI 10.1186/1742-6405-6-5; PARK MH, 1982, J BIOL CHEM, V257, P7217; PARK MH, 1993, BIOFACTORS, V4, P95; Pearse G, 2006, TOXICOL PATHOL, V34, P515, DOI 10.1080/01926230600978458; Perez OD, 2002, P NATL ACAD SCI USA, V99, P2270, DOI 10.1073/pnas.261711499; Petrovas C, 2005, CELL DEATH DIFFER, V12, P859, DOI 10.1038/sj.cdd.4401595; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Poon B, 2003, J VIROL, V77, P3962, DOI 10.1128/JVI.77.7.3962-3972.2003; Poon B, 2007, J VIROL, V81, P10515, DOI 10.1128/JVI.00947-07; RAYMOND KN, 1979, ACCOUNTS CHEM RES, V12, P183, DOI 10.1021/ar50137a004; Reno F, 1999, APOPTOSIS, V4, P469, DOI 10.1023/A:1009608628076; Rethi B, 2008, BLOOD, V112, P1195, DOI 10.1182/blood-2007-12-126698; Richardson DR, 2005, CURR MED CHEM, V12, P2711, DOI 10.2174/092986705774462996; Rider TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022572; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Romani B, 2010, J GEN VIROL, V91, P1, DOI 10.1099/vir.0.016303-0; Romani B, 2009, J GEN VIROL, V90, P1795, DOI 10.1099/vir.0.011726-0; RUHL M, 1993, J CELL BIOL, V123, P1309, DOI 10.1083/jcb.123.6.1309; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Saletta F, 2010, MOL PHARMACOL, V77, P443, DOI 10.1124/mol.109.061028; Salhi Y, 1998, J ACQ IMMUN DEF SYND, V18, P473, DOI 10.1097/00042560-199808150-00009; Sanchez M, 2007, NAT STRUCT MOL BIOL, V14, P420, DOI 10.1038/nsmb1222; Schacker TW, 2005, AIDS, V19, P2169, DOI 10.1097/01.aids.0000194801.51422.03; Schafer B, 2006, J INFECT DIS, V194, P740, DOI 10.1086/507043; Scheuring UJ, 1999, AIDS, V13, P167, DOI 10.1097/00002030-199902040-00004; SCHINAZI RF, 1993, ANTIMICROB AGENTS CH, V37, P875, DOI 10.1128/AAC.37.4.875; Schols D, 1996, J VIROL, V70, P4953, DOI 10.1128/JVI.70.8.4953-4960.1996; Schrell UMH, 1997, J NEUROSURG, V86, P840, DOI 10.3171/jns.1997.86.5.0840; Schrell UMH, 1997, J NEUROSURG, V86, P845, DOI 10.3171/jns.1997.86.5.0845; Scott LE, 2009, CHEM REV, V109, P4885, DOI 10.1021/cr9000176; Selliah N, 2001, CELL DEATH DIFFER, V8, P127, DOI 10.1038/sj.cdd.4400822; Sen S, 1993, Indian Pediatr, V30, P455; Shive CL, 2012, JAIDS-J ACQ IMM DEF, V61, P145, DOI 10.1097/QAI.0b013e31825ddbbf; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Sivakumaran H, 2009, J VIROL, V83, P11694, DOI 10.1128/JVI.00499-09; SMITH MS, 1987, J VIROL, V61, P3769, DOI 10.1128/JVI.61.12.3769-3773.1987; Snyder A, 2010, AIDS, V24, P1107, DOI 10.1097/QAD.0b013e328337b0ab; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Song S, 2011, CANCER RES, V71, P7628, DOI 10.1158/0008-5472.CAN-11-2745; Sozzani S, 1998, J EXP MED, V187, P439, DOI 10.1084/jem.187.3.439; Spetz AL, 2002, J IMMUNOL, V169, P5771, DOI 10.4049/jimmunol.169.10.5771; Spinillo A, 2005, AM J OBSTET GYNECOL, V192, P774, DOI 10.1016/j.ajog.2004.10.609; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Steinhauser S, 2004, EUR J INORG CHEM, P4177, DOI 10.1002/ejic.200400363; Stylianou E, 1999, CLIN EXP IMMUNOL, V116, P115; Sun Z, 2010, J CELL PHYSIOL, V223, P798, DOI 10.1002/jcp.22100; Swingler S, 2007, PLOS PATHOG, V3, P1281, DOI 10.1371/journal.ppat.0030134; Taylor CA, 2007, EXP CELL RES, V313, P437, DOI 10.1016/j.yexcr.2006.09.030; Theil EC, 2007, BIOMETALS, V20, P513, DOI 10.1007/s10534-006-9063-6; Tome ME, 1997, BIOCHEM J, V328, P847; Traore HN, 2004, J CLIN VIROL, V31, pS92, DOI 10.1016/j.jcv.2004.09.011; TSCHANK G, 1991, BIOCHEM J, V275, P469, DOI 10.1042/bj2750469; Ullum H, 1997, AIDS RES HUM RETROV, V13, P1039, DOI 10.1089/aid.1997.13.1039; VALLORY EAL, 1989, EUR J PEDIATR, V148, P503; van Asbeck BS, 2001, J CLIN VIROL, V20, P141, DOI 10.1016/S1386-6532(00)00122-0; Venkatachari NJ, 2008, VIROLOGY, V376, P140, DOI 10.1016/j.virol.2008.03.015; Vila J, 1997, LANCET, V350, P635, DOI 10.1016/S0140-6736(97)24035-3; Vocero-Akbani AM, 1999, NAT MED, V5, P29, DOI 10.1038/4710; Vu VV, 2009, P NATL ACAD SCI USA, V106, P14814, DOI 10.1073/pnas.0904553106; Wainberg Z, 1997, VIROLOGY, V233, P364, DOI 10.1006/viro.1997.8618; WANG GL, 1993, BLOOD, V82, P3610; Wang JF, 2008, DNA CELL BIOL, V27, P267, DOI 10.1089/dna.2007.0707; Wang ZD, 1999, VIROLOGY, V257, P502, DOI 10.1006/viro.1999.9688; Wermuth CG, 2006, DRUG DISCOV TODAY, V11, P160, DOI 10.1016/S1359-6446(05)03686-X; Wilson SS, 2009, ANTIVIR THER, V14, P1113, DOI 10.3851/IMP1463; Witvrouw M, 2000, ANTIVIR RES, V46, P215, DOI 10.1016/S0166-3542(00)00084-X; Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217; YARCHOAN R, 1986, LANCET, V1, P575; ZAULI G, 1995, BLOOD, V86, P3823, DOI 10.1182/blood.V86.10.3823.bloodjournal86103823; Zeng M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002437; Zhao LJ, 2004, FEBS LETT, V563, P170, DOI 10.1016/S0014-5793(04)00299-6; Zheng L, 2007, INTERVIROLOGY, V50, P224, DOI 10.1159/000100565; Zhou HY, 2010, INT J CANCER, V127, P2467, DOI 10.1002/ijc.25255; Zhou Y, 2005, J VIROL, V79, P2199, DOI 10.1128/JVI.79.4.2199-2210.2005; Zhu Y, 2003, APOPTOSIS, V8, P71, DOI 10.1023/A:1021653119934	218	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74414	10.1371/journal.pone.0074414	http://dx.doi.org/10.1371/journal.pone.0074414			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086341				2022-12-27	WOS:000326520200030
J	Fonville, JM; Burke, DF; Lewis, NS; Katzelnick, LC; Russell, CA				Fonville, Judith M.; Burke, David F.; Lewis, Nicola S.; Katzelnick, Leah C.; Russell, Colin A.			Quantifying the Fitness Advantage of Polymerase Substitutions in Influenza A/H7N9 Viruses during Adaptation to Humans	PLOS ONE			English	Article							A H7N9 VIRUS; HOST-RANGE DETERMINANTS; MOLECULAR-BASIS; AMINO-ACID; VIRAL POLYMERASE; PB2 PROTEIN; REPLICATION; INFECTION; CHINA	Adaptation of zoonotic influenza viruses towards efficient human-to-human transmissibility is a substantial public health concern. The recently emerged A/H7N9 influenza viruses in China provide an opportunity for quantitative studies of host-adaptation, as human-adaptive substitutions in the PB2 gene of the virus have been found in all sequenced human strains, while these substitutions have not been detected in any non-human A/H7N9 sequences. Given the currently available information, this observation suggests that the human-adaptive PB2 substitution might confer a fitness advantage to the virus in these human hosts that allows it to rise to proportions detectable by consensus sequencing over the course of a single human infection. We use a mathematical model of within-host virus evolution to estimate the fitness advantage required for a substitution to reach predominance in a single infection as a function of the duration of infection and the fraction of mutant present in the virus population that initially infects a human. The modeling results provide an estimate of the lower bound for the fitness advantage of this adaptive substitution in the currently sequenced A/H7N9 viruses. This framework can be more generally used to quantitatively estimate fitness advantages of adaptive substitutions based on the within-host prevalence of mutations. Such estimates are critical for models of cross-species transmission and host-adaptation of influenza virus infections.	[Fonville, Judith M.; Burke, David F.; Lewis, Nicola S.; Katzelnick, Leah C.; Russell, Colin A.] Univ Cambridge, Dept Zool, Cambridge, England	University of Cambridge	Russell, CA (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	car44@cam.ac.uk	Russell, Colin/ABE-7106-2020; Burke, David F/C-2091-2013	Burke, David F/0000-0001-8830-3951; Russell, Colin/0000-0002-2113-162X	NIAID Centers of Excellence for Influenza Research and Surveillance; United States Department of Agriculture [58-3625-2-103F]; ESNIP3 - European Surveillance Network for Influenza in Pigs EC [259949]; Gates Cambridge Trust; Royal Society; Medical Research Council [MR/K021885/1] Funding Source: researchfish; MRC [MR/K021885/1] Funding Source: UKRI	NIAID Centers of Excellence for Influenza Research and Surveillance; United States Department of Agriculture(United States Department of Agriculture (USDA)); ESNIP3 - European Surveillance Network for Influenza in Pigs EC; Gates Cambridge Trust; Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	JMF, DFB, and NSL acknowledge funding from the NIAID Centers of Excellence for Influenza Research and Surveillance. NSL was additionally supported by United States Department of Agriculture grant 58-3625-2-103F and by ESNIP3 - European Surveillance Network for Influenza in Pigs EC FP7 259949. LCK was supported by the Gates Cambridge Trust. CAR was supported by a University Research Fellowship from the Royal Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOND JW, 1977, NATURE, V270, P617, DOI 10.1038/270617a0; Bao CJ, 2013, NEW ENGL J MED, V368, P2337, DOI 10.1056/NEJMc1306100; Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; Chang SY, 2013, LANCET, V381, P1621, DOI 10.1016/S0140-6736(13)60943-5; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Chen Y, 2013, LANCET; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dennis KM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3693; Foeglein A, 2011, J GEN VIROL, V92, P1650, DOI 10.1099/vir.0.031492-0; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; GILLESPIE JH, 1984, SCIENCE, V224, P732, DOI 10.1126/science.224.4650.732; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; JONGES M, 2013, EURO SURVEILL, V18; Jonges M, 2011, J VIROL, V85, P10598, DOI 10.1128/JVI.05369-11; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; LI J, 2013, SCI CHINA LIFE SCI; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; LIU Q, 2013, MICROBES INFECT; LIUD SW, 2013, LANCET; Massin P, 2001, J VIROL, V75, P5398, DOI 10.1128/JVI.75.11.5398-5404.2001; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S18; Mok CKP, 2011, J VIROL, V85, P9641, DOI 10.1128/JVI.00702-11; Munster VJ, 2007, J INFECT DIS, V196, P258, DOI 10.1086/518792; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Park M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0333; Perelson AS, 2012, J INFECT DIS, V205, P1642, DOI 10.1093/infdis/jis265; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Ribeiro RM, 2000, P NATL ACAD SCI USA, V97, P7681, DOI 10.1073/pnas.97.14.7681; Ribeiro RM, 1999, AIDS, V13, P351, DOI 10.1097/00002030-199902250-00007; RICHARD M, 2013, NATURE; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Watanabe T, 2013, NATURE; Wu H, 2013, N ENGL J MED; Yamada S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001034; Zhang QY, 2013, INT J PLANT PROD, V7, P341; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532; ZHU H, 2013, SCIENCE	46	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76047	10.1371/journal.pone.0076047	http://dx.doi.org/10.1371/journal.pone.0076047			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086684	Green Published, Green Submitted, gold			2022-12-27	WOS:000325223900073
J	Hadaegh, F; Hasheminia, M; Lotfaliany, M; Mohebi, R; Azizi, F; Tohidi, M				Hadaegh, Farzad; Hasheminia, Mitra; Lotfaliany, Mojtaba; Mohebi, Reza; Azizi, Fereidoun; Tohidi, Maryam			Incidence of Metabolic Syndrome over 9 Years Follow-Up; the Importance of Sex Differences in the Role of Insulin Resistance and Other Risk Factors	PLOS ONE			English	Article							NUTRITION TRANSITION; SERUM CREATININE; IRANIAN ADULTS; MIDDLE-EAST; PREVALENCE; POPULATION; COMPONENTS; DISEASE; HEALTH; ASSOCIATION	To determine, the predictors of incident metabolic syndrome (MetS) in a community-based cohort of West Asians, during a mean follow-up of 9.3 years, a sample of 2858 non-MetS Iranian adults aged >= 20 years were examined at baseline and followed at three year intervals during three consecutive phases. The MetS was defined using the joint interim statement. Cox proportional hazard regression was used to determine the independent variables associated with incident MetS. Overall, 1117 new cases MetS were identified resulting in an incidence rate of 550.9/10000 person years (95% CI: 519.5-584.2). The corresponding incidence rates among women and men were 433.5/10000 person years (95% CI: 398.8-471.2) and 749.2/10000 person years (95% CI: 689.9-813.5), respectively. Baseline-adjusted predictors of developing MetS included all of the MetS components, being overweight or obese in both gender, and family history of diabetes and age only in women. There were significant effect modifications of gender on age (P<0.001), high blood pressure (0.026), high waist circumference (P<0001) and obesity categories (all P <= 0.01) in multivariate analysis. After considering HOMA-IR in the model, among women, all of the MetS predictors as well as those with HOMA-IR >= 2.23 showed a significant risk for incident MetS [HR: 1.63 (1.16-2.28)]; however, among men all the MetS components (WC was marginally significant) as well as the fourth quartile of HOMA-IR [HR: 1.50 (1.03-2.17)] and being overweight showed a significant risk. Finally, in the pooled analysis, we showed that female gender had lower risk for incident MetS than male [HR: 0.58 (0.47-0.70)]. In the Iranian population, high incidence of MetS, especially among men, was shown. Our findings confirmed that sex-specific risk predictors should be considered in primary prevention for incident MetS.	[Hadaegh, Farzad; Hasheminia, Mitra; Lotfaliany, Mojtaba; Mohebi, Reza; Tohidi, Maryam] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Tohidi, M (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran.	tohidi@endocrine.ac.ir	Azizi, Fereidoun/ABD-4136-2021; hadaegh, farzad/K-2460-2017; Lotfaliany, Mojtaba/ABB-6325-2020; Tohidi, Maryam/V-2261-2019; Mohebi, Reza/AAB-7178-2022; Mohebi, Reza/U-2192-2019	Azizi, Fereidoun/0000-0002-6470-2517; hadaegh, farzad/0000-0002-0352-8666; Mohebi, Reza/0000-0002-6744-3119; Lotfaliany Abrand Abadi, Mojtaba/0000-0001-6594-9004; Hadaegh, Farzad/0000-0002-8935-2744	National Research Council of the Islamic Republic of Iran [121]	National Research Council of the Islamic Republic of Iran	This study was supported by grant No. 121 from the National Research Council of the Islamic Republic of Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2002, METABOLISM, V51, P235, DOI 10.1053/meta.2002.28970; Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Agirbasli M, 2009, METABOLISM, V58, P1256, DOI 10.1016/j.metabol.2009.03.024; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Azizi F, 2010, ARCH IRAN MED, V13, P243; Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5; Bahreynian M, 2012, ARCH IRAN MED, V15, P648; Bozorgmanesh M, 2011, J HYPERTENS, V29, P1486, DOI 10.1097/HJH.0b013e328348fdb2; Cheung BMY, 2008, CLIN ENDOCRINOL, V68, P730, DOI 10.1111/j.1365-2265.2007.03110.x; Delavar MA, 2009, SE ASIAN J TROP MED, V40, P612; Erem C, 2008, ENDOCRINE, V33, P9, DOI 10.1007/s12020-008-9044-3; Esteghamati A, 2009, DIABETIC MED, V26, P745, DOI 10.1111/j.1464-5491.2009.02756.x; Ghassemi H, 2002, PUBLIC HEALTH NUTR, V5, P149, DOI 10.1079/PHN2001287; Guerrero-Romero F, 2005, DIABETES CARE, V28, P2588; Hadaegh F, 2012, J EPIDEMIOL COMMUN H, V66, P427, DOI 10.1136/jech.2010.117697; Hadaegh F, 2008, DIABETES RES CLIN PR, V80, P328, DOI 10.1016/j.diabres.2008.01.003; Harita N, 2009, DIABETES CARE, V32, P424, DOI 10.2337/dc08-1265; Hosseinpanah F, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-44; Hosseinpanah F, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-426; Kim HA, 2013, DIABETES RES CLIN PR, V99, P54, DOI 10.1016/j.diabres.2012.10.011; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Mommersteeg PMC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1109; Motlagh B, 2009, EUR J CARDIOV PREV R, V16, P268, DOI 10.1097/HJR.0b013e328322ca1b; Onat A, 2002, ATHEROSCLEROSIS, V165, P285, DOI 10.1016/S0021-9150(02)00236-8; ONAT A, 2013, CURR PHARM DESIGN, P65630; Onat A, 2007, KIDNEY BLOOD PRESS R, V30, P88, DOI 10.1159/000100487; Onat A, 2013, J INVEST MED, V61, P27, DOI 10.2310/JIM.0b013e318276de59; Palaniappan L, 2004, DIABETES CARE, V27, P788, DOI 10.2337/diacare.27.3.788; Reaven G, 2004, ENDOCRIN METAB CLIN, V33, P283, DOI 10.1016/j.ecl.2004.03.002; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Ryu S, 2007, ANN EPIDEMIOL, V17, P245, DOI 10.1016/j.annepidem.2006.10.001; Santos AC, 2010, PREV MED, V50, P99, DOI 10.1016/j.ypmed.2009.11.011; Sheu WHH, 2006, DIABETES RES CLIN PR, V74, P162, DOI 10.1016/j.diabres.2006.03.011; Sirdah MM, 2011, DIABETES METAB SYND, V5, P93, DOI 10.1016/j.dsx.2012.02.024; Sung KCC, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-108; Tomaszewski M, 2007, KIDNEY INT, V71, P816, DOI 10.1038/sj.ki.5002160; Tong J, 2007, DIABETOLOGIA, V50, P1156, DOI 10.1007/s00125-007-0651-y; von Loeffelholz C, 2010, EUR J ENDOCRINOL, V162, P507, DOI 10.1530/EJE-09-0737; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wilsgaard T, 2007, DIABETES RES CLIN PR, V78, P217, DOI 10.1016/j.diabres.2007.03.006; WU HY, 2012, INT J CARDIOL; Zabetian A, 2007, DIABETES RES CLIN PR, V77, P251, DOI 10.1016/j.diabres.2006.12.001; Zabetian A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-138; Zarkesh M, 2012, GENET RES, V94, P331, DOI 10.1017/S001667231200050X; ZAVARONI I, 1992, J INTERN MED, V231, P235, DOI 10.1111/j.1365-2796.1992.tb00529.x	45	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76304	10.1371/journal.pone.0076304	http://dx.doi.org/10.1371/journal.pone.0076304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086723	Green Published, gold			2022-12-27	WOS:000325223900094
J	Isticato, R; Sirec, T; Giglio, R; Baccigalupi, L; Rusciano, G; Pesce, G; Zito, G; Sasso, A; De Felice, M; Ricca, E				Isticato, Rachele; Sirec, Teja; Giglio, Rosa; Baccigalupi, Loredana; Rusciano, Giulia; Pesce, Giuseppe; Zito, Gianluigi; Sasso, Antonio; De Felice, Maurilio; Ricca, Ezio			Flexibility of the Programme of Spore Coat Formation in Bacillus subtilis: Bypass of CotE Requirement by Over-Production of CotH	PLOS ONE			English	Article							SURFACE-ENHANCED RAMAN; GENE; SPORULATION; RESISTANCE; EXPRESSION; ENDOSPORE; LOCALIZATION	Bacterial spores are surrounded by the coat, a multilayered shell that contributes in protecting the genome during stress conditions. In Bacillus subtilis, the model organism for spore formers, the coat is composed by about seventy different proteins, organized into four layers by the action of several regulatory proteins. A major component of this regulatory network, CotE, is needed to assemble the outer coat and develop spores fully resistant to lysozyme and able to germinate efficiently. Another regulator, CotH, is controlled by CotE and is present in low amounts both during sporulation and in mature spores. In spite of this CotH controls the assembly of at least nine outer coat proteins and cooperates with CotE in producing fully resistant and efficiently germinating spores. In order to improve our understanding of CotH role in spore formation, we over-produced CotH by placing its coding region under the control of a promoter stronger than its own promoter but with a similar timing of activity during sporulation. Over-production of CotH in an otherwise wild type strain did not cause any major effect, whereas in a cotE null background a partial recovery of the phenotypes associated to the cotE null mutation was observed. Western blot, fluorescence microscopy and Surface-Enhanced Raman Scattering spectroscopy data indicate that, in the absence of CotE, over-production of CotH allowed the formation of spores overall resembling wild type spores and carrying in their coat some CotE-/CotH-dependant proteins. Our results suggest that the B. subtilis spore differentiation programme is flexible, and that an increase in the amount of a regulatory protein can replace a missing partner and partially substitute its function in the assembly of the spore coat.	[Isticato, Rachele; Sirec, Teja; Giglio, Rosa; Baccigalupi, Loredana; De Felice, Maurilio; Ricca, Ezio] Univ Naples Federico II, Dept Biol, Naples, Italy; [Rusciano, Giulia; Pesce, Giuseppe; Zito, Gianluigi; Sasso, Antonio] Univ Naples Federico II, Dept Phys, Naples, Italy	University of Naples Federico II; University of Naples Federico II	Ricca, E (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	ericca@unina.it	Pesce, Giuseppe/AAX-8652-2020; Zito, Gianluigi/AAY-2420-2020; Isticato, Rachele/J-3476-2012; Ricca, Ezio/AAG-2998-2020; Rusciano, Giulia/A-2079-2010; ISTICATO, Rachele/AAX-9972-2021; Zito, Gianluigi/P-9424-2018; Pesce, Giuseppe/B-9618-2009	Zito, Gianluigi/0000-0003-2376-0080; Ricca, Ezio/0000-0002-7355-0332; Rusciano, Giulia/0000-0002-7152-5352; ISTICATO, Rachele/0000-0001-9141-4038; Zito, Gianluigi/0000-0003-2376-0080; Pesce, Giuseppe/0000-0002-2806-9769; Sasso, Antonio/0000-0003-3591-3531; Baccigalupi, Loredana/0000-0003-3070-161X	EU [KBBE-476 2007-207948]	EU(European Commission)	This work was supported by a grant (KBBE-476 2007-207948) from the EU 7th Framework to ER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccigalupi L, 2004, MICROBIOL-SGM, V150, P3441, DOI 10.1099/mic.0.27356-0; Costa T, 2007, J BACTERIOL, V189, P2401, DOI 10.1128/JB.01353-06; Cutting S., 1990, MOL BIOL METHODS BAC; DRIKS A, 1994, GENE DEV, V8, P234, DOI 10.1101/gad.8.2.234; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Giglio R, 2011, J BACTERIOL, V193, P6664, DOI 10.1128/JB.06121-11; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Isticato R, 2004, J BACTERIOL, V186, P1129, DOI 10.1128/JB.186.4.1129-1135.2004; Isticato R, 2008, J BACTERIOL, V190, P1267, DOI 10.1128/JB.01425-07; Isticato R, 2007, BIOTECHNIQUES, V42, P149, DOI 10.2144/000112329; Isticato R, 2010, J BACTERIOL, V192, P949, DOI 10.1128/JB.01408-09; Kim H, 2006, MOL MICROBIOL, V59, P487, DOI 10.1111/j.1365-2958.2005.04968.x; Klobutcher LA, 2006, P NATL ACAD SCI USA, V103, P165, DOI 10.1073/pnas.0507121102; Kneipp K, 1999, CHEM REV, V99, P2957, DOI 10.1021/cr980133r; LEE PC, 1982, J PHYS CHEM-US, V86, P3391, DOI 10.1021/j100214a025; LOSICK R, 1986, ANNU REV GENET, V20, P625, DOI 10.1146/annurev.ge.20.120186.003205; McKenney PT, 2013, NAT REV MICROBIOL, V11, P33, DOI 10.1038/nrmicro2921; Naclerio G, 1996, J BACTERIOL, V178, P4375, DOI 10.1128/jb.178.15.4375-4380.1996; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; RICCA E, 1992, J BACTERIOL, V174, P3177, DOI 10.1128/jb.174.10.3177-3184.1992; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANDMAN K, 1988, J MOL BIOL, V200, P461, DOI 10.1016/0022-2836(88)90536-0; Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; Svedberg F, 2006, FARADAY DISCUSS, V132, P35, DOI 10.1039/b509301p; Vepachedu VR, 2005, J BACTERIOL, V187, P5677, DOI 10.1128/JB.187.16.5677-5682.2005; YOUNGMAN P, 1984, MOL GEN GENET, V195, P424, DOI 10.1007/BF00341443; ZHENG LB, 1988, GENE DEV, V2, P1047, DOI 10.1101/gad.2.8.1047; Zilhao R, 2004, J BACTERIOL, V186, P1110, DOI 10.1128/JB.186.4.1110-1119.2004; Zilhao R, 1999, J BACTERIOL, V181, P2631	31	25	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74949	10.1371/journal.pone.0074949	http://dx.doi.org/10.1371/journal.pone.0074949			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086406	gold, Green Published, Green Submitted			2022-12-27	WOS:000325223900032
J	Liu, T; Liu, YY; Bao, XX; Tian, JG; Liu, Y; Yang, XS				Liu, Ting; Liu, Yueyang; Bao, Xiangxiang; Tian, Jiguang; Liu, Yang; Yang, Xingsheng			Overexpression of TROP2 Predicts Poor Prognosis of Patients with Cervical Cancer and Promotes the Proliferation and Invasion of Cervical Cancer Cells by Regulating ERK Signaling Pathway	PLOS ONE			English	Article							EXPRESSION; CARCINOMA; MARKER	Overwhelming evidence has demonstrated that the aberrant expression of the human trophoblast cell-surface antigen (TROP2) was associated with tumor aggressiveness and poor prognosis in a variety of human cancers, however the roles of TROP2 in cervical cancer have not been investigated. The purpose of our study was to elucidate the prognostic significance of TROP2 expression in patients with cervical cancer and determine its effect on tumor progression. Immunohistochemistry assay showed that 88.7% (94/106 cases) of cervical cancer specimens were positively stained with TROP2, and the overexpression of TROP2 was closely related with FIGO stage, histological grades, lymphatic metastasis, invasive interstitial depth and high expression of Ki-67. Patients with TROP2-positive staining exhibited a significantly decreased overall survival and progression free survival; it was also an independent predictor for prognosis according to multivariate analysis. Moreover, down-regulation of TROP2 mediated by siRNA in Siha and CaSki cells resulted in a strong inhibition of proliferation and invasion, TROP2 abrogation also elevated the apoptotic ratio and caused G1 arrest. Conversely, enforced expression of TROP2 in HeLa and C33A cells remarkably promoted cell growth, migration and invasion. In addition, the tumorigenic function of TROP2 was associated with the increased expressions of cyclin D1, cyclin E, CDK2 and CDK4 but reduced expression of p27 and E-cadherin via the activation of Erk1/2 signaling pathway. Furthermore, the inhibition of TROP2 expression in cervical cancer cell lines enhances sensitivity to cisplatin. The present study suggest that overexpression of TROP2 may play crucial roles in the development and pathogenesis of human cervical cancer, therefore, TROP2 may represent a prospective prognostic indicator and a potential therapeutic target of cervical cancer.	[Liu, Ting; Liu, Yueyang; Bao, Xiangxiang; Liu, Yang; Yang, Xingsheng] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Shandong, Peoples R China; [Tian, Jiguang] Shandong Univ, Qilu Hosp, Dept Orthoped, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Yang, XS (corresponding author), Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Shandong, Peoples R China.	xingshengyang@sdu.edu.cn			National Natural Science Foundation of China and Science [81372809]; Technology Development Planning of Shandong Province [2011GSF12121]	National Natural Science Foundation of China and Science; Technology Development Planning of Shandong Province	The project was supported by National Natural Science Foundation of China and Science (No. 81372809) and Technology Development Planning of Shandong Province (No. 2011GSF12121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSALEH W, 1995, AM J CLIN PATHOL, V104, P154; Beloueche-Babari M, 2005, CANCER RES, V65, P3356, DOI 10.1158/0008-5472.CAN-03-2981; Bignotti E, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-22; Bignotti E, 2010, EUR J CANCER, V46, P944, DOI 10.1016/j.ejca.2009.12.019; Bizari L, 2006, CANCER GENET CYTOGEN, V165, P41, DOI 10.1016/j.cancergencyto.2005.08.031; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chen CR, 2012, PHARMAZIE, V67, P351, DOI 10.1691/ph.2012.1634; Cubas R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-253; Farivar TN, 2012, N AM J MED SCI, V4, P582, DOI 10.4103/1947-2714.103319; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fong D, 2008, MODERN PATHOL, V21, P186, DOI 10.1038/modpathol.3801001; Govindan SV, 2004, BREAST CANCER RES TR, V84, P173, DOI 10.1023/B:BREA.0000018417.02580.ef; Guerra E, 2013, ONCOGENE, V32, P1594, DOI 10.1038/onc.2012.151; Guerra E, 2008, CANCER RES, V68, P8113, DOI 10.1158/0008-5472.CAN-07-6135; Hubalek MM, 2004, ONCOGENE, V23, P4187, DOI 10.1038/sj.onc.1207560; Lilic V, 2009, J BUON, V14, P587; Ning SL, 2013, J GASTROINTEST SURG, V17, P360, DOI 10.1007/s11605-012-2105-1; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Reuschenbach M, 2012, INT J CANCER, V130, P388, DOI 10.1002/ijc.26017; Ripani E, 1998, INT J CANCER, V76, P671; Villalba SR, 2011, CLIN TRANSL ONCOL, V13, P378, DOI 10.1007/s12094-011-0671-4; SZALA S, 1990, P NATL ACAD SCI USA, V87, P3542, DOI 10.1073/pnas.87.9.3542; Tang B, 2011, MED ONCOL, V28, P502, DOI 10.1007/s12032-010-9492-5; Trerotola M, 2013, ONCOGENE, V32, P222, DOI 10.1038/onc.2012.36; Varughese J, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.093; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Wang JB, 2008, MOL CANCER THER, V7, P280, DOI 10.1158/1535-7163.MCT-07-2003	27	58	75	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75864	10.1371/journal.pone.0075864	http://dx.doi.org/10.1371/journal.pone.0075864			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086649	Green Submitted, Green Published, gold			2022-12-27	WOS:000325223900065
J	Stern, A; Wold, AE; Ostman, S				Stern, Anna; Wold, Agnes E.; Ostman, Sofia			Neonatal Mucosal Immune Stimulation by Microbial Superantigen Improves the Tolerogenic Capacity of CD103(+) Dendritic Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; STAPHYLOCOCCAL-ENTEROTOXIN-B; ORAL TOLERANCE; COSTIMULATORY MOLECULES; CLONAL DELETION; INDUCTION; ANTIGEN; ANERGY; DIFFERENTIATION; OVALBUMIN	Food allergy represents failure to develop tolerance to dietary proteins. Food allergy has increased in prevalence in parallel with decreased exposure to microbes during infancy. In mice, neonatal peroral exposure to the strongly T cell stimulating superantigen staphylococcal enterotoxin A (SEA), enhances the capacity to develop oral tolerance to a novel antigen encountered in adult life. A population of antigen-presenting cells in the gut, the CD103(+) dendritic cells (DCs), is thought to be involved in oral tolerance development, as they convert naive T cells into FoxP3(+) regulatory T cells (Treg). This function depends on their capacity to convert vitamin A to retinoic acid, carried out by the retinal aldehyde dehydrogenase (RALDH) enzyme. Here, newborn mice were treated with superantigen and DC function and tolerogenic capacity was examined at six weeks of age. We observed that, in mice fed superantigen neonatally, the CD11c(+) DCs had increased expression of RALDH and in vitro more efficiently induced expression Foxp3 expression to stimulated T cells. Further, these mice showed an accumulation of FoxP3(+) T cells in the small intestinal lamina propria and had a more Ag-specific FoxP3(+) T cells after oral tolerance induction in vivo. Moreover, the improved oral tolerance, as shown by increased protection from food allergy, was eradicated if the Vitamin A metabolism was inhibited. These observations contribute to the understanding of how a strong immune stimulation during the neonatal period influences the maturation of the immune system and suggests that such stimulation may reduce the risk of later allergy development.	[Stern, Anna; Wold, Agnes E.; Ostman, Sofia] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Med, Gothenburg, Sweden	University of Gothenburg	Ostman, S (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Med, Gothenburg, Sweden.	sofia.ostman@microbio.gu.se	Wold, Agnes/M-6310-2013	Wold, Agnes/0000-0001-9196-5040	Swedish Research Council [K2007-58X-08298-20-3]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was founded by the Swedish Research Council (grant K2007-58X-08298-20-3), The Medical Faculty of Gothenburg (LUA), The Torsten and Ragnar Soderberg Foundation and IngaBritt and Arne Lundbergs foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bilsborough J, 2003, IMMUNOLOGY, V108, P481, DOI 10.1046/j.1365-2567.2003.01606.x; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; CALLAHAN JE, 1990, J IMMUNOL, V144, P2473; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Garside P, 2004, ANN NY ACAD SCI, V1029, P9, DOI 10.1196/annals.1309.002; GONZALO JA, 1992, EUR J IMMUNOL, V22, P1007, DOI 10.1002/eji.1830220420; Grundstrom S, 2003, J IMMUNOL, V170, P5008, DOI 10.4049/jimmunol.170.10.5008; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; Lonnqvist A, 2009, EUR J IMMUNOL, V39, P447, DOI 10.1002/eji.200838418; Lundell AC, 2007, CLIN EXP ALLERGY, V37, P62, DOI 10.1111/j.1365-2222.2006.02625.x; Lundell AC, 2009, CLIN EXP ALLERGY, V39, P662, DOI 10.1111/j.1365-2222.2008.03176.x; MACDONALD HR, 1991, EUR J IMMUNOL, V21, P1963, DOI 10.1002/eji.1830210827; MCCORMACK JE, 1993, J IMMUNOL, V150, P3785; Misra N, 2004, J IMMUNOL, V172, P4676, DOI 10.4049/jimmunol.172.8.4676; MOREAU MC, 1988, INFECT IMMUN, V56, P2766, DOI 10.1128/IAI.56.10.2766-2768.1988; Moreau MC, 1996, RES IMMUNOL, V147, P49, DOI 10.1016/0923-2494(96)81548-3; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Oderup C, 2006, IMMUNOLOGY, V118, P240, DOI 10.1111/j.1365-2567.2006.02362.x; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; RAMMENSEE HG, 1989, NATURE, V339, P541, DOI 10.1038/339541a0; RELLAHAN BL, 1990, J EXP MED, V172, P1091, DOI 10.1084/jem.172.4.1091; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Sudo N, 1997, J IMMUNOL, V159, P1739; SUNDSTEDT A, 1994, IMMUNOLOGY, V82, P117; Turnbull EL, 2005, J IMMUNOL, V174, P1374, DOI 10.4049/jimmunol.174.3.1374; Viney JL, 1998, J IMMUNOL, V160, P5815; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; Wang M, 2007, J ALLERGY CLIN IMMUN; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016	36	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75594	10.1371/journal.pone.0075594	http://dx.doi.org/10.1371/journal.pone.0075594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086582	Green Published, Green Submitted, gold			2022-12-27	WOS:000325223900048
J	Wang, K; Zhang, WP; Jiang, YQ; Zhang, TZ				Wang, Kai; Zhang, Wenpan; Jiang, Yanqin; Zhang, Tianzhen			Systematic Application of DNA Fiber-FISH Technique in Cotton	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; GOSSYPIUM-HIRSUTUM L.; ARABIDOPSIS-THALIANA; CYTOSINE METHYLATION; REPETITIVE DNA; TELOMERIC DNA; RIBOSOMAL DNA; CHROMOSOMES; RESOLUTION; ORGANIZATION	Fluorescence in situ hybridization on extended DNA (fiber-FISH) is a powerful tool in high-resolution physical mapping. To introduce this technique into cotton, we developed the technique and tested it by deliberately mapping of telomere and 5S rDNA. Results showed that telomere-length ranged from 0.80 kb to 37.86 kb in three species, G. hirsutum, G. herbaceum and G. arboreum. However, most of the telomeres (>91.0%) were below 10 kb. The length of 5S rDNA was revealed as 964 kb in G. herbaceum whereas, in G. arboreum, it was approximately three times longer (3.1 Mb). A fiber-FISH based immunofluorescence method was also described to assay the DNA methylation. Using this technique, we revealed that both telomere and 5S rDNA were methylated at different levels. In addition, we developed a BAC molecule-based fiber-FISH technique. Using this technique, we can precisely map BAC clones on each other and evaluated the size and location of overlapped regions. The development and application of fiber-FISH technique will facilitate high-resolution physical mapping and further directed sequencing projects for cotton.	[Wang, Kai; Zhang, Wenpan; Zhang, Tianzhen] Nanjing Agr Univ, Cotton Res Inst, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Jiang, Yanqin] Inst Bot, Nanjing, Jiangsu, Peoples R China; [Jiang, Yanqin] Chinese Acad Sci, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Nanjing Agricultural University; Chinese Academy of Sciences	Wang, K (corresponding author), Nanjing Agr Univ, Cotton Res Inst, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	kaiwang@njau.edu.cn; cotton@njau.edu.cn	Wang, Kai/A-2143-2011	Wang, Kai/0000-0002-1074-0438	National Natural Science Foundation of China [31071460]; New Century Excellent Talents in University [NCET-10-0496]; Priority Academic Program Development of Jiangsu Higher Education Institutions; 111 Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Priority Academic Program Development of Jiangsu Higher Education Institutions; 111 Program(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation of China (31071460) and New Century Excellent Talents in University (NCET-10-0496). This work was also supported partly by The Priority Academic Program Development of Jiangsu Higher Education Institutions and 111 Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Cheng ZK, 2002, CHROMOSOME RES, V10, P379, DOI 10.1023/A:1016849618707; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cook DE, 2012, SCIENCE, V338, P1206, DOI 10.1126/science.1228746; Cronn RC, 1996, J MOL EVOL, V42, P685, DOI 10.1007/BF02338802; de Jong JH, 1999, TRENDS PLANT SCI, V4, P258; Di Giulio M, 2010, J MOL EVOL, V71, P1, DOI 10.1007/s00239-010-9358-7; Endrizzi J. E., 1985, Advances in Genetics, V23, P271, DOI 10.1016/S0065-2660(08)60515-5; Fransz PF, 1996, PLANT J, V9, P421, DOI 10.1046/j.1365-313X.1996.09030421.x; Gong ZY, 2012, PLANT CELL, V24, P3559, DOI 10.1105/tpc.112.100511; Hanson RE, 1996, CHROMOSOMA, V105, P55, DOI 10.1007/BF02510039; HEISKANEN M, 1995, GENOMICS, V30, P31, DOI 10.1006/geno.1995.0005; Henegariu O, 2001, BIOTECHNIQUES, V31, P246, DOI 10.2144/01312bm01; Jackson SA, 1999, PLANT J, V17, P581, DOI 10.1046/j.1365-313X.1999.00398.x; Jackson SA, 1998, GENOME, V41, P566, DOI 10.1139/gen-41-4-566; Ji YF, 2007, GENETICS, V176, P115, DOI 10.1534/genetics.107.071738; Jiang JM, 2006, GENOME, V49, P1057, DOI 10.1139/G06-076; Jin WW, 2004, PLANT CELL, V16, P571, DOI 10.1105/tpc.018937; Koo DH, 2011, GENOME RES, V21, P908, DOI 10.1101/gr.116202.110; Kuznetsova I, 2006, CYTOGENET GENOME RES, V112, P248, DOI 10.1159/000089878; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Majerova E, 2011, PLANT MOL BIOL, V77, P533, DOI 10.1007/s11103-011-9834-5; Majerova E, 2011, PLANT MOL BIOL, V77, P371, DOI 10.1007/s11103-011-9816-7; Mathieu O, 2002, PLANT J, V29, P313, DOI 10.1046/j.0960-7412.2001.01212.x; McKnight TD, 2002, PLANT MOL BIOL, V48, P331, DOI 10.1023/A:1014091032750; MEYER P, 1994, EMBO J, V13, P2084, DOI 10.1002/j.1460-2075.1994.tb06483.x; Mizuno H, 2006, PLANT J, V46, P206, DOI 10.1111/j.1365-313X.2006.02684.X; O'Callaghan NJ, 2008, BIOTECHNIQUES, V44, P807, DOI 10.2144/000112761; Ohmido N, 2001, PLANT MOL BIOL, V47, P413, DOI 10.1023/A:1011632111845; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Saldanha SN, 2003, EUR J BIOCHEM, V270, P389, DOI 10.1046/j.1432-1033.2003.03410.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schwarzacher T, 2003, GENOME, V46, P953, DOI 10.1139/G03-119; Shiels C, 1997, CYTOGENET CELL GENET, V76, P20, DOI 10.1159/000134504; Sjoberg A, 1997, CHROMOSOME RES, V5, P247, DOI 10.1023/A:1018419619634; Sun FJ, 2009, J MOL EVOL, V69, P430, DOI 10.1007/s00239-009-9264-z; Uchida W, 2002, GENES GENET SYST, V77, P63, DOI 10.1266/ggs.77.63; Vaquero-Sedas MI, 2011, PLANT MOL BIOL, V77, P529, DOI 10.1007/s11103-011-9833-6; Vaquero-Sedas MI, 2011, NUCLEIC ACIDS RES, V39, P2007, DOI 10.1093/nar/gkq1119; Wang K, 2008, GENETICS, V178, P1117, DOI 10.1534/genetics.107.083576; Wang K, 2006, THEOR APPL GENET, V113, P73, DOI 10.1007/s00122-006-0273-7; Wang K, 2010, CHROMOSOMA, V119, P255, DOI 10.1007/s00412-009-0254-0; Wang K, 2009, CHROMOSOME RES, V17, P1041, DOI 10.1007/s10577-009-9085-3; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Watson JM, 2010, FEBS LETT, V584, P3752, DOI 10.1016/j.febslet.2010.06.017; WEIER HUG, 1995, HUM MOL GENET, V4, P1903; WENDEL JF, 1995, MOL PHYLOGENET EVOL, V4, P298, DOI 10.1006/mpev.1995.1027; Zhang H, 2012, PLANT J, V70, P357, DOI 10.1111/j.1365-313X.2011.04867.x; Zhao XP, 1998, GENOME RES, V8, P479, DOI 10.1101/gr.8.5.479; Zhong SL, 2013, NAT BIOTECHNOL, V31, P154, DOI 10.1038/nbt.2462; Zhong XB, 1998, PLANT J, V13, P507, DOI 10.1046/j.1365-313X.1998.00055.x	53	13	14	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75674	10.1371/journal.pone.0075674	http://dx.doi.org/10.1371/journal.pone.0075674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086609	gold, Green Published, Green Submitted			2022-12-27	WOS:000325223900057
J	Abdulghani, J; Allen, JE; Dicker, DT; Liu, YY; Goldenberg, D; Smith, CD; Humphreys, R; El-Deiry, WS				Abdulghani, Junaid; Allen, Joshua E.; Dicker, David T.; Liu, Yingqiu Yvette; Goldenberg, David; Smith, Charles D.; Humphreys, Robin; El-Deiry, Wafik S.			Sorafenib Sensitizes Solid Tumors to Apo2L/TRAIL and Apo2L/TRAIL Receptor Agonist Antibodies by the Jak2-Stat3-Mcl1 Axis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; RAF/MEK/ERK PATHWAY; SELECTIVE MUTANTS; TRAIL RESISTANCE; CANCER-CELLS; IN-VITRO; C-MYC; APOPTOSIS; MCL-1; STAT3	Background: Approximately half of tumor cell lines are resistant to the tumor-selective apoptotic effects of tumor necrosis factor-related apoptosis-inducing ligand (Apo22L/TRAIL). Previously, we showed that combining Apo2L/TRAIL with sorafenib, a multikinase inhibitor, results in dramatic efficacy in Apo2L/TRAIL-resistant tumor xenografts via inhibition of Mcl-1. Soluble Apo2L/TRAIL is capable of binding to several surface receptors, including the proapoptotic death receptors, DR4 and DR5, and decoy receptors, DcR1 and DcR2. Monoclonal antibodies targeting either of these death receptors are being investigated as antitumor agents in clinical trials. We hypothesized that sorafenib and Apo2L/TRAIL or Apo2L/TRAIL death receptor agonist (TRA) antibodies against DR4 (mapatumumab) and DR5 (lexatumumab) will overcome resistance to Apo2L/TRAIL-mediated apoptosis and as increase antitumor efficacy in Apo2L/TRAIL-sensitive solid tumors. Methodology/Principal Findings: We found that Apo2L/TRAIL or TRA antibodies combined with sorafenib synergistically reduce cell growth and increase cell death across a panel of solid tumor cell lines in vitro. This panel included human breast, prostate, colon, liver and thyroid cancers. The cooperativity of these combinations was also observed in vivo, as measured by tumor volume and TUNEL staining as a measure of apoptosis. We found that sorafenib inhibits Jak/Stat3 signaling and downregulates their target genes, including cyclin D1, cyclin D2 and Mcl-1, in a dose-dependent manner. Conclusions/Significance: The combination of sorafenib with Apo2L/TRAIL or Apo2L/TRAIL receptor agonist antibodies sensitizes Apo2L/TRAIL-resistant cells and increases the sensitivity of Apo2L/TRAIL-sensitive cells. Our findings demonstrate the involvement of the Jak2-Stat3-Mcl1 axis in response to sorafenib treatment, which may play a key role in sorafenib-mediated sensitization to Apo2L/TRAIL.	[El-Deiry, Wafik S.] Penn State Coll Med, Penn State Hershey Canc Inst, Lab Translat Oncol & Expt Canc Therapeut, Dept Med Hematol Oncol, Hershey, PA USA; Penn State Coll Med, Penn State Hershey Canc Inst, Dept Surg, Hershey, PA USA; Med Univ S Carolina, Coll Pharm, Pharmaceut & Biomed Sci Dept, Charleston, SC 29425 USA; Oncol Res Dept, Rockville, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Medical University of South Carolina	El-Deiry, WS (corresponding author), Penn State Coll Med, Penn State Hershey Canc Inst, Lab Translat Oncol & Expt Canc Therapeut, Dept Med Hematol Oncol, Hershey, PA USA.	wafik.eldeiry@gmail.com	El-Deiry, Wafik/AAJ-6080-2020	El-Deiry, Wafik/0000-0002-9577-8266	Penn State Hershey Cancer Institutional start-up fund; American Cancer Society	Penn State Hershey Cancer Institutional start-up fund; American Cancer Society(American Cancer Society)	This work was supported in part by Penn State Hershey Cancer Institutional start-up fund and the American Cancer Society Research Professorship received to Dr. WSED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulghani J, 2008, AM J PATHOL, V172, P1717, DOI 10.2353/ajpath.2008.071054; Abdulghani J, 2010, EXPERT OPIN THER TAR, V14, P1091, DOI 10.1517/14728222.2010.519701; Allen JE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004828; Allen JE, 2012, MOL CANCER THER, V11, P2087, DOI 10.1158/1535-7163.MCT-12-0366; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Bhattacharya S, 2005, BIOCHEM J, V392, P335, DOI 10.1042/BJ20050465; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Burns TF, 2001, J BIOL CHEM, V276, P37879; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Erovic BM, 2005, CLIN CANCER RES, V11, P8632, DOI 10.1158/1078-0432.CCR-05-1170; Garofalo M, 2008, ONCOGENE, V27, P3845, DOI 10.1038/onc.2008.6; Greco FA, 2008, LUNG CANCER, V61, P82, DOI 10.1016/j.lungcan.2007.12.011; Hall MA, 2007, CANCER CELL, V12, P4, DOI 10.1016/j.ccr.2007.06.011; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; ITO T, 1994, INT J ONCOL, V4, P583; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kane RC, 2006, CLIN CANCER RES, V12, P7271, DOI 10.1158/1078-0432.CCR-06-1249; Kane RC, 2009, ONCOLOGIST, V14, P95, DOI 10.1634/theoncologist.2008-0185; Kelley RF, 2005, J BIOL CHEM, V280, P2205, DOI 10.1074/jbc.M410660200; Kim SH, 2004, J BIOL CHEM, V279, P40044, DOI 10.1074/jbc.M404541200; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; MacFarlane M, 2005, CANCER RES, V65, P11265, DOI 10.1158/0008-5472.CAN-05-2801; Malin D, 2011, CLIN CANCER RES, V17, P5005, DOI 10.1158/1078-0432.CCR-11-0099; Masuda M, 2002, CANCER RES, V62, P3351; Nagane M, 2010, NEURO-ONCOLOGY, V12, P687, DOI 10.1093/neuonc/nop069; Park C, 2008, ACTA PHARMACOL SIN, V29, P341, DOI 10.1111/j.1745-7254.2008.00761.x; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sieghart W, 2006, J HEPATOL, V44, P151, DOI 10.1016/j.jhep.2005.09.010; Swers JS, 2013, MOL CANCER THER, V12, P1235, DOI 10.1158/1535-7163.MCT-12-1107; Wakelee HA, 2010, ANN ONCOL, V21, P376, DOI 10.1093/annonc/mdp292; Wang GL, 2013, NAT CHEM BIOL, V9, P84, DOI [10.1038/NCHEMBIO.1153, 10.1038/nchembio.1153]; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wang WG, 2003, CANCER BIOL THER, V2, P196, DOI 10.4161/cbt.2.2.347; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Younes A, 2010, BRIT J CANCER, V103, P1783, DOI 10.1038/sj.bjc.6605987; Zhang YQ, 2008, MOL CANCER RES, V6, P1861, DOI 10.1158/1541-7786.MCR-08-0313	41	37	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75414	10.1371/journal.pone.0075414	http://dx.doi.org/10.1371/journal.pone.0075414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086526	Green Submitted, gold, Green Published			2022-12-27	WOS:000325220000020
J	Kopf, J; Dresler, T; Reicherts, P; Herrmann, MJ; Reif, A				Kopf, Juliane; Dresler, Thomas; Reicherts, Philipp; Herrmann, Martin J.; Reif, Andreas			The Effect of Emotional Content on Brain Activation and the Late Positive Potential in a Word n-back Task	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; WORKING-MEMORY; TIME-COURSE; INTERFERENCE RESOLUTION; CORTEX; ATTENTION; PICTURES; STIMULI; AROUSAL	Introduction: There is mounting evidence for the influence of emotional content on working memory performance. This is particularly important in light of the emotion processing that needs to take place when emotional content interferes with executive functions. In this study, we used emotional words of different valence but with similar arousal levels in an n-back task. Methods: We examined the effects on activation in the prefrontal cortex by means of functional near-infrared spectroscopy (fNIRS) and on the late positive potential (LPP). FNIRS and LPP data were examined in 30 healthy subjects. Results: Behavioral results show an influence of valence on the error rate depending on the difficulty of the task: more errors were made when the valence was negative and the task difficult. Brain activation was dependent both on the difficulty of the task and on the valence: negative valence of a word diminished the increase in activation, whereas positive valence did not influence the increase in activation, while difficulty levels increased. The LPP also differentiated between the different valences, and in addition was influenced by the task difficulty, the more difficult the task, the less differentiation could be observed. Conclusions: Summarized, this study shows the influence of valence on a verbal working memory task. When a word contained a negative valence, the emotional content seemed to take precedence in contrast to words containing a positive valence. Working memory and emotion processing sites seemed to overlap and compete for resources even when words are carriers of the emotional content.	[Kopf, Juliane; Dresler, Thomas; Herrmann, Martin J.; Reif, Andreas] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, D-97070 Wurzburg, Germany; [Dresler, Thomas] Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany; [Reicherts, Philipp] Univ Wurzburg, Dept Psychol, D-97070 Wurzburg, Germany	University of Wurzburg; Eberhard Karls University of Tubingen; University of Wurzburg	Kopf, J (corresponding author), Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, D-97070 Wurzburg, Germany.	Kopf_J1@klinik.uni-wuerzburg.de	herrmann, martin/AAT-9836-2020; Herrmann, Martin J./C-9904-2009	Herrmann, Martin J./0000-0001-9970-2122	German Research Foundation; University of Wuerzburg; DFG [RE1632/5-1, He45411-1, KFO 125, SFB TRR 58 Z02, C04, RTG 1253]	German Research Foundation(German Research Foundation (DFG)); University of Wuerzburg; DFG(German Research Foundation (DFG))	This publication was funded by the German Research Foundation and the University of Wuerzburg in the funding programme Open Access Publishing. The study was supported by the DFG (URL: http://www.dfg.de/en/) (Grant RE1632/5-1 to AR, He45411-1 to MJH, KFO 125 to AR; SFB TRR 58 Z02 to AR, C04 to MJH, RTG 1253 to AR, MJH and JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A., 1986, WORKING MEMORY, P289; Cui X, 2011, NEUROIMAGE, V54, P2808, DOI 10.1016/j.neuroimage.2010.10.069; DEJONG R, 1990, J EXP PSYCHOL HUMAN, V16, P164, DOI 10.1037/0096-1523.16.1.164; Dresler T, 2009, PSYCHOL RES-PSYCH FO, V73, P364, DOI 10.1007/s00426-008-0154-6; Foti D, 2008, J COGNITIVE NEUROSCI, V20, P977, DOI 10.1162/jocn.2008.20066; Fruhholz S, 2011, BIOL PSYCHOL, V87, P265, DOI 10.1016/j.biopsycho.2011.03.008; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Gray JR, 2001, J EXP PSYCHOL GEN, V130, P436, DOI 10.1037//0096-3445.130.3.436; Hajcak G, 2007, BEHAV NEUROSCI, V121, P1156, DOI 10.1037/0735-7044.121.6.1156; Hajcak G, 2009, CLIN NEUROPHYSIOL, V120, P505, DOI 10.1016/j.clinph.2008.11.028; Herbert C, 2008, PSYCHOPHYSIOLOGY, V45, P487, DOI 10.1111/j.1469-8986.2007.00638.x; Herrmann MJ, 2008, HUM BRAIN MAPP, V29, P28, DOI 10.1002/hbm.20368; Hofmann MJ, 2009, COGN AFFECT BEHAV NE, V9, P389, DOI 10.3758/9.4.389; Horn W, 1983, LPS LEISTUNGSPRUFSYS; Hoshi Y, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804911; Hoshi Y, 2011, J NEUROIMAGING, V21, pe94, DOI 10.1111/j.1552-6569.2009.00454.x; Keil A, 2002, PSYCHOPHYSIOLOGY, V39, P641, DOI 10.1017/S0048577202394162; Keil A, 2004, EMOTION, V4, P23, DOI 10.1037/1528-3542.4.1.23; Kensinger EA, 2003, EMOTION, V3, P378, DOI 10.1037/1528-3542.3.4.378; Kissler J, 2009, BIOL PSYCHOL, V80, P75, DOI 10.1016/j.biopsycho.2008.03.004; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kopf J, 2011, NEUROIMAGE, V57, P1617, DOI 10.1016/j.neuroimage.2011.05.034; Krohne HW, 1996, DIAGNOSTICA, V42, P139; Lehrl S, 2005, MWT B MEHRFACHWAHL W; Leon-Carrion J, 2006, NEUROSCI LETT, V403, P90, DOI 10.1016/j.neulet.2006.04.050; Levens SA, 2008, EMOTION, V8, P267, DOI 10.1037/1528-3542.8.2.267; Levens SM, 2010, J COGNITIVE NEUROSCI, V22, P2790, DOI 10.1162/jocn.2010.21428; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; MacNamara A, 2011, COGN AFFECT BEHAV NE, V11, P321, DOI 10.3758/s13415-011-0036-z; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Perlstein WM, 2002, P NATL ACAD SCI USA, V99, P1736, DOI 10.1073/pnas.241650598; Pessoa L, 2003, PROG BRAIN RES, V144, P171, DOI 10.1016/S0079-6123(03)14401-2; Plichta MM, 2011, NEUROIMAGE, V55, P1200, DOI 10.1016/j.neuroimage.2011.01.011; Plichta MM, 2006, NEUROIMAGE, V31, P116, DOI 10.1016/j.neuroimage.2005.12.008; Plichta MM, 2006, NEUROPSYCHOBIOLOGY, V53, P77, DOI 10.1159/000091723; Schecklmann M, 2010, J PSYCHIATR RES, V44, P621, DOI 10.1016/j.jpsychires.2009.11.018; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Townsend JD, 2013, J AFFECT DISORDERS, V147, P389, DOI 10.1016/j.jad.2012.08.019; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; Vo MLH, 2009, BEHAV RES METHODS, V41, P534, DOI 10.3758/BRM.41.2.534; Weinberg A, 2010, EMOTION, V10, P767, DOI 10.1037/a0020242	44	26	28	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75598	10.1371/journal.pone.0075598	http://dx.doi.org/10.1371/journal.pone.0075598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VP	24086584	gold, Green Submitted, Green Published			2022-12-27	WOS:000325220000031
J	Schmitt, P; Santini, A; Vergnes, A; Degremont, L; de Lorgeril, J				Schmitt, Paulina; Santini, Adrien; Vergnes, Agnes; Degremont, Lionel; de Lorgeril, Julien			Sequence Polymorphism and Expression Variability of Crassostrea gigas Immune Related Genes Discriminate Two Oyster Lines Contrasted in Term of Resistance to Summer Mortalities	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PACIFIC OYSTER; SURVIVAL; PROTEIN; TRANSGLUTAMINASE; SUSCEPTIBILITY; IDENTIFICATION; ASSOCIATION; HEMOCYTES; SELECTION	Summer mortalities of Crassostrea gigas are a major concern in oyster aquaculture. They are the result of a complex interaction between the host, pathogens and environmental factors. Oyster genetics have been identified as an essential determinant of oyster susceptibility to summer mortalities. As the capability of oysters to circumvent diseases depends in part on their immune defenses, we aimed to analyze the gene expression and sequence polymorphism of 42 immune related genes in two oyster lines selected for their "High" (H) and "Low" (L) survival to summer mortalities. Results showed that the variability of gene expression and the sequence polymorphism acting on particular genes could enable the discrimination between H and L oyster lines. Besides, a higher sequence polymorphism was observed on the L line affecting 11 of the 42 analyzed genes. By analyzing gene expression, sequence polymorphism and gene copy number of two antimicrobial peptide families (Cg-Defs and Cg-Prp), and an antimicrobial protein (Cg-BPI) on individual oysters, we showed that gene expression and/or sequence polymorphism could also discriminate H and L oyster lines. Finally, we observed a positive correlation between the gene expression and the gene copy number of antimicrobials and that sequence polymorphism could be encoded in the genome. Overall, this study gives new insights in the relationship between oyster immunity and divergent phenotypes, and discusses the potential implication of antimicrobial diversity in oyster survival to summer mortalities.	[Schmitt, Paulina; Santini, Adrien; Vergnes, Agnes] Univ Montpellier I, Univ Montpellier 2, IFREMER, Ctr Natl Rech Sci,Inst Rech Dev,UMR Ecol Syst Mar, Montpellier, France; [Degremont, Lionel; de Lorgeril, Julien] IFREMER, Lab Genet & Pathol Mollusques Marins, La Tremblade, France	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Ifremer	Schmitt, P (corresponding author), Univ Montpellier I, Univ Montpellier 2, IFREMER, Ctr Natl Rech Sci,Inst Rech Dev,UMR Ecol Syst Mar, Montpellier, France.	julien.de.lorgeril@ifremer.fr	de Lorgeril, Julien/O-7488-2014; VERGNES, Agnès/O-3659-2014; degremont, lionel/A-4163-2011	de Lorgeril, Julien/0000-0002-6400-5455; degremont, lionel/0000-0001-6759-6791; Schmitt, Paulina/0000-0001-6598-837X	Institut Francais de Recherche et d'Exploitation de la Mer (Ifremer); Centre National de la Recherche Scientifique (CNRS) grant from EC2CO (Ecosphere Continentale et Cotiere) MicrobiEn; PNEC project MicroGigas [0405/1B1INEE]	Institut Francais de Recherche et d'Exploitation de la Mer (Ifremer); Centre National de la Recherche Scientifique (CNRS) grant from EC2CO (Ecosphere Continentale et Cotiere) MicrobiEn; PNEC project MicroGigas	Funding was received from the Institut Francais de Recherche et d'Exploitation de la Mer (Ifremer) and the Centre National de la Recherche Scientifique (CNRS) grant from EC2CO (Ecosphere Continentale et Cotiere) MicrobiEn and PNEC project MicroGigas (0405/1B1INEE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Chen B, 2009, EUR J CANCER, V45, P2598, DOI 10.1016/j.ejca.2009.06.023; Combie H., 2008, SUMMER MORTALITY PAC; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; David E, 2007, AQUAT TOXICOL, V84, P389, DOI 10.1016/j.aquatox.2007.06.017; David E, 2012, BIOMARKERS, V17, P85, DOI 10.3109/1354750X.2011.639464; de Lorgeril J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023142; Degenhardt JD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000346; Degremont L, 2005, AQUACULTURE, V249, P213, DOI 10.1016/j.aquaculture.2005.03.046; Degremont L, 2007, AQUACULTURE, V262, P41, DOI 10.1016/j.aquaculture.2006.10.025; Degremont L, 2011, AQUACULTURE, V317, P94, DOI 10.1016/j.aquaculture.2011.04.029; Degremont L, 2010, J SHELLFISH RES, V29, P847, DOI 10.2983/035.029.0419; Degremont L, 2010, AQUACULTURE, V299, P21, DOI 10.1016/j.aquaculture.2009.11.017; Derache C, 2009, DEV COMP IMMUNOL, V33, P959, DOI 10.1016/j.dci.2009.03.005; Duperthuy M, 2011, P NATL ACAD SCI USA, V108, P2993, DOI 10.1073/pnas.1015326108; Fagutao FE, 2012, FISH SHELLFISH IMMUN, V32, P711, DOI 10.1016/j.fsi.2012.01.018; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Fleury E, 2012, MAR BIOTECHNOL, V14, P203, DOI 10.1007/s10126-011-9403-6; Fleury E, 2010, MAR BIOTECHNOL, V12, P326, DOI 10.1007/s10126-009-9227-9; Garnier M, 2008, SYST APPL MICROBIOL, V31, P358, DOI 10.1016/j.syapm.2008.06.003; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gonzalez M, 2007, DEV COMP IMMUNOL, V31, P332, DOI 10.1016/j.dci.2006.07.006; Gonzalez M, 2007, P NATL ACAD SCI USA, V104, P17759, DOI 10.1073/pnas.0702281104; Gueguen Y, 2006, J BIOL CHEM, V281, P313, DOI 10.1074/jbc.M510850200; Gueguen Y, 2009, MOL IMMUNOL, V46, P516, DOI 10.1016/j.molimm.2008.07.021; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hedgecock D, 2005, J SHELLFISH RES, V24, P429, DOI 10.2983/0730-8000(2005)24[429:TCFSTP]2.0.CO;2; Hou YL, 2012, FUNCT INTEGR GENOMIC, V12, P81, DOI 10.1007/s10142-011-0252-1; Huvet A, 2004, GENE, V343, P211, DOI 10.1016/j.gene.2004.09.008; Kamerbeek NM, 2007, BLOOD, V109, P3560, DOI 10.1182/blood-2006-08-042531; Kikuchi S, 2005, J NEUROIMMUNOL, V167, P170, DOI 10.1016/j.jneuroim.2005.06.021; Le Roux F, 2002, AQUAT LIVING RESOUR, V15, P251, DOI 10.1016/S0990-7440(02)01176-2; Li YH, 2010, J INVEST DERMATOL, V130, P2768, DOI 10.1038/jid.2010.214; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; Lin ZY, 2012, DEV COMP IMMUNOL, V37, P164, DOI 10.1016/j.dci.2011.09.003; Loof TG, 2011, BLOOD, V118, P2589, DOI 10.1182/blood-2011-02-337568; Lopez-Gomez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021766; Maningas MBB, 2008, MOL IMMUNOL, V45, P1269, DOI 10.1016/j.molimm.2007.09.016; Otvos L, 2002, CELL MOL LIFE SCI, V59, P1138, DOI 10.1007/s00018-002-8493-8; Pazgier M, 2007, J BIOL CHEM, V282, P1819, DOI 10.1074/jbc.M607210200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rosa RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025594; Rosa RD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-252; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sauvage C, 2007, GENE, V406, P13, DOI 10.1016/j.gene.2007.05.011; Sauvage C, 2009, MOL ECOL RESOUR, V9, P853, DOI 10.1111/j.1755-0998.2009.02525.x; Schmitt P, 2012, DEV COMP IMMUNOL, V37, P363, DOI 10.1016/j.dci.2012.01.004; Schmitt P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-23; Scocchi M, 2011, CELL MOL LIFE SCI, V68, P2317, DOI 10.1007/s00018-011-0721-7; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Tanne A, 2009, J EXP MED, V206, P2205, DOI 10.1084/jem.20090188; Taris N, 2009, ANIM GENET, V40, P663, DOI 10.1111/j.1365-2052.2009.01894.x; Taris N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-234; Tennessen JA, 2009, DEV COMP IMMUNOL, V33, P1247, DOI 10.1016/j.dci.2009.07.004; Vasta GR, 2012, ADV EXP MED BIOL, V946, P21, DOI 10.1007/978-1-4614-0106-3_2; Yang H, 2012, AUTOIMMUNITY, V45, P226, DOI 10.3109/08916934.2011.633134; Yildiz Y, 2010, ARCH MED SCI, V6, P932, DOI 10.5114/aoms.2010.19304; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zervou MI, 2011, HUM IMMUNOL, V72, P1210, DOI 10.1016/j.humimm.2011.09.003; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang Y, 2011, FISH SHELLFISH IMMUN, V30, P1354, DOI 10.1016/j.fsi.2011.03.008	61	28	30	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75900	10.1371/journal.pone.0075900	http://dx.doi.org/10.1371/journal.pone.0075900			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086661	Green Published, gold			2022-12-27	WOS:000325220000051
J	Turner, HC; Baussano, I; Garnett, GP				Turner, Hugo C.; Baussano, Iacopo; Garnett, Geoff P.			Vaccinating Women Previously Exposed to Human Papillomavirus: A Cost-Effectiveness Analysis of the Bivalent Vaccine	PLOS ONE			English	Article							HPV-16/18 AS04-ADJUVANTED VACCINE; TRANSMISSION DYNAMIC-MODEL; BLIND PATRICIA TRIAL; OF-STUDY ANALYSIS; CERVICAL-CANCER; UNITED-KINGDOM; ECONOMIC-EVALUATION; HPV VACCINATION; ADULT WOMEN; INFECTION	Recent trials have indicated that women with prior exposure to Human papillomavirus (HPV) subtypes 16/18 receive protection against reinfection from the HPV vaccines. However, many of the original models investigating the cost effectiveness of different vaccination strategies for the protection of cervical cancer assumed, based on the trial results at that time, that these women received no protection. We developed a deterministic, dynamic transmission model that incorporates the vaccine-induced protection of women with prior exposure to HPV. The model was used to estimate the cost effectiveness of progressively extending a vaccination programme using the bivalent vaccine to older age groups both with and without protection of women with prior exposure. We did this under a range of assumptions on the level of natural immunity. Our modelling projections indicate that including the protection of women with prior HPV exposure can have a profound effect on the cost effectiveness of vaccinating adults. The impact of this protection is inversely related to the level of natural immunity. Our results indicate that adult vaccination strategies should potentially be reassessed, and that it is important to include the protection of non-naive women previously infected with HPV in future studies. Furthermore, they also highlight the need for a more thorough investigation of this protection.	[Turner, Hugo C.; Garnett, Geoff P.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Baussano, Iacopo] Int Agcy Res Canc, F-69372 Lyon, France	Imperial College London; World Health Organization; International Agency for Research on Cancer (IARC)	Turner, HC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	hugo.turner06@imperial.ac.uk	Garnett, Geoffrey P/A-9312-2008	Turner, Hugo/0000-0002-8428-3874	European Community [242061]; Bill & Melinda Gates Foundation [OPP1053353]; Wellcome Trust [090285/Z/09/Z]	European Community(European Commission); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Wellcome Trust(Wellcome TrustEuropean Commission)	Dr. Iacopo Baussano is supported by the following grant sponsors: European Community's Seventh Framework Programme (FP7/2007-2013; acronym PREHDICT), grant number: 242061; and the Bill & Melinda Gates Foundation, grant number: OPP1053353. Geoff P. Garnett acknowledges support from the Wellcome Trust, grant number: 090285/Z/09/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, HDB CANC PREV IARC; [Anonymous], 2010, CERV SCREEN PROGR EN; Bogaards JA, 2011, VACCINE, V29, P8929, DOI 10.1016/j.vaccine.2011.09.055; British Medical Association the Royal Pharmaceutical Society of Great Britain, 2010, 59 BMA ROYAL PHARM S, V59; Brown RE, 2006, CURR MED RES OPIN, V22, P663, DOI 10.1185/030079906X99972; Castellsague X, 2011, BRIT J CANCER, V105, P28, DOI 10.1038/bjc.2011.185; Choi YH, 2010, VACCINE, V28, P4091, DOI 10.1016/j.vaccine.2009.09.125; Curtis L, 2005, NIT COSTS HLTH SOCIA; Curtis L, 2007, NIT COSTS HLTH SOCIA; Department of Health, 2011, NNUAL HPV VACC COV E; Elbasha EH, 2009, VALUE HEALTH, V12, P697, DOI 10.1111/j.1524-4733.2009.00512.x; Goldie SJ, 2004, JNCI-J NATL CANCER I, V96, P604, DOI 10.1093/jnci/djh104; Health Protection Agency, 2012, HUM PAP HPV CERV CAN; Hildesheim A, 2007, JAMA-J AM MED ASSOC, V298, P743, DOI 10.1001/jama.298.7.743; Insinga RP, 2007, VACCINE, V26, P128, DOI 10.1016/j.vaccine.2007.10.056; JCVI, 2008, STAT HPV VACC; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Jit M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5775; Kim JJ, 2008, NEW ENGL J MED, V359, P821, DOI 10.1056/NEJMsa0707052; Kim JJ, 2009, ANN INTERN MED, V151, P538, DOI 10.7326/0003-4819-151-8-200910200-00007; Kitchener HC, 2006, BRIT J CANCER, V95, P56, DOI 10.1038/sj.bjc.6603210; Kreimer AR, 2011, JNCI-J NATL CANCER I, V103, P1444, DOI 10.1093/jnci/djr319; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Levy-Bruhl D, 2009, EUR J CANCER, V45, P2709, DOI 10.1016/j.ejca.2009.07.023; Markowitz Lauri E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Myers E, 2004, P 21 INT PAP C MEX M; National Institute for Health and Clinical Excellence, 2013, MEAS EFF COST EFF QA; National Institute for Health Clinical Excellence, 2004, N0515 NAT I HLTH CLI; NHS, 2013, HPV VACC GIV; Office for National Statistics, 2008, POP EST UK ENGL WAL; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Rondy M, 2010, VACCINE, V28, P2070, DOI 10.1016/j.vaccine.2009.12.042; Salisbury DM, 2012, LANCET INFECT DIS, V12, P582, DOI 10.1016/S1473-3099(12)70082-8; Szarewski A, 2012, INT J CANCER, V131, P106, DOI 10.1002/ijc.26362; Usher C, 2008, VACCINE, V26, P5654, DOI 10.1016/j.vaccine.2008.07.098; Wallace LA, 2005, VACCINE, V23, P5624, DOI 10.1016/j.vaccine.2005.06.034; Westra TA, 2011, J INFECT DIS, V204, P377, DOI 10.1093/infdis/jir281; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X; Wolstenholme JL, 1998, EUR J CANCER, V34, P1889, DOI 10.1016/S0959-8049(98)00232-9; World Health Organization, 2010, UK HUM PAP REL CANC	42	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75552	10.1371/journal.pone.0075552	http://dx.doi.org/10.1371/journal.pone.0075552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086567	Green Published, Green Submitted, gold			2022-12-27	WOS:000325220000027
J	van der Spek, N; Vos, J; van Uden-Kraan, CF; Breitbart, W; Tollenaar, RAEM; Cuijpers, P; Verdonck-de Leeuw, IM				van der Spek, Nadia; Vos, Joel; van Uden-Kraan, Cornelia F.; Breitbart, William; Tollenaar, Rob A. E. M.; Cuijpers, Pim; Verdonck-de Leeuw, Irma M.			Meaning Making in Cancer Survivors: A Focus Group Study	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; RANDOMIZED CONTROLLED-TRIAL; EXPRESSIVE GROUP-THERAPY; QUALITY-OF-LIFE; INTERVENTION; DISTRESS; GROWTH; WOMEN; EXPERIENCE; SENSE	Background: Confrontation with a life-threatening disease like cancer can evoke existential distress, which can trigger a search for meaning in people after having survived this disease. Methods: In an effort to gain more insight in the meaning making process, we conducted four focus groups with 23 cancer survivors on this topic. Participants responded to questions about experienced meaning making, perceived changes in meaning making after cancer and the perceived need for help in this area. Results: Most frequently mentioned meaning making themes were relationships and experiences. We found that, in general, cancer survivors experienced enhanced meaning after cancer through relationships, experiences, resilience, goal-orientation and leaving a legacy. Some participants, however, also said to have (also) experienced a loss of meaning in their lives through experiences, social roles, relationships and uncertainties about the future. Conclusions: The results indicated that there is a group of cancer survivors that has succeeded in meaning making efforts, and experienced sometimes even more meaning in life than before diagnosis, while there is also a considerable group of survivors that struggled with meaning making and has an unmet need for help with that. The results of this study contribute to develop a meaning centered intervention for cancer survivors.	[van der Spek, Nadia; van Uden-Kraan, Cornelia F.; Cuijpers, Pim; Verdonck-de Leeuw, Irma M.] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Vos, Joel] Leiden Univ, Dept Clin Genet, Med Ctr, Leiden, Netherlands; [Breitbart, William] Mem Sloan Kettering Canc Ctr, Dept Psychiat & Behav Sci, New York, NY 10021 USA; [Tollenaar, Rob A. E. M.] Leiden Univ, Dept Surg, Med Ctr, Leiden, Netherlands; [Verdonck-de Leeuw, Irma M.] Vrije Univ Amsterdam, Med Ctr, Dept Otolaryngol Head & Neck Surg, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Memorial Sloan Kettering Cancer Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	van der Spek, N (corresponding author), Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.	n.vander.spek@vu.nl	Vos, Joel/T-4567-2019; Cuijpers, Pim/G-1703-2013; van Uden-Kraan, Cornelia/AAH-4093-2021	Verdonck-de Leeuw, Irma/0000-0002-4507-4607; Cuijpers, Pim/0000-0001-5497-2743; Vos, Joel/0000-0002-7961-2354	Dutch Cancer Society/Alpe d'HuZes/KWF Fund [4864]	Dutch Cancer Society/Alpe d'HuZes/KWF Fund	The study is funded by the Dutch Cancer Society/Alpe d'HuZes/KWF Fund, grant-number 4864. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bordeleau L, 2003, J CLIN ONCOL, V21, P1944, DOI 10.1200/JCO.2003.04.080; Breitbart W, 2010, PSYCHO-ONCOLOGY, V19, P21, DOI 10.1002/pon.1556; Brenner H, 2002, LANCET, V360, P1131, DOI 10.1016/S0140-6736(02)11199-8; Carlson LE, 2010, J CLIN ONCOL, V28, P4884, DOI 10.1200/JCO.2009.27.3698; Chochinov HM, 2005, J CLIN ONCOL, V23, P5520, DOI 10.1200/JCO.2005.08.391; Classen C, 2001, ARCH GEN PSYCHIAT, V58, P494, DOI 10.1001/archpsyc.58.5.494; Coward Doris Dickerson, 2003, Oncol Nurs Forum, V30, P291, DOI 10.1188/03.ONF.291-300; Davis CG, 2000, DEATH STUD, V24, P497; Davis CG, 1998, J PERS SOC PSYCHOL, V75, P561, DOI 10.1037/0022-3514.75.2.561; Debats DL, 1996, BRIT J CLIN PSYCHOL, V35, P503, DOI 10.1111/j.2044-8260.1996.tb01207.x; Dutch Comprehensive Cancer Centres, 2011, KANK NED; Ferrell B, 2003, CANCER, V98, P1061, DOI 10.1002/cncr.11291; Frankl V., 1989, WILL MEANING FDN APP; Frankl V, 1986, PSYCHOTHERAPY LOGOTH; Frankl V.E., 1998, MANS SEARCH MEANING; Giese-Davis J, 2002, J CONSULT CLIN PSYCH, V70, P916, DOI 10.1037//0022-006X.70.4.916; Henoch I, 2009, PSYCHO-ONCOLOGY, V18, P225, DOI 10.1002/pon.1424; Hodgkinson K, 2007, SUPPORT CARE CANCER, V15, P515, DOI 10.1007/s00520-006-0170-2; Hoffman KE, 2009, ARCH INTERN MED, V169, P1274, DOI 10.1001/archinternmed.2009.179; Howlader N, 2012, SEER CANC STAT REV 1; Jaarsma TA, 2007, PSYCHO-ONCOL, V16, P241, DOI 10.1002/pon.1056; Kissane DW, 2003, PSYCHO-ONCOLOGY, V12, P532, DOI 10.1002/pon.683; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Lee Chun Hee, 2006, Taehan Kanho Hakhoe Chi, V36, P701; Lee V, 2006, SOC SCI MED, V62, P3133, DOI 10.1016/j.socscimed.2005.11.041; Lee V, 2008, SUPPORT CARE CANCER, V16, P779, DOI 10.1007/s00520-007-0396-7; Lee Virginia, 2004, Palliat Support Care, V2, P291; Litosseliti L., 2007, USING FOCUS GROUPS R; Park CL, 2008, J CONSULT CLIN PSYCH, V76, P863, DOI 10.1037/a0013348; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Rabiee F, 2004, P NUTR SOC, V63, P655, DOI 10.1079/PNS2004399; Richards MA, 2000, BRIT MED J, V320, P895, DOI 10.1136/bmj.320.7239.895; Ryff CD, 1998, PSYCHOL INQ, V9, P1, DOI 10.1207/s15327965pli0901_1; SILVER RL, 1983, J SOC ISSUES, V39, P81, DOI 10.1111/j.1540-4560.1983.tb00142.x; Spiegel D., 1991, SUPPORTIVE EXPRESSIV; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Thewes B, 2004, J PSYCHOSOC ONCOL, V22, P51, DOI 10.1300/J077v22n01_04; Thompson S. C, 1994, J PSYCHOSOC ONCOL, V11, P1, DOI [DOI 10.1300/J077V11N03_01, 10.1300/j077v11n03_01]; Thornton AA, 2002, J CLIN PSYCHOL MED S, V9, P153, DOI 10.1023/A:1014996127535; Tomich PL, 2005, PSYCHO-ONCOL, V14, P1018, DOI 10.1002/pon.914; Tomich PL, 2002, PSYCHO-ONCOLOGY, V11, P154, DOI 10.1002/pon.570; Yalom I.D., 1980, EXISTENTIAL PSYCHOTH, V1; ZIKA S, 1992, BRIT J PSYCHOL, V83, P133, DOI 10.1111/j.2044-8295.1992.tb02429.x	43	38	38	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76089	10.1371/journal.pone.0076089	http://dx.doi.org/10.1371/journal.pone.0076089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VP	24086695	Green Published, gold, Green Submitted			2022-12-27	WOS:000325220000058
J	Wu, GH; Day, MJ; Mafura, MT; Nunez-Garcia, J; Fenner, JJ; Sharma, M; van Essen-Zandbergen, A; Rodriguez, I; Dierikx, C; Kadlec, K; Schink, AK; Wain, J; Helmuth, R; Guerra, B; Schwarz, S; Threlfall, J; Woodward, MJ; Woodford, N; Coldham, N; Mevius, D				Wu, Guanghui; Day, Michaela J.; Mafura, Muriel T.; Nunez-Garcia, Javier; Fenner, Jackie J.; Sharma, Meenaxi; van Essen-Zandbergen, Alieda; Rodriguez, Irene; Dierikx, Cindy; Kadlec, Kristina; Schink, Anne-Kathrin; Wain, John; Helmuth, Reiner; Guerra, Beatriz; Schwarz, Stefan; Threlfall, John; Woodward, Martin J.; Woodford, Neil; Coldham, Nick; Mevius, Dik			Comparative Analysis of ESBL-Positive Escherichia coli Isolates from Animals and Humans from the UK, The Netherlands and Germany	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; EXTENDED-SPECTRUM; CTX-M; COMPANION ANIMALS; POULTRY PRODUCTS; PUBLIC-HEALTH; RESISTANCE; STRAINS; GENES; SALMONELLA	The putative virulence and antimicrobial resistance gene contents of extended spectrum beta-lactamase (ESBL)positive E. coli (n=629) isolated between 2005 and 2009 from humans, animals and animal food products in Germany, The Netherlands and the UK were compared using a microarray approach to test the suitability of this approach with regard to determining their similarities. A selection of isolates (n=313) were also analysed by multilocus sequence typing (MLST). Isolates harbouring bla(CTX-M-group-1) dominated (66%, n=418) and originated from both animals and cases of human infections in all three countries; 23% (n=144) of all isolates contained both bla(CTX-M-group-1) and bla(OXA-1-like) genes, predominantly from humans (n=127) and UK cattle (n=15). The antimicrobial resistance and virulence gene profiles of this collection of isolates were highly diverse. A substantial number of human isolates (32%, n=87) did not share more than 40% similarity (based on the Jaccard coefficient) with animal isolates. A further 43% of human isolates from the three countries (n=117) were at least 40% similar to each other and to five isolates from UK cattle and one each from Dutch chicken meat and a German dog; the members of this group usually harboured genes such as mph(A), mrx, aac(6')-Ib, catB3, bla(OXA-1-like) and bla(CTX-M-group-1). forty-four per cent of the MLST-typed isolates in this group belonged to ST131 (n=18) and 22% to ST405 (n=9), all from humans. Among animal isolates subjected to MLST (n=258), only 1.2% (n=3) were more than 70% similar to human isolates in gene profiles and shared the same MLST clonal complex with the corresponding human isolates. The results suggest that minimising human-to-human transmission is essential to control the spread of ESBL-positive E. coli in humans.	[Wu, Guanghui; Mafura, Muriel T.; Nunez-Garcia, Javier; Fenner, Jackie J.; Sharma, Meenaxi; Woodward, Martin J.; Coldham, Nick] AHVLA, Addlestone, Surrey, England; [Day, Michaela J.; Wain, John; Threlfall, John; Woodford, Neil] Publ Hlth England, London, England; [van Essen-Zandbergen, Alieda; Dierikx, Cindy; Mevius, Dik] Cent Vet Inst CVI Wageningen, Dept Bacteriol & TSEs, Lelystad, Netherlands; [Rodriguez, Irene; Helmuth, Reiner; Guerra, Beatriz] BfR Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany; [Kadlec, Kristina; Schink, Anne-Kathrin; Schwarz, Stefan] FLI, Inst Farm Anim Genet, Neustadt, Germany; [Wain, John] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	Public Health England; Wageningen University & Research; Federal Institute for Risk Assessment; Friedrich Loeffler Institute; University of East Anglia	Wu, GH (corresponding author), AHVLA, Addlestone, Surrey, England.	guanghui.wu@ahvla.gsi.gov.uk	Nunez, Javier/B-1981-2016; Wain, John/B-3446-2013; Rodríguez, Irene/F-7611-2015; Wu, Guanghui/A-3757-2016; Coldham, Nick/F-6151-2010; Staves, Peter/C-8219-2014	Wain, John/0000-0002-1257-1148; Rodríguez, Irene/0000-0001-8016-4459; Wu, Guanghui/0000-0002-9374-3190; 	United Kingdom Food Standards Agency [B14016]; EU-SAFEFOODERA project [08176]	United Kingdom Food Standards Agency; EU-SAFEFOODERA project	This project is supported by United Kingdom Food Standards Agency (http://www.food.gov.uk/, project B14016) as a part of the EU-SAFEFOODERA project 08176, entitled: The role of commensal microflora of animals in the transmission of extended spectrum beta-lactamases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2322; Anjum MF, 2007, APPL ENVIRON MICROB, V73, P5692, DOI 10.1128/AEM.00419-07; Batchelor M, 2008, INT J ANTIMICROB AG, V31, P440, DOI 10.1016/j.ijantimicag.2007.11.017; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Cloeckaert A, 2000, ANTIMICROB AGENTS CH, V44, P2858, DOI 10.1128/AAC.44.10.2858-2860.2000; Coque T M, 2008, Euro Surveill, V13; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Dhanji H, 2011, J ANTIMICROB CHEMOTH, V66, P512, DOI 10.1093/jac/dkq472; Dhanji H, 2011, J ANTIMICROB CHEMOTH, V66, P297, DOI 10.1093/jac/dkq463; Dho-Moulin M, 1999, VET RES, V30, P299; Dierikx CM, 2012, J ANTIMICROB CHEMOTH, V67, P1368, DOI 10.1093/jac/dks049; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Geue L, 2010, APPL ENVIRON MICROB, V76, P5510, DOI 10.1128/AEM.00743-10; Hasman H, 2005, J ANTIMICROB CHEMOTH, V56, P115, DOI 10.1093/jac/dki190; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Hunter PA, 2010, J ANTIMICROB CHEMOTH, V65, pI3, DOI 10.1093/jac/dkp433; Johnson JR, 2007, EMERG INFECT DIS, V13, P838, DOI 10.3201/eid1306.061576; Lau SH, 2008, J ANTIMICROB CHEMOTH, V62, P1241, DOI 10.1093/jac/dkn380; Laupland KB, 2008, J INFECTION, V57, P441, DOI 10.1016/j.jinf.2008.09.034; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Liebana E, 2006, J CLIN MICROBIOL, V44, P1630, DOI 10.1128/JCM.44.5.1630-1634.2006; Liebana E, 2004, MICROB DRUG RESIST, V10, P1, DOI 10.1089/107662904323047745; Livermore DM, 2005, J ANTIMICROB CHEMOTH, V56, P451, DOI 10.1093/jac/dki239; Meglic KM, 2009, ANTIMICROB AGENTS CH, V53, P287, DOI 10.1128/AAC.00746-08; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Pitout JDD, 2005, J CLIN MICROBIOL, V43, P2844, DOI 10.1128/JCM.43.6.2844-2849.2005; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Pitout JDD, 2009, ANTIMICROB AGENTS CH, V53, P2539, DOI 10.1128/AAC.00061-09; Randall LP, 2011, J ANTIMICROB CHEMOTH, V66, P86, DOI 10.1093/jac/dkq396; Roest HIJ, 2007, TIJDSCHR DIERGENEESK, V132, P954; Russo TA, 2003, MICROBES INFECT, V5, P449, DOI 10.1016/S1286-4579(03)00049-2; Schink AK, 2011, APPL ENVIRON MICROB, V77, P7142, DOI 10.1128/AEM.00559-11; Schwaber MJ, 2007, J ANTIMICROB CHEMOTH, V60, P913, DOI 10.1093/jac/dkm318; Snow LC, 2012, PREV VET MED, V106, P225, DOI 10.1016/j.prevetmed.2012.03.009; Stokes MO, 2012, J ANTIMICROB CHEMOTH, V67, P1639, DOI 10.1093/jac/dks126; Tangden T, 2010, ANTIMICROB AGENTS CH, V54, P3564, DOI 10.1128/AAC.00220-10; Vincent C, 2010, EMERG INFECT DIS, V16, P88, DOI 10.3201/eid1601.091118; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wu G, 2010, VET REC, V166, P691, DOI 10.1136/vr.b4791; Wu GH, 2008, INFECT IMMUN, V76, P845, DOI 10.1128/IAI.00956-07; Wu GH, 2012, VET MICROBIOL, V160, P197, DOI 10.1016/j.vetmic.2012.05.029; Wu GH, 2010, ENV MICROBIOL REP, V2, P228, DOI 10.1111/j.1758-2229.2009.00095.x	43	109	110	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75392	10.1371/journal.pone.0075392	http://dx.doi.org/10.1371/journal.pone.0075392			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086522	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000325220000019
J	Anderson, NM; Javadi, M; Berndl, E; Berberovic, Z; Bailey, ML; Huang, K; Flenniken, AM; Osborne, LR; Adamson, SL; Rossant, J; Carter-Su, C; Wang, C; McNagny, KM; Paulson, RF; Minden, MD; Stanford, WL; Barber, DL				Anderson, Nicole M.; Javadi, Mojib; Berndl, Elizabeth; Berberovic, Zorana; Bailey, Monica L.; Huang, Kai; Flenniken, Ann M.; Osborne, Lucy R.; Adamson, S. Lee; Rossant, Janet; Carter-Su, Christin; Wang, Chen; McNagny, Kelly M.; Paulson, Robert F.; Minden, Mark D.; Stanford, William L.; Barber, Dwayne L.			Enu Mutagenesis Identifies a Novel Platelet Phenotype in a Loss-Of-Function Jak2 Allele	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; TYROSINE-PHOSPHORYLATION; PSEUDOKINASE DOMAIN; ACTIVATING MUTATION; MYELOID-LEUKEMIA; PCM1-JAK2 FUSION; PROTEIN-KINASE; GENE; RECEPTOR; CRLF2	Utilizing ENU mutagenesis, we identified a mutant mouse with elevated platelets. Genetic mapping localized the mutation to an interval on chromosome 19 that encodes the Jak2 tyrosine kinase. We identified a A3056T mutation resulting in a premature stop codon within exon 19 of Jak2 (Jak2(K915X)), resulting in a protein truncation and functionally inactive enzyme. This novel platelet phenotype was also observed in mice bearing a hemizygous targeted disruption of the Jak2 locus (Jak2(+/-)). Timed pregnancy experiments revealed that Jak2(K915X/K915X) and Jak2(-/-) displayed embryonic lethality; however, Jak2(K915X/K915X) embryos were viable an additional two days compared to Jak2(-/-) embryos. Our data suggest that perturbing JAK2 activation may have unexpected consequences in elevation of platelet number and correspondingly, important implications for treatment of hematological disorders with constitutive Jak2 activity.	[Anderson, Nicole M.; Stanford, William L.] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada; [Javadi, Mojib; Minden, Mark D.; Barber, Dwayne L.] Univ Toronto, Fac Med, Dept Med Biophys, Toronto, ON, Canada; [Berndl, Elizabeth; Stanford, William L.] Univ Toronto, Fac Med, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Adamson, S. Lee] Univ Toronto, Fac Med, Dept Obstet & Gynecol, Toronto, ON, Canada; [Osborne, Lucy R.] Univ Toronto, Dept Med, Fac Med, Toronto, ON, Canada; [Osborne, Lucy R.; Rossant, Janet] Univ Toronto, Fac Med, Dept Mol Genet, Toronto, ON, Canada; [Adamson, S. Lee] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Wang, Chen] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Berberovic, Zorana; Flenniken, Ann M.] Toronto Ctr Phenogen, Toronto, ON, Canada; [Rossant, Janet] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Carter-Su, Christin] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [McNagny, Kelly M.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Bailey, Monica L.; Huang, Kai; Paulson, Robert F.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Minden, Mark D.; Barber, Dwayne L.] Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Stanford, William L.] Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Ottawa, ON, Canada; [Stanford, William L.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Michigan System; University of Michigan; University of British Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Barber, DL (corresponding author), Univ Toronto, Fac Med, Dept Med Biophys, Toronto, ON, Canada.	dbarber@uhnres.utoronto.ca	Wang, Chen/J-2346-2016; McNagny, Kelly/P-5239-2014; Adamson, S. Lee/E-4581-2013	McNagny, Kelly/0000-0003-4737-3499; Adamson, S. Lee/0000-0002-7340-3041; Rossant, Janet/0000-0002-3731-5466; Barber, Dwayne/0000-0001-5528-8150; Stanford, William/0000-0002-5813-8016	Dina Gordon Malkin Ontario Graduate Scholarship in Science and Technology; Heart and Stroke/Richard Lewar Centre of Ecellence Scholarship; NSERC Canada; Canadian Institutes of Health Research [FRN 74611]; Heart and Stroke Foundation of Ontario [NA-6363]; Canada Research Chair; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034171] Funding Source: NIH RePORTER	Dina Gordon Malkin Ontario Graduate Scholarship in Science and Technology; Heart and Stroke/Richard Lewar Centre of Ecellence Scholarship; NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NA was supported by the Dina Gordon Malkin Ontario Graduate Scholarship in Science and Technology and a Heart and Stroke/Richard Lewar Centre of Ecellence Scholarship. EB was supported by a NSERC Canada Graduate Scholarship award. This sutdy was funded by a group operatiing grant form the Canadian Institutes of Health Research (FRN 74611) to DLB, RP, CW, MDM, KMM and WLS and a grant from the Heart and Stroke Foundation of Ontario (NA-6363) to WLS. WLS is supported by a Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NM, 2012, EXP HEMATOL, V40, P48, DOI 10.1016/j.exphem.2011.09.007; Argetsinger LS, 2004, MOL CELL BIOL, V24, P4955, DOI 10.1128/MCB.24.11.4955-4967.2004; BACON CM, 1995, FEBS LETT, V370, P63, DOI 10.1016/0014-5793(95)00796-C; Ballmaier M, 2001, BLOOD, V97, P139, DOI 10.1182/blood.V97.1.139; Bandaranayake RM, 2012, NAT STRUCT MOL BIOL, V19, P754, DOI 10.1038/nsmb.2348; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bercovich D, 2008, LANCET, V372, P1484, DOI 10.1016/S0140-6736(08)61341-0; Bousquet M, 2005, ONCOGENE, V24, P7248, DOI 10.1038/sj.onc.1208850; Deshpande A, 2012, LEUKEMIA, V26, P708, DOI 10.1038/leu.2011.255; Griesinger F, 2005, GENE CHROMOSOME CANC, V44, P329, DOI 10.1002/gcc.20235; Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556; Hertzberg L, 2010, BLOOD, V115, P1006, DOI 10.1182/blood-2009-08-235408; Ho JMY, 1999, BLOOD, V93, P4354, DOI 10.1182/blood.V93.12.4354.412k30_4354_4364; Hughes MR, 2011, EXP HEMATOL, V39, P305, DOI 10.1016/j.exphem.2010.12.009; Ihara K, 1999, P NATL ACAD SCI USA, V96, P3132, DOI 10.1073/pnas.96.6.3132; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Ishida-Takahashi R, 2006, MOL CELL BIOL, V26, P4063, DOI 10.1128/MCB.01589-05; Ito CY, 2003, BLOOD, V101, P517, DOI 10.1182/blood-2002-06-1918; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Javadi M, 2012, J BIOL CHEM, V287, P26223, DOI 10.1074/jbc.M112.382721; Kearney L, 2009, BLOOD, V113, P646, DOI 10.1182/blood-2008-08-170928; Koppikar P, 2012, NATURE, V489, P155, DOI 10.1038/nature11303; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Levine RL, 2005, BLOOD, V106, P3377, DOI 10.1182/blood-2005-05-1898; Marit MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043437; Mazurkiewicz-Munoz AM, 2006, MOL CELL BIOL, V26, P4052, DOI 10.1128/MCB.01591-05; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; Morita H, 1996, FEBS LETT, V395, P228, DOI 10.1016/0014-5793(96)01047-2; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Murati A, 2005, LEUKEMIA, V19, P1692, DOI 10.1038/sj.leu.2403879; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nebral K, 2009, LEUKEMIA, V23, P134, DOI 10.1038/leu.2008.306; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; PALLARD C, 1995, EMBO J, V14, P2847, DOI 10.1002/j.1460-2075.1995.tb07284.x; Pardanani A, 2011, J CLIN ONCOL, V29, P789, DOI 10.1200/JCO.2010.32.8021; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Peeters P, 1997, BLOOD, V90, P2535, DOI 10.1182/blood.V90.7.2535.2535_2535_2540; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Poitras JL, 2008, GENE CHROMOSOME CANC, V47, P884, DOI 10.1002/gcc.20585; Reiter A, 2005, CANCER RES, V65, P2662, DOI 10.1158/0008-5472.CAN-04-4263; Rouyez MC, 1997, MOL CELL BIOL, V17, P4991, DOI 10.1128/MCB.17.9.4991; Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; TORTOLANI PJ, 1995, BLOOD, V85, P3444, DOI 10.1182/blood.V85.12.3444.bloodjournal85123444; Tyner JW, 2010, BLOOD, V115, P5232, DOI 10.1182/blood-2009-05-223727; Ungureanu D, 2011, NAT STRUCT MOL BIOL, V18, P971, DOI 10.1038/nsmb.2099; Van Roosbroeck K, 2011, BLOOD, V117, P4056, DOI 10.1182/blood-2010-06-291310; Verstovsek S, 2012, BLOOD, V120, P1202, DOI 10.1182/blood-2012-02-414631; Verstovsek S, 2012, NEW ENGL J MED, V366, P799, DOI 10.1056/NEJMoa1110557; Weigert O, 2012, J EXP MED, V209, P259, DOI 10.1084/jem.20111694; Wiestner A, 1998, NAT GENET, V18, P49, DOI 10.1038/ng0198-49; Yoda A, 2010, P NATL ACAD SCI USA, V107, P252, DOI 10.1073/pnas.0911726107	54	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75472	10.1371/journal.pone.0075472	http://dx.doi.org/10.1371/journal.pone.0075472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086539	gold, Green Submitted, Green Published			2022-12-27	WOS:000325218700089
J	Dunlop, RA; Cox, PA; Banack, SA; Rodgers, KJ				Dunlop, Rachael Anne; Cox, Paul Alan; Banack, Sandra Anne; Rodgers, Kenneth John			The Non-Protein Amino Acid BMAA Is Misincorporated into Human Proteins in Place of L-Serine Causing Protein Misfolding and Aggregation	PLOS ONE			English	Article							METHYLAMINO-L-ALANINE; AMYOTROPHIC-LATERAL-SCLEROSIS; CYANOBACTERIAL NEUROTOXINS; NEURODEGENERATIVE DISEASE; POSSIBLE LINK; EXPOSURE; ALS; BIOMAGNIFICATION; SYNTHETASE; TOXICITY	Mechanisms of protein misfolding are of increasing interest in the aetiology of neurodegenerative diseases characterized by protein aggregation and tangles including Amyotrophic Lateral Sclerosis (ALS), Alzheimer's disease (AD), Parkinson's disease (PD), Lewy Body Dementia (LBD), and Progressive Supranuclear Palsy (PSP). Some forms of neurodegenerative illness are associated with mutations in genes which control assembly of disease related proteins. For example, the mouse sticky mutation sti, which results in undetected mischarging of tRNA Ala with serine resulting in the substitution of serine for alanine in proteins causes cerebellar Purkinje cell loss and ataxia in laboratory animals. Replacement of serine 422 with glutamic acid in tau increases the propensity of tau aggregation associated with neurodegeneration. However, the possibility that environmental factors can trigger abnormal folding in proteins remains relatively unexplored. We here report that a non-protein amino acid, b-N-methylamino-L-alanine (BMAA), can be misincorporated in place of L-serine into human proteins. We also report that this misincorporation can be inhibited by L-serine. Misincorporation of BMAA into human neuroproteins may shed light on putative associations between human exposure to BMAA produced by cyanobacteria and an increased incidence of ALS.	[Dunlop, Rachael Anne; Rodgers, Kenneth John] Univ Technol Sydney, Cell Biol Grp, Sch Med & Mol Biosci, Ultimo, NSW, Australia; [Cox, Paul Alan; Banack, Sandra Anne] Inst Ethnomed, Jackson Hole, WY USA	University of Technology Sydney	Rodgers, KJ (corresponding author), Univ Technol Sydney, Cell Biol Grp, Sch Med & Mol Biosci, Ultimo, NSW, Australia.	kenneth.rodgers@uts.edu.au	Rodgers, Kenneth J./AGM-3353-2022; Rodgers, Kenneth/R-9196-2019	Rodgers, Kenneth J./0000-0002-3627-9651; Cox, Paul/0000-0001-6401-2981; Dunlop, Rachael/0000-0002-7816-3251	Deerbrook Charitable Trust (Institute for Ethnomedicine, Wyoming); University of Technology, New South Wales	Deerbrook Charitable Trust (Institute for Ethnomedicine, Wyoming); University of Technology, New South Wales	This work was funded by D. M. Kinney and the Deerbrook Charitable Trust (Institute for Ethnomedicine, Wyoming) and University of Technology, New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDE CC, 1964, J BIOL CHEM, V239, P1102; Banack SA, 2011, TOXICON, V57, P730, DOI 10.1016/j.toxicon.2011.02.005; Banack SA, 2007, MAR DRUGS, V5, P180, DOI 10.3390/md20070014; Bell EA, 2009, AMYOTROPH LATERAL SC, V10, P21, DOI 10.3109/17482960903268700; Bell EA, 2003, J AGR FOOD CHEM, V51, P2854, DOI 10.1021/jf020880w; Bradley WG, 2013, AMYOTROPH LAT SCL FR, V14, P325, DOI 10.3109/21678421.2012.750364; Caller TA, 2009, AMYOTROPH LATERAL SC, V10, P101, DOI 10.3109/17482960903278485; Chan SW, 2012, EXP NEUROL, V238, P29, DOI 10.1016/j.expneurol.2011.09.029; Cheng R, 2009, AMYOTROPH LATERAL SC, V10, P41, DOI 10.3109/17482960903273528; Chiu AS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01482; Chiu AS, 2011, INT J ENV RES PUB HE, V8, P3728, DOI 10.3390/ijerph8093728; Costanzo M, 2013, BIOCHEM J, V452, P1, DOI 10.1042/BJ20121898; Cox PA, 2003, P NATL ACAD SCI USA, V100, P13380, DOI 10.1073/pnas.2235808100; Cox PA, 2005, P NATL ACAD SCI USA, V102, P5074, DOI 10.1073/pnas.0501526102; Cox PA, 2009, AMYOTROPH LATERAL SC, V10, P109, DOI 10.3109/17482960903286066; de Munck E, 2013, ENVIRON TOXICOL PHAR, V36, P243, DOI 10.1016/j.etap.2013.04.007; Dunlop RA, 2008, BIOCHEM J, V410, P131, DOI 10.1042/BJ20070161; Dunlop RA, 2011, BIOCHEM J, V435, P207, DOI 10.1042/BJ20100682; Field NC, 2013, TOXICON, V70, P179, DOI 10.1016/j.toxicon.2013.04.010; Haase C, 2004, J NEUROCHEM, V88, P1509, DOI 10.1046/j.1471-4159.2003.02287.x; Hendrickson TL, 2004, ANNU REV BIOCHEM, V73, P147, DOI 10.1146/annurev.biochem.73.012803.092429; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Karlsson O, 2013, J PROTEOME RES, V12, P1678, DOI 10.1021/pr3010265; Karlsson O, 2009, PIGM CELL MELANOMA R, V22, P120, DOI 10.1111/j.1755-148X.2008.00508.x; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lobner D, 2007, NEUROBIOL DIS, V25, P360, DOI 10.1016/j.nbd.2006.10.002; MINTER AJ, 1992, THROMB HAEMOSTASIS, V67, P718; Mondo K, 2012, MAR DRUGS, V10, P509, DOI 10.3390/md10020509; Murch SJ, 2004, P NATL ACAD SCI USA, V101, P12228, DOI 10.1073/pnas.0404926101; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Okle O, 2013, TOXICOL APPL PHARM, V270, P9, DOI 10.1016/j.taap.2013.04.003; Okle O, 2013, TOXICOL SCI, V131, P217, DOI 10.1093/toxsci/kfs291; Pablo J, 2009, ACTA NEUROL SCAND, V120, P216, DOI 10.1111/j.1600-0404.2008.01150.x; POLSKY FI, 1972, FED PROC, V31, P1473; Rodgers KJ, 2008, INT J BIOCHEM CELL B, V40, P1452, DOI 10.1016/j.biocel.2008.01.009; Rodgers KJ, 2004, FREE RADICAL BIO MED, V37, P1756, DOI 10.1016/j.freeradbiomed.2004.08.009; Rodgers KJ, 2002, FREE RADICAL BIO MED, V32, P766, DOI 10.1016/S0891-5849(02)00768-2; ROSENTHAL GA, 1977, SCIENCE, V196, P658, DOI 10.1126/science.854740; Rubenstein E, 2000, MEDICINE, V79, P80, DOI 10.1097/00005792-200003000-00002; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tang J, 2011, PHYTOTHER RES, V25, P417, DOI 10.1002/ptr.3283; Tso C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037091; Xie XB, 2013, NEUROREPORT, V24, P779, DOI 10.1097/WNR.0b013e328363fd89; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036	44	204	211	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75376	10.1371/journal.pone.0075376	http://dx.doi.org/10.1371/journal.pone.0075376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086518	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700082
J	Muszewska, A; Steczkiewicz, K; Ginalski, K				Muszewska, Anna; Steczkiewicz, Kamil; Ginalski, Krzysztof			DIRS and Ngaro Retrotransposons in Fungi	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; SEQUENCE; GENOME; FAMILIES; ACCURATE; DATABASE; ORIGINS; TOOL	Retrotransposons with a tyrosine recombinase (YR) have been discovered recently and lack thorough annotation in fungi. YR retrotransposons are divided into 3 groups: DIRS, Ngaro and VIPER (known only from kinetoplastida). We used comparative genomics to investigate the evolutionary patterns of retrotransposons in the fungal kingdom. The identification of both functional and remnant elements provides a unique view on both recent and past transposition activity. Our searches covering a wide range of fungal genomes allowed us to identify 2241 YR retrotransposons. Based on CLANS clustering of concatenated sequences of the reverse transcriptase (RT), RNase H (RH), DNA N-6-adenine-methyltransferase (MT) and YR protein domains we propose a revised classification of YR elements expanded by two new categories of Ngaro elements. A phylogenetic analysis of 477 representatives supports this observation and additionally demonstrates that DIRS and Ngaro abundance changed independently in Basidiomycota and Blastocladiomycota/Mucoromycotina/Kixellomycotina. Interestingly, a single remnant Ngaro element could be identified in an Ascomycota genome. Our analysis revealed also that 3 Pucciniomycotina taxa, known for their overall mobile element abundance and big genome size, encode an elevated number of Ngaro retrotransposons. Considering the presence of DIRS elements in all analyzed Mucoromycotina, Kickxellomycotina and Blastocladiomycota genomes one might assume a common origin of fungal DIRS retrotransposons with a loss in Dicarya. Ngaro elements described to date from Opisthokonta, seem to have invaded the common ancestor of Agaricomycotina and Pucciniomycotina after Ustilagomycotina divergence. Yet, most of analyzed genomes are devoid of YR elements and most identified retrotransposons are incomplete.	[Muszewska, Anna; Steczkiewicz, Kamil; Ginalski, Krzysztof] Univ Warsaw, CeNT, Lab Bioinformat & Syst Biol, Warsaw, Poland	University of Warsaw	Muszewska, A (corresponding author), Univ Warsaw, CeNT, Lab Bioinformat & Syst Biol, Warsaw, Poland.	musze@ibb.waw.pl	Muszewska, Anna/S-9406-2019; Steczkiewicz, Kamil/ABB-2260-2021	Muszewska, Anna/0000-0002-4578-844X; Steczkiewicz, Kamil/0000-0002-6223-1694	Ministry of Science and Higher Education [0376/IP1/2011/71]; Foundation for Polish Science [TEAM/2010-6/5]; European Social Fund [UDA-POKL.04.01.01-00-072/09-00]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Social Fund(European Social Fund (ESF))	This work was supported by Ministry of Science and Higher Education (0376/IP1/2011/71), Foundation for Polish Science (TEAM/2010-6/5) and European Social Fund (UDA-POKL.04.01.01-00-072/09-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chicas A, 2004, NUCLEIC ACIDS RES, V32, P4237, DOI 10.1093/nar/gkh764; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Duplessis S, 2011, P NATL ACAD SCI USA, V108, P9166, DOI 10.1073/pnas.1019315108; Eddy Sean R, 2009, Genome Inform, V23, P205; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Goodwin TJD, 2004, MOL BIOL EVOL, V21, P746, DOI 10.1093/molbev/msh072; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hua-Van A, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-19; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-44; Kapitonov VV, 2007, TRENDS GENET, V23, P521, DOI 10.1016/j.tig.2007.08.004; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kojima KK, 2011, REPBASE REPORTS; Kwon-Chung KJ, 2012, CLIN INFECT DIS, V54, pS8, DOI 10.1093/cid/cir864; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liu Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-272; Llorens C, 2011, NUCLEIC ACIDS RES, V39, pD70, DOI 10.1093/nar/gkq1061; Lorenzi HA, 2006, MOL BIOCHEM PARASIT, V145, P184, DOI 10.1016/j.molbiopara.2005.10.002; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Malik HS, 2005, CYTOGENET GENOME RES, V110, P392, DOI 10.1159/000084971; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Muszewska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029425; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Olson Sue A, 2002, Brief Bioinform, V3, P87, DOI 10.1093/bib/3.1.87; Pei JM, 2003, BIOINFORMATICS, V19, P427, DOI 10.1093/bioinformatics/btg008; Piednoel M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-621; Pritham EJ, 2007, GENE, V390, P3, DOI 10.1016/j.gene.2006.08.008; Rachidi N, 1999, MOL GEN GENET, V261, P841, DOI 10.1007/s004380050028; RuizPerez VL, 1996, MOL GEN GENET, V253, P324, DOI 10.1007/s004380050328; Smit AFA, 2008, REPEATMODELER OPEN 1; Wang XY, 2010, GENE DEV, V24, P2566, DOI 10.1101/gad.1970910; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Windhofer F, 2000, CURR GENET, V37, P194, DOI 10.1007/s002940050519; Zemojtel T, 2009, TRENDS GENET, V25, P63, DOI 10.1016/j.tig.2008.11.005	41	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76319	10.1371/journal.pone.0076319	http://dx.doi.org/10.1371/journal.pone.0076319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086727	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700125
J	Powers, SP; Hernandez, FJ; Condon, RH; Drymon, JM; Free, CM				Powers, Sean P.; Hernandez, Frank J.; Condon, Robert H.; Drymon, J. Marcus; Free, Christopher M.			Novel Pathways for Injury from Offshore Oil Spills: Direct, Sublethal and Indirect Effects of the Deepwater Horizon Oil Spill on Pelagic Sargassum Communities	PLOS ONE			English	Article							GULF-OF-MEXICO; PATTERNS; HABITAT; FISHES	The pelagic brown alga Sargassum forms an oasis of biodiversity and productivity in an otherwise featureless ocean surface. The vast pool of oil resulting from the Deepwater Horizon oil spill came into contact with a large portion of the Gulf of Mexico's floating Sargassum mats. Aerial surveys performed during and after the oil spill show compelling evidence of loss and subsequent recovery of Sargassum. Expanding on the trends observed in the aerial surveys, we conducted a series of mesocosm experiments to test the effect of oil and dispersants on the vertical position and weight of the Sargassum complex (Sargassum natans and S. fluitans), as well as on the dissolved oxygen concentrations surrounding the algae. Dispersant and dispersed-oil had significant effects on the vertical position of both species of Sargassum over a period of 72 hours. Similarly, dissolved oxygen concentrations were lowest in dispersant and dispersed-oil treatments, respectively. Cumulatively, our findings suggest three pathways for oil-spill related injury: (1) Sargassum accumulated oil on the surface exposing animals to high concentrations of contaminants; (2) application of dispersant sank Sargassum, thus removing the habitat and potentially transporting oil and dispersant vertically; and (3) low oxygen surrounded the habitat potentially stressing animals that reside in the alga. These pathways represent direct, sublethal, and indirect effects of oil and dispersant release that minimize the ecosystem services provided by floating Sargassum - the latter two effects are rarely considered in assessing impacts of oil spills or response procedures.	[Powers, Sean P.; Drymon, J. Marcus] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA; [Powers, Sean P.; Hernandez, Frank J.; Condon, Robert H.; Drymon, J. Marcus; Free, Christopher M.] Dauphin Isl Sea Lab, Dauphin Isl, AL USA	University of South Alabama; Dauphin Island Sea Lab	Powers, SP (corresponding author), Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA.	spowers@disl.org	Free, Christopher/N-2813-2013; Free, Christopher Michael/AAC-5103-2019	Free, Christopher/0000-0002-2557-8920; Free, Christopher Michael/0000-0002-2557-8920; Hernandez, Frank/0000-0002-0757-2525; Powers, Sean/0000-0002-4770-9944	NSF RAPID grant from the Division of Ocean Sciences; Gulf of Mexico Research Initiative Phase I; Gulf of Mexico Research Initiative Phase III	NSF RAPID grant from the Division of Ocean Sciences; Gulf of Mexico Research Initiative Phase I; Gulf of Mexico Research Initiative Phase III	The study was funded by a NSF RAPID grant from the Division of Ocean Sciences (SPP and FJH), Gulf of Mexico Research Initiative Phase I (RHC) and III (SPP and FJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbriano RM, 2011, OCEANOGRAPHY, V24, P294, DOI 10.5670/oceanog.2011.80; BORTONE S A, 1977, Northeast Gulf Science, V1, P60; CARPENTER EJ, 1974, LIMNOL OCEANOGR, V19, P429, DOI 10.4319/lo.1974.19.3.0429; Coston-Clements L., 1991, NMFSSEFSC296 NOAA; Craig BA, 2004, MAR MAMMAL SCI, V20, P386, DOI 10.1111/j.1748-7692.2004.tb01168.x; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; DOOLEY JK, 1972, CONTRIB MAR SCI, V16, P1; Driskell WB, 2001, ECOL APPL, V11, P815; Environmental Response Management Application (ERMA), ACT REP DEEPW HOR MC; FALLER AJ, 1964, J MAR RES, V22, P22; Fingas M., 2008, REV LIT RELATED OIL; Gower J., 2008, NATURE P; Gower JFR, 2011, INT J REMOTE SENS, V32, P1917, DOI 10.1080/01431161003639660; Henry C, 2005, P 2005 INT OIL SPILL, P4; Houghton JDR, 2006, ECOLOGY, V87, P1967, DOI 10.1890/0012-9658(2006)87[1967:JAALTF]2.0.CO;2; HURKA H, 1971, MAR BIOL, V11, P82, DOI 10.1007/BF00348024; JOHNSON DL, 1977, J EXP MAR BIOL ECOL, V28, P255, DOI 10.1016/0022-0981(77)90095-8; LAPOINTE BE, 1995, LIMNOL OCEANOGR, V40, P625, DOI 10.4319/lo.1995.40.3.0625; LO NCH, 1992, CAN J FISH AQUAT SCI, V49, P2515, DOI 10.1139/f92-278; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; Ortmann AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042548; PARR ALBERT EIDE, 1939, BULL BINGHAM OCEANOGR COLL PEABODY MUS NAT HIST, V6, P1; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; Peterson CH, 2012, BIOSCIENCE, V62, P461, DOI 10.1525/bio.2012.62.5.7; Powers SP, 2005, MAR ECOL PROG SER, V302, P233, DOI 10.3354/meps302233; Rooker JR, 2006, MAR ECOL PROG SER, V313, P249, DOI 10.3354/meps313249; South Atlantic Fishery Management Council, 2002, FISH MAN PLAN PEL SA, P1; Szekielda KH, 2010, J APPL REMOTE SENS, V4, DOI 10.1117/1.3431044; Wells RJD, 2004, B MAR SCI, V74, P81; Witherington B, 2012, MAR ECOL PROG SER, V463, P1, DOI 10.3354/meps09970	30	21	23	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74802	10.1371/journal.pone.0074802	http://dx.doi.org/10.1371/journal.pone.0074802			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086378	gold, Green Submitted, Green Published			2022-12-27	WOS:000325218700039
J	Yu, S; Tajiri, N; Franzese, N; Franzblau, M; Bae, E; Platt, S; Kaneko, Y; Borlongan, CV				Yu, SeongJin; Tajiri, Naoki; Franzese, Nick; Franzblau, Max; Bae, EunKyung; Platt, Simon; Kaneko, Yuji; Borlongan, Cesar V.			Stem Cell-Like Dog Placenta Cells Afford Neuroprotection against Ischemic Stroke Model via Heat Shock Protein Upregulation	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; HUMAN TERM PLACENTA; MESENCHYMAL STEM; DEMYELINATING DISORDERS; UMBILICAL-CORD; BRAIN-INJURY; RAT; TRANSPLANTATION; THERAPY	In this study, we investigated the dog placenta as a viable source of stem cells for stroke therapy. Immunocytochemical evaluation of phenotypic markers of dog placenta cells (DPCs) cultured in proliferation and differentiation medium revealed that DPCs expressed both stem cell and neural cell markers, respectively. Co-culture with DPCs afforded neuroprotection of rat primary neural cells in a dose-dependent manner against oxygen-glucose deprivation. Subsequent in vivo experiments showed that transplantation of DPCs, in particular intravenous and intracerebral cell delivery, produced significant behavioral recovery and reduced histological deficits in ischemic stroke animals compared to those that received intra-arterial delivery of DPCs or control stroke animals. Furthermore, both in vitro and in vivo studies implicated elevated expression of heat shock protein 27 (Hsp27) as a potential mechanism of action underlying the observed therapeutic benefits of DPCs in stroke. This study supports the use of stem cells for stroke therapy and implicates a key role of Hsp27 signaling pathway in neuroprotection.	[Yu, SeongJin; Tajiri, Naoki; Franzese, Nick; Franzblau, Max; Bae, EunKyung; Kaneko, Yuji; Borlongan, Cesar V.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Tampa, FL 33620 USA; [Platt, Simon] Univ Georgia, Coll Vet Med, Dept Small Anim Med & Surg, Atlanta, GA USA	State University System of Florida; University of South Florida; University System of Georgia; University of Georgia	Borlongan, CV (corresponding author), Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Tampa, FL 33620 USA.	cborlong@health.usf.edu	Tajiri, Naoki/K-1230-2012; Kaneko, Yuji/J-6447-2012; Borlongan, Cesar/I-5696-2012	Tajiri, Naoki/0000-0003-2189-662X; Borlongan, Cesar/0000-0002-2966-9782; Platt, Simon/0000-0002-7818-1011	National Institutes of Health, National Institute of Neurological Disorders and Stroke [1R01NS071956-01]; James and Esther King Foundation for Biomedical Research Program; SanBio Inc.; Celgene Cellular Therapeutics; KMPHC; NeuralStem Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071956] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); James and Esther King Foundation for Biomedical Research Program; SanBio Inc.; Celgene Cellular Therapeutics(Bristol-Myers SquibbCelgene Corporation); KMPHC; NeuralStem Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	CVB is supported by National Institutes of Health, National Institute of Neurological Disorders and Stroke 1R01NS071956-01, James and Esther King Foundation for Biomedical Research Program, SanBio Inc., Celgene Cellular Therapeutics, KMPHC and NeuralStem Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JJ, 2008, FEBS J, V275, P1296, DOI 10.1111/j.1742-4658.2008.06291.x; Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267; Bailo M, 2004, TRANSPLANTATION, V78, P1439, DOI 10.1097/01.TP.0000144606.84234.49; Barcena A, 2009, REPROD SCI, V16, P178, DOI 10.1177/1933719108327621; Barlow S, 2008, STEM CELLS DEV, V17, P1095, DOI 10.1089/scd.2007.0154; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Black L, 2008, VET THER, V9; Black LL, 2007, VET THER, V8, P272; Bliss TM, 2010, NEUROBIOL DIS, V37, P275, DOI 10.1016/j.nbd.2009.10.003; Borlongan CV, 2009, STROKE, V40, pS146, DOI 10.1161/STROKEAHA.108.533091; Borlongan CV, 1998, EXP NEUROL, V149, P310, DOI 10.1006/exnr.1997.6730; Borlongan CV, 2000, FASEB J, V14, P1307, DOI 10.1096/fj.14.10.1307; Brambilla R, 2001, ANN NY ACAD SCI, V939, P54; Chen J, 2012, CELL TRANSPLANT; Dawson DA, 1996, J CEREBR BLOOD F MET, V16, P170, DOI 10.1097/00004647-199601000-00020; El-Badri NS, 2004, STEM CELLS DEV, V13, P463, DOI 10.1089/scd.2004.13.463; Franklin TB, 2005, INT J HYPERTHER, V21, P379, DOI 10.1080/02656730500069955; Gredal H, 2013, VET J, V196, P408, DOI 10.1016/j.tvjl.2012.10.018; Heneidi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064752; Ilancheran S, 2009, PLACENTA, V30, P2, DOI 10.1016/j.placenta.2008.09.009; Imura T, 1999, J NEUROSCI, V19, P9768; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; KATO H, 1995, BRAIN RES, V679, P1, DOI 10.1016/0006-8993(95)00198-Y; Kholodenko IV, 2012, B EXP BIOL MED+, V154, P118, DOI 10.1007/s10517-012-1890-6; Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038; Kranz A, 2010, BRAIN RES, V1315, P128, DOI 10.1016/j.brainres.2009.12.001; Krueger-Naug AMR, 2000, J COMP NEUROL, V428, P495, DOI 10.1002/1096-9861(20001218)428:3<495::AID-CNE7>3.0.CO;2-4; Liu SP, 2010, CELL TRANSPLANT, V19, P1261, DOI 10.3727/096368910X507204; Luyten FP, 2004, CURR OPIN RHEUMATOL, V16, P599, DOI 10.1097/01.bor.0000130284.64686.63; Meamar R, 2013, INT J PREVENTIVE MED, V4, pS139; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Noto T, 2007, BIOL PHARM BULL, V30, P313, DOI 10.1248/bpb.30.313; Onteniente B, 2013, CURR MOL MED, V13, P821, DOI 10.2174/1566524011313050013; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Pluchino S, 2005, J NEUROL SCI, V233, P117, DOI 10.1016/j.jns.2005.03.026; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037; Revencu T, 2013, ROM J MORPHOL EMBRYO, V54, P291; Reynolds LPR, 2003, CEREBELLUM, V2, P171, DOI 10.1080/14734220310016114; Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105; Rosado-de-Castro PH, 2013, STEM CELLS DEV; Sanberg PR, 1997, NAT MED, V3, P1129, DOI 10.1038/nm1097-1129; Shen CC, 2010, CURR NEUROVASC RES, V7, P167, DOI 10.2174/156720210792231822; Stetler RA, 2012, J NEUROSCI, V32, P2667, DOI 10.1523/JNEUROSCI.5169-11.2012; Stetler RA, 2008, J NEUROSCI, V28, P13038, DOI 10.1523/JNEUROSCI.4407-08.2008; Teramoto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066001; Thirumala S, 2013, EXPERT OPIN BIOL TH, V13, P673, DOI 10.1517/14712598.2013.763925; Timmins NE, 2012, BIOTECHNOL BIOENG, V109, P1817, DOI 10.1002/bit.24425; Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439; Uccelli A, 2006, EXPERT OPIN BIOL TH, V6, P17, DOI 10.1517/14712598.6.1.17; Wang LQ, 2013, NEUROL RES, V35, P470, DOI 10.1179/1743132813Y.0000000210; Wechsler L, 2009, STROKE, V40, P510, DOI 10.1161/STROKEAHA.108.526863; Yarygin KN, 2009, B EXP BIOL MED+, V148, P862, DOI 10.1007/s10517-010-0837-z; Yen BL, 2005, STEM CELLS, V23, P3, DOI 10.1634/stemcells.2004-0098	55	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76329	10.1371/journal.pone.0076329	http://dx.doi.org/10.1371/journal.pone.0076329			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086730	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700127
J	Guo, Y; Liu, LJ; Xu, L; Tang, P; Lv, YY; Feng, Y; Meng, M; Jonas, JB				Guo, Yin; Liu, Li Juan; Xu, Liang; Tang, Ping; Lv, Yan Yun; Feng, Yi; Meng, Meng; Jonas, Jost B.			Myopic Shift and Outdoor Activity among Primary School Children: One-Year Follow-Up Study in Beijing	PLOS ONE			English	Article							PROGRESSIVE-ADDITION LENSES; SINGLE-VISION LENSES; RANDOMIZED-TRIAL; FORM-DEPRIVATION; CHINESE CHILDREN; OCULAR COMPONENTS; JAPANESE CHILDREN; REFRACTIVE ERRORS; VISUAL ACTIVITY; CONTACT-LENSES	Purpose: To assess whether a change in myopia related oculometric parameters of primary school children in Beijing was associated with indoors and outdoors activity. Methods: The longitudinal school-based study included school children who were examined in 2011 and who were re-examined in 2012. The children underwent a comprehensive eye examination including ocular biometry by optical low-coherence reflectometry and non-cycloplegic refractometry. Parents and children had a detailed interview including questions on time spent indoors and outdoors. Results: Out of 681 students examined at baseline, 643 (94.4%) returned for follow-up examination. Within the one-year period, mean time spent daily outdoors increased by 0.4 +/- 0.9 hours, mean axial length by 0.26 +/- 0.49 mm, the ratio of axial length divided by anterior corneal curvature (AL/CC) by 0.03 +/- 0.06, and myopic refractive error by -0.06 +/- 0.89 diopters. In multivariate analysis, elongation of axial length was significantly associated with less total time spent outdoors (P = 0.02; standardized coefficient beta -0.12) and more time spent indoors with studying (P = 0.007; beta: 0.14) after adjustment for maternal myopia (P = 0.02; beta: 0.12). An increase in AL/CC was significantly associated with less time spent outdoors (P = 0.01; beta: -0.12) after adjustment for paternal myopia (P = 0.003; beta: 0.15) and if region of habitation was excludedors for leisure (P = 0.006; beta: -0.13), with less total time spent outdoors (P = 0.04; beta: -0.10), or with more time spent i. An increase in myopic refractive error, after adjustment for age, was significantly associated with less time spent outdo ndoors with studying (P = 0.005; beta: 0.13). Conclusions: A change in oculometric parameters indicating an increase in myopia was significantly associated with less time spent outdoors and more time spent indoors in school children in Greater Beijing within a study period of one year. Our study provides additional information on the potentially helpful role of outdoors activity in the prevention of myopia. Public health care measures such as school agendas may potentially take it into account.	[Guo, Yin; Tang, Ping; Lv, Yan Yun; Feng, Yi; Meng, Meng] Capital Med Univ, Beijing Tongren Hosp, Tongren Eye Care Ctr, Beijing, Peoples R China; [Liu, Li Juan; Xu, Liang; Jonas, Jost B.] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany	Capital Medical University; Capital Medical University; Ruprecht Karls University Heidelberg	Xu, L (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China.	xlbio1@163.com	Guo, Yin/ABC-2134-2020	Guo, Yin/0000-0003-3806-3771	National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby RS, 2010, INVEST OPHTH VIS SCI, V51, P5247, DOI 10.1167/iovs.09-4689; Berntsen DA, 2012, INVEST OPHTH VIS SCI, V53, P640, DOI 10.1167/iovs.11-7769; Breslin KMM, 2013, INVEST OPHTH VIS SCI, V54, P4843, DOI 10.1167/iovs.13-11813; Cheng D, 2010, ARCH OPHTHALMOL-CHIC, V128, P12, DOI 10.1001/archophthalmol.2009.332; Cui DM, 2013, OPHTHALMOLOGY, V120, P1074, DOI 10.1016/j.ophtha.2012.10.022; Dirani M, 2009, BRIT J OPHTHALMOL, V93, P997, DOI 10.1136/bjo.2008.150979; Donovan L, 2012, OPTOMETRY VISION SCI, V89, P1196, DOI 10.1097/OPX.0b013e3182640996; Fan DSP, 2004, ANN ACAD MED SINGAP, V33, P39; Feldkaemper M, 2013, EXP EYE RES, DOI [10.1016/j.exer.2013.02.007, DOI 10.1016/J.EXER.2013.02.007.[]; Flitcroft DI, 2012, PROG RETIN EYE RES, V31, P622, DOI 10.1016/j.preteyeres.2012.06.004; French AN, 2012, INVEST OPHTH VIS SCI, V53, P4021, DOI 10.1167/iovs.12-9556; French AN, 2013, OPHTHALMOLOGY; French AN, 2013, EXP EYE RES, V2013; Fujiwara M, 2012, JPN J OPHTHALMOL, V56, P401, DOI 10.1007/s10384-012-0148-1; GROSVENOR T, 1994, OPTOMETRY VISION SCI, V71, P573, DOI 10.1097/00006324-199409000-00005; Guggenheim JA, 2012, INVEST OPHTH VIS SCI, V53, P2856, DOI 10.1167/iovs.11-9091; Guo Y, 2013, OPHTHALMOLOGY, V120, P277, DOI 10.1016/j.ophtha.2012.07.086; Gwiazda J, 2003, INVEST OPHTH VIS SCI, V44, P1492, DOI 10.1167/iovs.02-0816; Gwiazda J, 2011, INVEST OPHTH VIS SCI, V52, P2749, DOI 10.1167/iovs.10-6631; Hasebe S, 2008, INVEST OPHTH VIS SCI, V49, P2781, DOI 10.1167/iovs.07-0385; Jones LA, 2007, INVEST OPHTH VIS SCI, V48, P3524, DOI 10.1167/iovs.06-1118; Jones-Jordan LA, 2012, INVEST OPHTH VIS SCI, V53, P7169, DOI 10.1167/iovs.11-8336; Jones-Jordan LA, 2011, INVEST OPHTH VIS SCI, V52, P1841, DOI 10.1167/iovs.09-4997; Katz J, 2003, AM J OPHTHALMOL, V136, P82, DOI 10.1016/S0002-9394(03)00106-5; Lam CSY, 1999, OPTOMETRY VISION SCI, V76, P370, DOI 10.1097/00006324-199906000-00016; Li SM, 2011, SURV OPHTHALMOL, V56, P451, DOI 10.1016/j.survophthal.2011.06.002; Liang YB, 2013, BRIT J OPHTHALMOL, V97, P765, DOI 10.1136/bjophthalmol-2012-302468; Low W, 2010, BRIT J OPHTHALMOL, V94, P1012, DOI 10.1136/bjo.2009.173187; Lu B, 2009, ARCH OPHTHALMOL-CHIC, V127, P769, DOI 10.1001/archophthalmol.2009.105; McCarthy CS, 2007, EXP EYE RES, V84, P100, DOI 10.1016/j.exer.2006.09.018; Megaw PL, 1997, AUST NZ J OPHTHALMOL, V25, pS76; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Nickla DL, 2011, EXP EYE RES, V93, P782, DOI 10.1016/j.exer.2011.08.001; Onal S, 2007, OPTOMETRY VISION SCI, V84, P175, DOI 10.1097/OPX.0b013e3180335c52; PARSSINEN O, 1993, INVEST OPHTH VIS SCI, V34, P2794; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Saw SM, 2005, BRIT J OPHTHALMOL, V89, P1489, DOI 10.1136/bjo.2005.071118; Sherwin JC, 2012, INVEST OPHTH VIS SCI, V53, P4363, DOI 10.1167/iovs.11-8677; Smith EL, 2013, INVEST OPHTH VIS SCI, V54, P2959, DOI 10.1167/iovs.13-11713; Tong L, 2009, OPHTHALMOLOGY, V116, P572, DOI 10.1016/j.ophtha.2008.10.020; Walline JJ, 2004, ARCH OPHTHALMOL-CHIC, V122, P1760, DOI 10.1001/archopht.122.12.1760; Wang YX, 2006, AM J OPHTHALMOL, V141, P1078, DOI 10.1016/j.ajo.2006.01.023; Wu PC, 2013, OPHTHALMOLOGY, V120, P1080, DOI 10.1016/j.ophtha.2012.11.009; Xiang F, 2012, OPHTHALMOLOGY, V119, P1478, DOI 10.1016/j.ophtha.2012.01.017; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035	45	67	71	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75260	10.1371/journal.pone.0075260	http://dx.doi.org/10.1371/journal.pone.0075260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086484	Green Published, Green Submitted, gold			2022-12-27	WOS:000325025200033
J	Hirano, M; Kato, S; Kobayashi, K; Okada, T; Yaginuma, H; Kobayashi, K				Hirano, Miyabi; Kato, Shigeki; Kobayashi, Kenta; Okada, Tomoaki; Yaginuma, Hiroyuki; Kobayashi, Kazuto			Highly Efficient Retrograde Gene Transfer into Motor Neurons by a Lentiviral Vector Pseudotyped with Fusion Glycoprotein	PLOS ONE			English	Article							NERVOUS-SYSTEM; ACETYLCHOLINE-RECEPTOR; ADENOASSOCIATED VIRUS; RABIES; TRANSDUCTION; DELIVERY; MOTONEURONS; CELLS; EXPRESSION; MUTATIONS	The development of gene therapy techniques to introduce transgenes that promote neuronal survival and protection provides effective therapeutic approaches for neurological and neurodegenerative diseases. Intramuscular injection of adenoviral and adeno-associated viral vectors, as well as lentiviral vectors pseudotyped with rabies virus glycoprotein (RV-G), permits gene delivery into motor neurons in animal models for motor neuron diseases. Recently, we developed a vector with highly efficient retrograde gene transfer (HiRet) by pseudotyping a human immunodeficiency virus type 1 (HIV-1)-based vector with fusion glycoprotein B type (FuG-B) or a variant of FuG-B (FuG-B2), in which the cytoplasmic domain of RV-G was replaced by the corresponding part of vesicular stomatitis virus glycoprotein (VSV-G). We have also developed another vector showing neuron-specific retrograde gene transfer (NeuRet) with fusion glycoprotein C type, in which the short C-terminal segment of the extracellular domain and transmembrane/cytoplasmic domains of RV-G was substituted with the corresponding regions of VSV-G. These two vectors afford the high efficiency of retrograde gene transfer into different neuronal populations in the brain. Here we investigated the efficiency of the HiRet (with FuG-B2) and NeuRet vectors for retrograde gene transfer into motor neurons in the spinal cord and hindbrain in mice after intramuscular injection and compared it with the efficiency of the RV-G pseudotype of the HIV-1-based vector. The main highlight of our results is that the HiRet vector shows the most efficient retrograde gene transfer into both spinal cord and hindbrain motor neurons, offering its promising use as a gene therapeutic approach for the treatment of motor neuron diseases.	[Hirano, Miyabi; Kato, Shigeki; Kobayashi, Kazuto] Fukushima Med Univ, Sch Med, Inst Biomed Sci, Dept Mol Genet, Fukushima, Japan; [Kobayashi, Kenta] Natl Inst Physiol Sci, Sect Viral Vector Dev, Okazaki, Aichi 444, Japan; [Okada, Tomoaki] Fukushima Med Univ, Sch Med, Dept Neuroanat & Embryol, Fukushima, Japan; [Yaginuma, Hiroyuki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Japan	Fukushima Medical University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Fukushima Medical University; Japan Science & Technology Agency (JST)	Kobayashi, K (corresponding author), Fukushima Med Univ, Sch Med, Inst Biomed Sci, Dept Mol Genet, Fukushima, Japan.	kazuto@fmu.ac.jp	Kato, Shigeki/S-8016-2018	Kato, Shigeki/0000-0002-8792-7591	Core Research for Evolutional Science and Technology of Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan	Core Research for Evolutional Science and Technology of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid from Core Research for Evolutional Science and Technology of Japan Science and Technology Agency. Part of this work was supported by "Highly Creative Animal Model Development for Brain Sciences" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Azzouz M, 2004, J CLIN INVEST, V114, P1726, DOI 10.1172/JCI200422922; Azzouz M, 2004, J GENE MED, V6, P951, DOI 10.1002/jgm.600; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Baumgartner BJ, 1998, EXP NEUROL, V153, P102, DOI 10.1006/exnr.1998.6878; de Carvalho M, 2011, CURR OPIN NEUROL, V24, P497, DOI 10.1097/WCO.0b013e32834916a9; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; ElMallah MK, 2012, HUM GENE THER METHOD, V23, P148, DOI 10.1089/hgtb.2012.009; Federici Thais, 2009, Genet Vaccines Ther, V7, P1, DOI 10.1186/1479-0556-7-1; Finiels F, 1995, NEUROREPORT, V7, P373, DOI 10.1097/00001756-199512000-00088; Gastka M, 1996, J GEN VIROL, V77, P2437, DOI 10.1099/0022-1317-77-10-2437; Gravel C, 1997, NAT MED, V3, P765, DOI 10.1038/nm0797-765; Hanawa H, 2004, BLOOD, V103, P4062, DOI 10.1182/blood-2004-01-0045; Hanawa H, 2002, MOL THER, V5, P242, DOI 10.1006/mthe.2002.0549; HANHAM CA, 1993, J VIROL, V67, P530, DOI 10.1128/JVI.67.1.530-542.1993; Kato S, 2007, HUM GENE THER, V18, P1141, DOI 10.1089/hum.2007.082; Kato S, 2013, REV NEUROSCIENCE, V24, P1, DOI 10.1515/revneuro-2012-0043; Kato S, 2011, HUM GENE THER, V22, P1511, DOI 10.1089/hum.2011.111; Kato S, 2011, J NEUROSCI, V31, P17169, DOI 10.1523/JNEUROSCI.4005-11.2011; Kato S, 2011, HUM GENE THER, V22, P197, DOI 10.1089/hum.2009.179; Kolb SJ, 2011, ARCH NEUROL-CHICAGO, V68, P979, DOI 10.1001/archneurol.2011.74; Kumar M, 2001, HUM GENE THER, V12, P1893, DOI 10.1089/104303401753153947; Lafon M, 2005, J NEUROVIROL, V11, P82, DOI 10.1080/13550280590900427; Lentz T L, 1990, J Mol Recognit, V3, P82, DOI 10.1002/jmr.300030205; LENTZ TL, 1987, PROTEINS, V2, P298, DOI 10.1002/prot.340020406; Lundberg C, 2008, CURR GENE THER, V8, P461, DOI 10.2174/156652308786847996; Mazarakis ND, 2001, HUM MOL GENET, V10, P2109, DOI 10.1093/hmg/10.19.2109; Mentis GZ, 2006, J NEUROSCI METH, V157, P208, DOI 10.1016/j.jneumeth.2006.04.011; Mitrophanous KA, 1999, GENE THER, V6, P1808, DOI 10.1038/sj.gt.3301023; Mochizuki H, 1998, J VIROL, V72, P8873, DOI 10.1128/JVI.72.11.8873-8883.1998; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Owens Roland A., 2002, Current Gene Therapy, V2, P145, DOI 10.2174/1566523024605627; Perrelet D, 2000, EUR J NEUROSCI, V12, P2059, DOI 10.1046/j.1460-9568.2000.00098.x; Reiser J, 1996, P NATL ACAD SCI USA, V93, P15266, DOI 10.1073/pnas.93.26.15266; Ribotta MGY, 1997, J NEUROSCI RES, V48, P281; Sakamoto T, 2003, J NEUROSCI RES, V72, P54, DOI 10.1002/jnr.10558; Thoulouze MI, 1998, J VIROL, V72, P7181, DOI 10.1128/JVI.72.9.7181-7190.1998; Towne C, 2010, GENE THER, V17, P141, DOI 10.1038/gt.2009.119; Towne C, 2011, MOL THER, V19, P274, DOI 10.1038/mt.2010.260; Tuffereau C, 1998, EMBO J, V17, P7250, DOI 10.1093/emboj/17.24.7250; Wee CD, 2010, CURR OPIN NEUROL, V23, P450, DOI 10.1097/WCO.0b013e32833e1765; Wong LF, 2006, HUM GENE THER, V17, P1, DOI 10.1089/hum.2006.17.1; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Yan ZY, 2000, P NATL ACAD SCI USA, V97, P6716, DOI 10.1073/pnas.97.12.6716	46	35	37	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75896	10.1371/journal.pone.0075896	http://dx.doi.org/10.1371/journal.pone.0075896			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086660	gold, Green Published, Green Submitted			2022-12-27	WOS:000325025200070
J	Mahani, A; Henriksson, J; Wright, APH				Mahani, Amir; Henriksson, Johan; Wright, Anthony P. H.			Origins of Myc Proteins - Using Intrinsic Protein Disorder to Trace Distant Relatives	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RNA-POLYMERASE-I; C-MYC; TRANSACTIVATION DOMAIN; TRANSCRIPTION FACTORS; ENERGY CONTENT; RIBOSOMAL DNA; MAX NETWORK; WEB SERVER; CELL-SIZE	Mammalian Myc proteins are important determinants of cell proliferation as well as the undifferentiated state of stem cells and their activity is frequently deregulated in cancer. Based mainly on conservation in the C-terminal DNA-binding and dimerization domain, Myc-like proteins have been reported in many simpler organisms within and outside the Metazoa but they have not been found in fungi or plants. Several important signature motifs defining mammalian Myc proteins are found in the N-terminal domain but the extent to which these are found in the Myc-like proteins from simpler organisms is not well established. The extent of N-terminal signature sequence conservation would give important insights about the evolution of Myc proteins and their current function in mammalian physiology and disease. In a systematic study of Myc-like proteins we show that N-terminal signature motifs are not readily detectable in individual Myc-like proteins from invertebrates but that weak similarities to Myc boxes 1 and 2 can be found in the N-termini of the simplest Metazoa as well as the unicellular choanoflagellate, Monosiga brevicollis, using multiple protein alignments. Phylogenetic support for the connections of these proteins to established Myc proteins is however poor. We show that the pattern of predicted protein disorder along the length of Myc proteins can be used as a complementary approach to making dendrograms of Myc proteins that aids the classification of Myc proteins. This suggests that the pattern of disorder within Myc proteins is more conserved through evolution than their amino acid sequence. In the disorder-based dendrograms the Myc-like proteins from simpler organisms, including M. brevicollis, are connected to established Myc proteins with a higher degree of certainty. Our results suggest that protein disorder based dendrograms may be of general significance for studying distant relationships between proteins, such as transcription factors, that have high levels of intrinsic disorder.	[Wright, Anthony P. H.] Karolinska Inst, Dept Lab Med, Huddinge, Sweden; Karolinska Inst, Ctr Biosci, Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet	Wright, APH (corresponding author), Karolinska Inst, Dept Lab Med, Huddinge, Sweden.	anthony.wright@ki.se	Henriksson, Johan/ABD-2430-2021; Wright, Anthony/J-8187-2015	Henriksson, Johan/0000-0002-7745-2844; Wright, Anthony/0000-0003-1029-9969	Swedish Research Council; Swedish Cancer Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	The work was financed by the Swedish Research Council (www.vr.se) and the Swedish Cancer Society (www.cancerfonden.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andresen C, 2012, NUCLEIC ACIDS RES, V40, P6353, DOI 10.1093/nar/gks263; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Bordoli L, 2007, PROTEINS, V69, P129, DOI 10.1002/prot.21671; Brown CJ, 2011, CURR OPIN STRUC BIOL, V21, P441, DOI 10.1016/j.sbi.2011.02.005; Brown CJ, 2010, MOL BIOL EVOL, V27, P609, DOI 10.1093/molbev/msp277; Chang DW, 2000, MOL CELL BIOL, V20, P4309, DOI 10.1128/MCB.20.12.4309-4319.2000; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Daughdrill GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029207; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Ferreira ME, 2005, J BIOL CHEM, V280, P21779, DOI 10.1074/jbc.M502627200; Flinn EM, 1998, MOL CELL BIOL, V18, P5961, DOI 10.1128/MCB.18.10.5961; Fuxreiter M, 2011, TRENDS BIOCHEM SCI, V36, P415, DOI 10.1016/j.tibs.2011.04.006; Gallant P, 2006, CURR TOP MICROBIOL, V302, P235; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grothendieck G., 2012, SQLDF PERFORM SQL SE; Hartl M, 2010, P NATL ACAD SCI USA, V107, P4051, DOI 10.1073/pnas.0911060107; Hermann S, 2001, J BIOL CHEM, V276, P40127, DOI 10.1074/jbc.M103793200; Hsu WL, 2013, PROTEIN SCI, V22, P258, DOI 10.1002/pro.2207; Hydbring P, 2010, AGING-US, V2, P244, DOI 10.18632/aging.100140; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Luscher B, 2012, GENE, V494, P145, DOI 10.1016/j.gene.2011.12.027; Luscher B, 1999, ONCOGENE, V18, P2955, DOI 10.1038/sj.onc.1202750; Marandel L, 2012, MOL REPROD DEV, V79, P85, DOI 10.1002/mrd.22004; McEwan IJ, 1996, BIOCHEMISTRY-US, V35, P9584, DOI 10.1021/bi960793v; McFerrin LG, 2011, GENOME BIOL EVOL, V3, P915, DOI 10.1093/gbe/evr082; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; MORTON CC, 1989, GENOMICS, V4, P367, DOI 10.1016/0888-7543(89)90344-3; Mulder Nicola, 2007, V396, P59; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Nilsson J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r65; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Obradovic Romero, 1997, GENOME INFORM SER WO, V8, P110; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Radivojac Predrag, 2003, Pac Symp Biocomput, P216; ROBERTSON NG, 1991, NUCLEIC ACIDS RES, V19, P3129, DOI 10.1093/nar/19.11.3129; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Skinner MK, 2010, DIFFERENTIATION, V80, P1, DOI 10.1016/j.diff.2010.02.003; Smith K, 2010, REGEN MED, V5, P947, DOI 10.2217/RME.10.79; SmithSorensen B, 1996, J BIOL CHEM, V271, P5513, DOI 10.1074/jbc.271.10.5513; Sodir NM, 2011, FINDING CANC WEAKEST; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Toth-Petroczy A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000243; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Walsh I, 2012, BIOINFORMATICS, V28, P503, DOI 10.1093/bioinformatics/btr682; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xue B, 2012, MOL BIOSYST, V8, P134, DOI 10.1039/c1mb05163f; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Young SL, 2011, MOL BIOL EVOL, V28, P2961, DOI 10.1093/molbev/msr132	69	20	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75057	10.1371/journal.pone.0075057	http://dx.doi.org/10.1371/journal.pone.0075057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086436	gold, Green Submitted, Green Published			2022-12-27	WOS:000325025200020
J	Short, MA; Gradisar, M; Gill, J; Camfferman, D				Short, Michelle A.; Gradisar, Michael; Gill, Jason; Camfferman, Danny			Identifying Adolescent Sleep Problems	PLOS ONE			English	Article							DAYTIME SLEEPINESS; CIRCADIAN PHASE; SCHOOL CHILDREN; WAKE PATTERNS; DEPRESSION; DISORDERS; INSOMNIA; BEHAVIOR; ASSOCIATIONS; RESTRICTION	Objectives: To examine the efficacy of self-report and parental report of adolescent sleep problems and compare these findings to the incidence of adolescents who fulfill clinical criteria for a sleep problem. Sleep and daytime functioning factors that predict adolescents' self-identification of a sleep problem will also be examined. Method: 308 adolescents (aged 13-17 years) from eight socioeconomically diverse South Australian high schools participated in this study. Participants completed a survey battery during class time, followed by a 7-day Sleep Diary and the Flinders Fatigue Scale completed on the final day of the study. Parents completed a Sleep, Medical, Education and Family History Survey. Results: The percentage of adolescents fulfilling one or more of the criteria for a sleep problem was inordinately high at 66%. Adolescent self-reporting a sleep problem was significantly lower than the adolescents who had one or more of the clinical criteria for a sleep problem (23.1% vs. 66.6%; chi(2) = 17.46, p<. 001). Parental report of their adolescent having a sleep problem was significantly lower than adolescent self-report (14.3% vs. 21.1%, p<. 001). Adolescents who reported unrefreshing sleep were 4.81 times more likely to report a sleep problem. For every hour that bedtime was delayed, the odds of self-reporting a sleep problem increased by 1.91 times, while each additional 10 minutes taken to fall asleep increased the odds 1.40 times. Conclusion: While many adolescents were found to have sleep patterns indicative of a sleep problem, only a third of this number self-identify having a sleep problem, while only a sixth of this number are indicated by parental report. This study highlights important features to target in future sleep education and intervention strategies for both adolescents and parents.	[Short, Michelle A.; Gradisar, Michael; Gill, Jason] Flinders Univ South Australia, Sch Psychol, Adelaide, SA, Australia; [Short, Michelle A.] Univ S Australia, Ctr Sleep Res, Adelaide, SA 5001, Australia; [Camfferman, Danny] Univ S Australia, Samson Inst, Sch Hlth Sci, Adelaide, SA 5001, Australia	Flinders University South Australia; University of South Australia; University of South Australia	Short, MA (corresponding author), Flinders Univ South Australia, Sch Psychol, Adelaide, SA, Australia.	michelle.short@unisa.edu.au		Camfferman, Danny/0000-0002-4108-7099; , Michael/0000-0002-5146-2657	Australian Research Council [DP0881261]	Australian Research Council(Australian Research Council)	This study was funded by Australian Research Council grant #DP0881261 (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AASM, 2005, INT CLASS SLEEP DIS; Alexandru G, 2006, J SLEEP RES, V15, P266, DOI 10.1111/j.1365-2869.2006.00530.x; Blunden S, 2000, J CLIN EXP NEUROPSYC, V22, P554, DOI 10.1076/1380-3395(200010)22:5;1-9;FT554; Buysse DJ, 2006, SLEEP, V29, P1155, DOI 10.1093/sleep/29.9.1155; Cain N, 2011, SLEEP MED, V12, P246, DOI 10.1016/j.sleep.2010.06.008; CARSKADON M A, 1990, Pediatrician, V17, P5; CARSKADON MA, 1981, PSYCHOPHYSIOLOGY, V18, P107, DOI 10.1111/j.1469-8986.1981.tb02921.x; Carskadon MA, 1998, SLEEP, V21, P871, DOI 10.1093/sleep/21.8.871; CARSKADON MA, 1979, PERCEPT MOTOR SKILL, V48, P495, DOI 10.2466/pms.1979.48.2.495; CARSKADON MA, 1981, SLEEP, V4, P299; CARSKADON MA, 1981, PERCEPT MOTOR SKILL, V53, P103, DOI 10.2466/pms.1981.53.1.103; Carskadon MA, 2013, SLEEP MED ED FAMILY; Chung KF, 2008, SLEEP, V31, P185, DOI 10.1093/sleep/31.2.185; Crowley SJ, 2007, SLEEP MED, V8, P602, DOI 10.1016/j.sleep.2006.12.002; Crowley SJ, 2010, CHRONOBIOL INT, V27, P1469, DOI 10.3109/07420528.2010.503293; Dahl RE, 2002, J ADOLESCENT HEALTH, V31, P175, DOI 10.1016/S1054-139X(02)00506-2; Drake C, 2003, SLEEP, V26, P455; Gangwisch JE, 2010, SLEEP, V33, P97, DOI 10.1093/sleep/33.1.97; GARRISON CZ, 1991, J AM ACAD CHILD PSY, V30, P636, DOI 10.1097/00004583-199107000-00017; Gradisar M, 2008, SLEEP BIOL RHYTHMS, V6, P146, DOI 10.1111/j.1479-8425.2008.00353.x; Gradisar M, 2007, J CLIN SLEEP MED, V3, P722; Gradisar M, 2011, SLEEP, V34, P1671, DOI 10.5665/sleep.1432; Gradisar M, 2011, SLEEP MED, V12, P110, DOI 10.1016/j.sleep.2010.11.008; Gregory AM, 2005, J ABNORM CHILD PSYCH, V33, P157, DOI 10.1007/s10802-005-1824-0; Henshel A, 1987, SLEEP RES, V16, P354; Johnson EO, 2006, J PSYCHIATR RES, V40, P700, DOI 10.1016/j.jpsychires.2006.07.008; KAHN A, 1989, PEDIATRICS, V84, P542; Leger D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045204; Lichstein KL, 2003, BEHAV RES THER, V41, P427, DOI 10.1016/S0005-7967(02)00023-2; Link S, 1995, SLEEP RES, V24, P184; Liu XC, 2005, PEDIATRICS, V115, P241, DOI 10.1542/peds.2004-0815F; Martin J, 2007, PEDIATRICS, V119, P947, DOI 10.1542/peds.2006-2569; Mindell JA, 2009, SLEEP MED, V10, P771, DOI 10.1016/j.sleep.2008.07.016; Mottl RW, 2005, EDUC PSYCHOL MEAS, V65, P190; NSF (National Sleep Foundation), 2006, SLEEP AM POLL; O'Brien Erin M, 2005, Behav Sleep Med, V3, P113, DOI 10.1207/s15402010bsm0303_1; Ohida T, 2004, SLEEP, V27, P978, DOI 10.1093/sleep/27.5.978; Pizza F, 2010, J CLIN SLEEP MED, V6, P41; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROGERS AE, 1993, NURS RES, V42, P368; Russo PM, 2007, J SLEEP RES, V16, P163, DOI 10.1111/j.1365-2869.2007.00584.x; Scholle S, 2011, SLEEP MED, V12, P542, DOI 10.1016/j.sleep.2010.11.011; Short MA, 2011, SLEEP, V34, P797, DOI 10.5665/SLEEP.1052; SMITH CS, 1989, J APPL PSYCHOL, V74, P728, DOI 10.1037/0021-9010.74.5.728; STRAUCH I, 1988, SLEEP, V11, P378, DOI 10.1093/sleep/11.4.378; Taylor A, 2008, SLEEP BIOL RHYTHMS, V6, P172, DOI 10.1111/j.1479-8425.2008.00356.x; White L, 1980, SLEEP RES, V9, P108; Wolfson AR, 1998, CHILD DEV, V69, P875, DOI 10.2307/1132351; Yang CK, 2005, PEDIATRICS, V115, P250, DOI 10.1542/peds.2004-0815G	49	38	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75301	10.1371/journal.pone.0075301	http://dx.doi.org/10.1371/journal.pone.0075301			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	226HG	24086501	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000325025200038
J	Cheng, XF; Virk, N; Chen, W; Ji, SQ; Ji, SX; Sun, YQ; Wu, XY				Cheng, Xiaofei; Virk, Nasar; Chen, Wei; Ji, Shuqin; Ji, Shuxian; Sun, Yuqiang; Wu, Xiaoyun			CpG Usage in RNA Viruses: Data and Hypotheses	PLOS ONE			English	Article							DNA METHYLATION; STRANDED-RNA; CYTOSINE METHYLATION; TOLL; DINUCLEOTIDE; PATTERNS; GENOMES; HOST; BIAS; RECOGNITION	CpG repression in RNA viruses has been known for decades, but a reasonable explanation has not yet been proposed to explain this phenomenon. In this study, we calculated the CpG odds ratio of all RNA viruses that have available genome sequences and analyzed the correlation with their genome polarity, base composition, synonymous codon usage, phylogenetic relationship, and host. The results indicated that the viral base composition, synonymous codon usage and host selection were the dominant factors that determined the CpG bias in RNA viruses. CpG usage variation between the different viral groups was caused by different combinations of these pressures, which also differed from each other in strength. The consistent under-representation of CpG usage in -ssRNA viruses is determined predominantly by base composition, which may be a consequence of the U/A preferred mutation bias of -ssRNA viruses, whereas the CpG usage of +ssRNA viruses is affected greatly by their hosts. As a result, most +ssRNA viruses mimic their hosts' CpG usage. Unbiased CpG usage in dsRNA viruses is most likely a result of their dsRNA genome, which allows the viruses to escape from the host-driven CpG elimination pressure. CpG was under-represented in all reverse-transcribing viruses (RT viruses), suggesting that DNA methylation is an important factor affecting the CpG usage of retroviruses. However, vertebrate-infecting RT viruses may also suffer host' CpG elimination pressure that also acts on +ssRNA viruses, which results in further under-representation of CpG in the vertebrate-infecting RT viruses.	[Cheng, Xiaofei; Chen, Wei; Sun, Yuqiang] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Virk, Nasar] Natl Univ Sci & Technol, Atta ur Rahman Sch Appl Biosci, Islamabad, Pakistan; [Ji, Shuqin; Wu, Xiaoyun] Zhejiang Agr & Forestry Univ, Coll Agr & Food Sci, Linan, Zhejiang, Peoples R China; [Ji, Shuxian] Zhejiang Univ Sci & Technol, Sch Econ & Management, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University; National University of Sciences & Technology - Pakistan; Zhejiang A&F University; Zhejiang University of Science & Technology	Cheng, XF (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	xfcheng@hznu.edu.cn; wxy@zafu.edu.cn	Cheng, Xiaofei/M-6239-2014; Cheng, Xiaofei/AAT-2600-2020	Cheng, Xiaofei/0000-0002-9771-9059; 	Natural Science Foundation of China [31101417, 31101415]; Natural Science Foundation of Zhejiang Province [Y3110175, Y3110277]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This study was supported by the Natural Science Foundation of China (Project No. 31101417 and 31101415) and the Natural Science Foundation of Zhejiang Province (Project No: Y3110175 and Y3110277). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2004, ARCH VIROL, V149, P113, DOI 10.1007/s00705-003-0186-6; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Auewarakul P, 2005, VIRUS RES, V109, P33, DOI 10.1016/j.virusres.2004.10.004; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Burns CC, 2009, J VIROL, V83, P9957, DOI 10.1128/JVI.00508-09; Cheng XF, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-113; De Amicis F, 2000, NUCLEIC ACIDS RES, V28, P3339, DOI 10.1093/nar/28.17.3339; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Elango N, 2008, MOL BIOL EVOL, V25, P1602, DOI 10.1093/molbev/msn110; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; Ellis J, 2007, CELL, V131, P13, DOI 10.1016/j.cell.2007.09.029; Eyre-Walker A, 1999, GENETICS, V152, P675; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Greenbaum BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005969; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hohn T, 2011, BBA-GENE REGUL MECH, V1809, P588, DOI 10.1016/j.bbagrm.2011.06.002; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X; Jimenez-Baranda S, 2011, J VIROL, V85, P3893, DOI 10.1128/JVI.01908-10; KARLIN S, 1994, J VIROL, V68, P2889, DOI 10.1128/JVI.68.5.2889-2897.1994; KARLIN S, 1995, TRENDS GENET, V11, P283; Karlin S, 1997, P NATL ACAD SCI USA, V94, P10227, DOI 10.1073/pnas.94.19.10227; Karlin S, 1998, CURR OPIN MICROBIOL, V1, P598, DOI 10.1016/S1369-5274(98)80095-7; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Leung DC, 2012, TRENDS BIOCHEM SCI, V37, P127, DOI 10.1016/j.tibs.2011.11.006; Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Megremis S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044557; Rima BK, 1997, J GEN VIROL, V78, P2859, DOI 10.1099/0022-1317-78-11-2859; Schubert AM, 2010, INFECT GENET EVOL, V10, P129, DOI 10.1016/j.meegid.2009.11.004; Serra MJ, 1995, METHOD ENZYMOL, V259, P242; SHPAER EG, 1990, NUCLEIC ACIDS RES, V18, P5793, DOI 10.1093/nar/18.19.5793; Simmen MW, 2008, GENOMICS, V92, P33, DOI 10.1016/j.ygeno.2008.03.009; Thompson AJ, 2007, IMMUNOL CELL BIOL, V85, P435, DOI 10.1038/sj.icb.7100100; van der Kuyl AC, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-92; Wang Y, 2004, J MOL EVOL, V58, P692, DOI 10.1007/s00239-004-2591-1; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102	44	88	90	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74109	10.1371/journal.pone.0074109	http://dx.doi.org/10.1371/journal.pone.0074109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086312	Green Submitted, gold, Green Published			2022-12-27	WOS:000326520200021
J	Dashti, A; Komarov, I; D'Souza, RM				Dashti, Ali; Komarov, Ivan; D'Souza, Roshan M.			Efficient Computation of k-Nearest Neighbour Graphs for Large High-Dimensional Data Sets on GPU Clusters	PLOS ONE			English	Article							CONSTRUCTION	This paper presents an implementation of the brute-force exact k-Nearest Neighbor Graph (k-NNG) construction for ultra-large high-dimensional data cloud. The proposed method uses Graphics Processing Units (GPUs) and is scalable with multi-levels of parallelism (between nodes of a cluster, between different GPUs on a single node, and within a GPU). The method is applicable to homogeneous computing clusters with a varying number of nodes and GPUs per node. We achieve a 6-fold speedup in data processing as compared with an optimized method running on a cluster of CPUs and bring a hitherto impossible k-NNG generation for a dataset of twenty million images with 15 k dimensionality into the realm of practical possibility.	[Dashti, Ali; Komarov, Ivan; D'Souza, Roshan M.] Univ Wisconsin, Complex Syst Simulat Lab, Dept Mech Engn, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	D'Souza, RM (corresponding author), Univ Wisconsin, Complex Syst Simulat Lab, Dept Mech Engn, Milwaukee, WI 53201 USA.	dsouza@uwm.edu	Valiyaveettill, Suresh/D-4848-2009	Valiyaveettill, Suresh/0000-0001-6990-660X	National Science Foundation (NSF) [CNS-0968519, CCF-1013278]; Direct For Computer & Info Scie & Enginr [0968519] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work is partially funded by the National Science Foundation (NSF) through the grants CNS-0968519 and CCF-1013278. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arefin AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044000; ARYA S, 1994, PROCEEDINGS OF THE FIFTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P573; Barrientos RJ, 2011, LECT NOTES COMPUT SC, V6852, P380, DOI 10.1007/978-3-642-23400-2_35; BENTLEY JL, 1980, COMMUN ACM, V23, P214, DOI 10.1145/358841.358850; Chan TM, 1998, DISCRETE COMPUT GEOM, V20, P359, DOI 10.1007/PL00009390; Chapman Barbara, 2007, USING OPENMP PORTABL; Chen J, 2009, J MACH LEARN RES, V10, P1989; Clarkson K., 1983, S FDN COMP SCI, P26, DOI DOI 10.1109/SFCS.1983.16; Connor M, 2010, IEEE T VIS COMPUT GR, V16, P599, DOI 10.1109/TVCG.2010.9; Dasgupta S, 2008, ACM S THEORY COMPUT, P537; Datar M., 2004, P 20 ANN S COMP GEOM, P253; Dong W., 2011, P 20 INT C WORLD WID, P577, DOI DOI 10.1145/1963405.1963487; Duda R.O., 2006, PATTERN CLASSIFICATI; Franti P, 2006, IEEE T PATTERN ANAL, V28, P1875, DOI 10.1109/TPAMI.2006.227; Garcia V, 2010, IEEE IMAGE PROC, P3757, DOI 10.1109/ICIP.2010.5654017; Ho Ching-Tien, 2000, LECT NOTES COMPUTER, V1759; Indyk P., 2004, HDB DISCRETE COMPUTA; Jones PW, 2011, P NATL ACAD SCI USA, V108, P15679, DOI 10.1073/pnas.1107769108; Kato K, 2009, ABS09060231 CORR; Kuang QS, 2009, PROCEEDINGS OF INTERNATIONAL SYMPOSIUM ON COMPUTER SCIENCE AND COMPUTATIONAL TECHNOLOGY (ISCSCT 2009), P151; Liu W., 2010, P 27 INT C MACH LEAR, P679; Maier M, 2009, THEOR COMPUT SCI, V410, P1749, DOI 10.1016/j.tcs.2009.01.009; nVidia, 2012, CUBLAS LIB US GUID N; Pacheco PS, 1996, PARALLEL PROGRAMMING; Paredes R, 2006, LECT NOTES COMPUT SC, V4007, P85; Roberts A, 2007, BIOINFORMATICS, V23, pI401, DOI 10.1093/bioinformatics/btm220; Sanders J., 2010, CUDA EXAMPLE INTRO G; Schwander P, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/035007; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; VAIDYA PM, 1989, DISCRETE COMPUT GEOM, V4, P101, DOI 10.1007/BF02187718; Wang J, 2012, PROC CVPR IEEE, P1106, DOI 10.1109/CVPR.2012.6247790; Weston J, 2004, P NATL ACAD SCI USA, V101, P6559, DOI 10.1073/pnas.0308067101; Whaley R. C., 1998, P 1998 ACMIEEE C SUP, P38, DOI [10.5555/509058.509096, DOI 10.1109/SC.1998.10004]	33	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74113	10.1371/journal.pone.0074113	http://dx.doi.org/10.1371/journal.pone.0074113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086314	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200022
J	Marconi, G; Pace, R; Traini, A; Raggi, L; Lutts, S; Chiusano, M; Guiducci, M; Falcinelli, M; Benincasa, P; Albertini, E				Marconi, Gianpiero; Pace, Roberta; Traini, Alessandra; Raggi, Lorenzo; Lutts, Stanley; Chiusano, Marialuisa; Guiducci, Marcello; Falcinelli, Mario; Benincasa, Paolo; Albertini, Emidio			Use of MSAP Markers to Analyse the Effects of Salt Stress on DNA Methylation in Rapeseed (Brassica napus var. oleifera)	PLOS ONE			English	Article							SALINITY STRESS; GENOMIC DNA; RICE; TOLERANCE; PLANTS; ACCUMULATION; EXPRESSION; LEAVES; DEMETHYLATION; PROTEIN	Excessive soil salinity is a major ecological and agronomical problem, the adverse effects of which are becoming a serious issue in regions where saline water is used for irrigation. Plants can employ regulatory strategies, such as DNA methylation, to enable relatively rapid adaptation to new conditions. In this regard, cytosine methylation might play an integral role in the regulation of gene expression at both the transcriptional and post-transcriptional levels. Rapeseed, which is the most important oilseed crop in Europe, is classified as being tolerant of salinity, although cultivars can vary substantially in their levels of tolerance. In this study, the Methylation Sensitive Amplified Polymorphism (MSAP) approach was used to assess the extent of cytosine methylation under salinity stress in salinity-tolerant (Exagone) and salinity-sensitive (Toccata) rapeseed cultivars. Our data show that salinity affected the level of DNA methylation. In particular methylation decreased in Exagone and increased in Toccata. Nineteen DNA fragments showing polymorphisms related to differences in methylation were sequenced. In particular, two of these were highly similar to genes involved in stress responses (Lacerata and trehalose-6-phosphatase synthase S4) and were chosen to further characterization. Bisulfite sequencing and quantitative RT-PCR analysis of selected MSAP loci showed that cytosine methylation changes under salinity as well as gene expression varied. In particular, our data show that salinity stress influences the expression of the two stress-related genes. Moreover, we quantified the level of trehalose in Exagone shoots and found that it was correlated to TPS4 expression and, therefore, to DNA methylation. In conclusion, we found that salinity could induce genome-wide changes in DNA methylation status, and that these changes, when averaged across different genotypes and developmental stages, accounted for 16.8% of the total site-specific methylation differences in the rapeseed genome, as detected by MSAP analysis.	[Marconi, Gianpiero; Raggi, Lorenzo; Falcinelli, Mario; Albertini, Emidio] Univ Perugia, Dept Appl Biol, I-06100 Perugia, Italy; [Pace, Roberta; Guiducci, Marcello; Benincasa, Paolo] Univ Perugia, Dept Agr & Environm Sci, I-06100 Perugia, Italy; [Traini, Alessandra; Chiusano, Marialuisa] Univ Naples Federico II, Dept Soil Plant Environm & Anim Prod Sci, Naples, Italy; [Lutts, Stanley] Catholic Univ Louvain, Earth & Life Inst Agron, Grp Rech Physiol Vegetale, B-1348 Louvain, Belgium	University of Perugia; University of Perugia; University of Naples Federico II; Universite Catholique Louvain	Albertini, E (corresponding author), Univ Perugia, Dept Appl Biol, I-06100 Perugia, Italy.	emidio.albertini@unipg.it	luisa, chiusano maria/AAQ-3064-2021; Raggi, Lorenzo/G-5645-2013; Guiducci, Marcello/N-6002-2015; Albertini, Emidio/F-7393-2014	luisa, chiusano maria/0000-0002-6296-7132; Raggi, Lorenzo/0000-0003-0484-8669; Guiducci, Marcello/0000-0003-1888-4732; Albertini, Emidio/0000-0003-2585-5649; MARCONI, GIANPIERO/0000-0003-2669-0399; BENINCASA, Paolo/0000-0001-8502-8026	University of Perugia - Department of Applied Biology projects - Molecular characterization of agronomically important species	University of Perugia - Department of Applied Biology projects - Molecular characterization of agronomically important species	This study was supported by the University of Perugia - Department of Applied Biology projects - Molecular characterization of agronomically important species (project code ALBERPREST) Associazione Produttori Olivicoli (A.PR.OL) (http://www.aprolperugia.it/aprol/index.php) Molecular characterization of oil crops (project code APRO09ALB and APRO10ALB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2013, MOL BIOTECHNOL, V54, P102, DOI 10.1007/s12033-012-9538-3; Aina R, 2004, PHYSIOL PLANTARUM, V121, P472, DOI 10.1111/j.1399-3054.2004.00343.x; ALBERTINI E, 2013, DIAGNOSTICS PLANT BR, DOI DOI 10.1007/978-94-007-5687-8.P.12; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angers B, 2010, MOL ECOL, V19, P1283, DOI 10.1111/j.1365-294X.2010.04580.x; Baurens FC, 2003, PLANT MOL BIOL REP, V21, P339, DOI 10.1007/BF02772583; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Cameron KD, 2006, PLANT PHYSIOL, V140, P176, DOI 10.1104/pp.105.069724; Cao DH, 2012, PLANT MOL BIOL REP, V30, P1102, DOI 10.1007/s11105-012-0420-z; Capomaccio Stefano, 2011, BMC Physiology, V11, P3, DOI 10.1186/1472-6793-11-3; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Carillo P, 2011, ABIOTIC STRESS IN PLANTS - MECHANISMS AND ADAPTATIONS, P21; Causevic A, 2005, PLANT PHYSIOL BIOCH, V43, P681, DOI 10.1016/j.plaphy.2005.05.011; Cheng F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-136; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; CRAMER GR, 1992, PHYSIOL PLANTARUM, V84, P600, DOI 10.1111/j.1399-3054.1992.tb04710.x; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Duan H, 2005, PLANT PHYSIOL, V137, P1067, DOI 10.1104/pp.104.055715; Fernandez O, 2010, TRENDS PLANT SCI, V15, P409, DOI 10.1016/j.tplants.2010.04.004; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Hare PD, 1998, PLANT CELL ENVIRON, V21, P535, DOI 10.1046/j.1365-3040.1998.00309.x; Hasbun R, 2008, PLANT PHYSIOL BIOCH, V46, P815, DOI 10.1016/j.plaphy.2008.04.009; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hetzl J, 2007, PLANT J, V51, P526, DOI 10.1111/j.1365-313X.2007.03152.x; Johnston JW, 2009, PLANT PHYSIOL BIOCH, V47, P123, DOI 10.1016/j.plaphy.2008.10.008; JONES MM, 1980, AUST J PLANT PHYSIOL, V7, P181, DOI 10.1071/PP9800181; Karan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040203; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; Kosma DK., 2007, ADV MOL BREEDING DRO, P91, DOI DOI 10.1007/978-1-4020-5578-2_5; Kosma DK, 2009, PLANT PHYSIOL, V151, P1918, DOI 10.1104/pp.109.141911; Kovarik A, 1997, THEOR APPL GENET, V95, P301, DOI 10.1007/s001220050563; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Kumar R, 2012, PLANT MOL BIOL, V79, P555, DOI 10.1007/s11103-012-9928-8; Labra M, 2002, PLANT BIOSYST, V136, P269, DOI 10.1080/11263500212331351179; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li XueLin, 2009, Acta Agronomica Sinica, V35, P588, DOI 10.3724/SP.J.1006.2009.00588; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lizal P, 2001, PHYSIOL PLANTARUM, V113, P121, DOI 10.1034/j.1399-3054.2001.1130116.x; Lu GY, 2007, J INTEGR PLANT BIOL, V49, P1599, DOI 10.1111/j.1774-7909.2007.00566.x; Lu YL, 2008, J GENET GENOMICS, V35, P41, DOI 10.1016/S1673-8527(08)60006-5; Lukens LN, 2007, CURR OPIN PLANT BIOL, V10, P317, DOI 10.1016/j.pbi.2007.04.012; Manjunath S, 1997, PLANT MOL BIOL, V33, P97, DOI 10.1023/A:1005729112038; Ruiz-Lozano JM, 2012, J EXP BOT, V63, P4033, DOI 10.1093/jxb/ers126; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; Muller T, 2012, J AGRON CROP SCI, V198, P207, DOI 10.1111/j.1439-037X.2011.00502.x; MUNNS R, 1986, AUST J PLANT PHYSIOL, V13, P143, DOI 10.1071/PP9860143; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nemati I, 2011, PLANT SOIL ENVIRON, V57, P26, DOI 10.17221/71/2010-PSE; NIU XM, 1995, PLANT PHYSIOL, V109, P735, DOI 10.1104/pp.109.3.735; Pace R., 2010, Italian Journal of Agronomy, V5, P69; Pace R, 2012, EXP AGR, V48, P238, DOI 10.1017/S0014479711001189; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Paszkowski J, 2001, CURR OPIN PLANT BIOL, V4, P123, DOI 10.1016/S1369-5266(00)00147-3; Peleg Z, 2011, ADV BOT RES, V57, P405, DOI 10.1016/B978-0-12-387692-8.00012-6; Peng H, 2009, PROG NAT SCI-MATER, V19, P1037, DOI 10.1016/j.pnsc.2008.10.014; Portis E, 2004, PLANT SCI, V166, P169, DOI 10.1016/j.plantsci.2003.09.004; Qi JN, 2010, PLANT MOL BIOL REP, V28, P597, DOI 10.1007/s11105-010-0185-1; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Redillas MCFR, 2012, PLANT BIOTECHNOL REP, V6, P89, DOI 10.1007/s11816-011-0210-3; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rozen S, 2000, Methods Mol Biol, V132, P365; Salmon A, 2008, PLANT SCI, V174, P61, DOI 10.1016/j.plantsci.2007.09.012; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Tan MP, 2010, PLANT PHYSIOL BIOCH, V48, P21, DOI 10.1016/j.plaphy.2009.10.005; Turkan I, 2009, ENVIRON EXP BOT, V67, P2, DOI 10.1016/j.envexpbot.2009.05.008; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Voisin D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000703; Wang WS, 2011, J EXP BOT, V62, P1951, DOI 10.1093/jxb/erq391; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wu RH, 2011, PLANT CELL, V23, P3392, DOI 10.1105/tpc.111.088625; WURR DCE, 1985, SEED SCI TECHNOL, V13, P11; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Xu ML, 2000, PLANT MOL BIOL REP, V18, P361, DOI 10.1007/BF02825064; Yi CX, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-259; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang N, 2011, MOL BIOL REP, V38, P2241, DOI 10.1007/s11033-010-0354-1; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhong L, 2009, AFR J BIOTECHNOL, V8, P6201; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	83	64	66	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75597	10.1371/journal.pone.0075597	http://dx.doi.org/10.1371/journal.pone.0075597			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086583	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200114
J	Miller, KA; Williams, LH; Dahl, HHM; Manji, SSM				Miller, Kerry A.; Williams, Louise H.; Dahl, Hans-Henrik M.; Manji, Shehnaaz S. M.			Eeyore: A Novel Mouse Model of Hereditary Deafness	PLOS ONE			English	Article							HEARING-LOSS; MOLECULAR CHARACTERIZATION; XERODERMA-PIGMENTOSUM; HISTAMINE-RECEPTOR; CADHERIN GENE; HUMAN-DISEASE; INNER-EAR; TIP-LINK; MUTATIONS; EXPRESSION	Animal models that recapitulate human disease are proving to be an invaluable tool in the identification of novel disease-associated genes. These models can improve our understanding of the complex genetic mechanisms involved in disease and provide a basis to guide therapeutic strategies to combat these conditions. We have identified a novel mouse model of non-syndromic sensorineural hearing loss with linkage to a region on chromosome 18. Eeyore mutant mice have early onset progressive hearing impairment and show abnormal structure of the sensory epithelium from as early as 4 weeks of age. Ultrastructural and histological analyses show irregular hair cell structure and degeneration of the sensory hair bundles in the cochlea. The identification of new genes involved in hearing is central to understanding the complex genetic pathways involved in the hearing process and the loci at which these pathways are interrupted in people with a genetic hearing loss. We therefore discuss possible candidate genes within the linkage region identified in eeyore that may underlie the deafness phenotype in these mice. Eeyore provides a new model of hereditary sensorineural deafness and will be an important tool in the search for novel deafness genes.	[Miller, Kerry A.; Williams, Louise H.; Dahl, Hans-Henrik M.; Manji, Shehnaaz S. M.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Dahl, Hans-Henrik M.; Manji, Shehnaaz S. M.] Univ Melbourne, HEARing CRC Audiol Hearing & Speech Sci, Melbourne, Vic, Australia; [Dahl, Hans-Henrik M.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Manji, Shehnaaz S. M.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Dept Otolaryngol, East Melbourne, Vic, Australia	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Royal Victorian Eye & Ear Hospital; University of Melbourne	Miller, KA (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.	kerry.miller@mcri.edu.au			NHMRC [436944]; J. & J. Calvert-Jones; Victorian Government's Operational Infrastructure Support (OIS) Program; HEARing CRC	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); J. & J. Calvert-Jones; Victorian Government's Operational Infrastructure Support (OIS) Program; HEARing CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by NHMRC grant #436944, J. & J. Calvert-Jones and the Victorian Government's Operational Infrastructure Support (OIS) Program. The authors acknowledge the financial support from the HEARing CRC, established and supported under the Cooperative Research Centers Program, an Australian Government Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahituv N, 2002, TRENDS MOL MED, V8, P447, DOI 10.1016/S1471-4914(02)02388-2; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Avraham KB, 2003, EAR HEARING, V24, P332, DOI 10.1097/01.AUD.0000079840.96472.DB; Bedell MA, 1997, GENE DEV, V11, P11, DOI 10.1101/gad.11.1.11; Beltramello M, 2005, NAT CELL BIOL, V7, P63, DOI 10.1038/ncb1205; BEMENT WM, 1994, P NATL ACAD SCI USA, V91, P11767; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Bruzzone R, 2005, NAT CELL BIOL, V7, P14, DOI 10.1038/ncb0105-14; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Han F, 2012, PHARMACOGENOMICS J, V12, P30, DOI 10.1038/tpj.2010.60; Henn A, 2005, J BIOL CHEM, V280, P39665, DOI 10.1074/jbc.M507667200; Hilgert N, 2009, CURR MOL MED, V9, P546, DOI 10.2174/156652409788488775; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; KANDA Y, 1974, J BIOL CHEM, V249, P6796; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kobayashi N, 2008, BIOINFORMATICS, V24, P1002, DOI 10.1093/bioinformatics/btn054; Lammens T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031206; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Li J, 2001, J BIOL CHEM, V276, P31233, DOI 10.1074/jbc.M104368200; Manji SSM, 2012, AM J PATHOL, V180, P1560, DOI 10.1016/j.ajpath.2011.12.034; Manji SSM, 2011, AM J PATHOL, V179, P903, DOI 10.1016/j.ajpath.2011.04.002; Manji SSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017607; Manji SSM, 2006, J NEUROSCI RES, V83, P181, DOI 10.1002/jnr.20721; Mburu Philomena, 1997, Genes and Function, V1, P191; Mhatre AN, 2002, BIOCHEM BIOPH RES CO, V297, P987, DOI 10.1016/S0006-291X(02)02296-9; Miller KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051284; Mohr PE, 2000, INT J TECHNOL ASSESS, V16, P1120, DOI 10.1017/S0266462300103162; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Nakamura T, 2000, BIOCHEM BIOPH RES CO, V279, P615, DOI 10.1006/bbrc.2000.4008; Nakano A, 2002, HUM GENET, V110, P41, DOI 10.1007/s00439-001-0630-1; Nicchia GP, 2011, NEUROSCIENCE, V197, P80, DOI 10.1016/j.neuroscience.2011.09.023; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; Oda T, 2000, J BIOL CHEM, V275, P36781, DOI 10.1074/jbc.M006480200; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; REID RA, 1990, NUCLEIC ACIDS RES, V18, P5896, DOI 10.1093/nar/18.19.5896; Rhodes CR, 2004, MAMM GENOME, V15, P686, DOI 10.1007/s00335-004-2344-x; Rosenthal N, 2007, NAT CELL BIOL, V9, P993, DOI 10.1038/ncb437; Rothenberg ME, 2010, NAT GENET, V42, P289, DOI 10.1038/ng.547; Rozen S, 2003, BIOINFORMATICS METHO, P365; RYAN MC, 1994, J BIOL CHEM, V269, P22779; Saraiva MJM, 2001, HUM MUTAT, V17, P493, DOI 10.1002/humu.1132; Schrijver I, 2004, J MOL DIAGN, V6, P275, DOI 10.1016/S1525-1578(10)60522-3; Schwander M, 2009, J NEUROSCI, V29, P15810, DOI 10.1523/JNEUROSCI.4876-09.2009; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Tamagawa Y, 2002, LARYNGOSCOPE, V112, P292, DOI 10.1097/00005537-200202000-00017; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; VERMEULEN W, 1994, AM J HUM GENET, V54, P191; VOLINIA S, 1995, EMBO J, V14, P3339, DOI 10.1002/j.1460-2075.1995.tb07340.x; Wada T, 2001, BIOCHEM BIOPH RES CO, V283, P113, DOI 10.1006/bbrc.2001.4724; Wayne S, 1996, HUM MOL GENET, V5, P1689, DOI 10.1093/hmg/5.10.1689; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U; Whitlon DS, 2001, BRAIN RES PROTOC, V6, P159, DOI 10.1016/S1385-299X(00)00048-9; Yonezawa S, 2006, HUM MUTAT, V27, P88, DOI 10.1002/humu.20266; Yoshida Y, 2009, NUCLEIC ACIDS RES, V37, pW147, DOI 10.1093/nar/gkp384; Yueh B, 2003, JAMA-J AM MED ASSOC, V289, P1976, DOI 10.1001/jama.289.15.1976; Zhang YP, 2005, P NATL ACAD SCI USA, V102, P15201, DOI 10.1073/pnas.0501859102	64	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74243	10.1371/journal.pone.0074243	http://dx.doi.org/10.1371/journal.pone.0074243			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086324	Green Published, gold			2022-12-27	WOS:000326520200025
J	Ren, LL; Xiao, Y; Li, JG; Chen, L; Zhang, J; Vernet, G; Wang, JW				Ren, Lili; Xiao, Yan; Li, Jianguo; Chen, Lan; Zhang, Jing; Vernet, Guy; Wang, Jianwei			Multiple Genomic Recombination Events in the Evolution of Saffold Cardiovirus	PLOS ONE			English	Article							RNA RECOMBINATION; PHYLOGENETIC ANALYSIS; VIRUS-INFECTIONS; CHILDREN; FREQUENCY; DYNAMICS; SEQUENCE; CIRCULATION; SELECTION; GENETICS	Background: Saffold cardiovirus (SAFV) is a new human cardiovirus with 11 identified genotypes. Little is known about the natural history and pathogenicity of SAFVs. Methodology/Principal Findings: We sequenced the genome of five SAFV-1 strains which were identified from fecal samples taken from children with viral diarrhea in Beijing, China between March 2006 and November 2007, and analyzed the phylogenetic and phylodynamic properties of SAFVs using the genome sequences of every known SAFV genotypes. We identified multiple recombination events in our SAFV-1 strains, specifically recombination between SAFV-2, -3, -4, -9, -10 and the prototype SAFV-1 strain in the VP4 region and recombination between SAFV-4, -6, -8, -10, -11 and prototype SAFV-1 in the VP1/2A region. Notably, recombination in the structural gene VP4 is a rare event in Cardiovirus. The ratio of nonsynonymous substitutions to synonymous substitutions indicates a purifying selection of the SAFV genome. Phylogenetic and molecular clock analysis indicates the existence of at least two subclades of SAFV-1 with different origins. Subclade 1 includes two strains isolated from Pakistan, whereas subclade 2 includes the prototype strain and strains isolated in China, Pakistan, and Afghanistan. The most recent common ancestor of all SAFV genotypes dates to the 1710s, and SAFV-1, -2, and -3 to the 1940s, 1950s, and 1960s, respectively. No obvious relationship between variation and pathogenicity exists in the critical domains of the CD and EF loops of viral capsid proteins or the multi-functional proteins L based on animo acid sequence identity comparison between SAFV genotypes. Conclusions/Significance: Our findings suggest that intertypic recombination plays an important role in the diversity of SAFVs, highlighting the diversity of the five strains with the previously described SAFV-1 strains.	[Ren, Lili; Xiao, Yan; Li, Jianguo; Chen, Lan; Zhang, Jing; Wang, Jianwei] Chinese Acad Med Sci, Inst Pathogen Biol, CAMS Fdn Merieux, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Ren, Lili; Xiao, Yan; Li, Jianguo; Chen, Lan; Zhang, Jing; Wang, Jianwei] Chinese Acad Med Sci, Inst Pathogen Biol, CAMS Fdn Merieux, Dr Christophe Merieux Lab, Beijing 100730, Peoples R China; [Ren, Lili; Xiao, Yan; Li, Jianguo; Chen, Lan; Zhang, Jing; Wang, Jianwei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Vernet, Guy] Fdn Merieux, Lyon, France	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, JW (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, CAMS Fdn Merieux, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	wangjw28@163.com	Wang, Jianwei/W-5916-2019; Wang, Jianwei/AAW-9499-2020	Wang, Jianwei/0000-0002-1116-4559	China National Funds for Distinguished Young Scientists [81225014]; International Science and Technology Cooperation Program of China [2010DFB33270]; National Major Science and Technology Project for Control and Prevention of Major Infectious Diseases of China [2012ZX10004-206]	China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation Program of China; National Major Science and Technology Project for Control and Prevention of Major Infectious Diseases of China	This study was supported in part by China National Funds for Distinguished Young Scientists (81225014) (http://www.nsfc.gov.cn), the International Science and Technology Cooperation Program of China (2010DFB33270) (http://www.cistc.gov.cn) and National Major Science and Technology Project for Control and Prevention of Major Infectious Diseases of China (2012ZX10004-206) (http://www.nmp.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abed Y, 2008, EMERG INFECT DIS, V14, P834, DOI 10.3201/eid1405.071675; Austermann-Busch S, 2012, J VIROL, V86, P7393, DOI 10.1128/JVI.00864-12; Becher P, 2001, J VIROL, V75, P6256, DOI 10.1128/JVI.75.14.6256-6264.2001; Blinkova O, 2009, J VIROL, V83, P4631, DOI 10.1128/JVI.02085-08; Borghese F, 2011, J VIROL, V85, P9614, DOI 10.1128/JVI.00480-11; Brown DWG, 1997, REV MED VIROL, V7, P239, DOI 10.1002/(SICI)1099-1654(199712)7:4&lt;239::AID-RMV210&gt;3.0.CO;2-Q; Calvert J, 2010, J GEN VIROL, V91, P1229, DOI 10.1099/vir.0.018747-0; Cuervo NS, 2001, J VIROL, V75, P5740, DOI 10.1128/JVI.75.13.5740-5751.2001; Drexler JF, 2008, EMERG INFECT DIS, V14, P1398, DOI 10.3201/eid1409.080570; Drexler JF, 2010, J GEN VIROL, V91, P1418, DOI 10.1099/vir.0.018887-0; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Himeda T, 2012, J VIROL, V86, P1292, DOI 10.1128/JVI.06087-11; Itagaki T, 2010, SCAND J INFECT DIS, V42, P950, DOI 10.3109/00365548.2010.496791; Jones MS, 2007, J CLIN MICROBIOL, V45, P2144, DOI 10.1128/JCM.00174-07; Kapusinszky B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036685; KHATCHIKIAN D, 1989, NATURE, V340, P156, DOI 10.1038/340156a0; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Lam TTY, 2010, CRIT REV CL LAB SCI, V47, P5, DOI 10.3109/10408361003633318; Liang Z, 2008, J VIROL, V82, P11545, DOI 10.1128/JVI.01160-08; McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10; Nielsen ACY, 2012, EMERG INFECT DIS, V18, P7, DOI 10.3201/eid1801.110725; Nora T, 2007, J VIROL, V81, P7620, DOI 10.1128/JVI.00083-07; Norstrom MM, 2012, NEW MICROBIOL, V35, P101; Oberste MS, 2004, J VIROL, V78, P2948, DOI 10.1128/JVI.78.6.2948-2955.2004; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ren LL, 2010, EMERG INFECT DIS, V16, P1158, DOI 10.3201/eid1607.091682; Ren LL, 2009, EMERG INFECT DIS, V15, P1509, DOI 10.3201/eid1509.081531; Shapka N, 2004, J VIROL, V78, P2288, DOI 10.1128/JVI.78.5.2288-2300.2004; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Simmonds P, 2006, J VIROL, V80, P11124, DOI 10.1128/JVI.01076-06; Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614; Sun GM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-439; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; Tosh C, 2002, J GEN VIROL, V83, P2455, DOI 10.1099/0022-1317-83-10-2455; van Eyll O, 2002, J VIROL, V76, P10665, DOI 10.1128/JVI.76.21.10665-10673.2002; Xu ZQ, 2009, EMERG INFECT DIS, V15, P993, DOI 10.3201/eid1506.090109; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zoll J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000416	41	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74947	10.1371/journal.pone.0074947	http://dx.doi.org/10.1371/journal.pone.0074947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086404	Green Published, gold			2022-12-27	WOS:000326520200059
J	Iyer, A; LaPointe, NE; Zielke, K; Berdynski, M; Guzman, E; Barczak, A; Chodakowska-Zebrowska, M; Barcikowska, M; Feinstein, S; Zekanowski, C				Iyer, Abhinaya; LaPointe, Nichole E.; Zielke, Krzysztof; Berdynski, Mariusz; Guzman, Elmer; Barczak, Anna; Chodakowska-Zebrowska, Malgorzata; Barcikowska, Maria; Feinstein, Stuart; Zekanowski, Cezary			A Novel MAPT Mutation, G55R, in a Frontotemporal Dementia Patient Leads to Altered Tau Function	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; PAIRED HELICAL FILAMENTS; MICROTUBULE DYNAMICS; ALZHEIMERS-DISEASE; GENE-MUTATIONS; EPOTHILONE D; IN-VITRO; PROTEIN; FTDP-17; INSTABILITY	Over two dozen mutations in the gene encoding the microtubule associated protein tau cause a variety of neurodegenerative dementias known as tauopathies, including frontotemporal dementia (FTD), PSP, CBD and Pick's disease. The vast majority of these mutations map to the C-terminal region of tau possessing microtubule assembly and microtubule dynamics regulatory activities as well as the ability to promote pathological tau aggregation. Here, we describe a novel and non-conservative tau mutation (G55R) mapping to an alternatively spliced exon encoding part of the N-terminal region of the protein in a patient with the behavioral variant of FTD. Although less well understood than the C-terminal region of tau, the N-terminal region can influence both MT mediated effects as well as tau aggregation. The mutation changes an uncharged glycine to a basic arginine in the midst of a highly conserved and very acidic region. In vitro, 4-repeat G55R tau nucleates microtubule assembly more effectively than wild-type 4-repeat tau; surprisingly, this effect is tau isoform specific and is not observed in a 3-repeat G55R tau versus 3-repeat wild-type tau comparison. In contrast, the G55R mutation has no effect upon the abilities of tau to regulate MT growing and shortening dynamics or to aggregate. Additionally, the mutation has no effect upon kinesin translocation in a microtubule gliding assay. Together, (i) we have identified a novel tau mutation mapping to a mutation deficient region of the protein in a bvFTD patient, and (ii) the G55R mutation affects the ability of tau to nucleate microtubule assembly in vitro in a 4-repeat tau isoform specific manner. This altered capability could markedly affect in vivo microtubule function and neuronal cell biology. We consider G55R to be a candidate mutation for bvFTD since additional criteria required to establish causality are not yet available for assessment.	[Iyer, Abhinaya; LaPointe, Nichole E.; Guzman, Elmer; Feinstein, Stuart] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Iyer, Abhinaya; LaPointe, Nichole E.; Guzman, Elmer; Feinstein, Stuart] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Zielke, Krzysztof] 105 Mil Hosp Outpatient Clin Zary SPZOZ, Dept Psychiat, Zary, Poland; [Berdynski, Mariusz; Barcikowska, Maria; Zekanowski, Cezary] Polish Acad Sci, Neurogenet Lab, Mossakowski Med Res Ctr, Warsaw, Poland; [Barczak, Anna; Chodakowska-Zebrowska, Malgorzata; Barcikowska, Maria] MSWiA Hosp, Neurol Clin, Warsaw, Poland	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Feinstein, S (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA.	feinstei@lifesci.ucsb.edu	Berdyński, Mariusz/W-2382-2018	Berdyński, Mariusz/0000-0003-2076-4318; Zekanowski, Cezary/0000-0001-7332-8494; Barcikowska, Maria/0000-0001-5657-9670	National Institutes of Health [NS35010]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by grant NS35010 from the National Institutes of Health (www.nih.gov) to SF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonarakis SE, 2010, VOGEL AND MOTULSKY'S HUMAN GENETICS, FOURTH EDITION, P319, DOI 10.1007/978-3-540-37654-5_10; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Borroni B, 2009, NEUROBIOL AGING, V30, P34, DOI 10.1016/j.neurobiolaging.2007.05.009; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Brunden KR, 2010, J NEUROSCI, V30, P13861, DOI 10.1523/JNEUROSCI.3059-10.2010; Bunker JM, 2006, J BIOL CHEM, V281, P11856, DOI 10.1074/jbc.M509420200; Bunker JM, 2004, MOL BIOL CELL, V15, P2720, DOI 10.1091/mbc.E04-01-0062; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; CACERES A, 1991, J NEUROSCI, V11, P1515; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; Cohn-Hokke PE, 2012, AM J MED GENET B, V159B, P628, DOI 10.1002/ajmg.b.32080; Combs B, 2012, BIOCHEMISTRY-US, V51, P8597, DOI 10.1021/bi3010818; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Cotton RGH, 1998, HUM MUTAT, V12, P1, DOI 10.1002/(SICI)1098-1004(1998)12:1<1::AID-HUMU1>3.0.CO;2-M; Delobel P, 2002, J BIOL CHEM, V277, P9199, DOI 10.1074/jbc.M107716200; Dolan PJ, 2010, CURR OPIN DRUG DISC, V13, P595; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Duncan JE, 2006, PLOS GENET, V2, P1275, DOI 10.1371/journal.pgen.0020124; ESMAELIAZAD B, 1994, J CELL SCI, V107, P869; Feinstein SC, 2005, BBA-MOL BASIS DIS, V1739, P268, DOI 10.1016/j.bbadis.2004.07.002; Ferrari R, 2011, J MOL NEUROSCI, V45, P500, DOI 10.1007/s12031-011-9635-y; Galimberti D., 2012, FRONT NEUROL, V3, P1; Gamblin TC, 2000, BIOCHEMISTRY-US, V39, P6136, DOI 10.1021/bi000201f; Goedert M, 2000, ANN NY ACAD SCI, V920, P74; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Goedert M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006254; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; Guerreiro RJ, 2010, NEUROBIOL AGING, V31, P725, DOI 10.1016/j.neurobiolaging.2008.06.012; Hayashi S, 2002, ANN NEUROL, V51, P525, DOI 10.1002/ana.10163; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; HIMMLER A, 1989, MOL CELL BIOL, V9, P1389, DOI 10.1128/MCB.9.4.1389; Hogg M, 2003, ACTA NEUROPATHOL, V106, P323, DOI 10.1007/s00401-003-0734-x; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Kertesz A, 2010, IDEGGYOGY SZEMLE, V63, P4; Kim W, 2010, FEBS LETT, V584, P3085, DOI 10.1016/j.febslet.2010.05.042; Kim W, 2010, J ALZHEIMERS DIS, V19, P647, DOI 10.3233/JAD-2010-1273; King ME, 2000, J NEUROCHEM, V74, P1749, DOI 10.1046/j.1471-4159.2000.0741749.x; Kiris E, 2011, J BIOL CHEM, V286, P14257, DOI 10.1074/jbc.M111.219311; KWON J, 2009, TAU MUTATIONS TABLE; LEBOEUF AC, 2008, J BIOL CHEM; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; Levy SF, 2005, J BIOL CHEM, V280, P13520, DOI 10.1074/jbc.M413490200; Lopus M, 2010, MOL CANCER THER, V9, P2689, DOI 10.1158/1535-7163.MCT-10-0644; Makrides V, 2003, J BIOL CHEM, V278, P33298, DOI 10.1074/jbc.M305207200; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Mi Kaihong, 2006, Current Alzheimer Research, V3, P449, DOI 10.2174/156720506779025279; Michaelis ML, 2005, J PHARMACOL EXP THER, V312, P659, DOI 10.1124/jpet.104.074450; Miller HP, 2010, METHOD CELL BIOL, V95, P3, DOI 10.1016/S0091-679X(10)95001-2; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neumann M, 2001, ANN NEUROL, V50, P503, DOI 10.1002/ana.1223; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Peck A, 2011, CYTOSKELETON, V68, P44, DOI 10.1002/cm.20494; Pickering-Brown SM, 2004, BRAIN, V127, P1415, DOI 10.1093/brain/awh147; Pittman AM, 2005, J MED GENET, V42, P837, DOI 10.1136/jmg.2005.031377; Poorkaj P, 2002, ANN NEUROL, V52, P511, DOI 10.1002/ana.10340; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Rohrer JD, 2011, CURR OPIN NEUROL, V24, P542, DOI 10.1097/WCO.0b013e32834cd442; Rohrer JD, 2011, BRAIN, V134, P2565, DOI 10.1093/brain/awr198; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; Seelaar H, 2011, J NEUROL NEUROSUR PS, V82, P476, DOI 10.1136/jnnp.2010.212225; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Stiess M, 2010, SCIENCE, V327, P704, DOI 10.1126/science.1182179; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; Whitwell JL, 2009, BRAIN, V132, P2932, DOI 10.1093/brain/awp232; Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200; Yenjerla M, 2010, METHOD CELL BIOL, V95, P189, DOI 10.1016/S0091-679X(10)95011-5; YU WQ, 1993, J CELL BIOL, V122, P349, DOI 10.1083/jcb.122.2.349; Zekanowski C, 2003, DEMENT GERIATR COGN, V16, P126, DOI 10.1159/000070999; Zhang B, 2012, J NEUROSCI, V32, P3601, DOI 10.1523/JNEUROSCI.4922-11.2012; Zhong Q, 2012, J BIOL CHEM, V287, P20711, DOI 10.1074/jbc.M112.364067	87	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76409	10.1371/journal.pone.0076409	http://dx.doi.org/10.1371/journal.pone.0076409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086739	gold, Green Submitted, Green Published			2022-12-27	WOS:000325223900101
J	Murai, M; Ruffler, H; Berlemont, A; Campbell, G; Esono, F; Agbor, A; Mbomio, D; Ebana, A; Nze, A; Kuhl, HS				Murai, Mizuki; Ruffler, Heidi; Berlemont, Antoine; Campbell, Genevieve; Esono, Fidel; Agbor, Anthony; Mbomio, Domingo; Ebana, Agustin; Nze, Antonio; Kuehl, Hjalmar S.			Priority Areas for Large Mammal Conservation in Equatorial Guinea	PLOS ONE			English	Article							GORILLA-GORILLA; PROTECTED AREAS; NATIONAL-PARK; RAIN-FORESTS; CONGO BASIN; RIO-MUNI; BUSHMEAT; ABUNDANCE; PRIMATE; CENSUS	Hunting is one of the main driving forces behind large mammal density distribution in many regions of the world. In tropical Africa, urban demand for bushmeat has been shown to dominate over subsistence hunting and its impact often overrides spatial-ecological species characteristics. To effectively protect remaining mammal populations the main factors that influence their distribution need to be integrated into conservation area prioritisation and management plans. This information has been lacking for Rio Muni, Equatorial Guinea, as prior studies have been outdated or have not systematically covered the continental region of the country. In this study we evaluated: 1) the relative importance of local vs. commercial hunting; 2) wildlife density of protected vs. non-protected areas; and 3) the importance of ecological factors vs. human influence in driving mammal density distribution in Rio Muni. We adopted a systematic countrywide line transect approach with particular focus on apes and elephants, but also including other mammal species. For analysis of field data we used generalised linear models with a set of predictor variables representing ecological conditions, anthropogenic pressure and protected areas. We estimate that there are currently 884 (437-1,789) elephants and 11,097 (8,719-13,592) chimpanzees and gorillas remaining in Rio Muni. The results indicate strong hunting pressures on both local and commercial levels, with roads demonstrating a negative impact on elephants and overall mammal body mass. Protected areas played no role in determining any of the mammal species distributions and significant human hunting signs were found inside these protected areas, illustrating the lack of environmental law enforcement throughout the country. Rio Muni is currently under-represented in conservation efforts in Western Equatorial Africa, and we recommend a focus on cross-boundary conservation, in particular in the Monte Alen-Monts de Cristal and Rio Campo Ma'an conservation landscapes, where the highest densities and diversity of large mammals remain.	[Murai, Mizuki; Campbell, Genevieve; Kuehl, Hjalmar S.] Max Planck Inst Evolutionary Anthropol MPI EVA, Leipzig, Germany; [Murai, Mizuki; Ruffler, Heidi; Berlemont, Antoine; Agbor, Anthony; Mbomio, Domingo] CI, Arlington, VA USA; [Esono, Fidel] Natl Inst Forestry Dev & Protected Area Managemen, Bata, Equat Guinea; [Ebana, Agustin; Nze, Antonio] Natl Univ Equatorial Guinea UNGE, Malabo, Equat Guinea	Max Planck Society	Murai, M (corresponding author), Max Planck Inst Evolutionary Anthropol MPI EVA, Leipzig, Germany.	m.murai@hotmail.co.uk			United States Fish and Wildlife Service; Margot Marsh Biodiversity Foundation; USAID/CARPE (United States Agency for International Development's Central African Regional Program for the Environment)	United States Fish and Wildlife Service(US Fish & Wildlife Service); Margot Marsh Biodiversity Foundation; USAID/CARPE (United States Agency for International Development's Central African Regional Program for the Environment)(United States Agency for International Development (USAID))	This project was funded by the United States Fish and Wildlife Service, the Margot Marsh Biodiversity Foundation, and the USAID/CARPE (United States Agency for International Development's Central African Regional Program for the Environment). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allebone-Webb SM, 2011, CONSERV BIOL, V25, P597, DOI 10.1111/j.1523-1739.2011.01681.x; [Anonymous], 2012, BBC; BARNES REW, 1989, IVORY TRADE FUTURE A; BARNES RFW, 1991, AFR J ECOL, V29, P54, DOI 10.1111/j.1365-2028.1991.tb00820.x; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; Blanc Julian J., 2007, AFRICAN ELEPHANT STA; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Buckland S.T., 2001, pi; Campbell G., 2008, CURR BIOL, V18, P904; *CARPE, 2006, FOR CONG BAS STAT FO; CARROLL RW, 1986, PRIM CONSERV, V7, P38; CASTROVIEJO J, 1994, BIODIVERS CONSERV, V3, P951, DOI 10.1007/BF00129669; *CI, 2012, REP CHIN URB RES CON; *CITES, 2011, STAT EL POP LEV ILL; Cowlishaw G, 2005, J APPL ECOL, V42, P460, DOI 10.1111/j.1365-2664.2005.01046.x; Dupain J, 2004, ORYX, V38, P209, DOI 10.1017/S0030605304000365; East T, 2005, BIOL CONSERV, V126, P206, DOI 10.1016/j.biocon.2005.05.012; Fa J.E., 1992, Oryx, V26, P87; Fa JE, 2005, BIOL CONSERV, V121, P167, DOI 10.1016/j.biocon.2004.04.016; FA JE, 1995, CONSERV BIOL, V9, P1107, DOI 10.1046/j.1523-1739.1995.951107.x; Fa JE, 1997, J ANIM ECOL, V66, P98, DOI 10.2307/5968; Fa JE, 2009, MAMMAL REV, V39, P231, DOI 10.1111/j.1365-2907.2009.00149.x; FAY JM, 1992, AM J PRIMATOL, V27, P275, DOI 10.1002/ajp.1350270405; Garcia JE, 1997, ORYX, V31, P67, DOI 10.1046/j.1365-3008.1997.d01-5.x; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; GonzalezKirchner JP, 1997, FOLIA ZOOL, V46, P15; Hart JA, 1996, CONSERV BIOL, V10, P316, DOI 10.1046/j.1523-1739.1996.10020316.x; Hedges S., 2006, DUNG SURVEY STANDARD; Hedley SL, 2004, J AGR BIOL ENVIR ST, V9, P181, DOI 10.1198/1085711043578; Inogwabini BI, 2012, AFR J ECOL, V50, P285, DOI 10.1111/j.1365-2028.2012.01323.x; ISSAC NJB, 2004, P ROY SOC LOND B BIO, V271, P1135; Jennings S, 1998, P ROY SOC B-BIOL SCI, V265, P333, DOI 10.1098/rspb.1998.0300; Jones C, 1971, Biblthca primatol, V13, P1; Junker J, 2012, DIVERS DISTRIB, V18, P1077, DOI 10.1111/ddi.12005; K?hl H., 2008, BEST PRACTICE GUIDEL; Kaplinsky R., 2007, 291 IDS; Karsenty A., 2007, OVERVIEW IND FOREST; Khl H., 2007, GORILLA J, V34, P20; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; Koops K, 2012, INT J PRIMATOL, V33, P356, DOI 10.1007/s10764-012-9585-4; Kouakou CY, 2009, AM J PRIMATOL, V71, P447, DOI 10.1002/ajp.20673; Kuehl HS, 2007, ECOL APPL, V17, P2403, DOI 10.1890/06-0934.1; Kuehl HS, 2009, BIOL CONSERV, V142, P1500, DOI 10.1016/j.biocon.2009.02.032; Kumpel NF, 2010, HUM ECOL, V38, P251, DOI 10.1007/s10745-010-9316-4; Laing SE, 2003, J APPL ECOL, V40, P1102, DOI 10.1111/j.1365-2664.2003.00861.x; LARISON B, 1999, BIOTIC SURVEYS BIOKO; Lee MC, 2006, J CONTEMP AFR STUD, V24, P303, DOI 10.1080/02589000600976570; Matthews A, 2004, PRIMATES, V45, P15, DOI 10.1007/s10329-003-0058-4; McCullagh P, 1989, GEN LINEAR MODELS; McNeilage A, 2006, ORYX, V40, P419, DOI 10.1017/S0030605306001311; Morgan D, 2006, INT J PRIMATOL, V27, P147, DOI 10.1007/s10764-005-9013-0; N'Goran PK, 2012, CONSERV BIOL, V26, P565, DOI 10.1111/j.1523-1739.2012.01821.x; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; NCHANJI AC, 2005, BIODIVERSITY ASSESSM, P70; Norris K, 2010, BIOL CONSERV, V143, P2341, DOI 10.1016/j.biocon.2009.12.032; PI JS, 1972, MAN, V7, P239; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Plumptre AJ, 2006, PRIMATES, V47, P65, DOI 10.1007/s10329-005-0146-8; Puit Marielle, 2006, Pachyderm, V41, P44; R Development Core Team, 2012, R LANG ENV STAT COMP; Remis MJ, 2012, AM J PRIMATOL, V74, P602, DOI 10.1002/ajp.22012; Remis MJ, 2011, AFR J ECOL, V49, P70, DOI 10.1111/j.1365-2028.2010.01229.x; Sanz C, 2007, J APPL ECOL, V44, P263, DOI 10.1111/j.1365-2664.2007.01278.x; Stokes EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010294; Struhsaker TT, 2005, BIOL CONSERV, V123, P45, DOI 10.1016/j.biocon.2004.10.007; SUNDERLAND TCH, 2005, BIODIVERSITY ASSESSM; TCHAMBA MN, 1991, NATURE FAUNE, V7, P27; Thomas L., 2009, DISTANCE 6 0 RELEASE; THOMAS S, 2012, HUMAN ELEPHANT CONFL; Tranquilli S, 2012, CONSERV LETT, V5, P48, DOI 10.1111/j.1755-263X.2011.00211.x; TUTIN CEG, 1984, AM J PRIMATOL, V6, P313, DOI 10.1002/ajp.1350060403; Walsh PD, 2005, ECOL APPL, V15, P1342, DOI 10.1890/03-5283; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Walsh PD, 2001, J APPL ECOL, V38, P217, DOI 10.1046/j.1365-2664.2001.00578.x; Wich SA, 2012, BIOL CONSERV, V146, P163, DOI 10.1016/j.biocon.2011.12.006; Wilkie DS, 1999, BIODIVERS CONSERV, V8, P927, DOI 10.1023/A:1008877309871; *WORLD BANK, 2011, SUB SAH AFR; YAMAGIWA J, 2008, AFRICAN STUDY MONO S, V29, P3	78	21	21	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75024	10.1371/journal.pone.0075024	http://dx.doi.org/10.1371/journal.pone.0075024			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086426	Green Submitted, Green Published, gold			2022-12-27	WOS:000325223900034
J	Shore, DA; Yang, H; Balish, AL; Shepard, SS; Carney, PJ; Chang, JC; Davis, CT; Donis, RO; Villanueva, JM; Klimov, AI; Stevens, J				Shore, David A.; Yang, Hua; Balish, Amanda L.; Shepard, Samuel S.; Carney, Paul J.; Chang, Jessie C.; Davis, Charles T.; Donis, Ruben O.; Villanueva, Julie M.; Klimov, Alexander I.; Stevens, James			Structural and Antigenic Variation among Diverse Clade 2 H5N1 Viruses	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RECEPTOR-BINDING SPECIFICITY; AVIAN INFLUENZA-VIRUSES; TO-PERSON TRANSMISSION; A VIRUSES; HEMAGGLUTININ; VACCINE; EVOLUTION; SELECTION; IMMUNOGENICITY	Antigenic variation among circulating H5N1 highly pathogenic avian influenza A viruses mandates the continuous production of strain-specific pre-pandemic vaccine candidates and represents a significant challenge for pandemic preparedness. Here we assessed the structural, antigenic and receptor-binding properties of three H5N1 HPAI virus hemagglutinins, which were recently selected by the WHO as vaccine candidates [A/Egypt/N03072/2010 (Egypt10, clade 2.2.1), A/Hubei/1/2010 (Hubei10, clade 2.3.2.1) and A/Anhui/1/2005 (Anhui05, clade 2.3.4)]. These analyses revealed that antigenic diversity among these three isolates was restricted to changes in the size and charge of amino acid side chains at a handful of positions, spatially equivalent to the antigenic sites identified in H1 subtype viruses circulating among humans. All three of the H5N1 viruses analyzed in this study were responsible for fatal human infections, with the most recently-isolated strains, Hubei10 and Egypt10, containing multiple residues in the receptor-binding site of the HA, which were suspected to enhance mammalian transmission. However, glycan-binding analyses demonstrated a lack of binding to human alpha 2-6-linked sialic acid receptor analogs for all three HAs, reinforcing the notion that receptor-binding specificity contributes only partially to transmissibility and pathogenesis of HPAI viruses and suggesting that changes in host specificity must be interpreted in the context of the host and environmental factors, as well as the virus as a whole. Together, our data reveal structural linkages with phylogenetic and antigenic analyses of recently emerged H5N1 virus clades and should assist in interpreting the significance of future changes in antigenic and receptor-binding properties.	[Shore, David A.; Yang, Hua; Balish, Amanda L.; Shepard, Samuel S.; Carney, Paul J.; Chang, Jessie C.; Davis, Charles T.; Donis, Ruben O.; Villanueva, Julie M.; Klimov, Alexander I.; Stevens, James] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Stevens, J (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30329 USA.	fwb4@cdc.gov	Stevens, James/GQH-1081-2022		Centers for Disease Control and Prevention; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Centers for Disease Control by the Consortium for Functional Glycomics (CFG); National Institute of General Medical Sciences [GM62116]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Centers for Disease Control by the Consortium for Functional Glycomics (CFG); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Centers for Disease Control and Prevention. This research was supported in part by an appointment to the Research Participation Program at the Centers for Disease Control and Prevention administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and CDC. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Glycan microarrays were produced under contract for the Centers for Disease Control by the Consortium for Functional Glycomics (CFG) funded by National Institute of General Medical Sciences Grant GM62116. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P418; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P97; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P93; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P359; Auewarakul P, 2007, J VIROL, V81, P9950, DOI 10.1128/JVI.00468-07; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrera-Badillo Gisela, 2012, Morbidity and Mortality Weekly Report, V61, P726; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Blixt O, 2008, GLYCOCONJUGATE J, V25, P27, DOI 10.1007/s10719-007-9045-0; Brown IH, 2009, INFLUENZA OTHER RESP, V3, P59, DOI 10.1111/j.1750-2659.2009.00078.x; Cai ZP, 2012, J MOL BIOL, V422, P145, DOI 10.1016/j.jmb.2012.05.011; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; *CDC, 2012, H5N1 GEN CHANG INV T; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; CHAYEN NE, 1992, J CRYST GROWTH, V122, P176, DOI 10.1016/0022-0248(92)90241-A; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Vries RP, 2010, VIROLOGY, V403, P17, DOI 10.1016/j.virol.2010.03.047; Donis R. O., 2008, Emerging Infectious Diseases, V14, pe1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fauci AS, 2006, J INFECT DIS, V194, pS73, DOI 10.1086/507550; FITCH WM, 1991, P NATL ACAD SCI USA, V88, P4270, DOI 10.1073/pnas.88.10.4270; Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Ilyushina NA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000043; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Imai M, 2012, CURR OPIN VIROL, V2, P160, DOI 10.1016/j.coviro.2012.03.003; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Jia N, 2009, J CLIN VIROL, V44, P225, DOI 10.1016/j.jcv.2008.12.014; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Klimov Alexander, 2012, Methods Mol Biol, V865, P25, DOI 10.1007/978-1-61779-621-0_3; Kongchanagul A, 2008, J GEN VIROL, V89, P1805, DOI 10.1099/vir.0.2008/002469-0; Lee MS, 2003, J INFECT DIS, V188, P1362, DOI 10.1086/379045; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Naughtin M, 2011, ANTIMICROB AGENTS CH, V55, P2004, DOI 10.1128/AAC.01773-10; O'Neill E, 2009, CURR TOP MICROBIOL, V333, P83, DOI 10.1007/978-3-540-92165-3_4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peiris JSM, 2012, SCIENCE, V335, P1173, DOI 10.1126/science.1219936; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Russell CA, 2008, VACCINE, V26, pD31, DOI 10.1016/j.vaccine.2008.07.078; Russell RJ, 2006, GLYCOCONJUGATE J, V23, P85, DOI 10.1007/s10719-006-5440-1; SHEPARD SS, 2013, LABEL FAST ACCURATE; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Su Y, 2008, ARCH VIROL, V153, P2253, DOI 10.1007/s00705-008-0255-y; Subbarao K, 2003, VIROLOGY, V305, P192, DOI 10.1006/viro.2002.1742; Tang JW, 2008, J MED VIROL, V80, P1992, DOI 10.1002/jmv.21321; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Wan XF, 2011, J VIROL, V85, P13432, DOI 10.1128/JVI.05266-11; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; Wang WJ, 2010, J VIROL, V84, P6570, DOI 10.1128/JVI.00221-10; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WHO, 2013, CAND VACC VIR POT TE; *WHO, 2006, AV INFL SIT IND UPD; *WHO, 2011, MAN LAB DIAGN VIR SU, P48; WHO, 2012, CUM NUMB CONF HUM CA; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu WL, 2008, J VIROL, V82, P1798, DOI 10.1128/JVI.02256-07; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; YANG H, 2010, PLOS CURR; Yang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001081; Yang Ji-xing, 2009, Zhonghua Yufang Yixue Zazhi, V43, P305, DOI 10.3760/cma.j.issn.0253-9624.2009.04.009; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Yen HL, 2009, P NATL ACAD SCI USA, V106, P286, DOI 10.1073/pnas.0811052106; Younan M, 2013, EMERG INFECT DIS, V19, P43, DOI 10.3201/eid1901.121080	84	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75209	10.1371/journal.pone.0075209	http://dx.doi.org/10.1371/journal.pone.0075209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086467	gold, Green Published, Green Submitted			2022-12-27	WOS:000325223900038
J	Yan, J; Seibenhener, ML; Calderilla-Barbosa, L; Diaz-Meco, MT; Moscat, J; Jiang, JX; Wooten, MW; Wooten, MC				Yan, Jin; Seibenhener, Michael Lamar; Calderilla-Barbosa, Luis; Diaz-Meco, Maria-Theresa; Moscat, Jorge; Jiang, Jianxiong; Wooten, Marie W.; Wooten, Michael C.			SQSTM1/p62 Interacts with HDAC6 and Regulates Deacetylase Activity	PLOS ONE			English	Article							SEQUESTOSOME 1/P62; PROTEIN; TUBULIN; ACETYLATION; BINDING; P62; MICROTUBULES; P62/SQSTM1; AGGRESOMES; DEGRADATION	Protein aggregates can form in the cytoplasm of the cell and are accumulated at aggresomes localized to the microtubule organizing center (MTOC) where they are subsequently degraded by autophagy. In this process, aggregates are engulfed into autophagosomes which subsequently fuse with lysosomes for protein degradation. A member of the class II histone deacetylase family, histone deacetylase 6(HDAC6) has been shown to be involved in both aggresome formation and the fusion of autophagosomes with lysosomes making it an attractive target to regulate protein aggregation. The scaffolding protein sequestosome 1(SQSTM1)/p62 has also been shown to regulate accumulation and autophagic clearance of protein aggregates. Recent studies have revealed colocalization of HDAC6 and p62 to ubiquitinated mitochondria, as well as, ubiquitinated protein aggregates associated with the E3 ubiquitin ligase TRIM50. HDAC6 deacetylase activity is required for aggresome formation and can be regulated by protein interaction with HDAC6. Due to their colocalization at ubiquitinated protein aggregates, we sought to examine if p62 specifically interacted with HDAC6 and if so, if this interaction had any effect on HDAC6 activity and/or the physiological function of cortactin-F-actin assembly. We succeeded in identifying and mapping the direct interaction between HDAC6 and p62. We further show that this interaction regulates HDAC6 deacetylase activity. Data are presented demonstrating that the absence of p62 results in hyperactivation of HDAC6 and deacetylation of alpha-tubulin and cortactin. Further, upon induction of protein misfolding we show that p62 is required for perinuclear co-localization of cortactin-F-actin assemblies. Thus, our findings indicate that p62 plays a key role in regulating the recruitment of F-actin network assemblies to the MTOC, a critical cellular function that is required for successful autophagic clearance of protein aggregates.	[Yan, Jin; Seibenhener, Michael Lamar; Calderilla-Barbosa, Luis; Wooten, Marie W.; Wooten, Michael C.] Auburn Univ, Dept Biol Sci, Cellular & Mol Biosci Program, Auburn, AL 36849 USA; [Diaz-Meco, Maria-Theresa; Moscat, Jorge] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Jiang, Jianxiong] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Auburn University System; Auburn University; Sanford Burnham Prebys Medical Discovery Institute; Emory University	Wooten, MC (corresponding author), Auburn Univ, Dept Biol Sci, Cellular & Mol Biosci Program, Auburn, AL 36849 USA.	wootemc@auburn.edu	Jiang, Jianxiong/A-1987-2010	Jiang, Jianxiong/0000-0003-3955-8928; Diaz-Meco, Maria/0000-0003-0147-0998	National Institute of Health [NIH-2RO1NS033661]; NATIONAL CANCER INSTITUTE [R01CA172025, R01CA132847, R01CA134530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033661] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the National Institute of Health (Grant number NIH-2RO1NS033661 (MCW)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu JR, 2008, J NEUROCHEM, V106, P107, DOI 10.1111/j.1471-4159.2008.05340.x; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Di Fulvio S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028563; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Duran A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9; Fusco C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040440; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kirkin V, 2009, AUTOPHAGY, V5, P732, DOI 10.4161/auto.5.5.8566; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; LEE G, 1992, J CELL SCI, V102, P227; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Li GY, 2011, J NEUROL SCI, V304, P1, DOI 10.1016/j.jns.2011.02.017; MACRAE TH, 1992, BIOCHEM CELL BIOL, V70, P835, DOI 10.1139/o92-131; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; Perez M, 2009, J NEUROCHEM, V109, P1756, DOI 10.1111/j.1471-4159.2009.06102.x; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Puls A, 1997, P NATL ACAD SCI USA, V94, P6191, DOI 10.1073/pnas.94.12.6191; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rosenbaum J, 2000, CURR BIOL, V10, pR801, DOI 10.1016/S0960-9822(00)00767-3; Sadoul K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/970382; Seibenhener ML, 2013, BBA-MOL CELL RES, V1833, P452, DOI 10.1016/j.bbamcr.2012.11.004; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Sokal R. R., 2012, BIOMETRY; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Verdel A, 2000, CURR BIOL, V10, P747, DOI 10.1016/S0960-9822(00)00542-X; Watabe M, 2011, J CELL SCI, V124, P1519, DOI 10.1242/jcs.081778; Watanabe Y, 2011, J CELL SCI, V124, P2692, DOI 10.1242/jcs.081232; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Wickstrom SA, 2010, EMBO J, V29, P131, DOI 10.1038/emboj.2009.317; Wooten MW, 2005, J BIOL CHEM, V280, P35625, DOI 10.1074/jbc.C500237200; Yao Tso-Pang, 2010, Genes Cancer, V1, P779; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang Y, 2006, J BIOL CHEM, V281, P2401, DOI 10.1074/jbc.C500241200; Zhou J, 2004, BIOCHEM PHARMACOL, V68, P2435, DOI 10.1016/j.bcp.2004.08.032; Zhou J, 2009, J BIOL CHEM, V284, P9648, DOI 10.1074/jbc.M808708200; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	58	77	79	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76016	10.1371/journal.pone.0076016	http://dx.doi.org/10.1371/journal.pone.0076016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086678	Green Published, Green Submitted, gold			2022-12-27	WOS:000325223900070
J	Honea, RA; Cruchaga, C; Perea, RD; Saykin, AJ; Burns, JM; Weinberger, DR; Goate, AM				Honea, Robyn A.; Cruchaga, Carlos; Perea, Rodrigo D.; Saykin, Andrew J.; Burns, Jeffrey M.; Weinberger, Daniel R.; Goate, Alison M.		Alzheimer's Dis Neuroimaging Initi	Characterizing the Role of Brain Derived Neurotrophic Factor Genetic Variation in Alzheimer's Disease Neurodegeneration	PLOS ONE			English	Article							BDNF VAL66MET POLYMORPHISM; GENOME-WIDE ASSOCIATION; PARKINSONS-DISEASE; VAL(66)MET POLYMORPHISM; HIPPOCAMPAL VOLUME; EXECUTIVE FUNCTION; MESSENGER-RNA; HUMAN-MEMORY; ONSET; SUSCEPTIBILITY	There is accumulating evidence that neurotrophins, like brain-derived neurotrophic factor (BDNF), may impact aging and Alzheimer's Disease. However, traditional genetic association studies have not found a clear relationship between BDNF and AD. Our goal was to test whether BDNF single nucleotide polymorphisms (SNPs) impact Alzheimer's Disease-related brain imaging and cognitive markers of disease. We completed an imaging genetics study on 645 Alzheimer's Disease Neuroimaging Initiative participants (ND=175, MCI=316, AD=154) who had cognitive, brain imaging, and genetics data at baseline and a subset of those with brain imaging data at two years. Samples were genotyped using the Illumina Human610-Quad BeadChip. 13 SNPs in BDNF were identified in the dataset following quality control measures (rs6265(Val66Met), rs12273363, rs11030094, rs925946, rs1050187, rs2203877, rs11030104, rs11030108, rs10835211, rs7934165, rs908867, rs1491850, rs1157459). We analyzed a subgroup of 8 SNPs that were in low linkage disequilibrium with each other. Automated brain morphometric measures were available through ADNI investigators, and we analyzed baseline cognitive scores, hippocampal and whole brain volumes, and rates of hippocampal and whole brain atrophy and rates of change in the ADAS-Cog over one and two years. Three out of eight BDNF SNPs analyzed were significantly associated with measures of cognitive decline (rs1157659, rs11030094, rs11030108). No SNPs were significantly associated with baseline brain volume measures, however six SNPs were significantly associated with hippocampal and/or whole brain atrophy over two years (rs908867, rs11030094, rs6265, rs10501087, rs1157659, rs1491850). We also found an interaction between the BDNF Val66Met SNP and age with whole brain volume. Our imaging-genetics analysis in a large dataset suggests that while BDNF genetic variation is not specifically associated with a diagnosis of AD, it appears to play a role in AD-related brain neurodegeneration.	[Honea, Robyn A.; Perea, Rodrigo D.; Burns, Jeffrey M.] Univ Kansas, Med Ctr, Dept Neurol, Alzheimers Dis Ctr, Kansas City, KS 66103 USA; [Cruchaga, Carlos; Goate, Alison M.] Washington Univ, Sch Med, Dept Psychiat & Neurol, St Louis, MO USA; [Saykin, Andrew J.] Indiana Univ Sch Med, Dept Radiol, Ctr Computat Biol & Bioinformat, Ctr Neuroimaging,Div Imaging Sci, Indianapolis, IN 46202 USA; [Saykin, Andrew J.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Weinberger, Daniel R.] Lieber Inst Brain Dev, Baltimore, MD USA; [Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Psychiat, Baltimore, MD USA; [Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD USA; [Weinberger, Daniel R.] Johns Hopkins Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA	University of Kansas; University of Kansas Medical Center; Washington University (WUSTL); Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Honea, RA (corresponding author), Univ Kansas, Med Ctr, Dept Neurol, Alzheimers Dis Ctr, Kansas City, KS 66103 USA.	rhonea@kumc.edu	Cruchaga, Carlos/ABF-4065-2020; Saykin, Andrew/A-1318-2007	Cruchaga, Carlos/0000-0002-0276-2899; Goate, Alison/0000-0002-0576-2472; Burns, Jeffrey/0000-0001-7609-8954; Saykin, Andrew/0000-0002-1376-8532	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; Alzheimer's Disease Genetics Consortium [U01AG032984]; NIA [R01AG19771, P30AG010133]; NCRAD [U24AG021886]; NIH [K01 AG035042, P30 AG010129]; Alzheimer's Disease Neuroimaging Initiative (ADNI); NATIONAL INSTITUTE ON AGING [U01AG024904, R01AG019771, P30AG010133, P30AG035982, U24AG021886, P30AG010129, U01AG032984, K01AG035042] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer's Disease Genetics Consortium; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRAD; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Disease Neuroimaging Initiative (ADNI); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. Additional support was provided by U01AG032984 (Alzheimer's Disease Genetics Consortium), NIA R01AG19771 and P30AG010133. Samples from the NCRAD, which receives government support under a cooperative agreement (U24AG021886) awarded by the NIA were used in this study. RAH is supported by NIH grants K01 AG035042 and P30 AG010129. RAH had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, all commercial funding was made through the Alzheimer's Disease Neuroimaging Initiative (ADNI) and no direct commercial funding was received.	Arancibia S, 2008, NEUROBIOL DIS, V31, P316, DOI 10.1016/j.nbd.2008.05.012; Bertram Anthony, 2010, N Z Med J, V123, P122; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Erickson KI, 2010, J NEUROSCI, V30, P5368, DOI 10.1523/JNEUROSCI.6251-09.2010; Fukumoto N, 2010, AM J MED GENET B, V153B, P235, DOI 10.1002/ajmg.b.30986; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Harris SE, 2006, MOL PSYCHIATR, V11, P505, DOI 10.1038/sj.mp.4001799; Hashimoto R, 2008, GENES BRAIN BEHAV; Ho AJ, 2011, HUM BRAIN MAPP, V32, P1371, DOI 10.1002/hbm.21113; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; Holland D, 2009, P NATL ACAD SCI USA, V106, P20954, DOI 10.1073/pnas.0906053106; Huang R, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.044883; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; KNUSEL B, 1992, J NEUROSCI, V12, P4391; Kocabas NA, 2011, INT CLIN PSYCHOPHARM, V26, P1, DOI 10.1097/YIC.0b013e32833d18f8; Kunugi H, 2001, MOL PSYCHIATR, V6, P83, DOI 10.1038/sj.mp.4000792; Laumet G, 2010, J ALZHEIMERS DIS, V20, P1181, DOI 10.3233/JAD-2010-100126; Lim YY, 2013, NEUROBIOL AGING; LINDVALL O, 1994, TRENDS NEUROSCI, V17, P490, DOI 10.1016/0166-2236(94)90139-2; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; Nagata T, 2012, DEMENT GERIATR COGN, V33, P266, DOI 10.1159/000339358; Nagata T, 2011, PSYCHOGERIATRICS, V11, P141, DOI 10.1111/j.1479-8301.2011.00364.x; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Real E, 2009, BIOL PSYCHIAT, V66, P674, DOI 10.1016/j.biopsych.2009.05.017; Reiman EM, 2007, ANN NY ACAD SCI, V1097, P94, DOI 10.1196/annals.1379.011; Saarela MS, 2006, FOLIA NEUROPATHOL, V44, P12; Sambataro F, 2010, MOL PSYCHIATR, V15, P116, DOI 10.1038/mp.2009.64; Siegel GJ, 2000, BRAIN RES REV, V33, P199, DOI 10.1016/S0165-0173(00)00030-8; Tost H, 2013, NEUROPSYCHOPHARMACOL, V38, P525, DOI 10.1038/npp.2012.214; Tsai SJ, 2004, NEUROPSYCHOBIOLOGY, V49, P10, DOI 10.1159/000075332; Tsai SJ, 2006, DEMENT GERIATR COGN, V21, P139, DOI 10.1159/000090673; Tseng KY, 2001, J NEUROSCI, V21, P6430, DOI 10.1523/JNEUROSCI.21-16-06430.2001; Ventriglia M, 2002, MOL PSYCHIATR, V7, P136, DOI 10.1038/sj.mp.4000952; Voineskos AN, 2011, ARCH GEN PSYCHIAT, V68, P198, DOI 10.1001/archgenpsychiatry.2010.194; Xu CL, 2010, NEUROREPORT, V21, P802, DOI 10.1097/WNR.0b013e32833ccaf4; Zdanys KF, 2009, J ALZHEIMERS DIS, V17, P887, DOI 10.3233/JAD-2009-1106; Ziegenhorn AA, 2007, NEUROBIOL AGING, V28, P1436, DOI 10.1016/j.neurobiolaging.2006.06.011	45	39	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76001	10.1371/journal.pone.0076001	http://dx.doi.org/10.1371/journal.pone.0076001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086677	gold, Green Published			2022-12-27	WOS:000325220000056
J	Shi, SL; Yu, LP; Zhang, TR; Qi, HY; Xavier, S; Ju, WJ; Bottinger, E				Shi, Shaolin; Yu, Liping; Zhang, Taoran; Qi, Haiying; Xavier, Sandhya; Ju, Wenjun; Bottinger, Erwin			Smad2-Dependent Downregulation of miR-30 Is Required for TGF-beta-Induced Apoptosis in Podocytes	PLOS ONE			English	Article							INDUCED COLLAGEN EXPRESSION; GROWTH-FACTOR-BETA; MIR-200 FAMILY; DELETION; MICRORNA-155; TARGETS; SMAD2; CELLS; ZEB1	Transforming growth factors beta (TGF-beta) are multi-functional cytokines capable of inducing apoptosis in epithelial cells, including glomerular podocytes. We and others have previously shown that podocyte-selective genetic deletion of the microRNA (miR)-processing enzyme, Dicer, caused glomerulosclerosis that was associated with podocyte apoptosis, and the miR-30 family was implicated in the process. Here, we report that apoptosis-associated genes were highly enriched among the predicted targets of miR-30 when compared with randomly selected miRs (26% vs. 4.5 +/- 2.1%) or with the known TGF-beta-regulated miR-192 (6%), miR-216a (5.1%), and miR-217 (0%). miR-30 family members were abundantly expressed in podocytes in normal mice but were downregulated in albumin/TGF-beta transgenic mice with podocyte apoptosis and glomerulosclerosis. In vitro, TGF-beta downregulated miR-30s in wildtype and Smad3-deficient, but not Smad2- or Smad2/Smad3-deficient, podocytes. The TGF-beta-induced activation of caspase 3 and an increase in TUNEL-positive nuclei were significantly inhibited by the lentivirus-mediated overexpression of miR-30d, but not by a scrambled control miR, in podocytes. TGF-beta stimulated the phosphorylation of pro-apoptotic p53 in podocytes with lentiviral expression of a scrambled miR, but not in podocytes expressing miR-30d. In contrast, miR-30d had no effect on the phosphorylation of pro-apoptotic p38 MAP kinase induced by TGF-beta. Thus, we report that Smad2-dependent inhibition of miR-30s in podocytes is required for the activation of p53 and the induction of apoptosis by TGF-beta. These results demonstrate a novel functional role for miR-30 in podocyte survival and indicate that the loss of miR-30 survival signaling is a novel and specific mechanism of TGF-beta-induced podocyte apoptosis during glomerulosclerosis. We propose the therapeutic replacement of miR-30 as a novel strategy to prevent the podocyte apoptosis that is characteristic of progressive glomerular diseases.	[Shi, Shaolin; Yu, Liping; Zhang, Taoran; Qi, Haiying; Xavier, Sandhya; Ju, Wenjun; Bottinger, Erwin] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Shi, SL (corresponding author), Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA.	shaolinshi1001@yahoo.com; erwin.bottinger@mssm.edu		Ju, Wenjun/0000-0002-9136-8454; Shi, Shaolin/0000-0003-2297-6496	National Institute of Health [R01- DK60043, R01-DK073960, R01-DK056077, U01-DK060995, R01-DK097253]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097253, R01DK056077, R01DK073960, R01DK060043, U01DK060995] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institute of Health grants R01- DK60043, R01-DK073960, R01-DK056077, U01-DK060995, and R01-DK097253 to EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2009, DEVELOPMENT, V136, P3927, DOI 10.1242/dev.037432; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Chung ACK, 2010, J AM SOC NEPHROL, V21, P1317, DOI 10.1681/ASN.2010020134; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hand NJ, 2009, GASTROENTEROLOGY, V136, P1081, DOI 10.1053/j.gastro.2008.12.006; Harvey SJ, 2008, J AM SOC NEPHROL, V19, P2150, DOI 10.1681/ASN.2008020233; Ho J, 2008, J AM SOC NEPHROL, V19, P2069, DOI 10.1681/ASN.2008020162; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Ju WJ, 2006, MOL CELL BIOL, V26, P654, DOI 10.1128/MCB.26.2.654-667.2006; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kato M, 2010, J BIOL CHEM, V285, P34004, DOI 10.1074/jbc.M110.165027; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kriz W, 1998, NEPHROL DIAL TRANSPL, V13, P2781, DOI 10.1093/ndt/13.11.2781; Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30; Long JY, 2010, J BIOL CHEM, V285, P23455, DOI 10.1074/jbc.M110.136168; Louafi F, 2010, J BIOL CHEM, V285, P41328, DOI 10.1074/jbc.M110.146852; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; ROBERTS AB, 1990, PHILOS T R SOC B, V327, P145, DOI 10.1098/rstb.1990.0050; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; SANDERSON N, 1995, P NATL ACAD SCI USA, V92, P2572, DOI 10.1073/pnas.92.7.2572; Schiffer M, 2004, J BIOL CHEM, V279, P37004, DOI 10.1074/jbc.M403534200; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Sequeira-Lopez MLS, 2010, J AM SOC NEPHROL, V21, P460, DOI 10.1681/ASN.2009090964; Shi SL, 2008, J AM SOC NEPHROL, V19, P2159, DOI 10.1681/ASN.2008030312; TAKEUCHI A, 1992, AM J PATHOL, V141, P107; Wei QQ, 2010, J AM SOC NEPHROL, V21, P756, DOI 10.1681/ASN.2009070718; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Wu DT, 2005, J AM SOC NEPHROL, V16, P3211, DOI 10.1681/ASN.2004121055; Xavier S, 2009, J AM SOC NEPHROL, V20, P2127, DOI 10.1681/ASN.2008070806; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	39	44	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75572	10.1371/journal.pone.0075572	http://dx.doi.org/10.1371/journal.pone.0075572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086574	Green Submitted, Green Published, gold			2022-12-27	WOS:000325220000029
J	Ye, H; Deng, G; Mauger, SJ; Hersbach, AA; Dawson, PW; Heasman, JM				Ye, Hua; Deng, Guang; Mauger, Stefan J.; Hersbach, Adam A.; Dawson, Pam W.; Heasman, John M.			A Wavelet-Based Noise Reduction Algorithm and Its Clinical Evaluation in Cochlear Implants	PLOS ONE			English	Article							SPEECH ENHANCEMENT; INTELLIGIBILITY; SIMULATIONS; SUPPRESSION; TRANSFORM; USERS	Noise reduction is often essential for cochlear implant (CI) recipients to achieve acceptable speech perception in noisy environments. Most noise reduction algorithms applied to audio signals are based on time-frequency representations of the input, such as the Fourier transform. Algorithms based on other representations may also be able to provide comparable or improved speech perception and listening quality improvements. In this paper, a noise reduction algorithm for CI sound processing is proposed based on the wavelet transform. The algorithm uses a dual-tree complex discrete wavelet transform followed by shrinkage of the wavelet coefficients based on a statistical estimation of the variance of the noise. The proposed noise reduction algorithm was evaluated by comparing its performance to those of many existing wavelet-based algorithms. The speech transmission index (STI) of the proposed algorithm is significantly better than other tested algorithms for the speech-weighted noise of different levels of signal to noise ratio. The effectiveness of the proposed system was clinically evaluated with CI recipients. A significant improvement in speech perception of 1.9 dB was found on average in speech weighted noise.	[Ye, Hua; Deng, Guang] La Trobe Univ, Dept Elect Engn, Melbourne, Vic, Australia; [Mauger, Stefan J.; Hersbach, Adam A.; Dawson, Pam W.; Heasman, John M.] Cochlear Ltd, Melbourne, Vic, Australia; [Dawson, Pam W.] HEARing CRC, Melbourne, Vic, Australia	La Trobe University; Cochlear	Deng, G (corresponding author), La Trobe Univ, Dept Elect Engn, Melbourne, Vic, Australia.	d.deng@latrobe.edu.au			HEARing CRC; Cochlear Limited	HEARing CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Cochlear Limited	In-kind audiological funding was provided by the HEARing CRC. In-kind engineering funding was provided by Cochlear Limited. Clinical testing was carried out at Cochlear, Melbourne, Research & Applications. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boll S., 1979, ACOUSTICS SPEECH SIG, V27, P113, DOI DOI 10.1109/TASSP.1979.1163209; Boothroyd A, 1968, INT J AUDIOL, V7, P368; Buechner A, 2010, OTOL NEUROTOL, V31, P1386, DOI 10.1097/MAO.0b013e3181f1cdc6; Cameron S, 2007, EAR HEARING, V28, P196, DOI 10.1097/AUD.0b013e318031267f; Chung King, 2004, Cochlear Implants Int, V5 Suppl 1, P192, DOI 10.1179/cim.2004.5.Supplement-1.192; COIFMAN R, 1995, 475 STANF U DEP STAT; Dawson PW, 2011, EAR HEARING, V32, P382, DOI 10.1097/AUD.0b013e318201c200; Dawson PW, 2013, EAR HEAR, V34; EPHRAIM Y, 1984, IEEE T ACOUST SPEECH, V32, P1109, DOI 10.1109/TASSP.1984.1164453; Goldsworthy RL, 2004, J ACOUST SOC AM, V116, P3679, DOI 10.1121/1.1804628; Gopalakrishna V, 2010, IEEE T BIO-MED ENG, V57, P2053, DOI 10.1109/TBME.2010.2047644; Hagerman B., 1976, SCAND AUDIOL, V5, P219, DOI [10.3109/01050397609044991, DOI 10.3109/01050397609044991]; Hersbach AA, 2012, EAR HEARING, V33, pE13, DOI 10.1097/AUD.0b013e31824b9e21; HOCHBERG I, 1992, EAR HEARING, V13, P263, DOI 10.1097/00003446-199208000-00008; Hu Y, 2007, J ACOUST SOC AM, V122, pEL128, DOI 10.1121/1.2772401; Hu Y, 2007, SPEECH COMMUN, V49, P588, DOI 10.1016/j.specom.2006.12.006; Hu Y, 2010, J ACOUST SOC AM, V127, P3689, DOI 10.1121/1.3365256; Lei SF, 2008, IEICE T FUND ELECTR, VE91A, P2555, DOI 10.1093/ietfec/e91-a.9.2555; LIM JS, 1979, P IEEE, V67, P1586, DOI 10.1109/PROC.1979.11540; Loizou Philipos C, 2006, Adv Otorhinolaryngol, V64, P109, DOI 10.1159/000094648; Mauger SJ, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/6/065007; Mauger SJ, 2012, J ACOUST SOC AM, V131, P327, DOI 10.1121/1.3665990; MCAULAY RJ, 1980, IEEE T ACOUST SPEECH, V28, P137, DOI 10.1109/TASSP.1980.1163394; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; NOGUEIRA W, 2006, INT CONF ACOUST SPEE, P121; Patrick James F, 2006, Trends Amplif, V10, P175, DOI 10.1177/1084713806296386; Pesquet JC, 1996, IEEE T SIGNAL PROCES, V44, P1964, DOI 10.1109/78.533717; Poissant SF, 2006, J ACOUST SOC AM, V119, P1606, DOI 10.1121/1.2168428; Seligman P., 1995, Annals of Otology Rhinology and Laryngology, V104, P139; Sendur L, 2002, IEEE T SIGNAL PROCES, V50, P2744, DOI 10.1109/TSP.2002.804091; Wouters J, 2001, EAR HEARING, V22, P420, DOI 10.1097/00003446-200110000-00006; Yang LP, 2005, J ACOUST SOC AM, V117, P1001, DOI 10.1121/1.1852873; Yao J, 2002, IEEE T BIO-MED ENG, V49, P1299, DOI 10.1109/TBME.2002.804590; Yao J, 2001, IEEE T BIO-MED ENG, V48, P856, DOI 10.1109/10.936362	35	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75662	10.1371/journal.pone.0075662	http://dx.doi.org/10.1371/journal.pone.0075662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086605	Green Submitted, gold, Green Published			2022-12-27	WOS:000325220000033
J	Kollipara, A; Polkinghorne, A; Beagley, KW; Timms, P				Kollipara, Avinash; Polkinghorne, Adam; Beagley, Kenneth W.; Timms, Peter			Vaccination of Koalas with a Recombinant Chlamydia pecorum Major Outer Membrane Protein Induces Antibodies of Different Specificity Compared to Those Following a Natural Live Infection	PLOS ONE			English	Article							GENITAL-TRACT INFECTION; CD8(+) T-CELLS; PHASCOLARCTOS-CINEREUS; PARTIAL PROTECTION; CAPTIVE KOALAS; IMMUNITY; IMMUNIZATION; QUEENSLAND; ADJUVANTS; PSITTACI	Chlamydial infection in koalas is common across the east coast of Australia and causes significant morbidity, infertility and mortality. An effective vaccine to prevent the adverse consequences of chlamydial infections in koalas (particularly blindness and infertility in females) would provide an important management tool to prevent further population decline of this species. An important step towards developing a vaccine in koalas is to understand the host immune response to chlamydial infection. In this study, we used the Pepscan methodology to identify B cell epitopes across the Major Outer Membrane Protein (MOMP) of four C. pecorum strains/genotypes that are recognized, either following (a) natural live infection or (b) administration of a recombinant MOMP vaccine. Plasma antibodies from the koalas naturally infected with a C. pecorum G genotype strain recognised the epitopes located in the variable domain (VD) four of MOMP G and also VD4 of MOMP H. By comparison, plasma antibodies from an animal infected with a C. pecorum F genotype strain recognised epitopes in VD1, 2 and 4 of MOMP F, but not from other genotype MOMPs. When Chlamydia-free koalas were immunised with recombinant MOMP protein they produced antibodies not only against epitopes in the VDs but also in conserved domains of MOMP. Naturally infected koalas immunised with recombinant MOMP protein also produced antibodies against epitopes in the conserved domains. This work paves the way for further refinement of a MOMP-based Chlamydia vaccine that will offer wide cross-protection against the variety of chlamydial infections circulating in wild koala populations.	[Kollipara, Avinash; Polkinghorne, Adam; Beagley, Kenneth W.; Timms, Peter] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia	Queensland University of Technology (QUT)	Timms, P (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia.	p.timms@qut.edu.au	Beagley, Kenneth/J-1129-2012	Beagley, Kenneth/0000-0003-3112-6557; Polkinghorne, Adam/0000-0002-6803-9222; Timms, Peter/0000-0002-1682-0025; Polkinghorne, Adam/0000-0002-6567-2962	Australian Research Council [LP0990147]; Queensland Government National and International Research Alliances Program (NIRAP) Scheme	Australian Research Council(Australian Research Council); Queensland Government National and International Research Alliances Program (NIRAP) Scheme	This study was funded by Australian Research Council Linkage Grant LP0990147 and the Queensland Government National and International Research Alliances Program (NIRAP) Scheme. The funding partners had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry LJ, 2004, INFECT IMMUN, V72, P1019, DOI 10.1128/IAI.72.2.1019-1028.2004; CANFIELD PJ, 1991, AUST VET J, V68, P167, DOI 10.1111/j.1751-0813.1991.tb03171.x; CANFIELD PJ, 1989, AUST VET J, V66, P103, DOI 10.1111/j.1751-0813.1989.tb09758.x; CANFIELD PJ, 1991, AUST VET J, V68, P165, DOI 10.1111/j.1751-0813.1991.tb03170.x; Carey AJ, 2010, AM J REPROD IMMUNOL, V63, P161, DOI 10.1111/j.1600-0897.2009.00776.x; Cunningham KA, 2009, J REPROD IMMUNOL, V81, P34, DOI 10.1016/j.jri.2009.04.002; Dique DS, 2003, WILDLIFE RES, V30, P419, DOI 10.1071/WR02029; Farris CM, 2011, INFECT IMMUN, V79, P986, DOI 10.1128/IAI.00881-10; GIRJES AA, 1993, FEMS IMMUNOL MED MIC, V6, P21, DOI 10.1111/j.1574-695X.1993.tb00299.x; Gordon G., 1978, P125; Kari L, 2009, J IMMUNOL, V182, P8063, DOI 10.4049/jimmunol.0804375; Kollipara A, 2013, VACCINE, V31, P1217, DOI 10.1016/j.vaccine.2012.12.057; Kollipara A, 2012, VACCINE, V30, P1875, DOI 10.1016/j.vaccine.2011.12.125; Lau Q, 2013, IMMUNOGENETICS, V65, P37, DOI 10.1007/s00251-012-0658-5; MCKENZIE RA, 1981, AUST VET J, V57, P243, DOI 10.1111/j.1751-0813.1981.tb02670.x; Morrison SG, 2000, INFECT IMMUN, V68, P6979, DOI 10.1128/IAI.68.12.6979-6987.2000; Morrison SG, 2001, INFECT IMMUN, V69, P2643, DOI 10.1128/IAI.69.4.2643-2649.2001; Pal S, 2006, VACCINE, V24, P766, DOI 10.1016/j.vaccine.2005.08.074; Polkinghorne A, 2013, VET MICROBIOL, V165, P214, DOI 10.1016/j.vetmic.2013.02.026; Rhodes JR, 2011, BIOL CONSERV, V144, P1081, DOI 10.1016/j.biocon.2010.12.027; Rhodes JR, 2006, CONSERV BIOL, V20, P449, DOI 10.1111/j.1523-1739.2006.00330.x; Stansfield Scott H, 2013, Results Immunol, V3, P33, DOI 10.1016/j.rinim.2013.05.001; Wan C, 2011, AUST VET J, V89, P409, DOI 10.1111/j.1751-0813.2011.00827.x; WILMER JMW, 1993, WILDLIFE RES, V20, P177, DOI 10.1071/WR9930177; Yi H, 1993, INFECT IMMUN, V61, P1117	25	15	16	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74808	10.1371/journal.pone.0074808	http://dx.doi.org/10.1371/journal.pone.0074808			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086379	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700040
J	Sakai, K; Imamura, M; Tanaka, Y; Iwata, M; Hirose, H; Kaku, K; Maegawa, H; Watada, H; Tobe, K; Kashiwagi, A; Kawamori, R; Maeda, S				Sakai, Kensuke; Imamura, Minako; Tanaka, Yasushi; Iwata, Minoru; Hirose, Hiroshi; Kaku, Kohei; Maegawa, Hiroshi; Watada, Hirotaka; Tobe, Kazuyuki; Kashiwagi, Atsunori; Kawamori, Ryuzo; Maeda, Shiro			Replication Study for the Association of 9 East Asian GWAS-Derived Loci with Susceptibility to Type 2 Diabetes in a Japanese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FASTING PLASMA-GLUCOSE; INSULIN-RESISTANCE; RISK LOCI; VARIANTS; POLYMORPHISM; GENE; HOMEOSTASIS; MTNR1B; HMGA1	Aims: East Asian genome-wide association studies (GWAS) for type 2 diabetes identified 8 loci with genome-wide significance, and 2 loci with a borderline association. However, the associations of these loci except MAEA locus with type 2 diabetes have not been evaluated in independent East Asian cohorts. We performed a replication study to investigate the association of these susceptibility loci with type 2 diabetes in an independent Japanese population. Methods: We genotyped 7,379 Japanese participants (5,315 type 2 diabetes and 2,064 controls) for each of the 9 single nucleotide polymorphisms (SNPs), rs7041847 in GLIS3, rs6017317 in FITM2-R3HDML-HNF4A, rs6467136 near GCCI-PAX4, rs831571 near PSMD6, rs9470794 in ZFAND3, rs3786897 in PEPD, rs1535500 in KCNK16, rs16955379 in CMIP, and rs17797882 near WWOX. Because the sample size in this study was not sufficient to replicate single SNP associations, we constructed a genetic risk score (GRS) by summing a number of risk alleles of the 9 SNPs, and examined the association of the GRS with type 2 diabetes using logistic regression analysis. Results: With the exception of rs1535500 in KCNK16, all SNPs had the same direction of effect (odds ratio [OR]>1.0) as in the original reports. The GRS constructed from the 9 SNPs was significantly associated with type 2 diabetes in the Japanese population (p = 4.0 x 10(-4), OR = 1.05, 95% confidence interval: 1.02-1.09). In quantitative trait analyses, rs16955379 in CMIP was nominally associated with a decreased homeostasis model assessment of beta-cell function and with increased fasting plasma glucose, but neither the individual SNPs nor the GRS showed a significant association with the glycemic traits. Conclusions: These results indicate that 9 loci that were identified in the East Asian GWAS meta-analysis have a significant effect on the susceptibility to type 2 diabetes in the Japanese population.	[Sakai, Kensuke; Imamura, Minako; Maeda, Shiro] RIKEN Ctr Integrat Med Sci, Lab Endocrinol Metab & Kidney Dis, Yokohama, Kanagawa, Japan; [Sakai, Kensuke; Tanaka, Yasushi] St Marianna Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Kawasaki, Kanagawa, Japan; [Iwata, Minoru; Tobe, Kazuyuki] Toyama Univ, Dept Internal Med 1, Toyama 930, Japan; [Hirose, Hiroshi] Keio Univ, Sch Med, Ctr Hlth, Tokyo, Japan; [Kaku, Kohei] Kawasaki Med Sch, Dept Internal Med, Div Diabet Endocrinol & Metab, Kurashiki, Okayama, Japan; [Maegawa, Hiroshi; Kashiwagi, Atsunori] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 52021, Japan; [Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Dept Endocrinol & Metab, Tokyo, Japan; [Watada, Hirotaka; Kawamori, Ryuzo] Juntendo Univ, Grad Sch Med, Sportol Ctr, Tokyo, Japan	RIKEN; Saint Marianna University; University of Toyama; Keio University; Kawasaki Medical School; Shiga University of Medical Science; Juntendo University; Juntendo University	Maeda, S (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Endocrinol Metab & Kidney Dis, Yokohama, Kanagawa, Japan.	smaeda@src.riken.jp	Kashiwagi, Atsunori/H-8712-2019; Hirose, Hiroshi/F-8556-2014	Watada, Hirotaka/0000-0001-5961-1816; Maegawa, Hiroshi/0000-0002-4611-8149	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Chiefari E, 2011, JAMA-J AM MED ASSOC, V305, P903, DOI 10.1001/jama.2011.207; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fukuda H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046263; Hayashi T, 2007, DIABETOLOGIA, V50, P980, DOI 10.1007/s00125-007-0618-z; Horikoshi M, 2007, DIABETOLOGIA, V50, P747, DOI 10.1007/s00125-006-0588-6; Imamura M, 2011, DIABETOLOGIA, V54, P3071, DOI 10.1007/s00125-011-2293-3; Imamura M, 2013, J DIABETES INVEST, V4, P168, DOI 10.1111/jdi.12017; Imamura M, 2012, HUM MOL GENET, V21, P3042, DOI 10.1093/hmg/dds113; Imamura M, 2011, ENDOCR J, V58, P723, DOI 10.1507/endocrj.EJ11-0113; International Diabetes Federation, 2012, DIABETES ATLAS, P2012; Iwata M, 2012, DIABETES CARE, V35, P1763, DOI 10.2337/dc11-2006; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Liu L, 2012, DIABETOLOGIA, V55, P1685, DOI 10.1007/s00125-012-2518-0; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Maeda S, 2005, J HUM GENET, V50, P283, DOI 10.1007/s10038-005-0253-9; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; Ohshige T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026911; Onuma H, 2010, J HUM GENET, V55, P600, DOI 10.1038/jhg.2010.75; Peterson RE, 2011, HUM GENET, V129, P221, DOI 10.1007/s00439-010-0917-1; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	42	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76317	10.1371/journal.pone.0076317	http://dx.doi.org/10.1371/journal.pone.0076317			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086726	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000325218700124
J	Scortichini, M; Marcelletti, S; Ferrante, P; Firrao, G				Scortichini, Marco; Marcelletti, Simone; Ferrante, Patrizia; Firrao, Giuseppe			A Genomic Redefinition of Pseudomonas avellanae species	PLOS ONE			English	Article							SYRINGAE PV AVELLANAE; BACTERIUM CAUSING CANKER; AD-HOC-COMMITTEE; GENETIC DIVERSITY; CORYLUS-AVELLANA; SEQUENCE; DNA; DEFINITION; HAZELNUT; IDENTIFICATION	The circumscription of bacterial species is a complex task. So far, DNA-DNA hybridization (DDH), 16S rRNA gene sequencing, and multiocus sequence typing analysis (MLSA) are currently the preferred techniques for their genetic determination. However, the average nucleotide identity (ANI) analysis of conserved and shared genes between two bacterial strains based on the pair-wise genome comparisons, with support of the tetranucleotide frequency correlation coefficients (TETRA) value, has recently been proposed as a reliable substitute for DDH. The species demarcation boundary has been set to a value of 95-96% of the ANI identity, with further confirmation through the assessment of the corresponding TETRA value. In this study, we performed a genome-wide MLSA of 14 phytopathogenic pseudomonads genomes, and assessed the ANI and TETRA values of 27 genomes, representing seven out of the nine genomospecies of Pseudomonas spp. sensu Gardan et alii, and their phylogenetic relationships using maximum likelihood and Bayesian approaches. The results demonstrate the existence of a well demarcated genomic cluster that includes strains classified as P. avellanae, P. syringae pv. theae, P. s. pv. actinidiae and one P. s. pv. morsprunorum strain all belonging to the single species P. avellanae. In addition, when compared with P. avellanae, five strains of P. s. pv. tomato, including the model strain DC3000, and one P. s. pv. lachrymans strain, appear as very closely related to P. avellanae, with ANI values of nearly 96% as confirmed by the TETRA analysis. Conversely, one representative strain, previously classified as P. avellanae and isolated in central Italy, is a genuine member of the P. syringae species complex and can be defined as P. s. pv. avellanae. Currently. The core and pan genomes of P. avellanae species consist of 3,995 and 5,410 putative protein-coding genes, respectively.	[Scortichini, Marco; Marcelletti, Simone; Ferrante, Patrizia] Ctr Ric Frutticoltura, Consiglio Ric & Sperimentaz Agr, Rome, Italy; [Scortichini, Marco] Consiglio Ric & Sperimentaz Agr, Unita Ric Frutticoltura, Rome, Italy; [Firrao, Giuseppe] Univ Udine, Dipartimento Sci Agr & Ambientali, I-33100 Udine, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Udine	Scortichini, M (corresponding author), Ctr Ric Frutticoltura, Consiglio Ric & Sperimentaz Agr, Rome, Italy.	marco.scortichini@entecra.it		FIRRAO, Giuseppe/0000-0002-7890-0899; Scortichini, Marco/0000-0003-1565-9097; FERRANTE, PATRIZIA/0000-0001-7577-9096	Italian Ministry of Agriculture, Food and Forestry	Italian Ministry of Agriculture, Food and Forestry	The work was funded by the Italian Ministry of Agriculture, Food and Forestry in the framework of the project ARDICA: "Azioni di ricerca e difesa al cancro batterico dell'Actinidia (Psa)". No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai Y, 2000, INT J SYST EVOL MICR, V50, P1563, DOI 10.1099/00207713-50-4-1563; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Bull CT, 2008, J PLANT PATHOL, V90, P403; Bull CT, 2011, PHYTOPATHOLOGY, V101, P847, DOI 10.1094/PHYTO-11-10-0318; Butler MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057464; Carrion VJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036709; Chan JZM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-302; Coenye T, 2005, FEMS MICROBIOL REV, V29, P147, DOI 10.1016/j.femsre.2004.11.004; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dellaglio F, 2004, INT J SYST EVOL MICR, V54, P279, DOI 10.1099/ijs.0.02782-0; Dress AWM, 2004, IEEE ACM T COMPUT BI, V1, P109, DOI 10.1109/TCBB.2004.27; Ferrante P, 2011, J PLANT PATHOL, V93, P659; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Gardan L, 1999, INT J SYST BACTERIOL, V49, P469, DOI 10.1099/00207713-49-2-469; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Gilbert V, 2009, EUR J PLANT PATHOL, V124, P199, DOI 10.1007/s10658-008-9406-y; Godreuil Sylvain, 2005, Infection Genetics and Evolution, V5, P375, DOI 10.1016/j.meegid.2004.03.004; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hofte M, 2006, PLANT-ASSOCIATED BACTERIA, P507; Holland BR, 2004, MOL BIOL EVOL, V21, P1459, DOI 10.1093/molbev/msh145; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Janse JD, 1996, SYST APPL MICROBIOL, V19, P589, DOI 10.1016/S0723-2020(96)80030-0; Kaluzna M, 2010, J PLANT PATHOL, V92, P781; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kuo CH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-108; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lapage SP, 1992, INT CODE NOMENCLATUR; Marcelletti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027297; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; MOORE ERB, 2006, PROKARYOTES, V0006, P00021; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Murillo J, 2011, RES MICROBIOL, V162, P253, DOI 10.1016/j.resmic.2010.10.011; Parkinson N, 2011, PLANT PATHOL, V60, P338, DOI 10.1111/j.1365-3059.2010.02366.x; Poptsova MS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-120; PSALLIDAS PG, 1979, PHYTOPATHOL Z, V94, P103; PSALLIDAS PG, 1993, PLANT PATHOL, V42, P358, DOI 10.1111/j.1365-3059.1993.tb01512.x; R Core Team, 2018, R LANG ENV STAT COMP; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Sarris PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059366; Scortichini M, 2006, PLANT PATHOL, V55, P451, DOI 10.1111/j.1365-3059.2006.01352.x; Scortichini M, 2003, PLANT PATHOL, V52, P277, DOI 10.1046/j.1365-3059.2003.00860.x; Scortichini M., 1999, Journal of Plant Pathology, V81, P55; Scortichini M, 1998, J PHYTOPATHOL, V146, P417, DOI 10.1111/j.1439-0434.1998.tb04774.x; SCORTICHINI M, 1994, J PHYTOPATHOL, V140, P65, DOI 10.1111/j.1439-0434.1994.tb00177.x; Scortichini M, 2002, EUR J PLANT PATHOL, V108, P269, DOI 10.1023/A:1015178104513; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Vicente JG, 2007, EUR J PLANT PATHOL, V117, P383, DOI 10.1007/s10658-007-9107-y; Vinatzer Boris A., 2009, P37; Wall DP, 2003, BIOINFORMATICS, V19, P1710, DOI 10.1093/bioinformatics/btg213; Wang PW, 2007, MICROBIOL-SGM, V153, P2067, DOI 10.1099/mic.0.2006/001545-0; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463	63	32	34	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75794	10.1371/journal.pone.0075794	http://dx.doi.org/10.1371/journal.pone.0075794			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086635	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700112
J	Gonzalez, RA; Kallis, C; Coid, JW				Gonzalez, Rafael A.; Kallis, Constantinos; Coid, Jeremy W.			Adult Attention Deficit Hyperactivity Disorder and Violence in the Population of England: Does Comorbidity Matter?	PLOS ONE			English	Article							NATIONAL HOUSEHOLD POPULATION; PROSPECTIVE FOLLOW-UP; MAJOR LIFE ACTIVITIES; ONSET SUBSTANCE USE; REPORT SCALE ASRS; DEFICIT/HYPERACTIVITY DISORDER; CONDUCT PROBLEMS; PSYCHIATRIC MORBIDITY; CHILDHOOD ADHD; CHILDREN	Background: It is unclear whether the association between Attention Deficit/Hyperactivity Disorder (ADHD) and violence is explained by ADHD symptoms or co-existing psychopathology. We investigated associations of ADHD and its symptom domains of hyperactivity and inattention, among individuals reporting violence in the UK population. Methods: We report data from the Adult Psychiatric Morbidity Survey (2007), a representative sample of the household population of England. A randomly selected sample of 7,369 completed the Adult Self-Report Scale for ADHD and the self-reported violence module, including repetition, injury, minor violence, victims and location of incidents. All models were weighted to account for non-response and carefully adjusted for demography and clinical predictors of violence: antisocial personality, substance misuse and anxiety disorders. Results: ADHD was moderately associated with violence after adjustments (OR 1.75, p = .01). Hyperactivity, but not inattention was associated with several indicators of violence in the domestic context (OR 1.16, p = .03). Mild and moderate ADHD symptoms were significantly associated with violence repetition, but not severe ADHD where the association was explained by co-existing disorders. Stratified analyses further indicated that most violence reports are associated with co-occurring psychopathology. Conclusions: The direct effect of ADHD on violence is only moderate at the population level, driven by hyperactivity, and involving intimate partners and close persons. Because violence associated with severe ADHD is explained by co-existing psychopathology, interventions should primarily target co-existing disorders.	[Gonzalez, Rafael A.; Kallis, Constantinos; Coid, Jeremy W.] Univ London, Barts & London Sch Med & Dent, Forens Psychiat Res Unit, London, England	University of London; Queen Mary University London	Gonzalez, RA (corresponding author), Univ London, Barts & London Sch Med & Dent, Forens Psychiat Res Unit, London, England.	r.gonzalez@qmul.ac.uk		Kallis, Constantinos/0000-0003-0866-5421; Kallis, Constantinos/0000-0002-4584-8844; Gonzalez, Rafael A./0000-0002-0482-7318	National Institute for Health Research (NIHR), United Kingdom Program Grant [RP-PG-6407-10500]; National Institute for Health Research [RP-PG-0407-10500] Funding Source: researchfish	National Institute for Health Research (NIHR), United Kingdom Program Grant; National Institute for Health Research(National Institute for Health Research (NIHR))	RAG, CK and JWC were funded by the National Institute for Health Research (NIHR), United Kingdom Program Grant (RP-PG-6407-10500). RAG had access to all of the data in the study and takes full responsibility for the integrity of the data and the accuracy of the data analysis. All authors had full access to all the data in the study. The views expressed in this article are those of the authors and not necessarily those of NIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abikoff H, 2004, J AM ACAD CHILD PSY, V43, P802, DOI 10.1097/01.chi.0000128791.10014.ac; Able SL, 2007, PSYCHOL MED, V37, P97, DOI 10.1017/S0033291706008713; Adler Lenard A, 2006, Ann Clin Psychiatry, V18, P145, DOI 10.1080/10401230600801077; Adler LA, 2009, POSTGRAD MED, V121, P7, DOI 10.3810/pgm.2009.09.2047; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ANDRADE BF, 2012, J ATTEN DISORD, P2628; Antshel KM, 2008, CHILD ADOL PSYCH CL, V17, P421, DOI 10.1016/j.chc.2007.11.005; Barkley RA, 2001, NEUROPSYCHOL REV, V11, P1, DOI 10.1023/A:1009085417776; Barkley RA, 2011, DEV NEUROPSYCHOL, V36, P137, DOI 10.1080/87565641.2010.549877; Barkley Russell A, 2010, J Clin Psychiatry, V71, pe17, DOI 10.4088/JCP.9066tx1c; Barkley RA, 2010, J AM ACAD CHILD PSY, V49, P503, DOI 10.1016/j.jaac.2010.01.019; BEBBINGTON P, 1995, INT J METHOD PSYCH, V5, P11; Bernat DH, 2012, AM J PREV MED, V43, pS41, DOI 10.1016/j.amepre.2012.04.023; Bernfort L, 2008, ACTA PAEDIATR, V97, P239, DOI 10.1111/j.1651-2227.2007.00611.x; Biederman J, 2003, J CLIN PSYCHIAT, V64, P3; Biederman J, 2006, PSYCHOL MED, V36, P167, DOI 10.1017/S0033291705006410; Boots DP, 2010, AGGRESSIVE BEHAV, V36, P141, DOI 10.1002/ab.20338; Brugha T, 2009, ADULT PSYCHIAT MORBI; Chang Z, 2012, J ABNORM CHILD PSYCH, V40, P425, DOI 10.1007/s10802-011-9575-6; Coid J, 2006, AM J EPIDEMIOL, V164, P1199, DOI 10.1093/aje/kwj339; Coid J, 2006, BRIT J PSYCHIAT, V189, P12, DOI 10.1192/bjp.189.1.12; Das D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031500; Fang XM, 2010, ARCH GEN PSYCHIAT, V67, P1179, DOI 10.1001/archgenpsychiatry.2010.137; Fayyad J, 2007, BRIT J PSYCHIAT, V190, P402, DOI 10.1192/bjp.bp.106.034389; First M. B., 1997, STRUCTURED CLIN INTE; Fischer M, 2002, J ABNORM CHILD PSYCH, V30, P463, DOI 10.1023/A:1019864813776; Gordon V, 2012, PUBLIC HEALTH, V126, P343, DOI 10.1016/j.puhe.2012.01.004; Hofvander B, 2011, PSYCHIAT RES, V185, P280, DOI 10.1016/j.psychres.2010.05.008; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kessler RC, 2007, INT J METH PSYCH RES, V16, P52, DOI 10.1002/mpr.208; Kessler RC, 2010, ARCH GEN PSYCHIAT, V67, P1168, DOI 10.1001/archgenpsychiatry.2010.146; Kish L, 1965, SURVEY SAMPLING; Koesters M, 2009, J PSYCHOPHARMACOL, V23, P733, DOI 10.1177/0269881108092338; Kooij JJS, 2005, PSYCHOL MED, V35, P817, DOI 10.1017/S003329170400337X; Kooij SJJ, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-67; KRUEGER RF, 2011, CAUSALITY PSYCHOPATH, P2628; Lahey BB, 2010, J CLIN CHILD ADOLESC, V39, P761, DOI 10.1080/15374416.2010.517173; Lee SS, 2006, J CLIN CHILD ADOLESC, V35, P356, DOI 10.1207/s15374424jccp3503_2; Lewis G, 1990, MANUAL REVISED CLIN; Lichtenstein P, 2012, NEW ENGL J MED, V367, P2006, DOI 10.1056/NEJMoa1203241; Long J.S., 2006, REGRESSION MODELS CA; MALGADY RG, 1992, J PSYCHIAT RES, V26, P59, DOI 10.1016/0022-3956(92)90016-H; Mannuzza S, 1998, AM J PSYCHIAT, V155, P493, DOI 10.1176/ajp.155.4.493; MANNUZZA S, 1993, ARCH GEN PSYCHIAT, V50, P565; Mannuzza S, 2008, PSYCHIAT RES, V160, P237, DOI 10.1016/j.psychres.2007.11.003; Meszaros A, 2009, INT J NEUROPSYCHOPH, V12, P1137, DOI 10.1017/S1461145709990198; Molina BSG, 2009, J AM ACAD CHILD PSY, V48, P484, DOI 10.1097/CHI.0b013e31819c23d0; MONAHAN J, 2001, ANN NY ACAD SCI, V931, P84; OPCS, 1991, STAND OCC CLASS, V3; Pingault JB, 2013, MOL PSYCHIATR, V18, P806, DOI 10.1038/mp.2012.87; PRATT TC, 2002, INT J POLICE SCI MAN, V4, P2628; Retz W, 2010, ADHD-ATTEND DEFICIT, V2, P195, DOI 10.1007/s12402-010-0037-8; Satterfield JH, 1997, J AM ACAD CHILD PSY, V36, P1726, DOI 10.1097/00004583-199712000-00021; Sleet DA, 2012, J SAFETY RES, V43, P233, DOI 10.1016/j.jsr.2012.09.002; SMITH LC, 2012, ATTEN DEFIC HYPERACT, P2628; Solanto MV, 2010, AM J PSYCHIAT, V167, P958, DOI 10.1176/appi.ajp.2009.09081123; STOCKWELL T, 1983, BRIT J ADDICT, V78, P145, DOI 10.1111/j.1360-0443.1983.tb05502.x; Toplak ME, 2012, J CHILD PSYCHOL PSYC, V53, P292, DOI 10.1111/j.1469-7610.2011.02500.x; Tweed R G, 1998, Violence Vict, V13, P217; Ullrich S, 2008, J FORENSIC PSYCHI PS, V19, P301, DOI 10.1080/14789940802045182; WEISS G, 1985, J AM ACAD CHILD PSY, V24, P211, DOI 10.1016/S0002-7138(09)60450-7; Weiss M, 2008, J ATTEN DISORD, V11, P642, DOI 10.1177/1087054708315063; Wilens TE, 1997, J NERV MENT DIS, V185, P475, DOI 10.1097/00005053-199708000-00001; Wilens Timothy E, 2007, J Clin Psychiatry, V68, pe20; Young S, 2011, J PSYCHOPHARMACOL, V25, P1524, DOI 10.1177/0269881110370502; Young S, 2009, PERS INDIV DIFFER, V46, P265, DOI 10.1016/j.paid.2008.10.003	66	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75575	10.1371/journal.pone.0075575	http://dx.doi.org/10.1371/journal.pone.0075575			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	226HG	24086575	Green Published, Green Submitted, gold			2022-12-27	WOS:000325025200049
J	Kamaraj, B; Kumar, A; Purohit, R				Kamaraj, Balu; Kumar, Ambuj; Purohit, Rituraj			Evolutionary Reconstruction and Population Genetics Analysis of Aurora Kinases	PLOS ONE			English	Article							SYNONYMOUS CODON USAGE; INFERENCE; SELECTION; SEQUENCE; IDENTIFICATION; MRBAYES; BIAS	Background: Aurora kinases belong to the highly conserved kinase family and play a vital role in cell cycle regulation. The structure and function of these kinases are inter-related and sometimes they also act as substitutes in case of knockdown of other aurora kinases. Method: In this work we carried out the evolutionary reconstruction and population genetic studies of aurora kinase proteins. Substitution saturation test, CAI (Codon adaptation index), gene expression and RSCU (Relative synonymous codon usage) values were computed for all the three aurora kinases. Linear regression method was used to check the dependency of gene expression on their CAI values. Results: The results suggested that aurora-B and aurora-C has shown convergence in their evolutionary pathway. Moreover, the aurora-A I57V mutation showed high penetrance in human population and exist at very high frequency (84.4%) when compared to the native residue (15.6%). The mutation showed notable range of functional gain and seemed to be promising for the evolution of aurora-A function. Mutant allele might also become a challenging prospect for understanding the pattern of evolution followed by cell cycle kinases. Conclusion: The overall result suggested that the aurora-A is currently under the evolutionary transition and to determine the functional significance of the mutation further investigation are required.	[Kamaraj, Balu; Kumar, Ambuj; Purohit, Rituraj] Vellore Inst Technol Univ, Bioinformat Div, Sch Bio Sci & Technol, Vellore, Tamil Nadu, India	Vellore Institute of Technology	Purohit, R (corresponding author), Vellore Inst Technol Univ, Bioinformat Div, Sch Bio Sci & Technol, Vellore, Tamil Nadu, India.	riturajpurohit@gmail.com	Kumar, Ambuj/E-4649-2012; Purohit, Rituraj/I-8856-2012; Kamaraj, Balu/AAE-2852-2019; Purohit, Rituraj/AAF-6257-2021; Kumar, Ambuj/U-5268-2019	Kumar, Ambuj/0000-0003-3692-3694; Purohit, Rituraj/0000-0002-2101-9398; Kamaraj, Balu/0000-0002-9747-3984; Purohit, Rituraj/0000-0002-2101-9398; 				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amigo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-428; Bazykin GA, 2011, GENOME BIOL EVOL, V3, P1006, DOI 10.1093/gbe/evr086; Bolanos-Garcia VM, 2005, INT J BIOCHEM CELL B, V37, P1572, DOI 10.1016/j.biocel.2005.02.021; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Brown JR, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-39; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Castro A, 2002, EMBO REP, V3, P457, DOI 10.1093/embo-reports/kvf095; Castro A, 2002, EMBO REP, V3, P1209, DOI 10.1093/embo-reports/kvf241; Chen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019996; Crane R, 2004, J CELL SCI, V117, P5975, DOI 10.1242/jcs.01418; De Baets G, 2012, NUCLEIC ACIDS RES, V40, pD935, DOI 10.1093/nar/gkr996; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Eyers PA, 2005, CELL CYCLE, V4, P784, DOI 10.4161/cc.4.6.1693; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Gabillard JC, 2011, BIOCHEM BIOPH RES CO, V408, P647, DOI 10.1016/j.bbrc.2011.04.078; Gautschi O, 2008, CLIN CANCER RES, V14, P1639, DOI 10.1158/1078-0432.CCR-07-2179; Gupta SK, 2004, J BIOMOL STRUCT DYN, V21, P527, DOI 10.1080/07391102.2004.10506946; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Loewe L, 2008, NATURE, V1; Macarulla T, 2008, RECENT PAT ANTI-CANC, V3, P114, DOI 10.2174/157489208784638785; Machado JP, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-342; Naya H, 2001, FEBS LETT, V501, P127, DOI 10.1016/S0014-5793(01)02644-8; Nguyen HG, 2005, MOL CELL BIOL, V25, P4977, DOI 10.1128/MCB.25.12.4977-4992.2005; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santos MA, 2011, HUM REPROD, V26, P1868, DOI 10.1093/humrep/der111; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Swpfford DL, 1999, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wolf JBW, 2009, GENOME BIOL EVOL, V1, P308, DOI 10.1093/gbe/evp030; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yan XM, 2005, GENES CELLS, V10, P617, DOI 10.1111/j.1365-2443.2005.00863.x; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	42	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75763	10.1371/journal.pone.0075763	http://dx.doi.org/10.1371/journal.pone.0075763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086628	Green Published, gold, Green Submitted			2022-12-27	WOS:000325025200061
J	Liu, C; Yang, DR; Compton, SG; Peng, YQ				Liu, Cong; Yang, Da-Rong; Compton, Stephen G.; Peng, Yan-Qiong			Larger Fig Wasps Are More Careful About Which Figs to Enter - With Good Reason	PLOS ONE			English	Article							SEX-RATIO ADJUSTMENT; BODY-SIZE; POLLINATOR; LONGEVITY; SELECTION; COEVOLUTION; STABILITY; CONSEQUENCES; ATTRACTION; MECHANISM	Floral longevity reflects a balance between gains in pollinator visitation and the costs of flower maintenance. Because rewards to pollinators change over time, older flowers may be less attractive, reducing the value of extended longevity. Un-pollinated figs, the inflorescences of Ficus species, can remain receptive for long periods, but figs that are older when entered by their host-specific fig wasp pollinators produce fewer seeds and fig wasp offspring. Our field experiments with Ficus hispida, a dioecious fig tree, examined how the length of time that receptive figs have remained un-pollinated influences the behaviour and reproductive success of its short-lived fig wasp pollinator, Ceratosolen solmsi marchali. The results were consistent in three different seasons, and on male and female trees, although receptivity was greatly extended during colder months. Pollinators took longer to find the ostioles of older figs, and longer to penetrate them. They also became increasingly unwilling to enter figs as they aged, and increasing numbers of the wasps became trapped in the ostiolar bracts. Larger individuals were particularly unwilling to enter older figs, resulting in older figs being pollinated by smaller wasps. On female trees, where figs produce only seeds, seed production declined rapidly with fig age. On male trees, the numbers and size of fig wasp offspring declined, and a higher proportion were male. Older male figs are harder to enter, especially for larger individuals, and offer poorer quality oviposition opportunities. This study opens an interesting new perspective on the coevolution of figs and their pollinators, especially factors influencing pollinator body size and emphasises the subtleties of interactions between mutualists.	[Liu, Cong; Yang, Da-Rong; Peng, Yan-Qiong] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China; [Liu, Cong] Grad Univ, Okinawa Inst Sci & Technol, Okinawa, Japan; [Compton, Stephen G.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Okinawa Institute of Science & Technology Graduate University; Rhodes University	Peng, YQ (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China.	pengyq@xtbg.ac.cn	Liu, Cong/B-9927-2015	Liu, Cong/0000-0002-8664-6931; Compton, Stephen/0000-0002-1247-8058	CAS 135 program [XTBG-T01]; Chinese Natural Science Foundation [31120002];  [2011HB041]	CAS 135 program; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); 	This work was funded by Candidates of the Young and Middle Aged Academic Leaders of Yunnan Province (2011HB041), and the CAS 135 program (XTBG-T01), and the Chinese Natural Science Foundation (31120002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstett MC, 1996, J BIOGEOGR, V23, P459, DOI 10.1111/j.1365-2699.1996.tb00007.x; ASHMAN TL, 1994, NATURE, V371, P788, DOI 10.1038/371788a0; Berg CC., 2005, FLORA MALESIANA, V17, P1, DOI DOI 10.1663/0007-196X(2006)58[; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Bronstein JL, 1998, ENTOMOL EXP APPL, V87, P321, DOI 10.1023/A:1003242205324; Charnov EL, 1996, EVOL ECOL, V10, P245, DOI 10.1007/BF01237682; Chen C, 2009, FUNCT ECOL, V23, P941, DOI 10.1111/j.1365-2435.2009.01622.x; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; D'Amico LJ, 2001, P ROY SOC B-BIOL SCI, V268, P1589, DOI 10.1098/rspb.2001.1698; Dunn DW, 2008, J ANIM ECOL, V77, P927, DOI 10.1111/j.1365-2656.2008.01416.x; GALIL J, 1968, NEW PHYTOL, V67, P745, DOI 10.1111/j.1469-8137.1968.tb05497.x; Gibernau M, 1996, J BIOGEOGR, V23, P425, DOI 10.1111/j.1365-2699.1996.tb00004.x; GRAFEN A, 1991, P ROY SOC B-BIOL SCI, V245, P73, DOI 10.1098/rspb.1991.0090; Grison-Pige L, 2002, J CHEM ECOL, V28, P283, DOI 10.1023/A:1017930023741; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Herre EA, 1997, P ROY SOC B-BIOL SCI, V264, P1501, DOI 10.1098/rspb.1997.0208; HERRE EA, 1989, EXPERIENTIA, V45, P637, DOI 10.1007/BF01975680; HERRE EA, 1985, SCIENCE, V228, P896, DOI 10.1126/science.228.4701.896; Hu HY, 2010, ECOL ENTOMOL, V35, P115, DOI 10.1111/j.1365-2311.2009.01170.x; KHADARI B, 1995, AM J BOT, V82, P992, DOI 10.2307/2446228; Kjellberg F, 2005, BIOL ECOLOGY EVOLUTI, V1, P539; Liu C, 2011, ENTOMOL EXP APPL, V138, P249, DOI 10.1111/j.1570-7458.2011.01096.x; Moore JC, 2003, OIKOS, V101, P180, DOI 10.1034/j.1600-0706.2003.12212.x; Moya-Larano J, 2007, BIOLOGY LETT, V3, P475, DOI 10.1098/rsbl.2007.0300; Nefdt RJC, 1996, J ANIM ECOL, V65, P170, DOI 10.2307/5720; Parker Joseph, 2006, J Biol, V5, P15, DOI 10.1186/jbiol47; Partridge L, 1999, GENET RES, V74, P43, DOI 10.1017/S0016672399003778; Patel A, 1998, OECOLOGIA, V115, P391, DOI 10.1007/s004420050533; PATEL A, 1995, J EVOLUTION BIOL, V8, P301, DOI 10.1046/j.1420-9101.1995.8030301.x; Peng YQ, 2010, PLANT ECOL, V209, P227, DOI 10.1007/s11258-009-9690-4; Peng YQ, 2005, ECOL ENTOMOL, V30, P70, DOI 10.1111/j.0307-6946.2005.00650.x; PRIMACK RB, 1985, ANNU REV ECOL SYST, V16, P15, DOI 10.1146/annurev.es.16.110185.000311; Raja S, 2008, P ROY SOC B-BIOL SCI, V275, P1603, DOI 10.1098/rspb.2008.0136; RAMIREZ W, 1969, SCIENCE, V163, P580, DOI 10.1126/science.163.3867.580; Rathcke BJ, 2003, AM J BOT, V90, P1328, DOI 10.3732/ajb.90.9.1328; Roff Derek A., 1992; Schreiber SJ, 2002, EVOL ECOL RES, V4, P701; Slansky F. Jr, 1985, P87; Suleman N, 2011, ECOL ENTOMOL, V36, P417, DOI 10.1111/j.1365-2311.2011.01284.x; Teder T, 2008, AM NAT, V172, P223, DOI 10.1086/589896; VANNOORT S, 1989, S AFR J SCI, V85, P323; VOLLRATH F, 1980, Z TIERPSYCHOL, V53, P61; Wang RW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007802; WIEBES JT, 1979, ANNU REV ECOL SYST, V10, P1, DOI 10.1146/annurev.es.10.110179.000245; Yu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030833; Zhang Y, 2012, EVOL ECOL, V26, P513, DOI 10.1007/s10682-011-9525-3	46	11	18	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74117	10.1371/journal.pone.0074117	http://dx.doi.org/10.1371/journal.pone.0074117			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086315	gold, Green Published, Green Submitted			2022-12-27	WOS:000326520200023
J	Xue, Y; Shen, L; Cui, Y; Zhang, HB; Chen, Q; Cui, AF; Fang, FD; Chang, YS				Xue, Yuan; Shen, Lian; Cui, Ying; Zhang, Huabing; Chen, Qi; Cui, Anfang; Fang, Fude; Chang, Yongsheng			Tff3, as a Novel Peptide, Regulates Hepatic Glucose Metabolism	PLOS ONE			English	Article							INTESTINAL TREFOIL FACTOR; GENE-EXPRESSION; TRANSCRIPTIONAL COACTIVATOR; GAMMA COACTIVATOR-1-ALPHA; INSULIN-RESISTANCE; GLUCONEOGENESIS; RECEPTOR; CELLS; PGC-1; IDENTIFICATION	Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder strongly associated with hepatic glucose intolerance and insulin resistance. The trefoil peptides are a family of small regulatory proteins and Tff3 is widely expressed in multiple tissues including liver. But the roles of Tff3 in regulation of glucose metabolism and insulin sensitivity in liver remain unclear. Here we show that the hepatic Tff3 expression levels were decreased in ob/ob and high-fat diet-induced obese mice. Overexpression of Tff3 in primary mouse hepatocytes inhibited the expression of gluconeogenic genes, including G6pc, PEPCK and PGC-1 alpha, subsequently decreasing cellular glucose output. GTT and ITT experiments revealed that adenovirus-mediated overexpression of Tff3 in diabetic or obese mice improved glucose tolerance and insulin sensitivity. Collectively, our results indicated that Tff3 peptides are involved in glucose homeostasis and insulin sensitivity, providing a promising peptide on new therapies against the metabolic disorders associated with T2DM.	[Xue, Yuan; Shen, Lian; Cui, Ying; Zhang, Huabing; Chen, Qi; Cui, Anfang; Fang, Fude; Chang, Yongsheng] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China; [Xue, Yuan; Shen, Lian; Cui, Ying; Zhang, Huabing; Chen, Qi; Cui, Anfang; Fang, Fude; Chang, Yongsheng] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Fang, FD (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China.	fangfd@vip.sina.com; changy@ibms.pumc.edu.cn		zhang, huabing/0000-0001-8402-7830	National Natural Science Foundation of China [81170763]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grants 81170763). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrera Roa GJ, 2013, J HEALTH SCI, V3, P1, DOI DOI 10.17532/JHSCI.2013.26; Fernandez-Estivariz C, 2003, AM J PHYSIOL-REG I, V284, pR564, DOI 10.1152/ajpregu.00428.2002; Fueger PT, 2008, MOL ENDOCRINOL, V22, P1251, DOI 10.1210/me.2007-0500; Guillen N, 2009, PHYSIOL GENOMICS, V37, P187, DOI 10.1152/physiolgenomics.90339.2008; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; HAUSER F, 1993, P NATL ACAD SCI USA, V90, P6961, DOI 10.1073/pnas.90.15.6961; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Higginbotham JN, 2002, HUM GENE THER, V13, P129, DOI 10.1089/10430340152712683; KHAN A, 1995, ENDOCRINOLOGY, V136, P1934, DOI 10.1210/en.136.5.1934; Kinoshita K, 2000, MOL CELL BIOL, V20, P4680, DOI 10.1128/MCB.20.13.4680-4690.2000; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kumar KG, 2008, CELL METAB, V8, P468, DOI 10.1016/j.cmet.2008.10.011; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Ludeking A, 1998, FEBS LETT, V439, P180, DOI 10.1016/S0014-5793(98)01368-4; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Oberkofler H, 2003, BIOCHEM J, V371, P89, DOI 10.1042/BJ20021665; Ogata H, 1997, AM J PHYSIOL-GASTR L, V273, pG348, DOI 10.1152/ajpgi.1997.273.2.G348; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; SUEMORI S, 1991, P NATL ACAD SCI USA, V88, P11017, DOI 10.1073/pnas.88.24.11017; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Taupin D, 1999, J CLIN INVEST, V103, pR31, DOI 10.1172/JCI3304; Taupin DR, 2000, P NATL ACAD SCI USA, V97, P799, DOI 10.1073/pnas.97.2.799; Thim L, 2005, CELL MOL LIFE SCI, V62, P2956, DOI 10.1007/s00018-005-5484-6; Thim L, 1997, CELL MOL LIFE SCI, V53, P888, DOI 10.1007/s000180050108; THIM L, 1995, BIOCHEMISTRY-US, V34, P4757, DOI 10.1021/bi00014a033; Tran CP, 1998, AM J PHYSIOL-GASTR L, V275, pG85, DOI 10.1152/ajpgi.1998.275.1.G85; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wiernsperger NF, 1999, DRUGS, V58, P31, DOI 10.2165/00003495-199958001-00009; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026; Zsengeller Z, 2000, J VIROL, V74, P9655, DOI 10.1128/JVI.74.20.9655-9667.2000	41	19	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75240	10.1371/journal.pone.0075240	http://dx.doi.org/10.1371/journal.pone.0075240			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086476	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200092
J	Ishida, T; Alexandrov, M; Nishimura, T; Hirota, R; Ikeda, T; Kuroda, A				Ishida, Takenori; Alexandrov, Maxym; Nishimura, Tomoki; Hirota, Ryuichi; Ikeda, Takeshi; Kuroda, Akio			Molecular Engineering of a Fluorescent Bioprobe for Sensitive and Selective Detection of Amphibole Asbestos	PLOS ONE			English	Article							PROTEIN; FIBERS; IDENTIFICATION	Fluorescence microscopy-based affinity assay could enable highly sensitive and selective detection of airborne asbestos, an inorganic environmental pollutant that can cause mesothelioma and lung cancer. We have selected an Escherichia coli histone-like nucleoid structuring protein, H-NS, as a promising candidate for an amphibole asbestos bioprobe. H-NS has high affinity to amphibole asbestos, but also binds to an increasingly common asbestos substitute, wollastonite. To develop a highly specific Bioprobe for amphibole asbestos, we first identified a specific but low-affinity amosite-binding sequence by slicing H-NS into several fragments. Second, we constructed a streptavidin tetramer complex displaying four amosite-binding fragments, resulting in the 250-fold increase in the probe affinity as compared to the single fragment. The tetramer probe had sufficient affinity and specificity for detecting all the five types of asbestos in the amphibole group, and could be used to distinguish them from wollastonite. In order to clarify the binding mechanism and identify the amino acid residues contributing to the probe's affinity to amosite fibers, we constructed a number of shorter and substituted peptides. We found that the probable binding mechanism is electrostatic interaction, with positively charged side chains of lysine residues being primarily responsible for the probe's affinity to asbestos.	[Ishida, Takenori; Alexandrov, Maxym; Nishimura, Tomoki; Hirota, Ryuichi; Ikeda, Takeshi; Kuroda, Akio] Dept Mol Biotechnol, Higashihiroshima, Hiroshima, Japan		Kuroda, A (corresponding author), Dept Mol Biotechnol, Higashihiroshima, Hiroshima, Japan.	akuroda@hiroshima-u.ac.jp	Ikeda, Takeshi/B-4792-2008; Hirota, Ryuichi/Q-3138-2016	Ikeda, Takeshi/0000-0001-7159-5660; Hirota, Ryuichi/0000-0003-3959-5892; Ishida, Takenori/0000-0002-6705-915X	Ministry of the Environment, Japan [C-1101]; Japan Science and Technology Agency; JSPS KAKENHI [25249117]	Ministry of the Environment, Japan(Ministry of the Environment, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Environment Research and Technology Development Fund (C-1101) of the Ministry of the Environment, Japan, the Development of Systems and Technology for Advanced Measurement and Analysis Program of the Japan Science and Technology Agency, and the Grant-in-Aid for Scientific Research (A) from JSPS KAKENHI (grant number 25249117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DAVIS JMG, 1978, BRIT J CANCER, V37, P673, DOI 10.1038/bjc.1978.105; Esposito D, 2002, J MOL BIOL, V324, P841, DOI 10.1016/S0022-2836(02)01141-5; Ishida T, 2012, J FLUORESC, V22, P357, DOI 10.1007/s10895-011-0967-3; Ishida T, 2010, ENVIRON SCI TECHNOL, V44, P755, DOI 10.1021/es902395h; Kohyama N, 1997, IND HEALTH, V35, P415, DOI 10.2486/indhealth.35.415; Kuroda A, 2008, BIOTECHNOL BIOENG, V99, P285, DOI 10.1002/bit.21588; National Institute of Occupational Safety and Health (NIOSH), 2011, NAT I OCC SAF HLTH N; National Institute of Occupational Safety and Health (NIOSH), 1994, BIOSH MAN AN METH; Sano K, 2005, SMALL, V1, P826, DOI 10.1002/smll.200500010; Seker UOS, 2011, MOLECULES, V16, P1426, DOI 10.3390/molecules16021426; Shindo H, 1999, FEBS LETT, V455, P63, DOI 10.1016/S0014-5793(99)00862-5; TAYLOR DG, 1984, AM IND HYG ASSOC J, V45, P84, DOI 10.1080/15298668491399415; World Health Organisation, 2000, AIR QUAL GUID EUR, P273	13	4	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76231	10.1371/journal.pone.0076231	http://dx.doi.org/10.1371/journal.pone.0076231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086716	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900089
J	He, WF; Tong, YF; Wang, Y; Liu, JJ; Luo, GX; Wu, J; Zhang, J				He, Weifeng; Tong, Yifan; Wang, Ying; Liu, Jingjing; Luo, Gaoxing; Wu, Jun; Zhang, Jin			Serum Soluble CD14 Is a Potential Prognostic Indicator of Recurrence of Human Breast Invasive Ductal Carcinoma with Her2-Enriched Subtype	PLOS ONE			English	Article							CANCER; RECEPTOR; HER2	In clinical practice, breast cancers with lymph node positive, ER/PR-negative and overexpressed human epidermal growth factor receptor 2 (LN+ER/PR-Her2+) have high risk of recurrence, but the effective biomarkers of prognostic for this type tumor are still lacking. Since breast cancers with LN+ER/PR-Her2+ is at higher risk of recurrence than those with LN-ER/PR+Her2-. The differential proteins between those two groups could be related to the risk of recurrence. Herein, we report that serum soluble CD14 (sCD14) was revealed as the stable differential protein between LN+ER/PR-Her2+ (n=50) and LN-ER/PR+Her2-(n=50) breast cancer patients by proteomics analysis. To validate sCD14 as a biomarker for predicting recurrence of breast cancer, 90 breast cancer patients with LN+ER/PR-Her2+ and 93 patients with LN-ER/PR+Her2-were recruited. The patients with higher level of serum sCD14 at primary surgery showed to be at significantly lower risk of relapse in 3 years follow-up than those with lower level of serum sCD14 at primary surgery. The levels of serum sCD14 at primary surgery were significantly correlated to the risk of 3-year recurrence of LN+ER/PR-Her2+ breast cancer and the corresponding AUC of the ROC curve was 0.833 (95% CI, and 0.742 to 0.920). Therefore, we surmise that serum sCD14 could be a potential biomarker for predicting the prognosis of breast invasive ductal carcinoma with LN+ER/PR-Her2+.	[He, Weifeng; Wang, Ying; Luo, Gaoxing; Wu, Jun] Third Mil Med Univ, Chongqing Key Lab Dis Prote, State Key Lab Trauma Burns & Combined Injury, Inst Burn Res,Southwest Hosp, Chongqing, Peoples R China; [Liu, Jingjing; Zhang, Jin] Tianjin Med Univ, Canc Inst & Hosp, Dept Breast Canc 3, China Tianjin Breast Canc Prevent Treatment & Res, Tianjin, Peoples R China	Army Medical University; Tianjin Medical University	Luo, GX (corresponding author), Third Mil Med Univ, Chongqing Key Lab Dis Prote, State Key Lab Trauma Burns & Combined Injury, Inst Burn Res,Southwest Hosp, Chongqing, Peoples R China.	logxw@hotmail.com; junwupro1@yahoo.com.cn; davidz9132002@yahoo.com	Gaoxing, LUO/AAE-4505-2020	LUO, Gaoxing/0000-0003-4764-3209	Chongqing Key Laboratory	Chongqing Key Laboratory	This work was supported by the special fund of Chongqing Key Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoub N, 2011, ASIAN PAC J CANCER P, V12, P1127; Carlsson A, 2011, P NATL ACAD SCI USA, V108, P14252, DOI 10.1073/pnas.1103125108; GADDUCCI A, 1995, GYNECOL ONCOL, V58, P184, DOI 10.1006/gyno.1995.1207; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; He WF, 2012, PROTEOMICS, V12, P1059, DOI 10.1002/pmic.201100400; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lundell AC, 2007, INFECT IMMUN, V75, P4097, DOI 10.1128/IAI.01744-06; Onitilo AA, 2009, CLIN MED RES, V7, P4, DOI 10.3121/cmr.2009.825; Rody A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2234; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Standish Leanna J, 2008, J Soc Integr Oncol, V6, P158; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Wu CC, 2010, MOL CELL PROTEOMICS, V9, P1100, DOI 10.1074/mcp.M900398-MCP200; Zdolsek HA, 2004, CLIN EXP ALLERGY, V34, P532, DOI 10.1111/j.1365-2222.2004.1921.x; Zhou M, 2010, CANCER RES, V70, P7534, DOI 10.1158/0008-5472.CAN-10-0815; ZIEGLERHEITBROCK HWL, 1993, IMMUNOL TODAY, V14, P121, DOI 10.1016/0167-5699(93)90212-4	18	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75366	10.1371/journal.pone.0075366	http://dx.doi.org/10.1371/journal.pone.0075366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086515	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700081
J	Smith, RKW; Werling, NJ; Dakin, SG; Alam, R; Goodship, AE; Dudhia, J				Smith, Roger Kenneth Whealands; Werling, Natalie Jayne; Dakin, Stephanie Georgina; Alam, Rafiqul; Goodship, Allen E.; Dudhia, Jayesh			Beneficial Effects of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Naturally Occurring Tendinopathy	PLOS ONE			English	Article							PLATELET-RICH PLASMA; DIGITAL FLEXOR TENDINITIS; GENE-EXPRESSION PATTERNS; STROMAL CELLS; SULFATED GLYCOSAMINOGLYCANS; ADIPOSE-TISSUE; MESSENGER-RNA; TENDON REPAIR; EQUINE FLEXOR; HORSES	Tendon injuries are a common age-related degenerative condition where current treatment strategies fail to restore functionality and normal quality of life. This disease also occurs naturally in horses, with many similarities to human tendinopathy making it an ideal large animal model for human disease. Regenerative approaches are increasingly used to improve outcome involving mesenchymal stem cells (MSCs), supported by clinical data where injection of autologous bone marrow derived MSCs (BM-MSCs) suspended in marrow supernatant into injured tendons has halved the re-injury rate in racehorses. We hypothesized that stem cell therapy induces a matrix more closely resembling normal tendon than the fibrous scar tissue formed by natural repair. Twelve horses with career-ending naturally-occurring superficial digital flexor tendon injury were allocated randomly to treatment and control groups. 1x10(7) autologous BM-MSCs suspended in 2 ml of marrow supernatant were implanted into the damaged tendon of the treated group. The control group received the same volume of saline. Following a 6 month exercise programme horses were euthanized and tendons assessed for structural stiffness by non-destructive mechanical testing and for morphological and molecular composition. BM-MSC treated tendons exhibited statistically significant improvements in key parameters compared to saline-injected control tendons towards that of normal tendons and those in the contralateral limbs. Specifically, treated tendons had lower structural stiffness (p<0.05) although no significant difference in calculated modulus of elasticity, lower (improved) histological scoring of organisation (p<0.003) and crimp pattern (p<0.05), lower cellularity (p<0.007), DNA content (p<0.05), vascularity (p<0.03), water content (p<0.05), GAG content (p<0.05), and MMP-13 activity (p<0.02). Treatment with autologous MSCs in marrow supernatant therefore provides significant benefits compared to untreated tendon repair in enhancing normalisation of biomechanical, morphological, and compositional parameters. These data in natural disease, with no adverse findings, support the use of this treatment for human tendon injuries.	[Smith, Roger Kenneth Whealands; Dakin, Stephanie Georgina; Alam, Rafiqul; Dudhia, Jayesh] Univ London, Royal Vet Coll, Dept Clin Sci & Serv, Hatfield, Herts, England; [Werling, Natalie Jayne] Natl Inst Biol Stand & Controls, Dept Biotherapeut, S Mimms, Herts, England; [Goodship, Allen E.] Univ Coll London, Inst Orthopaed & Musculoskeletal Sci, Stanmore, Middx, England	University of London; University of London Royal Veterinary College; National Institute for Biological Standards & Control; University of London; University College London	Dudhia, J (corresponding author), Univ London, Royal Vet Coll, Dept Clin Sci & Serv, Hatfield, Herts, England.	jdudhia@rvc.ac.uk		Dakin, Stephanie Georgina/0000-0003-2470-1031; Werling, Natalie/0000-0001-5813-6128; Dudhia, Jayesh/0000-0002-2503-697X	Horserace Betting Levy Board, UK; Royal Veterinary College, UK; VetCell Bioscience Ltd, UK; Biotechnology and Biological Sciences Research Council	Horserace Betting Levy Board, UK; Royal Veterinary College, UK; VetCell Bioscience Ltd, UK; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the Horserace Betting Levy Board, UK, the Royal Veterinary College, UK (http://www.hblb.org.uk) and VetCell Bioscience Ltd, UK (http://www.vetcell.com). SGD was funded by a Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves AGL, 2011, VET CLIN N AM-EQUINE, V27, P315, DOI 10.1016/j.cveq.2011.06.001; Avella CS, 2009, EQUINE VET J, V41, P449, DOI 10.2746/042516409X391042; Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267; Awad HA, 2003, J ORTHOP RES, V21, P420, DOI 10.1016/S0736-0266(02)00163-8; Bancroft J., 2007, THEORY PRACTICE HIST, V6 ed; Barbero A, 2003, ARTHRITIS RHEUM-US, V48, P1315, DOI 10.1002/art.10950; Batson EL, 2003, EQUINE VET J, V35, P314, DOI 10.2746/042516403776148327; Becerra P, 2013, J ORTHOP RES, V31, P1096, DOI 10.1002/jor.22338; Birch HL, 1999, EQUINE VET J, V31, P391, DOI 10.1111/j.2042-3306.1999.tb03838.x; Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456; Cadby JA, 2013, EQUINE VET J, V45, P642, DOI 10.1111/evj.12035; Caniglia CJ, 2012, EQUINE VET J, V44, P587, DOI 10.1111/j.2042-3306.2011.00514.x; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Corps AN, 2006, RHEUMATOLOGY, V45, P291, DOI 10.1093/rheumatology/kei152; Corps AN, 2012, ANN RHEUM DIS, V71, P746, DOI 10.1136/annrheumdis-2011-200391; Crevier-Denoix N, 1997, Equine Vet J Suppl, P23; Crovace A, 2007, VET RES COMMUN, V31, P281, DOI 10.1007/s11259-007-0047-y; Crovace Antonio, 2010, Vet Med Int, V2010, P250978, DOI 10.4061/2010/250978; Dahlgren LA, 2005, J ORTHOP RES, V23, P84, DOI 10.1016/j.orthres.2004.05.007; Dakin SG, 2011, EQUINE VET J, V43, P418, DOI 10.1111/j.2042-3306.2010.00303.x; Dakin SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048978; Dakin SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032333; Duffy MM, 2011, EUR J IMMUNOL, V41, P2840, DOI 10.1002/eji.201141499; Dyson SJ, 2004, EQUINE VET J, V36, P415, DOI 10.2746/0425164044868422; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fortier LA, 1998, AM J VET RES, V59, P1182; Fu SC, 2007, CLIN J SPORT MED, V17, P129, DOI 10.1097/JSM.0b013e318037998f; Godwin EE, 2012, EQUINE VET J, V44, P25, DOI 10.1111/j.2042-3306.2011.00363.x; Guest DJ, 2008, EQUINE VET J, V40, P178, DOI 10.2746/042516408X276942; Guest DJ, 2010, EQUINE VET J, V42, P636, DOI 10.1111/j.2042-3306.2010.00112.x; Herthel D., 2001, P AM ASS EQ PRACT, V47, P319; Hildebrand KA, 2002, MICROSC RES TECHNIQ, V58, P34, DOI 10.1002/jemt.10114; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Lui PPY, 2011, SCAND J MED SCI SPOR, V21, P3, DOI 10.1111/j.1600-0838.2010.01164.x; Maffulli N, 2008, CLIN ORTHOP RELAT R, V466, P1605, DOI 10.1007/s11999-008-0261-0; Magnussen RA, 2009, CLIN J SPORT MED, V19, P54, DOI 10.1097/JSM.0b013e31818ef090; McCarrel T, 2009, J ORTHOP RES, V27, P1033, DOI 10.1002/jor.20853; Movin T, 1997, ACTA ORTHOP SCAND, V68, P170, DOI 10.3109/17453679709004002; O'Meara B, 2010, EQUINE VET J, V42, P322, DOI 10.1111/j.2042-3306.2009.00021.x; Ouyang HW, 2003, TISSUE ENG, V9, P431, DOI 10.1089/107632703322066615; Plaas A, 2011, J ORTHOP RES, V29, P900, DOI 10.1002/jor.21332; RILEY GP, 1994, ANN RHEUM DIS, V53, P367, DOI 10.1136/ard.53.6.367; Samiric T, 2009, MATRIX BIOL, V28, P230, DOI 10.1016/j.matbio.2009.04.001; Schnabel LV, 2008, EQUINE VET J, V40, P260, DOI 10.2746/042516408X278030; Schnabel LV, 2007, J ORTHOP RES, V25, P230, DOI 10.1002/jor.20278; Schnabel LV, 2009, J ORTHOP RES, V27, P1392, DOI 10.1002/jor.20887; Schramme M, 2010, VET COMP ORTHOPAED, V23, P231, DOI 10.3415/VCOT-09-10-0106; Schu S, 2012, J CELL MOL MED, V16, P2094, DOI 10.1111/j.1582-4934.2011.01509.x; Smith JJ, 2006, VET COMP ORTHOPAED, V19, P43; Smith MM, 2008, ARTHRITIS RHEUM-US, V58, P1055, DOI 10.1002/art.23388; Smith RKW, 2003, EQUINE VET J, V35, P99, DOI 10.2746/042516403775467388; SMITH RKW, 1994, EQUINE VET J, V26, P460, DOI 10.1111/j.2042-3306.1994.tb04050.x; Smith RWK, 2010, DIAGNOSIS MANAGEMENT; STRASSBURG S, 2006, T ORTH RES SOC ANN M, V31, P1113; Vidal MA, 2007, VET SURG, V36, P613, DOI 10.1111/j.1532-950X.2007.00313.x; Vidal MA, 2006, VET SURG, V35, P601, DOI 10.1111/j.1532-950X.2006.00197.x; Vidal MA, 2008, VET SURG, V37, P713, DOI 10.1111/j.1532-950X.2008.00462.x; Wang VM, 2012, J ORTHOP RES, V30, P620, DOI 10.1002/jor.21558; Williams RB, 2001, EQUINE VET J, V33, P478, DOI 10.2746/042516401776254808; Wilson AM, 2001, NATURE, V414, P895, DOI 10.1038/414895a; Young NJ, 2009, MATRIX BIOL, V28, P311, DOI 10.1016/j.matbio.2009.05.002; Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403	63	112	115	5	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75697	10.1371/journal.pone.0075697	http://dx.doi.org/10.1371/journal.pone.0075697			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086616	gold, Green Published			2022-12-27	WOS:000325218700110
J	Lai, D; Tan, CL; Gunaratne, J; Quek, LS; Nei, WL; Thierry, F; Bellanger, S				Lai, Deborah; Tan, Chye Ling; Gunaratne, Jayantha; Quek, Ling Shih; Nei, Wenlong; Thierry, Francoise; Bellanger, Sophie			Localization of HPV-18 E2 at Mitochondrial Membranes Induces ROS Release and Modulates Host Cell Metabolism	PLOS ONE			English	Article							HIGH-RISK; ELECTRON-TRANSPORT; TUMOR-SUPPRESSOR; PROTEIN; EXPRESSION; CANCER; TRANSCRIPTION; GENERATION; APOPTOSIS; PATHWAY	Papillomavirus E2 proteins are predominantly retained in the nuclei of infected cells, but oncogenic (high-risk) HPV-18 and 16 E2 can shuttle between the host nucleus and cytoplasm. We show here that cytoplasmic HPV-18 E2 localizes to mitochondrial membranes, and independent mass spectrometry analyses of the E2 interactome revealed association to the inner mitochondrial membrane including components of the respiratory chain. Mitochondrial E2 association modifies the cristae morphology when analyzed by electron microscopy and increases production of mitochondrial ROS. This ROS release does not induce apoptosis, but instead correlates with stabilization of HIF-1 alpha and increased glycolysis. These mitochondrial functions are not shared by the non-oncogenic (low-risk) HPV-6 E2 protein, suggesting that modification of cellular metabolism by high-risk HPV E2 proteins could play a role in carcinogenesis by inducing the Warburg effect.	[Lai, Deborah; Tan, Chye Ling; Quek, Ling Shih; Nei, Wenlong; Thierry, Francoise; Bellanger, Sophie] ASTAR, Inst Med Biol, Singapore, Singapore; [Gunaratne, Jayantha] ASTAR, Inst Mol & Cell Biol, Quantitat Prote Grp, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Bellanger, S (corresponding author), ASTAR, Inst Med Biol, Singapore, Singapore.	sophie.bellanger@imb.a-star.edu.sg		nei, wen long/0000-0001-6027-1652	Agency for Science, Technology and Research (A*STAR), Singapore	Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology and Research (A*STAR), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera-Aguirre L, 2009, J IMMUNOL, V183, P5379, DOI 10.4049/jimmunol.0900228; Alirol E, 2006, ONCOGENE, V25, P4706, DOI 10.1038/sj.onc.1209600; Ando M, 2008, LIVER INT, V28, P1158, DOI 10.1111/j.1478-3231.2008.01720.x; Bellanger S, 2005, CELL CYCLE, V4, P1608, DOI 10.4161/cc.4.11.2123; Bellanger S, 2011, AM J CANCER RES, V1, P373; Bellanger S, 2010, J VIROL, V84, P437, DOI 10.1128/JVI.01162-09; Blachon S, 2005, J BIOL CHEM, V280, P36088, DOI 10.1074/jbc.M505138200; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001; Demeret C, 2003, ONCOGENE, V22, P168, DOI 10.1038/sj.onc.1206108; Desaintes C, 1997, EMBO J, V16, P504, DOI 10.1093/emboj/16.3.504; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Klimova T, 2008, CELL DEATH DIFFER, V15, P660, DOI 10.1038/sj.cdd.4402307; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; Lee YI, 2004, J BIOL CHEM, V279, P15460, DOI 10.1074/jbc.M309280200; Maehama T, 1998, INT J CANCER, V76, P639, DOI 10.1002/(SICI)1097-0215(19980529)76:5<639::AID-IJC5>3.0.CO;2-R; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Nohl H, 2005, BIOCHEM PHARMACOL, V69, P719, DOI 10.1016/j.bcp.2004.12.002; Ohta A, 2011, MITOCHONDRION, V11, P1, DOI 10.1016/j.mito.2010.08.006; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Pfefferle R, 2008, J INVEST DERMATOL, V128, P2310, DOI 10.1038/jid.2008.73; Raj K, 2004, J VIROL, V78, P7199, DOI 10.1128/JVI.78.13.7199-7207.2004; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Silic-Benussi M, 2010, FEBS LETT, V584, P2070, DOI 10.1016/j.febslet.2010.02.030; Thierry F, 2004, CANCER RES, V64, P895, DOI 10.1158/0008-5472.CAN-03-2349; THIERRY F, 1987, EMBO J, V6, P3391, DOI 10.1002/j.1460-2075.1987.tb02662.x; Villota C, 2012, J BIOL CHEM, V287, P21303, DOI 10.1074/jbc.M111.326694; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xue YZ, 2010, CANCER RES, V70, P5316, DOI 10.1158/0008-5472.CAN-09-3789	32	50	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75625	10.1371/journal.pone.0075625	http://dx.doi.org/10.1371/journal.pone.0075625			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086592	gold, Green Published, Green Submitted			2022-12-27	WOS:000325025200056
J	Parkhouse, R; Ebong, IO; Robinson, CV; Monie, TP				Parkhouse, Rhiannon; Ebong, Ima-Obong; Robinson, Carol V.; Monie, Tom P.			The N-Terminal Region of the Human Autophagy Protein ATG16L1 Contains a Domain That Folds into a Helical Structure Consistent with Formation of a Coiled-Coil	PLOS ONE			English	Article							MASS-SPECTROMETRY; ISOLATION MEMBRANE; CONJUGATE; PATHWAY; COMPLEX; FIP200; ASSEMBLIES; CELLS; YEAST; LC3	Autophagy is a fundamental cellular process required for organelle degradation and removal of invasive pathogens. Autophagosome formation involves the recruitment of, and interaction between, multiple proteins produced from autophagy-related (ATG) genes. One of the key complexes in autophagosome formation is the ATG12-ATG5-ATG16L1 complex. ATG16L1 functions as a molecular scaffold mediating protein-protein interactions necessary for formation of the autophagosome in response to both classical and pathogen-related autophagy stimuli. The coiled-coil domain of the yeast ortholog, ATG16, exists as a homodimer both in solution and in the crystal form. The yeast and human orthologs show poor sequence identity. Here we have sought to determine the minimal boundaries of the human ATG16L1 coiled-coil domain and ascertain its oligomeric status in solution. Using a range of biochemical and biophysical techniques we show that the secondary structure of the human ATG16L1 coiled-coil has the expected helical composition and that the domain forms a homodimer in solution. We also observe extensive sequence conservation across vertebrates providing strong support for the crucial functional role of the ATG16L1 coiled-coil.	[Parkhouse, Rhiannon; Monie, Tom P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Ebong, Ima-Obong; Robinson, Carol V.] Univ Oxford, Dept Chem, Oxford OX1 3QZ, England	University of Cambridge; University of Oxford	Monie, TP (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	tpm22@cam.ac.uk	Monie, Tom/H-4662-2019	Monie, Tom/0000-0003-4097-1680; robinson, carol/0000-0001-7829-5505	Wellcome Trust [WT085090MA]; BBSRC Doctoral Training Grant; Biotechnology and Biological Sciences Research Council [979868] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC Doctoral Training Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a Wellcome Trust Career Development Fellowship to TPM (WT085090MA; www.wellcome.ac.uk) and a BBSRC Doctoral Training Grant for RP (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boada-Romero E, 2013, EMBO J, V32, P566, DOI 10.1038/emboj.2013.8; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Fujioka Y, 2008, ACTA CRYSTALLOGR F, V64, P1046, DOI 10.1107/S1744309108031898; Fujioka Y, 2010, J BIOL CHEM, V285, P1508, DOI 10.1074/jbc.M109.053520; Gammoh N, 2013, NAT STRUCT MOL BIOL, V20, P144, DOI 10.1038/nsmb.2475; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hernandez H, 2001, J BIOL CHEM, V276, P46685, DOI 10.1074/jbc.R100024200; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Heul AMV, 2013, J BIOL CHEM, V288, P6890, DOI 10.1074/jbc.M112.413781; Homer CR, 2010, GASTROENTEROLOGY, V139, P1630, DOI 10.1053/j.gastro.2010.07.006; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Li XH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1648; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Monie TP, 2005, RNA, V11, P1803, DOI 10.1261/rna.2214405; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Nishimura T, 2013, EMBO REP, V14, P284, DOI 10.1038/embor.2013.6; Otomo C, 2013, NAT STRUCT MOL BIOL, V20, P59, DOI 10.1038/nsmb.2431; Ruotolo BT, 2006, CURR OPIN CHEM BIOL, V10, P402, DOI 10.1016/j.cbpa.2006.08.020; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; van den Heuvel RH, 2004, CURR OPIN CHEM BIOL, V8, P519, DOI 10.1016/j.cbpa.2004.08.006; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Woolfson DN, 2012, CURR OPIN STRUC BIOL, V22, P432, DOI 10.1016/j.sbi.2012.03.002; Yorimitsu T, 2005, MOL BIOL CELL, V16, P1593, DOI 10.1091/mbc.E04-11-1035	30	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e76237	10.1371/journal.pone.0076237	http://dx.doi.org/10.1371/journal.pone.0076237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086718	Green Published, Green Submitted, gold			2022-12-27	WOS:000325025200075
J	Grant, LR; O'Brien, SE; O'Brien, E; Haston, M; Zancolli, M; Cowell, L; Johnson, M; Weatherholtz, RC; Reid, R; Santosham, M; O'Brien, KL; Goldblatt, D				Grant, Lindsay R.; O'Brien, Sarah E.; Burbidge, Polly; Haston, Mitch; Zancolli, Marta; Cowell, Lucy; Johnson, Marina; Weatherholtz, Robert C.; Reid, Raymond; Santosham, Mathuram; O'Brien, Katherine L.; Goldblatt, David			Comparative Immunogenicity of 7 and 13-Valent Pneumococcal Conjugate Vaccines and the Development of Functional Antibodies to Cross-Reactive Serotypes	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CHANGING EPIDEMIOLOGY; UNITED-STATES; DISEASE; INFANTS; CHILDREN; SAFETY; EFFICACY; NAVAJO; ERA	Background: Protection against disease or colonization from serotypes related to those in pneumococcal conjugate vaccines (i.e. cross-protection) vary by serotype; the basis for this variation is not understood. The 13-valent pneumococcal conjugate vaccine (PCV13) replaced 7-valent conjugate (PCV7) in the USA in 2010 allowing assessment of PCV7 and PCV13 immunogenicity and functional cross-protection in vitro. Methods: Post-primary, pre-booster and post-booster sera from American Indian children receiving exclusively PCV7 or PCV13 were collected. IgG was measured by ELISA for 13 vaccine serotypes; functional antibody was assessed by opsonophagocytic killing assays for serotypes 6A/B/C and 19A/F. Results: Post-primary IgG geometric mean concentrations (GMC) for serotypes 4 and 9V were lower in PCV13 recipients while 19F GMCs were higher. Only 19F differences persisted after receipt of the booster dose. Functional antibody activity was higher among PCV13 recipients for 6A, 6C, 19A and 19F (p<0.04), and among PCV7 recipients for 6B (p = 0.01). Following PCV7, functional antibodies to 6A but not 19A were observed. High levels of 6C functional activity were seen after PCV13 but not PCV7. Conclusions: Functional antibody activity against 6A/B/C and 19A/F suggest that PCV13 is likely to control the 19A disease and 6C disease remaining despite widespread use of PCV7.	[Grant, Lindsay R.; O'Brien, Sarah E.; Weatherholtz, Robert C.; Reid, Raymond; Santosham, Mathuram; O'Brien, Katherine L.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Amer Indian Hlth, Baltimore, MD USA; [Burbidge, Polly; Haston, Mitch; Zancolli, Marta; Cowell, Lucy; Johnson, Marina; Goldblatt, David] UCL, Inst Child Hlth, London, England	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; University College London	O'Brien, KL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Amer Indian Hlth, Baltimore, MD USA.	klobrien@jhsph.edu	Goldblatt, David/C-5972-2008	Goldblatt, David/0000-0002-0769-5242; O'Brien, Katherine/0000-0002-0164-4030	National Center on Minority Health and Health Disparities [R01MD004011]; Pfizer, Inc. [6096A1-4013]; National Institute for Health Research [NF-SI-0611-10066] Funding Source: researchfish; National Institute on Minority Health and Health Disparities [R01MD004011] Funding Source: NIH RePORTER	National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Pfizer, Inc.(Pfizer); National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The project described was supported by Award Number R01MD004011 from the National Center on Minority Health and Health Disparities. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center on Minority Health and Health Disparities or the National Institutes of Health. This work was also funded by Pfizer, Inc. (Grant number: 6096A1-4013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Black S, 2007, PEDIATR INFECT DIS J, V26, P771, DOI 10.1097/INF.0b013e318124a494; Burton RL, 2006, CLIN VACCINE IMMUNOL, V13, P1004, DOI 10.1128/CVI.00112-06; Cohen R, 2011, 51 ICAAC SEPT 17 20; Cooper D, 2011, VACCINE, V29, P7207, DOI 10.1016/j.vaccine.2011.06.056; Goldblatt D, 2006, PEDIATR INFECT DIS J, V25, P312, DOI 10.1097/01.inf.0000207483.60267.e7; Grant LR, 2012, 8 INT S PNEUM PNEUM, P214; Hausdorff WP, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-4; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Hsu KK, 2010, PEDIATR INFECT DIS J, V29, P289, DOI 10.1097/INF.0b013e3181c15471; Huebner RE, 2002, PEDIATR INFECT DIS J, V21, P1004, DOI 10.1097/00006454-200211000-00006; Isaacman DJ, 2010, INT J INFECT DIS, V14, pE197, DOI 10.1016/j.ijid.2009.05.010; Kellner JD, 2009, CLIN INFECT DIS, V49, P205, DOI 10.1086/599827; Kieninger DM, 2010, VACCINE, V28, P4192, DOI 10.1016/j.vaccine.2010.04.008; Kilpi T, 2003, CLIN INFECT DIS, V37, P1155, DOI 10.1086/378744; Lacapa R, 2008, CLIN INFECT DIS, V47, P476, DOI 10.1086/590001; Melin M, 2009, INFECT IMMUN, V77, P676, DOI 10.1128/IAI.01186-08; Millar EV, 2010, CLIN INFECT DIS, V51, P1258, DOI 10.1086/657070; Nurkka A, 2001, PEDIATR INFECT DIS J, V20, P25, DOI 10.1097/00006454-200101000-00006; O'Brien KL, 2007, J INFECT DIS, V196, P104, DOI 10.1086/518438; O'Brien KL, 2004, AM J EPIDEMIOL, V160, P270, DOI 10.1093/aje/kwh191; Obaro SK, 2000, PEDIATR INFECT DIS J, V19, P463, DOI 10.1097/00006454-200005000-00014; Park IH, 2008, J INFECT DIS, V198, P1818, DOI 10.1086/593339; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Pelton SI, 2007, PEDIATR INFECT DIS J, V26, P468, DOI 10.1097/INF.0b013e31803df9ca; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Rennels MB, 2001, PEDIATR INFECT DIS J, V20, P153, DOI 10.1097/00006454-200102000-00007; Rose CE, 2011, CLIN VACCINE IMMUNOL, V18, P135, DOI 10.1128/CVI.00370-10; Scott JR, 2012, J INFECT DIS, V205, P280, DOI 10.1093/infdis/jir730; Siber GR, 2007, VACCINE, V25, P3816, DOI 10.1016/j.vaccine.2007.01.119; Watt JP, 2004, CLIN INFECT DIS, V38, P496, DOI 10.1086/381198; Weatherholtz R, 2010, CLIN INFECT DIS, V50, P1238, DOI 10.1086/651680; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; World Health Organization, 2005, World Health Organ Tech Rep Ser, V927, P1; Yeh SH, 2010, PEDIATRICS, V126, pE493, DOI 10.1542/peds.2009-3027; Yildirim I, 2012, PEDIATR INFECT DIS J, V31, P1016, DOI 10.1097/INF.0b013e3182615615	36	52	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74906	10.1371/journal.pone.0074906	http://dx.doi.org/10.1371/journal.pone.0074906			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086394	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200051
J	Thureborn, P; Lundin, D; Plathan, J; Poole, AM; Sjoberg, BM; Sjoling, S				Thureborn, Petter; Lundin, Daniel; Plathan, Josefin; Poole, Anthony M.; Sjoberg, Britt-Marie; Sjoling, Sara			A Metagenomics Transect into the Deepest Point of the Baltic Sea Reveals Clear Stratification of Microbial Functional Capacities	PLOS ONE			English	Article							COMMUNITY STRUCTURE; CLIMATE VARIABILITY; GENOME ANNOTATION; NITROGEN-FIXATION; GOTLAND BASIN; WATER COLUMN; SEDIMENT; HYPOXIA; DENITRIFICATION; EUTROPHICATION	The Baltic Sea is characterized by hyposaline surface waters, hypoxic and anoxic deep waters and sediments. These conditions, which in turn lead to a steep oxygen gradient, are particularly evident at Landsort Deep in the Baltic Proper. Given these substantial differences in environmental parameters at Landsort Deep, we performed a metagenomic census spanning surface to sediment to establish whether the microbial communities at this site are as stratified as the physical environment. We report strong stratification across a depth transect for both functional capacity and taxonomic affiliation, with functional capacity corresponding most closely to key environmental parameters of oxygen, salinity and temperature. We report similarities in functional capacity between the hypoxic community and hadal zone communities, underscoring the substantial degree of eutrophication in the Baltic Proper. Reconstruction of the nitrogen cycle at Landsort deep shows potential for syntrophy between archaeal ammonium oxidizers and bacterial denitrification at anoxic depths, while anaerobic ammonium oxidation genes are absent, despite substantial ammonium levels below the chemocline. Our census also reveals enrichment in genetic prerequisites for a copiotrophic lifestyle and resistance mechanisms reflecting adaptation to prevalent eutrophic conditions and the accumulation of environmental pollutants resulting from ongoing anthropogenic pressures in the Baltic Sea.	[Thureborn, Petter; Lundin, Daniel; Sjoling, Sara] Sodertorn Univ, Sch Nat Sci & Environm Studies, Huddinge, Sweden; [Thureborn, Petter; Plathan, Josefin; Poole, Anthony M.; Sjoberg, Britt-Marie] Stockholm Univ, Dept Mol Biol & Funct Genom, S-10691 Stockholm, Sweden; [Lundin, Daniel] Royal Inst Technol, Sci Life Labs, Solna, Sweden; [Lundin, Daniel; Sjoberg, Britt-Marie] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Poole, Anthony M.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand	Sodertorn University; Stockholm University; Royal Institute of Technology; Stockholm University; University of Canterbury	Thureborn, P (corresponding author), Sodertorn Univ, Sch Nat Sci & Environm Studies, Huddinge, Sweden.	petter.thureborn@sh.se		Lundin, Daniel/0000-0002-8779-6464; Poole, Anthony/0000-0001-9940-2824; Sjoberg, Britt-Marie/0000-0001-5953-3360	Foundation for Baltic and East European Studies [1169/42/2007:17]; Helge Ax:son Johnson foundation; Science for Life Laboratories in Stockholm; Swedish Research Council; Rutherford Discovery Fellowship; Royal Swedish Academy of Sciences Research Fellowship from the Knut and Alice Wallenberg Foundation	Foundation for Baltic and East European Studies; Helge Ax:son Johnson foundation; Science for Life Laboratories in Stockholm; Swedish Research Council(Swedish Research CouncilEuropean Commission); Rutherford Discovery Fellowship; Royal Swedish Academy of Sciences Research Fellowship from the Knut and Alice Wallenberg Foundation	The work was funded by the Foundation for Baltic and East European Studies 1169/42/2007:17 (www.ostersjostiftelsen.se). Sequence analyses were co-funded by the Helge Ax:son Johnson foundation (http://www.haxsonj.se), the Science for Life Laboratories in Stockholm, and the Swedish Research Council (to BMS). AMP is supported by a Rutherford Discovery Fellowship, administered by the Royal Society of New Zealand, and acknowledges past receipt of a Royal Swedish Academy of Sciences Research Fellowship from the Knut and Alice Wallenberg Foundation (www.kva.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; Azam F, 2001, NATURE, V414, P495, DOI 10.1038/35107174; Barz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013846; Brettar I, 2006, APPL ENVIRON MICROB, V72, P1364, DOI 10.1128/AEM.72.2.1364-1372.2006; Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; CEDERWALL H, 1990, AMBIO, V19, P109; Coleman ML, 2010, P NATL ACAD SCI USA, V107, P18634, DOI 10.1073/pnas.1009480107; Conley DJ, 2009, ENVIRON SCI TECHNOL, V43, P3412, DOI 10.1021/es802762a; DeBruyn JM, 2009, ENVIRON SCI TECHNOL, V43, P3467, DOI 10.1021/es803348g; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dos Santos PC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-162; Edlund A, 2006, ENVIRON MICROBIOL, V8, P223, DOI 10.1111/j.1462-2920.2005.00887.x; Edlund A, 2008, ENVIRON MICROBIOL, V10, P2051, DOI 10.1111/j.1462-2920.2008.01624.x; Eloe EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020388; Erguder TH, 2009, FEMS MICROBIOL REV, V33, P855, DOI 10.1111/j.1574-6976.2009.00179.x; Falk S, 2007, BIOGEOSCIENCES, V4, P255, DOI 10.5194/bg-4-255-2007; Farnelid H, 2013, ISME J, V7, P1413, DOI 10.1038/ismej.2013.26; Feike J, 2012, ISME J, V6, P461, DOI 10.1038/ismej.2011.94; Galushko A, 1999, ENVIRON MICROBIOL, V1, P415; Ghai R, 2010, ISME J, V4, P1154, DOI 10.1038/ismej.2010.44; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P183, DOI 10.4056/sigs.1202536; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; Glaubitz S, 2009, ENVIRON MICROBIOL, V11, P326, DOI 10.1111/j.1462-2920.2008.01770.x; Grote J, 2012, P NATL ACAD SCI USA, V109, P506, DOI 10.1073/pnas.1111262109; Grote J, 2008, APPL ENVIRON MICROB, V74, P7546, DOI 10.1128/AEM.01186-08; Hakansson L., 2008, EUTROPHICATION BALTI; Hannig M, 2007, LIMNOL OCEANOGR, V52, P1336, DOI 10.4319/lo.2007.52.4.1336; Hannig M, 2006, FEMS MICROBIOL ECOL, V57, P260, DOI 10.1111/j.1574-6941.2006.00116.x; Hansson M. P., 2009, EXTENT ANOXIA HYPOXI; Havelsrud OE, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-221; HELCOM, 2018, BALTIC SEA ENV P, V162; HELCOM, 2003, BALT SEA ENV P; HELCOM, 2009, BALT SEA ENV P B; Hietanen S, 2008, HYDROBIOLOGIA, V596, P67, DOI 10.1007/s10750-007-9058-5; Hietanen S, 2012, LIMNOL OCEANOGR, V57, P325, DOI 10.4319/lo.2012.57.1.0325; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jantti H, 2012, AMBIO, V41, P161, DOI 10.1007/s13280-011-0233-6; Johnston AWB, 2005, TRENDS MICROBIOL, V13, P416, DOI 10.1016/j.tim.2005.07.002; Jost G, 2010, FEMS MICROBIOL ECOL, V71, P226, DOI 10.1111/j.1574-6941.2009.00798.x; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Knapp AN, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00374; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Koskinen K, 2011, FEMS MICROBIOL ECOL, V75, P99, DOI 10.1111/j.1574-6941.2010.00987.x; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Kuparinen J, 2001, AMBIO, V30, P190, DOI 10.1639/0044-7447(2001)030[0190:EASPCF]2.0.CO;2; Labrenz M, 2007, AQUAT MICROB ECOL, V46, P177, DOI 10.3354/ame046177; Labrenz M, 2010, ISME J, V4, P1496, DOI 10.1038/ismej.2010.78; Lacroix G, 2007, CONT SHELF RES, V27, P1422, DOI 10.1016/j.csr.2007.01.013; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Lu XY, 2011, APPL MICROBIOL BIOT, V89, P1357, DOI 10.1007/s00253-010-3072-7; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Mitra S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S21; Mitra S, 2010, ISME J, V4, P1236, DOI 10.1038/ismej.2010.51; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Pinhassi J, 2000, AQUAT MICROB ECOL, V21, P245, DOI 10.3354/ame021245; Pohl C, 2004, MAR CHEM, V84, P143, DOI 10.1016/j.marchem.2003.07.002; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; R Core Team, 2020, R LANG ENV STAT COMP; Raes J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.6; Rensing C, 2002, SOIL BIOL BIOCHEM, V34, P285, DOI 10.1016/S0038-0717(01)00183-3; Riemann L, 2008, APPL ENVIRON MICROB, V74, P503, DOI 10.1128/AEM.01983-07; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Savage C, 2010, LIMNOL OCEANOGR, V55, P1033, DOI 10.4319/lo.2010.55.3.1033; Schinke H, 1998, CONT SHELF RES, V18, P67, DOI 10.1016/S0278-4343(97)00071-X; Shi YM, 2011, ISME J, V5, P999, DOI 10.1038/ismej.2010.189; SOMERVILLE CC, 1989, APPL ENVIRON MICROB, V55, P548, DOI 10.1128/AEM.55.3.548-554.1989; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Tamminen T, 2007, MAR ECOL PROG SER, V340, P121, DOI 10.3354/meps340121; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Ulloa O, 2012, P NATL ACAD SCI USA, V109, P15996, DOI 10.1073/pnas.1205009109; Vahtera E, 2007, AMBIO, V36, P186, DOI 10.1579/0044-7447(2007)36[186:IEFENC]2.0.CO;2; Wright MS, 2008, ISME J, V2, P417, DOI 10.1038/ismej.2008.8; Wulff F, 1989, GLOBAL BIOGEOCHEM CY, V3, P63, DOI 10.1029/GB003i001p00063; Zillen L, 2008, EARTH-SCI REV, V91, P77, DOI 10.1016/j.earscirev.2008.10.001; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	83	35	35	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74983	10.1371/journal.pone.0074983	http://dx.doi.org/10.1371/journal.pone.0074983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086414	gold, Green Published, Green Submitted			2022-12-27	WOS:000326520200065
J	Wu, SF; Sun, FD; Qi, YX; Yao, Y; Fang, Q; Huang, J; Stanley, D; Ye, GY				Wu, Shun-Fan; Sun, Fang-Da; Qi, Yi-Xiang; Yao, Yao; Fang, Qi; Huang, Jia; Stanley, David; Ye, Gong-Yin			Parasitization by Cotesia chilonis Influences Gene Expression in Fatbody and Hemocytes of Chilo suppressalis	PLOS ONE			English	Article							RICE STEM BORER; PLUTELLAE BRACOVIRUS SUPPRESSES; HELIOTHIS-VIRESCENS LARVAE; SERINE PROTEINASE HOMOLOGS; MANDUCA-SEXTA; DIAMONDBACK MOTH; TRANSCRIPTOME ANALYSIS; ACTIVATING PROTEINASE; DEVELOPMENTAL ARREST; CALYX FLUID	Background: During oviposition many parasitoid wasps inject various factors, such as polydnaviruses (PDVs), along with eggs that manipulate the physiology and development of their hosts. These manipulations are thought to benefit the parasites. However, the detailed mechanisms of insect host-parasitoid interactions are not fully understood at the molecular level. Based on recent findings that some parasitoids influence gene expression in their hosts, we posed the hypothesis that parasitization by a braconid wasp, Cotesia chilonis, influences the expression of genes responsible for development, metabolism and immune functions in the fatbody and hemocytes of its host, Chilo suppressalis. Methodology/Principal Findings: We obtained 39,344,452 reads, which were assembled into 146,770 scaffolds, and 76,016 unigenes. Parasitization impacted gene expression in fatbody and hemocytes. Of these, 8096 fatbody or 5743 hemocyte unigenes were down-regulated, and 2572 fatbody or 1452 hemocyte unigenes were up-regulated. Gene ontology data showed that the majority of the differentially expressed genes are involved in enzyme-regulated activity, binding, transcription regulator activity and catalytic activity. qPCR results show that most anti-microbial peptide transcription levels were up-regulated after parasitization. Expression of bracovirus genes was detected in parasitized larvae with 19 unique sequences identified from six PDV gene families including ankyrin, CrV1 protein, cystatin, early-expressed (EP) proteins, lectin, and protein tyrosine phosphatase. Conclusions: The current study supports our hypothesis that parasitization influences the expression of fatbody and hemocyte genes in the host, C. suppressalis. The general view is that manipulation of host metabolism and immunity benefits the development and emergence of the parasitoid offsprings. The accepted beneficial mechanisms include the direct impact of parasitoid-associated virulence factors such as venom and polydnavirus on host tissues (such as cell damage) and, more deeply, the ability of these factors to influence gene expression. We infer that insect parasitoids generally manipulate their environments, the internal milieu of their hosts.	[Wu, Shun-Fan; Sun, Fang-Da; Qi, Yi-Xiang; Yao, Yao; Fang, Qi; Huang, Jia; Ye, Gong-Yin] Zhejiang Univ, State Key Lab Rice Biol, Minist Agr, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Shun-Fan; Sun, Fang-Da; Qi, Yi-Xiang; Yao, Yao; Fang, Qi; Huang, Jia; Ye, Gong-Yin] Zhejiang Univ, Minist Agr, Inst Insect Sci, Key Lab Agr Entomol, Hangzhou 310003, Zhejiang, Peoples R China; [Stanley, David] USDA ARS, Biol Control Insects Res Lab, Columbia, MO 65205 USA	Ministry of Agriculture & Rural Affairs; Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang University; United States Department of Agriculture (USDA)	Huang, J (corresponding author), Zhejiang Univ, State Key Lab Rice Biol, Minist Agr, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China.	Huangj@zju.edu.cn; chu@zju.edu.cn	Wu, Shunfan/AAU-9200-2020; HUANG, JIA/AGH-2069-2022	Wu, Shunfan/0000-0003-0096-147X; HUANG, JIA/0000-0001-8336-1562	China National Science Fund for Distinguished Young Scholars [31025021]; National Program on Key Basic Research Projects (973 Program) [2013CB127600]; China National Science Fund for Innovative Research Groups of Biological Control [31021003]; National Nature Science Foundation of China [31101488]	China National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Program on Key Basic Research Projects (973 Program)(National Basic Research Program of China); China National Science Fund for Innovative Research Groups of Biological Control(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the China National Science Fund for Distinguished Young Scholars (Grant no. 31025021, http://www.nsfc.gov.cn), the National Program on Key Basic Research Projects (973 Program, 2013CB127600), the China National Science Fund for Innovative Research Groups of Biological Control (Grant no. 31021003, http://www.nsfc.gov.cn), and the National Nature Science Foundation of China (Grant no. 31101488, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alic N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-222; Asgari S, 2006, ARCH INSECT BIOCHEM, V61, P146, DOI 10.1002/arch.20109; Asgari S, 2003, ARCH INSECT BIOCHEM, V53, P92, DOI 10.1002/arch.10088; Asgari S, 2011, ANNU REV ENTOMOL, V56, P313, DOI 10.1146/annurev-ento-120709-144849; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bae S, 2004, COMP BIOCHEM PHYS A, V138, P39, DOI 10.1016/j.cbpb.2004.02.018; Barandoc KP, 2010, J MICROBIOL, V48, P117, DOI 10.1007/s12275-009-9261-3; Beck M, 2000, J INSECT PHYSIOL, V46, P1275, DOI 10.1016/S0022-1910(00)00048-2; Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; Benjamini Y, 2001, ANN STAT, V29, P1165; Bonizzoni M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-82; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Chen HuaCai, 2002, Chinese Journal of Biological Control, V18, P90; Chen YF, 2011, VIROLOGY, V414, P42, DOI 10.1016/j.virol.2011.03.009; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Cui YD, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.10001; Cvejic S, 2004, NAT CELL BIOL, V6, P540, DOI 10.1038/ncb1133; Desjardins CA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r183; DOVER BA, 1987, J INSECT PHYSIOL, V33, P333, DOI 10.1016/0022-1910(87)90121-1; Espagne E, 2004, SCIENCE, V306, P286, DOI 10.1126/science.1103066; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; Fang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026888; Fang Q, 2011, INSECT BIOCHEM MOLEC, V41, P852, DOI 10.1016/j.ibmb.2011.07.001; Fang Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-484; Grosman AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002276; Gundersen-Rindal DE, 2010, ARCH VIROL, V155, P783, DOI 10.1007/s00705-010-0616-1; Gupta S, 2005, INSECT BIOCHEM MOLEC, V35, P241, DOI 10.1016/j.ibmb.2004.12.003; Han LZ, 2012, ANN ENTOMOL SOC AM, V105, P253, DOI 10.1603/AN10170; Hang S., 1989, Chinese Journal of Biological Control, V5, P16; Hang SB, 1989, J JIANGSU AGR COLL, V10, P33; HARWOOD SH, 1994, VIROLOGY, V205, P381, DOI 10.1006/viro.1994.1659; He YP, 2008, PEST MANAG SCI, V64, P308, DOI 10.1002/ps.1522; Hergarden AC, 2012, P NATL ACAD SCI USA, V109, P3967, DOI 10.1073/pnas.1200778109; Hwang SH, 2010, ARCH INSECT BIOCHEM, V75, P107, DOI 10.1002/arch.20384; Ja WW, 2007, NAT CHEM BIOL, V3, P415, DOI 10.1038/nchembio.2007.2; Jiang H, 1999, INSECT MOL BIOL, V8, P39, DOI 10.1046/j.1365-2583.1999.810039.x; Jiang HB, 2005, INSECT BIOCHEM MOLEC, V35, P931, DOI 10.1016/j.ibmb.2005.03.009; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Jiang HB, 1998, P NATL ACAD SCI USA, V95, P12220, DOI 10.1073/pnas.95.21.12220; Jiang XJ, 2009, BIOCHEM BIOPH RES CO, V378, P269, DOI 10.1016/j.bbrc.2008.11.046; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; Kwon B, 2008, DEV COMP IMMUNOL, V32, P932, DOI 10.1016/j.dci.2008.01.005; Kwon B, 2010, J INSECT PHYSIOL, V56, P650, DOI 10.1016/j.jinsphys.2010.01.013; LADENDORFF NE, 1991, ARCH INSECT BIOCHEM, V18, P285, DOI 10.1002/arch.940180410; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li X., 2011, THESIS CHINESE ACAD, P1, DOI DOI 10.1177/0142331211410101; Li XiuHua, 2011, Acta Phytophylacica Sinica, V38, P313; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mamidala P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-6; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; Provost B, 2011, INSECT BIOCHEM MOLEC, V41, P582, DOI 10.1016/j.ibmb.2011.03.010; Pruijssers AJ, 2007, J VIROL, V81, P1209, DOI 10.1128/JVI.02189-06; Reineke A, 2005, J INSECT PHYSIOL, V51, P923, DOI 10.1016/j.jinsphys.2005.04.007; Schafellner C, 2007, J INSECT PHYSIOL, V53, P858, DOI 10.1016/j.jinsphys.2007.05.010; Sheng CF, 2005, B CHINESE ACAD SCI, V20, P200; Sheng Cheng-Fa, 2003, Entomological Knowledge, V40, P289; Shi M, 2009, ARCH INSECT BIOCHEM, V70, P3, DOI 10.1002/arch.20249; Soller M, 1996, J INSECT PHYSIOL, V42, P471, DOI 10.1016/0022-1910(95)00132-8; Song KH, 2008, J INSECT PHYSIOL, V54, P1271, DOI 10.1016/j.jinsphys.2008.06.010; Sonoda S, 2006, INSECT MOL BIOL, V15, P853, DOI 10.1111/j.1365-2583.2006.00670.x; Strand MR, 2010, INSECT VIROLOGY, P171; Suderman RJ, 2008, J GEN VIROL, V89, P1411, DOI 10.1099/vir.0.2008/000307-0; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Webb BA, 2006, VIROLOGY, V347, P160, DOI 10.1016/j.virol.2005.11.010; WEBB BA, 1985, ARCH INSECT BIOCHEM, V2, P131, DOI 10.1002/arch.940020203; West AP, 2001, P NATL ACAD SCI USA, V98, P3744, DOI 10.1073/pnas.051625298; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Zhang SG, 2011, INSECT BIOCHEM MOLEC, V41, P733, DOI 10.1016/j.ibmb.2011.05.005; Zheng YP, 2009, COMP BIOCHEM PHYS B, V154, P165, DOI 10.1016/j.cbpb.2009.05.016; Zhu JY, 2011, J ZHEJIANG UNIV-SC B, V12, P93, DOI 10.1631/jzus.B1000158; Zhu JY, 2009, ARCH INSECT BIOCHEM, V71, P45, DOI 10.1002/arch.20304	73	29	32	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74309	10.1371/journal.pone.0074309	http://dx.doi.org/10.1371/journal.pone.0074309			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086331	Green Submitted, gold, Green Published			2022-12-27	WOS:000326520200027
J	Meikle, PJ; Wong, G; Barlow, CK; Weir, JM; Greeve, MA; MacIntosh, GL; Almasy, L; Comuzzie, AG; Mahaney, MC; Kowalczyk, A; Haviv, I; Grantham, N; Magliano, DJ; Jowett, JBM; Zimmet, P; Curran, JE; Blangero, J; Shaw, J				Meikle, Peter J.; Wong, Gerard; Barlow, Christopher K.; Weir, Jacquelyn M.; Greeve, Melissa A.; MacIntosh, Gemma L.; Almasy, Laura; Comuzzie, Anthony G.; Mahaney, Michael C.; Kowalczyk, Adam; Haviv, Izhac; Grantham, Narelle; Magliano, Dianna J.; Jowett, Jeremy B. M.; Zimmet, Paul; Curran, Joanne E.; Blangero, John; Shaw, Jonathan			Plasma Lipid Profiling Shows Similar Associations with Prediabetes and Type 2 Diabetes	PLOS ONE			English	Article							ACTIVATING-FACTOR ACETYLHYDROLASE; FATTY-ACID-COMPOSITION; GLUCOSE-TOLERANCE; RISK-FACTORS; MELLITUS; METABOLISM; LIPOPROTEIN; CANCER; SERUM	The relationship between lipid metabolism with prediabetes (impaired fasting glucose and impaired glucose tolerance) and type 2 diabetes mellitus is poorly defined. We hypothesized that a lipidomic analysis of plasma lipids might improve the understanding of this relationship. We performed lipidomic analysis measuring 259 individual lipid species, including sphingolipids, phospholipids, glycerolipids and cholesterol esters, on fasting plasma from 117 type 2 diabetes, 64 prediabetes and 170 normal glucose tolerant participants in the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) then validated our findings on 1076 individuals from the San Antonio Family Heart Study (SAFHS). Logistic regression analysis of identified associations with type 2 diabetes (135 lipids) and prediabetes (134 lipids), after adjusting for multiple covariates. In addition to the expected associations with diacylglycerol, triacylglycerol and cholesterol esters, type 2 diabetes and prediabetes were positively associated with ceramide, and its precursor dihydroceramide, along with phosphatidylethanolamine, phosphatidylglycerol and phosphatidylinositol. Significant negative associations were observed with the ether-linked phospholipids alkylphosphatidylcholine and alkenylphosphatidylcholine. Most of the significant associations in the AusDiab cohort (90%) were subsequently validated in the SAFHS cohort. The aberration of the plasma lipidome associated with type 2 diabetes is clearly present in prediabetes, prior to the onset of type 2 diabetes. Lipid classes and species associated with type 2 diabetes provide support for a number of existing paradigms of dyslipidemia and suggest new avenues of investigation.	[Meikle, Peter J.; Wong, Gerard; Barlow, Christopher K.; Weir, Jacquelyn M.; Greeve, Melissa A.; MacIntosh, Gemma L.; Haviv, Izhac; Grantham, Narelle; Magliano, Dianna J.; Jowett, Jeremy B. M.; Zimmet, Paul; Shaw, Jonathan] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Almasy, Laura; Comuzzie, Anthony G.; Mahaney, Michael C.; Curran, Joanne E.; Blangero, John] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA; [Kowalczyk, Adam] Univ Melbourne, Natl ICT Australia NICTA, Melbourne, Vic, Australia	Baker Heart and Diabetes Institute; Texas Biomedical Research Institute; NICTA; University of Melbourne	Meikle, PJ (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia.	peter.meikle@bakeridi.edu.au	Almasy, Laura/V-3156-2019; Haviv, Izhak/E-3782-2015; Zimmet, Paul/O-8486-2019; Shaw, Jonathan/E-7388-2010; Meikle, Peter J/B-4023-2009; Blangero, John/ABA-7175-2021	Haviv, Izhak/0000-0002-0837-5005; Zimmet, Paul/0000-0003-0627-0776; Shaw, Jonathan/0000-0002-6187-2203; Magliano, Dianna/0000-0002-9507-6096; Barlow, Christopher/0000-0001-9309-2829; Meikle, Peter/0000-0002-2593-4665; Curran, Joanne/0000-0002-6898-155X	Dairy Health and Nutrition Consortium, Australia; National Health and Medical Research Council of Australia; OIS Program of the Victorian Government, Australia; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, USA [1R01DK088972-01]; National Health and Medical Research Council (NHMRC) [233200]; Australian Government Department of Health and Ageing; Dairy Health and Nutrition Consortium; Abbott Australasia Pty Ltd; Alphapharm Pty Ltd; AstraZeneca; Bristol-Myers Squibb; City Health Centre-Diabetes Service-Canberra; Department of Health and Community Services - Northern Territory; Department of Health and Human Services - Tasmania; Department of Health - New South Wales; Department of Health - Western Australia; Department of Health - South Australia; Department of Human Services - Victoria; Diabetes Australia; Diabetes Australia Northern Territory; Eli Lilly Australia; Estate of the Late Edward Wilson; GlaxoSmithKline; Jack Brockhoff Foundation; Janssen-Cilag; Kidney Health Australia; Marian FH Flack Trust; Menzies Research Institute; Merck Sharp Dohme; Novartis Pharmaceuticals; Novo Nordisk Pharmaceuticals; Pfizer Pty Ltd; Pratt Foundation; Queensland Health; Roche Diagnostics Australia; Royal Prince Alfred Hospital, Sydney; Sanofi Aventis; sanofi-synthelabo; National Institutes of Health [P01 HL045522, R01 DK082610, R01 DK079169, R01 HL091035]; National Center for Research Resources of the National Institutes of Health [C06 RR013556, C06 RR017515]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045522, R01HL091035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088972, R01DK082610, R01DK079169] Funding Source: NIH RePORTER	Dairy Health and Nutrition Consortium, Australia; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); OIS Program of the Victorian Government, Australia; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)NIH National Institute of Neurological Disorders & Stroke (NINDS)); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Dairy Health and Nutrition Consortium; Abbott Australasia Pty Ltd(Abbott Laboratories); Alphapharm Pty Ltd; AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); City Health Centre-Diabetes Service-Canberra; Department of Health and Community Services - Northern Territory; Department of Health and Human Services - Tasmania; Department of Health - New South Wales; Department of Health - Western Australia; Department of Health - South Australia; Department of Human Services - Victoria; Diabetes Australia; Diabetes Australia Northern Territory; Eli Lilly Australia(Eli Lilly); Estate of the Late Edward Wilson; GlaxoSmithKline(GlaxoSmithKline); Jack Brockhoff Foundation; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Kidney Health Australia; Marian FH Flack Trust; Menzies Research Institute; Merck Sharp Dohme(Merck & Company); Novartis Pharmaceuticals(Novartis); Novo Nordisk Pharmaceuticals(Novo Nordisk); Pfizer Pty Ltd(Pfizer); Pratt Foundation; Queensland Health; Roche Diagnostics Australia; Royal Prince Alfred Hospital, Sydney(University of Sydney); Sanofi Aventis(Sanofi-Aventis); sanofi-synthelabo; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funding from the Dairy Health and Nutrition Consortium, Australia, The National Health and Medical Research Council of Australia, the OIS Program of the Victorian Government, Australia and by Award Number 1R01DK088972-01 from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, USA. The content is solely the responsibility of the authors and does not necessarily represent the official views of the aforementioned funding bodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The AusDiab study co-coordinated by the Baker IDI Heart and Diabetes Institute, gratefully acknowledges the generous support given by: The National Health and Medical Research Council (NHMRC grant 233200), Australian Government Department of Health and Ageing, the Dairy Health and Nutrition Consortium, Abbott Australasia Pty Ltd, Alphapharm Pty Ltd, AstraZeneca, Bristol-Myers Squibb, City Health Centre-Diabetes Service-Canberra, Department of Health and Community Services - Northern Territory, Department of Health and Human Services - Tasmania, Department of Health - New South Wales, Department of Health - Western Australia, Department of Health - South Australia, Department of Human Services - Victoria, Diabetes Australia, Diabetes Australia Northern Territory, Eli Lilly Australia, Estate of the Late Edward Wilson, GlaxoSmithKline, Jack Brockhoff Foundation, Janssen-Cilag,, Kidney Health Australia, Marian & FH Flack Trust, Menzies Research Institute, Merck Sharp & Dohme, Novartis Pharmaceuticals, Novo Nordisk Pharmaceuticals, Pfizer Pty Ltd, Pratt Foundation, Queensland Health, Roche Diagnostics Australia, Royal Prince Alfred Hospital, Sydney, Sanofi Aventis and sanofi-synthelabo. Also, for their invaluable contribution to the set-up and field activities of AusDiab, we are enormously grateful to A Allman, B Atkins, S Bennett, S Chadban, M de Courten, M Dalton, D Dunstan, T Dwyer, D Jolley, D McCarty, A Meehan, S Murray, P Phillips, C Reid, A Stewart, R Tapp, H Taylor, and F Wilson (Baker IDI Heart and Diabetes Institute). Data collection for the SAFHS was supported by grant P01 HL045522 from the National Institutes of Health (to JB). Additional work was supported by National Institutes of Health awards R01 DK082610 and R01 DK079169 (to JC), and R01 HL091035 (to JB). Parts of this investigation were conducted in facilities constructed with support from Research Facilities Improvement Program grants C06 RR013556 and C06 RR017515 from the National Center for Research Resources of the National Institutes of Health.	Adiels M, 2005, ARTERIOSCL THROM VAS, V25, P1697, DOI 10.1161/01.ATV.0000172689.53992.25; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borg ML, 2011, DIABETES, V60, P1458, DOI 10.2337/db10-0845; Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867; Drew BG, 2011, J LIPID RES, V52, P572, DOI 10.1194/jlr.P012518; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Elwood PC, 2010, LIPIDS, V45, P925, DOI 10.1007/s11745-010-3412-5; Fan P, 2012, REPROD BIOMED ONLINE, V24, P197, DOI 10.1016/j.rbmo.2011.10.010; Ford DA, 2010, CLIN LIPIDOL, V5, P835, DOI 10.2217/CLP.10.68; Frangioudakis G, 2010, ENDOCRINOLOGY, V151, P4187, DOI 10.1210/en.2010-0250; GRANTHAM N, 2012, PUBLIC HEALTH NUTR, V7, P1; Han LD, 2011, ANAL CHIM ACTA, V689, P85, DOI 10.1016/j.aca.2011.01.034; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Hodge AM, 2007, NUTR METAB CARDIOVAS, V17, P415, DOI 10.1016/j.numecd.2006.04.005; Huo TG, 2009, J PHARMACEUT BIOMED, V49, P976, DOI 10.1016/j.jpba.2009.01.008; Kaddurah-Daouk R, 2010, METABOLOMICS, V6, P191, DOI 10.1007/s11306-010-0207-x; Kroger J, 2011, AM J CLIN NUTR, V93, P127, DOI 10.3945/ajcn.110.005447; Lessig J, 2009, CURR MED CHEM, V16, P2021; Liu GY, 2011, NEPHROL DIAL TRANSPL, V26, P1493, DOI 10.1093/ndt/gfq633; Magliano DJ, 2008, DIABETOLOGIA, V51, P2179, DOI 10.1007/s00125-008-1150-5; Meikle PJ, 2011, ARTERIOSCL THROM VAS, V31, P2723, DOI 10.1161/ATVBAHA.111.234096; Meyer C, 2006, DIABETES CARE, V29, P1909, DOI 10.2337/dc06-0438; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; Mozaffarian D, 2010, ANN INTERN MED, V153, P790, DOI 10.7326/0003-4819-153-12-201012210-00005; Murphy RC, 2007, ANAL BIOCHEM, V366, P59, DOI 10.1016/j.ab.2007.03.012; Nelson TL, 2012, J CLIN ENDOCR METAB, V97, P1695, DOI 10.1210/jc.2011-3026; Patel PS, 2010, AM J CLIN NUTR, V92, P1214, DOI 10.3945/ajcn.2010.29182; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Sanchez-Quesada JL, 2012, AM J CARDIOL, V110, P67, DOI 10.1016/j.amjcard.2012.02.051; Sciacca MFM, 2012, BIOCHEMISTRY-US, V51, P7676, DOI 10.1021/bi3009888; Serban M, 2002, J CELL MOL MED, V6, P643, DOI 10.1111/j.1582-4934.2002.tb00462.x; Skaff O, 2008, BIOCHEMISTRY-US, V47, P8237, DOI 10.1021/bi800786q; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; Tandy S, 2010, ATHEROSCLEROSIS, V213, P142, DOI 10.1016/j.atherosclerosis.2010.07.050; Villegas R, 2009, AM J CLIN NUTR, V89, P1059, DOI 10.3945/ajcn.2008.27182; Wallner S, 2011, CHEM PHYS LIPIDS, V164, P573, DOI 10.1016/j.chemphyslip.2011.06.008; Wolk A, 2001, J NUTR, V131, P828, DOI 10.1093/jn/131.3.828; Xu ZW, 2005, J LIPID RES, V46, P1229, DOI 10.1194/jlr.M500001-JLR200; Zhu C, 2011, TALANTA, V85, P1711, DOI 10.1016/j.talanta.2011.05.036	39	196	199	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74341	10.1371/journal.pone.0074341	http://dx.doi.org/10.1371/journal.pone.0074341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086336	Green Published, gold			2022-12-27	WOS:000325223900024
J	Quiroz-Martinez, B; Salgado-Maldonado, G				Quiroz-Martinez, Benjamin; Salgado-Maldonado, Guillermo			Taxonomic Distinctness and Richness of Helminth Parasite Assemblages of Freshwater Fishes in Mexican Hydrological Basins	PLOS ONE			English	Article							SPECIES RICHNESS; TRANSITION ZONE; BIODIVERSITY; DIVERSITY; BIOGEOGRAPHY; COMMUNITIES; ECOLOGY; SIMILARITY; INDEX	In this paper, we analyse the distributional patterns of adult helminth parasites of freshwater fishes with respect to the main hydrological basins of Mexico. We use the taxonomic distinctness and the variation in taxonomic distinctness to explore patterns of parasite diversity and how these patterns change between zoogeographical regions. We address questions about the factors that determine the variation of observed diversity of helminths between basins. We also investigate patterns of richness, taxonomic distinctness and distance decay of similarity amongst basins. Our analyses suggest that the evolution of the fauna of helminth parasites in Mexico is mostly dominated by independent host colonization events and that intra - host speciation could be a minor factor explaining the origin of this diversity. This paper points out a clear separation between the helminth faunas of northern - nearctic and southern - neotropical components in Mexican continental waters, suggesting the availability of two distinct taxonomic pools of parasites in Mexican drainage basins. Data identifies Mexican drainage basins as unities inhabited by freshwater fishes, hosting a mixture of neotropical and nearctic species, in addition, data confirms neotropical and neartic basins/helminth faunas. The neotropical basins of Mexico are host to a richest and more diversified helminth fauna, including more families, genera and species, compared to the less rich and less diverse helminth fauna in the nearctic basins. The present analysis confirms distance - decay as one of the important factors contributing to the patterns of diversity observed. The hypothesis that helminth diversity could be explained by the ichthyological diversity of the basin received no support from present analysis.	[Quiroz-Martinez, Benjamin; Salgado-Maldonado, Guillermo] Univ Nacl Autonoma Mexico, Lab Helmintol, Inst Biol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Salgado-Maldonado, G (corresponding author), Univ Nacl Autonoma Mexico, Lab Helmintol, Inst Biol, Mexico City 04510, DF, Mexico.	gsalgado@ib.unam.mx	Salgado-Maldonado, Guillermo/AAB-4960-2021; Quiroz-Martinez, Benjamin/AAG-2856-2019	Salgado-Maldonado, Guillermo/0000-0002-0772-0938; Quiroz-Martinez, Benjamin/0000-0001-9791-7031	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [155372]; "Programa de Posgrado en Ciencias Biologicas, Instituto de Biologia, UNAM [174861]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); "Programa de Posgrado en Ciencias Biologicas, Instituto de Biologia, UNAM	This study was supported by the Consejo Nacional de Ciencia y Tecnologia (CONACyT) through Project no. 155372 awarded to GSM and a postdoctoral fellowship grant (no. 174861) awarded to BQM, through the "Programa de Posgrado en Ciencias Biologicas, Instituto de Biologia, UNAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Aguilar R, 2008, BIOL J LINN SOC, V94, P435, DOI 10.1111/j.1095-8312.2008.00994.x; Bhat A, 2006, ECOGRAPHY, V29, P104, DOI 10.1111/j.2006.0906-7590.04418.x; Choudhury A, 2000, J BIOGEOGR, V27, P935, DOI 10.1046/j.1365-2699.2000.00450.x; Clarke KR, 1999, MAR ECOL PROG SER, V184, P21, DOI 10.3354/meps184021; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Ellingsen KE, 2005, J ANIM ECOL, V74, P1069, DOI 10.1111/j.1365-2656.2005.01004.x; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; Garrido-Olvera L, 2012, PARASITOLOGY, V139, P1652, DOI 10.1017/S003118201200100X; Gorley C.K., 2006, GETTING STARTED PRIM; HALFFTER G, 1987, ANNU REV ENTOMOL, V32, P95, DOI 10.1146/annurev.ento.32.1.95; Halfter G., 1976, Folia Ent Mex, VNo. 35, P1; HUIDOBRO L, 2006, J BIOGEOGRAPHY, V33; Leonard DRP, 2006, J ENVIRON MANAGE, V78, P52, DOI 10.1016/j.jenvman.2005.04.008; Luque JL, 2008, J FISH BIOL, V72, P189, DOI 10.1111/j.1095-8649.2007.01695.x; Luque JL, 2007, PARASITOLOGY, V134, P865, DOI 10.1017/S0031182007002272; Luque JL, 2004, PARASITOLOGY, V128, P671, DOI 10.1017/S0031182004005050; MALDONADO GS, 2013, PARASITOL RES, V112, P1; Caspeta-Mandujano JM, 2009, J PARASITOL, V95, P403, DOI 10.1645/GE-1768.1; Mendoza-Franco EF, 2009, J PARASITOL, V95, P46, DOI 10.1645/GE-1592.1; MILLER RR, 1966, COPEIA, P773, DOI 10.2307/1441406; Mittermeier R. A., 1999, BIODIVERSIDAD AMENAZ; Monks S, 2011, COMP PARASITOL, V78, P21, DOI 10.1654/4462.1; Morrone JJ, 2001, J BIOGEOGR, V28, P635, DOI 10.1046/j.1365-2699.2001.00571.x; Morrone JJ, 2010, ECOGRAPHY, V33, P355, DOI 10.1111/j.1600-0587.2010.06266.x; Morrone Juan J., 2002, Acta Zool. Mex, P83; Mouillot D, 2004, OIKOS, V104, P205, DOI 10.1111/j.0030-1299.2004.12833.x; NORRIS S. M., 2005, FRESHWATER FISHES ME; Ponlet N, 2011, PARASITOLOGY, V138, P1804, DOI 10.1017/S003118201100028X; Poulin R, 2004, EVOL ECOL, V18, P231, DOI 10.1023/B:EVEC.0000035029.55952.68; Poulin R, 2003, J BIOGEOGR, V30, P1609, DOI 10.1046/j.1365-2699.2003.00949.x; Poulin R., 2007, EVOL ECOL, V2; Poulin R, 2011, PHILOS T R SOC B, V366, P2379, DOI 10.1098/rstb.2011.0048; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; QUIROZMARTINEZ B, 2013, PLOS ONE, V8, P1; Rubio-Godoy M, 2010, ZOOTAXA, P1; Salgado-Maldonado G, 2001, COMP PARASITOL, V68, P196; Salgado-Maldonado G, 2008, ZOOTAXA, P29; Salgado-Maldonado G, 2006, ZOOTAXA, P1; SalgadoMaldonado G, 1997, PARASITOLOGY, V114, P581; SALGADOMALDONADO G, 1992, MEM I OSWALDO CRUZ, V87, P239, DOI 10.1590/S0074-02761992000500044; Sanchez-Nava P, 2004, PARASITOL RES, V93, P396, DOI 10.1007/s00436-004-1146-0; Shimatani K, 2001, OIKOS, V93, P135, DOI 10.1034/j.1600-0706.2001.930115.x; Tolimieri N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010653; Vidal-Martinez V.M., 2000, P227; VIDALMARTINEZ VM, 1995, PROCESSES STRUCTURIN; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; Warwick RM, 2001, OCEANOGR MAR BIOL, V39, P207	50	11	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74419	10.1371/journal.pone.0074419	http://dx.doi.org/10.1371/journal.pone.0074419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086342	gold, Green Published, Green Submitted			2022-12-27	WOS:000325223900025
J	Svensson, CR; Messing, ME; Lundqvist, M; Schollin, A; Deppert, K; Pagels, JH; Rissler, J; Cedervall, T				Svensson, Christian R.; Messing, Maria E.; Lundqvist, Martin; Schollin, Alexander; Deppert, Knut; Pagels, Joakim H.; Rissler, Jenny; Cedervall, Tommy			Direct Deposition of Gas Phase Generated Aerosol Gold Nanoparticles into Biological Fluids - Corona Formation and Particle Size Shifts	PLOS ONE			English	Article							DIESEL EXHAUST PARTICLES; HUMAN RESPIRATORY-TRACT; AIR-LIQUID INTERFACE; CARBON NANOTUBES; EPITHELIAL-CELLS; PROTEIN CORONA; EXPOSURE; TOXICITY; MOBILITY; ANALYZER	An ongoing discussion whether traditional toxicological methods are sufficient to evaluate the risks associated with nanoparticle inhalation has led to the emergence of Air-Liquid interface toxicology. As a step in this process, this study explores the evolution of particle characteristics as they move from the airborne state into physiological solution. Airborne gold nanoparticles (AuNP) are generated using an evaporation-condensation technique. Spherical and agglomerate AuNPs are deposited into physiological solutions of increasing biological complexity. The AuNP size is characterized in air as mobility diameter and in liquid as hydrodynamic diameter. AuNP: Protein aggregation in physiological solutions is determined using dynamic light scattering, particle tracking analysis, and UV absorption spectroscopy. AuNPs deposited into homocysteine buffer form large gold-aggregates. Spherical AuNPs deposited in solutions of albumin were trapped at the Air-Liquid interface but was readily suspended in the solutions with a size close to that of the airborne particles, indicating that AuNP: Protein complex formation is promoted. Deposition into serum and lung fluid resulted in larger complexes, reflecting the formation of a more complex protein corona. UV absorption spectroscopy indicated no further aggregation of the AuNPs after deposition in solution. The corona of the deposited AuNPs shows differences compared to AuNPs generated in suspension. Deposition of AuNPs from the aerosol phase into biological fluids offers a method to study the protein corona formed, upon inhalation and deposition in the lungs in a more realistic way compared to particle liquid suspensions. This is important since the protein corona together with key particle properties (e. g. size, shape and surface reactivity) to a large extent may determine the nanoparticle effects and possible translocation to other organs.	[Svensson, Christian R.; Pagels, Joakim H.; Rissler, Jenny] Lund Univ, Dept Design Sci, Div Ergon & Aerosol Technol, Lund, Sweden; [Messing, Maria E.; Deppert, Knut] Lund Univ, Dept Phys, Div Solid State Phys, S-22362 Lund, Sweden; [Messing, Maria E.] Lund Univ, Dept Phys, Div Synchrotron Radiat Res, S-22362 Lund, Sweden; [Lundqvist, Martin; Schollin, Alexander; Cedervall, Tommy] Lund Univ, Dept Biochem & Struct Biol, Lund, Sweden	Lund University; Lund University; Lund University; Lund University	Svensson, CR (corresponding author), Lund Univ, Dept Design Sci, Div Ergon & Aerosol Technol, Lund, Sweden.	Christian.Svensson@design.lth.se	Lundqvist, Martin/K-3908-2012; Cedervall, Tommy/AAT-9766-2021; Pagels, Joakim/G-9118-2014; Rissler, Jenny/B-9176-2014; Messing, Maria E/D-5546-2009; Deppert, Knut/A-6719-2008	Lundqvist, Martin/0000-0003-1175-9103; Cedervall, Tommy/0000-0003-2255-8446; Pagels, Joakim/0000-0002-7423-3240; Rissler, Jenny/0000-0001-8650-4741; Messing, Maria E/0000-0003-1834-236X; Deppert, Knut/0000-0002-0471-951X	Forte - Swedish Research Council for Health, Working Life and Welfare [2009-1291]; FORMAS [216-2009-1294]; VINNOVA [2009-01117]; Nanometer Structure Consortium at Lund University	Forte - Swedish Research Council for Health, Working Life and Welfare; FORMAS(Swedish Research Council Formas); VINNOVA(Vinnova); Nanometer Structure Consortium at Lund University	The authors acknowledge Forte - Swedish Research Council for Health, Working Life and Welfare, Grant nr. 2009-1291; FORMAS, Grant nr. 216-2009-1294; VINNOVA, Grant nr. 2009-01117; and the Nanometer Structure Consortium at Lund University for their generous funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2011, TOXICOL IN VITRO, V25, P930, DOI 10.1016/j.tiv.2011.02.015; Albanese A, 2011, ACS NANO, V5, P5478, DOI 10.1021/nn2007496; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; Bitterle E, 2006, CHEMOSPHERE, V65, P1784, DOI 10.1016/j.chemosphere.2006.04.035; Blank F, 2006, J AEROSOL MED, V19, P392, DOI 10.1089/jam.2006.19.392; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Casals E, 2010, ACS NANO, V4, P3623, DOI 10.1021/nn901372t; Cedervall T, 2007, ANGEW CHEM INT EDIT, V46, P5754, DOI 10.1002/anie.200700465; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535; Cukalevski R, 2011, LANGMUIR, V27, P14360, DOI 10.1021/la203290a; Dell'Orco D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010949; Deppert K., 1996, J AEROSOL SCI, V27, P151, DOI DOI 10.1016/0021-8502(96)00148-6; Dobrovolskaia MA, 2009, NANOMED-NANOTECHNOL, V5, P106, DOI 10.1016/j.nano.2008.08.001; Donaldson K, 2006, TOXICOL SCI, V92, P5, DOI 10.1093/toxsci/kfj130; Ehara K, 1996, J AEROSOL SCI, V27, P217, DOI 10.1016/0021-8502(95)00562-5; Gaschen A, 2010, ENVIRON SCI TECHNOL, V44, P1424, DOI 10.1021/es902261m; Hellstrand E, 2009, FEBS J, V276, P3372, DOI 10.1111/j.1742-4658.2009.07062.x; Hinds W. C., 1999, AEROSOL TECHNOLOGY P; Huber DL, 2005, SMALL, V1, P482, DOI 10.1002/smll.200500006; Jacobsen NR, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-2; Ji ZX, 2010, ENVIRON SCI TECHNOL, V44, P7309, DOI 10.1021/es100417s; Knutson E. O., 1975, Journal of Aerosol Science, V6, P443, DOI 10.1016/0021-8502(75)90060-9; Lacerda SHD, 2010, ACS NANO, V4, P365, DOI 10.1021/nn9011187; Link S, 1999, J PHYS CHEM B, V103, P4212, DOI 10.1021/jp984796o; Londahl J, 2008, INHAL TOXICOL, V20, P923, DOI 10.1080/08958370802087124 ; Lu JR, 1999, LANGMUIR, V15, P6975, DOI 10.1021/la990131h; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lynch I, 2009, NAT NANOTECHNOL, V4, P546, DOI 10.1038/nnano.2009.248; Maiorano G, 2010, ACS NANO, V4, P7481, DOI 10.1021/nn101557e; McMurry PH, 2002, AEROSOL SCI TECH, V36, P227, DOI 10.1080/027868202753504083; Messing ME, 2013, NANOTOXICOLOGY, V7, P1052, DOI 10.3109/17435390.2012.697589; Messing ME, 2009, GOLD BULL, V42, P20, DOI 10.1007/BF03214902; Miyabara Y, 1998, EUR RESPIR J, V11, P291, DOI 10.1183/09031936.98.11020291; Montes-Burgos I, 2010, J NANOPART RES, V12, P47, DOI 10.1007/s11051-009-9774-z; Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06; Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378; Park K, 2008, AEROSOL SCI TECH, V42, P801, DOI 10.1080/02786820802339561; Paur HR, 2011, J AEROSOL SCI, V42, P668, DOI 10.1016/j.jaerosci.2011.06.005; Reischl GP, 1997, AEROSOL SCI TECH, V27, P651, DOI 10.1080/02786829708965503; Rissler J, 2012, J AEROSOL SCI, V48, P18, DOI 10.1016/j.jaerosci.2012.01.005; Royal Commission on Environmental Pollution, 2008, NOV MAT ENV CAS NAN; SCHEIBEL HG, 1983, J AEROSOL SCI, V14, P113, DOI 10.1016/0021-8502(83)90035-6; Schroedter A, 2002, ANGEW CHEM INT EDIT, V41, P3218, DOI 10.1002/1521-3773(20020902)41:17<3218::AID-ANIE3218>3.0.CO;2-P; Shin WG, 2010, J AEROSOL SCI, V41, P665, DOI 10.1016/j.jaerosci.2010.04.009; Shin WG, 2009, J AEROSOL SCI, V40, P573, DOI 10.1016/j.jaerosci.2009.02.006; Tantra R, 2010, COLLOID SURFACE B, V75, P275, DOI 10.1016/j.colsurfb.2009.08.049; Tippe A, 2002, J AEROSOL SCI, V33, P207, DOI 10.1016/S0021-8502(01)00158-6; Trouiller B, 2009, CANCER RES, V69, P8784, DOI 10.1158/0008-5472.CAN-09-2496; Tsai DH, 2011, LANGMUIR, V27, P2464, DOI 10.1021/la104124d; Tsurudome Y, 1999, CARCINOGENESIS, V20, P1573, DOI 10.1093/carcin/20.8.1573; Weir E, 2008, ANALYST, V133, P835, DOI 10.1039/b715532h; WIEDENSOHLER A, 1988, J AEROSOL SCI, V19, P387, DOI 10.1016/0021-8502(88)90278-9; Xie YM, 2012, TOXICOL SCI, V125, P450, DOI 10.1093/toxsci/kfr251	54	6	6	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74702	10.1371/journal.pone.0074702	http://dx.doi.org/10.1371/journal.pone.0074702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086363	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900029
J	Brennan, LD; Roland, T; Morton, DG; Fellman, SM; Chung, SY; Soltani, M; Kevek, JW; McEuen, PM; Kemphues, KJ; Wang, MD				Brennan, Lucy D.; Roland, Thibault; Morton, Diane G.; Fellman, Shanna M.; Chung, SueYeon; Soltani, Mohammad; Kevek, Joshua W.; McEuen, Paul M.; Kemphues, Kenneth J.; Wang, Michelle D.			Small Molecule Injection into Single-Cell C. elegans Embryos via Carbon-Reinforced Nanopipettes	PLOS ONE			English	Article							ANTERIOR-POSTERIOR AXIS; PAR PROTEINS; POLARITY; MYOSIN; POLARIZATION; ESTABLISHMENT; REORGANIZATION; MICROINJECTION; MICROFILAMENTS; COMMUNICATION	The introduction of chemical inhibitors into living cells at specific times in development is a useful method for investigating the roles of specific proteins or cytoskeletal components in developmental processes. Some embryos, such as those of Caenorhabditis elegans, however, possess a tough eggshell that makes introducing drugs and other molecules into embryonic cells challenging. We have developed a procedure using carbon-reinforced nanopipettes (CRNPs) to deliver molecules into C. elegans embryos with high temporal control. The use of CRNPs allows for cellular manipulation to occur just subsequent to meiosis II with minimal damage to the embryo. We have used our technique to replicate classical experiments using latrunculin A to inhibit microfilaments and assess its effects on early polarity establishment. Our injections of latrunculin A confirm the necessity of microfilaments in establishing anterior-posterior polarity at this early stage, even when microtubules remain intact. Further, we find that latrunculin A treatment does not prevent association of PAR-2 or PAR-6 with the cell cortex. Our experiments demonstrate the application of carbon-reinforced nanopipettes to the study of one temporally-confined developmental event. The use of CRNPs to introduce molecules into the embryo should be applicable to investigations at later developmental stages as well as other cells with tough outer coverings.	[Brennan, Lucy D.; Roland, Thibault; Fellman, Shanna M.; Chung, SueYeon; Soltani, Mohammad; Kevek, Joshua W.; McEuen, Paul M.; Wang, Michelle D.] Cornell Univ, Dept Phys, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Roland, Thibault; Fellman, Shanna M.; Chung, SueYeon; Soltani, Mohammad; Wang, Michelle D.] Cornell Univ, Howard Hughes Med Inst, Ithaca, NY USA; [Morton, Diane G.; Kemphues, Kenneth J.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University; Cornell University; Howard Hughes Medical Institute; Cornell University	Kemphues, KJ (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	kjk1@cornell.edu; mdw17@cornell.edu	Chung, SueYeon/ABI-7940-2020	Brennan, Lucy/0000-0002-4019-6904; Chung, SueYeon/0000-0001-5726-4865	NSF MRSEC program [DMR-1120296]; NIH [GM059849, GM79112, T32GM008267]; NSF [MCB-0820293]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008267, R01GM079112, R01GM059849] Funding Source: NIH RePORTER	NSF MRSEC program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work made use of the Cornell Center for Materials Research Shared Facilities which are supported through the NSF MRSEC program (DMR-1120296). We wish to acknowledge support from NIH grants (GM059849 to M.D.W; GM79112 to KJK), an NIH Molecular Biophysics Training grant (T32GM008267, traineeship for LB), and an NSF grant (MCB-0820293 to M.D.W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aono S, 2004, DEVELOPMENT, V131, P2865, DOI 10.1242/dev.01146; BOSSINGER O, 1992, DEV BIOL, V151, P401, DOI 10.1016/0012-1606(92)90180-O; Bossinger O, 1996, DEV GENES EVOL, V206, P25, DOI 10.1007/s004270050027; Boyd L, 1996, DEVELOPMENT, V122, P3075; BRENNER S, 1974, GENETICS, V77, P71; Carvalho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024656; Cheeks RJ, 2004, CURR BIOL, V14, P851, DOI 10.1016/j.cub.2004.05.022; Chitwood BG, 1974, INTRO NEMATOADE; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Cowan CR, 2007, DEVELOPMENT, V134, P1035, DOI 10.1242/dev.000513; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Edgar LG, 1995, METHOD CELL BIOL, V48, P303; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Goehring NW, 2011, SCIENCE, V334, P1137, DOI 10.1126/science.1208619; Goehring NW, 2011, J CELL BIOL, V193, P583, DOI 10.1083/jcb.201011094; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gonczy P., 2005, ASYMMETRIC CELL DIVI; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; Hao YS, 2006, DEV CELL, V10, P199, DOI 10.1016/j.devcel.2005.12.015; HILL DP, 1990, DEVELOPMENT, V108, P159; HIRD SN, 1993, J CELL BIOL, V121, P1343, DOI 10.1083/jcb.121.6.1343; Hung TJ, 1999, DEVELOPMENT, V126, P127; HYMAN AA, 1987, J CELL BIOL, V105, P2123, DOI 10.1083/jcb.105.5.2123; Johnston WL, 2012, GENESIS, V50, P333, DOI 10.1002/dvg.20823; Johnston WL, 2006, BIOMED CENTRAL BIOL, V4; KIRBY C, 1990, DEV BIOL, V142, P203, DOI 10.1016/0012-1606(90)90164-E; Laffafian I, 1998, BIOPHYS J, V75, P2558, DOI 10.1016/S0006-3495(98)77700-8; Lee JY, 2003, DEVELOPMENT, V130, P307, DOI 10.1242/dev.00211; Motegi F, 2011, NAT CELL BIOL, V13, P1361, DOI 10.1038/ncb2354; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Munro E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003400; Nance J, 2003, DEVELOPMENT, V130, P5339, DOI 10.1242/dev.00735; Nance J, 2011, DEVELOPMENT, V138, P799, DOI 10.1242/dev.053538; Noatynska A, 2012, ESSAYS BIOCHEM, V53, P1, DOI [10.1042/BSE0530001, 10.1042/bse0530001]; O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714; Olson SK, 2012, J CELL BIOL, V198, P731, DOI 10.1083/jcb.201206008; Rappleye CA, 1999, GENE DEV, V13, P2838, DOI 10.1101/gad.13.21.2838; Schonegg S, 2006, DEVELOPMENT, V133, P3507, DOI 10.1242/dev.02527; Schrlau MG, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/01/015101; Schrlau MG, 2009, ACS NANO, V3, P563, DOI 10.1021/nn800851d; Schrlau MG, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/32/325102; Severson AF, 2003, J CELL BIOL, V161, P21, DOI 10.1083/jcb.200210171; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Shelton CA, 1999, J CELL BIOL, V146, P439, DOI 10.1083/jcb.146.2.439; Stone TW, 1985, MICROIONTOPHORESIS P; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; Tagawa A, 2001, DEV BIOL, V233, P412, DOI 10.1006/dbio.2001.0234; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tsai MC, 2007, J CELL BIOL, V179, P397, DOI 10.1083/jcb.200708101; Velarde N, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-142; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; Wang XY, 2013, CHEM SOC REV, V42, P202, DOI 10.1039/c2cs35259a; Watts JL, 1996, DEVELOPMENT, V122, P3133; Wood E., 1994, BIOCHEM EDUC, V22, P83, DOI [10.1016/0307-4412(94)90083-3, DOI 10.1016/0307-4412(94)90083-3]; Zhang Y, 2007, MICROINJECTION TECHN; Zhang Y, 2008, BIOESSAYS, V30, P606, DOI 10.1002/bies.20759; Zonies S, 2010, DEVELOPMENT, V137, P1669, DOI 10.1242/dev.045823	59	9	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75712	10.1371/journal.pone.0075712	http://dx.doi.org/10.1371/journal.pone.0075712			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086620	Green Published, Green Submitted, gold			2022-12-27	WOS:000325220000036
J	Buggele, WA; Krause, KE; Horvath, CM				Buggele, William A.; Krause, Katherine E.; Horvath, Curt M.			Small RNA Profiling of Influenza A Virus-Infected Cells Identifies miR-449b as a Regulator of Histone Deacetylase 1 and Interferon Beta	PLOS ONE			English	Article							MICRORNA EXPRESSION; CELLULAR MICRORNAS; GENE-EXPRESSION; INNATE IMMUNITY; RIG-I; PROTEIN; TRANSCRIPTION; OLIGONUCLEOTIDE; DEADENYLATION; REQUIREMENT	The mammalian antiviral response relies on the alteration of cellular gene expression, to induce the production of antiviral effectors and regulate their activities. Recent research has indicated that virus infections can induce the accumulation of cellular microRNA (miRNA) species that influence the stability of host mRNAs and their protein products. To determine the potential for miRNA regulation of cellular responses to influenza A virus infection, small RNA profiling was carried out using next generation sequencing. Comparison of miRNA expression profiles in uninfected human A549 cells to cells infected with influenza A virus strains A/Udorn/72 and A/WSN/33, revealed virus-induced changes in miRNA abundance. Gene expression analysis identified mRNA targets for a cohort of highly inducible miRNAs linked to diverse cellular functions. Experiments demonstrate that the histone deacetylase, HDAC1, can be regulated by influenza-inducible miR-449b, resulting in altered mRNA and protein levels. Expression of miR-449b enhances virus and poly(I: C) activation of the IFN beta promoter, a process known to be negatively regulated by HDAC1. These findings demonstrate miRNA induction by influenza A virus infection and elucidate an example of miRNA control of antiviral gene expression in human cells, defining a role for miR-449b in regulation of HDAC1 and antiviral cytokine signaling.	[Buggele, William A.; Krause, Katherine E.; Horvath, Curt M.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Northwestern University	Horvath, CM (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	horvath@northwestern.edu		Horvath, Curt/0000-0003-2449-225X	NIH from the NIAID IMVC program [U01AI082984]; NIH from the Malkin Scholars Award; NIH from the Cell and Molecular Basis of Disease Pre-doctoral training grant [T32 GM008061]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER	NIH from the NIAID IMVC program; NIH from the Malkin Scholars Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from the Cell and Molecular Basis of Disease Pre-doctoral training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH Grant U01AI082984 from the NIAID IMVC program to CMH and a the Malkin Scholars Award and the Cell and Molecular Basis of Disease Pre-doctoral training grant (T32 GM008061) to WAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Buggele WA, 2013, J VIROL, V87, P9260, DOI 10.1128/JVI.01064-13; Buggele WA, 2012, J BIOL CHEM, V287, P31027, DOI 10.1074/jbc.M112.387670; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Control CfD, 2010, MMWR-MORBID MORTAL W, V59, P1057; Davis-Dusenbery BN, 2010, J BIOCHEM, V148, P381, DOI 10.1093/jb/mvq096; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Feng D, 2010, J IMMUNOL, V185, P6003, DOI 10.4049/jimmunol.1000482; Ford E, 2010, BBA-GENE REGUL MECH, V1799, P328, DOI 10.1016/j.bbagrm.2010.01.010; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Icardi L, 2012, FASEB J, V26, P240, DOI 10.1096/fj.11-191122; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Klampfer L, 2004, J BIOL CHEM, V279, P30358, DOI 10.1074/jbc.M401359200; KRUG RM, 1979, CELL, V18, P329, DOI 10.1016/0092-8674(79)90052-7; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2011, VIROLOGY, V421, P105, DOI 10.1016/j.virol.2011.09.011; Li Y, 2010, J VIROL, V84, P3023, DOI 10.1128/JVI.02203-09; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lize M, 2010, CELL DEATH DIFFER, V17, P452, DOI 10.1038/cdd.2009.188; Lize M, 2010, CELL CYCLE, V9, P4579, DOI 10.4161/cc.9.22.13870; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Miyoshi Keita, 2008, V442, P29, DOI 10.1007/978-1-59745-191-8_3; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Noonan EJ, 2010, ONCOTARGET, V1, P349, DOI 10.18632/oncotarget.167; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; Nusinzon I, 2006, MOL CELL BIOL, V26, P3106, DOI 10.1128/MCB.26.8.3106-3113.2006; Nusinzon Inna, 2005, Sci STKE, V2005, pre11, DOI 10.1126/stke.2962005re11; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Peng X, 2011, MBIO, V2; Perez JT, 2010, P NATL ACAD SCI USA, V107, P11525, DOI 10.1073/pnas.1001984107; Primo MN, 2012, CYTOKINE, V60, P741, DOI 10.1016/j.cyto.2012.07.031; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Terrier O, 2013, J GEN VIROL, V94, P985, DOI 10.1099/vir.0.049528-0; Thornburg NJ, 2012, MBIO, V3, DOI 10.1128/mBio.00220-12; Umbach JL, 2010, MBIO, V1, DOI 10.1128/mBio.00204-10; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Zhao H, 2012, J HEPATOL, V56, P326, DOI 10.1016/j.jhep.2011.07.026; Zhao PS, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-159; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	59	34	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76560	10.1371/journal.pone.0076560	http://dx.doi.org/10.1371/journal.pone.0076560			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086750	gold, Green Published, Green Submitted			2022-12-27	WOS:000325220000069
J	Granato, M; Santarelli, R; Lotti, LV; Di Renzo, L; Gonnella, R; Garufi, A; Trivedi, P; Frati, L; D'Orazi, G; Faggioni, A; Cirone, M				Granato, Marisa; Santarelli, Roberta; Lotti, Lavinia V.; Di Renzo, Livia; Gonnella, Roberta; Garufi, Alessia; Trivedi, Pankaj; Frati, Luigi; D'Orazi, Gabriella; Faggioni, Alberto; Cirone, Mara			JNK and Macroautophagy Activation by Bortezomib Has a Pro-Survival Effect in Primary Effusion Lymphoma Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; LUNG-CANCER CELLS; PROTEASOME INHIBITOR; CELLULAR-RESPONSE; INDUCED AUTOPHAGY; MYELOMA CELLS; APOPTOSIS; DEATH; P62/SQSTM1	Understanding the mechanisms of autophagy induction and its role during chemotherapeutic treatments is of fundamental importance in order to manipulate it to improve the outcome of chemotherapy. In particular whether the bortezomib-induced autophagy plays a pro-survival or pro-death role is still controversial. In this study we investigated if bortezomib induced endoplasmic reticulum (ER) stress and activated autophagy in Primary Effusion Lymphoma (PEL) cells and how they influenced cell survival. We found that bortezomib induced up-regulation of the pro-survival and pro-death ER stress molecules BIP and CHOP and activated c-Jun NH2-terminal kinase (JNK), resulting in Bcl-2 phosphorylation and induction of autophagy. JNK and autophagy activation played a pro-survival role in this setting, thus their inhibition increased the bortezomib cytotoxic effect and PARP cleavage in PEL cells. Based on our results we suggest that the combination of bortezomib with JNK or autophagy inhibitors could be exploited to improve the outcome of therapy of this aggressive B cell lymphoma.	[Granato, Marisa; Santarelli, Roberta; Lotti, Lavinia V.; Di Renzo, Livia; Gonnella, Roberta; Trivedi, Pankaj; Frati, Luigi; Faggioni, Alberto; Cirone, Mara] Univ Roma La Sapienza, Dept Expt Med, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy; [Garufi, Alessia; D'Orazi, Gabriella] Regina Elena Inst Canc Res, Dept Expt Oncol, Mol Oncogenesis Lab, Rome, Italy; [D'Orazi, Gabriella] Univ G DAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; G d'Annunzio University of Chieti-Pescara	Faggioni, A (corresponding author), Univ Roma La Sapienza, Dept Expt Med, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy.	alberto.faggioni@uniroma1.it; mara.cirone@uniroma1.it	Gonnella, Roberta/Y-5564-2019; Di Renzo, Livia/D-1143-2013; Granato, Marisa/K-6203-2014; Gonnella, Roberta/R-2028-2016; Garufi, Alessia/AAT-3363-2020; Santarelli, Roberta/K-5434-2015; D'Orazi, Gabriella/T-2792-2019; Frati, Luigi/ABI-7437-2020	Gonnella, Roberta/0000-0003-4894-4986; Di Renzo, Livia/0000-0003-3807-0760; Gonnella, Roberta/0000-0003-4894-4986; Santarelli, Roberta/0000-0002-9416-7594; D'Orazi, Gabriella/0000-0001-6876-9105; Garufi, Alessia/0000-0001-9354-993X; , Marisa/0000-0002-2758-5120	MIUR; Associazione Italiana per la Ricerca (AIRC) [Nu 10265]; Patseur Cenci-Bolognetti Foundation	MIUR(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana per la Ricerca (AIRC)(Fondazione AIRC per la ricerca sul cancro); Patseur Cenci-Bolognetti Foundation	This work was supported by MIUR, Associazione Italiana per la Ricerca (AIRC) Nu 10265 and Patseur Cenci-Bolognetti Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Benoit M, 2011, J SURG RES, V167, pE193, DOI 10.1016/j.jss.2011.01.015; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Butterfield L, 1997, J BIOL CHEM, V272, P10110; Chari A, 2010, BIOL-TARGETS THER, V4, P273, DOI 10.2147/BTT.S3419; Cirone M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031732; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Hoang B, 2009, MOL CANCER THER, V8, P1974, DOI 10.1158/1535-7163.MCT-08-1177; Hui B, 2012, CANCER-AM CANCER SOC, V118, P5560, DOI 10.1002/cncr.27586; Jager R, 2012, BIOL CELL, V104, P259, DOI 10.1111/boc.201100055; Jenner RG, 2003, P NATL ACAD SCI USA, V100, P10399, DOI 10.1073/pnas.1630810100; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Kawaguchi T, 2011, INT J ONCOL, V38, P643, DOI 10.3892/ijo.2010.882; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li CY, 2012, CANCER LETT, V314, P102, DOI 10.1016/j.canlet.2011.09.020; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Matta H, 2005, CANCER BIOL THER, V4, P77, DOI 10.4161/cbt.4.1.1379; Milani M, 2009, CANCER RES, V69, P4415, DOI 10.1158/0008-5472.CAN-08-2839; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nador RG, 1996, BLOOD, V88, P645, DOI 10.1182/blood.V88.2.645.bloodjournal882645; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Pattingre S, 2009, J BIOL CHEM, V284, P2719, DOI 10.1074/jbc.M805920200; Puca R, 2010, FREE RADICAL BIO MED, V48, P1338, DOI 10.1016/j.freeradbiomed.2010.02.015; Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Trusina A, 2010, DIABETES OBES METAB, V12, P27, DOI 10.1111/j.1463-1326.2010.01274.x; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Verfaillie T, 2010, INT J CELL BIOL, V2010; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wu WKK, 2010, DRUG RESIST UPDATE, V13, P87, DOI 10.1016/j.drup.2010.04.003; Wu WKK, 2010, AUTOPHAGY, V6, P228, DOI 10.4161/auto.6.2.11042; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang Y, 2004, CANCER SCI, V95, P176, DOI 10.1111/j.1349-7006.2004.tb03200.x	42	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75965	10.1371/journal.pone.0075965	http://dx.doi.org/10.1371/journal.pone.0075965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086672	Green Published, Green Submitted, gold			2022-12-27	WOS:000325220000054
J	Rosseel, T; Van Borm, S; Vandenbussche, F; Hoffmann, B; van den Berg, T; Beer, M; Hoper, D				Rosseel, Toon; Van Borm, Steven; Vandenbussche, Frank; Hoffmann, Bernd; van den Berg, Thierry; Beer, Martin; Hoeper, Dirk			The Origin of Biased Sequence Depth in Sequence-Independent Nucleic Acid Amplification and Optimization for Efficient Massive Parallel Sequencing	PLOS ONE			English	Article							INFLUENZA-VIRUS GENOMES; IDENTIFICATION; DISCOVERY; PARVOVIRUS; QUALITY; SAMPLES; SYSTEM; READS; PCR	Sequence Independent Single Primer Amplification is one of the most widely used random amplification approaches in virology for sequencing template preparation. This technique relies on oligonucleotides consisting of a 39 random part used to prime complementary DNA synthesis and a 59 defined tag sequence for subsequent amplification. Recently, this amplification method was combined with next generation sequencing to obtain viral sequences. However, these studies showed a biased distribution of the resulting sequence reads over the analyzed genomes. The aim of this study was to elucidate the mechanisms that lead to biased sequence depth when using random amplification. Avian paramyxovirus type 8 was used as a model RNA virus to investigate these mechanisms. We showed, based on in silico analysis of the sequence depth in relation to GC-content, predicted RNA secondary structure and sequence complementarity to the 39 part of the tag sequence, that the tag sequence has the main contribution to the observed bias in sequence depth. We confirmed this finding experimentally using both fragmented and non-fragmented viral RNAs as well as primers differing in random oligomer length (6 or 12 nucleotides) and in the sequence of the amplification tag. The observed oligonucleotide annealing bias can be reduced by extending the random oligomer sequence and by in silico combining sequence data from SISPA experiments using different 59 defined tag sequences. These findings contribute to the optimization of random nucleic acid amplification protocols that are currently required for downstream applications such as viral metagenomics and microarray analysis.	[Rosseel, Toon; Van Borm, Steven; Vandenbussche, Frank; van den Berg, Thierry] Vet & Agrochem Res Ctr, Operat Directorate Virol, Brussels, Belgium; [Hoffmann, Bernd; Beer, Martin; Hoeper, Dirk] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany	Friedrich Loeffler Institute	Van Borm, S (corresponding author), Vet & Agrochem Res Ctr, Operat Directorate Virol, Brussels, Belgium.	stevenvanborm@coda-cerva.be	Van Borm, Steven/P-3336-2014	Hoper, Dirk/0000-0001-8408-2274	Epi-SEQ under EMIDA ERA-NET [219235]; EU Network of Excellence EPIZONE [FOODCT-2006-016236]; CODA-CERVA [RP-RandSeq09]; German Federal Ministry for Education and Research (BMBF) [01KI1016A]	Epi-SEQ under EMIDA ERA-NET; EU Network of Excellence EPIZONE; CODA-CERVA; German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by Epi-SEQ: a research project supported under the 2nd joint call for transnational research projects by EMIDA ERA-NET (FP7 project nr 219235), the EU Network of Excellence EPIZONE (FOODCT-2006-016236), an internal research and development fund at CODA-CERVA (RP-RandSeq09) and by the German Federal Ministry for Education and Research (BMBF, grant 01KI1016A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/j.1364-3703.2009.00545.x]; Afonso CL, 2007, BIOTECHNIQUES, V43, P188, DOI 10.2144/000112529; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Ambrose HE, 2006, REV MED VIROL, V16, P365, DOI 10.1002/rmv.515; Bexfield N, 2010, VET J; Bishop-Lilly KA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000878; Blomstrom AL, 2010, J CLIN MICROBIOL, V48, P4392, DOI 10.1128/JCM.01040-10; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; Dong H, 2011, ACTA BIOCH BIOPH SIN, V43, P496, DOI 10.1093/abbs/gmr030; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Ghedin E, 2011, J INFECT DIS, V203, P168, DOI 10.1093/infdis/jiq040; Goebel SJ, 2007, J VIROL, V81, P12709, DOI 10.1128/JVI.01406-07; Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381; Hoper D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019075; Hoper D, 2009, J CLIN MICROBIOL, V47, P674, DOI 10.1128/JCM.01028-08; Jarrett RF, 2006, DEV BIOLOGICALS, V123, P77; Kapoor A, 2008, J VIROL, V82, P311, DOI 10.1128/JVI.01240-07; Leifer I, 2010, J GEN VIROL, V91, P2687, DOI 10.1099/vir.0.023200-0; Li Jin-Song, 2010, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V24, P14; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller PJ, 2010, J VIROL, V84, P11496, DOI 10.1128/JVI.00822-10; Neverov A, 2010, P NATL ACAD SCI USA, V107, P20063, DOI 10.1073/pnas.1012537107; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Onions D, 2010, BIOLOGICALS, V38, P377, DOI 10.1016/j.biologicals.2010.01.003; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REYES GR, 1991, MOL CELL PROBE, V5, P473, DOI 10.1016/S0890-8508(05)80020-9; Rosseel T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041967; Rosseel T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-463; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Stang A, 2005, J CLIN MICROBIOL, V43, P716, DOI 10.1128/JCM.43.2.716-720.2005; Stangegaard M, 2006, BIOTECHNIQUES, V40, P649, DOI 10.2144/000112153; Van Borm S, 2012, ARCH VIROL, V157, P1509, DOI 10.1007/s00705-012-1323-x; Victoria JG, 2010, J VIROL, V84, P6033, DOI 10.1128/JVI.02690-09; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Wong CW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r93; Wright CF, 2011, J VIROL, V85, P2266, DOI 10.1128/JVI.01396-10; Yu XL, 2009, J VIROL METHODS, V161, P91, DOI 10.1016/j.jviromet.2009.05.023; Zsak L, 2008, AVIAN PATHOL, V37, P435, DOI 10.1080/03079450802210648	47	39	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76144	10.1371/journal.pone.0076144	http://dx.doi.org/10.1371/journal.pone.0076144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086702	Green Submitted, Green Published, gold			2022-12-27	WOS:000325220000061
J	Sun, KY; Yang, W; Huang, YN; Wang, YZ; Xiang, L; Qi, JH				Sun, Kaiyue; Yang, Wei; Huang, Yanna; Wang, Yizhen; Xiang, Lan; Qi, Jianhua			Leu452His Mutation in Lipoprotein Lipase Gene Transfer Associated with Hypertriglyceridemia in Mice in vivo	PLOS ONE			English	Article							SKELETAL-MUSCLE; INSULIN SENSITIVITY; CHOLESTEROL LEVELS; HEPARIN-BINDING; TRANSGENIC MICE; PLASMID DNA; OVEREXPRESSION; ELECTROPORATION; HYPERLIPIDEMIA; RESISTANCE	Mutated mouse lipoprotein lipase (LPL) containing a leucine (L) to histidine (H) substitution at position 452 was transferred into mouse liver by hydrodynamics-based gene delivery (HD). Mutated-LPL (MLPL) gene transfer significantly increased the concentrations of plasma MLPL and triglyceride (TG) but significantly decreased the activity of plasma LPL. Moreover, the gene transfer caused adiposis hepatica and significantly increased TG content in mouse liver. To understand the effects of MLPL gene transfer on energy metabolism, we investigated the expression of key functional genes related to energy metabolism in the liver, epididymal fat, and leg muscles. The mRNA contents of hormone-sensitive lipase (HSL), adipose triglyceride lipase (ATGL), fatty acid-binding protein (FABP), and uncoupling protein (UCP) were found to be significantly reduced. Furthermore, we investigated the mechanism by which MLPL gene transfer affected fat deposition in the liver, fat tissue, and muscle. The gene expression and protein levels of forkhead Box O3 (FOXO3), AMP-activated protein kinase (AMPK), and peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha) were found to be remarkably decreased in the liver, fat and muscle. These results suggest that the Leu452His mutation caused LPL dysfunction and gene transfer of MLPL in vivo produced resistance to the AMPK/PGC-1 alpha signaling pathway in mice.	[Sun, Kaiyue; Yang, Wei; Xiang, Lan; Qi, Jianhua] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Huang, Yanna; Wang, Yizhen] Zhejiang Univ, Key Lab Feed & Anim Nutr Zhejiang Prov, Key Lab Mol Anim Nutr, Inst Feed Sci,Minist Educ, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Xiang, L (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China.	lxiang@zju.edu.cn	Yang, Wei/GWV-4107-2022; Yang, Wei/HIA-0360-2022	wang, yizhen/0000-0002-3908-7102	Special Fund for Cultivation and Breeding of New Transgenic Organism [2009ZX08009-144B]	Special Fund for Cultivation and Breeding of New Transgenic Organism	This study was supported financially by the Special Fund for Cultivation and Breeding of New Transgenic Organism (Grand No. 2009ZX08009-144B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBATE SL, 1990, J CARDIOVASC PHARM, V16, pS1, DOI 10.1097/00005344-199000169-00002; Arndt Claudia, 2012, Methods Mol Biol, V869, P49, DOI 10.1007/978-1-61779-821-4_5; Benlian P, 1996, AM J HUM GENET, V59, P431; ECKEL RH, 1989, NEW ENGL J MED, V320, P1060; Ferreira LDMCB, 2001, DIABETES, V50, P1064, DOI 10.2337/diabetes.50.5.1064; Hanyu O, 2004, ATHEROSCLEROSIS, V174, P385, DOI 10.1016/j.atherosclerosis.2004.01.034; Hanyu O, 2007, CLIN CHIM ACTA, V384, P118, DOI 10.1016/j.cca.2007.06.015; HIDE WA, 1992, J LIPID RES, V33, P167; Hill JS, 1998, J BIOL CHEM, V273, P30979, DOI 10.1074/jbc.273.47.30979; Hu Y, 2007, J LIPID RES, V48, P1681, DOI 10.1194/jlr.M600382-JLR200; Huang YN, 2012, GENE, V502, P87, DOI 10.1016/j.gene.2012.04.052; Jap TS, 2003, PANCREAS, V27, P122, DOI 10.1097/00006676-200308000-00003; Jensen DR, 1997, AM J PHYSIOL-REG I, V273, pR683, DOI 10.1152/ajpregu.1997.273.2.R683; Johansen CT, 2011, CURR OPIN LIPIDOL, V22, P247, DOI 10.1097/MOL.0b013e3283471972; Keiper T, 2001, J LIPID RES, V42, P1180; Kobayashi Y, 2002, EUR J BIOCHEM, V269, P4701, DOI 10.1046/j.1432-1033.2002.03179.x; Koike T, 2004, J BIOL CHEM, V279, P7521, DOI 10.1074/jbc.M311514200; LevakFrank S, 1997, J BIOL CHEM, V272, P17182, DOI 10.1074/jbc.272.27.17182; Liu EQ, 2005, METABOLISM, V54, P132, DOI 10.1016/j.metabol.2004.07.021; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Lookene A, 2004, J BIOL CHEM, V279, P49964, DOI 10.1074/jbc.M407419200; Lutz EP, 2004, J BIOL CHEM, V279, P238, DOI 10.1074/jbc.M310559200; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Razzaghi H, 2000, HUM GENET, V107, P257, DOI 10.1007/s004390000367; Seip RL, 1998, EXERCISE SPORT SCI R, V26, P191; SHIMADA M, 1995, ARTERIOSCL THROM VAS, V15, P1688, DOI 10.1161/01.ATV.15.10.1688; VANTILBEURGH H, 1994, J BIOL CHEM, V269, P4626; Wang YZ, 2011, INT J MOL MED, V28, P617, DOI 10.3892/ijmm.2011.711; Xiang L, 2005, INT J MOL MED, V16, P1015; Xiang L, 2003, BIOCHEM BIOPH RES CO, V307, P440, DOI 10.1016/S0006-291X(03)01172-0; Yang T, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9134; Yang Yuhong, 2007, Journal of Genetics and Genomics, V34, P381, DOI 10.1016/S1673-8527(07)60041-1; Zsigmond E, 1997, HUM GENE THER, V8, P1921, DOI 10.1089/hum.1997.8.16-1921	33	2	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75462	10.1371/journal.pone.0075462	http://dx.doi.org/10.1371/journal.pone.0075462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086538	gold, Green Submitted, Green Published			2022-12-27	WOS:000325220000023
J	Hazai, D; Szudoczki, R; Ding, JD; Soderling, SH; Weinberg, RJ; Stonyi, P; Racz, B				Hazai, Diana; Szudoczki, Robert; Ding, Jindong; Soderling, Scott H.; Weinberg, Richard J.; Stonyi, Peter; Racz, Bence			Ultrastructural Abnormalities in CA1 Hippocampus Caused by Deletion of the Actin Regulator WAVE-1	PLOS ONE			English	Article							DENDRITIC SPINE MORPHOGENESIS; SYNAPTIC PLASTICITY; ARP2/3 COMPLEX; CENTRAL SYNAPSES; AMPA RECEPTORS; SMALL GTPASES; RHO-GTPASES; IN-VIVO; CYTOSKELETON; MEMORY	By conveying signals from the small GTPase family of proteins to the Arp2/3 complex, proteins of the WAVE family facilitate actin remodeling. The WAVE-1 isoform is expressed at high levels in brain, where it plays a role in normal synaptic processing, and is implicated in hippocampus-dependent memory retention. We used electron microscopy to determine whether synaptic structure is modified in the hippocampus of WAVE-1 knockout mice, focusing on the neuropil of CA1 stratum radiatum. Mice lacking WAVE-1 exhibited alterations in the morphology of both axon terminals and dendritic spines; the relationship between the synaptic partners was also modified. The abnormal synaptic morphology we observed suggests that signaling through WAVE-1 plays a critical role in establishing normal synaptic architecture in the rodent hippocampus.	[Hazai, Diana; Szudoczki, Robert; Stonyi, Peter; Racz, Bence] Szent Istvan Univ, Fac Vet Sci, Dept Anat & Histol, Budapest, Hungary; [Ding, Jindong] Duke Univ, Dept Ophthalmol, Duke Eye Ctr, Durham, NC USA; [Soderling, Scott H.] Duke Univ, Dept Cell Biol, Durham, NC USA; [Soderling, Scott H.] Duke Univ, Dept Neurobiol, Durham, NC USA; [Weinberg, Richard J.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Weinberg, Richard J.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC USA	Hungarian University of Agriculture & Life Sciences; Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Racz, B (corresponding author), Szent Istvan Univ, Fac Vet Sci, Dept Anat & Histol, Budapest, Hungary.	racz.bence@aotk.szie.hu	Weinberg, Richard/AAC-1898-2020; Rácz, Bence/J-4220-2019; Ding, Jindong/B-3324-2008	Rácz, Bence/0000-0002-1933-5332; Ding, Jindong/0000-0003-0427-0369; Weinberg, Richard/0000-0001-9689-7278	Hungarian Scientific Research Fund (OTKA) [K83830]; National Institutes of Health [NS-39444, NS-35527, 2R56-NS059957]; Hungarian Academy of Sciences;  [TAMOP-4.2.2.B-10/1];  [TAMOP-4.2.1.B-11/2/KMR-2011-0003]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035527, R01NS039444, R56NS059957] Funding Source: NIH RePORTER	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hungarian Academy of Sciences(Hungarian Academy of Sciences); ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge grants from the Hungarian Scientific Research Fund (OTKA, grant number K83830 to BR) and from the National Institutes of Health (NS-39444 and NS-35527 to RJW, and 2R56-NS059957 to SHS). The study was also sponsored by the TAMOP-4.2.2.B-10/1 and TAMOP-4.2.1.B-11/2/KMR-2011-0003 projects. BR is supported by the Janos Bolyai Research Fellowship from the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Brunig I, 2004, NEUROPHARMACOLOGY, V47, P669, DOI 10.1016/j.neuropharm.2004.07.038; Ceglia I, 2010, J NEUROCHEM, V114, P182, DOI 10.1111/j.1471-4159.2010.06743.x; Choi J, 2005, J NEUROSCI, V25, P869, DOI 10.1523/JNEUROSCI.3212-04.2005; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; Fortin DA, 2012, NEUROSCIENTIST, V18, P326, DOI 10.1177/1073858411407206; Gonzalez-Billault C, 2012, CYTOSKELETON, V69, P464, DOI 10.1002/cm.21034; GOTOW T, 1991, NEUROSCIENCE, V40, P587, DOI 10.1016/0306-4522(91)90143-C; Grove M, 2004, MOL CELL BIOL, V24, P10905, DOI 10.1128/MCB.24.24.10905-10922.2004; Haditsch U, 2009, MOL CELL NEUROSCI, V41, P409, DOI 10.1016/j.mcn.2009.04.005; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Harris KM, 2012, COLD SPRING HARB PER; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Jensen V, 2007, J PHYSIOL-LONDON, V583, P129, DOI 10.1113/jphysiol.2007.131300; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kim IH, 2013, J NEUROSCI, V33, P6081, DOI 10.1523/JNEUROSCI.0035-13.2013; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Lippman J, 2005, J NEUROBIOL, V64, P47, DOI 10.1002/neu.20149; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Marra V, 2012, NEURON, V76, P579, DOI 10.1016/j.neuron.2012.08.042; Sanchez AM, 2013, MOL ENDOCRINOL, V27, P693, DOI 10.1210/me.2012-1278; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Miki H, 2003, J BIOCHEM, V134, P309, DOI 10.1093/jb/mvg146; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Murakoshi H, 2012, TRENDS NEUROSCI, V35, P135, DOI 10.1016/j.tins.2011.12.002; Nakagawa T, 2004, NEUROPHARMACOLOGY, V47, P734, DOI 10.1016/j.neuropharm.2004.07.022; Nakamura Y, 2011, EMBO J, V30, P719, DOI 10.1038/emboj.2010.357; Nozumi M, 2003, J CELL SCI, V116, P239, DOI 10.1242/jcs.00233; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Penzes P, 2012, ADV EXP MED BIOL, V970, P81, DOI 10.1007/978-3-7091-0932-8_4; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Proepper C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027045; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; Schenck A, 2004, DEV BIOL, V274, P260, DOI 10.1016/j.ydbio.2004.07.009; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2006, BIOCHEM SOC T, V34, P73, DOI 10.1042/BST0340073; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Spillane M, 2011, DEV NEUROBIOL, V71, P747, DOI 10.1002/dneu.20907; Stavoe AKH, 2012, GENE DEV, V26, P2206, DOI 10.1101/gad.193409.112; Tahirovic S, 2010, J NEUROSCI, V30, P6930, DOI 10.1523/JNEUROSCI.5395-09.2010; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200	54	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75248	10.1371/journal.pone.0075248	http://dx.doi.org/10.1371/journal.pone.0075248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086480	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000325218700061
J	Mazumdar, T; Sandhu, R; Qadan, M; DeVecchio, J; Magloire, V; Agyeman, A; Li, BB; Houghton, JA				Mazumdar, Tapati; Sandhu, Ranjodh; Qadan, Maha; DeVecchio, Jennifer; Magloire, Victoria; Agyeman, Akwasi; Li, Bibo; Houghton, Janet A.			Hedgehog Signaling Regulates Telomerase Reverse Transcriptase in Human Cancer Cells	PLOS ONE			English	Article							SONIC HEDGEHOG; HTERT GENE; STEM-CELL; GLI GENES; TARGET; ACTIVATION; PATHWAY; CATENIN; EXPRESSION; MECHANISM	The Hedgehog (HH) signaling pathway is critical for normal embryonic development, tissue patterning and cell differentiation. Aberrant HH signaling is involved in multiple human cancers. HH signaling involves a multi-protein cascade activating the GLI proteins that transcriptionally regulate HH target genes. We have previously reported that HH signaling is essential for human colon cancer cell survival and inhibition of this signal induces DNA damage and extensive cell death. Here we report that the HH/GLI axis regulates human telomerase reverse transcriptase (hTERT), which determines the replication potential of cancer cells. Suppression of GLI1/GLI2 functions by a C-terminus truncated GLI3 repressor mutant (GLI3R), or by GANT61, a pharmacological inhibitor of GLI1/GLI2, reduced hTERT protein expression in human colon cancer, prostate cancer and Glioblastoma multiforme (GBM) cell lines. Expression of an N-terminus deleted constitutively active mutant of GLI2 (GLI2DN) increased hTERT mRNA and protein expression and hTERT promoter driven luciferase activity in human colon cancer cells while GANT61 inhibited hTERT mRNA expression and hTERT promoter driven luciferase activity. Chromatin immunoprecipitation with GLI1 or GLI2 antibodies precipitated fragments of the hTERT promoter in human colon cancer cells, which was reduced upon exposure to GANT61. In contrast, expression of GLI1 or GLI2DN in nonmalignant 293T cells failed to alter the levels of hTERT mRNA and protein, or hTERT promoter driven luciferase activity. Further, expression of GLI2DN increased the telomerase enzyme activity, which was reduced by GANT61 administration in human colon cancer, prostate cancer, and GBM cells. These results identify hTERT as a direct target of the HH signaling pathway, and reveal a previously unknown role of the HH/GLI axis in regulating the replication potential of cancer cells. These findings are of significance in understanding the important regulatory mechanisms that determine the functions of HH/GLI signaling in cancer cells.	[Mazumdar, Tapati; Qadan, Maha; DeVecchio, Jennifer; Magloire, Victoria; Agyeman, Akwasi; Houghton, Janet A.] Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44106 USA; [Sandhu, Ranjodh; Li, Bibo] Cleveland State Univ, Dept Biol Geol & Environm Sci, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA	Cleveland Clinic Foundation; University System of Ohio; Cleveland State University	Mazumdar, T (corresponding author), Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44106 USA.	mazumdt@ccf.org	Sandhu, Ranjodh/AAN-5645-2020	Sandhu, Ranjodh/0000-0002-6459-7542	NCI [RO1 CA 87952]; Cleveland Clinic; NATIONAL CANCER INSTITUTE [R01CA087952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066095] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cleveland Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to acknowledge financial support from NCI award RO1 CA 87952 (JAH), and from the Cleveland Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Avilion AA, 1996, CANCER RES, V56, P645; Bai CB, 2002, DEVELOPMENT, V129, P4753; Barnes EA, 2001, EMBO J, V20, P2214, DOI 10.1093/emboj/20.9.2214; BLACKBURN EH, 1989, GENOME, V31, P553, DOI 10.1139/g89-104; Brewster R, 1998, NATURE, V393, P579, DOI 10.1038/31242; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Chun SG, 2009, CANCER BIOL THER, V8, P1328, DOI 10.4161/cbt.8.14.8633; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Daniel M, 2012, GENE, V498, P135, DOI 10.1016/j.gene.2012.01.095; Dosch JS, 2010, PANCREATOLOGY, V10, P151, DOI 10.1159/000225923; Ecke I, 2008, MOL CARCINOGEN, V47, P361, DOI 10.1002/mc.20394; Fan HR, 1999, J CELL BIOL, V147, P71, DOI 10.1083/jcb.147.1.71; Goueli BS, 2003, ONCOGENE, V22, P8042, DOI 10.1038/sj.onc.1206847; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Greider CW, 2012, SCIENCE, V336, P1519, DOI 10.1126/science.1223785; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hodes RJ, 1999, J EXP MED, V190, P153, DOI 10.1084/jem.190.2.153; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Horikawa I, 2003, CARCINOGENESIS, V24, P1167, DOI 10.1093/carcin/bgg085; Jaitner S, 2012, CELL CYCLE, V11, P3331, DOI 10.4161/cc.21790; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Katoh Y, 2008, INT J ONCOL, V33, P881, DOI 10.3892/ijo_00000076; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Lee J, 1997, DEVELOPMENT, V124, P2537; Liu C, 2007, CANCER RES, V67, P2626, DOI 10.1158/0008-5472.CAN-06-4126; Liu JL, 2006, WORLD J GASTROENTERO, V12, P465, DOI 10.3748/wjg.v12.i3.465; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Mazumdar T, 2011, ONCOTARGET, V2, P638; Mazumdar T, 2011, CANCER RES, V71, P5904, DOI 10.1158/0008-5472.CAN-10-4173; Mazumdar T, 2011, CANCER RES, V71, P1092, DOI 10.1158/0008-5472.CAN-10-2315; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Mill P, 2003, GENE DEV, V17, P282, DOI 10.1101/gad.1038103; Neidle S, 2003, CURR OPIN STRUC BIOL, V13, P275, DOI 10.1016/S0959-440X(03)00072-1; Nguyen V, 2005, DEVELOPMENT, V132, P3267, DOI 10.1242/dev.01905; Park HL, 2000, DEVELOPMENT, V127, P1593; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; Regl G, 2002, ONCOGENE, V21, P5529, DOI 10.1038/sj.onc.1205748; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Shi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013054; Singh RR, 2011, ONCOGENE, V30, P4874, DOI 10.1038/onc.2011.195; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Xu FG, 2009, CANCER LETT, V283, P119, DOI 10.1016/j.canlet.2009.01.014; Zhang Y, 2012, J BIOL CHEM, V287, P32494, DOI 10.1074/jbc.M112.368282	50	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75253	10.1371/journal.pone.0075253	http://dx.doi.org/10.1371/journal.pone.0075253			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086482	gold, Green Submitted, Green Published			2022-12-27	WOS:000325218700063
J	Banai, K; Ahissar, M				Banai, Karen; Ahissar, Merav			Musical Experience, Auditory Perception and Reading-Related Skills in Children	PLOS ONE			English	Article							SPEECH-PERCEPTION; FREQUENCY DISCRIMINATION; CORTICAL REPRESENTATION; DEVELOPMENTAL DYSLEXIA; PROCESSING DEFICITS; BRAIN PLASTICITY; VISUAL MEMORY; LANGUAGE; MUSICIANS; ABILITY	Background: The relationships between auditory processing and reading-related skills remain poorly understood despite intensive research. Here we focus on the potential role of musical experience as a confounding factor. Specifically we ask whether the pattern of correlations between auditory and reading related skills differ between children with different amounts of musical experience. Methodology/Principal Findings: Third grade children with various degrees of musical experience were tested on a battery of auditory processing and reading related tasks. Very poor auditory thresholds and poor memory skills were abundant only among children with no musical education. In this population, indices of auditory processing (frequency and interval discrimination thresholds) were significantly correlated with and accounted for up to 13% of the variance in reading related skills. Among children with more than one year of musical training, auditory processing indices were better, yet reading related skills were not correlated with them. A potential interpretation for the reduction in the correlations might be that auditory and reading-related skills improve at different rates as a function of musical training. Conclusions/Significance: Participants' previous musical training, which is typically ignored in studies assessing the relations between auditory and reading related skills, should be considered. Very poor auditory and memory skills are rare among children with even a short period of musical training, suggesting musical training could have an impact on both. The lack of correlation in the musically trained population suggests that a short period of musical training does not enhance reading related skills of individuals with within-normal auditory processing skills. Further studies are required to determine whether the associations between musical training, auditory processing and memory are indeed causal or whether children with poor auditory and memory skills are less likely to study music and if so, why this is the case.	[Banai, Karen] Univ Haifa, Dept Commun Sci & Disorders, IL-31999 Haifa, Israel; [Ahissar, Merav] Hebrew Univ Jerusalem, Dept Psychol, Jerusalem, Israel; [Ahissar, Merav] Hebrew Univ Jerusalem, Dept Cognit Sci, Jerusalem, Israel	University of Haifa; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Banai, K (corresponding author), Univ Haifa, Dept Commun Sci & Disorders, IL-31999 Haifa, Israel.	kbanai@research.haifa.ac.il	Banai, Karen/J-1448-2019	Banai, Karen/0000-0002-2990-0470; Ahissar, Merav/0000-0001-7694-8111	Israeli Science Foundation	Israeli Science Foundation(Israel Science Foundation)	The study was supported by the Israeli Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 2000, P NATL ACAD SCI USA, V97, P6832, DOI 10.1073/pnas.97.12.6832; Ahissar M, 2007, TRENDS COGN SCI, V11, P458, DOI 10.1016/j.tics.2007.08.015; Ahissar M, 2006, NAT NEUROSCI, V9, P1558, DOI 10.1038/nn1800; Ahissar M, 2009, PHILOS T R SOC B, V364, P285, DOI 10.1098/rstb.2008.0253; Anvari SH, 2002, J EXP CHILD PSYCHOL, V83, P111, DOI 10.1016/S0022-0965(02)00124-8; Banai K, 2004, AUDIOL NEURO-OTOL, V9, P328, DOI 10.1159/000081282; Banai K, 2006, CEREB CORTEX, V16, P1718, DOI 10.1093/cercor/bhj107; Banai K, 2013, COGNITIVE DEV, V28, P300, DOI 10.1016/j.cogdev.2013.05.002; Banai K, 2012, HEARING RES, V284, P59, DOI 10.1016/j.heares.2011.12.002; Banai K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019769; Banai K, 2009, CEREB CORTEX, V19, P2699, DOI 10.1093/cercor/bhp024; Bialystok E, 2009, J EXP PSYCHOL HUMAN, V35, P565, DOI 10.1037/a0012735; Bidelman GM, 2011, BRAIN COGNITION, V77, P1, DOI 10.1016/j.bandc.2011.07.006; Bidelman GM, 2011, EUR J NEUROSCI, V33, P530, DOI 10.1111/j.1460-9568.2010.07527.x; Bishop DVM, 1999, J SPEECH LANG HEAR R, V42, P155, DOI 10.1044/jslhr.4201.155; Boets B, 2008, BRAIN LANG, V106, P29, DOI 10.1016/j.bandl.2007.12.004; Butzlaff R, 2000, J AESTHET EDUC, V34, P167, DOI 10.2307/3333642; Chan AS, 1998, NATURE, V396, P128, DOI 10.1038/24075; Crncec R, 2006, MUSIC PERCEPT, V23, P305, DOI 10.1525/mp.2006.23.4.305; Deutsch A, 1996, J EXP CHILD PSYCHOL, V63, P386, DOI 10.1006/jecp.1996.0055; DEWEIRDT W, 1988, APPL PSYCHOLINGUIST, V9, P163, DOI 10.1017/S0142716400006792; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Forgeard M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003566; Foxton JM, 2003, NAT NEUROSCI, V6, P343, DOI 10.1038/nn1035; Fujioka T, 2006, BRAIN, V129, P2593, DOI 10.1093/brain/awl247; Georgiou GK, 2010, CORTEX, V46, P1330, DOI 10.1016/j.cortex.2010.06.006; Goswami U, 2011, J COGNITIVE NEUROSCI, V23, P325, DOI 10.1162/jocn.2010.21453; Grube M, 2012, P ROY SOC B-BIOL SCI, V279, P4496, DOI 10.1098/rspb.2012.1817; Heath SM, 1999, J CHILD PSYCHOL PSYC, V40, P637, DOI 10.1111/1469-7610.00480; Herholz SC, 2012, NEURON, V76, P486, DOI 10.1016/j.neuron.2012.10.011; Ho YC, 2003, NEUROPSYCHOLOGY, V17, P439, DOI 10.1037/0894-4105.17.3.439; Hughes CML, 2007, J MOTOR BEHAV, V39, P3, DOI 10.3200/JMBR.39.1.3-8; Hulslander J, 2004, J EXP CHILD PSYCHOL, V88, P274, DOI 10.1016/j.jecp.2004.03.006; Huss M, 2011, CORTEX, V47, P674, DOI 10.1016/j.cortex.2010.07.010; Jakobson LS, 2008, MUSIC PERCEPT, V26, P41, DOI 10.1525/MP.2008.26.1.41; Kishon-Rabin Liat, 2001, Journal of Basic and Clinical Physiology and Pharmacology, V12, P125; Kraus N, 2012, ANN NY ACAD SCI, V1252, P100, DOI 10.1111/j.1749-6632.2012.06463.x; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Magne C, 2006, J COGNITIVE NEUROSCI, V18, P199, DOI 10.1162/089892906775783660; McArthur GM, 2008, COGNITION, V107, P946, DOI 10.1016/j.cognition.2007.12.005; Meyer M, 2011, EUR J NEUROSCI, V34, P755, DOI 10.1111/j.1460-9568.2011.07795.x; Micheyl C, 2006, HEARING RES, V219, P36, DOI 10.1016/j.heares.2006.05.004; Mody M, 1997, J EXP CHILD PSYCHOL, V64, P199, DOI 10.1006/jecp.1996.2343; Moreno S, 2009, CEREB CORTEX, V19, P712, DOI 10.1093/cercor/bhn120; MORRONGIELLO BA, 1990, DEV PSYCHOL, V26, P814, DOI 10.1037/0012-1649.26.5.814; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Papadopoulos TC, 2012, RES DEV DISABIL, V33, P1841, DOI 10.1016/j.ridd.2012.04.009; Parbery-Clark A, 2011, NEUROPSYCHOLOGIA, V49, P3338, DOI 10.1016/j.neuropsychologia.2011.08.007; Parbery-Clark A, 2009, EAR HEARING, V30, P653, DOI 10.1097/AUD.0b013e3181b412e9; Penhune V, 2005, ANN NY ACAD SCI, V1060, P265, DOI 10.1196/annals.1360.049; Peretz I, 2005, ANNU REV PSYCHOL, V56, P89, DOI 10.1146/annurev.psych.56.091103.070225; Rammsayer T, 2006, MUSIC PERCEPT, V24, P37, DOI 10.1525/mp.2006.24.1.37; Raven J., 2000, MANUAL RAVENS PROGR; REED MA, 1989, J EXP CHILD PSYCHOL, V48, P270, DOI 10.1016/0022-0965(89)90006-4; Roden I, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00572; Rosen S, 2001, J SPEECH LANG HEAR R, V44, P720, DOI 10.1044/1092-4388(2001/057); Rosen S, 1999, CURR BIOL, V9, pR698, DOI 10.1016/S0960-9822(99)80443-6; Shahin AJ, 2008, NEUROIMAGE, V41, P113, DOI 10.1016/j.neuroimage.2008.01.067; Strait DL, 2010, HEARING RES, V261, P22, DOI 10.1016/j.heares.2009.12.021; Talcott JB, 2000, P NATL ACAD SCI USA, V97, P2952, DOI 10.1073/pnas.040546597; Talcott Joel B, 2002, Dyslexia, V8, P204, DOI 10.1002/dys.224; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; Tsang CD, 2011, MUSIC PERCEPT, V29, P157, DOI 10.1525/MP.2011.29.2.157; Virtala P, 2012, PSYCHOPHYSIOLOGY, V49, P1125, DOI 10.1111/j.1469-8986.2012.01386.x; Walker KMM, 2006, BRAIN RES, V1124, P126, DOI 10.1016/j.brainres.2006.09.080; Wan CY, 2010, NEUROSCIENTIST, V16, P566, DOI 10.1177/1073858410377805; Wechsler David, 1998, WECHSLER INTELLIGENC; WEISS MW, 2011, AUGMENTING COGNITION, P103; White S, 2006, DEVELOPMENTAL SCI, V9, P237, DOI 10.1111/j.1467-7687.2006.00483.x; Witton C, 1998, CURR BIOL, V8, P791, DOI 10.1016/S0960-9822(98)70320-3; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3	73	29	29	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75876	10.1371/journal.pone.0075876	http://dx.doi.org/10.1371/journal.pone.0075876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	226HG	24086654	Green Published, gold, Green Submitted			2022-12-27	WOS:000325025200066
J	Hayes, AJ; Reynolds, S; Nowell, MA; Meakin, LB; Habicher, J; Ledin, J; Bashford, A; Caterson, B; Hammond, CL				Hayes, Anthony J.; Reynolds, Scott; Nowell, Mari A.; Meakin, Lee B.; Habicher, Judith; Ledin, Johan; Bashford, Andrew; Caterson, Bruce; Hammond, Chrissy L.			Spinal Deformity in Aged Zebrafish Is Accompanied by Degenerative Changes to Their Vertebrae that Resemble Osteoarthritis	PLOS ONE			English	Article							CHONDROITIN SULFATE STRUCTURE; FACET JOINT OSTEOARTHRITIS; KERATAN SULFATE; ARTICULAR-CARTILAGE; MONOCLONAL-ANTIBODIES; HEPARAN-SULFATE; GLYCOSAMINOGLYCANS; EXPRESSION; GENETICS; MODEL	Age-related degenerative changes within the vertebral column are a significant cause of morbidity with considerable socio-economic impact worldwide. An improved understanding of these changes through the development of experimental models may lead to improvements in existing clinical treatment options. The zebrafish is a well-established model for the study of skeletogenesis with significant potential in gerontological research. With advancing age, zebrafish frequently develop gross deformities of their vertebral column, previously ascribed to reduced trunk muscle tone. In this study, we assess degenerative changes specifically within the bone and cartilage of the vertebral column of zebrafish at 1, 2 and 3-years of age. We show increased frequency and severity of spinal deformities/curvatures with age. Underlying the most severe phenotypes are partial or complete vertebral dislocations and focal thickening of the vertebral bone at the joint margins. MicroCT examination demonstrates small defects, fractures and morphological evidence suggestive of bone erosion and remodeling (i.e. osteophytes) within the vertebrae during aging, but no significant change in bone density. Light and electron microscopic examination reveal striking agerelated changes in cell morphology, suggestive of chondroptosis, and tissue remodelling of the vertebral cartilage, particularly within the pericellular micro-environment. Glycosaminoglycan analysis of the vertebral column by HPLC demonstrates a consistent, age-related increase in the yield of total chondroitin sulfate disaccharide, but no change in sulfation pattern, supported by immunohistochemical analysis. Immunohistochemistry strongly identifies all three chondroitin/dermatan sulphate isoforms (C-0-S, C-4-S/DS and C-6-S) within the vertebral cartilage, particularly within the pericellular micro-environment. In contrast, keratan sulfate immunolocalises specifically with the notochordal tissue of the intervertebral disc, and its labelling diminishes with age. In summary, these observations raise the prospect that zebrafish, in addition to modelling skeletal development, may have utility in modelling age-related degenerative changes that affect the skeleton during senescence.	[Hayes, Anthony J.; Bashford, Andrew; Caterson, Bruce] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Reynolds, Scott; Hammond, Chrissy L.] Univ Bristol, Dept Biochem & Physiol, Bristol, Avon, England; [Reynolds, Scott; Hammond, Chrissy L.] Univ Bristol, Dept Pharmacol, Bristol BS8 1TD, Avon, England; [Nowell, Mari A.] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales; [Meakin, Lee B.] Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England; [Habicher, Judith; Ledin, Johan] Uppsala Univ, Evolutionary Biol Ctr, Uppsala, Sweden	Cardiff University; University of Bristol; University of Bristol; Cardiff University; University of Bristol; Uppsala University	Hayes, AJ (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales.	hayesaj@cf.ac.uk	Meakin, Lee/H-7726-2019; Bashford, Andrew/G-9302-2014; Hammond, Chrissy/D-6568-2013	Meakin, Lee/0000-0002-2161-9414; Bashford, Andrew/0000-0003-1628-0898; Ledin, Johan/0000-0002-7319-7735; Hayes, Anthony/0000-0002-2918-3723; Nowell, Mari/0000-0003-0053-0127; Hammond, Chrissy/0000-0002-4935-6724; Caterson, Bruce/0000-0001-6016-0661	Arthritis Research UK grants [18331, 19858, 17654, 19476]; Arthritis Research UK PhD studentship [19986]; Wellcome Trust; MRC [G0800248] Funding Source: UKRI; Medical Research Council [G0800248] Funding Source: researchfish; Versus Arthritis [19476, 17654, 19858] Funding Source: researchfish; Healthway [19986] Funding Source: researchfish	Arthritis Research UK grants(Versus Arthritis); Arthritis Research UK PhD studentship(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); Healthway	AJH and BC received financial support from Arthritis Research UK grants 18331 and 19858. MAN and CL were funded by Arthritis Research UK career development grants 17654 and 19476 respectively. SR was funded by Arthritis Research UK PhD studentship 19986. LM was funded by an integrated Training Fellowship from the Wellcome Trust. The funder's had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2000, SPINE, V25, P1625, DOI 10.1097/00007632-200007010-00005; Bayliss MT, 1999, J BIOL CHEM, V274, P15892, DOI 10.1074/jbc.274.22.15892; Bendele A. M., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P501; Bensimon-Brito A, 2010, J APPL ICHTHYOL, V26, P235, DOI 10.1111/j.1439-0426.2010.01412.x; Bouvier DJ, 2000, DOUBLE TIME CU UNPUB, P313; CARNEY SL, 1992, MATRIX, V12, P137, DOI 10.1016/S0934-8832(11)80055-7; CATERSON B, 1985, FED PROC, V44, P386; CATERSON B, 1990, J CELL SCI, V97, P411; CATERSON B, 1983, J BIOL CHEM, V258, P8848; Christiansen HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008481; COUCHMAN JR, 1984, NATURE, V307, P650, DOI 10.1038/307650a0; Ellis K, 2013, J CELL BIOL, V200, P667, DOI 10.1083/jcb.201212095; Erwin WM, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3548; Erwin WM, 2006, SPINE, V31, P1094, DOI 10.1097/01.brs.0000216593.97157.dd; Feitsma H, 2008, MOL CANCER RES, V6, P685, DOI 10.1158/1541-7786.MCR-07-2167; Fiaz AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034072; Filipek-Gorniok B, 2013, DEV DYNAM, V242, P964, DOI 10.1002/dvdy.23981; Frobin W, 2001, EUR RADIOL, V11, P263, DOI 10.1007/s003300000556; Fujiwara A, 2000, SPINE, V25, P3036, DOI 10.1097/00007632-200012010-00011; Gerhard GS, 2002, AGING CELL, V1, P104, DOI 10.1046/j.1474-9728.2002.00012.x; Gerhard GS, 2002, EXP GERONTOL, V37, P1055, DOI 10.1016/S0531-5565(02)00088-8; Gorman KF, 2007, COMP BIOCHEM PHYS C, V145, P28, DOI 10.1016/j.cbpc.2006.10.004; Haga Y, 2009, TRANSGENIC RES, V18, P669, DOI 10.1007/s11248-009-9259-y; Hammond Chrissy L, 2012, Front Endocrinol (Lausanne), V3, P91, DOI 10.3389/fendo.2012.00091; Hardingham T, 1995, ACTA ORTHOP SCAND, V66, P107, DOI 10.3109/17453679509157663; Hayes AJ, 2013, DEV DYNAM, V242, P778, DOI 10.1002/dvdy.23970; Holmborn K, 2012, J BIOL CHEM, V287, P33905, DOI 10.1074/jbc.M112.401646; Kalb S, 2012, WORLD NEUROSURG, V77, P491, DOI 10.1016/j.wneu.2011.07.014; Kalichman L, 2007, SEMIN ARTHRITIS RHEU, V37, P69, DOI 10.1016/j.semarthrit.2007.01.007; Kanuga MK, 2011, J EXP ZOOL PART A, V315A, P156, DOI 10.1002/jez.661; Kapitonova M Yu, 2003, Malays J Pathol, V25, P15; Kishi S, 2009, GERONTOLOGY, V55, P430, DOI 10.1159/000228892; Kuiper JI, 1998, SPINE, V23, P657, DOI 10.1097/00007632-199803150-00003; Lall SP, 2007, AQUACULTURE, V267, P3, DOI 10.1016/j.aquaculture.2007.02.053; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Leone A, 2007, RADIOLOGY, V245, P62, DOI 10.1148/radiol.2451051359; Lotz MK, 2010, ARTHRITIS RHEUM-US, V62, P2206, DOI 10.1002/art.27528; Maniadakis N, 2000, PAIN, V84, P95, DOI 10.1016/S0304-3959(99)00187-6; Meakin LB, 2013, BONE, V54, P113, DOI 10.1016/j.bone.2013.01.029; MILLER JM, 1988, SYST BOT, V13, P173, DOI 10.1097/00007632-198802000-00008; Mistry D, 2004, OSTEOARTHR CARTILAGE, V12, P131, DOI 10.1016/j.joca.2003.10.006; Mitchell RE, 2013, OSTEOARTHR CARTILAGE, V21, P269, DOI 10.1016/j.joca.2012.11.004; Morin-Kensicki EM, 2002, DEVELOPMENT, V129, P3851; Muller UK, 2000, J EXP BIOL, V203, P193; Papadakis Michael, 2011, Open Orthop J, V5, P335, DOI 10.2174/1874325001105010335; Poole CA, 1997, J ANAT, V191, P1, DOI 10.1046/j.1469-7580.1997.19110001.x; POOLE CA, 1991, ARTHRITIS RHEUM-US, V34, P22, DOI 10.1002/art.1780340105; Prescher A, 1998, EUR J RADIOL, V27, P181, DOI 10.1016/S0720-048X(97)00165-4; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Roach HI, 2004, APOPTOSIS, V9, P265, DOI 10.1023/B:APPT.0000025803.17498.26; SHINMEI M, 1992, ARTHRITIS RHEUM, V35, P1304, DOI 10.1002/art.1780351110; Souza ARC, 2007, GLYCOCONJUGATE J, V24, P521, DOI 10.1007/s10719-007-9046-z; Spoorendonk KM, 2010, J APPL ICHTHYOL, V26, P219, DOI 10.1111/j.1439-0426.2010.01409.x; Tallroth K, 1998, EUR J RADIOL, V27, P206, DOI 10.1016/S0720-048X(97)00168-X; THONAR EJMA, 1987, J RHEUMATOL, V14, P23; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; van der Meulen T, 2006, AM J PHYSIOL-REG I, V291, pR1040, DOI 10.1152/ajpregu.00116.2006; VISCO DM, 1993, ARTHRITIS RHEUM, V36, P1718, DOI 10.1002/art.1780361211; Wang XG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051667, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0036274, 10.1371/journal.pone.0048069, 10.1371/journal.pone.0032405]; Westerfield M, 2012, ZEBRAFISH BOOK GUIDE; Williams FMK, 2011, BEST PRACT RES CL RH, V25, P69, DOI 10.1016/j.berh.2011.01.007; Yelick PC, 2002, CRIT REV ORAL BIOL M, V13, P308, DOI 10.1177/154411130201300402; Zamli Z, 2011, INT J RHEUM DIS, V14, P159, DOI 10.1111/j.1756-185X.2011.01618.x; Zhang FM, 2009, GLYCOCONJUGATE J, V26, P211, DOI 10.1007/s10719-008-9177-x	64	49	49	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75787	10.1371/journal.pone.0075787	http://dx.doi.org/10.1371/journal.pone.0075787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086633	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000325025200062
J	Zhang, JW; Jaeck, O; Menegat, A; Zhang, ZJ; Gerhards, R; Ni, HW				Zhang, Jinwei; Jaeck, Ortrud; Menegat, Alexander; Zhang, Zongjian; Gerhards, Roland; Ni, Hanwen			The Mechanism of Methylated Seed Oil on Enhancing Biological Efficacy of Topramezone on Weeds	PLOS ONE			English	Article							ZEA-MAYS L.; PRIMISULFURON DROPLET SPREAD; OPTIMIZING FOLIAR ACTIVITY; FOXTAIL SETARIA-FABERI; ECHINOCHLOA-CRUS-GALLI; ABSORPTION; ADJUVANTS; TRANSLOCATION; SELECTIVITY; HERBICIDES	Methylated seed oil (MSO) is a recommended adjuvant for the newly registered herbicide topramezone in China and also in other countries of the world, but the mechanism of MSO enhancing topramezone efficacy is still not clear. Greenhouse and laboratory experiments were conducted to determine the effects of MSO on efficacy, solution property, droplet spread and evaporation, active ingredient deposition, foliar absorption and translocation of topramezone applied to giant foxtail (Setaria faberi Herrm.) and velvetleaf (Abutilon theophrasti Medic.). Experimental results showed that 0.3% MSO enhanced the efficacy of topramezone by 1.5-fold on giant foxtail and by 1.0-fold on velvetleaf. When this herbicide was mixed with MSO, its solution surface tension and leaf contact angle decreased significantly, its spread areas on weed leaf surfaces increased significantly, its wetting time was shortened on giant foxtail but not changed on velvetleaf, and less of its active ingredient crystal was observed on the treated weed leaf surfaces. MSO increased the absorption of topramezone by 68.9% for giant foxtail and by 45.9% for velvetleaf 24 hours after treatment. It also apparently promoted the translocation of this herbicide in these two weeds.	[Zhang, Jinwei; Ni, Hanwen] China Agr Univ, Coll Agr & Biotechnol, Weed Management Lab, Beijing 100094, Peoples R China; [Zhang, Jinwei] Tianjin Acad Agr Sci, Inst Plant Protect, Tianjin, Peoples R China; [Jaeck, Ortrud; Menegat, Alexander; Gerhards, Roland] Univ Hohenheim, Dept Weed Sci, Inst Phytomed, Stuttgart, Germany; [Zhang, Zongjian] Cent Res Inst China Chem Sci & Technol, Off Natl Pesticide R&D South Ctr, R&D Ctr Funct Addit, Beijing, Peoples R China	China Agricultural University; University Hohenheim	Ni, HW (corresponding author), China Agr Univ, Coll Agr & Biotechnol, Weed Management Lab, Beijing 100094, Peoples R China.	hanwenni@cau.edu.cn	Menegat, Alexander/X-6759-2019	Menegat, Alexander/0000-0002-0735-3293; Gerhards, Roland/0000-0002-6720-5938	Special Fund for Agro-scientific Research in the Public Interest [201303022]; Deutsche Forschungsgemeinschaft, DFG (German ResearchFoundation, IRTG Sustainable Resource Use in North China) [DFG GRK 1070]	Special Fund for Agro-scientific Research in the Public Interest; Deutsche Forschungsgemeinschaft, DFG (German ResearchFoundation, IRTG Sustainable Resource Use in North China)(German Research Foundation (DFG))	This research was supported by the Special Fund for Agro-scientific Research in the Public Interest (201303022) and the Deutsche Forschungsgemeinschaft, DFG (German ResearchFoundation, DFG GRK 1070, IRTG Sustainable Resource Use in North China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckett TH, 1991, WEED SCI, V41, P218; Bhushan B, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/48/485004; Blackshaw RE, 2006, WEED BIOL MANAG, V6, P10, DOI 10.1111/j.1445-6664.2006.00190.x; Bollman J., 2007, P 2007 WISC FERT AGL, P216; Bukun B, 2010, WEED SCI, V58, P96, DOI 10.1614/WS-09-086.1; Bunting JA, 2004, WEED SCI, V52, P513, DOI 10.1614/WS-03-135R; CAPE JN, 1983, NEW PHYTOL, V93, P293, DOI 10.1111/j.1469-8137.1983.tb03432.x; Dodds DM, 2007, WEED SCI, V55, P406, DOI 10.1614/WS-06-147.1; Enloe SF, 1999, WEED SCI, V47, P136, DOI 10.1017/S0043174500091530; GAUVRIT C, 1993, PESTIC SCI, V37, P147, DOI 10.1002/ps.2780370207; Gitsopoulos TK, 2010, CROP PROT, V29, P1091, DOI 10.1016/j.cropro.2010.06.020; Green JM, 2000, WEED TECHNOL, V14, P819, DOI 10.1614/0890-037X(2000)014[0819:ATDIAP]2.0.CO;2; Grossmann K, 2007, PEST MANAG SCI, V63, P429, DOI 10.1002/ps.1341; HART SE, 1992, WEED TECHNOL, V6, P592, DOI 10.1017/S0890037X00035855; HESS FD, 1990, WEED SCI, V38, P280, DOI 10.1017/S004317450005654X; KIRKWOOD RC, 1993, PESTIC SCI, V38, P93, DOI 10.1002/ps.2780380205; Li YB, 2011, ANAL BIOANAL CHEM, V400, P3097, DOI 10.1007/s00216-011-4967-6; Miller P, 1996, B COLORADO STATE U C; Penner D, 2000, WEED TECHNOL, V14, P785, DOI 10.1614/0890-037X(2000)014[0785:AA]2.0.CO;2; Pester TA, 2001, WEED SCI, V49, P607, DOI 10.1614/0043-1745(2001)049[0607:ATAMOI]2.0.CO;2; Porter RM, 2005, P N CENTR WEED SCI S, P60; R Development Core Team, 2011, R LANG ENV STAT COMP; Ransom CV, 2005, MALHEUR EXPT STATION, P27; Rasmussen J, 2008, WEED RES, V48, P523, DOI 10.1111/j.1365-3180.2008.00661.x; Rasmussen J, 2009, WEED SCI, V57, P338, DOI 10.1614/WS-08-109.1; Ritz C, 2006, WEED SCI, V54, P407, DOI 10.1614/WS-05-185R.1; Sanyal D, 2006, WEED SCI, V54, P16, DOI 10.1614/WS-05-019R.1; Sanyal D, 2006, WEED SCI, V54, P627, DOI 10.1614/WS-05-173R.1; Schonhammer A, 2006, J PLANT DIS PROTECT, P1023; Senesac A, 2007, CROP TALK, V3, P7; Sharma SD, 2000, WEED RES, V40, P523, DOI 10.1046/j.1365-3180.2000.00209.x; Soltani N, 2007, HORTSCIENCE, V42, P110, DOI 10.21273/HORTSCI.42.1.110; Streibig J. C., 1993, Herbicide bioassays., P29; Sun JX, 1998, AM SOC TEST MATER, V1347, P281, DOI 10.1520/STP14171S; Thompson WM, 1996, WEED SCI, V44, P469, DOI 10.1017/S0043174500094200; Xu L, 2010, T ASABE, V53, P13; Xu LY, 2011, PEST MANAG SCI, V67, P842, DOI 10.1002/ps.2122; Young B.G., 2007, N CENTRAL WEED SCI S, V62, P141; Young BG, 1998, WEED SCI, V46, P397, DOI 10.1017/S0043174500090792; Zabkiewicz JA, 2000, WEED RES, V40, P139, DOI 10.1046/j.1365-3180.2000.00172.x; Zhang JW, 2013, CROP PROT, V52, P26, DOI 10.1016/j.cropro.2013.05.001; Zheng L., 2011, AGROCHEMICALS, V50, P597; Zhou X, 2010, PHYTOMEDICINE, V23, P41; Zollinger R, 2006, P N CENT WEED SCI SO, V61, P114	44	9	13	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e74280	10.1371/journal.pone.0074280	http://dx.doi.org/10.1371/journal.pone.0074280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086329	Green Published, Green Submitted, gold			2022-12-27	WOS:000325025200012
J	Schgoer, W; Theurl, M; Albrecht-Schgoer, K; Jonach, V; Koller, B; Lener, D; Franz, WM; Kirchmair, R				Schgoer, Wilfried; Theurl, Markus; Albrecht-Schgoer, Karin; Jonach, Verena; Koller, Bernhard; Lener, Daniela; Franz, Wolfgang M.; Kirchmair, Rudolf			Secretoneurin Gene Therapy Improves Blood Flow in an Ischemia Model in Type 1 Diabetic Mice by Enhancing Therapeutic Neovascularization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; COLLATERAL VESSEL DEVELOPMENT; DOUBLE-BLIND; MELLITUS; ANGIOGENESIS; PLACEBO; NEUROPEPTIDE; EXPRESSION; PATHWAY; VECTOR	Deficient angiogenesis after ischemia may contribute to worse outcome of peripheral arterial disease in patients with diabetes mellitus. Based on our previous work where we demonstrated that Secretoneurin (SN) is up-regulated under hypoxic conditions and enhances angiogenesis, we analyzed the therapeutic potential of SN gene therapy using a model of severe hind limb ischemia in streptozotocin-induced diabetic mice (STZ-DM). After induction of hind limb ischemia, blood flow was assessed by means of laser Doppler perfusion imaging (LDPI) and increased blood perfusion in the SN-treated animal group was observed. These results were complemented by the clinical observation of reduced necrosis and by an increased number of capillaries and arterioles in the SN-treated animal group. In vitro, we found that SN is capable of promoting proliferation and chemotaxis and reduces apoptosis in HUVECs cultured under hyperglycemic conditions. Additionally, SN activated ERK, eNOS and especially AKT as well as EGF-receptor in hyperglycemic HUVECs. In conclusion, we show that SN gene therapy improves post-ischemic neovascularization in diabetic mice through stimulation of angiogenesis and arteriogenesis indicating a possible therapeutic role of this factor in ischemia-related diseases in diabetic patients.	[Schgoer, Wilfried; Theurl, Markus; Albrecht-Schgoer, Karin; Jonach, Verena; Koller, Bernhard; Lener, Daniela; Franz, Wolfgang M.; Kirchmair, Rudolf] Med Univ Innsbruck, Internal Med Cardiol & Angiol 3, A-6020 Innsbruck, Austria	Medical University of Innsbruck	Kirchmair, R (corresponding author), Med Univ Innsbruck, Internal Med Cardiol & Angiol 3, A-6020 Innsbruck, Austria.	Rudolf.Kirchmair@i-med.ac.at	Albrecht-Schgoer, Karin/AAG-4463-2020	Albrecht-Schgoer, Karin/0000-0001-8551-4067; Theurl, Markus/0000-0002-3609-9730	Austrian Science Fund [P-21021-B05]	Austrian Science Fund(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund grant P-21021-B05 to R.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahari A, 1999, EUR J VASC ENDOVASC, V18, P122, DOI 10.1053/ejvs.1999.0852; Akhtar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039066; Albrecht-Schgoer K, 2012, CIRCULATION, V126, P2491, DOI 10.1161/CIRCULATIONAHA.111.076950; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Baumgartner I, 2000, ANN INTERN MED, V132, P880, DOI 10.7326/0003-4819-132-11-200006060-00005; Baumgartner I, 1998, CIRCULATION, V97, P1114, DOI 10.1161/01.CIR.97.12.1114; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Belch J, 2011, LANCET, V377, P1929, DOI 10.1016/S0140-6736(11)60394-2; Brem Harold, 2003, Surg Technol Int, V11, P85; Dunn LL, 2010, ARTERIOSCL THROM VAS, V30, P2089, DOI 10.1161/ATVBAHA.110.209643; Egger M, 2007, FASEB J, V21, P2906, DOI 10.1096/fj.06-7440com; Elezi S, 1998, J AM COLL CARDIOL, V32, P1866, DOI 10.1016/S0735-1097(98)00467-7; Federman DG, 2004, GERIATRICS-US, V59, P26; Heil M, 2004, CIRC RES, V94, P671, DOI 10.1161/01.RES.0000122041.73808.B5; Katare R, 2013, CARDIOVASC RES, V97, P55, DOI 10.1093/cvr/cvs291; Katare R, 2011, CIRC RES, V108, P1238, DOI 10.1161/CIRCRESAHA.110.239111; Kip KE, 1996, CIRCULATION, V94, P1818, DOI 10.1161/01.CIR.94.8.1818; Kirchmair R, 2004, CIRCULATION, V110, P1121, DOI 10.1161/01.CIR.0000139884.81390.56; Kirchmair R, 2004, CIRCULATION, V109, P777, DOI 10.1161/01.CIR.0000112574.07422.C1; Kusumanto YH, 2006, HUM GENE THER, V17, P683, DOI 10.1089/hum.2006.17.683; Li XN, 2009, BIOCHEM BIOPH RES CO, V381, P660, DOI 10.1016/j.bbrc.2009.02.132; Makinen K, 2002, MOL THER, V6, P127, DOI 10.1006/mthe.2002.0638; Mathew V, 2004, CIRCULATION, V109, P476, DOI 10.1161/01.CIR.0000109693.64957.20; Rajagopalan S, 2003, CIRCULATION, V108, P1933, DOI 10.1161/01.CIR.0000093398.16124.29; Rajagopalan S, 2002, AM J CARDIOL, V90, P512, DOI 10.1016/S0002-9149(02)02524-9; Rivard A, 1999, AM J PATHOL, V154, P355, DOI 10.1016/S0002-9440(10)65282-0; Roguin A, 2003, P NATL ACAD SCI USA, V100, P4644, DOI 10.1073/pnas.0330833100; Roguin A, 2003, CARDIOVASC DIABETOL, V2, DOI 10.1186/1475-2840-2-18; Sasso FC, 2005, J AM COLL CARDIOL, V46, P827, DOI 10.1016/j.jacc.2005.06.007; Schgoer W, 2009, CIRC RES, V105, P994, DOI 10.1161/CIRCRESAHA.109.199513; Waltenberger J, 2001, CARDIOVASC RES, V49, P554, DOI 10.1016/S0008-6363(00)00228-5; Zippo A, 2004, BLOOD, V103, P4536, DOI 10.1182/blood-2003-11-3827	32	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74029	10.1371/journal.pone.0074029	http://dx.doi.org/10.1371/journal.pone.0074029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086307	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200018
J	Zhang, Y; Wang, L; Sun, Y; Liang, GP; Wu, D; Lv, SJ; Wu, W; Peng, X				Zhang Yong; Wang Lin; Sun Yong; Liang Guang-ping; Wu Dan; Lv Shang-jun; Wu Wei; Peng Xi			Kinetic Characterization of an Intestinal Trefoil Factor Receptor	PLOS ONE			English	Article							FACTOR FAMILY-PEPTIDES; EPITHELIAL-CELLS; BINDING	Objective: To determine whether intestinal epithelial cells have a receptor for intestinal trefoil factor and characterize receptor-ligand binding kinetics. Methods: Radioligand binding assays were performed to characterize the binding kinetics between [I-125]-labeled ITF and IEC-6, HT-29, Caco2 and HaCaT cells. The K-d, B-max and other kinetic variables describing the interaction between ITF and its potential receptors were determined. Results: Radioligand binding assays performed at 4 degrees C showed that the K-d value for the association between [I-125]-ITF and IEC-6, HT-29, and Caco2 cells were 1.99 +/- 0.12x10(-9) M, 3.89 +/- 0.42x10(-9) M, and 2.04 +/- 0.17x10(-9) M, respectively. B-max values were 1.17 +/- 0.04x10(11), 3.97 +/- 0.29x10(11), and 2.03 +/- 0.08x10(11) sites/cell, respectively. The K-i values for the interaction between IEC-6, HT-29, and Caco2 cells and non-labeled ITF were 20.98 +/- 0.57 nM, 36.87 +/- 3.35 nM, and 21.38 +/- 0.93 nM, respectively, and the IC50 values were 25.21 +/- 0.39 nM, 40.68 +/- 0.27 nM, and 23.61 +/- 0.25 nM, respectively. Radioligand binding kinetic results showed the association rate constants (k(+1)) for IEC-6, HT-29, and Caco2 cells were 0.22 +/- 0.04 min(-1), 0.29 +/- 0.04 min(-1), and 0.26 +/- 0.05 min(-1), respectively, and the dissociation rate constants (k(-1)) were 0.06 +/- 0.02 min(-1), 0.03 +/- 0.01 min(-1), and 0.04 +/- 0.01 min(-1), respectively. For the HaCaT cells, the K-d was 4.86 +/- 0.28x10(-8) M and B-max was 5.81 +/- 0.15x10(8) sites/cell, the very low specific binding between [I-125]-ITF and these cells made it impossible to calculate binding kinetic parameters. Conclusions: An ITF-specific receptor appears to be present on the three types of intestinal epithelial cells (IEC-6, HT-29, and Caco-2), and there may be no ITF receptor on epidermal cells.	[Zhang Yong; Wang Lin; Sun Yong; Liang Guang-ping; Wu Dan; Lv Shang-jun; Wu Wei; Peng Xi] Third Mil Med Univ, Southwest Hosp, Inst Burns PLA, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China	Army Medical University	Peng, X (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Burns PLA, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China.	pxlrmm@tmmu.edu.cn	wang, lina/HGC-1592-2022; wang, lin/HHM-2225-2022		National Natural Science Foundation of China [30971075]; State Key Laboratory of independent subject [SKLZZ200807]; Project of National Great New Drug Research and Development [2009ZX09103-647]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of independent subject; Project of National Great New Drug Research and Development	This work was supported by the National Natural Science Foundation of China (Grant No. 30971075), the State Key Laboratory of independent subject (No. SKLZZ200807), and Project of National Great New Drug Research and Development (No. 2009ZX09103-647). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2008, BIOL PHARM BULL, V31, P598, DOI 10.1248/bpb.31.598; Borniquel S, 2012, J NUTR, V142, P2135, DOI 10.3945/jn.112.163931; CHINERY R, 1995, PEPTIDES, V16, P749, DOI 10.1016/0196-9781(95)00045-L; HAUSER F, 1993, P NATL ACAD SCI USA, V90, P6961, DOI 10.1073/pnas.90.15.6961; Hoffmann W, 2007, CURR MED CHEM, V14, P2716, DOI 10.2174/092986707782023226; Barrera GJ, 2012, BOSNIAN J BASIC MED, V12, P256; Kalabis J, 2006, J BIOL CHEM, V281, P6434, DOI 10.1074/jbc.M512905200; Li J, 2011, MOL BIOL REP, V38, P4787, DOI 10.1007/s11033-010-0616-y; Oertel M, 2001, AM J RESP CELL MOL, V25, P418, DOI 10.1165/ajrcmb.25.4.4429; Podosky, 2002, OFFICIAL GAZETTE US, Patent No. 1260; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; Sun Y, 2008, PROTEIN PEPTIDE LETT, V15, P255; Tan XD, 1997, BIOCHEM BIOPH RES CO, V237, P673, DOI 10.1006/bbrc.1997.7144; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Taupin DR, 2000, P NATL ACAD SCI USA, V97, P799, DOI 10.1073/pnas.97.2.799; Thim L, 2000, REGUL PEPTIDES, V90, P61, DOI 10.1016/S0167-0115(00)00110-5; Tomov S, 2005, J BUON, V10, P241; Xi P, 2003, CHINESE J BURNS, V19, P285; Xu LF, 2012, INFLAMMATION, V35, P308, DOI 10.1007/s10753-011-9320-x; Zhang Y, 2011, CELL MOL LIFE SCI, V68, P3771, DOI 10.1007/s00018-011-0678-6; zum Buschenfelde DM, 2004, PEPTIDES, V25, P873, DOI 10.1016/j.peptides.2003.11.024	21	4	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74669	10.1371/journal.pone.0074669	http://dx.doi.org/10.1371/journal.pone.0074669			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086361	gold, Green Submitted, Green Published			2022-12-27	WOS:000326520200037
J	Lachance, PA; Hazen, A; Sevick-Muraca, EM				Lachance, Pier-Anne; Hazen, Amy; Sevick-Muraca, Eva M.			Lymphatic Vascular Response to Acute Inflammation	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; SKIN INFLAMMATION; GROWTH-FACTOR; HYPERSENSITIVITY REACTIONS; ANGIOGENESIS; LYMPHANGIOGENESIS; INDUCTION; BLOOD; BASAL	During acute inflammation, functioning lymphatics are believed to reduce edema and to provide a transiting route for immune cells, but the extent at which the dermal lymphatic remodeling impacts lymphatic transport or the factors regulating these changes remains unclear. Herein we quantify the increase in lymphatic endothelial cells (LECs) and examine the expression of pro-angiogenenic and lymphangiogenic factors during acute cutaneous hypersensitivity (CHS). We found that LECs actively proliferate during CHS but that this proliferation does not affect the lymphatic vessel density. Instead, lymphatic remodeling is accompanied by lymphatic vessel leakiness and lower ejection of lymph fluid, which is observed only in the proximal lymphatic vessel draining the inflamed area. LECs and the immune cells release growth factors and cytokines during inflammation, which impact the lymphatic microenvironment and function. We identified that FGF-2, PLGF-2, HGF, EGF, and KC/CXCL17 are differentially expressed within tissues during acute CHS, but both VEGF-C and VEGF-D levels do not significantly change. Our results indicate that VEGF-C and VEGF-D are not the only players and other factors may be responsible for the LECs proliferation and altered lymphatic function in acute CHS.	[Lachance, Pier-Anne; Sevick-Muraca, Eva M.] Univ Texas Hlth Sci Ctr Houston, Ctr Mol Imaging, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; [Lachance, Pier-Anne] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Hazen, Amy] Univ Texas Hlth Sci Ctr Houston, IMM Flow Cytometry Ctr, Brown Fdn Inst Mol Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Sevick-Muraca, EM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Ctr Mol Imaging, Brown Fdn Inst Mol Med, Houston, TX 77030 USA.	Eva.sevick@uth.tmc.edu	Sevick-Muraca, Eva M/A-4152-2017	Sevick-Muraca, Eva M/0000-0002-8152-4847	National Institutes of Health [R01 CA128919]; Canadian Institutes of Health Research Doctoral Research Award; Cancer Prevention and Research Institute of Texas (CPRIT) [RP 110776]; NATIONAL CANCER INSTITUTE [R01CA128919] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research Doctoral Research Award(Canadian Institutes of Health Research (CIHR)); Cancer Prevention and Research Institute of Texas (CPRIT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health (R01 CA128919), the Canadian Institutes of Health Research Doctoral Research Award and in part by the shared instrumentation grant (RP 110776) from the Cancer Prevention and Research Institute of Texas (CPRIT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Bohlen HG, 2009, AM J PHYSIOL-HEART C, V297, pH1319, DOI 10.1152/ajpheart.00039.2009; Bracher A, 2013, J INVEST DERMATOL, V133, P230, DOI 10.1038/jid.2012.272; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; Capla JM, 2006, PLAST RECONSTR SURG, V117, P836, DOI 10.1097/01.prs.0000201459.91559.7f; Cappella P, 2008, CYTOM PART A, V73A, P626, DOI 10.1002/cyto.a.20582; Chang LK, 2004, P NATL ACAD SCI USA, V101, P11658, DOI 10.1073/pnas.0404272101; Dimmeler S, 2000, CIRC RES, V87, P434; Dixon JB, 2006, MICROCIRCULATION, V13, P597, DOI 10.1080/10739680600893909; Goldman J, 2005, CIRC RES, V96, P1193, DOI 10.1161/01.RES.0000168918.27576.78; Halin C, 2008, AM J PATHOL, V173, P265, DOI 10.2353/ajpath.2008.071074; Halin C, 2007, BLOOD, V110, P3158, DOI 10.1182/blood-2007-01-066811; Huggenberger R, 2011, J INVEST DERM SYMP P, V15, P24, DOI 10.1038/jidsymp.2011.5; Huggenberger R, 2011, BLOOD, V117, P4667, DOI 10.1182/blood-2010-10-316356; Huggenberger R, 2010, J EXP MED, V207, P2255, DOI 10.1084/jem.20100559; Im E, 2006, CELL CYCLE, V5, P2057, DOI 10.4161/cc.5.18.3210; Kajiya K, 2005, EMBO J, V24, P2885, DOI 10.1038/sj.emboj.7600763; Kajiya K, 2009, J INVEST DERMATOL, V129, P1292, DOI 10.1038/jid.2008.351; Kim Y, 2011, MOL IMMUNOL, V48, P1035, DOI 10.1016/j.molimm.2011.01.013; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Kunstfeld R, 2004, BLOOD, V104, P1048, DOI 10.1182/blood-2003-08-2964; Kwon Sunkuk, 2007, Lymphatic Research and Biology, V5, P219, DOI 10.1089/lrb.2007.1013; Lange-Asschenfeldt B, 2002, BLOOD, V99, P538, DOI 10.1182/blood.V99.2.538; Lee WY, 2013, AM J PHYSIOL-ENDOC M, V304, pE32, DOI 10.1152/ajpendo.00083.2012; Liao S, 2011, P NATL ACAD SCI USA, V108, P18784, DOI 10.1073/pnas.1116152108; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Mendez U, 2012, AM J PHYSIOL-HEART C, V303, pH1107, DOI 10.1152/ajpheart.00522.2012; Oura H, 2003, BLOOD, V101, P560, DOI 10.1182/blood-2002-05-1516; Rasmussen JC, 2010, TRANSL ONCOL, V3, P362, DOI 10.1593/tlo.10190; Robinson HA, 2013, JOVE-J VIS EXP, DOI 10.3791/4326; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Scallan JP, 2013, J PHYSIOL-LONDON, V591, P2139, DOI 10.1113/jphysiol.2012.250662; Team RDC, 2019, R LANG ENV STAT COMP; Unno N, 2010, J VASC SURG, V52, P946, DOI 10.1016/j.jvs.2010.04.067; Velasco P, 2009, J INVEST DERMATOL, V129, P2022, DOI 10.1038/jid.2008.447; Vigl B, 2011, BLOOD, V118, P205, DOI 10.1182/blood-2010-12-326447	36	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76078	10.1371/journal.pone.0076078	http://dx.doi.org/10.1371/journal.pone.0076078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086691	Green Published, Green Submitted, gold			2022-12-27	WOS:000325223900078
J	Misund, K; Selvik, LKM; Rao, S; Norsett, K; Bakke, I; Sandvik, AK; Laegreid, A; Bruland, T; Prestvik, WS; Thommesen, L				Misund, Kristine; Selvik, Linn-Karina Myrland; Rao, Shalini; Norsett, Kristin; Bakke, Ingunn; Sandvik, Arne K.; Laegreid, Astrid; Bruland, Torunn; Prestvik, Wenche S.; Thommesen, Liv			NR4A2 Is Regulated by Gastrin and Influences Cellular Responses of Gastric Adenocarcinoma Cells	PLOS ONE			English	Article							NUCLEAR RECEPTOR NURR1; GENE-EXPRESSION DATA; MOLECULAR MECHANISMS; C-FOS; IDENTIFICATION; PROMOTER; PROTEIN; CHOLECYSTOKININ; TRANSCRIPTION; SUPPRESSES	The peptide hormone gastrin is known to play a role in differentiation, growth and apoptosis of cells in the gastric mucosa. In this study we demonstrate that gastrin induces Nuclear Receptor 4A2 (NR4A2) expression in the adenocarcinoma cell lines AR42J and AGS-G(R), which both possess the gastrin/CCK2 receptor. In vivo, NR4A2 is strongly expressed in the gastrin responsive neuroendocrine ECL cells in normal mucosa, whereas gastric adenocarcinoma tissue reveals a more diffuse and variable expression in tumor cells. We show that NR4A2 is a primary early transient gastrin induced gene in adenocarcinoma cell lines, and that NR4A2 expression is negatively regulated by inducible cAMP early repressor (ICER) and zinc finger protein 36, C3H1 type-like 1 (Zfp36l1), suggesting that these gastrin regulated proteins exert a negative feedback control of NR4A2 activated responses. FRAP analyses indicate that gastrin also modifies the nucleus-cytosol shuttling of NR4A2, with more NR4A2 localized to cytoplasm upon gastrin treatment. Knock-down experiments with siRNA targeting NR4A2 increase migration of gastrin treated adenocarcinoma AGS-G(R) cells, while ectopically expressed NR4A2 increases apoptosis and hampers gastrin induced invasion, indicating a tumor suppressor function of NR4A2. Collectively, our results uncover a role of NR4A2 in gastric adenocarcinoma cells, and suggest that both the level and the localization of NR4A2 protein are of importance regarding the cellular responses of these cells.	[Misund, Kristine; Selvik, Linn-Karina Myrland; Rao, Shalini; Norsett, Kristin; Bakke, Ingunn; Sandvik, Arne K.; Laegreid, Astrid; Bruland, Torunn; Thommesen, Liv] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Trondheim, Norway; [Selvik, Linn-Karina Myrland; Rao, Shalini; Prestvik, Wenche S.; Thommesen, Liv] Sor Trondelag Univ Coll, Fac Technol, Trondheim, Norway; [Sandvik, Arne K.] St Olavs Univ Hosp, Med Clin, Dept Gastroenterol & Hepatol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Thommesen, L (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Trondheim, Norway.	Liv.Thommesen@ntnu.no	Bluland, Torunn/AAT-5730-2021	Bakke, Ingunn/0000-0003-0356-6184; Bruland, Torunn/0000-0002-1568-2476	Norwegian Cancer Association; St. Olavs Hospital, Trondheim, Norway	Norwegian Cancer Association; St. Olavs Hospital, Trondheim, Norway	This work was supported by the Norwegian Cancer Association and the Cancer Fund at St. Olavs Hospital, Trondheim, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne CM, 2009, MOL IMMUNOL, V46, P3345, DOI 10.1016/j.molimm.2009.07.019; Bakke I, 2001, SCAND J GASTROENTERO, V36, P1128; Borneman AR, 2006, GENE DEV, V20, P435, DOI 10.1101/gad.1389306; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Burkitt MD, 2009, WORLD J GASTROENTERO, V15, P1, DOI 10.3748/wjg.15.1; Caplin M, 2000, BRIT J SURG, V87, P1035, DOI 10.1046/j.1365-2168.2000.01488.x; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Cardarelli F, 2012, J BIOL CHEM, V287, P5554, DOI 10.1074/jbc.M111.304899; Chang WJ, 2009, INT J CANCER, V125, P2844, DOI 10.1002/ijc.24699; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Dabrowski A, 1997, DIGESTION, V58, P361, DOI 10.1159/000201466; Dabrowski A, 1997, AM J PHYSIOL-CELL PH, V273, pC1472, DOI 10.1152/ajpcell.1997.273.5.C1472; Dockray GJ, 2001, ANNU REV PHYSIOL, V63, P119, DOI 10.1146/annurev.physiol.63.1.119; Edkins JS, 1906, J PHYSIOL-LONDON, V34, P133; Goetze JP, 2000, CANCER, V88, P2487, DOI 10.1002/1097-0142(20000601)88:11<2487::AID-CNCR9>3.0.CO;2-E; Han YF, 2012, WORLD J GASTROENTERO, V18, P6865, DOI 10.3748/wjg.v18.i47.6865; Holla VR, 2006, J BIOL CHEM, V281, P2676, DOI 10.1074/jbc.M507752200; Ichinose H, 1999, GENE, V230, P233, DOI 10.1016/S0378-1119(99)00065-7; Inamoto T, 2008, MOL CANCER THER, V7, P3825, DOI 10.1158/1535-7163.MCT-08-0730; ISHIZUKA J, 1992, ANN SURG, V215, P528, DOI 10.1097/00000658-199205000-00016; Garcia-Yague AJ, 2013, J BIOL CHEM, V288, P5506, DOI 10.1074/jbc.M112.439190; Kitagawa H, 2007, MOL CELL BIOL, V27, P7486, DOI 10.1128/MCB.00409-07; Koh TJ, 1997, GASTROENTEROLOGY, V113, P1015, DOI 10.1016/S0016-5085(97)70199-9; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llopis S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-139; Lodige I, 2005, J BIOL CHEM, V280, P43087, DOI 10.1074/jbc.M509180200; Luciano F, 2007, BLOOD, V109, P3849, DOI 10.1182/blood-2006-11-056879; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; Mishra Prajna, 2010, J Mol Signal, V5, P9, DOI 10.1186/1750-2187-5-9; Misund K, 2007, J CELL BIOCHEM, V101, P1532, DOI 10.1002/jcb.21267; Mix KS, 2007, J BIOL CHEM, V282, P9492, DOI 10.1074/jbc.M608327200; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Norsett KG, 2005, PHYSIOL GENOMICS, V22, P24, DOI 10.1152/physiolgenomics.00245.2004; Norsett KG, 2011, AM J PHYSIOL-GASTR L, V301, pG446, DOI 10.1152/ajpgi.00527.2010; Norsetta KG, 2008, EUR J GASTROEN HEPAT, V20, P613, DOI 10.1097/MEG.0b013e3282f5dc19; OHMICHI M, 1994, J BIOL CHEM, V269, P3783; Parkinson H, 2005, NUCLEIC ACIDS RES, V33, pD553; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramirez-Herrick AM, 2011, BLOOD, V117, P2681, DOI 10.1182/blood-2010-02-267906; Selvik LKM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-429; SEVA C, 1990, DIGESTION, V46, P166, DOI 10.1159/000200381; SMITH JP, 1994, AM J PHYSIOL, V266, pR277, DOI 10.1152/ajpregu.1994.266.1.R277; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Steigedal TS, 2007, AM J PHYSIOL-GASTR L, V292, pG1062, DOI 10.1152/ajpgi.00287.2006; Steigedal TS, 2013, IN VITRO CELL DEV-AN, V49, P162, DOI 10.1007/s11626-013-9588-2; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; Thommesen L, 2000, J BIOL CHEM, V275, P4244, DOI 10.1074/jbc.275.6.4244; Thommesen L, 2001, AM J PHYSIOL-ENDOC M, V281, pE1316, DOI 10.1152/ajpendo.2001.281.6.E1316; Todisco A, 2001, AM J PHYSIOL-GASTR L, V280, pG298, DOI 10.1152/ajpgi.2001.280.2.G298; Torii T, 1999, GENE, V230, P225, DOI 10.1016/S0378-1119(99)00064-5; Watson F, 2001, J BIOL CHEM, V276, P7661, DOI 10.1074/jbc.M006697200; Willard MD, 2012, MOL CANCER RES, V10, P739, DOI 10.1158/1541-7786.MCR-11-0483; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Winoto A, 2002, CELL, V109, pS57, DOI 10.1016/S0092-8674(02)00710-9; Zhang T, 2009, MOL CANCER RES, V7, P1408, DOI 10.1158/1541-7786.MCR-08-0533	59	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76234	10.1371/journal.pone.0076234	http://dx.doi.org/10.1371/journal.pone.0076234			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086717	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900090
J	Okuma, H; Gonoi, W; Ishida, M; Shintani, Y; Takazawa, Y; Fukayama, M; Ohtomo, K				Okuma, Hidemi; Gonoi, Wataru; Ishida, Masanori; Shintani, Yukako; Takazawa, Yutaka; Fukayama, Masashi; Ohtomo, Kuni			Heart Wall Is Thicker on Postmortem Computed Tomography Than on Ante Mortem Computed Tomography: The First Longitudinal Study	PLOS ONE			English	Article							CLINICAL-EXPERIENCE; AUTOPSY; DEATH; GAS; RIGOR; SHAPE; MDCT; MRI	Objective: To evaluate the postmortem changes of the heart wall on postmortem (PM) computed tomography (CT) in comparison with those on ante mortem CT (AMCT), and in comparison with the pathological findings, obtained in the same patients. Materials and Methods: We studied 57 consecutive patients who had undergone AMCT, PMCT, and pathological autopsy in our tertiary care hospital between April 2009 and December 2010. PMCT was performed within 20 hours after death, followed by pathological autopsy. The cardiac chambers were measured at five sites on both AMCT and PMCT by two board-certified radiologists who were not provided with clinical information. The differences in heart wall thickness between AMCT with and without contrast medium, between AMCT and PMCT, and between PMCT and pathological anatomy were evaluated statistically. Confounding factors of postmortem change such as gender, presence of arteriosclerosis, the organ related to cause of death, age, and elapsed time since death were examined statistically. Results: No significant differences were observed on AMCT in comparison of contrasted and non-contrasted images. The heart wall was significantly thicker on PMCT than on AMCT (p < 0.0001) at all five measurement sites. The heart wall was significantly thicker on PMCT than on pathology specimens when measured in accordance with pathological standard mensuration. However, no significant difference was observed between PMCT measurements and those of pathology specimens at any site when the papillary muscles and epicardial fat were included. No significant association was found between postmortem change in heart wall thickness and gender, presence of arteriosclerosis, the organ related to cause of death, age, or elapsed time since death. Conclusion: This is the first longitudinal study to confirm greater thickness of heart wall on postmortem images compared with ante mortem images, in the same patients. Furthermore, the postmortem changes on CT were supported by the pathological findings.	[Okuma, Hidemi; Gonoi, Wataru; Ishida, Masanori; Ohtomo, Kuni] Univ Tokyo, Grad Sch Med, Dept Radiol, Tokyo, Japan; [Ishida, Masanori] Sanraku Hosp, Dept Radiol, Mutual Aid Assoc Tokyo Metropolitan Teachers & Of, Tokyo, Japan; [Shintani, Yukako; Takazawa, Yutaka; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan	University of Tokyo; University of Tokyo	Okuma, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Radiol, Tokyo, Japan.	hokuma-tky@umin.ac.jp	Gonoi, Wataru/AAB-2160-2019; Okuma, Hidemi/M-2660-2018	Gonoi, Wataru/0000-0002-5018-4683; Okuma, Hidemi/0000-0001-5325-2699; Shintani-Domoto, Yukako/0000-0002-8061-6176	Japanese Ministry of Health, Labor and Welfare; Grants-in-Aid for Scientific Research [25860264] Funding Source: KAKEN	Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Japanese Ministry of Health, Labor and Welfare, for research into "Usefulness of Postmortem Images as an Ancillary Method for Autopsy in Evaluation of Death Associated with Medical Practice (2008-2009)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cha JG, 2010, KOREAN J RADIOL, V11, P395, DOI 10.3348/kjr.2010.11.4.395; Ezawa H, 2003, PATHOL INT, V53, P865, DOI 10.1046/j.1440-1827.2003.01573.x; Hall JE, 2011, TXB MED PHYSL, P101; HUTCHINS GM, 1978, AM J CARDIOL, V41, P646, DOI 10.1016/0002-9149(78)90812-3; Hyodoh H, 2012, JPN J RADIOL, V30, P840, DOI 10.1007/s11604-012-0134-z; Ishida M, 2011, LEGAL MED-TOKYO, V13, P280, DOI 10.1016/j.legalmed.2011.09.004; Ishida M, 2011, LEGAL MED-TOKYO, V13, P318, DOI 10.1016/j.legalmed.2011.08.003; Ishida M, 2011, LEGAL MED-TOKYO, V13, P174, DOI 10.1016/j.legalmed.2011.03.002; Jackowski C, 2006, INVEST RADIOL, V41, P572, DOI 10.1097/01.rli.0000221323.38443.8d; Jackowski C, 2007, J TRAUMA, V62, P979, DOI 10.1097/01.ta.0000198733.22654.de; Joseph DR, 1909, J EXP MED, V11, P10, DOI 10.1084/jem.11.1.10; Kobayashi T, 2010, JPN J RADIOL, V28, P8, DOI 10.1007/s11604-009-0373-9; Levy AD, 2010, AM J FOREN MED PATH, V31, P12, DOI 10.1097/PAF.0b013e3181c65e1a; Macwilliam JA, 1901, J PHYSIOL-LONDON, V27, P336; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Patriquin L, 2001, J MAGN RESON IMAGING, V13, P277, DOI 10.1002/1522-2586(200102)13:2<277::AID-JMRI1040>3.0.CO;2-W; Roberts ISD, 2012, LANCET, V379, P136, DOI 10.1016/S0140-6736(11)61483-9; Sato T, 1996, HEART VESSELS, V11, P248, DOI 10.1007/BF01746205; Schoen FJ, 2010, PATHOLOGIC BASIS DIS, P571; Shiotani S, 2004, FORENSIC SCI INT, V139, P39, DOI 10.1016/j.forsciint.2003.09.016; Shiotani Seiji, 2002, Radiat Med, V20, P201; Shiotani Seiji, 2003, Radiat Med, V21, P29; Singh MKC, 2009, FORENSIC SCI MED PAT, V5, P236, DOI 10.1007/s12024-009-9103-y; SMITH RD, 1950, ANAT RECORD, V108, P207, DOI 10.1002/ar.1091080203; Somsen GA, 2011, CLINICAL CARDIOGENETICS, P63, DOI 10.1007/978-1-84996-471-5_4; Takahashi N, 2013, FORENSIC SCI INT, V225, P27, DOI 10.1016/j.forsciint.2012.04.037; Thali MJ, 2003, J FORENSIC SCI, V48, P386; Tsokos M., 2005, ENCY FORENSIC LEGAL, P456, DOI [10.1016/B0-12-369399-3/00091-4, DOI 10.1016/B0-12-369399-3/00091-4]; Yutani C, 2002, ATLAS CARDIOVASCULAR, P3	29	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76026	10.1371/journal.pone.0076026	http://dx.doi.org/10.1371/journal.pone.0076026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086680	Green Published, Green Submitted, gold			2022-12-27	WOS:000325223900072
J	Geraghty, PT; Williamson, JE; Macbeth, WG; Wintner, SP; Harry, AV; Ovenden, JR; Gillings, MR				Geraghty, Pascal T.; Williamson, Jane E.; Macbeth, William G.; Wintner, Sabine P.; Harry, Alastair V.; Ovenden, Jennifer R.; Gillings, Michael R.			Population Expansion and Genetic Structure in Carcharhinus brevipinna in the Southern Indo-Pacific	PLOS ONE			English	Article							GULF-OF-MEXICO; HUMAN MITOCHONDRIAL-DNA; SPINNER SHARK; BLACKTIP SHARK; CONTROL REGION; GLOBAL PHYLOGEOGRAPHY; REPRODUCTIVE-BIOLOGY; RELATIVE ABUNDANCE; NEUTRALITY TESTS; NURSERY GROUNDS	Background: Quantifying genetic diversity and metapopulation structure provides insights into the evolutionary history of a species and helps develop appropriate management strategies. We provide the first assessment of genetic structure in spinner sharks (Carcharhinus brevipinna), a large cosmopolitan carcharhinid, sampled from eastern and northern Australia and South Africa. Methods and Findings: Sequencing of the mitochondrial DNA NADH dehydrogenase subunit 4 gene for 430 individuals revealed 37 haplotypes and moderately high haplotype diversity (h = 0.6770 +/- 0.025). While two metrics of genetic divergence (Phi(ST) and F-ST) revealed somewhat different results, subdivision was detected between South Africa and all Australian locations (pairwise Phi(ST), range 0.02717-0.03508, p values <= 0.0013; pairwise F-ST South Africa vs New South Wales = 0.04056, p = 0.0008). Evidence for fine-scale genetic structuring was also detected along Australia's east coast (pairwise Phi(ST) = 0.01328, p < 0.015), and between south-eastern and northern locations (pairwise Phi(ST) = 0.00669, p < 0.04). Conclusions: The Indian Ocean represents a robust barrier to contemporary gene flow in C. brevipinna between Australia and South Africa. Gene flow also appears restricted along a continuous continental margin in this species, with data tentatively suggesting the delineation of two management units within Australian waters. Further sampling, however, is required for a more robust evaluation of the latter finding. Evidence indicates that all sampled populations were shaped by a substantial demographic expansion event, with the resultant high genetic diversity being cause for optimism when considering conservation of this commercially-targeted species in the southern Indo-Pacific.	[Geraghty, Pascal T.; Williamson, Jane E.; Gillings, Michael R.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Geraghty, Pascal T.; Macbeth, William G.] Cronulla Fisheries Res Ctr Excellence, New South Wales Dept Primary Ind, Sydney, NSW, Australia; [Wintner, Sabine P.] KwaZulu Natal Sharks Board, Umhlanga Rocks, Kwazulu Natal, South Africa; [Harry, Alastair V.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Ovenden, Jennifer R.] Univ Queensland, Mol Fisheries Lab, St Lucia, Qld, Australia	Macquarie University; NSW Department of Primary Industries; James Cook University; University of Queensland	Geraghty, PT (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	pascal.geraghty@mq.edu.au	Gillings, Michael/AAF-5772-2020; Harry, Alastair V/A-3370-2011; Gillings, Michael R/C-6553-2008; Ovenden, Jennifer/A-3717-2010; Williamson, Jane E/G-9871-2011	Gillings, Michael/0000-0002-4043-4351; Harry, Alastair V/0000-0002-9905-7909; Gillings, Michael R/0000-0002-4043-4351; Ovenden, Jennifer/0000-0001-7538-1504; Williamson, Jane E/0000-0003-3627-4508	Northern Rivers Catchment Management Authority (NRCMA); Wild Fisheries Division of the New South Wales Department of Primary Industries (NSW DPI); Department of Biological Sciences at Macquarie University (MQ); Queensland Government; Australian Postgraduate Award scholarship	Northern Rivers Catchment Management Authority (NRCMA); Wild Fisheries Division of the New South Wales Department of Primary Industries (NSW DPI); Department of Biological Sciences at Macquarie University (MQ); Queensland Government; Australian Postgraduate Award scholarship	Funding was provided by the Northern Rivers Catchment Management Authority (NRCMA), the Wild Fisheries Division of the New South Wales Department of Primary Industries (NSW DPI), the Department of Biological Sciences at Macquarie University (MQ), the Queensland Government, and an Australian Postgraduate Award scholarship awarded to PTG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen H, 2009, MOL ECOL, V18, P4409, DOI 10.1111/j.1365-294X.2009.04377.x; Allen BR, 2002, S AFR J MARINE SCI, V24, P1, DOI 10.2989/025776102784528484; Allen BR, 2000, S AFR J MARINE SCI, V22, P199, DOI 10.2989/025776100784125654; [Anonymous], 1963, ANIMAL SPECIES EVOLU; AREVALO E, 1994, SYST BIOL, V43, P387, DOI 10.2307/2413675; Arnaud-Haond S, 2006, MOL ECOL, V15, P3515, DOI 10.1111/j.1365-294X.2006.02997.x; Beheregaray LB, 2004, P NATL ACAD SCI USA, V101, P6514, DOI 10.1073/pnas.0400393101; Benavides MT, 2011, MAR FRESHWATER RES, V62, P861, DOI 10.1071/MF10236; Benavides Martin T., 2011, Endangered Species Research, V14, P13, DOI 10.3354/esr00337; Bird CE, 2011, CRUSTACEAN ISS, V19, P31; Blower DC, 2012, MAR ECOL PROG SER, V455, P229, DOI 10.3354/meps09659; BRANSTETTER S, 1987, COPEIA, P964; Broderick D, 2011, J FISH BIOL, V79, P633, DOI 10.1111/j.1095-8649.2011.03055.x; Burgess GH, 2005, FISHERIES, V30, P19, DOI 10.1577/1548-8446(2005)30[19:ITCOSP]2.0.CO;2; BURGESS GH, 2009, CARCHARHINUS BREVIPI; Capape C, 2003, ISR J ZOOL, V49, P269, DOI 10.1560/DHHM-A68M-VKQH-CY9F; Carlson JK, 2012, J FISH BIOL, V80, P1749, DOI 10.1111/j.1095-8649.2011.03193.x; Carlson JK, 2005, FISH B-NOAA, V103, P280; Carlson JK, 1999, MAR FISH REV, V61, P37; Castillo-Geniz JL, 1998, MAR FRESHWATER RES, V49, P611, DOI 10.1071/MF97120; CASTRO JI, 1993, ENVIRON BIOL FISH, V38, P37, DOI 10.1007/BF00842902; Chabot CL, 2009, MOL ECOL, V18, P545, DOI 10.1111/j.1365-294X.2008.04047.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Conrath CL, 2007, T AM FISH SOC, V136, P999, DOI 10.1577/T06-107.1; Cortes E, 2006, PANAMA CITY LAB CONT; Daly-Engel TS, 2012, PLOS ONE, V7, P279, DOI 10.1371/journal.pone.0029986; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Diaz-Jaimes P, 2006, FISH RES, V80, P333, DOI 10.1016/j.fishres.2006.04.015; Dudgeon CL, 2012, J FISH BIOL, V80, P1789, DOI 10.1111/j.1095-8649.2012.03265.x; Dudgeon CL, 2009, MOL ECOL, V18, P248, DOI 10.1111/j.1365-294X.2008.04025.x; Dudley SFJ, 2006, MAR FRESHWATER RES, V57, P225, DOI 10.1071/MF05156; Duncan KM, 2006, MOL ECOL, V15, P2239, DOI 10.1111/j.1365-294X.2006.02933.x; EXCOFFIER L, 1990, J MOL EVOL, V30, P125, DOI 10.1007/BF02099939; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Field IC, 2009, ADV MAR BIOL, V56, P275, DOI 10.1016/S0065-2881(09)56004-X; Fu YX, 1997, GENETICS, V147, P915; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Grubbs R. Dean, 2007, V50, P87; Hale L. F., 2011, NMFSSEFSC611 NOAA; HARPENDING HC, 1994, HUM BIOL, V66, P591; Harry AV, 2011, MAR FRESHWATER RES, V62, P710, DOI 10.1071/MF10155; Heist, 2005, BIOL STOCK ASSESSMEN; Henderson AC, 2007, FISH RES, V86, P159, DOI 10.1016/j.fishres.2007.05.012; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Hoelzel AR, 2002, P ROY SOC B-BIOL SCI, V269, P1467, DOI 10.1098/rspb.2002.2033; HOLM S, 1979, SCAND J STAT, V6, P65; HUETER R, 2007, 1241 MOT MAR LAB; Hueter R. E., 2005, Journal of Northwest Atlantic Fishery Science, V35, P239; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Hussey NE, 2009, MAR FRESHWATER RES, V60, P571, DOI 10.1071/MF08280; Inoue JG, 2001, MOL PHYLOGENET EVOL, V20, P275, DOI 10.1006/mpev.2001.0970; Joung SJ, 2005, ZOOL STUD, V44, P102; Karl SA, 2011, CONSERV GENET, V12, P371, DOI 10.1007/s10592-010-0145-1; Karl SA, 2012, MAR BIOL, V159, P489, DOI 10.1007/s00227-011-1828-y; Keeney DB, 2006, MOL ECOL, V15, P3669, DOI 10.1111/j.1365-294X.2006.03036.x; Keeney DB, 2003, MAR BIOL, V143, P1039, DOI 10.1007/s00227-003-1166-9; Keeney DB, 2005, MOL ECOL, V14, P1911, DOI 10.1111/j.1365-294X.2005.02549.x; Knip DM, 2010, MAR ECOL PROG SER, V402, P1, DOI 10.3354/meps08498; Kohler NE, 2001, ENVIRON BIOL FISH, V60, P191, DOI 10.1023/A:1007679303082; Lambeck K, 2002, NATURE, V419, P199, DOI 10.1038/nature01089; Last P. R., 2009, SHARKS RAYS AUSTR, V2; Lind CE, 2007, MOL ECOL, V16, P5193, DOI 10.1111/j.1365-294X.2007.03598.x; Lyrholm T, 1996, MOL BIOL EVOL, V13, P1318, DOI 10.1093/oxfordjournals.molbev.a025578; Macbeth W. G., 2009, IND INVESTMENT NSW F, V114; McVean AR, 2006, FISH RES, V82, P280, DOI 10.1016/j.fishres.2006.06.016; Merson RR, 2001, ENVIRON BIOL FISH, V61, P13, DOI 10.1023/A:1011017109776; MORGAN J, 2011, STOCK STRUCTURE EXPL; NAYLOR GJP, 2012, B AM MUS NAT HIST, V367, P262; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Ovenden JR, 2010, MAR FRESHWATER RES, V61, P253, DOI 10.1071/MF09151; Ovenden JR, 2011, MAR BIOL, V158, P1497, DOI 10.1007/s00227-011-1666-y; Ovenden JR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-40; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Pardini AT, 2001, NATURE, V412, P139, DOI 10.1038/35084125; Peakall R, 2003, MOL ECOL, V12, P2331, DOI 10.1046/j.1365-294X.2003.01926.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pereyra S, 2010, FISH RES, V106, P468, DOI 10.1016/j.fishres.2010.09.022; Pope LC, 1996, MOL ECOL, V5, P629, DOI 10.1111/j.1365-294X.1996.tb00358.x; Portnoy DS, 2012, J FISH BIOL, V80, P1120, DOI 10.1111/j.1095-8649.2011.03206.x; Portnoy DS, 2010, MOL ECOL, V19, P1994, DOI 10.1111/j.1365-294X.2010.04626.x; *QUEENSL GOV DEP A, 2006, REP QUEENSL SHARK SA; Ramirez-Soriano A, 2008, GENETICS, V179, P555, DOI 10.1534/genetics.107.083006; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Reid DD, 2011, MAR FRESHWATER RES, V62, P676, DOI 10.1071/MF10162; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rogers PJ, 2013, FISH OCEANOGR, V22, P102, DOI 10.1111/fog.12009; ROSE C, 2003, QLD DEP PRIM IND QI; Hoelzel AR, 2006, BIOL LETTERS, V2, P639, DOI 10.1098/rsbl.2006.0513; Schultz JK, 2008, MOL ECOL, V17, P5336, DOI 10.1111/j.1365-294X.2008.04000.x; Simpfendorfer C, 1998, MAR FRESHWATER RES, V49, P593, DOI 10.1071/MF97043; Sivasundar A, 2001, MOL ECOL, V10, P407, DOI 10.1046/j.1365-294x.2001.01194.x; Steeves TE, 2005, MOL ECOL, V14, P3877, DOI 10.1111/j.1365-294X.2005.02713.x; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor SM, 2013, J FISH BIOL, V82, P228, DOI 10.1111/jfb.12003; Thacker CE, 2004, CORAL REEFS, V23, P357, DOI 10.1007/s00338-004-0391-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorpe T, 2004, B MAR SCI, V74, P3; Tillett BJ, 2012, CONSERV GENET, V13, P99, DOI 10.1007/s10592-011-0268-z; Tillett BJ, 2012, FISH RES, V127, P109, DOI 10.1016/j.fishres.2012.04.007; Tillett J, 2012, J FISH BIOL, V80, P2140, DOI 10.1111/j.1095-8649.2012.03228.x; Verissimo A, 2010, MOL ECOL, V19, P1651, DOI 10.1111/j.1365-294X.2010.04598.x; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; White WT, 2007, J FISH BIOL, V71, P1512, DOI 10.1111/j.1095-8649.2007.01623.x; White WT, 2004, MAR BIOL, V145, P1023, DOI 10.1007/s00227-004-1386-7; Whitney NM, 2012, J BIOGEOGR, V39, P1144, DOI 10.1111/j.1365-2699.2011.02660.x; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Zhang YP, 2002, PURE APPL CHEM, V74, P575, DOI 10.1351/pac200274040575; 2011, SEDAR 21 STOCK ASS R	114	19	19	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75169	10.1371/journal.pone.0075169	http://dx.doi.org/10.1371/journal.pone.0075169			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086462	Green Published, gold, Green Accepted			2022-12-27	WOS:000325218700056
J	Herrmann-Werner, A; Nikendei, C; Keifenheim, K; Bosse, HM; Lund, F; Wagner, R; Celebi, N; Zipfel, S; Weyrich, P				Herrmann-Werner, Anne; Nikendei, Christoph; Keifenheim, Katharina; Bosse, Hans Martin; Lund, Frederike; Wagner, Robert; Celebi, Nora; Zipfel, Stephan; Weyrich, Peter			"Best Practice" Skills Lab Training vs. a "see one, do one" Approach in Undergraduate Medical Education: An RCT on Students' Long-Term Ability to Perform Procedural Clinical Skills	PLOS ONE			English	Article							STANDARDIZED PATIENTS; DELIBERATE PRACTICE; 4-STEP APPROACH; SIMULATION; RETENTION; CARE; INTERVENTION; ACQUISITION; INTEGRATION; COMPETENCE	Background: Benefits of skills lab training are widely accepted, but there is sparse research on its long-term effectiveness. We therefore conducted a prospective, randomised controlled-trial to investigate whether in a simulated setting students trained according to a "best practice" model (BPSL) perform two skills of different complexity (nasogastral tube insertion, NGT; intravenous cannulation, IVC) better than students trained with a traditional "see one, do one" teaching approach (TRAD), at follow-up of 3 or 6 months. Methodology and Principal Findings: 94 first-year medical students were randomly assigned to one of four groups: BPSL training or TRAD teaching with follow-up at 3 (3M) or 6 (6M) months. BPSL included structured feedback, practice on manikins, and Peyton's "Four-Step-Approach", while TRAD was only based on the "see one - do one" principle. At follow-up, manikins were used to assess students' performance by two independent blinded video-assessors using binary checklists and a single-item global assessment scale. BPSL students scored significantly higher immediately after training (NGT: BPSL3M 94.8%+/- 0.2 and BPSL6M 95.4%+/- 0.3 percentage of maximal score +/- SEM; TRAD3M 86.1%+/- 0.5 and TRAD6M 84.7%+/- 0.4. IVC: BPSL3M 86.4%+/- 0.5 and BPSL6M 88.0%+/- 0.5; TRAD3M 73.2%+/- 0.7 and TRAD6M 72.5%+/- 0.7) and lost significantly less of their performance ability at each follow-up (NGT: BPSL3M 86.3%+/- 0.3 and TRAD3M 70.3%+/- 0.6; BPSL6M 89.0%+/- 0.3 and TRAD6M 65.4%+/- 0.6; IVC: BPSL3M 79.5% +/- 0.5 and TRAD3M 56.5%+/- 0.5; BPSL6M 73.2%+/- 0.4 and TRAD6M 51.5%+/- 0.8). In addition, BPSL students were more often rated clinically competent at all assessment times. The superiority at assessment after training was higher for the more complex skill (IVC), whereas NGT with its lower complexity profited more with regard to long-term retention. Conclusions: This study shows that within a simulated setting BPSL is significantly more effective than TRAD for skills of different complexity assessed immediately after training and at follow-up. The advantages of BPSL training are seen especially in long-term retention.	[Herrmann-Werner, Anne; Keifenheim, Katharina; Zipfel, Stephan] Univ Tubingen Hosp, Dept Psychosomat Med & Psychotherapy, Tubingen, Germany; [Nikendei, Christoph] Univ Heidelberg Hosp, Dept Gen Internal Med & Psychosomat, Heidelberg, Germany; [Bosse, Hans Martin] Univ Hosp Dusseldorf, Dept Gen Paediat Neonatol & Child Cardiol, Dusseldorf, Germany; [Lund, Frederike] Univ Heidelberg Hosp, Dept Anaesthesiol, Heidelberg, Germany; [Wagner, Robert; Celebi, Nora; Weyrich, Peter] Univ Tubingen Hosp, Dept Diabet Endocrinol Angiol Nephrol & Clin Chem, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruprecht Karls University Heidelberg; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Celebi, N (corresponding author), Univ Tubingen Hosp, Dept Diabet Endocrinol Angiol Nephrol & Clin Chem, Tubingen, Germany.	nora.celebi1@gmail.com	Wagner, Robert/B-3689-2012; Bosse, Hans Martin/AAS-5652-2021; Steyaert, Tine/ABC-5521-2021	Wagner, Robert/0000-0002-6120-0191; Bosse, Hans Martin/0000-0001-7888-9434; Herrmann-Werner, Anne/0000-0003-2413-7047; Zipfel, Stephan/0000-0003-1659-4440				Ahya SN, 2012, SEMIN DIALYSIS, V25, P470, DOI 10.1111/j.1525-139X.2011.01018.x; Anderson GS, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-11; Arthur W, 1998, HUM PERFORM, V11, P57, DOI 10.1207/s15327043hup1101_3; Bandura Albert, 1977, SOCIAL LEARNING THEO; BARROWS HS, 1993, ACAD MED, V68, P443, DOI 10.1097/00001888-199306000-00002; Barsuk JH, 2009, J HOSP MED, V4, P397, DOI 10.1002/jhm.468; Boet S, 2011, BRIT J ANAESTH, V107, P533, DOI 10.1093/bja/aer160; Bonrath EM, 2012, SURGERY, V152, P12, DOI 10.1016/j.surg.2011.12.036; Bradley P, 2003, MED EDUC, V37, P6, DOI 10.1046/j.1365-2923.37.s1.11.x; Brydges R, 2012, MED EDUC, V46, P648, DOI 10.1111/j.1365-2923.2012.04268.x; COLLEGES A, 2003, ED DOCTORS HIGH PROV; Cook DA, 2008, MED EDUC, V42, P128, DOI 10.1111/j.1365-2923.2007.02974.x; Corbett E, 2004, AAMC PROJECT CLIN ED; DeCoux V M, 1990, J Nurs Educ, V29, P202; Dent JA, 2005, PRACTICAL GUIDE MED, P77; DeShazo J, 2010, DIABETES TECHNOL THE, V12, P815, DOI 10.1089/dia.2010.0030; Dewey J., 1933, WE THINK; Domuracki KJ, 2009, RESUSCITATION, V80, P346, DOI 10.1016/j.resuscitation.2008.10.036; Duran R, 2008, PEDIATR INT, V50, P644, DOI 10.1111/j.1442-200X.2008.02637.x; Ericsson KA, 2004, ACAD MED, V79, pS70, DOI 10.1097/00001888-200410001-00022; Ingram P, 2007, Nurs Stand, V22, P44; Issenberg SB, 2005, MED TEACH, V27, P10, DOI 10.1080/01421590500046924; Jiang GC, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-39; Khan K, 2011, MED TEACH, V33, P1, DOI 10.3109/0142159X.2010.519412; Knowles M. S., 1975, J CONTIN EDUC NURS; Kolb D. A, 2014, EXPERIENTIAL LEARNIN; KRAUTTER M, 2011, TEACH LEARN IN PRESS; Krautter M, 2011, TEACH LEARN MED, V23, P244, DOI 10.1080/10401334.2011.586917; Lund F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032831; Luszczynska A, 2005, J PSYCHOL, V139, P439, DOI 10.3200/JRLP.139.5.439-457; Lynagh M, 2007, MED EDUC, V41, P879, DOI 10.1111/j.1365-2923.2007.02821.x; Mahmood T, 2004, SURG ENDOSC, V18, P1224, DOI 10.1007/s00464-003-9143-4; Manthey D, 2012, CLIN TEACH, V9, P317, DOI 10.1111/j.1743-498X.2012.00561.x; McGaghie WC, 2011, SIMUL HEALTHC, V6, pS42, DOI 10.1097/SIH.0b013e318222fde9; McGaghie WC, 2011, ACAD MED, V86, P706, DOI 10.1097/ACM.0b013e318217e119; Moulton CAE, 2006, ANN SURG, V244, P400, DOI 10.1097/01.sla.0000234808.85789.6a; Nikendei C, 2007, MED TEACH, V29, P956, DOI 10.1080/01421590701601543; Nikendei C, 2007, MED TEACH, V29, P246, DOI 10.1080/01421590701299264; Nikendei C, 2005, MED TEACH, V27, P122, DOI 10.1080/01421590400019484; Perez-Ferre Natalia, 2010, Diabetes Res Clin Pract, V87, pe15, DOI 10.1016/j.diabres.2009.12.002; Peyton JWR, 1998, MANTICORE, P171; Peyton JWR, 1998, TEACHING LEARNING ME; Regehr G, 1998, ACAD MED, V73, P993, DOI 10.1097/00001888-199809000-00020; Rethans JJ, 2002, MED EDUC, V36, P901, DOI 10.1046/j.1365-2923.2002.01316.x; Ruetzler K, 2011, RESUSCITATION, V82, P593, DOI 10.1016/j.resuscitation.2011.01.008; Sandars J, 2011, MED TEACH, V33, P875, DOI 10.3109/0142159X.2011.595434; Schechter A, 2012, DIABETES TECHNOL THE, V14, P683, DOI 10.1089/dia.2012.0002; Schmidt RA, 1997, HUM FACTORS, V39, P509, DOI 10.1518/001872097778667979; SCHMIDT RA, 1992, PSYCHOL SCI, V3, P207, DOI 10.1111/j.1467-9280.1992.tb00029.x; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Smith CC, 2010, SIMUL HEALTHC, V5, P146, DOI 10.1097/SIH.0b013e3181dd9672; Smith KK, 2008, RESUSCITATION, V78, P59, DOI 10.1016/j.resuscitation.2008.02.007; Snyder CW, 2010, AM SURGEON, V76, P743; Sopka S, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-37; Stroud M, 2003, GUT, V52, P1; Supe A, 2012, J SURG EDUC, V69, P624, DOI 10.1016/j.jsurg.2012.05.002; Weyrich P, 2009, MED EDUC, V43, P113, DOI 10.1111/j.1365-2923.2008.03252.x; Williams GC, 2007, HEALTH PSYCHOL, V26, P728, DOI 10.1037/0278-6133.26.6.728; Yang CW, 2012, RESUSCITATION, V83, P1055, DOI 10.1016/j.resuscitation.2012.02.027; Ziv A, 2005, MED TEACH, V27, P193, DOI 10.1080/01421590500126718	60	64	65	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76354	10.1371/journal.pone.0076354	http://dx.doi.org/10.1371/journal.pone.0076354			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VC	24086732	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700128
J	Liu, G; Cao, P; Chen, HJ; Yuan, W; Wang, JX; Tang, XY				Liu, Gang; Cao, Peng; Chen, Huajiang; Yuan, Wen; Wang, Jianxi; Tang, Xianye			MiR-27a Regulates Apoptosis in Nucleus Pulposus Cells by Targeting PI3K	PLOS ONE			English	Article							INTERVERTEBRAL DISC DEGENERATION; GENE-EXPRESSION; DIFFERENTIATION; MICRORNAS; NETWORK; PATHWAY	The precise role of apoptosis in the pathogenesis of intervertebral disc degeneration (IDD) remains to be elucidated. We analyzed degenerative nucleus pulposus (NP) cells and found that the expression of miR-27a was increased. The overexpression of miR-27a was further verified using real-time RT-PCR. Bioinformatics target prediction identified phosphoinositide-3 kinases (PI3K) as putative targets of miR-27a. Furthermore, miR-27a inhibited PI3K expression by directly targeting their 3'-UTRs, and this inhibition was abolished by mutation of the miR-27a binding sites. Various cellular processes including cell growth, proliferation, migration and adhesion are regulated by activation of the PI3K/AKT signaling pathway, and nucleus pulposus cells are known to strongly express the phosphorylated survival protein AKT. Our results identify PI3K as a novel target of miR-27a. Upregulation of miR-27a thus targets PI3K, initiating apoptosis of nucleus pulposus cells. This present study revealed that downregulated miR-27a might develop a novel intervention for IDD treatment through the prevention of apoptosis in Nucleus pulposus Cells.	[Liu, Gang; Cao, Peng; Chen, Huajiang; Yuan, Wen; Wang, Jianxi; Tang, Xianye] Second Mil Med Univ, Changzheng Hosp, Dept Orthopaed Surg, Shanghai, Peoples R China	Naval Medical University	Chen, HJ (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Orthopaed Surg, Shanghai, Peoples R China.	spine.chen@163.com; yuanwenspine@163.com						Aguiar DJ, 1999, EXP CELL RES, V246, P129, DOI 10.1006/excr.1998.4287; Aladin DMK, 2007, SPINE, V32, P2820, DOI 10.1097/BRS.0b013e31815b75c5; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cheng CC, 2009, J CELL PHYSIOL, V221, P668, DOI 10.1002/jcp.21904; Feng J, 2009, BRIT J HAEMATOL, V145, P412, DOI 10.1111/j.1365-2141.2009.07632.x; Guehring T, 2005, SPINE, V30, P2510, DOI 10.1097/01.brs.0000186591.17114.e9; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hidaka K, 2001, INT J BIOCHEM CELL B, V33, P1094, DOI 10.1016/S1357-2725(01)00067-X; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hsieh AH, 2010, J BIOMECH, V43, P137, DOI 10.1016/j.jbiomech.2009.09.019; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Jovanovic M, 2006, ONCOGENE, V25, P6176, DOI 10.1038/sj.onc.1209912; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Rannou F, 2004, AM J PATHOL, V164, P915, DOI 10.1016/S0002-9440(10)63179-3; Reza AT, 2008, ANN BIOMED ENG, V36, P204, DOI 10.1007/s10439-007-9407-6; Risbud MV, 2005, SPINE, V30, P2503, DOI 10.1097/01.brs.0000186326.82747.13; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Solovieva S, 2006, EUR SPINE J, V15, P613, DOI 10.1007/s00586-005-0988-1; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Stokes IAF, 2004, SPINE, V29, P2724, DOI 10.1097/01.brs.0000146049.52152.da; Tschoeke SK, 2008, J ORTHOP RES, V26, P999, DOI 10.1002/jor.20601; Vonk LA, 2010, MATRIX BIOL, V29, P209, DOI 10.1016/j.matbio.2009.12.001; Waddell G, 1996, SPINE, V21, P2820, DOI 10.1097/00007632-199612150-00002; Wang DL, 2007, SPINE, V32, P2521, DOI 10.1097/BRS.0b013e318158cb61; Yang SX, 2012, ONCOL REP, V28, P1249, DOI 10.3892/or.2012.1955; Zhao CQ, 2007, APOPTOSIS, V12, P2155, DOI 10.1007/s10495-007-0137-x; Zhao XH, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-55	32	75	86	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75251	10.1371/journal.pone.0075251	http://dx.doi.org/10.1371/journal.pone.0075251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086481	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700062
J	Martinelli, F; Reagan, RL; Uratsu, SL; Phu, ML; Albrecht, U; Zhao, WX; Davis, CE; Bowman, KD; Dandekar, AM				Martinelli, Federico; Reagan, Russell L.; Uratsu, Sandra L.; Phu, My L.; Albrecht, Ute; Zhao, Weixiang; Davis, Cristina E.; Bowman, Kim D.; Dandekar, Abhaya M.			Gene Regulatory Networks Elucidating Huanglongbing Disease Mechanisms	PLOS ONE			English	Article							CANDIDATUS LIBERIBACTER-ASIATICUS; SWEET ORANGE; ARABIDOPSIS-THALIANA; METABOLOMIC DIFFERENTIATION; CITRUS-SINENSIS; INFECTED CITRUS; EXPRESSION; IDENTIFICATION; RESISTANCE; MANAGEMENT	Next-generation sequencing was exploited to gain deeper insight into the response to infection by Candidatus liberibacter asiaticus (CaLas), especially the immune disregulation and metabolic dysfunction caused by source-sink disruption. Previous fruit transcriptome data were compared with additional RNA-Seq data in three tissues: immature fruit, and young and mature leaves. Four categories of orchard trees were studied: symptomatic, asymptomatic, apparently healthy, and healthy. Principal component analysis found distinct expression patterns between immature and mature fruits and leaf samples for all four categories of trees. A predicted protein - protein interaction network identified HLB-regulated genes for sugar transporters playing key roles in the overall plant responses. Gene set and pathway enrichment analyses highlight the role of sucrose and starch metabolism in disease symptom development in all tissues. HLB-regulated genes (glucose-phosphate-transporter, invertase, starch-related genes) would likely determine the source-sink relationship disruption. In infected leaves, transcriptomic changes were observed for light reactions genes (downregulation), sucrose metabolism (upregulation), and starch biosynthesis (upregulation). In parallel, symptomatic fruits over-expressed genes involved in photosynthesis, sucrose and raffinose metabolism, and downregulated starch biosynthesis. We visualized gene networks between tissues inducing a source-sink shift. CaLas alters the hormone crosstalk, resulting in weak and ineffective tissue-specific plant immune responses necessary for bacterial clearance. Accordingly, expression of WRKYs (including WRKY70) was higher in fruits than in leaves. Systemic acquired responses were inadequately activated in young leaves, generally considered the sites where most new infections occur.	[Martinelli, Federico; Reagan, Russell L.; Uratsu, Sandra L.; Phu, My L.; Dandekar, Abhaya M.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Martinelli, Federico] Univ Palermo, Dipartimento Sistemi Agroambientali, Palermo, Italy; [Albrecht, Ute; Bowman, Kim D.] ARS, US Hort Res Lab, USDA, Ft Pierce, FL USA; [Zhao, Weixiang; Davis, Cristina E.] Univ Calif Davis, Dept Mech & Aerosp Engn, Davis, CA 95616 USA	University of California System; University of California Davis; University of Palermo; United States Department of Agriculture (USDA); University of California System; University of California Davis	Dandekar, AM (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	amdandekar@ucdavis.edu	Martinelli, Federico/F-7697-2013; Davis, Cristina E/C-4437-2008	Dandekar, Abhaya/0000-0001-7925-4086	Citrus Research and Development Foundation in Florida; Citrus Research Board of California	Citrus Research and Development Foundation in Florida; Citrus Research Board of California	This research was funded by grants obtained from the Citrus Research and Development Foundation in Florida and the Citrus Research Board of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 2008, PLANT SCI, V175, P291, DOI 10.1016/j.plantsci.2008.05.001; Albrecht U, 2012, PLANT SCI, V185, P118, DOI 10.1016/j.plantsci.2011.09.008; Albrecht U, 2011, HORTSCIENCE, V46, P16, DOI 10.21273/HORTSCI.46.1.16; ANDERS S, 2010, GENOME BIOL, V11; Boccara M, 2007, BIOCHIMIE, V89, P1252, DOI 10.1016/j.biochi.2007.04.011; Bove JM, 2006, J PLANT PATHOL, V88, P7; Cernadas RA, 2009, PLANT SCI, V177, P190, DOI 10.1016/j.plantsci.2009.05.006; Cevallos-Cevallos JM, 2012, PLANT PHYSIOL BIOCH, V53, P69, DOI 10.1016/j.plaphy.2012.01.010; Cevallos-Cevallos JM, 2011, PHYTOCHEM ANALYSIS, V22, P236, DOI 10.1002/pca.1271; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Dandekar AM, 2010, CRIT REV IMMUNOL, V30, P277, DOI 10.1615/CritRevImmunol.v30.i3.50; Donaire L, 2009, VIROLOGY, V392, P203, DOI 10.1016/j.virol.2009.07.005; Dong XN, 2004, CURR OPIN PLANT BIOL, V7, P547, DOI 10.1016/j.pbi.2004.07.005; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Fan J, 2012, MOL PLANT MICROBE IN, V25, P1396, DOI 10.1094/MPMI-06-12-0150-R; Fan J, 2011, PHYSIOL PLANTARUM, V143, P235, DOI 10.1111/j.1399-3054.2011.01502.x; Folimonova SY, 2010, PHYTOPATHOLOGY, V100, P949, DOI 10.1094/PHYTO-100-9-0949; Folimonova SY, 2009, PHYTOPATHOLOGY, V99, P1346, DOI 10.1094/PHYTO-99-12-1346; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Gmitter FG, 2012, TREE GENET GENOMES, V8, P611, DOI 10.1007/s11295-012-0499-2; Goffard N, 2007, NUCLEIC ACIDS RES, V35, pW176, DOI 10.1093/nar/gkm261; Jang JC, 1997, TRENDS PLANT SCI, V2, P208, DOI 10.1016/S1360-1385(97)01043-1; Kim JS, 2009, PHYTOPATHOLOGY, V99, P50, DOI 10.1094/PHYTO-99-1-0050; Kunz HH, 2010, PLANT BIOLOGY, V12, P115, DOI 10.1111/j.1438-8677.2010.00349.x; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Manjunath KL, 2008, PHYTOPATHOLOGY, V98, P387, DOI 10.1094/PHYTO-98-4-0387; Martinelli F, 2013, SCI HORTIC-AMSTERDAM, V159, P52, DOI 10.1016/j.scienta.2013.04.039; Martinelli F, 2012, SCI HORTIC-AMSTERDAM, V144, P201, DOI 10.1016/j.scienta.2012.07.012; Martinelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038039; Martinelli F, 2009, J EXP BOT, V60, P3873, DOI 10.1093/jxb/erp227; Minnocci A, 2010, EUR J HORTIC SCI, V75, P1; Mohr PG, 2007, FUNCT INTEGR GENOMIC, V7, P181, DOI 10.1007/s10142-006-0041-4; Nakashita H, 2003, PLANT J, V33, P887, DOI 10.1046/j.1365-313X.2003.01675.x; Natali L, 2007, J PLANT PHYSIOL, V164, P263, DOI 10.1016/j.jplph.2006.01.015; Ndamukong I, 2007, PLANT J, V50, P128, DOI 10.1111/j.1365-313X.2007.03039.x; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Ramel F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-450; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Rosales R, 2011, J PLANT GROWTH REGUL, V30, P312, DOI 10.1007/s00344-011-9193-0; Sagaram US, 2009, APPL ENVIRON MICROB, V75, P1566, DOI 10.1128/AEM.02404-08; Sechler A, 2009, PHYTOPATHOLOGY, V99, P480, DOI 10.1094/PHYTO-99-5-0480; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Slisz AM, 2012, J PROTEOME RES, V11, P4223, DOI 10.1021/pr300350x; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; Sulmon C, 2006, PLANT CELL REP, V25, P489, DOI 10.1007/s00299-005-0062-9; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tosetti R, 2012, ACTA HORTIC, V934, P1017; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tyler HL, 2009, MOL PLANT MICROBE IN, V22, P1624, DOI 10.1094/MPMI-22-12-1624; Usadel B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-535; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zheng Y, 2011, J AGR FOOD CHEM, V59, P6543, DOI 10.1021/jf2000053; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	60	89	96	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74256	10.1371/journal.pone.0074256	http://dx.doi.org/10.1371/journal.pone.0074256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086326	gold, Green Published, Green Submitted			2022-12-27	WOS:000325218700020
J	Phillips, M; Cataneo, RN; Chaturvedi, A; Kaplan, PD; Libardoni, M; Mundada, M; Patel, U; Zhang, X				Phillips, Michael; Cataneo, Renee N.; Chaturvedi, Anirudh; Kaplan, Peter D.; Libardoni, Mark; Mundada, Mayur; Patel, Urvish; Zhang, Xiang			Detection of an Extended Human Volatome with Comprehensive Two-Dimensional Gas Chromatography Time-of-Flight Mass Spectrometry	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; LUNG-CANCER; EXHALED BREATH; METABOLOME; BIOMARKERS	Background: Comprehensive two-dimensional gas chromatography coupled with time-of-flight mass spectrometry (GCxGC-TOF MS) has been proposed as a powerful new tool for multidimensional analysis of complex chemical mixtures. We investigated GCxGC-TOF MS as a new method for identifying volatile organic compounds (VOCs) in normal human breath. Methods: Samples of alveolar breath VOCs and ambient room air VOC were collected with a breath collection apparatus (BCA) onto separate sorbent traps from 34 normal healthy volunteers (mean age = 40 yr, SD = 17 yr, male/female = 19/15). VOCs were separated on two serial capillary columns separated by a cryogenic modulator, and detected with TOF MS. The first and second dimension columns were non-polar and polar respectively. Results: BCA collection combined with GCxGC-TOF MS analysis identified approximately 2000 different VOCs in samples of human breath, many of which have not been previously reported. The 50 VOCs with the highest alveolar gradients (abundance in breath minus abundance in ambient room air) mostly comprised benzene derivatives, acetone, methylated derivatives of alkanes, and isoprene. Conclusions: Collection and analysis of breath VOCs with the BCA-GCxGC-TOF MS system extended the size of the detectable human volatile metabolome, the volatome, by an order of magnitude compared to previous reports employing one-dimensional GC-MS. The size of the human volatome has been under-estimated in the past due to coelution of VOCs in one-dimensional GC analytical systems.	[Phillips, Michael; Cataneo, Renee N.; Chaturvedi, Anirudh; Kaplan, Peter D.; Mundada, Mayur; Patel, Urvish] Menssana Res Inc, Breath Res Lab, Newark, NJ 07103 USA; [Phillips, Michael] New York Med Coll, Dept Med, Valhalla, NY 10595 USA; [Libardoni, Mark] Southwest Res Inst, San Antonio, TX USA; [Zhang, Xiang] Univ Louisville, Dept Chem, Louisville, KY 40292 USA	New York Medical College; Southwest Research Institute; University of Louisville	Phillips, M (corresponding author), Menssana Res Inc, Breath Res Lab, Newark, NJ 07103 USA.	mphillips@menssanaresearch.com	Chaturvedi, Anirudh/M-1373-2016	Chaturvedi, Anirudh/0000-0001-7477-2300; Kaplan, Peter/0000-0002-2292-6862	Menssana Research, Inc.; LECO Corporation	Menssana Research, Inc.; LECO Corporation	This research was funded internally and performed by Menssana Research, Inc. The lease of the analytical system was subsidized by LECO Corporation, who had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghdassi E, 2000, FREE RADICAL BIO MED, V28, P880, DOI 10.1016/S0891-5849(00)00189-1; Amann A, 2007, MINI-REV MED CHEM, V7, P115, DOI 10.2174/138955707779802606; Amann A, 2010, J BREATH RES, V4, DOI 10.1088/1752-7155/4/1/010201; BATTEN JH, 1995, PHYTOCHEMISTRY, V39, P1351, DOI 10.1016/0031-9422(95)00126-R; Caldeira M, 2012, J CHROMATOGR A, V1254, P87, DOI 10.1016/j.chroma.2012.07.023; DAlessandro M., 2006, ASSESSING IMPORTANCE; Kim S, 2012, BIOINFORMATICS, V28, P1158, DOI 10.1093/bioinformatics/bts083; Libardoni M, 2006, J CHROMATOGR B, V842, P13, DOI 10.1016/j.jchromb.2006.05.008; Ligor M, 2009, CLIN CHEM LAB MED, V47, P550, DOI 10.1515/CCLM.2009.133; Pagonas N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046258; PAULING L, 1971, P NATL ACAD SCI USA, V68, P2374, DOI 10.1073/pnas.68.10.2374; Phillips M, 1999, J CHROMATOGR B, V729, P75, DOI 10.1016/S0378-4347(99)00127-9; Phillips M, 1997, ANAL BIOCHEM, V247, P272, DOI 10.1006/abio.1997.2069; PHILLIPS M, 1992, SCI AM, V267, P74, DOI 10.1038/scientificamerican0792-74; Phillips M, 2003, CHEST, V123, P2115, DOI 10.1378/chest.123.6.2115; PHILLIPS M, 1994, FREE RADICAL RES, V20, P333, DOI 10.3109/10715769409145633; Phillips Michael, 2007, Cancer Biomarkers, V3, P95; Phillips M, 2010, J BREATH RES, V4, DOI 10.1088/1752-7155/4/2/026003; Phillips M, 2010, TUBERCULOSIS, V90, P145, DOI 10.1016/j.tube.2010.01.003; Pierce KM, 2008, J CHROMATOGR A, V1184, P341, DOI 10.1016/j.chroma.2007.07.059; Scholler C, 1997, CHEMOSPHERE, V35, P1487, DOI 10.1016/S0045-6535(97)00209-9; Sinues PML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059909; Vautz W, 2010, J APPL PHYSIOL, V108, P697, DOI 10.1152/japplphysiol.00658.2009; Wallace L, 1996, ENVIRON HEALTH PERSP, V104, P861, DOI 10.2307/3433003; Wang B, 2010, ANAL CHEM, V82, P5069, DOI 10.1021/ac100064b; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Xu ZQ, 2013, BRIT J CANCER, V108, P941, DOI 10.1038/bjc.2013.44; Zhang J, 2011, J CHROMATOGR A, V1218, P6522, DOI 10.1016/j.chroma.2011.07.039	28	57	59	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75274	10.1371/journal.pone.0075274	http://dx.doi.org/10.1371/journal.pone.0075274			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086492	Green Submitted, Green Published, gold			2022-12-27	WOS:000325218700068
J	Tirapelle, EF; Muller-Santos, M; Tadra-Sfeir, MZ; Kadowaki, MAS; Steffens, MBR; Monteiro, RA; Souza, EM; Pedrosa, FO; Chubatsu, LS				Tirapelle, Evandro F.; Mueller-Santos, Marcelo; Tadra-Sfeir, Michelle Z.; Kadowaki, Marco A. S.; Steffens, Maria B. R.; Monteiro, Rose A.; Souza, Emanuel M.; Pedrosa, Fabio O.; Chubatsu, Leda S.			Identification of Proteins Associated with Polyhydroxybutyrate Granules from Herbaspirillum seropedicae SmR1-Old Partners, New Players	PLOS ONE			English	Article							POLYHYDROXYALKANOATE GRANULES; AZOSPIRILLUM-BRASILENSE; PSEUDOMONAS-PUTIDA; NITROGEN-FIXATION; PHB; POLY(3-HYDROXYBUTYRATE); LOCALIZATION; PHASINS; BINDING; ACCUMULATION	Herbaspirillum seropedicae is a diazotrophic beta-Proteobacterium found associated with important agricultural crops. This bacterium produces polyhydroxybutyrate (PHB), an aliphatic polyester, as a carbon storage and/or source of reducing equivalents. The PHB polymer is stored as intracellular insoluble granules coated mainly with proteins, some of which are directly involved in PHB synthesis, degradation and granule biogenesis. In this work, we have extracted the PHB granules from H. seropedicae and identified their associated-proteins by mass spectrometry. This analysis allowed us to identify the main phasin (PhaP1) coating the PHB granule as well as the PHB synthase (PhbC1) responsible for its synthesis. A phbC1 mutant is impaired in PHB synthesis, confirming its role in H. seropedicae. On the other hand, a phaP1 mutant produces PHB granules but coated mainly with the secondary phasin (PhaP2). Furthermore, some novel proteins not previously described to be involved with PHB metabolism were also identified, bringing new possibilities to PHB function in H. seropedicae.	[Tirapelle, Evandro F.; Mueller-Santos, Marcelo; Tadra-Sfeir, Michelle Z.; Kadowaki, Marco A. S.; Steffens, Maria B. R.; Monteiro, Rose A.; Souza, Emanuel M.; Pedrosa, Fabio O.; Chubatsu, Leda S.] Univ Fed Parana, Dept Bioquim & Biol Mol, BR-80060000 Curitiba, Parana, Brazil	Universidade Federal do Parana	Chubatsu, LS (corresponding author), Univ Fed Parana, Dept Bioquim & Biol Mol, BR-80060000 Curitiba, Parana, Brazil.	chubatsu@ufpr.br	Pedrosa, Fabio 0/C-1938-2013; Chubatsu, Leda S./H-2603-2012; Kadowaki, Marco/AAA-9024-2021; Müller-Santos, Marcelo/D-7272-2013	Chubatsu, Leda S./0000-0002-8687-2816; Kadowaki, Marco/0000-0003-0188-2079; Müller-Santos, Marcelo/0000-0001-9615-6007; Monteiro, Rose Adele/0000-0001-8226-0700; Muller-Santos, Marcelo/0000-0001-9524-9084	INCT - Fixacao Biologica de Nitrogenio; CNPq; CAPES; Institutos do Milenio; PRONEX; Fundacao Araucaria	INCT - Fixacao Biologica de Nitrogenio; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Institutos do Milenio; PRONEX; Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC))	This research was financially supported by INCT - Fixacao Biologica de Nitrogenio, CNPq, CAPES, Institutos do Milenio, PRONEX and Fundacao Araucaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babel W, 2001, ADV BIOCHEM ENG BIOT, V71, P125; BALDANI JI, 1986, INT J SYST BACTERIOL, V36, P86, DOI 10.1099/00207713-36-1-86; Beeby M, 2012, J BACTERIOL, V194, P1092, DOI 10.1128/JB.06125-11; BRAUNEGG G, 1978, EUR J APPL MICROBIOL, V6, P29, DOI 10.1007/BF00500854; Catalan AI, 2007, ENZYME MICROB TECH, V40, P1352, DOI 10.1016/j.enzmictec.2006.10.008; Chaves DFS, 2007, PROTEOMICS, V7, P3759, DOI 10.1002/pmic.200600859; Galan B, 2011, MOL MICROBIOL, V79, P402, DOI 10.1111/j.1365-2958.2010.07450.x; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; Grage K, 2009, BIOMACROMOLECULES, V10, P660, DOI 10.1021/bm801394s; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Gupta P, 2010, INT J BIOCHEM CELL B, V42, P683, DOI 10.1016/j.biocel.2010.01.002; Hervas AB, 2008, J BACTERIOL, V190, P416, DOI 10.1128/JB.01230-07; Huergo LF, 2010, FEMS MICROBIOL LETT, V308, P40, DOI 10.1111/j.1574-6968.2010.01986.x; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-33; Jendrossek D, 2009, J BACTERIOL, V191, P3195, DOI 10.1128/JB.01723-08; Jurasek L, 2002, BIOMACROMOLECULES, V3, P256, DOI 10.1021/bm010145d; Kadouri D, 2003, APPL ENVIRON MICROB, V69, P3244, DOI 10.1128/AEM.69.6.3244-3250.2003; Kadowaki MAS, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-230; Klint M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-81; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neumann L, 2008, J BACTERIOL, V190, P2911, DOI 10.1128/JB.01486-07; Pedersen LB, 1996, MOL MICROBIOL, V20, P295, DOI 10.1111/j.1365-2958.1996.tb02618.x; Pedrosa FO, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002064; PEDROSA FO, 1984, FEMS MICROBIOL LETT, V23, P95, DOI 10.1016/0378-1097(84)90080-6; Pfeiffer D, 2012, J BACTERIOL, V194, P5909, DOI 10.1128/JB.00779-12; Pfeiffer D, 2011, MOL MICROBIOL, V82, P936, DOI 10.1111/j.1365-2958.2011.07869.x; Poehlein A, 2011, J BACTERIOL, V193, P5017, DOI 10.1128/JB.05660-11; Potter M, 2005, BIOMACROMOLECULES, V6, P552, DOI 10.1021/bm049401n; Potter M, 2004, MICROBIOL-SGM, V150, P2301, DOI 10.1099/mic.0.26970-0; Ratcliff WC, 2008, FEMS MICROBIOL ECOL, V65, P391, DOI 10.1111/j.1574-6941.2008.00544.x; Ren Q, 2009, BIOMACROMOLECULES, V10, P916, DOI 10.1021/bm801431c; Reusch RN, 2013, INT J MOL SCI, V14, P10727, DOI 10.3390/ijms140610727; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Souza EM, 2000, MICROBIOL-UK, V146, P1407, DOI 10.1099/00221287-146-6-1407; Wang CX, 2007, J BACTERIOL, V189, P9050, DOI 10.1128/JB.01190-07	40	22	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75066	10.1371/journal.pone.0075066	http://dx.doi.org/10.1371/journal.pone.0075066			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086439	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700050
J	Barks, PM; Godin, JGJ				Barks, Patrick M.; Godin, Jean-Guy J.			Can Convict Cichlids (Amatitlania siquia) Socially Learn the Degree of Predation Risk Associated with Novel Visual Cues in Their Environment?	PLOS ONE			English	Article							MINNOWS PIMEPHALES-PROMELAS; CHEMICAL ALARM CUES; FATHEAD MINNOWS; ANTIPREDATOR BEHAVIOR; INFORMATION-TRANSFER; RECOGNITION; PREY; RESPONSES; SIZE; SPECIFICITY	For many animals, the ability to distinguish cues indicative of predation risk from cues unrelated to predation risk is not entirely innate, but rather is learned and improved with experience. Two pathways to such learning are possible. First, an animal could initially express antipredator behaviour toward a wide range of cues and subsequently learn which of those cues are non-threatening. Alternatively, it could initially express no antipredator behaviour toward a wide range of cues and subsequently learn which of them are threatening. While the learned recognition of threatening cues may occur either through personal interaction with a cue (asocial learning) or through observation of the behaviour of social companions toward a cue (social learning), the learned recognition of non-threatening cues seems to occur exclusively through habituation, a form of asocial learning. Here, we tested whether convict cichlid fish (Amatitlania siquia) can socially learn to recognize visual cues in their environment as either threatening or nonthreatening. We exposed juvenile convict cichlids simultaneously to a novel visual cue and one of three (visual) social cues: a social cue indicative of non-risk (the sight of conspecifics that had previously been habituated to the novel cue), a social cue indicative of predation risk (the sight of conspecifics trained to fear the novel cue), or a control treatment with no social cue. The subsequent response of focal fish, when presented with the novel cue alone, was not influenced by the social cue that they had previously witnessed. We therefore did not find evidence that convict cichlids in our study could use social learning to recognize novel visual cues as either threatening or non-threatening. We consider alternative explanations for our findings.	[Barks, Patrick M.; Godin, Jean-Guy J.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Barks, Patrick M.] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada	Carleton University; University of Lethbridge	Godin, JGJ (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	jgodin@carleton.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 8074-2010]; Ontario Government	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Government	This research was supported by a Discovery research grant (RGPIN 8074-2010) from the Natural Sciences and Engineering Research Council of Canada (NSERC) to J-GJG and post-graduate scholarships from NSERC and the Ontario Government to PMB. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo Jamie J., 2001, Journal of Aquariculture & Aquatic Sciences, V9, P208; Barrera JP, 2011, ANIM BEHAV, V81, P779, DOI 10.1016/j.anbehav.2011.01.010; Berger J, 2001, SCIENCE, V291, P1036, DOI 10.1126/science.1056466; Brown GE, 2006, CAN J ZOOL, V84, P1, DOI 10.1139/Z05-166; Brown GE, 2003, FISH FISH, V4, P227, DOI 10.1046/j.1467-2979.2003.00132.x; Brown GE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2712; CHIVERS DP, 1995, CAN J ZOOL, V73, P955, DOI 10.1139/z95-111; CHIVERS DP, 1994, ANIM BEHAV, V48, P597, DOI 10.1006/anbe.1994.1279; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; CSANYI V, 1985, BEHAVIOUR, V92, P227; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Deecke VB, 2002, NATURE, V420, P171, DOI 10.1038/nature01030; DILL LM, 1974, ANIM BEHAV, V22, P723, DOI 10.1016/S0003-3472(74)80023-0; Dowling LM, 2002, CAN J ZOOL, V80, P782, DOI 10.1139/Z02-036; DUGATKIN LA, 1992, ANN ZOOL FENN, V29, P233; Epp KJ, 2008, ETHOLOGY, V114, P607, DOI 10.1111/j.1439-0310.2008.01494.x; Evans JP, 2000, P NATL ACAD SCI USA, V97, P10074, DOI 10.1073/pnas.180207297; Ferrari MCO, 2008, ETHOLOGY, V114, P238, DOI 10.1111/j.1439-0310.2007.01468.x; Ferrari MCO, 2007, CHEMOECOLOGY, V17, P223, DOI 10.1007/s00049-007-0380-1; Ferrari MCO, 2006, BEHAV ECOL SOCIOBIOL, V60, P522, DOI 10.1007/s00265-006-0195-z; Ferrari MCO, 2011, ANIM COGN, V14, P309, DOI 10.1007/s10071-010-0363-4; Ferrari MCO, 2005, ANIM BEHAV, V70, P777, DOI 10.1016/j.anbehav.2005.01.009; Foam PE, 2005, BEHAVIOUR, V142, P129, DOI 10.1163/1568539053627631; Giraldeau LA, 2002, PHILOS T R SOC B, V357, P1559, DOI 10.1098/rstb.2002.1065; Godin Jean-Guy J., 1997, P191; Greenberg R.S., 1990, STUD AVIAN BIOL, V13, P431; Griffin AS, 2008, ANIM BEHAV, V75, P79, DOI 10.1016/j.anbehav.2007.04.008; Griffin AS, 2005, ANIM BEHAV, V69, P669, DOI 10.1016/j.anbehav.2004.05.020; Griffin AS, 2002, ETHOLOGY, V108, P1103, DOI 10.1046/j.1439-0310.2002.00840.x; Griffin AS, 2001, ANIM BEHAV, V62, P577, DOI 10.1006/anbe.2001.1781; Griffin AS, 2004, LEARN BEHAV, V32, P131; Hemmi JM, 2009, P R SOC B, V276, P4381, DOI 10.1098/rspb.2009.1452; KLOPFER PETER H., 1959, BEHAVIOUR, V14, P282, DOI 10.1163/156853959X00117; Krause J, 2002, LIVING GROUPS; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lima SL, 1998, ADV STUD BEHAV, V27, P215; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; MAGURRAN AE, 1988, ETHOLOGY, V78, P153; Mirza RS, 2006, BEHAVIOUR, V143, P877, DOI 10.1163/156853906778017926; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reader SM, 2001, BEHAV BRAIN SCI, V24, P353, DOI 10.1017/S0140525X01543964; RYER CH, 1991, ENVIRON BIOL FISH, V30, P317, DOI 10.1007/BF02028847; Shier DM, 2007, ANIM BEHAV, V73, P567, DOI 10.1016/j.anbehav.2006.09.009; SIH A, 1992, AM NAT, V139, P1052, DOI 10.1086/285372; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; SUBOSKI MD, 1990, J COMP PSYCHOL, V104, P101, DOI 10.1037/0735-7036.104.1.101; Veen T, 2000, P ROY SOC B-BIOL SCI, V267, P2253, DOI 10.1098/rspb.2000.1276; Vennesland RG, 2010, CAN J ZOOL, V88, P81, DOI 10.1139/Z09-118; Ward AJW, 2003, FISH FISH, V4, P348, DOI 10.1046/j.1467-2979.2003.00135.x; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wilkinson A, 2010, BIOL LETTERS, V6, P614, DOI 10.1098/rsbl.2010.0092; Wisenden BD, 1997, J CHEM ECOL, V23, P137, DOI 10.1023/B:JOEC.0000006350.66424.3d; Wisenden BD, 1997, ETHOLOGY, V103, P283; WISENDEN BD, 1994, CAN J ZOOL, V72, P2177, DOI 10.1139/z94-291; Wisenden BD, 2001, ETHOLOGY, V107, P357, DOI 10.1046/j.1439-0310.2001.00667.x; Wisenden BD, 2008, ENVIRON BIOL FISH, V81, P141, DOI 10.1007/s10641-006-9181-6; Yunker WK, 1999, J CHEM ECOL, V25, P2677, DOI 10.1023/A:1020843322518	57	2	2	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75858	10.1371/journal.pone.0075858	http://dx.doi.org/10.1371/journal.pone.0075858			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086648	Green Published, gold			2022-12-27	WOS:000325025200065
J	Chow, KT; Schulz, D; McWhirter, SM; Schlissel, MS				Chow, Kwan T.; Schulz, Danae; McWhirter, Sarah M.; Schlissel, Mark S.			Gfi1 and Gfi1b Repress Rag Transcription in Plasmacytoid Dendritic Cells In Vitro	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; FACTOR E2-2; EXPRESSION; GFI-1B; PROGENITORS; GENE; DIFFERENTIATION; HEMATOPOIESIS; REGULATOR; PU.1	Growth factor independence genes (Gfi1 and Gfi1b) repress recombination activating genes (Rag) transcription in developing B lymphocytes. Because all blood lineages originate from hematopoietic stem cells (HSCs) and different lineage progenitors have been shown to share transcription factor networks prior to cell fate commitment, we hypothesized that GFI family proteins may also play a role in repressing Rag transcription or a global lymphoid transcriptional program in other blood lineages. We tested the level of Rag transcription in various blood cells when Gfi1 and Gfi1b were deleted, and observed an upregulation of Rag expression in plasmacytoid dendritic cells (pDCs). Using microarray analysis, we observed that Gfi1 and Gfi1b do not regulate a lymphoid or pDC-specific transcriptional program. This study establishes a role for Gfi1 and Gfi1b in Rag regulation in a non-B lineage cell type.	[Chow, Kwan T.; Schulz, Danae; McWhirter, Sarah M.; Schlissel, Mark S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Schlissel, Mark S.] Brown Univ, Off Provost, Providence, RI 02912 USA	University of California System; University of California Berkeley; Brown University	Schlissel, MS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mark_schlissel@brown.edu	Chow, Kwan/AAH-6782-2019	Chow, Kwan/0000-0003-1012-0797; Schulz, Danae/0000-0002-0392-7245	NIH [RO1 HL48702, R37 AI40227]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040227] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by grants to MS from NIH (RO1 HL48702 and R37 AI40227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman D, 2006, BLOOD, V108, P4025, DOI 10.1182/blood-2006-03-007757; Borghesi L, 2004, J EXP MED, V199, P491, DOI 10.1084/jem.20031800; Borghesi L, 2004, J EXP MED, V199, P483, DOI 10.1084/jem.20031802; Brawand P, 2002, J IMMUNOL, V169, P6711, DOI 10.4049/jimmunol.169.12.6711; Cao W, 2007, PLOS BIOL, V5, P2190, DOI 10.1371/journal.pbio.0050248; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Dahl R, 2007, J BIOL CHEM, V282, P6473, DOI 10.1074/jbc.M607613200; Fiolka K, 2006, EMBO REP, V7, P326, DOI 10.1038/sj.embor.7400618; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hock H, 2006, CURR OPIN HEMATOL, V13, P1, DOI 10.1097/01.moh.0000190111.85284.8f; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Horman SR, 2009, BLOOD, V113, P5466, DOI 10.1182/blood-2008-09-179747; INABA K, 2009, CURR PROTOC IMMUNOL, V3, P32791; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Kawamoto H, 2009, TRENDS IMMUNOL, V30, P193, DOI 10.1016/j.it.2009.03.001; Khandanpour C, 2010, BLOOD, V116, P5149, DOI 10.1182/blood-2010-04-280305; KOURO T, 2005, CURR PROTOC IMMUNOL, V22, P32949; Lai AY, 2006, J EXP MED, V203, P1867, DOI 10.1084/jem.20060697; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Mak Ka Sin, 2011, Int J Cell Biol, V2011, P808524, DOI 10.1155/2011/808524; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Nagasawa M, 2008, EUR J IMMUNOL, V38, P2389, DOI 10.1002/eji.200838470; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Osawa M, 2002, BLOOD, V100, P2769, DOI 10.1182/blood-2002-01-0182; Pelayo R, 2005, BLOOD, V105, P4407, DOI 10.1182/blood-2004-07-2529; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Rathinam C, 2005, IMMUNITY, V22, P717, DOI 10.1016/j.immuni.2005.04.007; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Reizis B, 2010, CURR OPIN IMMUNOL, V22, P206, DOI 10.1016/j.coi.2010.01.005; Rock J, 2007, EUR J IMMUNOL, V37, P3564, DOI 10.1002/eji.200737711; Saleque S, 2002, GENE DEV, V16, P301, DOI 10.1101/gad.959102; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Sathe P, 2013, BLOOD, V121, P11, DOI 10.1182/blood-2012-02-413336; Schotte R, 2004, J EXP MED, V200, P1503, DOI 10.1084/jem.20041231; Schulz D, 2012, J EXP MED, V209, P187, DOI 10.1084/jem.20110645; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; SHIVDASANI RA, 2005, CURR PROTOC IMMUNOL, V22, P32953; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tong B, 1998, MOL CELL BIOL, V18, P2462, DOI 10.1128/MCB.18.5.2462; van der Meer LT, 2010, LEUKEMIA, V24, P1834, DOI 10.1038/leu.2010.195; Vassen L, 2007, BLOOD, V109, P2356, DOI 10.1182/blood-2006-06-030031; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Welner RS, 2009, J IMMUNOL, V183, P7768, DOI 10.4049/jimmunol.0902333; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Yoshida T, 2010, CURR OPIN IMMUNOL, V22, P154, DOI 10.1016/j.coi.2010.02.011; Yucel R, 2004, J BIOL CHEM, V279, P40906, DOI 10.1074/jbc.M400808200; Yucel R, 2003, J EXP MED, V197, P831, DOI 10.1084/jem.20021417; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhu JF, 2006, P NATL ACAD SCI USA, V103, P18214, DOI 10.1073/pnas.0608981103; ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024	56	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75891	10.1371/journal.pone.0075891	http://dx.doi.org/10.1371/journal.pone.0075891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086657	Green Submitted, Green Published, gold			2022-12-27	WOS:000325025200067
J	Leroy, F; Meziane, T; Riera, P; Comtet, T				Leroy, Fanny; Meziane, Tarik; Riera, Pascal; Comtet, Thierry			Seasonal Variations in Maternal Provisioning of Crepidula fornicata (Gastropoda): Fatty Acid Composition of Females, Embryos and Larvae	PLOS ONE			English	Article							INTRODUCED SUSPENSION-FEEDERS; ARBACIA-LIXULA ECHINODERMATA; SEA-URCHIN LARVAE; COD GADUS-MORHUA; PECTEN-MAXIMUS L; EGG QUALITY; BIOCHEMICAL-COMPOSITION; PHENOTYPIC PLASTICITY; REPRODUCTIVE OUTPUT; NUTRITIONAL-VALUE	Recruitment success of marine invertebrate populations not only depends on the number of recruits but also on their quality which affects their survival. In species characterized by a mixed development (encapsulated embryonic development and release of planktotrophic larvae), the offspring quality depends on both maternal provisioning and larval feeding. Here, we investigated potential changes of maternal provisioning over the whole reproductive period in a gastropod with a mixed development: Crepidula fornicata. In its introduction area, C. fornicata reproduces from February to October, which implies that both adults and larvae are exposed to different food availabilities. Maternal provisioning was assessed by measuring the fatty acid (FA) composition of females, encapsulated embryos and larvae, in February, May, July and September 2009. FA are essential resources for the development of embryos and larvae, and are key biomarkers of offspring quality. Our results showed differences in FA composition between muscles, visceral masses, and encapsulated embryos. In particular, FA composition of embryos was similar to that of the visceral mass. Seasonal variations in FA composition were observed: in the middle of the reproductive season (May and July), female tissues and embryos showed a higher proportion of polyunsaturated fatty acids and especially.3, as compared to the beginning and end of the reproductive season (February and September). This showed that through maternal provisioning the quality of C. fornicata offspring was higher in the middle of the reproductive season. Whether this would result in an increase of recruitment success and juvenile performance would require further investigations.	[Leroy, Fanny; Riera, Pascal; Comtet, Thierry] Univ Paris 06, UPMC, UMR 7144, Biol Stn, Roscoff, France; [Leroy, Fanny; Riera, Pascal; Comtet, Thierry] CNRS, Biol Stn, UMR 7144, Roscoff, France; [Meziane, Tarik] Museum Natl Hist Nat, UMR BOREA 7208, Comm Programme & Coordinat 53, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN)	Leroy, F (corresponding author), Univ Paris 06, UPMC, UMR 7144, Biol Stn, Roscoff, France.	Fanny.Leroy@obs-vlfr.fr	Meziane, Tarik/AAF-7906-2020; Comtet, Thierry/ABE-3212-2021; Meziane, Tarik/A-5465-2009	Meziane, Tarik/0000-0003-2142-6441; Meziane, Tarik/0000-0003-2142-6441	Ministere de la Recherche et de l'Enseignement Superieur; INSU [2009/10371755]	Ministere de la Recherche et de l'Enseignement Superieur; INSU(Centre National de la Recherche Scientifique (CNRS))	FL acknowledges a PhD fellowship from the Ministere de la Recherche et de l'Enseignement Superieur. This work was supported by INSU and IFREMER in the framework of the EC2CO program (project CRENULA, contract n 2009/10371755). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKMAN RG, 1968, J FISH RES BOARD CAN, V25, P1603, DOI 10.1139/f68-145; Bachan MM, 2012, MAR BIOL, V159, P2281, DOI 10.1007/s00227-012-2014-6; Bautista-Teruel MN, 2001, AQUAC RES, V32, P249, DOI 10.1046/j.1355-557x.2001.00022.x; Becker C, 2005, LIMNOL OCEANOGR, V50, P388, DOI 10.4319/lo.2005.50.1.0388; Beninger PG, 2007, MAR ECOL PROG SER, V334, P165, DOI 10.3354/meps334165; Berntsson KM, 1997, AQUACULTURE, V154, P139, DOI 10.1016/S0044-8486(97)00041-0; Bertram DF, 1998, ECOLOGY, V79, P315, DOI 10.2307/176885; Blanchard Michel, 1997, Scientia Marina, V61, P109; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brante A, 2009, J EXP BIOL, V212, P2287, DOI 10.1242/jeb.016329; Brett MT, 1997, FRESHWATER BIOL, V38, P483, DOI 10.1046/j.1365-2427.1997.00220.x; Byrne M, 2008, FUNCT ECOL, V22, P643, DOI 10.1111/j.1365-2435.2008.01427.x; Caers M, 2002, MAR BIOL, V140, P1157, DOI 10.1007/s00227-002-0798-5; Carboni S, 2012, AQUACULTURE, V324, P250, DOI 10.1016/j.aquaculture.2011.10.037; Chaparro OR, 2002, NEW ZEAL J MAR FRESH, V36, P661, DOI 10.1080/00288330.2002.9517122; Chaparro OR, 1999, J EXP MAR BIOL ECOL, V232, P261, DOI 10.1016/S0022-0981(98)00115-4; CHIPPERFIELD PNJ, 1951, J MAR BIOL ASSOC UK, V30, P49, DOI 10.1017/S0025315400012571; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Collin R, 2003, MAR ECOL PROG SER, V247, P103, DOI 10.3354/meps247103; Collin R, 2010, MAR ECOL PROG SER, V410, P89, DOI 10.3354/meps08638; Collin R, 2010, BIOL J LINN SOC, V99, P489, DOI 10.1111/j.1095-8312.2009.01388.x; Conklin E. G., 1897, Journal of Morphology Boston, Vxiii, P1; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; Decottignies P, 2007, J EXP MAR BIOL ECOL, V342, P231, DOI 10.1016/j.jembe.2006.10.005; deJongWestman M, 1995, CAN J ZOOL, V73, P2080, DOI 10.1139/z95-245; DELAUNAY F, 1993, J EXP MAR BIOL ECOL, V173, P163, DOI 10.1016/0022-0981(93)90051-O; Desvilettes C, 1997, FRESHWATER BIOL, V38, P629, DOI 10.1046/j.1365-2427.1997.00241.x; DUNSTAN GA, 1994, PHYTOCHEMISTRY, V35, P155, DOI 10.1016/S0031-9422(00)90525-9; Faleiro F, 2010, AQUACULTURE, V307, P56, DOI 10.1016/j.aquaculture.2010.07.005; GALLAGER SM, 1986, AQUACULTURE, V56, P81, DOI 10.1016/0044-8486(86)90020-7; GARDNER D, 1972, J MAR BIOL ASSOC UK, V52, P827, DOI 10.1017/S0025315400040571; Gehman ALM, 2010, J EXP MAR BIOL ECOL, V386, P86, DOI 10.1016/j.jembe.2010.01.017; GEORGE SB, 1990, J EXP MAR BIOL ECOL, V141, P107, DOI 10.1016/0022-0981(90)90217-Z; George SB, 1999, J EXP MAR BIOL ECOL, V237, P203, DOI 10.1016/S0022-0981(98)00205-6; GEORGE SB, 1990, INVERTEBR REPROD DEV, V17, P111, DOI 10.1080/07924259.1990.9672098; HELM MM, 1987, AQUACULTURE, V62, P281, DOI 10.1016/0044-8486(87)90170-0; HELM MM, 1991, J MAR BIOL ASSOC UK, V71, P691, DOI 10.1017/S0025315400053248; Hendriks IE, 2003, J EXP MAR BIOL ECOL, V296, P199, DOI 10.1016/S0022-0981(03)00323-X; HOAGLAND KE, 1979, NAUTILUS, V93, P143; HOAGLAND KE, 1986, AM MALACOL BULL, V4, P173; Ito K, 1997, MAR ECOL PROG SER, V152, P187, DOI 10.3354/meps152187; Iverson SJ, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P281, DOI 10.1007/978-0-387-89366-2_12; Jaeckle William B., 1995, P49; Jarrett JN, 2003, ECOLOGY, V84, P384, DOI 10.1890/0012-9658(2003)084[0384:SVILCA]2.0.CO;2; JORGENSEN CB, 1984, MAR ECOL PROG SER, V15, P283, DOI 10.3354/meps015283; Kach DJ, 2008, MAR BIOL, V153, P797, DOI 10.1007/s00227-007-0852-4; Kelly JR, 2008, MAR ECOL PROG SER, V373, P1, DOI 10.3354/meps07746; Labarta U, 1999, COMP BIOCHEM PHYS A, V123, P249, DOI 10.1016/S1095-6433(99)00054-9; LAING I, 1990, J MAR BIOL ASSOC UK, V70, P1, DOI 10.1017/S0025315400034147; Lanes CFC, 2012, AQUACULTURE, V324, P267, DOI 10.1016/j.aquaculture.2011.10.036; Leonardos N, 2000, AQUACULTURE, V184, P155, DOI 10.1016/S0044-8486(99)00320-8; Leroy F, 2011, THESIS U P M CURIE P; Leroy F, 2012, J SEA RES, V70, P23, DOI 10.1016/j.seares.2012.02.006; Leroy F, 2012, J MOLLUS STUD, V78, P100, DOI 10.1093/mollus/eyr044; LESSER MP, 1992, J EXP MAR BIOL ECOL, V165, P91, DOI 10.1016/0022-0981(92)90291-H; Lin H, 2007, AQUACULTURE, V264, P247, DOI 10.1016/j.aquaculture.2006.12.021; Liu H, 2007, AQUACULTURE, V264, P263, DOI 10.1016/j.aquaculture.2006.12.022; Marshall DJ, 2003, ECOLOGY, V84, P3131, DOI 10.1890/02-0311; Marshall DJ, 2008, AM NAT, V171, P214, DOI 10.1086/524954; Martin-Creuzburg D, 2009, AQUAT ECOL, V43, P943, DOI 10.1007/s10452-009-9239-6; Martinez-Pita I, 2005, J SHELLFISH RES, V24, P1209; MARTY Y, 1992, J EXP MAR BIOL ECOL, V163, P221, DOI 10.1016/0022-0981(92)90051-B; Mateos HT, 2010, FOOD CHEM, V123, P436, DOI 10.1016/j.foodchem.2010.04.062; Meziane T, 1997, J SEA RES, V38, P47, DOI 10.1016/S1385-1101(97)00035-X; Meziane T, 2002, J SEA RES, V47, P1, DOI 10.1016/S1385-1101(01)00092-2; Miloslavich P, 1996, J MOLLUS STUD, V62, P133, DOI 10.1093/mollus/62.1.133; Muller-Navarra DC, 2000, NATURE, V403, P74, DOI 10.1038/47469; Nelson MM, 2002, COMP BIOCHEM PHYS B, V131, P695, DOI 10.1016/S1096-4959(02)00042-8; Nevejan N, 2003, AQUACULTURE, V217, P613, DOI 10.1016/S0044-8486(02)00585-9; NEWELL RC, 1977, J MAR BIOL ASSOC UK, V57, P161, DOI 10.1017/S0025315400021317; Ojeda JA, 2004, MAR BIOL, V144, P263, DOI 10.1007/s00227-003-1194-5; OLSON RR, 1989, ANNU REV ECOL SYST, V20, P225; ORTON J.H., 1912, J MAR BIOL ASSOC UK, V9, P437, DOI DOI 10.1017/S0025315400048372; PANDIAN TJ, 1967, HELGOLAND WISS MEER, V16, P216, DOI 10.1007/BF01611705; PANDIAN TJ, 1970, MAR BIOL, V5, P154, DOI 10.1007/BF00352599; PANDIAN TJ, 1967, HELGOLAND WISS MEER, V16, P225, DOI 10.1007/BF01611706; PANDIAN TJ, 1969, MAR BIOL, V3, P117, DOI 10.1007/BF00353430; Patil V, 2007, AQUACULT INT, V15, P1, DOI 10.1007/s10499-006-9060-3; Pechenik JA, 2004, J EXP MAR BIOL ECOL, V306, P75, DOI 10.1016/j.jembe.2004.01.004; Pernet F, 2005, J EXP MAR BIOL ECOL, V327, P115, DOI 10.1016/j.jembe.2005.06.008; Pernet F, 2004, J EXP MAR BIOL ECOL, V310, P73, DOI 10.1016/j.jembe.2004.04.001; Pettersen AK, 2010, AQUACULTURE, V309, P115, DOI 10.1016/j.aquaculture.2010.09.024; Poorbagher H, 2010, J MAR BIOL ASSOC UK, V90, P527, DOI 10.1017/S0025315409990907; Richard J, 2006, MAR BIOL, V149, P789, DOI 10.1007/s00227-005-0157-4; RIGAL F, 2009, THESIS U P M CURIE P; Rosa R, 2005, COMP BIOCHEM PHYS B, V140, P241, DOI 10.1016/j.cbpc.2004.10.009; SCHERRER B, 1984, BIOSTATISTIQUE; Schomburg G, 1987, GASCHROMATOGRAPHIE G; Sewell MA, 2005, MAR ECOL PROG SER, V304, P133, DOI 10.3354/meps304133; Smith BL, 2007, MAR FRESHWATER RES, V58, P1002, DOI 10.1071/MF06103; Soudant P, 1996, AQUACULT INT, V4, P191, DOI 10.1007/BF00117381; Soudant P, 1998, COMP BIOCHEM PHYS A, V121, P279, DOI 10.1016/S1095-6433(98)10130-7; Soudant P, 1996, AQUACULTURE, V143, P361, DOI 10.1016/0044-8486(96)01276-8; SULLIVAN CH, 1984, BIOL BULL-US, V167, P378, DOI 10.2307/1541284; THIRIOTQUIEVREUX C, 1982, MALACOLOGIA, V23, P37; THOMPSON PA, 1993, MAR BIOL, V117, P259, DOI 10.1007/BF00345671; Torres P, 2008, ESTUAR COAST SHELF S, V80, P307, DOI 10.1016/j.ecss.2008.07.018; Tremblay R, 2007, MAR ECOL PROG SER, V340, P1, DOI 10.3354/meps340001; UNESCO, 1968, ZOOPL SAMPL, P174; Utting SD, 1997, AQUACULTURE, V155, P45, DOI 10.1016/S0044-8486(97)00108-7; Vanderploeg HA, 1996, J GREAT LAKES RES, V22, P36, DOI 10.1016/S0380-1330(96)70932-2; WALDOCK MJ, 1984, LIPIDS, V19, P332, DOI 10.1007/BF02534783; Werner B., 1955, Helgolander Wissenschaftliche Meeresuntersuchungen, V5, P169, DOI 10.1007/BF01610508; WHYTE JNC, 1991, J EXP MAR BIOL ECOL, V149, P67, DOI 10.1016/0022-0981(91)90117-F; WHYTE JNC, 1989, AQUACULTURE, V78, P333, DOI 10.1016/0044-8486(89)90110-5; WHYTE JNC, 1990, MAR BIOL, V106, P239, DOI 10.1007/BF01314806; Yanes-Roca C, 2009, AQUACULTURE, V287, P335, DOI 10.1016/j.aquaculture.2008.10.043	108	7	8	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75316	10.1371/journal.pone.0075316	http://dx.doi.org/10.1371/journal.pone.0075316			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086505	Green Submitted, gold, Green Published			2022-12-27	WOS:000325025200039
J	Shemilt, I; Hollands, GJ; Marteau, TM; Nakamura, R; Jebb, SA; Kelly, MP; Suhrcke, M; Ogilvie, D				Shemilt, Ian; Hollands, Gareth J.; Marteau, Theresa M.; Nakamura, Ryota; Jebb, Susan A.; Kelly, Michael P.; Suhrcke, Marc; Ogilvie, David			Economic Instruments for Population Diet and Physical Activity Behaviour Change: A Systematic Scoping Review	PLOS ONE			English	Review							HEALTH; POLICY; TAXES; INTERVENTIONS; DISEASE; FOOD	Background: Unhealthy diet and low levels of physical activity are common behavioural factors in the aetiology of many non-communicable diseases. Recent years have witnessed an upsurge of policy and research interest in the use of taxes and other economic instruments to improve population health. Objective: To assemble, configure and analyse empirical research studies available to inform the public health case for using economic instruments to promote dietary and physical activity behaviour change. Methods: We conducted a systematic scoping review of evidence for the effects of specific interventions to change, or general exposure to variations in, prices or income on dietary and physical activity behaviours and corollary outcomes. Systematic electronic searches and parallel snowball searches retrieved >1 million study records. Text mining technologies were used to prioritise title-abstract records for screening. Eligible studies were selected, classified and analysed in terms of key characteristics and principal findings, using a narrative, configuring synthesis focused on implications for policy and further research. Results: We identified 880 eligible studies, including 192 intervention studies and 768 studies that incorporated evidence for prices or income as correlates or determinants of target outcomes. Current evidence for the effects of economic instruments and exposures on diet and physical activity is limited in quality and equivocal in terms of its policy implications. Direct evidence for the effects of economic instruments is heavily skewed towards impacts on diet, with a relative lack of evidence for impacts on physical activity. Conclusions: The evidence-based case for using economic instruments to promote dietary and physical activity behaviour change may be less compelling than some proponents have claimed. Future research should include measurement of people's actual behavioural responses using study designs capable of generating reliable causal inferences regarding intervention effects. Policy implementation needs to be carefully aligned with evaluation planning and design.	[Shemilt, Ian; Hollands, Gareth J.; Marteau, Theresa M.; Nakamura, Ryota; Jebb, Susan A.; Kelly, Michael P.; Suhrcke, Marc; Ogilvie, David] Univ Cambridge, Behav & Hlth Res Unit, Cambridge, England	University of Cambridge	Shemilt, I (corresponding author), Univ Cambridge, Behav & Hlth Res Unit, Cambridge, England.	ian.shemilt@medschl.cam.ac.uk	Suhrcke, Marc/AAE-9024-2019	Hollands, Gareth/0000-0002-0492-3924; Suhrcke, Marc/0000-0001-7263-8626; Shemilt, Ian/0000-0003-4862-2135; Jebb, Susan/0000-0001-9190-2920; Marteau, Theresa/0000-0003-3025-1129; Ogilvie, David/0000-0002-0270-4672	UK Department of Health Policy Research Programme (Policy Research Unit in Behaviour and Health) [107/0001]; Medical Research Council [MC_UP_1001/1, MC_U105960389, MC_UU_12015/6] Funding Source: researchfish; MRC [MC_UU_12015/6, MC_UP_1001/1, MC_U105960389] Funding Source: UKRI	UK Department of Health Policy Research Programme (Policy Research Unit in Behaviour and Health); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by a grant from the UK Department of Health Policy Research Programme (107/0001-Policy Research Unit in Behaviour and Health). This support is gratefully acknowledged. The views expressed are those of the authors and not necessarily those of the UK Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyeva T, 2011, PREV MED, V52, P413, DOI 10.1016/j.ypmed.2011.03.013; Arksey Hilary., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bergman P, 2010, AM J PREV MED, V38, P171, DOI 10.1016/j.amepre.2009.09.042; Booth A, 2008, INDEPENDENT REV EF A; BRENNAN A, 2008, INDEPENDENT REV EF B, V2008; Brownson RC, 2006, ANNU REV PUBL HEALTH, V27, P341, DOI 10.1146/annurev.publhealth.27.021405.102137; Brunton G., 2012, INTRO SYSTEMATIC REV, P107; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; FAULKNER G, 2010, EC POLICY OBESITY HL; FOX MK, 2004, NUTR HLTH CHARACTERI, V1; French SA, 1997, J AM DIET ASSOC, V97, P1008, DOI 10.1016/S0002-8223(97)00242-3; French SA, 2001, AM J PUBLIC HEALTH, V91, P112, DOI 10.2105/AJPH.91.1.112; French SA, 2010, J OCCUP ENVIRON MED, V52, pS29, DOI 10.1097/JOM.0b013e3181c5c476; Gough D, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-28; GOUGH G, 2012, INTRO SYSTEMATIC REV, P257; Greenhalgh T, 2005, BRIT MED J, V331, P1064, DOI 10.1136/bmj.38636.593461.68; HAMMERSLEY M, 2002, SYSTEMATIC UNSYSTEMA; Hawkes C, 2012, NUTR BULL, V37, P51, DOI 10.1111/j.1467-3010.2011.01949.x; HERBST CM, 2009, CHILD CARE SUBSIDIES; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; HM Government, 2011, HLTH LIV HLTH PEOPL; HM Government, 2012, GOV ALC STRAT; HOLLANDS GJ, AM J PUBLIC HL UNPUB; *INT AG RES CANC, 2012, IARC HDB CANC PREV T, V14; Kahneman D., 2011, THINKING FAST SLOW; Kelly MP, 2011, RES SOCIAL WORK PRAC, V21, P644, DOI 10.1177/1049731511405070; Lachapelle U, 2009, J PUBLIC HEALTH POL, V30, pS73, DOI 10.1057/jphp.2008.52; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; LEVI J, 2010, F FAT OBESITY THREAT, P121; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lucove JC, 2007, AM J HEALTH PROMOT, V21, P196, DOI 10.4278/0890-1171-21.3.196; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; MADORE O, 2007, IMPACT EC INSTRUMENT; Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918; Marteau TM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d228; Matson-Koffman DM, 2005, AM J HEALTH PROMOT, V19, P167, DOI 10.4278/0890-1171-19.3.167; MCINNES MM, 2009, PHYS ACTIVITY EC POL; *MED RES COUNC, 2011, US NAT EXP EV POP HL; Mellor JM, 2011, HEALTH ECON, V20, P417, DOI 10.1002/hec.1598; MEYERS A, 1995, ARCH PEDIAT ADOL MED, V149, P1079, DOI 10.1001/archpedi.1995.02170230033004; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; Rashad I., 2006, E ECON J, V32, P133; RICE N, 2008, SYSTEMATIC REV EFFEC; Secretariat of the WHO Framework Convention on Tobacco Control, 2019, INF NOT CLASS NOV EM; SHEMILT I, EFFECTS CHANGES EC E, P201; SHEMILT I, RES SYN MET IN PRESS; Spence JC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-356; THOMAS J, 2010, EPPI REV P 4 0 SOFTW; Thomas J., 2012, INTRO SYSTEMATIC REV, P35; Thomas J, 2011, RES SYNTH METHODS, V2, P1, DOI 10.1002/jrsm.27; Thomas S, 2008, TOB CONTROL, V17, DOI 10.1136/tc.2007.023911; *TRANSP LOND, 2008, 6 TRANSP LOND; *UN, 2011, POL DECL HI IN PRESS, P13; von Tigerstrom Barbara, 2011, Am J Public Health, V101, pe10, DOI 10.2105/AJPH.2011.300201; Wallace BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-55; WHO, 2011, GLOB STAT REP NONC D; World Health Organization, 2012, WORLD HLTH STAT 2012	61	31	31	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75070	10.1371/journal.pone.0075070	http://dx.doi.org/10.1371/journal.pone.0075070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	226HG	24086440	gold, Green Published, Green Submitted			2022-12-27	WOS:000325025200022
J	Zarelli, VE; Dawid, IB				Zarelli, Valeria E.; Dawid, Igor B.			The BTB-Containing Protein Kctd15 Is SUMOylated In Vivo	PLOS ONE			English	Article							TRANSCRIPTION FACTOR AP-2; NEURAL CREST FORMATION; SUMO MODIFICATION; MOTIF; REPRESSION; MODIFIER; GENE; PHOSPHORYLATION; DIFFERENTIATION; DESUMOYLATION	Potassium Channel Tetramerization Domain containing 15 (Kctd15) has a role in regulating the neural crest (NC) domain in the embryo. Kctd15 inhibits NC induction by antagonizing Wnt signaling and by interaction with the transcription factor AP2a activation domain blocking its activity. Here we demonstrate that Kctd15 is SUMOylated by SUMO1 and SUMO2/3. Kctd15 contains a classical SUMO interacting motif, psi KxE, at the C-terminal end, and variants of the motif within the molecule. Kctd15 SUMOylation occurs exclusively in the C-terminal motif. Inability to be SUMOylated did not affect Kctd15's subcellular localization, or its ability to repress AP-2 transcriptional activity and to inhibit NC formation in zebrafish embryos. In contrast, a fusion of Kctd15 and SUMO had little effectiveness in AP-2 inhibition and in blocking of NC formation. These data suggest that the non-SUMOylated form of Kctd15 functions in NC development.	[Zarelli, Valeria E.; Dawid, Igor B.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dawid, IB (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD USA.	idawid@nih.gov			Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008809] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JW, 2009, BIOCHEM BIOPH RES CO, V379, P160, DOI 10.1016/j.bbrc.2008.12.043; Anckar J, 2007, BIOCHEM SOC T, V35, P1409, DOI 10.1042/BST0351409; Bayon Y, 2008, FEBS J, V275, P3900, DOI 10.1111/j.1742-4658.2008.06537.x; Belaguli NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048019; Berlato C, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2838; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Chang TH, 2012, J IMMUNOL, V189, P3548, DOI 10.4049/jimmunol.1201104; Correale S, 2011, BIOCHIMIE, V93, P715, DOI 10.1016/j.biochi.2010.12.014; Cubenas-Potts C, 2013, DEV CELL, V24, P1, DOI 10.1016/j.devcel.2012.11.020; Ding XF, 2009, J CELL BIOCHEM, V106, P285, DOI 10.1002/jcb.22002; Dutta S, 2010, DEVELOPMENT, V137, P3013, DOI 10.1242/dev.047548; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Eloranta JJ, 2002, J BIOL CHEM, V277, P30798, DOI 10.1074/jbc.M202780200; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Garee JP, 2011, BIOCHEM BIOPH RES CO, V408, P516, DOI 10.1016/j.bbrc.2011.04.040; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Holt EH, 2001, BIOCHEM BIOPH RES CO, V288, P752, DOI 10.1006/bbrc.2001.5846; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; Jian Ouyang, 2009, V497, P141, DOI 10.1007/978-1-59745-566-4_9; Jiang MS, 2000, P NATL ACAD SCI USA, V97, P12519, DOI 10.1073/pnas.220426097; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Lee CD, 2008, PROTEIN SCI, V17, P1241, DOI 10.1110/ps.035188.108; Li W, 2007, DEV BIOL, V304, P338, DOI 10.1016/j.ydbio.2006.12.042; Lomeli H, 2011, CELL MOL LIFE SCI, V68, P4045, DOI 10.1007/s00018-011-0792-5; Luo T, 2003, P NATL ACAD SCI USA, V100, P532, DOI 10.1073/pnas.0237226100; Meng XN, 2010, BIOCHEM BIOPH RES CO, V392, P526, DOI 10.1016/j.bbrc.2010.01.056; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Perdomo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050637; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rouviere JO, 2013, CHROMOSOMA; Skoblov M, 2013, BIOESSAYS, V35, P586, DOI 10.1002/bies.201300002; Snow JW, 2010, J BIOL CHEM, V285, P28064, DOI 10.1074/jbc.M109.096909; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; TOYAMA R, 1995, DEVELOPMENT, V121, P383; Van Rechem C, 2010, MOL CELL BIOL, V30, P4045, DOI 10.1128/MCB.00582-09; Wang YG, 2009, J CELL SCI, V122, P4249, DOI 10.1242/jcs.050542; Wei WZ, 2008, BIOCHEM BIOPH RES CO, V375, P454, DOI 10.1016/j.bbrc.2008.08.028; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Williams MJ, 2012, CELL MOL LIFE SCI, V69, P3819, DOI 10.1007/s00018-012-1022-5; Wilson VG, 2005, SCI STKE, V2005, ppe32; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; Yu LY, 2010, J EXP MED, V207, P1183, DOI 10.1084/jem.20092215; Zarelli VE, 2013, P NATL ACAD SCI USA, V110, P2870, DOI 10.1073/pnas.1300203110	57	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75016	10.1371/journal.pone.0075016	http://dx.doi.org/10.1371/journal.pone.0075016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086424	Green Submitted, Green Published, gold			2022-12-27	WOS:000325025200019
J	Brozovic, A; Vukovic, L; Polancac, DS; Arany, I; Koberle, B; Fritz, G; Fiket, Z; Majhen, D; Ambriovic-Ristov, A; Osmak, M				Brozovic, Anamaria; Vukovic, Lidija; Polancac, Darija Stupin; Arany, Istvan; Koeberle, Beate; Fritz, Gerhard; Fiket, Zeljka; Majhen, Dragomira; Ambriovic-Ristov, Andreja; Osmak, Maja			Endoplasmic Reticulum Stress Is Involved in the Response of Human Laryngeal Carcinoma Cells to Carboplatin but Is Absent in Carboplatin-Resistant Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; CANCER-CELLS; CELLULAR PHARMACOLOGY; CISPLATIN RESISTANCE; MEDIATED APOPTOSIS; DRUG-RESISTANCE; DNA-ADDUCTS; COPPER; INHIBITION; ACCUMULATION	The major obstacle of successful tumor treatment with carboplatin (CBP) is the development of drug resistance. In the present study, we found that following treatment with CBP the amount of platinum which enters the human laryngeal carcinoma (HEp2)-derived CBP-resistant (7T) cells is reduced relative to the parental HEp2. As a consequence, the formation of reactive oxidative species (ROS) is reduced, the induction of endoplasmic reticulum (ER) stress is diminished, the amount of inter-and intrastrand cross-links is lower, and the induction of apoptosis is depressed. In HEp2 cells, ROS scavenger tempol, inhibitor of ER stress salubrinal, as well as gene silencing of ER stress marker CCAAT/enhancer-binding protein (CHOP) increases their survival and renders them as resistant to CBP as 7T cell subline but did not influence the survival of 7T cells. Our results suggest that in HEp2 cells CBP-induced ROS is a stimulus for ER stress. To the contrary, despite the ability of CBP to induce formation of ROS and activate ER stress in 7T cells, the cell death mechanism in 7T cells is independent of ROS induction and activation of ER stress. The novel signaling pathway of CBP-driven toxicity that was found in the HEp2 cell line, i.e. increased ROS formation and induction of ER stress, may be predictive for therapeutic response of epithelial cancer cells to CBP-based therapy.	[Brozovic, Anamaria; Vukovic, Lidija; Majhen, Dragomira; Ambriovic-Ristov, Andreja; Osmak, Maja] Rudjer Boskovic Inst, Div Mol Biol, Zagreb, Croatia; [Polancac, Darija Stupin] Galapagos Res Ctr Ltd, Zagreb, Croatia; [Arany, Istvan] Univ Mississippi, Med Ctr, Dept Pediat, Jackson, MS 39216 USA; [Koeberle, Beate] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Toxicol, D-55122 Mainz, Germany; [Fritz, Gerhard] Univ Dusseldorf, Inst Toxicol, Dusseldorf, Germany; [Fiket, Zeljka] Rudjer Boskovic Inst, Div Marine & Environm Res, Zagreb, Croatia	Rudjer Boskovic Institute; University of Mississippi; University of Mississippi Medical Center; Johannes Gutenberg University of Mainz; Heinrich Heine University Dusseldorf; Rudjer Boskovic Institute	Brozovic, A (corresponding author), Rudjer Boskovic Inst, Div Mol Biol, Zagreb, Croatia.	Brozovic@lrb.Hr	Fiket, Zeljka/J-4985-2019; Brozovic, Anamaria/D-5270-2016	Fiket, Zeljka/0000-0002-7628-9045; Brozovic, Anamaria/0000-0002-6820-2173; Majhen, Dragomira/0000-0003-0385-0900	Ministry of Science, Education and Sport of the Republic of Croatia [098-0982913-2748, 098-0982913-2850, 098-0982934-2715]; Deutsche Forschungsgemeinschaft [DFG-KO 1732/1-1]; Deutscher Akademischer Austauschdienst of the Federal Republic of Germany [DAAD D07/00066]	Ministry of Science, Education and Sport of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst of the Federal Republic of Germany	This study was supported by funds of the Ministry of Science, Education and Sport of the Republic of Croatia (Projects No. 098-0982913-2748, No. 098-0982913-2850, and No. 098-0982934-2715) and by funds of Deutsche Forschungsgemeinschaft (DFG-KO 1732/1-1) and Deutscher Akademischer Austauschdienst (DAAD D07/00066) of the Federal Republic of Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhutani Manisha, 2006, Indian J Chest Dis Allied Sci, V48, P49; BLOMMAERT FA, 1995, BIOCHEMISTRY-US, V34, P8474, DOI 10.1021/bi00026a031; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brozovic A, 2004, INT J CANCER, V112, P974, DOI 10.1002/ijc.20522; Brozovic A, 2008, MOL PHARMACOL, V74, P298, DOI 10.1124/mol.107.043836; Brozovic A, 2010, CRIT REV TOXICOL, V40, P347, DOI 10.3109/10408441003601836; Brozovic A, 2009, MUTAT RES-FUND MOL M, V670, P32, DOI 10.1016/j.mrfmmm.2009.07.002; Carozzi VA, 2010, CURR CANCER DRUG TAR, V10, P670; Cheng CF, 2008, APOPTOSIS, V13, P883, DOI 10.1007/s10495-008-0214-9; Di Felice V, 1998, INT J ONCOL, V13, P225; England K, 2006, FREE RADICAL RES, V40, P1124, DOI 10.1080/10715760600838209; FICHTINGERSCHEPMAN AMJ, 1995, CARCINOGENESIS, V16, P2447, DOI 10.1093/carcin/16.10.2447; Gallerne C, 2013, BBA-MOL CELL RES, V1833, P1356, DOI 10.1016/j.bbamcr.2013.02.014; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Gregersen N, 2010, METHODS MOL BIOL, V648, P3, DOI 10.1007/978-1-60761-756-3_1; Hall MD, 2008, ANNU REV PHARMACOL, V48, P495, DOI 10.1146/annurev.pharmtox.48.080907.180426; Heffeter P, 2008, DRUG RESIST UPDATE, V11, P1, DOI 10.1016/j.drup.2008.02.002; Herraiz C, 2011, MOL ENDOCRINOL, V25, P138, DOI 10.1210/me.2010-0217; Hiss DC, 2009, EXPERT OPIN DRUG DIS, V4, P799, DOI 10.1517/17460440903052559; Holzer AK, 2006, MOL PHARMACOL, V70, P1390, DOI 10.1124/mol.106.022624; Husain K, 2003, INT J TOXICOL, V22, P335, DOI 10.1080/10915810390233357; Husain K, 2001, HEARING RES, V159, P14, DOI 10.1016/S0378-5955(01)00306-9; Katano K, 2002, CANCER RES, V62, P6559; Katano K, 2003, MOL PHARMACOL, V64, P466, DOI 10.1124/mol.64.2.466; Kloft C, 1999, THER DRUG MONIT, V21, P631, DOI 10.1097/00007691-199912000-00009; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Kubicek GJ, 2011, AM J CLIN ONCOL-CANC, V34, P380, DOI 10.1097/COC.0b013e3181e9c0a2; Liedert B, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl051; Liu H, 2005, J AM SOC NEPHROL, V16, P1985, DOI 10.1681/ASN.2004090768; Mahajan KN, 2002, MOL CELL BIOL, V22, P5194, DOI 10.1128/MCB.22.14.5194-5202.2002; Mandic A, 2003, J BIOL CHEM, V278, P9100, DOI 10.1074/jbc.M210284200; Materna V, 2005, INT J CANCER, V115, P393, DOI 10.1002/ijc.20899; MICKISCH G, 1990, UROL RES, V18, P131, DOI 10.1007/BF00302474; Moon IJ, 2011, CLIN EXP OTORHINOLAR, V4, P11, DOI 10.3342/ceo.2011.4.1.11; OSMAK M, 1995, MUTAT RES LETT, V347, P141, DOI 10.1016/0165-7992(95)00033-X; Park GB, 2010, J IMMUNOL, V185, P7274, DOI 10.4049/jimmunol.1001547; Pectasides D, 2007, CANCER TREAT REV, V33, P177, DOI 10.1016/j.ctrv.2006.10.007; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Reed E, 2010, CLIN CANCER RES, V16, P4511, DOI 10.1158/1078-0432.CCR-10-0528; Roos WP, 2012, CANC LETT; Safaei R, 2006, CANCER LETT, V234, P34, DOI 10.1016/j.canlet.2005.07.046; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Samimi G, 2004, CLIN CANCER RES, V10, P4661, DOI 10.1158/1078-0432.CCR-04-0137; Schonthal Axel H, 2012, Front Biosci (Schol Ed), V4, P412; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Stewart DJ, 2007, CRIT REV ONCOL HEMAT, V63, P12, DOI 10.1016/j.critrevonc.2007.02.001; Sue YM, 2011, BRIT J PHARMACOL, V162, P1716, DOI 10.1111/j.1476-5381.2010.01189.x; Todd RC, 2009, METALLOMICS, V1, P280, DOI 10.1039/b907567d; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Yu F, 2008, AM J PHYSIOL-RENAL, V295, pF44, DOI 10.1152/ajprenal.00593.2007; ZWELLING LA, 1979, CANCER TREAT REP, V63, P1439	51	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e76397	10.1371/journal.pone.0076397	http://dx.doi.org/10.1371/journal.pone.0076397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086737	Green Submitted, Green Published, gold			2022-12-27	WOS:000326520200135
J	Ellison, ML; Farrow, JM; Parrish, W; Danell, AS; Pesci, EC				Ellison, Matthew L.; Farrow, John Matthew; Parrish, Whitney; Danell, Allison S.; Pesci, Everett C.			The Transcriptional Regulator Np20 Is the Zinc Uptake Regulator in Pseudomonas aeruginosa	PLOS ONE			English	Article							ESCHERICHIA-COLI; UPTAKE SYSTEM; MYCOBACTERIUM-TUBERCULOSIS; XANTHOMONAS-CAMPESTRIS; CAENORHABDITIS-ELEGANS; SALMONELLA-ENTERICA; YERSINIA-PESTIS; IN-VITRO; ZUR; VIRULENCE	Zinc is essential for all bacteria, but excess amounts of the metal can have toxic effects. To address this, bacteria have developed tightly regulated zinc uptake systems, such as the ZnuABC zinc transporter which is regulated by the Fur-like zinc uptake regulator (Zur). In Pseudomonas aeruginosa, a Zur protein has yet to be identified experimentally, however, sequence alignment revealed that the zinc-responsive transcriptional regulator Np20, encoded by np20 (PA5499), shares high sequence identity with Zur found in other bacteria. In this study, we set out to determine whether Np20 was functioning as Zur in P. aeruginosa. Using RT-PCR, we determined that np20 (hereafter known as zur) formed a polycistronic operon with znuC and znuB. Mutant strains, lacking the putative znuA, znuB, or znuC genes were found to grow poorly in zinc deplete conditions as compared to wild-type strain PAO1. Intracellular zinc concentrations in strain PAO-Zur (Delta zur) were found to be higher than those for strain PAO1, further implicating the zur as the zinc uptake regulator. Reporter gene fusions and real time RT-PCR revealed that transcription of znuA was repressed in a zinc-dependent manner in strain PAO1, however zinc-dependent transcriptional repression was alleviated in strain PAO-Zur, suggesting that the P. aeruginosa Zur homolog (ZurPA) directly regulates expression of znuA. Electrophoretic mobility shift assays also revealed that recombinant ZurPA specifically binds to the promoter region of znuA and does not bind in the presence of the zinc chelator N,N',N-tetrakis(2-pyridylmethyl) ethylenediamine (TPEN). Taken together, these data support the notion that Np20 is the P. aeruginosa Zur, which regulates the transcription of the genes encoding the high affinity ZnuABC zinc transport system.	[Ellison, Matthew L.; Farrow, John Matthew; Pesci, Everett C.] E Carolina Univ, Dept Microbiol & Immunol, Greenville, NC 27858 USA; [Ellison, Matthew L.] Morehead State Univ, Dept Biol & Chem, Morehead, KY 40351 USA; [Parrish, Whitney; Danell, Allison S.] E Carolina Univ, Dept Chem, Greenville, NC 27858 USA	University of North Carolina; East Carolina University; Morehead State University; University of North Carolina; East Carolina University	Ellison, ML (corresponding author), E Carolina Univ, Dept Microbiol & Immunol, Greenville, NC 27858 USA.	M.Ellison@moreheadstate.edu		Pesci, Everett/0000-0002-7490-7591; Farrow, John/0000-0003-1619-2388	National Institute of Allergy and Infectious Disease [AI076272]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI076272, R01AI076272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103436] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a research grant from the National Institute of Allergy and Infectious Disease to ECP (grant AI076272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammendola S, 2007, INFECT IMMUN, V75, P5867, DOI 10.1128/IAI.00559-07; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; [Anonymous], 2010, HDB MICROBIOLOGICAL, DOI DOI 10.1201/EBK1439804063; Blaby-Haas CE, 2011, MOL MICROBIOL, V79, P700, DOI 10.1111/j.1365-2958.2010.07475.x; BRAY TM, 1990, FREE RADICAL BIO MED, V8, P281, DOI 10.1016/0891-5849(90)90076-U; Bremer H, 1996, ESCHERICHIA COLI SAL; Campoy S, 2002, INFECT IMMUN, V70, P4721, DOI 10.1128/IAI.70.8.4721-4725.2002; Cao H, 2001, ANNU REV PHYTOPATHOL, V39, P259, DOI 10.1146/annurev.phyto.39.1.259; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; COUDRAY C, 1993, BIOL TRACE ELEM RES, V38, P273, DOI 10.1007/BF02785311; Davis LM, 2009, J BACTERIOL, V191, P1631, DOI 10.1128/JB.01394-08; Desrosiers DC, 2010, INFECT IMMUN, V78, P5163, DOI 10.1128/IAI.00732-10; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Farrow JM, 2008, J BACTERIOL, V190, P7043, DOI 10.1128/JB.00753-08; Gabriel SE, 2008, J BACTERIOL, V190, P3482, DOI 10.1128/JB.01978-07; Gabriel SE, 2009, J BACTERIOL, V191, P6116, DOI 10.1128/JB.00802-09; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Hassan MET, 1999, GENE, V238, P417, DOI 10.1016/S0378-1119(99)00349-2; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Huang DL, 2008, NUCLEIC ACIDS RES, V36, P4295, DOI 10.1093/nar/gkn328; Huang DL, 2009, MOL PLANT MICROBE IN, V22, P321, DOI 10.1094/MPMI-22-3-0321; Kallifidas D, 2010, J BACTERIOL, V192, P608, DOI 10.1128/JB.01022-09; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Kim S, 2004, J VET MED SCI, V66, P1059, DOI 10.1292/jvms.66.1059; Knoten CA, 2011, J BACTERIOL, V193, P6567, DOI 10.1128/JB.05803-11; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Lewinson O, 2009, P NATL ACAD SCI USA, V106, P4677, DOI 10.1073/pnas.0900666106; Lewis DA, 1999, INFECT IMMUN, V67, P5060, DOI 10.1128/IAI.67.10.5060-5068.1999; Li YL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-128; Lucarelli D, 2007, J BIOL CHEM, V282, P9914, DOI 10.1074/jbc.M609974200; Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Makarova K.S., 2001, GENOME BIOL, V2; McDevitt CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002357; Mellies JL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-123; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Outten CE, 2001, BIOCHEMISTRY-US, V40, P10417, DOI 10.1021/bi0155448; Panina EM, 2003, P NATL ACAD SCI USA, V100, P9912, DOI 10.1073/pnas.1733691100; Patzer SI, 1998, MOL MICROBIOL, V28, P1199, DOI 10.1046/j.1365-2958.1998.00883.x; Petrarca P, 2010, J BACTERIOL, V192, P1553, DOI 10.1128/JB.01310-09; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rahme LG, 1997, P NATL ACAD SCI USA, V94, P13245, DOI 10.1073/pnas.94.24.13245; Sabri M, 2009, INFECT IMMUN, V77, P1155, DOI 10.1128/IAI.01082-08; Sambrook J., 2001, MOL CLONGING LAB MAN, V3rd ed.; Shin JH, 2011, P NATL ACAD SCI USA, V108, P5045, DOI 10.1073/pnas.1017744108; Silver S, 1996, GENE, V179, P9, DOI 10.1016/S0378-1119(96)00323-X; Smith KF, 2009, J BACTERIOL, V191, P1595, DOI 10.1128/JB.01392-08; Stork M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000969; Weston BF, 2009, INFECT IMMUN, V77, P2840, DOI 10.1128/IAI.01299-08; Yamamoto K, 2005, J BACTERIOL, V187, P6333, DOI 10.1128/JB.187.18.6333-6340.2005	53	37	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75389	10.1371/journal.pone.0075389	http://dx.doi.org/10.1371/journal.pone.0075389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086521	Green Published, gold			2022-12-27	WOS:000326520200099
J	Ghosh, M; van den Akker, NMS; Wijnands, KAP; Poeze, M; Weber, C; McQuade, LE; Pluth, MD; Lippard, SJ; Post, MJ; Molin, DGM; van Zandvoort, MAMJ				Ghosh, Mitrajit; van den Akker, Nynke M. S.; Wijnands, Karolina A. P.; Poeze, Martijn; Weber, Christian; McQuade, Lindsey E.; Pluth, Michael D.; Lippard, Stephen J.; Post, Mark J.; Molin, Daniel G. M.; van Zandvoort, Marc A. M. J.			Specific Visualization of Nitric Oxide in the Vasculature with Two-Photon Microscopy Using a Copper Based Fluorescent Probe	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; IN-VITRO; SYNTHASE; ARTERIES; CELLS; FLOW	To study the role and (sub) cellular nitric oxide (NO) constitution in various disease processes, its direct and specific detection in living cells and tissues is a major requirement. Several methods are available to measure the oxidation products of NO, but the detection of NO itself has proved challenging. We visualized NO production using a NO-sensitive copper-based fluorescent probe (Cu (2)FL2E) and two-photon laser scanning microscopy (TPLSM). Cu (2)FL2E demonstrated high sensitivity and specificity for NO synthesis, combined with low cytotoxicity. Furthermore, Cu (2)FL2E showed superior sensitivity over the conventionally used Griess assay. NO specificity of Cu (2)FL2E was confirmed in vitro in human coronary arterial endothelial cells and porcine aortic endothelial cells using various triggers for NO production. Using TPLSM on ex vivo mounted murine carotid artery and aorta, the applicability of the probe to image NO production in both endothelial cells and smooth muscle cells was shown. NO-production and time course was detected for multiple stimuli such as flow, acetylcholine and hydrogen peroxide and its correlation with vasodilation was demonstrated. NO-specific fluorescence and vasodilation was abrogated in the presence of NO-synthesis blocker L-NAME. Finally, the influence of carotid precontraction and vasorelaxation validated the functional properties of vessels. Specific visualization of NO production in vessels with Cu (2)FL2E-TPLSM provides a valid method for studying spatial-temporal synthesis of NO in vascular biology at an unprecedented level. This approach enables investigation of the pathways involved in the complex interplay between NO and vascular (dys) function.	[Ghosh, Mitrajit; van Zandvoort, Marc A. M. J.] Maastricht Univ, Dept Genet & Cell Biol Mol Biol, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [van den Akker, Nynke M. S.; Post, Mark J.; Molin, Daniel G. M.] Maastricht Univ, Dept Physiol, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Weber, Christian] Maastricht Univ, Dept Pathol, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Wijnands, Karolina A. P.; Poeze, Martijn] Maastricht Univ, Dept Surg, Nutr & Toxicol Res Inst Maastricht NUTRIM, Maastricht, Netherlands; [Ghosh, Mitrajit; van Zandvoort, Marc A. M. J.] Rhein Westfal TH Aachen, Inst Mol Cardiovasc Res IMCAR, Aachen, Germany; [van den Akker, Nynke M. S.] Univ Munster, Fak Med, Dept Cardiol & Angiol, D-48149 Munster, Germany; [Weber, Christian] Univ Munich, Inst Cardiovasc Prevent, Munich, Germany; [McQuade, Lindsey E.; Pluth, Michael D.; Lippard, Stephen J.] MIT, Dept Chem, Cambridge, MA 02139 USA	Maastricht University; Maastricht University; Maastricht University; Maastricht University; RWTH Aachen University; University of Munster; University of Munich; Massachusetts Institute of Technology (MIT)	Ghosh, M (corresponding author), Maastricht Univ, Dept Genet & Cell Biol Mol Biol, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands.	mitrajit.ghosh@maastrichtuniversity.nl	Weber, Christian/AAW-2153-2020; Pluth, Michael/A-7222-2012	Weber, Christian/0000-0003-4610-8714; Pluth, Michael/0000-0003-3604-653X	DFG (German Scientific Organization) [EuCAR GRK 1508/1]; NWO (Dutch Scientific Organization); STW/NWO smartmix for TeRM; Interreg Euregio Meuse-Rhine IVa grant BioMIMedics; Interreg IVa Flanders-The Netherlands grant VaRiA; medical section of NWO [902-16-276]; National Science Foundation [CHE-0907905]; National Institute of Health [K99GM092970]; Direct For Mathematical & Physical Scien [1265770, 0907905] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM092970] Funding Source: NIH RePORTER	DFG (German Scientific Organization)(German Research Foundation (DFG)); NWO (Dutch Scientific Organization)(Netherlands Organization for Scientific Research (NWO)); STW/NWO smartmix for TeRM; Interreg Euregio Meuse-Rhine IVa grant BioMIMedics; Interreg IVa Flanders-The Netherlands grant VaRiA; medical section of NWO; National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the DFG (German Scientific Organization) Grant for EuCAR GRK 1508/1 to IMCAR and by NWO (Dutch Scientific Organization) to CARIM, grant for MJP from STW/NWO smartmix for TeRM and for DGMM is supported by the Interreg Euregio Meuse-Rhine IVa grant BioMIMedics. NMSvdA and DGMM are support by the Interreg IVa Flanders-The Netherlands grant VaRiA. The Leica TPLSM was obtained via a grant (No. 902-16-276) from the medical section of NWO. This research was performed within the Vital Imaging Unit CARIM. Work at MIT is supported by the National Science Foundation (grant CHE-0907905 to SJL) and the National Institute of Health (grant K99GM092970 to MDP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boo YC, 2003, AM J PHYSIOL-CELL PH, V285, pC499, DOI 10.1152/ajpcell.00122.2003; Buchwalow IB, 2002, FASEB J, V16, P500, DOI 10.1096/fj.01-0842com; Cai H, 2002, J BIOL CHEM, V277, P48311, DOI 10.1074/jbc.M208884200; Carrillo A, 2002, VET IMMUNOL IMMUNOP, V89, P91, DOI 10.1016/S0165-2427(02)00170-8; FEELISCH M, 1991, J CARDIOVASC PHARM, V17, pS25, DOI 10.1097/00005344-199117003-00006; Hong H, 2009, FREE RADICAL BIO MED, V47, P684, DOI 10.1016/j.freeradbiomed.2009.06.011; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; JAY BF, 1979, ANAL CHEM, V51, P1493, DOI DOI 10.1021/AC50045A032; Lim MH, 2006, NAT CHEM BIOL, V2, P375, DOI 10.1038/nchembio794; Lu X, 2004, J PHYSIOL-LONDON, V561, P575, DOI 10.1113/jphysiol.2004.075218; McQuade LE, 2010, P NATL ACAD SCI USA, V107, P8525, DOI 10.1073/pnas.0914794107; Megens RTA, 2007, J VASC RES, V44, P87, DOI 10.1159/000098259; Moncada S, 2006, BRIT J PHARMACOL, V147, pS193, DOI 10.1038/sj.bjp.0706458; Nagano T, 2002, CHEM REV, V102, P1235, DOI 10.1021/cr010152s; Ouyang J, 2008, FREE RADICAL BIO MED, V45, P1426, DOI 10.1016/j.freeradbiomed.2008.08.016; Pluth MD, 2010, ORG LETT, V12, P2318, DOI 10.1021/ol1006289; REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x; Sartoretto JL, 2011, P NATL ACAD SCI USA, V108, P15792, DOI 10.1073/pnas.1111331108; Sato M, 2005, P NATL ACAD SCI USA, V102, P14515, DOI 10.1073/pnas.0505136102; Singh RJ, 1996, J BIOL CHEM, V271, P18596, DOI 10.1074/jbc.271.31.18596; Thomas SR, 2002, J BIOL CHEM, V277, P6017, DOI 10.1074/jbc.M109107200; Tian J, 2010, FREE RADICAL BIO MED, V49, P159, DOI 10.1016/j.freeradbiomed.2010.03.023; van Zandvoort M, 2004, J VASC RES, V41, P54, DOI 10.1159/000076246; Wiklund NP, 1999, ACTA PHYSIOL SCAND, V167, P161; Yamada M, 2001, P NATL ACAD SCI USA, V98, P14096, DOI 10.1073/pnas.251542998; Yuan SY, 2006, AM J PHYSIOL-HEART C, V291, pH1029, DOI 10.1152/ajpheart.00509.2006; Zadeh MS, 2000, J LEUKOCYTE BIOL, V67, P327, DOI 10.1002/jlb.67.3.327	27	15	15	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75331	10.1371/journal.pone.0075331	http://dx.doi.org/10.1371/journal.pone.0075331			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086509	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200097
J	Hohn, P; Menne-Lothmann, C; Peeters, F; Nicolson, NA; Jacobs, N; Derom, C; Thiery, E; van Os, J; Wichers, M				Hoehn, Petra; Menne-Lothmann, Claudia; Peeters, Frenk; Nicolson, Nancy A.; Jacobs, Nele; Derom, Catherine; Thiery, Evert; van Os, Jim; Wichers, Marieke			Moment-to-Moment Transfer of Positive Emotions in Daily Life Predicts Future Course of Depression in Both General Population and Patient Samples	PLOS ONE			English	Article							REWARD EXPERIENCE; PROSPECTIVELY PREDICTS; INERTIA; STRESS; MOOD; REACTIVITY; RECURRENT; DISORDER; QUALITY; ADULTS	Objective: Positive affect (PA) is closely linked to prevention of, and recovery from, depression. Previous studies have investigated PA reactivity to pleasant situations with respect to its protective properties in relation to mood disorder. The purpose of this study was to examine, and replicate, whether moment-to-moment transfer of PA in daily life (PA persistence) is relevant to the prediction of future course of depression. Method: Individuals from three different studies (one general population sample (n=540), and two patient samples (n=43 and n=50) with matching controls (n=39 and n=21, respectively)) participated in an Experience Sampling Method (ESM) study. Time-lagged multilevel analyses were used to assess the degree of transfer (or persistence) of momentary positive affective states over time, in relation to naturalistic outcome (study 1) or treatment outcome (studies 2 and 3). Depressive symptoms were measured using the Symptom Checklist (SCL-90R) in sample 1 and the Hamilton Depression Rating Scale (HDRS) in samples 2 and 3. Results: In study 1, participants with greater momentary PA persistence were less likely to show depressive symptoms at follow-up. In study 2, patients were more likely to respond to treatment if they displayed greater momentary PA persistence, particularly in those with recurrent depression. In study 3, patients with greater momentary PA persistence were similarly more likely to respond to treatment, especially when treated with imipramine rather than placebo. Conclusion: The ability to transfer PA from one moment to the next is an important factor in the prevention of and recovery from depressive symptoms. Patients with recurrent depression and those who receive antidepressants rather than placebo may benefit most from this effect. The results suggest that treatment-induced improvement in depression is mediated by increased levels of momentary transfer of PA in daily life, acquisition of which may be contingent on duration of exposure to depressive experience.	[Hoehn, Petra; Menne-Lothmann, Claudia; Peeters, Frenk; Nicolson, Nancy A.; Jacobs, Nele; van Os, Jim; Wichers, Marieke] Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Dept Psychiat & Psychol, Maastricht, Netherlands; [Jacobs, Nele] Open Univ, Fac Psychol, Heerlen, Netherlands; [Derom, Catherine] Katholieke Univ Leuven, Univ Hosp, Ctr Human Genet, Louvain, Belgium; [Derom, Catherine] Katholieke Univ Leuven, Dept Human Genet, Louvain, Belgium; [Thiery, Evert] Univ Ghent, Ghent Univ Hosp, Dept Neurol, B-9000 Ghent, Belgium; [van Os, Jim] Kings Coll London, Kings Hlth Partners, Inst Psychiat, Dept Psychosis Studies, London, England	Maastricht University; Open University Netherlands; KU Leuven; KU Leuven; Ghent University; Ghent University Hospital; University of London; King's College London	Hohn, P (corresponding author), Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Dept Psychiat & Psychol, Maastricht, Netherlands.	p.hohn@maastrichtuniversity.nl	Nicolson, Nancy/B-8209-2009; van Os, Jim/V-8884-2019; van Os, Jim/C-2113-2014; Wichers, Marieke/N-6667-2014; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022	Nicolson, Nancy/0000-0002-3106-8046; van Os, Jim/0000-0002-7245-1586; Wichers, Marieke/0000-0001-5024-9064; Peeters, F/0000-0002-6167-8582; Derom, Catherine/0000-0001-5574-796X	Fund of Scientific Research, Flanders and Twins, a non-profit Association for Scientific Research in Multiple Births (Belgium); Netherlands Organisation for Scientific Research (NWO) [916.76.147]; ZON-MW [171001002]	Fund of Scientific Research, Flanders and Twins, a non-profit Association for Scientific Research in Multiple Births (Belgium); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ZON-MW(Netherlands Organization for Health Research and Development)	Since its origin the East Flanders Prospective Survey has been partly supported by grants from the Fund of Scientific Research, Flanders and Twins, a non-profit Association for Scientific Research in Multiple Births (Belgium). Dr. M. Wichers was supported by the Netherlands Organisation for Scientific Research (NWO; VENI grant nr. 916.76.147) and by ZON-MW (grant nr. 171001002). www.zonmw.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2012, J NEUROSCI, V32, P1329, DOI 10.1523/JNEUROSCI.5826-11.2012; Barge-Schaapveld DQCM, 2002, J CLIN PSYCHIAT, V63, P477, DOI 10.4088/JCP.v63n0603; Barge-Schaapveld DQCM, 1999, PSYCHIAT RES, V88, P173, DOI 10.1016/S0165-1781(99)00081-5; CSIKSZENTMIHALYI M, 1987, J NERV MENT DIS, V175, P526, DOI 10.1097/00005053-198709000-00004; De Vries M, 1992, EXPERIENCE PSYCHOPAT; Delespaul P.A.E.G., 1995, ASSESSING SCHIZOPHRE; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; Derom C, 2013, TWIN RES HUM GENET, V16, P58, DOI 10.1017/thg.2012.75; Dowd H, 2010, INT J BEHAV MED, V17, P189, DOI 10.1007/s12529-009-9063-3; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Folkman S, 2000, AM PSYCHOL, V55, P647, DOI 10.1037//0003-066X.55.6.647; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Garland EL, 2010, CLIN PSYCHOL REV, V30, P849, DOI 10.1016/j.cpr.2010.03.002; Geschwind N, 2010, ACTA PSYCHIAT SCAND, V122, P129, DOI 10.1111/j.1600-0447.2009.01525.x; Geschwind N, 2011, J CONSULT CLIN PSYCH, V79, P618, DOI 10.1037/a0024595; Geschwind N, 2011, EUR NEUROPSYCHOPHARM, V21, P241, DOI 10.1016/j.euroneuro.2010.11.004; Guy W, 1976, ECDEU ASSESSMENT MAN, P59; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Heller AS, 2009, P NATL ACAD SCI USA, V106, P22445, DOI 10.1073/pnas.0910651106; Karasu TB, 2000, AM J PSYCHIAT, V157, P1; Kaymaz N, 2008, J CLIN PSYCHIAT, V69, P1423, DOI 10.4088/JCP.v69n0910; Knutson B, 2008, BIOL PSYCHIAT, V63, P686, DOI 10.1016/j.biopsych.2007.07.023; Kuppens P, 2012, EMOTION, V12, P283, DOI 10.1037/a0025046; Kuppens P, 2010, PSYCHOL SCI, V21, P984, DOI 10.1177/0956797610372634; Mak AKY, 2009, NEUROSCI LETT, V457, P101, DOI 10.1016/j.neulet.2009.03.094; McCabe C, 2010, BIOL PSYCHIAT, V67, P439, DOI 10.1016/j.biopsych.2009.11.001; Myin-Germeys I, 2001, ARCH GEN PSYCHIAT, V58, P1137, DOI 10.1001/archpsyc.58.12.1137; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; Oorschot M, 2012, SCHIZOPHRENIA BULL, V38, P405, DOI 10.1093/schbul/sbr166; Opbroek A, 2002, INT J NEUROPSYCHOPH, V5, P147, DOI 10.1017/S1461145702002870; Peeters F, 2003, J ABNORM PSYCHOL, V112, P203, DOI 10.1037/0021-843X.112.2.203; Peeters F, 2006, EMOTION, V6, P383, DOI 10.1037/1528-3542.6.3.383; Peeters F, 2010, BEHAV RES THER, V48, P754, DOI 10.1016/j.brat.2010.04.008; Pizzagalli DA, 2005, BIOL PSYCHIAT, V57, P319, DOI 10.1016/j.biopsych.2004.11.026; Price J, 2009, BRIT J PSYCHIAT, V195, P211, DOI 10.1192/bjp.bp.108.051110; Raes F, 2012, COGNITION EMOTION, V26, P75, DOI 10.1080/02699931.2011.555474; Rottenberg J, 2002, EMOTION, V2, P135, DOI 10.1037//1528-3542.2.2.135; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Thompson RJ, 2012, J ABNORM PSYCHOL, V121, P819, DOI 10.1037/a0027978; Tugade MM, 2004, J PERS SOC PSYCHOL, V86, P320, DOI 10.1037/0022-3514.86.2.320; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Watson D, 1999, J PERS SOC PSYCHOL, V76, P820, DOI 10.1037/0022-3514.76.5.820; Watson D, 1997, J PERS ASSESS, V68, P267, DOI 10.1207/s15327752jpa6802_4; Wichers M, 2010, J AFFECT DISORDERS, V124, P191, DOI 10.1016/j.jad.2009.11.010; Wichers MC, 2009, NEUROPSYCHOPHARMACOL, V34, P923, DOI 10.1038/npp.2008.66; Wichers M, 2012, BRIT J CLIN PSYCHOL, V51, P206, DOI 10.1111/j.2044-8260.2011.02021.x; Wichers MC, 2007, ACTA PSYCHIAT SCAND, V115, P451, DOI 10.1111/j.1600-0447.2006.00924.x	47	52	52	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75655	10.1371/journal.pone.0075655	http://dx.doi.org/10.1371/journal.pone.0075655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	246EK	24086602	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200117
J	Lu, DY; Liu, XF; Gao, YX; Huo, B; Kang, YY; Chen, J; Sun, SJ; Chen, L; Luo, XD; Long, MA				Lu, Dongyuan; Liu, Xiaofeng; Gao, Yuxin; Huo, Bo; Kang, Yingyong; Chen, Juan; Sun, Shujin; Chen, Li; Luo, Xiangdong; Long, Mian			Asymmetric Migration of Human Keratinocytes under Mechanical Stretch and Cocultured Fibroblasts in a Wound Repair Model	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; VACUUM-ASSISTED CLOSURE; GENE-EXPRESSION; FACTOR-ALPHA; TGF-ALPHA; CELL-PROLIFERATION; SKIN; REGENERATION; MICE; EPITHELIALIZATION	Keratinocyte migration during re-epithelization is crucial in wound healing under biochemical and biomechanical microenvironment. However, little is known about the underlying mechanisms whereby mechanical tension and cocultured fibroblasts or keratinocytes modulate the migration of keratinocytes or fibroblasts. Here we applied a tensile device together with a modified transwell assay to determine the lateral and transmembrane migration dynamics of human HaCaT keratinocytes or HF fibroblasts. A novel pattern of asymmetric migration was observed for keratinocytes when they were cocultured with non-contact fibroblasts, i.e., the accumulative distance of HaCaT cells was significantly higher when moving away from HF cells or migrating from down to up cross the membrane than that when moving close to HF cells or when migrating from up to down, whereas HF migration was symmetric. This asymmetric migration was mainly regulated by EGF derived from fibroblasts, but not transforming growth factor alpha or beta 1 production. Mechanical stretch subjected to fibroblasts fostered keratinocyte asymmetric migration by increasing EGF secretion, while no role of mechanical stretch was found for EGF secretion by keratinocytes. These results provided a new insight into understanding the regulating mechanisms of two- or three-dimensional migration of keratinocytes or fibroblasts along or across dermis and epidermis under biomechanical microenvironment.	[Lu, Dongyuan; Liu, Xiaofeng; Gao, Yuxin; Huo, Bo; Kang, Yingyong; Chen, Juan; Sun, Shujin; Long, Mian] Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Natl Micrograv Lab, Beijing 100080, Peoples R China; [Lu, Dongyuan; Liu, Xiaofeng; Gao, Yuxin; Huo, Bo; Kang, Yingyong; Chen, Juan; Sun, Shujin; Long, Mian] Chinese Acad Sci, Inst Mech, Ctr Biomech & Bioengn, Beijing 100080, Peoples R China; [Chen, Li; Luo, Xiangdong] Third Mil Med Univ, Southwest Hosp, Burn Res Inst, Chongqing, Peoples R China	Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; Institute of Mechanics, CAS; Army Medical University	Long, MA (corresponding author), Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Natl Micrograv Lab, Beijing 100080, Peoples R China.	mlong@imech.ac.cn	Huo, Bo/G-6186-2010; Huo, Bo/AAA-1331-2020	Huo, Bo/0000-0003-3194-3725; Huo, Bo/0000-0003-3194-3725	National Natural Science Foundation of China [30730032, 30730093, 31000421, 30870601]; National Key Basic Research Foundation of China [2011CB710904]; National High Technology Research and Development Program of China [2011AA020109]; Chinese Academy of Sciences [KJCX2-YW-L08]; Scientific Research Equipment Project [Y2010030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Foundation of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Scientific Research Equipment Project	This work was supported by National Natural Science Foundation of China grants 30730032, 30730093, 31000421, and 30870601 (http://www.nsfc.gov.cn/Portal0/default106.htm); National Key Basic Research Foundation of China grant 2011CB710904, and National High Technology Research and Development Program of China grant 2011AA020109 (http://www.most.gov.cn/eng/index.htm), and Chinese Academy of Sciences Knowledge Innovation Program grant KJCX2-YW-L08 and Scientific Research Equipment Project of grant Y2010030 (http://english.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendt C, 2002, J CELL SCI, V115, P2189; Argenta LC, 1997, ANN PLAS SURG, V38, P563, DOI 10.1097/00000637-199706000-00002; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Bartkova J, 2003, ARCH ORAL BIOL, V48, P125, DOI 10.1016/S0003-9969(02)00202-9; Bennett SP, 2003, BRIT J SURG, V90, P133, DOI 10.1002/bjs.4019; BHORA FY, 1995, J SURG RES, V59, P236, DOI 10.1006/jsre.1995.1160; Blumenberg M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-85; BROWN GL, 1988, ANN SURG, V208, P788, DOI 10.1097/00000658-198812000-00019; BROWN GL, 1986, J EXP MED, V163, P1319; Chiquet M, 1999, MATRIX BIOL, V18, P417, DOI 10.1016/S0945-053X(99)00039-6; COFFEY RJ, 1987, NATURE, V328, P817, DOI 10.1038/328817a0; COFFEY RJ, 1988, MOL CELL BIOL, V8, P3088, DOI 10.1128/MCB.8.8.3088; El-Ghalbzouri A, 2002, BRIT J DERMATOL, V147, P230, DOI 10.1046/j.1365-2133.2002.04871.x; GUO M, 1990, J CELL SCI, V96, P197; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Haase I, 2003, J CELL SCI, V116, P3227, DOI 10.1242/jcs.00610; Hashimoto K, 2000, J DERMATOL SCI, V24, pS46, DOI 10.1016/S0923-1811(00)00141-9; Ho E, 2012, MOL BIOL CELL, V23, P492, DOI 10.1091/mbc.E11-07-0596; JIANG CK, 1993, P NATL ACAD SCI USA, V90, P6786, DOI 10.1073/pnas.90.14.6786; Kempf M, 2011, BIOMATERIALS, V32, P4782, DOI 10.1016/j.biomaterials.2011.03.023; Kim I, 2001, WOUND REPAIR REGEN, V9, P386, DOI 10.1046/j.1524-475x.2001.00386.x; KIRSNER RS, 1993, DERMATOL CLIN, V11, P629, DOI 10.1016/S0733-8635(18)30216-X; KREJCI NC, 1991, J INVEST DERMATOL, V97, P843, DOI 10.1111/1523-1747.ep12491522; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Lohman RF, 2004, PLAST RECONSTR SURG, V114, P1097, DOI 10.1097/01.prs.0000135338.78447.4e; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Morris VL, 2007, WOUND REPAIR REGEN, V15, P907, DOI 10.1111/j.1524-475X.2007.00315.x; Morykwas MJ, 2006, PLAST RECONSTR SURG, V117, p121S, DOI 10.1097/01.prs.0000225450.12593.12; NICKOLOFF BJ, 1988, AM J PATHOL, V132, P543; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Orgill DP, 2009, SURGERY, V146, P40, DOI 10.1016/j.surg.2009.02.002; Puccinelli TJ, 2010, ACTA BIOMATER, V6, P3415, DOI 10.1016/j.actbio.2010.04.006; Raja, 2007, Front Biosci, V12, P2849; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; SARRET Y, 1992, J INVEST DERMATOL, V98, P12, DOI 10.1111/1523-1747.ep12493517; Schoop VM, 1999, J INVEST DERMATOL, V112, P343, DOI 10.1046/j.1523-1747.1999.00524.x; SCHULTZ G, 1991, J CELL BIOCHEM, V45, P346, DOI 10.1002/jcb.240450407; SELLHEYER K, 1993, P NATL ACAD SCI USA, V90, P5237, DOI 10.1073/pnas.90.11.5237; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; SMOLA H, 1993, J CELL BIOL, V122, P417, DOI 10.1083/jcb.122.2.417; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; URSCHEL JD, 1988, BRIT J PLAST SURG, V41, P182, DOI 10.1016/0007-1226(88)90049-5; Wang ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040951; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Witte RP, 2005, BIOMATERIALS, V26, P3673, DOI 10.1016/j.biomaterials.2004.09.054; Yamamoto M, 2011, BIOMATERIALS, V32, P4238, DOI 10.1016/j.biomaterials.2011.02.043; Yin CY, 2010, DEV CELL, V18, P973, DOI 10.1016/j.devcel.2010.05.009	49	27	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74563	10.1371/journal.pone.0074563	http://dx.doi.org/10.1371/journal.pone.0074563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086354	Green Published, gold			2022-12-27	WOS:000326520200036
J	Ragonese, S; Vitale, S; Dimech, M; Mazzola, S				Ragonese, Sergio; Vitale, Sergio; Dimech, Mark; Mazzola, Salvatore			Abundances of Demersal Sharks and Chimaera from 1994-2009 Scientific Surveys in the Central Mediterranean Sea	PLOS ONE			English	Article							DOGFISH SCYLIORHINUS-CANICULA; SQUALUS-BLAINVILLEI RISSO; REPRODUCTIVE-BIOLOGY; FISH ASSEMBLAGES; CANTABRIAN SEA; STRAIT; WATERS; GULF; RESOURCES; FISHERIES	Bibliographic and data gathered in scientific bottom trawl surveys carried out off the Southern Coasts of Sicily (Mediterranean Sea), from 1994 to 2009 and between a depth of 10 and 800 m, were analysed in order to prepare a checklist of demersal sharks and chimaera, which are species sensitive to fisheries exploitation. Out of the 27 previously reported demersal shark and chimaera taxa in the Mediterranean, only 23 were found in literature and 20 sampled during the surveys in the investigated area. Among the species sampled in the surveys, only 2 ubiquitous (Squalus blainville and Scyliorhinus canicula) and 3 deep-water (Chimaera monstrosa, Centrophorus granulosus and Galeus melastomus) species showed a wide geographical distribution with a consistent abundance. Excluding the rare (such as Oxynotus centrina) or uncommon shark (e.g. Squalus acanthias), the estimated frequencies of occurrence and abundance indexes show a possible risk of local extinction for the almost exclusively (e.g. angelshark, Squatina spp.) or preferential (e.g. Scyliorhinus stellaris) neritic species.	[Ragonese, Sergio; Vitale, Sergio; Mazzola, Salvatore] Natl Res Council CNR, Inst Coastal Marine Environm IAMC, Mazara Del Vallo, Sicily, Italy; [Dimech, Mark] Malta Ctr Fisheries Sci, Ft San Lucjan Marsaxlokk, Birzebbuga, Malta	Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR)	Vitale, S (corresponding author), Natl Res Council CNR, Inst Coastal Marine Environm IAMC, Mazara Del Vallo, Sicily, Italy.	sergio.vitale@cnr.it	Vitale, Sergio/AAX-5418-2020	Mazzola, Salvatore/0000-0002-4622-8129; vitale, sergio/0000-0001-6063-4126	Ministro delle Politiche Agricole e Forestali (MiPAF); European Community	Ministro delle Politiche Agricole e Forestali (MiPAF); European Community(European Commission)	The present research was jointly funded by Ministro delle Politiche Agricole e Forestali (MiPAF) and European Community. The funders have established the study design and data collection, but had no role in analysis, decision to publish, or preparation of the manuscript.	Abella A. J., 2005, Journal of Northwest Atlantic Fishery Science, V35, P345; Aldebert Y, 1997, VIE MILIEU, V47, P275; Andreoli MG, 1995, SPECIAL PUBLICATION, VII; Andreoli MG, 1982, 266 FAO, P111; Arena P, 1985, STUDIO POSSIBILITA R; Arena P, 1973, QUAD LAB TECHNOL PES, V1, P157; Baino R, 2001, RAPP COMM INT MER ME; Bauchot ML, 1987, FICHES FAO IDENTIFIC, P767; Bianchini ML, 2006, NATURALISTA SICIL, VXXX, P469; Bini G, 1967, ATLANTE PESCI DELLE, V1; Bombace G, 1970, ICHTYOL ROME JOURNEE, P157; Bourgois F, 1961, ESSAIS CHALUTAGE LAR; Bradai M.N., 2012, BIBLIOGRAPHIC ANAL S, V91; Bradai MN, 2000, THESIS U SFAX TUNISA; Bradai Mohamed Nejmeddine, 2004, Mesogee, V60, P61; Briand F, 2000, RAPPCOMM INT MER MED, V10, P85; Campillo A, 1992, RIDRV 92 019 RH SETE; CANNIZZARO L, 1995, FISH RES, V23, P113, DOI 10.1016/0165-7836(94)00333-R; Capape C., 1985, Bulletin de l'Institut National Scientifique et Technique d'Oceanographie et de Peche de Salammbo, V12, P97; Capape C, 2000, VIE MILIEU, V50, P123; Capape Christian, 2005, Acta Adriatica, V46, P109; Castro J. I., 1999, PRELIMINARY EVALUATI; Cavanagh R.D., 2007, OVERVIEW CONSERVATIO; Celona A, 2005, B MUS CIV ST NAT VEN, V56; Cingolani N, 1986, QUADERNI I RICERCH S, V5, P283; Compagno L. J. V., 1984, SHARKS WORLD ANNOTAT, V4; Compagno LJV, 2005, SHARKS WORLD, P480; Dagit DD, 2007, IUCN 2012 IUCN RED L; Davis MW, 2002, CAN J FISH AQUAT SCI, V59, P1834, DOI 10.1139/F02-139; Delattre G, 1986, 3 C ASS PLEN CIESM P; Dell'Apa A, 2012, ICES J MAR SCI, V69, P1045, DOI 10.1093/icesjms/fss067; Dimech M, 2012, MAR ECOL PROG SER, V449, P41, DOI 10.3354/meps09475; Dimech M, 2008, SCI MAR, V72, P669, DOI 10.3989/scimar.2008.72n4669; Ebert D.A., 2013, FAO SPECIES CAT FISH, V7, P1; Eschmeyer WN, 2012, CATALOG FISHES CALIF; European Union, 2006, MANAGEMENT MEASURES; Ferretti F, 2005, ICES CM, V25, P1; Fredj G, 1987, CYBIUM, P299; Frisk MG, 2001, CAN J FISH AQUAT SCI, V58, P969, DOI 10.1139/cjfas-58-5-969; FROESE R., 2012, FISHBASE; Garofalo G., 2007, BIOL MAR MEDITERR, V14, P250; Giudicelli M, 1978, MALTA SIMULATED COMM; Giudicelli M, 1983, RESULTATS OPERATIONS; Golani D, 1996, ISRAEL J ZOOL, V42, P15; GOLANI D, 1986, Israel Journal of Zoology, V34, P23; Gristina M, 2006, FISH RES, V81, P60, DOI 10.1016/j.fishres.2006.05.010; Hassan M, 2013, SYRIAN WATERS E MEDI, V6, pe7; HILBORN R, 1988, MAR POLICY, V12, P112, DOI 10.1016/0308-597X(88)90039-5; Iglesias SP, 2012, CLASSIFICATION NATUR, VI; Jones EG, 2003, MAR ECOL PROG SER, V251, P75, DOI 10.3354/meps251075; Jukic-Peladic S, 2000, FISH RES, V11, P1; Levi D., 1998, Biologia Marina Mediterranea, V5, P130; Macpherson E, 1980, VIE MILIEU, V30, P139; Marouani S, 2012, SCI MAR, V76, P97, DOI 10.3989/scimar.03440.22B; Medits, 2002, FIN REP 2000 2001 RA; Mifsud R, 2013, MEDITERR MAR SCI, V14, P298, DOI 10.12681/mms.413; Musick AJ, 2011, FAO FISHERIES AQUACU, P245; Olaso I, 1998, ICES J MAR SCI, V55, P331, DOI 10.1006/jmsc.1997.0263; Pipitone C, 1992, OEBALIA, V17, P151; Potoschi A., 2010, RAPPORTS PROCES VERB, V39, P636; Quero JC, 1984, FISHES NE ATLANTIC M, P95; Quignard J.P., 1971, B L INSTITUT NATL SC, V2, P131; Ragonese S, 2009, MEDITERR MAR SCI, V10, P55, DOI 10.12681/mms.122; Ragonese S., 2000, Biologia Marina Mediterranea, V7, P400; Ragonese S, 2001, HYDROBIOLOGIA, V449, P279, DOI 10.1023/A:1017564530716; RAGONESE S, 2008, NATURALISTA SICILIAN, V32, P3; Relini G, 2008, BIOL MAR MEDITERR, V15, P1; Relini G, 1999, BIOL MAR MEDIT S1, V6; RELINI G, 2000, ACTES C IFREMER, V26, P76; Revill AS, 2005, FISH RES, V71, P121, DOI 10.1016/j.fishres.2004.07.006; Rizzo P, 1993, BIOL MAR MEDIT, V1, P389; Rochet MJ, 2005, ICES J MAR SCI, V62, P1647, DOI 10.1016/j.icesjms.2005.06.009; Rodriguez-Cabello C, 2005, J MAR BIOL ASSOC UK, V85, P1145, DOI 10.1017/S002531540501221X; Rogers SI, 2000, ICES J MAR SCI, V57, P866, DOI 10.1006/jmsc.2000.0574; Saidi B, 2008, J FISH BIOL, V72, P1343, DOI 10.1111/j.1095-8649.2008.01801.x; Saidi B, 2009, SCI MAR, V73, P249, DOI 10.3989/scimar.2009.73n2249; Sara, 1972, MIN MAR MERC MEM, V33, P63; Sara R, 1969, PESCA STRASCICO FOND; SCACCINI A, 1970, B PESCA PISCIC IDROB, V25, P5; Schembri PJ, 2007, CAH BIOL MAR, V48, P77; Schembri Titian, 2003, Central Mediterranean Naturalist, V4, P71; Serena F., 2005, FIELD IDENTIFICATION; Serena F, 2008, ATT WORKSH HMAP MED, P127; Serena F, 2005, FAO REPORT DEEP SEA, P395; Serena F, 2009, BIOLOGY AND MANAGEMENT OF DOGFISH SHARKS, P139; Sion L, 2004, SCI MAR, V68, P153, DOI 10.3989/scimar.2004.68s3153; Smedbol RK, 2002, FISH RES, V55, P161; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Tortonese E., 1956, FAUNA ITALIA LEPTOCA; Walker TI, 1998, MAR FRESHWATER RES, V49, P553, DOI 10.1071/MF98017; Walker TI, 2005, 474 FAO, V474, P216; [No title captured]; 2006, REPORT WORKING GROUP	93	47	55	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74865	10.1371/journal.pone.0074865	http://dx.doi.org/10.1371/journal.pone.0074865			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086386	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200045
J	Wang, L; He, YR; Zhang, G; Ma, J; Liu, CZ; He, W; Wang, W; Han, HM; Boruah, BM; Gao, B				Wang, Lei; He, Yanran; Zhang, Ge; Ma, Juan; Liu, Changzhen; He, Wen; Wang, Wei; Han, Huamin; Boruah, Bhargavi M.; Gao, Bin			Retargeting T Cells for HER2-Positive Tumor Killing by a Bispecific Fv-Fc Antibody	PLOS ONE			English	Article							BREAST-CANCER; RECEPTOR; GROWTH; ERTUMAXOMAB; FRAGMENTS; TRIAL; HER2	To exploit the biological and pharmacological properties of immunoglobulin constant domain Fc fragment and increase the killing efficacy of T cells, a single chain variable fragment specific to CD3 was fused with Fcab (Fc antigen binding), a mutant Fc fragment with specificity against Human epidermal growth factor receptor 2 (HER2) developed by F-star. The bispecific fusion named as FcabCD3 was expressed by transient transfection in HEK-293T cells and purified by affinity chromatography. Specific cytolytic activity of retargeted T cells to kill HER2 positive SKBR3 cell line was evaluated in vitro. FcabCD3 was able to retarget T cells to kill both Herceptin insensitive Colo205-luc cell line and HER2 low expression MDA-MB-231-luc cell line. Furthermore, FcabCD3 was effective in eliminating the Colo205 tumor established on BALB/c nu/nu mice.	[Wang, Lei; Zhang, Ge; Ma, Juan; Liu, Changzhen; He, Wen; Wang, Wei; Han, Huamin; Boruah, Bhargavi M.; Gao, Bin] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol CASPMI, Beijing, Peoples R China; [Wang, Lei; Zhang, Ge; He, Wen; Boruah, Bhargavi M.] Univ Chinese Acad Sci, Beijing, Peoples R China; [He, Yanran] Univ Chinese Agr, Beijing, Peoples R China; [He, Wen] Hebei Med Univ, Hebei Key Lab Med Biotechnol, Shijiazhuang, Peoples R China; [Gao, Bin] Chinese Acad Sci, Inst Microbiol, China Japan Joint Lab Mol Immunol & Microbiol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Hebei Medical University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Gao, B (corresponding author), Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol CASPMI, Beijing, Peoples R China.	bgao2004@gmail.com		Boruah, Bhargavi/0000-0002-3645-785X	Ministry of Science and Technology of China [2012ZX10004701-001-002]; 973 program [2013CB531502]; National Natural Science Foundation of China [30771953, 31070783, 31170829, 81021003]; Beijing Natural Science Foundation [5112022]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); 973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was funded by research grants from the Ministry of Science and Technology of China (S & T Major Program: number 2012ZX10004701-001-002), 973 program (2013CB531502) and the National Natural Science Foundation of China (number 30771953, 31070783, 31170829, 81021003), Beijing Natural Science Foundation (5112022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeuerle PA, 2009, CURR OPIN MOL THER, V11, P22; Camp RL, 2003, CANCER RES, V63, P1445; Cao Y, 2003, ADV DRUG DELIVER REV, V55, P171, DOI 10.1016/S0169-409X(02)00178-3; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Carter PJ, 2011, EXP CELL RES, V317, P1261, DOI 10.1016/j.yexcr.2011.02.013; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Choi BD, 2011, EXPERT OPIN BIOL TH, V11, P843, DOI 10.1517/14712598.2011.572874; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Fu XP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011867; Grosse-Hovest L, 1999, INT J CANCER, V80, P138, DOI 10.1002/(SICI)1097-0215(19990105)80:1<138::AID-IJC25>3.0.CO;2-J; Jager M, 2009, CANCER RES, V69, P4270, DOI 10.1158/0008-5472.CAN-08-2861; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98; Kellner C, 2011, BISPECIFIC ANTIBODIES, P217, DOI 10.1007/978-3-642-20910-9_13; Kiewe P, 2006, CLIN CANCER RES, V12, P3085, DOI 10.1158/1078-0432.CCR-05-2436; Kontermann RE, 2011, CURR OPIN BIOTECH, V22, P868, DOI 10.1016/j.copbio.2011.06.012; LUTTERBUESE R, 2008, AACR M, P2402; May C, 2012, BIOCHEM PHARMACOL, V84, P1105, DOI 10.1016/j.bcp.2012.07.011; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Muller D, 2010, BIODRUGS, V24, P89, DOI 10.2165/11530960-000000000-00000; Repp R, 2003, BRIT J CANCER, V89, P2234, DOI 10.1038/sj.bjc.6601367; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Scholl S, 2001, ANN ONCOL, V12, P81, DOI 10.1023/A:1011192622688; Schrama D, 2006, NAT REV DRUG DISCOV, V5, P147, DOI 10.1038/nrd1957; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Weiner LM, 2005, NAT BIOTECHNOL, V23, P556, DOI 10.1038/nbt0505-556; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Wozniak-Knopp G, 2010, PROTEIN ENG DES SEL, V23, P289, DOI 10.1093/protein/gzq005	29	7	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75589	10.1371/journal.pone.0075589	http://dx.doi.org/10.1371/journal.pone.0075589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086580	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200113
J	Boyer, S; Wratten, SD; Holyoake, A; Abdelkrim, J; Cruickshank, RH				Boyer, Stephane; Wratten, Stephen D.; Holyoake, Andrew; Abdelkrim, Jawad; Cruickshank, Robert H.			Using Next-Generation Sequencing to Analyse the Diet of a Highly Endangered Land Snail (Powelliphanta augusta) Feeding on Endemic Earthworms	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PREY DNA; INVERTEBRATE PREDATION; INSECT PREDATORS; GUT; FECES; PCR; IDENTIFICATION; LUMBRICIDAE; OLIGOCHAETA	Predation is often difficult to observe or quantify for species that are rare, very small, aquatic or nocturnal. The assessment of such species' diet can be conducted using molecular methods that target prey DNA remaining in predators' guts and faeces. These techniques do not require high taxonomic expertise, are applicable to soft-bodied prey and allow for identification at the species level. However, for generalist predators, the presence of mixed prey DNA in guts and faeces can be a major impediment as it requires development of specific primers for each potential prey species for standard (Sanger) sequencing. Therefore, next generation sequencing methods have recently been applied to such situations. In this study, we used 454-pyrosequencing to analyse the diet of Powelliphanta augusta, a carnivorous landsnail endemic to New Zealand and critically endangered after most of its natural habitat has been lost to opencast mining. This species was suspected to feed mainly on earthworms. Although earthworm tissue was not detectable in snail faeces, earthworm DNA was still present in sufficient quantity to conduct molecular analyses. Based on faecal samples collected from 46 landsnails, our analysis provided a complete map of the earthworm-based diet of P. augusta. Predated species appear to be earthworms that live in the leaf litter or earthworms that come to the soil surface at night to feed on the leaf litter. This indicates that P. augusta may not be selective and probably predates any earthworm encountered in the leaf litter. These findings are crucial for selecting future translocation areas for this highly endangered species. The molecular diet analysis protocol used here is particularly appropriate to study the diet of generalist predators that feed on liquid or soft-bodied prey. Because it is non-harmful and non-disturbing for the studied animals, it is also applicable to any species of conservation interest.	[Boyer, Stephane; Wratten, Stephen D.; Holyoake, Andrew] Lincoln Univ, Bioprotect Res Ctr, Lincoln, New Zealand; [Boyer, Stephane; Cruickshank, Robert H.] Lincoln Univ, Fac Agr & Life Sci, Dept Ecol, Lincoln, New Zealand; [Abdelkrim, Jawad] Univ Otago, Dept Anat & Struct Biol, Ctr Reprod & Genom, Dunedin, New Zealand; [Abdelkrim, Jawad] Museum Natl Hist Nat, Unite Conservat Especes Restaurat & Suivi Populat, UMR 7204, F-75231 Paris, France	Lincoln University - New Zealand; Lincoln University - New Zealand; University of Otago; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Boyer, S (corresponding author), Lincoln Univ, Bioprotect Res Ctr, Lincoln, New Zealand.	Stephane.Boyer@lincoln.ac.nz	Boyer, Stéphane/H-8624-2013; Wratten, Steve D/J-3467-2013	Boyer, Stéphane/0000-0002-0750-4864; Wratten, Steve D/0000-0002-5168-8277	Solid Energy New Zealand Limited; Department of Ecology at Lincoln University; Bio-Protection Research Centre at Lincoln University	Solid Energy New Zealand Limited; Department of Ecology at Lincoln University; Bio-Protection Research Centre at Lincoln University	This work was funded by Solid Energy New Zealand Limited and supported by the Department of Ecology at Lincoln University and the Bio-Protection Research Centre at Lincoln University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti N, 1999, MOL ECOL, V8, P1467, DOI 10.1046/j.1365-294x.1999.00717.x; Ahmadian A, 2006, CLIN CHIM ACTA, V363, P83, DOI 10.1016/j.cccn.2005.04.038; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bohmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021441; BOORE JL, 1995, GENETICS, V141, P305; Bouche MB, 1972, ANN ZOOLOGIE ECOLOGI; Bowles E, 2011, MOL ECOL RESOUR, V11, P530, DOI 10.1111/j.1755-0998.2010.02974.x; Boyer S, 2011, ZOOTAXA, P21; Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038215; Boyer S, 2011, PEDOBIOLOGIA, V54, pS99, DOI 10.1016/j.pedobi.2011.09.006; Boyer S, 2011, PEDOBIOLOGIA, V54, pS153, DOI 10.1016/j.pedobi.2011.08.002; Boyer S, 2010, ZOOL MIDDLE EAST, P31; Brown DS, 2012, MOL ECOL RESOUR, V12, P259, DOI 10.1111/j.1755-0998.2011.03098.x; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Budarf AC, 2011, J FISH BIOL, V79, P112, DOI 10.1111/j.1095-8649.2011.02999.x; Chen Y, 2000, MOL ECOL, V9, P1887, DOI 10.1046/j.1365-294x.2000.01100.x; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Deagle BE, 2005, MOL ECOL, V14, P1831, DOI 10.1111/j.1365-294X.2005.02531.x; Deagle BE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000831; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FRYXELL JM, 1994, EVOL ECOL, V8, P407, DOI 10.1007/BF01238191; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Hibert F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025850; Hoogendoorn M, 2001, MOL ECOL, V10, P2059, DOI 10.1046/j.1365-294X.2001.01316.x; Jarman SN, 2004, MOL ECOL, V13, P1313, DOI 10.1111/j.1365-294X.2004.02109.x; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; King RA, 2011, MOL ECOL RESOUR, V11, P370, DOI 10.1111/j.1755-0998.2010.02913.x; King RA, 2010, MOL ECOL, V19, P1721, DOI 10.1111/j.1365-294X.2010.04602.x; Lavandero B, 2004, INT J PEST MANAGE, V50, P147, DOI 10.1080/09670870410001731853; LEE KE, 1959, EARTHWORM FAUNA NZ D; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Merfield CN, 2004, BIOL CONTROL, V29, P5, DOI 10.1016/S1049-9644(03)00095-1; Murray DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025776; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Pop AA, 2003, PEDOBIOLOGIA, V47, P428, DOI 10.1016/S0031-4056(04)70217-6; Pop AA, 2007, EUR J SOIL BIOL, V43, pS43, DOI 10.1016/j.ejsobi.2007.08.007; REID B, 1982, NEW ZEAL J ECOL, V5, P76; Riemann L, 2010, BIOL LETTERS, V6, P819, DOI 10.1098/rsbl.2010.0411; Simenc J, 2011, APPL BIOCHEM MICRO+, V47, P256, DOI 10.1134/S0003683811030136; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SOPP PI, 1992, J APPL ECOL, V29, P295, DOI 10.2307/2404498; SUNDERLAND KD, 1987, ACTA PHYTOPATHOL HUN, V22, P13; Suzuki N, 2006, FISHERIES SCI, V72, P342, DOI 10.1111/j.1444-2906.2006.01155.x; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Team RDC, 2009, R LANG ENV STAT COMP; Trewick SA, 2008, CONSERV GENET, V9, P1563, DOI 10.1007/s10592-007-9495-8; Turner AM, 2008, ANIM BEHAV, V76, P1211, DOI 10.1016/j.anbehav.2008.06.005; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Walker KJ, 2008, J ROY SOC NEW ZEAL, V38, P163, DOI 10.1080/03014220809510553; Zaidi RH, 1999, MOL ECOL, V8, P2081, DOI 10.1046/j.1365-294x.1999.00823.x; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x	54	40	42	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75962	10.1371/journal.pone.0075962	http://dx.doi.org/10.1371/journal.pone.0075962			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086671	gold, Green Submitted, Green Published			2022-12-27	WOS:000325223900068
J	Lefebvre, M; Tetaud, E; Thonnus, M; Salin, B; Boissier, F; Blancard, C; Sauvanet, C; Metzler, C; Espiau, B; Sahin, A; Merlin, G				Lefebvre, Michele; Tetaud, Emmanuel; Thonnus, Magali; Salin, Benedicte; Boissier, Fanny; Blancard, Corinne; Sauvanet, Cecile; Metzler, Christelle; Espiau, Benoit; Sahin, Annelise; Merlin, Gilles			LdFlabarin, a New BAR Domain Membrane Protein of Leishmania Flagellum	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR; PARAFLAGELLAR ROD; RAC1-INTERACTING PROTEIN; ACTIN CYTOSKELETON; TRYPANOSOMA-BRUCEI; STRUCTURAL BASIS; EXPRESSION; AMPHIPHYSIN; BIOGENESIS; PARASITES	During the Leishmania life cycle, the flagellum undergoes successive assembly and disassembly of hundreds of proteins. Understanding these processes necessitates the study of individual components. Here, we investigated LdFlabarin, an uncharacterized L. donovani flagellar protein. The gene is conserved within the Leishmania genus and orthologous genes only exist in the Trypanosoma genus. LdFlabarin associates with the flagellar plasma membrane, extending from the base to the tip of the flagellum as a helicoidal structure. Site-directed mutagenesis, deletions and chimera constructs showed that LdFlabarin flagellar addressing necessitates three determinants: an N-terminal potential acylation site and a central BAR domain for membrane targeting and the C-terminal domain for flagellar specificity. In vitro, the protein spontaneously associates with liposomes, triggering tubule formation, which suggests a structural/morphogenetic function. LdFlabarin is the first characterized Leishmania BAR domain protein, and the first flagellum-specific BAR domain protein.	[Lefebvre, Michele; Merlin, Gilles] CNRS, UMR 5290, Montpellier, France; [Lefebvre, Michele; Merlin, Gilles] Univ Montpellier I, Montpellier, France; [Lefebvre, Michele; Merlin, Gilles] Ctr Hosp Univ Colombiere, Montpellier, France; [Lefebvre, Michele; Merlin, Gilles] IRD 224, Montpellier, France; [Tetaud, Emmanuel; Salin, Benedicte; Boissier, Fanny; Blancard, Corinne; Sauvanet, Cecile] CNRS, Inst Biochim Genet & Cellulaire, UMR 5095, Bordeaux, France; [Thonnus, Magali; Sahin, Annelise] CNRS, UMR 5234, Bordeaux, France; [Tetaud, Emmanuel; Thonnus, Magali; Salin, Benedicte; Boissier, Fanny; Blancard, Corinne; Sauvanet, Cecile; Metzler, Christelle; Sahin, Annelise] Univ Bordeaux Segalen, Bordeaux, France; [Espiau, Benoit] CNRS, EPHE, USR 3278, Papetoai, Moorea, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE)	Merlin, G (corresponding author), CNRS, UMR 5290, Montpellier, France.	gmerlin@univ-montp1.fr			CNRS (Centre National de la Recherche Scientifique); Universite Bordeaux Segalen; IRD (Institut de Recherche pour le Developpement); Universite Montpellier I; CHU (Centre Hospitalier Universitaire) La Colombiere (Montpellier)	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Universite Bordeaux Segalen; IRD (Institut de Recherche pour le Developpement); Universite Montpellier I; CHU (Centre Hospitalier Universitaire) La Colombiere (Montpellier)	The project was funded by the CNRS (Centre National de la Recherche Scientifique), the Universite Bordeaux Segalen, the IRD (Institut de Recherche pour le Developpement), the Universite Montpellier I and the CHU (Centre Hospitalier Universitaire) La Colombiere (Montpellier). A. Sahin and C. Sauvanet were MENRT (Ministere de l'Education Nationale, de la Recherche et de la Technologie) PhD fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTOINE JC, 1999, LEISHMANIOSES, P41; Bastin P, 1999, MOL CELL BIOL, V19, P8191; Boman AL, 1999, CELL MOTIL CYTOSKEL, V44, P119, DOI 10.1002/(SICI)1097-0169(199910)44:2<119::AID-CM4>3.3.CO;2-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Buchanan KT, 2005, J BIOL CHEM, V280, P40104, DOI 10.1074/jbc.M505777200; CACHON J, 1988, BIOL CELL, V63, P169, DOI 10.1016/0248-4900(88)90056-1; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Cuvillier A, 2003, CELL MICROBIOL, V5, P717, DOI 10.1046/j.1462-5822.2003.00316.x; Cuvillier A, 2000, J CELL SCI, V113, P2065; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; DELAFAILLE MAC, 1992, P NATL ACAD SCI USA, V89, P2703, DOI 10.1073/pnas.89.7.2703; Denny PW, 2000, J BIOL CHEM, V275, P11017, DOI 10.1074/jbc.275.15.11017; DUTCHER SK, 1995, TRENDS GENET, V11, P398, DOI 10.1016/S0168-9525(00)89123-4; Emmer BT, 2009, J CELL SCI, V122, P867, DOI 10.1242/jcs.041764; Ersfeld K, 2001, J CELL SCI, V114, P141; Forestier CL, 2011, CELL HOST MICROBE, V9, P319, DOI 10.1016/j.chom.2011.03.011; Fridberg A, 2007, PARASITOL RES, V100, P205, DOI 10.1007/s00436-006-0329-2; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gehart H, 2012, DEV CELL, V23, P756, DOI 10.1016/j.devcel.2012.07.019; Gluenz E, 2010, CURR OPIN MICROBIOL, V13, P473, DOI 10.1016/j.mib.2010.05.008; Godsel LM, 1999, EMBO J, V18, P2057, DOI 10.1093/emboj/18.8.2057; Ilg T, 2000, PARASITOL TODAY, V16, P489, DOI 10.1016/S0169-4758(00)01791-9; Ilgoutz SC, 2001, INT J PARASITOL, V31, P899, DOI 10.1016/S0020-7519(01)00197-7; Kanoh H, 1997, J BIOL CHEM, V272, P5421, DOI 10.1074/jbc.272.9.5421; Kjaerulff O, 2011, CELL BIOCHEM BIOPHYS, V60, P137, DOI 10.1007/s12013-010-9137-5; Koumandou VL, 2011, J CELL SCI, V124, P1496, DOI 10.1242/jcs.081596; Kunz S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000455; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Lee L, 2011, GENE, V473, P57, DOI 10.1016/j.gene.2010.11.006; LICHTE B, 1992, EMBO J, V11, P2521, DOI 10.1002/j.1460-2075.1992.tb05317.x; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; LODES MJ, 1995, MOL CELL BIOL, V15, P6845; MacLean LM, 2012, CELL MICROBIOL, V14, P740, DOI 10.1111/j.1462-5822.2012.01756.x; Maga JA, 1999, TRENDS CELL BIOL, V9, P409, DOI 10.1016/S0962-8924(99)01635-9; Man ZQ, 2011, J BIOL CHEM, V286, P11569, DOI 10.1074/jbc.M110.201442; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; Masuda M, 2010, SEMIN CELL DEV BIOL, V21, P391, DOI 10.1016/j.semcdb.2010.01.010; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Moore LL, 1996, MOL BIOCHEM PARASIT, V80, P125, DOI 10.1016/0166-6851(96)02688-6; Nakamura K, 2012, J BIOL CHEM, V287, P25478, DOI 10.1074/jbc.M112.365783; Nasser MIA, 2004, MOL BIOCHEM PARASIT, V135, P89, DOI 10.1016/j.molbiopara.2004.01.009; Overath P, 1997, TRENDS CELL BIOL, V7, P27, DOI 10.1016/S0962-8924(97)10046-0; Pazour GJ, 2008, CURR TOP DEV BIOL, V85, P115, DOI 10.1016/S0070-2153(08)00805-3; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pullen TJ, 2004, MOL BIOL CELL, V15, P3257, DOI 10.1091/mbc.E04-03-0217; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Ralston KS, 2009, ANNU REV MICROBIOL, V63, P335, DOI 10.1146/annurev.micro.091208.073353; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Sahin A, 2004, EXP PARASITOL, V108, P126, DOI 10.1016/j.exppara.2004.07.010; Sahin A, 2008, MOL BIOCHEM PARASIT, V157, P83, DOI 10.1016/j.molbiopara.2007.08.003; Sahin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001620; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHLAEPPI K, 1989, J CELL BIOL, V109, P1695, DOI 10.1083/jcb.109.4.1695; Selvapandiyan A, 2001, J BIOL CHEM, V276, P43253, DOI 10.1074/jbc.M106806200; Silflow CD, 2001, PLANT PHYSIOL, V127, P1500, DOI 10.1104/pp.127.4.1500; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; SIVADON P, 1995, MOL GEN GENET, V246, P485, DOI 10.1007/BF00290452; Suetsugu S, 2010, SEMIN CELL DEV BIOL, V21, P340, DOI 10.1016/j.semcdb.2009.12.002; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Taschner M, 2012, DIFFERENTIATION, V83, pS12, DOI 10.1016/j.diff.2011.11.001; Tetaud E, 2002, MOL BIOCHEM PARASIT, V120, P195, DOI 10.1016/S0166-6851(02)00002-6; TETAUD E, 2011, PNUS SITE; Tran KD, 2012, J CELL SCI, V125, P3293, DOI 10.1242/jcs.103028; Tull D, 2004, MOL BIOL CELL, V15, P4775, DOI 10.1091/mbc.E04-06-0457; Tull D, 2010, J CELL SCI, V123, P544, DOI 10.1242/jcs.059097; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; van Weering JRT, 2010, SEMIN CELL DEV BIOL, V21, P371, DOI 10.1016/j.semcdb.2009.11.009; VanAelst L, 1996, EMBO J, V15, P3778, DOI 10.1002/j.1460-2075.1996.tb00751.x; Vincensini L, 2011, BIOL CELL, V103, P109, DOI 10.1042/BC20100104; 2013, GENEDB L MAJOR	76	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76380	10.1371/journal.pone.0076380	http://dx.doi.org/10.1371/journal.pone.0076380			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086735	Green Submitted, gold, Green Published			2022-12-27	WOS:000325223900099
J	Tortosa, P; Dsouli, N; Gomard, Y; Ramasindrazana, B; Dick, CW; Goodman, SM				Tortosa, Pablo; Dsouli, Najla; Gomard, Yann; Ramasindrazana, Beza; Dick, Carl W.; Goodman, Steven M.			Evolutionary History of Indian Ocean Nycteribiid Bat Flies Mirroring the Ecology of Their Hosts	PLOS ONE			English	Article							CHIROPTERA MINIOPTERIDAE; MITOCHONDRIAL-DNA; COMORES ARCHIPELAGO; PHYLOGENY; IDENTIFICATION; BIOGEOGRAPHY; SPECIFICITY; MADAGASCAR; PATTERNS; DIPTERA	Bats and their parasites are increasingly investigated for their role in maintenance and transmission of potentially emerging pathogens. The islands of the western Indian Ocean hold nearly 50 bat species, mostly endemic and taxonomically well studied. However, investigation of associated viral, bacterial, and external parasites has lagged behind. In the case of their ectoparasites, more detailed information should provide insights into the evolutionary history of their hosts, as well as pathogen cycles in these wild animals. Here we investigate species of Nycteribiidae, a family of obligate hematophagous wingless flies parasitizing bats. Using morphological and molecular approaches, we describe fly species diversity sampled on Madagascar and the Comoros for two cave-roosting bat genera with contrasting ecologies: Miniopterus and Rousettus. Within the sampling area, 11 endemic species of insect-feeding Miniopterus occur, two of which are common to Madagascar and Comoros, while fruit-consuming Rousettus are represented by one species endemic to each of these zones. Morphological and molecular characterization of flies reveals that nycteribiids associated with Miniopterus bats comprise three species largely shared by most host species. Flies of M. griveaudi, one of the two bats found on Madagascar and certain islands in the Comoros, belong to the same taxon, which accords with continued over-water population exchange of this bat species and the lack of inter-island genetic structuring. Flies parasitizing Rousettus belong to two distinct species, each associated with a single host species, again in accordance with the distribution of each endemic bat species.	[Tortosa, Pablo; Dsouli, Najla; Gomard, Yann; Ramasindrazana, Beza] Plateforme Rech CYROI, Ctr Rech & Veille Malad Emergentes Ocean Indien, Ste Clotilde, Reunion, France; [Tortosa, Pablo; Gomard, Yann; Ramasindrazana, Beza] Univ La Reunion, Ste Clotilde, Reunion, France; [Dsouli, Najla; Gomard, Yann; Ramasindrazana, Beza] Inst Rech Dev, St Clotilde, Reunion, France; [Dick, Carl W.] Western Kentucky Univ, Dept Biol, Bowling Green, KY 42101 USA; [Dick, Carl W.; Goodman, Steven M.] Field Museum Nat Hist, Chicago, IL 60605 USA; [Goodman, Steven M.] Assoc Vahatra, Antananarivo, Madagascar	University of La Reunion; Institut de Recherche pour le Developpement (IRD); Western Kentucky University; Field Museum of Natural History (Chicago)	Tortosa, P (corresponding author), Plateforme Rech CYROI, Ctr Rech & Veille Malad Emergentes Ocean Indien, Ste Clotilde, Reunion, France.	pablo.tortosa@univ-reunion.fr	Dick, Carl/AAE-7154-2022; RAMASINDRAZANA, Beza/AGY-9255-2022	Tortosa, Pablo/0000-0002-7928-7264; RAMASINDRAZANA, Beza/0000-0002-8838-949X	European Regional Development Fund/Programme Operationnel de Cooperation Territoriale Reunion; Pathogenes associes a la Faune Sauvage Ocean Indien [31189]; National Science Foundation/Division of Environmental Biology [1003459]; Research AMP; Creative Activity Program from Western Kentucky University [11-8020]	European Regional Development Fund/Programme Operationnel de Cooperation Territoriale Reunion; Pathogenes associes a la Faune Sauvage Ocean Indien; National Science Foundation/Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Research AMP; Creative Activity Program from Western Kentucky University	Funding comes from the European Regional Development Fund/Programme Operationnel de Cooperation Territoriale Reunion, Pathogenes associes a la Faune Sauvage Ocean Indien #31189, National Science Foundation/Division of Environmental Biology-1003459, and the Research & Creative Activity Program 11-8020 from Western Kentucky University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Ching L., 1968, MALAY NAT J, V21, P171; Dick CW, 2007, ECOL ENTOMOL, V32, P446, DOI 10.1111/j.1365-2311.2007.00836.x; Dick CW, 2007, INT J PARASITOL, V37, P871, DOI 10.1016/j.ijpara.2007.02.004; Dick CW, 2006, MICROMAMMALS AND MACROPARASITES: FROM EVOLUTIONARY ECOLOGY TO MANAGEMENT, P179, DOI 10.1007/978-4-431-36025-4_11; Drummond A., 2009, GENEIOUS V5 3; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EMERICK CM, 1982, EARTH PLANET SC LETT, V60, P415, DOI 10.1016/0012-821X(82)90077-2; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fourment M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-1; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Goodman SM, 2010, J ZOOL SYST EVOL RES, V48, P75, DOI 10.1111/j.1439-0469.2009.00524.x; Goodman SM, 2012, J MAMMAL, V93, P1440, DOI 10.1644/11-MAMM-A-271.1; Goodman SM, 2010, J MAMMAL, V91, P593, DOI 10.1644/09-MAMM-A-283.1; Goodman SM, 2009, ZOOL SCR, V38, P339, DOI 10.1111/j.1463-6409.2008.00377.x; Hastriter MW, 2007, ZOOTAXA, P1; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Johnstone RA, 1996, BIOL J LINN SOC, V58, P453, DOI 10.1111/j.1095-8312.1996.tb01446.x; Lagadec E, 2012, EMERG INFECT DIS, V18, P1696, DOI 10.3201/eid1810.111898; Legendre P, 2002, SYST BIOL, V51, P217, DOI 10.1080/10635150252899734; Marshall A.G., 1980, Proceedings International Bat Research Conference, V5, P135; MARSHALL AG, 1970, PARASITOLOGY, V61, P1, DOI 10.1017/S0031182000040798; Monadjem A, ZOOTAXA IN PRESS; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nougier J., 1986, Journal of African Earth Sciences, V5, P135, DOI 10.1016/0899-5362(86)90003-5; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patterson BD, 2007, J TROP ECOL, V23, P177, DOI 10.1017/S0266467406003816; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Core Team, 2021, R LANGUAGE ENV STAT; Ramasindrazana B, 2011, BIOL J LINN SOC, V104, P284, DOI 10.1111/j.1095-8312.2011.01740.x; Swofford D.L., 2002, PHYLOGENETIC ANAL US; Theodor O, 1967, BRIT MUSEUM NATURAL, V665, P1; Tortosa P, 2012, INFECT GENET EVOL, V12, P1333, DOI 10.1016/j.meegid.2012.03.024; Wenzel R. L., 1966, P405; Weyeneth N, 2011, J EVOLUTION BIOL, V24, P1298, DOI 10.1111/j.1420-9101.2011.02262.x; Weyeneth N, 2008, MOL ECOL, V17, P5205, DOI 10.1111/j.1365-294X.2008.03994.x; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; Wilkinson DA, 2012, VIRUS RES, V170, P159, DOI 10.1016/j.virusres.2012.08.022	40	22	23	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75215	10.1371/journal.pone.0075215	http://dx.doi.org/10.1371/journal.pone.0075215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086470	gold, Green Published, Green Submitted			2022-12-27	WOS:000325223900040
J	Alvarado-Martinez, R; Salgado-Puga, K; Pena-Ortega, F				Alvarado-Martinez, Reynaldo; Salgado-Puga, Karla; Pena-Ortega, Fernando			Amyloid Beta Inhibits Olfactory Bulb Activity and the Ability to Smell	PLOS ONE			English	Article							DEPENDENT LEARNING-DEFICITS; ALZHEIMERS-DISEASE; A-BETA; GAMMA-OSCILLATIONS; MOUSE MODEL; RAT HIPPOCAMPUS; IN-VIVO; GABAERGIC INTERNEURONS; ODOR DISCRIMINATION; NETWORK ACTIVITY	Early olfactory dysfunction has been consistently reported in both Alzheimer's disease (AD) and in transgenic mice that reproduce some features of this disease. In AD transgenic mice, alteration in olfaction has been associated with increased levels of soluble amyloid beta protein (A beta) as well as with alterations in the oscillatory network activity recorded in the olfactory bulb (OB) and in the piriform cortex. However, since AD is a multifactorial disease and transgenic mice suffer a variety of adaptive changes, it is still unknown if soluble A beta, by itself, is responsible for OB dysfunction both at electrophysiological and behavioral levels. Thus, here we tested whether or not A beta directly affects OB network activity in vitro in slices obtained from mice and rats and if it affects olfactory ability in these rodents. Our results show that A beta decreases, in a concentration- and time-dependent manner, the network activity of OB slices at clinically relevant concentrations (low nM) and in a reversible manner. Moreover, we found that intrabulbar injection of A beta decreases the olfactory ability of rodents two weeks after application, an effect that is not related to alterations in motor performance or motivation to seek food and that correlates with the presence of A beta deposits. Our results indicate that A beta disrupts, at clinically relevant concentrations, the network activity of the OB in vitro and can trigger a disruption in olfaction. These findings open the possibility of exploring the cellular mechanisms involved in early pathological AD as an approach to reduce or halt its progress.	[Alvarado-Martinez, Reynaldo; Salgado-Puga, Karla; Pena-Ortega, Fernando] Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Desarrollo & Neurofisiol, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico	Pena-Ortega, F (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Desarrollo & Neurofisiol, Campus Juriquilla, Queretaro, Mexico.	jfpena@unam.mx		Salgado-Puga, Karla/0000-0002-5215-4760; Pena-Ortega, Fernando/0000-0002-0348-4392	Consejo Nacional de Ciencia y Tecnologia [151261, 181323]; Direccion General de Asuntos del Personal Academico-UNAM [IACODI1201511, IB200212]; Alzheimer's Association [NIRG-11-205443]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico-UNAM(Universidad Nacional Autonoma de Mexico); Alzheimer's Association(Alzheimer's Association)	This work was funded by Consejo Nacional de Ciencia y Tecnologia: Grants 151261 and 181323 (to FPO) and a scholarships to KSP and RAM, by Direccion General de Asuntos del Personal Academico-UNAM: Grants IACODI1201511 and IB200212 (to FPO), and by Alzheimer's Association Grant NIRG-11-205443. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaya-Villanueva A, 2010, PEPTIDES, V31, P1761, DOI 10.1016/j.peptides.2010.06.003; ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; Araki T, 1997, J PHARM PHARMACOL, V49, P310, DOI 10.1111/j.2042-7158.1997.tb06802.x; Arnold SE, 2010, ANN NEUROL, V67, P462, DOI 10.1002/ana.21910; Attems J, 2005, J ALZHEIMERS DIS, V7, P149; Bacskai BJ, 2003, P NATL ACAD SCI USA, V100, P12462, DOI 10.1073/pnas.2034101100; Badonnel K, 2012, HORM BEHAV, V62, P120, DOI 10.1016/j.yhbeh.2012.05.010; Balleza-Tapia H, 2010, CURR ALZHEIMER RES, V7, P453, DOI 10.2174/156720510791383859; Barnes C. A., 2000, Neural Plasticity, V7, P167, DOI 10.1155/NP.2000.167; Baunez C, 2002, J NEUROSCI, V22, P562, DOI 10.1523/JNEUROSCI.22-02-00562.2002; Beshel J, 2007, J NEUROSCI, V27, P8358, DOI 10.1523/JNEUROSCI.1199-07.2007; Busciglio J, 1998, ANN NY ACAD SCI, V851, P429, DOI 10.1111/j.1749-6632.1998.tb09021.x; Calderon-Garciduenas L, 2007, TOXICOL PATHOL, V35, P154, DOI 10.1080/01926230601059985; Calderon-Garciduenas L, 2010, EXP TOXICOL PATHOL, V62, P91, DOI 10.1016/j.etp.2009.02.117; Cao LX, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2013; Chapman CA, 1998, NEUROSCIENCE, V86, P1307, DOI 10.1016/S0306-4522(98)00092-X; Cheng N, 2011, J NEUROSCI, V31, P13699, DOI 10.1523/JNEUROSCI.1714-11.2011; CLEARY J, 1995, BRAIN RES, V682, P69, DOI 10.1016/0006-8993(95)00323-I; Colom LV, 2010, NEUROBIOL AGING, V31, P46, DOI 10.1016/j.neurobiolaging.2008.05.006; Condello C, 2011, SCI REP-UK, V1, DOI 10.1038/srep00019; Coronas-Samano G, 2011, REV DIG U, V12, P1067; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Didier A, 2001, P NATL ACAD SCI USA, V98, P6441, DOI 10.1073/pnas.101126398; Edwards DA, 1996, PHYSIOL BEHAV, V60, P1347, DOI 10.1016/S0031-9384(96)00260-0; EECKMAN FH, 1990, BRAIN RES, V528, P238, DOI 10.1016/0006-8993(90)91663-2; Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106; Fourcaud-Trocme N, 2011, J PHYSIOL-PARIS, V105, P59, DOI 10.1016/j.jphysparis.2011.07.009; Frautschy SA, 1996, NEUROBIOL AGING, V17, P311, DOI 10.1016/0197-4580(95)02073-X; FREEMAN WJ, 1978, ELECTROEN CLIN NEURO, V44, P586, DOI 10.1016/0013-4694(78)90126-8; Friedman D, 2000, J NEUROPHYSIOL, V84, P39, DOI 10.1152/jn.2000.84.1.39; Friedman D, 2003, J NEUROPHYSIOL, V89, P2601, DOI 10.1152/jn.00887.2002; Gervais R, 2007, J PHYSIOL-PARIS, V101, P40, DOI 10.1016/j.jphysparis.2007.10.006; GIOVANNELLI L, 1995, NEUROSCIENCE, V66, P781, DOI 10.1016/0306-4522(94)00610-H; GRAY CM, 1988, EXP BRAIN RES, V69, P378; Guerin D, 2009, NEUROBIOL AGING, V30, P272, DOI 10.1016/j.neurobiolaging.2007.05.020; Gutierrez-Lerma Armando I, 2013, Int J Pept, V2013, P328140, DOI 10.1155/2013/328140; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; HUGHES JR, 1989, CLIN ELECTROENCEPHAL, V20, P77, DOI 10.1177/155005948902000204; Igelstrom KM, 2011, J NEUROPHYSIOL, V106, P2593, DOI 10.1152/jn.00601.2011; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Kameshima N, 2012, NEUROSCI LETT, V513, P166, DOI 10.1016/j.neulet.2012.02.026; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Kay LM, 2010, J NEUROPHYSIOL, V104, P829, DOI 10.1152/jn.00166.2010; Kay LM, 2009, TRENDS NEUROSCI, V32, P207, DOI 10.1016/j.tins.2008.11.008; Klementiev B, 2007, NEUROSCIENCE, V145, P209, DOI 10.1016/j.neuroscience.2006.11.060; Kovacs T, 2004, AGEING RES REV, V3, P215, DOI 10.1016/j.arr.2003.10.003; Kovacs T, 1999, NEUROPATH APPL NEURO, V25, P481; Lagier S, 2004, J NEUROSCI, V24, P4382, DOI 10.1523/JNEUROSCI.5570-03.2004; Lagier S, 2007, P NATL ACAD SCI USA, V104, P7259, DOI 10.1073/pnas.0701846104; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Langer F, 2011, J NEUROSCI, V31, P14488, DOI 10.1523/JNEUROSCI.3088-11.2011; Larriva-Sahd J, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00023; Le Pichon CE, 2009, NAT NEUROSCI, V12, P60, DOI 10.1038/nn.2238; Lehman EJH, 2003, NEUROBIOL AGING, V24, P645, DOI 10.1016/S0197-4580(02)00153-7; Lepousez G, 2010, J NEUROSCI, V30, P870, DOI 10.1523/JNEUROSCI.4958-09.2010; Li AA, 2011, P NATL ACAD SCI USA, V108, P5087, DOI 10.1073/pnas.1013814108; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Luna-Munoz J, 2008, ACTA NEUROPATHOL, V116, P507, DOI 10.1007/s00401-008-0431-x; Malm T, 2006, P NATL ACAD SCI USA, V103, P8852, DOI 10.1073/pnas.0602896103; Martin C, 2004, J PHYSIOLOGY-PARIS, V98, P467, DOI 10.1016/j.jphysparis.2005.09.003; Martin C, 2006, EUR J NEUROSCI, V23, P1801, DOI 10.1111/j.1460-9568.2006.04711.x; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Montgomery KS, 2011, NEUROBIOL AGING, V32, P1273, DOI 10.1016/j.neurobiolaging.2009.08.003; Morales R, 2012, MOL PSYCHIATR, V17, P1347, DOI 10.1038/mp.2011.120; MORI K, 1978, J PHYSIOL-LONDON, V279, P569, DOI 10.1113/jphysiol.1978.sp012362; Mostany R, 2013, J NEUROSCI, V33, P4094, DOI 10.1523/JNEUROSCI.4825-12.2013; Mucignat-Caretta C, 2009, AM J PHYSIOL-LUNG C, V297, pL1073, DOI 10.1152/ajplung.00014.2009; Murakami M, 2005, NEURON, V46, P285, DOI 10.1016/j.neuron.2005.02.025; MURPHY C, 1990, NEUROBIOL AGING, V11, P465, DOI 10.1016/0197-4580(90)90014-Q; Nakamura S, 2001, BRAIN RES, V912, P128, DOI 10.1016/S0006-8993(01)02704-4; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nieuwenhuys R, 1967, Prog Brain Res, V23, P1; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Nobakht Maliheh, 2011, Iranian Biomedical Journal, V15, P51; Nusser Z, 2001, J NEUROPHYSIOL, V86, P2823, DOI 10.1152/jn.2001.86.6.2823; O'Hare E, 1999, BRAIN RES, V815, P1, DOI 10.1016/S0006-8993(98)01002-6; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th, P456; Pena F, 1999, J NEUROCHEM, V72, P2006, DOI 10.1046/j.1471-4159.1999.0722006.x; Pena F, 2006, CURR NEUROPHARMACOL, V4, P149, DOI 10.2174/157015906776359531; Pena F, 2000, NEUROSCIENCE, V101, P547, DOI 10.1016/S0306-4522(00)00400-0; Pena F, 2010, HIPPOCAMPUS, V20, P78, DOI 10.1002/hipo.20592; Pena-Ortega F, 2013, NEURODEGENER DIS, V2013; Pena-Ortega Fernando, 2012, Int J Pept, V2012, P236289, DOI 10.1155/2012/236289; Pena-Ortega F, 2012, CURR ALZHEIMER RES, V9, P857, DOI 10.2174/156720512802455403; Portillo W, 2004, HORM BEHAV, V46, P330, DOI 10.1016/j.yhbeh.2004.03.001; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; Ramirez JM, 2004, CURR OPIN NEUROBIOL, V14, P665, DOI 10.1016/j.conb.2004.10.011; Ramirez-Jarquin JO, 2012, PEPTIDES, V34, P360, DOI 10.1016/j.peptides.2012.02.011; Rey NL, 2012, NEUROBIOL AGING, V33; Richardson RL, 2002, BRAIN RES, V954, P1, DOI 10.1016/S0006-8993(02)03006-8; Rojas-Libano D, 2008, COGN NEURODYNAMICS, V2, P179, DOI 10.1007/s11571-008-9053-1; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Sassoe-Pognetto M, 2009, ANN NY ACAD SCI, V1170, P259, DOI 10.1111/j.1749-6632.2009.03882.x; Schofield PW, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-24; SCHREITERGASSER U, 1994, ELECTROEN CLIN NEURO, V90, P267, DOI 10.1016/0013-4694(94)90144-9; SELKOE DJ, 1993, TRENDS NEUROSCI, V16, P403, DOI 10.1016/0166-2236(93)90008-A; SERBY M, 1991, AM J PSYCHIAT, V148, P357; SHEPHERD GM, 1972, PHYSIOL REV, V52, P864, DOI 10.1152/physrev.1972.52.4.864; Sigurdsson EM, 1996, NEUROBIOL AGING, V17, P893, DOI 10.1016/S0197-4580(96)00169-8; Stakic J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023990; Stephan A, 2001, J NEUROSCI, V21, P5703, DOI 10.1523/JNEUROSCI.21-15-05703.2001; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; Thompson MD, 1998, NEUROPSYCHOL REV, V8, P11, DOI 10.1023/A:1025627106073; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Villette V, 2010, J NEUROSCI, V30, P10991, DOI 10.1523/JNEUROSCI.6284-09.2010; Vreugdenhil M, 2005, NEUROSCIENCE, V132, P1151, DOI 10.1016/j.neuroscience.2005.01.025; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; WARNER MD, 1986, BIOL PSYCHIAT, V21, P116, DOI 10.1016/0006-3223(86)90013-2; Watts JC, 2011, P NATL ACAD SCI USA, V108, P2528, DOI 10.1073/pnas.1019034108; Wesson DW, 2013, BEHAV BRAIN RES, V237, P96, DOI 10.1016/j.bbr.2012.09.019; Wesson DW, 2010, J NEUROSCI, V30, P505, DOI 10.1523/JNEUROSCI.4622-09.2010; Xing CH, 2005, NEUROSCI LETT, V384, P93, DOI 10.1016/j.neulet.2005.04.063; Yamada K, 2005, BEHAV BRAIN RES, V162, P191, DOI 10.1016/j.bbr.2005.02.036; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Young JW, 2009, NEUROBIOL AGING, V30, P1430, DOI 10.1016/j.neurobiolaging.2007.11.018; Zussy C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053117; Zussy C, 2011, AM J PATHOL, V179, P315, DOI 10.1016/j.ajpath.2011.03.021	121	37	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75745	10.1371/journal.pone.0075745	http://dx.doi.org/10.1371/journal.pone.0075745			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086624	Green Published, gold, Green Submitted			2022-12-27	WOS:000325220000038
J	Ye, DM; Xu, YM; Zhang, H; Fu, TF; Jiang, L; Bai, YH				Ye, Dongmei; Xu, Yiming; Zhang, Han; Fu, Tengfei; Jiang, Lan; Bai, Yuehong			Effects of Low-Dose Microwave on Healing of Fractures with Titanium Alloy Internal Fixation: An Experimental Study in a Rabbit Model	PLOS ONE			English	Article							PULSED SHORTWAVE DIATHERMY; NONIONIZING RADIATION; SAR DISTRIBUTION; THERMAL-DAMAGE; TUMOR ABLATION; IN-VIVO; HYPERTHERMIA; TEMPERATURE; BONE; ULTRASOUND	Background: Microwave is a method for improving fracture repair. However, one of the contraindications for microwave treatment listed in the literature is surgically implanted metal plates in the treatment field. The reason is that the reflection of electromagnetic waves and the eddy current stimulated by microwave would increase the temperature of magnetic implants and cause heat damage in tissues. Comparing with traditional medical stainless steel, titanium alloy is a kind of medical implants with low magnetic permeability and electric conductivity. But the effects of microwave treatment on fracture with titanium alloy internal fixation in vivo were not reported. The aim of this article was to evaluate the security and effects of microwave on healing of a fracture with titanium alloy internal fixation. Methods: Titanium alloy internal fixation systems were implanted in New Zealand rabbits with a 3.0 mm bone defect in the middle of femur. We applied a 30-day microwave treatment (2,450MHz, 25W, 10 min per day) to the fracture 3 days after operation. Temperature changes of muscle tissues around implants were measured during the irradiation. Normalized radiographic density of the fracture gap was measured on the 10th day and 30th day of the microwave treatment. All of the animals were killed after 10 and 30 days microwave treatment with histologic and histomorphometric examinations performed on the harvested tissues. Findings: The temperatures did not increase significantly in animals with titanium alloy implants. The security of microwave treatment was also supported by histology of muscles, nerve and bone around the implants. Radiographic assessment, histologic and histomorphometric examinations revealed significant improvement in the healing bone. Conclusion: Our results suggest that, in the healing of fracture with titanium alloy internal fixation, a low dose of microwave treatment may be a promising method.	[Ye, Dongmei; Xu, Yiming; Zhang, Han; Fu, Tengfei; Jiang, Lan; Bai, Yuehong] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Rehabil, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Bai, YH (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Rehabil, Shanghai 200030, Peoples R China.	aibyhw@126.com	Xu, yiming/E-5687-2012	Xu, yiming/0000-0002-7123-5793				Akyol Y, 2012, RHEUMATOL INT, V32, P3007, DOI 10.1007/s00296-011-2097-2; BERNHARDT JH, 1992, PHYS MED BIOL, V37, P807, DOI 10.1088/0031-9155/37/4/001; Campbell RSD., 2013, IMAGING POSTOPERATIV, P365; Chang WHS, 2002, BIOELECTROMAGNETICS, V23, P256, DOI 10.1002/bem.10009; Cooper J, 1996, ELECTRON LETT, V32, P2217, DOI 10.1049/el:19961507; Dewhirst MW, 2003, INT J HYPERTHER, V19, P267, DOI 10.1080/0265673031000119006; Draper DO, 2004, ATHLET THER TODAY, V9, P28; Eggers G, 2005, MAGN RESON MATER PHY, V18, P103, DOI 10.1007/s10334-005-0101-0; ERIKSSON AR, 1983, J PROSTHET DENT, V50, P101, DOI 10.1016/0022-3913(83)90174-9; Funk RHW, 1999, ANAT REC, V255, P458; Ganapathi M, 2002, J HAND SURG-BRIT EUR, V27B, P165, DOI 10.1054/jhsb.2001.0717; GINZBURG EL, 1976, TSITOLOGIYA+, V18, P600; Giombini A, 2007, BRIT MED BULL, V83, P379, DOI 10.1093/bmb/ldm020; Giombini A, 2001, J SPORT MED PHYS FIT, V41, P521; Giombini A, 2006, AM J SPORT MED, V34, P1247, DOI 10.1177/0363546506287827; Goats G C, 1990, Br J Sports Med, V24, P212; GRANT EH, 1981, IEE PROC-A, V128, P602, DOI 10.1049/ip-a-1.1981.0091; GUY AW, 1987, HEALTH PHYS, V53, P569, DOI 10.1097/00004032-198712000-00001; HARRIS ED, 1974, NEW ENGL J MED, V290, P1, DOI 10.1056/NEJM197401032900101; HAUSCHKA PV, 1986, J BIOL CHEM, V261, P2665; Huidobro C, 2009, THESCIENTIFICWORLDJO, V9, P10, DOI 10.1100/tsw.2009.4; Ji ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030505; Kaasik A, 2010, CARDIOVASC RES, V87, P83, DOI 10.1093/cvr/cvq039; KENNEDY WF, 1993, CLIN ORTHOP RELAT R, P198; LATEUR BJD, 1978, ARCH PHYS MED REHAB, V59, P488; LEHMANN JF, 1975, ARCH PHYS MED REHAB, V56, P145; LEHMANN JF, 1983, ARCH PHYS MED REHAB, V64, P127; LEON SA, 1993, INT J HYPERTHER, V9, P69, DOI 10.3109/02656739309061479; LEON SA, 1993, INT J HYPERTHER, V9, P77, DOI 10.3109/02656739309061480; Li J, 2005, CLIN GUIDELINES PHYS, P54; Liebergall M, 2000, CLIN ORTHOP RELAT R, P272; Lubner MG, 2010, J VASC INTERV RADIOL, V21, pS192, DOI 10.1016/j.jvir.2010.04.007; McIntosh RL, 2005, BIOELECTROMAGNETICS, V26, P377, DOI 10.1002/bem.20112; MESHORER A, 1983, ARCH PATHOL LAB MED, V107, P328; Mougenot C, 2009, MAGN RESON MED, V61, P603, DOI 10.1002/mrm.21887; Muranaka H, 2011, MAGN RESON MED SCI, V10, P11, DOI 10.2463/mrms.10.11; Muranaka Hiroyuki, 2010, Nihon Hoshasen Gijutsu Gakkai Zasshi, V66, P725; Olchowik G, 1992, Chir Narzadow Ruchu Ortop Pol, V57, P297; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Perren SM, 2008, ACTA CHIR ORTHOP TR, V75, P241; Perry AC, 2003, CLIN ORTHOP RELAT R, P95, DOI 10.1097/01.blo.0000087322.60612.14; Pope GD, 1995, PHYSIOTHERAPY, V81, P82, DOI DOI 10.1016/S0031-9406(05)67050-2; Rabini A, 2012, EUR J PHYS REHAB MED, V48, P549; Ruggera PS, 2003, PHYS MED BIOL, V48, P2919, DOI 10.1088/0031-9155/48/17/312; SAPARETO SA, 1984, INT J RADIAT ONCOL, V10, P787, DOI 10.1016/0360-3016(84)90379-1; Seiger C, 2006, J ORTHOP SPORT PHYS, V36, P669, DOI 10.2519/jospt.2006.2198; SEKINS KM, 1984, ARCH PHYS MED REHAB, V65, P1; SEYEDIN SM, 1987, J BIOL CHEM, V262, P1946; Shields Nora, 2002, Physiother Res Int, V7, P191, DOI 10.1002/pri.259; Skonieczki BD, 2011, EUR J RADIOL, V79, P343, DOI 10.1016/j.ejrad.2010.04.004; Sokka SD, 2003, PHYS MED BIOL, V48, P223, DOI 10.1088/0031-9155/48/2/306; Virtanen H, 2007, PHYS MED BIOL, V52, P1221, DOI 10.1088/0031-9155/52/5/001; Virtanen H, 2005, PHYS MED BIOL, V50, P2689, DOI 10.1088/0031-9155/50/11/017; WELGUS HG, 1981, J BIOL CHEM, V256, P9516; Wyper D J, 1976, Br J Sports Med, V10, P19; Yarmolenko PS, 2011, INT J HYPERTHER, V27, P320, DOI 10.3109/02656736.2010.534527; YATVIN MB, 1977, INT J RADIAT BIOL, V32, P513, DOI 10.1080/09553007714551301; Yue ZX, 2003, J EUR CERAM SOC, V23, P189, DOI 10.1016/S0955-2219(02)00082-1; Zderic V, 2008, MED PHYS, V35, P4292, DOI 10.1118/1.2975149	59	9	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75756	10.1371/journal.pone.0075756	http://dx.doi.org/10.1371/journal.pone.0075756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086626	Green Submitted, Green Published, gold			2022-12-27	WOS:000325220000040
J	Palanca, L; Gaskett, AC; Gunther, CS; Newcomb, RD; Goddard, MR				Palanca, Loida; Gaskett, Anne C.; Guenther, Catrin S.; Newcomb, Richard D.; Goddard, Matthew R.			Quantifying Variation in the Ability of Yeasts to Attract Drosophila melanogaster	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; POPULATION; DISPERSAL; ESTERS; OVIPOSITION; MODULATION; PREFERENCE; AVOIDANCE; INCREASES; EVOLUTION	Yeasts that invade and colonise fruit significantly enhance the volatile chemical diversity of this ecosystem. These modified bouquets are thought to be more attractive to Drosophila flies than the fruit alone, but the variance of attraction in natural yeast populations is uncharacterised. Here we investigate how a range of yeast isolates affect the attraction of female D. melanogaster to fruit in a simple two choice assay comparing yeast to sterile fruit. Of the 43 yeast isolates examined, 33 were attractive and seven repellent to the flies. The results of isolate-versus-isolate comparisons provided the same relative rankings. Attractiveness varied significantly by yeast, with the strongly fermenting Saccharomyces species generally being more attractive than the mostly respiring non-Saccharomyces species (P = 0.0035). Overall the habitat (fruit or other) from which the isolates were directly sampled did not explain attraction (P = 0.2352). However, yeasts isolated from fruit associated niches were more attractive than those from non-fruit associated niches (P = 0.0188) regardless of taxonomic positioning. These data suggest that while attractiveness is primarily correlated with phylogenetic status, the ability to attract Drosophila is a labile trait among yeasts that is potentially associated with those inhabiting fruit ecosystems. Preliminary analysis of the volatiles emitted by four yeast isolates in grape juice show the presence/absence of ethanol and acetic acid were not likely explanations for the observed variation in attraction. These data demonstrate variation among yeasts for their ability to attract Drosophila in a pattern that is consistent with the hypothesis that certain yeasts are manipulating fruit odours to mediate interactions with their Drosophila dispersal agent.	[Palanca, Loida; Gaskett, Anne C.; Guenther, Catrin S.; Newcomb, Richard D.; Goddard, Matthew R.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Newcomb, Richard D.] New Zealand Inst Plant & Food Res Ltd, Auckland, New Zealand	University of Auckland; New Zealand Institute for Plant & Food Research Ltd	Goddard, MR (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	m.goddard@auckland.ac.nz	Newcomb, Richard/C-2067-2009; Goddard, Matthew/C-7462-2014	Newcomb, Richard/0000-0002-7307-9755; Goddard, Matthew/0000-0002-7482-4438; Gaskett, Anne/0000-0002-7659-9537; Gunther, Catrin S/0000-0002-9712-0169	Faculty of Science, University of Auckland; Marsden Fund [PAF-09-01]	Faculty of Science, University of Auckland; Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	Funding was provided by the Faculty of Science, University of Auckland to MG, and the Marsden Fund (PAF-09-01) to RDN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostou C, 2010, ENTOMOL EXP APPL, V136, P1, DOI 10.1111/j.1570-7458.2010.00997.x; Anfang N, 2009, AUST J GRAPE WINE R, V15, P1, DOI 10.1111/j.1755-0238.2008.00031.x; Barata A, 2012, INT J FOOD MICROBIOL, V153, P243, DOI 10.1016/j.ijfoodmicro.2011.11.025; Becher PG, 2012, FUNCT ECOL, V26, P822, DOI 10.1111/j.1365-2435.2012.02006.x; BEGG M, 1946, PROC R SOC SER B-BIO, V133, P1, DOI 10.1098/rspb.1946.0001; Chandler JA, 2012, APPL ENVIRON MICROB, V78, P7327, DOI 10.1128/AEM.01741-12; Chen H, 2004, P NATL ACAD SCI USA, V101, P5048, DOI 10.1073/pnas.0401416101; Costa A, 2008, FOOD MICROBIOL, V25, P422, DOI 10.1016/j.fm.2007.10.003; Devineni AV, 2009, CURR BIOL, V19, P2126, DOI 10.1016/j.cub.2009.10.070; FUYAMA Y, 1976, BEHAV GENET, V6, P407, DOI 10.1007/BF01065698; Ganter A, 2006, BIODIVERSITY ECOPHYS; Giglioli J., 1897, Nature, Vlvi, P575; GILBERT DG, 1980, OECOLOGIA, V46, P135, DOI 10.1007/BF00346979; Goddard MR, 2008, ECOLOGY, V89, P2077, DOI 10.1890/07-2060.1; Goddard MR, 2010, ENVIRON MICROBIOL, V12, P63, DOI 10.1111/j.1462-2920.2009.02035.x; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Gray JC, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-43; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Howell KS, 2004, FEMS MICROBIOL LETT, V240, P125, DOI 10.1016/j.femsle.2004.09.022; Johnson LJ, 2004, GENETICS, V166, P43, DOI 10.1534/genetics.166.1.43; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Joseph RM, 2009, P NATL ACAD SCI USA, V106, P11352, DOI 10.1073/pnas.0901419106; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1; Laland KN, 1999, P NATL ACAD SCI USA, V96, P10242, DOI 10.1073/pnas.96.18.10242; Lebreton S, 2012, J INSECT PHYSIOL, V58, P125, DOI 10.1016/j.jinsphys.2011.10.009; Markow TA, 2008, FUNCT ECOL, V22, P747, DOI 10.1111/j.1365-2435.2008.01457.x; Masse NY, 2009, CURR BIOL, V19, pR700, DOI 10.1016/j.cub.2009.06.026; Merico A, 2007, FEBS J, V274, P976, DOI 10.1111/j.1742-4658.2007.05645.x; Moreira N, 2005, INT J FOOD MICROBIOL, V103, P285, DOI 10.1016/j.ijfoodmicro.2004.12.029; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; Ogueta M, 2010, CHEM SENSES, V35, P813, DOI 10.1093/chemse/bjq084; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Piskur J, 2006, TRENDS GENET, V22, P183, DOI 10.1016/j.tig.2006.02.002; Reuter M, 2007, CURR BIOL, V17, pR81, DOI 10.1016/j.cub.2006.11.059; Romano P, 2003, INT J FOOD MICROBIOL, V86, P169, DOI 10.1016/S0168-1605(03)00290-3; Saerens SMG, 2010, MICROB BIOTECHNOL, V3, P165, DOI 10.1111/j.1751-7915.2009.00106.x; Simmons FH, 1997, J INSECT PHYSIOL, V43, P779, DOI 10.1016/S0022-1910(97)00037-1; Stamps JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042238; STARMER WT, 1988, ANIM BEHAV, V36, P1691, DOI 10.1016/S0003-3472(88)80109-X; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; Stensmyr MC, 2003, P ROY SOC B-BIOL SCI, V270, P2333, DOI 10.1098/rspb.2003.2512; Stokl J, 2010, CURR BIOL, V20, P1846, DOI 10.1016/j.cub.2010.09.033; Styger G, 2011, APPL MICROBIOL BIOT, V91, P713, DOI 10.1007/s00253-011-3237-z; Sumby KM, 2010, FOOD CHEM, V121, P1, DOI 10.1016/j.foodchem.2009.12.004; Swiegers JH, 2005, ADV APPL MICROBIOL, V57, P131, DOI 10.1016/S0065-2164(05)57005-9; THOMPSON J N JR, 1979, Southwestern Naturalist, V24, P204, DOI 10.2307/3670647; Thomson JM, 2005, NAT GENET, V37, P630, DOI 10.1038/ng1553; Tsai IJ, 2008, P NATL ACAD SCI USA, V105, P4957, DOI 10.1073/pnas.0707314105; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Vianna E, 2001, J AGR FOOD CHEM, V49, P589, DOI 10.1021/jf000907g; Vosshall LB, 2000, CURR OPIN NEUROBIOL, V10, P498, DOI 10.1016/S0959-4388(00)00111-2; Zhu JW, 2003, J CHEM ECOL, V29, P899, DOI 10.1023/A:1022931816351	54	72	73	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75332	10.1371/journal.pone.0075332	http://dx.doi.org/10.1371/journal.pone.0075332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086510	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000325218700077
J	Wu, CY; Young, L; Young, D; Martel, J; Young, JD				Wu, Cheng-Yeu; Young, Lena; Young, David; Martel, Jan; Young, John D.			Bions: A Family of Biomimetic Mineralo-Organic Complexes Derived from Biological Fluids	PLOS ONE			English	Article							AMORPHOUS CALCIUM-CARBONATE; NANOBACTERIA-LIKE PARTICLES; POLYCYSTIC KIDNEY-DISEASE; FETAL BOVINE SERUM; CALCIFYING NANOPARTICLES; FETUIN-A; STONE FORMATION; CALCIPROTEIN PARTICLES; OXIDATIVE STRESS; RANDALLS PLAQUE	Mineralo-organic nanoparticles form spontaneously in human body fluids when the concentrations of calcium and phosphate ions exceed saturation. We have shown previously that these mineralo-organic nanoparticles possess biomimetic properties and can reproduce the whole phenomenology of the so-called nanobacteria-mineralized entities initially described as the smallest microorganisms on earth. Here, we examine the possibility that various charged elements and ions may form mineral nanoparticles with similar properties in biological fluids. Remarkably, all the elements tested, including sodium, magnesium, aluminum, calcium, manganese, iron, cobalt, nickel, copper, zinc, strontium, and barium form mineralo-organic particles with bacteria-like morphologies and other complex shapes following precipitation with phosphate in body fluids. Upon formation, these mineralo-organic particles, which we term bions, invariably accumulate carbonate apatite during incubation in biological fluids; yet, the particles also incorporate additional elements and thus reflect the ionic milieu in which they form. Bions initially harbor an amorphous mineral phase that gradually converts to crystals in culture. Our results show that serum produces a dual inhibition-seeding effect on bion formation. Using a comprehensive proteomic analysis, we identify a wide range of proteins that bind to these mineral particles during incubation in medium containing serum. The two main binding proteins identified, albumin and fetuin-A, act as both inhibitors and seeders of bions in culture. Notably, bions possess several biomimetic properties, including the possibility to increase in size and number and to be sub-cultured in fresh culture medium. Based on these results, we propose that bions represent biological, mineralo-organic particles that may form in the body under both physiological and pathological homeostasis conditions. These mineralo-organic particles may be part of a physiological cycle that regulates the function, transport and disposal of elements and minerals in the human body.	[Wu, Cheng-Yeu; Young, Lena; Young, David; Martel, Jan; Young, John D.] Chang Gung Univ, Lab Nanomat, Tao Yuan, Taiwan; [Wu, Cheng-Yeu; Martel, Jan; Young, John D.] Chang Gung Univ, Ctr Mol & Clin Immunol, Tao Yuan, Taiwan; [Wu, Cheng-Yeu] Chang Gung Univ, Res Ctr Bacterial Pathogenesis, Tao Yuan, Taiwan; [Young, Lena] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Young, David] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Young, John D.] Rockefeller Univ, Lab Cellular Physiol & Immunol, New York, NY 10021 USA; [Young, John D.] Ming Chi Univ Technol, Biochem Engn Res Ctr, Taipei, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Harvard University; Massachusetts Institute of Technology (MIT); Rockefeller University; Ming Chi University of Technology	Young, JD (corresponding author), Chang Gung Univ, Lab Nanomat, Tao Yuan, Taiwan.	dingeyoung@hotmail.com		Young, David/0000-0002-8290-5561; Martel, Jan/0000-0003-0879-109X	Primordia Institute of New Sciences and Medicine; Chang Gung University [CLRPD1A0011, QZRPD88E]; Ming Chi University of Technology [0XB0]; Ministry of Education of Taiwan [EMRPD1B047]; National Science Council of Taiwan [101-2632-B-182-001-MY3]	Primordia Institute of New Sciences and Medicine; Chang Gung University; Ming Chi University of Technology; Ministry of Education of Taiwan(Ministry of Education, Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Primordia Institute of New Sciences and Medicine; by grants from Chang Gung University (CLRPD1A0011 and QZRPD88E), Ming Chi University of Technology (0XB0), the Ministry of Education of Taiwan (EMRPD1B047), and the National Science Council of Taiwan (101-2632-B-182-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-El-Sooud K, 2011, INSIGHT NANOTECHNOL, V1, P15; Aggarwal P, 2009, ADV DRUG DELIVER REV, V61, P428, DOI 10.1016/j.addr.2009.03.009; Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Aguzzi A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002651; Aizenberg J, 1996, ADV MATER, V8, P222, DOI 10.1002/adma.19960080307; Akerman KK, 1997, P SOC PHOTO-OPT INS, V3111, P436, DOI 10.1117/12.278798; [Anonymous], 2010, SCI AM, V302, P28; Ayman A, 2008, EUR PHYS J-SPEC TOP, V153, P497, DOI 10.1140/epjst/e2008-00493-5; Barr SC, 2003, AM J VET RES, V64, P176, DOI 10.2460/ajvr.2003.64.176; Barralet J, 1998, J BIOMED MATER RES, V41, P79, DOI 10.1002/(SICI)1097-4636(199807)41:1<79::AID-JBM10>3.0.CO;2-C; Barrere F, 2006, INT J NANOMED, V1, P317; Benzerara K, 2003, P NATL ACAD SCI USA, V100, P7438, DOI 10.1073/pnas.0832464100; Bonucci E, 2005, EUR J HISTOCHEM, V49, P1; Boskey AL, 1998, J CELL BIOCHEM, P83, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<83::AID-JCB12>3.0.CO;2-F; Bratos-Perez MA, 2008, EUR HEART J, V29, P371, DOI 10.1093/eurheartj/ehm592; BROWN WM, 1992, BIOESSAYS, V14, P749, DOI 10.1002/bies.950141105; Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994; Cedervall T, 2007, ANGEW CHEM INT EDIT, V46, P5754, DOI 10.1002/anie.200700465; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Chin WC, 1998, NATURE, V391, P568, DOI 10.1038/35345; Ciftcioglu N, 2005, KIDNEY INT, V67, P483, DOI 10.1111/j.1523-1755.2005.67105.x; Ciftcioglu N, 1999, KIDNEY INT, V56, P1893, DOI 10.1046/j.1523-1755.1999.00755.x; Ciftcioglu N, 1997, VACCINES, P99; Ciftcioglu N, 1998, PATHOPHYSIOLOGY, V4, P259, DOI DOI 10.1016/S0928-4680(97)10001-3; Ciftcioglu N, 2006, J INVEST MED, V54, P385, DOI 10.2310/6650.2006.06018; Ciftcioglu N, 2007, LANCET, V369, P2078, DOI 10.1016/S0140-6736(07)60977-5; Ciftcioglu N, 2008, INT J NANOMED, V3, P105; Cisar JO, 2000, P NATL ACAD SCI USA, V97, P11511, DOI 10.1073/pnas.97.21.11511; Colfen H, 2005, ANGEW CHEM INT EDIT, V44, P5576, DOI 10.1002/anie.200500496; Dell'Orco D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010949; Drancourt M, 2003, J CLIN MICROBIOL, V41, P368, DOI 10.1128/JCM.41.1.368-372.2003; EANES ED, 1973, CALC TISS RES, V12, P143, DOI 10.1007/BF02013730; Evan AP, 2010, PEDIATR NEPHROL, V25, P831, DOI 10.1007/s00467-009-1116-y; Evan AP, 2005, KIDNEY INT, V68, P145, DOI 10.1111/j.1523-1755.2005.00388.x; FOGHANDERSEN N, 1977, CLIN CHEM, V23, P2122; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; Garcia-Ruiz JM, 2009, SCIENCE, V323, P362, DOI 10.1126/science.1165349; GARNETT J, 1990, BIOCHEM J, V266, P863; Gatti AM, 2005, J MATER SCI-MATER M, V16, P1213, DOI 10.1007/s10856-005-4731-6; Gatti AM, 2008, NANOPATHOLOGY: THE HEALTH IMPACT OF NANOPARTICLES, P1; Gatti AM, 2002, BIOMATERIALS, V23, P2381, DOI 10.1016/S0142-9612(01)00374-X; Ghadially FN, 2001, ULTRASTRUCT PATHOL, V25, P243; GILMAN H, 1994, J INORG BIOCHEM, V55, P31, DOI 10.1016/0162-0134(94)85130-1; Gross M, 2012, CURR BIOL, V22, pR207, DOI 10.1016/j.cub.2012.03.040; Heiss A, 2007, BIOINTERPHASES, V2, P16, DOI 10.1116/1.2714924; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Heiss A, 2008, J BIOL CHEM, V283, P14815, DOI 10.1074/jbc.M709938200; Hendig D, 2006, CLIN CHEM, V52, P227, DOI 10.1373/clinchem.2005.059253; Herrmann M, 2012, CIRC RES, V111, P575, DOI 10.1161/CIRCRESAHA.111.261479; Hjelle JT, 2000, KIDNEY INT, V57, P2360, DOI 10.1046/j.1523-1755.2000.00096.x; Hohling H J, 1997, Adv Dent Res, V11, P462; Hudelist G, 2004, HISTOPATHOLOGY, V45, P633, DOI 10.1111/j.1365-2559.2004.02030.x; Hyde ST, 2003, PHYSICA A, V339, P24; Iannitti T, 2010, INT J NANOMED, V5, P955, DOI 10.2147/IJN.S14363; Jahnen-Dechent W, 2001, Z Kardiol, V90 Suppl 3, P47; Jahnen-Dechent W., 2005, BIOMINERALISATION, P243; Jahnen-Dechent W, 2008, J MOL MED, V86, P379, DOI 10.1007/s00109-007-0294-y; Jahnen-Dechent W, 2011, CIRC RES, V108, P1494, DOI 10.1161/CIRCRESAHA.110.234260; Jelic TM, 2004, SOUTH MED J, V97, P194, DOI 10.1097/01.SMJ.0000077067.44311.F0; Jersmann HPA, 2003, CLIN SCI, V105, P273, DOI 10.1042/CS20030126; Johansson L, 2003, CYTOTECHNOLOGY, V42, P67, DOI 10.1023/B:CYTO.0000009820.72920.cf; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Kajander EO, 2006, LETT APPL MICROBIOL, V42, P549, DOI 10.1111/j.1472-765X.2006.01945.x; Kajander EO, 1997, P SOC PHOTO-OPT INS, V3111, P420, DOI 10.1117/12.278796; Kajander EO, 2003, UROL RES, V31, P47, DOI 10.1007/s002440-003-0304-7; Kajander EO, 1998, P NATL ACAD SCI USA, V95, P8274, DOI 10.1073/pnas.95.14.8274; Kajander EO, 2001, CURR OPIN NEPHROL HY, V10, P445, DOI 10.1097/00041552-200105000-00023; Kajander EO, 1993, VIRUS VIRUS LIKE AGE, P41; Ketteler M, 2005, PEDIATR NEPHROL, V20, P383, DOI 10.1007/s00467-004-1614-x; Ketteler M, 2003, KIDNEY INT, V63, pS84, DOI 10.1046/j.1523-1755.63.s84.21.x; Khullar M, 2004, UROL RES, V32, P190, DOI 10.1007/s00240-004-0400-3; Knoll A, 1999, SIZ LIM VER SMALL MI; Komaba H, 2009, KIDNEY INT, V75, P874, DOI 10.1038/ki.2009.52; Kumar V, 2006, J INVEST MED, V54, P412, DOI 10.2310/6650.2006.06021; Kutikhin AG, 2012, INT J NANOMED, V7, P339, DOI 10.2147/IJN.S28069; LEGEROS RZ, 1981, PROG CRYST GROWTH CH, V4, P1; Lieske JC, 2008, NAT CLIN PRACT NEPHR, V4, P308, DOI 10.1038/ncpneph0794; Loohuis KMO, 2010, KIDNEY INT, V77, P77, DOI 10.1038/ki.2009.407; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lynch I., 2006, DETECTING CRYPTIC EP, V2006, DOI [10.1126/stke.3272006pe14, DOI 10.1126/STKE.3272006PE14]; Lynch I, 2007, PHYSICA A, V373, P511, DOI 10.1016/j.physa.2006.06.008; Lynch I, 2009, NAT NANOTECHNOL, V4, P546, DOI 10.1038/nnano.2009.248; Mahamid J, 2010, P NATL ACAD SCI USA, V107, P6316, DOI 10.1073/pnas.0914218107; Mann S., 2001, BIOMINERALIZATION PR; Martel J, 2008, P NATL ACAD SCI USA, V105, P5549, DOI 10.1073/pnas.0711744105; Martel J, 2012, ANNU REV EARTH PL SC, V40, P167, DOI 10.1146/annurev-earth-042711-105401; Martel J, 2011, ANAL BIOCHEM, V418, P111, DOI 10.1016/j.ab.2011.06.018; Martel J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010343; Miller VM, 2009, NANOMEDICINE-UK, V4, P725, DOI [10.2217/nnm.09.61, 10.2217/NNM.09.61]; Nadra I, 2008, ATHEROSCLEROSIS, V196, P98, DOI 10.1016/j.atherosclerosis.2007.02.005; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; NYLEN MU, 1972, CALC TISS RES, V9, P95, DOI 10.1007/BF02061948; Park MVDZ, 2009, NANOMEDICINE-UK, V4, P669, DOI 10.2217/nnm.09.40; Peng HH, 2013, SMALL, V9, P2297, DOI 10.1002/smll.201202270; Peng HH, 2011, NANOMEDICINE-UK, V6, P643, DOI [10.2217/NNM.11.24, 10.2217/nnm.11.24]; POSNER AS, 1969, PHYSIOL REV, V49, P760, DOI 10.1152/physrev.1969.49.4.760; Price PA, 2004, J BIOL CHEM, V279, P1594, DOI 10.1074/jbc.M305199200; Puskas LG, 2005, ACTA BIOL HUNG, V56, P233, DOI 10.1556/ABiol.56.2005.3-4.7; Raz S, 2002, BIOL BULL-US, V203, P269, DOI 10.2307/1543569; Robinson C, 2004, J MATER CHEM, V14, P2242, DOI 10.1039/b401154f; Rochette CN, 2009, CHEMBIOCHEM, V10, P735, DOI 10.1002/cbic.200800719; Ruiz JMG, 2002, ASTROBIOLOGY, V2, P353, DOI 10.1089/153110702762027925; Ryall RL, 2008, UROL RES, V36, P77, DOI 10.1007/s00240-007-0131-3; Schlieper G, 2010, J AM SOC NEPHROL, V21, P689, DOI 10.1681/ASN.2009080829; Schwartz MAK, 2008, INT J NANOMED, V3, P243; Schwartz MK, 2010, SURGERY, V147, P181, DOI 10.1016/j.surg.2009.07.009; Schwartz MK, 2009, NANOMEDICINE-UK, V4, P931, DOI 10.2217/NNM.09.72; Schwartz MK, 2009, AM J PHYSIOL-HEART C, V296, pH1434, DOI 10.1152/ajpheart.00993.2008; Sedivy R, 2003, APMIS, V111, P951, DOI 10.1034/j.1600-0463.2003.1111006.x; Shiekh FA, 2009, CLIN NEPHROL, V71, P1; Shiekh FA, 2006, UROL RES, V34, P53, DOI 10.1007/s00240-005-0034-0; Shiekh FA, 2010, ACTA BIOMATER, V6, P4065, DOI 10.1016/j.actbio.2010.05.004; Shoskes DA, 2005, J UROLOGY, V173, P474, DOI 10.1097/01.ju.0000150062.60633.b2; Shvedova AA, 2010, ANNU REV PHARMACOL, V50, P63, DOI 10.1146/annurev.pharmtox.010909.105819; Smith ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060904; Sommer AP, 2006, CHEMOTHERAPY, V52, P95, DOI 10.1159/000092475; Sommer AP, 2005, J PROTEOME RES, V4, P180, DOI 10.1021/pr0498382; Sommer AP, 2003, J PROTEOME RES, V2, P441, DOI 10.1021/pr034005h; SUZUKI M, 1994, J EXP ZOOL, V270, P501, DOI 10.1002/jez.1402700603; Thiele L, 2003, BIOMATERIALS, V24, P1409, DOI 10.1016/S0142-9612(02)00525-2; Tsurumoto T, 2006, J PROTEOME RES, V5, P1276, DOI 10.1021/pr050450w; Tsurumoto T, 2008, ENVIRON SCI TECHNOL, V42, P3324, DOI 10.1021/es702857s; Urbano P, 2007, PLOS PATHOG, V3, P567, DOI 10.1371/journal.ppat.0030055; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Vallet-Regi M, 2000, CHEM MATER, V12, P961, DOI 10.1021/cm991110b; Walczyk D, 2010, J AM CHEM SOC, V132, P5761, DOI 10.1021/ja910675v; Wang LM, 2006, DIGEST DIS SCI, V51, P1126, DOI 10.1007/s10620-006-8019-6; Wasdo SC, 2008, INT J NANOTECHNOL, V5, P92, DOI 10.1504/IJNT.2008.016550; Watari F, 2009, J R SOC INTERFACE, V6, pS371, DOI 10.1098/rsif.2008.0488.focus; Wong F, 2007, NAT CLIN PRACT GASTR, V4, P43, DOI 10.1038/ncpgasthep0680; Wu CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008058; Young J, 2009, BRIT J CRIMINOL, V49, P4, DOI 10.1093/bjc/azn074; Young JD, 2010, SCI AM, V302, P52, DOI 10.1038/scientificamerican0110-52; Young JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004417; Zhang SM, 2009, J PERIODONTOL, V80, P1462, DOI 10.1902/jop.2009.080659; Zhou HD, 2006, MOL IMMUNOL, V43, P1864, DOI 10.1016/j.molimm.2005.10.021; Zhou L, 2008, SMALL, V4, P1566, DOI 10.1002/smll.200800520; Zhou ZS, 2008, UROLOGY, V71, P1091, DOI 10.1016/j.urology.2008.02.041	138	33	43	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75501	10.1371/journal.pone.0075501	http://dx.doi.org/10.1371/journal.pone.0075501			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086546	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700092
J	Piras, BA; O'Connor, DM; French, BA				Piras, Bryan A.; O'Connor, Daniel M.; French, Brent A.			Systemic Delivery of shRNA by AAV9 Provides Highly Efficient Knockdown of Ubiquitously Expressed GFP in Mouse Heart, but Not Liver	PLOS ONE			English	Article							DAMAGE-RESPONSE PROTEINS; GENE-EXPRESSION; IN-VIVO; TRANSDUCTION; VECTORS; MICE; RNA; DNA; INJECTION; SEROTYPES	AAV9 is a powerful gene delivery vehicle capable of providing long-term gene expression in a variety of cell types, particularly cardiomyocytes. The use of AAV-delivery for RNA interference is an intense area of research, but a comprehensive analysis of knockdown in cardiac and liver tissues after systemic delivery of AAV9 has yet to be reported. We sought to address this question by using AAV9 to deliver a short-hairpin RNA targeting the enhanced green fluorescent protein (GFP) in transgenic mice that constitutively overexpress GFP in all tissues. The expression cassette was initially tested in vitro and we demonstrated a 61% reduction in mRNA and a 90% reduction in GFP protein in dual-transfected 293 cells. Next, the expression cassette was packaged as single-stranded genomes in AAV9 capsids to test cardiac GFP knockdown with several doses ranging from 1.8x1010 to 1.8x10(11) viral genomes per mouse and a dose-dependent response was obtained. We then analyzed GFP expression in both heart and liver after delivery of 4.4x10(11) viral genomes per mouse. We found that while cardiac knockdown was highly efficient, with a 77% reduction in GFP mRNA and a 71% reduction in protein versus control-treated mice, there was no change in liver expression. This was despite a 4.5-fold greater number of viral genomes in the liver than in the heart. This study demonstrates that single-stranded AAV9 vectors expressing shRNA can be used to achieve highly efficient cardiacselective knockdown of GFP expression that is sustained for at least 7 weeks after the systemic injection of 8 day old mice, with no change in liver expression and no evidence of liver damage despite high viral genome presence in the liver.	[Piras, Bryan A.; O'Connor, Daniel M.; French, Brent A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA; [French, Brent A.] Univ Virginia, Dept Radiol, Charlottesville, VA USA; [French, Brent A.] Univ Virginia, Dept Med Cardiovasc Med, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia	French, BA (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA.	bf4g@eservices.virginia.edu	O'Connor, Daniel M/J-9787-2015	O'Connor, Daniel M/0000-0001-5464-2031; Piras, Bryan/0000-0002-8352-2300	American Heart Association [09PRE2110007]; National Institutes of Health [NIH R01 HL058582]	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the American Heart Association (09PRE2110007 to BAP) and the National Institutes of Health (NIH R01 HL058582 to BAF). AHA: http://www.heart.org/HEARTORG/ NIH: http://grants.nih.gov/grants/oer.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa R, 2002, J BIOL CHEM, V277, P18979, DOI 10.1074/jbc.M201257200; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Cervelli T, 2008, J CELL SCI, V121, P349, DOI 10.1242/jcs.003632; Cunningham SC, 2008, MOL THER, V16, P1081, DOI 10.1038/mt.2008.72; Fechner H, 2008, J MOL MED, V86, P987, DOI 10.1007/s00109-008-0363-x; Flageul M, 2009, J GENE MED, V11, P689, DOI 10.1002/jgm.1343; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Konkalmatt PR, 2012, J GENE MED, V14, P609, DOI 10.1002/jgm.2673; Ku G, 2008, HUM GENE THER, V19, P17, DOI 10.1089/hum.2007.1226; Lovric J, 2012, MOL THER, V20, P2087, DOI 10.1038/mt.2012.144; Mayra A, 2011, BIOCHEM BIOPH RES CO, V405, P204, DOI 10.1016/j.bbrc.2011.01.009; Miyazaki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035875; Park CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043282; Prasad KMR, 2011, GENE THER, V18, P43, DOI 10.1038/gt.2010.105; Prasad KMR, 2007, MOL THER, V15, P764, DOI 10.1038/sj.mt.6300071; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schwartz RA, 2007, J VIROL, V81, P12936, DOI 10.1128/JVI.01523-07; Shen S, 2012, J VIROL, V86, P10408, DOI 10.1128/JVI.01155-12; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Wang Z, 2005, NAT BIOTECHNOL, V23, P321, DOI 10.1038/nbt1073; Wu JC, 2002, CIRCULATION, V105, P1631, DOI 10.1161/01.CIR.0000014984.95520.AD; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	25	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75894	10.1371/journal.pone.0075894	http://dx.doi.org/10.1371/journal.pone.0075894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086659	gold, Green Published, Green Submitted			2022-12-27	WOS:000325025200069
J	Andersson, LS; Wilbe, M; Viluma, A; Cothran, G; Ekesten, B; Ewart, S; Lindgren, G				Andersson, Lisa S.; Wilbe, Maria; Viluma, Agnese; Cothran, Gus; Ekesten, Bjorn; Ewart, Susan; Lindgren, Gabriella			Equine Multiple Congenital Ocular Anomalies and Silver Coat Colour Result from the Pleiotropic Effects of Mutant PMEL	PLOS ONE			English	Article							ROCKY-MOUNTAIN HORSES; DOMINANT-WHITE; CORNEA GLOBOSA; LOCUS; MUTATION; GENE; INSERTION; VARIANTS; SEQUENCE; HOMOLOG	Equine Multiple Congenital Ocular Anomalies (MCOA) syndrome is a heritable eye disorder mainly affecting silver colored horses. Clinically, the disease manifests in two distinct classes depending on the horse genotype. Horses homozygous for the mutant allele present with a wide range of ocular defects, such as iris stromal hypoplasia, abnormal pectinate ligaments, megaloglobus, iridociliary cysts and cataracts. The phenotype of heterozygous horses is less severe and predominantly includes iridociliary cysts, which occasionally extend into the temporal retina. In order to determine the genetic cause of MCOA syndrome we sequenced the entire previously characterized 208 kilobase region on chromosome 6 in ten individuals; five MCOA affected horses from three different breeds, one horse with the intermediate Cyst phenotype and four unaffected controls from two different breeds. This was performed using Illumina TruSeq technology with paired-end reads. Through the systematic exclusion of all polymorphisms barring two SNPs in PMEL, a missense mutation previously reported to be associated with the silver coat colour and a non-conserved intronic SNP, we establish that this gene is responsible for MCOA syndrome. Our finding, together with recent advances that show aberrant protein function due to the coding mutation, suggests that the missense mutation is causative and has pleiotrophic effect, causing both the horse silver coat color and MCOA syndrome.	[Andersson, Lisa S.; Wilbe, Maria; Viluma, Agnese; Lindgren, Gabriella] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Cothran, Gus] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX USA; [Ekesten, Bjorn] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Ewart, Susan] Michigan State Univ, Coll Vet Med, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA	Swedish University of Agricultural Sciences; Texas A&M University System; Texas A&M University College Station; Swedish University of Agricultural Sciences; Michigan State University	Lindgren, G (corresponding author), Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden.	Gabriella.Lindgren@slu.se		Ekesten, Bjorn/0000-0003-1003-6501; Lindgren, Gabriella/0000-0001-6046-9669	The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [221-2009-1631]; Swedish-Norwegian Foundation for Equine Research [H0947256, H0847211]; Carl Trygger Foundation [CTS 08:29]; Swedish Research Council	The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Swedish-Norwegian Foundation for Equine Research; Carl Trygger Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Financial support was obtained from The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (221-2009-1631), Swedish-Norwegian Foundation for Equine Research (H0947256 and H0847211) and Carl Trygger Foundation (CTS 08:29). Sequencing was performed by the SNP&SEQ Technology Platform in Uppsala. The platform is part of Science for Life Laboratory at Uppsala University and supported as a national infrastructure by the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson LS, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-21; Andersson LS, 2011, MAMM GENOME, V22, P353, DOI 10.1007/s00335-011-9325-7; Andersson LS, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-88; Bellone RR, 2010, ANIM GENET, V41, P100, DOI 10.1111/j.1365-2052.2010.02116.x; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Brunberg E, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-46; Chakraborty AK, 1996, EUR J BIOCHEM, V236, P180, DOI 10.1111/j.1432-1033.1996.t01-1-00180.x; Clark LA, 2006, P NATL ACAD SCI USA, V103, P1376, DOI 10.1073/pnas.0506940103; DAUSCH D, 1978, A GRAEF ARCH KLIN EX, V206, P135, DOI 10.1007/BF00414621; Ewart SL, 2000, J HERED, V91, P93, DOI 10.1093/jhered/91.2.93; Fowler Douglas M, 2006, PLoS Biol, V4, pe6; GELATT KN, 1981, AM J VET RES, V42, P1686; Grahn BH, 2008, CAN VET J, V49, P675; Hauswirth R, 2012, PLOS GENET, V8, P404, DOI 10.1371/journal.pgen.1002653; Hellstrom AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002285; Kaps S, 2010, PFERDEHEILKUNDE, V26, P536, DOI 10.21836/PEM20100407; Karlsson AC, 2009, VET OPHTHALMOL, V12, P292, DOI 10.1111/j.1463-5224.2009.00714.x; Kerje S, 2004, GENETICS, V168, P1507, DOI 10.1534/genetics.104.027995; Komaromy AM, 2011, VET OPHTHALMOL, V14, P313, DOI 10.1111/j.1463-5224.2011.00878.x; Kuehn C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-335; KWON BS, 1995, NUCLEIC ACIDS RES, V23, P154, DOI 10.1093/nar/23.1.154; Lee ZH, 1996, J INVEST DERMATOL, V106, P605, DOI 10.1111/1523-1747.ep12345163; Lenhard Boris, 2003, J Biol, V2, P13, DOI 10.1186/1475-4924-2-13; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Martinez-Esparza MM, 1999, MAMM GENOME, V10, P1168, DOI 10.1007/s003359901184; Pinard CL, 2011, VET OPHTHALMOL, V14, P100, DOI 10.1111/j.1463-5224.2010.00847.x; Plummer CE, 2011, VET OPHTHALMOL, V14, P239, DOI 10.1111/j.1463-5224.2010.00868.x; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramsey David T., 1999, Veterinary Ophthalmology, V2, P47; Ramsey DT, 2000, INVEST OPHTH VIS SCI, V41, pS135; Ramsey DT, 1999, AM J VET RES, V60, P1317; Reissmann M, 2007, ANIM GENET, V38, P1, DOI 10.1111/j.1365-2052.2006.01553.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmutz SM, 2013, ANIM GENET, V44, P9, DOI 10.1111/j.1365-2052.2012.02361.x; Schonthaler HB, 2005, DEV BIOL, V284, P421, DOI 10.1016/j.ydbio.2005.06.001; Solano F, 2000, PIGM CELL RES, V13, P118, DOI 10.1111/j.0893-5785.2000.130821.x; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Truve K, 2011, EMBNET J, V17, P38; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; WAHL JMB, 2008, GENETICS MERLE PATTE; Watt B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002286	42	26	28	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75639	10.1371/journal.pone.0075639	http://dx.doi.org/10.1371/journal.pone.0075639			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086599	Green Submitted, Green Published, gold			2022-12-27	WOS:000326520200116
J	Daigneault, J; Klemetsaune, L; Wasserman, SA				Daigneault, Jessica; Klemetsaune, Liv; Wasserman, Steven A.			The IRAK Homolog Pelle Is the Functional Counterpart of I kappa B Kinase in the Drosophila Toll Pathway	PLOS ONE			English	Article							REL PROTEIN DORSAL; IMMUNE-RESPONSE; DEGRADATION ESTABLISHES; DORSOVENTRAL POLARITY; NUCLEAR-LOCALIZATION; CACTUS; COMPLEX; EMBRYO; TUBE; PHOSPHORYLATION	Toll receptors transduce signals that activate Rel-family transcription factors, such as NF-kappa B, by directing proteolytic degradation of inhibitor proteins. In mammals, the I kappa B Kinase (IKK) phosphorylates the inhibitor I kappa B alpha. A beta TrCP protein binds to phosphorylated I kappa B alpha, triggering ubiquitination and proteasome mediated degradation. In Drosophila, Toll signaling directs Cactus degradation via a sequence motif that is highly similar to that in I kappa B alpha, but without involvement of IKK. Here we show that Pelle, the homolog of a mammalian regulator of IKK, acts as a Cactus kinase. We further find that the fly beta TrCP protein Slimb is required in cultured cells to mediate Cactus degradation. These findings enable us for the first time to trace an uninterrupted pathway from the cell surface to the nucleus for Drosophila Toll signaling.	[Daigneault, Jessica; Klemetsaune, Liv; Wasserman, Steven A.] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Wasserman, SA (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	stevenw@ucsd.edu			NIH [RO1 GM05054516]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding provided by NIH RO1 GM05054516. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; BARROGA CF, 1995, P NATL ACAD SCI USA, V92, P7637, DOI 10.1073/pnas.92.17.7637; BELVIN MP, 1995, GENE DEV, V9, P783, DOI 10.1101/gad.9.7.783; Bergmann A, 1996, MECH DEVELOP, V60, P109, DOI 10.1016/S0925-4773(96)00607-7; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Drier EA, 2000, CURR BIOL, V10, P23, DOI 10.1016/S0960-9822(99)00267-5; Edwards DN, 1997, DEVELOPMENT, V124, P3855; Elling RA, 2007, PROTEIN EXPRES PURIF, V54, P139, DOI 10.1016/j.pep.2007.03.002; Fernandez NQ, 2001, DEVELOPMENT, V128, P2963; GALINDO RL, 1995, DEVELOPMENT, V121, P2209; GEISLER R, 1992, CELL, V71, P613, DOI 10.1016/0092-8674(92)90595-4; GILLESPIE SKH, 1994, MOL CELL BIOL, V14, P3559, DOI 10.1128/MCB.14.6.3559; GROSSHANS J, 1994, NATURE, V372, P563, DOI 10.1038/372563a0; HECHT PM, 1993, GENETICS, V135, P405; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huang HR, 2010, P NATL ACAD SCI USA, V107, P8322, DOI 10.1073/pnas.1004031107; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; Kanarek N, 2012, IMMUNOL REV, V246, P77, DOI 10.1111/j.1600-065X.2012.01098.x; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; KIDD S, 1992, CELL, V71, P623, DOI 10.1016/0092-8674(92)90596-5; Kuttenkeuler D, 2010, J INNATE IMMUN, V2, P181, DOI 10.1159/000248649; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; LETSOU A, 1993, EMBO J, V12, P3449, DOI 10.1002/j.1460-2075.1993.tb06019.x; Leulier F, 2003, EMBO REP, V4, P976, DOI 10.1038/sj.embor.embor936; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lindsay SA, 2013, DEV COMP IM IN PRESS; Liu ZP, 1997, GENE DEV, V11, P3413, DOI 10.1101/gad.11.24.3413; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Moncrieffe MC, 2008, J BIOL CHEM, V283, P33447, DOI 10.1074/jbc.M805427200; Reach M, 1996, DEV BIOL, V180, P353, DOI 10.1006/dbio.1996.0308; ROTH S, 1991, DEVELOPMENT, V112, P371; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; SHELTON CA, 1993, CELL, V72, P515, DOI 10.1016/0092-8674(93)90071-W; Shen BH, 2002, DEVELOPMENT, V129, P1925; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Sun HY, 2004, EMBO J, V23, P100, DOI 10.1038/sj.emboj.7600033; Sun HY, 2002, P NATL ACAD SCI USA, V99, P12871, DOI 10.1073/pnas.202396399; Towb P, 1998, DEVELOPMENT, V125, P2443; Towb P, 2001, DEVELOPMENT, V128, P4729; Towb P, 2009, J INNATE IMMUN, V1, P309, DOI 10.1159/000200773; Valanne S, 2010, J IMMUNOL, V184, P6188, DOI 10.4049/jimmunol.1000261; Wang YH, 2006, BIOCHEM BIOPH RES CO, V346, P606, DOI 10.1016/j.bbrc.2006.05.180; Weijland A, 1996, EUR J BIOCHEM, V240, P756, DOI 10.1111/j.1432-1033.1996.0756h.x; WHALEN AM, 1993, J CELL BIOL, V123, P523, DOI 10.1083/jcb.123.3.523; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1; Yang J, 1997, P NATL ACAD SCI USA, V94, P14524, DOI 10.1073/pnas.94.26.14524; ZHUO S, 1993, J BIOL CHEM, V268, P17754	54	25	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75150	10.1371/journal.pone.0075150	http://dx.doi.org/10.1371/journal.pone.0075150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086459	Green Published, gold			2022-12-27	WOS:000326520200086
J	Lambotte, O; Pollara, J; Boufassa, F; Moog, C; Venet, A; Haynes, BF; Delfraissy, JF; Saez-Cirion, A; Ferrari, G				Lambotte, Olivier; Pollara, Justin; Boufassa, Faroudy; Moog, Christiane; Venet, Alain; Haynes, Barton F.; Delfraissy, Jean-Francois; Saez-Cirion, Asier; Ferrari, Guido			High Antibody-Dependent Cellular Cytotoxicity Responses Are Correlated with Strong CD8 T Cell Viral Suppressive Activity but Not with B57 Status in HIV-1 Elite Controllers	PLOS ONE			English	Article							HETEROGENEITY; INFECTION; MEMORY; ADCC; NK	The role of Antibody-dependent cellular cytotoxicity (ADCC) responses in HIV-1 controllers is still unclear due to the heterogeneity of these patients. We analyzed 67 HIV-1 controllers and found significantly higher levels of ADCC antibodies in controllers versus viremic subjects (p = 0.017). Moreover, multivariate analysis revealed significantly higher ADCC titers in HLA B57-controllers compared to HLA-B57+ ones (p = 0.0086). These data suggest a role for ADCC in immune control of HIV, especially in HLA B57 negative controllers.	[Lambotte, Olivier; Venet, Alain; Delfraissy, Jean-Francois] INSERM, U1012, Le Kremlin Bicetre, France; [Lambotte, Olivier; Delfraissy, Jean-Francois] Bicetre Hosp, AP HP, Dept Internal Med & Infect Dis, Le Kremlin Bicetre, France; [Lambotte, Olivier; Delfraissy, Jean-Francois] Univ Paris 11, Le Kremlin Bicetre, France; [Pollara, Justin; Haynes, Barton F.; Ferrari, Guido] Duke Sch Med, Dept Med, Duke Human Vaccine Inst, Durham, NC USA; [Pollara, Justin; Haynes, Barton F.; Ferrari, Guido] Duke Sch Med, Dept Surg, Durham, NC USA; [Boufassa, Faroudy] INSERM, CESP U1018, Le Kremlin Bicetre, France; [Moog, Christiane] INSERM, U778, Strasbourg, France; [Saez-Cirion, Asier] Inst Pasteur, Regulat Retroviral Infect Unit, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Duke University; Duke University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lambotte, O (corresponding author), INSERM, U1012, Le Kremlin Bicetre, France.	olivier.lambotte@bct.aphp.fr	Lambotte, Olivier/GRT-0160-2022; Saez-Cirion, Asier/A-8640-2008; Ferrari, Guido/Z-2137-2019; Ferrari, Guido/A-6088-2015; C, Moog/E-3962-2016	Saez-Cirion, Asier/0000-0003-2406-7536; Ferrari, Guido/0000-0001-7747-3349; C, Moog/0000-0002-0916-156X	Agence pour la Recherche Contre le SIDA (ANRS); Ensemble contre le SIDA (SIDACTION); INSERM; University Paris-Sud; Duke CFAR [1P30 AI 64518]; National Institutes of Health [AI 0678501, AI61734]; National Institues of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) [AI007392]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518, T32AI007392] Funding Source: NIH RePORTER	Agence pour la Recherche Contre le SIDA (ANRS); Ensemble contre le SIDA (SIDACTION); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Paris-Sud; Duke CFAR; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institues of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from Agence pour la Recherche Contre le SIDA (ANRS), Ensemble contre le SIDA (SIDACTION), INSERM, University Paris-Sud, Duke CFAR (1P30 AI 64518), and National Institutes of Health grants AI 0678501 and AI61734. J.P. was supported by the National Institues of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) grant AI007392. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman ME, 2013, J CLIN INVEST, V123, P2183, DOI 10.1172/JCI65708; Ahmad R, 2001, J CLIN IMMUNOL, V21, P227, DOI 10.1023/A:1011087132180; Alpert MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002890; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; Forthal DN, 1999, J INFECT DIS, V180, P1338, DOI 10.1086/314988; French MA, 2013, AIDS, V27, P519, DOI 10.1097/QAD.0b013e32835cb720; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Johansson SE, 2011, VIRAL IMMUNOL, V24, P359, DOI 10.1089/vim.2011.0025; Lambotte O, 2009, AIDS, V23, P897, DOI 10.1097/QAD.0b013e328329f97d; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Peipp M, 2008, BLOOD, V112, P2390, DOI 10.1182/blood-2008-03-144600; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pollara J, 2011, CYTOM PART A, V79A, P603, DOI 10.1002/cyto.a.21084; Potter SJ, 2007, J VIROL, V81, P13904, DOI 10.1128/JVI.01401-07; Saez-Cirion A, 2009, J IMMUNOL, V182, P7828, DOI 10.4049/jimmunol.0803928; Smalls-Mantey A, 2012, J VIROL, V86, P8672, DOI 10.1128/JVI.00287-12; Van Grevenynghe J, 2011, J CLIN INVEST, V121, P3877, DOI 10.1172/JCI59211; Wang J., 2011, MOL CELL PROTEOMICS, V10, DOI DOI 10.1074/MCP.M110.004655; Wren LH, 2013, IMMUNOLOGY, V138, P116, DOI 10.1111/imm.12016	21	71	72	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74855	10.1371/journal.pone.0074855	http://dx.doi.org/10.1371/journal.pone.0074855			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086385	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200044
J	Liu, D; Zhang, Y; Zhang, B; Xie, QY; Wang, CR; Liu, JB; Liao, DF; Jiang, K; Lei, W; Pan, XM				Liu, Da; Zhang, Yi; Zhang, Bo; Xie, Qing-yun; Wang, Cai-ru; Liu, Jin-biao; Liao, Dong-fa; Jiang, Kai; Lei, Wei; Pan, Xian-ming			Comparison of Expansive Pedicle Screw and Polymethylmethacrylate-Augmented Pedicle Screw in Osteoporotic Sheep Lumbar Vertebrae: Biomechanical and Interfacial Evaluations	PLOS ONE			English	Article							CALCIUM-PHOSPHATE; CANCELLOUS BONE; MINERAL DENSITY; FIXATION; CEMENT; SPINE; INSTRUMENTATION; COMPLICATIONS	Background: It was reported that expansive pedicle screw (EPS) and polymethylmethacrylate-augmented pedicle screw (PMMA-PS) could be used to increase screw stability in osteoporosis. However, there are no studies comparing the two kinds of screws in vivo. Thus, we aimed to compare biomechanical and interfacial performances of EPS and PMMA-PS in osteoporotic sheep spine. Methodology/Principal Findings: After successful induction of osteoporotic sheep, lumbar vertebrae in each sheep were randomly divided into three groups. The conventional pedicle screw (CPS) was inserted directly into vertebrae in CPS group; PMMA was injected prior to insertion of CPS in PMMA-PS group; and the EPS was inserted in EPS group. Sheep were killed and biomechanical tests, micro-CT analysis and histological observation were performed at both 6 and 12 weeks postoperation. At 6-week and 12-week, screw stabilities in EPS and PMMA-PS groups were significantly higher than that in CPS group, but there were no significant differences between EPS and PMMA-PS groups at two study periods. The screw stability in EPS group at 12-week was significantly higher than that at 6-week. The bone trabeculae around the expanding anterior part of EPS were more and denser than that in CPS group at 6-week and 12-week. PMMA was found without any degradation and absorption forming non-biological "screw-PMMA-bone'' interface in PMMA-PS group, however, more and more bone trabeculae surrounded anterior part of EPS improving local bone quality and formed biological "screw-bone'' interface. Conclusions/Significance: EPS can markedly enhance screw stability with a similar effect to the traditional method of screw augmentation with PMMA in initial surgery in osteoporosis. EPS can form better biological interface between screw and bone than PMMA-PS. In addition, EPS have no risk of thermal injury, leakage and compression caused by PMMA. We propose EPS has a great application potential in augmentation of screw stability in osteoporosis in clinic.	[Liu, Da; Zhang, Bo; Xie, Qing-yun; Wang, Cai-ru; Liu, Jin-biao; Liao, Dong-fa; Jiang, Kai; Pan, Xian-ming] Gen Hosp Chengdu Mil Reg, Dept Orthopaed, Chengdu, Sichuan Provinc, Peoples R China; [Zhang, Yi] Gen Hosp Chengdu Mil Reg, Affiliated Stomatol Hosp, Chengdu, Sichuan Provinc, Peoples R China; [Lei, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University	Lei, W (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Shaanxi Provinc, Peoples R China.	leiweispine@yahoo.cn; xianmingpan@yahoo.cn		Lei, Wei/0000-0002-7346-6915	National High Technology Research and Development Program of China (863 Program) [2007AA02Z468]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This study was supported by the National High Technology Research and Development Program of China (863 Program) (2007AA02Z468). No benefits in any form have been or will be received from a commercial party directly or indirectly by the authors of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang MC, 2008, SPINE, V33, pE317, DOI 10.1097/BRS.0b013e31816f6c73; Cook SD, 2000, J SPINAL DISORD, V13, P230, DOI 10.1097/00002517-200006000-00006; Cook Stephen D, 2004, Spine J, V4, P402, DOI 10.1016/j.spinee.2003.11.010; Derincek A, 2006, J SPINAL DISORD TECH, V19, P286, DOI 10.1097/01.bsd.0000211203.31244.a0; Di Silvestre M, 2007, SPINE, V32, P1655, DOI 10.1097/BRS.0b013e318074d604; Fisher C, 2009, J NEUROSURG-SPINE, V10, P207, DOI 10.3171/2008.12.SPINE0844; Frankel BA, 2007, NEUROSURGERY, V61, P531, DOI 10.1227/01.NEU.0000290899.15567.68; Frankel BM, 2007, J NEUROSURG-SPINE, V7, P47, DOI 10.3171/SPI-07/07/047; HALVORSON TL, 1994, SPINE, V19, P2415, DOI 10.1097/00007632-199411000-00008; Hashemi A, 2009, SPINE J, V9, P404, DOI 10.1016/j.spinee.2008.07.001; Hee HT, 2007, SPINE, V32, P1533, DOI 10.1097/BRS.0b013e318067dc3d; Hirano T, 1998, J SPINAL DISORD, V11, P493; Kiner DW, 2008, SPINE, V33, P2618, DOI 10.1097/BRS.0b013e3181882cac; Lei W, 2006, EUR SPINE J, V15, P321, DOI 10.1007/s00586-004-0867-1; Leung KS, 2006, J BIOMED MATER RES B, V78B, P153, DOI 10.1002/jbm.b.30467; Liu D, 2011, J SPINAL DISORD TECH, V24, P235, DOI 10.1097/BSD.0b013e3181ecf88a; Liu D, 2011, ARCH ORTHOP TRAUM SU, V131, P1227, DOI 10.1007/s00402-011-1290-9; Lonstein JE, 1999, J BONE JOINT SURG AM, V81A, P1519, DOI 10.2106/00004623-199911000-00003; Moon BJ, 2009, J KOREAN NEUROSURG S, V46, P305, DOI 10.3340/jkns.2009.46.4.305; Polly DW, 1998, SPINE, V23, P1374, DOI 10.1097/00007632-199806150-00015; Schorlemmer S, 2005, BONE, V37, P491, DOI 10.1016/j.bone.2005.05.002; Schorlemmer S, 2003, J BONE MINER RES, V18, P2010, DOI 10.1359/jbmr.2003.18.11.2010; Sheng SR, 2010, EUR SPINE J, V19, P46, DOI 10.1007/s00586-009-1192-5; Talu U, 2000, ACTA ORTHOP TRAUMATO, V34, P300; Wan SY, 2010, EUR SPINE J, V19, P2122, DOI 10.1007/s00586-010-1489-4; Wang Y, 2010, COMPARATIVE MED, V60, P374; Wu ZX, 2008, MED ENG PHYS, V30, P1112, DOI 10.1016/j.medengphy.2008.01.007; Zarrinkalam MR, 2009, EUR SPINE J, V18, P244, DOI 10.1007/s00586-008-0813-8	28	11	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74827	10.1371/journal.pone.0074827	http://dx.doi.org/10.1371/journal.pone.0074827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086381	Green Submitted, gold, Green Published			2022-12-27	WOS:000326520200042
J	Salema, V; Marin, E; Martinez-Arteaga, R; Ruano-Gallego, D; Fraile, S; Margolles, Y; Teira, X; Gutierrez, C; Bodelon, G; Fernandez, LA				Salema, Valencio; Marin, Elvira; Martinez-Arteaga, Rocio; Ruano-Gallego, David; Fraile, Sofia; Margolles, Yago; Teira, Xema; Gutierrez, Carlos; Bodelon, Gustavo; Fernandez, Luis Angel			Selection of Single Domain Antibodies from Immune Libraries Displayed on the Surface of E. coli Cells with Two beta-Domains of Opposite Topologies	PLOS ONE			English	Article							CHAIN FV ANTIBODIES; OUTER-MEMBRANE PROTEINS; ESCHERICHIA-COLI; BACTERIAL AUTOTRANSPORTERS; GENOME SEQUENCE; PHAGE; EXPRESSION; SECRETION; FRAGMENTS; TECHNOLOGY	Screening of antibody (Ab) libraries by direct display on the surface of E. coli cells is hampered by the presence of the outer membrane (OM). In this work we demonstrate that the native beta-domains of EhaA autotransporter and intimin, two proteins from enterohemorrhagic E. coli O157:H7 (EHEC) with opposite topologies in the OM, are effective systems for the display of immune libraries of single domain Abs (sdAbs) from camelids (nanobodies or V-HH) on the surface of E. coli K-12 cells and for the selection of high affinity sdAbs using magnetic cell sorting (MACS). We analyzed the capacity of EhaA and intimin beta-domains to display individual sdAbs and sdAb libraries obtained after immunization with the extracellular domain of the translocated intimin receptor from EHEC (TirM(EHEC)). We demonstrated that both systems displayed functional sdAbs on the surface of E. coli cells with little proteolysis and cellular toxicity, although E. coli cells displaying sdAbs with the beta-domain of intimin showed higher antigen-binding capacity. Both E. coli display libraries were screened for TirM(EHEC) binding clones by MACS. High affinity binders were selected by both display systems, although more efficiently with the intimin beta-domain. The specificity of the selected clones against TirM(EHEC) was demonstrated by flow cytometry of E. coli cells, along with ELISA and surface plasmon resonance with purified sdAbs. Finally, we employed the E. coli cell display systems to provide an estimation of the affinity of the selected sdAb by flow cytometry analysis under equilibrium conditions.	[Salema, Valencio; Marin, Elvira; Martinez-Arteaga, Rocio; Ruano-Gallego, David; Fraile, Sofia; Margolles, Yago; Teira, Xema; Bodelon, Gustavo; Fernandez, Luis Angel] CSIC, Dept Microbial Biotechnol, Ctr Nacl Biotecnol, Madrid, Spain; [Gutierrez, Carlos] Univ Las Palmas Gran Canaria UPGC, Fac Vet, Dept Anim Med & Surg, Las Palmas Gran Canaria, Canary Islands, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Fernandez, LA (corresponding author), CSIC, Dept Microbial Biotechnol, Ctr Nacl Biotecnol, Campus UAM Cantoblanco, Madrid, Spain.	lafdez@cnb.csic.es	Ruano-Gallego, David/ABB-4157-2021; Bodelon, Gustavo/H-2870-2013; Gutiérrez, Carlos/E-2989-2012; Fernández-Herrero, Luis Ángel/AAA-2583-2021; Fernández, Luis Ángel/D-2713-2009; Marin, Elvira/L-1701-2014; Ruano-Gallego, David/ABB-6273-2021; Ruano-Gallego, David/P-3734-2018	Bodelon, Gustavo/0000-0003-2815-7635; Gutiérrez, Carlos/0000-0003-0764-7408; Fernández-Herrero, Luis Ángel/0000-0001-5920-0638; Fernández, Luis Ángel/0000-0001-5920-0638; Marin, Elvira/0000-0003-2206-2328; Ruano-Gallego, David/0000-0002-2163-2088; Ruano-Gallego, David/0000-0002-2163-2088; SALEMA, VALENCIO/0000-0003-1359-2853	Spanish Ministry of "Economia y Competitividad" [BIO2011-26689]; Comunidad Autonoma de Madrid [S2010-BMD-2312]; "La Caixa" Foundation; contracts "Apoyo a la Investigacion" from the "Comunidad Autonoma de Madrid"	Spanish Ministry of "Economia y Competitividad"; Comunidad Autonoma de Madrid(Comunidad de Madrid); "La Caixa" Foundation(La Caixa Foundation); contracts "Apoyo a la Investigacion" from the "Comunidad Autonoma de Madrid"	Work in the laboratory of LAF is supported by Grants from the Spanish Ministry of "Economia y Competitividad" (BIO2011-26689) (http://www.mineco.gob.es/portal/site/mineco/) and the "Comunidad Autonoma de Madrid" (S2010-BMD-2312) (http://www.madrimasd.org/informacionidi/convocatorias/). VS is supported by an international PhD fellowship from the "La Caixa" Foundation (http://obrasocial.lacaixa.es/ambitos/home/becas_es.html). EM and DR were supported by contracts "Apoyo a la Investigacion" from the "Comunidad Autonoma de Madrid" (http://www.madrimasd.org/informacionidi/convocatorias/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbabi-Ghahroudi Mehdi, 2009, V525, P187, DOI 10.1007/978-1-59745-554-1_10; Barnard TJ, 2007, NAT STRUCT MOL BIOL, V14, P1214, DOI 10.1038/nsmb1322; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Bernstein HD, 2007, TRENDS MICROBIOL, V15, P441, DOI 10.1016/j.tim.2007.09.007; Binder U, 2010, J MOL BIOL, V400, P783, DOI 10.1016/j.jmb.2010.05.049; Blanco-Toribio A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015227; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1439, DOI 10.1111/j.1365-2958.1991.tb00790.x; Bodelon G, 2013, FEMS MICROBIOL REV, V37, P204, DOI 10.1111/j.1574-6976.2012.00347.x; Bodelon G, 2009, J BACTERIOL, V191, P5169, DOI 10.1128/JB.00458-09; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; CARTER P, 1985, NUCLEIC ACIDS RES, V13, P4431, DOI 10.1093/nar/13.12.4431; Daugherty PS, 1999, PROTEIN ENG, V12, P613, DOI 10.1093/protein/12.7.613; Daugherty PS, 1998, PROTEIN ENG, V11, P825, DOI 10.1093/protein/11.9.825; Dooley H, 2003, MOL IMMUNOL, V40, P25, DOI 10.1016/S0161-5890(03)00084-1; Fairman JW, 2012, STRUCTURE, V20, P1233, DOI 10.1016/j.str.2012.04.011; Fernandez LA, 2000, APPL ENVIRON MICROB, V66, P5024, DOI 10.1128/AEM.66.11.5024-5029.2000; Fleetwood F, 2013, CELL MOL LIFE SCI, V70, P1081, DOI 10.1007/s00018-012-1179-y; Fraile S, 2004, MOL MICROBIOL, V53, P1109, DOI 10.1111/j.1365-2958.2004.04205.x; FRANCISCO JA, 1993, P NATL ACAD SCI USA, V90, P10444, DOI 10.1073/pnas.90.22.10444; Frankel G, 2008, CELL MICROBIOL, V10, P549, DOI 10.1111/j.1462-5822.2007.01103.x; Georgiou G, 1996, PROTEIN ENG, V9, P239, DOI 10.1093/protein/9.2.239; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; GRODBERG J, 1988, J BACTERIOL, V170, P1245, DOI 10.1128/jb.170.3.1245-1253.1988; Harvey BR, 2004, P NATL ACAD SCI USA, V101, P9193, DOI 10.1073/pnas.0400187101; He Mingyue, 2002, Briefings in Functional Genomics & Proteomics, V1, P204, DOI 10.1093/bfgp/1.2.204; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Holt LJ, 2008, PROTEIN ENG DES SEL, V21, P283, DOI 10.1093/protein/gzm067; Hoogenboom Hennie R, 2002, Methods Mol Biol, V178, P1; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Hussack G, 2012, PROTEIN ENG DES SEL, V25, P313, DOI 10.1093/protein/gzs014; Jakobovits A, 2007, NAT BIOTECHNOL, V25, P1134, DOI 10.1038/nbt1337; Jurado P, 2006, J MOL BIOL, V357, P49, DOI 10.1016/j.jmb.2005.12.058; Jurado P, 2002, J MOL BIOL, V320, P1, DOI 10.1016/S0022-2836(02)00405-9; KEEN NT, 1986, J BACTERIOL, V168, P595, DOI 10.1128/jb.168.2.595-606.1986; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733; Lofblom J, 2011, BIOTECHNOL J, V6, P1115, DOI 10.1002/biot.201100129; Marin E, 2010, J BACTERIOL, V192, P5588, DOI 10.1128/JB.00432-10; Mazor Y, 2007, NAT BIOTECHNOL, V25, P563, DOI 10.1038/nbt1296; Mazor Y, 2010, FEBS J, V277, P2291, DOI 10.1111/j.1742-4658.2010.07645.x; MCCAFFERTY J, 1994, APPL BIOCHEM BIOTECH, V47, P157, DOI 10.1007/BF02787932; McCafferty John, 1996, P79, DOI 10.1016/B978-012402380-2/50008-3; Monegal A, 2009, PROTEIN ENG DES SEL, V22, P273, DOI 10.1093/protein/gzp002; Munera D, 2008, MOL MICROBIOL, V69, P911, DOI 10.1111/j.1365-2958.2008.06325.x; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Otto BR, 2005, J BIOL CHEM, V280, P17339, DOI 10.1074/jbc.M412885200; Pautsch A, 2000, J MOL BIOL, V298, P273, DOI 10.1006/jmbi.2000.3671; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rutherford N, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-22; Ryckaert S, 2010, J BIOTECHNOL, V145, P93, DOI 10.1016/j.jbiotec.2009.10.010; SCHNAITMAN CA, 1973, ARCH BIOCHEM BIOPHYS, V157, P541, DOI 10.1016/0003-9861(73)90673-5; Stathopoulos C, 1996, APPL MICROBIOL BIOT, V45, P112, DOI 10.1007/s002530050657; Thie H, 2008, NEW BIOTECHNOL, V25, P49, DOI 10.1016/j.nbt.2008.01.001; Veiga E, 1999, MOL MICROBIOL, V33, P1232, DOI 10.1046/j.1365-2958.1999.01571.x; Veiga E, 2004, MOL MICROBIOL, V52, P1069, DOI 10.1111/j.1365-2958.2004.04014.x; Wentzel A, 2001, J BACTERIOL, V183, P7273, DOI 10.1128/JB.183.24.7273-7284.2001; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; Yi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015285; Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618; ZELL R, 1987, EMBO J, V6, P1809, DOI 10.1002/j.1460-2075.1987.tb02435.x	67	56	61	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75126	10.1371/journal.pone.0075126	http://dx.doi.org/10.1371/journal.pone.0075126			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086454	Green Submitted, Green Published, gold			2022-12-27	WOS:000326520200085
J	Widya, RL; Hammer, S; Boon, MR; van der Meer, RW; Smit, JWA; de Roos, A; Rensen, PCN; Lamb, HJ				Widya, Ralph L.; Hammer, Sebastiaan; Boon, Mariette R.; van der Meer, Rutger W.; Smit, Johannes W. A.; de Roos, Albert; Rensen, Patrick C. N.; Lamb, Hildo J.			Effects of Short-Term Nutritional Interventions on Right Ventricular Function in Healthy Men	PLOS ONE			English	Article							MYOCARDIAL TRIGLYCERIDE CONTENT; DOPPLER WAVE-FORM; CALORIC RESTRICTION; TRIACYLGLYCEROL ACCUMULATION; DIASTOLIC DYSFUNCTION; HEART-DISEASE; PLASMA CETP; HIGH-FAT; METABOLISM; REPRODUCIBILITY	Background: A physiological model of increased plasma nonesterified fatty acid (NEFA) levels result in myocardial triglyceride (TG) accumulation, which is related to cardiac dysfunction. A pathophysiological model of increased plasma NEFA levels result in hepatic steatosis, which has been linked to abnormal myocardial energy metabolism. Hepatic steatosis is accompanied by hepatic inflammation, reflected by plasma cholesteryl ester transfer protein (CETP) levels. The current study aimed to investigate effects of these models via different nutritional interventions on right ventricular (RV) function. Methods: Fifteen men (age 25.0 +/- 6.6 years) were included and underwent magnetic resonance imaging and spectroscopy in this prospective crossover intervention study. RV function, myocardial and hepatic TG content, and CETP levels were assessed on three occasions: after normal diet, very low-calorie diet (VLCD, physiological model) and high-fat high-energy (HFHE, pathophysiological model) diet (all 3-days diets, randomly ordered, washout phase at least 14 days). Results: VLCD induced a decrease in mean E deceleration by 27%. Myocardial TG content increased by 55%, whereas hepatic TG content decreased by 32%. Plasma CETP levels decreased by 14% (all P<0.05). HFHE diet induced a decrease in E/A by 19% (P<0.05). Myocardial TG content did not change, whereas hepatic TG content increased by 112% (P<0.01). Plasma CETP levels increased by 14% (P<0.05). Conclusions: These findings show that RV diastolic function is impaired after short-term VLCD and HFHE diet in healthy men, respectively a physiological and a pathophysiological model of increased plasma NEFA levels. After short-term VLCD, myocardial lipotoxicity may be of importance in decreased RV diastolic function. RV diastolic dysfunction is accompanied by increased hepatic TG content and plasma CETP levels after short-term HFHE diet, suggesting that systemic inflammation reflecting local macrophage infiltration in the heart may be involved in RV dysfunction.	[Widya, Ralph L.; Hammer, Sebastiaan; van der Meer, Rutger W.; de Roos, Albert; Lamb, Hildo J.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Widya, Ralph L.; Boon, Mariette R.; Smit, Johannes W. A.; Rensen, Patrick C. N.] Leiden Univ, Med Ctr, Dept Endocrinol & Metab, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Widya, RL (corresponding author), Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands.	R.L.Widya@lumc.nl	Boon, Mariëtte/O-3660-2016; Lamb, Hildo/ABE-1171-2021; Smit, J.W.A./H-8091-2014; Rensen, Patrick C.N./D-7176-2018	Lamb, Hildo/0000-0002-6969-2418; Smit, J.W.A./0000-0003-1052-9314; Rensen, Patrick C.N./0000-0002-8455-4988; Widya, Ralph/0000-0003-4747-939X; Hammer, Sebastiaan/0000-0002-1576-1190	Center for Translational Molecular Medicine project PREDICCt [01C-104]; Netherlands Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Board of Directors of the Leiden University Medical Center, the Netherlands (Excellent MD/PhD program for Medical Students)	Center for Translational Molecular Medicine project PREDICCt; Netherlands Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Board of Directors of the Leiden University Medical Center, the Netherlands (Excellent MD/PhD program for Medical Students)	This research was performed within the framework of the Center for Translational Molecular Medicine (CTMM; www.ctmm.nl), project PREDICCt (grant 01C-104), and supported by the Netherlands Heart Foundation, the Dutch Diabetes Research Foundation and Dutch Kidney Foundation. M.R.B. is supported by the Board of Directors of the Leiden University Medical Center, the Netherlands (Excellent MD/PhD program for Medical Students). P.C.N.R. is an Established Investigator of the Netherlands Heart Foundation (2009T038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz EF, 2010, J CARD FAIL, V16, P827, DOI 10.1016/j.cardfail.2010.05.004; Balschi JA, 1997, J MOL CELL CARDIOL, V29, P471, DOI 10.1006/jmcc.1996.9997; Cappuzzello C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-28; Christoffersen C, 2003, ENDOCRINOLOGY, V144, P3483, DOI 10.1210/en.2003-0242; FERRANNINI E, 1993, AM J PHYSIOL, V264, pE308, DOI 10.1152/ajpendo.1993.264.2.E308; Ghio S, 2001, J AM COLL CARDIOL, V37, P183, DOI 10.1016/S0735-1097(00)01102-5; Grothues F, 2004, AM HEART J, V147, P218, DOI 10.1016/j.ahj.2003.10.005; Hammer S, 2008, J CLIN ENDOCR METAB, V93, P497, DOI 10.1210/jc.2007-2015; Han XL, 2004, BIOCHEMISTRY-US, V43, P15584, DOI 10.1021/bi048307o; HESLER CB, 1987, J BIOL CHEM, V262, P2275; HIRSCH J, 1964, J CLIN INVEST, V43, P1776, DOI 10.1172/JCI105052; HUANG JMC, 1992, P NATL ACAD SCI USA, V89, P6452, DOI 10.1073/pnas.89.14.6452; Korvald C, 2000, AM J PHYSIOL-HEART C, V278, pH1345, DOI 10.1152/ajpheart.2000.278.4.H1345; Lamb HJ, 2008, CURR OPIN CLIN NUTR, V11, P573, DOI 10.1097/MCO.0b013e32830a98e3; Li ZS, 2012, BIOCHEM PHARMACOL, V84, P821, DOI 10.1016/j.bcp.2012.06.020; Meluzin J, 2003, Eur J Echocardiogr, V4, P262, DOI 10.1016/S1525-2167(02)00171-3; Mertens LL, 2010, NAT REV CARDIOL, V7, P551, DOI 10.1038/nrcardio.2010.118; MIYATAKE K, 1984, AM J CARDIOL, V53, P586, DOI 10.1016/0002-9149(84)90035-3; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Oguzkurt L, 2005, EUR J RADIOL, V54, P253, DOI 10.1016/j.ejrad.2004.05.011; Ouwens DM, 2005, DIABETOLOGIA, V48, P1229, DOI 10.1007/s00125-005-1755-x; PATTYNAMA PMT, 1995, MAGN RESON IMAGING, V13, P53, DOI 10.1016/0730-725X(94)00076-F; Perseghin G, 2008, HEPATOLOGY, V47, P51, DOI 10.1002/hep.21983; REBERGEN SA, 1993, AM HEART J, V126, P1439, DOI 10.1016/0002-8703(93)90544-J; Rijzewijk LJ, 2010, J AM COLL CARDIOL, V56, P225, DOI 10.1016/j.jacc.2010.02.049; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Schilling JD, 2012, AM J PHYSIOL-HEART C, V303, pH1366, DOI 10.1152/ajpheart.00111.2012; Simms MG, 1999, AM J PHYSIOL-HEART C, V277, pH253, DOI 10.1152/ajpheart.1999.277.1.H253; Solhjoo E, 2011, HEPAT MON, V11, P740, DOI [10.5812/kowsar.1735143X.729, 10.5812/kowsar.1735143X.404]; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; van den Brom CE, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-25; van der Meer RW, 2008, J CLIN ENDOCR METAB, V93, P2702, DOI 10.1210/jc.2007-2524; van der Meer RW, 2007, DIABETES, V56, P2849, DOI 10.2337/db07-0768; van der Meer RW, 2007, RADIOLOGY, V245, P251, DOI 10.1148/radiol.2451061904; Wang YA, 2011, DIABETES CARE, V34, P2576, DOI 10.2337/dc11-0685; Warnes CA, 2009, J AM COLL CARDIOL, V54, P1903, DOI 10.1016/j.jacc.2009.06.048; Widya RL, 2013, DIABETES CARE, V36, P457, DOI 10.2337/dc12-0474; Winhofer Y, 2012, DIABETES, V61, P1210, DOI 10.2337/db11-1275; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784; Zile MR, 2002, CIRCULATION, V105, P1503, DOI 10.1161/hc1202.105290	42	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e76406	10.1371/journal.pone.0076406	http://dx.doi.org/10.1371/journal.pone.0076406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086738	gold, Green Submitted, Green Published			2022-12-27	WOS:000326520200136
J	Ye, J; Chen, Z; Zhang, B; Miao, H; Zohaib, A; Xu, QP; Chen, HC; Cao, SB				Ye, Jing; Chen, Zheng; Zhang, Bo; Miao, Huan; Zohaib, Ali; Xu, Qiuping; Chen, Huanchun; Cao, Shengbo			Heat Shock Protein 70 Is Associated with Replicase Complex of Japanese Encephalitis Virus and Positively Regulates Viral Genome Replication	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; MOLECULAR-MECHANISM; HSP70 CHAPERONES; RNA-POLYMERASE; INFECTED-CELLS; STEM-LOOP; APOPTOSIS; STRESS; NS5; BLOCKING	Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus that causes the most prevalent viral encephalitis in Asia. The NS5 protein of JEV is a key component of the viral replicase complex, which plays a crucial role in viral pathogenesis. In this study, tandem affinity purification (TAP) followed by mass spectrometry analysis was performed to identify novel host proteins that interact with NS5. Heat shock protein 70 (Hsp70), eukaryotic elongation factor 1-alpha (eEF-1 alpha) and ras-related nuclear protein (Ran) were demonstrated to interact with NS5. In addition to NS5, Hsp70 was also found to interact with NS3 which is another important member of the replicase complex. It was observed that the cytoplasmic Hsp70 partially colocalizes with the components of viral replicase complex including NS3, NS5 and viral dsRNA during JEV infection. Knockdown of Hsp70 resulted in a significantly reduced JEV genome replication. Further analysis reveals that Hsp70 enhances the stability of viral proteins in JEV replicase complex. These results suggest an important role for Hsp70 in regulating JEV replication, which provides a potential target for the development of anti-JEV therapies.	[Ye, Jing; Chen, Zheng; Miao, Huan; Zohaib, Ali; Xu, Qiuping; Chen, Huanchun; Cao, Shengbo] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Ye, Jing; Chen, Zheng; Miao, Huan; Zohaib, Ali; Xu, Qiuping; Chen, Huanchun; Cao, Shengbo] Huazhong Agr Univ, Lab Anim Virol, Coll Vet Med, Wuhan, Hubei, Peoples R China; [Zhang, Bo] Chinese Acad Sci, Wuhan Inst Viol, State Key Lab Virol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Chinese Academy of Sciences	Chen, HC (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.	chenhch@mail.hzau.edu.cn; sbcao@mail.hzau.edu.cn	Chen, Zheng/GPJ-9937-2022; Zohaib, Ali/AAE-2342-2019	Zohaib, Ali/0000-0003-3998-6017	973 Project of China [2010CB530100]; National Natural Sciences Foundation of China [31172325, 81261160325]; New Century Excellent Talents in University [NCETNCET-10-0422]; Fundamental Research Funds for the Central Universities [2011PY002]	973 Project of China(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by 973 Project of China (2010CB530100), National Natural Sciences Foundation of China (31172325, 81261160325), New Century Excellent Talents in University (NCETNCET-10-0422) and Fundamental Research Funds for the Central Universities (2011PY002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997; Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009; Broquet AH, 2007, J VIROL, V81, P1297, DOI 10.1128/JVI.01336-06; Carsillo T, 2006, J VIROL, V80, P11031, DOI 10.1128/JVI.01438-06; Chen YJ, 2010, J BIOL CHEM, V285, P28183, DOI 10.1074/jbc.M110.118323; Chen Z, 2012, HYBRIDOMA, V31, P137, DOI 10.1089/hyb.2011.0107; Collins MO, 2008, CURR OPIN BIOTECH, V19, P324, DOI 10.1016/j.copbio.2008.06.002; Das S, 2009, VIROLOGY, V385, P47, DOI 10.1016/j.virol.2008.10.025; Davidson AD, 2009, ADV VIRUS RES, V74, P41, DOI 10.1016/S0065-3527(09)74002-3; Davis WG, 2007, J VIROL, V81, P10172, DOI 10.1128/JVI.00531-07; Dziembowski A, 2004, FEBS LETT, V556, P1, DOI 10.1016/S0014-5793(03)01357-7; HARRIS KS, 1994, J BIOL CHEM, V269, P27004; Hirayama E, 2004, J VIROL, V78, P1263, DOI 10.1128/JVI.78.3.1263-1270.2004; Iordanskiy S, 2004, J VIROL, V78, P9697, DOI 10.1128/JVI.78.18.9697-9704.2004; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Katoh H, 2011, J VIROL, V85, P10976, DOI 10.1128/JVI.00846-11; Klomporn P, 2011, VIROLOGY, V409, P189, DOI 10.1016/j.virol.2010.10.010; Lahaye X, 2012, J VIROL, V86, P4743, DOI 10.1128/JVI.06501-11; Li G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016546; Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05; Matsuda D, 2004, VIROLOGY, V321, P47, DOI 10.1016/j.virol.2003.10.028; Mayer MP, 2005, REV PHYSIOL BIOCH P, V153, P1, DOI 10.1007/s10254-004-0025-5; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; Michels AA, 1999, J BIOL CHEM, V274, P36757, DOI 10.1074/jbc.274.51.36757; Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008; Nollen EAA, 1999, MOL CELL BIOL, V19, P2069; Padwad YS, 2010, VIRAL IMMUNOL, V23, P557, DOI 10.1089/vim.2010.0052; Pastorino B, 2010, ANTIVIR RES, V87, P281, DOI 10.1016/j.antiviral.2010.04.014; Pogany J, 2008, P NATL ACAD SCI USA, V105, P19956, DOI 10.1073/pnas.0810851105; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Qanungo KR, 2004, P NATL ACAD SCI USA, V101, P5952, DOI 10.1073/pnas.0401449101; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002; SUMIYOSHI H, 1987, VIROLOGY, V161, P497, DOI 10.1016/0042-6822(87)90144-9; Uchil PD, 2006, J VIROL, V80, P5451, DOI 10.1128/JVI.01982-05; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; Wang RYL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-471; Wu YP, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-128; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zhu YZ, 2012, J GEN VIROL, V93, P61, DOI 10.1099/vir.0.034637-0	45	45	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75188	10.1371/journal.pone.0075188	http://dx.doi.org/10.1371/journal.pone.0075188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086464	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200088
J	Howell, NA; Worbe, Y; Lange, I; Tait, R; Irvine, M; Banca, P; Harrison, NA; Bullmore, ET; Hutchison, WD; Voon, V				Howell, Nicholas A.; Worbe, Yulia; Lange, Iris; Tait, Roger; Irvine, Michael; Banca, Paula; Harrison, Neil A.; Bullmore, Edward T.; Hutchison, William D.; Voon, Valerie			Increased Ventral Striatal Volume in College-Aged Binge Drinkers	PLOS ONE			English	Article							ALCOHOL-USE DISORDERS; HIPPOCAMPAL VOLUME; DOPAMINE RELEASE; NUCLEUS-ACCUMBENS; ETHANOL EXPOSURE; AMYGDALA; DRINKING; CORTEX; NEUROGENESIS; DEFICITS	Background: Binge drinking is a serious public health issue associated with cognitive, physiological, and anatomical differences from healthy individuals. No studies, however, have reported subcortical grey matter differences in this population. To address this, we compared the grey matter volumes of college-age binge drinkers and healthy controls, focusing on the ventral striatum, hippocampus and amygdala. Method: T1-weighted images of 19 binge drinkers and 19 healthy volunteers were analyzed using voxel-based morphometry. Structural data were also covaried with Alcohol Use Disorders Identification Test (AUDIT) scores. Cluster-extent threshold and small volume corrections were both used to analyze imaging data. Results: Binge drinkers had significantly larger ventral striatal grey matter volumes compared to controls. There were no between group differences in hippocampal or amygdalar volume. Ventral striatal, amygdalar, and hippocampal volumes were also negatively related to AUDIT scores across groups. Conclusions: Our findings stand in contrast to the lower ventral striatal volume previously observed in more severe forms of alcohol use disorders, suggesting that college-age binge drinkers may represent a distinct population from those groups. These findings may instead represent early sequelae, compensatory effects of repeated binge and withdrawal, or an endophenotypic risk factor.	[Howell, Nicholas A.; Hutchison, William D.] Univ Hlth Network, Toronto Western Hosp, Div Brain Imaging & Behav Syst Neurosci, Toronto Western Res Inst, Toronto, ON, Canada; [Howell, Nicholas A.; Hutchison, William D.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Howell, Nicholas A.; Lange, Iris; Irvine, Michael; Banca, Paula; Voon, Valerie] Univ Cambridge, Dept Psychiat, Cambridge, England; [Worbe, Yulia; Harrison, Neil A.; Voon, Valerie] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Tait, Roger] Univ Cambridge, Dept Psychol, Cambridge, England; [Banca, Paula] Univ Coimbra, Inst Biomed Imaging & Life Sci, P-3000 Coimbra, Portugal; [Harrison, Neil A.; Voon, Valerie] Univ Sussex, Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Bullmore, Edward T.] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England; [Bullmore, Edward T.] Addenbrookes Hosp, GlaxoSmithKline, Clin Unit Cambridge, Cambridge, England; [Bullmore, Edward T.; Voon, Valerie] NIHR Cambridge Biomed Res Ctr, Cambridge, England; [Hutchison, William D.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Hutchison, William D.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Cambridge; University of Cambridge; University of Cambridge; Universidade de Coimbra; University of Brighton; University of Sussex; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; GlaxoSmithKline; University of Cambridge; University of Cambridge; University of Toronto; University of Toronto	Voon, V (corresponding author), Univ Cambridge, Dept Psychiat, Cambridge, England.	vv247@cam.ac.uk	Voon, Valerie/O-7038-2017; Bullmore, Ed/C-1706-2012; Banca, Paula/G-8330-2017; Worbe, Yulia/GYV-3751-2022	Voon, Valerie/0000-0001-6790-1776; Bullmore, Ed/0000-0002-8955-8283; Banca, Paula/0000-0001-7617-3635; Lange, Iris/0000-0002-6251-8978; Worbe, Yulia/0000-0001-5903-9370; Hutchison, William/0000-0002-3866-4940; Harrison, Neil/0000-0002-9584-3769	Unilever/Lipton Graduate Fellowship in Neuroscience; University of Toronto Open Fellowship; Fyssen Foundation; MRC Studentship; WT; MRC; NIHR Cambridge Biomedical Research Centre; Cambridgeshire & Peterborough NHS Foundation Trust, Cambridge UK; Medical Research Council [G0001354, G1000183B, G0001354B] Funding Source: researchfish	Unilever/Lipton Graduate Fellowship in Neuroscience; University of Toronto Open Fellowship(University of Toronto); Fyssen Foundation; MRC Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); WT; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridgeshire & Peterborough NHS Foundation Trust, Cambridge UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Nicholas A Howell is supported by the Unilever/Lipton Graduate Fellowship in Neuroscience and a University of Toronto Open Fellowship. Valerie Voon is a Wellcome Trust (WT) intermediate Clinical Fellow. Yulia Worbe is supported by the Fyssen Foundation and MRC Studentship. The BCNI is supported by a WT and MRC grant. This study was partly supported by the NIHR Cambridge Biomedical Research Centre, Cambridgeshire & Peterborough NHS Foundation Trust, Cambridge UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agartz I, 1999, ARCH GEN PSYCHIAT, V56, P356, DOI 10.1001/archpsyc.56.4.356; Anderson P, 2007, BINGE DRINKING EUROP; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barros-Loscertales A, 2011, NEUROIMAGE, V56, P1021, DOI 10.1016/j.neuroimage.2011.02.035; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beresford TP, 2006, ALCOHOL CLIN EXP RES, V30, P1866, DOI 10.1111/j.1530-0277.2006.00223.x; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Boileau I, 2003, SYNAPSE, V49, P226, DOI 10.1002/syn.10226; Bright P, 2002, J INT NEUROPSYCH SOC, V8, P847, DOI 10.1017/S1355617702860131; Bussing Regina, 2002, World J Biol Psychiatry, V3, P216, DOI 10.3109/15622970209150624; Chang L, 2005, BIOL PSYCHIAT, V57, P967, DOI 10.1016/j.biopsych.2005.01.039; Claus ED, 2011, NEUROPSYCHOPHARMACOL, V36, P2086, DOI 10.1038/npp.2011.99; Corson PW, 1999, AM J PSYCHIAT, V156, P1200; De Bellis MD, 2000, AM J PSYCHIAT, V157, P737, DOI 10.1176/appi.ajp.157.5.737; Engleman EA, 2009, ALCOHOL CLIN EXP RES, V33, P2162, DOI 10.1111/j.1530-0277.2009.01055.x; Ersche KD, 2012, SCIENCE, V335, P601, DOI 10.1126/science.1214463; Ersche KD, 2011, BRAIN, V134, P2013, DOI 10.1093/brain/awr138; Grucza RA, 2009, J AM ACAD CHILD PSY, V48, P692, DOI 10.1097/CHI.0b013e3181a2b32f; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hibell B., 2012, 2011 ESPAD REPORT SU; IMPERATO A, 1986, J PHARMACOL EXP THER, V239, P219; Jacobsen LK, 2001, AM J PSYCHIAT, V158, P486, DOI 10.1176/appi.ajp.158.3.486; Jernigan TL, 2005, AM J PSYCHIAT, V162, P1461, DOI 10.1176/appi.ajp.162.8.1461; Johnston L. D., 2012, MONITORING FUTURE NA, VII; KESHAVAN MS, 1994, LANCET, V344, P1434, DOI 10.1016/S0140-6736(94)90599-1; Kirby ED, 2012, MOL PSYCHIATR, V17, P527, DOI 10.1038/mp.2011.71; Lisdahl KM, 2013, PSYCHIAT RES-NEUROIM, V211, P17, DOI 10.1016/j.pscychresns.2012.07.009; Lynam D.R., 2006, UPPS P ASSESSING 5 P; Makris N, 2008, BIOL PSYCHIAT, V64, P192, DOI 10.1016/j.biopsych.2008.01.018; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; McQueeny T, 2009, ALCOHOL CLIN EXP RES, V33, P1278, DOI 10.1111/j.1530-0277.2009.00953.x; Medina KL, 2008, ALCOHOL CLIN EXP RES, V32, P386, DOI 10.1111/j.1530-0277.2007.00602.x; Medina KL, 2007, NEUROTOXICOL TERATOL, V29, P141, DOI 10.1016/j.ntt.2006.10.010; Mitchell J, 2012, TLS-TIMES LIT SUPPL, P6; Murray GK, 2008, MOL PSYCHIATR, V13, P267, DOI 10.1038/sj.mp.4002058; NIAAA, 2004, NIAAA NEWSLETTER, V3; Nixon K, 2002, J NEUROCHEM, V83, P1087, DOI 10.1046/j.1471-4159.2002.01214.x; Paul CA, 2008, ARCH NEUROL-CHICAGO, V65, P1363, DOI 10.1001/archneur.65.10.1363; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Spielberger CD, 1985, SO PSYCHOL, V2, P6; Squeglia Lindsay M, 2012, Psychopharmacology (Berl), V220, P529, DOI 10.1007/s00213-011-2500-4; STACEY D, P NATL ACAD SCI US; Stephens DN, 2005, BIOL PSYCHIAT, V58, P392, DOI 10.1016/j.biopsych.2005.04.025; Sullivan EV, 2005, BIOL PSYCHIAT, V57, P768, DOI 10.1016/j.biopsych.2004.12.012; SULLIVAN EV, 1995, ALCOHOL CLIN EXP RES, V19, P110, DOI 10.1111/j.1530-0277.1995.tb01478.x; Taki Y, 2006, ALCOHOL CLIN EXP RES, V30, P1045, DOI 10.1111/j.1530-0277.2006.00118.x; WEISS F, 1993, J PHARMACOL EXP THER, V267, P250; Weiss F, 1996, J NEUROSCI, V16, P3474; Wrase J, 2008, AM J PSYCHIAT, V165, P1179, DOI 10.1176/appi.ajp.2008.07121877	53	45	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74164	10.1371/journal.pone.0074164	http://dx.doi.org/10.1371/journal.pone.0074164			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086317	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000325223900021
J	Lee, HS; Schlereth, S; Khandelwal, P; Saban, DR				Lee, Hyun Soo; Schlereth, Simona; Khandelwal, Payal; Saban, Daniel R.			Ocular Allergy Modulation to Hi-Dose Antigen Sensitization Is a Treg-Dependent Process	PLOS ONE			English	Article							REGULATORY T-CELLS; MURINE MODEL; AIRWAY INFLAMMATION; FOXP3; RESOLUTION; DEPLETION; RESPONSES; ANTIBODY; IMPAIRS; IL-17	A reproducible method to inhibit allergic immune responses is accomplished with hi-dose Ag sensitization, via intraperitoneal (IP) injection. However, the role of CD4+ CD25+ FoxP3+ T regulatory cells (Treg) in this process is unknown, as is whether such modulation extends to ocular allergy. We therefore determined herein whether hi-dose sensitization modulates ocular allergy, and whether CD4+ CD25+ FoxP3+ Treg are involved. C57BL/6 mice were IP sensitized via low-dose (100 mu g) versus hi-dose (1000 mu g) ovalbumin (OVA), in aluminum hydroxide (1 mg) and pertussis-toxin (300 ng). Other mice received anti-CD25 Ab (PC61) to ablate Treg during sensitization. In another experiment, Treg from hi-dose sensitized mice were adoptively transferred into low-dose sensitized mice. Once daily OVA challenges were administered. Clinical signs, IgE, T cell cytokines, and eosinophils were assessed. Data revealed that hi-dose, but not low-dose, sensitization led to allergy modulation, indicated by decreased clinical signs, serum IgE levels, Th2 recall responses, and eosinophil recruitment. T cells from hi-dose sensitized mice showed a robust increase in TGF-b production, and Treg from these mice were able to efficiently suppress effector T cell proliferation in vitro. In addition, in vivo Treg ablation in hi-dose sensitized mice revoked allergy modulation. Lastly, Treg from hi-dose sensitized mice were able to adoptively transfer allergy modulation to their low-dose sensitized counterparts. Collectively, these findings indicate that modulation to hi-dose sensitization, which is extended to ocular allergy, occurs in a Treg-dependent manner. In addition, our data suggest that hi-dose sensitization may henceforth facilitate the further examination of CD4+ CD25+ FoxP3+ Treg in allergic disease.	[Saban, Daniel R.] Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC 27705 USA; [Saban, Daniel R.] Duke Univ, Sch Med, Dept Immunol, Durham, NC USA; [Lee, Hyun Soo; Schlereth, Simona; Khandelwal, Payal] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol,Schepens Eye Res Inst, Boston, MA USA	Duke University; Duke University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Saban, DR (corresponding author), Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC 27705 USA.	daniel.saban@duke.edu			National Institutes of Health [R01EY021798]; NATIONAL EYE INSTITUTE [R01EY021798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Institutes of Health R01EY021798 (Saban DR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Pimentel JA, 2010, AM J RESP CRIT CARE, V181, P7, DOI 10.1164/rccm.200902-0190OC; Arps V, 1998, EUR J IMMUNOL, V28, P681, DOI 10.1002/(SICI)1521-4141(199802)28:02<681::AID-IMMU681>3.3.CO;2-1; Barwig C, 2010, CLIN EXP ALLERGY, V40, P891, DOI 10.1111/j.1365-2222.2010.03476.x; Boudousquie C, 2009, CLIN EXP ALLERGY, V39, P1415, DOI 10.1111/j.1365-2222.2009.03314.x; Chauhan SK, 2009, J IMMUNOL, V182, P148, DOI 10.4049/jimmunol.182.1.148; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Fukushima A, 2008, INT ARCH ALLERGY IMM, V147, P206, DOI 10.1159/000142043; Guery JC, 1996, J EXP MED, V183, P485, DOI 10.1084/jem.183.2.485; Hellings PW, 2003, AM J RESP CELL MOL, V28, P42, DOI 10.1165/rcmb.4832; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Khandelwal P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064193; Leech MD, 2007, J IMMUNOL, V179, P7050, DOI 10.4049/jimmunol.179.10.7050; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Lin W, 2005, J ALLERGY CLIN IMMUN, V116, P1106, DOI 10.1016/j.jaci.2005.08.046; Mcgee HS, 2009, AM J RESP CRIT CARE, V180, P211, DOI 10.1164/rccm.200809-1505OC; Meiler F, 2008, J EXP MED, V205, P2887, DOI 10.1084/jem.20080193; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Morokata T, 2000, IMMUNOL LETT, V72, P119, DOI 10.1016/S0165-2478(00)00188-7; Palomares O, 2010, EUR J IMMUNOL, V40, P1232, DOI 10.1002/eji.200940045; PFEIFFER C, 1995, J EXP MED, V181, P1569, DOI 10.1084/jem.181.4.1569; Randolph DA, 1999, J CLIN INVEST, V104, P1021, DOI 10.1172/JCI7631; Ray A, 2010, MUCOSAL IMMUNOL, V3, P216, DOI 10.1038/mi.2010.4; Saban DR, 2013, CURR EYE RES, V38, P317, DOI 10.3109/02713683.2012.747617; Sakai K, 1999, CLIN EXP IMMUNOL, V118, P9; Schlereth S, 2012, AM J PATHOL, V180, P2351, DOI 10.1016/j.ajpath.2012.02.015; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Stern ME, 2005, CURR OPIN ALLERGY CL, V5, P446, DOI 10.1097/01.all.0000182547.60595.64; Stevens WW, 2007, J IMMUNOL METHODS, V327, P63, DOI 10.1016/j.jim.2007.07.011; Wang LF, 1996, J IMMUNOL, V156, P4079	29	11	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75769	10.1371/journal.pone.0075769	http://dx.doi.org/10.1371/journal.pone.0075769			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086630	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900062
J	MacDonald, AA; Seergobin, KN; Owen, AM; Tamjeedi, R; Monchi, O; Ganjavi, H; MacDonald, PA				MacDonald, Alex A.; Seergobin, Ken N.; Owen, Adrian M.; Tamjeedi, Ruzbeh; Monchi, Oury; Ganjavi, Hooman; MacDonald, Penny A.			Differential Effects of Parkinson's Disease and Dopamine Replacement on Memory Encoding and Retrieval	PLOS ONE			English	Article							VERBAL-LEARNING TEST; WORKING-MEMORY; COGNITIVE FUNCTION; STRIATUM; REWARD; RECOLLECTION; PERFORMANCE; MODULATION; RECOGNITION; MEDICATION	Increasingly memory deficits are recognized in Parkinson's disease (PD). In PD, the dopamine-producing cells of the substantia nigra (SN) are significantly degenerated whereas those in the ventral tegmental area (VTA) are relatively spared. Dopamine-replacement medication improves cognitive processes that implicate the SN-innervated dorsal striatum but is thought to impair those that depend upon the VTA-supplied ventral striatum, limbic and prefrontal cortices. Our aim was to examine memory encoding and retrieval in PD and how they are affected by dopamine replacement. Twenty-nine PD patients performed the Rey Auditory Verbal Learning Test (RAVLT) and a non-verbal analogue, the Aggie Figures Learning Test (AFLT), both on and off dopaminergic medications. Twenty-seven, age-matched controls also performed these memory tests twice and their data were analyzed to correspond to the ON-OFF order of the PD patients to whom they were matched. We contrasted measures that emphasized with those that accentuated retrieval and investigated the effect of PD and dopamine-replacement on these processes separately. For PD patients relative to controls, encoding performance was normal in the off state and was impaired on dopaminergic medication. Retrieval was impaired off medication and improved by dopamine repletion. This pattern of findings suggests that VTA-innervated brain regions such as ventral striatum, limbic and prefrontal cortices are implicated in encoding, whereas the SN-supplied dorsal striatum mediates retrieval. Understanding this pattern of spared functions and deficits in PD, and the effect of dopamine replacement on these distinct memory processes, should prompt closer scrutiny of patients' cognitive complaints to inform titration of dopamine replacement dosages along with motor symptoms.	[MacDonald, Alex A.; Seergobin, Ken N.; Owen, Adrian M.; MacDonald, Penny A.] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada; [Owen, Adrian M.] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Tamjeedi, Ruzbeh] Univ Ottawa, Fac Law, Ottawa, ON, Canada; [Monchi, Oury] Inst Univ Geriatrie Montreal, Ctr Rech, Funct Neuroimaging Unit, Montreal, PQ, Canada; [Monchi, Oury] Univ Montreal, Dept Radiol, Montreal, PQ, Canada; [Ganjavi, Hooman] Univ Western Ontario, Dept Psychiat, London, ON N6A 3K7, Canada; [MacDonald, Penny A.] Univ Western Ontario, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Ottawa; Universite de Montreal; Universite de Montreal; Western University (University of Western Ontario); Western University (University of Western Ontario)	MacDonald, PA (corresponding author), Univ Western Ontario, Brain & Mind Inst, London, ON, Canada.	penny.macdonald@gmail.com	Williams, Jackie/B-3495-2015		Canadian Institutes for Health Research (CIHR) Clinician-Scientist, Phase 1	Canadian Institutes for Health Research (CIHR) Clinician-Scientist, Phase 1(Canadian Institutes of Health Research (CIHR))	This research was supported by a Canadian Institutes for Health Research (CIHR) Clinician-Scientist, Phase 1 to Dr. Penny MacDonald. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2005, MOVEMENT DISORD, V20, P1255, DOI 10.1002/mds.20527; Aarsland D, 2003, J NEUROL NEUROSUR PS, V74, P1215, DOI 10.1136/jnnp.74.9.1215; Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; Algarabel S, 2010, NEUROPSYCHOLOGY, V24, P599, DOI 10.1037/a0019221; Argyelan M, 2008, J NEUROSCI, V28, P10687, DOI 10.1523/JNEUROSCI.2933-08.2008; Atallah HE, 2007, NAT NEUROSCI, V10, P126, DOI 10.1038/nn1817; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Beato R, 2008, ARQ NEURO-PSIQUIAT, V66, P147, DOI 10.1590/S0004-282X2008000200001; Benjamin AS, 2010, COGNITIVE PSYCHOL, V61, P228, DOI 10.1016/j.cogpsych.2010.05.004; Benke T, 2003, NEUROCASE, V9, P70, DOI 10.1076/neur.9.1.70.14374; Breitenstein C, 2006, NEUROPSYCHOPHARMACOL, V31, P2552, DOI 10.1038/sj.npp.1301167; Bronnick K, 2011, NEUROPSYCHOLOGY, V25, P114, DOI 10.1037/a0020857; Cohn M, 2010, NEUROPSYCHOLOGIA, V48, P4142, DOI 10.1016/j.neuropsychologia.2010.10.013; Cools R, 2001, CEREB CORTEX, V11, P1136, DOI 10.1093/cercor/11.12.1136; Cools R, 2006, J COGNITIVE NEUROSCI, V18, P1973, DOI 10.1162/jocn.2006.18.12.1973; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Cools R, 2010, BRAIN, V133, P225, DOI 10.1093/brain/awp301; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Cools R, 2007, NEUROPSYCHOPHARMACOL, V32, P180, DOI 10.1038/sj.npp.1301153; Costa A, 2003, DEMENT GERIATR COGN, V15, P55, DOI 10.1159/000067968; Costa A, 2009, NEUROPSYCHOLOGIA, V47, P1374, DOI 10.1016/j.neuropsychologia.2009.01.039; Craik FIM, 1996, J EXP PSYCHOL GEN, V125, P159, DOI 10.1037/0096-3445.125.2.159; CRAWFORD JR, 1989, J CLIN EXP NEUROPSYC, V11, P975, DOI 10.1080/01688638908400950; Daselaar SM, 2004, NEUROIMAGE, V23, P921, DOI 10.1016/j.neuroimage.2004.07.031; Davidson PSR, 2006, BRAIN, V129, P1768, DOI 10.1093/brain/awl115; de Zubicaray GI, 2005, COGNITIVE BRAIN RES, V22, P439, DOI 10.1016/j.cogbrainres.2004.10.002; Defer GL, 1999, MOVEMENT DISORD, V14, P572, DOI 10.1002/1531-8257(199907)14:4<572::AID-MDS1005>3.0.CO;2-C; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Drag LL, 2009, J INT NEUROPSYCH SOC, V15, P399, DOI 10.1017/S1355617709090572; Edelstyn NMJ, 2010, NEUROPSYCHOLOGIA, V48, P1367, DOI 10.1016/j.neuropsychologia.2009.12.039; Evans AH, 2004, MOVEMENT DISORD, V19, P397, DOI 10.1002/mds.20045; Feigin A, 2003, NEUROLOGY, V60, P1744, DOI 10.1212/01.WNL.0000072263.03608.42; Floel A, 2008, NEUROBIOL AGING, V29, P267, DOI 10.1016/j.neurobiolaging.2006.10.009; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Ghilardi MF, 2007, PARKINSONISM RELAT D, V13, P146, DOI 10.1016/j.parkreldis.2006.08.006; GOTHAM AM, 1988, BRAIN, V111, P299, DOI 10.1093/brain/111.2.299; Graef S, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00169; Helie S, 2010, J NEUROSCI, V30, P14225, DOI 10.1523/JNEUROSCI.2393-10.2010; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Huijbers W, 2013, J COGNITIVE NEUROSCI, V25, P1163, DOI 10.1162/jocn_a_00366; Hutchinson JB, 2009, LEARN MEMORY, V16, P343, DOI 10.1101/lm.919109; Jahanshahi M, 2010, NEUROPSYCHOLOGIA, V48, P1096, DOI 10.1016/j.neuropsychologia.2009.12.010; Kim H, 2010, NEUROIMAGE, V50, P1648, DOI 10.1016/j.neuroimage.2010.01.051; Kimberg DY, 1997, NEUROREPORT, V8, P3581, DOI 10.1097/00001756-199711100-00032; Kimberg DY, 2003, NEUROPSYCHOLOGIA, V41, P1020, DOI 10.1016/S0028-3932(02)00317-2; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Knecht S, 2004, ANN NEUROL, V56, P20, DOI 10.1002/ana.20125; Konishi S, 2000, NEUROIMAGE, V12, P276, DOI 10.1006/nimg.2000.0614; LANG AE, 1984, CAN MED ASSOC J, V131, P1031; LANGE KW, 1992, PSYCHOPHARMACOLOGY, V107, P394, DOI 10.1007/BF02245167; Lee J, 2008, BRAIN, V131, P1574, DOI 10.1093/brain/awn085; Lewis SJG, 2005, NEUROPSYCHOLOGIA, V43, P823, DOI 10.1016/j.neuropsychologia.2004.10.001; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, pxiv; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; LUCIANA M, 1992, J COGNITIVE NEUROSCI, V4, P58, DOI 10.1162/jocn.1992.4.1.58; Luciana M, 1997, J COGNITIVE NEUROSCI, V9, P330, DOI 10.1162/jocn.1997.9.3.330; MacDonald AA, 2013, MOVEMENT DISORD, V28, P153, DOI 10.1002/mds.25152; MacDonald P.A., 2011, PARKINSONS DIS-US, V2011, DOI DOI 10.4061/2011/572743; MacDonald PA, 2011, BRAIN, V134, P1447, DOI 10.1093/brain/awr075; Macmillan NA, 2005, DETECTION THEORY USE, VXIX; Mattay VS, 2002, ANN NEUROL, V51, P156, DOI 10.1002/ana.10078; Mayes AR, 2001, PHILOS T ROY SOC B, V356, P1395, DOI 10.1098/rstb.2001.0941; Mehta MA, 2001, PSYCHOPHARMACOLOGY, V159, P10, DOI 10.1007/s002130100851; Mitrushina MN, 1999, HDB NORMATIVE DATA N, Vxxii; Mollion H, 2003, NEUROPSYCHOLOGIA, V41, P1442, DOI 10.1016/S0028-3932(03)00114-3; MOSCOVITCH M, 1992, J COGNITIVE NEUROSCI, V4, P257, DOI 10.1162/jocn.1992.4.3.257; Muller U, 1998, J NEUROSCI, V18, P2720; Nelson H., 1991, NATL ADULT READING T; Otten LJ, 2001, CEREB CORTEX, V11, P1150, DOI 10.1093/cercor/11.12.1150; Pizzagalli DA, 2008, PSYCHOPHARMACOLOGY, V196, P221, DOI 10.1007/s00213-007-0957-y; Pollak Y, 2008, DEV NEUROPSYCHOL, V33, P62, DOI 10.1080/87565640701729789; Reiss JP, 2005, NEUROREPORT, V16, P1291, DOI 10.1097/01.wnr.0000175615.93312.1a; Rieger M, 2003, NEUROPSYCHOLOGY, V17, P272, DOI 10.1037/0894-4105.17.2.272; Santesso DL, 2009, HUM BRAIN MAPP, V30, P1963, DOI 10.1002/hbm.20642; Schacter DL, 1997, NEUROIMAGE, V6, P259, DOI 10.1006/nimg.1997.0305; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Seger CA, 2010, NEUROIMAGE, V50, P644, DOI 10.1016/j.neuroimage.2009.11.083; Seo M, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00036; Shohamy D, 2006, NEUROPSYCHOLOGIA, V44, P774, DOI 10.1016/j.neuropsychologia.2005.07.013; Shrager Y, 2008, NEURON, V59, P547, DOI 10.1016/j.neuron.2008.07.022; Slabosz A, 2006, NEUROPSYCHOLOGY, V20, P578, DOI 10.1037/0894-4105.20.5.578; Su CY, 2007, ARCH CLIN NEUROPSYCH, V22, P465, DOI 10.1016/j.acn.2007.01.025; Swainson R, 2000, NEUROPSYCHOLOGIA, V38, P596, DOI 10.1016/S0028-3932(99)00103-7; TAYLOR AE, 1990, BRAIN COGNITION, V13, P211, DOI 10.1016/0278-2626(90)90051-O; Tomer R, 2007, NEUROPSYCHOLOGIA, V45, P357, DOI 10.1016/j.neuropsychologia.2006.06.014; Torta DME, 2009, BRAIN COGNITION, V71, P84, DOI 10.1016/j.bandc.2009.04.003; Tremblay PL, 2010, EXP BRAIN RES, V205, P375, DOI 10.1007/s00221-010-2372-6; VAKIL E, 1993, J CLIN PSYCHOL, V49, P883, DOI 10.1002/1097-4679(199311)49:6<883::AID-JCLP2270490616>3.0.CO;2-6; Vakil E, 2010, CLIN NEUROPSYCHOL, V24, P662, DOI 10.1080/13854040903493522; van Eimeren T, 2009, NEUROPSYCHOPHARMACOL, V34, P2758, DOI [10.1038/sj.npp.npp2009124, 10.1038/npp.2009.124]; Weiermann B, 2010, INT J NEUROSCI, V120, P211, DOI 10.3109/00207450903506510; WIXTED JT, 1991, PSYCHOL SCI, V2, P409, DOI 10.1111/j.1467-9280.1991.tb00175.x; Woodard JL, 1999, J CLIN EXP NEUROPSYC, V21, P666, DOI 10.1076/jcen.21.5.666.872; World Medical Association, 1991, Law Med Health Care, V19, P264; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961	95	33	33	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e74044	10.1371/journal.pone.0074044	http://dx.doi.org/10.1371/journal.pone.0074044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086309	Green Published, Green Submitted, gold			2022-12-27	WOS:000325220000006
J	Shah, S; Conlin, LK; Gomez, L; Aagenaes, O; Eiklid, K; Knisely, AS; Mennuti, MT; Matthews, RP; Spinner, NB; Bull, LN				Shah, Sohela; Conlin, Laura K.; Gomez, Luis; Aagenaes, Oystein; Eiklid, Kristin; Knisely, A. S.; Mennuti, Michael T.; Matthews, Randolph P.; Spinner, Nancy B.; Bull, Laura N.			CCBE1 Mutation in Two Siblings, One Manifesting Lymphedema-Cholestasis Syndrome, and the Other, Fetal Hydrops	PLOS ONE			English	Article							FAMILIAL INTRAHEPATIC CHOLESTASIS; HEREDITARY CHOLESTASIS; RENAL DYSFUNCTION; ABC TRANSPORTER; GENE; HYPERCHOLANEMIA; ARTHROGRYPOSIS; EXPRESSION; DYSPLASIA; DISEASE	Background: Lymphedema-cholestasis syndrome (LCS; Aagenaes syndrome) is a rare autosomal recessive disorder, characterized by 1) neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema, mainly lower limb. LCS was originally described in a Norwegian kindred in which a locus, LCS1, was mapped to a 6.6cM region on chromosome 15. Mutations in CCBE1 on chromosome 18 have been reported in some cases of lymphatic dysplasia, but not in LCS. Methods: Consanguineous parents of Mexican ancestry had a child with LCS who did not exhibit extended homozygosity in the LCS1 region. A subsequent pregnancy was electively terminated due to fetal hydrops. We performed whole-genome single nucleotide polymorphism genotyping to identify regions of homozygosity in these siblings, and sequenced promising candidate genes. Results: Both siblings harbored a homozygous mutation in CCBE1, c.398 T>C, predicted to result in the missense change p.L133P. Regions containing known 'cholestasis genes' did not demonstrate homozygosity in the LCS patient. Conclusions: Mutations in CCBE1 may yield a phenotype not only of lymphatic dysplasia, but also of LCS or fetal hydrops; however, the possibility that the sibling with LCS also carries a homozygous mutation in an unidentified gene influencing cholestasis cannot be excluded.	[Shah, Sohela; Bull, Laura N.] Univ Calif San Francisco, Dept Med, Liver Ctr Lab, San Francisco, CA USA; [Conlin, Laura K.; Spinner, Nancy B.] Univ Penn, Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Conlin, Laura K.; Spinner, Nancy B.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Gomez, Luis; Mennuti, Michael T.] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Aagenaes, Oystein] Oslo Univ Hosp, Oslo, Norway; [Eiklid, Kristin] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Knisely, A. S.] Kings Coll Hosp London, Inst Liver Studies, London, England; [Matthews, Randolph P.] Univ Penn, Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Matthews, Randolph P.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Bull, Laura N.] Univ Calif San Francisco, Dept Med, Inst Human Genet, San Francisco, CA USA	University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Oslo; University of Oslo; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco	Bull, LN (corresponding author), Univ Calif San Francisco, Dept Med, Liver Ctr Lab, San Francisco, CA USA.	lbull@medsfgh.ucsf.edu			National Institutes of Health [R01 DK58214]; Genome Institute at Washington University School of Medicine as part of the NHGRI Medical Sequencing Program [2U54HG003079-09]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058214, P30DK026743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genome Institute at Washington University School of Medicine as part of the NHGRI Medical Sequencing Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health R01 DK58214 to LNB. Initial sequencing of LCS1 in Patient 1, which suggested locus heterogeneity, was performed by the Genome Institute at Washington University School of Medicine as part of the NHGRI Medical Sequencing Program (2U54HG003079-09 to R. K. Wilson). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAGENAES O, 1970, ARCH DIS CHILD, V45, P690, DOI 10.1136/adc.45.243.690; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alders M, 2013, MOL SYNDROMOL, V4, P107, DOI [10.1159/000342486, 10.1159/000354097]; Alders M, 2009, NAT GENET, V41, P1272, DOI 10.1038/ng.484; Bellini C, 2010, AM J MED GENET A, V152A, P1189, DOI 10.1002/ajmg.a.33191; Bos FL, 2011, CIRC RES, V109, P486, DOI 10.1161/CIRCRESAHA.111.250738; Bull LN, 2000, AM J HUM GENET, V67, P994, DOI 10.1086/303080; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Carlton VEH, 2004, ANN MED, V36, P606, DOI 10.1080/07853890410018916; Carlton VEH, 2003, NAT GENET, V34, P91, DOI 10.1038/ng1147; Chagnon P, 2002, AM J HUM GENET, V71, P1443, DOI 10.1086/344580; Chong CPK, 2012, J INHERIT METAB DIS, V35, P521, DOI 10.1007/s10545-011-9416-3; Connell FC, 2012, CLIN GENET, V81, P191, DOI 10.1111/j.1399-0004.2011.01731.x; Connell F, 2010, HUM GENET, V127, P231, DOI 10.1007/s00439-009-0766-y; Cullinane AR, 2010, NAT GENET, V42, P303, DOI 10.1038/ng.538; De Vree JML, 1998, P NATL ACAD SCI USA, V95, P282, DOI 10.1073/pnas.95.1.282; Fabris L, 2006, HEPATOLOGY, V43, P1001, DOI 10.1002/hep.21143; Facucho-Oliveira J, 2011, INT J DEV BIOL, V55, P1007, DOI 10.1387/ijdb.113394jf; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fruhwirth M, 2003, J PEDIATR-US, V142, P441, DOI 10.1067/mpd.2003.148; Gissen P, 2004, NAT GENET, V36, P400, DOI 10.1038/ng1325; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Hadj-Rabia S, 2004, GASTROENTEROLOGY, V127, P1386, DOI 10.1053/j.gastro.2004.07.022; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Jin ZW, 2010, J ANAT, V216, P671, DOI 10.1111/j.1469-7580.2010.01229.x; Klomp LWJ, 2004, HEPATOLOGY, V40, P27, DOI 10.1002/hep.20285; Lemonde HA, 2003, GUT, V52, P1494, DOI 10.1136/gut.52.10.1494; Schulte-Merker S, 2011, J CELL BIOL, V193, P607, DOI 10.1083/jcb.201012094; Schwarz M, 2000, J CLIN INVEST, V106, P1175, DOI 10.1172/JCI10902; Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034; Van Mil SWC, 2007, GASTROENTEROLOGY, V133, P507, DOI 10.1053/j.gastro.2007.05.015; Wada M, 1998, HUM MOL GENET, V7, P203, DOI 10.1093/hmg/7.2.203; Zhu QS, 2003, BBA-MOL BASIS DIS, V1638, P208, DOI 10.1016/S0925-4439(03)00085-1; Zollner G, 2006, WIEN MED WOCHENSCHR, V156, P380, DOI 10.1007/s10354-006-0312-7; Zou ZY, 2013, BLOOD, V121, P3228, DOI 10.1182/blood-2012-10-462689	35	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75770	10.1371/journal.pone.0075770	http://dx.doi.org/10.1371/journal.pone.0075770			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086631	Green Published, Green Submitted, gold			2022-12-27	WOS:000325220000042
J	Gruber, T; Zuberbuhler, K				Gruber, Thibaud; Zuberbuehler, Klaus			Vocal Recruitment for Joint Travel in Wild Chimpanzees	PLOS ONE			English	Article							PAN-TROGLODYTES-SCHWEINFURTHII; USE COPULATION CALLS; REFERENTIAL GESTURES; BUDONGO FOREST; COMMUNICATION; COMMUNITY; BEHAVIOR; SCREAMS	Joint travel is a common social activity of many group-living animals, which requires some degree of coordination, sometimes through communication signals. Here, we studied the use of an acoustically distinct vocalisation in chimpanzees, the 'travel hoo', a signal given specifically in the travel context. We were interested in how this call type was produced to coordinate travel, whether it was aimed at specific individuals and how recipients responded. We found that 'travel hoos' were regularly given prior to impending departures and that silent travel initiations were less successful in recruiting than vocal initiations. Other behaviours associated with departure were unrelated to recruitment, suggesting that 'travel hoos' facilitated joint travel. Crucially, 'travel hoos' were more often produced in the presence of allies than other individuals, with high rates of recruitment success. We discuss these findings as evidence for how motivation to perform a specific social activity can lead to the production of a vocal signal that qualifies as 'intentional' according to most definitions, suggesting that a key psychological component of human language may have already been present in the common ancestor of chimpanzees and humans.	[Gruber, Thibaud] EHESS, Ctr Norbert Elias, Marseille, France; [Gruber, Thibaud; Zuberbuehler, Klaus] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland; [Gruber, Thibaud] Univ Zurich, Inst Anthropol, Zurich, Switzerland; [Zuberbuehler, Klaus] Univ Neuchatel, Ctr Cognit Sci, CH-2000 Neuchatel, Switzerland; [Gruber, Thibaud; Zuberbuehler, Klaus] Budongo Conservat Field Stn, Masindi, Uganda	UDICE-French Research Universities; Aix-Marseille Universite; University of St Andrews; University of Zurich; University of Neuchatel	Gruber, T (corresponding author), EHESS, Ctr Norbert Elias, Marseille, France.	thibaud.gruber@gmail.com	Zuberbühler, Klaus/A-9053-2011; Gruber, Thibaud/D-1628-2014	Zuberbühler, Klaus/0000-0001-8378-088X; Gruber, Thibaud/0000-0002-6766-3947	Leverhulme Trust (UK); Wissenschaftskolleg zu Berlin; European Research Council; Fyssen Foundation	Leverhulme Trust (UK)(Leverhulme Trust); Wissenschaftskolleg zu Berlin(Austrian Science Fund (FWF)); European Research Council(European Research Council (ERC)European Commission); Fyssen Foundation	The study was funded by the Leverhulme Trust (UK) with additional support by the Wissenschaftskolleg zu Berlin, the European Research Council and the Fyssen Foundation during the writing of this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; BARD KA, 1992, CHILD DEV, V63, P1186, DOI 10.2307/1131526; Bates LA, 2009, BEHAV ECOL SOCIOBIOL, V64, P247, DOI 10.1007/s00265-009-0841-3; Boesch C, 2000, CHIMPANZEES TAI FORE; Boinski S, 1999, MOVE WHY ANIMALS TRA; Call J., 2007, GESTURAL COMMUNICATI; Clay Z, 2011, BIOL LETTERS, V7, P513, DOI 10.1098/rsbl.2010.1227; Crockford C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2765; Crockford C, 2012, CURR BIOL, V22, P142, DOI 10.1016/j.cub.2011.11.053; Deschner T, 2003, ANIM BEHAV, V66, P551, DOI 10.1006/anbe.2003.2210; DEWAAL F, 1982, CHIMPANZEE POLITICS; EGGELING WJ, 1947, J ECOL, V34, P20, DOI 10.2307/2256760; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hare B, 2010, CURR BIOL, V20, pR230, DOI 10.1016/j.cub.2009.12.038; HAUSER MD, 1992, P NATL ACAD SCI USA, V89, P12137, DOI 10.1073/pnas.89.24.12137; Hobaiter C, 2011, ANIM COGN, V14, P827, DOI 10.1007/s10071-011-0416-3; Laporte MNC, 2010, ANIM BEHAV, V80, P467, DOI 10.1016/j.anbehav.2010.06.005; Leavens DA, 2004, J COMP PSYCHOL, V118, P48, DOI 10.1037/0735-7036.118.1.48; Liebal K, 2004, AM J PRIMATOL, V64, P377, DOI 10.1002/ajp.20087; Moore JW, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00023; Murray CM, 2007, ANIM BEHAV, V74, P1795, DOI 10.1016/j.anbehav.2007.03.024; Newton-Fisher NE, 2003, AFR J ECOL, V41, P150, DOI 10.1046/j.1365-2028.2003.00408.x; Owren MJ, 2011, AM J PRIMATOL, V73, P530, DOI 10.1002/ajp.20913; Pika S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1567; Plumptre A. J., 2003, ALBERTINE RIFT TECHN, V2; Plumptre AJ, 1996, FOREST ECOL MANAG, V89, P101, DOI 10.1016/S0378-1127(96)03854-6; Reynolds V., 2005, CHIMPANZEES BUDONGO; Slocombe KE, 2007, P NATL ACAD SCI USA, V104, P17228, DOI 10.1073/pnas.0706741104; Slocombe KE, 2010, BEHAV ECOL SOCIOBIOL, V64, P1959, DOI 10.1007/s00265-010-1006-0; Slocombe KE, 2005, J COMP PSYCHOL, V119, P67, DOI 10.1037/0735-7036.119.1.67; Slocombe KE, 2005, AM J PRIMATOL, V65, P385, DOI 10.1002/ajp.20123; Tomasello M, 2008, JEAN NICOD LECT, P1; Townsend SW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002431; TUTIN CEG, 1979, BEHAV ECOL SOCIOBIOL, V6, P29, DOI 10.1007/BF00293242; Vail AL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2781; Williams JM, 2008, AM J PRIMATOL, V70, P766, DOI 10.1002/ajp.20573; Wrangham R., 1996, DEMONIC MALES; Zuberbuhler K, 2008, CURR BIOL, V18, pR189, DOI 10.1016/j.cub.2007.12.041	38	41	41	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76073	10.1371/journal.pone.0076073	http://dx.doi.org/10.1371/journal.pone.0076073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086688	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000325218700120
J	Issur, M; Bougie, I; Despins, S; Bisaillon, M				Issur, Moheshwarnath; Bougie, Isabelle; Despins, Simon; Bisaillon, Martin			Enzymatic Synthesis of RNAs Capped with Nucleotide Analogues Reveals the Molecular Basis for Substrate Selectivity of RNA Capping Enzyme: Impacts on RNA Metabolism	PLOS ONE			English	Article							TRANSLATION FACTOR EIF4E; INITIATION-FACTOR EIF4E; CHLORELLA-VIRUS PBCV-1; MESSENGER-RNA; BINDING-PROTEIN; SCHIZOSACCHAROMYCES-POMBE; DNA-LIGASE; GUANYLYLTRANSFERASE; TRIPHOSPHATASE; EFFICIENCY	RNA cap binding proteins have evolved to specifically bind to the N7-methyl guanosine cap structure found at the 5' ends of eukaryotic mRNAs. The specificity of RNA capping enzymes towards GTP for the synthesis of this structure is therefore crucial for mRNA metabolism. The fact that ribavirin triphosphate was described as a substrate of a viral RNA capping enzyme, raised the possibility that RNAs capped with nucleotide analogues could be generated in cellulo. Owing to the fact that this prospect potentially has wide pharmacological implications, we decided to investigate whether the active site of the model Paramecium bursaria Chlorella virus-1 RNA capping enzyme was flexible enough to accommodate various purine analogues. Using this approach, we identified several key structural determinants at each step of the RNA capping reaction and generated RNAs harboring various different cap analogues. Moreover, we monitored the binding affinity of these novel capped RNAs to the eIF4E protein and evaluated their translational properties in cellulo. Overall, this study establishes a molecular rationale for the specific selection of GTP over other NTPs by RNA capping enzyme It also demonstrates that RNAs can be enzymatically capped with certain purine nucleotide analogs, and it also describes the impacts of modified RNA caps on specific steps involved in mRNA metabolism. For instance, our results indicate that the N7-methyl group of the classical N7-methyl guanosine cap is not always indispensable for binding to eIF4E and subsequently for translation when compensatory modifications are present on the capped residue. Overall, these findings have important implications for our understanding of the molecular determinants involved in both RNA capping and RNA metabolism.	[Issur, Moheshwarnath; Bougie, Isabelle; Despins, Simon; Bisaillon, Martin] Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Bisaillon, M (corresponding author), Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada.	Martin.Bisaillon@USherbrooke.ca			Canadian Institutes for Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); CIHR; Universite de Sherbrooke; Fonds de Recherche en Sante du Quebec	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); Universite de Sherbrooke; Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work as supported by the following: Canadian Institutes for Health Research (CIHR) and Natural Sciences and Engineering Research Council of Canada (NSERC) grants to MB; CIHR and Universite de Sherbrooke grant to RNA group; M. B is a Chercheur Boursier Senior from the Fonds de recherche en sante du Quebec; Doctoral training award from the Fonds de Recherche en Sante du Quebec to M. I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS BL, 1978, J BIOL CHEM, V253, P2589; Bachand F, 2006, MOL CELL BIOL, V26, P1731, DOI 10.1128/MCB.26.5.1731-1742.2006; Benzaghou I, 2006, FEBS LETT, V580, P867, DOI 10.1016/j.febslet.2006.01.006; Bougie I, 2004, J BIOL CHEM, V279, P22124, DOI 10.1074/jbc.M400908200; Bougie I, 2006, BIOCHEM J, V398, P557, DOI 10.1042/BJ20060198; Brown CJ, 2007, J MOL BIOL, V372, P7, DOI 10.1016/j.jmb.2007.06.033; Doherty AJ, 1997, ACTA CRYSTALLOGR D, V53, P482, DOI 10.1107/S090744499700231X; Fabrega C, 2003, MOL CELL, V11, P1549, DOI 10.1016/S1097-2765(03)00187-4; Fechter P, 2005, J GEN VIROL, V86, P1239, DOI 10.1099/vir.0.80755-0; Fischer PM, 2009, CELL CYCLE, V8, P2535, DOI 10.4161/cc.8.16.9301; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; Graff JR, 2007, J CLIN INVEST, V117, P2638, DOI 10.1172/JCI32044; Grudzien E, 2004, RNA, V10, P1479, DOI 10.1261/rna.7380904; Grudzien-Nogalska E, 2007, METHOD ENZYMOL, V431, P203, DOI 10.1016/S0076-6879(07)31011-2; Grudzien-Nogalska E, 2007, RNA, V13, P1745, DOI 10.1261/rna.701307; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; Ho CK, 1996, J VIROL, V70, P6658, DOI 10.1128/JVI.70.10.6658-6664.1996; Jemielity J, 2003, RNA, V9, P1108, DOI 10.1261/rna.5430403; Kalek M, 2005, NUCLEOS NUCLEOT NUCL, V24, P615, DOI 10.1081/NCN-200060091; Kampf G, 2002, J CHEM SOC PERK T 2, P1320, DOI 10.1039/b202023h; Kore AR, 2008, BIOORG MED CHEM LETT, V18, P880, DOI 10.1016/j.bmcl.2007.12.049; Kore AR, 2009, J AM CHEM SOC, V131, P6364, DOI 10.1021/ja901655p; Kowalska J, 2008, RNA, V14, P1119, DOI 10.1261/rna.990208; Kuhn AN, 2010, GENE THER, V17, P961, DOI 10.1038/gt.2010.52; Lewis JD, 1997, EUR J BIOCHEM, V247, P461, DOI 10.1111/j.1432-1033.1997.00461.x; Mao XD, 1996, MOL CELL BIOL, V16, P475; Marcotrigiano J, 1997, Nucleic Acids Symp Ser, P8; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Nair PA, 2007, NAT STRUCT MOL BIOL, V14, P770, DOI 10.1038/nsmb1266; Niedzwiecka A, 2003, NUCLEOS NUCLEOT NUCL, V22, P1557, DOI 10.1081/NCN-120023033; Niedzwiecka A, 2002, BIOCHEMISTRY-US, V41, P12140, DOI 10.1021/bi0258142; Rhoads RE, 2009, J BIOL CHEM, V284, P16711, DOI 10.1074/jbc.R900002200; Roitzsch M, 2010, NAT CHEM BIOL, V6, P218, DOI 10.1038/NCHEMBIO.312; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Saha N, 1999, J BIOL CHEM, V274, P16553, DOI 10.1074/jbc.274.23.16553; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; SHUMAN S, 1994, P NATL ACAD SCI USA, V91, P12046, DOI 10.1073/pnas.91.25.12046; SHUMAN S, 1995, MOL MICROBIOL, V17, P405, DOI 10.1111/j.1365-2958.1995.mmi_17030405.x; Slepenkov SV, 2006, J BIOL CHEM, V281, P14927, DOI 10.1074/jbc.M601653200; Sonenberg N, 2008, BIOCHEM CELL BIOL, V86, P178, DOI 10.1139/O08-034; Souliere MF, 2008, BIOCHEMISTRY-US, V47, P3863, DOI 10.1021/bi702054a; Stepinski J, 2005, NUCLEOS NUCLEOT NUCL, V24, P629, DOI 10.1081/NCN-200060103; UEDA H, 1991, J BIOCHEM-TOKYO, V109, P882, DOI 10.1093/oxfordjournals.jbchem.a123475; VENKATESAN S, 1980, J BIOL CHEM, V255, P903; VENKATESAN S, 1982, P NATL ACAD SCI-BIOL, V79, P340, DOI 10.1073/pnas.79.2.340	46	12	13	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75310	10.1371/journal.pone.0075310	http://dx.doi.org/10.1371/journal.pone.0075310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086504	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700073
J	Laloy, F; Rage, JC; Evans, SE; Boistel, R; Lenoir, N; Laurin, M				Laloy, Fabien; Rage, Jean-Claude; Evans, Susan E.; Boistel, Renaud; Lenoir, Nicolas; Laurin, Michel			A Re-Interpretation of the Eocene Anuran Thaumastosaurus Based on MicroCT Examination of a 'Mummified' Specimen	PLOS ONE			English	Article							FROG; PHYLOGENY; DIVERSIFICATION; LEPTODACTYLIDAE; AMPHIBIANS; AFFINITIES; OSTEOLOGY; ENGLAND; RANIDAE; EUROPE	What originally appeared to be only an external cast of an anuran 'mummy' from the Quercy Phosphorites (southwestern France) was described as Rana plicata during the 19th century. Its geographical provenance is only vaguely known; therefore its precise age within the Paleogene was uncertain. The taxon was erected on the basis of the external morphology of the specimen, which includes few diagnostic characters. As a further complication, the name Rana plicata was recently shown to be unavailable at the time of the description, and the name Rana cadurcorum was proposed as a replacement. In order to see whether internal features were fossilized, the fossil was CT scanned. This showed that a large part of the skeleton is preserved. Unexpectedly, the scans revealed that the skull of the mummy is almost identical to that of Thaumastosaurus gezei, another anuran from the late middle or late Eocene of the Quercy Phosphorites. The few observed differences are attributable to intraspecific and ontogenetic variation, and R. cadurcorum is a junior subjective synonym of T. gezei. The mummy is therefore probably from the same time interval as T. gezei. The latter was previously known only by its skull, but the mummy provides important information on the postcranial skeleton. Earlier assessments, based only on the skull, placed Thaumastosaurus close to South American hyloid anurans, but a new phylogenetic analysis including postcranial characters reveals ranoid affinities. This study exemplifies the usefulness of modern imaging technologies that allow non-destructive study of previously inaccessible internal anatomical features.	[Laloy, Fabien; Rage, Jean-Claude; Laurin, Michel] Univ Paris 06, CNRS, Museum Natl Hist Nat, Unite Mixte Rech 7207, Paris, France; [Evans, Susan E.] UCL, Dept Cell & Dev Biol, London, England; [Boistel, Renaud] Univ Poitiers, CNRS, Unite Mixte Rech 7262, Inst Int Paleoprimatol & Paleontol Humaine, Poitiers, France; [Lenoir, Nicolas] Ecole Natl Ponts & Chaussees, CNRS, Inst Francais Sci & Technol Transports Amenagemen, Lab Navier,Unite Mixte Rech 8205, Marne La Vallee, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); Ecole des Ponts ParisTech; Universite Gustave-Eiffel	Laurin, M (corresponding author), Univ Paris 06, CNRS, Museum Natl Hist Nat, Unite Mixte Rech 7207, Paris, France.	laurin@mnhn.fr	Laurin, Michel/B-7884-2008; Evans, Susan/C-1888-2008	Laurin, Michel/0000-0003-2974-9835; Evans, Susan/0000-0002-0799-4154	Region Ile-de-France; French Ministry of Research; CNRS	Region Ile-de-France(Region Ile-de-France); French Ministry of Research(Ministry of Research, FranceEuropean Commission); CNRS(Centre National de la Recherche Scientifique (CNRS))	The Laboratoire Navier microtomograph used to scan the specimens has been acquired with the financial support of Region Ile-de-France. J.-C. Rage and M. Laurin were funded by the French Ministry of Research and CNRS grants to UMR 7207. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baez AM, 2009, CRETACEOUS RES, V30, P829, DOI 10.1016/j.cretres.2009.01.002; Bossuyt F, 2006, SYST BIOL, V55, P579, DOI 10.1080/10635150600812551; Boulenger GA, 1886, B SOC ZOOL FRANCE, V11, P320; Cope E. D., 1864, Proceedings of the Academy of Natural Sciences of Philadelphia, P181; Cope ED, 1865, NAT HIST REV, V5, P97; Daudin FM, 1802, HIST NATURELLE RAINE; Duellman W. E., 1986, BIOL AMPHIBIANS; Evans SE, 2008, P NATL ACAD SCI USA, V105, P2951, DOI 10.1073/pnas.0707599105; Fabrezi M, 2006, J ZOOL SYST EVOL RES, V44, P153, DOI 10.1111/j.1439-0469.2005.00349.x; Filhol H, 1876, B SOC PHILOMATIQUE P, V11, P27; Filhol H, 1877, RECHERCHES PHOSPHORI; Filhol H., 1873, CR HEBD ACAD SCI, V77, P1556; Fischer von Waldheim G, 1813, ZOOGNOSIA TABULIS SY, V1; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Gheerbrant E, 2006, PALAEOGEOGR PALAEOCL, V241, P224, DOI 10.1016/j.palaeo.2006.03.016; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Grand A, BIOL J LINN IN PRESS; Holman JA, 2003, ACTA PALAEONTOL POL, V48, P157; Holman JA, 2002, J HERPETOL, V36, P621, DOI 10.1670/0022-1511(2002)036[0621:ANTAFI]2.0.CO;2; JAROSOVA J, 1982, Amphibia-Reptilia, V3, P111, DOI 10.1163/156853882X00347; Laloy F, 2012, THESIS MUSEUM NATL H; Legendre S, 1992, N JB GEOL PALAONT MH, V7, P414; Lynch J. D., 1971, Misc Publs Mus nat Hist Univ Kansas, VNo. 53, P1; Lynch J. D., 1973, EVOLUTIONARY BIOL AN, P131; Maddison WP, 2011, MESQUITE MODULAR SYS; Martin C., 2012, Graellsia, V68, P159, DOI 10.3989/graellsia.2012.v68.056; Nicholls G. E., 1916, Proceedings of the Linnean Society London, V128; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Noble G.K., 1931, BIOL AMPHIBIA; Noble GK, 1922, B AM MUS NAT HIST, V56; Pelissie T, 2006, STRATA, V13, P3; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Rage J.-C., 2006, Strata Series 1 Communications, V13, P161; Rage JC, 2007, J VERTEBR PALEONTOL, V27, P329, DOI 10.1671/0272-4634(2007)27[329:ANSOTA]2.0.CO;2; Rocek Z, 1995, J VERTEBR PALEONTOL, V15, P506; Rocek Z, 1980, ACTA U CAROLINAE BIO, V1-2, P1; Rocek Zbynik, 2003, Amphibian Biology, V5, P1877; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Sheil CA, 1999, J MORPHOL, V240, P49, DOI 10.1002/(SICI)1097-4687(199904)240:1<49::AID-JMOR5>3.0.CO;2-Z; SIGE B, 1991, GEOBIOS-LYON, V24, P497, DOI 10.1016/S0016-6995(06)80251-2; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; van der Meijden A, 2007, MOL PHYLOGENET EVOL, V44, P1017, DOI 10.1016/j.ympev.2007.02.008; Wild ER, 1999, J MORPHOL, V242, P229, DOI 10.1002/(SICI)1097-4687(199912)242:3<229::AID-JMOR3>3.0.CO;2-N; Wild ER, 1997, J MORPHOL, V232, P169, DOI 10.1002/(SICI)1097-4687(199705)232:2<169::AID-JMOR4>3.0.CO;2-5	46	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74874	10.1371/journal.pone.0074874	http://dx.doi.org/10.1371/journal.pone.0074874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086389	gold, Green Submitted, Green Published			2022-12-27	WOS:000325218700044
J	Shin, RM; Higuchi, M; Suhara, T				Shin, Ryong-Moon; Higuchi, Makoto; Suhara, Tetsuya			Nitric Oxide Signaling Exerts Bidirectional Effects on Plasticity Inductions in Amygdala	PLOS ONE			English	Article							LONG-TERM POTENTIATION; TIMING-DEPENDENT PLASTICITY; LATERAL AMYGDALA; MEMORY CONSOLIDATION; SYNAPTIC PLASTICITY; CA2+ CHANNELS; PATHWAY; LTP; ACTIVATION; INVOLVEMENT	It has been well known that long-term potentiation (LTP) of synaptic transmission in the lateral nucleus of the amygdala (LA) constitutes an essential cellular mechanism contributing to encoding of conditioned fear. Nitric oxide (NO), produced by activation of the postsynaptic N-methyl-D-aspartate receptors (NMDAR) in thalamic input to the LA, has been thought to promote LTP, contributing to the establishment of conditioned fear. However, it is not known whether and how NO, released from cortical input to the LA, plays the role on the plasticity induction and fear memory. Here we report that the diffusion of NO, released in response to activation of presynaptic NMDAR on cortical afferent fibers in the LA, could suppress heterosynaptically a form of presynaptic kainate receptor (KAR) dependent LTP (pre-LTP) in thalamic input, which was induced by low-frequency presynaptic stimuli without postsynaptic depolarization. We also confirmed that NO, produced by activation of postsynaptic NMDAR in thalamic input, can promote postsynaptic NMDAR-dependent LTP (post-LTP), which was induced by pairing protocol. These LTPs were occluded following fear conditioning, indicating that they could contribute to encoding of conditioned fear memory. However, their time courses are different; Post-LTP was more rapidly formed than pre-LTP in the course of fear conditioning. NO, produced by activation of presynaptic NMDAR in cortical input and postsynaptic NMDAR in thalamic input, may control conditioned fear by suppressing pre-LTP and promoting post-LTP, respectively, in thalamic input to the LA.	[Shin, Ryong-Moon; Higuchi, Makoto; Suhara, Tetsuya] Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, Chiba 260, Japan	National Institutes for Quantum Science & Technology	Shin, RM (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, Anagawa 4-9-1, Chiba 260, Japan.	moon@nirs.go.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [2311109]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Japan Advanced Molecular Imaging Program (R-M.S., M.H. and T.S) and Scientific Research on innovative Areas ("Brain Environment") 2311109 (M.H) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MS, 2009, NEURON, V63, P372, DOI 10.1016/j.neuron.2009.07.013; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Burnashev N, 1996, J PHYSIOL-LONDON, V496, P165, DOI 10.1113/jphysiol.1996.sp021674; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; Casado M, 2002, NEURON, V33, P123, DOI 10.1016/S0896-6273(01)00568-2; Cho JH, 2012, NAT NEUROSCI, V15, P113, DOI 10.1038/nn.2993; Corlew R, 2007, J NEUROSCI, V27, P9835, DOI 10.1523/JNEUROSCI.5494-06.2007; Doyere V, 2003, EUR J NEUROSCI, V17, P2703, DOI 10.1046/j.1460-9568.2003.02707.x; Feil R, 2005, REV NEUROSCIENCE, V16, P23; Fi XF, 1996, SYNAPSE, V24, P115, DOI 10.1002/(SICI)1098-2396(199610)24:2<115::AID-SYN3>3.0.CO;2-I; Fourcaudot E, 2009, NAT NEUROSCI, V12, P1093, DOI 10.1038/nn.2378; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Humeau Y, 2007, J NEUROSCI, V27, P10947, DOI 10.1523/JNEUROSCI.2603-07.2007; IZUMI Y, 1992, SCIENCE, V257, P1273, DOI 10.1126/science.1519065; Jacoby S, 2001, J PHYSIOL-LONDON, V535, P825, DOI 10.1111/j.1469-7793.2001.t01-1-00825.x; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Kodirov SA, 2006, P NATL ACAD SCI USA, V103, P15218, DOI 10.1073/pnas.0607131103; Lang EJ, 1997, J NEUROPHYSIOL, V77, P341, DOI 10.1152/jn.1997.77.1.341; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; Li H, 2001, NAT NEUROSCI, V4, P612, DOI 10.1038/88432; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Ota KT, 2008, LEARN MEMORY, V15, P792, DOI 10.1101/lm.1114808; Paul C, 2008, J NEUROSCI, V28, P14202, DOI 10.1523/JNEUROSCI.2216-08.2008; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sato T, 2006, NEUROPSYCHOBIOLOGY, V53, P142, DOI 10.1159/000093100; Schafe GE, 2005, EUR J NEUROSCI, V22, P201, DOI 10.1111/j.1460-9568.2005.04209.x; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; Sequeira SM, 2001, MOL BRAIN RES, V89, P111, DOI 10.1016/S0169-328X(01)00069-9; Shin RM, 2006, NEURON, V52, P883, DOI 10.1016/j.neuron.2006.10.010; Shin RM, 2010, P NATL ACAD SCI USA, V107, P19073, DOI 10.1073/pnas.1009803107; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Sugita S, 1997, J PHYSL, V460, P705; Tsvetkov E, 2004, NEURON, V41, P139, DOI 10.1016/S0896-6273(03)00800-6; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Tully K, 2007, P NATL ACAD SCI USA, V104, P14146, DOI 10.1073/pnas.0704621104; WATANABE Y, 1995, BRAIN RES, V688, P233, DOI 10.1016/0006-8993(95)00563-6; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	47	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74668	10.1371/journal.pone.0074668	http://dx.doi.org/10.1371/journal.pone.0074668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086360	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700030
J	Yu, Y; Xiang, ZF; Yao, H; Grueter, CC; Li, M				Yu, Yang; Xiang, Zuo-Fu; Yao, Hui; Grueter, Cyril C.; Li, Ming			Female Snub-Nosed Monkeys Exchange Grooming for Sex and Infant Handling	PLOS ONE			English	Article							RHINOPITHECUS-ROXELLANA; AGONISTIC SUPPORT; QINLING MOUNTAINS; SOCIAL-BEHAVIOR; RECIPROCITY; EVOLUTION; RECONCILIATION; INTERCHANGE; BABOONS	Allogrooming in primates has acquired an important social function beyond its original hygienic function and can be exchanged either for itself or used as a currency to obtain other benefits such as copulations, access to infants or agonistic support. We explore the strategic use of grooming as a social tool in semi-wild golden snub-nosed monkeys (Rhinopithecus roxellana) in central China, a species where two desirable resources, viz. reproductive males and infants, are restricted to the mating and birth season, respectively. We predict that females expend their grooming selectively to different individuals according to their "value". Our results show that in the mating season, females devoted more grooming to the resident male than in the birth season, and this effect was particularly strong in non-mothers (females without newborn infants). Moreover, females were more likely to groom the resident male after copulation than during baseline social conditions. In the birth season, females devoted more grooming to other females than in the mating season, and mothers (females with newborn infants) were the most valuable grooming partners. The mean rate of contact by non-mothers toward infants of other females was significantly higher after grooming the mothers than in baseline social conditions. In conclusion, our findings lend credence to the notion that primate females use grooming as a strategic tool to obtain limited resources such as males and infants and vary preference for particular individuals depending on the seasonal availability of valuable resources.	[Yu, Yang; Xiang, Zuo-Fu] Cent South Univ Forestry & Technol, Coll Life Sci & Technol, Changsha, Hunan, Peoples R China; [Yao, Hui] Key Lab Conservat Biol Shennongjia Golden Monkey, Shennongjia Forest Dist, Hubei, Peoples R China; [Grueter, Cyril C.] Univ Western Australia, Sch Anat Physiol & Human Biol, Crawley, WA, Australia; [Li, Ming] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China	Central South University of Forestry & Technology; University of Western Australia; Chinese Academy of Sciences; Institute of Zoology, CAS	Xiang, ZF (corresponding author), Cent South Univ Forestry & Technol, Coll Life Sci & Technol, Changsha, Hunan, Peoples R China.	xiangzf@csuft.edu.cn	Yao, Huiqin/AAX-3787-2020; Grueter, Cyril C./H-9319-2014	Yao, Huiqin/0000-0003-4742-8971; Grueter, Cyril C./0000-0001-8770-8148; Xiang, Zuofu/0000-0001-6133-3261	National Key Technology R&D Program of China [2013BAD03B03]; National Natural Science Foundation of China [31071937]; Innovation Platform Open Projects of Education Bureau of Hunan Province [11K078]; State Forestry Administration of China	National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Platform Open Projects of Education Bureau of Hunan Province; State Forestry Administration of China	This study was supported by National Key Technology R&D Program of China (2013BAD03B03), the National Natural Science Foundation of China (31071937), Innovation Platform Open Projects of Education Bureau of Hunan Province (11K078) and the State Forestry Administration of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Arave W, 2008, EVOL HUM BEHAV, V29, P305, DOI 10.1016/j.evolhumbehav.2008.03.002; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Arnold K, 2003, BEHAVIOUR, V140, P519, DOI 10.1163/156853903322127968; Barelli C, 2011, ANIM BEHAV, V82, P801, DOI 10.1016/j.anbehav.2011.07.012; Barrett L, 1999, P ROY SOC B-BIOL SCI, V266, P665, DOI 10.1098/rspb.1999.0687; Barrett L, 2002, ANIM BEHAV, V63, P1047, DOI 10.1006/anbe.2002.3008; Barrett L, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P209, DOI 10.1007/3-540-28277-7_12; CHEN F, 1983, Acta Theriologica Sinica, V3, P141; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; DEWAAL FBM, 1983, BEHAVIOUR, V85, P224, DOI 10.1163/156853983X00237; DUNBAR RIM, 1991, FOLIA PRIMATOL, V57, P121, DOI 10.1159/000156574; Frank RE, 2009, BEHAVIOUR, V146, P889, DOI 10.1163/156853908X396656; Fruteau C, 2011, ANIM BEHAV, V81, P153, DOI 10.1016/j.anbehav.2010.09.028; Gomes CM, 2009, P ROY SOC B-BIOL SCI, V276, P699, DOI 10.1098/rspb.2008.1324; Goodall J, 1986, CHIMPANZEES GOMBE, DOI DOI 10.1002/AJPA.1330730313; Grueter CC, 2013, EVOL HUM BEHAV, V34, P61, DOI 10.1016/j.evolhumbehav.2012.09.004; Gruter CC, 2004, PRIMATES, V45, P197; Gumert MD, 2007, ANIM BEHAV, V74, P1655, DOI 10.1016/j.anbehav.2007.03.009; Gumert MD, 2007, INT J PRIMATOL, V28, P1059, DOI 10.1007/s10764-007-9202-0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HART BL, 1992, ANIM BEHAV, V44, P615, DOI 10.1016/S0003-3472(05)80290-8; HEMELRIJK CK, 1994, ANIM BEHAV, V48, P479, DOI 10.1006/anbe.1994.1264; Henzi SP, 1999, PRIMATES, V40, P47, DOI 10.1007/BF02557701; HENZI SP, 2002, ANIM BEHAV, V63, P1; Kirkpatrick RC, 2010, EVOL ANTHROPOL, V19, P98, DOI 10.1002/evan.20259; Kirkpatrick RC, 2011, PRIMATES PERSPECTIVE, P189; Koyama NF, 2006, INT J PRIMATOL, V27, P1293, DOI 10.1007/s10764-006-9074-8; LANCASTER JB, 1971, FOLIA PRIMATOL, V15, P161, DOI 10.1159/000155377; Leone A, 2010, PRIMATES, V51, P203, DOI 10.1007/s10329-010-0188-4; Li BG, 2007, PRIMATES, V48, P190, DOI 10.1007/s10329-006-0029-7; Li Yin-Hua, 2005, Acta Zoologica Sinica, V51, P953; Nicolson NA, 1987, PRIMATE SOC, P330, DOI DOI 10.1017/S0952836903004576; PACKER C, 1977, NATURE, V265, P441, DOI 10.1038/265441a0; Perez AP, 2000, PRIMATES, V41, P199, DOI 10.1007/BF02557801; Qi XG, 2008, AM J PRIMATOL, V70, P311, DOI 10.1002/ajp.20480; Ren R, 2000, FIELD STUDY SOC RHIN; Ren RM, 2010, ZOOL STUD, V49, P1; SCHINO G, 1988, AM J PRIMATOL, V16, P43, DOI 10.1002/ajp.1350160106; SCHINO G, 1990, BEHAVIOUR, V113, P264, DOI 10.1163/156853990X00518; Schino G, 2007, BEHAV ECOL, V18, P115, DOI 10.1093/beheco/arl045; Schino G, 2010, ECOL LETT, V13, P45, DOI 10.1111/j.1461-0248.2009.01396.x; Silk JB, 1999, ANIM BEHAV, V57, P1021, DOI 10.1006/anbe.1998.1065; Silk JB, 1999, BEHAVIOUR, V136, P679, DOI 10.1163/156853999501522; Smuts B.B., 1987, P385; Stockley P, 2011, BIOL REV, V86, P341, DOI 10.1111/j.1469-185X.2010.00149.x; Tiddi B, 2011, BEHAV ECOL, V22, P663, DOI 10.1093/beheco/arr028; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wang XW, 2013, INTEGR ZOOL, V8, P400, DOI 10.1111/1749-4877.12026; Wei W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036802; Xiang ZF, 2011, CHINESE SCI BULL, V56, P2553, DOI 10.1007/s11434-011-4613-x; Zhang P, 2003, ACTA ZOOL SINICA, V49, P722; Zhang P, 2008, AM J PRIMATOL, V70, P1013, DOI 10.1002/ajp.20591; Zhang SY, 2000, AM J PRIMATOL, V51, P265, DOI 10.1002/1098-2345(200008)51:4<265::AID-AJP6>3.3.CO;2-#	53	18	20	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74822	10.1371/journal.pone.0074822	http://dx.doi.org/10.1371/journal.pone.0074822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086380	gold, Green Submitted, Green Published			2022-12-27	WOS:000325218700041
J	Antelmi, E; Cardone, RA; Greco, MR; Rubino, R; Di Sole, F; Martino, NA; Casavola, V; Carcangiu, M; Moro, L; Reshkin, SJ				Antelmi, Ester; Cardone, Rosa A.; Greco, Maria R.; Rubino, Rosa; Di Sole, Francesca; Martino, Nicola A.; Casavola, Valeria; Carcangiu, MariaLuisa; Moro, Loredana; Reshkin, Stephan J.			beta 1 Integrin Binding Phosphorylates Ezrin at T567 to Activate a Lipid Raft Signalsome Driving Invadopodia Activity and Invasion	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE; SCAFFOLDING PROTEIN EBP50; NA+-H+ EXCHANGER; BREAST-CANCER; CELL INVASION; ERM PROTEINS; NASOPHARYNGEAL CARCINOMA; OSTEOSARCOMA CELLS; CARDIAC MYOCYTES; LOCAL RECURRENCE	Extracellular matrix (ECM) degradation is a critical process in tumor cell invasion and requires matrix degrading protrusions called invadopodia. The Na+/H+ exchanger (NHE1) has recently been shown to be fundamental in the regulation of invadopodia actin cytoskeleton dynamics and activity. However, the structural link between the invadopodia cytoskeleton and NHE1 is still unknown. A candidate could be ezrin, a linker between the NHE1 and the actin cytoskeleton known to play a pivotal role in invasion and metastasis. However, the mechanistic basis for its role remains unknown. Here, we demonstrate that ezrin phosphorylated at T567 is highly overexpressed in the membrane of human breast tumors and positively associated with invasive growth and HER2 overexpression. Further, in the metastatic cell line, MDA-MB-231, p-ezrin was almost exclusively expressed in invadopodia lipid rafts where it co-localized in a functional complex with NHE1, EGFR, beta 1-integrin and phosphorylated-NHERF1. Manipulation by mutation of ezrins T567 phosphorylation state and/or PIP2 binding capacity or of NHE1s binding to ezrin or PIP2 demonstrated that p-ezrin expression and binding to PIP2 are required for invadopodia-mediated ECM degradation and invasion and identified NHE1 as the membrane protein that p-ezrin regulates to induce invadopodia formation and activity.	[Antelmi, Ester; Cardone, Rosa A.; Greco, Maria R.; Rubino, Rosa; Casavola, Valeria; Reshkin, Stephan J.] Univ Bari, Dept Biosci Biotechnol & Biopharmacol, Bari, Italy; [Antelmi, Ester; Carcangiu, MariaLuisa] Ist Nazl Tumori, Dept Pathol, Anat Pathol Unit A, I-20133 Milan, Italy; [Di Sole, Francesca] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Di Sole, Francesca] Dept Vet Affairs Med Ctr, Med Serv, Baltimore, MD USA; [Martino, Nicola A.] Univ Bari, Dept Anim Prod, Fac Biotechnol Sci, Bari, Italy; [Moro, Loredana] CNR, Inst Biomembranes & Bioenerget IBBE, I-70126 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Fondazione IRCCS Istituto Nazionale Tumori Milan; University System of Maryland; University of Maryland Baltimore; Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomembrane e Bioenergetica (IBBE-CNR)	Reshkin, SJ (corresponding author), Univ Bari, Dept Biosci Biotechnol & Biopharmacol, Bari, Italy.	reshkin@biologia.uniba.it	Reshkin, Stephan/AAI-6680-2020; Antelmi, Elena/K-3252-2018; Martino, Nicola/AAP-9891-2020; Martino, Nicola Antonio/N-4096-2014	Reshkin, Stephan/0000-0001-9757-5908; Martino, Nicola Antonio/0000-0001-6853-2757; Antelmi, Ester/0000-0003-0685-4827; CASAVOLA, Valeria/0000-0003-4471-4948; GRECO, Maria Raffaella/0000-0001-7454-8990; Antelmi, Elena/0000-0003-1739-6139	"Associazione Italiana per la Ricerca sul Cancro" (AIRC) [11348]; PRIN Grant [N.1341]; American Society of Nephrology	"Associazione Italiana per la Ricerca sul Cancro" (AIRC)(Fondazione AIRC per la ricerca sul cancro); PRIN Grant(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); American Society of Nephrology	This work was funded by the "Associazione Italiana per la Ricerca sul Cancro" (AIRC) grant #11348 to SJR and PRIN Grant 2009 N.1341 to SJR and LM. Dr. F. Di Sole was supported by a Carl W. Gottschalk Research Scholar Award from the American Society of Nephrology and MLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou AG, 2011, ANN DIAGN PATHOL, V15, P394, DOI 10.1016/j.anndiagpath.2011.05.005; Agarwal SR, 2011, J MOL CELL CARDIOL, V50, P500, DOI 10.1016/j.yjmcc.2010.11.015; Akisawa N, 1999, BIOCHEM BIOPH RES CO, V258, P395, DOI 10.1006/bbrc.1999.0653; Lacalle RA, 2007, J CELL BIOL, V179, P1539, DOI 10.1083/jcb.200705044; Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Arslan AA, 2012, BREAST CANCER RES TR, V134, P981, DOI 10.1007/s10549-012-2017-5; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Brambilla D, 2009, INT J CANCER, V125, P2239, DOI 10.1002/ijc.24734; Bravo-Cordero JJ, 2012, CURR OPIN CELL BIOL, V24, P277, DOI 10.1016/j.ceb.2011.12.004; Brisson L, 2012, EUR J CELL BIOL, V91, P847, DOI 10.1016/j.ejcb.2012.04.004; Bruce B, 2007, CLIN EXP METASTAS, V24, P69, DOI 10.1007/s10585-006-9050-x; Bulut G, 2012, ONCOGENE, V31, P269, DOI 10.1038/onc.2011.245; Busco G, 2010, FASEB J, V24, P3903, DOI 10.1096/fj.09-149518; Caldieri G, 2012, EUR J CELL BIOL, V91, P961, DOI 10.1016/j.ejcb.2012.03.005; Caldieri G, 2009, J CELL MOL MED, V13, P1728, DOI 10.1111/j.1582-4934.2008.00568.x; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Cardone RA, 2005, MOL BIOL CELL, V16, P3117, DOI 10.1091/mbc.e04-10-0945; Cardone RA, 2007, MOL BIOL CELL, V18, P1768, DOI 10.1091/mbc.E06-07-0617; Cardone RA, 2012, MOL BIOL CELL, V23, P2028, DOI 10.1091/mbc.E11-11-0911; Carneiro A, 2011, J CLIN PATHOL, V64, P689, DOI 10.1136/jcp.2011.089805; Chabadel A, 2007, MOL BIOL CELL, V18, P4899, DOI 10.1091/mbc.E07-04-0378; Chen Y, 2011, CANCER RES, V71, P1721, DOI 10.1158/0008-5472.CAN-09-4683; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; Coghlin C, 2010, J PATHOL, V222, P1, DOI 10.1002/path.2727; Cornez I, 2010, FEBS LETT, V584, P2681, DOI 10.1016/j.febslet.2010.04.056; Damodaran Senthilkumar, 2012, Hosp Pract (1995), V40, P7, DOI 10.3810/hp.2012.10.997; Darmellah A, 2009, CARDIOVASC RES, V81, P294, DOI 10.1093/cvr/cvn320; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Destaing O, 2011, CURR OPIN CELL BIOL, V23, P597, DOI 10.1016/j.ceb.2011.04.002; Di Sole F, 2009, J AM SOC NEPHROL, V20, P1776, DOI 10.1681/ASN.2008121255; Donatello S, 2012, AM J PATHOL, V181, P2172, DOI 10.1016/j.ajpath.2012.08.025; Elzagheid A, 2008, HUM PATHOL, V39, P1737, DOI 10.1016/j.humpath.2008.04.020; Endo K, 2009, ONCOGENE, V28, P1725, DOI 10.1038/onc.2009.20; Favia M, 2010, MOL BIOL CELL, V21, P73, DOI 10.1091/mbc.E09-03-0185; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Garbett D, 2012, J CELL BIOL, V198, P195, DOI 10.1083/jcb.201204008; Garbett D, 2010, J CELL BIOL, V191, P397, DOI 10.1083/jcb.201004115; Geiger KD, 2000, AM J PATHOL, V157, P1785, DOI 10.1016/S0002-9440(10)64816-X; Greene FL, 2002, J SURG ONCOL, V80, P119, DOI 10.1002/jso.10114; Harvey RD, 2012, J MOL CELL CARDIOL, V52, P366, DOI 10.1016/j.yjmcc.2011.07.007; Jorgren F, 2012, INT J COLORECTAL DIS, V27, P893, DOI 10.1007/s00384-011-1397-z; Khan S, 2006, CELL MOL BIOL, V52, P115, DOI 10.1170/T769; Kobel M, 2006, MODERN PATHOL, V19, P581, DOI 10.1038/modpathol.3800567; LaLonde DP, 2010, MOL BIOL CELL, V21, P1519, DOI 10.1091/mbc.E10-01-0008; Lau SKM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036753; Li L, 2011, PATHOL ONCOL RES, V17, P909, DOI 10.1007/s12253-011-9402-y; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Li QC, 2012, TUMOR BIOL, V33, P1493, DOI 10.1007/s13277-012-0400-9; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Lucien F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028851; Magalhaes MAO, 2011, J CELL BIOL, V195, P903, DOI 10.1083/jcb.201103045; Makitie T, 2001, INVEST OPHTH VIS SCI, V42, P2442; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Morello V, 2011, ONCOGENE, V30, P4087, DOI 10.1038/onc.2011.107; Morozevich GE, 2012, AGING-US, V4, P368, DOI 10.18632/aging.100457; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Neisch AL, 2011, CURR OPIN CELL BIOL, V23, P377, DOI 10.1016/j.ceb.2011.04.011; Ohtani K, 2002, CANCER LETT, V179, P79, DOI 10.1016/S0304-3835(01)00857-6; Patara M, 2011, PATHOL ONCOL RES, V17, P827, DOI 10.1007/s12253-011-9389-4; Pignochino Y, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-118; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Rebillard A, 2007, CANCER RES, V67, P7865, DOI 10.1158/0008-5472.CAN-07-0353; Ren L, 2009, ONCOGENE, V28, P792, DOI 10.1038/onc.2008.437; Ren L, 2012, CANCER RES, V72, P1001, DOI 10.1158/0008-5472.CAN-11-0210; Reshkin SJ, 2013, RECENT PAT ANTI-CANC, V8, P85; Ringner Markus, 2013, Methods Mol Biol, V973, P279, DOI 10.1007/978-1-62703-281-0_18; Sarrio D, 2006, BREAST CANCER RES TR, V98, P71, DOI 10.1007/s10549-005-9133-4; Schlecht NF, 2012, HEAD NECK PATHOL, V6, P232, DOI 10.1007/s12105-011-0328-1; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; Shang XF, 2012, MOL CELL BIOCHEM, V364, P363, DOI 10.1007/s11010-012-1238-6; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Song J, 2005, CANCER LETT, V220, P57, DOI 10.1016/j.canlet.2004.04.024; Stamenkovic I, 2010, CURR PROTEIN PEPT SC, V11, P471, DOI 10.2174/138920310791824011; Sundquist M, 1999, BREAST CANCER RES TR, V53, P1, DOI 10.1023/A:1006052115874; Tan J, 2011, TUMOR BIOL, V32, P1241, DOI 10.1007/s13277-011-0228-8; Tang FQ, 2011, J BIOL CHEM, V286, P36956, DOI 10.1074/jbc.M111.259234; Tang FQ, 2009, J BIOL CHEM, V284, P27456, DOI 10.1074/jbc.M109.033795; Tekpli X, 2008, J CELL PHYSIOL, V216, P207, DOI 10.1002/jcp.21395; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wei YC, 2009, MODERN PATHOL, V22, P1351, DOI 10.1038/modpathol.2009.107; Wu B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-527; Xie JJ, 2011, J SURG ONCOL, V104, P538, DOI 10.1002/jso.21909; Yamaguchi H, 2012, EUR J CELL BIOL, V91, P902, DOI 10.1016/j.ejcb.2012.04.005; Yamaguchi H, 2010, CANCER SCI, V101, P1632, DOI 10.1111/j.1349-7006.2010.01574.x; Yamaguchi H, 2009, CANCER RES, V69, P8594, DOI 10.1158/0008-5472.CAN-09-2305; Yamaguchi H, 2010, PHYSCS PROC, V9, P1, DOI 10.1016/j.phpro.2010.11.001; Yi YH, 2009, J BIOL CHEM, V284, P3855, DOI 10.1074/jbc.M804334200; Yonemura S, 2002, J CELL SCI, V115, P2569; Zhao J, 2011, HISTOL HISTOPATHOL, V26, P1111, DOI 10.14670/HH-26.1111	92	28	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75113	10.1371/journal.pone.0075113	http://dx.doi.org/10.1371/journal.pone.0075113			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086451	Green Published, Green Submitted, gold			2022-12-27	WOS:000325025200026
J	Veedin-Rajan, VB; Fischer, RM; Raible, F; Tessmar-Raible, K				Veedin-Rajan, Vinoth Babu; Fischer, Ruth M.; Raible, Florian; Tessmar-Raible, Kristin			Conditional and Specific Cell Ablation in the Marine Annelid Platynereis dumerilii	PLOS ONE			English	Article							COMMON ORIGIN; ZEBRAFISH; BRAIN; PHOTORECEPTORS; TRANSGENESIS; REGENERATION; BILATERIA; EVOLUTION; LIGHT	The marine annelid Platynereis dumerilii has become a model system for evo-devo, neurobiology and marine biology. The functional assessment of its cell types, however, has so far been very limited. Here we report on the establishment of a generally applicable, cell type specific ablation technique to overcome this restriction. Using a transgenic strain expressing the bacterial enzyme nitroreductase (ntr) under the control of the worm's r-opsin1 locus, we show that the demarcated photoreceptor cells can be specifically ablated by the addition of the prodrug metronidazole (mtz). TUNEL staining indicates that ntr expressing cells undergo apoptotic cell death. As we used a transgenic strain co-expressing ntr with enhanced green fluorescent protein (egfp) coding sequence, we were able to validate the ablation of photoreceptors not only in fixed tissue, using r-opsin1 riboprobes, but also by monitoring eGFP+ cells in live animals. The specificity of the ablation was demonstrated by the normal presence of the eye pigment cells, as well as of neuronal markers expressed in other cells of the brain, such as phc2, tyrosine hydroxylase and brn1/2/4. Additional analyses of the position of DAPI stained nuclei, the brain's overall neuronal scaffold, as well as the positions and projections of serotonergic neurons further confirmed that mtz treatment did not induce general abnormalities in the worm's brain. As the prodrug is administered by adding it to the water, targeted ablation of specific cell types can be achieved throughout the life of the animal. We show that ablation conditions need to be adjusted to the size of the worms, likely due to differences in the penetration of the prodrug, and establish ablation conditions for worms containing 10 to 55 segments. Our results establish mtz/ntr mediated conditional cell ablation as a powerful functional tool in Platynereis.	[Veedin-Rajan, Vinoth Babu; Fischer, Ruth M.; Raible, Florian; Tessmar-Raible, Kristin] Univ Vienna, Max F Perutz Labs, Vienna, Austria; [Veedin-Rajan, Vinoth Babu; Fischer, Ruth M.; Raible, Florian; Tessmar-Raible, Kristin] Res Platform Marine Rhythms Life, Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Tessmar-Raible, K (corresponding author), Univ Vienna, Max F Perutz Labs, Vienna, Austria.	kristin.tessmar@mfpl.ac.at	Raible, Florian/G-6019-2011; Tessmar-Raible, Kristin/F-9642-2011	Tessmar-Raible, Kristin/0000-0002-8038-1741; Raible, Florian/0000-0002-4515-6485; Veedin Rajan, Vinoth Babu/0000-0002-2430-7395	PhD fellowship of the Bohringer Ingelheim Foundation; Max F. Perutz Laboratories; START award [AY0041321]; HFSP [RGY0082/2010]; European Research Council under the European Community [260304]; Austrian Science Fund (FWF) [Y 413] Funding Source: researchfish	PhD fellowship of the Bohringer Ingelheim Foundation; Max F. Perutz Laboratories; START award; HFSP(Human Frontier Science Program); European Research Council under the European Community(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by a PhD fellowship of the Bohringer Ingelheim Foundation (http://www.bifonds.de/homepage.html) to RMF, funds of the Max F. Perutz Laboratories (http://www.mfpl.ac.at/home.html), the research platform "Marine rhythms of Life" of the University of Vienna, a FWF (http://www. fwf.ac.at/) START award (# AY0041321) and HFSP(http://www.hfsp.org/) research grant (# RGY0082/2010) to KTR. The research leading to these results has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement 260304 (to FR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; Arendt D, 2002, DEVELOPMENT, V129, P1143; Backfisch B, 2013, P NATL ACAD SCI USA, V110, P193, DOI 10.1073/pnas.1209657109; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Dray N, 2010, SCIENCE, V329, P339, DOI 10.1126/science.1188913; Ejsmont RK, 2009, NAT METHODS, V6, P435, DOI [10.1038/NMETH.1334, 10.1038/nmeth.1334]; Fernandes AM, 2012, CURR BIOL, V22, P2042, DOI 10.1016/j.cub.2012.08.016; Fischer AHL, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-31; Hauenschild C., 1969, PLATYNEREIS DUMERILI, P1; Jekely G, 2008, NATURE, V456, P395, DOI 10.1038/nature07590; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Michal G, 1999, BIOCH PATHWAYS; Palermo AM, 2013, CURRENT DRUG SAF; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Tomer R, 2010, CELL, V142, P800, DOI 10.1016/j.cell.2010.07.043; White YAR, 2011, DEV DYNAM, V240, P1929, DOI 10.1002/dvdy.22695	20	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75811	10.1371/journal.pone.0075811	http://dx.doi.org/10.1371/journal.pone.0075811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086637	Green Published, Green Submitted, gold			2022-12-27	WOS:000325025200063
J	Bubnell, J; Pfister, P; Sapar, ML; Rogers, ME; Feinstein, P				Bubnell, Jaclyn; Pfister, Patrick; Sapar, Maria L.; Rogers, Matthew E.; Feinstein, Paul			beta(2) Adrenergic Receptor Fluorescent Protein Fusions Traffic to the Plasma Membrane and Retain Functionality	PLOS ONE			English	Article							TAGGED BETA(2)-ADRENERGIC RECEPTOR; COUPLED-RECEPTORS; STRUCTURAL BIOLOGY; DRUG DISCOVERY; LIVING CELLS; GPCRS; RED; ACTIVATION; DIVERSITY; SURFACE	Green fluorescent protein (GFP) has proven useful for the study of protein interactions and dynamics for the last twenty years. A variety of new fluorescent proteins have been developed that expand the use of available excitation spectra. We have undertaken an analysis of seven of the most useful fluorescent proteins (XFPs), Cerulean (and mCerulean3), Teal, GFP, Venus, mCherry and TagRFP657, as fusions to the archetypal G-protein coupled receptor, the beta(2) adrenergic receptor (beta(2)AR). We have characterized these beta(2)AR:: XFP fusions in respect to membrane trafficking and G-protein activation. We noticed that in the mouse neural cell line, OP 6, that membrane bound beta(2)AR:: XFP fusions robustly localized in the filopodia identical to gap::XFP fusions. All beta(2)AR::XFP fusions show responses indistinguishable from each other and the non-fused form after isoprenaline exposure. Our results provide a platform by which G-protein coupled receptors can be dissected for their functionality.	[Bubnell, Jaclyn; Sapar, Maria L.; Feinstein, Paul] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; [Bubnell, Jaclyn; Sapar, Maria L.; Feinstein, Paul] CUNY, Grad Ctr Biochem, Biol Program, New York, NY 10021 USA; [Bubnell, Jaclyn; Sapar, Maria L.; Feinstein, Paul] CUNY, Biopsychol & Behav Neurosci Program, New York, NY 10021 USA; [Pfister, Patrick; Rogers, Matthew E.] Firmenich Inc, Corp Res & Dev, Plainsboro, NJ USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; Firmenich	Feinstein, P (corresponding author), CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA.	Feinstein@genectr.hunter.cuny.edu		Pfister, Patrick/0000-0002-1192-8600	National Institutes of Health (NIH) [R21 DC011100-01, RCMI 41398-01-27]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011100] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	JB, MS and PF used National Institutes of Health (NIH) R21 Grant: R21 DC011100-01 for experiments and NIH grant: RCMI 41398-01-27 for departmental infrastructure, PP and MB, Firmenich Inc (no website available). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Barak LS, 1997, MOL PHARMACOL, V51, P177, DOI 10.1124/mol.51.2.177; Barak LS, 1999, METHOD ENZYMOL, V302, P153, DOI 10.1016/S0076-6879(99)02016-9; Bohme I, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-16; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Illing N, 2002, MOL CELL NEUROSCI, V20, P225, DOI 10.1006/mcne.2002.1106; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; Kallal L, 2000, TRENDS PHARMACOL SCI, V21, P175, DOI 10.1016/S0165-6147(00)01477-2; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kennedy DC, 2009, ACS NANO, V3, P2329, DOI 10.1021/nn900488u; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; LIU YC, 1994, J NEUROSCI, V14, P5807; Lohse MJ, 2008, TRENDS PHARMACOL SCI, V29, P159, DOI 10.1016/j.tips.2007.12.002; Lundstrom K, 2005, BIOORG MED CHEM LETT, V15, P3654, DOI 10.1016/j.bmcl.2005.05.041; Lundstrom K, 2005, TRENDS BIOTECHNOL, V23, P103, DOI 10.1016/j.tibtech.2004.12.006; Lundstrom K, 2009, METHODS MOL BIOL, V552, P51, DOI 10.1007/978-1-60327-317-6_4; Luttrell LM, 2002, J CELL SCI, V115, P455; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; Morozova KS, 2010, BIOPHYS J, V99, pL13, DOI 10.1016/j.bpj.2010.04.025; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rizzo MA, 2009, COLD SPRING HARBOR P, V2009; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Sunaguchi M, 2003, BRAIN RES, V984, P21, DOI 10.1016/S0006-8993(03)03004-X; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Vobornik D, 2009, BIOCHEM BIOPH RES CO, V382, P85, DOI 10.1016/j.bbrc.2009.02.144; Wallukat G, 2002, HERZ, V27, P683, DOI 10.1007/s00059-002-2434-z; ZUBER MX, 1989, NATURE, V341, P345, DOI 10.1038/341345a0	34	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74941	10.1371/journal.pone.0074941	http://dx.doi.org/10.1371/journal.pone.0074941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086401	Green Published, gold			2022-12-27	WOS:000326520200056
J	Campbell, CT; Llewellyn, SR; Damberg, T; Morgan, IL; Robert-Guroff, M; Gildersleeve, JC				Campbell, Christopher T.; Llewellyn, Sean R.; Damberg, Thorsten; Morgan, Ian L.; Robert-Guroff, Marjorie; Gildersleeve, Jeffrey C.			High-Throughput Profiling of Anti-Glycan Humoral Responses to SIV Vaccination and Challenge	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; SITE-SPECIFIC ANALYSIS; RHESUS MACAQUES; NEUTRALIZATION EPITOPE; ENVELOPE GLYCOPROTEIN; CARBOHYDRATE EPITOPES; SIVMAC251 CHALLENGE; SERUM ANTIBODIES; HIV-INFECTION; PROTECTION	Recent progress toward an HIV vaccine highlights both the potential of vaccines to end the AIDS pandemic and the need to boost efficacy by incorporating additional vaccine strategies. Although many aspects of the immune response can contribute to vaccine efficacy, the key factors have not been defined fully yet. A particular area that may yield new insights is anti-glycan immune responses, such as those against the glycan shield that HIV uses to evade the immune system. In this study, we used glycan microarray technology to evaluate anti-glycan antibody responses induced by SIV vaccination and infection in a non-human primate model of HIV infection. This comprehensive profiling of circulating anti-glycan antibodies found changes in anti-glycan antibody levels after both vaccination with the Ad5hr-SIV vaccine and SIV infection. Notably, SIV infection produced generalized declines in anti-glycan IgM antibodies in a number of animals. Additionally, some infected animals generated antibodies to the Tn antigen, which is a cryptic tumor-associated antigen exposed by premature termination of O-linked glycans; however, the Ad5hr-SIV vaccine did not induce anti-Tn IgG antibodies. Overall, this study demonstrates the potential contributions that glycan microarrays can make for HIV vaccine development.	[Campbell, Christopher T.; Llewellyn, Sean R.; Gildersleeve, Jeffrey C.] NCI, Biol Chem Lab, NIH, Frederick, MD 21701 USA; [Damberg, Thorsten; Morgan, Ian L.; Robert-Guroff, Marjorie] NCI, Vaccine Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Robert-Guroff, M (corresponding author), NCI, Vaccine Branch, NIH, Bethesda, MD 20892 USA.	gildersj@mail.nih.gov; guroffm@mail.nih.gov	Gildersleeve, Jeffrey/N-3392-2014	Llewellyn, Sean/0000-0001-8712-5567; Gildersleeve, Jeffrey/0000-0002-3744-6423	NCI, NIH; Pharmacology Research Training (PRAT) program of the NIGMS; NATIONAL CANCER INSTITUTE [ZIABC011055] Funding Source: NIH RePORTER	NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pharmacology Research Training (PRAT) program of the NIGMS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the intramural research program of the NCI, NIH. C. T. C. received fellowship funding from the Pharmacology Research Training (PRAT) program of the NIGMS. There were no external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelian A, 2004, AIDS RES HUM RETROV, V20, P127, DOI 10.1089/088922204322749576; Astronomo RD, 2010, CHEM BIOL, V17, P357, DOI 10.1016/j.chembiol.2010.03.012; Baader J, 2011, BIOSENS BIOELECTRON, V26, P1839, DOI 10.1016/j.bios.2010.01.021; Baroncelli S, 2008, EXPERT REV VACCINES, V7, P1419, DOI 10.1586/14760584.7.9.1419; BERNSTEIN HB, 1994, J VIROL, V68, P463, DOI 10.1128/JVI.68.1.463-468.1994; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Blixt O, 2010, J PROTEOME RES, V9, P5250, DOI 10.1021/pr1005229; Bonomelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023521; Borggren M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020135; Bovin N, 2012, BBA-GEN SUBJECTS, V1820, P1373, DOI 10.1016/j.bbagen.2012.02.005; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Campbell CT, 2013, CLIN CANCER RES, V19, P1290, DOI 10.1158/1078-0432.CCR-12-2478; Campbell Christopher T, 2010, Curr Protoc Chem Biol, V2, P37, DOI 10.1002/9780470559277.ch090228; Casali P, 1996, CURR TOP MICROBIOL, V210, P167; Clark BE, 2012, CHEM BIOL, V19, P254, DOI 10.1016/j.chembiol.2011.12.019; CORBEAU P, 1995, IMMUNOL LETT, V47, P141, DOI 10.1016/0165-2478(95)00047-9; de Boer AR, 2008, GLYCOCONJUGATE J, V25, P75, DOI 10.1007/s10719-007-9100-x; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; De Milito A, 2004, CURR HIV RES, V2, P11, DOI 10.2174/1570162043485068; Demberg T, 2012, J VIROL, V86, P12591, DOI 10.1128/JVI.00298-12; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Dunlop DC, 2010, GLYCOBIOLOGY, V20, P812, DOI 10.1093/glycob/cwq020; Go EP, 2008, J PROTEOME RES, V7, P1660, DOI 10.1021/pr7006957; Go EP, 2011, J VIROL, V85, P8270, DOI 10.1128/JVI.05053-11; Go EP, 2009, J PROTEOME RES, V8, P4231, DOI 10.1021/pr9002728; Gomez-Roman VR, 2005, J IMMUNOL, V174, P2185, DOI 10.4049/jimmunol.174.4.2185; Griffin DO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00122; HANSEN JES, 1991, J VIROL, V65, P6461, DOI 10.1128/JVI.65.12.6461-6467.1991; HANSEN JES, 1992, ARCH VIROL, V126, P11, DOI 10.1007/BF01309680; Hansen JES, 1996, ARCH VIROL, V141, P291, DOI 10.1007/BF01718400; HARADA S, 1985, J CLIN MICROBIOL, V22, P908, DOI 10.1128/JCM.22.6.908-911.1985; Huflejt ME, 2009, MOL IMMUNOL, V46, P3037, DOI 10.1016/j.molimm.2009.06.010; Kabanova A, 2010, GLYCOCONJUGATE J, V27, P501, DOI 10.1007/s10719-010-9295-0; KALYANARAMAN VS, 1990, AIDS RES HUM RETROV, V6, P371, DOI 10.1089/aid.1990.6.371; Kracun SK, 2010, J PROTEOME RES, V9, P6705, DOI 10.1021/pr1008477; Lackner AA, 2007, ANNU REV MED, V58, P461, DOI 10.1146/annurev.med.58.082405.094316; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Luallen RJ, 2008, J VIROL, V82, P6447, DOI 10.1128/JVI.00412-08; Malkevitch NV, 2006, VIROLOGY, V353, P83, DOI 10.1016/j.virol.2006.05.012; Manimala JC, 2007, GLYCOBIOLOGY, V17, p17C, DOI 10.1093/glycob/cwm047; Manimala JC, 2006, ANGEW CHEM INT EDIT, V45, P3607, DOI 10.1002/anie.200600591; Martinez V, 2009, CLIN INFECT DIS, V48, P123, DOI 10.1086/595013; Matyas GR, 2009, BBA-BIOMEMBRANES, V1788, P660, DOI 10.1016/j.bbamem.2008.11.015; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; MOND JJ, 1995, CURR OPIN IMMUNOL, V7, P349, DOI 10.1016/0952-7915(95)80109-X; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Nagase H, 2001, CLIN IMMUNOL, V100, P250, DOI 10.1006/clim.2001.5054; Oyelaran O, 2010, PROTEOM CLIN APPL, V4, P285, DOI 10.1002/prca.200900130; Oyelaran O, 2009, CURR OPIN CHEM BIOL, V13, P406, DOI 10.1016/j.cbpa.2009.06.021; Oyelaran O, 2009, J PROTEOME RES, V8, P4301, DOI 10.1021/pr900515y; Oyelaran O, 2009, J PROTEOME RES, V8, P3529, DOI 10.1021/pr9002245; Patterson LJ, 2011, VIROLOGY, V411, P87, DOI 10.1016/j.virol.2010.12.033; Patterson LJ, 2004, J VIROL, V78, P2212, DOI 10.1128/JVI.78.5.2212-2221.2004; Persing DH, 2002, TRENDS MICROBIOL, V10, pS32, DOI 10.1016/S0966-842X(02)02426-5; Pochechueva T, 2011, ANALYST, V136, P560, DOI 10.1039/c0an00758g; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; Rinaldi S, 2009, GLYCOBIOLOGY, V19, P789, DOI 10.1093/glycob/cwp049; Schwarz M, 2003, GLYCOBIOLOGY, V13, P749, DOI 10.1093/glycob/cwg091; Shilova N, 2012, GLYCOCONJUGATE J, V29, P87, DOI 10.1007/s10719-011-9368-8; Stansell E, 2011, J VIROL, V85, P582, DOI 10.1128/JVI.01871-10; Tateno H, 2008, GLYCOBIOLOGY, V18, P789, DOI 10.1093/glycob/cwn068; Tran NT, 2000, GLYCOCONJUGATE J, V17, P401, DOI 10.1023/A:1007160115293; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; TRYPHONAS H, 1991, J MED PRIMATOL, V20, P58; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Yu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043903; Zhang YL, 2010, MOL BIOSYST, V6, P1583, DOI 10.1039/c002259d; Zhao J, 2003, J VIROL, V77, P8354, DOI 10.1128/JVI.77.15.8354-8365.2003	72	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75302	10.1371/journal.pone.0075302	http://dx.doi.org/10.1371/journal.pone.0075302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086502	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200096
J	de Kreuk, BJ; Schaefer, A; Anthony, EC; Tol, S; Fernandez-Borja, M; Geerts, D; Pool, J; Hambach, L; Goulmy, E; Hordijk, PL				de Kreuk, Bart-Jan; Schaefer, Antje; Anthony, Eloise C.; Tol, Simon; Fernandez-Borja, Mar; Geerts, Dirk; Pool, Jos; Hambach, Lothar; Goulmy, Els; Hordijk, Peter L.			The Human Minor Histocompatibility Antigen1 Is a RhoGAP	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GTPASE-ACTIVATING PROTEIN; BAR DOMAIN; BINDING-PROTEIN; CELL-MIGRATION; CDC42 GTPASES; GRAF FAMILY; ADHESION; RAC; ACTIN	The human minor Histocompatibility Antigen HMHA-1 is a major target of immune responses after allogeneic stem cell transplantation applied for the treatment of leukemia and solid tumors. The restriction of its expression to hematopoietic cells and many solid tumors raised questions regarding its cellular functions. Sequence analysis of the HMHA-1 encoding HMHA1 protein revealed the presence of a possible C-terminal RhoGTPase Activating Protein (GAP) domain and an N-terminal BAR domain. Rho-family GTPases, including Rac1, Cdc42, and RhoA are key regulators of the actin cytoskeleton and control cell spreading and migration. RhoGTPase activity is under tight control as aberrant signaling can lead to pathology, including inflammation and cancer. Whereas Guanine nucleotide Exchange Factors (GEFs) mediate the exchange of GDP for GTP resulting in RhoGTPase activation, GAPs catalyze the low intrinsic GTPase activity of active RhoGTPases, resulting in inactivation. Here we identify the HMHA1 protein as a novel RhoGAP. We show that HMHA1 constructs, lacking the N-terminal region, negatively regulate the actin cytoskeleton as well as cell spreading. Furthermore, we show that HMHA1 regulates RhoGTPase activity in vitro and in vivo. Finally, we demonstrate that the HMHA1 N-terminal BAR domain is auto-inhibitory as HMHA1 mutants lacking this region, but not full-length HMHA1, showed GAP activity towards RhoGTPases. In conclusion, this study shows that HMHA1 acts as a RhoGAP to regulate GTPase activity, cytoskeletal remodeling and cell spreading, which are crucial functions in normal hematopoietic and cancer cells.	[de Kreuk, Bart-Jan; Schaefer, Antje; Anthony, Eloise C.; Tol, Simon; Fernandez-Borja, Mar; Hordijk, Peter L.] Univ Amsterdam, Swammerdam Inst Life Sci, Acad Med Ctr, Dept Mol Cell Biol,Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands; [Geerts, Dirk] Erasmus Univ, Med Ctr, Dept Pediat Oncol Hematol, Rotterdam, Netherlands; [Pool, Jos; Goulmy, Els] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Hambach, Lothar] Hannover Med Sch, Dept Hematol Hemostaseol Oncol & Stem Cell Transp, Hannover, Germany	University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Hannover Medical School	Hordijk, PL (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Acad Med Ctr, Dept Mol Cell Biol,Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands.	p.hordijk@sanquin.nl	Geerts, Dirk/K-8260-2015	Geerts, Dirk/0000-0002-6386-8187; Hordijk, Peter/0000-0002-3348-078X; Schaefer, Antje/0000-0002-2716-9899	LSBR (Landsteiner Foundation for Blood Transfusion Research) [0731]; LSBR [0903]	LSBR (Landsteiner Foundation for Blood Transfusion Research); LSBR	BJDK was supported by LSBR (Landsteiner Foundation for Blood Transfusion Research) grant 0731. AS was supported by LSBR grant 0903. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; CICCHETTI P, 1995, EMBO J, V14, P3127, DOI 10.1002/j.1460-2075.1995.tb07315.x; Citi S, 2011, MOL MEMBR BIOL, V28, P427, DOI 10.3109/09687688.2011.603101; de Kreu BJ, 2011, J CELL SCI, V124, P2375, DOI 10.1242/jcs.080630; de Kreuk Bart-Jan, 2012, Small GTPases, V3, P45, DOI 10.4161/sgtp.18960; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; DEBUEGER M, 1992, J IMMUNOL, V149, P1788; Eberth A, 2009, BIOCHEM J, V417, P371, DOI 10.1042/BJ20081535; Elvers M, 2012, CARDIOVASC RES, V94, P526, DOI 10.1093/cvr/cvs079; Fauchereau F, 2003, MOL CELL NEUROSCI, V23, P574, DOI 10.1016/S1044-7431(03)00078-2; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; GOULMY E, 1983, NATURE, V302, P159, DOI 10.1038/302159a0; Goulmy E, 1996, CURR OPIN IMMUNOL, V8, P75, DOI 10.1016/S0952-7915(96)80108-7; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Hambach L, 2005, CURR OPIN IMMUNOL, V17, P202, DOI 10.1016/j.coi.2005.01.010; Hambach L, 2006, LEUKEMIA, V20, P371, DOI 10.1038/sj.leu.2404056; Hambach L, 2008, BLOOD, V112, P1844, DOI 10.1182/blood-2007-11-125492; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; Jelen F, 2009, J STRUCT BIOL, V165, P10, DOI 10.1016/j.jsb.2008.09.007; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klein CA, 2002, J EXP MED, V196, P359, DOI 10.1084/jem.20011838; Marijt WAE, 2003, P NATL ACAD SCI USA, V100, P2742, DOI 10.1073/pnas.0530192100; Meller J, 2008, J CELL SCI, V121, P1981, DOI 10.1242/jcs.025130; Nethe M, 2012, J CELL SCI, V125, P3430, DOI 10.1242/jcs.100925; Nethe M, 2010, J CELL SCI, V123, P1948, DOI 10.1242/jcs.062919; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Richnau N, 2001, J BIOL CHEM, V276, P35060, DOI 10.1074/jbc.M103540200; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Schaefer A, 2011, J MOL BIOL, V411, P808, DOI 10.1016/j.jmb.2011.06.033; Spierings E, 2004, TRENDS IMMUNOL, V25, P56, DOI 10.1016/j.it.2003.12.002; van Buul JD, 2003, J BIOL CHEM, V278, P30302, DOI 10.1074/jbc.M304764200; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Wheeler AP, 2006, J CELL SCI, V119, P2749, DOI 10.1242/jcs.03024; Wilke Martina, 2003, Hematol J, V4, P315, DOI 10.1038/sj.thj.6200318; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058	44	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e73962	10.1371/journal.pone.0073962	http://dx.doi.org/10.1371/journal.pone.0073962			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086303	Green Submitted, Green Published, gold			2022-12-27	WOS:000326520200017
J	Ioerger, TR; O'Malley, T; Liao, R; Guinn, KM; Hickey, MJ; Mohaideen, N; Murphy, KC; Boshoff, HIM; Mizrahi, V; Rubin, EJ; Sassetti, CM; Barry, CE; Sherman, DR; Parish, T; Sacchettini, JC				Ioerger, Thomas R.; O'Malley, Theresa; Liao, Reiling; Guinn, Kristine M.; Hickey, Mark J.; Mohaideen, Nilofar; Murphy, Kenan C.; Boshoff, Helena I. M.; Mizrahi, Valerie; Rubin, Eric J.; Sassetti, Christopher M.; Barry, Clifton E., III; Sherman, David R.; Parish, Tanya; Sacchettini, James C.			Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosis	PLOS ONE			English	Article							TRANSFER-RNA-SYNTHETASE; EFFLUX PUMP; MYCOLIC ACIDS; ETHIONAMIDE; INHIBITORS; ACTIVATION; DISCOVERY; SYNTHASE; PROTEIN; PERSISTENCE	Identification of new drug targets is vital for the advancement of drug discovery against Mycobacterium tuberculosis, especially given the increase of resistance worldwide to first-and second-line drugs. Because traditional target-based screening has largely proven unsuccessful for antibiotic discovery, we have developed a scalable platform for target identification in M. tuberculosis that is based on whole-cell screening, coupled with whole-genome sequencing of resistant mutants and recombineering to confirm. The method yields targets paired with whole-cell active compounds, which can serve as novel scaffolds for drug development, molecular tools for validation, and/or as ligands for co-crystallization. It may also reveal other information about mechanisms of action, such as activation or efflux. Using this method, we identified resistance-linked genes for eight compounds with anti-tubercular activity. Four of the genes have previously been shown to be essential: AspS, aspartyl-tRNA synthetase, Pks13, a polyketide synthase involved in mycolic acid biosynthesis, MmpL3, a membrane transporter, and EccB3, a component of the ESX-3 type VII secretion system. AspS and Pks13 represent novel targets in protein translation and cell-wall biosynthesis. Both MmpL3 and EccB3 are involved in membrane transport. Pks13, AspS, and EccB3 represent novel candidates not targeted by existing TB drugs, and the availability of whole-cell active inhibitors greatly increases their potential for drug discovery.	[Ioerger, Thomas R.] Texas A&M Univ, Dept Comp Sci & Engn, College Stn, TX USA; [O'Malley, Theresa; Parish, Tanya] Infect Dis Res Inst, Seattle, WA USA; [Liao, Reiling; Hickey, Mark J.; Sherman, David R.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Guinn, Kristine M.; Rubin, Eric J.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Mohaideen, Nilofar; Sacchettini, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Murphy, Kenan C.; Sassetti, Christopher M.] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; [Boshoff, Helena I. M.; Barry, Clifton E., III] NIAID, Lab Clin Infect Dis, TB Res Sect, Bethesda, MD 20892 USA; [Mizrahi, Valerie] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Sassetti, Christopher M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Texas A&M University System; Texas A&M University College Station; Center for Infectious Disease Research; Harvard University; Harvard T.H. Chan School of Public Health; Texas A&M University System; Texas A&M University College Station; University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Cape Town; Howard Hughes Medical Institute	Sacchettini, JC (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	jim.sacchettini@gmail.com	Barry, Clifton E/ABE-7992-2020; Murphy, Kenan/AHB-4771-2022; Barry, III, Clifton/H-3839-2012	Barry, Clifton E/0000-0002-2927-270X; Murphy, Kenan/0000-0002-3677-2876; Barry, III, Clifton/0000-0002-2927-270X; Rubin, Eric/0000-0001-5120-962X	Bill & Melinda Gates Foundation; Paul G. Allen Family Foundation; NIH [U01GM094568]; Robert A. Welch Foundation [A-0015]; NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068135, ZIAAI000693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094568] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Paul G. Allen Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants from the Bill & Melinda Gates Foundation, the Paul G. Allen Family Foundation (to DRS), NIH grant U01GM094568 (JCS, EJR, TRI), grant A-0015 from the Robert A. Welch Foundation (JCS), and the intramural research program of NIAID, NIH (to CEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral L, 2007, J ANTIMICROB CHEMOTH, V59, P1237, DOI 10.1093/jac/dkl500; Ananthan S, 2009, TUBERCULOSIS, V89, P334, DOI 10.1016/j.tube.2009.05.008; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Ballell L, 2013, CHEMMEDCHEM, V8, P313, DOI 10.1002/cmdc.201200428; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Baulard AR, 2000, J BIOL CHEM, V275, P28326; Belisle John T., 2008, V465, P1, DOI 10.1007/978-1-59745-207-6_1; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Braibant M, 2000, FEMS MICROBIOL REV, V24, P449, DOI 10.1111/j.1574-6976.2000.tb00550.x; Briand C, 2000, J MOL BIOL, V299, P1051, DOI 10.1006/jmbi.2000.3819; Carroll P, 2011, APPL ENVIRON MICROB, V77, P5040, DOI 10.1128/AEM.02880-10; Colangeli R, 2005, MOL MICROBIOL, V55, P1829, DOI 10.1111/j.1365-2958.2005.04510.x; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; De Rossi Edda, 2002, Molecular Medicine (Baltimore), V8, P714; DeBarber AE, 2000, P NATL ACAD SCI USA, V97, P9677, DOI 10.1073/pnas.97.17.9677; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; ERIANI G, 1993, P NATL ACAD SCI USA, V90, P10816, DOI 10.1073/pnas.90.22.10816; Freundlich JS, 2009, CHEMMEDCHEM, V4, P241, DOI 10.1002/cmdc.200800261; Frueh DP, 2008, NATURE, V454, P903, DOI 10.1038/nature07162; Gavalda S, 2009, J BIOL CHEM, V284, P19255, DOI 10.1074/jbc.M109.006940; Ghanekar K, 1999, MOL MICROBIOL, V33, P982, DOI 10.1046/j.1365-2958.1999.01539.x; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Hanoulle X, 2006, J ANTIMICROB CHEMOTH, V58, P768, DOI 10.1093/jac/dkl332; Hasan A, 2011, MOLECULES, V16, P1297, DOI 10.3390/molecules16021297; Ioerger TR, 2010, J BACTERIOL, V192, P3645, DOI 10.1128/JB.00166-10; Jarvest RL, 2002, J MED CHEM, V45, P1959, DOI 10.1021/jm025502x; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; La Rosa V, 2012, ANTIMICROB AGENTS CH, V56, P324, DOI 10.1128/AAC.05270-11; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Louw GE, 2009, ANTIMICROB AGENTS CH, V53, P3181, DOI 10.1128/AAC.01577-08; Louw GE, 2011, AM J RESP CRIT CARE, V184, P269, DOI 10.1164/rccm.201011-1924OC; Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06; Maddry JA, 2009, TUBERCULOSIS, V89, P354, DOI 10.1016/j.tube.2009.07.006; Manos-Turvey A, 2010, CHEMMEDCHEM, V5, P1067, DOI 10.1002/cmdc.201000137; McEvoy CRE, 2007, TUBERCULOSIS, V87, P393, DOI 10.1016/j.tube.2007.05.010; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Milano A, 2009, TUBERCULOSIS, V89, P84, DOI 10.1016/j.tube.2008.08.003; Murphy Kenan C, 2010, F1000 Biol Rep, V2, P56; Pasca MR, 2004, ANTIMICROB AGENTS CH, V48, P3175, DOI 10.1128/AAC.48.8.3175-3178.2004; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Poole K, 2007, ANN MED, V39, P162, DOI 10.1080/07853890701195262; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; Ramon-Garcia S, 2006, J ANTIMICROB CHEMOTH, V57, P252, DOI 10.1093/jac/dki436; Ramon-Garcia S, 2007, J ANTIMICROB CHEMOTH, V59, P544, DOI 10.1093/jac/dkl510; Ramon-Garcia S, 2009, ANTIMICROB AGENTS CH, V53, P3675, DOI 10.1128/AAC.00550-09; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Timmers LFSM, 2008, ARCH BIOCHEM BIOPHYS, V479, P28, DOI 10.1016/j.abb.2008.08.015; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Serafini A, 2009, J BACTERIOL, V191, P6340, DOI 10.1128/JB.00756-09; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; Sirgel Frederick A., 2008, V465, P173, DOI 10.1007/978-1-59745-207-6_11; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Teo JWP, 2006, ANTIMICROB AGENTS CH, V50, P3665, DOI 10.1128/AAC.00555-06; Tullius MV, 2011, P NATL ACAD SCI USA, V108, P5051, DOI 10.1073/pnas.1009516108; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Vannelli TA, 2002, J BIOL CHEM, V277, P12824, DOI 10.1074/jbc.M110751200; Vasan M, 2010, CHEMMEDCHEM, V5, P2079, DOI 10.1002/cmdc.201000275; Verma A, 2008, EUR J MED CHEM, V43, P897, DOI 10.1016/j.ejmech.2007.07.017; Vilcheze C, 2005, ANTIMICROB AGENTS CH, V49, P708, DOI 10.1128/AAC.49.2.708-720.2005; Wei JR, 2011, P NATL ACAD SCI USA, V108, P4176, DOI 10.1073/pnas.1018301108; Wilson R, 2013, NAT CHEM BIOL, V9, P499, DOI 10.1038/nchembio.1277; World Health Organization, 2010, WHOHTMTB20103; YANAGISAWA T, 1994, J BIOL CHEM, V269, P24304; Yano T, 2006, J BIOL CHEM, V281, P11456, DOI 10.1074/jbc.M508844200	71	156	159	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75245	10.1371/journal.pone.0075245	http://dx.doi.org/10.1371/journal.pone.0075245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086479	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200093
J	Lee, SH; Shin, HJ; Kim, DY; Shim, DW; Kim, TJ; Ye, SK; Won, HS; Koppula, S; Kang, TB; Lee, KH				Lee, Seung-Hwan; Shin, Hee Jae; Kim, Dong-Young; Shim, Do-Wan; Kim, Tack-Joong; Ye, Sang-Kyu; Won, Hyung-Sik; Koppula, Sushruta; Kang, Tae-Bong; Lee, Kwang-Ho			Streptochlorin Suppresses Allergic Dermatitis and Mast Cell Activation via Regulation of Lyn/Fyn and Syk Signaling Pathways in Cellular and Mouse Models	PLOS ONE			English	Article								Allergic diseases are chronic inflammatory conditions with specific immune and inflammatory mechanisms. Scientific interest in understanding the mechanisms and discovering novel agents for the prevention and treatment of allergic disease is increasing. Streptochlorin, a small compound derived from marine actinomycete possesses anti-angiogenic and anti-tumor activities. However, the anti-allergic effects and underlying mechanisms remain to be elucidated. In the present study, we investigated the effect of streptochlorin on allergic responses in vitro and in vivo. Streptochlorin inhibited degranulation and production of tumor necrosis factor-alpha and IL-4 by antigen-stimulated mast cells. Streptochlorin also inhibited the phosphorylation of Akt and the mitogen-activated protein kinases (MAPKs), including p38, ERK, and JNK. Further, streptochlorin reduced the phosphorylation of Syk in RBL-2H3 cells and inhibited the activity of Lyn and Fyn. Furthermore, administration of streptochlorin suppressed the allergic reactions in both passive cutaneous anaphylaxis reaction and 2, 4-dinitrofluorobenzene (DNFB)-induced allergic dermatitis in mice model. Considering the data obtained, we report for the first time that streptochlorin possess anti-allergic properties. The underlying mechanism of streptochlorin in exhibiting potent anti-allergic activity might be through the inhibition of the Lyn/Fyn and Syk signaling pathways.	[Lee, Seung-Hwan; Kim, Dong-Young; Shim, Do-Wan; Won, Hyung-Sik; Koppula, Sushruta; Kang, Tae-Bong; Lee, Kwang-Ho] Konkuk Univ, Res Inst Inflammatory Dis, Coll Biomed & Hlth Sci, Dept Biotechnol, Chungju, South Korea; [Shin, Hee Jae] Korea Inst Ocean Sci & Technol, Marine Nat Prod Chem Lab, Ansan, South Korea; [Kim, Tack-Joong] Yonsei Univ, Div Biol Sci & Technol, Wonju, South Korea; [Ye, Sang-Kyu] Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul, South Korea	Konkuk University; Korea Institute of Ocean Science & Technology (KIOST); Yonsei University; Seoul National University (SNU)	Lee, KH (corresponding author), Konkuk Univ, Res Inst Inflammatory Dis, Coll Biomed & Hlth Sci, Dept Biotechnol, Chungju, South Korea.	kwangho@kku.ac.kr	kang, Tae-bong/AAD-7950-2022	kang, Tae-bong/0000-0003-1441-9470; Shim, Do-Wan/0000-0003-1893-8323	Ministry of Education, Science Technology (MEST); Korea Institute for Advancement of Technology (KIAT) through the Human Resources Training Project for Regional Innovation; Korea Institute of Ocean Science and Technology [PE99121]	Ministry of Education, Science Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Institute for Advancement of Technology (KIAT) through the Human Resources Training Project for Regional Innovation; Korea Institute of Ocean Science and Technology	This work was financially supported by the Ministry of Education, Science Technology (MEST) and Korea Institute for Advancement of Technology (KIAT) through the Human Resources Training Project for Regional Innovation and also supported in part by Korea Institute of Ocean Science and Technology (Grant PE99121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi IK, 2007, J MICROBIOL BIOTECHN, V17, P1338; Costanzo R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/815269; de Castro RO, 2011, J SIGNAL TRANSDUCT, DOI DOI 10.1155/2011/507291; Debbab A, 2010, MICROB BIOTECHNOL, V3, P544, DOI 10.1111/j.1751-7915.2010.00179.x; Draber P, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00095; Galli SJ, 1999, CURR OPIN IMMUNOL, V11, P53, DOI 10.1016/S0952-7915(99)80010-7; Georas SN, 2005, EUR RESPIR J, V26, P1119, DOI 10.1183/09031936.05.00006005; Gilfillan AM, 2009, IMMUNOL REV, V228, P149, DOI 10.1111/j.1600-065X.2008.00742.x; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Jiang J, 2013, FOOD CHEM TOXICOL, V57, P256, DOI 10.1016/j.fct.2013.03.040; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Longui CA, 2007, J PEDIAT-BRAZIL, V83, pS163, DOI 10.2223/JPED.1713; MacDonald AJ, 1989, IMMUNOLOGY; Ohanian M, 2012, EXPERT OPIN PHARMACO, V13, P927, DOI 10.1517/14656566.2012.672974; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Perez A, 2004, CONTACT DERMATITIS, V51, P314, DOI 10.1111/j.0105-1873.2004.0459e.x; Proksch P, 2002, APPL MICROBIOL BIOT, V59, P125, DOI 10.1007/s00253-002-1006-8; Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015; Sakai S, 2009, J BIOL CHEM, V284, P28172, DOI 10.1074/jbc.M109.001099; Schweder T, 2005, ADV BIOCHEM ENG BIOT, V96, P1, DOI 10.1007/b135781; Shichijo M, 2003, BIOL PHARM BULL, V26, P1685, DOI 10.1248/bpb.26.1685; Shin HJ, 2007, J MICROBIOL BIOTECHN, V17, P1403; Siraganian RP, 2002, MOL IMMUNOL, V38, P1229, DOI 10.1016/S0161-5890(02)00068-8; Theoharides TC, 2006, ANN NY ACAD SCI, V1088, P78, DOI 10.1196/annals.1366.025; Toncic RJ, 2011, ACTA DERMATOVENER CR, V19, P51; Tsai M, 2011, ADV EXP MED BIOL, V716, P186, DOI 10.1007/978-1-4419-9533-9_11	27	7	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74194	10.1371/journal.pone.0074194	http://dx.doi.org/10.1371/journal.pone.0074194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086321	Green Submitted, gold, Green Published			2022-12-27	WOS:000325223900023
J	Alvarez, LAJ; Bourke, B; Pircalabioru, G; Georgiev, AY; Knaus, UG; Daff, S; Corcionivoschi, N				Alvarez, Luis A. J.; Bourke, Billy; Pircalabioru, Gratiela; Georgiev, Atanas Y.; Knaus, Ulla G.; Daff, Simon; Corcionivoschi, Nicolae			Cj1411c Encodes for a Cytochrome P450 Involved in Campylobacter jejuni 81-176 Pathogenicity	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE; LIPOPOLYSACCHARIDE; IDENTIFICATION; COMPLEMENT; VIRULENCE; GENE	Cytochrome P450s are b-heme-containing enzymes that are able to introduce oxygen atoms into a wide variety of organic substrates. They are extremely widespread in nature having diverse functions at both biochemical and physiological level. The genome of C. jejuni 81-176 encodes a single cytochrome P450 (Cj1411c) that has no close homologues. Cj1411c is unusual in its genomic location within a cluster involved in the biosynthesis of outer surface structures. Here we show that E. coli expressed and affinity-purified C. jejuni cytochrome P450 is lipophilic, containing one equivalent Cys-ligated heme. Immunoblotting confirmed the association of cytochrome P450 with membrane fractions. A Cj1411c deletion mutant had significantly reduced ability to infect human cells and was less able to survive following exposure to human serum when compared to the wild type strain. Phenotypically following staining with Alcian blue, we show that a Cj1411c deletion mutant produces significantly less capsular polysaccharide. This study describes the first known membrane-bound bacterial cytochrome P450 and its involvement in Campylobacter virulence.	[Alvarez, Luis A. J.; Bourke, Billy; Knaus, Ulla G.; Corcionivoschi, Nicolae] Our Ladys Childrens Hosp Crumlin, Natl Childrens Res Ctr, Dublin, Ireland; [Bourke, Billy; Pircalabioru, Gratiela; Knaus, Ulla G.] Univ Coll Dublin, Conway Inst, Sch Med & Med Sci, Dublin 2, Ireland; [Georgiev, Atanas Y.; Daff, Simon] Univ Edinburgh, Sch Chem, Edinburgh, Midlothian, Scotland; [Corcionivoschi, Nicolae] Banats Univ Agr Sci & Vet Med, Sch Anim Sci & Biotechnol, Timisoara, Romania	National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; University College Dublin; University of Edinburgh; Banat University of Agricultural Sciences & Veterinary Medicine	Corcionivoschi, N (corresponding author), Our Ladys Childrens Hosp Crumlin, Natl Childrens Res Ctr, Dublin, Ireland.	nicolae.corcionivoschi@ucd.ie	Corcionivoschi, nicolae/L-8778-2019; Gradisteanu, Gratiela/GYJ-6972-2022; Alvarez, Luis/H-1946-2012; Gradisteanu, Gratiela/AAE-1875-2019	Alvarez, Luis/0000-0003-1316-1906; Corcionivoschi, Nicolae/0000-0002-3011-3108; GRADISTEANU PIRCALABIORU, GRATIELA/0000-0002-6384-1822	National Children's Research Centre [K12/2]	National Children's Research Centre	This work was supported by the National Children's Research Centre, grant K12/2 awarded to NC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachtiar BM, 2007, FEMS IMMUNOL MED MIC, V49, P149, DOI 10.1111/j.1574-695X.2006.00182.x; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; BLASER MJ, 1985, J INFECT DIS, V151, P227, DOI 10.1093/infdis/151.2.227; Blaser MJ, 1997, J INFECT DIS, V176, pS103, DOI 10.1086/513780; Cojocaru V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002152; Corcionivoschi N, 2009, INFECT IMMUN, V77, P1959, DOI 10.1128/IAI.01239-08; Corcionivoschi N, 2012, CELL HOST MICROBE, V12, P47, DOI 10.1016/j.chom.2012.05.018; Cordwell SJ, 2008, PROTEOMICS, V8, P122, DOI 10.1002/pmic.200700561; Davis L, 2008, GENETIC MANIPULATION; Davydov R, 2013, BIOCHEMISTRY-US, V52, P667, DOI 10.1021/bi301527c; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; Guerry P, 2002, INFECT IMMUN, V70, P787, DOI 10.1128/IAI.70.2.787-793.2002; Hansen CR, 2007, LETT APPL MICROBIOL, V45, P599, DOI 10.1111/j.1472-765X.2007.02232.x; HITCHCOCK PJ, 1983, EUR J BIOCHEM, V133, P685, DOI 10.1111/j.1432-1033.1983.tb07517.x; Karlyshev AV, 2001, J CLIN MICROBIOL, V39, P279, DOI 10.1128/JCM.39.1.279-284.2001; Lamb DC, 2002, J BIOL CHEM, V277, P24000, DOI 10.1074/jbc.M111109200; Lawson RJ, 2004, BIOCHEMISTRY-US, V43, P12410, DOI 10.1021/bi049132l; Li ZZ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-130; Luthra A, 2013, Methods Mol Biol, V987, P115, DOI 10.1007/978-1-62703-321-3_10; McLean KJ, 2009, J BIOL CHEM, V284, P35524, DOI 10.1074/jbc.M109.032706; McLennan MK, 2008, J BACTERIOL, V190, P1097, DOI 10.1128/JB.00516-07; Ost TWB, 2003, J AM CHEM SOC, V125, P15010, DOI 10.1021/ja035731o; Rahn A, 1999, J BACTERIOL, V181, P2307, DOI 10.1128/JB.181.7.2307-2313.1999; ROBERSON EB, 1992, APPL ENVIRON MICROB, V58, P1284, DOI 10.1128/AEM.58.4.1284-1291.1992; Verma S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025273; YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771	27	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75534	10.1371/journal.pone.0075534	http://dx.doi.org/10.1371/journal.pone.0075534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086558	Green Submitted, gold, Green Published			2022-12-27	WOS:000325220000025
J	Wei, Q; Wang, HH; Tian, YH; Xu, FC; Chen, XW; Wang, K				Wei, Qiang; Wang, Honghao; Tian, Yanghua; Xu, Fangcheng; Chen, Xianwen; Wang, Kai			Reduced Serum Levels of Triglyceride, Very Low Density Lipoprotein Cholesterol and Apolipoprotein B in Parkinson's Disease Patients	PLOS ONE			English	Article							RISK-FACTORS; ADRENOCORTICOTROPIC HORMONE; ISCHEMIC-STROKE; LIPIDS; ATHEROSCLEROSIS; HYPERTENSION; CORTISOL	Background: Previous studies have shown a lower incidence of stroke in Parkinson's disease (PD) patients. The role of the lipids and lipoproteins as risk factors for stroke is uncertain in the lower prevalence of stroke in PD patients. Objectives: To explore the lipids and lipoproteins serum levels in PD patients. Methods: A retrospective study was performed on 110 PD patients (PD group), 130 controls with non-cerebrovascular neurological diseases (OD group), 140 acute intracerebral hemorrhage patients (ICH group) and 140 acute cerebral infarction patients (CI group). The records about serum levels of lipids and lipoproteins were analyzed. Results: There were significant differences for the serum level of triglyceride (F = 5.031, p=0.002), very low density lipoprotein cholesterol (F = 5.313, p=0.001), apolipoprotein B (F = 16.038, p<0.0001) in the four groups. PD group had a significantly lower serum level of triglyceride (TG) than the OD (p=0.032), ICH (p=0.00047) and CI (p=0.001) groups. Very low density lipoprotein cholesterol (VLDL-C) serum level was significantly lower in PD group than in OD (p=0.039), ICH (p=0.00021) and CI (p=0.001) groups. There was a significantly lower serum level of apolipoprotein B (apo B) in PD group than in OD (p=0.002), ICH (p<0.0001) and CI (p<0.0001) groups. Conclusions: There are reduced serum levels of TG, VLDL-C and apo B in PD patients, which may be related to the decreased prevalence of stroke in PD patients.	[Wei, Qiang; Wang, Honghao; Tian, Yanghua; Xu, Fangcheng; Chen, Xianwen; Wang, Kai] Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Anhui, Peoples R China	Anhui Medical University	Wang, K (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Anhui, Peoples R China.	wangkai1964@126.com	wang, honghao/AAF-5764-2020	wang, honghao/0000-0002-1215-6219; Tian, Yanghua/0000-0001-5038-0599				Ahmed E, 1999, STROKE, V30, P2541, DOI 10.1161/01.STR.30.12.2541; Barichella M, 2003, EUR J CLIN NUTR, V57, P543, DOI 10.1038/sj.ejcn.1601581; BELLOMO G, 1991, J NEUROL, V238, P19, DOI 10.1007/BF00319704; Benson RT, 2000, NEUROL CLIN, V18, P309, DOI 10.1016/S0733-8619(05)70194-8; Berg AL, 2006, METABOLISM, V55, P1083, DOI 10.1016/j.metabol.2006.04.001; Bhatia M, 2006, CEREBROVASC DIS, V21, P323, DOI 10.1159/000091537; CALNE DB, 1992, ANN NEUROL, V32, pS125, DOI 10.1002/ana.410320721; Cannon CP, 2008, AM J CARDIOL, V102, p5L, DOI 10.1016/j.amjcard.2008.09.067; Cui K, 2012, CELL IMMUNOL, V272, P290, DOI 10.1016/j.cellimm.2011.09.013; Goldberg IJ, 1996, J LIPID RES, V37, P693; Gorelick PB, 1997, NEUROEPIDEMIOLOGY, V16, P107, DOI 10.1159/000109679; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Holme I, 2009, J INTERN MED, V265, P275, DOI 10.1111/j.1365-2796.2008.02016.x; Kimura Takashi, 2002, Masui, V51, P286; Korten A, 2001, MOVEMENT DISORD, V16, P119, DOI 10.1002/1531-8257(200101)16:1<119::AID-MDS1024>3.0.CO;2-W; Krauss RM, 1998, AM J CARDIOL, V81, p13B, DOI 10.1016/S0002-9149(98)00032-0; Labreuche J, 2009, ATHEROSCLEROSIS, V203, P331, DOI 10.1016/j.atherosclerosis.2008.08.040; Laloux P, 2004, ACTA NEUROL BELG, V104, P13; LEVINE RL, 1992, STROKE, V23, P839, DOI 10.1161/01.STR.23.6.839; MURAI A, 1986, TOHOKU J EXP MED, V148, P57, DOI 10.1620/tjem.148.57; Nataraj A, 2005, MOVEMENT DISORD, V20, P1476, DOI 10.1002/mds.20608; Norata GD, 2009, ATHEROSCLEROSIS, V206, P556, DOI 10.1016/j.atherosclerosis.2009.03.017; Nutt JG, 2005, NEW ENGL J MED, V353, P1021, DOI 10.1056/NEJMcp043908; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; Pfeiffer RF, 2009, NAT REV NEUROL, V5, P531, DOI 10.1038/nrneurol.2009.156; Pischon T, 2005, CIRCULATION, V112, P3375, DOI 10.1161/CIRCULATIONAHA.104.532499; Scigliano G, 2006, STROKE, V37, P1184, DOI 10.1161/01.STR.0000217384.03237.9c; Scigliano G, 2009, PARKINSONISM RELAT D, V15, P138, DOI 10.1016/j.parkreldis.2008.04.036; SHIEH S-M, 1985, Proceedings of the National Science Council Republic of China Part B Life Sciences, V9, P298; STRUCK LK, 1990, STROKE, V21, P1395, DOI 10.1161/01.STR.21.10.1395; van der Marck MA, 2012, PARKINSONISM RELAT D, V18, P263, DOI 10.1016/j.parkreldis.2011.10.016; WOO J, 1991, STROKE, V22, P203, DOI 10.1161/01.STR.22.2.203	33	30	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75743	10.1371/journal.pone.0075743	http://dx.doi.org/10.1371/journal.pone.0075743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086623	Green Published, Green Submitted, gold			2022-12-27	WOS:000325220000037
J	Liang, W; Tonini, G; Mulder, P; Kelder, T; van Erk, M; van den Hoek, AM; Mariman, R; Wielinga, PY; Baccini, M; Kooistra, T; Biggeri, A; Kleemann, R				Liang, Wen; Tonini, Giulia; Mulder, Petra; Kelder, Thomas; van Erk, Marjan; van den Hoek, Anita M.; Mariman, Rob; Wielinga, Peter Y.; Baccini, Michela; Kooistra, Teake; Biggeri, Annibale; Kleemann, Robert			Coordinated and Interactive Expression of Genes of Lipid Metabolism and Inflammation in Adipose Tissue and Liver during Metabolic Overload	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; FAT; INSULIN; OBESITY; SP1; DIET; PPAR; CERAMIDE; BIOLOGY; DISEASE	Background: Chronic metabolic overload results in lipid accumulation and subsequent inflammation in white adipose tissue (WAT), often accompanied by non-alcoholic fatty liver disease (NAFLD). In response to metabolic overload, the expression of genes involved in lipid metabolism and inflammatory processes is adapted. However, it still remains unknown how these adaptations in gene expression in expanding WAT and liver are orchestrated and whether they are interrelated. Methodology/Principal Findings: ApoE*3Leiden mice were fed HFD or chow for different periods up to 12 weeks. Gene expression in WAT and liver over time was evaluated by micro-array analysis. WAT hypertrophy and inflammation were analyzed histologically. Bayesian hierarchical cluster analysis of dynamic WAT gene expression identified groups of genes ('clusters') with comparable expression patterns over time. HFD evoked an immediate response of five clusters of 'lipid metabolism' genes in WAT, which did not further change thereafter. At a later time point (>6 weeks), inflammatory clusters were induced. Promoter analysis of clustered genes resulted in specific key regulators which may orchestrate the metabolic and inflammatory responses in WAT. Some master regulators played a dual role in control of metabolism and inflammation. When WAT inflammation developed (>6 weeks), genes of lipid metabolism and inflammation were also affected in corresponding livers. These hepatic gene expression changes and the underlying transcriptional responses in particular, were remarkably similar to those detected in WAT. Conclusion: In WAT, metabolic overload induced an immediate, stable response on clusters of lipid metabolism genes and induced inflammatory genes later in time. Both processes may be controlled and interlinked by specific transcriptional regulators. When WAT inflammation began, the hepatic response to HFD resembled that in WAT. In all, WAT and liver respond to metabolic overload by adaptations in expression of gene clusters that control lipid metabolism and inflammatory processes in an orchestrated and interrelated manner.	[Liang, Wen; Mulder, Petra; van den Hoek, Anita M.; Mariman, Rob; Wielinga, Peter Y.; Kooistra, Teake; Kleemann, Robert] TNO, Dept Metab Hlth Res, Leiden, Netherlands; [Tonini, Giulia; Baccini, Michela; Kooistra, Teake] Canc Prevent & Res Inst, Biostat Unit, Florence, Italy; [Kelder, Thomas; van Erk, Marjan] TNO, Dept Microbiol & Syst Biol, NL-3700 AJ Zeist, Netherlands; [Tonini, Giulia; Baccini, Michela; Biggeri, Annibale] Univ Florence, Dept Stat Informat & Applicat G Parenti, Florence, Italy	Netherlands Organization Applied Science Research; Netherlands Organization Applied Science Research; University of Florence	Kleemann, R (corresponding author), TNO, Dept Metab Hlth Res, Leiden, Netherlands.	Robert.kleemann@tno.nl		Mulder, Petra/0000-0002-0982-4466; Mariman, Rob/0000-0001-6405-1091	TNO research program Biomedical Innovations 'Personalized health/Op Maat'; European Nutrigenomics Organisation (NuGO) [CT-2004-505944]; Center for Translational Molecular Medicine [01C-104]; Dutch Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation	TNO research program Biomedical Innovations 'Personalized health/Op Maat'; European Nutrigenomics Organisation (NuGO); Center for Translational Molecular Medicine; Dutch Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation	This present study was mainly sponsored by the TNO research program Biomedical Innovations 'Personalized health/Op Maat' (to WL, RM, PM, T. Kooistra, MvE, AvdH, T. Kelder, PW, RK). The authors gratefully acknowledge additional grant support from the European Nutrigenomics Organisation (NuGO, CT-2004-505944 to GT, AB, MB, MvE, RK). WL was sponsored by the Center for Translational Molecular Medicine (www.ctmm.nl), project PREDICCt (grant 01C-104), supported by the Dutch Heart Foundation, Dutch Diabetes Research Foundation and Dutch Kidney Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2006, ANNU REV GENOM HUM G, V7, P175, DOI 10.1146/annurev.genom.7.080505.115715; Anghel SI, 2007, CELL RES, V17, P486, DOI 10.1038/cr.2007.48; Baccini M, 2008, GENES NUTR, V3, P147, DOI 10.1007/s12263-008-0102-5; Boini KM, 2010, J PHARMACOL EXP THER, V334, P839, DOI 10.1124/jpet.110.168815; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Caesar R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011525; Catelan D, 2010, BIOMETRICAL J, V52, P784, DOI 10.1002/bimj.200900209; Chaput JP, 2012, OBES REV, V13, P681, DOI 10.1111/j.1467-789X.2012.00992.x; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cooke EJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-399; De Groot PJ, 2008, GENES NUTR, V3, P143, DOI 10.1007/s12263-008-0093-2; de Wit NJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019145; Duan R, 1998, ENDOCRINOLOGY, V139, P1981, DOI 10.1210/en.139.4.1981; Duivenvoorden I, 2006, AM J CLIN NUTR, V84, P312; Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Grove KL, 2010, INT J OBESITY, V34, P989, DOI 10.1038/ijo.2010.12; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; Hotamisligil GS, 2008, INT J OBESITY, V32, pS52, DOI 10.1038/ijo.2008.238; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Keophiphath M, 2010, ARTERIOSCL THROM VAS, V30, P39, DOI 10.1161/ATVBAHA.109.197442; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; Kleemann R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-125; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kolak M, 2007, DIABETES, V56, P1960, DOI 10.2337/db07-0111; Krasowski MD, 2011, MOL CELL ENDOCRINOL, V334, P39, DOI 10.1016/j.mce.2010.06.016; Kreeft AJ, 2005, ATHEROSCLEROSIS, V182, P249, DOI 10.1016/j.atherosclerosis.2005.01.049; Li C, 2001, ENDOCRINOLOGY, V142, P1546, DOI 10.1210/en.142.4.1546; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mollica MP, 2011, NUTR METAB CARDIOVAS, V21, P222, DOI 10.1016/j.numecd.2010.10.012; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Pihlajamaki J, 2012, J HEPATOL, V56, P663, DOI 10.1016/j.jhep.2011.10.005; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200; Shah C, 2008, J BIOL CHEM, V283, P13538, DOI 10.1074/jbc.M709950200; Solomon SS, 2008, LIFE SCI, V83, P305, DOI 10.1016/j.lfs.2008.06.024; SONDERGAARD L, 1993, TRENDS GENET, V9, P193, DOI 10.1016/0168-9525(93)90113-V; Strissel KJ, 2010, OBESITY, V18, P1918, DOI 10.1038/oby.2010.1; Sun GL, 1998, MOL ENDOCRINOL, V12, P882, DOI 10.1210/me.12.6.882; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Ulven SM, 2005, PROSTAG LEUKOTR ESS, V73, P59, DOI 10.1016/j.plefa.2005.04.009; van Erk MJ, 2008, GENES NUTR, V3, P127, DOI 10.1007/s12263-008-0096-z; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Verschuren L, 2009, J LIPID RES, V50, P301, DOI 10.1194/jlr.M800374-JLR200; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wielinga PY, 2012, MOL NUTR FOOD RES, V56, P1081, DOI 10.1002/mnfr.201100762; Zadelaar ASM, 2006, ARTERIOSCL THROM VAS, V26, P2560, DOI 10.1161/01.ATV.0000242904.34700.66	54	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75290	10.1371/journal.pone.0075290	http://dx.doi.org/10.1371/journal.pone.0075290			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086498	Green Published, gold			2022-12-27	WOS:000325218700070
J	Lima, AA; Aragao, CWS; de Castro, MEB; Oliveira, JVD; Gomez, DRS; Ribeiro, BM				Lima, Anabele Azevedo; Silva Aragao, Clara Wandenkolck; Batista de Castro, Maria Elita; de Castro Oliveira, Juliana Velasco; Sosa Gomez, Daniel Ricardo; Ribeiro, Bergmann Morais			A Recombinant Anticarsia gemmatalis MNPV Harboring chiA and v-cath Genes from Choristoneura fumiferana Defective NPV Induce Host Liquefaction and Increased Insecticidal Activity	PLOS ONE			English	Article							CALIFORNICA NUCLEOPOLYHEDROVIRUS CHITINASE; VELVETBEAN CATERPILLAR; HUBNER LEPIDOPTERA; BACULOVIRUS; EXPRESSION; DELETION; CONSTRUCTION; PROTEINS; FORMS	One of the interesting features of Anticarsia gemmatalis multiple nucleopolyhedrovirus isolate 2D (AgMNPV-2D) genome is the absence of chitinase (chiA) and cathepsin (v-cath) genes. This characteristic may be responsible for the lack of liquefaction and melanization in A. gemmatalis larvae killed by AgMNPV-2D infection. This study aimed to test the hypothesis that CHIA and V-CATH proteins from Choristonera fumiferana DEF multiple nucleopolyhedrovirus (CfDEFNPV) are able to liquefy and melanize the cuticle of A. gemmatalis larvae infected by a recombinant AgMNPV containing chiA and v-cath genes inserted in its genome. A fragment from the CfDefNPV genome containing chiA and v-cath genes was inserted into the genome of AgMNPV-2D. The recombinant virus (vAgp2100Cf.chiA/v-cath) was purified and used to infect insect cells and larvae. Transcripts of v-cath and chiA genes were detected along the infection of insect cells by qRT-PCR, from early to late phases of infection. The analysis of A. gemmatalis larvae killed by vAgp2100Cf.chiA/v-cath infection confirmed the hypothesis proposed. The vAgp2100Cf.chiA/v-cath showed higher insecticidal activity against third instar A. gemmatalis larvae when compared to AgMNPV-2D. The mean time to death was also lower for the vAgp2100Cf.chiA/v-cath when compared to AgMNPV-2D at 10 days post infection. Occlusion body production was higher in A. gemmatalis larvae infected with vAgp2100Cf.chiA/v-cath when compared to AgMNPV-2D. Enzyme assays showed higher chitinase and cysteine protease activities in insect cells and insects infected with vAgp2100Cf.chiA/v-cath when compared to AgMNPV-2D. The introduction of chiA and v-cath genes into the genome of AgMNPV improves its insecticidal activity against A. gemmatalis larvae and this recombinant virus could be used as an alternative to the wild type virus to control this important insect pest.	[Lima, Anabele Azevedo; Silva Aragao, Clara Wandenkolck; Ribeiro, Bergmann Morais] Univ Brasilia, Grad Program Mol Pathol, Brasilia, DF, Brazil; [Batista de Castro, Maria Elita] Embrapa Genet Resources & Biotechnol, Brasilia, DF, Brazil; [de Castro Oliveira, Juliana Velasco] Univ Sao Paulo, Dept Microbiol, Sao Paulo, Brazil; [Sosa Gomez, Daniel Ricardo] Embrapa Soybean, Londrina, Parana, Brazil	Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Ribeiro, BM (corresponding author), Univ Brasilia, Grad Program Mol Pathol, Brasilia, DF, Brazil.	bergmann@unb.br	GUO, Zhaoyu/AAS-5699-2020; Sosa-Gomez, Daniel Ricardo/J-3421-2012; Ribeiro, Bergmann Morais/C-7114-2015; Sosa-Gomez, Daniel/AAH-7223-2019	Sosa-Gomez, Daniel Ricardo/0000-0003-2633-1644; Ribeiro, Bergmann Morais/0000-0002-1061-196X; Sosa-Gomez, Daniel/0000-0003-2633-1644	Consenho Nacional de Desenvolvimento Cientifico e Tecnologico [475579/2010-0, 490253/2011-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [AUXPE-PROCAD/NF 886/2010]; Fundacao de Apoio a Pesquisa do Distrito Federal [193.000.583/2009]	Consenho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio a Pesquisa do Distrito Federal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Consenho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br) grant numbers 475579/2010-0 and 490253/2011-3, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br) grant number AUXPE-PROCAD/NF 886/2010, Fundacao de Apoio a Pesquisa do Distrito Federal (www.fap.df.gov.br) grant number: 193.000.583/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves SB, 1998, QUANTIFICACAO INOCUL, P765; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cordeiro BA, 2008, J INVERTEBR PATHOL, V98, P7, DOI 10.1016/j.jip.2008.01.001; Daimon T, 2006, BIOCHEM BIOPH RES CO, V345, P825, DOI 10.1016/j.bbrc.2006.04.112; Oliveira JVD, 2006, J GEN VIROL, V87, P3233, DOI 10.1099/vir.0.82161-0; FEDERICI BA, 1997, BACULOVIRUSES; GOPALAKRISHNAN B, 1995, INSECT BIOCHEM MOLEC, V25, P255, DOI 10.1016/0965-1748(94)00070-X; Gramkow AW, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-143; GREENE GL, 1976, J ECON ENTOMOL, V69, P487, DOI 10.1093/jee/69.4.487; Harrison RL, 2001, BIOL CONTROL, V20, P199, DOI 10.1006/bcon.2000.0899; Hawtin RE, 1997, VIROLOGY, V238, P243, DOI 10.1006/viro.1997.8816; Hawtin RE, 1995, VIROLOGY, V238, P243; Herniou EA, 2012, VIRUS TAXONOMY, P163; Hill EJ, 1995, BIOCHIM BIOPHYS ACTA, V1264, P275; Hodgson JJ, 2007, J GEN VIROL, V88, P2479, DOI 10.1099/vir.0.82863-0; Hodgson JJ, 2011, J VIROL, V85, P3918, DOI 10.1128/JVI.02165-10; Hoffmann-Campo CB, 2003, INTEGRATED PEST MANA, P285; Hom LG, 2000, VIROLOGY, V277, P178, DOI 10.1006/viro.2000.0586; Hom LG, 2002, VIROLOGY, V296, P212, DOI 10.1006/viro.2002.1378; Jehle JA, 2006, ARCH VIROL, V151, P1257, DOI 10.1007/s00705-006-0763-6; JOHNSON DW, 1989, J GEN VIROL, V70, P1877, DOI 10.1099/0022-1317-70-7-1877; Kamita SG, 2005, COMPREHENSIVE MOL IN, P271; Katsuma S, 2009, VIRUS RES, V140, P155, DOI 10.1016/j.virusres.2008.11.014; Kramer KJ, 1997, INSECT BIOCHEM MOLEC, V27, P887, DOI 10.1016/S0965-1748(97)00078-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lauzon HAM, 2005, J GEN VIROL, V86, P945, DOI 10.1099/vir.0.80489-0; Lauzon HAM, 2006, J GEN VIROL, V87, P1477, DOI 10.1099/vir.0.81727-0; LEE HH, 1978, J VIROL, V27, P754, DOI 10.1128/JVI.27.3.754-767.1978; LeOra Software Company, 2003, POLOPLUS PROB LOG AN; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; MOLANO J, 1977, ANAL BIOCHEM, V83, P648, DOI 10.1016/0003-2697(77)90069-0; Morales Lauro, 1993, Anais da Sociedade Entomologica do Brasil, V22, P535; OHKAWA T, 1994, J VIROL, V68, P6619, DOI 10.1128/JVI.68.10.6619-6625.1994; Oliveira JVC, 2010, THESIS U SAO PAULO U; Oliveira VC, 2011, VIRUS RES, V155, P259, DOI 10.1016/j.virusres.2010.10.019; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; OREILLY DR, 1991, BIO-TECHNOL, V9, P1086, DOI 10.1038/nbt1191-1086; Pinedo FJR, 2003, BIOL CONTROL, V27, P336, DOI 10.1016/S1049-9644(03)00026-4; Reed RJ, 1938, AM J HYG, V7, P493; RIBEIRO BM, 1993, J INVERTEBR PATHOL, V62, P121, DOI 10.1006/jipa.1993.1087; Ribeiro BM, 2001, ARCH VIROL, V146, P1355, DOI 10.1007/s007050170096; Robertson J. L., 1992, PESTICIDE BIOASSAYS; Saville GP, 2004, J GEN VIROL, V85, P821, DOI 10.1099/vir.0.19732-0; Saville GP, 2002, J GEN VIROL, V83, P685, DOI 10.1099/0022-1317-83-3-685; Seidl Verena, 2008, Fungal Biology Reviews, V22, P36, DOI 10.1016/j.fbr.2008.03.002; SIEBURTH PJ, 1988, IN VITRO CELL DEV B, V24, P195, DOI 10.1007/bf02623546; SLACK JM, 1995, J GEN VIROL, V76, P1091, DOI 10.1099/0022-1317-76-5-1091; SMITH GE, 1983, J VIROL, V45, P215, DOI 10.1128/JVI.45.1.215-225.1983; Souza ML, 2002, BIOTECNOLOGIA CIENCI, V24, P18; STEWART LMD, 1991, NATURE, V352, P85, DOI 10.1038/352085a0; Thomas CJ, 1998, J VIROL, V72, P10207, DOI 10.1128/JVI.72.12.10207-10212.1998; Thomas CJ, 2000, J GEN VIROL, V81, P1403, DOI 10.1099/0022-1317-81-5-1403; TOMALSKI MD, 1991, NATURE, V352, P82, DOI 10.1038/352082a0; TRUDEL J, 1989, MOL PLANT MICROBE IN, V2, P315, DOI 10.1094/MPMI-2-315; VOLKMAN L.E., 1990, SEMIN VIROL, V1, P249; Wang F, 2005, ARCH VIROL, V150, P981, DOI 10.1007/s00705-004-0458-9	56	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74592	10.1371/journal.pone.0074592	http://dx.doi.org/10.1371/journal.pone.0074592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086357	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700028
J	Rogers, GB; van der Gast, CJ; Bruce, KD; Marsh, P; Collins, JE; Sutton, J; Wright, M				Rogers, Geraint B.; van der Gast, Christopher J.; Bruce, Kenneth D.; Marsh, Peter; Collins, Jane E.; Sutton, Julian; Wright, Mark			Ascitic Microbiota Composition Is Correlated with Clinical Severity in Cirrhosis with Portal Hypertension	PLOS ONE			English	Article							SPONTANEOUS BACTERIAL PERITONITIS; PROPIDIUM MONOAZIDE; QUANTITATIVE PCR; DNA; DISCRIMINATION; IDENTIFICATION; COMMUNITIES; COMBINATION; MANAGEMENT; DIVERSITY	Identification of pathogenic bacteria in ascites correlates with poor clinical outcomes. Ascites samples are commonly reported culture-negative, even where frank infection is indicated. Culture-independent methods have previously reported bacterial DNA in ascites, however, whether this represents viable bacterial populations has not been determined. We report the first application of 16S rRNA gene pyrosequencing and quantitative PCR in conjunction with propidium monoazide sample treatment to characterise the viable bacterial composition of ascites. Twenty five cirrhotic patients undergoing paracentesis provided ascites. Samples were treated with propidium monoazide to exclude non-viable bacterial DNA. Total bacterial load was quantified by 16S rRNA Q-PCR with species identity and relative abundance determined by 16S rRNA gene pyrosequencing. Correlation of molecular microbiology data with clinical measures and diagnostic microbiology was performed. Viable bacterial signal was obtained in 84% of ascites samples, both by Q-PCR and pyrosequencing. Approximately 190,000 ribosomal pyrosequences were obtained, representing 236 species, including both gut and non gut-associated species. Substantial variation in the species detected was observed between patients. Statistically significant relationships were identified between the bacterial community similarity and clinical measures, including ascitic polymorphonuclear leukocyte count and Child-Pugh class. Viable bacteria are present in the ascites of a majority of patients with cirrhosis including those with no clinical signs of infection. Microbiota composition significantly correlates with clinical measures. Entry of bacteria into ascites is unlikely to be limited to translocation from the gut, raising fundamental questions about the processes that underlie the development of spontaneous bacterial peritonitis.	[Rogers, Geraint B.; Bruce, Kenneth D.] Kings Coll London, Inst Pharmaceut Sci, London, England; [van der Gast, Christopher J.] NERC Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Marsh, Peter; Sutton, Julian] Southampton Gen Hosp, Hlth Protect Agcy, Southampton SO9 4XY, Hants, England; [Collins, Jane E.; Wright, Mark] Southampton Gen Hosp, Hepatol Grp, Southampton SO9 4XY, Hants, England	University of London; King's College London; UK Centre for Ecology & Hydrology (UKCEH); Health Protection Agency; University of Southampton; University of Southampton	Rogers, GB (corresponding author), Kings Coll London, Inst Pharmaceut Sci, London, England.	geraint.rogers@kcl.ac.uk	Rogers, Geraint B/N-1957-2013; Rogers, Geraint/AAD-1011-2020; van der Gast, Christopher/G-1153-2011	Rogers, Geraint B/0000-0003-4054-1947; van der Gast, Christopher/0000-0003-1101-4048; Collins, Jane/0000-0002-9914-3890	Southampton Hospital Charity Hepatology Research Fund; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Southampton Hospital Charity Hepatology Research Fund; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by Southampton Hospital Charity Hepatology Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SW, 2009, APPL ENVIRON MICROB, V75, P2940, DOI 10.1128/AEM.01333-08; Bruns T, 2009, LIVER INT, V29, P1206, DOI 10.1111/j.1478-3231.2009.02073.x; Chen YF, 2011, HEPATOLOGY, V54, P562, DOI 10.1002/hep.24423; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edwards ML, 2001, FEMS MICROBIOL ECOL, V35, P295, DOI 10.1111/j.1574-6941.2001.tb00815.x; Harris KA, 2003, J MED MICROBIOL, V52, P685, DOI 10.1099/jmm.0.05213-0; Kralik P, 2010, INT J FOOD MICROBIOL, V141, pS80, DOI 10.1016/j.ijfoodmicro.2010.03.018; Liu Q, 2004, HEPATOLOGY, V39, P1441, DOI 10.1002/hep.20194; Moore KP, 2006, GUT, V55, P1, DOI 10.1136/gut.2006.099580; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nam S, 2011, MICROBIOL IMMUNOL, V55, P841, DOI 10.1111/j.1348-0421.2011.00388.x; Nocker A, 2007, APPL ENVIRON MICROB, V73, P5111, DOI 10.1128/AEM.02987-06; Nocker A, 2010, INT MICROBIOL, V13, P59, DOI 10.2436/20.1501.01.111; Rao RK, 2004, AM J PHYSIOL-GASTR L, V286, pG881, DOI 10.1152/ajpgi.00006.2004; Rogers GB, 2010, CLIN MICROBIOL INFEC, V16, P1656, DOI 10.1111/j.1469-0691.2010.03189.x; Rogers GB, 2010, EUR J CLIN MICROBIOL, V29, P533, DOI 10.1007/s10096-010-0891-5; Rogers GB, 2013, ISME J, V7, P697, DOI 10.1038/ismej.2012.145; Rogers Geraint B, 2009, BMC Pulm Med, V9, P14, DOI 10.1186/1471-2466-9-14; Rogers GB, 2009, J MED MICROBIOL, V58, P1401, DOI 10.1099/jmm.0.013334-0; Roges GB, 2008, DIAGN MICR INFEC DIS, V62, P133, DOI 10.1016/j.diagmicrobio.2008.06.011; RUNYON BA, 1990, J CLIN MICROBIOL, V28, P2811, DOI 10.1128/JCM.28.12.2811-2812.1990; Runyon BA, 2009, HEPATOLOGY, V49, P2087, DOI 10.1002/hep.22853; Sort P, 1999, NEW ENGL J MED, V341, P403, DOI 10.1056/NEJM199908053410603; Stressmann FA, 2011, J CYST FIBROS, V10, P357, DOI 10.1016/j.jcf.2011.05.002; Such J, 2002, HEPATOLOGY, V36, P135, DOI 10.1053/jhep.2002.33715; Taskin B, 2011, APPL ENVIRON MICROB, V77, P4329, DOI 10.1128/AEM.02895-10; Thuluvath PJ, 2001, AM J GASTROENTEROL, V96, P1232, DOI 10.1111/j.1572-0241.2001.03708.x; van der Gast CJ, 2011, ENVIRON MICROBIOL, V13, P241, DOI 10.1111/j.1462-2920.2010.02326.x; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Wiest R, 2012, GUT, V61, P297, DOI 10.1136/gutjnl-2011-300779; Zapater P, 2008, HEPATOLOGY, V48, P1924, DOI 10.1002/hep.22564	32	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74884	10.1371/journal.pone.0074884	http://dx.doi.org/10.1371/journal.pone.0074884			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086392	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000325218700045
J	Zennaro, F; Gomes, JAO; Casalino, A; Lonardi, M; Starc, M; Paoletti, P; Gobbo, D; Giusto, C; Not, T; Lazzerini, M				Zennaro, Floriana; Oliveira Gomes, Joaquim Antonio; Casalino, Armando; Lonardi, Magda; Starc, Meta; Paoletti, Pierpaolo; Gobbo, Daniele; Giusto, Chiara; Not, Tarcisio; Lazzerini, Marzia			Digital Radiology to Improve the Quality of Care in Countries with Limited Resources: A Feasibility Study from Angola	PLOS ONE			English	Article							PEDIATRIC CARE; TELEMEDICINE; TELERADIOLOGY; SUPPORT; BORDERS	Objective: Sub-standard quality in X-ray image acquisition and interpretation is common in low-resource countries, and can ultimately result in higher patient morbidity and mortality. This study aimed at evaluating; 1) feasibility of implementing a digital X-ray device in a second level hospital in Angola; 2) quality of digital X-ray images, when digital radiology was in the hands of local technicians; 3) feasibility of digital teleradiology and its potential impact on case management. Methods: We developed and tested at the Hospital Divina Providencia (HDP) in Luanda, Angola, a digital X-ray device and a telemedicine network to acquire and print digital X-ray images and send them as DICOM files for remote consultation. Results: 20,564 digital X-ray images were made at HDP from November 2010 to December 2012, with no major technical problems and no need for on-site supervision. Digital radiology largely improved the number of X-ray images of good and very good quality (100% of images with digital radiology, compared to 15% of screen-film images, p<0.0001). Teleradiology using digital images was used in 7.6% of paediatric cases, and provided, in these cases, an important contribution to case management. Conclusions: The implementation of a digital X-ray device is feasible in low resource settings with significant improvement in quality of X-ray images compared to standard screen film radiology.	[Zennaro, Floriana; Casalino, Armando; Starc, Meta; Paoletti, Pierpaolo; Not, Tarcisio; Lazzerini, Marzia] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Oliveira Gomes, Joaquim Antonio; Lonardi, Magda; Gobbo, Daniele; Giusto, Chiara] Hosp Divina Providencia, Luanda, Angola	IRCCS Burlo Garofolo	Lazzerini, M (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.	marzia.lazzerini@burlo.trieste.it	Not, Tarcisio/K-2616-2018	Not, Tarcisio/0000-0003-1059-3009	European funds for International Cooperation delivered through Regione Friuli Venezia Giulia, Italy	European funds for International Cooperation delivered through Regione Friuli Venezia Giulia, Italy	This project was partly supported by European funds for International Cooperation delivered through Regione Friuli Venezia Giulia, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Al-Shorbaji N, 2012, B WORLD HEALTH ORGAN, V90, P322, DOI 10.2471/BLT.12.106146; Andronikou S, 2011, PEDIATR RADIOL, V41, P811, DOI 10.1007/s00247-011-2081-8; Andronikou S, 2011, PEDIATR RADIOL, V41, P826, DOI 10.1007/s00247-011-2080-9; Corr P, 1998, S AFR MED J, V88, P48; Corr P, 2000, J TELEMED TELECARE, V6, P233, DOI 10.1258/1357633001935293; Coulborn RM, 2012, B WORLD HEALTH ORGAN, V90, P705, DOI 10.2471/BLT.11.099473; Ellis S. M., 2006, WHO MANUAL DIAGNOSTI; Jarvis L, 2005, CLIN RADIOL, V60, P840, DOI 10.1016/j.crad.2005.04.001; Javadi M, 2006, INT J INFECT DIS, V10, P129, DOI 10.1016/j.ijid.2005.01.007; Salazar AJ, 2012, J DIGIT IMAGING, V25, P91, DOI 10.1007/s10278-011-9391-0; Meade K, 2007, TELEMED J E-HEALTH, V13, P331, DOI 10.1089/tmj.2006.0040; Nyathi T, 2010, Biomed Imaging Interv J, V6, pe5, DOI 10.2349/biij.6.1.e5; Saliba V, 2012, INT J MED INFORM, V81, P793, DOI 10.1016/j.ijmedinf.2012.08.003; Shiferaw F, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.15638; Singh M, 2010, POSTGRAD MED J, V86, P688, DOI 10.1136/pgmj.2009.082735; Szot A, 2004, INT J MED INFORM, V73, P65, DOI 10.1016/j.ijmedinf.2003.10.002; WHO, 2010, WHO MAN DIAGN IM PAE; Zachariah R, 2012, TROP MED INT HEALTH, V17, P1156, DOI 10.1111/j.1365-3156.2012.03047.x	18	24	24	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e73939	10.1371/journal.pone.0073939	http://dx.doi.org/10.1371/journal.pone.0073939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086301	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700014
J	Moodley, D; Geerts, S; Richardson, DM; Wilson, JRU				Moodley, Desika; Geerts, Sjirk; Richardson, David M.; Wilson, John R. U.			Different Traits Determine Introduction, Naturalization and Invasion Success In Woody Plants: Proteaceae as a Test Case	PLOS ONE			English	Article							ALIEN PLANTS; PROPAGULE PRESSURE; AUSTRALIAN ACACIAS; INVASIVENESS; BANKSIA; ATTRIBUTES; LESSONS; BIOLOGY; SPREAD; PINUS	A major aim of invasion ecology is to identify characteristics of successful invaders. However, most plant groups studied in detail (e. g. pines and acacias) have a high percentage of invasive taxa. Here we examine the global introduction history and invasion ecology of Proteaceae-a large plant family with many taxa that have been widely disseminated by humans, but with few known invaders. To do this we compiled a global list of species and used boosted regression tree models to assess which factors are important in determining the status of a species (not introduced, introduced, naturalized or invasive). At least 402 of 1674 known species (24%) have been moved by humans out of their native ranges, 58 species (14%) have become naturalized but not invasive, and 8 species (2%) are invasive. The probability of naturalization was greatest for species with large native ranges, low susceptibility to Phytophthora root-rot fungus, large mammal-dispersed seeds, and with the capacity to resprout. The probability of naturalized species becoming invasive was greatest for species with large native ranges, those used as barrier plants, tall species, species with small seeds, and serotinous species. The traits driving invasiveness of Proteaceae were similar to those for acacias and pines. However, while some traits showed a consistent influence at introduction, naturalization and invasion, others appear to be influential at one stage only, and some have contrasting effects at different stages. Trait-based analyses therefore need to consider different invasion stages separately. On their own, these observations provide little predictive power for risk assessment, but when the causative mechanisms are understood (e. g. Phytophthora susceptibility) they provide valuable insights. As such there is considerable value in seeking the correlates and mechanisms underlying invasions for particular taxonomic or functional groups.	[Moodley, Desika; Geerts, Sjirk; Richardson, David M.; Wilson, John R. U.] Univ Stellenbosch, Dept Bot & Zool, Ctr Invas Biol, ZA-7600 Stellenbosch, South Africa; [Moodley, Desika; Geerts, Sjirk; Wilson, John R. U.] Kirstenbosch Res Ctr, South African Natl Biodivers Inst, Invas Species Programme, Cape Town, South Africa	Stellenbosch University; South African National Biodiversity Institute	Moodley, D (corresponding author), Univ Stellenbosch, Dept Bot & Zool, Ctr Invas Biol, ZA-7600 Stellenbosch, South Africa.	desikamoodley29@gmail.com	Geerts, Sjirk/AAQ-6375-2021; Geerts, Sjirk/B-9659-2011; Wilson, John/B-4101-2008; Richardson, David M/A-1495-2008	Wilson, John/0000-0003-0174-3239; Richardson, David M/0000-0001-9574-8297; Geerts, Sjirk/0000-0003-0149-2783; Moodley, Desika/0000-0002-0788-2136	South African National Biodiversity Institute's Invasive Species Programme; Working for Water Programme of the Natural Resources Management Programmes (Department of Environmental Affairs); DST-NRF Centre of Excellence for Invasion Biology; National Research Foundation	South African National Biodiversity Institute's Invasive Species Programme; Working for Water Programme of the Natural Resources Management Programmes (Department of Environmental Affairs); DST-NRF Centre of Excellence for Invasion Biology(Department of Science & Technology (India)); National Research Foundation	The authors acknowledge financial support from the South African National Biodiversity Institute's Invasive Species Programme, the Working for Water Programme of the Natural Resources Management Programmes (Department of Environmental Affairs), and the DST-NRF Centre of Excellence for Invasion Biology. DMR also acknowledges funding from the National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Bufford J.L., 2011, ENCY BIOL INVASIONS, P437; Cadotte MW, 2006, BIOL INVASIONS, V8, P809, DOI 10.1007/s10530-005-3839-4; Coetzee JH, 2001, PROTEACEOUS ORNAMENT, P77; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; COLLINS BG, 1987, AUST J ECOL, V12, P387, DOI 10.1111/j.1442-9993.1987.tb00958.x; COWLING RM, 1985, AUST J ECOL, V10, P345, DOI 10.1111/j.1442-9993.1985.tb00895.x; Dawson W, 2009, J ECOL, V97, P657, DOI 10.1111/j.1365-2745.2009.01519.x; Dehnen-Schmutz K, 2007, CONSERV BIOL, V21, P224, DOI 10.1111/j.1523-1739.2006.00538.x; Diez JM, 2012, BIOL INVASIONS, V14, P681, DOI 10.1007/s10530-011-0109-5; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Geerts S, AUSTRAL ECOLOGY; Gravuer K, 2008, P NATL ACAD SCI USA, V105, P6344, DOI 10.1073/pnas.0712026105; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Hamilton MA, 2005, ECOL LETT, V8, P1066, DOI 10.1111/j.1461-0248.2005.00809.x; Higgins SI, 2008, J ECOL, V96, P679, DOI 10.1111/j.1365-2745.2008.01391.x; HONIG MA, 1992, AUST J ECOL, V17, P305, DOI 10.1111/j.1442-9993.1992.tb00812.x; Hui C, 2011, DIVERS DISTRIB, V17, P872, DOI 10.1111/j.1472-4642.2011.00804.x; Hulme PE, 2006, J APPL ECOL, V43, P835, DOI 10.1111/j.1365-2664.2006.01227.x; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kuster EC, 2008, J ECOL, V96, P860, DOI 10.1111/j.1365-2745.2008.01406.x; Lambers H, 2011, PLANT PHYSIOL, V156, P1058, DOI 10.1104/pp.111.174318; Leonhardt K, 1999, PERSPECTIVES NEW CRO; Lloret F, 2005, J ECOL, V93, P512, DOI 10.1111/j.1365-2745.2005.00979.x; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Mast AR, 2007, AUST SYST BOT, V20, P63, DOI 10.1071/SB06016; McGregor KF, 2012, DIVERS DISTRIB, V18, P1013, DOI 10.1111/j.1472-4642.2012.00942.x; Middelmann M., 2012, PROTEAS BIRTH WORLDW; Milbau A, 2008, CONSERV BIOL, V22, P308, DOI 10.1111/j.1523-1739.2007.00877.x; Myerscough P. J., 2000, Cunninghamia, V6, P951; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; Pysek P, 2008, INVASIVE PLANTS, P2011; Pysek Petr, 2007, V193, P97; Pysek P, 2009, ECOLOGY, V90, P2734, DOI 10.1890/08-0857.1; Pysek P, 2009, DIVERS DISTRIB, V15, P891, DOI 10.1111/j.1472-4642.2009.00602.x; R Core Team, 2020, R LANG ENV STAT COMP; REBELO AG, 1995, SASOL PROTEAS FIELD; Reichard SH, 2001, BIOSCIENCE, V51, P103, DOI 10.1641/0006-3568(2001)051[0103:HAAPOI]2.0.CO;2; Reichard SH, 1997, CONSERV BIOL, V11, P193, DOI 10.1046/j.1523-1739.1997.95473.x; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Rejmanek M, 1996, BIOL CONSERV, V78, P171, DOI 10.1016/0006-3207(96)00026-2; Rejmanek M, 2000, AUSTRAL ECOL, V25, P497, DOI 10.1046/j.1442-9993.2000.01080.x; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Richardson DM, 2012, NEW PHYTOL, V196, P383, DOI 10.1111/j.1469-8137.2012.04292.x; Richardson DM, 2011, DIVERS DISTRIB, V17, P771, DOI 10.1111/j.1472-4642.2011.00824.x; Richardson DM, 2011, DIVERS DISTRIB, V17, P788, DOI 10.1111/j.1472-4642.2011.00782.x; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; RICHARDSON DM, 1990, J VEG SCI, V1, P629, DOI 10.2307/3235569; Ridgeway G, 2012, GBM GEN BOOSTED REGR; Schmidt JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017391; Sedgley M, 2007, PROTEACEOUS ORNAMENT; Simberloff D, 2010, AUSTRAL ECOL, V35, P489, DOI 10.1111/j.1442-9993.2009.02058.x; Swart, 2004, CULTIVATION DIS PROT; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Van Kleunen M, 2007, J ECOL, V95, P674, DOI 10.1111/j.1365-2745.2007.01250.x; Vila M, 2011, LANDSCAPE ECOL, V26, P461, DOI 10.1007/s10980-011-9585-3; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Weston Peter H., 2006, Telopea, V11, P314	58	59	61	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75078	10.1371/journal.pone.0075078	http://dx.doi.org/10.1371/journal.pone.0075078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086442	Green Submitted, Green Published, gold			2022-12-27	WOS:000325025200023
J	Raymond, F; Boucher, N; Allary, R; Robitaille, L; Lefebvre, B; Tremblay, C; Corbeil, J; Gervaix, A				Raymond, Frederic; Boucher, Nancy; Allary, Robin; Robitaille, Lynda; Lefebvre, Brigitte; Tremblay, Cecile; Corbeil, Jacques; Gervaix, Alain			Serotyping of Streptococcus pneumoniae Based on Capsular Genes Polymorphisms	PLOS ONE			English	Article							SEQUENTIAL MULTIPLEX PCR; PNEUMOCOCCAL CONJUGATE VACCINE; FRAGMENT LENGTH POLYMORPHISM; DISEASE; MENINGITIS; CHILDREN; ANTIGEN; IDENTIFICATION; IMMUNOASSAY; DIAGNOSIS	Streptococcus pneumoniae serotype epidemiology is essential since serotype replacement is a concern when introducing new polysaccharide-conjugate vaccines. A novel PCR-based automated microarray assay was developed to assist in the tracking of the serotypes. Autolysin, pneumolysin and eight genes located in the capsular operon were amplified using multiplex PCR. This step was followed by a tagged fluorescent primer extension step targeting serotype-specific polymorphisms. The tagged primers were then hybridized to a microarray. Results were exported to an expert system to identify capsular serotypes. The assay was validated on 166 cultured S. pneumoniae samples from 63 different serotypes as determined by the Quellung method. We show that typing only 12 polymorphisms located in the capsular operon allows the identification at the serotype level of 22 serotypes and the assignation of 24 other serotypes to a subgroup of serotypes. Overall, 126 samples (75.9%) were correctly serotyped, 14 were assigned to a member of the same serogroup, 8 rare serotypes were erroneously serotyped, and 18 gave negative serotyping results. Most of the discrepancies involved rare serotypes or serotypes that are difficult to discriminate using a DNA-based approach, for example 6A and 6B. The assay was also tested on clinical specimens including 43 cerebrospinal fluid samples from patients with meningitis and 59 nasopharyngeal aspirates from bacterial pneumonia patients. Overall, 89% of specimens positive for pneumolysin were serotyped, demonstrating that this method does not require culture to serotype clinical specimens. The assay showed no crossreactivity for 24 relevant bacterial species found in these types of samples. The limit of detection for serotyping and S. pneumoniae detection was 100 genome equivalent per reaction. This automated assay is amenable to clinical testing and does not require any culturing of the samples. The assay will be useful for the evaluation of serotype prevalence changes after new conjugate vaccines introduction.	[Raymond, Frederic; Boucher, Nancy; Allary, Robin; Robitaille, Lynda; Corbeil, Jacques] Univ Laval, Ctr Rech & Infectiol, Quebec City, PQ, Canada; [Lefebvre, Brigitte] Univ Laval, Dept Microbiol & Immunol, Quebec City, PQ, Canada; [Tremblay, Cecile] Inst Natl Sante Publ, Lab Sante Publ Quebec, Quebec City, PQ, Canada; [Gervaix, Alain] Univ Hosp Geneva, Dept Pediat, Geneva, Switzerland	Laval University; Laval University; Institut national de sante publique du Quebec (INSPQ); University of Geneva	Raymond, F (corresponding author), Univ Laval, Ctr Rech & Infectiol, Quebec City, PQ, Canada.	frederic.raymond@crchul.ulaval.ca	Corbeil, Jacques/AAW-9739-2020; Raymond, Frederic/I-4135-2019	Corbeil, Jacques/0000-0002-9973-2740; Raymond, Frederic/0000-0002-3606-4060	CIHR; Pfizer	CIHR(Canadian Institutes of Health Research (CIHR)); Pfizer(Pfizer)	FR was the recipient of a CIHR studentship. JC is the holder of the Canada Research Chair in Medical Genomics. CT is the holder of Pfizer/University of Montreal Chair on Translational HIV Research. The authors thank AutoGenomics inc., for providing reagents necessary to conduct this study, and Pfizer, for financing part of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Jong Gyun, 2012, Korean J Pediatr, V55, P424, DOI 10.3345/kjp.2012.55.11.424; Azzari C, 2008, J MED MICROBIOL, V57, P1205, DOI 10.1099/jmm.0.2008/000935-0; Batt SL, 2005, J CLIN MICROBIOL, V43, P2656, DOI 10.1128/JCM.43.6.2656-2661.2005; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Coskun-Ari FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050406; Dias CA, 2007, J MED MICROBIOL, V56, P1185, DOI 10.1099/jmm.0.47347-0; Elberse KEM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020390; Feikin DR, 2002, CLIN INFECT DIS, V35, P547, DOI 10.1086/341896; Gervaix A, 2012, PEDIATR INFECT DIS J, V31, P1084, DOI 10.1097/INF.0b013e318260552d; HASSANKING M, 1994, J CLIN MICROBIOL, V32, P1721, DOI 10.1128/JCM.32.7.1721-1724.1994; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Jin P, 2009, J CLIN MICROBIOL, V47, P2470, DOI 10.1128/JCM.00484-09; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Johnston C, 2010, J CLIN MICROBIOL, V48, P2762, DOI 10.1128/JCM.01746-09; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Lalitha MK, 1999, J CLIN MICROBIOL, V37, P263, DOI 10.1128/JCM.37.1.263-265.1999; Leeming JP, 2005, J CLIN MICROBIOL, V43, P4972, DOI 10.1128/JCM.43.10.4972-4976.2005; Leung MH, 2012, J CLIN MICROBIOL, V50, P2419, DOI 10.1128/JCM.06384-11; Modak JK, 2012, J CLIN MICROBIOL, V50, P3388, DOI 10.1128/JCM.01912-12; Morais L, 2007, J MED MICROBIOL, V56, P1181, DOI 10.1099/jmm.0.47346-0; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Sullivan MVN, 2011, JOVE-J VIS EXP, DOI 10.3791/2781; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pai R, 2005, J CLIN MICROBIOL, V43, P4820, DOI 10.1128/JCM.43.9.4820-4822.2005; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Pimenta FC, 2013, J CLIN MICROBIOL, V51, P647, DOI 10.1128/JCM.02927-12; Pimenta FC, 2009, J CLIN MICROBIOL, V47, P2353, DOI 10.1128/JCM.00704-09; Raymond F, 2009, J CLIN MICROBIOL, V47, P743, DOI 10.1128/JCM.01297-08; Resti M, 2010, CLIN INFECT DIS, V51, P1042, DOI 10.1086/656579; Saha SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003576; Scott JR, 2012, J INFECT DIS, V206, P73, DOI 10.1093/infdis/jis307; Selva L, 2012, J CLIN MICROBIOL, V50, P3451, DOI 10.1128/JCM.01368-12; Shaaly A, 2005, J MED MICROBIOL, V54, P467, DOI 10.1099/jmm.0.45912-0; Sheppard CL, 2011, J MED MICROBIOL, V60, P1879, DOI 10.1099/jmm.0.034975-0; Sheppard CL, 2011, J MED MICROBIOL, V60, P49, DOI 10.1099/jmm.0.023150-0; Siira L, 2012, J CLIN MICROBIOL, V50, P2727, DOI 10.1128/JCM.00689-12; Tomita Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/352736; Witten I. H., 2005, DATA MINING PRACTICA	39	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e76197	10.1371/journal.pone.0076197	http://dx.doi.org/10.1371/journal.pone.0076197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086706	Green Published, gold, Green Submitted			2022-12-27	WOS:000325025200074
J	Rollason, R; Dunstan, K; Billcliff, PG; Bishop, P; Gleeson, P; Wise, H; Digard, P; Banting, G				Rollason, Ruth; Dunstan, Katie; Billcliff, Peter G.; Bishop, Paul; Gleeson, Paul; Wise, Helen; Digard, Paul; Banting, George			Expression of HIV-1 Vpu Leads to Loss of the Viral Restriction Factor CD317/Tetherin from Lipid Rafts and Its Enhanced Lysosomal Degradation	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; STROMAL CELL ANTIGEN-2; TRANSMEMBRANE DOMAIN; PROTEIN; BST-2/TETHERIN; RELEASE; SURFACE; BST-2; BST2/TETHERIN; SENSITIVITY	CD317/tetherin (aka BST2 or HM1.24 antigen) is an interferon inducible membrane protein present in regions of the lipid bilayer enriched in sphingolipids and cholesterol (often termed lipid rafts). It has been implicated in an eclectic mix of cellular processes including, most notably, the retention of fully formed viral particles at the surface of cells infected with HIV and other enveloped viruses. Expression of the HIV viral accessory protein Vpu has been shown to lead to intracellular sequestration and degradation of tetherin, thereby counteracting the inhibition of viral release. There is evidence that tetherin interacts directly with Vpu, but it remains unclear where in the cell this interaction occurs or if Vpu expression affects the lipid raft localisation of tetherin. We have addressed these points using biochemical and cell imaging approaches focused on endogenous rather than ectopically over-expressed tetherin. We find i) no evidence for an interaction between Vpu and endogenous tetherin at the cell surface, ii) the vast majority of endogenous tetherin that is at the cell surface in control cells is in lipid rafts, iii) internalised tetherin is present in non-raft fractions, iv) expression of Vpu in cells expressing endogenous tetherin leads to the loss of tetherin from lipid rafts, v) internalised tetherin enters early endosomes, and late endosomes, in both control cells and cells expressing Vpu, but the proportion of tetherin molecules destined for degradation rather than recycling is increased in cells expressing Vpu vi) lysosomes are the primary site for degradation of endogenous tetherin in cells expressing Vpu. Our studies underlie the importance of studying endogenous tetherin and let us propose a model in which Vpu intercepts newly internalised tetherin and diverts it for lysosomal destruction rather than recycling to the cell surface.	[Rollason, Ruth; Dunstan, Katie; Billcliff, Peter G.; Bishop, Paul; Banting, George] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Gleeson, Paul] Univ Melbourne, Inst Bio21, Melbourne, Vic, Australia; [Wise, Helen; Digard, Paul] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland	University of Bristol; University of Melbourne; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Banting, G (corresponding author), Univ Bristol, Sch Biochem, Bristol, Avon, England.	g.banting@bristol.ac.uk	Digard, Paul/B-7717-2008	Digard, Paul/0000-0002-0872-9440; Emery-Billcliff, Peter/0000-0002-4448-6175; Banting, George/0000-0001-8249-1621; Rollason, Ruth/0000-0001-5834-6360	Wellcome Trust [086783/Z/08/Z]; Leverhulme Trust [2009/0621]; Royal Society [TG101953]; Biotechnology and Biological Sciences Research Council [BBS/E/D/20241864, BB/G021031/1] Funding Source: researchfish; BBSRC [BB/G021031/1, BBS/E/D/20241864] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Leverhulme Trust(Leverhulme Trust); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by The Wellcome Trust http://www.wellcome.ac.uk (086783/Z/08/Z), the Leverhulme Trust http://www.leverhulme.ac.uk (2009/0621) and the Royal Society http://royalsociety.org (TG101953). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SM, 2002, STRUCTURE, V10, P1085, DOI 10.1016/S0969-2126(02)00808-0; Andrew A, 2010, MOL ASPECTS MED, V31, P407, DOI 10.1016/j.mam.2010.08.002; Andrew AJ, 2011, J BIOL CHEM, V286, P39967, DOI 10.1074/jbc.M111.287011; Andrew AJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-80; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Bernal AL, 2007, SEMIN CELL DEV BIOL, V18, P340, DOI 10.1016/j.semcdb.2007.05.002; BERNAL AL, 2007, PRETERM BIRTH MECH M, P167; Billcliff PG, 2013, J CELL SCI, V126, P1553, DOI 10.1242/jcs.112953; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2011, TRAFFIC, V12, P1714, DOI 10.1111/j.1600-0854.2011.01277.x; Dube M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-114; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; Elortza F, 2006, J PROTEOME RES, V5, P935, DOI 10.1021/pr050419u; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Florin EL, 1998, APPL PHYS A-MATER, V66, pS75, DOI 10.1007/s003390051103; GOTO T, 1994, BLOOD, V84, P1922; Hammonds J, 2010, CELL HOST MICROBE, V7, P261, DOI 10.1016/j.chom.2010.04.001; Hauser H, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-51; Hinz A, 2010, CELL HOST MICROBE, V7, P314, DOI 10.1016/j.chom.2010.03.005; Hussain A, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-81; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kobayashi T, 2011, J VIROL, V85, P932, DOI 10.1128/JVI.01668-10; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Kusumi A, 2011, TRENDS BIOCHEM SCI, V36, P604, DOI 10.1016/j.tibs.2011.08.001; Lee CK, 2007, MICRON, V38, P446, DOI 10.1016/j.micron.2006.06.014; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lopez CF, 2002, BIOPHYS J, V83, P1259, DOI 10.1016/S0006-3495(02)73898-8; Lopez LA, 2010, J VIROL, V84, P7243, DOI 10.1128/JVI.02636-09; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Mansouri M, 2009, J VIROL, V83, P9672, DOI 10.1128/JVI.00597-09; Masuyama N, 2009, J BIOL CHEM, V284, P15927, DOI 10.1074/jbc.M109.005124; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Oakley FD, 2009, J BIOL CHEM, V284, P33255, DOI 10.1074/jbc.M109.042127; Pardieu C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000843; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Pralle A, 1999, MICROSC RES TECHNIQ, V44, P378, DOI 10.1002/(SICI)1097-0029(19990301)44:5<378::AID-JEMT10>3.0.CO;2-Z; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Rong LW, 2009, J VIROL, V83, P7536, DOI 10.1128/JVI.00620-09; Ruiz A, 2010, VIROLOGY, V408, P89, DOI 10.1016/j.virol.2010.08.031; Schubert HL, 2010, P NATL ACAD SCI USA, V107, P17951, DOI 10.1073/pnas.1008206107; Swiecki M, 2011, J BIOL CHEM, V286, P2987, DOI 10.1074/jbc.M110.190538; Tischer C, 2001, APPL PHYS LETT, V79, P3878, DOI 10.1063/1.1423404; Tokarev Andrey, 2011, Cell Logist, V1, P90; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Vidal-Laliena M, 2005, CELL IMMUNOL, V236, P6, DOI 10.1016/j.cellimm.2005.08.002; Yang HT, 2010, P NATL ACAD SCI USA, V107, P18428, DOI 10.1073/pnas.1011485107	51	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75680	10.1371/journal.pone.0075680	http://dx.doi.org/10.1371/journal.pone.0075680			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086611	Green Published, gold			2022-12-27	WOS:000325025200059
J	Sharma, R; Lomash, S; Salunke, DM				Sharma, Raghava; Lomash, Suvendu; Salunke, Dinakar M.			Putative Bioactive Motif of Tritrpticin Revealed by an Antibody with Biological Receptor-Like Properties	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE INDOLICIDIN; PROLINE-RICH MOTIFS; RECOGNITION DOMAINS; AUTOMATED DOCKING; ANTIBACTERIAL; ANALOGS; BINDING; TRYPTOPHAN; MEMBRANE; PROTEIN	Antimicrobial peptides represent one of the most promising future strategies for combating infections and microbial drug resistance. Tritrpticin is a 13mer tryptophan-rich cationic antimicrobial peptide with a broad spectrum of activity whose application in antimicrobial therapy has been hampered by ambiguity about its biological target and consequently the molecular interactions necessary for its antimicrobial activity. The present study provides clues about the mechanism of action of tritripticin by using a unique monoclonal antibody (mAb) as a 'physiological' structural scaffold. A pool of mAbs were generated against tritrpticin and based on its high affinity and ability to bind tritrpticin analogs, mAb 6C6D7 was selected and characterized further. In a screening of phage displayed random peptides, this antibody was able to identify a novel antimicrobial peptide with low sequence homology to tritrpticin, suggesting that the mAb possessed the physico-chemical characteristics mimicking the natural receptor. Subsequently, thermodynamics and molecular modeling identified a core group of hydrophobic residues in tritrpticin arranged in a distorted's' shaped conformation as critical for antibody binding. Comparison of the mAb induced conformation with the micelle bound structure of tritrpticin reveals how a common motif may be able to interact with multiple classes of biomolecules thus extending the target range of this innate immune peptide. Based on the concurrence between thermodynamic and structural data our results reveal a template that can be used to design novel antimicrobial pharmacophores while simultaneously demonstrating at a more fundamental level the potential of mAbs to act as receptor surrogates.	[Sharma, Raghava; Lomash, Suvendu; Salunke, Dinakar M.] Natl Inst Immunol, New Delhi 110067, India; [Salunke, Dinakar M.] Reg Ctr Biotechnol, Gurgaon, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; Regional Centre for Biotechnology	Salunke, DM (corresponding author), Natl Inst Immunol, New Delhi 110067, India.	dinakar.salunke@gmail.com			Department of Biotechnology, Govt. of India	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro JC, 1998, IMMUNOGENETICS, V47, P355, DOI 10.1007/s002510050370; Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; BASS SH, 1991, P NATL ACAD SCI USA, V88, P4498, DOI 10.1073/pnas.88.10.4498; Bikker FJ, 2006, CHEM BIOL DRUG DES, V68, P148, DOI 10.1111/j.1747-0285.2006.00424.x; Boman HG, 1996, SCAND J IMMUNOL, V43, P475, DOI 10.1046/j.1365-3083.1996.d01-76.x; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Freund C., 2008, V186, P407, DOI 10.1007/978-3-540-72843-6_17; Gennaro R, 2000, BIOPOLYMERS, V55, P31, DOI 10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.3.CO;2-0; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Hilpert K, 2010, ANTIMICROB AGENTS CH, V54, P4480, DOI 10.1128/AAC.01664-09; Hsu CH, 2005, NUCLEIC ACIDS RES, V33, P4053, DOI 10.1093/nar/gki725; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Kaur KJ, 2008, PROTEIN SCI, V17, P545, DOI 10.1110/ps.073145008; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lawyer C, 1996, FEBS LETT, V390, P95, DOI 10.1016/0014-5793(96)00637-0; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Lomash S, 2010, J BIOL CHEM, V285, P35750, DOI 10.1074/jbc.M110.150516; Marchand C, 2006, NUCLEIC ACIDS RES, V34, P5157, DOI 10.1093/nar/gkl667; Mayer BJ, 2001, J CELL SCI, V114, P1253; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Nagpal S, 1999, J BIOL CHEM, V274, P23296, DOI 10.1074/jbc.274.33.23296; Nair DT, 2000, J IMMUNOL, V165, P6949, DOI 10.4049/jimmunol.165.12.6949; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Rozek A, 2000, BIOCHEMISTRY-US, V39, P15765, DOI 10.1021/bi000714m; Salay LC, 2004, FEBS LETT, V565, P171, DOI 10.1016/j.febslet.2004.03.093; Schibli DJ, 2006, BIOPHYS J, V91, P4413, DOI 10.1529/biophysj.106.085837; Schibli DJ, 1999, BIOCHEMISTRY-US, V38, P16749, DOI 10.1021/bi990701c; Scocchi M, 2011, CELL MOL LIFE SCI, V68, P2317, DOI 10.1007/s00018-011-0721-7; Sircar A, 2009, NUCLEIC ACIDS RES, V37, pW474, DOI 10.1093/nar/gkp387; Sitaram N, 2003, BIOCHEM BIOPH RES CO, V309, P879, DOI 10.1016/j.bbrc.2003.08.095; Sivasubramanian A, 2009, PROTEINS, V74, P497, DOI 10.1002/prot.22309; Sklute G, 2004, CHEM-EUR J, V10, P2159, DOI 10.1002/chem.200305034; Spiegel PC, 2001, BLOOD, V98, P13, DOI 10.1182/blood.V98.1.13; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Stura EA, 2002, ACTA CRYSTALLOGR D, V58, P1715, DOI 10.1107/S0907444902012829; Subbalakshmi C, 2000, BIOCHEM BIOPH RES CO, V274, P714, DOI 10.1006/bbrc.2000.3214; Xu JA, 1999, SCIENCE, V286, P2345, DOI 10.1126/science.286.5448.2345; Yang ST, 2003, FEBS LETT, V540, P229, DOI 10.1016/S0014-5793(03)00266-7; Yang ST, 2002, BIOCHEM BIOPH RES CO, V296, P1044, DOI 10.1016/S0006-291X(02)02048-X; Zarrinpar A, 2003, SCI STKE, V2003, pRE8; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhu WL, 2006, BIOCHEMISTRY-US, V45, P13007, DOI 10.1021/bi060487+	50	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75582	10.1371/journal.pone.0075582	http://dx.doi.org/10.1371/journal.pone.0075582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086578	Green Published, gold, Green Submitted			2022-12-27	WOS:000325025200052
J	Tsubaki, S; Sugimura, K; Teramoto, Y; Yonemori, K; Azuma, J				Tsubaki, Shuntaro; Sugimura, Kazuki; Teramoto, Yoshikuni; Yonemori, Keizo; Azuma, Jun-ichi			Cuticular Membrane of Fuyu Persimmon Fruit Is Strengthened by Triterpenoid Nano-Fillers	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; MECHANICAL-PROPERTIES; PLANT CUTICLES; RHEOLOGICAL PROPERTIES; CHEMICAL-COMPOSITION; GAS-CHROMATOGRAPHY; URSOLIC ACID; MAS NMR; CUTIN; BIOMECHANICS	The mechanical defensive performance of fruit cuticular membranes (CMs) is largely dependent on the molecular arrangement of their constituents. Here, we elucidated nano-sized interactions between cutin and triterpenoids in the cuticular matrix of Fuyu persimmon fruits (Diospyros kaki Thunb. cv. Fuyu), focusing on the mechanical properties using a combination of polymer analyses. The fruit CMs of Fuyu were primarily composed of wax (34.7%), which was predominantly triterpenoids followed by higher aliphatic compounds, and cutin (48.4%), primarily consisting of 9,10-epoxy-18-hydroxyoctadecanoic acid and 9,10,18-trihydroxyoctadecanoic acid. Based on the tensile tests of the CM, the removal of wax lead to a considerable decrease in the maximum stress and elastic modulus accompanied by an increase in the maximum strain, indicating that wax is of significant importance for maintaining the mechanical strength of the CM. Wide-angle X-ray diffraction and relaxation time measurements using solid-state C-13 nuclear magnetic resonance indicated that the triterpenoids in the cuticular matrix construct a nanocomposite at a mixing scale below 20-24 nm; however, the higher aliphatic compounds did not exhibit clear interactions with cutin. The results indicated that the triterpenoids in the cuticular matrix endow toughness to the CM by functioning as a nanofiller.	[Tsubaki, Shuntaro] Kochi Univ, Ctr Sci Res, Kochi 780, Japan; [Sugimura, Kazuki; Yonemori, Keizo] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto, Japan; [Teramoto, Yoshikuni] Gifu Univ, Fac Appl Biol Sci, Gifu, Japan; [Azuma, Jun-ichi] Osaka Univ, Grad Sch Engn, Suita, Osaka, Japan	Kochi University; Kyoto University; Gifu University; Osaka University	Tsubaki, S (corresponding author), Kochi Univ, Ctr Sci Res, Kochi 780, Japan.	stsubaki@kochi-u.ac.jp	Tsubaki, Shuntaro/W-9727-2019; TERAMOTO, Yoshikuni/A-1773-2013	Tsubaki, Shuntaro/0000-0002-9656-4470; TERAMOTO, Yoshikuni/0000-0003-3850-3570; Sugimura, Kazuki/0000-0003-2394-1420	Grant for Environmental Research Projects from the Sumitomo Foundation	Grant for Environmental Research Projects from the Sumitomo Foundation	This work was supported in part by Grant for Environmental Research Projects from the Sumitomo Foundation. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargel H, 2004, J PLANT GROWTH REGUL, V23, P61, DOI 10.1007/s00344-004-0036-0; Bargel H, 2005, J EXP BOT, V56, P1049, DOI 10.1093/jxb/eri098; Bargel H, 2006, FUNCT PLANT BIOL, V33, P893, DOI 10.1071/FP06139; BATAL K M, 1970, Hortscience, V5, P223; Belding RD, 1998, J AM SOC HORTIC SCI, V123, P348, DOI 10.21273/JASHS.123.3.348; BURNOUFRADOSEVICH M, 1985, PHYTOCHEMISTRY, V24, P2063, DOI 10.1016/S0031-9422(00)83122-2; Buschhaus C, 2007, NEW PHYTOL, V176, P311, DOI 10.1111/j.1469-8137.2007.02190.x; Buschhaus C, 2011, J EXP BOT, V62, P841, DOI 10.1093/jxb/erq366; Casado CG, 1999, J EXP BOT, V50, P175, DOI 10.1093/jexbot/50.331.175; Deshmukh AP, 2003, PHYTOCHEMISTRY, V64, P1163, DOI 10.1016/S0031-9422(03)00505-3; Dominguez E, 2011, PLANT SCI, V181, P77, DOI 10.1016/j.plantsci.2011.04.016; Dominguez E, 2011, NEW PHYTOL, V189, P938, DOI 10.1111/j.1469-8137.2010.03553.x; Dominguez E, 2009, FUNCT PLANT BIOL, V36, P613, DOI 10.1071/FP09039; Edelmann HG, 2005, J PLANT GROWTH REGUL, V24, P116, DOI 10.1007/s00344-004-0015-5; Fang XH, 2001, PHYTOCHEMISTRY, V57, P1035, DOI 10.1016/S0031-9422(01)00106-6; GARBOW JR, 1990, MACROMOLECULES, V23, P2814, DOI 10.1021/ma00212a037; Graca J, 2010, J AGR FOOD CHEM, V58, P9666, DOI 10.1021/jf1015297; Heredia A, 2003, BBA-GEN SUBJECTS, V1620, P1, DOI 10.1016/S0304-4165(02)00510-X; Holloway P. J., 1982, The plant cuticle, P45; Jarvinen R, 2011, J FOOD COMPOS ANAL, V24, P334, DOI 10.1016/j.jfca.2010.09.022; Jeffree C. E, 1996, PLANT CUTICLES INTEG, P33; Johnson EJ, 2007, COMMUN SOIL SCI PLAN, V38, P2461, DOI 10.1080/00103620701588841; Lopez-Casado G, 2007, J EXP BOT, V58, P3875, DOI 10.1093/jxb/erm233; LUQUE P, 1994, Z NATURFORSCH C, V49, P273; Matas AJ, 2005, AM J BOT, V92, P462, DOI 10.3732/ajb.92.3.462; Pereira SI, 2005, PHYTOCHEM ANALYSIS, V16, P364, DOI 10.1002/pca.859; PETRACEK PD, 1995, PLANT PHYSIOL, V109, P675, DOI 10.1104/pp.109.2.675; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; REYNHARDT EC, 1991, J PHYS D APPL PHYS, V24, P478, DOI 10.1088/0022-3727/24/3/036; Round AN, 2000, BIOPHYS J, V79, P2761, DOI 10.1016/S0006-3495(00)76515-5; Seebacher W, 2003, MAGN RESON CHEM, V41, P636, DOI 10.1002/mrc.1214; Stark RE, 2008, PHYTOCHEMISTRY, V69, P2689, DOI 10.1016/j.phytochem.2008.08.016; STEJSKAL EO, 1981, MACROMOLECULES, V14, P275, DOI 10.1021/ma50003a010; Szakiel A, 2012, PHYTOCHEM REV, V11, P263, DOI 10.1007/s11101-012-9241-9; Takahashi Y, 2012, PLANT CELL ENVIRON, V35, P1201, DOI 10.1111/j.1365-3040.2012.02482.x; Thuong PT, 2008, J NAT PROD, V71, P1775, DOI 10.1021/np800298w; Tian SY, 2008, J AGR FOOD CHEM, V56, P10318, DOI 10.1021/jf801028g; Tsubaki S, 2008, J AGR FOOD CHEM, V56, P11293, DOI 10.1021/jf802253s; Tsubaki S, 2012, FOOD CHEM, V132, P2135, DOI 10.1016/j.foodchem.2011.12.039; Tulloch A. P., 1976, CHEM BIOCH NATURAL W, P235; WALTON TJ, 1972, BIOCHEMISTRY-US, V11, P1885, DOI 10.1021/bi00760a025; Wiedemann P, 1998, BOT ACTA, V111, P28, DOI 10.1111/j.1438-8677.1998.tb00673.x; Yeats TH, 2012, NAT CHEM BIOL, V8, P609, DOI [10.1038/NCHEMBIO.960, 10.1038/nchembio.960]; Zhou CH, 2010, MOLECULES, V15, P6580, DOI 10.3390/molecules15096580; ZLOTNIKMAZORI T, 1988, MACROMOLECULES, V21, P2412, DOI 10.1021/ma00186a019	45	47	47	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75275	10.1371/journal.pone.0075275	http://dx.doi.org/10.1371/journal.pone.0075275			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086493	Green Published, gold, Green Submitted			2022-12-27	WOS:000325025200036
J	Hinojosa, CV; Galvan, MAL; Rodriguez, MT; Ortega, GL; Cervantes, MAC; Rodriguez, CAM; Cortes, PP; Mendez, LAM; Trejo, FJJ				Vela Hinojosa, Cristian; Leon Galvan, Miguel Angel; Tapia Rodriguez, Miguel; Lopez Ortega, Gerardo; Cerbon Cervantes, Marco Antonio; Mendoza Rodriguez, Carmen Adriana; Padilla Cortes, Patricia; Martinez Mendez, Luis Antonio; Jimenez Trejo, Francisco Javier			Differential Expression of Serotonin, Tryptophan Hydroxylase and Monoamine Oxidase A in the Mammary Gland of the Myotis velifer Bat	PLOS ONE			English	Article							REPRODUCTIVE-CYCLE; INHIBITION; LACTATION; BIOLOGY	The mammary gland has long drawn the attention of the scientific community due to the limited knowledge of some fundamental aspects involved in the control of its function. Myotis velifer, a microchiropteran species, provides an interesting model to study some of the regulatory factors involved in the control of the mammary gland cycle. Having an asynchronous, monoestrous reproductive pattern, female M. velifer bats undergo drastic morphological changes of the breast during the reproductive cycle. Current research on non-chiropteran mammals indicates that serotonin (5-HT) plays a major role in the intraluminal volume homeostasis of the mammary gland during lactation; however, an analysis of both the expression and localization of the main components of the serotonergic system in the bat mammary gland is lacking. Thus, the objectives of the present study were: to describe the gross and histological anatomy of the mammary gland of M. velifer to establish the lactation period for this species; to analyze the distribution and expression of the main serotonergic components in the mammary tissues of these bats under the physiological conditions of lactation, involution and the resting phase; and to provide information on the involvement of 5-HT in the regulation of the physiological function of this organ. To assess the expression and localization of serotonergic components, multiple immunofluorescence, Western blot and HPLC methods were used. 5-HT and the enzyme that catalyzes its synthesis (TPH) were located in both myoepithelial and luminal epithelial cells, while the enzyme responsible for the catabolism of this neurohormone (MAO A) was found in luminal epithelial cells as well as in secreted products. We also found an increased expression of serotonergic components during lactation, indicating that elements of the serotonergic system may play an important role in lactation in this species of bat in a way similar to that of other mammal species.	[Vela Hinojosa, Cristian; Cerbon Cervantes, Marco Antonio; Mendoza Rodriguez, Carmen Adriana; Jimenez Trejo, Francisco Javier] Univ Nacl Autonoma Mexico, Fac Chem, Mexico City 04510, DF, Mexico; [Leon Galvan, Miguel Angel; Lopez Ortega, Gerardo; Martinez Mendez, Luis Antonio] Univ Autonoma Metropolitana Iztapalapa, Dept Biol, Mexico City 09340, DF, Mexico; [Leon Galvan, Miguel Angel; Padilla Cortes, Patricia] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Microscopy Unit, Mexico City 04510, DF, Mexico; [Tapia Rodriguez, Miguel; Padilla Cortes, Patricia] Univ Nacl Autonoma Mexico, Inst Invest Biomed, HPLC Unit, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Autonoma Metropolitana - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Trejo, FJJ (corresponding author), Univ Nacl Autonoma Mexico, Fac Chem, Mexico City 04510, DF, Mexico.	trejofj@hotmail.com		Mendoza-Rodriguez, C. Adriana/0000-0002-7004-6712; Tapia-Rodriguez, Miguel/0000-0002-2248-6596	CONACYT, Mexico City, Mexico [80338, PAPIIT IN210412, PAIP 4194-08]; Universidad Nacional Autonoma de Mexico; Universidad Autonoma Metropolitana-Iztapalapa	CONACYT, Mexico City, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Universidad Autonoma Metropolitana-Iztapalapa	This work was supported by financial grants from CONACYT Number: 80338; PAPIIT IN210412; PAIP 4194-08, Mexico City, Mexico. The authors would also like to thank Universidad Nacional Autonoma de Mexico and Universidad Autonoma Metropolitana-Iztapalapa for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen H, 1880, P ACAD NAT SCI PHILA, V32, P133; Anthony E.L.P., 1988, P47; Barbour R.W., 1969, BATS AM; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Cabrera V, 2009, NEUROSCI LETT, V461, P136, DOI 10.1016/j.neulet.2009.06.017; DAVIS RB, 1962, ECOL MONOGR, V32, P311, DOI 10.2307/1942378; Evarts JL, 2004, BIOL REPROD, V70, P1573, DOI 10.1095/biolreprod.103.022988; FITCH J H, 1981, Mammalian Species, P1, DOI 10.2307/3504035; FRANCIS CM, 1994, NATURE, V367, P691, DOI 10.1038/367691a0; Gleiman D, 2003, GRZIMEKS ANIMAL LIFE; Haaksma CJ, 2011, BIOL REPROD, V85, P13, DOI 10.1095/biolreprod.110.090639; HARVEY M. J., 2011, BATS US CANADA; Hayward B. J., 1970, W NEW MEXICO U RES S, V1, P1; HEIDEMAN PD, 1988, J ZOOL, V215, P577, DOI 10.1111/j.1469-7998.1988.tb02396.x; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; IUCN, 2008, 2008 IUCN RED LIST T; Jimenez-Trejo F, 2007, J ANDROL, V28, P136, DOI 10.2164/jandrol.106.000653; Jimenez-Trejo F, 2013, J EXP ZOOL PART A, V319A, P249, DOI 10.1002/jez.1789; Jimenez-Trejo F, 2012, REPRODUCTION, V144, P677, DOI 10.1530/REP-12-0145; JOHANSEN PA, 1991, BIOCHEM PHARMACOL, V41, P625, DOI 10.1016/0006-2952(91)90636-J; Kortner G, 2000, CHRONOBIOL INT, V17, P103, DOI 10.1081/CBI-100101036; Krutzsch PH, 2009, ACTA CHIROPTEROL, V11, P89, DOI 10.3161/150811009X465712; Kunz TH, 1996, J TROP ECOL, V12, P121, DOI 10.1017/S0266467400009342; KUNZ TH, 1982, J MAMMAL, V63, P23, DOI 10.2307/1380667; Kunz TH, 2000, REPROD BIOL BATS; Laporta J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057847; LAWRENCE RA, 1999, BREASTFEEDING GUIDE; Leon-Galvan MA, 2005, SOUTHWEST NAT, V50, P453, DOI 10.1894/0038-4909(2005)050[0453:MRCOMB]2.0.CO;2; Marshall AM, 2010, J CLIN ENDOCR METAB, V95, P837, DOI 10.1210/jc.2009-1575; Mateos A, 1995, THESIS U CASTILLA LA; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; Mejia JM, 2002, BIOL PSYCHIAT, V52, P811, DOI 10.1016/S0006-3223(02)01418-X; Mepham TB, 1986, PHYSL LACTATION; Neuweiler G., 2000, BIOL BATS; Nowak RM, 1994, WALKERS BATS WORLD; Pai VP, 2008, J BIOL CHEM, V283, P30901, DOI 10.1074/jbc.M802476200; Secretaria del Medio Ambiente y Recursos Naturales (SEMARNAT), 2010, NOM059ECOL2010 SEMAR; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Stull MA, 2007, P NATL ACAD SCI USA, V104, P16708, DOI 10.1073/pnas.0708136104; Vaibhav PP, 2011, COMMUN INTEGR BIOL, V4, P532; Villa RB, 1967, MURCIELAGOS MEXICO I; Watson CJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1401; Whitaker-Azmitia PM, 1999, NEUROPSYCHOPHARMACOL, V21, pS2, DOI 10.1016/S0893-133X(99)00031-7; WILSON D. E., 1996, MEASURING MONITORING	44	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75062	10.1371/journal.pone.0075062	http://dx.doi.org/10.1371/journal.pone.0075062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086437	Green Submitted, Green Published, gold			2022-12-27	WOS:000325025200021
J	Wu, J; Kong, XY; Shi, C; Gu, YQ; Jin, CY; Gao, LZ; Jia, JZ				Wu, Jing; Kong, Xiuying; Shi, Chao; Gu, Yongqiang; Jin, Cuiyun; Gao, Lizhi; Jia, Jizeng			Dynamic Evolution of Rht-1 Homologous Regions in Grass Genomes	PLOS ONE			English	Article							ORYZA-SATIVA; BRACHYPODIUM-DISTACHYON; DRAFT SEQUENCE; WHEAT; GENE; LOCUS; MODEL; RICE; TRITICUM; COMPLEX	Hexaploid bread wheat contains A, B, and D three subgenomes with its well-characterized ancestral genomes existed at diploid and tetraploid levels, making the wheat act as a good model species for studying evolutionary genomic dynamics. Here, we performed intra- and inter-species comparative analyses of wheat and related grass genomes to examine the dynamics of homologous regions surrounding Rht-1, a well-known "green revolution" gene. Our results showed that the divergence of the two A genomes in the Rht-1 region from the diploid and tetraploid species is greater than that from the tetraploid and hexaploid wheat. The divergence of D genome between diploid and hexaploid is lower than those of A genome, suggesting that D genome diverged latter than others. The divergence among the A, B and D subgenomes was larger than that among different ploidy levels for each subgenome which mainly resulted from genomic structural variation of insertions and, perhaps deletions, of the repetitive sequences. Meanwhile, the repetitive sequences caused genome expansion further after the divergence of the three subgenomes. However, several conserved non-coding sequences were identified to be shared among the three subgenomes of wheat, suggesting that they may have played an important role to maintain the homolog of three subgenomes. This is a pilot study on evolutionary dynamics across the wheat ploids, subgenomes and differently related grasses. Our results gained new insights into evolutionary dynamics of Rht-1 region at sequence level as well as the evolution of wheat during the plolyploidization process.	[Wu, Jing; Kong, Xiuying; Jin, Cuiyun; Jia, Jizeng] Chinese Acad Agr Sci, Key Lab Crop Germplasm Resources & Utilizat, Natl Key Facil Crop Gene Resources & Genet Improv, Minist Agr,Inst Crop Sci, Beijing 100193, Peoples R China; [Shi, Chao; Gao, Lizhi] Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species Southwest China, Kunming, Peoples R China; [Gu, Yongqiang] ARS, USDA, Western Reg Res Ctr, Albany, CA USA	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; United States Department of Agriculture (USDA)	Gao, LZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species Southwest China, Kunming, Peoples R China.	Lgao@mail.kib.ac.cn; Jiajizeng@caas.cn			863 project from Ministry of Science and Technology of China [2011AA100104]; Key Project of Natural Science Foundation of Yunnan Province [2008CC016]; Talents Program of Yunnan Province [20080A009]; Hundreds Talents Program of the Chinese Academy of Sciences (CAS); Chinese Academy of Science [KSCX2-YW-N-029]; Chinese Department of Science and Technology (973 Program) [2007CB815703]; Kunming Institute of Botany, CAS	863 project from Ministry of Science and Technology of China(National High Technology Research and Development Program of China); Key Project of Natural Science Foundation of Yunnan Province; Talents Program of Yunnan Province; Hundreds Talents Program of the Chinese Academy of Sciences (CAS); Chinese Academy of Science(Chinese Academy of Sciences); Chinese Department of Science and Technology (973 Program); Kunming Institute of Botany, CAS(Chinese Academy of Sciences)	The research was funded by 863 project (2011AA100104) from Ministry of Science and Technology of China, Key Project of Natural Science Foundation of Yunnan Province (2008CC016), Talents Program of Yunnan Province (20080A009), the Hundreds Talents Program of the Chinese Academy of Sciences (CAS), a grant from the Chinese Academy of Science (KSCX2-YW-N-029), a grant from Chinese Department of Science and Technology (973 Program 2007CB815703), and a start-up grant from Kunming Institute of Botany, CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson O. D., 2003, Functional & Integrative Genomics, V3, P56; Bartos J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-155; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Carretero-Paulet L, 2012, MOL BIOL EVOL, V29, P3541, DOI 10.1093/molbev/mss162; Chalupska D, 2008, P NATL ACAD SCI USA, V105, P9691, DOI 10.1073/pnas.0803981105; Chantret N, 2005, PLANT CELL, V17, P1033, DOI 10.1105/tpc.104.029181; Duan JL, 2012, FUNCT INTEGR GENOMIC, V12, P489, DOI 10.1007/s10142-012-0283-2; Dubchak Inna, 2007, V395, P3; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gu YQ, 2003, GENOME, V46, P1084, DOI [10.1139/g03-071, 10.1139/G03-071]; Gupta P K, 2008, Int J Plant Genomics, V2008, P896451, DOI 10.1155/2008/896451; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Huo NX, 2006, GENOME, V49, P1099, DOI 10.1139/G06-087; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kroymann J, 2003, P NATL ACAD SCI USA, V100, P14587, DOI 10.1073/pnas.1734046100; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Li W. H, 1997, MOL EVOLUTION; Li YY, 2012, NEW PHYTOL, V196, P282, DOI 10.1111/j.1469-8137.2012.04243.x; Massa AN, 2011, MOL BIOL EVOL, V28, P2537, DOI 10.1093/molbev/msr080; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pearce S, 2011, PLANT PHYSIOL, V157, P1820, DOI 10.1104/pp.111.183657; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Uchida N, 2007, P NATL ACAD SCI USA, V104, P15953, DOI 10.1073/pnas.0707577104; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629; Wu J, 2011, PLANT PHYSIOL, V157, P2120, DOI 10.1104/pp.111.185272; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zheng WX, 2008, J BIOMOL STRUCT DYN, V26, P1; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	40	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75544	10.1371/journal.pone.0075544	http://dx.doi.org/10.1371/journal.pone.0075544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086561	Green Published, Green Submitted, gold			2022-12-27	WOS:000325025200047
J	Brookes, ZLS; Stedman, EN; Brown, NJ; Hebbes, CP; Guerrini, R; Calo, G; Reilly, CS; Lambert, DG				Brookes, Zoe L. S.; Stedman, Emily N.; Brown, Nicola J.; Hebbes, Christopher P.; Guerrini, Remo; Calo, Girolamo; Reilly, Charles S.; Lambert, David G.			The Nociceptin/Orphanin FQ Receptor Antagonist UFP-101 Reduces Microvascular Inflammation to Lipopolysaccharide In Vivo	PLOS ONE			English	Article							RECOMBINANT HUMAN; PEPTIDE; EXPRESSION; RESPONSES; CELLS; BRADYCARDIA; HYPOTENSION; LYMPHATICS; DIURESIS; BINDING	Microvascular inflammation occurs during sepsis and the endogenous opioid-like peptide nociceptin/orphanin FQ (N/OFQ) is known to regulate inflammation. This study aimed to determine the inflammatory role of N/OFQ and its receptor NOP (ORL1) within the microcirculation, along with anti-inflammatory effects of the NOP antagonist UFP-101 (University of Ferrara Peptide-101) in an animal model of sepsis (endotoxemia). Male Wistar rats (220 to 300 g) were administered lipopolysaccharide (LPS) for 24 h (-24 h, 1 mg kg(-1); -2 h, 1 mg kg(-1) i.v., tail vein). They were then either anesthetised for observation of the mesenteric microcirculation using fluorescent in vivo microscopy, or isolated arterioles (similar to 200 mu m) were studied in vitro with pressure myography. 200 nM kg(-1) fluorescently labelled N/OFQ (FITC-N/OFQ, i.a., mesenteric artery) bound to specific sites on the microvascular endothelium in vivo, indicating sparse distribution of NOP receptors. In vitro, arterioles (similar to 200 mu m) dilated to intraluminal N/OFQ (10(-5)M) (32.6 +/- 8.4%) and this response was exaggerated with LPS (62.0 +/- 7.9%, p=0.031). In vivo, LPS induced macromolecular leak of FITC-BSA (0.02 g kg(-1) i.v.) (LPS: 95.3 (86.7 to 97.9)%, p=0.043) from post-capillary venules (<40 mu m) and increased leukocyte rolling as endotoxemia progressed (p=0.027), both being reduced by 150 nmol kg(-1) UFP-101 (i. v., jugular vein). Firstly, the rat mesenteric microcirculation expresses NOP receptors and secondly, NOP function (ability to induce dilation) is enhanced with LPS. UFP-101 also reduced microvascular inflammation to endotoxemia in vivo. Hence inhibition of the microvascular N/OFQ-NOP pathway may have therapeutic potential during sepsis and warrants further investigation.	[Brookes, Zoe L. S.; Stedman, Emily N.; Brown, Nicola J.; Reilly, Charles S.] Univ Sheffield, Microcirculat Res Grp, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Hebbes, Christopher P.; Lambert, David G.] Univ Leicester, Leicester Royal Infirm, Dept Cardiovasc Sci, Div Anaesthesia Crit Care & Pain Management, Leicester, Leics, England; [Guerrini, Remo; Calo, Girolamo] Univ Ferrara, Dept Pharmaceut Sci, I-44100 Ferrara, Italy; [Guerrini, Remo; Calo, Girolamo] Univ Ferrara, Ctr Biotechnol, I-44100 Ferrara, Italy; [Calo, Girolamo] Univ Ferrara, Pharmacol Sect, Dept Expt & Clin Med, I-44100 Ferrara, Italy; [Calo, Girolamo] Italian Inst Neurosci, Ferrara, Italy	University of Sheffield; University of Leicester; University of Ferrara; University of Ferrara; University of Ferrara	Lambert, DG (corresponding author), Univ Leicester, Leicester Royal Infirm, Dept Cardiovasc Sci, Div Anaesthesia Crit Care & Pain Management, Leicester, Leics, England.	dgl3@leicester.ac.uk	; Hebbes, Christopher/J-7683-2015	Guerrini, Remo/0000-0002-7619-0918; Brown, Nicola/0000-0002-2100-1905; Lambert, David/0000-0003-4769-8090; Hebbes, Christopher/0000-0002-2816-714X; Brookes, Zoe/0000-0002-8096-6256	British Journal of Anaesthesia project grant; Anaesthetic Research Society	British Journal of Anaesthesia project grant; Anaesthetic Research Society	This work was funded by a British Journal of Anaesthesia project grant and Emily Stedman was the recipient of an Anaesthetic Research Society summer studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta C, 2008, J NEUROSCI RES, V86, P1077, DOI 10.1002/jnr.21565; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Brookes ZLS, 2005, J PHYSIOL-LONDON, V565, P269, DOI 10.1113/jphysiol.2005.083147; Brookes ZLS, 2003, AM J PHYSIOL-REG I, V284, pR1604, DOI 10.1152/ajpregu.00411.2002; Brookes ZLS, 2007, AM J PHYSIOL-HEART C, V293, pH2977, DOI 10.1152/ajpheart.00448.2007; Brookes Zoe L. S., 2009, Lymphatic Research and Biology, V7, P131, DOI 10.1089/lrb.2008.1019; Burmeister MA, 2008, J PHARMACOL EXP THER, V326, P897, DOI 10.1124/jpet.107.135905; Burmeister MA, 2007, J PHARMACOL EXP THER, V322, P324, DOI 10.1124/jpet.107.120394; BYCROFT BW, 1993, J CHEM SOC CHEM COMM, P778, DOI 10.1039/c39930000778; Calo G, 2005, CNS DRUG REV, V11, P97; Calo G, 2002, BRIT J PHARMACOL, V136, P303, DOI 10.1038/sj.bjp.0704706; Carvalho D, 2008, INTENS CARE MED, V34, P2284, DOI 10.1007/s00134-008-1313-3; Champion HC, 1998, REGUL PEPTIDES, V78, P69, DOI 10.1016/S0167-0115(98)00117-7; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; GARDINER SM, 1995, BRIT J PHARMACOL, V116, P2005, DOI 10.1111/j.1476-5381.1995.tb16405.x; Granata F, 2003, EUR J PHARMACOL, V482, P17, DOI 10.1016/j.ejphar.2003.09.049; Guerrini R, 1997, J MED CHEM, V40, P1789, DOI 10.1021/jm970011b; Hashiba E, 2003, N-S ARCH PHARMACOL, V367, P342, DOI 10.1007/s00210-003-0704-9; Hashiba E, 2002, NEUROSCI LETT, V328, P5, DOI 10.1016/S0304-3940(02)00259-8; HEBERT MT, 1988, J PHYSIOL-LONDON, V400, P29, DOI 10.1113/jphysiol.1988.sp017108; Ibba M, 2008, N-S ARCH PHARMACOL, V378, P553, DOI 10.1007/s00210-008-0350-3; Kapusta DR, 1999, AM J PHYSIOL-REG I, V277, pR987, DOI 10.1152/ajpregu.1999.277.4.R987; Kitayama M, 2003, N-S ARCH PHARMACOL, V368, P528, DOI 10.1007/s00210-003-0821-5; Krowicki ZK, 2006, J PHARMACOL EXP THER, V317, P446, DOI 10.1124/jpet.105.094441; Lambert DG, 2008, NAT REV DRUG DISCOV, V7, P694, DOI 10.1038/nrd2572; Leggett JD, 2009, J NEUROENDOCRINOL, V21, P888, DOI 10.1111/j.1365-2826.2009.01912.x; Madeddu P, 1999, HYPERTENSION, V33, P914, DOI 10.1161/01.HYP.33.3.914; McDonald J, 2003, BRIT J PHARMACOL, V140, P61, DOI 10.1038/sj.bjp.0705401; McGown CC, 2010, BRIT J ANAESTH, V104, P183, DOI 10.1093/bja/aep361; Miller TR, 2007, PEPTIDES, V28, P2243, DOI 10.1016/j.peptides.2007.09.004; Niwa H, 2012, BRIT J ANAESTH, V108, P530, DOI 10.1093/bja/aes015; REED MWR, 1988, J SURG RES, V45, P452, DOI 10.1016/0022-4804(88)90195-3; Serrano-Gomez A, 2011, BRIT J ANAESTH, V106, P6, DOI 10.1093/bja/aeq337; Williams JP, 2008, ANESTH ANALG, V106, P865, DOI 10.1213/ane.0b013e3181617646; Williams JP, 2007, ANESTH ANALG, V105, P998, DOI 10.1213/01.ane.0000278865.11991.9d; Williams JP, 2010, BRIT J ANAESTH, V100, P810	36	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74943	10.1371/journal.pone.0074943	http://dx.doi.org/10.1371/journal.pone.0074943			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086402	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000326520200057
J	Deeni, YY; Ibbotson, SH; Woods, JA; Wolf, CR; Smith, G				Deeni, Yusuf Y.; Ibbotson, Sally H.; Woods, Julie A.; Wolf, C. Roland; Smith, Gillian			Cytochrome P450 CYP1B1 Interacts with 8-Methoxypsoralen (8-MOP) and Influences Psoralen-Ultraviolet A (PUVA) Sensitivity	PLOS ONE			English	Article							MECHANISM-BASED INACTIVATION; LIVER-MICROSOMES; GRAPEFRUIT JUICE; PLUS ULTRAVIOLET; FURANOCOUMARINS; POLYMORPHISMS; METABOLISM; PSORIASIS; 2A6; OXIDOREDUCTASE	Background: There are unpredictable inter-individual differences in sensitivity to psoralen-UVA (PUVA) photochemotherapy, used to treat skin diseases including psoriasis. Psoralens are metabolised by cytochrome P450 enzymes (P450), and we hypothesised that variability in cutaneous P450 expression may influence PUVA sensitivity. We previously showed that P450 CYP1B1 was abundantly expressed in human skin and regulated by PUVA, and described marked inter-individual differences in cutaneous CYP1B1 expression. Objectives: We investigated whether CYP1B1 made a significant contribution to 8-methoxypsoralen (8-MOP) metabolism, and whether individuality in CYP1B1 activity influenced PUVA sensitivity. Methods: We used E. coli membranes co-expressing various P450s and cytochrome P450 reductase (CPR) to study 8-MOP metabolism and cytotoxicity assays in CYP1B1-expressing mammalian cells to assess PUVA sensitivity. Results: We showed that P450s CYP1A1, CYP1A2, CYP1B1, CYP2A6 and CYP2E1 influence 8-MOP metabolism. As CYP1B1 is the most abundant P450 in human skin, we further demonstrated that: (i) CYP1B1 interacts with 8-MOP (ii) metabolism of the CYP1B1 substrates 7-ethoxyresorufin and 17-beta-estradiol showed concentration-dependent inhibition by 8-MOP and (iii) inhibition of 7-ethoxyresorufin metabolism by 8-MOP was influenced by CYP1B1 genotype. The influence of CYP1B1 on PUVA cytotoxicity was further investigated in a Chinese hamster ovary cell line, stably expressing CYP1B1 and CPR, which was more sensitive to PUVA than control cells, suggesting that CYP1B1 metabolises 8-MOP to a more phototoxic metabolite(s). Conclusion: Our data therefore suggest that CYP1B1 significantly contributes to cutaneous 8-MOP metabolism, and that individuality in CYP1B1 expression may influence PUVA sensitivity.	[Deeni, Yusuf Y.; Wolf, C. Roland; Smith, Gillian] Univ Dundee, Med Res Inst, Div Canc Res, Dundee, Scotland; [Ibbotson, Sally H.; Woods, Julie A.] Univ Dundee, Photobiol Unit, Dundee, Scotland; [Wolf, C. Roland] Univ Dundee, Ninewells Hosp & Med Sch, Canc Res UK Mol Pharmacol Unit, Dundee DD1 9SY, Scotland; [Deeni, Yusuf Y.] Univ Abertay Dundee, Sch Contemporary Sci, Dundee, Scotland	University of Dundee; University of Dundee; University of Dundee; University of Abertay Dundee	Smith, G (corresponding author), Univ Dundee, Med Res Inst, Div Canc Res, Dundee, Scotland.	g.smith@dundee.ac.uk	Ibbotson, Sally H/H-7061-2019	Ibbotson, Sally H/0000-0001-5685-752X; Deeni, Yusuf Y./0000-0002-8529-7469; Wolf, Charles Roland/0000-0002-6969-0113; Smith, Gillian/0000-0001-9288-7566	Medical Research Council [G0000281]; Cancer Research UK [10822] Funding Source: researchfish; MRC [G0000281] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors gratefully acknowledge funding from the Medical Research Council (Project Grant reference G0000281). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2004, J INVEST DERMATOL, V123, P417, DOI 10.1111/j.0022-202X.2004.23307.x; Bandiera S, 2005, MOL PHARMACOL, V67, P435, DOI 10.1124/mol.104.006056; BURKE MD, 1985, BIOCHEM PHARMACOL, V34, P3337, DOI 10.1016/0006-2952(85)90355-7; Chen Q, 2011, CURR DRUG METAB, V12, P436, DOI 10.2174/138920011795495259; Deeni YY, 2001, ARCH BIOCHEM BIOPHYS, V396, P16, DOI 10.1006/abbi.2001.2585; DEWOLFF FA, 1986, CLIN PHARMACOKINET, V11, P62, DOI 10.2165/00003088-198611010-00004; Ding S, 2001, BIOCHEM J, V356, P613, DOI 10.1042/0264-6021:3560613; GASPARRO FP, 1988, J INVEST DERMATOL, V90, P234, DOI 10.1111/1523-1747.ep12462304; Girennavar B, 2006, BIOORGAN MED CHEM, V14, P2606, DOI 10.1016/j.bmc.2005.11.039; GOLDSTEIN DP, 1982, J INVEST DERMATOL, V78, P429, DOI 10.1111/1523-1747.ep12507768; Goto T, 2010, DRUG METAB DISPOS, V38, P2110, DOI 10.1124/dmd.110.034553; Guengerich F Peter, 2003, Mol Interv, V3, P194, DOI 10.1124/mi.3.4.194; Guo LQ, 2004, ACTA PHARMACOL SIN, V25, P129; Ibbotson SH, 2012, BRIT J DERMATOL, V166, P380, DOI 10.1111/j.1365-2133.2011.10661.x; Inzinger M, 2011, BRIT J DERMATOL, V165, P640, DOI 10.1111/j.1365-2133.2011.10396.x; Kang AY, 2011, PROTEIN J, V30, P447, DOI 10.1007/s10930-011-9350-0; Kharasch ED, 2000, DRUG METAB DISPOS, V28, P28; Kleiner HE, 2002, CHEM RES TOXICOL, V15, P226, DOI 10.1021/tx010151v; Koenigs LL, 1998, BIOCHEMISTRY-US, V37, P13184, DOI 10.1021/bi981198r; Koenigs LL, 1998, BIOCHEMISTRY-US, V37, P10047, DOI 10.1021/bi980003c; Li DN, 2000, PHARMACOGENETICS, V10, P343, DOI 10.1097/00008571-200006000-00008; Li W, 2004, INSECT MOL BIOL, V13, P603, DOI 10.1111/j.0962-1075.2004.00518.x; Mammen JS, 2005, PHARMACOGENET GENOM, V15, P183, DOI 10.1097/01213011-200503000-00007; MARRAKCHI S, 1991, PHOTODERMATOL PHOTO, V8, P206; MAYS DC, 1987, DRUG METAB DISPOS, V15, P318; MCLELLAND J, 1991, BRIT J DERMATOL, V124, P585, DOI 10.1111/j.1365-2133.1991.tb04956.x; McNeilly AD, 2012, DRUG METAB DISPOS, V40, P283, DOI 10.1124/dmd.111.042085; Mukhtar H, 1996, PHOTOCHEM PHOTOBIOL, V63, P355, DOI 10.1111/j.1751-1097.1996.tb03040.x; Nebert DW, 2000, CLIN CHEM LAB MED, V38, P857, DOI 10.1515/CCLM.2000.124; NORRIS PG, 1994, BRIT J DERMATOL, V130, P246; Obach RS, 2002, DRUG METAB DISPOS, V30, P831, DOI 10.1124/dmd.30.7.831; OMURA T, 1964, J BIOL CHEM, V239, P2370; PAPADOPOULO D, 1985, MUTAT RES, V151, P281, DOI 10.1016/0027-5107(85)90081-8; Patel RV, 2009, J AM ACAD DERMATOL, V60, P1001, DOI 10.1016/j.jaad.2008.12.031; Shimada T, 1999, CARCINOGENESIS, V20, P1607, DOI 10.1093/carcin/20.8.1607; Smith G, 2003, J INVEST DERMATOL, V121, P390, DOI 10.1046/j.1523-1747.2003.12354.x; Smith G, 2003, LANCET, V361, P1336, DOI 10.1016/S0140-6736(03)13081-4; SMITH GCM, 1994, P NATL ACAD SCI USA, V91, P8710, DOI 10.1073/pnas.91.18.8710; STERN RS, 1994, CANCER-AM CANCER SOC, V73, P2759, DOI 10.1002/1097-0142(19940601)73:11<2759::AID-CNCR2820731118>3.0.CO;2-C; Tantcheva-Poor I, 2001, BRIT J DERMATOL, V144, P1127, DOI 10.1046/j.1365-2133.2001.04233.x; TRIGLIA D, 1991, IN VITRO CELL DEV B, V27, P239; Ueng YF, 2011, BRIT J PHARMACOL, V163, P1250, DOI 10.1111/j.1476-5381.2011.01341.x; von Weymarn LB, 2006, CARCINOGENESIS, V27, P782, DOI 10.1093/carcin/bgi301; Wen ZM, 2003, INSECT BIOCHEM MOLEC, V33, P937, DOI 10.1016/S0965-1748(03)00100-0; Wolf CR, 1999, BRIT MED BULL, V55, P366, DOI 10.1258/0007142991902439	45	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75494	10.1371/journal.pone.0075494	http://dx.doi.org/10.1371/journal.pone.0075494			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086543	Green Submitted, Green Published, gold			2022-12-27	WOS:000326520200105
J	Ounap, K; Kasper, L; Kurg, A; Kurg, R				Ounap, Kadri; Kaesper, Ly; Kurg, Ants; Kurg, Reet			The Human WBSCR22 Protein Is Involved in the Biogenesis of the 40S Ribosomal Subunits in Mammalian Cells	PLOS ONE			English	Article							NUCLEAR EXPORT; RNA; BYSTIN; YEAST; PRECURSORS; STEPS	The human WBSCR22 protein was previously shown to be up-regulated in invasive breast cancer and its ectopic expression enhances tumor cell survival in the vasculature. In the current study, we show that the WBSCR22 protein is important for cell growth. Knock-down of WBSCR22 with siRNA results in slower growth of WBSCR22-depleted cells. Treatment with siWBSCR22 causes defects in the processing of pre-rRNAs and reduces the level of free 40S ribosomal subunit, suggesting that WBSCR22 is involved in ribosome small subunit biosynthesis. The human WBSCR22 partially complements the growth of WBSCR22 yeast homologue, bud23 deletion mutant suggesting that the human WBSCR22 is a functional homologue of yeast Bud23. WBSCR22 is localized throughout the cell nucleus and is not stably associated with ribosomal subunits within the cell nucleus. We also show that the WBSCR22 protein level is decreased in lymphoblastoid cell lines derived from William-Beuren Syndrome (WBS) patients compared to healthy controls. Our data suggest that the WBSCR22 protein is a ribosome biogenesis factor involved in the biosynthesis of 40S ribosomal particles in mammalian cells.	[Ounap, Kadri; Kaesper, Ly; Kurg, Reet] Univ Tartu, Inst Technol, Ctr Biomed Technol, EE-50090 Tartu, Estonia; [Kurg, Ants] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia	University of Tartu; University of Tartu	Kurg, R (corresponding author), Univ Tartu, Inst Technol, Ctr Biomed Technol, Ulikooli 18, EE-50090 Tartu, Estonia.	reet.kurg@ut.ee	Kurg, Ants/J-2616-2015; Kurg, Reet/J-2829-2015; Kurg, Ants/AAM-1292-2020	Kurg, Reet/0000-0001-7188-9693; Kurg, Ants/0000-0002-0829-1987; Ounap, Kadri/0000-0001-7397-3231	Estonian Ministry of Education and Research [SF0180175, SF0180027s10]; European Regional Development Fund through the Center of Excellence in Chemical Biology	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Regional Development Fund through the Center of Excellence in Chemical Biology(European Commission)	This work was supported by research programmes (SF0180175; SF0180027s10) from Estonian Ministry of Education and Research; and by the European Regional Development Fund through the Center of Excellence in Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert M, 2010, SEMIN CELL DEV BIOL, V21, P209, DOI 10.1016/j.semcdb.2009.10.007; Belin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007147; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Carron C, 2011, NUCLEIC ACIDS RES, V39, P280, DOI 10.1093/nar/gkq734; Figaro S, MOL CELL BIOL; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Henrichsen CN, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001054; LAFONTAINE D, 1995, GENE DEV, V9, P2470, DOI 10.1101/gad.9.20.2470; Lafontaine DLJ, 1998, MOL CELL BIOL, V18, P2360, DOI 10.1128/MCB.18.4.2360; Leulliot N, 2008, NUCLEIC ACIDS RES, V36, P629, DOI 10.1093/nar/gkm1074; Li Z, 2009, PLOS BIOL, V10; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Miyoshi M, 2007, BIOCHEM J, V404, P373, DOI 10.1042/BJ20061597; Nakazawa Y, 2011, CANCER RES, V71, P1146, DOI 10.1158/0008-5472.CAN-10-2695; Ohbayashi I, 2011, PLANT J, V67, P49, DOI 10.1111/j.1365-313X.2011.04574.x; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Rouquette J, 2005, EMBO J, V24, P2862, DOI 10.1038/sj.emboj.7600752; Saijou E, 2004, NUCLEIC ACIDS RES, V32, P1028, DOI 10.1093/nar/gkh264; Sardana R, 2012, MOL BIOL CELL, V23, P4313, DOI 10.1091/mbc.E12-05-0370; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Scherer SW, 2006, GENOMIC DISORDERS: THE GENOMIC BASIS OF DISEASE, P221, DOI 10.1007/978-1-59745-039-3_15; Schubert C, 2009, CELL MOL LIFE SCI, V66, P1178, DOI 10.1007/s00018-008-8401-y; Tiedemann R, 2012, CANC RES IN PRESS; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Wang HZ, 2009, CELL RES, V19, P1150, DOI 10.1038/cr.2009.99; White J, 2008, MOL CELL BIOL, V28, P3151, DOI 10.1128/MCB.01674-07; Wild T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000522; Zemp I, 2009, J CELL BIOL, V185, P1167, DOI 10.1083/jcb.200904048	30	38	39	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75686	10.1371/journal.pone.0075686	http://dx.doi.org/10.1371/journal.pone.0075686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086612	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200118
J	Pisula, E; Kawa, R; Szostakiewicz, L; Lucka, I; Kawa, M; Rynkiewicz, A				Pisula, Ewa; Kawa, Rafal; Szostakiewicz, Lukasz; Lucka, Izabela; Kawa, Magdalena; Rynkiewicz, Agnieszka			Autistic Traits in Male and Female Students and Individuals with High Functioning Autism Spectrum Disorders Measured by the Polish Version of the Autism-Spectrum Quotient	PLOS ONE			English	Article							GENERAL-POPULATION; EMPATHY QUOTIENT; AQ; PHENOTYPE; CHILDREN; ADULTS; RELIABILITY; VALIDITY; PARENTS	So far no standardized screening instrument for autism spectrum disorders for adults has been developed in Poland. The main aim of the study was to explore the properties of the Polish version of the Autism-Spectrum Quotient (AQ), especially its reliability and discriminating power. The second purpose was to establish whether the pattern of sex and area of study differences in the amount of autistic traits found in other countries also exist in Poland. The groups in the study included students (n = 2819), adults with ASD (n = 60) and a non-clinical sample (n = 60) matched with the ASD group for age, sex, education and place of residence. The Polish version of AQ proved to be reliable, although - as in studies conducted in other countries - the internal consistency coefficients for subscales (with exception for social skill) were low. ASD diagnosis was the most powerful determinant of AQ scores. Sex differences in autistic traits and a relationship between autistic traits and area of study were found.	[Pisula, Ewa; Kawa, Rafal; Kawa, Magdalena] Univ Warsaw, Fac Psychol, Warsaw, Poland; [Szostakiewicz, Lukasz; Lucka, Izabela; Rynkiewicz, Agnieszka] Med Univ Gdansk, Dept Dev Psychot & Geriatr Psychiat, Gdansk, Poland	University of Warsaw; Fahrenheit Universities; Medical University Gdansk	Pisula, E (corresponding author), Univ Warsaw, Fac Psychol, Warsaw, Poland.	ewa.pisula@psych.uw.edu.pl	Rynkiewicz, Agnieszka/U-7280-2019; Rynkiewicz, Agnieszka/W-5685-2018	Rynkiewicz, Agnieszka/0000-0002-9175-4937; Pisula, Ewa/0000-0002-7458-5043	Polish National Science Centre [N N106 352940]; Warsaw University	Polish National Science Centre; Warsaw University	The study was supported by a grant from the Polish National Science Centre (N N106 352940) and by the Warsaw University. No additional external funding received for this study. The funding institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin EJ, 2005, PERS INDIV DIFFER, V38, P451, DOI 10.1016/j.paid.2004.04.022; Bailey A, 1998, J AUTISM DEV DISORD, V28, P369, DOI 10.1023/A:1026048320785; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S., 2003, ESSENTIAL DIFFERENCE; Baron-Cohen S., 1997, MINDBLINDNESS ESSAY; Baron-Cohen S, 1998, AUTISM, V2, P296, DOI [10.1177/1362361398023008, DOI 10.1177/1362361398023008]; Bishop DVM, 2004, J CHILD PSYCHOL PSYC, V45, P1431, DOI 10.1111/j.1469-7610.2004.00325.x; Bishop SL, 2012, J AUTISM DEV DISORD, V42, P2354, DOI 10.1007/s10803-012-1483-2; Brzezinski J, 2004, WAIS R PL SKALA INTE, P220; Constantino JN, 2006, AM J PSYCHIAT, V163, P294, DOI 10.1176/appi.ajp.163.2.294; Constantino JN, 2005, BIOL PSYCHIAT, V57, P655, DOI 10.1016/j.biopsych.2004.12.014; Constantino JN, 2003, ARCH GEN PSYCHIAT, V60, P524, DOI 10.1001/archpsyc.60.5.524; Constantino JN, 2012, J AM ACAD CHILD PSY, V51, P756, DOI 10.1016/j.jaac.2012.05.017; Diamond Adele, ANNU REV PSYCHOL, V64, P135, DOI [DOI 10.1146/annurev-clinpsy-032813-153724, 10.1146/annurev-psych-113011-143750, DOI 10.1146/ANNUREV-PSYCH-113011-143750]; Dworzynski K, 2012, J AM ACAD CHILD PSY, V51, P788, DOI 10.1016/j.jaac.2012.05.018; Guilford J. P., 1954, PSYCHOMETRICS METHOD; Hoekstra RA, 2008, J AUTISM DEV DISORD, V38, P1555, DOI 10.1007/s10803-008-0538-x; Hoekstra RA, 2007, ARCH PEDIAT ADOL MED, V161, P372, DOI 10.1001/archpedi.161.4.372; Hofstede G., 2001, CULTURES CONSEQUENCE; House Robert., 2004, CULTURE LEADERSHIP; Hurst RM, 2007, PERS INDIV DIFFER, V43, P1938, DOI 10.1016/j.paid.2007.06.012; Hurst RM, 2007, J AUTISM DEV DISORD, V37, P1711, DOI 10.1007/s10803-006-0302-z; Ingersoll B, 2011, J AUTISM DEV DISORD, V41, P1646, DOI 10.1007/s10803-011-1192-2; Ketelaars C, 2008, J AUTISM DEV DISORD, V38, P176, DOI 10.1007/s10803-007-0358-4; Kloosterman PH, 2011, PERS INDIV DIFFER, V50, P310, DOI 10.1016/j.paid.2010.10.015; Kossakowska Z, 2008, POSZUKIWANIU WSPARCI, P32; Krahn TM, 2010, J BIOETHIC INQ, V9, P93; Kunihira Y, 2006, J AUTISM DEV DISORD, V36, P553, DOI 10.1007/s10803-006-0094-1; Kurita H, 2005, PSYCHIAT CLIN NEUROS, V59, P490, DOI 10.1111/j.1440-1819.2005.01403.x; Lau WYP, 2013, RES DEV DISABIL, V34, P294, DOI 10.1016/j.ridd.2012.08.005; Lepage JF, 2009, CAN J BEHAV SCI, V41, P272, DOI 10.1037/a0016248; Lombardo MV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000883; Lord C., 2012, AUTISM DIAGNOSTIC 1; Meng-Chuan L, 2011, PLOS ONE, V6, DOI DOI 10.1371/JOURNAL.PONE.0020835; Piven J, 1997, AM J PSYCHIAT, V154, P185; Rakotomalala R, 2005, ACT EGC 2005, P697; Robinson EB, 2011, ARCH GEN PSYCHIAT, V68, P1113, DOI 10.1001/archgenpsychiatry.2011.119; Ruta L, 2012, J AUTISM DEV DISORD, V42, P625, DOI 10.1007/s10803-011-1290-1; Rutter M, 2003, SOCIAL COMMUNICATION, P26; Rutter M, 2003, AUTISM DIAGNOSTIC IN, P60; Scheeren AM, 2008, J AUTISM DEV DISORD, V38, P276, DOI 10.1007/s10803-007-0389-x; Sizoo BB, 2009, J AUTISM DEV DISORD, V39, P1291, DOI 10.1007/s10803-009-0743-2; Stewart ME, 2009, PERS INDIV DIFFER, V47, P224, DOI 10.1016/j.paid.2009.03.004; Sucksmith E, 2011, NEUROPSYCHOL REV, V21, P360, DOI 10.1007/s11065-011-9183-9; Wakabayashi A, 2006, PERS INDIV DIFFER, V41, P873, DOI 10.1016/j.paid.2006.04.003; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Wheelan SJ, 2010, APPL BIOINF BIOSTAT, P1, DOI [10.1007/978-0-387-69745-1_1, 10.1186/2040-2392-1-10]; Wheelwright S, 2006, BRAIN RES, V1079, P47, DOI 10.1016/j.brainres.2006.01.012; Woodbury-Smith MR, 2005, J AUTISM DEV DISORD, V35, P331, DOI 10.1007/s10803-005-3300-7; World Health Organization, 2002, MAN INT STAT CLASS D, V1	50	41	42	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75236	10.1371/journal.pone.0075236	http://dx.doi.org/10.1371/journal.pone.0075236			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	246EK	24086474	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200091
J	Takabayashi, N; Urushihara, H; Kawakami, K				Takabayashi, Nobuyoshi; Urushihara, Hisashi; Kawakami, Koji			Biased Safety Reporting in Blinded Randomized Clinical Trials: Meta-Analysis of Angiotensin Receptor Blocker Trials	PLOS ONE			English	Article							COUGH	Background: Cough is listed as an adverse drug reaction (ADR) on the labels of angiotensin receptor blockers (ARB). However, a causal association with cough has also been reported for angiotensin converting enzyme inhibitors (ACEI), which have frequently been used as comparator drugs in the registration clinical trials of ARBs. This prompted us to examine the possible influence of using comparator drugs with well-known ADRs on the safety reporting of investigational drugs in blinded randomized clinical trials. Methods and Findings: The double-blinded, randomized clinical trials with comparator drugs were identified in the Japanese dossiers for the new drug applications of ARBs. The risk ratios (RR) of reporting cough and headache in ARB arms were calculated for each ARB by comparing trials using ACEIs and trials using non-ACEIs, were then combined with a meta-analysis. 23 trials with a total of 6643 patients were identified, consisting 6 trials using an ACEI comparator including 819 ARB patients and 17 trials using a non-ACEI comparator including 5824 ARB patients. The combined RR of cough reporting was significantly elevated (20.77; 95% confidence interval [CI], 7.47 to 57.76), indicating more frequent reporting of cough in clinical trials using an ACEI comparator. In contrast, the combined RR of headache, a negative control, was insignificant (1.45; 95% CI, 0.34 to 6.22). Conclusion: The use of comparators with well-known ADRs in blinded randomized trials produces potential bias in the reporting frequency of ADRs for investigational drugs. The selection of appropriate comparator drugs should be critical in unbiased safety assessment in double-blinded, randomized clinical trials and thus have relevance in reviewing the safety results from a regulatory point of view.	[Takabayashi, Nobuyoshi; Urushihara, Hisashi; Kawakami, Koji] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Kyoto, Japan	Kyoto University	Kawakami, K (corresponding author), Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Kyoto, Japan.	kawakami.koji.4e@kyoto-u.ac.jp	Kawakami, Koji/GZA-6582-2022	Kawakami, Koji/0000-0002-7477-4071; Urushihara, Hisashi/0000-0001-6913-9930				[Anonymous], [No title captured]; Arakawa K, 1998, J CLIN THERAPEUTICS, V14, P871; Arakawa K, 2004, J CLIN THERAPEUTICS, V20, P115; Arakawa K, 2002, JAPANESE PHARM THERA, V30, P639; Astellas Pharma Inc. Pfizer Japan Inc., 2007, SUBM DOSS CEL; Bangalore S, 2010, AM J MED, V123, P1016, DOI 10.1016/j.amjmed.2010.06.014; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Elliott WJ, 1996, CLIN PHARMACOL THER, V60, P582, DOI 10.1016/S0009-9236(96)90155-1; Evans SJW, 2001, PHARMACOEPIDEM DR S, V10, P483, DOI 10.1002/pds.677; Ferreira-Gonzalez I, 2007, BRIT MED J, V334, P786, DOI 10.1136/bmj.39136.682083.AE; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; ICH, 2000, ICH PRINC CLIN EV NE; ICH, 1998, ICH HARM TRIP GUID S; Ministry of Health Labour and Welfare, 1989, GUID CLIN EV ANT DRU; Ministry of Health Labour and Welfare, 1997, GOOD CLIN PRACT; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; MSD K K, 2011, PHARM INT FORM PAC S; Pariente A, 2007, DRUG SAFETY, V30, P891, DOI 10.2165/00002018-200730100-00007; RAD-AR council, 2003, STUD DAT CONSTR ANT; Rang HP, 2011, VASCULAR SYSTEM, P302; SESOKO S, 1985, ARCH INTERN MED, V145, P1524, DOI 10.1001/archinte.145.8.1524; Sumita S, 1995, KISO TO RINSHO, V29, P161; Urushihara H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028483; Yoshinaga K, 1998, J CLIN THERAPEUTICS, V14, P2355; Yoshinaga K, 2008, J CLIN THERAPEUTICS, V24, P543; Yoshinaga K, 1995, J CLIN EXPT MED, V172, P785; Yoshinaga K, 2008, J CLIN THERAPEUTICS, V24, P507	29	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75027	10.1371/journal.pone.0075027	http://dx.doi.org/10.1371/journal.pone.0075027			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086427	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200072
J	Yamauchi, K; Yamauchi, T; Mantuano, E; Murakami, K; Henry, K; Takahashi, K; Campana, WM				Yamauchi, Kazuyo; Yamauchi, Tomonori; Mantuano, Elisabetta; Murakami, Kenichi; Henry, Kenneth; Takahashi, Kazuhisa; Campana, Wendy Marie			Low-Density Lipoprotein Receptor Related protein-1 (LRP1)-Dependent Cell Signaling Promotes Neurotrophic Activity in Embryonic Sensory Neurons	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; SCHWANN-CELLS; PC12 CELLS; MAPK PATHWAY; KAPPA-B; SURVIVAL; BINDING; DIFFERENTIATION; ACTIVATION; PHOSPHORYLATION	Developing sensory neurons require neurotrophic support for survival, neurite outgrowth and myelination. The low-density lipoprotein receptor-related protein-1 (LRP1) transactivates Trk receptors and thereby functions as a putative neurotrophin. Herein, we show that LRP1 is abundantly expressed in developing dorsal root ganglia (DRG) and that LRP1-dependent cell signaling supports survival, neurite extension and receptivity to Schwann cells even in the absence of neurotrophins. Cultured embryonic DRG neurons (E15) were treated with previously characterized LRP1 ligands, LRP1-receptor binding domain of alpha 2-macroglobulin (RBD), hemopexin domain of MMP-9 (PEX) or controls (GST) for two weeks. These structurally diverse LRP1 ligands significantly activated and sustained extracellular signal-regulated kinases (ERK1/2) 5-fold (p<0.05), increased expression of growth-associated protein-43(GAP43) 15-fold (P<0.01), and increased neurite outgrowth 20-fold (P<0.01). Primary sensory neurons treated with LRP1 ligands survived >2 weeks in vitro, to an extent equaling NGF, a finding associated with canonical signaling mechanisms and blockade of caspase-3 cleavage. LRP1 ligand-induced survival and sprouting were blocked by co-incubation with the LRP1 antagonist, receptor associated protein (RAP), whereas RAP had no effect on NGF-induced activity. Site directed mutagenesis of the LRP1 ligand, RBD, in which Lys(1370) and Lys(1374) are converted to alanine to preclude LRP1 binding, were ineffective in promoting cell signaling, survival or inducing neurite extension in primary sensory neurons, confirming LRP1 specificity. Furthermore, LRP1-induced neurite sprouting was mediated by Src-family kinase (SFK) activation, suggesting transactivation of Trk receptors. Co-cultures of primary embryonic neurons and Schwann cells showed that LRP1 agonists promoted axonal receptivity to myelination to Schwann cells. Collectively, these findings identify LRP1 as a novel and perhaps essential trophic molecule for sensory neuronal survival and development.	[Yamauchi, Kazuyo; Yamauchi, Tomonori; Mantuano, Elisabetta; Murakami, Kenichi; Henry, Kenneth; Campana, Wendy Marie] Univ Calif San Diego, Sch Med, Dept Anesthesiol, La Jolla, CA 92093 USA; [Yamauchi, Kazuyo; Yamauchi, Tomonori; Murakami, Kenichi] Chiba Univ, Grad Sch Med, Dept Orthoped Surg, Chiba, Japan; [Campana, Wendy Marie] Univ Calif San Diego, Program Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Chiba University; University of California System; University of California San Diego	Campana, WM (corresponding author), Univ Calif San Diego, Sch Med, Dept Anesthesiol, La Jolla, CA 92093 USA.	wcampana@ucsd.edu	Yamauchi, Kazuyo/AAR-3549-2020; Mantuano, Elisabetta/C-1769-2015	Mantuano, Elisabetta/0000-0001-5728-9261; Sanyal, Subhabrata/0000-0003-2590-2732	NINDS [R01 NS-057456, R01 NS-054671, P30 NS047101]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101, R01NS057456, R01NS054671] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NINDS R01 NS-057456, R01 NS-054671 and P30 NS047101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; Bennett DLH, 1996, EUR J NEUROSCI, V8, P2204; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BUCHMAN VL, 1993, DEVELOPMENT, V118, P989; Campana WM, 2006, J NEUROSCI, V26, P11197, DOI 10.1523/JNEUROSCI.2709-06.2006; Campana WM, 1998, FASEB J, V12, P307, DOI 10.1096/fasebj.12.3.307; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Chang JH, 2003, J BIOL CHEM, V278, P42877, DOI 10.1074/jbc.M308155200; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Davies Alun M., 1994, Progress in Growth Factor Research, V5, P263, DOI 10.1016/0955-2235(94)90010-8; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Ernsberger U, 2009, CELL TISSUE RES, V336, P349, DOI 10.1007/s00441-009-0784-z; Fuentealba RA, 2009, J BIOL CHEM, V284, P34045, DOI 10.1074/jbc.M109.021030; Geetha N, 2011, J BIOL CHEM, V286, P25663, DOI 10.1074/jbc.M111.221903; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; HEASLEY LE, 1992, MOL BIOL CELL, V3, P545, DOI 10.1091/mbc.3.5.545; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Howard GC, 1996, J BIOL CHEM, V271, P14105, DOI 10.1074/jbc.271.24.14105; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Hu KB, 2006, J BIOL CHEM, V281, P2120, DOI 10.1074/jbc.M504988200; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; KLEITMAN N, 1988, J NEUROSCI, V8, P653; KOO PH, 1994, J BIOL CHEM, V269, P5369; KREMER NE, 1991, J CELL BIOL, V115, P809, DOI 10.1083/jcb.115.3.809; LEVIMONTALCINI R, 1956, P NATL ACAD SCI USA, V42, P695, DOI 10.1073/pnas.42.9.695; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; Mantuano E, 2008, J BIOL CHEM, V283, P19904, DOI 10.1074/jbc.M801762200; Mantuano E, 2011, J NEUROSCI, V31, P13376, DOI 10.1523/JNEUROSCI.2850-11.2011; Melli G, 2009, EXPERT OPIN DRUG DIS, V4, P1035, DOI 10.1517/17460440903266829; Mettenburg JM, 2002, J BIOL CHEM, V277, P13338, DOI 10.1074/jbc.M106792200; Nickols JC, 2003, NAT NEUROSCI, V6, P161, DOI 10.1038/nn995; Nielsen KL, 1996, J BIOL CHEM, V271, P12909, DOI 10.1074/jbc.271.22.12909; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; Orita S, 2013, J NEUROSCI, V33, P5590, DOI 10.1523/JNEUROSCI.3342-12.2013; Padmasekar M, 2007, CARDIOVASC RES, V75, P118, DOI 10.1016/j.cardiores.2007.03.003; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; WOOD PM, 1986, J NEUROL SCI, V74, P153, DOI 10.1016/0022-510X(86)90101-2; WYATT S, 1993, DEVELOPMENT, V119, P635; Yoon C, 2013, J BIOL CHEM; Yoon C, 2008, J NEUROSCI, V28, P3738, DOI 10.1523/JNEUROSCI.4439-07.2008	50	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75497	10.1371/journal.pone.0075497	http://dx.doi.org/10.1371/journal.pone.0075497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086544	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200106
J	Yang, GY; Wang, YY; Tian, JZ; Liu, JP				Yang, Guoyan; Wang, Yuyi; Tian, Jinzhou; Liu, Jian-Ping			Huperzine A for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials	PLOS ONE			English	Review							THERAPY	Background: Huperzine A is a Chinese herb extract used for Alzheimer's disease. We conducted this review to evaluate the beneficial and harmful effect of Huperzine A for treatment of Alzheimer's disease. Methods: We searched for randomized clinical trials (RCTs) of Huperzine A for Alzheimer's disease in PubMed, Cochrane Library, and four major Chinese electronic databases from their inception to June 2013. We performed meta-analyses using RevMan 5.1 software. (Protocol ID: CRD42012003249) Results: 20 RCTs including 1823 participants were included. The methodological quality of most included trials had a high risk of bias. Compared with placebo, Huperzine A showed a significant beneficial effect on the improvement of cognitive function as measured by Mini-Mental State Examination (MMSE) at 8 weeks, 12 weeks and 16 weeks, and by Hastgawa Dementia Scale (HDS) and Wechsler Memory Scale (WMS) at 8 weeks and 12 weeks. Activities of daily living favored Huperzine A as measured by Activities of Daily Living Scale (ADL) at 6 weeks, 12 weeks and 16 weeks. One trial found Huperzine A improved global clinical assessment as measured by Clinical Dementia Rating Scale (CDR). One trial demonstrated no significant change in cognitive function as measured by Alzheimer's disease Assessment Scale-Cognitive Subscale (ADAS-Cog) and activity of daily living as measured by Alzheimer's disease Cooperative Study Activities of Daily Living Inventory (ADCS-ADL) in Huperzine A group. Trials comparing Huperzine A with no treatment, psychotherapy and conventional medicine demonstrated similar findings. No trial evaluated quality of life. No trial reported severe adverse events of Huperzine A. Conclusions: Huperzine A appears to have beneficial effects on improvement of cognitive function, daily living activity, and global clinical assessment in participants with Alzheimer's disease. However, the findings should be interpreted with caution due to the poor methodological quality of the included trials.	[Yang, Guoyan; Wang, Yuyi; Liu, Jian-Ping] Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing, Peoples R China; [Tian, Jinzhou] Beijing Univ Chinese Med, Dongzhimen Hosp, Dept Neurol 3, Beijing, Peoples R China	Beijing University of Chinese Medicine; Beijing University of Chinese Medicine	Liu, JP (corresponding author), Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing, Peoples R China.	jianping_l@hotmail.com	Yang, Guoyan/AAG-7873-2021	Yang, Guoyan/0000-0002-8012-2379; Liu, Jianping/0000-0002-0320-061X	Program for Innovative Research Teams of Beijing University of Chinese Medicine [2011-CXTD-09, 2011-CXTD-21]; 111 Project [B08006]; Technological Platform of Clinical Evaluation and Research for New Herbal Medicinal Products [2011ZX09302-006-01]	Program for Innovative Research Teams of Beijing University of Chinese Medicine; 111 Project(Ministry of Education, China - 111 Project); Technological Platform of Clinical Evaluation and Research for New Herbal Medicinal Products	This review was funded by the Program for Innovative Research Teams of Beijing University of Chinese Medicine (2011-CXTD-09 and -21). Prof Jinzhou Tian and Jian-Ping Liu were supported by the grant the 111 Project (No.B08006), and the Technological Platform of Clinical Evaluation and Research for New Herbal Medicinal Products (2011ZX09302-006-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's Association, FDA APPR TREATM ALZH; Alzhermer's Disease International, 2012, WORLD ALZH REP WORLD; Alzhermer's Disease International, 2009, WORLD ALZH REP WORLD; Chai XS, 1998, SHANGHAI MED PHARM J, V1, P16; Chen W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028093; Chen YM, 2000, MODERN REHABIL, V4, P1622; Dong H.T., 2002, SHANGHAI U TRADITION, V03, P26, DOI DOI 10.16306/J.1008-861X.2002.03.009; Fu LM, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep136; Gu P, 2000, PRACTICAL GERIATRICS, V14, P307; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hippius Hanns, 2003, Dialogues Clin Neurosci, V5, P101; Huang MZ, 2005, CHINESE MED J METALL, V22, P377; Jia YP, 2010, CHINESE J INTEGRATIV, V8, P37; Kuang MZ, 2004, CHINESE J CLIN REHAB, V8, P1216; Li J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005592.pub2; Liu FG, 1995, CHIN J PHARMACOEPIDE, V4, P196; Liu JN, 1998, CHIN J CLIN PHAR, V7, P270; Qin HY, 2008, SHANGHAI ARCH PSYCHI, V20, P339; Rafii MS, 2011, NEUROLOGY, V76, P1389, DOI 10.1212/WNL.0b013e318216eb7b; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Robert P, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt48; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Shi BaoHe, 2013, Practical Pharmacy and Clinical Remedies, V16, P37; Tian JZ, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt54; Wang WS, 2009, CHINA MED, V4, P800; WANG YE, 1986, ACTA PHARMACOL SIN, V7, P110; XU SS, 1995, ACTA PHARM SINIC, V16, P391; Yang CY, 2003, CHIN J CLIN REHABIL, V7, P4258; Yang GY, 2012, PROSPERO; [张振馨 Zhang Zhenxin], 2002, [中华医学杂志, National Medical Journal of China], V82, P941; Zhou BR, 2004, CHINESE J CLIN REHAB, V8, P1214; Zhou BR, 2004, CHINESE J CLIN REHAB, V8, P3020; 杨静, 2012, [中国老年学杂志, Chinese Journal of Gerontology], V32, P4631; 李雯妮, 2011, [中国老年学杂志, Chinese Journal of Gerontology], V31, P2096	34	109	114	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74916	10.1371/journal.pone.0074916	http://dx.doi.org/10.1371/journal.pone.0074916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086396	gold, Green Submitted, Green Published			2022-12-27	WOS:000326520200053
J	Aschauer, DF; Kreuz, S; Rumpel, S				Aschauer, Dominik F.; Kreuz, Sebastian; Rumpel, Simon			Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS VECTORS; CENTRAL-NERVOUS-SYSTEM; GENE-TRANSFER; TRANSGENE EXPRESSION; GABAERGIC NEURONS; IMMUNE-RESPONSES; CELL TROPISM; MICE; RECEPTOR; PATHWAYS	Recombinant Adeno-associated virus vectors (rAAV) are widely used for gene delivery and multiple naturally occurring serotypes have been harnessed to target cells in different tissues and organs including the brain. Here, we provide a detailed and quantitative analysis of the transduction profiles of rAAV vectors based on six of the most commonly used serotypes (AAV1, AAV2, AAV5, AAV6, AAV8, AAV9) that allows systematic comparison and selection of the optimal vector for a specific application. In our studies we observed marked differences among serotypes in the efficiency to transduce three different brain regions namely the striatum, hippocampus and neocortex of the mouse. Despite the fact that the analyzed serotypes have the general ability to transduce all major cell types in the brain (neurons, microglia, astrocytes and oligodendrocytes), the expression level of a reporter gene driven from a ubiquitous promoter varies significantly for specific cell type / serotype combinations. For example, rAAV8 is particularly efficient to drive transgene expression in astrocytes while rAAV9 appears well suited for the transduction of cortical neurons. Interestingly, we demonstrate selective retrograde transport of rAAV5 along axons projecting from the ventral part of the entorhinal cortex to the dentate gyrus. Furthermore, we show that self-complementing rAAV can be used to significantly decrease the time required for the onset of transgene expression in the mouse brain.	[Aschauer, Dominik F.; Rumpel, Simon] Res Inst Mol Pathol IMP, Vienna, Austria; [Kreuz, Sebastian] Boehringer Ingelheim Pharma GmbH & Co KG, Target Discovery Res, Biberach, Germany	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Boehringer Ingelheim	Rumpel, S (corresponding author), Res Inst Mol Pathol IMP, Vienna, Austria.	rumpel@imp.ac.at			Boehringer Ingelheim Pharmaceuticals; Research Institute of Molecular Pathology (IMP)	Boehringer Ingelheim Pharmaceuticals(Boehringer Ingelheim); Research Institute of Molecular Pathology (IMP)	The research was funded by Boehringer Ingelheim Pharmaceuticals directly (SK) or through core funding of the Research Institute of Molecular Pathology (IMP) (DFA, SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Bantel-Schaal U, 2009, J GEN VIROL, V90, P317, DOI 10.1099/vir.0.005595-0; Beier KT, 2011, P NATL ACAD SCI USA, V108, P15414, DOI 10.1073/pnas.1110854108; Berges BK, 2007, MOL THER, V15, P20, DOI 10.1038/sj.mt.6300018; Buie LK, 2010, INVEST OPHTH VIS SCI, V51, P236, DOI 10.1167/iovs.09-3847; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; Carter BJ, 2004, MOL THER, V10, P981, DOI 10.1016/j.ymthe.2004.09.011; Cearley CN, 2006, MOL THER, V13, P528, DOI 10.1016/j.ymthe.2005.11.015; de Backer MWA, 2011, METHODS MOL BIOL, V789, P357, DOI 10.1007/978-1-61779-310-3_24; DEDEREN PJWC, 1994, HISTOCHEM J, V26, P856, DOI 10.1007/BF00162931; Di Pasquale G, 2003, NAT MED, V9, P1306, DOI 10.1038/nm929; Ehrengruber MU, 1999, P NATL ACAD SCI USA, V96, P7041, DOI 10.1073/pnas.96.12.7041; Ferrari FK, 1996, J VIROL, V70, P3227, DOI 10.1128/JVI.70.5.3227-3234.1996; Fitzsimons HL, 2002, METHODS, V28, P227, DOI 10.1016/S1046-2023(02)00227-X; Fu HY, 2003, MOL THER, V8, P911, DOI 10.1016/j.ymthe.2003.08.021; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; Grimm D, 2003, MOL THER, V7, P839, DOI 10.1016/S1525-0016(03)00095-9; Harbison CE, 2008, TRENDS MICROBIOL, V16, P208, DOI 10.1016/j.tim.2008.01.012; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; He M, 2012, NEURON, V73, P35, DOI 10.1016/j.neuron.2011.11.010; Herzog RW, 2007, MOL THER, V15, P649, DOI 10.1038/sj.mt.6300123; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; HOGGAN MD, 1966, P NATL ACAD SCI USA, V55, P1467, DOI 10.1073/pnas.55.6.1467; Howard DB, 2008, VIROLOGY, V372, P24, DOI 10.1016/j.virol.2007.10.007; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Hueffer K, 2003, CURR OPIN MICROBIOL, V6, P392, DOI 10.1016/S1369-5274(03)00083-3; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; JOHNSON RT, 1965, AM J PATHOL, V46, P929; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Latimer CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026812; Lazarini F, 2012, J NEUROSCI, V32, P3652, DOI 10.1523/JNEUROSCI.6394-11.2012; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lo LC, 2011, NEURON, V72, P938, DOI 10.1016/j.neuron.2011.12.002; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Ma WQ, 2011, HUM GENE THER, V22, P633, DOI 10.1089/hum.2010.243; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MARR D, 1970, PROC R SOC SER B-BIO, V176, P161, DOI 10.1098/rspb.1970.0040; Masamizu Y, 2011, NEUROSCIENCE, V193, P249, DOI 10.1016/j.neuroscience.2011.06.080; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; Melzer S, 2012, SCIENCE, V335, P1506, DOI 10.1126/science.1217139; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Muzyczka N, 2005, HUM GENE THER, V16, P408, DOI 10.1089/hum.2005.16.408; Nathwani AC, 2011, MOL THER, V19, P876, DOI 10.1038/mt.2010.274; Ohsawa K, 2000, J CELL SCI, V113, P3073; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Salegio EA, 2013, GENE THER, V20, P348, DOI 10.1038/gt.2012.27; Shen S, 2011, J BIOL CHEM, V286, P13532, DOI 10.1074/jbc.M110.210922; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Taymans JM, 2007, HUM GENE THER, V18, P195, DOI 10.1089/hum.2006.178; Towne C, 2010, GENE THER, V17, P141, DOI 10.1038/gt.2009.119; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; Urabe M, 2002, HUM GENE THER, V13, P1935, DOI 10.1089/10430340260355347; Vela JM, 2002, J NEUROTRAUM, V19, P1503, DOI 10.1089/089771502320914723; White MD, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00008; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Witter MP, 2007, PROG BRAIN RES, V163, P43, DOI 10.1016/S0079-6123(07)63003-9; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; Zabner J, 2000, J VIROL, V74, P3852, DOI 10.1128/JVI.74.8.3852-3858.2000; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	68	324	340	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76310	10.1371/journal.pone.0076310	http://dx.doi.org/10.1371/journal.pone.0076310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086725	Green Published, Green Submitted, gold			2022-12-27	WOS:000325223900096
J	Miller, TR; Beversdorf, L; Chaston, SD; McMahon, KD				Miller, Todd R.; Beversdorf, Lucas; Chaston, Sheena D.; McMahon, Katherine D.			Spatiotemporal Molecular Analysis of Cyanobacteria Blooms Reveals Microcystis-Aphanizomenon Interactions	PLOS ONE			English	Article							LARGE SHALLOW LAKE; GENETIC DIVERSITY; BACTERIAL COMMUNITIES; PHYTOPLANKTON ASSEMBLAGES; PLANKTOTHRIX-AGARDHII; FORMING CYANOBACTERIA; EUTROPHIC LAKES; ALGAL BLOOMS; DOMINANCE; AERUGINOSA	Spatial and temporal variability in cyanobacterial community composition (CCC) within and between eutrophic lakes is not well-described using culture independent molecular methods. We analyzed CCC across twelve locations in four eutrophic lakes and within-lake locations in the Yahara Watershed, WI, on a weekly basis, for 5 months. Taxa were discriminated by length of MspI-digested cpcB/A intergenic spacer gene sequences and identified by comparison to a PCR-based clone library. CCC across all stations was spatially segregated by depth of sampling locations (ANOSIM R = 0.23, p < 0.001). Accordingly, CCC was correlated with thermal stratification, nitrate and soluble reactive phosphorus (SRP, R = 0.2-0.3). Spatial variability in CCC and temporal trends in taxa abundances were rarely correlative between sampling locations in the same lake indicating significant within lake spatiotemporal heterogeneity. Across all stations, a total of 37 bloom events were observed based on distinct increases in phycocyanin. Out of 97 taxa, a single Microcystis, and two different Aphanizomenon taxa were the dominant cyanobacteria detected during bloom events. The Microcystis and Aphanizomenon taxa rarely bloomed together and were significantly anti-correlated with each other at 9 of 12 stations with Pearson R values of -0.6 to -0.9 (p < 0.001). Of all environmental variables measured, nutrients, especially nitrate were significantly greater during periods of Aphanizomenon dominance while the nitrate+nitrite: SRP ratio was lower. This study shows significant spatial variability in CCC within and between lakes structured by depth of the sampling location. Furthermore, our study reveals specific genotypes involved in bloom formation. More in-depth characterization of these genotypes should lead to a better understanding of factors promoting bloom events in these lakes and more reliable bloom prediction models.	[Miller, Todd R.; Chaston, Sheena D.; McMahon, Katherine D.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Beversdorf, Lucas; McMahon, Katherine D.] Univ Wisconsin, Dept Civil & Environm Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Miller, TR (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	millertr@uwm.edu	Miller, Todd/Y-3612-2019	McMahon, Katherine D./0000-0002-7038-026X; Miller, Todd/0000-0002-2113-1662	Wisconsin SeaGrant [R/BT-24]; National Science Foundation [CAREER CBET-0644949, MCB-0702395, NTL-LTER DEB-0822700]	Wisconsin SeaGrant; National Science Foundation(National Science Foundation (NSF))	Funding provided by a Wisconsin SeaGrant (R/BT-24; http://www.seagrant.wisc.edu/home/), and the National Science Foundation (CAREER CBET-0644949; NTL-Microbial Observatory MCB-0702395; NTL-LTER DEB-0822700; http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association APH, 1995, STAND METH EX WAT WA; Beversdorf LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056103; Birge EA, 1926, P NATL ACAD SCI USA, V12, P515, DOI 10.1073/pnas.12.8.515; Briand E, 2008, ENVIRON MICROBIOL, V10, P3337, DOI 10.1111/j.1462-2920.2008.01730.x; Briand E, 2009, ISME J, V3, P419, DOI 10.1038/ismej.2008.121; Budikova D, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009206; Carraro E, 2012, HYDROBIOLOGIA, V698, P77, DOI 10.1007/s10750-012-1096-y; Chakraborty S, 2012, ECOL COMPLEX, V11, P144, DOI 10.1016/j.ecocom.2012.05.006; Chen YW, 2003, J PLANKTON RES, V25, P445, DOI 10.1093/plankt/25.4.445; Deblois CP, 2012, J PHYCOL, V48, P1002, DOI 10.1111/j.1529-8817.2012.01191.x; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Dokulil MT, 2000, HYDROBIOLOGIA, V438, P1, DOI 10.1023/A:1004155810302; Fewer DP, 2009, ENVIRON MICROBIOL, V11, P855, DOI 10.1111/j.1462-2920.2008.01806.x; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Flowers JJ, 2009, ENV MICROBIOL REP, V1, P583, DOI 10.1111/j.1758-2229.2009.00090.x; JACOBSON L, 1982, J PLANKTON RES, V4, P481, DOI 10.1093/plankt/4.3.481; Kanoshina I, 2003, HARMFUL ALGAE, V2, P29, DOI 10.1016/S1568-9883(02)00085-9; Kent AD, 2003, APPL ENVIRON MICROB, V69, P6768, DOI 10.1128/AEM.69.11.6768-6776.2003; Kim SG, 2006, APPL ENVIRON MICROB, V72, P3252, DOI 10.1128/AEM.72.5.3252-3258.2006; LAMPERT W, 1987, NEW ZEAL J MAR FRESH, V21, P483, DOI 10.1080/00288330.1987.9516244; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Marsac NTD, 1988, METHODS ENZYMOL, V167; Miller TR, 2011, FEMS MICROBIOL ECOL, V78, P336, DOI 10.1111/j.1574-6941.2011.01162.x; NEILAN BA, 1995, APPL ENVIRON MICROB, V61, P3875, DOI 10.1128/AEM.61.11.3875-3883.1995; Nixdorf B, 2003, HYDROBIOLOGIA, V502, P111, DOI 10.1023/B:HYDR.0000004274.65831.e5; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; Padisak J., 1997, ARCH HYDROBIOL, V107, P563; Paerl H, 2008, ADV EXP MED BIOL, V619, P217, DOI 10.1007/978-0-387-75865-7_10; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Paerl Hans W., 1996, Phycologia, V35, P25, DOI 10.2216/i0031-8884-35-6S-25.1; POOLE H. H., 1929, JOUR MARINE BIOL ASSOC UNITED KINGDOM, V16, P297; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; REYNOLDS CS, 1987, NEW ZEAL J MAR FRESH, V21, P379, DOI 10.1080/00288330.1987.9516234; Ricke P, 2005, APPL ENVIRON MICROB, V71, P1671, DOI 10.1128/AEM.71.3.1671-1673.2005; ROBARTS RD, 1987, NEW ZEAL J MAR FRESH, V21, P391, DOI 10.1080/00288330.1987.9516235; Rucker J, 1997, HYDROBIOLOGIA, V342, P107, DOI 10.1023/A:1017013208039; Scheffer M, 1997, ECOLOGY, V78, P272; Shade A, 2007, LIMNOL OCEANOGR, V52, P487, DOI 10.4319/lo.2007.52.2.0487; SIMON RD, 1971, P NATL ACAD SCI USA, V68, P265, DOI 10.1073/pnas.68.2.265; STEINBERG CEW, 1988, FRESHWATER BIOL, V20, P279, DOI 10.1111/j.1365-2427.1988.tb00452.x; ter Braak CJF, 2002, CANOCO REFERENCE MAN; Tonno I, 2003, HYDROBIOLOGIA, V490, P23, DOI 10.1023/A:1023452828667; van Gremberghe I, 2009, OIKOS, V118, P1647, DOI 10.1111/j.1600-0706.2009.17538.x; Vezie C, 2002, MICROB ECOL, V43, P443, DOI 10.1007/s00248-001-0041-9; Walsby A E, 1972, Symp Soc Exp Biol, V26, P233; Wang XY, 2012, MICROB ECOL, V64, P986, DOI 10.1007/s00248-012-0083-1; WATSON VJ, 1979, J WATER POLLUT CON F, V51, P2876; Willen T, 1997, HYDROBIOLOGIA, V353, P181, DOI 10.1023/A:1003047019422; Wilson AE, 2005, APPL ENVIRON MICROB, V71, P6126, DOI 10.1128/AEM.71.10.6126-6133.2005; Yang Z, 2005, ANN LIMNOL-INT J LIM, V41, P169, DOI 10.1051/limn:20054130169; Yannarell AC, 2003, MICROB ECOL, V46, P391, DOI 10.1007/s00248-003-1008-9	51	27	28	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e74933	10.1371/journal.pone.0074933	http://dx.doi.org/10.1371/journal.pone.0074933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086400	gold, Green Published			2022-12-27	WOS:000325223900031
J	Smith, SB; Magid-Slav, M; Brown, JR				Smith, Steven B.; Magid-Slav, Michal; Brown, James R.			Host Response to Respiratory Bacterial Pathogens as Identified by Integrated Analysis of Human Gene Expression Data	PLOS ONE			English	Article							EPITHELIUM-DERIVED FACTOR; INHIBITORY FACTOR MIF; PSEUDOMONAS-AERUGINOSA; STREPTOCOCCUS-PNEUMONIAE; CELLS; INVASION; SUSCEPTIBILITY; PATHWAY; PROTEIN; KINASE	Respiratory bacterial pathogens are one of the leading causes of infectious death in the world and a major health concern complicated by the rise of multi-antibiotic resistant strains. Therapeutics that modulate host genes essential for pathogen infectivity could potentially avoid multi-drug resistance and provide a wider scope of treatment options. Here, we perform an integrative analysis of published human gene expression data generated under challenges from the gram-negative and Gram-positive bacteria pathogens, Pseudomonas aeruginosa and Streptococcus pneumoniae, respectively. We applied a previously described differential gene and pathway enrichment analysis pipeline to publicly available host mRNA GEO datasets resulting from exposure to bacterial infection. We found 72 canonical human pathways common between four GEO datasets, representing P. aeruginosa and S. pneumoniae. Although the majority of these pathways are known to be involved with immune response, we found several interesting new interactions such as the SUMO1 pathway that might have a role in bacterial infections. Furthermore, 36 host-bacterial pathways were also shared with our previous results for respiratory virus host gene expression. Based on our pathway analysis we propose several drug-repurposing opportunities supported by the literature.	[Smith, Steven B.; Magid-Slav, Michal; Brown, James R.] GlaxoSmithKline, Quantitat Sci, Computat Biol, Collegeville, PA 19426 USA; [Smith, Steven B.] Univ Maryland, Inst Genome Sci, Baltimore, MD 21201 USA	GlaxoSmithKline; University System of Maryland; University of Maryland Baltimore	Brown, JR (corresponding author), GlaxoSmithKline, Quantitat Sci, Computat Biol, Collegeville, PA 19426 USA.	James.R.Brown@gsk.com		Smith, Steven/0000-0003-2799-6621; Brown, James/0000-0002-9368-627X	GlaxoSmithKline RD	GlaxoSmithKline RD(GlaxoSmithKline)	We acknowledge GlaxoSmithKline R&D for their support of this study. We also thank Jacques Ravel, University of Maryland, for his support and encouragement.	Ali S, 2006, CLIN EXP IMMUNOL, V144, P425, DOI 10.1111/j.1365-2249.2006.03087.x; Arnold R, 2005, J IMMUNOL, V174, P7359, DOI 10.4049/jimmunol.174.11.7359; Beran O, 2011, FOLIA MICROBIOL, V56, P138, DOI 10.1007/s12223-011-0001-9; Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Bootsma HJ, 2007, INFECT IMMUN, V75, P5489, DOI 10.1128/IAI.01823-06; Breen EC, 2013, J CELL PHYSIOL, V228, P371, DOI 10.1002/jcp.24140; Brown JR, 2011, DRUG DISCOV TODAY, V16, P229, DOI 10.1016/j.drudis.2011.01.008; Burnham CAD, 2007, MICROBIOL-SGM, V153, P4240, DOI 10.1099/mic.0.2007/008417-0; Core R Team, 2012, R LANG ENV STAT COMP; Courval M, 2004, PHARMACOTHERAPY, V24, P558, DOI 10.1592/phco.24.6.558.34734; Dai JF, 2008, J VIROL, V82, P4164, DOI 10.1128/JVI.02621-07; Eberl M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000308; Esmon CT, 2011, J THROMB HAEMOST, V9, P182, DOI 10.1111/j.1538-7836.2011.04323.x; Esmon CT, 2013, THROMB HAEMOSTASIS, V109, P416, DOI 10.1160/TH12-08-0634; Eto DS, 2007, PLOS PATHOG, V3, P949, DOI 10.1371/journal.ppat.0030100; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Fowler T, 2003, CELL MICROBIOL, V5, P417, DOI 10.1046/j.1462-5822.2003.00290.x; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Ghosh N, 2012, INT REV IMMUNOL, V31, P410, DOI 10.3109/08830185.2012.690794; Hajishengallis G, 2011, NAT REV IMMUNOL, V11, P187, DOI 10.1038/nri2918; Hasnain SZ, 2012, IMMUNOL CELL BIOL, V90, P260, DOI 10.1038/icb.2011.112; Hofman P, 2012, GUT MICROBES, V3, P176, DOI 10.4161/gmic.20288; Hoogendijk AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018519; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Ichikawa JK, 2005, CELL MICROBIOL, V7, P1635, DOI 10.1111/j.1462-5822.2005.00581.x; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Jenkins Stephen G, 2008, Ann Clin Microbiol Antimicrob, V7, P1, DOI 10.1186/1476-0711-7-1; Kierbel A, 2005, MOL BIOL CELL, V16, P2577, DOI 10.1091/mbc.E04-08-0717; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Kung VL, 2012, P NATL ACAD SCI USA, V109, P1275, DOI 10.1073/pnas.1109285109; Li YL, 2012, CYTOKINE, V60, P64, DOI 10.1016/j.cyto.2012.06.010; Loeb L, 1904, J MED RES, V10, P407; Marriott HM, 2012, INFECT IMMUN, V80, P1140, DOI 10.1128/IAI.05697-11; Mayer AK, 2007, J IMMUNOL, V178, P3134, DOI 10.4049/jimmunol.178.5.3134; McAdow M, 2012, J INNATE IMMUN, V4, P141, DOI 10.1159/000333447; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Moens L, 2008, J ALLERGY CLIN IMMUN, V122, P1231, DOI 10.1016/j.jaci.2008.09.006; Newton P, 2013, J BIOMOL SCREEN, V18, P237, DOI 10.1177/1087057112469047; *OM, 2011, ARR STUD VERS 4 1 1; Paolillo R, 2011, INT J IMMUNOPATH PH, V24, P961, DOI 10.1177/039463201102400414; Patel VS, 2013, AM J RESP CELL MOL, V48, P280, DOI 10.1165/rcmb.2012-0279OC; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pendleton JN, 2013, EXPERT REV ANTI-INFE, V11, P297, DOI [10.1586/eri.13.12, 10.1586/ERI.13.12]; Petersen HJ, 2010, INFECT IMMUN, V78, P413, DOI 10.1128/IAI.00664-09; Petronilho F, 2012, MOL MED, V18, P1209, DOI 10.2119/molmed.2012.00083; Pfeifer P, 2013, AM J RESP CELL MOL, V48, P415, DOI 10.1165/rcmb.2012-0232OC; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Reglero-Real N, 2012, CELL MOL LIFE SCI, V69, P3079, DOI 10.1007/s00018-012-0987-4; Reidy T, 2013, J BIOL CHEM, V288, P8269, DOI 10.1074/jbc.M112.351064; Restrepo MI, 2013, CURR OPIN INFECT DIS, V26, P151, DOI 10.1097/QCO.0b013e32835ebc6d; Roger T, 2013, J INFECT DIS, V207, P331, DOI 10.1093/infdis/jis673; Sanagi T, 2005, NEUROSCI LETT, V380, P105, DOI 10.1016/j.neulet.2005.01.035; Scibelli A, 2007, VET J, V173, P482, DOI 10.1016/j.tvjl.2006.01.010; Sharron M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041549; Shin S, 2006, MICROB PATHOGENESIS, V41, P168, DOI 10.1016/j.micpath.2006.07.003; Sinigalia E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049630; Siranovic M, 2011, ACTA CLIN CROAT, V50, P345; Smith SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033174; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Tang ACL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032893; Um JW, 2006, J NEUROSCI RES, V84, P1543, DOI 10.1002/jnr.21041; van der Flier M, 2000, INFECT IMMUN, V68, P4792, DOI 10.1128/IAI.68.8.4792-4794.2000; Viasus D, 2013, CURR OPIN PULM MED, V19, P209, DOI 10.1097/MCP.0b013e32835f1c0b; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; Weber SS, 2009, MOL MICROBIOL, V71, P1341, DOI 10.1111/j.1365-2958.2009.06608.x; Wilkosz S, 2012, AM J RESP CELL MOL, V46, P180, DOI 10.1165/rcmb.2011-0182OC; Wimmer P, 2012, J VIROL, V86, P642, DOI 10.1128/JVI.06227-11; Wolfenson H, 2013, DEV CELL, V24, P447, DOI 10.1016/j.devcel.2013.02.012; Worgall S, 2002, PEDIATR RES, V52, P636, DOI 10.1203/01.PDR.0000032382.17567.FB; Xing L, 2003, J VIROL, V77, P6101, DOI 10.1128/JVI.77.11.6101-6107.2003; XU H, 1994, J EXP MED, V180, P95, DOI 10.1084/jem.180.1.95; Yabe T, 2005, GLIA, V50, P223, DOI 10.1002/glia.20171; Zhang YR, 2012, SCI CHINA LIFE SCI, V55, P800, DOI 10.1007/s11427-012-4368-x	74	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75607	10.1371/journal.pone.0075607	http://dx.doi.org/10.1371/journal.pone.0075607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086587	Green Submitted, Green Published, gold			2022-12-27	WOS:000325223900049
J	Kibengo, FM; Ruzagira, E; Katende, D; Bwanika, AN; Bahemuka, U; Haberer, JE; Bangsberg, DR; Barin, B; Rooney, JF; Mark, D; Chetty, P; Fast, P; Kamali, A; Priddy, FH				Kibengo, Freddie M.; Ruzagira, Eugene; Katende, David; Bwanika, Agnes N.; Bahemuka, Ubaldo; Haberer, Jessica E.; Bangsberg, David R.; Barin, Burc; Rooney, James F.; Mark, David; Chetty, Paramesh; Fast, Patricia; Kamali, Anatoli; Priddy, Frances H.			Safety, Adherence and Acceptability of Intermittent Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis (PrEP) among HIV-Uninfected Ugandan Volunteers Living in HIV-Serodiscordant Relationships: A Randomized, Clinical Trial	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY ADHERENCE; SEXUAL RISK BEHAVIOR; SELF-REPORT; PREVENTION; TRANSMISSION; INFECTION; WOMEN	Background: Efficacy of oral pre-exposure prophylaxis (PrEP) in prevention of HIV acquisition has been evaluated using a daily regimen. However, adherence to long term daily medication is rarely perfect. Intermittent regimen may be a feasible alternative. Preclinical studies have demonstrated effectiveness of intermittent PrEP in SHIV prevention among animals. However, little is known about intermittent PrEP regimens. Design: Seventy two HIV-uninfected volunteers in HIV serodiscordant couple relationships in Uganda were randomly assigned to receive daily oral Tenofovir/Emtricitabine (TDF/FTC-Truvada) or placebo, or intermittent (Monday, Friday and within 2 hours after sex, not to exceed one dose per day) oral TDF/FTC or placebo in a 2: 1: 2: 1 ratio. Volunteers and study staff were blinded to drug assignment, but not to regimen assignment. Methods: Volunteers were followed for 4 months after randomization, with monthly clinical and laboratory safety assessments and comprehensive HIV risk reduction services. Adherence was monitored using medication event monitoring system (MEMS) and self-report. Sexual activity data were collected via daily short text message (SMS) and self-report. HIV-specific immune responses were assessed by IFN-gamma ELISPOT. Results: Both daily and intermittent oral TDF/FTC regimens were well tolerated. Median MEMS adherence rates were 98% (IQR: 93-100) for daily PrEP regimen, 91% (IQR: 73-97) for fixed intermittent dosing and 45% (IQR: 20-63) for post-coital dosing. SMS response rate was 74%, but increased to 80% after excluding server outages; results may have been affected by the novelty of this measure. The majority of volunteers expressed willingness with no particular preference for either regimen. Conclusions: Both daily and intermittent oral PrEP dosing regimens were safe. Adherence was high for daily and fixed intermittent dosing; post-coital dosing was associated with poor adherence. Fixed intermittent PrEP regimens may be feasible especially if a minimum effective drug concentration correlating with HIV prevention can be achieved with this dosing.	[Kibengo, Freddie M.; Ruzagira, Eugene; Katende, David; Bwanika, Agnes N.; Bahemuka, Ubaldo; Kamali, Anatoli] Med Res Council MRC Uganda Virus Res Inst UVRI Ug, Entebbe, Uganda; [Haberer, Jessica E.; Bangsberg, David R.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Haberer, Jessica E.; Bangsberg, David R.] Harvard Univ, Sch Med, Boston, MA USA; [Barin, Burc] EMMES Corp, Rockville, MD USA; [Rooney, James F.] Gilead Sci Inc, Foster City, CA 94404 USA; [Mark, David] Int AIDS Vaccine Initiat, Nairobi, Kenya; [Chetty, Paramesh] Int AIDS Vaccine Initiat, Johannesburg, South Africa; [Fast, Patricia; Priddy, Frances H.] Int AIDS Vaccine Initiat, New York, NY USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Emmes Corporation; Gilead Sciences; International AIDS Vaccine Initiative; International AIDS Vaccine Initiative; International AIDS Vaccine Initiative	Priddy, FH (corresponding author), Int AIDS Vaccine Initiat, New York, NY USA.	fpriddy@iavi.org	Haberer, Jessica/AAH-7976-2019	Haberer, Jessica/0000-0001-5845-3190; Ruzagira, Eugene/0000-0002-7291-1693; Bwanika Naggirinya, Agnes/0000-0001-6795-3138	International AIDS Vaccine Initiative	International AIDS Vaccine Initiative	The study was funded by the International AIDS Vaccine Initiative (www.iavi.org) with support in form of study medication (both active drug and placebo) provided by Gilead Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amico R, 2011, RETROVIRUSES; Anderson P, 2012, 19 C RETR OPP INF WA; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; [Anonymous], 2011, FHI STAT FEM PREP HI; [Anonymous], MICR TRIALS NETW STA; Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Carey MP, 2001, INT J STD AIDS, V12, P365, DOI 10.1258/0956462011923309; Commission Uganda AIDS, 2007, UN ACC HIV PREV TREA; Donnell D, 2012, 19 C RETR OPP INF WA; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Government of Uganda, 2010, UNGASS PROGR REP UG; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grohskopf L, 2010, AIDS; Guest G, 2008, SEX TRANSM DIS, V35, P1002, DOI 10.1097/OLQ.0b013e3181812939; Guest G, 2010, J WOMENS HEALTH, V19, P791, DOI 10.1089/jwh.2009.1576; Haberer J, 2012, 7 INT C HIV TREATM A; Hugen PWH, 2002, J ACQ IMMUN DEF SYND, V30, P324, DOI [10.1097/00126334-200207010-00009, 10.1097/01.QAI.0000014768.35851.DB]; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Kearney BP, 2004, CLIN PHARMACOKINET, V43, P595, DOI 10.2165/00003088-200443090-00003; Malamba SS, 2005, JAIDS-J ACQ IMM DEF, V39, P576; Ministry of Health Republic of Uganda ORC Macro, 2006, HIV UG AIDS SER SURV; Mutua G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033103; Peterson Leigh, 2007, PLoS Clin Trials, V2, pe27, DOI 10.1371/journal.pctr.0020027; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ruzagira E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024037; Simoni JM, 2006, AIDS BEHAV, V10, P227, DOI 10.1007/s10461-006-9078-6; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Sobell LC, 1996, ADDICTION; Steinbrook R, 2012, JAMA-J AM MED ASSOC, V308, P865, DOI 10.1001/jama.2012.9885; Stiles T, 2011, PRACTICE; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Van der Elst EM, 2012, PUBMED, V17; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; Wang LH, 2004, AIDS RES HUM RETROV, V20, P1173, DOI 10.1089/aid.2004.20.1173; Ware NC, 2012, JAIDS-J ACQ IMM DEF, V59, P463, DOI 10.1097/QAI.0b013e31824a060b; Weinhardt LS, 1998, ANN BEHAV MED, V20, P25, DOI 10.1007/BF02893805	39	56	60	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e74314	10.1371/journal.pone.0074314	http://dx.doi.org/10.1371/journal.pone.0074314			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086333	Green Submitted, Green Published, gold			2022-12-27	WOS:000325220000008
J	Xuan, JP; Song, YF; Zhang, HX; Liu, JX; Guo, ZR; Hua, YL				Xuan, Jiping; Song, Yufeng; Zhang, Hongxiao; Liu, Jianxiu; Guo, Zhongren; Hua, Yuelou			Comparative Proteomic Analysis of the Stolon Cold Stress Response between the C-4 Perennial Grass Species Zoysia japonica and Zoysia metrella	PLOS ONE			English	Article							ASSISTED-LASER-DESORPTION/IONIZATION; LOW-TEMPERATURE TOLERANCE; HIGH-SALINITY STRESSES; EXPRESSION PROFILES; FREEZE TOLERANCE; GENE-EXPRESSION; PROTEINS; ARABIDOPSIS; RICE; ACCLIMATION	Zoysiagrass, the most cold-tolerant grass among the warm-season turfgrasses, is often used as a model species for isolating cellular components related to cold stress. To understand the proteomic responses to cold stress in zoysiagrass stolons, we extracted stolon proteins from Zoysia japonica, cv. Meyer (cold-tolerant) and Z. metrella, cv. Diamond (cold-sensitive), which were grown with or without cold treatment. Approximately 700 proteins were resolved on 2-DE gels, and 70 protein spots were differentially accumulated. We further observed that 45 of the identified proteins participate in 10 metabolic pathways and cellular processes. A significantly greater number of proteins accumulated in the Meyer than in the Diamond and 15 increased proteins were detected only in the Meyer cultivar under cold stress. Furthermore, we propose a cold stress-responsive protein network composed of several different functional components that exhibits a balance between reactive oxygen species (ROS) production and scavenging, accelerated protein biosynthesis and proteolysis, reduced protein folding, enhanced photosynthesis, abundant energy supply and enhanced biosynthesis of carbohydrates and nucleotides. Generally, the cold-tolerant Meyer cultivar showed a greater ROS scavenging ability, more abundant energy supply and increased photosynthesis and protein synthesis than did the cold-sensitive Diamond cultivar, which may partly explain why Meyer is more cold tolerant.	[Xuan, Jiping; Liu, Jianxiu; Guo, Zhongren; Hua, Yuelou] Jiangsu Prov & Chinese Acad Sci, Inst Bot, Nanjing, Jiangsu, Peoples R China; [Song, Yufeng] Nanjing Agr Univ, Coll Life & Sci, Nanjing, Jiangsu, Peoples R China; [Zhang, Hongxiao] Henan Univ Sci & Technol, Coll Agr, Luoyang, Henan Province, Peoples R China	Nanjing Agricultural University; Henan University of Science & Technology	Liu, JX (corresponding author), Jiangsu Prov & Chinese Acad Sci, Inst Bot, 1 Qianhu Houcun, Nanjing, Jiangsu, Peoples R China.	turfunit@aliyun.com; zhongrenguo@cnbg.net			Jiangsu Provincial Key Lab for Plant EX Situ Conservation Fund [EX200901]	Jiangsu Provincial Key Lab for Plant EX Situ Conservation Fund	This research project was supported by Jiangsu Provincial Key Lab for Plant EX Situ Conservation Fund (EX200901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama F, 1994, B NAT GRASSL RES I; ALEXANDER C, 1995, J BIOL CHEM, V270, P14541, DOI 10.1074/jbc.270.24.14541; Andre CM, 2009, PHYTOCHEMISTRY, V70, P1107, DOI 10.1016/j.phytochem.2009.07.008; [Anonymous], 2012, FROST SURVIVAL PLANT, DOI DOI 10.1002/joc.4518; Bae MS, 2003, PLANT J, V36, P652, DOI 10.1046/j.1365-313X.2003.01907.x; Beard J. B., 1972, TURFGRASS SCI CULTUR; Bernhardt R, 2006, J BIOTECHNOL, V124, P128, DOI 10.1016/j.jbiotec.2006.01.026; Bouly JP, 1999, PLANT J, V18, P541, DOI 10.1046/j.1365-313X.1999.00476.x; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Cho SH, 2005, PHYSIOL MOL PLANT P, V67, P100, DOI 10.1016/j.pmpp.2005.09.011; Cui SX, 2005, PROTEOMICS, V5, P3162, DOI 10.1002/pmic.200401148; Degand H, 2009, PROTEOMICS, V9, P2903, DOI 10.1002/pmic.200800744; Dong WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022394; Dumont E, 2011, PLANT SCI, V180, P86, DOI 10.1016/j.plantsci.2010.09.006; Dunn JH, 1999, HORTSCIENCE, V34, P96, DOI 10.21273/HORTSCI.34.1.96; Fukazawa J, 2000, PLANT CELL, V12, P901, DOI 10.1105/tpc.12.6.901; Fuller R., 1999, LOW TEMPERATURE TOLE; Gao F, 2009, PLANTA, V230, P1033, DOI 10.1007/s00425-009-1003-6; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; GILMOUR SJ, 1988, PLANT PHYSIOL, V87, P745, DOI 10.1104/pp.87.3.745; Giraldo E, 2012, J PROTEOMICS, V75, P5774, DOI 10.1016/j.jprot.2012.08.005; Gollop R, 2002, J EXP BOT, V53, P1397, DOI 10.1093/jexbot/53.373.1397; Grove H, 2009, ELECTROPHORESIS, V30, P1856, DOI 10.1002/elps.200800568; Guera A, 2005, J EXP BOT, V56, P205; Guilfoyle TJ, 2001, J PLANT GROWTH REGUL, V20, P281, DOI 10.1007/s003440010026; Halford NG, 2000, ADV BOT RES, V32, P405, DOI 10.1016/S0065-2296(00)32031-6; Hashimoto M, 2007, PROTEOMICS, V7, P1293, DOI 10.1002/pmic.200600921; Hilt W, 1996, TRENDS BIOCHEM SCI, V21, P96, DOI 10.1016/S0968-0004(96)10012-8; Hoagland DR, 1950, CALIF AGR EXPSTA CIR, V347; Huang HK, 2005, MOL CELL BIOL, V25, P9000, DOI 10.1128/MCB.25.20.9000-9015.2005; Hughes M.A., 1990, BIOTECHNOL GENET, V8, P161, DOI DOI 10.1080/02648725.1990.10647868; Imin N, 2006, MOL CELL PROTEOMICS, V5, P274, DOI 10.1074/mcp.M500242-MCP200; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kawamura Y, 2003, PLANT J, V36, P141, DOI 10.1046/j.1365-313X.2003.01864.x; Kosmala A, 2009, J EXP BOT, V60, P3595, DOI 10.1093/jxb/erp205; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Lee DG, 2007, CR BIOL, V330, P215, DOI 10.1016/j.crvi.2007.01.001; Lee DG, 2009, J PLANT PHYSIOL, V166, P1, DOI 10.1016/j.jplph.2008.02.001; LELIEVRE JM, 1995, POSTHARVEST BIOL TEC, V5, P11, DOI 10.1016/0925-5214(94)00004-C; Matsuba K, 1997, PLANT CELL ENVIRON, V20, P268, DOI 10.1046/j.1365-3040.1997.d01-55.x; MERRIL CR, 1982, ELECTROPHORESIS, V3, P17, DOI 10.1002/elps.1150030104; Miller I, 2006, PROTEOMICS, V6, P5385, DOI 10.1002/pmic.200600323; Molendijk AJ, 2004, CURR OPIN PLANT BIOL, V7, P694, DOI 10.1016/j.pbi.2004.09.014; Parry MAJ, 2008, J EXP BOT, V59, P1569, DOI 10.1093/jxb/ern084; Patton AJ, 2007, CROP SCI, V47, P2162, DOI 10.2135/cropsci2006.11.0739; Patton AJ, 2007, CROP SCI, V47, P2170, DOI 10.2135/cropsci2006.12.0784; Patton AJ, 2007, CROP SCI, V47, P1619, DOI 10.2135/cropsci2006.11.0737; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Ramagli LS, 1999, METH MOL B, V112, P99; SAKAI A, 1968, CRYOBIOLOGY, V5, P160, DOI 10.1016/S0011-2240(68)80161-0; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Sinha P, 2001, PROTEOMICS, V1, P835, DOI 10.1002/1615-9861(200107)1:7<835::AID-PROT835>3.3.CO;2-U; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; SWITZER RC, 1979, ANAL BIOCHEM, V98, P231, DOI 10.1016/0003-2697(79)90732-2; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Thomashow MF, 2001, PLANT PHYSIOL, V125, P89, DOI 10.1104/pp.125.1.89; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Wang XQ, 2009, PROTEOMICS, V9, P4529, DOI 10.1002/pmic.200900062; Xuan JP, 2009, TROP GRASSLANDS, V43, P118; Yamagami T, 2003, J BIOL CHEM, V278, P49102, DOI 10.1074/jbc.M308297200; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Yan SP, 2005, PROTEOMICS, V5, P235, DOI 10.1002/pmic.200400853; Yan YS, 2011, MOL PLANT, V4, P190, DOI 10.1093/mp/ssq066; Yuasa K, 2005, PLANT J, V41, P81, DOI 10.1111/j.1365-313X.2004.02279.x; Zhang HX, 2009, ANN BOT-LONDON, V103, P923, DOI 10.1093/aob/mcp012; Zhang Q, 2009, J AM SOC HORTIC SCI, V134, P322, DOI 10.21273/JASHS.134.3.322; Zhou JM, 2000, MOL PLANT MICROBE IN, V13, P191, DOI 10.1094/MPMI.2000.13.2.191; Zrenner R, 2009, NEW PHYTOL, V183, P117, DOI 10.1111/j.1469-8137.2009.02843.x	74	27	29	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75705	10.1371/journal.pone.0075705	http://dx.doi.org/10.1371/journal.pone.0075705			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086619	Green Published, Green Submitted, gold			2022-12-27	WOS:000325220000035
J	Baker, ME; Vidal-Dorsch, DE; Ribecco, C; Sprague, LJ; Angert, M; Lekmine, N; Ludka, C; Martella, A; Ricciardelli, E; Bay, SM; Gully, JR; Kelley, KM; Schlenk, D; Carnevali, O; Sasik, R; Hardiman, G				Baker, Michael E.; Vidal-Dorsch, Doris E.; Ribecco, Cataldo; Sprague, L. James; Angert, Mila; Lekmine, Narimene; Ludka, Colleen; Martella, Andrea; Ricciardelli, Eugenia; Bay, Steven M.; Gully, Joseph R.; Kelley, Kevin M.; Schlenk, Daniel; Carnevali, Oliana; Sasik, Roman; Hardiman, Gary			Molecular Analysis of Endocrine Disruption in Hornyhead Turbot at Wastewater Outfalls in Southern California Using a Second Generation Multi-Species Microarray	PLOS ONE			English	Article							REPRODUCTIVE STATUS; SEASONAL EVALUATION; ESTROGEN-RECEPTORS; EMERGING CONCERN; RISK-ASSESSMENT; ORANGE-COUNTY; BISPHENOL-A; EXPRESSION; FISH; BIOMARKERS	Sentinel fish hornyhead turbot (Pleuronichthys verticalis) captured near wastewater outfalls are used for monitoring exposure to industrial and agricultural chemicals of similar to 20 million people living in coastal Southern California. Although analyses of hormones in blood and organ morphology and histology are useful for assessing contaminant exposure, there is a need for quantitative and sensitive molecular measurements, since contaminants of emerging concern are known to produce subtle effects. We developed a second generation multi-species microarray with expanded content and sensitivity to investigate endocrine disruption in turbot captured near wastewater outfalls in San Diego, Orange County and Los Angeles California. Analysis of expression of genes involved in hormone [e.g., estrogen, androgen, thyroid] responses and xenobiotic metabolism in turbot livers was correlated with a series of phenotypic end points. Molecular analyses of turbot livers uncovered altered expression of vitellogenin and zona pellucida protein, indicating exposure to one or more estrogenic chemicals, as well as, alterations in cytochrome P450 (CYP) 1A, CYP3A and glutathione S-transferase-a indicating induction of the detoxification response. Molecular responses indicative of exposure to endocrine disruptors were observed in field-caught hornyhead turbot captured in Southern California demonstrating the utility of molecular methods for monitoring environmental chemicals in wastewater outfalls. Moreover, this approach can be adapted to monitor other sites for contaminants of emerging concern in other fish species for which there are few available gene sequences.	[Baker, Michael E.; Ribecco, Cataldo; Martella, Andrea; Ricciardelli, Eugenia; Sasik, Roman; Hardiman, Gary] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Vidal-Dorsch, Doris E.; Bay, Steven M.] Southern Calif Coastal Water Res Project, Costa Mesa, CA USA; [Ribecco, Cataldo; Martella, Andrea; Ricciardelli, Eugenia; Carnevali, Oliana] Univ Politecn Marche, Dept Life & Environm Sci, Ancona, Italy; [Sprague, L. James; Angert, Mila; Lekmine, Narimene; Ludka, Colleen; Sasik, Roman; Hardiman, Gary] Univ Calif San Diego, Sch Med, BIOGEM, La Jolla, CA 92093 USA; [Gully, Joseph R.] Los Angeles Cty Sanit Dist, Whittier, CA USA; [Kelley, Kevin M.] Calif State Univ Long Beach, Environm Endocrinol Lab, Long Beach, CA 90840 USA; [Schlenk, Daniel] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA	University of California System; University of California San Diego; Southern California Coastal Water Research Project; Marche Polytechnic University; University of California System; University of California San Diego; California State University System; California State University Long Beach; University of California System; University of California Riverside	Hardiman, G (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	gthardiman@ucsd.edu	Carnevali, Oliana/P-2751-2015; Baker, Michael/ABB-8508-2020	Carnevali, Oliana/0000-0001-5994-0572; Baker, Michael/0000-0003-4387-3269; Martella, Andrea/0000-0002-4680-7702; Hardiman, Gary/0000-0003-4558-0400	SCCWRP; USC Sea Grant Program (NOAA grant) [NA06OAR4170012, 11.417]; NIH [DK063491, CA023100, DK080506]; UC Senate [RK126H-HARDIMAN]; Campus World Program; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R24DK080506] Funding Source: NIH RePORTER	SCCWRP; USC Sea Grant Program (NOAA grant); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Senate; Campus World Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a contract from the SCCWRP and USC Sea Grant Program (NOAA grant #NA06OAR4170012, CFDA No. 11.417, Project CE-17). The authors also wish to acknowledge partial financial support and assistance from the Los Angeles Sanitation Districts, Orange County Sanitation District, City of San Diego Public Utilities Department, Wastewater Branch, Environmental Monitoring and Technical Services Division and the City of Los Angeles, Environmental Monitoring Division. GH gratefully acknowledge support from NIH grants DK063491, CA023100 and DK080506 and UC Senate grant RK126H-HARDIMAN. C. Ribecco and A. Martella were recipients of training grants from 'The Campus World Program'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Atanasov AG, 2005, ENVIRON HEALTH PERSP, V113, P1600, DOI 10.1289/ehp.8209; Baker ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046078; Baker ME, 2011, MOL CELL ENDOCRINOL, V334, P14, DOI 10.1016/j.mce.2010.07.013; Baker ME, 2009, ENVIRON HEALTH PERSP, V117, P223, DOI 10.1289/ehp.11627; Balesaria S, 2010, FEBS LETT, V584, P719, DOI 10.1016/j.febslet.2009.12.023; Bay SM, 2012, ENVIRON TOXICOL CHEM, V31, P2711, DOI 10.1002/etc.2007; Blanchette B, 2007, MAR BIOTECHNOL, V9, P513, DOI 10.1007/s10126-007-9034-0; Brar NK, 2010, AQUAT TOXICOL, V96, P203, DOI 10.1016/j.aquatox.2009.10.023; Brown JS, 2004, ECOL INDIC, V3, P263, DOI 10.1016/j.ecolind.2003.11.004; Deng X, 2007, ENVIRON TOXICOL, V22, P464, DOI 10.1002/tox.20287; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Filby AL, 2007, ENVIRON SCI TECHNOL, V41, P8187, DOI 10.1021/es071278v; Forsgren KL, 2012, ENVIRON TOXICOL CHEM, V31, P2701, DOI 10.1002/etc.2006; Fortunati N, 2010, MOL CELL ENDOCRINOL, V316, P86, DOI 10.1016/j.mce.2009.09.012; Hardiman G, 2004, PHARMACOGENOMICS, V5, P487, DOI 10.1517/14622416.5.5.487; Heindel JJ, 2009, MOL CELL ENDOCRINOL, V304, P90, DOI 10.1016/j.mce.2009.02.025; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hutchinson TH, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI 10.1289/ehp.8062; Jin YX, 2010, COMP BIOCHEM PHYS C, V151, P258, DOI 10.1016/j.cbpc.2009.11.004; Jobling S, 2009, ENVIRON HEALTH PERSP, V117, P797, DOI 10.1289/ehp.0800197; Katchamart S, 2002, ENVIRON TOXICOL CHEM, V21, P2445, DOI 10.1897/1551-5028(2002)021<2445:EOXEOT>2.0.CO;2; Kirchner S, 2010, MOL ENDOCRINOL, V24, P526, DOI 10.1210/me.2009-0261; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lam SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000121; Larkin P, 2007, ENVIRON TOXICOL CHEM, V26, P1497, DOI 10.1897/06-501R.1; LeBlanc GA, 2007, ECOTOXICOLOGY, V16, P61, DOI 10.1007/s10646-006-0115-z; Li GY, 2008, AQUAT TOXICOL, V88, P75, DOI 10.1016/j.aquatox.2008.03.007; Li XY, 2005, NUCLEIC ACIDS RES, V33, P6114, DOI 10.1093/nar/gki914; Maradonna F, 2007, BIOMARKERS, V12, P240, DOI 10.1080/13547500601070859; Maruya KA, 2012, ENVIRON TOXICOL CHEM, V31, P2683, DOI 10.1002/etc.2003; Miguel-Queralt S, 2008, ENDOCRINOLOGY, V149, P4269, DOI 10.1210/en.2008-0384; Millan A, 2010, MAR BIOTECHNOL, V12, P452, DOI 10.1007/s10126-009-9231-0; Moens LN, 2006, TOXICOL SCI, V93, P298, DOI 10.1093/toxsci/kfl057; Monserrat JM, 2007, COMP BIOCHEM PHYS C, V146, P221, DOI 10.1016/j.cbpc.2006.08.012; Mortensen AS, 2007, AQUAT TOXICOL, V85, P113, DOI 10.1016/j.aquatox.2007.08.004; Nielsen HB, 2003, NUCLEIC ACIDS RES, V31, P3491, DOI 10.1093/nar/gkg622; Oehlmann J, 2008, ENVIRON RES, V108, P140, DOI 10.1016/j.envres.2008.07.016; Ollikainen N, 2006, INTEGR COMP BIOL, V46, P815, DOI 10.1093/icb/icl035; PAJOR AM, 1990, J EXP ZOOL, V253, P51, DOI 10.1002/jez.1402530108; Pereiro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035369; Ramirez AJ, 2009, ENVIRON TOXICOL CHEM, V28, P2587, DOI 10.1897/08-561.1; Rempel MA, 2006, AQUAT TOXICOL, V77, P241, DOI 10.1016/j.aquatox.2005.12.007; Rhee JS, 2009, ECOTOX ENVIRON SAFE, V72, P206, DOI 10.1016/j.ecoenv.2008.06.001; Robertson LS, 2009, FISH SHELLFISH IMMUN, V26, P898, DOI 10.1016/j.fsi.2009.03.023; Santos EM, 2007, AQUAT TOXICOL, V83, P134, DOI 10.1016/j.aquatox.2007.03.019; Sarkar A, 2006, ECOTOXICOLOGY, V15, P333, DOI 10.1007/s10646-006-0069-1; Sasik R, 2004, J MOL ENDOCRINOL, V33, P1, DOI 10.1677/jme.0.0330001; Scholz S, 2008, MOL CELL ENDOCRINOL, V293, P57, DOI 10.1016/j.mce.2008.06.008; Shike H, 2002, EUR J BIOCHEM, V269, P2232, DOI 10.1046/j.1432-1033.2002.02881.x; Soto AM, 2008, BASIC CLIN PHARMACOL, V102, P125, DOI 10.1111/j.1742-7843.2007.00165.x; Sugiyama N, 2010, TRENDS ENDOCRIN MET, V21, P545, DOI 10.1016/j.tem.2010.05.001; Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007; Swan Shanna H, 2008, Fertil Steril, V89, pe45, DOI 10.1016/j.fertnstert.2007.12.027; Team RDC, 2005, R LANG ENV STAT COMP; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tyler Charles R., 2007, Environmental Sciences, V14, P235; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Vidal-Dorsch DE, 2012, ENVIRON TOXICOL CHEM, V31, P2674, DOI 10.1002/etc.2004; Wernersson R, 2005, NUCLEIC ACIDS RES, V33, pW611, DOI 10.1093/nar/gki399; Williams TD, 2003, AQUAT TOXICOL, V65, P141, DOI 10.1016/S0166-445X(03)00119-X; Yang LX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r227	65	35	35	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75553	10.1371/journal.pone.0075553	http://dx.doi.org/10.1371/journal.pone.0075553			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086568	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700100
J	Bobinet, M; Vignard, V; Florenceau, L; Lang, F; Labarriere, N; Moreau-Aubry, A				Bobinet, Mathilde; Vignard, Virginie; Florenceau, Laetitia; Lang, Francois; Labarriere, Nathalie; Moreau-Aubry, Agnes			Overexpression of Meloe Gene in Melanomas Is Controlled Both by Specific Transcription Factors and Hypomethylation	PLOS ONE			English	Article							MELANOCYTE DEVELOPMENT; PROMOTER; EXPRESSION; CELLS; MICROPHTHALMIA; ANTIGEN; FAMILY; MITF; ACTIVATION; SOX	The melanoma antigens MELOE-1 and MELOE-2 are encoded by a messenger, called meloe, overexpressed in melanomas compared with other tumour cell types and healthy tissues. They are both able to elicit melanoma-specific T cell responses in melanoma patients, and MELOE-1-specific CD8 T cells have been involved in melanoma immunosurveillance. With the aim to develop immunotherapies targeting this antigen, we investigated the transcriptional mechanisms leading to the preferential expression of meloe messenger in the melanocytic lineage. We defined the minimal promoter region of meloe gene and identified binding motifs for a set of transcription factors. Using mutagenesis, co-transfection experiments and chromatin immunoprecipitation, we showed that transcription factors involved in meloe promoter activity in melanomas were the melanocytic specific SOX9 and SOX10 proteins together with the activated P-CREB protein. Furthermore, we showed that meloe promoter was hypomethylated in melanomas and melanocytes, and hypermethylated in colon cancer cell lines and mesotheliomas, thus explaining the absence of P-CREB binding in these cell lines. This was a second key to explain the overerexpression of meloe messenger in the melanocytic lineage. To our knowledge, such a dual transcriptional control conferring tissue-specificity has never been described for the expression of tumour antigens.	[Bobinet, Mathilde; Vignard, Virginie; Florenceau, Laetitia; Lang, Francois; Labarriere, Nathalie; Moreau-Aubry, Agnes] INSERM, UMR 892, Nantes, France; [Bobinet, Mathilde; Vignard, Virginie; Florenceau, Laetitia; Lang, Francois; Labarriere, Nathalie; Moreau-Aubry, Agnes] Univ Nantes, Nantes, France; [Bobinet, Mathilde; Vignard, Virginie; Florenceau, Laetitia; Lang, Francois; Labarriere, Nathalie; Moreau-Aubry, Agnes] CNRS, UMR 6299, Nantes, France; [Vignard, Virginie] Univ Hosp Nantes, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; CHU de Nantes	Labarriere, N (corresponding author), INSERM, UMR 892, Nantes, France.	nathalie.labarriere@inserm.fr; Agnes.Aubry@univ-nantes.fr	LANG, François/K-7403-2015; Aubry, Agnes/K-8771-2015; Vignard, Virginie/K-7540-2015; Florenceau, Laetitia/K-7428-2015; Labarriere, Nathalie/H-8876-2015	LANG, François/0000-0002-0762-4647; Vignard, Virginie/0000-0002-6702-2824; Florenceau, Laetitia/0000-0003-1284-414X; Labarriere, Nathalie/0000-0002-1407-6546	"Ligue contre le cancer du Grand Ouest" committee 44; "Ligue contre le cancer du Grand Ouest" committee 85	"Ligue contre le cancer du Grand Ouest" committee 44; "Ligue contre le cancer du Grand Ouest" committee 85	This work was supported by the "Ligue contre le cancer du Grand Ouest" committee 44, and committee 85 for Mathilde Bobinet salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakos RM, 2010, EXP DERMATOL, V19, pE89, DOI 10.1111/j.1600-0625.2009.00991.x; BENTLEY NJ, 1994, MOL CELL BIOL, V14, P7996, DOI 10.1128/MCB.14.12.7996; Bobinet M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051716; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Butterfield LH, 1997, GENE, V191, P129, DOI 10.1016/S0378-1119(96)00789-5; Castillo SD, 2012, EXPERT OPIN THER TAR, V16, P903, DOI 10.1517/14728222.2012.709239; Chenchik A, 1996, BIOTECHNIQUES, V21, P526; De Smet C, 1999, MOL CELL BIOL, V19, P7327; DEPLAEN E, 1994, IMMUNOGENETICS, V40, P360, DOI 10.1007/BF01246677; DeSmet C, 1996, P NATL ACAD SCI USA, V93, P7149, DOI 10.1073/pnas.93.14.7149; Dong L, 2011, ONCOGENE, V30, P3716, DOI 10.1038/onc.2011.87; Du JY, 2003, AM J PATHOL, V163, P333, DOI 10.1016/S0002-9440(10)63657-7; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; Flammiger A, 2009, J INVEST DERMATOL, V129, P945, DOI 10.1038/jid.2008.316; Godet Y, 2008, J EXP MED, V205, P2673, DOI 10.1084/jem.20081356; Godet Y, 2010, EUR J IMMUNOL, V40, P1786, DOI 10.1002/eji.200940132; Godet Y, 2010, CANCER IMMUNOL IMMUN, V59, P431, DOI 10.1007/s00262-009-0762-z; Goding CR, 2000, GENE DEV, V14, P1712; Gueugnon F, 2011, AM J PATHOL, V178, P1033, DOI 10.1016/j.ajpath.2010.12.014; Harris ML, 2010, PIGM CELL MELANOMA R, V23, P496, DOI 10.1111/j.1755-148X.2010.00711.x; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Huber WE, 2003, J BIOL CHEM, V278, P45224, DOI 10.1074/jbc.M309036200; Jean D, 2001, CRIT REV IMMUNOL, V21, P275; Kaneda A, 2004, CANCER SCI, V95, P58, DOI 10.1111/j.1349-7006.2004.tb03171.x; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P6458, DOI 10.1073/pnas.91.14.6458; Kellerer S, 2006, DEVELOPMENT, V133, P2875, DOI 10.1242/dev.02477; LOWINGS P, 1992, MOL CELL BIOL, V12, P3653, DOI 10.1128/MCB.12.8.3653; Lucas S, 2012, INT J CANCER, V130, P1960, DOI 10.1002/ijc.26198; Madireddi MT, 2000, J CELL PHYSIOL, V185, P36, DOI 10.1002/1097-4652(200010)185:1<36::AID-JCP3>3.0.CO;2-V; Matz M, 1999, NUCLEIC ACIDS RES, V27, P1558, DOI 10.1093/nar/27.6.1558; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Melnikova VO, 2006, J BIOL CHEM, V281, P2911, DOI 10.1074/jbc.M508683200; Minev B, 2000, P NATL ACAD SCI USA, V97, P4796, DOI 10.1073/pnas.070560797; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; Passeron T, 2007, P NATL ACAD SCI USA, V104, P13984, DOI 10.1073/pnas.0705117104; Riva A, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-33; Rogel A, 2011, CANCER IMMUNOL IMMUN, V60, P327, DOI 10.1007/s00262-010-0938-6; Ropke M, 1996, P NATL ACAD SCI USA, V93, P14704, DOI 10.1073/pnas.93.25.14704; Sato Y, 2001, CELL STRUCT FUNCT, V26, P19, DOI 10.1247/csf.26.19; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Tachibana M, 2000, PIGM CELL RES, V13, P230, DOI 10.1034/j.1600-0749.2000.130404.x; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058	43	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75421	10.1371/journal.pone.0075421	http://dx.doi.org/10.1371/journal.pone.0075421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086527	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700084
J	Jung, CR; Lin, YT; Hwang, BF				Jung, Chau-Ren; Lin, Yu-Ting; Hwang, Bing-Fang			Air Pollution and Newly Diagnostic Autism Spectrum Disorders: A Population-Based Cohort Study in Taiwan	PLOS ONE			English	Article							OXIDATIVE STRESS; LIPID-PEROXIDATION; NITROGEN-DIOXIDE; CHILDREN; EXPOSURE; OZONE; BRAIN; RISK; RAT; MECHANISMS	There is limited evidence that long-term exposure to ambient air pollution increases the risk of childhood autism spectrum disorder (ASD). The objective of the study was to investigate the associations between long-term exposure to air pollution and newly diagnostic ASD in Taiwan. We conducted a population-based cohort of 49,073 children age less than 3 years in 2000 that were retrieved from Taiwan National Insurance Research Database and followed up from 2000 through 2010. Inverse distance weighting method was used to form exposure parameter for ozone (O-3), carbon monoxide (CO), nitrogen dioxide (NO2), sulfur dioxide (SO2), and particles with aerodynamic diameter less than 10 mu m (PM10). Time-dependent Cox proportional hazards (PH) model was performed to evaluate the relationship between yearly average exposure air pollutants of preceding years and newly diagnostic ASD. The risk of newly diagnostic ASD increased according to increasing O-3, CO, NO2, and SO2 levels. The effect estimate indicating an approximately 59% risk increase per 10 ppb increase in O-3 level (95% CI 1.42-1.79), 37% risk increase per 10 ppb in CO (95% CI 1.31-1.44), 340% risk increase per 10 ppb increase in NO2 level (95% CI 3.31-5.85), and 17% risk increase per 1 ppb in SO2 level (95% CI 1.09-1.27) was stable with different combinations of air pollutants in the multi-pollutant models. Our results provide evident that children exposure to O-3, CO, NO2, and SO2 in the preceding 1 year to 4 years may increase the risk of ASD diagnosis.	[Jung, Chau-Ren; Lin, Yu-Ting; Hwang, Bing-Fang] China Med Univ, Coll Publ Hlth, Dept Occupat Safety & Hlth, Taichung, Taiwan	China Medical University Taiwan	Hwang, BF (corresponding author), China Med Univ, Coll Publ Hlth, Dept Occupat Safety & Hlth, Taichung, Taiwan.	bfhwang@mail.cmu.edu.tw	Hwang, Bing-Fang/O-2709-2015; Jung, Chau-Ren/I-7618-2019	Hwang, Bing-Fang/0000-0002-5951-9662; Jung, Chau-Ren/0000-0003-0673-9968	China Medical University [100-Award-07]	China Medical University(China Medical University)	This study was supported by grant CMU#100-Award-07 from China Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Avila-Costa MR, 1999, NEUROSCI LETT, V270, P107, DOI 10.1016/S0304-3940(99)00458-9; Banks WA, 2002, NEUROIMMUNOMODULAT, V10, P319, DOI 10.1159/000071472; Bayram H, 2001, J ALLERGY CLIN IMMUN, V107, P287, DOI 10.1067/mai.2001.111141; Becerra TA, 2013, ENVIRON HEALTH PERSP, V121, P380, DOI 10.1289/ehp.1205827; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bureau of National Health Insurance, 2012, NAT HLTH INS RES DAT; Chauhan A, 2004, LIFE SCI, V75, P2539, DOI 10.1016/j.lfs.2004.04.038; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Colin-Barenque L, 1999, NEUROSCI LETT, V274, P1, DOI 10.1016/S0304-3940(99)00639-4; Durkin MS, 2008, AM J EPIDEMIOL, V168, P1268, DOI 10.1093/aje/kwn250; Enstrom A, 2009, BRAIN BEHAV IMMUN, V23, P389, DOI 10.1016/j.bbi.2008.12.005; Gillberg C, 1998, J AUTISM DEV DISORD, V28, P415, DOI 10.1023/A:1026004505764; Hwang YS, 2013, RES DEV DISABIL, V34, P2462, DOI 10.1016/j.ridd.2013.05.019; James SJ, 2009, FASEB J, V23, P2374, DOI 10.1096/fj.08-128926; Kalkbrenner AE, 2010, EPIDEMIOLOGY, V21, P631, DOI 10.1097/EDE.0b013e3181e65d76; Karalliedde L, 2012, ESSENTIALS TOXICOLOG, P157; Kelly FJ, 2003, OCCUP ENVIRON MED, V60, P612, DOI 10.1136/oem.60.8.612; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L; Leyfer OT, 2006, J AUTISM DEV DISORD, V36, P849, DOI 10.1007/s10803-006-0123-0; Li XH, 2009, J NEUROIMMUNOL, V207, P111, DOI 10.1016/j.jneuroim.2008.12.002; Lin HC, 2010, AUST NZ J PSYCHIAT, V44, P273, DOI 10.3109/00048670903487209; Matson JL, 2007, RES DEV DISABIL, V28, P341, DOI 10.1016/j.ridd.2005.12.004; Meng ZQ, 2003, INHAL TOXICOL, V15, P181, DOI 10.1080/08958370304476; Ming X, 2005, PROSTAG LEUKOTR ESS, V73, P379, DOI 10.1016/j.plefa.2005.06.002; Naira PM, 2006, J CHEM NEUROANAT, V31, P114, DOI 10.1016/j.jchemneu.2005.09.006; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Prockop LD, 2007, J NEUROL SCI, V262, P122, DOI 10.1016/j.jns.2007.06.037; Rivas-Arancibia S, 2003, PHARMACOL BIOCHEM BE, V74, P891, DOI 10.1016/S0091-3057(03)00011-X; RODKEY FL, 1969, BLOOD-J HEMATOL, V33, P57, DOI 10.1182/blood.V33.1.57.57; Rosen NJ, 2007, PEDIATRICS, V119, pE61, DOI 10.1542/peds.2006-1788; Rutter M, 2005, ACTA PAEDIATR, V94, P2, DOI 10.1080/08035250410023124; Santiago-Lopez D, 2010, TOXICOL LETT, V197, P193, DOI 10.1016/j.toxlet.2010.05.020; Sogut S, 2003, CLIN CHIM ACTA, V331, P111, DOI 10.1016/S0009-8981(03)00119-0; Sorace A, 2001, ENVIRON RES, V85, P122, DOI 10.1006/enrs.2000.4097; Stroh E, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-19; TABACOVA S, 1985, NEUROTOXICOL TERATOL, V7, P785; Tamagawa E, 2006, CHEST, V130, P1631, DOI 10.1378/chest.130.6.1631; THOM SR, 1990, J APPL PHYSIOL, V68, P997, DOI 10.1152/jappl.1990.68.3.997; Volk HE, 2012, ENV HLTH PERSPECT, V119, P873; Volk HE, 2013, JAMA PSYCHIAT, V70, P71, DOI 10.1001/jamapsychiatry.2013.266; Windham GC, 2006, ENVIRON HEALTH PERSP, V114, P1438, DOI 10.1289/ehp.9120; Wu CY, 2010, GASTROENTEROLOGY, V139, P1165, DOI 10.1053/j.gastro.2010.06.067; Yorbik O, 2002, PROSTAG LEUKOTR ESS, V67, P341, DOI 10.1054/plef.2002.0439; ZHANG J, 1992, J CLIN INVEST, V90, P1193, DOI 10.1172/JCI115980; Zoroglu SS, 2004, EUR ARCH PSY CLIN N, V254, P143, DOI 10.1007/s00406-004-0456-7	46	76	79	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75510	10.1371/journal.pone.0075510	http://dx.doi.org/10.1371/journal.pone.0075510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VC	24086549	Green Submitted, gold, Green Published			2022-12-27	WOS:000325218700093
J	Mascarenhas, R; Dougherty, JA; Schoenberg, DR				Mascarenhas, Roshan; Dougherty, Julie A.; Schoenberg, Daniel R.			SMG6 Cleavage Generates Metastable Decay Intermediates from Nonsense-Containing beta-Globin mRNA	PLOS ONE			English	Article							ENDONUCLEOLYTIC CLEAVAGE; POLYSOMAL RIBONUCLEASE-1; ERYTHROID TISSUES; IN-VIVO; CELLS; PMR1; IDENTIFICATION; DEGRADATION; TERMINATION; EXPRESSION	mRNAs targeted by endonuclease decay generally disappear without detectable decay intermediates. The exception to this is nonsense-containing human beta-globin mRNA, where the destabilization of full-length mRNA is accompanied by the cytoplasmic accumulation of 5'-truncated transcripts in erythroid cells of transgenic mice and in transfected erythroid cell lines. The relationship of the shortened RNAs to the decay process was characterized using an inducible erythroid cell system and an assay for quantifying full-length mRNA and a truncated RNA missing 169 nucleotides from the 5' end. In cells knocked down for Upf1 a reciprocal increase in full-length and decrease in shortened RNA confirmed the role of NMD in this process. Kinetic analysis demonstrated that the 5'-truncated RNAs are metastable intermediates generated during the decay process. SMG6 previously was identified as an endonuclease involved in NMD. Consistent with involvement of SMG6 in the decay process full-length nonsense-containing beta-globin mRNA was increased and the Delta 169 decay intermediate was decreased in cells knocked down for SMG6. This was reversed by complementation with siRNA-resistant SMG6, but not by SMG6 with inactivating PIN domain mutations. Importantly, none of these altered the phosphorylation state of Upf1. These data provide the first proof for accumulation of stable NMD products by SMG6 endonuclease cleavage.	[Mascarenhas, Roshan; Dougherty, Julie A.; Schoenberg, Daniel R.] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Mascarenhas, Roshan; Dougherty, Julie A.; Schoenberg, Daniel R.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Dougherty, Julie A.; Schoenberg, Daniel R.] Ohio State Univ, Biomed Sci Grad Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Schoenberg, DR (corresponding author), Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA.	schoenberg.3@osu.edu	Schoenberg, Daniel/J-3423-2019	Schoenberg, Daniel/0000-0003-4570-1946; Dougherty, Julie/0000-0001-5778-1512	National Institute of General Medical Sciences of the United States National Institutes of Health [GM038277, GM079707, GM084177]; Ohio State University Center for RNA Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084177, R01GM038277, R01GM079707] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the United States National Institutes of Health; Ohio State University Center for RNA Biology(Ohio State University); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institute of General Medical Sciences of the United States National Institutes of Health grant numbers GM038277, GM079707, and GM084177. JA was supported by a fellowship from The Ohio State University Center for RNA Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bremer KA, 2003, RNA, V9, P1157, DOI 10.1261/rna.5720303; Eberle AB, 2009, NAT STRUCT MOL BIOL, V16, P49, DOI 10.1038/nsmb.1530; Gatfield D, 2004, NATURE, V429, P575, DOI 10.1038/nature02559; Hanson MN, 2001, J BIOL CHEM, V276, P12331, DOI 10.1074/jbc.M010483200; Huntzinger E, 2008, RNA, V14, P2609, DOI 10.1261/rna.1386208; Jiang Y, 2006, MOL CELL BIOL, V26, P2419, DOI 10.1128/MCB.26.6.2419-2429.2006; Karginov FV, 2010, MOL CELL, V38, P781, DOI 10.1016/j.molcel.2010.06.001; Kashima I, 2010, GENE DEV, V24, P2440, DOI 10.1101/gad.604610; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Lasham A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1076; LIM SK, 1992, EMBO J, V11, P3271, DOI 10.1002/j.1460-2075.1992.tb05405.x; LIM SK, 1989, EMBO J, V8, P2613, DOI 10.1002/j.1460-2075.1989.tb08401.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Okada-Katsuhata Y, 2012, NUCLEIC ACIDS RES, V40, P1251, DOI 10.1093/nar/gkr791; Otsuka Y, 2009, MOL CELL BIOL, V29, P2155, DOI 10.1128/MCB.01325-08; Otsuka Y, 2008, METHOD ENZYMOL, V448, P241, DOI 10.1016/S0076-6879(08)02613-X; Peng Y, 2007, MOL CELL, V25, P779, DOI 10.1016/j.molcel.2007.01.026; Poddie D, 2003, HEMOGLOBIN, V27, P219, DOI 10.1081/HEM-120026046; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Schoenberg DR, 2011, WIRES RNA, V2, P582, DOI 10.1002/wrna.78; Stevens A, 2002, P NATL ACAD SCI USA, V99, P12741, DOI 10.1073/pnas.192442399; Trcek T, 2013, GENE DEV, V27, P541, DOI 10.1101/gad.209635.112; Wang J, 2002, J BIOL CHEM, V277, P18489, DOI 10.1074/jbc.M111781200; Yang F, 2004, J BIOL CHEM, V279, P48993, DOI 10.1074/jbc.M409776200	25	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74791	10.1371/journal.pone.0074791	http://dx.doi.org/10.1371/journal.pone.0074791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086375	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700037
J	Riese, F; Grinschgl, S; Gersbacher, MT; Russi, N; Hock, C; Nitsch, RM; Konietzko, U				Riese, Florian; Grinschgl, Sonja; Gersbacher, Manuel T.; Russi, Natalie; Hock, Christoph; Nitsch, Roger M.; Konietzko, Uwe			Visualization and Quantification of APP Intracellular Domain-Mediated Nuclear Signaling by Bimolecular Fluorescence Complementation	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; TYROSINE; PHOSPHORYLATION; TRANSCRIPTION; DIMERIZATION; TRAFFICKING; INTERACTOME; HYPOTHESIS; MUTATION	Background: The amyloid precursor protein (APP) intracellular domain (AICD) is released from full-length APP upon sequential cleavage by either alpha- or beta-secretase followed by gamma-secretase. Together with the adaptor protein Fe65 and the histone acetyltransferase Tip60, AICD forms nuclear multiprotein complexes (AFT complexes) that function in transcriptional regulation. Objective: To develop a medium-throughput machine-based assay for visualization and quantification of AFT complex formation in cultured cells. Methods: We used cotransfection of bimolecular fluorescence complementation (BiFC) fusion constructs of APP and Tip60 for analysis of subcellular localization by confocal microscopy and quantification by flow cytometry (FC). Results: Our novel BiFC-constructs show a nuclear localization of AFT complexes that is identical to conventional fluorescence-tagged constructs. Production of the BiFC signal is dependent on the adaptor protein Fe65 resulting in fluorescence complementation only after Fe65-mediated nuclear translocation of AICD and interaction with Tip60. We applied the AFT-BiFC system to show that the Swedish APP familial Alzheimer's disease mutation increases AFT complex formation, consistent with the notion that AICD mediated nuclear signaling mainly occurs following APP processing through the amyloidogenic beta-secretase pathway. Next, we studied the impact of posttranslational modifications of AICD on AFT complex formation. Mutation of tyrosine 682 in the YENPTY motif of AICD to phenylalanine prevents phosphorylation resulting in increased nuclear AFT-BiFC signals. This is consistent with the negative impact of tyrosine phosphorylation on Fe65 binding to AICD. Finally, we studied the effect of oxidative stress. Our data shows that oxidative stress, at a level that also causes cell death, leads to a reduction in AFT-BiFC signals. Conclusion: We established a new method for visualization and FC quantification of the interaction between AICD, Fe65 and Tip60 in the nucleus based on BiFC. It enables flow cytometric analysis of AICD nuclear signaling and is characterized by scalability and low background fluorescence.	[Riese, Florian; Grinschgl, Sonja; Gersbacher, Manuel T.; Russi, Natalie; Hock, Christoph; Nitsch, Roger M.; Konietzko, Uwe] Univ Zurich, Div Psychiat Res & Psychogeriatr Med, Zurich, Switzerland	University of Zurich	Konietzko, U (corresponding author), Univ Zurich, Div Psychiat Res & Psychogeriatr Med, Zurich, Switzerland.	uwekon@bli.uzh.ch	Riese, Florian/I-1887-2019	Riese, Florian/0000-0001-5531-5833; Russi, Natalie/0000-0002-9121-8851	Swiss National Science Foundation (SNF) [31003A_130148]; SNF SPUM [33CM3O-124111]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); SNF SPUM	This work was supported by the Swiss National Science Foundation (SNF) grant 31003A_130148 and the SNF SPUM grant 33CM3O-124111. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banning C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009344; Belyaev ND, 2010, J BIOL CHEM, V285, P41443, DOI 10.1074/jbc.M110.141390; Ben Khalifa N, 2012, FASEB J, V26, P855, DOI 10.1096/fj.11-190207; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Cacquevel M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035133; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Chen CD, 2006, J NEUROCHEM, V97, P30, DOI 10.1111/j.1471-4159.2006.03705.x; Flammang B, 2012, J ALZHEIMERS DIS, V30, P145, DOI 10.3233/JAD-2012-112186; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Gersbacher MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069363; Goncalves SA, 2010, TRENDS BIOCHEM SCI, V35, P643, DOI 10.1016/j.tibs.2010.05.007; Goodger ZV, 2009, J CELL SCI, V122, P3703, DOI 10.1242/jcs.048090; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Iborra FJ, 1996, J CELL SCI, V109, P1427; Isbert S, 2012, CELL MOL LIFE SCI, V69, P1353, DOI 10.1007/s00018-011-0882-4; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kodama Y, 2012, BIOTECHNIQUES, V53, P285, DOI [10.2144/0000113943, 10.2144/000113943]; Kohli BM, 2012, J PROTEOME RES, V11, P4075, DOI 10.1021/pr300123g; Konietzko U, 2012, CURR ALZHEIMER RES, V9, P200, DOI 10.2174/156720512799361673; Konietzko U, 2010, NEUROBIOL AGING, V31, P58, DOI 10.1016/j.neurobiolaging.2008.03.001; Matrone C, 2011, J NEUROSCI, V31, P11756, DOI 10.1523/JNEUROSCI.1960-11.2011; Minopoli G, 2007, NEURODEGENER DIS, V4, P94, DOI 10.1159/000101833; Morell M, 2008, NAT PROTOC, V3, P22, DOI 10.1038/nprot.2007.496; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Oh SY, 2010, J NEUROCHEM, V113, P262, DOI 10.1111/j.1471-4159.2010.06603.x; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Pombo A, 1999, EMBO J, V18, P2241, DOI 10.1093/emboj/18.8.2241; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; So Pauline Pl, 2013, Am J Neurodegener Dis, V2, P15; Tamayev R, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-28; Tarr PE, 2002, BIOCHEM BIOPH RES CO, V295, P324, DOI 10.1016/S0006-291X(02)00678-2; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Ventura S, 2011, CURR MOL MED, V11, P582, DOI 10.2174/156652411800615117; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Waldron E, 2008, NEUROBIOL DIS, V31, P188, DOI 10.1016/j.nbd.2008.04.006; Weyer S.W., 2011, EMBO J; XU X, 2011, EMBO REP, V12, P1, DOI DOI 10.1038/EMB0R.2010.210.PUBMED:21293490; Zambrano N, 2001, J BIOL CHEM, V276, P19787, DOI 10.1074/jbc.M100792200; Zhou DW, 2009, J ALZHEIMERS DIS, V16, P301, DOI 10.3233/JAD-2009-0970	46	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76094	10.1371/journal.pone.0076094	http://dx.doi.org/10.1371/journal.pone.0076094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086696	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000325218700121
J	Parihar, SP; Guler, R; Lang, DM; Suzuki, H; Marais, AD; Brombacher, F				Parihar, Suraj P.; Guler, Reto; Lang, Dirk M.; Suzuki, Harukazu; Marais, A. David; Brombacher, Frank			Simvastatin Enhances Protection against Listeria monocytogenes Infection in Mice by Counteracting Listeria-Induced Phagosomal Escape	PLOS ONE			English	Article							HMG-COA REDUCTASE; LIPID RAFTS; CHOLESTEROL DEPLETION; STATINS; ACTIVATION; INHIBITION; PROLIFERATION; PHAGOCYTOSIS; MACROPHAGES; RESISTANCE	Statins are well-known cholesterol lowering drugs targeting HMG-CoA-reductase, reducing the risk of coronary disorders and hypercholesterolemia. Statins are also involved in immunomodulation, which might influence the outcome of bacterial infection. Hence, a possible effect of statin treatment on Listeriosis was explored in mice. Statin treatment prior to subsequent L. monocytogenes infection strikingly reduced bacterial burden in liver and spleen (up to 100-fold) and reduced histopathological lesions. Statin-treatment in infected macrophages resulted in increased IL-12p40 and TNF-alpha and up to 4-fold reduced bacterial burden within 6 hours post infection, demonstrating a direct effect of statins on limiting bacterial growth in macrophages. Bacterial uptake was normal investigated in microbeads and GFP-expressing Listeria experiments by confocal microscopy. However, intracellular membrane-bound cholesterol level was decreased, as analyzed by cholesterol-dependent filipin staining and cellular lipid extraction. Mevalonate supplementation restored statin-inhibited cholesterol biosynthesis and reverted bacterial growth in Listeria monocytogenes but not in listeriolysin O (LLO)-deficient Listeria. Together, these results suggest that statin pretreatment increases protection against L. monocytogenes infection by reducing membrane cholesterol in macrophages and thereby preventing effectivity of the cholesterol-dependent LLO-mediated phagosomal escape of bacteria.	[Parihar, Suraj P.; Guler, Reto; Brombacher, Frank] Univ Cape Town, Int Ctr Genet Engn & Biotechnol ICGEB, ZA-7925 Cape Town, South Africa; [Parihar, Suraj P.; Guler, Reto; Brombacher, Frank] Univ Cape Town, Fac Hlth Sci, Div Immunol, Inst Infect Dis & Mol Med IIDMM, ZA-7925 Cape Town, South Africa; [Lang, Dirk M.] Univ Cape Town, Fac Hlth Sci, Dept Human Biol, ZA-7925 Cape Town, South Africa; [Suzuki, Harukazu] RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan; [Marais, A. David] Univ Cape Town, Fac Hlth Sci, Div Chem Pathol, ZA-7925 Cape Town, South Africa	International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; RIKEN; University of Cape Town	Brombacher, F (corresponding author), Univ Cape Town, Int Ctr Genet Engn & Biotechnol ICGEB, ZA-7925 Cape Town, South Africa.	fbrombac@mweb.co.za	Suzuki, Harukazu/N-9553-2015; Lang, Dirk/I-2554-2015; Parihar, Suraj/HCI-2597-2022	Suzuki, Harukazu/0000-0002-8087-0836; Lang, Dirk/0000-0003-3901-2079; Parihar, Suraj/0000-0002-4932-7990	International Centre for Genetic Engineering & Biotechnology (ICGEB), Cape Town; South African Medical Research Council (SAMRC) Unit on Immunology of Infectious Diseases; SAMRC; SAMRC research group development grant; University and Faculty Research Committee funding (URC/FRC); Kwazulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) South Africa; National Research Funding (NRF) South Africa; South African Research Chair initiative (SARChi)	International Centre for Genetic Engineering & Biotechnology (ICGEB), Cape Town; South African Medical Research Council (SAMRC) Unit on Immunology of Infectious Diseases; SAMRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); SAMRC research group development grant; University and Faculty Research Committee funding (URC/FRC); Kwazulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) South Africa; National Research Funding (NRF) South Africa; South African Research Chair initiative (SARChi)	This work was supported by the International Centre for Genetic Engineering & Biotechnology (ICGEB), Cape Town with a PhD-fellowship to SPP, South African Medical Research Council (SAMRC) Unit on Immunology of Infectious Diseases (FB). A SAMRC self-initiated research grant (SIR), SAMRC research group development grant, University and Faculty Research Committee funding (URC/FRC) and grants from Kwazulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) South Africa to RG, National Research Funding (NRF) South Africa and the South African Research Chair initiative (SARChi) to FB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIN CC, 1974, CLIN CHEM, V20, P470; Bakowski MA, 2008, TRAFFIC, V9, P2022, DOI 10.1111/j.1600-0854.2008.00827.x; Bjorkhem-Bergman L, 2011, BRIT J CLIN PHARMACO, V72, P164, DOI 10.1111/j.1365-2125.2011.03907.x; Blum A, 2009, ATHEROSCLEROSIS, V203, P325, DOI 10.1016/j.atherosclerosis.2008.08.022; Bochar DA, 1999, MOL GENET METAB, V66, P122, DOI 10.1006/mgme.1998.2786; Brombacher F, 1999, INT IMMUNOL, V11, P325, DOI 10.1093/intimm/11.3.325; Catron DM, 2004, INFECT IMMUN, V72, P1036, DOI 10.1128/IAI.72.2.1036-1042.2004; Catron DM, 2002, CELL MICROBIOL, V4, P315, DOI 10.1046/j.1462-5822.2002.00198.x; Chen X, 2002, J BIOL CHEM, V277, P49631, DOI 10.1074/jbc.M208327200; Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005; COSSART P, 1989, INFECT IMMUN, V57, P3629, DOI 10.1128/IAI.57.11.3629-3636.1989; Djaldetti M, 2006, EXP MOL PATHOL, V80, P160, DOI 10.1016/j.yexmp.2005.09.009; Ehrenstein MR, 2005, NEW ENGL J MED, V352, P73, DOI 10.1056/NEJMe048326; Erkkila L, 2005, ANTIMICROB AGENTS CH, V49, P3959, DOI 10.1128/AAC.49.9.3959-3962.2005; FERRARI M, 1990, J IMMUNOL METHODS, V131, P165, DOI 10.1016/0022-1759(90)90187-Z; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; GINSBACH C, 1987, HISTOCHEMISTRY, V86, P241, DOI 10.1007/BF00490254; Glynn SA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-9; Guler R, 2011, VACCINE, V29, P1339, DOI 10.1016/j.vaccine.2010.10.045; Hamelin BA, 1998, TRENDS PHARMACOL SCI, V19, P26, DOI 10.1016/S0165-6147(97)01147-4; Hedl M, 2004, PROTEIN SCI, V13, P1693, DOI 10.1110/ps.03597504; Hillyard DZ, 2004, ATHEROSCLEROSIS, V172, P219, DOI 10.1016/j.atherosclerosis.2003.11.004; Holscher C, 2006, J IMMUNOL, V176, P1115, DOI 10.4049/jimmunol.176.2.1115; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Katano H, 2004, P NATL ACAD SCI USA, V101, P4960, DOI 10.1073/pnas.0305149101; KATO K, 1989, MED MICROBIOL IMMUN, V178, P337; Kerrigan AM, 2009, J IMMUNOL, V182, P4150, DOI 10.4049/jimmunol.0802808; Khanna KV, 2002, J CLIN INVEST, V109, P205; Khurana V, 2007, CHEST, V131, P1282, DOI 10.1378/chest.06-0931; KITA T, 1980, J CLIN INVEST, V66, P1094, DOI 10.1172/JCI109938; Krause BR, 1998, ATHEROSCLEROSIS, V140, P15, DOI 10.1016/S0021-9150(98)00141-5; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Loike JD, 2004, ARTERIOSCL THROM VAS, V24, P2051, DOI 10.1161/01.ATV.0000143858.15909.29; Matsumoto M, 2004, J IMMUNOL, V172, P7377, DOI 10.4049/jimmunol.172.12.7377; NegreAminou P, 1997, BBA-LIPID LIPID MET, V1345, P259, DOI 10.1016/S0005-2760(96)00184-1; Ponce J, 2008, STROKE, V39, P1269, DOI 10.1161/STROKEAHA.107.498923; Port GC, 2007, INFECT IMMUN, V75, P5886, DOI 10.1128/IAI.00845-07; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Pucadyil TJ, 2004, MOL BIOCHEM PARASIT, V133, P145, DOI 10.1016/j.molbiopara.2003.10.002; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Rosch JW, 2010, J CLIN INVEST, V120, P627, DOI 10.1172/JCI39843; Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025; Salman H, 2008, BIOMED PHARMACOTHER, V62, P41, DOI 10.1016/j.biopha.2007.07.007; Schwegmann A, 2007, P NATL ACAD SCI USA, V104, P16251, DOI 10.1073/pnas.0703496104; Seveau S, 2004, J CELL BIOL, V166, P743, DOI 10.1083/jcb.200406078; Singh R, 2008, NATURE, V455, P1244, DOI 10.1038/nature07344; Soltani CE, 2007, P NATL ACAD SCI USA, V104, P20226, DOI 10.1073/pnas.0708104105; Thomsen RW, 2006, CRIT CARE MED, V34, P1080, DOI 10.1097/01.CCM.0000207345.92928.E4; WAGNER RD, 1994, MICROB PATHOGENESIS, V17, P175, DOI 10.1006/mpat.1994.1064; Yilmaz A, 2006, J LEUKOCYTE BIOL, V79, P529, DOI 10.1189/jlb.0205064; Zou T, 2011, INFECT IMMUN, V79, P1526, DOI 10.1128/IAI.01195-10	51	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75490	10.1371/journal.pone.0075490	http://dx.doi.org/10.1371/journal.pone.0075490			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086542	Green Published, Green Submitted, gold			2022-12-27	WOS:000325025200044
J	Everett, KL; Cooper, DMF				Everett, Katy L.; Cooper, Dermot M. F.			An Improved Targeted cAMP Sensor to Study the Regulation of Adenylyl Cyclase 8 by Ca2+ Entry through Voltage-Gated Channels	PLOS ONE			English	Article							PROTEIN-KINASE-A; PULSATILE INSULIN-SECRETION; YELLOW FLUORESCENT PROTEIN; SINGLE BETA-CELLS; DIFFERENT ISOFORMS; SIGNALING COMPLEX; CALCIUM-CHANNELS; LIPID RAFTS; CYCLIC-AMP; GLUCOSE	Here we describe an improved sensor with reduced pH sensitivity tethered to adenylyl cyclase (AC) 8. The sensor was used to study cAMP dynamics in the AC8 microdomain of MIN6 cells, a pancreatic beta-cell line. In these cells, AC8 was activated by Ca2+ entry through L-type voltage-gated channels following depolarisation. This activation could be reconstituted in HEK293 cells co-expressing AC8 and either the alpha 1C or alpha 1D subunit of L-type voltage-gated Ca2+ channels. The development of this improved sensor opens the door to the study of cAMP microdomains in excitable cells that have previously been challenging due to the sensitivity of fluorescent proteins to pH changes.	[Everett, Katy L.; Cooper, Dermot M. F.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	University of Cambridge	Cooper, DMF (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	dmfc2@cam.ac.uk			Wellcome Trust, UK; Newton Trust, University of Cambridge	Wellcome Trust, UK(Wellcome Trust); Newton Trust, University of Cambridge	Support for this work was provided by the Wellcome Trust, UK and the Newton Trust, University of Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; CALI JJ, 1994, J BIOL CHEM, V269, P12190; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; Delmeire D, 2003, DIABETOLOGIA, V46, P1383, DOI 10.1007/s00125-003-1203-8; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; DiPilato LM, 2009, MOL BIOSYST, V5, P832, DOI 10.1039/b823243a; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Dyachok O, 2008, CELL METAB, V8, P26, DOI 10.1016/j.cmet.2008.06.003; Efendiev R, 2010, J BIOL CHEM, V285, P14450, DOI 10.1074/jbc.M110.109769; Everett KL, 2012, BIOCHEM SOC T, V40, P179, DOI 10.1042/BST20110616; Fagan KA, 2000, J BIOL CHEM, V275, P26530, DOI 10.1074/jbc.M001369200; Fagan KA, 1998, J BIOL CHEM, V273, P9297, DOI 10.1074/jbc.273.15.9297; Fagan KA, 1996, J BIOL CHEM, V271, P12438, DOI 10.1074/jbc.271.21.12438; Fagan KA, 2000, J BIOL CHEM, V275, P40187, DOI 10.1074/jbc.M006606200; GIBBS NK, 1992, J PHOTOCH PHOTOBIO B, V13, P275, DOI 10.1016/1011-1344(92)85067-5; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Halls ML, 2010, EMBO J, V29, P2772, DOI 10.1038/emboj.2010.168; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Idevall-Hagren O, 2010, J BIOL CHEM, V285, P23005, DOI 10.1074/jbc.M109.095992; IRWIN RP, 1994, J NEUROSCI, V14, P1352, DOI 10.1523/JNEUROSCI.14-03-01352.1994; Jacobo SMP, 2009, J PHARMACOL EXP THER, V330, P283, DOI 10.1124/jpet.109.150672; Kitaguchi T, 2013, BIOCHEM J, V450, P365, DOI 10.1042/BJ20121022; Klarenbeek JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019170; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Martin ACL, 2009, MOL PHARMACOL, V75, P830, DOI 10.1124/mol.108.051748; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Naraghi M, 1997, J NEUROSCI, V17, P6961; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Patterson G, 2001, J CELL SCI, V114, P837; Qu YX, 2005, AM J PHYSIOL-HEART C, V288, pH2123, DOI 10.1152/ajpheart.01023.2004; Renstrom E, 1997, J PHYSIOL-LONDON, V502, P105, DOI 10.1111/j.1469-7793.1997.105bl.x; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Roger B, 2011, DIABETOLOGIA, V54, P390, DOI 10.1007/s00125-010-1955-x; Salonikidis PS, 2011, J BIOL CHEM, V286, P23419, DOI 10.1074/jbc.M111.236869; Smith KE, 2002, J BIOL CHEM, V277, P6025, DOI 10.1074/jbc.M109615200; Tengholm A, 2009, MOL CELL ENDOCRINOL, V297, P58, DOI 10.1016/j.mce.2008.07.009; Wachten S, 2010, J CELL SCI, V123, P95, DOI 10.1242/jcs.058594; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Willoughby D, 2005, J BIOL CHEM, V280, P30864, DOI 10.1074/jbc.M414355200; Willoughby D, 2002, J PHYSIOL-LONDON, V544, P487, DOI 10.1113/jphysiol.2002.027508; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Willoughby D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002299; Willoughby D, 2010, J BIOL CHEM, V285, P20328, DOI 10.1074/jbc.M110.120725; Willoughby D, 2010, J CELL SCI, V123, P107, DOI 10.1242/jcs.062067; Xia FZ, 2004, J BIOL CHEM, V279, P24685, DOI 10.1074/jbc.M314314200; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888	56	25	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75942	10.1371/journal.pone.0075942	http://dx.doi.org/10.1371/journal.pone.0075942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086669	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200127
J	Godin, JP; Ross, AB; Cleroux, M; Pouteau, E; Montoliu, I; Moser, M; Kochhar, S				Godin, Jean-Philippe; Ross, Alastair B.; Cleroux, Marilyn; Pouteau, Etienne; Montoliu, Ivan; Moser, Mireille; Kochhar, Sunil			Natural Carbon Isotope Abundance of Plasma Metabolites and Liver Tissue Differs between Diabetic and Non-Diabetic Zucker Diabetic Fatty Rats	PLOS ONE			English	Article							MASS-SPECTROMETRY; STABLE-ISOTOPES; LIQUID-CHROMATOGRAPHY; INSULIN-RESISTANCE; NITROGEN-BALANCE; AMINO-ACIDS; ZDF RAT; FRACTIONATION; TRACER; EAT	Background: 'You are what you eat' is an accurate summary for humans and animals when it comes to carbon isotope abundance. In biological material, natural(13)C/C-12 ratio is subject to minute variations due to diet composition (mainly from ingestion of C-3 and C-4 metabolism plants) and to the discrimination between 'light' and 'heavy' isotopes during biochemical reactions (isotope effects and isotopic fractionation). Methodology/Principal Findings: Carbon isotopic abundance was measured in ZDF (fa/+) and ZDF (fa/fa), (lean and obese-diabetic rats respectively) fed the same diet. By analysing plasma metabolites (glucose and non-esterified fatty acids), breath and liver tissue by high-precision isotope ratio mass spectrometry, we demonstrate for the first time statistically distinguishable metabolic carbon isotope abundance between ZDF (fa/+) and ZDF (fa/fa) rats based on plasma glucose, palmitic, oleic, linoleic, arachidonic acids and bulk analysis of liver tissue (P<0.005) resulting into clear isotopic fingerprints using principal component analysis. We studied the variation of isotopic abundance between both groups for each metabolite and through the metabolic pathways using the precursor/product approach. We confirmed that lipids were depleted in C-13 compared to glucose in both genotypes. We found that isotopic abundance of linoleic acid (C18: 2n-6), even though both groups had the same feed, differed significantly between both groups. The likely reason for these changes between ZDF (fa/+) and ZDF (fa/fa) are metabolic dysregulation associated with various routing and fluxes of metabolites. Conclusion/Significance: This work provides evidence that measurement of natural abundance isotope ratio of both bulk tissue and individual metabolites can provide meaningful information about metabolic changes either associated to phenotype or to genetic effects; irrespective of concentration. In the future measuring the natural abundance delta C-13 of key metabolites could be used as endpoints for studying in vivo metabolism, especially with regards to metabolic dysregulation, and development and progression of metabolic diseases.	[Godin, Jean-Philippe; Ross, Alastair B.; Cleroux, Marilyn; Pouteau, Etienne; Montoliu, Ivan; Moser, Mireille; Kochhar, Sunil] Nestle Res Ctr, Analyt Sci, CH-1000 Lausanne, Switzerland	Nestle SA	Godin, JP (corresponding author), Nestle Res Ctr, Analyt Sci, CH-1000 Lausanne, Switzerland.	jean-philippe.godin@rdls.nestle.com		Ross, Alastair/0000-0002-9585-0141	Nestle	Nestle(Nestle SA)	Nestle has funded the work. The funder had no role in the study design, data collection and analysis or preparation of the manuscript.	ABELSON PH, 1961, P NATL ACAD SCI USA, V47, P623, DOI 10.1073/pnas.47.5.623; Bassilian S, 2002, AM J PHYSIOL-ENDOC M, V282, pE507, DOI 10.1152/ajpendo.00211.2001; Brenna JT, 1997, MASS SPECTROM REV, V16, P227, DOI 10.1002/(SICI)1098-2787(1997)16:5<227::AID-MAS1>3.0.CO;2-J; Brenna JT, 2001, RAPID COMMUN MASS SP, V15, P1252, DOI 10.1002/rcm.325; Cherel Y, 2005, PHYSIOL BIOCHEM ZOOL, V78, P106, DOI 10.1086/425202; CLARK JB, 1983, P SOC EXP BIOL MED, V173, P68; Corpeleijn E, 2009, OBES REV, V10, P178, DOI 10.1111/j.1467-789X.2008.00544.x; CUNNANE SC, 1995, LIPIDS, V30, P781, DOI 10.1007/BF02537807; Friedman MI, 1998, AM J CLIN NUTR, V67, p513S, DOI 10.1093/ajcn/67.3.513S; Fuller BT, 2005, RAPID COMMUN MASS SP, V19, P2497, DOI 10.1002/rcm.2090; Fuller BT, 2004, RAPID COMMUN MASS SP, V18, P2889, DOI 10.1002/rcm.1708; Godin JP, 2007, MASS SPECTROM REV, V26, P751, DOI 10.1002/mas.20149; Godin JP, 2011, RAPID COMMUN MASS SP, V25, P2989, DOI 10.1002/rcm.5179; Godin JP, 2010, ANAL CHEM, V82, P646, DOI 10.1021/ac902086g; Griffen SC, 2001, DIABETES, V50, P63, DOI 10.2337/diabetes.50.1.63; Hayes JM, 2001, REV MINERAL GEOCHEM, V43, P225, DOI 10.2138/gsrmg.43.1.225; Hellerstein MK, 2004, METAB ENG, V6, P85, DOI 10.1016/j.ymben.2003.10.005; Jones DP, 2012, ANNU REV NUTR, V10, P1146; KALHAN SC, 1977, J LAB CLIN MED, V89, P285; Kuo TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032137; Lee WNP, 2005, J NUTR, V135, p3027S, DOI 10.1093/jn/135.12.3027S; Lee WNP, 2000, AM J PHYSIOL-ENDOC M, V279, pE425, DOI 10.1152/ajpendo.2000.279.2.E425; Leonard BL, 2005, ACTA DIABETOL, V42, P162, DOI 10.1007/s00592-005-0197-8; MacAvoy SE, 2006, OECOLOGIA, V150, P190, DOI 10.1007/s00442-006-0522-0; MACKO SA, 1986, GEOCHIM COSMOCHIM AC, V50, P2143, DOI 10.1016/0016-7037(86)90068-2; Masood A, 2005, J LIPID RES, V46, P2299, DOI 10.1194/jlr.D500022-JLR200; McMahon KW, 2010, J ANIM ECOL, V79, P1132, DOI 10.1111/j.1365-2656.2010.01722.x; Mittendorfer B, 2003, DIABETES, V52, P1641, DOI 10.2337/diabetes.52.7.1641; O'Grady SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011699; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; OLEARY MH, 1989, ANNU REV BIOCHEM, V58, P377; Phillips DL, 2006, OECOLOGIA, V147, P195, DOI 10.1007/s00442-005-0292-0; Pickavance L, 1998, BRIT J PHARMACOL, V125, P767, DOI 10.1038/sj.bjp.0702158; Poupin N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028046; Rhee SK, 1997, LIPIDS, V32, P1257, DOI 10.1007/s11745-006-0161-6; Schoeller DA, 1999, J ARCHAEOL SCI, V26, P667, DOI 10.1006/jasc.1998.0391; Tcherkez G, 2011, TRENDS PLANT SCI, V16, P499, DOI 10.1016/j.tplants.2011.05.010; Thompson DR, 2005, OECOLOGIA, V144, P517, DOI 10.1007/s00442-005-0171-8; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; West JB, 2006, TRENDS ECOL EVOL, V21, P408, DOI 10.1016/j.tree.2006.04.002	40	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74866	10.1371/journal.pone.0074866	http://dx.doi.org/10.1371/journal.pone.0074866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086387	Green Submitted, Green Published, gold			2022-12-27	WOS:000326520200046
J	Lin, H; Shen, Q; Zhan, JM; Wang, Q; Zhao, YH				Lin, Hui; Shen, Qi; Zhan, Ju-Mei; Wang, Qun; Zhao, Yu-Hua			Evaluation of Bacterial Expansin EXLX1 as a Cellulase Synergist for the Saccharification of Lignocellulosic Agro-Industrial Wastes	PLOS ONE			English	Article							ENZYMATIC-HYDROLYSIS; CRYSTALLINE CELLULOSE; BACILLUS-SUBTILIS; CELL-WALLS; BINDING; BIOMASS; PROTEIN; STRAW; FERMENTATION; BSEXLX1	Various types of lignocellulosic wastes extensively used in biofuel production were provided to assess the potential of EXLX1 as a cellulase synergist. Enzymatic hydrolysis of natural wheat straw showed that all the treatments using mixtures of cellulase and an optimized amount of EXLX1, released greater quantities of sugars than those using cellulase alone, regardless of cellulase dosage and incubation time. EXLX1 exhibited different synergism and binding characteristics for different wastes, but this can be related to their lignocellulosic components. The cellulose proportion could be one of the important factors. However, when the cellulose proportion of different biomass samples exhibited no remarkable differences, a higher synergism of EXLX1 is prone to occur on these materials, with a high proportion of hemicellulose and a low proportion of lignin. The information could be favorable to assess whether EXLX1 is effective as a cellulase synergist for the hydrolysis of the used materials. Binding assay experiments further suggested that EXLX1 bound preferentially to alkali pretreated materials, as opposed to acid pretreated materials under the assay condition and the binding preference would be affected by incubation temperature.	[Lin, Hui; Shen, Qi; Wang, Qun; Zhao, Yu-Hua] Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhan, Ju-Mei] Zhejiang Univ, Coll Life Sci, Inst Plant Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Hui] Zhejiang Acad Agr Sci, Inst Environm Resource Soil & Fertilizer, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang Academy of Agricultural Sciences	Zhao, YH (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China.	yhzhao225@zju.edu.cn	Lin, Hui/GQB-0146-2022	Lin, Hui/0000-0002-5446-8069	Science and Technology Project of Zhejiang Province [2011C13016]; National Natural Science Foundation of China [31070079, 41271335]; International Cooperation Project in Science and Technology of Zhejiang Province [2008C14038]; High Technology Research and Development Program of China (863 Program) [2012AA06A203]; National Key Technology Rand D Program [2012BAC17B04]	Science and Technology Project of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Project in Science and Technology of Zhejiang Province; High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Key Technology Rand D Program(National Key Technology R&D Program)	This study was supported by the Science and Technology Project of Zhejiang Province (2011C13016), National Natural Science Foundation of China (31070079; 41271335), the International Cooperation Project in Science and Technology of Zhejiang Province (2008C14038), High Technology Research and Development Program of China (863 Program)(2012AA06A203), and the National Key Technology Rand D Program (2012BAC17B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adney B., 1996, MEASUREMENT CELLULAS; Baker JO, 2000, APPL BIOCHEM BIOTECH, V84-6, P217, DOI 10.1385/ABAB:84-86:1-9:217; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; Chen XA, 2010, APPL ENVIRON MICROB, V76, P2556, DOI 10.1128/AEM.02499-09; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578; DETROY RW, 1983, CRC CR REV MICROBIOL, V10, P203; Georgelis N, 2012, P NATL ACAD SCI USA, V109, P14830, DOI 10.1073/pnas.1213200109; Georgelis N, 2011, J BIOL CHEM, V286, P16814, DOI 10.1074/jbc.M111.225037; Gourlay K, 2013, BIORESOURCE TECHNOL, V142, P498, DOI 10.1016/j.biortech.2013.05.053; Gusakov AV, 2007, BIOTECHNOL BIOENG, V97, P1028, DOI 10.1002/bit.21329; Kerff F, 2008, P NATL ACAD SCI USA, V105, P16876, DOI 10.1073/pnas.0809382105; Kim ES, 2009, BIOTECHNOL BIOENG, V102, P1342, DOI 10.1002/bit.22193; Kim IJ, 2013, APPL MICROBIOL BIOT, V97, P5381, DOI 10.1007/s00253-012-4412-6; Kim IJ, 2013, BIOTECHNOL BIOENG, V110, P401, DOI 10.1002/bit.24719; Lee HJ, 2010, MOL CELLS, V29, P379, DOI 10.1007/s10059-010-0033-z; Li LC, 2003, PLANT PHYSIOL, V132, P2073, DOI 10.1104/pp.103.020024; Lin H, 2011, BIORESOURCE TECHNOL, V102, P10569, DOI 10.1016/j.biortech.2011.08.095; MCQUEENMASON SJ, 1995, PLANT PHYSIOL, V107, P87, DOI 10.1104/pp.107.1.87; Quiroz-Castaneda RE, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-8; Saha BC, 2010, NEW BIOTECHNOL, V27, P10, DOI 10.1016/j.nbt.2009.10.005; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Suwannarangsee S, 2012, BIORESOURCE TECHNOL, V119, P252, DOI 10.1016/j.biortech.2012.05.098; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Wang YG, 2011, APPL MICROBIOL BIOT, V91, P1353, DOI 10.1007/s00253-011-3421-1; Whitney SEC, 2000, PLANT J, V22, P327, DOI 10.1046/j.1365-313x.2000.00742.x	27	16	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75022	10.1371/journal.pone.0075022	http://dx.doi.org/10.1371/journal.pone.0075022			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086425	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200071
J	Mahendran, V; Tan, YS; Riordan, SM; Grimm, MC; Day, AS; Lemberg, DA; Octavia, S; Lan, RT; Zhang, L				Mahendran, Vikneswari; Tan, Ye Sing; Riordan, Stephen M.; Grimm, Michael C.; Day, Andrew S.; Lemberg, Daniel A.; Octavia, Sophie; Lan, Ruiting; Zhang, Li			The Prevalence and Polymorphisms of Zonula Occluden Toxin Gene in Multiple Campylobacter concisus Strains Isolated from Saliva of Patients with Inflammatory Bowel Disease and Controls	PLOS ONE			English	Article							INCREASED INTESTINAL PERMEABILITY; TIGHT JUNCTIONS; CROHNS-DISEASE; HELICOBACTER; ARCOBACTER; RELATIVES; SAMPLES; HUMANS; SPP.	Campylobacter concisus is an oral bacterium. A number of studies detected a significantly higher prevalence of C. concisus in the intestinal tract of patients with inflammatory bowel disease (IBD) as compared to controls. The prevalence of zonula occluden toxin (zot) gene, which encodes a toxin known to increase intestinal permeability, in oral C. concisus strains is unknown. Increased intestinal permeability is a feature of IBD. A total of 56 oral C. concisus strains isolated from 19 patients with IBD and 20 controls were examined (some individuals were colonized with multiple strains). A filtration method was used for isolation of C. concisus from saliva samples. SDS-PAGE was used to define strains. PCR was used to amplify zot from C. concisus strains. Positive PCR products were sequenced and the nucleotides and amino acids were compared. Of the 56 oral C. concisus strains examined, 17 strains (30.4%) were positive for zot. The prevalence of zot-positive oral C. concisus strains was 54.5% in patients with active IBD, which was not significantly different from that in healthy controls (40%). Polymorphisms of C. concisus zot were revealed. zot(808T), zot(350-351AC) and zot(Multiple) were detected only in patients with IBD, but not in healthy controls. Both zot(808T) and zot(Multiple) alleles resulted in substitution of valine at position 270, which occurred in 36.4% of patients with active IBD but not in healthy controls (P = 0.011). Furthermore, the prevalence of multiple oral C. concisus strains in patients with active IBD was significantly higher than that in healthy controls (P = 0.013). This is the first study reporting the prevalence of zot in human oral C. concisus strains and the polymorphisms of C. concisus zot gene. The data suggest that the possible role of C. concisus strains containing specific polymorphic forms of zot gene in human IBD should be investigated.	[Mahendran, Vikneswari; Tan, Ye Sing; Octavia, Sophie; Lan, Ruiting; Zhang, Li] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Riordan, Stephen M.] Prince Wales Hosp, Gastrointestinal & Liver Unit, Sydney, NSW, Australia; [Grimm, Michael C.] Univ New S Wales, St George Clin Sch, Sydney, NSW, Australia; [Day, Andrew S.; Lemberg, Daniel A.] Sydney Childrens Hosp, Dept Gastroenterol, Sydney, NSW, Australia; [Day, Andrew S.] Univ Otago, Dept Paediat, Christchurch, New Zealand; [Day, Andrew S.] Univ New S Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Riordan, Stephen M.] Univ New S Wales, Fac Med, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; University of Otago; University of New South Wales Sydney; University of New South Wales Sydney	Zhang, L (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	L.Zhang@unsw.edu.au		Zhang, Li/0000-0001-7506-8278; Grimm, Michael/0000-0001-9426-3917; Lemberg, Daniel/0000-0002-8583-0956; Lan, Ruiting/0000-0001-9834-5258; Octavia, Sophie/0000-0001-8506-9127	Faculty Research Grant of the University of New South Wales	Faculty Research Grant of the University of New South Wales	This work was supported by a Faculty Research Grant of the University of New South Wales awarded to Dr LZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Engberg J, 2000, J CLIN MICROBIOL, V38, P286; FASANO A, 1995, J CLIN INVEST, V96, P710, DOI 10.1172/JCI118114; FASANO A, 1991, P NATL ACAD SCI USA, V88, P5242, DOI 10.1073/pnas.88.12.5242; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Goldblum SE, 2011, FASEB J, V25, P144, DOI 10.1096/fj.10-158972; Hansen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058825; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Irvine EJ, 2000, GASTROENTEROLOGY, V119, P1740, DOI 10.1053/gast.2000.20231; Ismail Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056888; Ismail Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038217; Kalischuk LD, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-53; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lastovica A. J., 2006, Clinical Microbiology Newsletter, V28, P49, DOI 10.1016/j.clinmicnews.2006.03.004; LEVINE MM, 1988, INFECT IMMUN, V56, P161, DOI 10.1128/IAI.56.1.161-167.1988; LINDBLOM GB, 1995, SCAND J INFECT DIS, V27, P187, DOI 10.3109/00365549509019006; Lynch OA, 2011, INT J FOOD MICROBIOL, V150, P171, DOI 10.1016/j.ijfoodmicro.2011.07.037; Mahendran V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025417; Man SM, 2010, J INFECT DIS, V202, P1855, DOI 10.1086/657316; Man SM, 2010, INFLAMM BOWEL DIS, V16, P1008, DOI 10.1002/ibd.21157; MAY GR, 1993, GASTROENTEROLOGY, V104, P1627, DOI 10.1016/0016-5085(93)90638-S; Mukhopadhya I, 2011, PLOS ONE, V6; Nielsen HL, 2013, CLIN MICROBIOL INFEC, V19, P445, DOI 10.1111/j.1469-0691.2012.03852.x; Nielsen HL, 2012, CLIN MICROBIOL INFEC, V18, pE459, DOI 10.1111/j.1469-0691.2012.03990.x; Nielsen HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023858; Petersen RF, 2007, J APPL MICROBIOL, V103, P2601, DOI 10.1111/j.1365-2672.2007.03515.x; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TANNER ACR, 1981, INT J SYST BACTERIOL, V31, P432, DOI 10.1099/00207713-31-4-432; Vandamme P, 2005, BERGEYS MANUAL SYSTE, V2, P1147; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Welcker K, 2004, EUR J MED RES, V9, P456; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375; Zhang L, 2010, J CLIN MICROBIOL, V48, P2965, DOI 10.1128/JCM.02391-09; Zhang L, 2009, J CLIN MICROBIOL, V47, P453, DOI 10.1128/JCM.01949-08	36	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75525	10.1371/journal.pone.0075525	http://dx.doi.org/10.1371/journal.pone.0075525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086553	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200109
J	Meng, H; Zhang, XJ; Lee, SJ; Wang, MM				Meng, He; Zhang, Xiaojie; Lee, Soo Jung; Wang, Michael M.			Von Willebrand Factor Inhibits Mature Smooth Muscle Gene Expression through Impairment of Notch Signaling	PLOS ONE			English	Article							SMALL-VESSEL DISEASE; WHITE-MATTER LESIONS; ISCHEMIC-STROKE; CELL DIFFERENTIATION; PARKINSONS-DISEASE; DEPENDENT PATHWAY; COGNITIVE DECLINE; ACTIN EXPRESSION; CADASIL PATIENTS; TRANSGENIC MICE	Von Willebrand factor (vWF), a hemostatic protein normally synthesized and stored by endothelial cells and platelets, has been localized beyond the endothelium in vascular disease states. Previous studies have implicated potential non-hemostatic functions of vWF, but signaling mechanisms underlying its effects are currently undefined. We present evidence that vWF breaches the endothelium and is expressed in a transmural distribution pattern in cerebral small vessel disease (SVD). To determine the potential molecular consequences of vWF permeation into the vessel wall, we also tested whether vWF impairs Notch regulation of key smooth muscle marker genes. In a co-culture system using Notch ligand expressing cells to stimulate Notch in A7R5 cells, vWF strongly inhibited both the Notch pathway and the activation of mature smooth muscle gene promoters. Similar repressive effects were observed in primary human cerebral vascular smooth muscle cells. Expression of the intracellular domain of NOTCH3 allowed cells to bypass the inhibitory effects of vWF. Moreover, vWF forms molecular complexes with all four mammalian Notch ectodomains, suggesting a novel function of vWF as an extracellular inhibitor of Notch signaling. In sum, these studies demonstrate vWF in the vessel wall as a common feature of cerebral SVD; furthermore, we provide a plausible mechanism by which non-hemostatic vWF may play a novel role in the promotion of vascular disease.	[Meng, He; Zhang, Xiaojie; Lee, Soo Jung; Wang, Michael M.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Wang, Michael M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Wang, Michael M.] VA Ann Arbor Healthcare Syst, Neurol Serv, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Wang, MM (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.	micwang@umich.edu			National Iinstitutes of Health - National Institute of Neurological Disorders and Stroke [NS054724, NS062816]; VA Merit award [5I01BX000375]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062816, K02NS054724] Funding Source: NIH RePORTER	National Iinstitutes of Health - National Institute of Neurological Disorders and Stroke; VA Merit award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants NS054724 and NS062816 from National Iinstitutes of Health - National Institute of Neurological Disorders and Stroke, and VA Merit award 5I01BX000375. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamowitch S, 2009, NEUROLOGY, V73, P1873, DOI 10.1212/WNL.0b013e3181c3fd12; Bohnen NI, 2011, BRAIN, V134, P2358, DOI 10.1093/brain/awr139; Bohnen NI, 2011, NAT REV NEUROL, V7, P229, DOI 10.1038/nrneurol.2011.21; Bongers TN, 2006, STROKE, V37, P2672, DOI 10.1161/01.STR.0000244767.39962.f7; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Dang L, 2006, ONCOGENE, V25, P487, DOI 10.1038/sj.onc.1209074; de Groot JC, 2000, ANN NEUROL, V47, P145; De Meyer GRY, 1999, ARTERIOSCL THROM VAS, V19, P2524, DOI 10.1161/01.ATV.19.10.2524; Deaton RA, 2009, AM J PHYSIOL-HEART C, V296, pH1027, DOI 10.1152/ajpheart.01230.2008; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; DUBAND JL, 1993, DIFFERENTIATION, V55, P1, DOI 10.1111/j.1432-0436.1993.tb00027.x; Farkas E, 2000, ACTA NEUROPATHOL, V100, P395, DOI 10.1007/s004010000195; Folsom AR, 1999, CIRCULATION, V100, P736, DOI 10.1161/01.CIR.100.7.736; GABBIANI G, 1984, J CLIN INVEST, V73, P148, DOI 10.1172/JCI111185; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hungerford JE, 1996, DEV BIOL, V178, P375, DOI 10.1006/dbio.1996.0225; Jokinen H, 2011, NEUROLOGY, V76, P1872, DOI 10.1212/WNL.0b013e31821d752f; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 1997, LANCET, V350, P1511, DOI 10.1016/S0140-6736(97)08083-5; KOCKX MM, 1993, VIRCHOWS ARCH A, V422, P293, DOI 10.1007/BF01608338; Lammie GA, 1997, STROKE, V28, P2222, DOI 10.1161/01.STR.28.11.2222; Lammie GA, 2002, BRAIN PATHOL, V12, P358; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Mazzucato M, 1999, J BIOL CHEM, V274, P3033, DOI 10.1074/jbc.274.5.3033; Meng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044964; Meng H, 2010, J BIOL CHEM, V285, P23045, DOI 10.1074/jbc.M110.144634; Meng H, 2009, J BIOL CHEM, V284, P7866, DOI 10.1074/jbc.M803650200; MIANO JM, 1994, CIRC RES, V75, P803, DOI 10.1161/01.RES.75.5.803; Moessler H, 1996, DEVELOPMENT, V122, P2415; Mohlke KL, 1999, CELL, V96, P111, DOI 10.1016/S0092-8674(00)80964-2; Morrow D, 2005, AM J PHYSIOL-CELL PH, V289, pC1188, DOI 10.1152/ajpcell.00198.2005; Norrving B, 2003, LANCET NEUROL, V2, P238, DOI 10.1016/S1474-4422(03)00352-1; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Qin F, 2003, J VASC SURG, V37, P433, DOI 10.1067/mva.2003.63; Qizilbash N, 1997, NEUROLOGY, V49, P1552, DOI 10.1212/WNL.49.6.1552; Sadler JE, 2005, J THROMB HAEMOST, V3, P1702, DOI 10.1111/j.1538-7836.2005.01369.x; Scheppke L, 2011, BLOOD; Sibon I, 2007, ANN NEUROL, V62, P177, DOI 10.1002/ana.21191; Small D, 2001, J BIOL CHEM, V276, P32022, DOI 10.1074/jbc.M100933200; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Tang YF, 2008, CIRC RES, V102, P661, DOI 10.1161/CIRCRESAHA.107.165134; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; van Dijk EJ, 2008, STROKE, V39, P2712, DOI 10.1161/STROKEAHA.107.513176; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; Wannamethee SG, 2012, STROKE; Wen HM, 2004, STROKE, V35, P1826, DOI 10.1161/01.STR.0000133686.29320.58; Zhang XJ, 2012, TRANSL STROKE RES, V3, P138, DOI 10.1007/s12975-011-0112-2; Zhao N, 2012, J BIOL CHEM, V287, P16111, DOI 10.1074/jbc.M111.322107	52	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75808	10.1371/journal.pone.0075808	http://dx.doi.org/10.1371/journal.pone.0075808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086636	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200120
J	Odutola, A; Antonio, M; Owolabi, O; Bojang, A; Foster-Nyarko, E; Donkor, S; Adetifa, I; Taylor, S; Bottomley, C; Greenwood, B; Ota, M				Odutola, Aderonke; Antonio, Martin; Owolabi, Olumuyiwa; Bojang, Abdoulie; Foster-Nyarko, Ebenezer; Donkor, Simon; Adetifa, Ifedayo; Taylor, Sylvia; Bottomley, Christian; Greenwood, Brian; Ota, Martin			Comparison of the Prevalence of Common Bacterial Pathogens in the Oropharynx and Nasopharynx of Gambian Infants	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; UPPER RESPIRATORY-TRACT; STREPTOCOCCUS-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE; STAPHYLOCOCCUS-AUREUS; CARRIAGE; CHILDREN; COLONIZATION; HEALTHY; YOUNGER	Background: CRM-based pneumococcal conjugate vaccines generally have little impact on the overall prevalence of pneumococcal carriage because of serotype replacement. In contrast, protein vaccines could substantially reduce the overall prevalence of pneumococcal carriage with potential microbiological and clinical consequences. Therefore, trials of pneumococcal protein vaccines need to evaluate their impact on carriage of other potentially pathogenic bacteria in addition to the pneumococcus. Methods: As a prelude to a trial of an investigational pneumococcal vaccine containing pneumococcal polysaccharide conjugates and pneumococcal proteins, the prevalence of carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella species and Staphylococcus aureus in the nasopharynx of 1030 Gambian infants (median age 35 weeks) was determined. An oropharyngeal swab was obtained at the same time from the first 371 infants enrolled. Standard microbiological techniques were used to evaluate the bacterial flora of the pharynx and to compare that found in the oropharynx and in the nasopharynx. Results: The overall pneumococcal carriage rate was high. Isolation rates of S. pneumoniae and Moraxella species were significantly higher using nasopharyngeal rather than oropharyngeal swabs (76.1% [95% CI 73.4%, 78.7%] vs. 21.3% [95% CI 17.2%, 25.8%] and 48.9% [95% CI 45.8%, 52.0%] vs. 20.5% % [95% CI 16.5%, 25.0%] respectively). In contrast, S. aureus and H. influenzae were isolated more frequently from oropharyngeal than from nasopharyngeal swabs (65.0% [95% CI 59.9%, 69.8%] vs. 33.6% [95% CI 30.7%, 36.5%] and 31.8% [95% CI 16.5%, 25.0%] vs. 22.4% [95% CI 19.9%, 25.1%] respectively). No group A beta haemolytic streptococci were isolated. Conclusion: Collection of an oropharyngeal swab in addition to a nasopharyngeal swab will provide little additional information on the impact of a novel pneumococcal vaccine on pneumococcal carriage but it might provide additional, valuable information on the impact of the vaccine on the overall microbiota of the pharynx.	[Odutola, Aderonke; Antonio, Martin; Owolabi, Olumuyiwa; Bojang, Abdoulie; Foster-Nyarko, Ebenezer; Donkor, Simon; Adetifa, Ifedayo; Ota, Martin] MRC Unit, Banjul, Gambia; [Taylor, Sylvia] GlaxoSmithKline Vaccines, Global Epidemiol, Wavre, Belgium; [Bottomley, Christian; Greenwood, Brian] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Ota, Martin] WHO, Reg Off Africa, Brazzaville, Rep Congo	University of London; London School of Hygiene & Tropical Medicine; GlaxoSmithKline; University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Odutola, A (corresponding author), MRC Unit, Banjul, Gambia.	aaodutola@mrc.gm		Foster-Nyarko, Ebenezer/0000-0001-6620-9403; Bottomley, Christian/0000-0002-5241-8412	MRC UK; PATH, Seattle; MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837] Funding Source: researchfish	MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); PATH, Seattle; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by MRC UK and by a grant from PATH, Seattle. A steering committee which included staff employed by PATH or GSK in addition to representative of the partner academic organisations provided overall advice on the conduct of the trial but played no direct role in the analysis of data, its interpretation or in the writing of the paper.	Altman D.G., 1991, PRACTICAL STATISTIC; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; CAPEDING MRZ, 1995, J CLIN MICROBIOL, V33, P3077, DOI 10.1128/JCM.33.11.3077-3079.1995; Cheung YB, 2009, PEDIATR INFECT DIS J, V28, P990, DOI 10.1097/INF.0b013e3181a78185; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Greenberg D, 2004, J CLIN MICROBIOL, V42, P4604, DOI 10.1128/JCM.42.10.4604-4609.2004; Hare KM, 2011, J MICROBIOL METH, V86, P364, DOI 10.1016/j.mimet.2011.06.016; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941; Kwambana BA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-175; Kwambana BA, 2011, BMC CLIN PATHOL, V11, DOI 10.1186/1472-6890-11-2; Lieberman D, 2006, J CLIN MICROBIOL, V44, P525, DOI 10.1128/JCM.44.2.525-528.2006; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; LloydEvans N, 1996, PEDIATR INFECT DIS J, V15, P866, DOI 10.1097/00006454-199610000-00007; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Madhi SA, 2007, J INFECT DIS, V196, P1662, DOI 10.1086/522164; MASTERS PL, 1958, BMJ-BRIT MED J, V1, P1200, DOI 10.1136/bmj.1.5081.1200; Morais L, 2007, J MED MICROBIOL, V56, P1181, DOI 10.1099/jmm.0.47346-0; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Prymula R, 2012, SAFETY IMMUNOGENICIT; Rapola S, 1997, J CLIN MICROBIOL, V35, P1077, DOI 10.1128/JCM.35.5.1077-1079.1997; Regev-Yochay G, 2004, JAMA-J AM MED ASSOC, V292, P716, DOI 10.1001/jama.292.6.716; Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107; Spijkerman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039730; van der Veen EL, 2006, ARCH OTOLARYNGOL, V132, P752, DOI 10.1001/archotol.132.7.752; van Gils EJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020229; Watt JP, 2004, J CLIN MICROBIOL, V42, P4974, DOI 10.1128/JCM.42.11.4974-4976.2004; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8	28	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75558	10.1371/journal.pone.0075558	http://dx.doi.org/10.1371/journal.pone.0075558			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086570	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000326520200112
J	Wright, DM; Allen, AR; Mallon, TR; McDowell, SWJ; Bishop, SC; Glass, EJ; Bermingham, ML; Woolliams, JA; Skuce, RA				Wright, David M.; Allen, Adrian R.; Mallon, Thomas R.; McDowell, Stanley W. J.; Bishop, Stephen C.; Glass, Elizabeth J.; Bermingham, Mairead L.; Woolliams, John A.; Skuce, Robin A.			Field-Isolated Genotypes of Mycobacterium bovis Vary in Virulence and Influence Case Pathology but Do Not Affect Outbreak Size	PLOS ONE			English	Article							NORTHERN-IRELAND; MOLECULAR EPIDEMIOLOGY; CATTLE FARMS; TUBERCULOSIS; MODEL; PATHOGENESIS; DETERMINANTS; SURVEILLANCE; TRANSMISSION; EVOLUTION	Strains of many infectious agents differ in fundamental epidemiological parameters including transmissibility, virulence and pathology. We investigated whether genotypes of Mycobacterium bovis (the causative agent of bovine tuberculosis, bTB) differ significantly in transmissibility and virulence, combining data from a nine-year survey of the genetic structure of the M. bovis population in Northern Ireland with detailed records of the cattle population during the same period. We used the size of herd breakdowns as a proxy measure of transmissibility and the proportion of skin test positive animals (reactors) that were visibly lesioned as a measure of virulence. Average breakdown size increased with herd size and varied depending on the manner of detection (routine herd testing or tracing of infectious contacts) but we found no significant variation among M. bovis genotypes in breakdown size once these factors had been accounted for. However breakdowns due to some genotypes had a greater proportion of lesioned reactors than others, indicating that there may be variation in virulence among genotypes. These findings indicate that the current bTB control programme may be detecting infected herds sufficiently quickly so that differences in virulence are not manifested in terms of outbreak sizes. We also investigated whether pathology of infected cattle varied according to M. bovis genotype, analysing the distribution of lesions recorded at post mortem inspection. We concentrated on the proportion of cases lesioned in the lower respiratory tract, which can indicate the relative importance of the respiratory and alimentary routes of infection. The distribution of lesions varied among genotypes and with cattle age and there were also subtle differences among breeds. Age and breed differences may be related to differences in susceptibility and husbandry, but reasons for variation in lesion distribution among genotypes require further investigation.	[Wright, David M.; Skuce, Robin A.] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Allen, Adrian R.; Mallon, Thomas R.; McDowell, Stanley W. J.; Skuce, Robin A.] Agri Food & Biosci Inst, Vet Sci Div, Bacteriol Branch, Belfast, Antrim, North Ireland; [Bishop, Stephen C.; Glass, Elizabeth J.; Bermingham, Mairead L.; Woolliams, John A.] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; [Bishop, Stephen C.; Glass, Elizabeth J.; Bermingham, Mairead L.; Woolliams, John A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH8 9YL, Midlothian, Scotland	Queens University Belfast; Agri-Food & Biosciences Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Wright, DM (corresponding author), Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland.	david.m.wright@cantab.net	Glass, Elizabeth J/L-4612-2016; Bermingham, Mairead L./A-3372-2015; Allen, Adrian R/C-6242-2009	Glass, Elizabeth J/0000-0002-6183-0185; Bermingham, Mairead L./0000-0002-0931-0051; McDowell, Stanley/0000-0002-9081-1469; Wright, David/0000-0001-8948-3691	BBSRC under CEDFAS initiative [BB/E018335/1, BB/E018335/2]; Northern Ireland Department of Agriculture and Rural Development [DARD0407]; BBSRC Institute Strategic Programme; BBSRC [BB/E018386/1, BB/E018335/2, BB/E018335/1, BBS/E/D/20231761] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20231761, BB/E018335/1, BB/E018335/2, BB/E018386/1] Funding Source: researchfish	BBSRC under CEDFAS initiative(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Northern Ireland Department of Agriculture and Rural Development; BBSRC Institute Strategic Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the BBSRC (http://www.bbsrc.ac.uk/) under the CEDFAS initiative, grant numbers BB/E018335/1 and BB/E018335/2; and by the Northern Ireland Department of Agriculture and Rural Development (http://www.dardni.gov.uk/), grant number DARD0407. SCB, JAW, and EJG also acknowledge BBSRC Institute Strategic Programme funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy DA, 2013, VET REC, V172, DOI 10.1136/vr.100969; Abernethy DA, 2006, VET MICROBIOL, V112, P231, DOI 10.1016/j.vetmic.2005.11.023; Aguilar D, 2010, TUBERCULOSIS, V90, P319, DOI 10.1016/j.tube.2010.08.004; Leon DA, 2009, CLIN EXP IMMUNOL, V157, P139, DOI 10.1111/j.1365-2249.2009.03923.x; Allen AR, 2010, P ROY SOC B-BIOL SCI, V277, P2737, DOI 10.1098/rspb.2010.0830; Alvarez J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-100; Ameni G, 2006, CLIN VACCINE IMMUNOL, V13, P1030, DOI 10.1128/CVI.00134-06; Amos W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058245; Bates D, 2012, LME4 LINEAR MIXED EF; Bermingham ML, 2009, J DAIRY SCI, V92, P3447, DOI 10.3168/jds.2008-1848; Biek R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003008; Biffa D, 2012, TROP ANIM HEALTH PRO, V44, P991, DOI 10.1007/s11250-011-0031-y; Blanco FC, 2009, MICROBES INFECT, V11, P956, DOI 10.1016/j.micinf.2009.06.006; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Boukary AR, 2012, TRANSBOUND EMERG DIS, V59, P490, DOI 10.1111/j.1865-1682.2011.01302.x; Brooks-Pollock E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008479; Brooks-Pollock E, 2009, PREV VET MED, V92, P360, DOI 10.1016/j.prevetmed.2009.08.022; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carrique-Mas JJ, 2008, PREV VET MED, V84, P85, DOI 10.1016/j.prevetmed.2007.11.001; Cassidy JP, 2006, VET MICROBIOL, V112, P151, DOI 10.1016/j.vetmic.2005.11.031; Claridge J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1840; Click ES, 2012, CLIN INFECT DIS, V54, P211, DOI 10.1093/cid/cir788; Cohen T, 2007, J R SOC INTERFACE, V4, P523, DOI 10.1098/rsif.2006.0193; Defra, 2011, BOV TB ER PROGR ENGL; Driscoll EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018806; Elston DA, 2001, PARASITOLOGY, V122, P563, DOI 10.1017/S0031182001007740; Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188; Frankena K, 2007, VET REC, V161, P679, DOI 10.1136/vr.161.20.679; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Garcia de Viedma D, 2005, J INFECT DIS, V192, P2059, DOI 10.1086/498245; Garske T, 2008, J THEOR BIOL, V253, P228, DOI 10.1016/j.jtbi.2008.02.038; Glynn JR, 2008, EMERG INFECT DIS, V14, P1060, DOI 10.3201/eid1407.060468; Goodchild A. V., 2003, Society for Veterinary Epidemiology and Preventive Medicine. Proceedings of a meeting held at University of Warwick, England, 31st March-2nd April 2003, P45; Hernandez-Pando R, 2012, INFECT GENET EVOL, V12, P725, DOI 10.1016/j.meegid.2012.02.013; Houston R, 2001, REV SCI TECH OIE, V20, P652, DOI 10.20506/rst.20.2.1293; Humblet MF, 2009, VET RES, V40, DOI 10.1051/vetres/2009033; James A, 2007, P ROY SOC B-BIOL SCI, V274, P741, DOI 10.1098/rspb.2006.0219; Krishnan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023870; Li WJ, 2009, FEMS MICROBIOL REV, V33, P892, DOI 10.1111/j.1574-6976.2009.00182.x; Liebana E, 2008, VET J, V176, P354, DOI 10.1016/j.tvjl.2007.07.001; Lloyd-Smith JO, 2006, CONTEMP MATH, V410, P235; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Matthews L, 2009, EPIDEMICS-NETH, V1, P221, DOI 10.1016/j.epidem.2009.10.002; Murray M, 2002, P NATL ACAD SCI USA, V99, P1538, DOI 10.1073/pnas.022618299; Neill SD, 2005, J APPL MICROBIOL, V98, P1261, DOI 10.1111/j.1365-2672.2005.02599.x; Neill SD, 2001, TUBERCULOSIS, V81, P79, DOI 10.1054/tube.2000.0279; Nickbakhsh S, 2011, BMC VET RES, V7, DOI [10.1186/1746-6148-7-66, 10.1186/1746-6148-8-51]; Olea-Popelka F, 2012, IRISH VET J, V65, DOI 10.1186/2046-0481-65-2; Palanisamy GS, 2009, TUBERCULOSIS, V89, P203, DOI 10.1016/j.tube.2009.01.005; Palmer MV, 2006, VET MICROBIOL, V112, P181, DOI 10.1016/j.vetmic.2005.11.028; Pollock JM, 2002, VET J, V163, P115, DOI 10.1053/tvjl.2001.0655; Porco TC, 2001, J ACQ IMMUN DEF SYND, V28, P437, DOI 10.1097/00042560-200112150-00005; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rhee JT, 1999, J CLIN MICROBIOL, V37, P1764, DOI 10.1128/JCM.37.6.1764-1770.1999; Skuce RA, 2010, VET REC, V167, P684, DOI 10.1136/vr.c5108; Skuce RA, 2005, VET REC, V157, P501, DOI 10.1136/vr.157.17.501; Smith NH, 2003, P NATL ACAD SCI USA, V100, P15271, DOI 10.1073/pnas.2036554100; Smith NH, 2006, NAT REV MICROBIOL, V4, P670, DOI 10.1038/nrmicro1472; Smith NH, 2011, INFECT GENET EVOL, V11, P1340, DOI 10.1016/j.meegid.2011.04.027; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Theus SA, 2005, J INFECT DIS, V191, P453, DOI 10.1086/425936; Valway SE, 1998, NEW ENGL J MED, V338, P633, DOI 10.1056/NEJM199803053381001; Vordermeier M, 2012, COMP IMMUNOL MICROB, V35, P227, DOI 10.1016/j.cimid.2012.01.003; Wolfe DM, 2010, PREV VET MED, V94, P170, DOI 10.1016/j.prevetmed.2010.02.010; Wright DM, 2013, INFECT GENET EVOL, V19, P15, DOI 10.1016/j.meegid.2013.05.011	66	24	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74503	10.1371/journal.pone.0074503	http://dx.doi.org/10.1371/journal.pone.0074503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086351	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200033
J	Yang, WK; Kang, CK; Chang, CH; Hsu, AD; Lee, TH; Hwang, PP				Yang, Wen-Kai; Kang, Chao-Kai; Chang, Chia-Hao; Hsu, An-Di; Lee, Tsung-Han; Hwang, Pung-Pung			Expression Profiles of Branchial FXYD Proteins in the Brackish Medaka Oryzias dancena: A Potential Saltwater Fish Model for Studies of Osmoregulation	PLOS ONE			English	Article							PHOSPHOLEMMAN-LIKE PROTEIN; NA+/K+-ATPASE EXPRESSION; SHARK RECTAL GLANDS; FUNCTIONAL INTERACTION; ION REGULATION; GENUS ORYZIAS; SODIUM-PUMP; FRESH-WATER; K+-ATPASE; NA,K-ATPASE	FXYD proteins are novel regulators of Na+-K+-ATPase (NKA). In fish subjected to salinity challenges, NKA activity in osmoregulatory organs (e. g., gills) is a primary driving force for the many ion transport systems that act in concert to maintain a stable internal environment. Although teleostean FXYD proteins have been identified and investigated, previous studies focused on only a limited group of species. The purposes of the present study were to establish the brackish medaka (Oryzias dancena) as a potential saltwater fish model for osmoregulatory studies and to investigate the diversity of teleostean FXYD expression profiles by comparing two closely related euryhaline model teleosts, brackish medaka and Japanese medaka (O. latipes), upon exposure to salinity changes. Seven members of the FXYD protein family were identified in each medaka species, and the expression of most branchial fxyd genes was salinity-dependent. Among the cloned genes, fxyd11 was expressed specifically in the gills and at a significantly higher level than the other fxyd genes. In the brackish medaka, branchial fxyd11 expression was localized to the NKA-immunoreactive cells in gill epithelia. Furthermore, the FXYD11 protein interacted with the NKA a-subunit and was expressed at a higher level in freshwater-acclimated individuals relative to fish in other salinity groups. The protein sequences and tissue distributions of the FXYD proteins were very similar between the two medaka species, but different expression profiles were observed upon salinity challenge for most branchial fxyd genes. Salinity changes produced different effects on the FXYD11 and NKA a-subunit expression patterns in the gills of the brackish medaka. To our knowledge, this report is the first to focus on FXYD expression in the gills of closely related euryhaline teleosts. Given the advantages conferred by the well-developed Japanese medaka system, we propose the brackish medaka as a saltwater fish model for osmoregulatory studies.	[Yang, Wen-Kai; Kang, Chao-Kai; Chang, Chia-Hao; Hsu, An-Di; Lee, Tsung-Han] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Yang, Wen-Kai] MingDao Univ, Dept Biotechnol, Changhua, Taiwan; [Lee, Tsung-Han] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan; [Hwang, Pung-Pung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan	National Chung Hsing University; Mingdao University; China Medical University Taiwan; Academia Sinica - Taiwan	Lee, TH (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	thlee@email.nchu.edu.tw	Zheng, Yong/AAN-8928-2021; Gao 高程, Cheng/J-9586-2012; Hwang, Pung-Pung/AEQ-4633-2022; GUO, Liang-dong/C-1407-2015; Zheng, Yong/E-3947-2012; hwang, pp/A-3641-2011; Chang, Chia-Hao/AAW-2598-2020; Hwang, Pung-Pung/AAH-1538-2022; He, Xinhua/B-8047-2015	Zheng, Yong/0000-0001-5239-9824; Gao 高程, Cheng/0000-0003-2522-7909; Zheng, Yong/0000-0001-5239-9824; Chang, Chia-Hao/0000-0002-7583-4291; He, Xinhua/0000-0002-5570-3454; Lee, Tsung-Han/0000-0002-3542-4335; Yang, Wen-Kai/0000-0001-8095-2420	Academia Sinica of Taiwan [AS-98-TP-B08]; ATU plan of the Ministry of Education, Taiwan [CC-97118]; NICHD, USA [N01-HD-6-2915]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD062915] Funding Source: NIH RePORTER	Academia Sinica of Taiwan(Academia Sinica - Taiwan); ATU plan of the Ministry of Education, Taiwan; NICHD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by grants from the Academia Sinica of Taiwan to PPH and THL (AS-98-TP-B08). The work was also supported in part by a grant from the ATU plan of the Ministry of Education, Taiwan, to THL (CC-97118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The monoclonal antibody against the Na<SUP>+</SUP>-K<SUP>+</SUP>-ATPase alpha-subunit (alpha 5) was purchased from the Developmental Studies Hybridoma Bank maintained by the Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, and the Department of Biological Sciences, University of Iowa, Iowa City, IA 52242, under Contract N01-HD-6-2915, NICHD, USA.	Aperia A, 2007, J INTERN MED, V261, P44, DOI 10.1111/j.1365-2796.2006.01745.x; Beguin P, 2002, EMBO J, V21, P3264, DOI 10.1093/emboj/cdf330; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bystriansky JS, 2011, J EXP BIOL, V214, P2435, DOI 10.1242/jeb.050633; Chen XP, 2009, COMP BIOCHEM PHYS C, V149, P647, DOI 10.1016/j.cbpc.2009.01.009; Cornelius F, 2003, NEWS PHYSIOL SCI, V18, P119, DOI 10.1152/nips.01434.2003; Crambert Gilles, 2003, Sci STKE, V2003, pRE1, DOI 10.1126/stke.2003.166.re1; Cutler CP, 2000, AM J PHYSIOL-REG I, V279, pR222, DOI 10.1152/ajpregu.2000.279.1.R222; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Feschenko MS, 2003, J NEUROSCI, V23, P2161; Freire CA, 2008, COMP BIOCHEM PHYS A, V149, P435, DOI 10.1016/j.cbpa.2008.02.003; Garty H, 2002, AM J PHYSIOL-RENAL, V283, pF607, DOI 10.1152/ajprenal.00112.2002; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2005, J BIOENERG BIOMEMBR, V37, P387, DOI 10.1007/s10863-005-9476-x; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hirose S, 2003, COMP BIOCHEM PHYS B, V136, P593, DOI 10.1016/S1096-4959(03)00287-2; Hwang PP, 2007, COMP BIOCHEM PHYS A, V148, P479, DOI 10.1016/j.cbpa.2007.06.416; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; Inoue K, 2003, COMP BIOCHEM PHYS B, V136, P635, DOI 10.1016/S1096-4959(03)00204-5; Inoue K, 2002, ZOOL SCI, V19, P727, DOI 10.2108/zsj.19.727; Inoue K, 2012, ENVIRON BIOL FISH, V94, P559, DOI 10.1007/s10641-011-9852-9; Johansen MB, 2006, GLYCOBIOLOGY, V16, P844, DOI 10.1093/glycob/cwl009; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kang CK, 2013, COMP BIOCHEM PHYS A, V164, P181, DOI 10.1016/j.cbpa.2012.08.010; Kang CK, 2010, COMP BIOCHEM PHYS A, V157, P7, DOI 10.1016/j.cbpa.2010.05.013; Kang CK, 2008, COMP BIOCHEM PHYS A, V151, P566, DOI 10.1016/j.cbpa.2008.07.020; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kinoshita M., 2009, MEDAKA BIOL MANAGEME; Li CM, 2004, J BIOL CHEM, V279, P38895, DOI 10.1074/jbc.M406697200; Lin YM, 2003, COMP BIOCHEM PHYS A, V135, P489, DOI 10.1016/S1095-6433(03)00136-3; Mahmmoud YA, 2000, J BIOL CHEM, V275, P35969, DOI 10.1074/jbc.M005168200; Mahmmoud YA, 2005, J BIOL CHEM, V280, P27776, DOI 10.1074/jbc.M503150200; Mahmmoud YA, 2003, J BIOL CHEM, V278, P37427, DOI 10.1074/jbc.M305126200; Parenti LR, 2008, ZOOL J LINN SOC-LOND, V154, P494, DOI 10.1111/j.1096-3642.2008.00417.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Roberts TR, 1998, ICHTHYOL RES, V45, P213, DOI 10.1007/BF02673919; Saito K, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00129; Sakamoto T, 2001, AQUACULTURE, V193, P347, DOI 10.1016/S0044-8486(00)00471-3; Sasado T, 2010, EXP ANIM TOKYO, V59, P13, DOI 10.1538/expanim.59.13; Scheiner-Bobis G, 2002, EUR J BIOCHEM, V269, P2424, DOI 10.1046/j.1432-1033.2002.02909.x; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Takehana Y, 2005, MOL PHYLOGENET EVOL, V36, P417, DOI 10.1016/j.ympev.2005.01.016; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang CH, 2012, COMP BIOCHEM PHYS A, V163, P302, DOI 10.1016/j.cbpa.2012.07.017; Tipsmark CK, 2011, J ENDOCRINOL, V209, P237, DOI 10.1530/JOE-10-0495; Tipsmark CK, 2010, AM J PHYSIOL-REG I, V299, pR1212, DOI 10.1152/ajpregu.00015.2010; Tipsmark CK, 2008, AM J PHYSIOL-REG I, V294, pR1367, DOI 10.1152/ajpregu.00454.2007; Toyoshima C, 2011, STRUCTURE, V19, P1732, DOI 10.1016/j.str.2011.10.016; Wang PJ, 2008, J EXP BIOL, V211, P3750, DOI 10.1242/jeb.018440; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Yang WK, 2011, J COMP PHYSIOL B, V181, P953, DOI 10.1007/s00360-011-0568-0; Yang WK, 2009, J EXP MAR BIOL ECOL, V375, P41, DOI 10.1016/j.jembe.2009.05.004; Yusof S, 2012, ENVIRON BIOL FISH, V93, P43, DOI 10.1007/s10641-011-9888-x	55	118	135	10	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55470	10.1371/journal.pone.0055470	http://dx.doi.org/10.1371/journal.pone.0055470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	24086741	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600108
J	Li, ZY; Xu, ZS; Chen, Y; He, GY; Yang, GX; Chen, M; Li, LC; Ma, YZ				Li, Zhi-Yong; Xu, Zhao-Shi; Chen, Yang; He, Guang-Yuan; Yang, Guang-Xiao; Chen, Ming; Li, Lian-Cheng; Ma, You-Zhi			A Novel Role for Arabidopsis CBL1 in Affecting Plant Responses to Glucose and Gibberellin during Germination and Seedling Development	PLOS ONE			English	Article							SUCROSE-SPECIFIC INDUCTION; SUGAR SIGNAL-TRANSDUCTION; GENE-EXPRESSION; ABSCISIC-ACID; CALCIUM SENSORS; PROTEIN-KINASE; BETA-AMYLASE; BINDING; CA2+; ABA	Glucose and phytohormones such as abscisic acid (ABA), ethylene, and gibberellin (GA) coordinately regulate germination and seedling development. However, there is still inadequate evidence to link their molecular roles in affecting plant responses. Calcium acts as a second messenger in a diverse range of signal transduction pathways. As calcium sensors unique to plants, calcineurin B-like (CBL) proteins are well known to modulate abiotic stress responses. In this study, it was found that CBL1 was induced by glucose in Arabidopsis. Loss-of-function mutant cbl1 exhibited hypersensitivity to glucose and paclobutrazol, a GA biosynthetic inhibitor. Several sugar-responsive and GA biosynthetic gene expressions were altered in the cbl1 mutant. CBL1 protein physically interacted with AKIN beta 1, the regulatory beta subunit of the SnRK1 complex which has a central role in sugar signaling. Our results indicate a novel role for CBL1 in modulating responses to glucose and GA signals.	[Li, Zhi-Yong; Xu, Zhao-Shi; Chen, Yang; Chen, Ming; Li, Lian-Cheng; Ma, You-Zhi] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Triticeae Crops, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci,Minist Agr, Beijing 100193, Peoples R China; [Li, Zhi-Yong; He, Guang-Yuan; Yang, Guang-Xiao] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Chinese Natl Ctr Plant Gene Res Wuhan HUST Part, Genet Engn Int Cooperat Base,Chinese Minist Sci &, Wuhan 430074, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Huazhong University of Science & Technology	Xu, ZS (corresponding author), Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Triticeae Crops, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci,Minist Agr, Beijing 100193, Peoples R China.	xuzhaoshi@yahoo.com.cn; tuissa_2009@yahoo.com.cn; mayouzhi@yahoo.com.cn	LI, ZHIYONG/AAE-3158-2019; Li, Zhiyong/U-9472-2018	LI, ZHIYONG/0000-0002-2151-5535; Li, Zhiyong/0000-0002-2151-5535	National Transgenic Key Project of MOA [2011ZX08002-002]; International S & T Cooperation Key Projects of MoST [2009DFB30340]	National Transgenic Key Project of MOA; International S & T Cooperation Key Projects of MoST	This research was financially supported by National Transgenic Key Project of MOA (2011ZX08002-002) and International S & T Cooperation Key Projects of MoST (Grant No. 2009DFB30340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht V, 2003, PLANT J, V36, P457, DOI 10.1046/j.1365-313X.2003.01892.x; Arenas-Huertero F, 2000, GENE DEV, V14, P2085; Avila J, 2012, PLANT PHYSIOL, V159, P1277, DOI 10.1104/pp.112.198432; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Barker L, 2000, PLANT CELL, V12, P1153, DOI 10.1105/tpc.12.7.1153; Batistic O, 2008, PLANT CELL, V20, P1346, DOI 10.1105/tpc.108.058123; Batistic O, 2012, BBA-GEN SUBJECTS, V1820, P1283, DOI 10.1016/j.bbagen.2011.10.012; Batistic O, 2009, BBA-MOL CELL RES, V1793, P985, DOI 10.1016/j.bbamcr.2008.10.006; BENTSINK L, 2002, ARABIDOPSIS BOOK, P1, DOI DOI 10.1199/TAB.0050; Chan MT, 1998, P NATL ACAD SCI USA, V95, P6543, DOI 10.1073/pnas.95.11.6543; Chen PW, 2006, PLANT CELL, V18, P2326, DOI 10.1105/tpc.105.038844; Cheong YH, 2003, PLANT CELL, V15, P1833, DOI 10.1105/tpc.012393; Cheong YH, 2007, PLANT J, V52, P223, DOI 10.1111/j.1365-313X.2007.03236.x; Crevillen P, 2005, J BIOL CHEM, V280, P8143, DOI 10.1074/jbc.M411713200; D'Angelo C, 2006, PLANT J, V48, P857, DOI 10.1111/j.1365-313X.2006.02921.x; Daviere JM, 2008, CURR OPIN GENET DEV, V18, P295, DOI 10.1016/j.gde.2008.05.004; Dekkers BJW, 2004, PLANTA, V218, P579, DOI 10.1007/s00425-003-1154-9; Finkelstein RR, 2002, CURR OPIN PLANT BIOL, V5, P26, DOI 10.1016/S1369-5266(01)00225-4; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Furuichi T, 2001, PLANT CELL PHYSIOL, V42, P1149, DOI 10.1093/pcp/pce150; Gibson SI, 2005, CURR OPIN PLANT BIOL, V8, P93, DOI 10.1016/j.pbi.2004.11.003; Gibson SI, 2004, J EXP BOT, V55, P253, DOI 10.1093/jxb/erh048; Gibson SI, 2001, BIOCHEM BIOPH RES CO, V280, P196, DOI 10.1006/bbrc.2000.4062; GRIERSON C, 1994, PLANT J, V5, P815, DOI 10.1046/j.1365-313X.1994.5060815.x; Gu ZM, 2008, GENE, V415, P1, DOI 10.1016/j.gene.2008.02.011; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Harper JF, 2001, TRENDS PLANT SCI, V6, P395, DOI 10.1016/S1360-1385(01)02023-4; Hauvermale AL, 2012, PLANT PHYSIOL, V160, P83, DOI 10.1104/pp.112.200956; Huang CL, 2011, PLANT SCI, V181, P57, DOI 10.1016/j.plantsci.2011.03.011; Huijser C, 2000, PLANT J, V23, P577, DOI 10.1046/j.1365-313x.2000.00822.x; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; JANG JC, 1994, PLANT CELL, V6, P1665, DOI 10.1105/tpc.6.11.1665; Jossier M, 2009, PLANT J, V59, P316, DOI 10.1111/j.1365-313X.2009.03871.x; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; Kolukisaoglu U, 2004, PLANT PHYSIOL, V134, P43, DOI 10.1104/pp.103.033068; Lan WZ, 2011, MOL PLANT, V4, P527, DOI 10.1093/mp/ssr031; Lee SC, 2002, GENE DEV, V16, P646, DOI 10.1101/gad.969002; Leon P, 2003, TRENDS PLANT SCI, V8, P110, DOI 10.1016/S1360-1385(03)00011-6; Li XF, 2009, J INTEGR PLANT BIOL, V51, P513, DOI 10.1111/j.1744-7909.2009.00811.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CA, 2002, PLANT CELL, V14, P1963, DOI 10.1105/tpc.001735; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Luan S, 2009, TRENDS PLANT SCI, V14, P37, DOI 10.1016/j.tplants.2008.10.005; Maeo K, 2001, PLANT MOL BIOL, V46, P627, DOI 10.1023/A:1010684908364; Martin T, 1997, PLANT J, V11, P53, DOI 10.1046/j.1365-313X.1997.11010053.x; Mitchum MG, 2006, PLANT J, V45, P804, DOI 10.1111/j.1365-313X.2005.02642.x; Mitsui T, 1999, PLANT CELL PHYSIOL, V40, P884, DOI 10.1093/oxfordjournals.pcp.a029618; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; MORELL MK, 1987, PLANT PHYSIOL, V85, P182, DOI 10.1104/pp.85.1.182; Nagira Y, 2006, J PLANT RES, V119, P137, DOI 10.1007/s10265-005-0256-9; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Pandey GK, 2004, PLANT CELL, V16, P1912, DOI 10.1105/tpc.021311; Pego JV, 2000, TRENDS PLANT SCI, V5, P531, DOI 10.1016/S1360-1385(00)01783-0; Pierre M, 2007, PLANT CELL, V19, P2804, DOI 10.1105/tpc.107.051870; Polge C, 2008, PLANT PHYSIOL, V148, P1570, DOI 10.1104/pp.108.123026; Polge C, 2007, TRENDS PLANT SCI, V12, P20, DOI 10.1016/j.tplants.2006.11.005; Preuss ML, 2006, J CELL BIOL, V172, P991, DOI 10.1083/jcb.200508116; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; Price J, 2003, PLANT PHYSIOL, V132, P1424, DOI 10.1104/pp.103.020347; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rushton PJ, 1995, PLANT MOL BIOL, V29, P691, DOI 10.1007/BF00041160; SADKA A, 1994, PLANT CELL, V6, P737, DOI 10.1105/tpc.6.5.737; Sanders D, 1999, PLANT CELL, V11, P691, DOI 10.1105/tpc.11.4.691; Sheen J, 1999, CURR OPIN PLANT BIOL, V2, P410, DOI 10.1016/S1369-5266(99)00014-X; Shi JR, 1999, PLANT CELL, V11, P2393, DOI 10.1105/tpc.11.12.2393; Sivak M.N., 1998, ADV FOOD NUTR RES, V41, P1; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Sun CX, 2003, PLANT CELL, V15, P2076, DOI 10.1105/tpc.014597; Taniguchi H, 1999, BIOPHYS CHEM, V82, P129, DOI 10.1016/S0301-4622(99)00112-X; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Urwin NAR, 1997, PLANT MOL BIOL, V35, P929, DOI 10.1023/A:1005950915499; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang MY, 2007, PLANT MOL BIOL, V65, P733, DOI 10.1007/s11103-007-9238-8; Weinl S, 2009, NEW PHYTOL, V184, P517, DOI 10.1111/j.1469-8137.2009.02938.x; Xiao WY, 2000, PLANT MOL BIOL, V44, P451, DOI 10.1023/A:1026501430422; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011; Yang TB, 2003, TRENDS PLANT SCI, V8, P505, DOI 10.1016/j.tplants.2003.09.004; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yuan K, 2006, J EXP BOT, V57, P3359, DOI 10.1093/jxb/erl096; Zhou L, 1998, P NATL ACAD SCI USA, V95, P10294, DOI 10.1073/pnas.95.17.10294	83	51	60	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56412	10.1371/journal.pone.0056412	http://dx.doi.org/10.1371/journal.pone.0056412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	24086647	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200070
J	Kim, HS; Park, SH; Gunzl, A; Cross, GAM				Kim, Hee-Sook; Park, Sung Hee; Guenzl, Arthur; Cross, George A. M.			MCM-BP Is Required for Repression of Life-Cycle Specific Genes Transcribed by RNA Polymerase I in the Mammalian Infectious Form of Trypanosoma brucei	PLOS ONE			English	Article							VSG EXPRESSION SITE; ORIGIN RECOGNITION COMPLEX; BLOOD-STREAM FORMS; POLO-LIKE KINASE; DNA-REPLICATION; ANTIGENIC VARIATION; TOPOISOMERASE-II; DISTINCT ROLES; PROTEIN; TELOMERES	Trypanosoma brucei variant surface glycoprotein (VSG) expression is a classic example of allelic exclusion. While the genome of T. brucei contains >2,000 VSG genes and VSG pseudogenes, only one allele is expressed at the surface of each infectious trypanosome and the others are repressed. Along with recombinatorial VSG switching, allelic exclusion provides a major host evasion mechanism for trypanosomes, a phenomenon known as antigenic variation. To extend our understanding of how trypanosomes escape host immunity by differential expression of VSGs, we attempted to identify genes that contribute to VSG silencing, by performing a loss-of-silencing screen in T. brucei using a transposon-mediated random insertional mutagenesis. One identified gene, which we initially named LOS1, encodes a T. brucei MCM-Binding Protein (TbMCM-BP). Here we show that TbMCM-BP is essential for viability of infectious bloodstream-form (BF) trypanosome and is required for proper cell-cycle progression. Tandem affinity purification of TbMCM-BP followed by mass spectrometry identified four subunits (MCM4-MCM7) of the T. brucei MCM complex, a replicative helicase, and MCM8, a subunit that is uniquely co-purified with TbMCM-BP. TbMCM-BP is required not only for repression of subtelomeric VSGs but also for silencing of life-cycle specific, insect-stage genes, procyclin and procyclin-associated genes (PAGs), that are normally repressed in BF trypanosomes and are transcribed by RNA polymerase I. Our study uncovers a functional link between chromosome maintenance and RNA pol I-mediated gene silencing in T. brucei.	[Kim, Hee-Sook; Cross, George A. M.] Rockefeller Univ, Mol Parasitol Lab, New York, NY 10021 USA; [Park, Sung Hee; Guenzl, Arthur] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Storrs, CT 06269 USA; [Guenzl, Arthur] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Storrs, CT 06269 USA	Rockefeller University; University of Connecticut; University of Connecticut	Kim, HS (corresponding author), Rockefeller Univ, Mol Parasitol Lab, New York, NY 10021 USA.	khee-sook@rockefeller.edu	; Cross, George/B-7444-2011	Gunzl, Arthur/0000-0002-7487-2261; Cross, George/0000-0003-1374-6955	Rockefeller University Women in Science Fellowship; U.S. National Institutes of Health (NIH) [R01 AI021729, R01 AI059377]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021729, R01AI059377] Funding Source: NIH RePORTER	Rockefeller University Women in Science Fellowship; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the Rockefeller University Women in Science Fellowship to HK and by grants R01 AI021729 (GAMC) and R01 AI059377 (AG) from the U.S. National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases (NIAID) or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALARCON CM, 1994, MOL CELL BIOL, V14, P5579, DOI 10.1128/MCB.14.8.5579; Alsford S, 2007, MOL MICROBIOL, V63, P724, DOI 10.1111/j.1365-2958.2006.05553.x; Alsford S, 2012, NUCLEIC ACIDS RES, V40, P10150, DOI 10.1093/nar/gks813; Becker M, 2004, GENOME RES, V14, P2319, DOI 10.1101/gr.2955304; Benmerzouga I, 2013, MOL MICROBIOL, V87, P196, DOI 10.1111/mmi.12093; Biebinger S, 1996, NUCLEIC ACIDS RES, V24, P1202, DOI 10.1093/nar/24.7.1202; Boothroyd CE, 2009, NATURE, V459, P278, DOI 10.1038/nature07982; BRUN R, 1979, ACTA TROP, V36, P289; CROSS GAM, 1973, PARASITOLOGY, V67, P315, DOI 10.1017/S0031182000046540; DaFonseca CJ, 2001, P NATL ACAD SCI USA, V98, P3034, DOI 10.1073/pnas.061487598; Dang HQ, 2011, J BIOL CHEM, V286, P32424, DOI 10.1074/jbc.M111.240143; Godoy PDD, 2009, EUKARYOT CELL, V8, P1592, DOI 10.1128/EC.00161-09; Denninger V, 2010, MOL MICROBIOL, V78, P459, DOI 10.1111/j.1365-2958.2010.07350.x; Ding L, 2011, J BIOL CHEM, V286, P32918, DOI 10.1074/jbc.M111.282541; Dziak R, 2003, J BIOL CHEM, V278, P27372, DOI 10.1074/jbc.M301110200; Fachinetti D, 2010, MOL CELL, V39, P595, DOI 10.1016/j.molcel.2010.07.024; Figueiredo LM, 2008, PLOS BIOL, V6, P1539, DOI 10.1371/journal.pbio.0060161; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Fox CA, 1997, SCIENCE, V276, P1547, DOI 10.1126/science.276.5318.1547; Germe T, 2009, EMBO J, V28, P2803, DOI 10.1038/emboj.2009.223; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; GueirosFilho FJ, 1996, MOL CELL BIOL, V16, P5655; Gunzl A, 2003, EUKARYOT CELL, V2, P542, DOI 10.1128/EC.2.3.542-551.2003; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; Hertz-Fowler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003527; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Holland L, 2002, EUR J BIOCHEM, V269, P5192, DOI 10.1046/j.1432-1033.2002.03224.x; Horn D, 2005, CHROMOSOME RES, V13, P525, DOI 10.1007/s10577-005-0991-8; Horn D, 1997, EMBO J, V16, P7422, DOI 10.1093/emboj/16.24.7422; HORN D, 1995, CELL, V83, P555, DOI 10.1016/0092-8674(95)90095-0; Horn D, 2010, CURR OPIN MICROBIOL, V13, P700, DOI 10.1016/j.mib.2010.08.009; Hughes K, 2007, EMBO J, V26, P2400, DOI 10.1038/sj.emboj.7601678; Ishimi Y, 1996, J BIOL CHEM, V271, P24115, DOI 10.1074/jbc.271.39.24115; Jagannathan M, 2012, J CELL SCI, V125, P133, DOI 10.1242/jcs.089938; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kawahara T, 2008, MOL MICROBIOL, V69, P1054, DOI 10.1111/j.1365-2958.2008.06346.x; Kim HS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000992; Kim HY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024749, 10.1371/journal.pone.0019867]; Landeira D, 2009, J CELL BIOL, V186, P243, DOI 10.1083/jcb.200902119; Leal S, 2004, J BIOL CHEM, V279, P28979, DOI 10.1074/jbc.M403479200; Li B, 2005, MOL CELL BIOL, V25, P5011, DOI 10.1128/MCB.25.12.5011-5021.2005; Li JJ, 2011, FEBS LETT, V585, P3850, DOI 10.1016/j.febslet.2011.10.033; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Lowell JE, 2004, J CELL SCI, V117, P5937, DOI 10.1242/jcs.01515; Luo KT, 2009, NAT CELL BIOL, V11, P204, DOI 10.1038/ncb1828; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Mancio-Silva L, 2008, J CELL SCI, V121, P2046, DOI 10.1242/jcs.026427; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; NAGOSHI YL, 1995, MOL BIOCHEM PARASIT, V72, P33, DOI 10.1016/0166-6851(95)00062-6; Narayanan MS, 2011, NUCLEIC ACIDS RES, V39, P2018, DOI 10.1093/nar/gkq950; Nishiyama A, 2011, GENE DEV, V25, P165, DOI 10.1101/gad.614411; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Peacock L, 2011, P NATL ACAD SCI USA, V108, P3671, DOI 10.1073/pnas.1019423108; Ploubidou A, 1999, J CELL SCI, V112, P4641; Pospiech H, 2010, SUBCELL BIOCHEM, V50, P79, DOI 10.1007/978-90-481-3471-7_5; Povelones ML, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003010; Prasanth SG, 2010, P NATL ACAD SCI USA, V107, P15093, DOI 10.1073/pnas.1009945107; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Sakwe AM, 2007, MOL CELL BIOL, V27, P3044, DOI 10.1128/MCB.02384-06; Scahill MD, 2008, MOL BIOCHEM PARASIT, V157, P73, DOI 10.1016/j.molbiopara.2007.10.003; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Shareef MM, 2001, MOL BIOL CELL, V12, P1671, DOI 10.1091/mbc.12.6.1671; Sheader K, 2004, J BIOL CHEM, V279, P13363, DOI 10.1074/jbc.M312307200; Snyder M, 2005, P NATL ACAD SCI USA, V102, P14539, DOI 10.1073/pnas.0507479102; Stanne TM, 2011, EUKARYOT CELL, V10, P964, DOI 10.1128/EC.05048-11; Takahashi N, 2008, EMBO J, V27, P1840, DOI 10.1038/emboj.2008.107; Takahashi N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000817; Tiengwe C, 2012, CELL REP, V2, P185, DOI 10.1016/j.celrep.2012.06.007; Tiengwe C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032674; Nguyen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035931; Tu XM, 2005, EUKARYOT CELL, V4, P755, DOI 10.1128/EC.4.4.755-764.2005; Umeyama T, 2008, EUKARYOT CELL, V7, P1582, DOI 10.1128/EC.00150-08; Vanhamme L, 2000, MOL MICROBIOL, V36, P328, DOI 10.1046/j.1365-2958.2000.01844.x; Wang QP, 2010, MOL MICROBIOL, V77, P1237, DOI 10.1111/j.1365-2958.2010.07284.x; Wickstead B, 2004, GENOME RES, V14, P1014, DOI 10.1101/gr.2227704; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yang XF, 2009, CELL, V137, P99, DOI 10.1016/j.cell.2009.01.037	80	100	102	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57001	10.1371/journal.pone.0057001	http://dx.doi.org/10.1371/journal.pone.0057001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	24086697	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849500052
J	Tandon, M; Johnson, J; Li, ZH; Xu, SP; Wipf, P; Wang, QJ				Tandon, Manuj; Johnson, James; Li, Zhihong; Xu, Shuping; Wipf, Peter; Wang, Qiming Jane			New Pyrazolopyrimidine Inhibitors of Protein Kinase D as Potent Anticancer Agents for Prostate Cancer Cells	PLOS ONE			English	Article							IN-VIVO; C-MU; GROWTH; IDENTIFICATION; PROLIFERATION; ACTIVATION; EXPRESSION; SLINGSHOT; EPIDERMIS; INVASION	The emergence of protein kinase D (PKD) as a potential therapeutic target for several diseases including cancer has triggered the search for potent, selective, and cell-permeable small molecule inhibitors. In this study, we describe the identification, in vitro characterization, structure-activity analysis, and biological evaluation of a novel PKD inhibitory scaffold exemplified by 1-naphthyl PP1 (1-NA-PP1). 1-NA-PP1 and IKK-16 were identified as pan-PKD inhibitors in a small-scale targeted kinase inhibitor library assay. Both screening hits inhibited PKD isoforms at about 100 nM and were ATP-competitive inhibitors. Analysis of several related kinases indicated that 1-NA-PP1 was highly selective for PKD as compared to IKK-16. SAR analysis showed that 1-NA-PP1 was considerably more potent and showed distinct substituent effects at the pyrazolopyrimidine core. 1-NA-PP1 was cell-active, and potently blocked prostate cancer cell proliferation by inducing G2/M arrest. It also potently blocked the migration and invasion of prostate cancer cells, demonstrating promising anticancer activities on multiple fronts. Overexpression of PKD1 or PKD3 almost completely reversed the growth arrest and the inhibition of tumor cell invasion caused by 1-NA-PP1, indicating that its anti-proliferative and anti-invasive activities were mediated through the inhibition of PKD. Interestingly, a 12-fold increase in sensitivity to 1-NA-PP1 could be achieved by engineering a gatekeeper mutation in the active site of PKD1, suggesting that 1-NA-PP1 could be paired with the analog-sensitive PKD1(M659G) for dissecting PKD-specific functions and signaling pathways in various biological systems.	[Tandon, Manuj; Li, Zhihong; Xu, Shuping; Wang, Qiming Jane] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Johnson, James; Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Johnson, James; Wipf, Peter] Univ Pittsburgh, Ctr Chem Methodol & Lib Dev, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wipf, P (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.	pwipf@pitt.edu; qjw1@pitt.edu	Wang, Qiming Jane/B-6064-2012; Wipf, Peter/AAG-1771-2021; Johnson, Eric/C-5668-2012	Wang, Qiming Jane/0000-0002-9502-4851; Wipf, Peter/0000-0001-7693-5863; Johnson, Eric/0000-0001-7797-8347; Baker, Tom/0000-0002-0876-2312	National Institutes of Health [R01CA129127-01, R01CA142580-01, P50-GM067082]; NATIONAL CANCER INSTITUTE [R01CA142580, R01CA129127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM067082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health (R01CA129127-01, R01CA142580-01, and P50-GM067082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Azoitei N, 2011, NEURO-ONCOLOGY, V13, P710, DOI 10.1093/neuonc/nor084; Barluenga J, 1999, PURE APPL CHEM, V71, P431, DOI 10.1351/pac199971030431; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bishop AC, 1998, CURR BIOL, V8, P257, DOI 10.1016/S0960-9822(98)70198-8; Bishop AC, 1999, J AM CHEM SOC, V121, P627, DOI 10.1021/ja983267v; Biswas MHU, 2010, CANCER RES, V70, P2095, DOI 10.1158/0008-5472.CAN-09-4155; Bravo-Altamirano K, 2011, ACS MED CHEM LETT, V2, P154, DOI 10.1021/ml100230n; Chen J, 2008, CANCER RES, V68, P3844, DOI 10.1158/0008-5472.CAN-07-5156; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Endo S, 2006, BIOCHEM BIOPH RES CO, V341, P261, DOI 10.1016/j.bbrc.2005.12.179; Evans IM, 2010, BIOCHEM J, V429, P565, DOI 10.1042/BJ20100578; Gamber GG, 2011, BIOORG MED CHEM LETT, V21, P1447, DOI 10.1016/j.bmcl.2011.01.014; George Kara M, 2011, Pharmaceutics, V3, P186, DOI 10.3390/pharmaceutics3020186; Guo J, 2012, CANC CHEMOTHER PHARM; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; Huynh QK, 2006, ARCH BIOCHEM BIOPHYS, V450, P141, DOI 10.1016/j.abb.2006.02.014; Kuan YH, 2006, BIOCHEM PHARMACOL, V71, P1735, DOI 10.1016/j.bcp.2006.03.012; LaValle CR, 2010, BBA-REV CANCER, V1806, P183, DOI 10.1016/j.bbcan.2010.05.003; LaValle Courtney R., 2010, BMC Chemical Biology, V10, P5, DOI 10.1186/1472-6769-10-5; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Meredith EL, 2010, J MED CHEM, V53, P5400, DOI 10.1021/jm100075z; Meredith EL, 2010, J MED CHEM, V53, P5422, DOI 10.1021/jm100076w; Monovich L, 2010, FEBS LETT, V584, P631, DOI 10.1016/j.febslet.2009.12.014; Murphy RC, 2010, ACS MED CHEM LETT, V1, P331, DOI 10.1021/ml100096t; Niswender CM, 2002, J BIOL CHEM, V277, P28916, DOI 10.1074/jbc.M203327200; O'Dwyer M E, 2000, Lancet Oncol, V1, P207, DOI 10.1016/S1470-2045(00)00149-2; Ochi N, 2011, J CELL PHYSIOL, V226, P1074, DOI 10.1002/jcp.22421; Oumata N, 2008, J MED CHEM, V51, P5229, DOI 10.1021/jm800109e; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Rennecke J, 1999, INT J CANCER, V80, P98, DOI 10.1002/(SICI)1097-0215(19990105)80:1<98::AID-IJC19>3.3.CO;2-4; Ristich VL, 2006, BRIT J DERMATOL, V154, P586, DOI 10.1111/j.1365-2133.2005.07073.x; Sharlow ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025134; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Sreenivasan A, 2003, MOL CELL BIOL, V23, P6327, DOI 10.1128/MCB.23.17.6327-6337.2003; Tandon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044653; Todorovic N, 2011, TETRAHEDRON LETT, V52, P5761, DOI 10.1016/j.tetlet.2011.08.103; Verheijen JC, 2009, J MED CHEM, V52, P8010, DOI 10.1021/jm9013828; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Wang H, 2003, P NATL ACAD SCI USA, V100, P4287, DOI 10.1073/pnas.0636870100; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Weiss EL, 2000, NAT CELL BIOL, V2, P677, DOI 10.1038/35036300	44	36	42	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75601	10.1371/journal.pone.0075601	http://dx.doi.org/10.1371/journal.pone.0075601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24367484	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200115
J	Yang, W; Zheng, Y; Gao, C; He, XH; Ding, Q; Kim, Y; Rui, YC; Wang, SP; Guo, LD				Yang, Wei; Zheng, Yong; Gao, Cheng; He, Xinhua; Ding, Qiong; Kim, Yongchan; Rui, Yichao; Wang, Shiping; Guo, Liang-Dong			The Arbuscular Mycorrhizal Fungal Community Response to Warming and Grazing Differs between Soil and Roots on the Qinghai-Tibetan Plateau	PLOS ONE			English	Article							SPECIES COMPOSITION; ATMOSPHERIC CO2; CARBON ALLOCATION; ELEVATED CO2; PLANT; DIVERSITY; GRASSLAND; TEMPERATURE; SPORE; COLONIZATION	Arbuscular mycorrhizal (AM) fungi form symbiotic associations with most plant species in terrestrial ecosystems, and are affected by environmental variations. To reveal the impact of disturbance on an AM fungal community under future global warming, we examined the abundance and community composition of AM fungi in both soil and mixed roots in an alpine meadow on the Qinghai-Tibetan Plateau, China. Warming and grazing had no significant effect on AM root colonization, spore density and extraradical hyphal density. A total of 65 operational taxonomic units (OTUs) of AM fungi were identified from soil and roots using molecular techniques. AM fungal OTU richness was higher in soil (54 OTUs) than in roots (34 OTUs), and some AM fungi that differed between soil and roots, showed significantly biased occurrence to warming or grazing. Warming and grazing did not significantly affect AM fungal OTU richness in soil, but warming with grazing significantly increased AM fungal OTU richness in roots compared to the grazing-only treatment. Non-metric multidimensional scaling analysis showed that the AM fungal community composition was significantly different between soil and roots, and was significantly affected by grazing in roots, whereas in soil it was significantly affected by warming and plant species richness. The results suggest that the AM fungal community responds differently to warming and grazing in soil compared with roots. This study provides insights into the role of AM fungi under global environmental change scenarios in alpine meadows of the Qinghai-Tibetan Plateau.	[Yang, Wei; Zheng, Yong; Gao, Cheng; Ding, Qiong; Kim, Yongchan; Guo, Liang-Dong] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [Yang, Wei; Kim, Yongchan; Rui, Yichao] Univ Chinese Acad Sci, Beijing, Peoples R China; [He, Xinhua] Univ Western Australia, Sch Plant Biol, Crawley, Australia; [Wang, Shiping] Chinese Acad Sci, Inst Tibetan Plateau Res, Lab Alpine Ecol & Biodivers, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Western Australia; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS	Guo, LD (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China.	guold@sun.im.ac.cn	Zheng, Yong/AAN-8928-2021; Gao 高程, Cheng/J-9586-2012; Hwang, Pung-Pung/AEQ-4633-2022; GUO, Liang-dong/C-1407-2015; Zheng, Yong/E-3947-2012; hwang, pp/A-3641-2011; Chang, Chia-Hao/AAW-2598-2020; Hwang, Pung-Pung/AAH-1538-2022; He, Xinhua/B-8047-2015	Zheng, Yong/0000-0001-5239-9824; Gao 高程, Cheng/0000-0003-2522-7909; Zheng, Yong/0000-0001-5239-9824; Chang, Chia-Hao/0000-0002-7583-4291; He, Xinhua/0000-0002-5570-3454; Lee, Tsung-Han/0000-0002-3542-4335; Yang, Wen-Kai/0000-0001-8095-2420	National Natural Science Foundation of China [31070434]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD062915] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Natural Science Foundation of China (No. 31070434). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ba L, 2012, PLANT SOIL, V352, P143, DOI 10.1007/s11104-011-0985-6; Bai G, 2013, MYCORRHIZA, V23, P289, DOI 10.1007/s00572-012-0468-5; Barto EK, 2010, J ECOL, V98, P745, DOI 10.1111/j.1365-2745.2010.01658.x; Beauregard MS, 2013, MYCORRHIZA, V23, P143, DOI 10.1007/s00572-012-0459-6; Borstler B, 2006, BIOL FERT SOILS, V42, P286, DOI 10.1007/s00374-005-0026-9; Bunn R, 2009, ECOLOGY, V90, P1378, DOI 10.1890/07-2080.1; Clark NM, 2009, J ARID ENVIRON, V73, P834, DOI 10.1016/j.jaridenv.2009.03.004; Colwell RK, 2013, ESTIMATES STAT ESTIM; Daniels B. A., 1982, Methods and principles of mycorrhizal research., P29; Davison J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041938; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Eom AH, 2001, MYCOLOGIA, V93, P233, DOI 10.2307/3761643; Frank DA, 2003, OECOLOGIA, V137, P603, DOI 10.1007/s00442-003-1385-2; Gange AC, 2002, OECOLOGIA, V131, P103, DOI 10.1007/s00442-001-0863-7; Gosling P, 2013, NEW PHYTOL, V198, P546, DOI 10.1111/nph.12169; Hamilton EW, 2001, ECOLOGY, V82, P2397, DOI 10.1890/0012-9658(2001)082[2397:CPSSMA]2.0.CO;2; Hart MM, 2002, NEW PHYTOL, V153, P335, DOI 10.1046/j.0028-646X.2001.00312.x; Hawkes CV, 2008, GLOBAL CHANGE BIOL, V14, P1181, DOI 10.1111/j.1365-2486.2007.01535.x; Heinemeyer A, 2004, GLOBAL CHANGE BIOL, V10, P52, DOI 10.1111/j.1365-2486.2003.00713.x; Hempel S, 2007, ENVIRON MICROBIOL, V9, P1930, DOI 10.1111/j.1462-2920.2007.01309.x; Holland JN, 1996, OECOLOGIA, V107, P87, DOI 10.1007/BF00582238; Hu YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057593, 10.1371/journal.pone.0056362, 10.1371/journal.pone.0073264, 10.1371/journal.pone.0056440]; Johnson D, 2004, NEW PHYTOL, V161, P503, DOI 10.1046/j.1469-8137.2003.00938.x; Johnson NC, 2005, GLOBAL CHANGE BIOL, V11, P1156, DOI 10.1111/j.1365-2486.2005.00967.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kimball BA, 2008, GLOBAL CHANGE BIOL, V14, P309, DOI 10.1111/j.1365-2486.2007.01486.x; Klein JA, 2004, ECOL LETT, V7, P1170, DOI 10.1111/j.1461-0248.2004.00677.x; Klironomos JN, 2005, NATURE, V433, P621, DOI 10.1038/nature03268; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Kruger M, 2009, NEW PHYTOL, V183, P212, DOI 10.1111/j.1469-8137.2009.02835.x; Kula AAR, 2005, ECOL LETT, V8, P61, DOI 10.1111/j.1461-0248.2004.00690.x; Lekberg Y, 2008, BOTANY, V86, P1117, DOI 10.1139/B08-077; Lekberg Y, 2012, J ECOL, V100, P151, DOI 10.1111/j.1365-2745.2011.01894.x; Liu YJ, 2012, NEW PHYTOL, V194, P523, DOI 10.1111/j.1469-8137.2012.04050.x; Liu YJ, 2012, MYCORRHIZA, V22, P31, DOI 10.1007/s00572-011-0378-y; Liu Y, 2009, FEMS MICROBIOL ECOL, V67, P81, DOI 10.1111/j.1574-6941.2008.00597.x; Lugo MA, 2002, MYCOLOGIA, V94, P579, DOI 10.2307/3761709; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Luo CY, 2010, GLOBAL CHANGE BIOL, V16, P1606, DOI 10.1111/j.1365-2486.2009.02026.x; Martinez-Garcia LB, 2011, SOIL BIOL BIOCHEM, V43, P682, DOI 10.1016/j.soilbio.2010.12.006; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; MILLER RM, 1995, OECOLOGIA, V103, P17, DOI 10.1007/BF00328420; Miller SP, 1999, OECOLOGIA, V119, P586, DOI 10.1007/s004420050823; MONZ CA, 1994, PLANT SOIL, V165, P75, DOI 10.1007/BF00009964; Murray TR, 2010, ECOLOGY, V91, P815, DOI 10.1890/09-0209.1; Opik M, 2006, J ECOL, V94, P778, DOI 10.1111/j.1365-2745.2006.01136.x; Pringle A, 2002, AM J BOT, V89, P1439, DOI 10.3732/ajb.89.9.1439; R Development Core Team, 2010, R LANG ENV STAT COMP; Renker C, 2005, ENVIRON POLLUT, V135, P255, DOI 10.1016/j.envpol.2004.11.002; Rillig MC, 1999, OECOLOGIA, V119, P572, DOI 10.1007/s004420050821; Rillig MC, 2004, ECOL LETT, V7, P740, DOI 10.1111/j.1461-0248.2004.00620.x; Rillig MC, 2002, OIKOS, V97, P52, DOI 10.1034/j.1600-0706.2002.970105.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rui YC, 2011, J SOIL SEDIMENT, V11, P903, DOI 10.1007/s11368-011-0388-6; Sanders IR, 2004, NEW PHYTOL, V164, P415, DOI 10.1111/j.1469-8137.2004.01208.x; Schwarzott D, 2001, MOL PHYLOGENET EVOL, V21, P190, DOI 10.1006/mpev.2001.1007; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Staddon PL, 2004, GLOBAL CHANGE BIOL, V10, P1909, DOI 10.1111/j.1365-2486.2004.00861.x; Stockinger H, 2010, NEW PHYTOL, V187, P461, DOI 10.1111/j.1469-8137.2010.03262.x; Stockinger H, 2009, NEW PHYTOL, V183, P1176, DOI 10.1111/j.1469-8137.2009.02874.x; Su YY, 2007, MYCORRHIZA, V17, P689, DOI 10.1007/s00572-007-0151-4; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 2004, NEW PHYTOL, V164, P201, DOI 10.1111/j.1469-8137.2004.01205.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van Diepen LTA, 2011, MOL ECOL, V20, P799, DOI 10.1111/j.1365-294X.2010.04969.x; Wagner H, 2009, VEGAN COMMUNITY ECOL; Wang SP, 2012, ECOLOGY, V93, P2365, DOI 10.1890/11-1408.1; Wilde P, 2009, ENVIRON MICROBIOL, V11, P1548, DOI 10.1111/j.1462-2920.2009.01882.x; Wolf J, 2003, NEW PHYTOL, V157, P579, DOI 10.1046/j.1469-8137.2003.00696.x; Zarei M, 2010, ENVIRON POLLUT, V158, P2757, DOI 10.1016/j.envpol.2010.04.017; Zavalloni C, 2012, PLANT SOIL, V359, P121, DOI 10.1007/s11104-012-1190-y; Zheng Y, 2012, APPL MICROBIOL BIOT, V93, P2193, DOI 10.1007/s00253-011-3535-5	74	118	135	10	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76447	10.1371/journal.pone.0076447	http://dx.doi.org/10.1371/journal.pone.0076447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086741	Green Published, Green Submitted, gold			2022-12-27	WOS:000325220000067
J	Xu, XJ; Shou, XJ; Li, J; Jia, MX; Zhang, JS; Guo, Y; Wei, QY; Zhang, XT; Han, SP; Zhang, R; Han, JS				Xu, Xin-Jie; Shou, Xiao-Jing; Li, Jin; Jia, Mei-Xiang; Zhang, Ji-Shui; Guo, Yan; Wei, Qing-Yun; Zhang, Xiu-Ting; Han, Song-Ping; Zhang, Rong; Han, Ji-Sheng			Mothers of Autistic Children: Lower Plasma Levels of Oxytocin and Arg-Vasopressin and a Higher Level of Testosterone	PLOS ONE			English	Article							ARGININE-VASOPRESSIN; SOCIAL-BEHAVIOR; SPECTRUM; GENES; BRAIN; DISORDERS; PHENOTYPE; PARENTS; BROADER; WOMEN	Background: Autism is a pervasive neurodevelopmental disorder, thought to be caused by a combination of genetic heritability and environmental risk factors. Some autistic-like traits have been reported in mothers of autistic children. We hypothesized that dysregulation of oxytocin (OXT), Arg-vasopressin (AVP) and sex hormones, found in autistic children, may also exist in their mothers. Methods: We determined plasma levels of OXT (40 in autism vs. 26 in control group), AVP (40 vs. 17) and sex hormones (61 vs. 47) in mothers of autistic and normal children by enzyme immunoassay and radioimmunoassay, respectively and investigated their relationships with the children's autistic behavior scores (Childhood Autism Rating Scale (CARS) and Autism Behavior Checklist (ABC)). Results: Significantly lower plasma concentrations of OXT (p<0.001) and AVP (p<0.001), as well as a higher level of plasma testosterone (p<0.05), were found in mothers of autistic children vs. those of control. The children's autistic behavior scores were negatively associated with maternal plasma levels of OXT and AVP. Conclusions: These results suggest that dysregulation of OXT, AVP and/or testosterone systems exist in mothers of autistic children, which may impact children's susceptibility to autism.	[Xu, Xin-Jie; Shou, Xiao-Jing; Li, Jin; Zhang, Rong; Han, Ji-Sheng] Peking Univ, Neurosci Res Inst, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Xu, Xin-Jie; Shou, Xiao-Jing; Li, Jin; Zhang, Rong; Han, Ji-Sheng] Peking Univ, Dept Neurobiol, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Xu, Xin-Jie; Shou, Xiao-Jing; Li, Jin; Zhang, Rong; Han, Ji-Sheng] Peking Univ, Minist Educ, Key Lab Neurosci, Natl Hlth & Family Planning Commiss, Beijing 100871, Peoples R China; [Jia, Mei-Xiang] Peking Univ, Mental Hlth Inst, Beijing 100871, Peoples R China; [Zhang, Ji-Shui] Capital Univ Med Sci, Beijing Childrens Hosp, Dept Neurol, Beijing, Peoples R China; [Zhang, Ji-Shui] Capital Univ Med Sci, Beijing Childrens Hosp, Ctr Rehabil, Beijing, Peoples R China; [Guo, Yan] Beijing Univ Chinese Med, Dept Ophthalmol, Affiliated Hosp 3, Beijing, Peoples R China; [Wei, Qing-Yun] Beijing Yangguang Youyi Rehabil Ctr, Beijing, Peoples R China; [Zhang, Xiu-Ting] Beijing Tongkang Rehabil Ctr, Beijing, Peoples R China; [Han, Song-Ping] HANS Int Inc, Belle Mead, NJ USA	Peking University; Peking University; Peking University; Peking University; Capital Medical University; Capital Medical University; Beijing University of Chinese Medicine	Zhang, R (corresponding author), Peking Univ, Neurosci Res Inst, Sch Basic Med Sci, Beijing 100871, Peoples R China.	zhangrong@bjmu.edu.cn; hanjisheng@bjmu.edu.cn	XU, XINJIE/GQH-5210-2022; Jia, Mei/GXZ-9967-2022; Zhang, Rong/O-5078-2017; Wang, Minggui/AAR-8281-2020	Zhang, Rong/0000-0002-6889-5571; Wang, Minggui/0000-0001-7682-5859	National Natural Science Foundation of China [81271507]; Peking University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking University(Peking University)	This project was supported by grants from the National Natural Science Foundation of China (81271507, http://www.nsfc.gov.cn/) to JSH. The study was also supported by Peking University Special Project for promoting joint research between basic and clinical sciences (http://www.pku.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ayadhi Laila Y, 2005, Neurosciences (Riyadh), V10, P47; Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; Auyeung B, 2009, BRIT J PSYCHOL, V100, P1, DOI 10.1348/000712608X311731; BANKS WA, 1992, PROG BRAIN RES, V91, P139; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Carter MT, 2013, CLIN GENET, V83, P399, DOI 10.1111/cge.12101; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Ebstein RP, 2012, HORM BEHAV, V61, P359, DOI 10.1016/j.yhbeh.2011.12.014; Green JJ, 2010, NEUROTHERAPEUTICS, V7, P250, DOI 10.1016/j.nurt.2010.05.006; Green LA, 2001, BIOL PSYCHIAT, V50, P609, DOI 10.1016/S0006-3223(01)01139-8; Gregory SG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-62; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P3, DOI 10.1016/j.biopsych.2007.06.026; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Harony H, 2010, NEUROSIGNALS, V18, P82, DOI 10.1159/000321035; Hollander E, 2003, NEUROPSYCHOPHARMACOL, V28, P193, DOI 10.1038/sj.npp.1300021; Ingudomnuku E, 2007, HORM BEHAV, V51, P597, DOI 10.1016/j.yhbeh.2007.02.001; Keefe DL, 2002, ARCH SEX BEHAV, V31, P401, DOI 10.1023/A:1019883923346; Kose S, 2013, PSYCHIAT CLIN NEUROS, V67, P20, DOI 10.1111/pcn.12005; Kuehn BM, 2011, JAMA-J AM MED ASSOC, V305, P659, DOI 10.1001/jama.2011.117; Lukas M, 2012, BEHAV BRAIN RES; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Mikolajczak M, 2010, BIOL PSYCHOL, V85, P182, DOI 10.1016/j.biopsycho.2010.05.010; Modahl C, 1998, BIOL PSYCHIAT, V43, P270, DOI 10.1016/S0006-3223(97)00439-3; Mohammadi Mohammad Reza, 2012, Iran J Psychiatry, V7, P157; Murakami G, 2011, EUR J NEUROSCI, V34, P469, DOI 10.1111/j.1460-9568.2011.07761.x; Palomba S, 2012, CLIN ENDOCRINOL, V77, P898, DOI 10.1111/j.1365-2265.2012.04443.x; Rellini E, 2004, J AUTISM DEV DISORD, V34, P703, DOI 10.1007/s10803-004-5290-2; Rice Catherine, 2009, Morbidity and Mortality Weekly Report, V58, P1; Ronald A, 2011, AM J MED GENET B, V156B, P255, DOI 10.1002/ajmg.b.31159; Ruta L, 2011, PSYCHONEUROENDOCRINO, V36, P1154, DOI 10.1016/j.psyneuen.2011.02.007; Santangelo SL, 2005, AM J PHARMACOGENOMIC, V5, P71, DOI 10.2165/00129785-200505020-00001; Sarachana T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017116; Schmidtova E, 2010, ENDOCRINOLOGIST, V20, P245, DOI 10.1097/TEN.0b013e3181f661d2; Ufer F, 2013, CLIN ENDOCRINOL, V78, P431, DOI 10.1111/cen.12006; Wheelwright S, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-10; Xu XJ, 2012, NEUROCHEM RES, V37, P2270; Zhang R, 2012, RES DEV DISABIL, V33, P1136, DOI 10.1016/j.ridd.2012.02.001	37	50	53	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74849	10.1371/journal.pone.0074849	http://dx.doi.org/10.1371/journal.pone.0074849			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086383	Green Submitted, Green Published, gold			2022-12-27	WOS:000325218700043
J	Wang, RC; Kniazeva, M; Han, M				Wang, Rencheng; Kniazeva, Marina; Han, Min			Peroxisome Protein Transportation Affects Metabolism of Branched-Chain Fatty Acids That Critically Impact Growth and Development of C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; BIOSYNTHESIS; ROLES; DISORDERS; PATHWAY; GENES	The impact of specific lipid molecules, including fatty acid variants, on cellular and developmental regulation is an important research subject that remains under studied. Monomethyl branched-chain fatty acids (mmBCFAs) are commonly present in multiple organisms including mammals, however our understanding of mmBCFA functions is very limited. C. elegans has been the premier model system to study the functions of mmBCFAs and their derived lipids, as mmBCFAs have been shown to play essential roles in post-embryonic development in this organism. To understand more about the metabolism of mmBCFAs in C. elegans, we performed a genetic screen for suppressors of the L1 developmental arrest phenotype caused by mmBCFA depletion. Extensive characterization of one suppressor mutation identified prx-5, which encodes an ortholog of the human receptor for the type-1 peroxisomal targeting signal protein. Our study showed that inactivating prx-5 function compromised the peroxisome protein import, resulting in an increased level of branched-chain fatty acid C17ISO in animals lacking normal mmBCFA synthesis, thereby restoring wild-type growth and development. This work reveals a novel connection between peroxisomal functions and mmBCFA metabolism.	[Han, Min] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Han, M (corresponding author), Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.	mhan@colorado.edu		You, Hai-Lu/0000-0003-2203-6461	Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by the Howard Hughes Medical Institute Investigator fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigelow H, 2009, NAT METHODS, V6, P549, DOI 10.1038/nmeth.f.260; Brock TJ, 2006, PLOS GENET, V2, P997, DOI 10.1371/journal.pgen.0020108; Butcher RA, 2009, P NATL ACAD SCI USA, V106, P1875, DOI 10.1073/pnas.0810338106; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Heird WC, 2005, ANNU REV NUTR, V25, P549, DOI 10.1146/annurev.nutr.24.012003.132254; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; HRADEC J, 1994, J CHROMATOGR B, V660, P386, DOI 10.1016/0378-4347(94)00292-4; Jones LN, 1997, MICRON, V28, P469, DOI 10.1016/S0968-4328(97)00039-5; Joo HJ, 2009, BIOCHEM J, V422, P61, DOI 10.1042/BJ20090513; Jordan SD, 2010, CELL MOL LIFE SCI, V67, P3255, DOI 10.1007/s00018-010-0414-7; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Kniazeva M, 2008, GENE DEV, V22, P2102, DOI 10.1101/gad.1692008; Kniazeva M, 2012, GENE DEV, V26, P554, DOI 10.1101/gad.187054.112; Moser HW, 1999, MOL GENET METAB, V68, P316, DOI 10.1006/mgme.1999.2926; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Seamen E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000589; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; Thieringer H, 2003, J CELL SCI, V116, P1797, DOI 10.1242/jcs.00380; Vrablik TL, 2013, MOL REPROD DEV, V80, P244, DOI 10.1002/mrd.22167; Vrablik TL, 2012, GENE DEV, V26, P631, DOI 10.1101/gad.190777.112; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Webster CM, 2013, DEV BIOL, V373, P14, DOI 10.1016/j.ydbio.2012.10.002; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; YEAGLE PL, 1989, FASEB J, V3, P1833, DOI 10.1096/fasebj.3.7.2469614; Zhang SBO, 2010, P NATL ACAD SCI USA, V107, P4640, DOI 10.1073/pnas.0912308107; Zhang YR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-164; Zhu H, 2013, ELIFE IN PRESS; Zhu HH, 2013, ELIFE, V2, DOI 10.7554/eLife.00429; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	35	14	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76270	10.1371/journal.pone.0076270	http://dx.doi.org/10.1371/journal.pone.0076270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24204734	Green Published, Green Submitted, gold			2022-12-27	WOS:000325223900092
J	Nakamura, K; Aizawa, K; Nakabayashi, K; Kato, N; Yamauchi, J; Hata, K; Tanoue, A				Nakamura, Kazuaki; Aizawa, Kazuko; Nakabayashi, Kazuhiko; Kato, Natsuko; Yamauchi, Junji; Hata, Kenichiro; Tanoue, Akito			DNA Methyltransferase Inhibitor Zebularine Inhibits Human Hepatic Carcinoma Cells Proliferation and Induces Apoptosis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CYCLE ARREST; METHYLATION INHIBITOR; CANCER-CELLS; G(1) ARREST; HEPG2 CELLS; IN-VITRO; EXPRESSION; ACTIVATION; INDUCTION	Hepatocellular carcinoma is one of the most common cancers worldwide. During tumorigenesis, tumor suppressor and cancer-related genes are commonly silenced by aberrant DNA methylation in their promoter regions. Zebularine (1-(beta-(D)-ribofuranosyl)- 1,2-dihydropyrimidin-2-one) acts as an inhibitor of DNA methylation and exhibits chemical stability and minimal cytotoxicity both in vitro and in vivo. In this study, we explore the effect and possible mechanism of action of zebularine on hepatocellular carcinoma cell line HepG2. We demonstrate that zebularine exhibits antitumor activity on HepG2 cells by inhibiting cell proliferation and inducing apoptosis, however, it has little effect on DNA methylation in HepG2 cells. On the other hand, zebularine treatment downregulated CDK2 and the phosphorylation of retinoblastoma protein (Rb), and upregulated p21(WAF/CIP1) and p53. We also found that zebularine treatment upregulated the phosphorylation of p44/42 mitogen-activated protein kinase (MAPK). These results suggest that the p44/42 MAPK pathway plays a role in zebularine-induced cell-cycle arrest by regulating the activity of p21(WAF/CIP1) and Rb. Furthermore, although the proapoptotic protein Bax levels were not affected, the antiapoptotic protein Bcl-2 level was downregulated with zebularine treatment. In addition, the data in the present study indicate that inhibition of the double-stranded RNA-dependent protein kinase (PKR) is involved in inducing apoptosis with zebularine. These results suggest a novel mechanism of zebularine-induced cell growth arrest and apoptosis via a DNA methylation-independent pathway in hepatocellular carcinoma.	[Nakamura, Kazuaki; Aizawa, Kazuko; Kato, Natsuko; Yamauchi, Junji; Tanoue, Akito] Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Tokyo, Japan; [Nakabayashi, Kazuhiko; Hata, Kenichiro] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan	Nakamura, K (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Tokyo, Japan.	nakamura-kz@ncchd.go.jp		Nakayama, Karina/0000-0001-5426-7446	Takeda Science Foundation (Osaka, Japan); Grant of National Center for Child Health and Development (Tokyo, Japan) [22A-6]	Takeda Science Foundation (Osaka, Japan)(Takeda Science Foundation (TSF)); Grant of National Center for Child Health and Development (Tokyo, Japan)	This work was supported in part by research grants from the Takeda Science Foundation (Osaka, Japan, http://www.takeda-sci.or.jp/index.html), and The Grant of National Center for Child Health and Development (22A-6) (Tokyo, Japan, http://www.ncchd.go.jp/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Amara K, 2010, CANCER SCI, V101, P1722, DOI 10.1111/j.1349-7006.2010.01569.x; Andersen JB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001338; Ben-Kasus T, 2005, BIOCHEM PHARMACOL, V70, P121, DOI 10.1016/j.bcp.2005.04.010; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Billam M, 2010, BREAST CANCER RES TR, V120, P581, DOI 10.1007/s10549-009-0420-3; Calvisi DF, 2007, J CLIN INVEST, V117, P2713, DOI 10.1172/JCI31457; Cheng JC, 2003, J NATL CANCER I, V95, P399, DOI 10.1093/jnci/95.5.399; Cheng JC, 2004, MOL CELL BIOL, V24, P1270, DOI 10.1128/MCB.24.3.1270-1278.2004; Cheng JC, 2004, CANCER CELL, V6, P151, DOI 10.1016/j.ccr.2004.06.023; Dai XY, 2012, CELL PHYSIOL BIOCHEM, V29, P281, DOI 10.1159/000337609; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Dote H, 2005, CLIN CANCER RES, V11, P4571, DOI 10.1158/1078-0432.CCR-05-0050; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fandy TE, 2009, CURR MED CHEM, V16, P2075, DOI 10.2174/092986709788612738; Feinberg AP, 2004, SEMIN CANCER BIOL, V14, P427, DOI 10.1016/j.semcancer.2004.06.005; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Gan LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016916; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gravina GL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-305; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Hubina E, 2006, EUR J ENDOCRINOL, V155, P371, DOI 10.1530/eje.1.02213; Hurd PJ, 1999, J MOL BIOL, V286, P389, DOI 10.1006/jmbi.1998.2491; Issa JPJ, 2009, CLIN CANCER RES, V15, P3938, DOI 10.1158/1078-0432.CCR-08-2783; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; Kouroumalis E, 1998, GUT, V42, P442, DOI 10.1136/gut.42.3.442; LEIST M, 1994, J IMMUNOL, V153, P1778; Liedtke C, 2002, HEPATOLOGY, V36, P315, DOI 10.1053/jhep.2002.34615; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Marques CJ, 2011, EPIGENETICS-US, V6, P1354, DOI 10.4161/epi.6.11.17993; MICHIELI P, 1994, CANCER RES, V54, P3391; Motomura W, 2005, BIOCHEM BIOPH RES CO, V332, P89, DOI 10.1016/j.bbrc.2005.04.095; Neureiter D, 2007, SCAND J GASTROENTERO, V42, P103, DOI 10.1080/00365520600874198; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; ORRENIUS S, 1989, TRENDS PHARMACOL SCI, V10, P281, DOI 10.1016/0165-6147(89)90029-1; PINTO A, 1993, LEUKEMIA, V7, P51; PROUD CG, 1995, TRENDS BIOCHEM SCI, V20, P241, DOI 10.1016/S0968-0004(00)89025-8; Qu Y, 2010, AM J CLIN PATHOL, V134, P826, DOI 10.1309/AJCPHGQ69FXDFWII; RUSSO T, 1995, J BIOL CHEM, V270, P29386, DOI 10.1074/jbc.270.49.29386; Samali A, 1999, BIOCHEM BIOPH RES CO, V255, P6, DOI 10.1006/bbrc.1998.0139; Samonakis DN, 2002, ONCOL REP, V9, P903; Schwartsmann G, 2000, INVEST NEW DRUG, V18, P83, DOI 10.1023/A:1006388031954; Serfas MS, 1997, CELL GROWTH DIFFER, V8, P951; Shen GX, 2006, CANCER CHEMOTH PHARM, V57, P317, DOI 10.1007/s00280-005-0050-3; Taya Y, 1997, TRENDS BIOCHEM SCI, V22, P14, DOI 10.1016/S0968-0004(96)10070-0; Taylor SS, 2005, CELL, V122, P823, DOI 10.1016/j.cell.2005.09.007; Thomas MB, 2005, J CLIN ONCOL, V23, P2892, DOI 10.1200/JCO.2005.03.196; Tsagarakis NJ, 2011, WORLD J GASTROENTERO, V17, P313, DOI 10.3748/wjg.v17.i3.313; Tsukada Y, 2004, J BIOCHEM, V136, P701, DOI 10.1093/jb/mvh177; Tu YG, 2007, J BIOL CHEM, V282, P11722, DOI 10.1074/jbc.M609623200; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013; Weisenberger DJ, 2004, MOL CANCER RES, V2, P62; Yang XR, 2009, CELL RES, V19, P469, DOI 10.1038/cr.2009.25; Yoo CB, 2004, BIOCHEM SOC T, V32, P910, DOI 10.1042/BST0320910; You BR, 2012, MOL BIOL REP, V39, P9723, DOI 10.1007/s11033-012-1837-z	59	113	118	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e54036	10.1371/journal.pone.0054036	http://dx.doi.org/10.1371/journal.pone.0054036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	24086366	Green Submitted, Green Published, gold			2022-12-27	WOS:000313429800086
J	Li, X; Xu, F; Xie, L; Ji, YJ; Cheng, K; Zhou, QM; Wang, T; Shively, C; Wu, QY; Gong, W; Fang, L; Zhan, QL; Melgiri, ND; Xie, P				Li, Xin; Xu, Fan; Xie, Liang; Ji, Yongjia; Cheng, Ke; Zhou, Qinmin; Wang, Tao; Shively, Carol; Wu, Qingyuan; Gong, Wei; Fang, Liang; Zhan, Qunlin; Melgiri, N. D.; Xie, Peng			Depression-Like Behavioral Phenotypes by Social and Social Plus Visual Isolation in the Adult Female Macaca fascicularis	PLOS ONE			English	Article							ANIMAL-MODELS; BODY-IMAGE; MACAQUES; THERMOREGULATION; ACTIVATION; ATTACHMENT; DISORDER; BRAIN; US	Major depressive disorder (MDD) is a debilitating psychiatric mood disorder that affects millions of individuals globally. Our understanding of the biological basis of MDD is poor, and current treatments are ineffective in a significant proportion of cases. This current situation may relate to the dominant rodent animal models of depression, which possess translational limitations due to limited homologies with humans. Therefore, a more homologous primate model of depression is needed to advance investigation into the pathophysiological mechanisms underlying depression and to conduct pre-clinical therapeutic trials. Here, we report two convenient methods - social isolation and social plus visual isolation - which can be applied to construct a non-human primate model of depression in the adult female cynomolgus monkey (Macaca fascicularis). Both social and social plus visual isolation were shown to be effective in inducing depression-like behavior by significantly reducing socially dominant aggressive conflict behavior, communicative behavior, sexual behavior, and parental behavior. The addition of visual isolation produced more profound behavioral changes than social isolation alone by further reducing parental behavior and sexual behavior. Thus, the degree of behavioral pathology may be manipulated by the degree of isolation. These methods can be applied to construct a non-human primate model of depression in order to assess physiological, behavioral, and social phenomena in a controlled laboratory setting.	[Li, Xin; Xu, Fan; Xie, Liang; Ji, Yongjia; Cheng, Ke; Zhou, Qinmin; Wang, Tao; Wu, Qingyuan; Gong, Wei; Fang, Liang; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Li, Xin; Xu, Fan; Xie, Liang; Ji, Yongjia; Cheng, Ke; Zhou, Qinmin; Wang, Tao; Wu, Qingyuan; Gong, Wei; Fang, Liang; Melgiri, N. D.; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Li, Xin; Xu, Fan; Xie, Liang; Ji, Yongjia; Cheng, Ke; Zhou, Qinmin; Wang, Tao; Wu, Qingyuan; Gong, Wei; Fang, Liang; Melgiri, N. D.; Xie, Peng] Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Zhan, Qunlin] Fifth Peoples Hosp, Dept Neurol, Chongqing, Peoples R China; [Shively, Carol] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC USA	Chongqing Medical University; Chongqing Medical University; Wake Forest University	Xie, P (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn	Cheng, Ke/HCH-8846-2022; Shively, Carol/L-2921-2019	Wong, Frank Y./0000-0001-5835-9938	National Basic Research Program of China (973 Program) [2009CB918300]; National Natural Science Foundation of China [31271189]; Chongqing Postdoctoral Science Foundation [XM20120010]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Postdoctoral Science Foundation	This work was supported by the National Basic Research Program of China (973 Program) (Grant NO. 2009CB918300), the National Natural Science Foundation of China (Grant NO. 31271189), the Chongqing Postdoctoral Science Foundation (Grant No. XM20120010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bifulco A, 2004, BRIT J PSYCHIAT, V184, pS31, DOI 10.1192/bjp.184.46.s31; BROTHERS L, 1990, MOTIV EMOTION, V14, P81, DOI 10.1007/BF00991637; Cacioppo JT, 2003, PERSPECT BIOL MED, V46, pS39, DOI 10.1353/pbm.2003.0049; Canales JZ, 2010, REV BRAS PSIQUIATR, V32, P375, DOI 10.1590/S1516-44462010000400010; CLARKE AS, 1988, INT J PRIMATOL, V9, P347, DOI 10.1007/BF02737382; Clarke AS, 2005, AM J PRIMATOL, V14, P37; Ehlers CL, 1989, ANIMAL MODELS DEPRES; Ellgring H, 1989, NONVERBAL COMMUNICAT, P168; Fava M, 1997, J NERV MENT DIS, V185, P140, DOI 10.1097/00005053-199703000-00002; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Gelenberg AJ, 2010, J CLIN PSYCHIAT, V71, P6; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; GOTTMAN JM, 1977, CHILD DEV, V48, P513, DOI 10.1111/j.1467-8624.1977.tb01191.x; Grippo AJ, 2007, PSYCHOSOM MED, V69, P149, DOI 10.1097/PSY.0b013e31802f054b; Hanya G, 2007, AM J PRIMATOL, V69, P802, DOI 10.1002/ajp.20397; HARLOW HF, 1974, BEHAV BIOL, V12, P273, DOI 10.1016/S0091-6773(74)91475-8; Hayward BA, 2007, INT J MENT HEALTH NU, V16, P15, DOI 10.1111/j.1447-0349.2006.00439.x; Helms CM, 2012, PSYCHOPHARMACOLOGY, V224, P133, DOI 10.1007/s00213-012-2707-z; Kennedy SH, 2009, J CLIN PSYCHOPHARM, V29, P157, DOI 10.1097/JCP.0b013e31819c76e9; Kim JW, 1996, BIOL PSYCHIAT, V40, P918, DOI 10.1016/0006-3223(95)00546-3; Liu RT, 2010, CLIN PSYCHOL REV, V30, P582, DOI 10.1016/j.cpr.2010.04.010; Maestripieri D, 1997, EVOL COMMUN, V1, P193, DOI [10.1075/eoc.1.2.03mae, DOI 10.1075/E0C.1.2.03MAE]; Maestripieri D., 2005, GESTURE, V5, P57, DOI [DOI 10.1075/GEST.5.1.06MAE, 10.1075/gest.5.1.06mae]; Maestripieri D, 2009, PHYSIOL BEHAV, V96, P613, DOI 10.1016/j.physbeh.2008.12.016; Malkesman O, 2006, BEHAV BRAIN RES, V175, P408, DOI 10.1016/j.bbr.2006.09.017; Masayuki Nakamichi FC, 1990, PRIMATES, V31, P213; MAXIM PE, 1972, BRAIN RES, V42, P243, DOI 10.1016/0006-8993(72)90529-X; Michopoulos V, 2012, PSYCHONEUROENDOCRINO, V37, P1071, DOI 10.1016/j.psyneuen.2011.12.004; Nakamichi M, 2003, INT J PRIMATOL, V24, P607, DOI 10.1023/A:1023744515134; Noldus LPJJ, 2000, BEHAV RES METH INS C, V32, P197, DOI 10.3758/BF03200802; NOLES SW, 1985, J CONSULT CLIN PSYCH, V53, P88, DOI 10.1037/0022-006X.53.1.88; Palanza P, 2001, NEUROSCI BIOBEHAV R, V25, P219, DOI 10.1016/S0149-7634(01)00010-0; Perera TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017600; PETIT O, 1994, ANIM BEHAV, V48, P1427, DOI 10.1006/anbe.1994.1378; Rahaman H., 1968, Primates, V9, P259, DOI 10.1007/BF01730973; Reding K, 2012, HORM BEHAV, V62, P612, DOI 10.1016/j.yhbeh.2012.09.010; RUBIN KH, 1989, J PERS, V57, P237, DOI 10.1111/j.1467-6494.1989.tb00482.x; Rubin KH, 1998, SOCIAL NONSOCIAL PLA; Scaccianoce S, 2006, BEHAV BRAIN RES, V168, P323, DOI 10.1016/j.bbr.2005.04.024; SCHINO G, 1990, PHYSIOL BEHAV, V47, P1125, DOI 10.1016/0031-9384(90)90362-8; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; Smolmsky AN, 2009, MOOD ANXIETY RELATED; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; SWARTZ KB, 1982, J HUM EVOL, V11, P237, DOI 10.1016/S0047-2484(82)80039-0; THIERRY B, 1986, INT J PRIMATOL, V7, P191, DOI 10.1007/BF02692318; Tse WS, 2002, PSYCHOPHARMACOLOGY, V161, P324, DOI 10.1007/s00213-002-1049-7; Vollmayr B, 2007, EUR ARCH PSY CLIN N, V257, P300, DOI 10.1007/s00406-007-0734-2; Watson SL, 1998, ATHEROSCLEROSIS, V137, P259, DOI 10.1016/S0021-9150(97)00277-3; Willard SL, 2012, AM J PRIMATOL, V74, P528, DOI 10.1002/ajp.21013; Xu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037486	50	43	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73293	10.1371/journal.pone.0073293	http://dx.doi.org/10.1371/journal.pone.0073293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24086565	Green Published, Green Submitted, gold			2022-12-27	WOS:000324515600094
